data_2n44_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2n44 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.778 0.323 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.7 mt -104.37 134.42 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -145.0 143.12 30.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -54.66 136.17 45.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.794 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.44 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 99.27 3.14 56.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.488 -173.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -166.34 149.83 7.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.797 0.332 . . . . 0.0 110.962 173.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.695 HD23 HD11 ' A' ' 33' ' ' ILE . 1.5 pt? -149.53 154.05 38.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.978 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.489 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 75.8 t -109.41 135.05 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.118 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.75 HG22 ' CG1' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -123.07 133.02 70.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.104 179.023 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.485 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 45.9 m0 -109.46 133.32 53.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.945 173.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.524 HD13 ' HB2' ' A' ' 20' ' ' LEU . 4.4 tt -109.99 149.79 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.136 -169.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -57.54 155.31 9.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.93 -14.47 16.94 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.531 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -76.46 -13.52 60.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.855 0.359 . . . . 0.0 110.843 -172.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 15' ' ' LYS . 26.1 mmmt -138.91 144.27 39.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 166.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.06 -84.11 1.01 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.452 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -112.99 -37.66 4.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.925 0.393 . . . . 0.0 110.895 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -66.33 -52.26 48.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.969 -144.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.7 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -62.92 -48.07 83.7 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.556 -176.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.677 HD22 HG13 ' A' ' 9' ' ' ILE . 10.9 tp -67.02 -35.87 80.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.947 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.74 84.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 173.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -65.07 -52.78 53.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.831 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.416 HG23 ' HA ' ' A' ' 20' ' ' LEU . 14.1 m -73.9 -35.58 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 -176.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.531 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -66.67 -44.39 89.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.519 176.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -64.95 -40.02 94.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -65.39 -38.88 91.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.424 ' CE2' HD12 ' A' ' 33' ' ' ILE . 73.6 t80 -66.14 -39.81 90.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.857 174.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -57.49 -39.98 77.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.2 -30.18 68.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -83.51 -38.96 21.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 -170.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.615 ' OG1' HG13 ' A' ' 33' ' ' ILE . 61.1 p -105.73 -12.93 15.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.41 5.91 89.09 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.519 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.836 HD13 ' O ' ' A' ' 33' ' ' ILE . 2.6 pp -99.29 133.96 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 0.0 111.159 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -70.47 129.25 38.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 -168.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.531 HG11 ' HA3' ' A' ' 24' ' ' GLY . 90.2 t -110.81 119.79 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.135 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.8 m -115.44 116.99 29.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.127 -173.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.46 HG23 ' HG ' ' A' ' 20' ' ' LEU . 79.0 t -98.77 139.29 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.485 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 73.9 mm-40 -121.25 161.83 21.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.888 176.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -84.78 141.04 37.98 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.612 0.72 . . . . 0.0 110.898 -171.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.43 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 85.6 Cg_exo -52.33 -30.72 43.96 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.724 2.282 . . . . 0.0 112.339 -177.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -49.34 -48.97 46.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.937 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.92 -19.31 48.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.875 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.618 ' C ' HD21 ' A' ' 43' ' ' LEU . 7.3 tt -52.4 -59.29 4.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.918 -171.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.06 -39.22 83.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.67 -42.7 57.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.845 -170.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -85.25 -29.27 24.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -171.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.553 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 91.2 t80 -47.72 -51.85 42.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.744 . . . . 0.0 110.885 -165.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 62.9 Cg_endo -69.04 -29.26 27.59 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 0.0 112.313 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -76.99 -43.4 35.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.6 m -72.29 -26.69 25.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.186 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.45 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . . . -65.65 -34.23 77.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 173.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.33 -29.64 70.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.077 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.2 p -92.38 -14.01 29.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.155 175.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.56 14.79 81.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.497 173.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -140.01 129.91 24.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.797 0.332 . . . . 0.0 110.916 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.85 -115.01 0.54 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.523 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.489 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 98.3 Cg_endo -72.84 151.41 51.1 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.658 2.239 . . . . 0.0 112.367 173.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.86 -35.49 15.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 168.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.75 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -138.51 150.03 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.054 177.073 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.587 HD12 HD22 ' A' ' 43' ' ' LEU . 4.1 tp -125.95 126.42 69.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.051 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.455 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 7.9 m-85 -108.07 123.35 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 177.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 16.7 t-105 -143.94 -172.81 3.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.3 -88.72 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.195 172.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -106.5 -54.64 2.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.82 -39.55 77.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 -159.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.58 -29.99 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 -174.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.819 ' O ' ' HD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -49.99 -52.95 29.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.934 -175.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.96 -41.33 97.4 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.495 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.97 -61.34 7.47 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.582 ' HD1' HD23 ' A' ' 76' ' ' LEU . 4.8 p90 -81.63 -25.52 35.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 110.929 -168.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.449 ' N ' ' CD1' ' A' ' 70' ' ' TYR . . . -70.22 -54.44 12.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.165 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -67.27 -34.14 76.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.845 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.6 m -84.77 -8.0 58.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 -173.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.39 31.75 63.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.481 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' A' ' 51' ' ' ALA . 2.5 mp -86.81 -4.63 59.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.929 0.395 . . . . 0.0 110.947 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.582 HD23 ' HD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -124.36 149.41 46.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.994 -175.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.01 140.53 37.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 169.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -71.63 135.35 46.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.909 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.872 HG13 ' HB3' ' A' ' 103' ' ' LEU . 42.5 pt -116.89 165.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 176.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 p -115.3 150.06 43.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.607 0.718 . . . . 0.0 111.122 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.32 144.99 47.3 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -103.14 119.96 39.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.61 -41.99 98.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.66 -46.46 82.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.16 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.455 ' HB3' ' HZ2' ' A' ' 94' ' ' TRP . 18.1 m-85 -73.55 -31.24 63.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.482 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.7 tt0 -53.5 -45.07 69.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.911 174.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -67.6 -33.9 75.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 175.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -77.84 -24.85 48.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.469 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 1.9 mp -104.98 -105.06 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 -174.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -169.26 128.1 0.9 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.637 0.732 . . . . 0.0 110.967 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -53.33 -36.51 78.85 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.586 2.19 . . . . 0.0 112.365 -171.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.62 -30.01 67.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.976 -173.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.4 p -76.66 -31.12 57.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.158 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.612 ' HA ' HG23 ' A' ' 97' ' ' VAL . 92.0 m95 -72.37 -27.51 62.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.932 171.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -72.78 -31.45 64.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 169.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . 0.429 ' CB ' HG21 ' A' ' 329' ' ' ILE . . . -65.03 -28.1 69.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.065 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.612 HG23 ' HA ' ' A' ' 94' ' ' TRP . 29.9 m -110.9 17.2 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.16 -171.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 72.3 ttt180 -112.46 138.06 49.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -143.05 125.24 15.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.4 t30 60.83 34.93 19.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.852 174.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.82 -6.44 74.29 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.499 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -122.53 145.31 48.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 0.0 110.915 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.872 ' HB3' HG13 ' A' ' 79' ' ' ILE . 3.6 tp -73.62 139.68 45.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -178.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.479 ' C ' HD13 ' A' ' 104' ' ' ILE . 2.5 pp -127.17 10.01 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 -173.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -173.26 169.63 4.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.093 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.491 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 89.4 m-85 -116.13 144.52 33.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.729 0.776 . . . . 0.0 110.88 166.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 15.0 Cg_exo -69.66 117.12 4.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.693 2.262 . . . . 0.0 112.316 172.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 29.7 mm -97.81 -47.01 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.14 154.98 38.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.108 -170.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.9 t -120.45 133.35 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 -178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -120.83 134.19 55.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.63 161.78 41.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.06 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.6 ' HG ' ' HA3' ' A' ' 228' ' ' GLY . 6.0 mp -112.58 159.07 19.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.899 -173.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.9 p -154.37 162.92 40.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.854 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -93.64 123.72 37.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.953 176.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.553 ' N ' HD23 ' A' ' 115' ' ' LEU . 47.0 mt -108.44 132.06 57.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 -174.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -135.09 151.4 50.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 -175.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -96.33 117.86 31.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -66.91 -17.51 64.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -73.09 -29.61 63.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.837 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 220' ' ' GLY . 7.2 mp -99.94 -49.62 4.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 18.0 mt -102.25 125.55 36.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.608 0.718 . . . . 0.0 110.899 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.36 -23.5 23.87 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.643 2.229 . . . . 0.0 112.331 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -153.07 130.0 5.69 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.637 0.732 . . . . 0.0 110.873 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.1 153.6 77.11 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.71 2.273 . . . . 0.0 112.363 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.34 144.83 41.97 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.717 2.278 . . . . 0.0 112.324 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -94.01 -28.74 15.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.929 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 79.8 p -130.13 156.11 45.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.443 ' HA ' HD11 ' A' ' 132' ' ' ILE . 26.9 t-105 -68.76 -24.47 64.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.9 -23.95 63.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.899 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.55 -23.2 53.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.59 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.5 mp -62.32 -51.87 70.57 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.685 0.755 . . . . 0.0 111.173 -170.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 39.7 Cg_endo -71.57 -39.09 3.84 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.66 2.24 . . . . 0.0 112.378 -171.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.37 -39.69 85.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.195 173.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.8 tp -60.89 -44.53 96.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.538 ' OD1' ' HB1' ' A' ' 146' ' ' ALA . 40.5 m-20 -49.72 -35.01 20.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.821 178.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.14 -34.55 68.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 -178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -74.61 -53.36 9.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -171.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.548 HD21 ' N ' ' A' ' 140' ' ' LYS . 0.9 OUTLIER -80.08 -10.96 59.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -175.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.548 ' N ' HD21 ' A' ' 139' ' ' LEU . 86.3 tttt -55.39 -31.22 61.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 168.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.74 -25.02 67.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.141 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -95.0 7.66 45.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.45 26.89 66.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.462 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.475 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 42.1 mmtm -116.83 162.7 17.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.839 0.352 . . . . 0.0 110.911 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.0 t -127.14 132.37 50.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.884 175.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.701 ' HA ' ' HB1' ' A' ' 223' ' ' ALA . . . -80.57 -38.3 29.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.084 -162.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -139.78 130.21 25.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.915 -174.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.786 ' SD ' ' HB3' ' A' ' 213' ' ' ALA . 56.8 ttm -117.04 130.15 56.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -177.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -151.04 157.2 42.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.8 -171.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -101.21 98.13 8.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.802 HD22 HD11 ' A' ' 195' ' ' LEU . 0.8 OUTLIER -69.24 -36.98 77.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -76.23 -3.77 38.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.891 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -99.87 148.92 35.45 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.624 0.726 . . . . 0.0 110.908 174.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.481 ' HD3' ' HD3' ' A' ' 344' ' ' ARG . 24.9 Cg_endo -63.0 -18.69 66.52 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.723 2.282 . . . . 0.0 112.379 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -64.33 -40.87 96.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.524 ' CD2' HD21 ' A' ' 151' ' ' LEU . 90.4 t80 -86.22 -37.8 18.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.875 -176.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 60.7 p -61.13 -36.95 81.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.226 -170.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.556 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 78.8 t90 -69.22 -53.65 13.12 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.504 0.669 . . . . 0.0 110.84 -174.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 44.0 Cg_endo -67.86 -17.17 46.82 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.647 2.231 . . . . 0.0 112.446 -176.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.844 HD13 ' O ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER -82.5 -48.49 10.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 172.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 68.0 mt -74.84 -40.03 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.97 65.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.136 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -63.34 -34.86 78.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.059 -168.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -91.87 2.6 56.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 120.08 3.41 11.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.503 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.54 60.6 4.8 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.488 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -79.84 134.45 36.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 110.969 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.42 5.29 18.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 -174.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -147.04 149.99 34.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.907 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 79.2 tttt -103.87 122.45 45.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 158.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -118.81 122.1 41.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.968 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -152.36 130.83 12.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 55.42 39.08 31.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.81 16.54 80.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.03 138.14 50.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 110.888 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -96.45 144.89 26.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -129.31 104.94 7.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.894 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.499 ' C ' HD13 ' A' ' 178' ' ' ILE . 1.4 pp -74.71 -11.21 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.204 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -97.56 -12.26 22.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 -174.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.54 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 51.4 t0 -124.3 62.54 1.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.11 174.9 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.167 -166.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -104.82 17.96 44.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.501 -164.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.41 HG22 HD13 ' A' ' 368' ' ' ILE . 2.5 m -100.2 -19.91 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 111.148 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -86.7 19.08 3.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -113.77 175.14 5.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.94 -25.28 67.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.89 -39.85 96.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.471 -172.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.669 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -68.77 -36.88 78.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 111.113 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.529 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 93.5 mttt -59.54 -33.25 71.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 174.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.0 69.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.152 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.19 -51.1 59.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.413 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.5 mt -64.51 -34.92 79.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.87 0.367 . . . . 0.0 110.916 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 94.9 m -56.81 -46.77 81.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.603 ' HD2' HD22 ' A' ' 160' ' ' LEU . 71.8 t80 -75.66 -44.89 40.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.802 HD11 HD22 ' A' ' 151' ' ' LEU . 7.7 tt -52.84 -44.41 66.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -171.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.405 ' HA ' HD12 ' A' ' 199' ' ' ILE . 34.9 m -70.45 -21.21 23.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.101 -177.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.649 ' HB3' HD13 ' A' ' 198' ' ' LEU . 38.8 t70 -56.96 -49.87 74.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 -166.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.764 HD13 ' N ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -87.09 -30.47 21.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 -170.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.534 ' H ' HD23 ' A' ' 198' ' ' LEU . 2.3 pp -78.33 -34.28 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.01 -27.6 68.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 168.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -83.94 4.68 28.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 174.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 65.11 39.31 5.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.901 172.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -77.43 -8.63 58.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 27.9 ptm -144.17 159.59 42.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.871 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -98.78 159.27 15.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.36 -26.3 68.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.049 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -93.76 -2.13 54.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.3 m -64.26 135.0 55.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -144.66 169.3 18.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -68.43 -34.59 76.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.854 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 91.6 p -67.47 -33.18 74.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.795 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 82.6 mt -63.48 -39.3 84.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.125 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.786 ' HB3' ' SD ' ' A' ' 148' ' ' MET . . . -62.43 -40.06 95.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 234' ' ' ASN . 92.9 mt-10 -63.1 -40.74 98.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -70.0 -38.95 76.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.089 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.45 -33.17 74.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.185 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -60.05 -30.69 69.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -62.01 -36.31 81.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.77 -19.01 19.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.546 ' O ' HD22 ' A' ' 121' ' ' LEU . . . 87.78 28.03 25.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.459 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -81.92 -28.61 32.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 0.0 110.901 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 93.1 m -119.24 131.36 55.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.701 ' HB1' ' HA ' ' A' ' 146' ' ' ALA . . . -75.82 -47.14 26.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.065 -174.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 61.0 mtm -134.97 158.95 43.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.853 -174.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 9.6 t -149.15 166.33 29.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 mm -109.46 124.23 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 172.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -155.33 171.8 19.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.835 -170.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.6 ' HA3' ' HG ' ' A' ' 113' ' ' LEU . . . -155.56 -115.71 0.53 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.504 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.3 -22.84 74.71 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.681 2.254 . . . . 0.0 112.317 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -78.26 -10.8 59.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.998 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.93 -16.57 61.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.092 -170.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 36.1 p-90 -54.94 -30.0 57.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.981 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.5 t -50.16 -56.34 11.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 214' ' ' GLU . 49.3 t30 -163.79 64.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 32.1 mm . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 167.918 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.898 0.38 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -112.8 82.09 1.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -117.99 148.59 42.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.82 162.17 25.52 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.552 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.801 HG11 ' O ' ' A' ' 315' ' ' PRO . 10.1 p -144.04 138.49 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.942 0.401 . . . . 0.0 111.169 -175.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.6 t -150.68 149.2 29.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.106 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 30.4 m -63.62 168.44 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.135 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.826 ' HB3' ' HB2' ' A' ' 255' ' ' SER . 3.9 mm? -63.27 137.01 96.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.569 0.7 . . . . 0.0 110.903 -162.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -72.04 -172.68 0.89 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.359 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 82.5 p -105.67 151.79 23.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.134 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.427 ' HD2' ' HB1' ' A' ' 163' ' ' ALA . 33.5 t80 -136.48 120.48 17.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 176.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 56.55 35.5 26.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.81 9.3 74.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.486 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -129.97 140.88 39.98 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.722 . . . . 0.0 110.877 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.2 142.17 33.57 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.672 2.248 . . . . 0.0 112.35 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.826 ' HB2' ' HB3' ' A' ' 247' ' ' LEU . 64.3 m -85.3 0.83 50.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.823 173.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -45.01 112.49 1.53 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.61 0.719 . . . . 0.0 110.935 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.11 162.0 32.03 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.724 2.282 . . . . 0.0 112.325 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -72.98 152.5 41.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 -172.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.13 134.99 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.112 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -112.48 135.19 12.51 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.44 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.3 t -125.88 128.4 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.884 0.373 . . . . 0.0 111.147 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.49 ' HB3' ' HB ' ' A' ' 108' ' ' ILE . 1.7 tt -69.99 130.13 41.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 77.3 p -122.23 135.92 54.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.825 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.472 ' HB2' HD11 ' A' ' 280' ' ' LEU . . . -124.8 127.53 47.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.12 -178.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.2 160.9 14.69 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.474 -170.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.428 ' HA ' HG22 ' A' ' 59' ' ' ILE . 20.6 mm -99.98 121.62 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.819 0.342 . . . . 0.0 111.129 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -66.68 129.5 40.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -175.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.429 ' HB3' ' C ' ' A' ' 76' ' ' LEU . . . -60.67 -27.72 68.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.083 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.83 -11.77 57.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.041 -173.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.8 t -75.48 121.25 84.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.719 . . . . 0.0 110.934 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -68.76 -10.42 29.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.658 2.239 . . . . 0.0 112.286 167.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -102.44 17.65 23.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.937 -171.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -48.78 -34.84 13.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.884 -172.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -70.37 -48.26 57.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 -170.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.0 pp -81.76 -30.38 32.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.51 -46.28 73.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.09 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -67.53 -34.47 77.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 89.2 tt0 -63.92 -52.28 60.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 -173.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.498 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.2 p90 -69.99 -34.18 73.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.473 HD22 HD12 ' A' ' 108' ' ' ILE . 4.3 tt -58.38 -50.99 71.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -80.11 -31.26 39.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 61.9 m-80 -101.4 -28.94 12.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.921 -165.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.564 ' O ' HG23 ' A' ' 286' ' ' THR . 85.4 t80 -110.25 -43.4 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 -169.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.2 mp -72.54 -47.07 51.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.414 HD11 ' HA ' ' A' ' 108' ' ' ILE . 1.2 mp -83.33 61.29 6.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 283' ' ' TYR . 14.5 t -153.1 155.72 37.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.16 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.508 ' HA ' HD11 ' A' ' 290' ' ' LEU . 39.1 p-10 -52.41 -27.25 15.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.857 -168.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -78.23 -46.02 21.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.92 -49.39 17.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.449 -168.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.605 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.4 OUTLIER -74.96 -21.56 59.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 0.0 110.908 -178.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.435 ' N ' HD12 ' A' ' 290' ' ' LEU . 83.1 tt0 -67.22 -40.91 86.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.95 170.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.31 76.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.129 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.7 HG13 ' HA3' ' A' ' 19' ' ' GLY . 19.7 t -80.22 -43.67 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.134 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.422 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 41.7 t30 -65.77 -28.78 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.926 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.55 -26.01 67.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -82.33 -45.21 15.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.838 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -153.51 135.52 9.09 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.583 0.706 . . . . 0.0 110.947 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -49.3 114.66 1.39 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.632 2.221 . . . . 0.0 112.414 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.422 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 40.1 mt -92.74 -19.04 22.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 -177.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 114.94 -60.48 0.39 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -176.4 168.43 2.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.815 0.34 . . . . 0.0 111.064 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 30.3 m -124.62 157.7 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.157 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.96 -17.28 61.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.605 ' CD2' HD22 ' A' ' 290' ' ' LEU . 58.4 tp -81.0 123.5 28.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.977 -174.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -61.44 -33.25 73.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.89 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.2 m -61.84 -47.67 84.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.815 -170.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.463 ' CD2' HD21 ' A' ' 311' ' ' LEU . 20.8 t80 -89.11 -28.66 19.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -57.78 -42.63 84.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.909 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.68 -34.96 79.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -73.02 -45.55 57.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.702 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.4 pp -73.43 -27.04 61.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.874 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.416 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.58 -11.23 57.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.34 -15.98 61.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -86.24 128.76 56.25 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.539 0.685 . . . . 0.0 110.882 169.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.801 ' O ' HG11 ' A' ' 244' ' ' VAL . 83.6 Cg_exo -52.6 -31.69 50.8 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.536 ' HG3' HG13 ' A' ' 317' ' ' ILE . 27.6 ptt-85 -66.3 -31.05 71.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -171.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.702 HG21 ' CD1' ' A' ' 311' ' ' LEU . 63.3 mt -95.12 -37.38 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 -176.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.53 -44.5 62.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 -168.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.97 -42.4 80.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.053 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 71.9 p -63.85 -28.22 69.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.408 ' HA ' ' HE3' ' A' ' 321' ' ' MET . 33.5 mmt -66.75 -31.91 72.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -66.06 -44.18 85.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 327' ' ' GLY . 40.9 t30 -64.46 -37.21 86.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 174.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.7 -45.05 95.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.1 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -73.78 -34.37 64.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.9 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -100.49 -0.0 38.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -96.57 -155.63 30.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.408 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.56 139.19 42.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 0.0 110.922 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.587 ' O ' ' C ' ' A' ' 330' ' ' MET . 42.6 mm -76.69 110.01 11.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.1 -173.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.587 ' C ' ' O ' ' A' ' 329' ' ' ILE . 99.3 mmm . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 170.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.765 0.317 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 87.4 mmm -72.81 -26.12 61.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.953 -172.061 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.0 m -60.88 -41.43 95.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.4 -36.44 71.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -65.22 -37.73 88.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -61.04 -37.84 84.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -75.91 -35.26 59.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.92 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.417 ' HB2' ' HB2' ' A' ' 367' ' ' ARG . . . -62.68 -41.27 99.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.134 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.6 m -79.86 -25.17 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.481 ' HD3' ' HD3' ' A' ' 154' ' ' PRO . 54.5 ttp85 -61.3 -45.31 94.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.821 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 84.6 m -57.23 -36.63 71.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.131 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.751 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -60.58 -43.93 96.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.116 -175.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 344' ' ' ARG . 2.0 m -73.75 -32.69 35.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.171 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.74 -46.21 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.196 173.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 89.5 m-20 -69.13 -34.97 75.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.47 -45.35 65.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.01 -41.18 87.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 89.3 p -77.19 -11.96 59.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.836 -175.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.31 14.06 82.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.576 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.75 -29.85 56.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.755 0.312 . . . . 0.0 110.85 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 86.9 mt-30 -135.63 157.26 47.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 175.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.4 p -77.64 169.77 17.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.197 168.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 69.5 t -55.55 -42.83 70.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 170.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -59.87 -45.28 92.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -71.25 -52.78 17.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.838 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.24 -45.04 74.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 -173.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.669 HD11 ' HB1' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -66.75 -39.95 88.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.907 -176.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.546 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 87.9 tttt -64.68 -39.62 93.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 177.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.82 -37.91 89.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.751 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -64.75 -45.83 84.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.074 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 1.2 pp0? -73.82 -30.09 62.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 56.8 m -64.04 -41.54 97.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . 0.417 ' HB2' ' HB2' ' A' ' 342' ' ' ALA . 99.6 mtt180 -66.08 -39.07 89.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.41 HD13 HG22 ' A' ' 183' ' ' VAL . 70.4 mt -65.4 -37.86 81.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.209 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.3 p -92.37 -10.12 39.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.158 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.874 176.07 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.8 0.333 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 98.9 mt -91.44 125.03 44.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.132 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.31 146.07 36.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.855 -176.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.47 136.83 43.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.775 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.27 4.79 58.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.484 -174.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -169.89 153.22 4.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.869 0.366 . . . . 0.0 110.899 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.549 ' H ' HD21 ' A' ' 7' ' ' LEU . 1.0 OUTLIER -151.68 157.0 41.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.51 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 89.8 t -110.65 135.63 49.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.749 HG22 ' CG1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -122.98 132.01 72.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.075 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.454 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 41.9 m0 -108.77 125.75 52.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.936 171.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.468 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 14.8 tt -106.3 150.02 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.094 -170.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -59.21 151.46 22.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.91 -15.73 21.69 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.511 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -75.06 -11.14 60.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.845 -172.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -147.84 137.75 22.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.943 160.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.15 -83.26 1.04 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.443 -167.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -110.52 -45.67 3.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.013 0.435 . . . . 0.0 110.942 -172.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -68.22 -51.93 39.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.944 -151.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.536 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -60.09 -48.05 88.0 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.582 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.696 ' CD2' HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -58.13 -45.61 87.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.369 . . . . 0.0 110.884 176.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.99 76.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -64.86 -48.25 74.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 -177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.0 m -74.38 -36.05 41.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.451 ' CA ' HG11 ' A' ' 35' ' ' VAL . . . -66.68 -48.34 62.55 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.576 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -65.45 -39.26 91.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.999 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -64.47 -41.58 96.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.467 ' CD2' HD12 ' A' ' 33' ' ' ILE . 63.1 t80 -65.42 -38.0 88.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.55 -41.76 99.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.89 -31.92 69.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.822 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -82.43 -40.48 21.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -171.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.641 ' OG1' HG13 ' A' ' 33' ' ' ILE . 60.8 p -102.61 -9.46 20.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.11 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.44 9.73 84.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.56 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 1.042 HD13 ' O ' ' A' ' 33' ' ' ILE . 2.0 pp -103.91 132.15 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.011 0.434 . . . . 0.0 111.07 -175.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -71.11 127.78 33.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.957 -168.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.489 HG23 HD22 ' A' ' 7' ' ' LEU . 99.2 t -110.67 122.06 64.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.086 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.474 ' HB ' HG23 ' A' ' 8' ' ' VAL . 99.7 m -111.57 117.94 34.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.146 -175.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.537 HG23 HD13 ' A' ' 20' ' ' LEU . 84.7 t -93.78 134.98 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.061 176.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.454 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 74.5 mm-40 -121.58 162.95 19.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.861 173.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.4 t-80 -84.9 139.73 37.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.615 0.722 . . . . 0.0 110.897 -167.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 70.9 Cg_exo -60.49 -16.85 44.71 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.754 2.303 . . . . 0.0 112.307 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -49.21 -56.37 9.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.936 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 73.1 mmtt -86.69 1.31 52.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -175.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.538 HD11 ' O ' ' A' ' 61' ' ' PHE . 9.4 tt -43.65 -53.34 5.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 -175.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -71.28 -43.8 66.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.21 -48.05 16.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.879 -161.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.467 ' HG2' HG13 ' A' ' 50' ' ' VAL . 84.3 tttt -84.58 -33.09 23.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -170.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.6 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 90.3 t80 -47.8 -53.54 30.61 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.69 0.757 . . . . 0.0 110.9 -172.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 31.5 Cg_endo -61.99 -29.31 81.62 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.612 2.208 . . . . 0.0 112.375 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -74.78 -43.47 54.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.467 HG13 ' HG2' ' A' ' 46' ' ' LYS . 35.7 m -74.97 -25.12 18.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.219 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.43 -33.9 74.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.13 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.18 -27.14 66.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.02 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.3 p -91.83 -13.6 31.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.164 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.26 14.27 82.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.478 170.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -145.89 137.29 24.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 0.0 110.876 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.454 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . 165.01 -131.2 2.34 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.466 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.51 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 54.1 Cg_endo -62.83 139.06 72.38 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.666 2.244 . . . . 0.0 112.372 171.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.461 ' HB2' HD11 ' A' ' 59' ' ' ILE . 2.6 m-20 -86.57 -35.03 19.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 171.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.749 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -132.51 148.12 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.134 177.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.7 tp -127.98 127.16 67.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.154 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.538 ' O ' HD11 ' A' ' 43' ' ' LEU . 9.1 m-85 -99.86 125.52 45.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.428 ' CG ' ' N ' ' A' ' 63' ' ' ALA . 41.6 t-105 -145.02 -175.81 4.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.928 169.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.428 ' N ' ' CG ' ' A' ' 62' ' ' TRP . . . -90.52 -87.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.136 173.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -126.23 -58.14 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.93 -44.4 96.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 -151.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -66.57 -28.52 68.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.836 -170.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -51.86 -42.9 62.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.868 -175.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.63 -49.66 74.26 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.531 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.84 -43.35 99.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.568 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -66.52 -46.97 74.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 110.874 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.91 -43.91 91.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.154 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.93 -34.96 79.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.016 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.5 m -84.91 -7.03 59.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.91 29.54 60.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.491 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.1 mp -84.13 -12.1 55.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.819 0.342 . . . . 0.0 110.837 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.615 HD11 HG22 ' A' ' 104' ' ' ILE . 4.4 pp -131.2 143.17 50.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.956 -177.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -79.65 144.94 33.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.45 134.2 48.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.864 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.821 HG13 ' HB3' ' A' ' 103' ' ' LEU . 36.4 pt -110.39 160.72 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.18 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.6 p -103.68 141.62 22.88 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.621 0.724 . . . . 0.0 111.065 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.79 145.19 31.99 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.728 2.285 . . . . 0.0 112.386 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -111.53 119.52 39.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.66 -41.63 98.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.897 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.45 89.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -73.43 -33.75 65.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.504 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.3 tt0 -53.6 -49.0 68.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.901 174.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -60.6 -34.98 75.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.01 -22.9 52.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.822 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -103.22 -109.43 0.25 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.813 -173.316 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -169.9 133.13 1.1 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.599 0.714 . . . . 0.0 110.992 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.8 -40.12 81.38 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.685 2.257 . . . . 0.0 112.303 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -69.13 -29.95 68.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -171.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 107' ' ' PRO . 54.3 p -73.38 -31.36 63.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.112 -174.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.611 ' HA ' HG23 ' A' ' 97' ' ' VAL . 81.0 m95 -71.89 -25.47 61.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.042 174.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.53 -38.33 71.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.779 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.33 -26.98 63.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.611 HG23 ' HA ' ' A' ' 94' ' ' TRP . 19.7 m -100.01 15.44 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.132 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 34.8 ttp-105 -110.2 141.85 42.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.788 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -138.83 122.76 17.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.864 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 59.82 34.94 21.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.945 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.24 -2.64 84.08 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.451 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.56 144.52 48.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 0.0 110.912 174.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.821 ' HB3' HG13 ' A' ' 79' ' ' ILE . 4.9 tp -79.5 138.51 37.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.803 -173.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.615 HG22 HD11 ' A' ' 76' ' ' LEU . 2.5 pp -126.93 1.53 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 -171.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -167.14 168.41 13.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.457 ' CZ ' HD13 ' A' ' 79' ' ' ILE . 93.6 m-85 -114.52 139.91 24.56 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.676 0.751 . . . . 0.0 110.962 170.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HB3' ' HB ' ' A' ' 93' ' ' THR . 74.1 Cg_endo -73.74 120.16 6.28 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.75 2.3 . . . . 0.0 112.368 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.6 mm -100.13 -56.13 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -142.16 154.87 45.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.162 -166.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.0 t -120.7 136.85 56.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.111 -169.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -126.34 131.1 51.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.433 ' HB1' ' HB ' ' A' ' 320' ' ' THR . . . -148.8 157.91 43.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.122 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.528 ' CD2' ' HA3' ' A' ' 228' ' ' GLY . 72.5 mt -102.02 168.76 9.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.89 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.8 p -155.93 158.15 37.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.938 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -96.26 127.74 42.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.889 172.594 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.562 ' N ' HD23 ' A' ' 115' ' ' LEU . 4.9 mp -110.95 133.05 57.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.066 -175.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -132.57 149.98 52.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.913 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -88.05 111.77 21.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.854 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.416 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 88.6 tttt -62.69 -22.9 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -76.54 -22.5 54.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.866 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.469 HD22 ' O ' ' A' ' 220' ' ' GLY . 7.0 mp -97.46 -49.23 4.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.823 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 223' ' ' ALA . 22.8 mt -107.17 132.49 20.89 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 110.898 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.04 -20.68 28.57 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.632 2.221 . . . . 0.0 112.384 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.587 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 20.3 p30 -154.26 161.72 28.63 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.685 0.755 . . . . 0.0 110.805 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.587 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 58.8 Cg_endo -70.23 158.5 56.16 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 0.0 112.388 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.48 148.33 66.65 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.679 2.253 . . . . 0.0 112.306 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -103.54 -44.99 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.8 p -133.24 157.88 44.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.14 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.414 ' HA ' HD11 ' A' ' 132' ' ' ILE . 75.9 m95 -70.02 -24.89 63.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 177.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.92 -19.81 66.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -73.99 -30.13 62.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.492 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 1.4 mp -63.34 -47.76 83.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.63 0.728 . . . . 0.0 111.138 -167.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.492 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 85.3 Cg_exo -53.93 -51.62 10.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.569 2.179 . . . . 0.0 112.293 -176.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.6 -40.45 73.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.6 tp -54.55 -43.46 72.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.904 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.43 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . 1.8 m-20 -50.09 -44.29 51.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.816 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.77 -33.48 75.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 -176.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.8 -46.93 27.95 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 -173.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.43 ' CD2' ' HA ' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -90.53 -19.95 23.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.872 -173.026 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 85.8 tttt -61.81 -26.39 68.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.901 170.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.89 -24.94 67.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.111 171.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -95.37 8.88 41.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.81 28.08 65.68 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.501 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 89.3 mttt -117.26 170.03 9.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 110.908 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.4 t -131.53 142.23 49.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.803 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.443 ' HA ' ' HB1' ' A' ' 223' ' ' ALA . . . -73.14 -51.3 18.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.049 -170.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -139.24 130.78 27.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.91 -169.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 94.9 mtp -117.9 129.76 55.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.853 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -153.47 162.94 40.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.884 -169.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -95.81 104.37 16.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.027 169.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.765 HD22 HD11 ' A' ' 195' ' ' LEU . 0.7 OUTLIER -75.05 -35.96 61.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 177.271 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . 0.5 ' HA ' HD12 ' A' ' 348' ' ' ILE . 88.2 mt-30 -78.69 0.13 27.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.826 -175.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -106.82 150.44 39.72 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.635 0.731 . . . . 0.0 110.962 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.11 -20.31 69.39 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.691 2.26 . . . . 0.0 112.321 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -59.86 -44.07 94.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.011 -172.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -84.89 -39.99 17.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.863 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.0 p -64.02 -37.88 89.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.198 -169.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.574 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 19.9 t-105 -64.36 -55.47 30.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.583 0.706 . . . . 0.0 110.872 -173.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 23.6 Cg_endo -65.96 -30.74 48.03 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.616 2.211 . . . . 0.0 112.513 -171.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.7 HD21 ' O ' ' A' ' 160' ' ' LEU . 6.4 tt -72.89 -41.77 64.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.978 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 69.1 mt -73.81 -39.75 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.026 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.37 -33.17 67.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.17 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.494 ' HB1' ' HD2' ' A' ' 250' ' ' PHE . . . -61.7 -36.41 80.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.99 -168.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -89.12 1.03 56.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 121.84 1.22 10.73 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.49 169.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.36 64.99 3.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.446 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -86.71 132.88 33.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.868 0.366 . . . . 0.0 110.926 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.35 10.2 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.462 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.1 p90 -147.27 153.88 40.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -105.87 126.61 52.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 158.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -116.27 126.72 53.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.931 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -151.78 129.78 11.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.885 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.5 t30 55.07 44.55 27.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.04 14.0 82.19 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.484 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -129.92 139.62 51.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 110.887 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -99.98 145.96 27.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 170.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -121.26 110.1 15.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.839 171.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.517 ' C ' HD13 ' A' ' 178' ' ' ILE . 1.3 pp -80.0 -11.92 12.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.189 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.77 -12.71 19.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -123.33 88.17 2.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 169.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 169' ' ' PHE . 33.5 m -116.58 170.96 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.177 -168.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.04 26.11 23.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.484 -168.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.529 HG22 HD13 ' A' ' 368' ' ' ILE . 12.6 m -109.9 -13.66 10.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.81 0.338 . . . . 0.0 111.145 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -85.07 20.04 2.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -112.81 -176.8 2.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.878 -175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.51 -25.09 63.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.425 ' O ' ' HB1' ' A' ' 190' ' ' ALA . . . -72.01 -42.43 51.94 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.492 -169.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.64 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -63.26 -36.75 84.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.353 . . . . 0.0 111.038 176.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.523 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.2 mttt -59.97 -34.09 72.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 173.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 187' ' ' GLY . . . -65.15 -31.85 73.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.091 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.64 -45.48 95.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.439 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.433 HD21 ' HA ' ' A' ' 192' ' ' LEU . 21.7 mt -64.98 -38.34 90.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.857 0.36 . . . . 0.0 110.902 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.9 m -57.56 -46.32 84.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.275 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -73.49 -47.75 38.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.765 HD11 HD22 ' A' ' 151' ' ' LEU . 6.8 tt -53.72 -47.14 70.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 -170.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 30.3 m -67.96 -18.82 24.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 -176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -59.99 -58.08 10.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -171.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 1.044 ' H ' HD13 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.67 -23.73 56.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.908 -166.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.602 ' H ' HD23 ' A' ' 198' ' ' LEU . 2.0 pp -83.77 -36.41 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 174.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.36 -32.6 73.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 168.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -82.25 4.1 24.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 65.06 39.79 5.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 168.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -85.88 -14.94 43.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.784 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -146.64 161.85 39.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.926 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -99.88 150.5 22.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.849 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.59 -25.83 68.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.5 p-10 -93.78 5.34 51.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 59.7 m -62.55 129.99 43.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.086 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -137.45 169.83 17.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.957 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -63.91 -42.68 97.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.3 m -64.77 -39.45 93.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.11 -40.03 86.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.154 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.81 -37.34 87.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.086 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 234' ' ' ASN . 94.1 mt-10 -63.17 -40.47 97.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.925 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.91 94.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 175.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.92 -38.25 90.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -61.58 -42.04 98.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -57.94 -32.31 67.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.799 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -89.39 -23.8 22.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.469 ' O ' HD22 ' A' ' 121' ' ' LEU . . . 90.51 25.78 24.81 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.504 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.59 -23.98 21.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.922 0.391 . . . . 0.0 110.877 -173.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 99.8 m -119.11 128.76 54.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 -176.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.521 ' HB2' HD11 ' A' ' 122' ' ' LEU . . . -65.58 -52.07 54.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.052 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.472 ' HB3' HD22 ' A' ' 115' ' ' LEU . 71.2 mtm -135.65 156.26 49.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.859 -169.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.3 t -150.82 161.56 42.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 44.6 mm -110.05 124.25 66.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.158 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.408 ' OD1' ' HB2' ' A' ' 230' ' ' TRP . 7.7 t-20 -154.34 170.63 20.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.804 -166.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.528 ' HA3' ' CD2' ' A' ' 113' ' ' LEU . . . -157.16 -113.69 0.41 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.522 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.419 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 40.4 Cg_endo -61.29 -22.34 74.32 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.618 2.212 . . . . 0.0 112.366 173.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.408 ' HB2' ' OD1' ' A' ' 227' ' ' ASN . 6.7 m-90 -78.89 -16.51 56.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.05 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.29 -23.7 67.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.057 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -60.04 -23.13 63.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.928 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 42.9 t -57.65 -59.64 4.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 214' ' ' GLU . 66.1 t30 -152.03 45.56 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -173.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.0 mm . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.164 168.646 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.909 0.385 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -100.0 70.0 1.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.416 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 87.0 m-85 -130.91 146.67 52.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.019 174.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -130.95 155.66 21.36 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 316' ' ' ARG . 3.3 p -134.79 134.88 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.961 0.41 . . . . 0.0 111.167 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.9 t -154.41 149.76 27.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.071 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 27.9 m -59.93 162.03 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.116 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 247' ' ' LEU . 5.5 mp -70.48 150.11 95.63 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.577 0.703 . . . . 0.0 110.906 -159.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.48 -179.24 2.66 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.706 2.271 . . . . 0.0 112.347 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 52.1 p -101.02 161.19 13.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.131 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.494 ' HD2' ' HB1' ' A' ' 163' ' ' ALA . 55.0 t80 -138.6 119.56 14.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 55.53 33.69 21.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.97 -169.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.15 9.77 72.77 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.529 171.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 86.1 mm-40 -132.66 129.46 21.33 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.651 0.738 . . . . 0.0 110.879 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 60.2 Cg_exo -59.59 144.8 99.34 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.577 2.185 . . . . 0.0 112.327 -175.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 65.2 p -88.65 16.69 6.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.809 171.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -43.05 112.34 1.17 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.634 0.731 . . . . 0.0 110.903 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.18 160.38 32.98 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.754 2.302 . . . . 0.0 112.326 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -72.51 161.55 30.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.801 -171.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 56.2 t -109.06 136.17 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.057 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -113.43 131.09 9.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.511 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.9 t -121.13 119.11 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 111.166 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.416 HD22 ' HB3' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -67.91 117.94 10.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 175.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 19.4 m -130.6 151.29 51.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 -170.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.06 129.79 44.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.15 -171.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -118.07 168.45 13.09 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.45 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.569 HD11 HG22 ' A' ' 59' ' ' ILE . 23.9 mm -99.68 126.84 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.0 111.183 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -68.36 129.3 39.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.853 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.447 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -66.2 -24.21 66.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.096 -176.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.91 -11.08 58.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.041 -171.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.6 t -75.97 120.28 80.98 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.642 0.734 . . . . 0.0 110.898 -176.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -69.0 -11.78 32.7 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.294 168.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -111.76 36.1 3.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.878 -171.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.85 -25.07 66.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 -167.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -71.32 -38.51 71.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 7' ' ' LEU . 37.8 tp -63.13 -48.65 77.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 173.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.634 ' HB2' HG23 ' A' ' 59' ' ' ILE . . . -69.05 -48.8 61.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.093 -173.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -63.82 -41.58 97.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -66.27 -54.57 23.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 -173.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -68.31 -34.0 75.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 -173.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.588 HD21 ' O ' ' A' ' 280' ' ' LEU . 4.8 tt -56.0 -45.54 79.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.875 176.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -72.93 -42.68 63.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -102.35 -9.3 20.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.889 -159.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 67.9 t80 -123.33 -48.65 1.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 284' ' ' LEU . 0.0 OUTLIER -68.56 -46.59 69.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.495 ' HA ' HD13 ' A' ' 285' ' ' LEU . 0.8 OUTLIER -82.92 63.24 6.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 174.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.498 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 30.1 p -143.51 150.18 38.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.172 170.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.576 ' HA ' HD11 ' A' ' 290' ' ' LEU . 41.4 p-10 -53.19 -25.24 13.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -79.5 -44.08 21.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.49 -50.57 25.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.432 -170.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.576 HD11 ' HA ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -73.97 -21.27 60.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.438 ' N ' HD12 ' A' ' 290' ' ' LEU . 82.8 tt0 -66.07 -42.31 89.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 169.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.32 -34.77 75.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.536 HG13 ' HA3' ' A' ' 19' ' ' GLY . 21.6 t -76.83 -41.91 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.173 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.508 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 52.6 t30 -64.96 -25.42 67.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.981 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -66.83 -30.95 71.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.9 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -88.79 -40.87 12.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -141.97 130.05 11.79 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.514 0.673 . . . . 0.0 110.911 172.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.09 111.59 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.642 2.228 . . . . 0.0 112.376 174.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.508 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 43.0 mt -93.32 -13.1 28.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.016 -171.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.44 -53.71 1.0 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.433 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -173.77 166.15 4.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.795 0.331 . . . . 0.0 111.02 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 31.3 m -123.76 156.49 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.166 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 89' ' ' LEU . . . -69.96 -17.16 63.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.018 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.457 ' HA ' HD12 ' A' ' 89' ' ' LEU . 57.6 tp -85.87 120.69 27.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.049 -171.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.2 -40.02 70.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.926 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.8 m -64.55 -50.33 67.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -167.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.495 ' HB3' HG22 ' A' ' 302' ' ' VAL . 38.2 t80 -81.13 -26.73 35.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.11 -42.28 94.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.4 -34.46 76.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.831 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -70.62 -48.53 54.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.669 HD13 HD11 ' A' ' 317' ' ' ILE . 4.6 pp -66.72 -28.81 68.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.856 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.467 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.95 -11.12 58.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.053 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.94 -15.57 62.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -79.78 128.66 73.61 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.633 0.73 . . . . 0.0 110.805 170.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -49.21 -38.37 41.17 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.678 2.252 . . . . 0.0 112.305 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.498 ' HA ' HG11 ' A' ' 244' ' ' VAL . 8.5 ptp85 -71.26 -24.83 62.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.918 -169.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.669 HD11 HD13 ' A' ' 311' ' ' LEU . 78.9 mt -92.26 -32.45 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.09 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.91 -34.95 63.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.059 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.497 ' CB ' HG23 ' A' ' 244' ' ' VAL . . . -65.01 -45.58 84.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.058 174.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.433 ' HB ' ' HB1' ' A' ' 112' ' ' ALA . 68.7 p -69.01 -24.38 64.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.162 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 87.6 mmm -58.84 -36.39 74.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -69.47 -46.92 65.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 327' ' ' GLY . 34.7 t30 -66.04 -36.01 82.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.995 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.28 84.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -72.62 -35.07 67.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -94.97 -1.83 51.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -100.01 -161.62 28.61 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.458 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -140.8 141.5 34.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 110.812 -176.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.605 ' O ' ' C ' ' A' ' 330' ' ' MET . 18.8 mm -81.74 100.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.094 -169.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.605 ' C ' ' O ' ' A' ' 329' ' ' ILE . 95.3 mtp . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.55 0.691 . . . . 0.0 110.88 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.751 0.31 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 79.4 mmm -72.38 -24.0 61.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.8 m -63.59 -39.2 93.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -77.35 -35.4 54.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.136 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -62.66 -39.24 93.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.855 174.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -58.38 -36.28 73.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.809 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -75.9 -37.1 59.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.933 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.05 94.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.135 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.2 m -80.2 -25.46 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.177 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.497 ' O ' HG23 ' A' ' 347' ' ' VAL . 7.3 tmm_? -64.39 -43.33 94.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 173.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.5 m -58.67 -34.62 71.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.166 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.608 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -58.93 -42.22 89.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 -177.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 344' ' ' ARG . 1.3 m -74.08 -32.85 33.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -174.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 152' ' ' GLN . 1.6 mp -62.01 -48.74 87.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.184 173.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 86.5 m-20 -65.6 -38.12 88.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.85 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.71 -46.22 63.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.188 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.15 -42.03 85.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.025 -176.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.6 p -76.5 -11.24 59.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.11 13.57 82.81 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.547 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.18 -31.36 58.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 110.883 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 90.9 mt-30 -136.33 159.53 41.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.4 p -78.45 169.75 17.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.131 168.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 72.9 t -55.52 -43.83 73.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.125 170.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -59.64 -44.79 93.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -70.44 -52.39 22.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.79 -45.93 70.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.079 -173.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.64 HD11 ' HB1' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -65.21 -40.01 93.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -177.404 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.569 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.0 tttt -65.3 -38.35 89.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 176.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -65.04 -38.91 92.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.795 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.608 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -64.79 -46.47 81.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.085 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.569 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 5.0 pp0? -70.55 -31.39 68.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.979 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 81.8 m -65.69 -42.63 91.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.199 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.29 -36.56 81.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.799 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.529 HD13 HG22 ' A' ' 183' ' ' VAL . 64.0 mt -64.96 -39.82 86.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.189 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.3 p -91.51 -11.05 38.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.195 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.917 176.71 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.806 0.336 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.404 HG21 ' HD2' ' A' ' 271' ' ' PRO . 83.6 mt -95.67 135.1 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.102 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -149.43 142.1 24.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -55.12 137.4 46.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 97.77 1.85 58.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.544 -172.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -166.1 149.16 7.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.837 0.351 . . . . 0.0 110.968 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.717 HD23 HD11 ' A' ' 33' ' ' ILE . 1.6 pt? -148.73 153.51 38.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.451 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 69.9 t -108.84 138.67 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.104 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.82 HG13 HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -122.21 132.55 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.001 177.018 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.487 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 45.2 m0 -108.82 127.81 54.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.887 172.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.565 ' HB ' HD23 ' A' ' 20' ' ' LEU . 7.2 tt -109.76 148.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.22 -168.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -57.28 146.86 27.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.888 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.89 -12.93 16.69 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.459 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -75.15 -10.29 59.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 110.842 -173.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -150.12 135.39 18.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 162.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.14 -84.71 1.0 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 -166.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -113.19 -45.65 3.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.923 0.392 . . . . 0.0 110.922 -170.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -68.05 -52.83 30.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.908 -149.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.647 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -63.17 -46.85 92.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.513 -176.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.82 HD22 HG13 ' A' ' 9' ' ' ILE . 17.7 tp -65.69 -39.94 91.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.839 0.352 . . . . 0.0 110.879 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.74 72.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.082 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -65.75 -48.23 72.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 m -75.36 -36.07 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.065 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.463 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -66.94 -46.41 73.95 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.444 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -65.58 -40.37 92.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.961 -176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.94 -40.45 95.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.413 ' CE2' HD12 ' A' ' 33' ' ' ILE . 78.0 t80 -64.81 -39.34 93.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.05 -40.04 79.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.913 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -69.1 -30.02 68.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -84.42 -40.13 18.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.803 -170.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.61 ' OG1' HG13 ' A' ' 33' ' ' ILE . 62.3 p -103.79 -12.32 17.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.48 7.93 87.79 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.496 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.854 HD13 ' O ' ' A' ' 33' ' ' ILE . 2.6 pp -102.7 132.54 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 111.105 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -71.17 130.16 40.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 -168.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.534 HG23 HD22 ' A' ' 7' ' ' LEU . 90.0 t -110.57 120.17 60.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.402 ' HB ' HG23 ' A' ' 8' ' ' VAL . 99.5 m -113.62 118.03 33.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.159 -173.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.509 HG23 ' HG ' ' A' ' 20' ' ' LEU . 92.3 t -94.41 134.11 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.487 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 73.5 mm-40 -119.8 161.63 20.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.9 t-80 -83.41 139.38 41.51 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.626 0.727 . . . . 0.0 110.771 -168.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 75.6 Cg_exo -56.59 -25.09 57.39 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.768 2.312 . . . . 0.0 112.303 -176.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -47.64 -50.18 25.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -173.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -86.61 -8.56 57.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 61' ' ' PHE . 9.4 tt -46.73 -54.28 10.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.896 -167.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -75.03 -34.69 61.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -71.69 -48.87 44.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -168.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -87.2 -28.63 22.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 -170.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.562 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 91.5 t80 -47.49 -51.66 42.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.769 0.795 . . . . 0.0 110.922 -166.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 59.7 Cg_endo -68.3 -28.98 32.75 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.725 2.283 . . . . 0.0 112.296 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -76.56 -43.66 37.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.67 -24.96 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.127 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.86 -32.71 74.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.049 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.5 -27.65 67.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.03 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.2 p -94.61 -13.85 25.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.114 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.74 15.6 81.19 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.405 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -142.55 130.42 21.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.831 0.348 . . . . 0.0 110.998 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.69 -115.09 0.57 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.58 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.451 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 84.4 Cg_endo -70.32 146.48 56.83 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.306 168.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.401 ' HB2' HD11 ' A' ' 59' ' ' ILE . 1.4 m-20 -90.72 -36.34 14.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 169.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.7 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -138.46 150.04 24.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.175 176.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.0 tp -126.44 125.25 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 -169.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 4.8 m-85 -110.06 126.38 53.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 20.7 t-105 -143.1 -171.51 3.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 169.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.16 -89.53 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.119 171.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -106.55 -54.79 2.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.835 -172.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.49 -38.59 63.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.902 -158.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -74.46 -18.76 60.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 -169.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -39.99 -55.32 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.47 -38.43 44.72 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.493 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.32 -57.78 11.06 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 -171.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.603 ' HD1' HD23 ' A' ' 76' ' ' LEU . 8.8 p90 -85.79 -27.06 25.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.935 0.398 . . . . 0.0 110.93 -172.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.421 ' N ' ' CD1' ' A' ' 70' ' ' TYR . . . -71.62 -57.25 4.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.091 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -65.55 -32.02 73.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 -176.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.3 m -82.21 -7.88 59.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.58 30.42 68.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.503 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.457 ' HA ' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -87.45 -4.23 59.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.842 0.353 . . . . 0.0 110.835 -174.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.603 HD23 ' HD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -125.68 147.94 49.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -177.117 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.96 143.7 37.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.033 171.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -71.79 135.1 46.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.866 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.913 HG13 ' HB3' ' A' ' 103' ' ' LEU . 37.9 pt -117.31 164.97 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.087 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.2 p -115.81 150.03 44.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.543 0.687 . . . . 0.0 111.181 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.45 146.42 44.55 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.683 2.255 . . . . 0.0 112.32 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -105.65 119.92 40.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.828 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.03 -41.93 99.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.41 -45.02 89.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.555 ' HB3' ' HZ2' ' A' ' 94' ' ' TRP . 7.4 m-85 -72.4 -33.32 67.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.503 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.5 tt0 -52.1 -46.64 65.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.27 -36.14 82.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 174.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -78.86 -24.42 44.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.815 -173.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.3 OUTLIER -104.96 -105.04 0.31 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -172.164 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.476 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 39.7 t80 -164.6 129.63 1.97 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.671 0.748 . . . . 0.0 110.983 -174.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 96.9 Cg_exo -57.15 -43.03 56.98 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.62 2.213 . . . . 0.0 112.421 -169.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -72.44 -26.35 61.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.964 -173.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.652 ' CG2' ' HB3' ' A' ' 107' ' ' PRO . 96.7 m -69.75 -40.01 76.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.151 -174.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.599 ' HA ' HG23 ' A' ' 97' ' ' VAL . 92.2 m95 -65.68 -27.6 68.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.985 174.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -71.76 -35.24 70.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.54 -27.39 63.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.081 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.599 HG23 ' HA ' ' A' ' 94' ' ' TRP . 19.4 m -101.2 16.36 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.129 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.468 ' HB2' HD12 ' A' ' 103' ' ' LEU . 75.2 ttt180 -113.48 137.42 51.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -144.29 127.7 16.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.1 t30 62.19 34.78 15.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.899 174.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.82 -6.24 71.26 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.44 172.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -124.05 147.25 47.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.965 173.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.913 ' HB3' HG13 ' A' ' 79' ' ' ILE . 4.2 tp -73.28 139.99 46.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.924 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.465 ' C ' HD13 ' A' ' 104' ' ' ILE . 2.5 pp -126.28 10.01 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.012 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 263' ' ' SER . . . -170.72 162.12 7.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -112.75 145.67 33.48 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.738 0.78 . . . . 0.0 110.914 164.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.652 ' HB3' ' CG2' ' A' ' 93' ' ' THR . 90.9 Cg_endo -75.63 118.52 5.13 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.668 2.246 . . . . 0.0 112.386 173.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 27.3 mm -94.75 -49.35 12.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.097 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.74 157.57 43.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.129 -170.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.401 HG23 HG23 ' A' ' 261' ' ' VAL . 79.7 t -121.46 134.64 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 -173.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -115.85 138.01 51.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.847 169.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.493 ' HB1' ' HB ' ' A' ' 320' ' ' THR . . . -151.48 160.04 43.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.023 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.435 ' HG ' ' HA3' ' A' ' 228' ' ' GLY . 7.0 mp -109.72 158.09 18.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 -170.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.5 p -154.82 161.9 41.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.925 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.937 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.98 128.19 46.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.996 176.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.578 ' N ' HD23 ' A' ' 115' ' ' LEU . 5.3 mp -109.64 130.97 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.099 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -133.17 153.42 51.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -93.02 116.69 29.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.877 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.04 -20.22 66.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.854 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 11.8 t70 -77.33 -29.89 53.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.841 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.673 HD22 ' O ' ' A' ' 220' ' ' GLY . 8.8 mp -95.17 -47.91 6.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.6 mt -102.28 115.02 65.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.535 0.683 . . . . 0.0 111.032 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.79 -27.09 21.99 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.646 2.231 . . . . 0.0 112.333 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.422 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 60.5 t-20 -145.95 102.47 4.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.587 0.708 . . . . 0.0 110.88 173.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.0 Cg_endo -71.02 146.17 51.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.677 2.251 . . . . 0.0 112.324 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 150.83 62.89 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.384 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -110.47 -6.34 14.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.971 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 79.1 p -131.15 157.4 43.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.226 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -66.74 -30.63 70.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.998 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.06 -26.14 68.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.928 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -78.96 -23.32 44.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.614 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.5 mp -60.94 -51.21 81.0 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.645 0.736 . . . . 0.0 111.153 -169.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.5 Cg_endo -71.18 -40.63 3.1 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.62 2.213 . . . . 0.0 112.439 -170.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.31 -41.93 80.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.956 HD21 ' O ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -56.8 -42.8 80.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.973 172.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.435 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . 24.7 t70 -54.39 -35.34 62.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.772 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.0 -34.31 75.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.819 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -76.29 -51.75 11.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.864 -172.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.582 HD21 ' N ' ' A' ' 140' ' ' LYS . 0.8 OUTLIER -80.04 -10.06 59.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.839 -176.088 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.582 ' N ' HD21 ' A' ' 139' ' ' LEU . 87.1 tttt -55.41 -31.99 62.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 167.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.66 -24.34 67.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.97 5.53 51.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.5 25.56 67.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.482 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.496 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 41.4 mmtm -118.35 165.81 13.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.886 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.6 t -126.67 142.03 51.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.831 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.17 -58.38 4.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.094 -166.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.421 HD13 ' C ' ' A' ' 147' ' ' LEU . 3.0 tm? -139.96 124.58 18.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.937 -168.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 58.0 ttm -109.93 128.82 55.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.4 ' HB2' ' CD2' ' A' ' 156' ' ' PHE . 18.1 p90 -155.83 157.18 36.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.832 -171.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -99.98 81.82 2.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.868 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.913 HD22 HD11 ' A' ' 195' ' ' LEU . 1.2 tm? -56.17 -32.52 64.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.876 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.37 9.53 3.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -108.73 145.01 30.76 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.597 0.713 . . . . 0.0 110.933 170.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.7 -24.91 68.88 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.706 2.271 . . . . 0.0 112.349 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -69.4 -32.11 70.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.4 ' CD2' ' HB2' ' A' ' 149' ' ' PHE . 68.7 m-85 -87.98 -30.82 19.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.87 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 57.2 p -66.4 -32.46 73.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.233 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.591 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 29.8 t-105 -61.94 -55.57 40.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.903 -171.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 13.4 Cg_endo -61.13 -36.79 79.5 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.703 2.269 . . . . 0.0 112.481 -171.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.685 HD21 ' O ' ' A' ' 160' ' ' LEU . 6.3 tt -72.59 -43.0 63.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 73.3 mt -70.64 -40.04 76.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.66 -30.48 62.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.11 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.536 ' HB1' ' HD2' ' A' ' 250' ' ' PHE . . . -63.29 -34.48 77.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 -169.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -92.57 3.03 56.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.968 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.21 1.96 13.87 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.462 169.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.17 65.55 3.96 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.472 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -86.31 134.12 33.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.821 0.343 . . . . 0.0 110.964 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.61 7.14 10.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.106 -170.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.458 ' HA ' HG12 ' A' ' 181' ' ' VAL . 50.3 p90 -150.06 154.37 38.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.951 0.405 . . . . 0.0 110.931 -175.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -102.61 127.71 49.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.92 155.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -118.19 124.42 47.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.017 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -153.05 132.21 12.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.05 42.03 31.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.912 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.94 16.06 80.69 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.507 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -130.03 138.62 50.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.764 0.316 . . . . 0.0 110.923 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -95.78 143.42 27.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.863 169.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -121.39 109.83 15.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.932 172.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.634 ' O ' HD13 ' A' ' 178' ' ' ILE . 1.0 OUTLIER -79.24 -12.3 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.164 -178.225 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.7 -12.06 24.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.896 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -123.83 89.28 3.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.833 169.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 169' ' ' PHE . 32.9 m -117.17 166.48 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.087 -171.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.01 24.0 29.3 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.514 -170.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.505 HG22 HD13 ' A' ' 368' ' ' ILE . 13.8 m -108.9 -15.4 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 111.112 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -85.26 19.92 2.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -112.14 -178.25 3.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.95 -24.86 63.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.999 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.407 ' O ' ' HB1' ' A' ' 190' ' ' ALA . . . -69.98 -40.5 73.45 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.438 -171.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.646 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -64.68 -37.32 87.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.872 0.367 . . . . 0.0 111.124 176.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.515 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.0 mttt -59.98 -34.21 72.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.953 173.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' A' ' 187' ' ' GLY . . . -65.09 -30.9 71.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 174.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.42 93.9 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.458 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.434 HD11 ' HB2' ' A' ' 346' ' ' ALA . 24.9 mt -66.03 -37.52 86.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.952 0.406 . . . . 0.0 110.916 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.2 m -56.67 -45.27 81.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.226 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -75.26 -44.57 45.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.913 HD11 HD22 ' A' ' 151' ' ' LEU . 8.7 tt -56.99 -53.66 55.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.936 -172.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.545 ' HA ' HD11 ' A' ' 199' ' ' ILE . 13.6 m -64.96 -21.2 29.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.185 -176.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.33 -29.9 66.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.813 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -71.4 -48.88 47.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 177.053 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.814 ' H ' HD13 ' A' ' 199' ' ' ILE . 2.6 mp -64.23 -36.66 77.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.151 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.95 -39.84 94.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -90.47 -1.32 57.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.971 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.66 39.99 6.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -77.6 -14.31 59.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.834 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -139.31 154.34 47.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -100.22 151.32 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 -176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.89 -27.65 69.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.119 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -95.0 2.97 55.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.795 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.8 m -58.64 133.26 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.125 -177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -144.07 170.08 16.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 175.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -65.96 -35.78 81.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.906 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 97.4 p -65.65 -36.01 82.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.839 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 75.2 mt -65.06 -40.27 88.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.27 93.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.984 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.24 -39.5 86.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.868 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.01 -36.73 85.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.129 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.71 -32.71 71.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.131 -176.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -61.39 -32.08 72.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -61.32 -35.63 77.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -101.69 -21.61 14.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.673 ' O ' HD22 ' A' ' 121' ' ' LEU . . . 88.96 31.71 11.83 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.538 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -82.54 -30.67 29.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.881 0.372 . . . . 0.0 110.915 -171.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 93.0 m -116.62 127.28 54.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -69.86 -45.79 66.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.417 ' HB3' HD22 ' A' ' 115' ' ' LEU . 76.3 mtp -134.19 145.75 49.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 -175.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 30.6 p -142.35 161.87 36.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.203 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 31.0 mm -111.64 125.42 68.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.148 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.405 ' OD1' ' HB2' ' A' ' 230' ' ' TRP . 14.2 t-20 -154.33 158.08 39.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -174.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.435 ' HA3' ' HG ' ' A' ' 113' ' ' LEU . . . -137.53 -108.58 0.87 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.529 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.76 -17.28 47.35 Favored 'Trans proline' 0 C--O 1.23 0.096 0 C-N-CA 122.645 2.23 . . . . 0.0 112.359 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.405 ' HB2' ' OD1' ' A' ' 227' ' ' ASN . 97.5 m95 -80.25 -12.43 59.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.897 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -50.46 -39.0 46.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.017 -168.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -57.12 -24.38 53.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 27.8 t -50.08 -59.28 4.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.826 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -155.1 54.64 0.64 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.41 ' O ' ' HD3' ' A' ' 316' ' ' ARG . 29.2 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 170.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 74.4 m-80 -110.68 71.64 0.76 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.802 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -117.68 147.45 42.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -135.54 160.09 24.36 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.593 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.715 HG11 ' O ' ' A' ' 315' ' ' PRO . 5.8 p -140.82 138.23 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.928 0.394 . . . . 0.0 111.112 -176.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.1 t -152.86 152.19 31.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.118 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 24.4 m -60.02 167.4 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.085 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.471 HD13 ' HB2' ' A' ' 115' ' ' LEU . 3.5 mm? -63.2 141.09 97.76 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.608 0.718 . . . . 0.0 110.919 -159.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.97 167.68 19.18 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.641 2.228 . . . . 0.0 112.335 174.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 71.1 p -103.51 161.44 13.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.15 -170.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.536 ' HD2' ' HB1' ' A' ' 163' ' ' ALA . 30.7 t80 -143.18 121.06 11.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.864 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 57.25 34.98 25.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.89 10.32 79.09 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.462 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -126.44 145.06 51.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.651 0.739 . . . . 0.0 110.877 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -71.95 139.23 32.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.66 2.24 . . . . 0.0 112.309 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 70.2 m -84.95 0.14 52.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 171.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -46.18 110.16 1.14 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.658 0.742 . . . . 0.0 110.916 -176.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -76.7 161.09 34.11 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.783 2.322 . . . . 0.0 112.359 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -75.17 153.18 38.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -174.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.421 HG22 ' HA ' ' A' ' 324' ' ' ALA . 63.4 t -99.88 134.0 40.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.159 -170.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.21 133.62 11.75 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.438 -178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.401 HG23 HG23 ' A' ' 110' ' ' VAL . 86.0 t -124.91 131.44 72.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.936 0.398 . . . . 0.0 111.155 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 108' ' ' ILE . 2.5 tt -67.98 131.1 44.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 171.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.583 ' HB2' ' HB2' ' A' ' 105' ' ' ALA . 70.8 p -118.84 140.62 49.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.85 -176.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.561 ' HB2' HD11 ' A' ' 280' ' ' LEU . . . -127.87 130.17 48.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.089 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -122.52 163.19 16.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.495 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.485 ' HA ' HG22 ' A' ' 59' ' ' ILE . 15.7 mm -100.96 125.06 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 111.159 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -66.01 127.8 33.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.437 ' HB3' ' C ' ' A' ' 76' ' ' LEU . . . -60.92 -28.42 68.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.121 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.9 -10.9 56.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.061 -172.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.3 t -75.88 121.11 84.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.674 0.75 . . . . 0.0 110.865 -174.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.404 ' HD2' HG21 ' A' ' 2' ' ' ILE . 80.4 Cg_endo -67.23 -8.77 22.95 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 167.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -103.05 17.86 23.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 -173.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -52.72 -34.41 52.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 -168.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -71.38 -47.85 53.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.841 -170.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.3 pp -80.04 -31.02 39.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.966 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.481 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -67.84 -45.92 73.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -69.41 -34.05 73.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 89.2 tt0 -62.9 -52.93 61.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.483 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.2 p90 -69.9 -33.61 72.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.82 -176.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 264' ' ' ALA . 5.6 tt -56.93 -47.55 80.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -85.15 -32.11 22.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 69.4 m-20 -101.95 -14.01 17.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 -164.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.483 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 73.2 t80 -121.92 -49.49 2.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -175.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.515 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -64.39 -46.99 80.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 177.062 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.408 HD22 HD11 ' A' ' 108' ' ' ILE . 64.2 mt -85.98 59.98 5.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.984 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.491 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 47.5 p -139.18 150.42 45.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.065 172.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.546 ' HA ' HD11 ' A' ' 290' ' ' LEU . 42.4 p-10 -51.01 -26.4 6.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 -175.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -81.0 -43.9 18.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.834 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.05 -50.82 21.24 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.478 -169.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.565 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.4 OUTLIER -74.37 -20.85 59.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.894 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.433 ' N ' HD12 ' A' ' 290' ' ' LEU . 82.4 tt0 -67.12 -41.86 85.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.937 170.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.08 -34.37 74.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.145 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.647 HG13 ' HA3' ' A' ' 19' ' ' GLY . 21.1 t -79.4 -42.23 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.47 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 47.0 t30 -64.96 -27.4 68.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.944 177.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.82 -29.67 70.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -85.97 -39.99 16.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -150.87 133.77 8.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.584 0.707 . . . . 0.0 110.888 173.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.52 112.33 0.73 Allowed 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.662 2.242 . . . . 0.0 112.375 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.47 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 36.9 mt -91.05 -12.48 35.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.15 -58.98 0.49 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.43 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -175.01 167.28 3.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.846 0.355 . . . . 0.0 111.097 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 27.8 m -124.04 156.8 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.119 176.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -71.77 -17.73 62.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.983 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.565 ' CD2' HD22 ' A' ' 290' ' ' LEU . 58.6 tp -80.13 122.34 26.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.991 -173.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -56.09 -39.74 72.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -173.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.2 m -63.18 -48.47 78.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.825 -167.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.456 ' CD2' HD21 ' A' ' 311' ' ' LEU . 24.0 t80 -84.86 -28.31 26.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.74 -43.07 90.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.937 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.56 -37.9 89.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -72.32 -47.88 46.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.865 -176.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.719 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.5 pp -69.42 -27.76 65.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.959 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.44 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.0 -11.52 57.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.201 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.13 -15.02 61.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -81.2 130.09 64.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.503 0.668 . . . . 0.0 110.92 170.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.715 ' O ' HG11 ' A' ' 244' ' ' VAL . 87.1 Cg_exo -51.69 -35.21 56.9 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.272 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.54 ' HG3' HG13 ' A' ' 317' ' ' ILE . 23.3 ptt-85 -66.91 -32.61 73.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.838 -173.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.719 HG21 ' CD1' ' A' ' 311' ' ' LEU . 64.9 mt -93.35 -33.78 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.094 -175.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -52.47 -43.08 64.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -172.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.464 ' CB ' HG23 ' A' ' 244' ' ' VAL . . . -66.47 -43.1 86.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.493 ' HB ' ' HB1' ' A' ' 112' ' ' ALA . 72.4 p -65.3 -28.81 69.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.086 -174.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' MET . . . . . 0.41 ' HG2' HG22 ' A' ' 317' ' ' ILE . 34.6 mmt -68.72 -30.15 68.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 177.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -64.95 -44.41 89.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 327' ' ' GLY . 39.1 t30 -64.61 -36.88 85.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 174.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.421 ' HA ' HG22 ' A' ' 259' ' ' VAL . . . -62.14 -45.3 94.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -73.54 -34.5 65.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.54 -1.15 51.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -175.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -103.45 -157.3 24.76 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.431 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -141.17 142.09 34.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 0.0 110.952 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.577 ' O ' ' C ' ' A' ' 330' ' ' MET . 37.9 mm -81.69 110.6 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 -171.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.577 ' C ' ' O ' ' A' ' 329' ' ' ILE . 96.1 mmm . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 121.553 0.692 . . . . 0.0 110.782 174.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.812 0.339 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 89.4 mmm -74.35 -24.59 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -172.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.7 m -64.13 -39.88 94.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.46 -36.7 65.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.045 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.411 ' O ' HG13 ' A' ' 343' ' ' VAL . 11.1 m-30 -65.04 -41.22 95.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -61.97 -35.42 78.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.764 177.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -69.3 -43.83 72.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.958 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' A' ' 367' ' ' ARG . . . -61.45 -40.5 94.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.221 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 339' ' ' PHE . 16.1 m -79.47 -24.86 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.121 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.407 ' O ' HG23 ' A' ' 347' ' ' VAL . 4.4 tmt_? -62.29 -45.44 93.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 175.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 87.2 m -57.28 -35.08 69.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.042 173.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -60.25 -44.42 95.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.057 -175.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.425 ' HA ' HD23 ' A' ' 192' ' ' LEU . 1.5 m -74.06 -33.63 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.124 -174.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.42 HD13 HG21 ' A' ' 347' ' ' VAL . 1.5 mp -63.5 -47.92 89.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.242 173.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 84.9 m-20 -67.02 -37.72 84.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.83 -47.9 49.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.154 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.21 -37.1 80.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.177 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.5 p -74.81 -13.92 60.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.823 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.53 12.2 84.5 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.436 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -81.74 -26.46 34.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.777 0.322 . . . . 0.0 110.91 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.524 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 93.3 mt-30 -133.43 159.4 40.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 170.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.2 p -80.42 169.54 17.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.249 170.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 69.7 t -56.48 -43.09 77.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.175 170.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -59.13 -45.09 91.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -70.1 -52.66 21.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.919 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.15 74.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.093 -173.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.646 HD11 ' HB1' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -67.05 -40.01 87.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.002 -176.185 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.557 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.0 tttt -65.1 -39.12 92.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.935 176.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -64.71 -37.08 86.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -63.95 -45.56 88.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.091 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.557 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -73.5 -30.04 62.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.073 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 67.9 m -64.6 -41.16 96.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.118 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . 0.429 ' HB2' ' HB2' ' A' ' 342' ' ' ALA . 99.7 mtt180 -66.75 -39.98 88.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.848 175.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.505 HD13 HG22 ' A' ' 183' ' ' VAL . 67.1 mt -65.93 -38.42 82.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.099 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 70.7 p -93.9 -8.95 38.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.168 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 173.713 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.74 0.305 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.8 mt -97.71 128.5 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.215 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -158.01 145.8 18.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -51.86 138.39 24.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.517 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 98.1 2.52 58.08 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.405 -173.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -170.35 152.38 4.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.609 HD23 HD11 ' A' ' 33' ' ' ILE . 1.3 pt? -153.51 155.37 36.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.984 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.498 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 71.4 t -109.92 135.8 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.159 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.691 HG22 ' CG1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -122.78 132.27 71.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.458 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 40.0 m0 -107.05 125.8 51.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.939 169.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.494 ' HB ' HD12 ' A' ' 20' ' ' LEU . 15.8 tt -107.74 149.71 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.194 -171.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -58.97 148.11 31.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.796 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.75 -14.64 37.66 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.476 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -73.84 -9.94 59.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.0 110.856 -174.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -150.23 133.76 16.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 159.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.91 -84.97 0.98 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.534 -163.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -106.69 -45.02 4.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.905 0.383 . . . . 0.0 110.921 -173.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -68.22 -52.46 33.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 -151.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.611 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -59.2 -48.04 87.89 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.556 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.608 ' CD1' HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -58.69 -46.38 87.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.933 176.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.65 -38.14 77.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -65.51 -49.4 69.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.8 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.6 m -73.36 -34.66 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.443 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -67.31 -43.22 88.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.87 -44.87 96.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.817 0.341 . . . . 0.0 110.932 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -67.33 -40.11 85.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.547 ' CE2' HD12 ' A' ' 33' ' ' ILE . 42.6 t80 -64.58 -38.85 92.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 176.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.93 -41.86 97.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.966 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.68 -36.4 82.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.842 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -81.49 -39.7 24.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.793 -170.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.636 ' OG1' HG13 ' A' ' 33' ' ' ILE . 63.9 p -103.62 -8.54 19.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.95 11.07 83.99 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.557 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 1.048 HD13 ' O ' ' A' ' 33' ' ' ILE . 2.0 pp -105.14 131.11 55.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.889 0.376 . . . . 0.0 111.168 -174.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -68.68 128.21 35.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.94 -168.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.479 HG23 HD22 ' A' ' 7' ' ' LEU . 95.8 t -110.42 119.97 60.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.476 ' HB ' HG23 ' A' ' 8' ' ' VAL . 99.8 m -111.12 116.71 31.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.516 HG23 HD13 ' A' ' 20' ' ' LEU . 87.9 t -92.82 133.51 33.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.12 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.458 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 74.0 mm-40 -120.02 160.88 21.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 174.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 64.7 t-80 -84.03 138.13 40.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 110.775 -167.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 58.8 Cg_exo -61.45 -17.42 53.52 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.717 2.278 . . . . 0.0 112.304 -174.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -47.39 -49.69 24.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 75.4 mmtt -90.88 -0.1 57.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.723 HD11 ' O ' ' A' ' 61' ' ' PHE . 9.8 tt -45.29 -56.93 4.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.954 -170.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -76.63 -38.42 54.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.879 -175.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -79.86 -44.84 19.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.896 -166.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 85.3 tttt -85.13 -36.02 21.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -171.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.601 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 84.0 t80 -49.23 -53.82 35.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.666 0.746 . . . . 0.0 110.989 -171.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 22.7 Cg_endo -59.17 -30.63 93.6 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.654 2.236 . . . . 0.0 112.325 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -74.46 -44.67 50.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.942 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.7 m -75.01 -24.71 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.168 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.65 -34.39 78.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.22 -31.0 71.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.071 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.5 p -89.99 -13.42 36.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.189 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.2 16.35 80.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.513 168.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -137.81 130.0 29.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.823 0.344 . . . . 0.0 110.821 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.3 -118.56 0.76 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.493 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.498 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 68.1 Cg_endo -70.54 153.22 65.51 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.711 2.274 . . . . 0.0 112.349 176.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.443 ' HB2' HD11 ' A' ' 59' ' ' ILE . 1.8 m-20 -86.4 -38.88 16.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.901 169.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.764 HG23 ' HB2' ' A' ' 276' ' ' ALA . 0.0 OUTLIER -133.81 149.69 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 178.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 tp -128.97 125.07 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.107 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.723 ' O ' HD11 ' A' ' 43' ' ' LEU . 2.3 m-85 -101.5 134.51 44.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.417 ' CH2' ' HB3' ' A' ' 105' ' ' ALA . 32.0 p90 -144.94 -178.74 6.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.948 175.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.96 -98.71 0.32 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -107.3 -55.1 2.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.822 -176.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.12 -34.35 73.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.872 -162.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.57 -20.01 54.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 -171.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -45.55 -53.14 9.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.928 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.42 -52.28 44.89 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.556 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.23 -49.93 73.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.576 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -70.93 -47.52 58.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.96 -172.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.3 -47.7 63.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.162 -173.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -64.45 -35.35 80.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.1 m -83.76 -7.48 59.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.814 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.26 33.48 61.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mp -84.0 -4.82 59.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 110.975 -176.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.756 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.8 pp -132.34 145.66 51.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.974 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.23 142.19 43.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.126 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -66.73 134.26 51.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.883 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.853 HG13 ' HB3' ' A' ' 103' ' ' LEU . 39.8 pt -111.58 160.71 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.137 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.9 m -101.46 130.06 25.53 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.627 0.727 . . . . 0.0 111.173 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.27 147.91 54.32 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.655 2.236 . . . . 0.0 112.33 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -114.46 120.06 38.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.15 -38.73 91.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.07 -44.77 83.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -71.44 -35.19 70.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.509 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 43.6 tt0 -53.32 -46.53 69.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.929 173.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.63 -34.55 75.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.905 174.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.26 -23.3 54.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.4 OUTLIER -108.09 -93.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.879 -171.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 39.3 t80 -169.98 129.18 0.87 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.631 0.729 . . . . 0.0 111.067 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 94.8 Cg_exo -56.2 -43.68 53.85 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.6 2.2 . . . . 0.0 112.291 -171.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 1.8 t80 -72.04 -32.78 67.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.994 -173.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.558 ' CG2' ' HB3' ' A' ' 107' ' ' PRO . 96.2 m -64.39 -34.77 78.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.011 -171.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.701 ' HA ' HG23 ' A' ' 97' ' ' VAL . 61.0 m95 -70.37 -21.61 62.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.986 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 92' ' ' PHE . 97.5 m-20 -72.99 -33.73 65.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.83 171.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.92 -27.7 64.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.701 HG23 ' HA ' ' A' ' 94' ' ' TRP . 15.7 m -100.38 15.51 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.09 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 70.8 ttt180 -110.4 136.48 49.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -140.12 126.59 20.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.975 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.4 t30 59.87 34.7 21.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.95 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.41 -3.0 83.77 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.528 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.14 147.41 49.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.707 0.289 . . . . 0.0 110.961 174.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.853 ' HB3' HG13 ' A' ' 79' ' ' ILE . 3.3 tp -76.87 140.1 40.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.857 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 76' ' ' LEU . 2.0 pp -122.14 -6.16 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 -171.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.417 ' HB3' ' CH2' ' A' ' 62' ' ' TRP . . . -164.97 166.67 19.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.085 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.45 ' HB3' HD11 ' A' ' 285' ' ' LEU . 87.1 m-85 -112.93 146.42 35.09 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.696 0.76 . . . . 0.0 110.939 169.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.558 ' HB3' ' CG2' ' A' ' 93' ' ' THR . 72.0 Cg_endo -76.16 118.93 5.13 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.631 2.22 . . . . 0.0 112.426 176.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.446 HD11 HD22 ' A' ' 285' ' ' LEU . 27.2 mm -92.5 -55.26 6.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.43 160.48 43.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.08 -168.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.41 HG23 HG23 ' A' ' 261' ' ' VAL . 89.0 t -119.41 136.67 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.101 -172.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -121.33 140.14 52.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.907 171.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.47 ' HB2' HD21 ' A' ' 323' ' ' ASN . . . -150.45 159.27 44.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.436 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 8.8 mp -92.31 169.23 10.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.903 -173.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.5 p -157.05 157.86 35.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.904 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -100.03 126.06 46.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.021 171.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.578 ' N ' HD23 ' A' ' 115' ' ' LEU . 4.8 mp -110.2 133.3 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.177 -174.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -133.25 150.37 51.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -91.12 118.75 30.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.58 -20.71 66.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.939 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -77.76 -27.94 50.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 220' ' ' GLY . 6.7 mp -95.5 -44.76 7.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.946 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 24.6 mt -108.74 103.32 51.24 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.631 0.729 . . . . 0.0 110.89 177.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 122' ' ' LEU . 72.6 Cg_endo -67.7 -23.61 42.09 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.686 2.257 . . . . 0.0 112.358 171.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -147.16 94.02 4.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.621 0.724 . . . . 0.0 110.894 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.94 152.7 79.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.684 2.256 . . . . 0.0 112.364 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.37 144.9 63.57 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.65 2.234 . . . . 0.0 112.389 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.53 -13.62 27.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.0 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.4 p -130.22 155.88 45.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.079 -174.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.573 ' HA ' HD11 ' A' ' 132' ' ' ILE . 64.2 m95 -68.44 -29.27 67.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.958 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.53 -25.02 67.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 -176.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -78.74 -21.22 48.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.894 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.605 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.6 mp -60.43 -52.88 69.78 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.661 0.743 . . . . 0.0 111.065 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 27.7 Cg_endo -66.89 -40.04 13.16 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.623 2.215 . . . . 0.0 112.441 -171.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.18 -41.61 76.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.118 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.7 tp -55.14 -43.45 74.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.446 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . 1.5 m-20 -49.87 -42.37 47.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.95 -35.13 79.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.898 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -75.5 -46.17 33.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 -171.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.471 ' HG ' ' HB2' ' A' ' 144' ' ' LYS . 0.8 OUTLIER -89.94 -18.74 25.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.96 -174.218 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -53.67 -30.33 42.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.83 167.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.18 -25.08 67.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.12 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -95.0 7.01 47.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.865 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.16 24.91 72.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.464 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.471 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 26.5 mmtp -110.04 167.55 10.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.37 . . . . 0.0 110.904 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.0 t -130.64 137.95 49.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.899 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 224' ' ' MET . . . -72.94 -53.48 11.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.068 -166.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 148' ' ' MET . 1.9 tm? -138.24 138.12 38.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 -167.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.463 ' H ' HD23 ' A' ' 147' ' ' LEU . 98.7 mtp -125.14 133.27 52.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.852 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.416 ' HE2' HD21 ' A' ' 151' ' ' LEU . 22.0 p90 -159.98 161.69 34.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.823 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -95.47 90.05 5.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.843 HD22 HD11 ' A' ' 195' ' ' LEU . 1.2 tm? -66.44 -32.75 74.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.951 -173.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.29 0.07 23.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -100.4 142.87 25.44 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.586 0.707 . . . . 0.0 110.914 176.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.613 ' HG3' ' CE1' ' A' ' 341' ' ' TYR . 29.9 Cg_endo -64.32 -22.47 66.36 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.672 2.248 . . . . 0.0 112.429 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -69.26 -35.47 76.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.964 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -92.09 -29.97 16.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.836 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.2 p -65.68 -45.67 81.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.271 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.614 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 90.6 t90 -66.21 -46.83 61.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.521 0.677 . . . . 0.0 110.82 -166.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 96.9 Cg_exo -48.81 -45.39 28.5 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.685 2.257 . . . . 0.0 112.422 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.77 HD21 ' O ' ' A' ' 160' ' ' LEU . 6.2 tt -69.15 -39.11 79.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 67.2 mt -71.55 -40.5 71.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.73 -26.47 44.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -60.41 -33.68 72.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.046 -171.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -95.02 3.3 55.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.846 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.88 -1.06 13.52 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.45 171.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.3 67.14 3.11 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.422 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -87.76 132.38 34.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 0.0 110.928 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.07 13.98 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.424 ' HA ' HG12 ' A' ' 181' ' ' VAL . 49.1 p90 -147.47 151.45 36.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.868 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -103.21 129.62 50.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.836 158.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -120.88 125.03 46.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -151.99 129.81 11.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.994 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.09 41.78 31.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 172.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.02 15.35 81.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.525 173.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -129.97 139.03 51.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.739 0.304 . . . . 0.0 110.842 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -99.74 144.6 28.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 171.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -122.06 108.05 12.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.865 172.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.533 ' C ' HD13 ' A' ' 178' ' ' ILE . 1.4 pp -77.77 -11.99 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.134 -178.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.14 -11.44 22.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -176.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -130.01 85.08 2.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 172.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 169' ' ' PHE . 30.6 m -113.84 173.08 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 -169.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -101.97 23.76 33.57 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.455 -166.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.547 HG22 HD13 ' A' ' 368' ' ' ILE . 31.3 m -114.41 -7.59 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 0.0 111.131 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.5 p-10 -85.5 18.07 2.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -125.74 -170.02 2.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.84 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.07 -27.64 68.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.111 -173.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.2 -44.76 74.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.479 -164.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.759 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -67.01 -36.01 81.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.81 0.338 . . . . 0.0 111.07 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.487 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.5 mttt -59.04 -33.7 71.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.898 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.13 -31.68 73.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.105 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.83 -45.22 96.16 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.481 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.482 HD11 ' HB2' ' A' ' 346' ' ' ALA . 22.7 mt -64.98 -38.63 91.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.9 0.381 . . . . 0.0 110.98 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.1 m -58.2 -44.99 88.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.244 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -75.88 -45.49 35.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.843 HD11 HD22 ' A' ' 151' ' ' LEU . 6.5 tt -54.39 -48.57 71.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.961 -170.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.431 ' HA ' HD12 ' A' ' 199' ' ' ILE . 23.0 m -70.1 -19.93 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 -174.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.458 ' HB3' HD13 ' A' ' 198' ' ' LEU . 38.6 t70 -56.52 -56.74 17.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 -168.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.97 ' H ' HD13 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.5 -26.6 58.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.928 -167.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.581 ' H ' HD23 ' A' ' 198' ' ' LEU . 1.8 pp -86.99 -34.52 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.176 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.74 -32.6 69.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.914 166.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -84.88 5.0 30.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 65.19 36.84 6.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -86.24 -14.44 43.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 57.9 ttp -138.08 153.27 49.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.962 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -97.7 150.16 21.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.81 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.97 -26.65 68.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.103 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -93.78 4.9 53.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.809 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 91.5 m -61.03 129.97 44.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -139.81 169.65 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.837 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -66.63 -36.19 81.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 99.5 p -66.08 -36.57 83.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.745 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 73.4 mt -64.94 -39.36 85.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.31 83.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.172 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.41 -45.73 93.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.949 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.03 -38.64 91.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.15 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.93 97.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.176 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -65.22 -36.91 85.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -61.35 -34.01 74.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -89.59 -22.59 22.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.506 ' O ' HD22 ' A' ' 121' ' ' LEU . . . 88.19 24.92 32.81 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.505 -178.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -87.91 -26.84 22.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.38 . . . . 0.0 110.861 -173.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . 0.451 HG22 ' SD ' ' A' ' 148' ' ' MET . 75.6 m -116.87 129.92 56.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 -173.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.92 -49.8 55.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.439 ' HB3' HD22 ' A' ' 115' ' ' LEU . 71.1 mtm -136.43 157.06 47.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -170.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.9 t -149.15 157.68 43.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.2 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.3 mm -112.81 121.26 64.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.119 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.561 ' HB3' ' HB3' ' A' ' 231' ' ' ALA . 9.4 t-20 -156.05 170.0 23.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -172.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -132.42 -100.32 0.77 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.571 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.26 -22.94 39.45 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.703 2.269 . . . . 0.0 112.306 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -83.56 -20.11 34.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.002 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 227' ' ' ASN . . . -55.6 -45.1 77.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.073 -166.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -63.14 -19.1 64.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 -171.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.1 p -54.05 -25.41 21.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.879 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -136.17 39.94 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.46 ' HB ' ' HG2' ' A' ' 316' ' ' ARG . 95.6 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 170.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 CA--C 1.524 -0.026 0 CA-C-O 120.907 0.384 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -123.41 82.49 2.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.836 176.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.03 147.88 47.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.868 171.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -127.67 153.09 19.12 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.542 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.54 HG23 ' CB ' ' A' ' 319' ' ' ALA . 5.0 p -137.8 134.07 45.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 111.166 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.8 t -155.78 147.86 23.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.105 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.4 m -60.66 168.87 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.068 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.662 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.8 mm? -64.09 149.13 94.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.615 0.721 . . . . 0.0 110.855 -159.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 32.1 Cg_exo -65.12 179.08 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.705 2.27 . . . . 0.0 112.254 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 97.3 m -101.04 146.41 27.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.189 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -136.79 119.42 16.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 56.14 35.05 24.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.51 3.33 86.64 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.478 171.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -133.7 142.73 44.85 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.683 0.754 . . . . 0.0 110.886 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.78 144.94 44.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.727 2.284 . . . . 0.0 112.315 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.662 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 70.0 p -87.03 10.28 16.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 173.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -43.07 112.21 1.16 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.648 0.737 . . . . 0.0 110.887 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.415 ' CD ' HD21 ' A' ' 247' ' ' LEU . 80.7 Cg_endo -78.5 164.63 26.0 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.654 2.236 . . . . 0.0 112.355 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -71.27 163.26 28.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -174.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 60.5 t -107.88 135.22 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 -172.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.12 135.98 13.17 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.455 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.41 HG23 HG23 ' A' ' 110' ' ' VAL . 89.6 t -122.8 132.13 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 111.114 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.4 HD21 ' N ' ' A' ' 263' ' ' SER . 2.4 tt -66.61 128.89 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 171.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.4 ' N ' HD21 ' A' ' 262' ' ' LEU . 59.7 p -123.11 132.17 53.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -177.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.484 ' HB2' HD11 ' A' ' 280' ' ' LEU . . . -124.92 127.75 47.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.163 -173.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.78 167.01 14.46 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.416 -171.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 59' ' ' ILE . 12.6 mm -99.98 126.81 53.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 111.148 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -62.86 126.39 27.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.889 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.85 -25.11 68.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.083 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.59 -10.52 55.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.112 -173.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.3 t -75.61 120.37 81.33 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.581 0.705 . . . . 0.0 110.928 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -70.91 -12.24 30.45 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.631 2.221 . . . . 0.0 112.289 171.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -112.07 35.75 3.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.984 -170.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.05 -25.11 65.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -169.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.94 -39.07 76.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.802 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.412 HD21 ' HB3' ' A' ' 7' ' ' LEU . 43.1 tp -66.26 -48.21 71.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 173.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.764 ' HB2' HG23 ' A' ' 59' ' ' ILE . . . -68.0 -50.0 58.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.053 -172.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -62.97 -41.34 99.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -63.86 -53.46 50.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.954 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.472 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -70.05 -36.88 75.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -173.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.519 ' HA ' HD23 ' A' ' 284' ' ' LEU . 6.4 tt -58.53 -46.56 86.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -77.23 -40.31 45.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.832 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -102.8 -9.68 19.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 -160.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.472 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 75.7 t80 -122.48 -49.07 2.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 280' ' ' LEU . 0.1 OUTLIER -64.43 -47.1 80.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 178.082 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 106' ' ' TYR . 64.6 mt -85.0 59.2 5.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.49 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 37.4 p -140.23 151.16 44.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.149 172.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.539 ' HA ' HD11 ' A' ' 290' ' ' LEU . 43.1 p-10 -51.12 -26.06 6.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.916 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -79.6 -44.93 20.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.801 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.88 -50.1 20.12 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.532 -168.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.539 HD11 ' HA ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -74.79 -20.9 59.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.737 0.303 . . . . 0.0 110.903 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.43 ' N ' HD12 ' A' ' 290' ' ' LEU . 82.4 tt0 -66.13 -40.43 90.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.931 169.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.68 -34.74 76.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.193 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.611 HG13 ' HA3' ' A' ' 19' ' ' GLY . 24.7 t -78.45 -45.23 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.182 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.415 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 48.3 t30 -65.53 -27.79 68.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.04 -27.31 69.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -85.99 -41.33 14.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.928 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -150.96 129.82 6.27 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.576 0.703 . . . . 0.0 110.906 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.8 110.35 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.396 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 55.8 mt -88.19 -17.81 30.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.98 -171.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.633 ' O ' HG23 ' A' ' 317' ' ' ILE . . . 105.13 -42.78 1.81 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.445 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 300' ' ' GLY . . . -176.04 173.17 2.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.861 0.362 . . . . 0.0 111.059 164.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.54 HG23 HD22 ' A' ' 311' ' ' LEU . 23.2 m -122.7 153.69 27.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.149 170.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -68.19 -18.8 64.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.041 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.472 ' HA ' HD12 ' A' ' 89' ' ' LEU . 52.6 tp -83.03 121.95 27.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.967 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -60.37 -34.99 74.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 -174.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.7 m -64.06 -50.21 69.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.844 -169.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.607 ' CD2' HD21 ' A' ' 311' ' ' LEU . 36.0 t80 -82.8 -26.93 31.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.954 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -55.71 -43.85 76.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.903 177.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.22 -36.89 85.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -77.62 -48.49 16.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.787 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.834 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.5 pp -65.68 -24.78 67.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.988 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.514 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -62.72 -18.74 63.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.094 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.36 -19.93 64.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -79.15 122.12 83.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.575 0.703 . . . . 0.0 110.903 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.511 ' O ' HG11 ' A' ' 244' ' ' VAL . 84.0 Cg_exo -48.58 -31.97 19.97 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.721 2.28 . . . . 0.0 112.241 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.46 ' HG2' ' HB ' ' A' ' 235' ' ' ILE . 99.1 mtt180 -59.01 -36.73 75.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.846 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.834 HG21 ' CD1' ' A' ' 311' ' ' LEU . 38.7 mt -99.97 -34.25 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -171.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.39 -41.52 20.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 -164.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.54 ' CB ' HG23 ' A' ' 244' ' ' VAL . . . -65.69 -44.49 86.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.013 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 317' ' ' ILE . 73.1 p -68.09 -29.7 68.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.074 -176.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -68.24 -38.17 81.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.894 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.1 -46.67 80.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.47 HD21 ' HB2' ' A' ' 112' ' ' ALA . 27.6 t30 -65.43 -35.49 81.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 176.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.79 -46.27 89.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -77.18 -32.96 56.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.05 -2.52 50.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -100.26 -156.63 27.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.449 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -137.36 143.08 41.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.585 ' O ' ' C ' ' A' ' 330' ' ' MET . 45.2 mm -78.79 104.79 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 -170.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.585 ' C ' ' O ' ' A' ' 329' ' ' ILE . 22.1 ptp . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 121.57 0.7 . . . . 0.0 110.846 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.846 0.355 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 88.2 mmm -75.17 -23.18 57.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 -171.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.6 m -62.25 -42.25 99.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.08 -33.0 63.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.989 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -64.85 -38.78 92.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.869 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 154' ' ' PRO . 38.3 m0 -60.59 -35.33 75.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 175.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . 0.613 ' CE1' ' HG3' ' A' ' 154' ' ' PRO . 32.3 m-85 -73.61 -38.62 65.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.33 94.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.148 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.402 ' O ' ' HB1' ' A' ' 346' ' ' ALA . 17.1 m -80.4 -25.12 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.463 ' O ' HG23 ' A' ' 347' ' ' VAL . 7.9 tmm_? -62.12 -45.58 92.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 173.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 98.1 m -55.61 -34.74 65.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.206 173.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.528 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -61.34 -42.99 99.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 -176.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 344' ' ' ARG . 1.4 m -74.35 -33.72 34.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.138 -174.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.44 -47.04 94.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.204 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 95.1 m-20 -64.98 -39.67 93.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.29 -46.74 60.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.2 -42.66 88.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.6 p -76.04 -10.61 59.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.82 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.18 14.97 81.68 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.581 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.65 -31.29 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.684 0.278 . . . . 0.0 110.848 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 84.9 mm-40 -139.56 158.3 44.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 51.2 p -78.39 166.55 22.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.194 170.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 62.7 t -55.72 -42.46 69.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 172.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -60.16 -46.09 90.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -69.89 -52.5 24.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.848 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -67.66 -45.5 75.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.041 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.759 HD11 ' HB1' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -67.42 -39.78 85.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.001 -177.068 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.57 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 87.9 tttt -64.78 -38.42 90.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -63.96 -38.02 89.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 175.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.528 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -64.61 -45.97 84.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.016 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 1.1 pp0? -73.03 -30.91 64.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -177.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 73.9 m -65.62 -42.73 91.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.153 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -66.26 -37.11 84.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.547 HD13 HG22 ' A' ' 183' ' ' VAL . 62.9 mt -66.0 -39.9 85.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.186 177.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 72.0 p -90.36 -11.15 41.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.153 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.927 175.487 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.784 0.326 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.9 mt -102.11 127.77 55.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -152.4 144.08 23.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.6 137.65 30.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.784 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.415 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 97.66 3.15 58.44 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.505 -172.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -170.1 153.31 4.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.76 0.315 . . . . 0.0 110.983 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.562 HD23 HD11 ' A' ' 33' ' ' ILE . 1.3 pt? -153.17 155.97 37.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.472 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 78.1 t -110.62 137.87 41.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.128 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.937 HG13 HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -122.09 132.76 70.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.095 -179.32 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.467 ' HB3' HD12 ' A' ' 43' ' ' LEU . 45.6 m0 -109.89 127.44 54.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 168.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.554 ' HB ' HD23 ' A' ' 20' ' ' LEU . 6.9 tt -108.18 145.6 15.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.137 -170.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -53.01 143.96 16.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.28 -13.53 21.99 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.418 -174.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -74.76 -10.29 59.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.861 0.363 . . . . 0.0 110.854 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -145.29 136.92 25.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 158.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.93 -83.86 1.01 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.537 -164.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -114.5 -45.0 3.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.951 0.405 . . . . 0.0 110.908 -173.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -68.6 -52.94 26.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.886 -149.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.608 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -60.27 -48.99 83.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 -175.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.937 HD22 HG13 ' A' ' 9' ' ' ILE . 18.0 tp -65.09 -41.41 95.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 110.978 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.23 67.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 173.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -67.17 -48.77 66.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.941 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 20' ' ' LEU . 14.3 m -74.7 -34.47 34.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.503 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -65.53 -45.11 91.44 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.536 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -64.2 -38.93 92.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.84 0.352 . . . . 0.0 110.905 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -63.31 -42.65 99.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.974 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.475 ' CD2' HD12 ' A' ' 33' ' ' ILE . 56.3 t80 -65.06 -37.74 88.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.822 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.98 -41.55 98.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.974 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.96 -31.99 69.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.875 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -80.61 -41.53 23.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.83 -172.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.61 ' OG1' HG13 ' A' ' 33' ' ' ILE . 51.1 p -105.11 -8.44 18.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.031 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.71 10.0 84.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.555 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 1.004 HD13 ' O ' ' A' ' 33' ' ' ILE . 2.0 pp -103.29 132.51 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.943 0.401 . . . . 0.0 111.119 -174.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -70.61 126.94 31.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.911 -168.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.523 HG23 HD22 ' A' ' 7' ' ' LEU . 93.2 t -110.27 120.52 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.099 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.402 ' HB ' HG23 ' A' ' 8' ' ' VAL . 99.6 m -112.83 113.83 26.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.064 -174.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.492 HG23 ' HG ' ' A' ' 20' ' ' LEU . 96.1 t -93.22 132.62 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.149 176.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.4 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 94.9 mt-10 -126.06 155.15 42.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.3 t-80 -77.04 140.03 66.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.604 0.716 . . . . 0.0 110.841 -161.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 72.7 Cg_exo -56.76 -22.22 43.77 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.72 2.28 . . . . 0.0 112.332 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -47.1 -50.16 20.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 -173.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -86.98 -9.85 54.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.467 HD12 ' HB3' ' A' ' 10' ' ' TRP . 7.7 tt -46.93 -54.24 10.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 -167.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.05 -35.23 66.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.868 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -74.96 -47.2 30.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.906 -168.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -84.75 -33.66 23.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -170.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.595 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 94.4 t80 -48.22 -53.12 36.5 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.587 0.708 . . . . 0.0 110.966 -165.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 39.1 Cg_endo -62.8 -30.51 77.92 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.65 2.233 . . . . 0.0 112.443 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -76.7 -43.72 36.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.1 m -74.78 -25.05 18.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.208 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.83 -33.67 76.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.119 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.97 69.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.3 p -91.4 -13.85 31.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.17 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.14 15.27 81.76 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.499 170.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -138.92 130.04 26.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.884 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.09 -118.84 0.73 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.472 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 84.4 Cg_endo -72.8 154.11 53.75 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.756 2.304 . . . . 0.0 112.432 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.439 ' CB ' HD11 ' A' ' 59' ' ' ILE . 1.7 m-20 -87.15 -38.42 16.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 170.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.749 HG23 ' HB2' ' A' ' 276' ' ' ALA . 0.0 OUTLIER -134.05 150.05 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.077 179.155 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 tp -129.33 124.73 60.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.1 -174.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.461 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 2.4 m-85 -100.15 134.75 42.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.466 ' CH2' ' HB3' ' A' ' 105' ' ' ALA . 32.2 p90 -145.01 -177.82 5.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.842 174.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.75 -97.14 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.144 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -110.44 -55.43 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -58.83 -35.75 73.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -162.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.532 ' HD3' ' CZ ' ' A' ' 70' ' ' TYR . 4.4 mmp_? -74.56 -21.24 59.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 -172.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -45.95 -54.59 8.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.95 -53.58 36.42 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.45 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.69 -52.44 53.07 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.532 ' CZ ' ' HD3' ' A' ' 66' ' ' ARG . 15.8 m-30 -75.78 -41.98 51.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.919 0.39 . . . . 0.0 110.893 -168.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.34 -47.18 71.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.096 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -65.07 -34.93 79.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.8 m -81.7 -7.97 59.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.45 32.08 62.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.472 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mp -84.75 -4.5 59.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 110.978 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.746 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.2 pp -128.28 145.02 51.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.18 141.43 47.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.4 mp0 -69.27 132.33 46.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.909 HG13 ' HB3' ' A' ' 103' ' ' LEU . 37.7 pt -118.82 167.11 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.154 175.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.5 p -113.76 149.55 41.95 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.599 0.714 . . . . 0.0 111.118 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.08 146.82 41.93 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.691 2.261 . . . . 0.0 112.39 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -108.11 119.25 38.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.999 0.428 . . . . 0.0 110.789 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.14 -42.23 99.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.852 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.12 -46.52 80.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.142 -177.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.549 ' HB3' ' HZ2' ' A' ' 94' ' ' TRP . 9.1 m-85 -72.07 -33.86 68.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -177.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.458 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.6 tt0 -53.95 -48.07 70.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.933 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.6 -35.02 79.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.95 -23.26 55.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.978 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.584 HD21 ' HG2' ' A' ' 107' ' ' PRO . 1.4 mp -108.75 -92.3 0.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 -173.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.442 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 33.6 t80 -169.68 127.84 0.84 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.597 0.713 . . . . 0.0 110.996 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 87.3 Cg_exo -57.07 -42.66 61.47 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.646 2.23 . . . . 0.0 112.341 -170.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.599 ' O ' ' HD1' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -70.18 -33.27 71.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -174.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.642 ' CG2' ' HB3' ' A' ' 107' ' ' PRO . 88.3 m -67.56 -36.26 80.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 -173.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.612 ' HA ' HG23 ' A' ' 97' ' ' VAL . 68.5 m95 -67.83 -26.45 66.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.933 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -73.76 -32.17 63.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.82 171.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.11 -25.8 62.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.085 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.612 HG23 ' HA ' ' A' ' 94' ' ' TRP . 19.8 m -101.39 17.81 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.099 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 75.7 ttt180 -112.91 132.1 55.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.933 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -138.41 127.75 24.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 62.05 34.87 16.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.919 175.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.31 -4.17 78.34 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.578 173.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.42 150.05 48.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.353 . . . . 0.0 110.959 173.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.909 ' HB3' HG13 ' A' ' 79' ' ' ILE . 2.9 tp -74.42 140.4 44.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.563 HG22 HD11 ' A' ' 76' ' ' LEU . 2.0 pp -118.56 -7.35 11.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.091 -174.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.466 ' HB3' ' CH2' ' A' ' 62' ' ' TRP . . . -164.78 168.83 17.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.117 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.45 ' HB3' HD11 ' A' ' 285' ' ' LEU . 94.5 m-85 -112.22 146.41 34.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.714 0.769 . . . . 0.0 110.903 168.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.642 ' HB3' ' CG2' ' A' ' 93' ' ' THR . 73.9 Cg_endo -74.11 118.23 5.31 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.629 2.219 . . . . 0.0 112.381 172.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.423 HD12 HD22 ' A' ' 280' ' ' LEU . 29.7 mm -92.09 -54.97 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.147 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.89 158.63 44.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.059 -167.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.65 137.47 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.076 -172.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -122.01 139.07 54.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.543 ' HB2' HD21 ' A' ' 323' ' ' ASN . . . -152.1 160.16 43.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.063 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -94.56 168.68 10.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.852 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 100.0 p -154.87 152.92 30.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.819 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.966 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -100.03 128.38 46.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 169.316 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.518 ' N ' HD23 ' A' ' 115' ' ' LEU . 4.3 mp -111.07 137.01 45.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -133.75 149.58 51.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -86.45 110.98 20.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.461 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 88.9 tttt -62.1 -23.12 66.34 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -76.01 -24.19 55.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.893 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.537 HD22 ' O ' ' A' ' 220' ' ' GLY . 7.0 mp -94.76 -53.37 3.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.862 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 223' ' ' ALA . 1.7 mp -105.07 132.31 20.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.678 0.751 . . . . 0.0 110.863 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.44 -16.99 24.21 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.686 2.257 . . . . 0.0 112.331 -175.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.585 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 20.8 p30 -154.33 161.62 28.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.614 0.721 . . . . 0.0 110.915 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.585 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 57.8 Cg_endo -69.59 155.12 67.38 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.646 2.231 . . . . 0.0 112.392 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.14 146.38 70.02 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.669 2.246 . . . . 0.0 112.299 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -100.12 -48.6 4.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 72.7 p -133.17 158.56 42.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 48.9 t-105 -64.2 -30.23 71.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 175.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.06 -23.67 65.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -174.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -72.75 -32.17 65.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.506 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 1.6 mp -66.03 -47.17 63.55 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.644 0.735 . . . . 0.0 111.085 -163.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.506 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 97.9 Cg_exo -53.31 -50.89 12.37 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.653 2.235 . . . . 0.0 112.267 -175.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.94 -39.21 69.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.134 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 30.3 tp -56.02 -45.32 79.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.406 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . 19.5 t70 -53.74 -34.97 60.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.837 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.47 -36.76 79.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -73.44 -53.21 11.23 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -172.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.573 HD21 ' N ' ' A' ' 140' ' ' LYS . 0.8 OUTLIER -80.01 -10.64 59.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -175.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.573 ' N ' HD21 ' A' ' 139' ' ' LEU . 86.5 tttt -55.99 -31.61 63.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.943 166.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.87 -25.1 68.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -95.14 5.59 51.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.47 28.85 60.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.528 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -120.09 170.09 9.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.758 0.313 . . . . 0.0 110.904 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.3 t -131.25 141.25 49.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -70.42 -55.13 9.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.048 -166.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -141.97 131.05 23.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 -170.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.734 ' SD ' ' HB3' ' A' ' 213' ' ' ALA . 52.7 ttm -110.54 123.76 50.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -150.46 157.15 42.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -167.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -101.81 96.24 6.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.965 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.861 HD22 HD11 ' A' ' 195' ' ' LEU . 1.8 tm? -76.12 -18.29 59.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.973 172.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -80.36 -2.49 45.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.434 ' O ' HG21 ' A' ' 157' ' ' THR . 38.4 mt-10 -113.53 152.21 45.17 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.574 0.702 . . . . 0.0 110.909 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.541 ' HD3' ' CD ' ' A' ' 344' ' ' ARG . 30.5 Cg_endo -66.91 -19.82 51.97 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.68 2.254 . . . . 0.0 112.367 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -65.02 -40.66 95.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -172.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . 0.434 ' HD2' HD21 ' A' ' 151' ' ' LEU . 74.7 t80 -82.97 -36.04 25.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.807 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.434 HG21 ' O ' ' A' ' 153' ' ' GLU . 81.9 p -60.51 -46.7 89.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.189 -170.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.661 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 89.0 t90 -67.84 -48.17 41.53 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.502 0.667 . . . . 0.0 110.897 -167.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.661 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 78.5 Cg_exo -47.57 -46.37 20.86 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.666 2.244 . . . . 0.0 112.512 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.684 HD21 ' O ' ' A' ' 160' ' ' LEU . 6.5 tt -70.07 -39.87 75.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.965 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 71.0 mt -70.39 -41.02 78.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.014 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.63 -28.6 61.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.116 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.529 ' HB1' ' HD2' ' A' ' 250' ' ' PHE . . . -63.12 -34.96 78.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 -170.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -91.48 1.99 56.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.884 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.01 1.31 14.48 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.467 170.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.33 65.02 4.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.55 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -84.86 133.55 34.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.912 0.387 . . . . 0.0 110.893 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.25 5.43 10.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.076 -170.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.435 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.0 p90 -146.85 152.9 39.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.944 0.402 . . . . 0.0 110.956 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -103.78 126.15 50.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.98 156.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -115.69 126.28 53.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.857 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -151.58 130.07 12.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.913 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.1 t30 55.02 43.87 29.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 171.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.98 14.85 81.41 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.48 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.23 138.71 50.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 0.0 110.845 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -99.37 144.61 28.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 170.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -121.48 110.59 16.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.876 172.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.579 ' C ' HD13 ' A' ' 178' ' ' ILE . 1.2 pp -80.0 -12.64 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.082 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.96 -13.13 20.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -122.94 85.23 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.874 170.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 169' ' ' PHE . 34.1 m -116.9 170.48 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.115 -169.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.63 24.42 29.84 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.45 -167.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.529 HG22 HD13 ' A' ' 368' ' ' ILE . 11.3 m -110.01 -15.45 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.0 111.112 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -85.92 19.61 2.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.786 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -110.32 -179.91 3.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.1 -24.6 64.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.097 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . 0.413 ' O ' ' HB1' ' A' ' 190' ' ' ALA . . . -70.87 -40.63 63.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.456 -171.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.642 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -64.38 -35.35 80.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 111.115 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.546 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.1 mttt -59.05 -31.22 68.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 175.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 187' ' ' GLY . . . -65.51 -30.69 71.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.115 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.16 -47.46 84.9 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.379 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 346' ' ' ALA . 19.7 mt -64.89 -38.91 92.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.883 0.373 . . . . 0.0 110.936 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.3 m -58.71 -45.12 90.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.21 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -77.28 -43.06 34.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.843 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.861 HD11 HD22 ' A' ' 151' ' ' LEU . 6.0 tt -55.57 -48.6 74.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 -171.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 24.8 m -68.58 -19.22 24.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -57.5 -54.87 41.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 -169.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 1.049 ' H ' HD13 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -76.1 -26.48 56.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.925 -168.021 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.609 ' H ' HD23 ' A' ' 198' ' ' LEU . 1.8 pp -86.65 -34.42 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.172 177.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.86 -31.81 68.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.856 165.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -85.86 6.06 29.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.861 177.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 65.0 39.94 5.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 170.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -84.54 -9.76 58.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 58.7 ttp -134.54 151.38 51.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -97.69 155.56 16.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.921 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.95 -27.76 69.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -95.25 4.25 53.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.903 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.409 ' CG2' ' HG3' ' A' ' 148' ' ' MET . 90.0 m -63.08 132.14 50.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.15 -176.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.427 ' H ' HD13 ' A' ' 212' ' ' ILE . 23.6 t0 -149.75 167.39 26.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.858 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -68.58 -34.01 75.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.0 p -63.57 -32.58 74.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 209' ' ' ASP . 79.7 mt -62.42 -36.56 75.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.08 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.734 ' HB3' ' SD ' ' A' ' 148' ' ' MET . . . -66.07 -42.22 89.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.081 -173.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -64.82 -39.24 93.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.986 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.32 -40.3 85.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.102 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.89 -34.59 78.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.121 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -59.95 -33.66 72.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.825 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -59.91 -34.98 73.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.954 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -96.45 -21.13 17.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.98 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . 0.537 ' O ' HD22 ' A' ' 121' ' ' LEU . . . 91.05 30.51 11.0 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.439 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -84.73 -27.75 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.876 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 94.9 m -116.96 131.1 57.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.216 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.493 ' HB2' HD23 ' A' ' 122' ' ' LEU . . . -66.26 -54.57 23.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.098 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 67.0 mtm -137.82 160.0 40.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.797 -168.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 10.4 t -149.76 164.17 36.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.7 mm -111.29 125.58 68.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.07 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -144.65 167.82 21.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.893 -169.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.407 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -118.52 -155.13 9.85 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.471 -174.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.407 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 30.7 Cg_endo -59.99 -22.53 69.49 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.725 2.283 . . . . 0.0 112.289 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.9 p90 -81.54 4.33 21.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.949 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -51.57 -29.24 16.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.0 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -53.54 -20.59 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 26.3 t -42.03 -57.81 2.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.808 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -150.65 40.36 0.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.482 HD13 HG21 ' A' ' 116' ' ' ILE . 46.5 mm . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.124 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.828 0.347 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -99.14 70.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -174.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.461 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 82.4 m-85 -130.03 145.58 51.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.004 172.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -128.26 153.13 19.36 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.509 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.643 HG23 ' HB3' ' A' ' 319' ' ' ALA . 6.7 p -138.53 135.96 43.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.381 . . . . 0.0 111.193 -177.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.2 t -153.44 149.89 28.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.416 ' CG1' ' HB2' ' A' ' 323' ' ' ASN . 25.1 m -60.76 167.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.674 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.3 mm? -64.77 146.19 98.62 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.586 0.708 . . . . 0.0 110.899 -160.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.85 -177.01 2.61 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.727 2.284 . . . . 0.0 112.285 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.2 p -106.76 162.63 13.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.143 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.529 ' HD2' ' HB1' ' A' ' 163' ' ' ALA . 44.7 t80 -146.03 123.43 11.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 176.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 55.33 35.25 24.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.84 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.53 12.12 70.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.531 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -137.05 140.37 31.19 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.56 0.695 . . . . 0.0 110.947 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.36 140.82 30.94 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.677 2.251 . . . . 0.0 112.407 -174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.674 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 89.8 p -83.33 -5.1 59.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.798 169.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 50.9 mtmt -48.33 110.07 1.33 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.546 0.689 . . . . 0.0 110.901 -176.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 32.1 Cg_exo -66.0 163.53 30.83 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.623 2.216 . . . . 0.0 112.32 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -73.66 174.82 7.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.828 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.5 t -108.39 132.32 56.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.048 -170.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -112.12 126.85 7.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.436 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 96.9 t -116.0 134.41 59.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.854 0.359 . . . . 0.0 111.098 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.416 HD21 ' N ' ' A' ' 263' ' ' SER . 2.6 tt -67.32 129.75 40.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.945 171.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.416 ' N ' HD21 ' A' ' 262' ' ' LEU . 64.3 p -124.63 131.82 53.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.899 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -125.25 125.87 44.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.137 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -119.75 170.34 14.08 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.424 -171.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 59' ' ' ILE . 13.1 mm -99.96 127.93 52.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.768 0.318 . . . . 0.0 111.107 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -64.91 127.25 30.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.4 ' HB3' ' C ' ' A' ' 76' ' ' LEU . . . -64.9 -24.29 67.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.122 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.65 -11.57 55.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.037 -172.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.6 t -77.67 122.38 85.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.632 0.73 . . . . 0.0 110.87 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.34 -11.57 30.31 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.591 2.194 . . . . 0.0 112.349 171.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -111.73 35.19 3.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.917 -169.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -59.31 -26.68 65.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.834 -170.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -69.03 -39.86 78.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.864 -172.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.38 -48.45 72.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.749 ' HB2' HG23 ' A' ' 59' ' ' ILE . . . -67.38 -48.17 68.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.153 -172.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -65.25 -37.46 87.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.5 tt0 -68.21 -53.7 22.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 -172.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.413 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.1 p90 -67.54 -35.13 78.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.837 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.484 ' HA ' HD23 ' A' ' 284' ' ' LEU . 4.8 tt -58.58 -50.04 75.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -79.95 -33.51 39.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 65.6 m-80 -100.01 -17.71 17.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 -164.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 40.0 t80 -121.33 -48.64 2.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.954 -172.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 280' ' ' LEU . 0.3 OUTLIER -65.04 -46.39 81.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.82 176.228 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 106' ' ' TYR . 64.8 mt -84.97 59.39 5.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.494 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 52.5 p -138.47 150.2 46.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.187 172.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.587 ' HA ' HD11 ' A' ' 290' ' ' LEU . 42.9 p-10 -51.56 -26.0 7.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.84 -174.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -78.65 -44.8 22.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.791 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.4 -51.07 13.68 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 -169.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.587 HD11 ' HA ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -73.31 -20.78 60.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 110.91 -179.251 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.436 ' N ' HD12 ' A' ' 290' ' ' LEU . 81.8 tt0 -66.06 -40.75 91.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.933 168.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.79 76.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.075 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.608 HG13 ' HA3' ' A' ' 19' ' ' GLY . 24.9 t -77.4 -44.62 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.143 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.438 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 49.8 t30 -65.03 -25.86 68.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.968 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.4 -28.96 70.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -87.01 -41.65 13.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.822 -176.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -147.69 132.8 9.08 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 121.515 0.674 . . . . 0.0 111.027 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -51.99 111.92 0.72 Allowed 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.628 2.219 . . . . 0.0 112.408 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.438 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 55.3 mt -90.98 -17.17 26.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -172.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.537 ' O ' HG23 ' A' ' 317' ' ' ILE . . . 102.96 -43.04 1.75 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.394 175.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -176.27 168.72 2.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.823 0.344 . . . . 0.0 110.974 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.526 HG23 HD22 ' A' ' 311' ' ' LEU . 23.9 m -122.6 154.29 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.199 170.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -69.44 -18.39 63.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.09 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.487 ' CD2' HD22 ' A' ' 290' ' ' LEU . 63.3 tp -83.63 122.62 28.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.014 -173.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -59.55 -36.33 75.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.787 -173.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.8 m -63.11 -49.87 72.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 -168.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.6 ' CD2' HD21 ' A' ' 311' ' ' LEU . 33.1 t80 -83.79 -26.97 29.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -56.43 -44.38 80.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.918 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.01 -36.23 83.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.875 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -76.01 -48.89 19.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.826 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.6 pp -66.72 -25.43 66.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.482 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -64.2 -17.37 63.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.061 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -67.3 -17.86 64.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.872 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -80.02 123.28 83.61 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.557 0.694 . . . . 0.0 110.904 173.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.562 ' O ' HG11 ' A' ' 244' ' ' VAL . 83.7 Cg_exo -52.85 -35.59 70.68 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.582 2.188 . . . . 0.0 112.319 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -64.79 -26.83 68.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.92 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.826 HG21 ' CD1' ' A' ' 311' ' ' LEU . 56.3 mt -96.75 -34.54 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.115 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.21 -39.41 13.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.012 -167.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.643 ' HB3' HG23 ' A' ' 244' ' ' VAL . . . -65.15 -44.32 88.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.05 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 317' ' ' ILE . 69.2 p -68.27 -29.9 68.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.128 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 18.0 tmm? -69.99 -40.13 75.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -65.69 -45.6 82.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.543 HD21 ' HB2' ' A' ' 112' ' ' ALA . 25.4 t30 -63.42 -36.3 83.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.967 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.79 -48.28 79.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.032 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -75.4 -32.69 60.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -94.75 -5.6 44.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.931 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -95.28 -157.73 32.43 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.496 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -140.02 142.73 36.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 110.925 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.581 ' O ' ' C ' ' A' ' 330' ' ' MET . 31.4 mm -79.91 108.47 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.215 -170.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.646 ' O ' ' HG3' ' A' ' 330' ' ' MET . 20.4 ptp . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.503 0.668 . . . . 0.0 110.848 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.804 0.335 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 79.7 mmm -71.33 -25.02 62.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.91 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.0 m -61.76 -40.06 93.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 176.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.88 -34.3 60.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.995 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -63.39 -37.97 89.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.891 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 154' ' ' PRO . 21.0 m0 -61.07 -34.5 75.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -76.79 -35.27 57.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' A' ' 367' ' ' ARG . . . -63.2 -39.98 96.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.057 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.8 m -81.82 -24.2 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.091 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.541 ' CD ' ' HD3' ' A' ' 154' ' ' PRO . 52.9 ttt180 -55.63 -55.45 31.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.824 173.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 96.6 m -56.87 -33.0 66.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.131 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -56.94 -44.51 82.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.136 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.447 ' HA ' HD23 ' A' ' 192' ' ' LEU . 1.3 m -74.96 -33.1 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.179 -174.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.3 -47.21 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.22 173.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 84.5 m-20 -66.73 -37.01 83.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.52 -47.26 61.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.091 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.45 -39.87 92.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.094 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.5 p -74.86 -14.17 60.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.007 0.432 . . . . 0.0 110.85 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 76.67 10.61 85.83 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.505 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -79.77 -25.09 41.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.765 0.317 . . . . 0.0 110.844 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.577 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 87.5 mt-30 -133.15 158.26 43.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 169.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.5 p -79.37 171.01 15.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.154 168.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 67.1 t -55.88 -44.5 78.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.07 169.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -58.21 -44.93 88.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -70.84 -52.02 22.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -69.19 -44.66 71.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.132 -173.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.642 HD11 ' HB1' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -65.49 -39.99 92.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 -177.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . 0.574 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.0 tttt -64.91 -38.4 90.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.894 176.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -65.83 -36.89 84.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -63.92 -44.77 91.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.077 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -73.26 -30.38 63.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.942 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 68.5 m -64.34 -41.17 96.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . 0.438 ' HB2' ' HB2' ' A' ' 342' ' ' ALA . 99.6 mtt180 -67.74 -39.62 84.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.748 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.529 HD13 HG22 ' A' ' 183' ' ' VAL . 67.9 mt -65.6 -39.27 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.164 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.8 p -92.59 -9.04 42.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.064 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.99 173.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.733 0.301 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.475 HG21 ' HD2' ' A' ' 271' ' ' PRO . 87.1 mt -79.75 126.35 39.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -148.49 147.38 29.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.801 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.3 129.77 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.817 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.474 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 96.33 5.85 59.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.448 -174.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.0 tttt -164.71 139.86 5.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.779 0.324 . . . . 0.0 110.945 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.683 HD23 HD11 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -146.39 157.45 43.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 75.3 t -108.94 133.43 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.114 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.773 HG13 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -123.11 135.36 63.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 -178.493 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -109.07 160.87 15.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.572 HG21 ' HB2' ' A' ' 15' ' ' LYS . 87.9 mt -132.93 149.26 31.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.154 166.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.511 ' O ' HG22 ' A' ' 11' ' ' ILE . 62.0 t30 -58.26 159.81 5.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 174.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.51 -15.36 8.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.555 -174.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.91 -24.05 65.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 110.872 -172.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.572 ' HB2' HG21 ' A' ' 11' ' ' ILE . 35.4 mtmt -134.25 132.04 39.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.944 169.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.07 -94.07 0.76 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.459 -168.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -115.24 -46.67 2.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 110.943 -172.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -64.03 -47.85 78.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.963 -155.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.93 ' HA3' HG21 ' A' ' 293' ' ' VAL . . . -57.91 -45.66 93.39 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.431 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.773 HD11 HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -51.51 -50.73 59.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.872 0.368 . . . . 0.0 110.865 177.024 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.18 -39.37 63.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.167 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -70.1 -52.33 24.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.0 m -69.2 -36.33 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.574 ' HA3' HG22 ' A' ' 35' ' ' VAL . . . -66.72 -41.14 93.93 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.513 173.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -54.07 -46.06 71.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.889 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.9 -44.06 90.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.945 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.672 ' CE2' HD12 ' A' ' 33' ' ' ILE . 44.0 t80 -65.71 -38.09 88.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.812 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 34.7 tt0 -64.5 -42.94 95.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.841 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.6 -32.46 68.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -81.14 -39.35 25.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.872 -171.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.722 ' OG1' HG13 ' A' ' 33' ' ' ILE . 67.8 p -103.78 -10.21 18.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.42 7.39 85.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.453 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 1.085 HD13 ' O ' ' A' ' 33' ' ' ILE . 1.8 pp -104.08 132.51 50.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.882 0.372 . . . . 0.0 111.064 -175.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.8 mttt -70.41 136.74 49.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -171.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.574 HG22 ' HA3' ' A' ' 24' ' ' GLY . 3.0 m -111.99 133.07 58.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 174.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.409 ' HB ' HG23 ' A' ' 8' ' ' VAL . 94.6 m -110.1 125.66 53.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.102 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.595 HG23 ' HG ' ' A' ' 20' ' ' LEU . 60.9 t -89.66 126.29 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 178.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -112.91 148.88 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 175.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 64.8 t-80 -86.27 136.19 35.95 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.658 0.742 . . . . 0.0 110.883 -169.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 83.2 Cg_exo -56.04 -21.36 34.17 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.721 2.28 . . . . 0.0 112.322 -175.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -48.07 -53.99 14.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 43' ' ' LEU . 99.1 mttt -88.78 0.92 56.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -172.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 12' ' ' ASN . 16.4 tp -39.88 -54.73 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.975 -173.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.48 -35.27 68.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.844 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.19 -47.93 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 -166.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 79.1 tttt -78.6 -43.81 25.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 -171.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 83.6 t80 -50.87 -53.88 42.76 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.574 0.702 . . . . 0.0 110.851 -167.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 38.9 Cg_endo -65.98 -30.11 48.44 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.629 2.22 . . . . 0.0 112.351 -177.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -74.8 -41.99 58.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.44 HG22 ' HD3' ' A' ' 57' ' ' PRO . 24.9 m -75.48 -21.5 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.201 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 -31.69 72.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.057 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.15 -29.76 70.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.11 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.9 p -92.62 -15.19 27.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.199 170.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.98 18.38 79.64 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.432 171.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -140.2 143.85 36.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.863 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.48 -78.31 0.33 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.477 168.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.488 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 89.0 Cg_endo -78.52 140.99 17.35 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.727 2.284 . . . . 0.0 112.329 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.424 ' HB2' HD11 ' A' ' 59' ' ' ILE . 1.5 m-20 -101.41 -41.13 6.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.97 173.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.65 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -132.92 143.68 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.195 176.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.0 tp -136.08 128.06 44.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.174 -169.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.498 ' N ' ' HD1' ' A' ' 61' ' ' PHE . 2.0 m-30 -97.89 142.28 29.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.926 -175.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 80.3 m95 -140.72 159.74 41.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 174.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.17 -88.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.059 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.407 ' CG ' HG21 ' A' ' 329' ' ' ILE . 86.1 t60 -125.48 -62.54 1.19 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.874 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -75.39 -35.42 61.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 -161.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.483 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 9.4 mpt_? -54.66 -33.75 61.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.895 -168.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.577 ' HB3' HD11 ' A' ' 104' ' ' ILE . 51.0 m-85 -56.79 -38.71 72.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -172.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.06 -50.49 57.31 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.485 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.13 -42.35 99.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.515 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -74.66 -33.21 62.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.945 0.403 . . . . 0.0 110.985 -176.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.414 ' HA ' HD12 ' A' ' 76' ' ' LEU . . . -65.11 -38.71 91.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.074 170.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -63.97 -34.63 78.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 98.9 p -86.7 -10.14 54.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.886 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.54 28.97 62.41 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.554 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 mp -90.39 -17.2 27.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 -173.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 1.33 ' O ' HD13 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.09 121.17 37.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.826 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -64.73 137.83 58.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.084 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.21 137.05 56.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.452 HD13 ' CE2' ' A' ' 106' ' ' TYR . 37.2 pt -109.98 160.42 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.8 p -96.97 149.87 36.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.547 0.689 . . . . 0.0 111.214 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.13 137.93 29.8 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.74 2.294 . . . . 0.0 112.397 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -104.06 108.8 20.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.888 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.77 -41.78 91.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.969 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.38 -41.88 98.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.218 -176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.574 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 13.0 m-30 -74.35 -47.6 33.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -49.44 -42.53 43.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -57.35 -30.58 64.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.889 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 305' ' ' LYS . 84.9 mttt -87.45 -13.81 42.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.931 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 46.8 mt -104.93 -145.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.973 -170.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.97 140.69 37.11 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.743 0.782 . . . . 0.0 110.888 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.48 -28.78 38.31 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.628 2.218 . . . . 0.0 112.405 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -65.58 -42.81 91.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.522 HG23 HG22 ' A' ' 261' ' ' VAL . 81.2 p -78.25 -38.37 42.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.161 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -49.37 -46.97 47.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.931 169.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.42 -35.6 80.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.76 -24.94 65.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.024 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.49 HG21 HD11 ' A' ' 103' ' ' LEU . 31.7 m -112.46 20.77 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.206 -171.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.478 ' HB3' HD12 ' A' ' 103' ' ' LEU . 54.7 ptt85 -120.01 146.7 45.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.919 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -136.93 125.58 23.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.014 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.3 t30 60.01 37.05 21.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.73 1.07 90.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.517 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -117.46 150.15 39.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.758 0.314 . . . . 0.0 110.905 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.49 HD11 HG21 ' A' ' 97' ' ' VAL . 6.3 tp -81.68 136.79 35.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.577 HD11 ' HB3' ' A' ' 67' ' ' PHE . 2.1 pp -128.04 2.72 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.153 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.494 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . . . -168.32 169.22 10.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.064 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 263' ' ' SER . 99.4 m-85 -120.1 139.67 28.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.682 0.753 . . . . 0.0 110.887 166.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.413 ' HD3' HG22 ' A' ' 97' ' ' VAL . 98.4 Cg_endo -78.52 122.99 5.75 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.586 2.19 . . . . 0.0 112.362 172.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 106' ' ' TYR . 2.2 mp -109.66 -42.92 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.039 -174.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -137.36 144.46 42.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 -165.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.27 131.49 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.17 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -117.6 125.37 50.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.519 ' HB1' ' CG2' ' A' ' 320' ' ' THR . . . -163.57 163.74 24.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.145 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.436 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 6.6 mp -101.03 170.93 7.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.917 -167.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 86.7 p -158.84 154.4 26.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 171.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.877 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -100.06 129.62 46.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.898 174.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.63 ' N ' HD23 ' A' ' 115' ' ' LEU . 5.2 mp -114.34 135.99 52.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 -177.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -135.8 154.93 51.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 -172.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -96.78 119.31 35.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.462 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 98.4 mttt -65.6 -18.98 65.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -83.38 -28.16 29.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.811 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 223' ' ' ALA . 10.4 mp -88.09 -44.6 10.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.76 HD23 ' HB2' ' A' ' 223' ' ' ALA . 2.2 pt? -139.94 127.29 12.67 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.607 0.718 . . . . 0.0 110.907 168.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.73 -10.37 17.03 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.592 2.195 . . . . 0.0 112.412 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.448 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 61.0 t-20 -143.48 108.32 5.2 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.643 0.735 . . . . 0.0 110.881 -175.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 48.0 Cg_endo -68.03 148.61 76.04 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.728 2.286 . . . . 0.0 112.222 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.17 142.7 56.57 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.721 2.281 . . . . 0.0 112.341 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -83.38 -27.93 29.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.4 p -127.15 154.54 44.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.106 -177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.686 ' HA ' HD11 ' A' ' 132' ' ' ILE . 54.4 m95 -69.89 -23.96 63.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.29 -23.1 63.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -78.52 -22.59 47.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.686 HD11 ' HA ' ' A' ' 129' ' ' TRP . 1.4 mp -56.16 -51.13 83.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.677 0.751 . . . . 0.0 111.15 -170.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.6 Cg_endo -69.36 -41.25 4.97 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.621 2.214 . . . . 0.0 112.299 -172.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.0 -40.54 71.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.994 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 0.832 ' CD2' ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -58.35 -42.67 87.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.963 174.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.52 ' HA ' ' HB3' ' A' ' 146' ' ' ALA . 32.7 t70 -52.65 -37.24 58.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.09 -31.01 69.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.9 -56.39 5.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.842 -174.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.527 HD21 ' N ' ' A' ' 140' ' ' LYS . 1.0 OUTLIER -80.89 -10.06 59.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -175.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.527 ' N ' HD21 ' A' ' 139' ' ' LEU . 86.0 tttt -54.36 -30.77 52.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.804 165.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.82 -24.92 68.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.086 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -95.01 4.05 54.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.36 27.37 59.72 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.478 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.46 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 38.4 mmtm -116.48 155.52 28.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 0.0 110.891 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.9 t -100.73 147.53 25.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.834 173.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.52 ' HB3' ' HA ' ' A' ' 136' ' ' ASP . . . -67.25 -43.32 82.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.171 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.475 HD11 HG12 ' A' ' 226' ' ' ILE . 48.9 tp -141.4 152.6 44.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.843 -177.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 61.5 tpp -128.0 125.17 38.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.793 170.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -161.07 165.05 30.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -110.0 165.63 11.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 172.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.5 HD11 HD11 ' A' ' 195' ' ' LEU . 36.6 tp -130.15 -16.81 3.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.856 171.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -71.92 0.71 8.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.847 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 70.3 mm-40 -121.82 144.9 41.99 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.672 0.749 . . . . 0.0 110.882 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.446 ' HB3' ' HB3' ' A' ' 340' ' ' TRP . 53.9 Cg_exo -55.22 -28.74 63.33 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.789 2.326 . . . . 0.0 112.313 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -59.49 -42.29 91.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -86.47 -32.24 20.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.467 HG23 HG22 ' A' ' 347' ' ' VAL . 65.0 p -64.84 -37.47 87.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.225 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.572 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 42.7 t-105 -61.93 -54.52 49.92 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 121.597 0.713 . . . . 0.0 111.016 -173.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 33.2 Cg_endo -67.14 -27.6 41.56 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.699 2.266 . . . . 0.0 112.38 -174.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.673 ' C ' HD13 ' A' ' 160' ' ' LEU . 2.9 tm? -64.77 -41.85 95.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.581 HG22 ' HA3' ' A' ' 166' ' ' GLY . 2.9 mp -78.08 -41.91 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.23 176.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.32 -20.21 65.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.072 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -57.87 -34.17 69.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.985 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -101.51 5.37 41.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.864 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.33 9.21 24.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.379 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.581 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -75.09 65.79 2.25 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.344 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -95.69 134.81 38.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.885 0.374 . . . . 0.0 110.96 173.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.549 ' HB2' HG21 ' A' ' 368' ' ' ILE . . . -47.77 -31.0 4.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 -175.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.42 ' CD1' HG12 ' A' ' 181' ' ' VAL . 98.5 m-85 -138.48 148.03 43.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.911 174.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -69.11 127.66 33.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -102.04 119.95 39.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.933 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -150.83 130.61 13.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.809 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.3 t30 55.38 42.43 30.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.934 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.38 9.39 81.39 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.416 173.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.03 141.55 49.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.7 0.286 . . . . 0.0 110.892 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -94.11 135.33 35.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 172.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -95.92 105.41 17.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.907 -170.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.458 ' C ' HD13 ' A' ' 178' ' ' ILE . 2.4 pp -71.31 -6.52 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -100.89 -16.7 17.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -134.95 100.75 4.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 168' ' ' ALA . 32.4 m -101.45 162.14 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.132 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -101.75 -0.1 52.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.527 -168.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.5 m -100.72 -20.03 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 0.0 111.128 -171.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -96.28 20.11 10.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -106.62 -175.08 2.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 -174.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.49 71.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.061 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -71.4 -41.25 58.96 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.461 -170.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.413 ' HB1' HD22 ' A' ' 361' ' ' LEU . . . -61.71 -34.68 76.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.775 0.321 . . . . 0.0 111.036 177.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -61.75 -40.87 96.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.969 174.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.06 76.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.025 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.512 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -58.68 -48.88 82.5 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.458 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 346' ' ' ALA . 25.8 mt -66.41 -39.11 88.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.943 0.402 . . . . 0.0 110.967 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.9 m -58.55 -45.39 89.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.197 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.439 ' O ' HD23 ' A' ' 198' ' ' LEU . 82.3 t80 -68.91 -48.53 63.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 174.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.839 ' C ' HD21 ' A' ' 195' ' ' LEU . 3.2 tt -50.76 -51.79 46.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -174.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.516 ' HA ' HG23 ' A' ' 199' ' ' ILE . 34.7 m -63.52 -23.47 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.071 -175.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.54 -34.01 73.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.961 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 194' ' ' PHE . 0.6 OUTLIER -82.15 -40.02 22.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -174.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.551 ' O ' HG12 ' A' ' 199' ' ' ILE . 0.0 OUTLIER -75.23 -29.56 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 175.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . 0.435 ' N ' HD11 ' A' ' 199' ' ' ILE . 87.6 tttt -72.36 -46.54 54.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.901 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -90.16 5.75 45.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 67.27 37.72 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 170.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -83.04 -13.78 55.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.918 173.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -138.22 155.15 48.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.917 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -103.78 139.83 38.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.824 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.96 -22.24 64.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.071 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.72 -5.84 58.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.895 -172.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 86.7 m -60.03 137.98 57.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.457 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 20.9 t0 -139.25 175.41 9.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -60.82 -45.8 93.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.917 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 96.3 p -67.57 -35.97 80.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.457 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 85.8 mt -64.17 -41.61 92.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.145 175.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.76 -38.89 84.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.091 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -63.17 -45.86 89.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.803 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.14 95.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.159 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.67 97.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.02 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -66.78 -47.38 72.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.873 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -66.0 -30.52 71.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -86.02 -13.6 46.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.924 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.03 26.23 53.56 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.47 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -86.42 -28.62 23.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 0.0 110.911 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 15.3 t -119.79 134.38 55.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.109 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.76 ' HB2' HD23 ' A' ' 122' ' ' LEU . . . -78.45 -34.14 47.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.107 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.477 ' HB3' HD22 ' A' ' 115' ' ' LEU . 77.7 mtm -128.94 150.33 50.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.847 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.8 t -145.34 150.97 37.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.475 HG12 HD11 ' A' ' 147' ' ' LEU . 39.2 mm -107.04 122.22 60.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.11 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -140.98 149.39 41.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -127.24 -150.58 7.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.482 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.05 -20.36 71.22 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.658 2.239 . . . . 0.0 112.282 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -71.6 -24.47 61.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.905 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 55.09 54.92 8.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.079 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -60.27 -38.17 82.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.953 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 35.7 t -105.0 118.79 37.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 168.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -75.45 72.83 2.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.424 HD11 HG21 ' A' ' 116' ' ' ILE . 78.7 mt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.155 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 25.5 m . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -92.71 121.06 33.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.897 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.462 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 31.3 p90 -143.53 152.56 41.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.937 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -143.01 167.8 26.23 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.606 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.435 HG21 HG13 ' A' ' 116' ' ' ILE . 7.7 p -132.27 139.5 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.966 0.412 . . . . 0.0 111.061 -172.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.0 t -144.92 147.16 32.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 168.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 16.6 m -56.92 156.45 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.133 168.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.483 ' N ' HD12 ' A' ' 247' ' ' LEU . 7.4 mp -66.76 148.99 98.61 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.514 0.673 . . . . 0.0 110.897 -157.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 48.1 Cg_exo -60.69 178.34 0.49 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.781 2.321 . . . . 0.0 112.369 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 82.1 p -99.96 153.98 18.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -135.31 117.05 15.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 54.77 35.17 23.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 89.11 5.7 72.73 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.472 171.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -124.36 140.54 35.35 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.606 0.717 . . . . 0.0 110.854 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.02 129.5 17.43 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.688 2.258 . . . . 0.0 112.326 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 68.0 m -78.81 -26.76 44.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.87 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -47.63 109.92 1.22 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.557 0.694 . . . . 0.0 110.91 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -58.72 161.31 15.33 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.731 2.287 . . . . 0.0 112.307 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -62.4 162.1 10.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 112' ' ' ALA . 3.5 p -108.3 134.03 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.11 -175.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.25 142.94 16.06 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.451 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.522 HG22 HG23 ' A' ' 93' ' ' THR . 73.3 t -127.65 122.54 59.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 111.194 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.643 HD21 ' N ' ' A' ' 263' ' ' SER . 1.6 tt -82.05 130.77 35.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 172.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.643 ' N ' HD21 ' A' ' 262' ' ' LEU . 62.2 m -132.32 158.16 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.902 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.18 138.98 50.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.063 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.76 178.27 18.23 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.46 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 77' ' ' ALA . 27.0 mm -103.6 137.06 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.908 0.385 . . . . 0.0 111.092 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -72.29 127.4 32.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.826 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -65.43 -23.06 66.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.1 -176.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.75 -11.72 55.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.054 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.7 t -77.16 120.84 83.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.66 0.743 . . . . 0.0 110.917 -173.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.475 ' HD2' HG21 ' A' ' 2' ' ' ILE . 77.7 Cg_endo -69.12 -10.57 29.42 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.707 2.271 . . . . 0.0 112.32 170.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -103.01 21.41 15.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 -170.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -52.97 -31.63 41.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 -170.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -66.18 -47.3 74.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.83 -170.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.04 -26.94 20.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.948 -177.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.582 ' HB2' HG23 ' A' ' 59' ' ' ILE . . . -63.14 -45.11 93.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.16 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -69.73 -33.95 73.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.987 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 92.4 mt-10 -66.43 -35.52 80.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.827 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.498 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 0.8 OUTLIER -56.27 -53.56 55.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.795 175.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.512 ' HB2' HD12 ' A' ' 284' ' ' LEU . 2.1 pp -79.06 -34.78 43.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.906 -170.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.22 -42.4 72.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 95.4 m-20 -97.56 -4.38 37.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 -164.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.624 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 47.3 m-85 -118.36 -54.4 2.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.033 173.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.567 ' O ' ' HB3' ' A' ' 290' ' ' LEU . 25.3 mt -81.17 -42.49 20.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.942 -169.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.486 HD21 HD12 ' A' ' 280' ' ' LEU . 4.0 mm? -81.58 19.94 0.97 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 169.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.638 ' O ' HD23 ' A' ' 290' ' ' LEU . 94.0 m -132.61 142.67 49.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.101 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 47.9 p-10 -51.44 -26.19 7.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -168.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -74.46 -46.8 37.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -175.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -80.62 -48.04 6.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 -165.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.722 HD21 ' N ' ' A' ' 291' ' ' GLU . 0.7 OUTLIER -70.21 -16.06 63.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 110.936 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.722 ' N ' HD21 ' A' ' 290' ' ' LEU . 83.2 tt0 -71.99 -47.33 52.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 167.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.81 -40.75 98.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.087 -172.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.93 HG21 ' HA3' ' A' ' 19' ' ' GLY . 3.3 p -70.75 -36.83 66.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -67.43 -25.21 65.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.784 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.84 -29.36 70.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -90.67 -43.11 10.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.419 ' O ' HD13 ' A' ' 299' ' ' LEU . 65.8 mttm -127.92 145.78 56.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.531 0.681 . . . . 0.0 110.902 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.7 107.14 1.59 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.748 2.298 . . . . 0.0 112.329 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.47 ' HG ' ' HD3' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -91.89 -19.21 22.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.944 -179.021 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.495 ' O ' HD12 ' A' ' 317' ' ' ILE . . . 88.58 -62.02 3.78 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.573 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -160.25 167.49 27.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 111.17 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.748 HG22 ' HB3' ' A' ' 307' ' ' TYR . 33.2 m -131.14 156.15 42.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.213 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.06 -14.82 60.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.077 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.463 ' HA ' HD21 ' A' ' 89' ' ' LEU . 50.4 tp -81.21 126.83 31.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -173.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 87.2 tttt -55.41 -44.99 76.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 63.7 m -61.59 -52.18 65.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.802 -168.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.748 ' HB3' HG22 ' A' ' 302' ' ' VAL . 12.6 t80 -78.02 -32.67 51.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -62.91 -42.03 99.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.921 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -62.09 -38.99 90.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.894 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.69 -48.76 29.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.617 HD22 HG23 ' A' ' 302' ' ' VAL . 4.6 pp -69.13 -23.48 63.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.854 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.429 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.41 -14.96 63.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.14 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.45 -16.4 62.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.965 176.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.48 133.48 44.43 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.575 0.702 . . . . 0.0 110.864 169.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . 0.43 ' O ' HG11 ' A' ' 244' ' ' VAL . 90.5 Cg_exo -47.74 -35.74 24.3 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.673 2.249 . . . . 0.0 112.342 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -61.96 -27.64 68.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -167.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.495 HD12 ' O ' ' A' ' 300' ' ' GLY . 2.1 mp -100.03 -40.85 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.162 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.11 -47.24 61.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -162.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.25 -34.77 75.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.19 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.519 ' CG2' ' HB1' ' A' ' 112' ' ' ALA . 62.9 m -61.42 -37.01 81.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.058 -176.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.6 mtp -60.16 -30.46 69.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.896 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -65.45 -43.95 88.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -77.06 -39.75 48.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.36 -39.79 73.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.156 -168.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.3 -28.32 69.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -108.6 -1.68 19.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -86.16 -160.21 33.68 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.414 -168.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -140.93 154.75 46.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.987 0.422 . . . . 0.0 110.825 -173.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.407 HG21 ' CG ' ' A' ' 64' ' ' HIS . 40.6 mm -68.07 116.28 7.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.114 -171.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 63.3 ttp . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 121.515 0.674 . . . . 0.0 110.904 174.784 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.8 0.333 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.474 ' HA ' ' CD2' ' A' ' 339' ' ' PHE . 68.0 ttp -54.84 -34.88 63.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 95.9 p -65.14 -31.12 72.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.29 -35.54 63.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.163 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.56 ' HB3' ' CZ3' ' A' ' 158' ' ' TRP . 3.2 m-30 -56.34 -55.65 30.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 176.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 154' ' ' PRO . 52.5 m0 -62.79 -37.82 88.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.92 -172.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -69.71 -48.04 61.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.826 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.14 -42.36 93.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.168 -173.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 158' ' ' TRP . 19.6 m -73.0 -28.0 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.065 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.401 ' O ' HG23 ' A' ' 347' ' ' VAL . 78.6 ttt-85 -62.71 -40.95 98.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.938 173.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 93.0 m -57.33 -36.07 70.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.157 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.493 ' HB2' HD11 ' A' ' 192' ' ' LEU . . . -65.41 -45.76 82.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.017 -175.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.467 HG22 HG23 ' A' ' 157' ' ' THR . 2.4 m -72.18 -34.42 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.132 -174.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.447 HD13 HG21 ' A' ' 347' ' ' VAL . 1.5 mp -63.18 -46.36 96.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.187 173.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -67.81 -39.49 83.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.924 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.59 -47.61 39.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.105 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.32 -37.43 80.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.12 -173.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.2 p -74.99 -9.1 58.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 75.51 11.66 84.2 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -78.77 -27.14 44.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.791 0.329 . . . . 0.0 110.893 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 360' ' ' ALA . 82.4 mm-40 -139.67 156.23 46.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.939 173.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.6 p -77.15 164.96 25.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.194 170.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.7 t -51.91 -41.01 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 175.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.78 -48.94 76.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.994 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -76.82 -44.23 33.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.937 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.409 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . . . -63.56 -47.35 81.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.102 -177.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.413 HD22 ' HB1' ' A' ' 188' ' ' ALA . 13.5 tp -67.07 -52.86 36.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.957 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -54.03 -46.8 71.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.939 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -72.23 -43.68 64.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.08 -47.07 54.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.168 -175.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -67.66 -30.77 70.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 24.9 m -55.14 -31.87 61.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.111 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -58.98 -29.84 67.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.549 HG21 ' HB2' ' A' ' 168' ' ' ALA . 77.9 mt -56.15 -40.11 62.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.113 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.6 p -100.99 -10.43 20.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.115 -174.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.882 179.643 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.718 0.294 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.2 mt -94.08 125.11 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -150.07 147.96 28.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -50.79 133.85 25.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.799 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.96 4.92 64.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.508 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.9 tttt -163.11 141.71 8.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 110.959 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.589 ' CD2' HD12 ' A' ' 33' ' ' ILE . 2.3 pt? -146.51 154.49 41.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.93 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 88.6 t -110.91 134.7 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.09 -177.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.672 HD12 ' HB ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -119.96 133.56 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 -178.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.73 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 65.2 m95 -106.59 124.19 49.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.942 164.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.519 HD13 ' HG ' ' A' ' 20' ' ' LEU . 12.1 tt -110.01 150.0 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.114 -165.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -62.74 148.18 47.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 -173.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.61 -17.69 21.02 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.454 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.88 -27.34 68.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -173.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 15' ' ' LYS . 35.7 mmtm -140.06 133.67 30.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 166.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.63 -80.77 0.95 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.497 -169.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -99.97 -38.7 8.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.839 0.352 . . . . 0.0 110.914 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -68.15 -51.91 40.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -151.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.11 -55.47 23.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.461 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.519 ' HG ' HD13 ' A' ' 11' ' ' ILE . 5.7 mt -53.82 -53.04 57.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.44 -40.21 7.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.082 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -72.12 -59.51 2.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.854 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 20' ' ' LEU . 20.7 m -70.33 -38.16 73.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 -172.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.78 ' HA3' HG22 ' A' ' 35' ' ' VAL . . . -66.98 -48.39 60.62 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.525 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -56.75 -35.0 68.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.846 0.355 . . . . 0.0 110.957 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -55.36 -39.62 70.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.987 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 5.6 m-30 -59.17 -46.32 88.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -65.0 -39.61 93.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -69.44 -38.23 77.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.853 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -94.95 -48.2 6.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -169.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.8 p -110.62 -1.47 16.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 -171.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.87 3.71 90.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.45 168.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 1.079 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -99.99 134.02 40.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.928 0.394 . . . . 0.0 111.124 -176.046 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.5 mttt -83.08 144.09 30.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.924 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.78 HG22 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -120.01 134.62 62.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 175.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.498 ' O ' HD13 ' A' ' 9' ' ' ILE . 97.0 m -102.21 129.09 48.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.145 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 20' ' ' LEU . 87.2 t -99.57 125.86 53.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -115.06 149.9 36.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.4 t-80 -86.13 138.92 34.45 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.573 0.702 . . . . 0.0 110.928 -165.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 77.1 Cg_exo -56.49 -27.57 69.41 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.695 2.263 . . . . 0.0 112.291 -175.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -47.97 -50.55 26.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -172.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -88.79 -5.04 58.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.6 tt -46.11 -54.85 7.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.897 -169.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.32 -38.32 90.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.953 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.95 -40.82 95.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.899 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.437 ' HB3' HG13 ' A' ' 50' ' ' VAL . 75.3 mmtt -82.91 -20.01 36.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.581 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 84.4 t80 -49.29 -50.73 62.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.635 0.731 . . . . 0.0 110.799 -165.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 43.3 Cg_endo -82.85 -30.16 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.673 2.248 . . . . 0.0 112.385 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -74.86 -41.45 59.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 -167.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.494 HG22 ' HG3' ' A' ' 57' ' ' PRO . 32.1 m -67.58 -27.11 37.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 -175.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.505 ' CB ' ' HB3' ' A' ' 75' ' ' LEU . . . -69.33 -36.52 77.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.12 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.36 -33.49 75.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.147 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.8 p -94.46 -21.9 18.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.111 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.83 9.16 65.4 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.44 174.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -123.01 120.04 32.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.88 -95.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.427 172.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.73 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 64.5 Cg_endo -79.79 147.3 19.26 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.734 2.29 . . . . 0.0 112.394 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.04 -35.17 12.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.781 161.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.616 ' HB ' HG23 ' A' ' 9' ' ' ILE . 45.8 mt -125.24 136.87 59.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.141 -175.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.0 tp -132.88 126.41 53.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.187 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -92.22 138.98 31.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.857 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.492 ' CZ2' ' HB3' ' A' ' 105' ' ' ALA . 24.9 p90 -145.07 163.35 34.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.042 170.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.25 -90.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.039 -168.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -123.34 -68.04 0.9 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.868 -171.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -103.29 -12.36 17.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.844 -159.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 55.8 ttm-85 -51.05 -20.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 -174.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.486 ' HB2' HD11 ' A' ' 104' ' ' ILE . 32.6 p90 -59.21 -33.48 71.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.06 -50.45 65.97 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.46 -168.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.16 -37.65 94.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.5 174.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.642 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 9.3 t80 -69.01 -42.1 76.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.849 0.357 . . . . 0.0 110.89 -175.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.61 -42.95 70.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.095 175.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -58.24 -37.59 75.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.957 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.418 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 58.1 m -84.55 -5.01 59.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.795 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.01 30.27 59.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.464 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.505 ' HB3' ' CB ' ' A' ' 51' ' ' ALA . 46.1 mt -89.39 -10.04 48.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.867 0.365 . . . . 0.0 110.905 -168.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.642 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -131.03 153.27 49.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.877 -179.074 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -80.0 139.73 36.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.128 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.4 mp0 -65.68 137.34 57.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.3 pt -100.57 152.09 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.107 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.7 m -96.91 119.0 64.39 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.591 0.71 . . . . 0.0 111.085 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.63 ' HB3' HD12 ' A' ' 103' ' ' LEU . 73.1 Cg_endo -73.97 155.55 47.95 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.745 2.297 . . . . 0.0 112.324 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -105.52 117.86 35.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.842 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -52.87 -35.06 57.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.02 90.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.5 m-30 -75.87 -33.28 59.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.896 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.511 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 86.4 mt-30 -54.9 -51.93 64.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.71 -33.84 70.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -81.96 -18.43 43.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.841 -172.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -104.7 -105.02 0.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 -172.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.517 ' CG ' ' HD2' ' A' ' 91' ' ' PRO . 5.0 t80 -178.72 142.74 0.42 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.705 0.764 . . . . 0.0 110.956 -166.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 90' ' ' TYR . 31.3 Cg_endo -68.25 -37.6 13.72 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.731 2.287 . . . . 0.0 112.337 -175.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -75.08 -29.28 60.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.9 p -72.68 -37.05 68.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.266 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.754 ' CE3' HD13 ' A' ' 103' ' ' LEU . 86.4 m95 -73.61 -26.43 60.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.893 173.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -73.02 -31.31 64.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.853 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.23 -23.88 63.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.07 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 94' ' ' TRP . 17.9 m -106.16 16.4 6.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.075 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.3 ttp85 -100.97 126.31 47.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.974 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -125.82 115.8 20.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.7 t30 57.17 35.11 25.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.897 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.65 -0.97 89.18 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.558 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -120.97 143.55 48.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 110.862 174.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.754 HD13 ' CE3' ' A' ' 94' ' ' TRP . 41.5 mt -89.59 135.58 33.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 -172.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.486 HD11 ' HB2' ' A' ' 67' ' ' PHE . 2.1 pp -127.21 3.36 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 -166.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.492 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . . . -160.97 160.21 30.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.166 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.437 ' HB3' ' CD2' ' A' ' 285' ' ' LEU . 97.0 m-85 -108.53 139.57 20.94 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.582 0.706 . . . . 0.0 110.871 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -78.91 121.63 5.06 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.708 2.272 . . . . 0.0 112.327 170.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 1.06 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -105.59 -40.92 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.225 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.586 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -141.74 150.84 42.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.103 -164.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.6 t -115.65 123.91 71.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -112.92 122.34 47.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.648 ' HB2' HD22 ' A' ' 323' ' ' ASN . . . -150.18 144.8 25.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.065 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 257' ' ' PRO . 7.1 mp -87.56 170.03 11.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -174.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.2 p -158.33 154.92 27.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.845 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.824 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -91.92 129.1 37.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 169.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.619 ' N ' HD23 ' A' ' 115' ' ' LEU . 4.9 mp -116.37 130.89 70.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.116 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -133.19 154.26 50.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 -171.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.46 ' O ' HD21 ' A' ' 122' ' ' LEU . 69.8 m-80 -88.0 119.57 28.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.862 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.434 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.6 mttt -64.82 -27.35 68.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -82.84 -24.13 33.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.819 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.0 mp -80.49 -54.43 5.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 172.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.703 ' H ' HD21 ' A' ' 122' ' ' LEU . 1.6 pt? -140.36 127.9 12.51 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.617 0.722 . . . . 0.0 110.952 176.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.44 -9.43 14.91 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.659 2.239 . . . . 0.0 112.436 -176.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -149.28 98.0 3.53 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.554 0.693 . . . . 0.0 110.871 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.27 157.08 63.36 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.623 2.215 . . . . 0.0 112.293 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -66.4 143.07 68.34 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.633 2.222 . . . . 0.0 112.36 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.1 -17.48 37.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.5 p -134.5 157.53 46.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.185 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.517 ' HA ' HD11 ' A' ' 132' ' ' ILE . 71.4 m95 -70.15 -23.15 62.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.967 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.02 -24.59 67.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -85.59 -18.38 33.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.901 -177.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.58 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -59.54 -42.87 94.32 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.686 0.755 . . . . 0.0 111.163 -170.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 92.9 Cg_endo -80.01 -37.83 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.664 2.243 . . . . 0.0 112.35 -173.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.88 -58.92 6.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.12 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 1.238 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.49 -17.08 64.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -176.038 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.556 ' N ' HD13 ' A' ' 135' ' ' LEU . 37.8 t70 -60.04 -41.39 92.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 168.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.72 -30.8 70.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.29 -47.29 61.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.88 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.1 pp -85.16 -14.61 46.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.888 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.637 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.8 tttt -60.36 -34.47 73.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.955 174.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.06 -23.4 67.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -95.03 4.23 54.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.935 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.06 32.6 56.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.369 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -111.09 169.96 8.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 0.0 110.836 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.8 t -120.82 139.4 53.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 167.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -67.64 -44.02 78.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 -171.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -138.88 131.46 28.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 52.2 ttm -117.11 130.85 56.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -153.62 155.13 35.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -174.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -86.17 -51.98 5.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.78 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 1.044 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.5 tm? 48.34 31.71 2.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.919 -169.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -102.11 -9.02 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -129.71 152.39 79.7 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 121.726 0.774 . . . . 0.0 110.818 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.419 ' HB3' ' HB3' ' A' ' 340' ' ' TRP . 51.8 Cg_exo -55.01 -29.62 65.75 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.675 2.25 . . . . 0.0 112.343 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -68.45 -30.0 68.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -79.91 -41.05 26.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 172.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.445 HG21 HG11 ' A' ' 347' ' ' VAL . 19.4 m -60.8 -52.45 65.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.132 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.581 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 15.1 t-105 -59.23 -48.75 95.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.488 0.661 . . . . 0.0 110.907 -161.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 90.8 Cg_exo -52.25 -44.71 44.36 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.694 2.262 . . . . 0.0 112.355 -177.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.609 ' C ' HD21 ' A' ' 160' ' ' LEU . 7.7 tt -71.26 -40.09 71.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.826 -171.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 83.0 mt -71.08 -43.44 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.71 -22.0 60.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.158 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.49 -28.57 68.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.107 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -99.11 1.77 45.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.856 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 108.5 5.65 31.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.478 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.59 67.97 2.52 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.541 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -83.83 132.68 34.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.895 0.379 . . . . 0.0 110.999 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.38 6.77 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.134 -174.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.445 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.3 p90 -149.73 155.01 39.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.912 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 87.3 tttt -104.97 124.69 49.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 157.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -116.26 124.42 50.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -153.91 130.63 10.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.02 43.04 30.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.75 17.29 80.06 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.518 173.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.63 138.58 48.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.71 0.29 . . . . 0.0 110.866 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -96.99 144.69 26.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 169.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -123.51 111.66 16.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.59 ' C ' HD13 ' A' ' 178' ' ' ILE . 1.1 pp -79.98 -12.74 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.55 -11.05 25.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.899 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 66.0 t0 -127.28 88.24 2.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 171.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 169' ' ' PHE . 32.7 m -116.13 166.92 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.063 -170.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.16 22.3 31.54 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.517 -170.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.494 HG22 HD13 ' A' ' 368' ' ' ILE . 1.5 m -105.47 -20.0 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.753 0.311 . . . . 0.0 111.083 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -86.48 21.16 2.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -104.96 -174.97 2.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 -175.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.9 -29.37 67.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.05 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.64 -40.18 77.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.437 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.511 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -62.57 -37.64 86.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.934 0.397 . . . . 0.0 111.162 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.607 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 88.6 mttt -62.92 -37.97 89.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 174.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.13 -36.99 85.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.079 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.42 -47.57 62.39 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.507 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' A' ' 347' ' ' VAL . 20.6 tp -66.41 -34.25 77.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 0.0 110.841 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.521 ' OG1' HG22 ' A' ' 357' ' ' VAL . 91.5 m -63.69 -40.68 97.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.227 174.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.483 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 61.8 t80 -67.15 -49.27 65.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.62 ' C ' HD21 ' A' ' 195' ' ' LEU . 7.2 tt -50.43 -51.69 44.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.884 -175.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 199' ' ' ILE . 35.2 m -63.9 -22.48 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.145 -174.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.5 m-20 -61.8 -34.58 76.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 194' ' ' PHE . 0.9 OUTLIER -80.95 -40.15 24.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -173.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.61 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.7 pp -72.98 -29.76 30.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 172.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.91 -37.59 79.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.917 173.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -80.09 2.31 24.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 68.16 38.57 2.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.773 168.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -78.99 -17.33 55.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.823 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.61 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.2 ppp? -145.2 158.14 43.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.864 176.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -94.94 148.87 21.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.87 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.89 -25.75 67.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.169 -175.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -95.9 1.72 53.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 94.7 m -62.48 124.97 22.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.196 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.43 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 14.5 t0 -119.93 177.68 4.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -64.89 -37.38 87.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.035 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 96.1 p -70.32 -38.37 74.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.43 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 77.7 mt -65.09 -42.66 95.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.105 174.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.16 -36.18 83.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.046 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -61.5 -47.26 86.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.836 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.48 89.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.004 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.0 -44.87 87.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.141 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -62.75 -44.48 96.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.992 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -64.77 -31.86 73.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.885 -177.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -83.72 -15.82 47.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.55 26.43 30.1 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.551 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -84.83 -21.79 29.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 110.84 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.1 t -123.91 137.47 54.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.615 ' HB3' HD23 ' A' ' 139' ' ' LEU . . . -62.74 -48.57 78.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.009 177.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.772 ' HB3' HD22 ' A' ' 115' ' ' LEU . 71.7 mtm -134.19 160.01 39.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 -172.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.4 t -151.33 157.16 42.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.199 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 48.4 mm -111.55 129.14 67.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.164 -175.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -155.05 175.02 14.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -81.74 -159.15 23.6 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.449 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.82 -24.92 24.28 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.584 2.189 . . . . 0.0 112.348 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 51.5 m0 -75.0 -29.44 60.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.961 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 47.4 45.52 17.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 174.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -65.62 -17.63 64.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.964 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 91.1 p -74.93 -9.41 58.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.961 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -76.8 -171.31 1.88 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.4 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 -173.821 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 88.9 t . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.858 0.361 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -79.95 139.92 36.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.434 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 45.1 p90 -144.95 158.65 43.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.881 176.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.65 166.67 26.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.496 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.1 p -135.02 135.16 53.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.888 0.375 . . . . 0.0 111.125 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.639 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 9.5 t -159.37 142.53 14.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.082 175.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.0 m -63.89 168.31 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.065 -169.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 2.1 mp -68.71 155.55 92.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.562 0.696 . . . . 0.0 110.942 -161.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -77.93 -176.22 3.12 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.739 2.293 . . . . 0.0 112.353 -173.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 93.9 m -85.93 145.13 27.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.225 -173.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -130.56 113.33 14.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.799 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 54.94 34.63 22.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.81 -0.54 86.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.471 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -127.54 127.54 24.08 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.598 0.713 . . . . 0.0 110.863 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 249' ' ' THR . 81.2 Cg_exo -54.73 131.05 43.68 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.662 2.242 . . . . 0.0 112.351 -176.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 256' ' ' LYS . 96.0 p -83.77 1.36 43.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 172.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 97.8 mttt -37.09 130.2 0.76 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.512 0.672 . . . . 0.0 110.832 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.5 ' HB3' ' HB2' ' A' ' 113' ' ' LEU . 74.0 Cg_exo -61.56 155.91 50.38 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.66 2.24 . . . . 0.0 112.378 -169.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -74.98 165.15 25.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.845 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.88 126.76 69.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.192 -168.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -112.28 137.35 14.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.454 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 62.5 t -125.04 116.03 45.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 111.13 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.17 123.42 19.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.941 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 47.4 m -127.59 130.39 48.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.803 -168.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.01 136.17 52.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 -171.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.88 169.35 16.85 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.403 -171.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.925 HG13 ' HG2' ' A' ' 277' ' ' LYS . 31.2 mm -112.69 130.16 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 111.082 -174.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -63.37 126.02 26.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -60.6 -28.24 68.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.144 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.0 -6.52 59.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.074 -170.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.4 t -75.08 122.91 88.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.644 0.735 . . . . 0.0 110.868 -173.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -68.59 -12.59 35.14 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.727 2.285 . . . . 0.0 112.373 166.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.449 HD22 HD23 ' A' ' 275' ' ' LEU . 55.5 t30 -111.12 31.27 6.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.919 -168.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -60.84 -29.78 69.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -57.52 -40.11 78.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.706 HD21 HG13 ' A' ' 33' ' ' ILE . 8.6 mp -75.16 -45.67 39.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.963 174.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -62.7 -56.22 19.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.058 -171.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.925 ' HG2' HG13 ' A' ' 266' ' ' ILE . 91.7 mttt -60.92 -40.26 92.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.922 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.7 tt0 -71.0 -49.26 47.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.834 -173.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -67.16 -34.11 76.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.501 ' HA ' HD23 ' A' ' 284' ' ' LEU . 4.6 tt -62.46 -51.39 67.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.965 -175.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -77.88 -33.33 52.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 67.7 m-80 -98.72 -11.19 22.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -163.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.864 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 77.5 m-85 -129.67 -52.32 1.16 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.873 177.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' ' 280' ' ' LEU . 0.5 OUTLIER -62.81 -35.69 80.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -168.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 1.06 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.5 pp -123.96 37.76 4.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.885 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.435 ' CG2' ' N ' ' A' ' 287' ' ' ASP . 8.2 m -117.97 153.7 33.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.109 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.47 ' HA ' HD11 ' A' ' 290' ' ' LEU . 31.0 t70 -43.45 -36.38 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.85 -166.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -79.36 -40.62 29.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.864 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.14 -56.73 5.56 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.446 -171.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.657 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.1 -21.08 66.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 0.0 110.98 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.0 tt0 -66.74 -45.87 77.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.788 171.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.2 -46.64 88.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.102 -174.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -46.06 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.172 -175.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.529 ' HB2' HD23 ' A' ' 299' ' ' LEU . 43.2 t30 -63.38 -27.89 69.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.21 -27.59 68.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -91.14 -47.64 7.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.943 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -136.31 145.46 51.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.545 0.688 . . . . 0.0 110.93 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.6 110.08 1.78 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.729 2.286 . . . . 0.0 112.402 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' ' 294' ' ' ASN . 0.8 OUTLIER -82.02 -27.67 32.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 176.309 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 103.69 -58.55 0.52 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.419 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.614 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -169.25 165.02 10.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.915 0.388 . . . . 0.0 111.129 174.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 26.1 m -125.92 153.93 34.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.02 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.39 -10.88 60.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.143 173.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.657 ' CD2' HD22 ' A' ' 290' ' ' LEU . 51.4 tp -85.23 120.27 26.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.31 -39.96 76.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.948 -172.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 41.3 t -64.75 -51.36 62.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 -168.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.507 ' HB3' HG22 ' A' ' 302' ' ' VAL . 19.0 t80 -76.73 -29.04 56.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -64.34 -38.46 91.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.16 -37.24 82.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.91 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -74.25 -39.93 62.71 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.93 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.614 HD13 ' HA ' ' A' ' 301' ' ' ALA . 77.4 mt -60.05 -33.01 71.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 175.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.31 -19.58 61.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.08 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.73 -20.32 66.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -90.12 123.59 65.49 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.664 0.745 . . . . 0.0 110.807 167.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -47.93 -28.86 10.78 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.649 2.232 . . . . 0.0 112.377 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -61.75 -32.58 72.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.95 -173.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.597 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.4 mp -80.07 -35.53 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.082 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.1 -39.63 72.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.085 -174.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.16 75.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.051 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 82.6 p -59.82 -28.38 67.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.147 -174.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.3 mmm -66.36 -33.11 74.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.86 174.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -62.52 -47.43 83.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 -175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.648 HD22 ' HB2' ' A' ' 112' ' ' ALA . 14.4 p-10 -83.42 -25.92 30.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.06 -43.96 97.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -67.4 -35.03 78.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.84 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -106.03 -4.48 20.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.829 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.94 -170.02 39.89 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.534 -167.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -139.91 149.39 43.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.881 0.372 . . . . 0.0 110.805 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 42.9 mm -63.85 117.7 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.082 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 59.6 ttm . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 121.463 0.649 . . . . 0.0 110.982 -176.033 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.806 0.336 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 40.4 tpp -73.6 -26.89 61.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.854 -170.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.0 m -57.37 -37.95 73.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.846 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.96 -36.12 59.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.011 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.532 ' O ' HG13 ' A' ' 343' ' ' VAL . 4.7 m-30 -66.87 -46.98 73.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.455 ' HA ' HG23 ' A' ' 343' ' ' VAL . 28.1 m0 -61.07 -32.5 72.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -66.92 -47.09 72.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.03 -40.36 94.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.163 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 339' ' ' PHE . 17.9 m -74.1 -30.83 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.128 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.5 ' O ' HG23 ' A' ' 347' ' ' VAL . 4.9 tmt_? -65.0 -38.98 92.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.2 m -58.22 -36.19 72.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.194 173.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.57 95.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.189 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.792 ' HA ' HD11 ' A' ' 192' ' ' LEU . 5.8 m -73.99 -35.01 40.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.191 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.472 HD13 HG21 ' A' ' 347' ' ' VAL . 1.5 mp -62.44 -47.94 90.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.191 174.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -63.91 -39.18 93.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.05 -45.55 60.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.098 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.37 -39.86 77.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.0 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.8 p -75.58 -10.7 59.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.911 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.96 17.25 72.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.449 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.25 -33.29 43.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 0.0 110.907 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -138.63 154.4 48.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.4 p -77.19 169.89 17.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.18 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.521 HG22 ' OG1' ' A' ' 193' ' ' THR . 53.5 t -56.53 -42.34 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 173.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -62.09 -45.62 92.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -69.94 -51.59 31.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -75.4 -51.79 12.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.188 -173.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.607 ' HG ' ' HA ' ' A' ' 189' ' ' LYS . 1.9 tm? -65.04 -48.97 71.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 -171.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.51 -52.83 61.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 -173.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -67.94 -48.65 65.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.808 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.25 85.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.156 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.595 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 66.3 mm-40 -78.04 -29.03 49.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.907 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 89.5 m -65.92 -33.96 77.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.178 170.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -56.39 -31.95 64.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.854 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.494 HD13 HG22 ' A' ' 183' ' ' VAL . 62.0 mt -59.02 -34.93 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.951 0.405 . . . . 0.0 111.191 173.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 69.9 p -95.07 -14.34 24.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 89.7 mttt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 177.096 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.729 0.3 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.467 HG21 ' HD2' ' A' ' 271' ' ' PRO . 60.1 mt -97.81 139.96 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.181 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -140.13 145.03 37.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.822 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.29 133.5 39.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.83 11.58 61.63 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.494 -175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.2 tttt -165.07 134.77 3.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.834 0.349 . . . . 0.0 110.944 177.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.595 ' CD2' HD12 ' A' ' 33' ' ' ILE . 1.6 pt? -144.0 152.71 41.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.94 -173.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 87.2 t -110.76 137.67 42.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.02 -177.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.728 HD12 HG13 ' A' ' 35' ' ' VAL . 1.1 mp -119.79 134.47 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.094 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.62 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 76.6 m95 -103.69 124.66 49.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 164.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.511 HD13 ' HG ' ' A' ' 20' ' ' LEU . 11.5 tt -108.83 150.04 11.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.052 -163.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -58.43 153.2 16.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 -174.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.38 -15.97 40.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.416 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -79.2 -13.28 59.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.866 0.365 . . . . 0.0 110.897 -172.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 15' ' ' LYS . 11.0 mmmm -139.96 129.2 23.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 163.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.52 -70.72 1.29 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.469 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -109.92 -39.19 5.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.958 0.409 . . . . 0.0 110.98 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -67.37 -52.28 41.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.871 -150.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.442 ' CA ' HG21 ' A' ' 293' ' ' VAL . . . -54.1 -50.35 55.78 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.565 -175.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.516 ' HB3' HG23 ' A' ' 37' ' ' VAL . 6.0 mt -55.08 -52.57 62.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.699 0.285 . . . . 0.0 110.933 171.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.48 -35.92 21.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.125 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -72.45 -59.99 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' A' ' 20' ' ' LEU . 21.5 m -71.64 -38.15 65.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.158 -172.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.561 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -65.64 -47.84 73.25 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.422 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -54.73 -35.65 63.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -57.93 -39.12 77.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.039 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 4.8 m-30 -62.9 -45.42 92.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 99.8 mt-10 -60.7 -36.96 80.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -71.24 -41.17 70.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.898 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -94.52 -47.81 6.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.889 -164.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.3 p -109.1 -7.83 15.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.18 -172.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.65 8.12 87.97 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.514 167.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 1.0 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.52 133.86 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 111.085 -179.074 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.426 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.2 mttt -72.02 136.0 46.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 -169.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.728 HG13 HD12 ' A' ' 9' ' ' ILE . 99.2 t -115.87 125.01 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.061 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.57 ' O ' HD13 ' A' ' 9' ' ' ILE . 95.5 m -109.93 130.02 55.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.067 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 20' ' ' LEU . 87.4 t -103.58 131.17 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.159 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -119.36 154.09 34.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.3 t-80 -88.25 139.93 30.41 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.694 0.759 . . . . 0.0 110.863 -167.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 87.3 Cg_exo -55.02 -29.86 66.99 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.758 2.305 . . . . 0.0 112.335 -175.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -49.03 -52.62 24.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.873 -172.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -90.07 0.68 57.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.832 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.433 ' C ' HD21 ' A' ' 43' ' ' LEU . 10.5 tt -45.86 -51.09 13.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.937 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -74.44 -40.37 61.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.862 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -80.44 -51.88 8.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.956 -164.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -83.33 -38.39 22.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.919 -170.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.61 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 83.9 t80 -49.83 -53.39 42.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.684 0.754 . . . . 0.0 110.872 -169.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 29.4 Cg_endo -61.19 -30.83 89.3 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.668 2.245 . . . . 0.0 112.331 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -73.08 -44.18 60.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.425 HG22 ' HD3' ' A' ' 57' ' ' PRO . 21.2 m -75.56 -24.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.112 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.13 78.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.054 174.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.11 -29.74 70.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.099 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.0 p -88.36 -14.54 37.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.11 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.44 14.72 81.72 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.477 168.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -135.39 129.39 33.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 110.816 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.47 -92.34 0.14 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.497 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.62 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 67.6 Cg_endo -79.36 148.0 20.71 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.68 2.253 . . . . 0.0 112.375 -177.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -107.52 -32.09 7.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.798 165.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.564 ' HB ' HG23 ' A' ' 9' ' ' ILE . 57.6 mt -128.11 137.53 57.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.169 -176.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.5 HD13 ' HB2' ' A' ' 10' ' ' TRP . 6.3 tp -132.64 127.13 55.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -92.55 128.21 38.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.771 170.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -114.38 145.15 42.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.994 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.58 -83.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.036 -168.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -120.81 -65.85 1.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.835 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -99.98 -16.54 17.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.84 -167.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -61.36 -6.31 2.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -165.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 70' ' ' TYR . 31.5 p90 -59.08 -25.58 63.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 173.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.47 -48.36 86.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.46 -174.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.04 -32.16 83.25 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.515 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.721 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 2.3 t80 -54.96 -51.71 65.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.857 0.36 . . . . 0.0 110.931 175.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.92 -42.98 56.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.164 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -56.1 -38.94 71.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.967 -175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.404 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 63.0 m -83.68 -7.65 59.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.93 31.1 58.39 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.582 172.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.404 ' HG ' ' HB2' ' A' ' 73' ' ' SER . 63.4 mt -88.86 -5.01 58.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.859 0.362 . . . . 0.0 110.972 -165.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.721 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -128.01 154.3 45.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.912 -171.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.19 144.58 29.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.086 167.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -65.1 136.18 56.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.884 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.413 HD13 ' CZ ' ' A' ' 106' ' ' TYR . 42.3 pt -100.12 151.54 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.09 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.5 m -96.15 126.5 44.06 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.585 0.707 . . . . 0.0 111.09 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.07 134.06 61.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.637 2.225 . . . . 0.0 112.349 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -103.22 119.71 39.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.99 -41.66 99.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.794 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.73 -44.75 89.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.1 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -75.0 -32.3 61.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.484 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 67.0 tt0 -53.48 -49.71 66.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.936 174.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.35 -32.63 72.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.894 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.39 -20.3 54.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.828 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.86 -106.54 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -172.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 29.2 t80 171.52 129.51 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.687 0.756 . . . . 0.0 110.973 -168.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -52.82 -36.01 72.16 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.762 2.308 . . . . 0.0 112.39 -173.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -64.91 -36.5 84.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -173.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.2 p -73.83 -30.35 62.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.17 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.598 ' HA ' HG23 ' A' ' 97' ' ' VAL . 80.7 m95 -67.27 -30.03 69.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 173.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.62 -31.31 68.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.827 174.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.07 -24.27 61.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.106 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.598 HG23 ' HA ' ' A' ' 94' ' ' TRP . 20.0 m -107.8 16.01 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.143 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -101.56 136.25 41.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -136.43 117.35 14.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 173.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 60.56 36.05 19.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.868 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.49 2.19 89.03 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.51 172.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -127.97 149.87 50.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.825 0.345 . . . . 0.0 110.875 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.529 HD23 HG21 ' A' ' 97' ' ' VAL . 15.3 mt -86.01 135.49 33.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.838 -175.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 67' ' ' PHE . 1.8 pp -122.15 -1.52 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.026 -170.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.407 ' N ' HD13 ' A' ' 104' ' ' ILE . . . -164.89 165.86 20.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 -176.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.413 ' CZ ' HD13 ' A' ' 79' ' ' ILE . 97.1 m-85 -114.35 145.05 32.92 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.604 0.716 . . . . 0.0 110.926 170.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.21 125.23 7.0 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.686 2.257 . . . . 0.0 112.304 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 1.081 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp -106.29 -39.91 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.194 177.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.596 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -143.19 150.9 40.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.11 -167.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.3 t -114.69 130.89 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.164 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -120.53 119.89 34.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.553 ' HB1' ' HB ' ' A' ' 320' ' ' THR . . . -150.06 144.95 26.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.068 -173.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.6 mp -89.88 170.04 10.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.973 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.0 p -158.81 157.98 32.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.915 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.88 127.03 46.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.924 170.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.575 ' N ' HD23 ' A' ' 115' ' ' LEU . 5.2 mp -110.3 130.32 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.14 -175.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -128.39 146.52 50.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -92.75 115.0 27.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.806 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.426 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.9 mttt -65.66 -23.26 66.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.917 -175.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -78.68 -25.23 44.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.811 -175.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.7 mp -84.26 -49.24 8.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.871 174.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.649 ' H ' HD21 ' A' ' 122' ' ' LEU . 1.7 pt? -143.67 128.5 9.61 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.743 0.782 . . . . 0.0 110.832 174.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.72 -9.03 15.89 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.634 2.223 . . . . 0.0 112.366 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.408 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 59.7 t-20 -143.19 97.01 5.75 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.64 0.733 . . . . 0.0 110.812 -174.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 64.4 Cg_endo -70.26 156.04 62.92 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.746 2.297 . . . . 0.0 112.365 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.43 144.95 63.34 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.748 2.299 . . . . 0.0 112.314 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.18 -17.16 28.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.89 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 71.5 p -130.71 157.68 42.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.192 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.515 ' HA ' HD11 ' A' ' 132' ' ' ILE . 57.0 m95 -68.83 -28.94 67.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.951 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.04 -22.13 66.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.85 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.84 -24.25 41.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.627 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -55.88 -50.05 89.44 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.676 0.751 . . . . 0.0 111.197 -172.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.8 Cg_endo -68.24 -39.11 10.74 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.622 2.215 . . . . 0.0 112.376 -173.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.02 -60.15 3.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 1.265 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.28 -17.01 63.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.989 -175.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.521 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.8 t70 -58.47 -40.42 82.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.848 168.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.07 -30.75 69.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.49 -46.42 54.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.773 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.0 pp -84.86 -14.35 48.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.964 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.647 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.7 tttt -61.15 -34.41 74.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.955 174.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.95 -23.44 67.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -94.96 3.62 54.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.921 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.48 33.16 53.45 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.56 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -111.75 169.95 8.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 0.0 110.867 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.0 t -121.12 140.22 52.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.917 168.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.441 ' HA ' HD22 ' A' ' 139' ' ' LEU . . . -66.69 -40.37 88.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.112 -172.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -144.53 130.59 19.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 55.2 ttm -118.18 132.92 56.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -153.53 157.35 39.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -173.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -84.93 -54.64 4.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.94 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.825 HD13 ' O ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER 49.28 30.72 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.022 -168.362 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -103.45 -4.35 24.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -129.91 156.53 78.88 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.59 0.71 . . . . 0.0 110.952 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.422 ' HD3' ' HD2' ' A' ' 344' ' ' ARG . 40.3 Cg_endo -60.76 -24.37 78.7 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.684 2.256 . . . . 0.0 112.321 174.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -68.23 -30.02 68.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.822 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -84.27 -38.31 20.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.844 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.443 HG21 HG11 ' A' ' 347' ' ' VAL . 23.0 m -61.11 -47.23 87.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.979 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.584 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 39.2 t-105 -56.96 -54.58 52.96 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.534 0.683 . . . . 0.0 110.949 -169.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 31.2 Cg_endo -65.83 -19.63 58.78 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.731 2.287 . . . . 0.0 112.41 -174.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.723 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.3 tm? -81.63 -45.29 16.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.513 HG22 ' HA3' ' A' ' 166' ' ' GLY . 80.1 mt -74.23 -43.3 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.116 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.9 -22.57 64.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.099 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -58.87 -32.28 69.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.172 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -100.87 1.13 39.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 112.29 5.48 24.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.492 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.513 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -77.2 69.6 2.48 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.509 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -87.36 132.64 33.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.86 0.362 . . . . 0.0 110.98 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.75 10.34 9.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.154 -171.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.45 ' HA ' HG12 ' A' ' 181' ' ' VAL . 52.8 p90 -158.13 152.34 24.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -93.28 128.38 39.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.816 159.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -118.08 121.57 40.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.827 172.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.02 130.05 11.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.901 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.02 41.83 31.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.842 174.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.37 17.52 79.75 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.533 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.01 139.35 51.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.768 0.318 . . . . 0.0 110.86 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -98.88 145.01 27.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -128.32 108.95 11.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.874 174.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.578 ' C ' HD13 ' A' ' 178' ' ' ILE . 1.3 pp -79.1 -8.52 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.131 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -100.27 -12.31 19.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 -177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -119.49 85.81 2.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 170.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 169' ' ' PHE . 27.4 m -114.28 161.3 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 -170.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.02 22.66 32.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.495 -172.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.527 HG22 HD13 ' A' ' 368' ' ' ILE . 6.8 m -107.37 -17.05 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.772 0.32 . . . . 0.0 111.112 -178.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -87.04 20.47 2.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -119.97 -171.51 2.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.91 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.29 -29.71 69.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.106 -173.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.7 -41.41 95.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.484 -167.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.625 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -65.24 -38.06 89.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.972 0.415 . . . . 0.0 111.093 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.589 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 96.8 mttt -62.04 -37.82 86.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.943 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.07 -37.91 89.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.074 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.424 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -66.2 -46.47 79.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.576 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.678 HD11 ' HA ' ' A' ' 347' ' ' VAL . 27.3 tp -65.08 -35.92 82.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 110.855 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.416 ' OG1' HG22 ' A' ' 357' ' ' VAL . 90.0 m -64.52 -41.17 96.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.151 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 65.0 t80 -66.32 -47.94 71.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.861 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.677 ' C ' HD21 ' A' ' 195' ' ' LEU . 5.2 tt -50.32 -51.56 44.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.963 -175.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.437 ' HA ' ' CG1' ' A' ' 199' ' ' ILE . 27.9 m -65.04 -21.61 29.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.075 -173.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.0 m-20 -62.59 -33.92 75.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.802 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 194' ' ' PHE . 0.9 OUTLIER -81.21 -39.9 24.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.959 -174.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.585 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.6 pp -73.95 -26.99 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.07 172.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.25 -38.23 84.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 170.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -80.95 2.92 24.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 176.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 66.53 37.68 4.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 56.0 m170 -77.58 -18.94 56.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.819 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.585 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.1 ppp? -144.14 156.95 44.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -95.02 152.0 18.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.14 -26.93 68.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -95.5 1.73 54.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.813 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.1 m -63.84 126.08 26.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.101 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.429 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 16.9 t0 -120.05 174.28 6.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.843 177.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -64.98 -37.0 86.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.969 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.8 p -70.45 -37.52 74.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.429 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 80.3 mt -65.01 -42.48 94.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.077 173.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.68 81.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.06 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.0 -45.04 94.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.865 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.8 -41.44 95.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.096 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.86 -42.86 97.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.058 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -63.8 -39.67 94.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.936 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -64.33 -35.73 81.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -83.59 -20.02 34.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.982 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.84 25.83 33.71 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.418 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -84.79 -21.65 29.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.976 0.417 . . . . 0.0 110.902 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.2 t -124.45 136.81 54.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.076 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.603 ' HB3' HD23 ' A' ' 139' ' ' LEU . . . -65.03 -47.68 76.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.061 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.534 ' HB3' HD22 ' A' ' 115' ' ' LEU . 71.8 mtm -134.49 158.32 44.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -174.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 60.8 p -139.73 161.29 37.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.171 172.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.412 HD13 HD11 ' A' ' 247' ' ' LEU . 50.2 mm -110.75 127.18 67.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.03 175.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -154.95 175.04 14.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.957 -172.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -88.64 -156.87 31.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.523 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -22.26 32.28 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.66 2.24 . . . . 0.0 112.384 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -78.36 -24.93 46.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 48.76 51.95 14.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.175 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -60.04 -23.94 64.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 61.3 m -50.05 -43.95 51.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -87.0 176.7 7.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 -172.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.211 -171.698 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.834 0.35 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -108.29 128.28 54.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.426 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 50.2 p90 -145.21 158.21 43.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.92 162.35 25.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.387 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.1 p -135.72 135.32 51.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 111.142 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.7 t -154.39 148.75 26.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.9 167.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.173 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 1.036 HD21 ' HD3' ' A' ' 257' ' ' PRO . 2.6 mm? -63.1 149.53 90.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.575 0.702 . . . . 0.0 110.961 -164.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.84 -176.33 3.11 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.691 2.261 . . . . 0.0 112.382 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 96.8 m -92.47 145.17 24.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.057 -172.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -130.91 113.26 13.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.933 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 55.0 36.59 27.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.815 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.43 2.79 84.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.494 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -131.36 130.62 22.61 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.539 0.685 . . . . 0.0 110.843 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 249' ' ' THR . 22.9 Cg_endo -65.42 133.93 36.7 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.715 2.277 . . . . 0.0 112.324 -173.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.611 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 97.0 p -84.52 0.19 50.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.766 173.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -37.4 135.02 0.73 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.522 0.677 . . . . 0.0 110.9 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 1.036 ' HD3' HD21 ' A' ' 247' ' ' LEU . 38.0 Cg_endo -80.05 157.85 23.66 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.729 2.286 . . . . 0.0 112.336 -166.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -75.09 169.67 17.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.53 129.67 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 -166.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.96 137.7 14.48 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.369 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 76.9 t -125.36 117.11 48.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.806 0.336 . . . . 0.0 111.207 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.434 HD21 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -65.27 119.73 11.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 178.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.9 m -126.4 126.61 44.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.79 -167.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -125.67 137.07 53.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.041 -171.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -131.42 171.44 21.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.486 -170.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.858 HG13 ' HG2' ' A' ' 277' ' ' LYS . 25.0 mm -113.41 126.17 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.81 0.338 . . . . 0.0 111.297 -171.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -61.27 131.12 49.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.472 ' HB3' ' C ' ' A' ' 76' ' ' LEU . . . -59.81 -26.17 65.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.125 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.21 -8.49 57.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 -173.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.8 t -70.81 127.16 92.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.674 0.75 . . . . 0.0 110.913 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.467 ' HD2' HG21 ' A' ' 2' ' ' ILE . 74.1 Cg_endo -72.87 -10.46 24.83 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.658 2.239 . . . . 0.0 112.401 165.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -104.04 19.09 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -169.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -54.09 -34.91 61.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.925 -171.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.14 -52.43 63.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.6 pp -84.36 -27.97 27.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.924 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.81 -50.51 56.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.06 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.858 ' HG2' HG13 ' A' ' 266' ' ' ILE . 96.1 mttt -59.74 -38.49 81.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.839 173.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.7 tt0 -68.45 -48.25 65.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -175.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -67.59 -35.37 78.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.512 ' HA ' HD23 ' A' ' 284' ' ' LEU . 7.3 tt -61.8 -51.96 66.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.892 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -78.15 -31.5 49.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.836 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.547 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 63.8 m-80 -99.46 -11.61 20.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.848 -165.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.929 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 66.6 m-85 -129.95 -52.82 1.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.512 HD23 ' HA ' ' A' ' 280' ' ' LEU . 0.6 OUTLIER -62.73 -36.74 83.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.912 -169.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 1.081 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.6 pp -124.27 37.63 4.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.979 176.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.457 ' CG2' ' N ' ' A' ' 287' ' ' ASP . 4.1 m -116.08 154.91 29.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.099 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.517 ' HA ' HD11 ' A' ' 290' ' ' LEU . 33.0 t70 -42.93 -37.42 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.796 -167.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -78.03 -40.81 37.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.971 -176.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.929 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.06 -57.16 5.37 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 -172.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.594 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.1 -21.17 66.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.34 . . . . 0.0 110.974 -178.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.59 ' N ' HD12 ' A' ' 290' ' ' LEU . 84.6 tt0 -67.44 -45.1 77.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 170.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.81 95.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.131 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.442 HG21 ' CA ' ' A' ' 19' ' ' GLY . 1.4 p -80.03 -30.0 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.11 -174.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -70.12 -27.17 64.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 172.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.32 -25.79 67.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.927 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.95 -51.28 8.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -143.2 152.7 58.47 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 121.615 0.722 . . . . 0.0 110.847 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -62.17 116.4 3.46 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.771 2.314 . . . . 0.0 112.298 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 299' ' ' LEU . 0.2 OUTLIER -87.55 -18.58 29.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 176.194 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 103.64 -58.55 0.52 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.525 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.656 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -170.73 164.76 8.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 111.138 175.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.596 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 21.7 m -124.23 156.08 31.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.101 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.22 -11.02 59.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.109 172.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.594 ' CD2' HD22 ' A' ' 290' ' ' LEU . 47.3 tp -83.2 122.06 27.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -175.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.32 -39.15 75.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 46.5 t -64.73 -49.95 68.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.881 -168.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.487 ' HB3' HG22 ' A' ' 302' ' ' VAL . 18.4 t80 -81.62 -29.07 33.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -61.95 -39.73 93.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.831 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -59.39 -38.21 79.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -73.7 -38.49 64.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.656 HD13 ' HA ' ' A' ' 301' ' ' ALA . 78.5 mt -62.82 -32.91 74.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.26 -18.83 62.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.113 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.06 -20.07 66.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 174.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -91.34 121.07 68.11 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.636 0.731 . . . . 0.0 110.87 166.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.98 -26.76 7.91 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.756 2.304 . . . . 0.0 112.313 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -61.76 -35.63 78.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.873 -175.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.555 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.1 mp -80.12 -32.6 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.076 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.4 -40.09 85.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 -172.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.17 -46.25 74.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.108 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.553 ' HB ' ' HB1' ' A' ' 112' ' ' ALA . 81.2 p -64.97 -29.21 70.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.066 -174.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.5 mtp -63.7 -34.38 77.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.6 tp10 -64.75 -47.7 77.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -173.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.515 HD22 ' HB2' ' A' ' 112' ' ' ALA . 8.9 p-10 -82.14 -28.01 32.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.864 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.01 -50.24 67.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.011 -175.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -69.25 -29.92 67.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.922 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -108.2 -8.55 15.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 -169.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.13 -153.55 29.99 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.43 -166.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -147.33 143.69 28.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.796 0.332 . . . . 0.0 110.902 -170.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 44.4 mm -61.76 124.01 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.092 -167.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 95.5 mtp . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.49 0.662 . . . . 0.0 110.969 -177.838 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.804 0.335 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.402 ' HB3' ' HE3' ' A' ' 336' ' ' MET . 69.1 mmm -80.01 -17.83 51.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.826 -172.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 47.6 t -62.18 -41.99 98.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.831 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.49 -37.04 63.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.156 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.437 ' O ' HG13 ' A' ' 343' ' ' VAL . 7.4 m-30 -66.28 -36.29 82.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -54.93 -37.9 66.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.982 172.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -71.79 -38.05 70.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.939 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.92 -42.81 80.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.105 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 339' ' ' PHE . 21.4 m -72.72 -31.36 36.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.184 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 347' ' ' VAL . 74.0 ttt-85 -61.67 -40.93 96.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 175.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.0 m -55.76 -36.14 66.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.186 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.13 -46.19 81.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.084 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.678 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.4 m -75.55 -34.78 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.199 -172.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.462 HD13 HG21 ' A' ' 347' ' ' VAL . 1.5 mp -62.42 -48.01 90.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.21 -37.94 88.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.32 -46.61 60.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.66 81.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.053 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.2 p -75.74 -11.88 60.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.981 0.419 . . . . 0.0 110.927 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.57 18.02 69.46 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.424 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.83 -32.95 46.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.757 0.313 . . . . 0.0 110.848 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -140.08 157.01 46.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 50.0 p -77.27 165.76 24.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.159 169.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.416 HG22 ' OG1' ' A' ' 193' ' ' THR . 55.4 t -54.94 -42.7 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.167 174.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.04 -44.13 96.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.832 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -69.38 -54.0 16.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -69.37 -47.78 63.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.625 HD11 ' HB1' ' A' ' 188' ' ' ALA . 1.5 tm? -64.95 -45.03 87.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.96 -174.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -65.41 -53.04 48.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.945 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -69.64 -45.68 67.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -173.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.23 -42.87 83.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.075 -174.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 85.6 mm-40 -72.49 -30.96 64.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.979 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 55.5 m -59.01 -32.59 69.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.093 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -57.11 -29.94 63.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.527 HD13 HG22 ' A' ' 183' ' ' VAL . 69.8 mt -59.72 -39.6 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 175.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.3 p -94.78 -14.98 24.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.808 179.074 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.745 0.307 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.474 HG21 ' HD2' ' A' ' 271' ' ' PRO . 83.2 mt -97.54 133.05 40.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.179 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -144.97 146.8 32.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.97 132.99 48.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.1 7.74 63.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.406 -176.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.1 tttt -164.44 134.67 4.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.744 0.306 . . . . 0.0 110.959 176.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.676 HD23 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -141.72 154.81 45.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.956 -172.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.434 HG23 ' HB ' ' A' ' 36' ' ' THR . 77.3 t -113.59 135.74 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.133 -177.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.649 HG23 ' HB ' ' A' ' 59' ' ' ILE . 1.4 mp -119.65 133.97 64.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.744 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 74.9 m95 -105.18 124.24 49.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.943 166.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.497 HD13 ' HG ' ' A' ' 20' ' ' LEU . 13.6 tt -110.35 149.97 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.146 -167.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -64.52 158.63 23.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.756 -171.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.36 -16.07 26.43 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.511 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -68.25 -29.9 68.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.883 0.373 . . . . 0.0 110.853 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -139.18 130.02 26.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.845 166.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.16 -80.14 1.01 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.468 -172.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -96.72 -42.36 8.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.941 0.401 . . . . 0.0 110.97 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -67.59 -49.93 60.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.837 -153.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.12 -56.97 20.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.407 -176.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.564 ' HB3' HG23 ' A' ' 37' ' ' VAL . 5.5 mt -51.72 -46.48 63.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.797 0.332 . . . . 0.0 110.923 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.04 -37.48 45.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.061 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -75.68 -60.04 2.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.972 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 20' ' ' LEU . 20.3 m -71.94 -36.61 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.171 -172.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.46 -40.84 99.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.477 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -61.04 -31.24 70.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.928 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -50.0 -39.94 42.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.919 172.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 0.9 OUTLIER -54.97 -49.24 71.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 176.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -71.75 -34.92 69.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.899 -174.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.23 -37.99 84.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.958 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -95.2 -47.29 6.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 -168.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.8 p -115.1 -5.96 12.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.197 -169.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.53 4.9 85.44 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.377 169.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.995 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -89.73 132.36 34.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.826 0.346 . . . . 0.0 111.078 -179.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.4 mttt -70.03 136.73 50.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 -170.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.506 HG21 HD12 ' A' ' 9' ' ' ILE . 9.8 p -112.76 134.32 55.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.067 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.511 ' O ' HD13 ' A' ' 9' ' ' ILE . 99.3 m -113.19 129.24 56.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.124 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 20' ' ' LEU . 84.8 t -102.41 128.43 55.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.204 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -120.12 152.0 38.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.919 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -91.64 150.62 41.32 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.566 0.698 . . . . 0.0 110.823 -166.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.558 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 37.1 Cg_endo -68.92 -19.62 39.97 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.611 2.207 . . . . 0.0 112.39 -175.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -54.13 -49.02 70.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -174.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -89.58 -9.1 51.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.592 ' C ' HD21 ' A' ' 43' ' ' LEU . 8.3 tt -48.64 -53.86 16.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 -168.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.77 -35.37 80.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.852 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -70.13 -36.4 74.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.857 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.411 ' O ' HG23 ' A' ' 50' ' ' VAL . 74.7 mmtt -80.64 -24.54 38.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.591 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 86.3 t80 -49.45 -50.6 64.53 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 0.0 110.877 -163.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.591 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 46.2 Cg_endo -82.58 -32.08 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.648 2.232 . . . . 0.0 112.391 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -77.22 -44.17 30.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.867 -165.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.528 HG22 ' HG3' ' A' ' 57' ' ' PRO . 24.8 m -70.31 -27.72 32.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.075 -173.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.638 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . . . -71.85 -35.19 69.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.042 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.48 -32.56 73.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.106 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.7 p -89.13 -18.87 26.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.11 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.94 8.77 78.79 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.49 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -128.18 130.01 47.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 110.827 174.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.97 -91.57 0.13 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.554 169.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.744 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 77.4 Cg_endo -80.07 146.92 18.41 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.349 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -94.25 -35.03 12.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.777 161.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.649 ' HB ' HG23 ' A' ' 9' ' ' ILE . 29.4 mt -127.03 138.48 54.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.173 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 tp -133.23 127.39 54.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.101 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -87.94 140.7 29.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.516 ' CZ2' ' HB3' ' A' ' 105' ' ' ALA . 24.2 p90 -145.11 160.83 40.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.001 170.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.73 -87.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.113 -166.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -127.19 -68.41 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -171.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -99.33 -10.65 22.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.839 -162.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -56.11 -19.07 11.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -169.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.535 ' HB2' HD11 ' A' ' 104' ' ' ILE . 36.0 p90 -57.67 -31.45 66.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.851 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.76 -52.32 53.13 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.572 -171.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.92 -35.99 85.64 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.528 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.625 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 11.1 t80 -66.87 -41.73 86.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.726 0.298 . . . . 0.0 110.902 -176.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -39.87 67.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 174.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -58.51 -35.9 72.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.928 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.426 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 64.5 m -87.67 -5.01 58.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.01 31.25 58.05 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.526 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.638 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 53.6 mt -87.73 -12.06 46.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -169.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.625 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -129.08 151.66 49.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.934 -178.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -78.95 140.83 37.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.021 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -74.16 141.43 45.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.836 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.411 HD13 ' CZ ' ' A' ' 106' ' ' TYR . 42.7 pt -110.45 162.84 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.125 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 p -107.25 149.91 39.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 111.119 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.14 141.22 35.7 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.624 2.216 . . . . 0.0 112.417 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -105.26 120.02 40.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.928 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.22 -42.0 98.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.841 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.9 91.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.154 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -74.3 -32.89 63.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.47 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 65.1 tt0 -54.88 -50.09 69.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.043 176.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.36 -30.33 70.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.751 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -78.86 -20.03 50.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.18 -104.92 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -172.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 22.4 t80 172.12 129.47 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.704 0.764 . . . . 0.0 110.885 -169.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.63 -37.59 83.58 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.647 2.231 . . . . 0.0 112.356 -174.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -65.22 -34.06 77.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -173.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.9 p -75.5 -31.01 60.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.079 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.585 ' HA ' HG23 ' A' ' 97' ' ' VAL . 88.6 m95 -65.54 -30.01 70.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.935 173.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -69.56 -32.07 70.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.55 -26.24 62.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.645 HG21 HD23 ' A' ' 103' ' ' LEU . 18.5 m -108.28 16.88 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 -175.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -104.71 135.76 45.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -132.45 117.47 18.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.7 t30 58.68 35.07 24.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.818 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.62 -0.85 89.19 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.588 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.11 145.11 50.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.356 . . . . 0.0 110.843 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.645 HD23 HG21 ' A' ' 97' ' ' VAL . 28.8 mt -80.86 139.14 36.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -172.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 67' ' ' PHE . 1.8 pp -123.46 -2.7 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.096 -174.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.516 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . . . -161.74 165.29 28.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.152 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.411 ' CZ ' HD13 ' A' ' 79' ' ' ILE . 90.2 m-85 -114.31 144.47 31.77 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.646 0.736 . . . . 0.0 110.93 170.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.57 122.26 5.45 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.606 2.204 . . . . 0.0 112.326 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 1.027 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -106.49 -36.64 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.205 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -144.44 150.86 38.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.183 -169.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.6 t -120.33 134.91 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.134 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -124.97 136.78 54.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.845 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.625 ' HB2' HD22 ' A' ' 323' ' ' ASN . . . -151.89 145.78 25.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 176.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -85.57 164.16 17.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.7 p -157.22 154.86 29.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.918 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -95.92 127.04 41.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.96 169.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.614 ' N ' HD23 ' A' ' 115' ' ' LEU . 5.2 mp -110.02 133.17 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -133.63 148.85 51.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -90.92 115.14 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.861 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.497 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.3 mttt -63.06 -22.75 67.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.979 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.34 -25.42 51.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -88.33 -52.9 4.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.679 ' H ' HD21 ' A' ' 122' ' ' LEU . 1.7 pt? -141.74 126.13 10.26 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.725 0.774 . . . . 0.0 110.844 174.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -81.92 -2.32 11.27 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.671 2.247 . . . . 0.0 112.293 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -150.78 102.6 3.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.61 0.719 . . . . 0.0 110.812 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.64 156.74 60.46 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.667 2.245 . . . . 0.0 112.375 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -66.45 145.08 75.91 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.663 2.242 . . . . 0.0 112.251 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -81.27 -18.28 46.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.8 p -133.92 159.0 42.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.2 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.412 ' HE1' ' HG ' ' A' ' 255' ' ' SER . 69.6 m95 -72.08 -29.95 64.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.405 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 97.5 mt-10 -65.85 -20.35 66.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.864 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -77.69 -27.24 50.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.56 ' HA ' HD12 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -55.24 -47.22 99.07 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.57 0.7 . . . . 0.0 111.152 -169.455 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.471 ' N ' HG22 ' A' ' 132' ' ' ILE . 81.9 Cg_exo -51.15 -49.31 17.5 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.695 2.263 . . . . 0.0 112.377 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.67 -58.39 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.149 -176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 1.253 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.34 -17.64 64.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 -173.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.584 ' N ' HD13 ' A' ' 135' ' ' LEU . 34.3 t70 -60.28 -41.83 94.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.869 168.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.38 -30.83 69.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -70.4 -47.39 61.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.658 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.9 pp -85.0 -14.38 47.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.658 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.9 tttt -61.75 -34.7 76.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 174.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.96 -23.2 67.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.06 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -95.03 5.0 53.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.918 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 31.89 57.32 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.463 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -110.36 170.14 8.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.857 0.361 . . . . 0.0 110.832 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.6 t -123.29 140.41 53.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 166.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -65.62 -41.24 92.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.144 -172.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -144.45 128.4 17.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 98.3 mmm -106.73 134.43 49.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -157.82 161.92 38.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 -175.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -96.64 -47.61 5.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 1.16 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.1 tm? 46.17 33.47 1.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 -168.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -99.43 -7.75 25.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -118.86 153.82 52.71 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.7 0.762 . . . . 0.0 110.917 -174.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.26 -24.46 50.88 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.669 2.246 . . . . 0.0 112.354 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -75.53 -29.88 59.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.832 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -83.04 -31.53 27.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.843 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.6 m -58.48 -43.29 88.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.046 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.574 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 43.9 t-105 -58.14 -55.63 43.37 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.532 0.682 . . . . 0.0 110.85 -171.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.606 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 23.7 Cg_endo -64.23 -18.64 64.08 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.682 2.255 . . . . 0.0 112.416 -174.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.718 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.7 tm? -82.3 -45.55 14.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.897 177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.589 HG22 ' HA3' ' A' ' 166' ' ' GLY . 85.4 mt -75.48 -44.65 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.052 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.17 -23.35 60.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.05 -173.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -58.98 -35.27 72.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -171.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.7 p30 -103.06 8.42 38.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 118.52 3.76 14.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.442 171.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.589 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -76.78 65.87 2.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.507 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -89.32 135.01 33.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.855 0.36 . . . . 0.0 110.945 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.23 0.45 36.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.223 -174.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.403 ' HA ' ' CE1' ' A' ' 176' ' ' TYR . 51.6 p90 -152.13 141.65 21.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -176.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 37.9 tptt -72.68 135.69 45.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.998 156.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -124.69 116.38 22.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.922 164.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -147.77 118.47 7.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 53.51 38.17 27.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.35 23.96 74.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.519 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -127.26 139.22 53.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.854 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.403 ' CE1' ' HA ' ' A' ' 169' ' ' PHE . 1.7 t80 -97.47 120.61 38.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 171.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -110.86 105.13 13.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.845 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.4 tp -63.51 -17.34 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.063 -174.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.95 -7.54 48.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.941 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 48.8 t0 -130.87 60.35 1.65 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 29.0 m -107.93 167.56 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.115 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -102.61 5.22 51.15 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.562 -166.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 365' ' ' GLN . 0.8 OUTLIER -101.25 -25.49 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 111.096 -168.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -93.65 24.96 3.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 173.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -116.71 176.12 5.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.15 -27.25 68.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.047 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.87 -40.69 97.44 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.521 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.606 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -64.05 -37.85 88.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.997 0.427 . . . . 0.0 111.19 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.601 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 90.5 mttt -62.38 -37.62 86.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.813 175.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.07 89.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.099 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.493 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -66.99 -47.99 62.66 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.535 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.532 HD11 ' HA ' ' A' ' 347' ' ' VAL . 27.4 tp -65.95 -35.25 80.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.904 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.538 ' OG1' HG22 ' A' ' 357' ' ' VAL . 93.4 m -64.97 -43.29 93.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.186 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.488 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 91.4 t80 -67.81 -47.12 69.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.73 ' C ' HD21 ' A' ' 195' ' ' LEU . 4.7 tt -50.39 -50.38 51.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 199' ' ' ILE . 35.7 m -65.04 -22.45 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.15 -174.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.9 m-20 -61.86 -33.14 73.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 194' ' ' PHE . 0.8 OUTLIER -81.16 -40.07 24.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.876 -173.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 196' ' ' VAL . 1.6 pp -72.65 -29.76 31.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 171.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -68.22 -38.14 81.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -82.67 3.67 28.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.847 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 66.36 40.22 3.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.832 170.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -76.73 -14.93 59.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.767 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -142.0 154.58 45.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.865 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -94.6 155.0 17.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.902 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.86 -27.71 68.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.044 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -96.04 0.14 51.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.817 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.2 m -63.26 135.06 56.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.061 -176.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -142.62 174.41 10.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.991 176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -61.94 -41.58 98.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.975 0.416 . . . . 0.0 111.014 -175.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.0 m -62.25 -40.45 96.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.883 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 66.3 mt -64.94 -43.66 96.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.122 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.86 -34.24 77.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -61.83 -47.79 83.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.928 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.59 95.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.088 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.67 -44.27 90.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -64.81 -39.9 94.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -64.83 -34.2 77.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -86.29 -16.77 36.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.828 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.85 28.31 29.3 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.502 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -84.07 -22.77 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.923 0.392 . . . . 0.0 110.861 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 67.4 p -130.91 144.02 51.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.519 ' HB3' HD23 ' A' ' 139' ' ' LEU . . . -66.55 -60.99 2.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.058 -173.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.534 ' HB3' HD22 ' A' ' 115' ' ' LEU . 59.4 mtm -134.62 158.5 43.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 -166.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.4 t -150.43 157.29 42.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.26 126.98 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.182 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -154.62 174.26 15.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -172.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -85.11 -158.29 29.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.52 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.87 -23.66 40.98 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.677 2.251 . . . . 0.0 112.404 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -78.04 -30.38 49.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.914 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 45.69 49.91 11.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -59.98 -24.0 64.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.6 p -79.01 -5.22 53.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -81.03 -174.95 5.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 89.5 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.172 -177.897 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 99.6 t . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.822 0.344 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -88.09 147.91 24.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.497 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 49.3 p90 -145.9 163.23 35.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.967 178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -128.78 158.0 21.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.446 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.39 135.28 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 111.111 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.4 t -153.73 149.86 27.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.132 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.2 m -61.23 163.4 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.157 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 247' ' ' LEU . 3.9 mp -69.1 150.01 97.55 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.59 0.71 . . . . 0.0 111.049 -164.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.56 -176.4 2.95 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.809 2.339 . . . . 0.0 112.366 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.4 m -84.25 143.15 29.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.161 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -130.08 112.79 13.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 55.16 35.78 25.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.41 0.97 84.17 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.534 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 91.4 mm-40 -125.73 125.82 24.93 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.496 0.665 . . . . 0.0 110.914 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 73.0 Cg_exo -54.54 132.82 53.4 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.736 2.291 . . . . 0.0 112.312 -178.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.412 ' HG ' ' HE1' ' A' ' 129' ' ' TRP . 66.7 m -81.14 -4.97 57.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.862 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -39.69 129.45 1.47 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.547 0.689 . . . . 0.0 110.874 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -82.19 164.16 17.33 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.758 2.305 . . . . 0.0 112.287 -164.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -74.96 170.04 16.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 29.2 t -114.46 134.4 57.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.207 -168.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -115.18 135.09 12.02 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.416 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.8 t -125.64 117.43 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.773 0.321 . . . . 0.0 111.19 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -66.13 122.92 18.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.914 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 45.2 m -125.43 132.26 52.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 -168.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.92 137.5 53.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.118 -174.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.9 173.99 21.31 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.377 -171.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.2 mm -113.3 130.68 66.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.702 0.287 . . . . 0.0 111.166 -172.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -62.36 129.48 40.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.453 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -59.58 -29.33 67.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.9 -6.07 59.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.081 -174.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.8 t -75.33 122.14 86.66 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.579 0.704 . . . . 0.0 110.88 -175.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.474 ' HD2' HG21 ' A' ' 2' ' ' ILE . 89.5 Cg_endo -68.88 -6.99 19.45 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.695 2.263 . . . . 0.0 112.437 167.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -102.92 14.38 32.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -51.73 -35.0 41.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.798 -168.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -72.15 -47.68 49.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.989 -171.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.0 pp -79.97 -33.68 39.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.906 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.73 -48.77 70.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.071 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -66.81 -34.42 77.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.14 -45.39 88.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.955 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -70.28 -36.12 74.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.786 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.693 HD21 ' O ' ' A' ' 280' ' ' LEU . 4.5 tt -59.4 -47.1 86.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -177.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -78.75 -28.53 44.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.03 -17.71 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -161.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.87 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 14.7 m-30 -121.18 -46.42 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.842 -178.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 280' ' ' LEU . 1.0 OUTLIER -63.94 -44.11 93.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -171.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 1.027 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.7 pp -124.42 37.95 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -166.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.485 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 82.0 p -121.46 162.25 20.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.16 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.424 ' HA ' HD11 ' A' ' 290' ' ' LEU . 36.1 p-10 -47.84 -35.06 9.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.806 -167.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -80.18 -40.32 27.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.87 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -71.6 -58.64 5.28 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 -171.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.66 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.11 -22.23 66.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.719 0.295 . . . . 0.0 110.907 -178.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.585 ' N ' HD12 ' A' ' 290' ' ' LEU . 87.9 tt0 -68.19 -46.25 71.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.819 172.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.94 -46.32 89.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.052 -174.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 289' ' ' GLY . 0.2 OUTLIER -70.04 -44.82 78.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 178.297 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.548 ' HB2' HD23 ' A' ' 299' ' ' LEU . 29.0 t30 -55.54 -31.46 62.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.853 175.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.76 -26.82 68.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.974 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -83.75 -40.76 18.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -161.41 139.89 7.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.576 0.703 . . . . 0.0 110.861 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -48.86 126.52 15.01 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.68 2.253 . . . . 0.0 112.295 -174.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.548 HD23 ' HB2' ' A' ' 294' ' ' ASN . 0.1 OUTLIER -87.67 -19.11 28.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 173.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.37 -67.18 1.43 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.663 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.598 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -157.9 144.98 18.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.933 0.397 . . . . 0.0 111.082 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 24.8 m -125.55 159.93 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.041 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.59 -13.24 60.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.021 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.66 ' CD2' HD22 ' A' ' 290' ' ' LEU . 43.2 tp -81.3 125.21 30.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.887 -174.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -61.58 -36.04 79.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.876 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.3 m -60.7 -50.07 74.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -170.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.565 ' CE2' HD22 ' A' ' 311' ' ' LEU . 23.0 t80 -77.1 -35.25 56.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.987 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.68 ' HA ' HD12 ' A' ' 311' ' ' LEU . 87.3 tt0 -53.37 -39.88 64.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.885 175.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -52.11 -38.69 58.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.905 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -79.85 -34.37 39.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.68 HD12 ' HA ' ' A' ' 308' ' ' GLU . 54.2 mt -64.1 -30.66 71.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 -175.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.84 -22.36 47.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.216 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.67 -20.57 65.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.003 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -89.3 122.64 68.38 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.695 0.76 . . . . 0.0 110.88 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -48.44 -30.2 15.19 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.754 2.303 . . . . 0.0 112.317 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -62.62 -30.72 71.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 -172.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.541 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.3 mp -74.9 -30.09 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.037 -173.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.14 -41.63 93.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 -170.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.66 -43.63 68.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.451 ' HB ' ' HB1' ' A' ' 112' ' ' ALA . 76.5 p -63.86 -31.27 72.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.093 -171.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 38.4 mmt -70.35 -31.43 68.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -64.38 -49.17 72.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 -175.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.625 HD22 ' HB2' ' A' ' 112' ' ' ALA . 10.2 p-10 -80.35 -25.6 39.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.807 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.37 -50.58 69.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.143 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.72 -34.7 77.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.952 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -104.13 -5.03 22.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -170.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -96.53 -156.35 30.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.448 -168.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -151.12 148.08 27.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.832 0.349 . . . . 0.0 110.843 -171.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 44.3 mm -60.85 124.94 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.132 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 96.9 mtp . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 121.5 0.667 . . . . 0.0 110.962 -178.405 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.671 0.272 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 87.2 mmm -69.62 -28.27 65.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.837 -168.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.9 m -52.13 -42.76 63.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.821 -171.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.65 -36.28 73.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.99 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 2.5 m-30 -64.91 -42.7 94.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.851 -175.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -54.67 -42.69 71.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -70.72 -43.24 69.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.3 95.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.122 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 339' ' ' PHE . 17.7 m -73.8 -31.56 31.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.436 ' O ' HG23 ' A' ' 347' ' ' VAL . 55.2 ttt180 -62.9 -41.82 99.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 90.8 m -57.19 -38.05 73.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.145 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.71 91.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 -173.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.532 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.5 m -74.53 -34.9 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.16 -174.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.46 HD13 HG21 ' A' ' 347' ' ' VAL . 1.4 mp -63.52 -49.14 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.209 174.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 82.4 m-20 -65.36 -39.1 91.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.926 -176.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.17 -45.55 59.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.109 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.83 -39.57 79.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.138 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.6 p -76.38 -10.44 59.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.881 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.8 17.2 70.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.39 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.12 -33.46 44.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.934 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 93.9 mt-30 -140.06 155.45 47.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.7 p -77.82 169.16 18.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 170.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.538 HG22 ' OG1' ' A' ' 193' ' ' THR . 53.3 t -56.82 -41.34 75.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -62.06 -45.96 91.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -70.0 -52.92 20.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -72.64 -49.73 29.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.048 -172.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.606 HD11 ' HB1' ' A' ' 188' ' ' ALA . 1.6 tm? -65.1 -47.7 76.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.75 -50.79 63.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.49 -49.97 55.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.47 -43.64 84.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.134 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.534 ' HB3' ' HB ' ' A' ' 183' ' ' VAL . 78.8 mm-40 -71.7 -35.01 70.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.974 -175.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 31.1 m -60.31 -28.08 67.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.243 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -56.83 -30.78 64.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 365' ' ' GLN . 78.3 mt -59.09 -40.57 81.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.162 173.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 63.5 p -97.99 -13.54 21.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.227 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.9 tttt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.817 177.313 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.729 0.299 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.401 HG21 ' HD2' ' A' ' 271' ' ' PRO . 86.7 mt -94.48 139.83 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.155 178.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.92 138.95 53.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.856 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.97 134.57 43.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.35 8.02 71.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.492 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -160.37 140.61 11.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.757 0.313 . . . . 0.0 110.901 171.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.656 ' H ' HD21 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -143.02 156.39 44.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 -167.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.498 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 69.7 t -112.33 136.43 48.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.705 HD12 HG13 ' A' ' 35' ' ' VAL . 1.1 mp -118.4 131.46 71.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.182 175.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.787 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 73.0 m95 -104.37 126.04 51.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 165.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.522 HD13 ' HG ' ' A' ' 20' ' ' LEU . 13.3 tt -109.49 150.32 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.06 -166.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -58.14 155.05 11.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.808 -170.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.04 -17.51 23.2 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.472 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -78.16 -15.08 59.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.318 . . . . 0.0 110.843 -173.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.429 ' HE3' ' HB3' ' A' ' 15' ' ' LYS . 28.8 mmmt -135.0 136.04 41.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 171.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.0 -84.25 1.0 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.495 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -110.25 -38.08 5.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 110.891 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -65.56 -50.97 63.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -150.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.07 -59.98 9.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.443 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.522 ' HG ' HD13 ' A' ' 11' ' ' ILE . 2.0 mt -45.53 -49.95 13.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.952 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.68 -38.01 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.044 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -70.61 -54.42 12.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.853 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.0 m -74.44 -37.74 45.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.186 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.498 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -63.03 -46.76 92.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.443 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -56.88 -30.04 63.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.938 0.399 . . . . 0.0 110.898 -177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -58.35 -37.41 75.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.955 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 1.5 m-30 -60.71 -48.82 80.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.929 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.12 -34.91 78.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -72.18 -37.26 69.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -94.78 -50.0 5.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 -167.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.2 p -116.42 -3.25 11.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.155 -171.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.48 14.2 82.21 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.427 166.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.824 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -98.25 133.27 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.352 . . . . 0.0 111.107 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -74.54 134.18 42.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -166.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.705 HG13 HD12 ' A' ' 9' ' ' ILE . 94.5 t -113.45 127.12 70.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.138 -172.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.589 ' O ' HD13 ' A' ' 9' ' ' ILE . 97.2 m -110.85 128.01 55.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.096 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.403 HG23 ' HB3' ' A' ' 20' ' ' LEU . 81.6 t -102.24 132.16 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.195 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -118.67 155.17 31.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.936 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.1 t-80 -89.09 140.11 28.92 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.543 0.687 . . . . 0.0 110.945 -170.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 85.6 Cg_exo -55.02 -27.97 57.52 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.603 2.202 . . . . 0.0 112.406 -174.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -48.39 -51.11 28.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 -171.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.23 -1.19 57.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.984 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 tt -46.64 -53.03 12.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.048 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -67.39 -39.41 85.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.963 175.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -63.8 -40.54 96.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.914 -171.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -80.85 -22.93 39.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.558 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 75.9 t80 -48.32 -50.47 56.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 0.0 110.883 -166.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 60.0 Cg_endo -80.59 -28.68 2.66 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.721 2.281 . . . . 0.0 112.343 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -74.5 -37.6 63.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 -170.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.607 HG11 ' HD3' ' A' ' 57' ' ' PRO . 33.6 m -65.9 -26.86 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.03 78.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 173.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.06 68.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.0 p -87.3 -12.23 47.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.135 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.98 11.11 84.07 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.525 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -164.46 156.97 16.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.753 0.311 . . . . 0.0 110.934 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.91 -114.99 0.53 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.505 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.787 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 89.6 Cg_endo -77.6 150.67 28.07 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.739 2.293 . . . . 0.0 112.318 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.25 -35.3 21.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.805 163.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.538 ' HB ' HG23 ' A' ' 9' ' ' ILE . 40.5 mt -126.5 136.33 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.108 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 tp -132.12 125.84 55.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.119 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -89.81 139.56 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.805 166.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.446 ' CH2' ' HB3' ' A' ' 105' ' ' ALA . 35.2 p90 -141.12 163.0 34.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.936 171.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.53 -85.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.09 -168.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.543 ' NE2' ' HA3' ' A' ' 260' ' ' GLY . 11.3 m170 -126.89 -68.2 0.81 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -100.65 -10.01 21.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 -158.029 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -51.83 -20.0 2.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.85 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.496 ' HB2' HD11 ' A' ' 104' ' ' ILE . 34.3 p90 -55.92 -28.88 58.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.53 -51.08 59.95 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.24 -36.7 90.21 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.425 172.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 1.4 t80 -55.83 -51.73 66.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.811 0.338 . . . . 0.0 110.913 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.32 -42.26 59.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.131 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -56.9 -37.98 72.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.938 -175.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.416 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 62.3 m -84.9 -6.42 59.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.949 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.96 30.47 59.24 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.591 173.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.416 ' HG ' ' HB2' ' A' ' 73' ' ' SER . 52.6 mt -89.04 -12.18 42.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.829 -167.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.457 ' HA ' ' H ' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -128.94 151.39 49.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 -173.246 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -77.07 142.21 39.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.118 175.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.94 135.89 48.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.903 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -104.22 153.7 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.255 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 99.2 m -96.39 126.74 42.65 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 111.112 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 80' ' ' THR . 51.2 Cg_exo -54.98 134.79 65.56 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.653 2.236 . . . . 0.0 112.347 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -104.93 120.1 40.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.85 -39.84 94.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.88 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.13 -45.27 85.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.059 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -75.31 -31.75 60.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.499 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 65.4 tt0 -53.94 -51.18 64.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.52 -32.18 70.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 174.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -76.66 -22.01 54.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.51 -105.36 0.3 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.952 -171.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.487 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 25.0 t80 171.94 130.02 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.624 0.726 . . . . 0.0 110.966 -168.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -52.79 -37.68 76.73 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.727 2.285 . . . . 0.0 112.359 -175.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -66.57 -34.78 78.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.852 -172.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.5 p -73.93 -30.01 62.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.17 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.511 ' HA ' HG23 ' A' ' 97' ' ' VAL . 75.8 m95 -65.82 -31.99 73.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.931 173.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.66 -32.33 72.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.812 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.72 -23.9 62.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.518 HG21 HD23 ' A' ' 103' ' ' LEU . 19.5 m -107.27 14.06 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 -177.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -100.02 130.12 46.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.823 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -126.07 113.71 17.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.2 t30 58.99 38.31 24.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.839 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.36 0.64 89.46 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.502 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -118.9 151.62 37.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.878 0.37 . . . . 0.0 110.843 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.518 HD23 HG21 ' A' ' 97' ' ' VAL . 14.6 mt -89.93 133.53 34.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -124.0 4.15 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 -172.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.446 ' HB3' ' CH2' ' A' ' 62' ' ' TRP . . . -163.47 164.58 24.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.106 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -114.11 142.21 27.59 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.575 0.702 . . . . 0.0 110.923 171.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.93 122.16 5.25 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.625 2.216 . . . . 0.0 112.296 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 1.074 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp -104.22 -37.69 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.61 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -146.48 154.09 41.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.034 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.4 t -115.49 129.86 71.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.089 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -109.96 129.28 55.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.522 ' HB1' ' HB ' ' A' ' 320' ' ' THR . . . -154.93 143.67 20.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.06 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.407 ' HB2' ' CB ' ' A' ' 257' ' ' PRO . 7.2 mp -89.97 169.0 11.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.95 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.7 p -157.31 156.37 32.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.898 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -100.06 128.58 46.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.902 169.451 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.624 ' N ' HD23 ' A' ' 115' ' ' LEU . 4.9 mp -110.07 133.14 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.102 -175.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -131.01 145.28 52.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -93.5 113.9 26.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.856 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.33 -20.79 66.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -175.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -79.5 -28.46 41.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.895 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.19 -49.61 11.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 175.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.653 ' H ' HD21 ' A' ' 122' ' ' LEU . 1.7 pt? -141.71 133.76 13.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.564 0.697 . . . . 0.0 110.831 175.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.44 -14.38 14.55 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.625 2.217 . . . . 0.0 112.352 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -143.72 98.35 5.32 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.564 0.697 . . . . 0.0 110.879 -173.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.45 156.5 61.41 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.684 2.256 . . . . 0.0 112.357 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.44 143.83 59.15 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.664 2.243 . . . . 0.0 112.321 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -89.89 -13.84 35.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.404 HG23 ' HB ' ' A' ' 249' ' ' THR . 63.6 p -132.44 158.38 42.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.132 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -68.64 -30.04 68.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.56 -19.97 65.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.953 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -79.99 -26.97 39.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.851 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.478 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -56.7 -46.94 99.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.613 0.721 . . . . 0.0 111.303 -169.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 86.7 Cg_exo -52.58 -50.78 12.87 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.657 2.238 . . . . 0.0 112.374 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.71 -57.68 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 -174.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 1.161 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.37 -17.26 63.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 -173.18 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.58 ' N ' HD13 ' A' ' 135' ' ' LEU . 36.2 t70 -61.17 -40.16 92.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 168.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.16 -30.89 71.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.879 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.8 -46.24 58.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.842 -177.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.641 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.0 pp -84.11 -13.9 51.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.641 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.7 tttt -58.77 -34.92 71.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.93 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.72 -24.14 67.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.057 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -95.0 3.4 54.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.888 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.75 32.32 54.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.445 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -110.65 171.76 7.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 110.911 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.6 t -124.63 140.17 53.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.753 168.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -67.28 -42.95 82.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.168 -170.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -138.54 128.79 25.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 63.2 tpp -110.81 129.32 55.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -153.22 155.18 36.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -88.57 -50.94 5.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.845 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 1.085 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.8 tm? 48.47 31.12 2.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -170.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -103.06 -7.36 21.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.977 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -129.99 152.52 80.12 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-O 121.652 0.739 . . . . 0.0 110.882 -174.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.49 -32.51 53.36 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.752 2.301 . . . . 0.0 112.315 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -69.7 -30.05 67.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -80.01 -39.64 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.835 172.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.405 HG21 HG11 ' A' ' 347' ' ' VAL . 17.8 m -60.1 -52.3 65.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.124 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.593 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 22.7 t-105 -60.7 -48.65 92.56 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.598 0.713 . . . . 0.0 110.889 -160.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 84.3 Cg_exo -50.82 -44.43 41.33 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.62 2.213 . . . . 0.0 112.276 -176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.637 ' C ' HD21 ' A' ' 160' ' ' LEU . 7.0 tt -72.92 -39.99 65.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 -171.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.17 -42.07 66.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.136 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.14 -23.32 60.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.126 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.26 -35.02 71.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.111 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.6 p30 -104.29 9.44 35.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.877 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.44 4.75 23.32 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.472 169.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.37 68.89 2.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.531 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -92.62 133.53 35.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.771 0.32 . . . . 0.0 110.944 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.453 ' HB2' HD11 ' A' ' 368' ' ' ILE . . . -83.94 12.61 5.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 -173.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.501 ' HD1' ' HE2' ' A' ' 336' ' ' MET . 53.1 p90 -151.52 153.32 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.911 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -99.79 122.29 42.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 156.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -112.72 122.31 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.872 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -152.2 130.58 12.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.2 t30 54.99 43.96 29.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.77 15.46 79.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.602 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.38 139.75 50.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.867 -176.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -96.99 145.0 26.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 170.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -126.03 110.15 13.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.87 172.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.559 ' C ' HD13 ' A' ' 178' ' ' ILE . 1.6 pp -80.04 -9.02 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -98.2 -11.93 22.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -121.93 89.14 3.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 169.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.414 HG12 ' HA ' ' A' ' 169' ' ' PHE . 26.0 m -116.61 164.55 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.082 -172.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -107.45 24.78 23.4 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.574 -173.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.438 HG22 HD13 ' A' ' 368' ' ' ILE . 2.5 m -109.24 -21.05 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.811 0.338 . . . . 0.0 111.055 -176.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -90.96 28.9 1.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.794 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -125.12 -170.04 2.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.893 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.85 -29.09 68.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.88 -41.71 95.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.477 -168.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.66 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -64.03 -37.04 85.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.942 0.401 . . . . 0.0 111.156 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.594 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -61.83 -38.13 87.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.868 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.14 -38.07 89.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.136 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.09 -47.73 63.38 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.505 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.556 HD11 ' HA ' ' A' ' 347' ' ' VAL . 22.6 tp -67.39 -34.8 78.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.912 0.387 . . . . 0.0 110.901 -177.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.499 ' OG1' HG22 ' A' ' 357' ' ' VAL . 93.1 m -65.09 -41.43 94.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.148 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 59.8 t80 -67.33 -47.02 71.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.903 177.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.619 ' C ' HD21 ' A' ' 195' ' ' LEU . 7.4 tt -51.6 -51.42 55.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 -175.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 199' ' ' ILE . 31.2 m -64.01 -22.67 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.0 m-20 -61.59 -34.43 75.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.946 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 194' ' ' PHE . 0.8 OUTLIER -81.28 -39.91 24.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.922 -173.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.526 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.8 pp -73.46 -29.3 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.135 172.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.6 -37.29 79.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -80.82 2.6 25.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.885 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 67.1 39.74 3.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.799 170.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -77.32 -17.94 57.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.91 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.526 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.2 ppp? -146.11 157.12 43.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.885 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -94.09 150.09 20.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.844 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.97 -25.88 67.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.075 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -95.4 0.99 54.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 94.0 m -63.55 127.18 30.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.095 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.42 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 14.7 t0 -120.02 177.36 5.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.853 177.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -65.01 -36.96 86.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.94 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.3 p -70.48 -38.03 74.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.911 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.42 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 78.7 mt -65.83 -43.12 93.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.072 175.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.31 87.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.209 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -61.6 -46.8 88.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.88 -40.77 97.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.056 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.91 -49.11 76.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.124 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -64.7 -41.1 96.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.966 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -63.51 -31.58 72.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.903 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.24 -13.17 44.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.962 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.14 25.01 35.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.556 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -85.87 -21.18 28.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 110.907 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.8 t -125.63 138.48 53.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.592 ' HB3' HD23 ' A' ' 139' ' ' LEU . . . -63.08 -48.84 76.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.012 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.504 ' HB3' HD22 ' A' ' 115' ' ' LEU . 69.9 mtm -133.3 159.89 38.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.949 -173.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.4 t -149.07 155.66 41.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.237 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.0 mm -111.47 130.05 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.178 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -155.77 174.63 15.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.5 -151.48 9.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.441 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.69 -26.18 28.16 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.621 2.214 . . . . 0.0 112.337 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -74.32 -32.06 62.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.942 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 43.19 45.04 4.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.151 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 35.6 m0 -69.45 -16.77 63.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 66.6 m -65.03 -26.42 68.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . 0.528 ' HB3' HG21 ' A' ' 116' ' ' ILE . 39.1 p30 -82.62 -179.1 7.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 -172.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.8 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.125 -177.254 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 87.9 t . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.781 0.324 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -79.05 140.11 37.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.29 151.52 38.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.72 161.93 26.23 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 173.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.1 p -137.03 138.47 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.418 . . . . 0.0 111.025 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.4 t -155.72 150.97 26.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.176 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 30.7 m -59.97 167.08 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.119 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.964 HD21 ' HD3' ' A' ' 257' ' ' PRO . 2.8 mm? -59.24 149.82 66.25 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.519 0.676 . . . . 0.0 110.946 -168.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.23 -176.58 2.76 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.786 2.324 . . . . 0.0 112.406 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' THR . . . . . 0.404 ' HB ' HG23 ' A' ' 128' ' ' THR . 99.3 m -88.92 144.03 26.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.108 -173.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -131.34 110.96 11.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 54.92 36.16 26.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.988 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 89.81 -0.16 79.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.449 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -128.78 139.16 34.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.543 0.687 . . . . 0.0 110.843 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -67.38 138.28 45.9 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.734 2.289 . . . . 0.0 112.375 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' A' ' 247' ' ' LEU . 75.6 m -81.48 -4.81 56.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 173.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 255' ' ' SER . 91.3 mttt -37.41 130.93 0.82 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.494 0.664 . . . . 0.0 110.878 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.964 ' HD3' HD21 ' A' ' 247' ' ' LEU . 37.8 Cg_endo -84.24 168.07 11.94 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.7 2.266 . . . . 0.0 112.278 -159.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -60.36 166.83 2.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.4 t -117.88 130.23 73.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.152 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.543 ' HA3' ' NE2' ' A' ' 64' ' ' HIS . . . -117.93 139.72 14.98 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.438 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 83.8 t -124.77 116.95 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.756 0.312 . . . . 0.0 111.189 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.441 HD21 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -65.14 119.97 11.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.961 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.3 m -123.8 130.88 53.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.809 -167.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.93 138.69 52.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.049 -174.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.6 170.82 22.21 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.43 -171.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.588 HG13 ' HB3' ' A' ' 277' ' ' LYS . 23.1 mm -114.96 127.64 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 0.0 111.198 -173.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -63.24 129.56 40.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 -175.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -58.68 -29.94 67.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.16 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.92 -6.34 59.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 -172.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 18.2 t -70.66 123.47 89.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.557 0.694 . . . . 0.0 110.981 -173.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.401 ' HD2' HG21 ' A' ' 2' ' ' ILE . 97.0 Cg_endo -68.47 -8.34 22.84 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.669 2.246 . . . . 0.0 112.388 167.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.402 ' O ' ' HG ' ' A' ' 275' ' ' LEU . 74.2 m-80 -106.35 11.12 31.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.907 -176.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -47.58 -37.52 12.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 -168.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.54 -47.18 61.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.875 -171.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 272' ' ' ASN . 2.1 pp -81.02 -30.7 34.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.945 -176.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.35 -49.55 68.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.071 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.588 ' HB3' HG13 ' A' ' 266' ' ' ILE . 57.9 pttt -69.33 -34.1 74.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.56 -45.82 81.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.822 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -67.75 -38.88 84.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.797 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 7.5 tt -58.55 -50.73 72.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 -175.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -72.2 -26.7 62.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -100.02 -11.06 20.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.967 -169.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.877 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 79.1 m-85 -128.33 -55.27 1.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 3.5 mp -66.13 -34.88 79.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 -165.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 1.074 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.2 pp -123.82 37.45 4.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.97 175.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 287' ' ' ASP . 9.3 m -115.53 153.86 30.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.108 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.581 ' HA ' HD11 ' A' ' 290' ' ' LEU . 28.7 t70 -45.7 -34.82 3.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -166.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -78.49 -41.09 33.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.877 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.04 -56.53 5.72 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.472 -171.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 291' ' ' GLU . 0.5 OUTLIER -66.42 -21.26 66.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.908 -179.157 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.582 ' N ' HD12 ' A' ' 290' ' ' LEU . 84.4 tt0 -68.29 -46.94 68.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.798 171.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.91 -42.87 99.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.071 -174.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 4.0 m -79.59 -36.31 17.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.182 -174.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -64.97 -28.73 69.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.934 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.79 -26.72 68.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -87.95 -41.96 12.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -146.13 135.53 11.47 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.541 0.686 . . . . 0.0 110.902 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -53.12 113.9 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.655 2.236 . . . . 0.0 112.394 175.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' A' ' 299' ' ' LEU . 0.7 OUTLIER -86.45 -24.94 25.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.949 177.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 103.63 -57.01 0.56 Allowed Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.506 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.596 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -168.18 161.83 12.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.384 . . . . 0.0 111.036 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.624 HG22 ' HB3' ' A' ' 307' ' ' TYR . 32.6 m -124.33 155.55 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.099 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.02 -9.99 59.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.034 173.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.567 ' CD2' HD22 ' A' ' 290' ' ' LEU . 45.0 tp -86.5 119.95 27.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.858 -176.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.61 -38.64 72.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.945 -174.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 42.7 t -64.56 -50.32 67.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.916 -169.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.624 ' HB3' HG22 ' A' ' 302' ' ' VAL . 16.9 t80 -78.52 -29.13 46.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -64.74 -37.76 88.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.37 -37.9 85.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.939 173.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -72.81 -39.8 66.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.963 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.596 HD13 ' HA ' ' A' ' 301' ' ' ALA . 79.2 mt -61.93 -32.64 73.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.928 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.26 -17.52 58.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.8 -19.12 65.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.978 173.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -91.63 121.74 66.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.746 0.784 . . . . 0.0 110.852 164.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -48.2 -26.93 8.73 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.679 2.252 . . . . 0.0 112.344 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -61.26 -29.64 69.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -172.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 1.2 mp -76.84 -29.86 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.188 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.51 85.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.046 -170.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.21 -43.74 77.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.522 ' HB ' ' HB1' ' A' ' 112' ' ' ALA . 80.8 p -63.78 -30.99 72.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -171.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.5 mmm -70.91 -32.86 69.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.85 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -64.46 -46.68 82.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.869 -173.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.456 ' OD1' ' HB2' ' A' ' 112' ' ' ALA . 7.5 p-10 -80.08 -27.07 39.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.728 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.13 -49.21 73.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.116 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -68.0 -34.98 77.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -105.51 -6.54 19.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.823 -169.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -93.18 -159.6 34.94 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.435 -170.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -142.22 148.53 38.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 0.0 110.92 -172.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 41.7 mm -65.13 122.3 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.083 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 36.2 ttp . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.574 0.702 . . . . 0.0 110.913 -179.639 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 . . . . . 0 C--O 1.23 0.04 0 CA-C-O 120.704 0.287 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.501 ' HE2' ' HD1' ' A' ' 169' ' ' PHE . 85.1 mmm -79.99 -22.76 42.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 -173.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.5 m -55.52 -39.95 71.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.806 -171.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -68.71 -33.48 74.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.031 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 1.5 m-30 -67.51 -37.33 82.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -54.98 -42.04 71.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -78.28 -36.18 47.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.774 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.12 -38.44 90.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.043 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 339' ' ' PHE . 19.3 m -74.72 -31.32 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.071 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.495 ' O ' HG23 ' A' ' 347' ' ' VAL . 4.9 tmt_? -64.16 -37.33 87.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.863 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.9 m -57.27 -36.73 71.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.212 174.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.89 -42.54 94.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.183 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.556 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.9 m -74.26 -34.57 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.202 -174.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.465 HD13 HG21 ' A' ' 347' ' ' VAL . 1.4 mp -63.37 -47.91 89.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.119 173.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.97 -40.29 97.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.26 -46.39 41.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.105 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.33 78.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.039 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.2 p -75.26 -10.73 59.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.3 18.31 69.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.484 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.87 -33.32 45.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.764 0.316 . . . . 0.0 110.938 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 360' ' ' ALA . 90.3 mm-40 -140.58 156.44 46.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 52.3 p -77.48 166.59 22.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.183 171.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.499 HG22 ' OG1' ' A' ' 193' ' ' THR . 53.2 t -56.19 -41.92 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.226 173.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.52 -46.85 88.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.951 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -70.49 -56.42 6.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . . . -68.45 -48.42 64.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.11 -172.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.66 HD11 ' HB1' ' A' ' 188' ' ' ALA . 1.8 tm? -65.0 -45.85 83.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -175.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.34 -53.76 50.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 -176.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 367' ' ' ARG . 32.1 t70 -68.07 -50.08 57.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 -174.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -64.06 -38.29 90.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 -172.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 75.5 mm-40 -78.08 -32.34 50.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 40.9 m -66.21 -29.13 69.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.172 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 363' ' ' ASP . 79.6 mtt180 -56.9 -32.16 65.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 174.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 365' ' ' GLN . 71.4 mt -59.89 -40.72 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 41.6 p -97.1 -11.07 24.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.189 -175.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.812 175.363 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.755 0.312 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.441 HG21 ' HD2' ' A' ' 271' ' ' PRO . 62.3 mt -99.45 140.06 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.154 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -143.9 145.0 31.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -54.34 138.24 39.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 176.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.15 8.35 68.88 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.538 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.2 tttt -166.09 131.09 2.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.827 0.346 . . . . 0.0 110.91 176.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.618 HD23 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -141.76 155.97 45.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.963 -172.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 69.3 t -114.45 135.43 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.18 -175.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.727 HD12 HG13 ' A' ' 35' ' ' VAL . 0.9 OUTLIER -120.0 134.88 62.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.047 176.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.87 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 60.5 m95 -108.62 124.46 50.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 163.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.531 HD13 ' HG ' ' A' ' 20' ' ' LEU . 12.1 tt -109.75 151.77 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.074 -163.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -54.75 148.28 13.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.807 -172.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.99 -16.85 41.87 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.504 -175.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -80.61 -14.12 58.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.854 0.359 . . . . 0.0 110.888 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 15' ' ' LYS . 33.0 mmtm -140.0 128.09 22.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 166.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.1 -78.13 1.07 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.49 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -104.88 -35.92 7.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -67.33 -52.47 39.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.862 -150.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.403 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -54.32 -52.62 43.16 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.508 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.542 HD23 HD11 ' A' ' 9' ' ' ILE . 5.8 mt -55.09 -53.44 55.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.359 . . . . 0.0 110.907 174.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.29 -39.02 6.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.133 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -71.47 -57.99 3.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.48 HG23 ' HA ' ' A' ' 20' ' ' LEU . 20.9 m -74.29 -36.19 42.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.199 -170.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.565 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -63.6 -45.62 94.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.489 174.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -54.33 -36.49 63.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.878 0.37 . . . . 0.0 110.831 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -58.92 -41.12 86.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.967 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 4.7 m-30 -62.34 -47.03 86.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.441 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 98.1 mt-10 -61.27 -36.05 78.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -75.42 -40.18 58.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.924 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -91.24 -49.84 6.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 -166.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.6 p -108.66 -7.55 15.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.174 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.13 8.83 87.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.369 167.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.934 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.8 133.66 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 111.219 -178.39 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.7 mttt -69.97 136.18 50.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.853 -172.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.727 HG13 HD12 ' A' ' 9' ' ' ILE . 92.1 t -114.7 125.02 71.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.007 -175.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.575 ' O ' HD13 ' A' ' 9' ' ' ILE . 98.6 m -108.91 125.66 52.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.098 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 20' ' ' LEU . 84.8 t -102.43 130.91 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.138 177.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -118.13 154.27 32.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.958 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 65.8 t-80 -87.13 138.61 32.48 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.558 0.694 . . . . 0.0 110.884 -169.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 81.4 Cg_exo -57.34 -25.51 65.88 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.652 2.235 . . . . 0.0 112.303 -173.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -48.36 -51.1 27.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.838 -173.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.94 -0.82 57.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 -175.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 8.1 tt -46.56 -52.71 12.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -174.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -65.01 -40.81 95.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.81 -40.89 97.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.865 -172.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -81.55 -21.14 38.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.538 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 53.2 t80 -50.06 -51.16 64.45 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.696 0.76 . . . . 0.0 110.816 -165.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.538 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 55.5 Cg_endo -81.69 -30.06 1.55 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.656 2.238 . . . . 0.0 112.405 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -75.12 -40.05 60.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -167.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.51 -27.69 41.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.032 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.723 ' HB2' HD23 ' A' ' 75' ' ' LEU . . . -68.08 -36.21 79.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.096 177.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.81 -32.08 71.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.051 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.2 p -92.18 -15.7 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.135 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.76 10.89 80.64 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.403 173.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -140.2 132.62 28.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 0.0 110.811 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.439 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . 170.69 -127.76 1.51 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.474 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.87 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 35.0 Cg_endo -64.18 149.01 91.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.713 2.275 . . . . 0.0 112.399 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -92.1 -33.2 14.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.826 161.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.692 ' HB ' HG23 ' A' ' 9' ' ' ILE . 38.7 mt -124.16 136.09 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.114 -177.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 tp -131.44 127.56 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.157 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -93.77 136.7 33.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.802 170.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.489 ' CH2' ' HB3' ' A' ' 105' ' ' ALA . 33.0 p90 -140.89 167.17 22.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.969 171.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.59 -82.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.016 -167.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -127.32 -73.42 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.881 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -99.96 -10.73 21.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -159.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -51.25 -22.34 2.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.527 ' HB2' HD11 ' A' ' 104' ' ' ILE . 32.9 p90 -56.8 -31.77 65.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.807 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.89 -50.99 60.91 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.447 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.73 -35.98 90.56 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.533 171.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.452 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -55.1 -51.63 65.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 0.0 110.946 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.73 -44.07 51.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.072 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -57.04 -38.86 73.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.982 -174.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.414 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 63.4 m -85.02 -7.15 59.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.77 30.3 59.9 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.545 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.723 HD23 ' HB2' ' A' ' 51' ' ' ALA . 35.5 mt -88.83 -9.35 52.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.808 0.337 . . . . 0.0 110.904 -170.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.467 ' HA ' ' H ' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -128.61 152.11 48.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 -178.161 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -80.37 142.82 34.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.069 175.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -73.12 135.38 44.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.836 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 pt -105.06 155.87 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.109 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.9 m -97.65 130.04 30.08 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.536 0.684 . . . . 0.0 111.08 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.42 135.55 66.2 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.669 2.246 . . . . 0.0 112.335 176.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -103.39 117.85 35.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 175.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.31 -41.34 98.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.849 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.25 87.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.002 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.435 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 16.5 m-85 -75.84 -31.75 59.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.857 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.448 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 66.8 tt0 -53.4 -50.84 64.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.949 173.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.76 -32.99 72.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.435 ' HB2' ' HA ' ' A' ' 85' ' ' PHE . 93.7 mttt -75.87 -21.04 57.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -174.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -104.76 -105.08 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -171.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 26.9 t80 171.66 128.33 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.68 0.752 . . . . 0.0 110.956 -167.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -52.77 -36.78 74.69 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.406 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 62.9 t80 -65.19 -35.11 80.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.4 p -73.79 -31.08 63.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.168 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.665 ' HA ' HG23 ' A' ' 97' ' ' VAL . 79.6 m95 -67.95 -29.72 68.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 173.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.04 -31.48 72.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.95 -23.84 58.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.665 HG23 ' HA ' ' A' ' 94' ' ' TRP . 17.7 m -111.51 19.28 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 -173.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.1 ttp-105 -111.95 136.5 51.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.842 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -135.39 121.89 20.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.952 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.2 t30 58.91 35.39 24.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.96 0.76 89.78 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.57 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -118.29 151.0 38.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 110.853 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.625 HD23 HG21 ' A' ' 97' ' ' VAL . 22.2 mt -86.58 135.27 33.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.951 177.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.527 HD11 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -124.79 3.6 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.065 -173.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.489 ' HB3' ' CH2' ' A' ' 62' ' ' TRP . . . -163.46 165.83 23.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.196 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.473 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 90.2 m-85 -114.87 140.57 25.64 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.618 0.723 . . . . 0.0 110.976 170.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 12.0 Cg_exo -70.07 123.63 10.19 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.603 2.202 . . . . 0.0 112.294 170.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 1.021 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -106.98 -39.83 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 175.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -144.51 153.78 42.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 -166.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.8 t -118.68 129.86 74.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.135 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -119.89 127.78 53.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.615 ' HB2' HD22 ' A' ' 323' ' ' ASN . . . -155.02 146.42 23.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.036 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.6 mp -85.71 170.01 12.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.996 -175.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.4 p -154.75 153.63 31.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.988 0.423 . . . . 0.0 110.853 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.883 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -94.89 126.79 40.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 169.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.602 ' N ' HD23 ' A' ' 115' ' ' LEU . 5.1 mp -111.63 131.73 62.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 -175.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -132.47 147.93 52.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 -175.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -92.37 115.49 28.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.872 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.474 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.2 mttt -66.56 -22.12 66.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -77.94 -23.35 48.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 -176.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.8 mp -85.29 -57.5 3.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 168.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.734 ' H ' HD21 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -144.32 125.89 8.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.696 0.76 . . . . 0.0 110.785 177.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.46 -0.76 10.66 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.594 2.196 . . . . 0.0 112.41 -176.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -147.93 101.87 3.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.654 0.74 . . . . 0.0 110.761 -174.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.52 155.06 50.39 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.755 2.303 . . . . 0.0 112.401 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.452 ' HD2' ' SD ' ' A' ' 224' ' ' MET . 52.4 Cg_exo -55.28 143.06 77.56 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.699 2.266 . . . . 0.0 112.294 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -78.87 -22.03 46.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 52.9 p -135.62 159.95 40.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.202 -177.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.441 ' HA ' HD11 ' A' ' 132' ' ' ILE . 77.8 m95 -70.82 -28.13 64.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.09 -19.41 65.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -84.07 -20.63 32.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.559 ' O ' HD13 ' A' ' 135' ' ' LEU . 0.7 OUTLIER -57.36 -45.35 99.9 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.635 0.731 . . . . 0.0 111.133 -171.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 82.0 Cg_exo -51.27 -47.67 24.81 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.612 2.208 . . . . 0.0 112.335 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.84 -59.84 3.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.054 -174.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 1.122 HD23 ' C ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.99 -16.8 63.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.866 -173.328 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.549 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.4 t70 -61.3 -40.1 92.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 168.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.36 -30.07 69.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.7 -47.95 57.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.832 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.1 pp -87.42 -16.69 34.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.924 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.61 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.4 tttt -59.45 -32.86 70.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.41 -25.13 68.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.983 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -95.36 7.04 47.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.919 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.9 30.96 58.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.531 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -109.7 169.99 8.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 0.0 110.887 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.5 t -125.63 142.22 51.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 174.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.63 -42.48 74.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.124 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -139.3 127.78 22.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.945 -175.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 63.3 tpp -105.25 129.14 53.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 -174.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.18 158.33 38.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.929 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -98.63 -42.87 7.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.82 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 1.032 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.5 tm? 48.46 31.2 2.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 -170.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -103.73 -6.76 21.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.887 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -137.67 156.5 74.63 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.645 0.736 . . . . 0.0 110.901 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.495 ' HA ' ' HB ' ' A' ' 157' ' ' THR . 67.7 Cg_exo -52.37 -26.39 27.6 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.671 2.247 . . . . 0.0 112.339 176.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -63.22 -38.49 91.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -85.85 -37.19 19.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.495 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 20.0 m -58.87 -52.13 67.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.116 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.589 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 23.6 t-105 -62.54 -49.23 84.21 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.561 0.696 . . . . 0.0 110.893 -163.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 81.6 Cg_exo -50.07 -48.26 20.42 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.724 2.283 . . . . 0.0 112.392 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.7 HD21 ' O ' ' A' ' 160' ' ' LEU . 6.8 tt -72.0 -39.91 68.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 -170.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.3 mt -71.12 -42.41 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.119 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.38 -25.86 59.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -60.66 -35.03 75.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -169.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.409 ' HB3' ' CD2' ' A' ' 250' ' ' PHE . 59.6 p30 -97.53 3.48 50.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.76 2.15 13.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.415 173.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.89 64.78 3.0 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.563 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -87.08 136.02 33.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.916 0.388 . . . . 0.0 110.987 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.49 -0.33 22.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.484 ' HA ' HG12 ' A' ' 181' ' ' VAL . 49.6 p90 -154.05 154.82 34.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.909 -175.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -97.22 121.96 39.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.952 157.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -109.76 123.14 49.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.882 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -152.69 131.52 12.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.3 t30 55.74 44.97 25.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 172.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.92 15.29 78.34 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.463 173.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.89 139.11 50.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.0 110.864 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -98.75 140.43 32.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 172.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -122.33 109.94 15.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.534 ' C ' HD13 ' A' ' 178' ' ' ILE . 2.1 pp -83.4 -6.2 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.071 -177.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -99.67 -16.92 18.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -117.01 88.74 2.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.834 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 169' ' ' PHE . 22.9 m -117.82 165.03 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.094 -169.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -109.96 25.71 15.86 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.509 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 365' ' ' GLN . 1.2 m -106.6 -23.06 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.821 0.344 . . . . 0.0 111.06 -176.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -92.09 24.15 3.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -107.72 -174.97 2.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.8 -28.31 63.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.11 -40.43 92.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.524 -171.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.599 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -60.45 -38.39 84.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 111.099 177.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.604 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.6 mttt -61.67 -37.3 83.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.9 176.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.77 88.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.042 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.0 -46.62 71.39 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.564 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.565 HD11 ' HA ' ' A' ' 347' ' ' VAL . 20.2 tp -67.56 -33.63 75.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.958 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.527 ' OG1' HG22 ' A' ' 357' ' ' VAL . 91.8 m -65.57 -42.02 92.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.24 176.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 92.3 t80 -69.4 -44.68 70.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.638 ' C ' HD21 ' A' ' 195' ' ' LEU . 6.9 tt -51.13 -51.6 51.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.932 -175.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 199' ' ' ILE . 35.1 m -63.89 -22.48 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 -174.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.0 m-20 -62.25 -34.18 76.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.843 -177.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 194' ' ' PHE . 0.7 OUTLIER -82.02 -39.96 22.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.959 -173.444 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 196' ' ' VAL . 1.8 pp -72.02 -29.96 34.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.151 172.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -67.47 -37.73 83.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 171.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -82.72 2.54 33.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.925 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 66.86 39.94 3.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.829 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -75.96 -15.66 60.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.811 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -144.1 156.1 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.842 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -94.19 152.61 18.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.58 -27.11 68.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -94.1 2.67 55.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.9 m -65.62 134.92 54.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -138.36 171.73 13.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.918 176.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.07 -46.04 82.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 -176.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.8 m -60.37 -40.61 91.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.95 -42.25 94.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.178 173.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.98 -36.91 85.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.136 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 233' ' ' SER . 93.8 mt-10 -65.04 -44.24 89.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.874 177.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.96 -39.56 93.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.087 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.18 -45.02 95.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.099 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -64.25 -38.67 91.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.22 -34.7 76.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.0 -19.26 27.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.39 26.1 26.48 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -82.07 -19.96 39.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.928 0.395 . . . . 0.0 110.915 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.9 t -123.89 134.76 53.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 174.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.527 ' HB2' HD22 ' A' ' 122' ' ' LEU . . . -66.8 -47.38 72.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.996 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.64 ' HB3' HD22 ' A' ' 115' ' ' LEU . 72.9 mtm -133.86 153.78 51.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -171.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 10.1 t -151.04 155.81 39.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.213 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.2 mm -109.69 124.76 66.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.185 -175.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -153.51 174.64 14.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 -170.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.41 -164.13 34.17 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.435 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.2 -20.9 49.1 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.662 2.241 . . . . 0.0 112.341 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -78.16 -25.52 47.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 49.4 53.52 12.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.115 178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -60.0 -23.61 63.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 -177.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.414 ' HA ' ' HG2' ' A' ' 214' ' ' GLU . 65.2 m -57.09 -40.69 77.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.89 -176.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -85.91 179.19 7.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 69.8 mt . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 -167.543 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.809 0.338 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -106.15 124.25 49.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.474 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 52.5 p90 -143.82 155.97 44.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.89 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -135.84 160.16 24.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.512 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.38 135.12 54.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.938 0.399 . . . . 0.0 111.061 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.8 t -153.8 149.14 27.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.36 162.07 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 3.1 mp -68.05 151.58 97.09 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.539 0.685 . . . . 0.0 110.919 -162.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.09 -173.6 1.85 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.663 2.242 . . . . 0.0 112.327 -174.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 99.5 m -89.03 143.01 27.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 -171.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.409 ' CD2' ' HB3' ' A' ' 164' ' ' ASP . 11.1 t80 -132.17 113.13 12.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -176.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 56.22 35.46 25.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.37 1.89 83.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.583 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 90.0 mm-40 -126.86 127.94 24.32 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 121.555 0.693 . . . . 0.0 110.887 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 78.1 Cg_exo -55.12 133.24 57.0 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.631 2.221 . . . . 0.0 112.375 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 256' ' ' LYS . 69.4 m -78.81 -9.61 59.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.855 173.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 85.7 mttt -39.8 128.61 1.53 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.539 0.685 . . . . 0.0 110.861 -173.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 71.2 Cg_exo -63.51 156.25 57.77 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.648 2.232 . . . . 0.0 112.377 -167.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -70.75 166.6 20.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 173.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.83 131.68 61.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.146 -167.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.95 135.13 12.09 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.436 173.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 96.4 t -123.53 115.91 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 0.0 111.159 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.453 HD21 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -64.17 120.71 12.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.992 -178.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 48.4 m -124.74 131.63 53.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.835 -169.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.84 138.89 52.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.105 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -135.04 172.85 21.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.463 -170.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 23.4 mm -111.39 127.91 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.759 0.314 . . . . 0.0 111.244 -173.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -62.48 132.03 51.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.988 -176.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.467 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -60.13 -28.48 67.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.113 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.7 -5.15 59.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.8 t -74.79 120.06 79.75 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.675 0.75 . . . . 0.0 110.917 -174.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.441 ' HD2' HG21 ' A' ' 2' ' ' ILE . 92.0 Cg_endo -70.4 -7.1 20.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.637 2.225 . . . . 0.0 112.389 164.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -101.11 14.93 30.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 -171.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -51.87 -40.18 60.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.898 -169.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.3 -52.4 58.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 -172.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.4 pp -80.51 -33.65 36.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.004 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.62 -47.43 69.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.018 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -61.48 -41.75 97.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.854 173.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.592 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.8 tt0 -61.38 -47.32 86.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 17.9 m-30 -68.4 -36.56 79.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.813 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.537 ' HA ' HD23 ' A' ' 284' ' ' LEU . 5.8 tt -59.37 -52.4 65.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.873 -177.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -77.91 -33.5 51.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 -176.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.592 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 61.7 m-80 -99.97 -13.19 19.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.845 -163.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.771 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 59.2 m-85 -127.36 -50.49 1.41 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.537 HD23 ' HA ' ' A' ' 280' ' ' LEU . 0.5 OUTLIER -63.85 -39.36 94.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -170.523 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 1.021 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.7 pp -124.38 38.2 4.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 -175.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.484 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 5.9 t -115.66 162.73 16.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.088 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.438 ' HA ' HD11 ' A' ' 290' ' ' LEU . 28.4 t70 -48.51 -34.12 10.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -169.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -80.24 -41.09 25.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.859 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.771 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.77 -57.24 5.48 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.452 -170.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.558 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -66.42 -21.47 66.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.0 110.973 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.545 ' N ' HD12 ' A' ' 290' ' ' LEU . 83.9 tt0 -67.06 -46.49 74.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.825 171.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.67 -37.66 88.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.403 HG13 ' HA3' ' A' ' 19' ' ' GLY . 61.0 t -74.61 -46.33 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.086 -177.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -65.81 -30.09 70.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.797 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.05 -27.8 67.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.95 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -87.41 -49.92 6.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.83 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 74.1 mmtt -138.6 139.15 23.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.57 0.7 . . . . 0.0 110.865 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 297' ' ' LYS . 80.1 Cg_exo -55.03 115.83 2.71 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.66 2.24 . . . . 0.0 112.381 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 299' ' ' LEU . 0.3 OUTLIER -84.41 -22.54 30.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 173.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 96.8 -59.71 1.22 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.516 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.676 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -167.53 160.23 12.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.814 0.34 . . . . 0.0 111.231 174.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.706 HG22 ' HB3' ' A' ' 307' ' ' TYR . 22.1 m -120.84 153.3 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.87 -9.58 58.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.061 173.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.558 ' CD2' HD22 ' A' ' 290' ' ' LEU . 44.0 tp -83.48 121.1 26.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.886 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.58 -38.61 75.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.86 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.7 t -64.46 -50.0 69.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.847 -169.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.706 ' HB3' HG22 ' A' ' 302' ' ' VAL . 13.6 t80 -77.26 -31.32 54.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.91 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.93 -39.15 93.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -58.67 -38.01 77.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -75.05 -38.78 61.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.979 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.676 HD13 ' HA ' ' A' ' 301' ' ' ALA . 80.3 mt -61.84 -34.25 75.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.98 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.38 -18.05 63.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.055 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.12 -19.56 66.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.934 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -93.14 121.43 65.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.6 0.715 . . . . 0.0 110.865 166.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -47.9 -26.65 7.56 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.66 2.24 . . . . 0.0 112.396 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -62.91 -34.88 78.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 -175.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.546 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.0 OUTLIER -81.5 -35.95 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.2 90.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.118 -170.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.92 -47.96 73.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.035 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.545 ' HB ' ' HB1' ' A' ' 112' ' ' ALA . 75.6 p -67.84 -27.16 66.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.086 -176.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.5 ttp -62.48 -34.96 77.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -62.31 -51.37 67.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.84 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.615 HD22 ' HB2' ' A' ' 112' ' ' ALA . 12.3 p-10 -80.06 -26.48 39.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.77 -177.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.41 -51.62 62.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.095 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -69.33 -29.77 67.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.88 -8.13 16.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.824 -168.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -91.39 -153.24 29.33 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.436 -168.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.0 144.83 37.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.856 0.36 . . . . 0.0 110.895 -172.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 36.0 mm -63.78 119.54 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.089 -172.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 60.2 ttm . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.517 0.675 . . . . 0.0 110.89 178.058 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 339' ' ' PHE . 99.4 mm-40 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.73 0.3 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 88.4 mmm -64.96 -28.64 69.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.871 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.1 m -58.07 -39.91 79.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.767 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.07 -39.39 63.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 3.8 m-30 -63.17 -46.74 85.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -60.14 -37.71 80.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.901 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -69.63 -39.67 77.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.2 -43.01 83.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.104 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 339' ' ' PHE . 19.7 m -73.91 -33.17 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.133 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.0 tmt_? -65.2 -38.68 91.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 86.1 m -58.53 -38.6 78.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.76 94.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.565 ' HA ' HD11 ' A' ' 192' ' ' LEU . 12.4 m -73.97 -35.51 42.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.084 -174.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.453 HD13 HG21 ' A' ' 347' ' ' VAL . 1.4 mp -63.68 -47.01 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.221 173.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.02 -40.98 99.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.891 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.96 -45.94 47.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.11 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.01 -40.17 78.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.7 p -75.67 -10.11 59.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.32 18.67 68.43 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.375 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.13 -32.85 44.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 0.0 110.911 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -140.88 157.72 44.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.6 p -77.21 169.11 18.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.288 170.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.527 HG22 ' OG1' ' A' ' 193' ' ' THR . 53.0 t -57.56 -43.07 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.14 172.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.65 -47.04 88.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -69.52 -55.3 10.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.5 -47.7 66.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.084 -172.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.604 ' HG ' ' HA ' ' A' ' 189' ' ' LYS . 1.6 tm? -65.08 -44.96 87.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -174.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.46 -53.71 38.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.949 -177.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.01 -47.07 66.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 -172.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.07 -43.92 81.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 -174.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.52 ' HB3' ' HB ' ' A' ' 183' ' ' VAL . 86.9 mm-40 -73.36 -32.98 64.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.933 -175.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 35.9 m -61.76 -28.23 69.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.172 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.88 -30.11 65.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.435 ' HB ' ' O ' ' A' ' 365' ' ' GLN . 74.5 mt -60.9 -37.7 77.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.233 174.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 43.4 p -98.01 -12.01 22.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.174 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 176.539 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.752 0.31 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.6 mt -108.96 138.16 37.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -121.37 136.13 55.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.83 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -54.32 134.92 45.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.843 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.24 9.4 67.32 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.475 -174.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 39.2 ttpt -160.07 129.97 5.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.363 . . . . 0.0 110.936 173.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.672 ' H ' HD21 ' A' ' 7' ' ' LEU . 1.1 pt? -136.24 152.77 51.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.93 -169.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 74.5 t -112.64 135.22 52.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.189 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.643 HD12 HG21 ' A' ' 35' ' ' VAL . 1.1 mp -118.64 132.69 67.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 177.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.819 ' HD1' ' HB3' ' A' ' 57' ' ' PRO . 78.7 m95 -104.45 125.77 50.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.929 164.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.535 HD13 ' HG ' ' A' ' 20' ' ' LEU . 10.4 tt -110.88 150.03 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.096 -166.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -58.99 150.09 25.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -173.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.83 -16.62 12.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.417 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -72.68 -15.21 61.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.917 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -139.98 137.85 35.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.899 167.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.97 -81.56 1.07 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.504 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -109.99 -37.13 5.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.932 0.396 . . . . 0.0 110.946 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -66.9 -50.01 63.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.92 -151.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.757 ' HA3' HG21 ' A' ' 293' ' ' VAL . . . -54.67 -53.6 38.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.537 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.535 ' HG ' HD13 ' A' ' 11' ' ' ILE . 8.1 mt -55.01 -48.07 73.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.783 0.325 . . . . 0.0 110.926 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.73 -34.77 12.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.11 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -78.66 -60.13 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.848 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.473 HG23 ' HA ' ' A' ' 20' ' ' LEU . 26.4 m -74.55 -42.1 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 -169.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.47 ' N ' HG21 ' A' ' 23' ' ' VAL . . . -64.99 -40.61 97.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -59.04 -29.95 67.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.908 0.385 . . . . 0.0 110.88 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -56.99 -33.08 66.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.026 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 2.5 m-30 -56.6 -47.76 78.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.895 177.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -70.36 -41.42 73.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.07 -34.85 79.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.846 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -92.63 -48.94 6.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.908 0.385 . . . . 0.0 110.853 -170.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.1 p -116.56 -0.72 12.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.213 -169.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.04 11.72 85.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.429 167.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.967 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.02 133.86 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.868 0.366 . . . . 0.0 111.11 -179.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 73.4 mmtt -74.13 140.62 45.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.844 -171.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.643 HG21 HD12 ' A' ' 9' ' ' ILE . 13.1 p -122.72 128.1 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.065 -174.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.631 ' O ' HD13 ' A' ' 9' ' ' ILE . 96.9 m -111.94 129.08 56.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.093 -174.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 20' ' ' LEU . 91.6 t -104.48 131.51 53.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.125 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -117.18 155.02 30.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.0 t-80 -85.07 138.96 36.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.683 0.754 . . . . 0.0 110.837 -170.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 86.6 Cg_exo -54.98 -29.39 64.34 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.627 2.218 . . . . 0.0 112.303 -175.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -48.28 -51.34 26.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 -172.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.03 -0.85 57.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.885 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.2 tt -47.06 -53.12 13.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -68.69 -38.45 80.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.7 -41.35 96.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 -171.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -81.66 -21.43 38.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.54 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 65.9 t80 -48.6 -50.71 57.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.624 0.726 . . . . 0.0 110.84 -167.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 66.3 Cg_endo -80.06 -28.48 3.13 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.596 2.198 . . . . 0.0 112.352 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -74.43 -39.16 62.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 -171.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.444 HG11 ' HD3' ' A' ' 57' ' ' PRO . 33.5 m -67.88 -27.97 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.13 -177.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.591 ' HB2' HD23 ' A' ' 75' ' ' LEU . . . -68.29 -37.77 80.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.057 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.19 -32.11 72.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.076 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.8 p -92.89 -14.92 27.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.56 10.79 79.95 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.407 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -142.79 136.2 28.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.776 0.322 . . . . 0.0 110.766 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.95 -114.95 0.52 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.514 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.819 ' HB3' ' HD1' ' A' ' 10' ' ' TRP . 61.2 Cg_endo -73.97 154.54 47.89 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.709 2.273 . . . . 0.0 112.285 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.67 -32.77 13.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 160.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.624 ' HB ' HG23 ' A' ' 9' ' ' ILE . 39.0 mt -127.63 137.77 56.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.229 -177.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 tp -131.38 126.84 59.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.193 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -88.97 141.6 28.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 167.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.589 ' CZ2' ' HB3' ' A' ' 67' ' ' PHE . 1.8 p90 -138.41 160.9 38.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.968 172.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.43 -82.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.164 -169.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.544 ' CD2' ' HA3' ' A' ' 260' ' ' GLY . 40.5 m170 -121.88 -71.07 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -170.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.95 -11.78 16.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.815 -164.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -56.78 -17.07 7.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -158.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.589 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . 27.9 p90 -61.77 -23.23 66.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.826 -173.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.55 -48.81 63.53 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.404 -174.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.43 -36.77 92.03 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.474 171.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.505 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 1.5 t80 -55.17 -51.23 67.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.897 0.38 . . . . 0.0 110.874 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.99 -41.91 40.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.119 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -59.19 -36.18 74.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.41 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 67.0 m -85.06 -7.69 59.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 178.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.28 31.73 58.95 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.591 HD23 ' HB2' ' A' ' 51' ' ' ALA . 52.1 mt -88.12 -9.62 52.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.812 0.339 . . . . 0.0 110.884 -167.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.549 HD11 ' HB ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -128.42 152.95 47.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -172.254 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -79.18 141.25 37.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.091 175.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -70.74 137.85 50.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 173.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.436 HD13 ' CZ ' ' A' ' 106' ' ' TYR . 39.3 pt -103.88 156.64 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.143 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.9 m -92.08 130.04 39.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.536 0.684 . . . . 0.0 111.088 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.428 ' HB3' HD12 ' A' ' 103' ' ' LEU . 50.0 Cg_endo -67.41 141.14 55.03 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.687 2.258 . . . . 0.0 112.328 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -110.14 118.75 37.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.94 -36.78 73.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.25 -45.17 92.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.178 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -75.64 -32.44 60.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.494 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.5 tt0 -51.51 -49.1 62.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -66.35 -32.89 74.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.799 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.02 -23.26 52.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 -172.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -104.96 -104.64 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.993 -169.392 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 t80 174.94 107.98 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.668 0.747 . . . . 0.0 111.036 -160.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.0 -32.17 30.0 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.725 2.283 . . . . 0.0 112.329 -177.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.99 -36.93 85.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.2 p -78.3 -31.52 48.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.591 ' HA ' HG23 ' A' ' 97' ' ' VAL . 86.2 m95 -63.16 -29.99 71.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 171.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -69.46 -32.15 70.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.792 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.73 -23.01 61.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.08 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.591 HG23 ' HA ' ' A' ' 94' ' ' TRP . 19.8 m -110.7 17.98 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.134 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -107.57 132.93 52.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.817 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -126.2 119.22 26.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 174.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.2 t30 57.57 37.04 27.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.868 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.64 1.12 90.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.482 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -121.83 148.75 44.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.843 0.354 . . . . 0.0 110.852 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.584 HD23 HG21 ' A' ' 97' ' ' VAL . 16.8 mt -86.03 133.79 33.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -176.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.549 ' HB ' HD11 ' A' ' 76' ' ' LEU . 1.2 pp -114.84 -9.29 12.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.095 -172.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.571 ' HB1' ' HH2' ' A' ' 62' ' ' TRP . . . -169.44 173.4 6.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.183 -173.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.459 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 99.2 m-85 -115.88 140.17 25.86 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.671 0.748 . . . . 0.0 110.925 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 12.2 Cg_exo -70.82 127.85 14.29 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.705 2.27 . . . . 0.0 112.323 172.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.913 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -108.9 -39.93 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.117 177.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.607 ' HB1' ' HB3' ' A' ' 262' ' ' LEU . . . -143.29 154.17 43.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.149 -171.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.2 t -116.15 127.28 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.204 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -110.62 125.23 53.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.467 ' HB1' ' HB ' ' A' ' 320' ' ' THR . . . -146.36 141.05 26.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.9 mp -89.66 167.12 13.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.004 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.5 p -156.27 154.99 31.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.845 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.879 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -92.27 123.48 35.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 168.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.564 ' N ' HD23 ' A' ' 115' ' ' LEU . 5.0 mp -109.94 131.56 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.177 -175.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -132.35 148.41 52.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 -173.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -91.06 113.97 26.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.909 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.11 -25.41 68.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -173.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -83.47 -22.15 32.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 -173.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 mp -81.23 -55.51 4.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.857 169.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.7 ' H ' HD21 ' A' ' 122' ' ' LEU . 1.7 pt? -141.05 127.34 11.5 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.554 0.693 . . . . 0.0 110.888 173.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.18 -5.54 13.64 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.663 2.242 . . . . 0.0 112.365 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -149.27 102.43 3.32 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.621 0.725 . . . . 0.0 110.793 -175.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -72.01 156.92 55.49 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.769 2.312 . . . . 0.0 112.321 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.14 144.84 82.98 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.737 2.291 . . . . 0.0 112.247 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.02 -17.97 44.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.977 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 56.8 p -135.06 159.51 41.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.21 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.536 ' HA ' HD11 ' A' ' 132' ' ' ILE . 64.7 m95 -70.76 -28.35 64.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.039 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.99 -22.78 67.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.807 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -82.34 -21.96 35.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.791 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.643 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -56.76 -48.73 96.76 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.67 0.747 . . . . 0.0 111.2 -173.6 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 41.8 Cg_endo -69.07 -37.41 10.87 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.669 2.246 . . . . 0.0 112.332 -174.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.89 -60.74 2.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.081 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 1.278 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.23 -16.95 64.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -175.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.512 ' N ' HD13 ' A' ' 135' ' ' LEU . 34.5 t70 -57.79 -40.4 79.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.039 0.447 . . . . 0.0 110.866 168.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.25 -30.66 69.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -70.97 -47.69 57.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.812 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.9 pp -84.91 -14.47 47.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.627 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.8 tttt -60.87 -34.01 73.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.968 174.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.73 -24.05 67.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.085 175.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -95.12 4.35 53.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.877 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.02 32.13 56.96 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -110.22 170.72 7.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.932 173.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.9 t -124.14 138.73 54.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 168.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -65.4 -43.69 89.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 -170.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -143.11 127.87 18.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 63.5 tpp -107.55 132.58 53.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -153.57 158.44 41.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -172.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -90.11 -51.08 5.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.851 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 1.071 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.6 tm? 48.04 32.36 2.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.03 -167.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -101.2 -6.16 24.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.866 175.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.36 155.02 80.72 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.638 0.732 . . . . 0.0 110.939 -174.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.06 -25.95 77.9 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.743 2.295 . . . . 0.0 112.391 177.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -72.26 -27.48 62.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -80.01 -38.88 31.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.848 170.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.414 HG21 HG11 ' A' ' 347' ' ' VAL . 22.5 m -63.15 -45.66 90.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.07 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.596 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 46.2 t-105 -54.95 -54.55 48.66 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.609 0.719 . . . . 0.0 110.931 -169.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 22.1 Cg_endo -63.99 -19.92 67.15 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.634 2.222 . . . . 0.0 112.38 -173.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.712 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.7 tm? -82.77 -45.87 13.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.858 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.542 HG22 ' HA3' ' A' ' 166' ' ' GLY . 85.3 mt -75.3 -44.77 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.143 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.11 -23.65 61.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 -173.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -59.59 -35.95 75.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.104 -170.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 58.9 p30 -102.51 8.39 39.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.94 2.01 12.81 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.501 170.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.542 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -77.34 65.49 3.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.498 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -88.23 134.57 33.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.865 0.364 . . . . 0.0 111.035 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.6 2.1 17.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.135 -174.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.46 ' HA ' HG12 ' A' ' 181' ' ' VAL . 44.3 p90 -159.45 154.74 25.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 -175.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -93.67 123.13 36.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.847 160.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -114.95 120.58 40.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.987 175.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -151.93 130.13 11.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -173.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.04 41.41 31.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.955 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.21 17.81 79.67 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.536 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.32 138.5 50.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.853 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -99.24 144.98 27.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -126.39 110.0 12.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.832 174.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.7 pt -77.48 -15.73 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.105 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.95 -9.52 33.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -121.78 84.17 2.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.833 172.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' A' ' 169' ' ' PHE . 27.6 m -112.75 160.44 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 -172.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -104.53 19.06 43.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.516 -174.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.407 HG22 ' CD1' ' A' ' 368' ' ' ILE . 2.3 m -102.6 -20.65 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 0.0 111.098 -175.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -87.61 21.71 2.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.788 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -117.13 175.01 5.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.81 -24.95 67.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.076 -175.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.99 -40.61 97.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.491 -173.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.611 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -64.86 -37.77 88.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 111.055 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.577 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -61.14 -38.5 86.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 174.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.08 89.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.078 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.5 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -66.52 -47.74 67.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.5 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.732 HD11 ' HA ' ' A' ' 347' ' ' VAL . 20.3 tp -66.67 -34.72 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.954 0.406 . . . . 0.0 110.926 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.554 ' OG1' HG22 ' A' ' 357' ' ' VAL . 91.7 m -64.84 -42.64 94.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.11 177.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 91.5 t80 -68.06 -47.75 67.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.705 ' C ' HD21 ' A' ' 195' ' ' LEU . 5.3 tt -50.83 -50.66 56.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.91 -174.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 35.0 m -64.38 -22.7 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.111 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.3 m-20 -62.45 -33.95 75.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.918 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 194' ' ' PHE . 0.6 OUTLIER -81.66 -39.86 23.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.966 -173.368 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.423 ' H ' HG13 ' A' ' 199' ' ' ILE . 1.7 pp -72.05 -29.77 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.15 171.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.93 -36.82 83.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 171.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -83.65 4.03 30.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.952 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 66.23 39.9 4.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.835 170.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -75.73 -17.87 59.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -143.01 154.93 44.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.892 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -94.39 154.56 17.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.01 -26.85 68.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.151 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -95.03 0.42 54.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 97.1 m -66.17 128.82 37.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.153 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -122.0 173.6 7.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -62.77 -40.96 98.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.6 p -68.28 -37.37 80.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.862 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 79.9 mt -65.03 -42.22 94.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.081 174.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.1 93.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.078 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.26 -41.92 89.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.04 90.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.076 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.85 -39.11 93.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.129 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -63.68 -39.64 94.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.914 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -61.27 -33.19 73.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.3 -13.93 48.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.867 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.16 25.15 41.32 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.483 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -85.45 -22.16 28.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.952 0.406 . . . . 0.0 110.893 -175.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.9 t -129.57 139.95 51.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.582 ' HB3' HD23 ' A' ' 139' ' ' LEU . . . -65.05 -54.23 33.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.05 -174.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.674 ' HB3' HD22 ' A' ' 115' ' ' LEU . 67.8 mtm -134.42 153.2 52.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 -170.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 68.8 p -139.37 161.64 36.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.185 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 44.9 mm -108.94 126.21 65.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -154.75 175.05 14.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 -171.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -85.93 -159.98 33.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.411 -174.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.26 -23.52 33.0 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.679 2.253 . . . . 0.0 112.391 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -75.92 -24.88 55.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 48.05 50.08 16.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.153 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -59.98 -20.49 57.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 70.0 m -48.78 -50.1 35.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.865 174.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -85.02 179.33 7.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -172.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.2 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.158 -176.607 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 87.5 t . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.85 0.357 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -90.95 132.02 36.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -127.29 147.65 50.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.846 176.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -129.6 156.81 21.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.489 170.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.468 HG11 ' HA ' ' A' ' 316' ' ' ARG . 3.1 p -135.72 135.17 51.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.962 0.411 . . . . 0.0 111.086 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.6 t -154.62 150.95 28.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.2 m -61.04 164.75 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.17 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 2.5 mp -71.26 152.75 94.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.583 0.706 . . . . 0.0 110.95 -163.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.62 -176.44 3.22 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.28 . . . . 0.0 112.479 -171.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.2 m -86.02 143.84 27.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.196 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -129.85 111.78 12.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.957 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 54.99 36.84 27.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.53 0.78 84.05 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.462 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 91.2 mm-40 -126.5 125.89 24.53 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 121.576 0.703 . . . . 0.0 110.862 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 77.3 Cg_exo -54.43 128.58 30.71 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.736 2.29 . . . . 0.0 112.338 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 82.4 p -84.32 0.41 49.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.024 0.44 . . . . 0.0 110.9 174.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -37.71 134.95 0.79 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.54 0.686 . . . . 0.0 110.825 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.465 ' HD3' HD13 ' A' ' 247' ' ' LEU . 30.3 Cg_endo -79.05 156.66 26.57 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.657 2.238 . . . . 0.0 112.385 -163.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . 0.559 ' HB2' ' SD ' ' A' ' 330' ' ' MET . 10.4 m-85 -75.46 167.19 22.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.885 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 42.6 t -114.49 132.77 62.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.181 -167.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.544 ' HA3' ' CD2' ' A' ' 64' ' ' HIS . . . -115.2 141.78 17.21 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.41 173.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 81.4 t -121.42 112.08 33.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.767 0.318 . . . . 0.0 111.122 -176.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.607 ' HB3' ' HB1' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -75.82 114.51 14.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -176.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.424 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . 19.1 m -131.62 154.11 49.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.777 -164.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -132.61 133.56 43.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.123 -176.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.01 171.24 16.3 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.459 -174.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.648 HG13 ' HB3' ' A' ' 277' ' ' LYS . 37.5 mm -113.31 124.99 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.246 -170.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -62.97 130.68 45.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 -176.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.479 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -59.26 -29.36 67.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.2 -177.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.03 -8.19 58.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.001 -172.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.4 t -67.39 123.56 86.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.58 0.705 . . . . 0.0 110.866 -172.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -69.71 -11.49 31.02 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.576 2.184 . . . . 0.0 112.408 168.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -103.92 14.1 31.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -51.82 -35.25 43.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 -167.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . 0.42 ' HA ' ' HE3' ' A' ' 277' ' ' LYS . 72.0 mm-40 -70.08 -49.4 51.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.006 -174.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.94 -30.33 39.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.901 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.83 -50.53 66.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.648 ' HB3' HG13 ' A' ' 266' ' ' ILE . 13.7 pttp -71.96 -34.07 68.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.915 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -63.39 -46.62 85.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 177.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -69.7 -36.33 75.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.884 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 284' ' ' LEU . 5.9 tt -55.73 -51.32 67.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.922 -178.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -75.79 -26.35 57.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.816 -177.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -100.28 -13.25 18.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.78 -166.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.856 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 63.0 m-85 -120.15 -59.77 1.75 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.813 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 280' ' ' LEU . 1.6 mp -62.37 -34.23 76.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.951 -161.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.913 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.3 pp -124.77 37.52 4.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.483 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 66.7 p -118.59 160.6 21.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.176 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.586 ' HA ' HD11 ' A' ' 290' ' ' LEU . 42.2 p-10 -51.12 -28.51 10.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.778 -167.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -78.93 -45.0 21.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 175.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.856 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.27 -56.8 6.0 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.497 -169.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.6 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.5 -21.63 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.766 0.317 . . . . 0.0 110.976 -178.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.59 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.1 tt0 -69.34 -49.31 56.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 172.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.65 96.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.077 -172.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.757 HG21 ' HA3' ' A' ' 19' ' ' GLY . 1.5 p -79.78 -29.89 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.435 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 27.7 t30 -63.9 -29.79 70.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 174.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.58 -20.76 66.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.935 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -82.17 -39.96 22.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.917 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -161.89 138.37 6.09 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.424 0.631 . . . . 0.0 110.935 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -45.82 115.94 1.23 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.685 2.256 . . . . 0.0 112.448 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 49.4 mt -93.49 -12.15 30.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 98.33 -61.7 0.89 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.528 171.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.624 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -167.1 159.55 13.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.844 0.354 . . . . 0.0 111.141 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 19.3 m -124.95 159.85 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.212 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.81 -14.44 61.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 172.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.6 ' CD2' HD22 ' A' ' 290' ' ' LEU . 49.9 tp -83.74 121.01 26.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -172.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -59.4 -33.79 71.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.944 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.9 m -61.34 -47.53 85.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.775 -172.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.526 ' HB3' HG22 ' A' ' 302' ' ' VAL . 4.5 t80 -78.78 -32.69 46.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.933 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.27 -40.89 62.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.849 173.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -55.14 -40.19 70.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.877 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -78.12 -37.83 45.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 177.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.624 HD13 ' HA ' ' A' ' 301' ' ' ALA . 83.4 mt -63.68 -33.03 74.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.58 -20.26 59.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.05 -20.22 66.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -93.09 121.28 65.94 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.65 0.738 . . . . 0.0 110.899 168.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.97 -25.13 11.81 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 0.0 112.373 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.468 ' HA ' HG11 ' A' ' 244' ' ' VAL . 78.3 mtt85 -62.25 -29.87 70.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.935 -175.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.578 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.2 mp -75.3 -28.67 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.81 87.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.031 -171.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.26 -45.32 73.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.145 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.467 ' HB ' ' HB1' ' A' ' 112' ' ' ALA . 67.0 p -64.47 -29.61 70.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.151 -173.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 61.9 tpp -68.63 -35.66 77.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.791 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -65.03 -47.75 76.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -173.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 327' ' ' GLY . 8.2 p-10 -79.94 -24.78 40.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.39 -42.79 92.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.93 -38.84 86.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.925 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.47 -4.14 15.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.818 -166.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.87 -162.7 36.99 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.526 -166.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -150.31 147.11 27.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 -171.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 36.8 mm -59.85 123.14 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.115 -170.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.559 ' SD ' ' HB2' ' A' ' 258' ' ' PHE . 74.4 mmm . . . . . 0 C--N 1.331 -0.222 0 CA-C-O 121.554 0.692 . . . . 0.0 110.917 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.949 0.404 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 80.8 mmm -75.43 -18.36 59.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.812 -171.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.4 m -58.4 -42.17 86.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.774 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.0 -39.45 63.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.528 ' O ' HG13 ' A' ' 343' ' ' VAL . 4.2 m-30 -67.3 -45.42 76.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -174.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.473 ' HA ' HG23 ' A' ' 343' ' ' VAL . 6.9 m0 -59.7 -37.32 78.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.955 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -63.6 -45.18 91.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.23 79.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.106 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 339' ' ' PHE . 18.4 m -73.49 -32.46 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -175.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.451 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.1 tmt_? -66.05 -39.04 89.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 175.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.2 m -58.74 -36.96 75.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 173.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.85 91.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -174.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.732 ' HA ' HD11 ' A' ' 192' ' ' LEU . 8.5 m -73.01 -34.79 46.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.211 -175.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.471 HD13 HG21 ' A' ' 347' ' ' VAL . 1.5 mp -64.22 -46.78 92.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.09 174.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -67.9 -37.18 81.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.815 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.86 -44.93 65.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.18 85.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.062 -176.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.6 p -77.7 -10.16 59.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.09 17.07 73.01 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.45 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.02 -31.12 50.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.74 0.305 . . . . 0.0 110.881 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . 0.569 ' HB2' ' HB3' ' A' ' 360' ' ' ALA . 77.8 mt-30 -139.98 155.07 47.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.901 176.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 57.2 p -78.81 166.04 22.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 169.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.554 HG22 ' OG1' ' A' ' 193' ' ' THR . 53.8 t -56.12 -41.95 70.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.116 174.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -60.9 -48.13 83.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.854 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -69.58 -54.96 11.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.947 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . . . -68.61 -47.75 65.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.115 -172.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.611 HD11 ' HB1' ' A' ' 188' ' ' ALA . 1.5 tm? -65.46 -44.63 86.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.964 -174.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.45 -53.12 53.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.986 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -67.5 -45.89 74.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.54 85.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 78.4 mm-40 -76.02 -25.73 55.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.001 -176.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 53.5 m -62.39 -35.08 78.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.086 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -59.94 -30.23 68.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.893 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.407 ' CD1' HG22 ' A' ' 183' ' ' VAL . 71.4 mt -60.46 -37.6 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.088 174.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 60.9 p -94.56 -15.0 24.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.168 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 179.252 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.726 0.298 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.432 HG21 ' HD2' ' A' ' 271' ' ' PRO . 49.4 mt -100.47 141.26 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.144 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -139.13 144.86 38.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.8 133.74 37.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.79 10.6 64.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.46 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.2 tttt -163.78 130.79 3.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.91 176.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.624 ' CD2' HD12 ' A' ' 33' ' ' ILE . 1.4 pt? -141.58 151.89 43.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.974 -169.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 80.4 t -110.48 135.97 47.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.091 -176.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.669 HD12 HG13 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -120.03 134.08 64.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.159 176.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.793 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 72.4 m95 -103.75 128.05 51.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 163.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.455 HD13 ' HG ' ' A' ' 20' ' ' LEU . 13.8 tt -108.52 149.95 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.193 -165.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.67 153.16 13.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.795 -173.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.17 -22.45 29.22 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.509 -177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -72.42 -17.11 61.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.359 . . . . 0.0 110.924 -169.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 15' ' ' LYS . 11.5 mmmm -140.07 131.87 27.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 168.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.93 -71.96 1.23 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.544 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -109.08 -40.15 5.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -66.9 -52.44 43.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.866 -149.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.421 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -52.96 -51.61 44.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.425 -176.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.481 ' HB3' HG23 ' A' ' 37' ' ' VAL . 3.9 mt -54.98 -57.35 12.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.775 0.321 . . . . 0.0 110.919 173.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.85 -37.4 13.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 -176.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.56 -55.69 9.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.3 m -73.79 -35.27 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.187 -173.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.581 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -66.66 -46.67 73.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.482 176.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -53.42 -36.64 61.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 110.898 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -56.22 -42.8 77.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.904 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -64.0 -43.49 95.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.833 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.44 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 98.8 mt-10 -61.23 -37.64 83.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.944 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.77 -41.49 68.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.886 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -94.46 -46.96 6.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.944 -164.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.7 p -108.57 -7.87 15.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.111 -172.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.81 8.3 87.84 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.436 168.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 1.045 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.64 134.69 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.807 0.337 . . . . 0.0 111.168 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.44 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.1 mttt -73.34 135.69 44.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.959 -170.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.669 HG13 HD12 ' A' ' 9' ' ' ILE . 96.6 t -115.74 126.34 73.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.989 0.423 . . . . 0.0 111.075 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.565 ' O ' HD13 ' A' ' 9' ' ' ILE . 96.7 m -108.47 127.9 54.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.126 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.481 HG23 ' HB3' ' A' ' 20' ' ' LEU . 94.2 t -103.1 130.07 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -119.38 152.01 37.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.835 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 64.9 t-80 -90.72 141.66 27.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.612 0.72 . . . . 0.0 110.902 -167.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.477 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 86.2 Cg_exo -55.11 -26.66 51.72 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.676 2.25 . . . . 0.0 112.386 -175.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -49.72 -55.72 12.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.96 -1.74 58.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.853 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 8.8 tt -46.9 -53.33 12.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.901 -175.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -67.81 -38.31 83.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.869 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.21 -42.21 89.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.843 -171.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -83.63 -21.56 32.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.536 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 62.1 t80 -47.11 -50.27 47.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.669 0.747 . . . . 0.0 110.832 -169.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 69.7 Cg_endo -79.89 -28.82 3.05 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.25 . . . . 0.0 112.347 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -73.86 -40.01 63.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -172.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.45 HG11 ' HD3' ' A' ' 57' ' ' PRO . 33.7 m -67.91 -28.12 40.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.197 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.679 ' HB2' HD23 ' A' ' 75' ' ' LEU . . . -70.38 -38.06 74.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.055 175.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.57 -33.86 75.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.164 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 p -90.11 -15.97 30.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.224 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.44 9.15 77.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.395 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -139.96 132.25 28.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 110.815 177.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.02 -114.95 0.52 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.51 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.793 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 61.2 Cg_endo -74.75 149.06 37.39 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.677 2.251 . . . . 0.0 112.282 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -86.97 -32.89 19.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 158.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.611 ' HB ' HG23 ' A' ' 9' ' ' ILE . 40.7 mt -128.19 137.77 56.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.116 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 tp -131.78 126.1 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -89.79 139.65 30.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 169.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.522 ' CZ2' ' HB3' ' A' ' 105' ' ' ALA . 35.6 p90 -142.61 165.04 28.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.966 171.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.9 -88.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.034 -163.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.493 ' NE2' ' HA3' ' A' ' 260' ' ' GLY . 27.4 m170 -111.65 -75.72 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.861 -174.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -103.69 -3.89 24.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 -161.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -56.52 -16.89 6.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 -169.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.514 ' HB2' HD11 ' A' ' 104' ' ' ILE . 37.6 p90 -57.42 -28.52 63.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -177.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.41 -50.6 63.55 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.493 -173.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.12 -38.06 94.86 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.56 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 1.6 t80 -57.22 -48.22 79.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 0.0 110.93 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.37 -43.79 31.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.053 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -56.58 -38.85 72.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.9 -175.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.424 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 60.3 m -83.72 -6.75 59.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.878 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.46 30.52 60.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.452 173.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.679 HD23 ' HB2' ' A' ' 51' ' ' ALA . 52.8 mt -88.01 -9.74 52.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.905 0.384 . . . . 0.0 110.914 -167.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.483 ' HA ' ' H ' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -130.15 153.16 48.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -172.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.83 144.93 31.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.081 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.28 139.22 54.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 175.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.6 pt -105.05 153.92 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.067 -173.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.5 m -108.66 125.15 32.39 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.577 0.704 . . . . 0.0 111.104 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.65 156.0 53.89 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.631 2.22 . . . . 0.0 112.328 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -105.96 122.51 46.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 175.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.23 -35.02 48.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.807 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.05 -37.92 89.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.098 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -88.29 -25.47 22.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -54.9 -45.27 74.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -68.11 -23.81 64.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.831 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.55 -19.63 22.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.976 -167.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -99.67 -32.44 11.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.956 -168.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.598 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 11.7 m-30 92.42 144.45 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.638 0.733 . . . . 0.0 110.947 175.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.32 -40.0 87.58 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 0.0 112.406 -174.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -71.34 -23.17 61.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.949 -171.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.4 p -80.17 -37.67 32.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.231 173.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.538 ' HA ' HG23 ' A' ' 97' ' ' VAL . 55.7 m95 -65.03 -29.21 70.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.996 171.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -71.13 -34.62 71.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 177.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.14 -24.77 63.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.585 HG21 HD23 ' A' ' 103' ' ' LEU . 18.4 m -106.96 15.64 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.164 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -101.34 131.62 47.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -130.94 116.03 17.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 174.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 t30 58.65 35.95 24.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.77 0.26 89.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.511 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -118.17 148.07 42.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 110.818 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.585 HD23 HG21 ' A' ' 97' ' ' VAL . 32.6 mt -88.74 134.42 33.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -125.81 3.42 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.033 -169.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.522 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . . . -163.7 162.71 24.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.184 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.506 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 94.0 m-85 -111.12 138.13 21.14 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.563 0.697 . . . . 0.0 110.941 173.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 15.1 Cg_exo -68.09 121.35 8.34 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.654 2.236 . . . . 0.0 112.362 170.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 1.051 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp -104.72 -40.02 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 173.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.617 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -145.72 154.86 42.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.064 -167.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.7 t -114.95 125.57 72.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.177 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -104.02 124.48 49.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.949 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.554 ' HB1' ' HB ' ' A' ' 320' ' ' THR . . . -149.07 141.41 24.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.147 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.8 mp -90.91 168.65 11.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.7 p -156.67 154.74 30.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.868 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -93.68 124.45 37.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 168.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.558 ' N ' HD23 ' A' ' 115' ' ' LEU . 5.1 mp -110.15 131.46 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.067 -175.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -131.31 145.28 51.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -94.49 114.37 26.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.825 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.416 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.7 mttt -66.03 -19.42 65.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.847 -173.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -84.67 -25.35 28.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.831 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.0 mp -82.17 -52.55 6.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.547 ' H ' HD21 ' A' ' 122' ' ' LEU . 2.0 pt? -140.03 128.55 13.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.621 0.724 . . . . 0.0 110.878 173.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -77.8 -11.97 16.59 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.709 2.272 . . . . 0.0 112.349 -173.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 61.1 t-20 -144.46 102.84 4.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.6 0.714 . . . . 0.0 110.895 -175.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 70.6 Cg_endo -71.27 153.84 61.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.618 2.212 . . . . 0.0 112.364 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.07 143.02 70.31 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.654 2.236 . . . . 0.0 112.314 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.0 -18.73 42.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.8 p -135.05 159.66 40.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.178 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.436 ' HA ' HD11 ' A' ' 132' ' ' ILE . 79.9 m95 -69.77 -28.14 65.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.994 177.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.68 -22.32 66.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.817 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -82.26 -24.63 34.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.869 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -57.15 -46.95 99.8 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.564 0.697 . . . . 0.0 111.243 -171.073 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.478 ' N ' HG22 ' A' ' 132' ' ' ILE . 84.0 Cg_exo -51.92 -49.25 17.91 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.613 2.209 . . . . 0.0 112.457 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.76 -59.08 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 -174.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 1.133 HD23 ' C ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -70.09 -16.15 63.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -172.02 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.536 ' N ' HD13 ' A' ' 135' ' ' LEU . 32.2 t70 -61.32 -38.61 87.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.879 168.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.76 -30.5 71.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.05 -48.01 47.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -177.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.654 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.4 pp -84.96 -13.24 51.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.654 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.2 tttt -57.99 -34.46 70.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 170.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.48 -24.83 67.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.078 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -94.97 3.67 54.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.912 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.27 30.74 56.52 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.439 177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -109.68 171.19 7.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.914 0.387 . . . . 0.0 110.824 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.6 t -124.49 140.13 53.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 168.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -68.09 -43.47 78.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.09 -170.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -143.21 127.36 17.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 57.5 ttm -110.49 132.75 53.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -152.9 158.27 41.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.896 -173.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -84.87 -59.15 2.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.972 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 1.151 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.1 tm? 48.27 30.49 2.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 -163.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -103.06 -6.8 21.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.99 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 97.5 mt-10 -129.7 152.36 79.64 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.656 0.741 . . . . 0.0 110.921 -175.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.459 ' HB3' ' HB3' ' A' ' 340' ' ' TRP . 53.9 Cg_exo -56.48 -32.21 88.61 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.694 2.262 . . . . 0.0 112.317 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -70.6 -27.47 64.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -79.67 -41.18 27.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.823 171.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.465 HG21 HG11 ' A' ' 347' ' ' VAL . 15.7 m -61.64 -49.58 75.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.121 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.58 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 17.4 t-105 -59.56 -48.65 95.1 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.471 0.653 . . . . 0.0 110.903 -161.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 94.5 Cg_exo -51.26 -44.78 40.96 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.812 2.341 . . . . 0.0 112.329 -176.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.718 HD21 ' O ' ' A' ' 160' ' ' LEU . 6.7 tt -72.16 -39.33 68.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -171.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.43 -41.59 73.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.149 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.15 -23.91 59.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.068 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.47 -35.24 71.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.188 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -103.58 10.05 37.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.973 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.88 4.7 22.62 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 169.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.38 67.87 3.02 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.46 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -89.86 133.15 34.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.858 0.361 . . . . 0.0 110.978 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.45 10.18 7.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.08 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -152.21 154.48 35.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -99.75 123.37 43.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 157.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -112.42 121.76 45.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.959 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -152.64 130.07 11.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -174.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 54.89 43.67 29.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 174.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.14 16.77 78.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.572 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.86 138.73 49.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.773 0.321 . . . . 0.0 110.862 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.87 144.25 27.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 170.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -125.51 112.42 16.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.569 ' C ' HD13 ' A' ' 178' ' ' ILE . 1.2 pp -79.53 -12.02 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -177.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.96 -12.08 22.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -119.43 87.85 2.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.866 169.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.7 m -115.88 161.08 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -171.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.02 25.47 25.17 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.464 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.494 HG22 HD13 ' A' ' 368' ' ' ILE . 3.4 m -109.44 -19.01 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.838 0.351 . . . . 0.0 111.032 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -87.29 19.88 3.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -177.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -122.19 -170.06 2.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.019 -178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.36 -29.55 70.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 -172.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.64 -42.99 95.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.529 -167.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.618 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -64.99 -37.23 86.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.988 0.423 . . . . 0.0 111.107 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.572 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -62.3 -38.25 88.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.825 175.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.9 -37.99 89.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.138 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.09 -46.3 81.44 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.521 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.716 HD11 ' HA ' ' A' ' 347' ' ' VAL . 19.7 tp -68.63 -34.23 75.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.87 0.367 . . . . 0.0 110.826 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.492 ' OG1' HG22 ' A' ' 357' ' ' VAL . 90.7 m -64.3 -42.77 96.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.197 176.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 74.8 t80 -68.43 -47.0 68.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.841 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.629 HD11 HD22 ' A' ' 151' ' ' LEU . 7.3 tt -50.45 -51.47 46.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 -174.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 199' ' ' ILE . 30.9 m -63.95 -23.06 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.126 -174.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.3 m-20 -62.14 -33.39 74.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.946 -177.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 194' ' ' PHE . 0.8 OUTLIER -81.49 -39.99 23.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.847 -173.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.415 ' H ' HG13 ' A' ' 199' ' ' ILE . 1.8 pp -73.53 -28.81 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.175 171.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.54 -37.61 80.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -79.22 -0.32 31.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 65.3 40.72 4.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 169.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -76.06 -16.11 59.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.782 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -144.71 157.99 43.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.873 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -95.44 152.01 18.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.871 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.02 -26.26 68.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -94.96 1.79 55.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.7 m -66.31 128.34 35.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -121.57 171.38 8.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -66.05 -36.85 84.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.029 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 97.2 p -68.76 -37.33 79.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.852 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.03 -41.0 90.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.052 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.99 -38.29 90.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.004 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -65.26 -43.52 91.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.927 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.37 95.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.132 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.66 -41.59 98.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.203 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -64.07 -39.56 94.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.939 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -63.97 -33.63 76.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.895 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -85.08 -17.38 37.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.969 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.66 24.44 46.13 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.545 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.39 -22.45 28.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 110.895 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.8 t -128.3 137.42 51.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.187 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.492 ' HB3' HD23 ' A' ' 139' ' ' LEU . . . -64.07 -52.14 60.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.128 -175.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.57 ' HB3' HD22 ' A' ' 115' ' ' LEU . 61.8 mtm -135.82 155.1 50.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.765 -172.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 65.3 p -139.64 162.21 35.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.239 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.7 mm -110.41 126.92 67.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.136 174.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -153.0 174.68 13.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.913 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -87.14 -156.27 29.25 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.471 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.3 -21.94 26.02 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.645 2.23 . . . . 0.0 112.341 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . 0.658 ' HD1' ' O ' ' A' ' 230' ' ' TRP . 4.9 t90 -67.37 -30.01 69.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 48.74 44.96 21.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -65.07 -20.82 66.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -173.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 67.6 m -47.75 -41.1 22.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.913 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 49.8 p30 -85.02 -178.86 6.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.881 -171.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 77.7 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.228 -168.364 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.84 0.353 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -104.28 128.73 52.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 -176.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.416 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 37.8 p90 -148.13 154.25 39.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.27 160.73 24.79 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.444 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.424 HG11 ' HA ' ' A' ' 316' ' ' ARG . 2.8 p -134.52 135.13 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.967 0.413 . . . . 0.0 111.099 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.3 t -154.13 149.88 27.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.136 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.5 m -60.54 165.57 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.09 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 1.4 mp -66.16 152.29 94.23 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.521 0.676 . . . . 0.0 111.047 -164.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -75.78 -176.41 2.99 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.747 2.298 . . . . 0.0 112.358 -173.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 94.9 m -86.9 145.43 26.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.07 -171.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -130.99 111.4 12.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 54.85 35.3 23.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.927 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.94 2.62 80.86 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -126.59 126.2 24.52 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.566 0.698 . . . . 0.0 110.844 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.01 134.98 66.74 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.654 2.236 . . . . 0.0 112.306 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 256' ' ' LYS . 73.1 m -82.52 -1.48 50.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.046 0.451 . . . . 0.0 110.844 174.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 255' ' ' SER . 90.9 mttt -37.28 130.0 0.8 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.605 0.717 . . . . 0.0 110.881 -178.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -78.16 163.17 28.13 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.632 2.221 . . . . 0.0 112.333 -163.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -74.52 163.97 27.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.842 -175.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 47.7 t -111.45 127.49 68.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.181 -168.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.493 ' HA3' ' NE2' ' A' ' 64' ' ' HIS . . . -112.85 141.49 16.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.426 174.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 89.2 t -124.7 116.98 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.746 0.308 . . . . 0.0 111.183 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.33 119.97 11.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.881 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.7 m -126.18 131.1 52.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.785 -167.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.58 139.07 51.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.093 -175.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.67 170.13 21.21 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.432 -169.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.708 HG13 ' HG2' ' A' ' 277' ' ' LYS . 24.7 mm -111.23 125.03 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 -174.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -63.14 130.79 46.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.483 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -58.17 -28.56 64.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.123 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.17 -7.0 58.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.019 -173.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 22.3 t -67.31 119.04 62.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.649 0.738 . . . . 0.0 110.915 -172.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.432 ' HD2' HG21 ' A' ' 2' ' ' ILE . 83.8 Cg_endo -71.26 -10.47 27.23 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.587 2.192 . . . . 0.0 112.327 168.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -103.4 12.88 34.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.824 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -49.33 -35.89 19.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -167.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -68.49 -47.52 66.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.969 -171.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.3 pp -81.47 -27.47 34.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.24 -46.89 75.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.054 173.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.708 ' HG2' HG13 ' A' ' 266' ' ' ILE . 50.3 mtmt -58.08 -41.73 84.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.902 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 95.6 mt-10 -69.87 -40.66 75.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.898 -177.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.444 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 15.9 m-30 -67.63 -39.5 84.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.545 ' HA ' HD23 ' A' ' 284' ' ' LEU . 4.0 tt -65.29 -53.26 46.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.977 -172.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.447 ' HA ' HD22 ' A' ' 285' ' ' LEU . 40.3 tt0 -75.19 -35.6 61.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -175.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 82.8 m-20 -103.57 -12.77 16.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.846 -160.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.654 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 62.3 m-85 -128.55 -48.6 1.28 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -177.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.545 HD23 ' HA ' ' A' ' 280' ' ' LEU . 0.7 OUTLIER -64.39 -36.56 84.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.98 -174.061 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 1.051 ' HB3' HG13 ' A' ' 108' ' ' ILE . 2.4 pp -124.71 38.27 4.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -175.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.461 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 6.6 t -114.25 163.65 14.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 286' ' ' THR . 16.4 p-10 -40.15 -43.88 1.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -175.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -74.85 -41.42 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.893 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.654 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.75 -53.9 7.84 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.516 -169.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.562 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -72.63 -20.1 61.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.725 0.298 . . . . 0.0 110.9 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.511 ' N ' HD12 ' A' ' 290' ' ' LEU . 86.5 tt0 -67.16 -45.56 76.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.813 169.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.93 -38.77 92.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.071 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.421 HG13 ' HA3' ' A' ' 19' ' ' GLY . 59.9 t -75.18 -46.8 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.116 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -64.97 -28.89 69.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.62 -25.95 68.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.826 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -82.23 -48.14 11.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.935 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.414 ' O ' HD13 ' A' ' 299' ' ' LEU . 85.7 tttt -151.03 138.94 12.49 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.511 0.672 . . . . 0.0 110.942 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -50.66 116.76 2.76 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.769 2.312 . . . . 0.0 112.363 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 299' ' ' LEU . 0.2 OUTLIER -85.98 -19.99 29.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.005 174.275 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 98.49 -57.7 0.99 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.442 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.624 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -168.19 155.33 7.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.787 0.327 . . . . 0.0 111.165 175.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.822 HG22 ' HB3' ' A' ' 307' ' ' TYR . 18.4 m -115.89 154.58 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.03 -15.62 61.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.103 173.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.562 ' CD2' HD22 ' A' ' 290' ' ' LEU . 39.9 tp -80.92 121.93 26.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.936 -174.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -53.91 -41.88 68.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.935 -177.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 48.3 t -62.99 -49.98 72.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -169.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.822 ' HB3' HG22 ' A' ' 302' ' ' VAL . 10.9 t80 -76.5 -30.71 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.987 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -60.73 -40.67 93.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 176.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.33 -36.94 76.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.65 -39.33 57.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.624 HD13 ' HA ' ' A' ' 301' ' ' ALA . 76.7 mt -61.19 -34.57 75.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.11 -19.12 61.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 -176.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -64.89 -21.12 66.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.005 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -93.17 121.86 64.57 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.663 0.744 . . . . 0.0 110.916 167.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.29 -25.41 9.84 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.776 2.318 . . . . 0.0 112.35 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . 0.424 ' HA ' HG11 ' A' ' 244' ' ' VAL . 82.7 mtt85 -60.91 -33.38 73.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -176.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.595 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.1 mp -81.19 -26.98 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.088 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.83 -40.41 79.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.07 -172.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.9 81.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.088 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.554 ' HB ' ' HB1' ' A' ' 112' ' ' ALA . 58.1 p -64.18 -29.55 70.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 -173.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.6 mtp -67.92 -34.87 77.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -65.64 -47.07 76.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.842 -172.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.404 ' O ' ' N ' ' A' ' 327' ' ' GLY . 8.7 p-10 -80.0 -25.69 40.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.797 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.44 -49.18 74.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.103 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -70.72 -37.18 73.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.89 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -105.44 -7.55 18.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 -168.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -90.94 -159.92 36.09 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.481 -172.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -139.9 147.78 41.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.776 0.322 . . . . 0.0 111.03 -175.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 40.7 mm -64.74 123.2 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.136 -171.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 50.2 tpp . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.565 0.697 . . . . 0.0 110.898 -178.786 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.741 0.305 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 73.9 mmm -80.07 -17.5 52.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -172.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.6 m -61.94 -40.97 97.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.825 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.62 -37.05 60.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.558 ' O ' HG13 ' A' ' 343' ' ' VAL . 3.6 m-30 -65.12 -41.27 95.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.812 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.459 ' HB3' ' HB3' ' A' ' 154' ' ' PRO . 12.2 m0 -60.03 -35.66 75.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 176.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -68.06 -41.85 81.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.25 -44.1 84.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.004 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 339' ' ' PHE . 16.9 m -74.07 -31.03 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 -176.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.495 ' O ' HG23 ' A' ' 347' ' ' VAL . 4.9 tmt_? -65.6 -39.65 91.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 175.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 87.4 m -58.72 -35.39 72.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 174.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.78 -43.63 95.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 -175.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.716 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.0 m -74.17 -34.13 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.169 -174.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.454 HD13 HG21 ' A' ' 347' ' ' VAL . 1.5 mp -63.34 -47.1 93.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 174.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -64.85 -39.51 93.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.26 -44.42 62.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.114 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.33 -39.9 77.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.086 -175.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.2 p -75.69 -11.09 59.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.838 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.21 16.56 74.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.463 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.21 -32.45 44.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.318 . . . . 0.0 110.883 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -138.78 155.35 48.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.1 p -76.74 171.43 14.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 170.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.492 HG22 ' OG1' ' A' ' 193' ' ' THR . 53.1 t -57.51 -43.22 82.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.124 171.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -61.44 -45.71 93.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.863 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -69.64 -52.41 26.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -72.3 -48.25 43.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.121 -173.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.618 HD11 ' HB1' ' A' ' 188' ' ' ALA . 1.4 tm? -65.59 -45.02 84.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -173.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.82 -53.57 48.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.965 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -68.09 -46.03 72.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -173.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.71 -42.31 91.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 -174.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 79.0 mm-40 -76.81 -27.93 55.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.97 -176.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 53.3 m -61.73 -34.99 76.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.225 171.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -58.77 -30.09 67.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.494 HD13 HG22 ' A' ' 183' ' ' VAL . 70.3 mt -60.85 -38.14 78.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.151 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.0 p -94.64 -14.98 24.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.154 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.831 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.773 0.32 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.445 HG21 ' HD2' ' A' ' 271' ' ' PRO . 74.8 mt -100.46 131.81 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 177.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -148.15 139.81 23.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -51.93 136.47 28.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.792 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.74 2.69 62.88 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.529 -173.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 64.3 pttt -165.03 146.96 7.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 0.0 110.954 171.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.556 HD23 HD12 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -147.68 160.01 43.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -177.231 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 71.2 t -111.98 134.05 55.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.081 -177.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.743 HG23 ' HB ' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -120.02 131.56 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.082 179.094 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.726 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 65.2 m95 -107.51 128.25 54.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.952 168.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.47 ' HB ' HD23 ' A' ' 20' ' ' LEU . 7.2 tt -109.59 149.86 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.076 -166.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -58.1 155.35 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -173.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.35 -22.76 24.06 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.378 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -73.78 -14.12 61.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.877 0.37 . . . . 0.0 110.906 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.422 ' HD2' ' HD3' ' A' ' 297' ' ' LYS . 24.0 mmmt -134.3 137.25 44.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.924 171.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.02 -85.08 0.98 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.466 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -110.04 -44.91 3.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.904 0.383 . . . . 0.0 110.92 -176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -68.16 -51.87 40.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 -148.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.999 ' HA3' HG21 ' A' ' 293' ' ' VAL . . . -57.74 -49.82 70.83 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.516 -176.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.613 HD22 ' HB ' ' A' ' 9' ' ' ILE . 55.1 tp -57.24 -41.94 80.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.827 0.346 . . . . 0.0 110.914 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.82 -38.61 67.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.071 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 67.2 mm-40 -70.57 -50.4 37.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.807 -176.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.422 HG23 ' HA ' ' A' ' 20' ' ' LEU . 17.7 m -72.53 -36.54 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.185 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.42 ' HA3' HG22 ' A' ' 35' ' ' VAL . . . -64.34 -49.34 66.33 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.494 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 57.7 pttt -59.47 -24.71 63.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.924 0.392 . . . . 0.0 110.956 -175.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -59.88 -37.11 78.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 1.2 m-30 -56.75 -47.73 79.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.482 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 88.7 mt-10 -66.6 -35.96 81.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.981 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.53 -35.49 73.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.85 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -94.8 -50.04 5.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.811 -170.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.2 p -115.86 -1.08 12.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 -169.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.41 9.92 84.48 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.421 167.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.866 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -99.36 132.93 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 111.159 -177.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.482 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.8 mttt -74.21 140.36 45.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 -171.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.558 ' HB ' HD12 ' A' ' 9' ' ' ILE . 2.9 m -116.72 134.34 60.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.113 177.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.523 ' O ' HD13 ' A' ' 9' ' ' ILE . 99.6 m -103.94 127.8 51.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 176.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.608 HG13 HD21 ' A' ' 20' ' ' LEU . 54.8 t -93.07 126.66 45.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.201 175.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -119.93 145.74 46.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.974 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -88.95 141.14 29.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.528 0.68 . . . . 0.0 110.929 -168.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 85.2 Cg_exo -56.62 -26.29 64.0 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.736 2.291 . . . . 0.0 112.251 -174.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -47.34 -51.28 19.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 -171.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.84 -8.92 55.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 9.8 tt -47.85 -55.26 10.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 -170.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -64.76 -35.83 82.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.36 -39.52 92.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 50' ' ' VAL . 75.1 mmtt -80.44 -23.84 39.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.583 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 83.9 t80 -50.87 -50.26 75.25 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.665 0.745 . . . . 0.0 110.807 -160.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 44.4 Cg_endo -82.72 -32.32 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.685 2.256 . . . . 0.0 112.306 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -75.89 -46.41 30.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 -165.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.52 HG22 ' HG3' ' A' ' 57' ' ' PRO . 21.0 m -72.36 -27.16 25.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.04 -171.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.728 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . . . -70.28 -35.78 73.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.098 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.11 -33.2 74.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.124 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.9 p -90.58 -20.25 22.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.2 8.35 69.73 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.542 172.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -118.35 116.84 27.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.35 . . . . 0.0 110.87 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.94 -92.75 0.13 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.502 171.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.726 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 71.2 Cg_endo -79.42 146.79 19.7 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.68 2.254 . . . . 0.0 112.362 -177.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -97.53 -35.06 10.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.777 163.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.743 ' HB ' HG23 ' A' ' 9' ' ' ILE . 35.4 mt -124.79 137.37 57.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.106 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.3 tp -132.77 125.22 52.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -88.34 140.11 29.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.731 168.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.47 ' CZ2' ' HB3' ' A' ' 105' ' ' ALA . 21.9 p90 -142.85 163.39 32.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.979 171.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.83 -90.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 -164.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.675 ' CE1' ' HA3' ' A' ' 260' ' ' GLY . 23.2 m170 -130.56 -64.63 0.83 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 -173.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -95.13 -13.92 24.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -167.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.78 -14.49 14.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.997 -165.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.567 ' HB2' HD11 ' A' ' 104' ' ' ILE . 30.5 p90 -57.42 -32.43 66.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.875 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.77 -51.21 60.05 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.492 -170.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.59 -36.96 92.15 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.576 175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.697 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 13.6 t80 -66.56 -41.94 87.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 -176.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.85 -40.98 68.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.169 174.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -57.58 -37.54 73.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.414 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 59.9 m -85.47 -4.98 59.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.982 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.32 30.07 59.21 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.492 174.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.728 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 58.9 mt -87.17 -10.07 53.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.919 0.39 . . . . 0.0 110.929 -167.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.697 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -130.95 153.77 48.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.924 -176.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -81.4 142.12 33.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 174.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.81 142.3 49.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.442 HD13 ' CZ ' ' A' ' 106' ' ' TYR . 36.9 pt -106.52 155.41 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 -177.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.6 m -96.1 130.57 30.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.666 0.746 . . . . 0.0 111.064 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.36 142.31 65.6 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.673 2.248 . . . . 0.0 112.326 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -113.92 114.78 26.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.21 -36.02 60.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.78 -43.47 98.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.021 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -74.54 -32.98 62.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.875 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.478 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 85.6 mt-30 -54.94 -51.49 65.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -57.6 -34.71 69.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.781 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.27 -24.53 57.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 -175.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.97 -104.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 -170.573 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 33.9 t80 172.66 128.84 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.739 0.781 . . . . 0.0 110.903 -169.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -52.31 -36.26 67.5 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.345 -173.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -65.14 -35.19 80.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 -173.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.3 p -73.47 -29.7 62.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.169 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.638 ' HA ' HG23 ' A' ' 97' ' ' VAL . 92.5 m95 -67.88 -30.55 69.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.972 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -69.25 -30.17 68.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.943 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.14 -26.04 62.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.038 175.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.638 HG23 ' HA ' ' A' ' 94' ' ' TRP . 16.3 m -109.96 20.7 5.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.14 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -113.8 132.52 55.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -132.1 119.45 20.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.5 t30 58.4 35.29 24.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.918 176.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.21 -0.41 89.74 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.449 175.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.25 149.42 42.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 0.0 110.861 175.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.614 HD23 HG21 ' A' ' 97' ' ' VAL . 18.4 mt -84.03 136.0 34.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.567 HD11 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -123.11 -2.3 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.051 -175.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.47 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . . . -161.15 164.45 30.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.12 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.442 ' CZ ' HD13 ' A' ' 79' ' ' ILE . 89.9 m-85 -112.27 143.26 28.49 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.626 0.727 . . . . 0.0 110.948 170.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.33 121.42 5.24 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.669 2.246 . . . . 0.0 112.336 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.936 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -104.25 -36.72 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.177 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -146.0 153.12 40.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 -170.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.3 t -117.96 130.42 72.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.5 mp0 -110.64 131.98 54.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.806 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.624 ' HB1' ' HB ' ' A' ' 320' ' ' THR . . . -153.09 144.66 23.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.119 177.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.6 mp -89.0 160.25 17.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.972 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.9 p -151.49 152.44 33.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.86 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.874 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -93.76 128.88 40.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 171.043 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.636 ' N ' HD23 ' A' ' 115' ' ' LEU . 4.7 mp -111.39 132.04 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.236 -174.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -131.81 146.97 52.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.988 0.423 . . . . 0.0 110.86 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -91.88 117.4 29.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.893 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.91 -25.92 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.964 -172.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -84.68 -20.82 30.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 -172.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.9 mp -80.08 -54.03 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 169.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.754 ' H ' HD21 ' A' ' 122' ' ' LEU . 1.3 pt? -140.32 127.23 12.23 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.564 0.697 . . . . 0.0 110.921 173.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.42 -7.06 14.87 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.665 2.244 . . . . 0.0 112.348 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.435 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 56.3 t-20 -147.22 95.27 4.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.725 0.774 . . . . 0.0 110.839 -176.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 58.6 Cg_endo -68.23 155.68 68.48 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.64 2.227 . . . . 0.0 112.376 177.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.52 143.67 76.4 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.64 2.226 . . . . 0.0 112.423 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -86.72 -15.76 38.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 80.6 p -133.68 156.75 47.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.426 ' HA ' HD11 ' A' ' 132' ' ' ILE . 74.1 m95 -70.77 -27.98 64.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.982 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.21 -19.58 65.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.843 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -80.3 -25.53 39.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.488 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -57.56 -46.27 99.79 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.567 0.698 . . . . 0.0 111.184 -169.249 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 86.4 Cg_exo -52.93 -50.74 13.02 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.712 2.274 . . . . 0.0 112.385 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.95 -59.49 4.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 1.165 HD23 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.41 -16.24 63.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -172.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.585 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.7 t70 -61.88 -41.69 98.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 167.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.66 -30.59 69.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.923 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.1 -46.86 60.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.84 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.621 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.1 pp -85.08 -14.32 47.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.965 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.621 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.6 tttt -60.98 -33.99 74.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.95 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.32 -24.03 67.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.993 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -94.98 4.3 53.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.942 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.03 31.98 57.11 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.572 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -110.24 170.14 8.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 0.0 110.885 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.7 t -121.04 140.94 51.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.827 168.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -67.67 -40.6 84.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.144 -174.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 148' ' ' MET . 2.1 tm? -140.78 133.48 28.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.958 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.404 ' H ' HD23 ' A' ' 147' ' ' LEU . 53.2 ttm -119.22 131.35 55.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.844 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -153.99 155.64 35.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 -174.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -86.27 -53.37 5.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -177.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.993 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.3 tm? 48.01 32.81 3.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.909 -169.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -100.24 -7.15 24.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.887 175.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.65 154.92 80.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.68 0.753 . . . . 0.0 110.922 -172.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.41 ' HA ' ' HB ' ' A' ' 157' ' ' THR . 38.5 Cg_endo -59.94 -25.07 78.48 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.673 2.248 . . . . 0.0 112.38 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -71.62 -29.41 64.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.84 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -81.43 -39.79 24.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 171.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.42 HG21 HG11 ' A' ' 347' ' ' VAL . 22.1 m -60.35 -48.34 82.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.589 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 40.5 t-105 -57.07 -54.42 54.78 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.444 0.64 . . . . 0.0 110.81 -168.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 24.3 Cg_endo -63.99 -20.04 67.31 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.544 2.163 . . . . 0.0 112.388 -174.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.779 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.7 tm? -81.6 -44.92 16.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.52 HG22 ' HA3' ' A' ' 166' ' ' GLY . 79.2 mt -74.98 -43.78 45.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.84 -24.7 66.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.972 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -58.26 -30.87 66.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.56 3.59 42.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 104.63 8.32 37.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.547 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.52 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -75.7 67.41 2.3 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.435 177.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -80.5 132.2 35.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.772 0.32 . . . . 0.0 110.939 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.86 6.36 11.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.127 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.471 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.2 p90 -154.0 155.81 36.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.906 -175.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -99.99 127.4 46.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.915 156.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -114.19 120.6 41.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -153.26 130.03 10.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -171.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 54.97 42.2 31.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.19 16.09 78.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.526 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.97 139.95 50.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.698 0.285 . . . . 0.0 110.93 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -96.47 144.94 26.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.923 170.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -128.06 111.97 14.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.885 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.567 ' C ' HD13 ' A' ' 178' ' ' ILE . 1.2 pp -80.06 -11.38 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -96.9 -10.16 27.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -125.51 85.97 2.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 169' ' ' PHE . 31.1 m -113.97 164.79 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.056 -170.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.8 25.55 22.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.562 -173.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.451 HG22 HD13 ' A' ' 368' ' ' ILE . 2.1 m -106.53 -19.99 6.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.904 0.383 . . . . 0.0 111.156 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -87.39 21.79 2.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.799 -176.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -109.31 -176.32 2.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.927 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.52 -28.34 66.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.071 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.53 -40.08 78.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.492 -169.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.529 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -59.88 -40.08 87.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 111.11 175.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.59 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.2 mttt -62.23 -39.04 91.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.979 175.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.0 86.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.196 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.448 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -67.15 -46.02 76.02 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.516 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.751 HD11 ' HA ' ' A' ' 347' ' ' VAL . 22.8 tp -66.62 -35.5 80.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 110.821 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.56 ' OG1' HG22 ' A' ' 357' ' ' VAL . 94.3 m -65.07 -41.48 95.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 176.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.477 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 51.8 t80 -66.03 -49.68 66.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 177.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.708 ' C ' HD21 ' A' ' 195' ' ' LEU . 5.4 tt -50.72 -51.11 52.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.884 -174.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 199' ' ' ILE . 31.2 m -64.25 -22.47 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.177 -174.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.2 m-20 -62.27 -33.53 74.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 194' ' ' PHE . 0.9 OUTLIER -80.69 -40.09 26.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -174.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.555 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.8 pp -73.7 -28.67 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.234 172.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -68.57 -37.63 80.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -80.63 2.79 24.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 68.0 38.51 2.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 169.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -78.28 -17.04 57.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.555 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.2 ppp? -145.3 157.18 44.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.934 174.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -94.63 150.65 20.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.4 -26.22 67.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -96.59 1.52 51.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.936 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 94.1 m -64.0 125.05 23.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.07 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.415 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 17.3 t0 -120.45 174.98 6.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.905 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -62.82 -40.41 97.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.999 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 98.6 p -67.58 -38.05 83.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.823 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.415 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 76.6 mt -65.05 -42.32 94.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.14 174.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.47 -35.6 80.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.107 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.27 -48.1 82.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.49 -42.36 95.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.111 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.05 -49.03 71.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.2 -43.39 98.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.911 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -63.18 -29.61 70.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.861 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -85.92 -16.74 37.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.24 25.04 29.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.431 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -83.28 -21.28 33.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 110.916 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.8 t -126.16 136.37 52.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.25 178.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.608 ' HB3' HD23 ' A' ' 139' ' ' LEU . . . -62.18 -48.8 78.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.024 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.602 ' HB3' HD22 ' A' ' 115' ' ' LEU . 66.9 mtm -135.0 160.06 39.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 -173.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.0 t -150.44 157.34 42.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.183 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 mm -111.58 129.42 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 -176.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -155.42 173.71 16.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -83.73 -153.37 15.64 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.395 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.11 -26.4 36.69 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.736 2.29 . . . . 0.0 112.328 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -76.01 -29.18 58.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 43.79 44.96 5.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.169 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 32.1 m0 -66.11 -20.63 66.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 63.6 m -71.22 -18.1 62.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -81.2 -175.37 5.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -174.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 87.9 mt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 176.561 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 97.9 t . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.892 0.377 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -77.77 140.98 39.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.33 149.93 38.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.3 161.73 26.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.503 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.08 139.4 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.932 0.396 . . . . 0.0 111.1 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.3 t -153.4 149.08 27.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.161 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 22.4 m -59.95 163.51 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.153 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 3.8 mp -67.7 153.3 95.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.625 0.726 . . . . 0.0 111.029 -159.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 47.5 Cg_exo -63.75 178.92 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.699 2.266 . . . . 0.0 112.393 -175.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.0 m -92.52 145.71 24.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.21 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -131.26 112.2 12.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.952 -172.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 54.65 34.97 22.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.943 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.1 1.59 81.74 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.565 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -128.38 127.03 23.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.582 0.706 . . . . 0.0 110.896 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -55.28 136.9 75.56 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.673 2.249 . . . . 0.0 112.337 -176.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 256' ' ' LYS . 67.7 m -80.06 -5.05 55.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.798 170.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 255' ' ' SER . 97.3 mttt -38.31 129.05 1.05 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.514 0.673 . . . . 0.0 110.912 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -83.09 163.11 15.52 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.666 2.244 . . . . 0.0 112.384 -163.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -72.99 164.95 25.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.4 t -110.89 132.29 59.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.173 -168.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.675 ' HA3' ' CE1' ' A' ' 64' ' ' HIS . . . -114.85 138.92 15.19 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.443 176.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 74.0 t -126.13 116.54 46.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 111.24 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.421 ' HA ' HD21 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -66.28 122.52 17.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.984 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 51.0 m -124.11 131.11 53.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 -166.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.99 133.88 50.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.02 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.55 172.5 20.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.455 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.403 HG13 ' HB3' ' A' ' 277' ' ' LYS . 34.9 mm -113.99 130.48 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.785 0.326 . . . . 0.0 111.178 -173.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -61.86 128.99 38.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.984 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.471 ' HB3' ' C ' ' A' ' 76' ' ' LEU . . . -58.85 -30.93 68.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.165 -178.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.28 -5.21 59.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.033 -172.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 15.6 t -71.51 120.23 78.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.68 0.752 . . . . 0.0 110.951 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.445 ' HD2' HG21 ' A' ' 2' ' ' ILE . 97.8 Cg_endo -67.49 -9.89 26.85 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.623 2.215 . . . . 0.0 112.342 167.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -109.06 16.89 22.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -55.79 -32.93 63.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -170.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.67 -47.48 63.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.958 0.409 . . . . 0.0 110.896 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.0 pp -78.69 -31.03 46.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.9 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.77 -48.74 68.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.064 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.403 ' HB3' HG13 ' A' ' 266' ' ' ILE . 46.8 pttt -65.97 -34.98 79.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.51 -40.98 73.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 19.0 m-30 -66.97 -38.73 86.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 176.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 284' ' ' LEU . 5.3 tt -57.62 -51.5 69.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 -176.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -75.31 -27.98 59.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -98.68 -13.5 20.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -167.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.763 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 69.0 m-85 -121.19 -60.13 1.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 280' ' ' LEU . 1.4 mp -61.44 -33.68 74.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.937 -161.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.936 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.2 pp -123.78 37.88 4.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.994 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.468 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 67.9 p -121.25 162.36 20.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 177.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.447 ' HA ' HD11 ' A' ' 290' ' ' LEU . 38.7 t70 -45.66 -36.29 4.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 -167.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -78.73 -42.02 29.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.984 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.763 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.9 -52.9 8.57 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.505 -170.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.613 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -72.62 -20.08 61.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.754 0.312 . . . . 0.0 110.965 -178.457 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.571 ' N ' HD12 ' A' ' 290' ' ' LEU . 35.3 tt0 -70.62 -47.93 57.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.774 172.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.65 97.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.098 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.999 HG21 ' HA3' ' A' ' 19' ' ' GLY . 2.8 p -78.71 -32.17 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 -176.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.407 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 48.3 t30 -68.78 -27.72 66.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.785 171.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.62 -25.05 67.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -88.39 -40.12 13.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.422 ' HD3' ' HD2' ' A' ' 15' ' ' LYS . 85.2 tttt -146.06 135.17 11.26 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.475 0.655 . . . . 0.0 110.951 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -58.28 109.03 0.44 Allowed 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.744 2.296 . . . . 0.0 112.289 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.407 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 61.6 mt -89.89 -18.59 25.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.978 -171.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 109.49 -59.49 0.35 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.525 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.619 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -169.37 165.24 10.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.359 . . . . 0.0 111.095 175.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.701 HG22 ' HB3' ' A' ' 307' ' ' TYR . 29.8 m -124.9 153.92 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.02 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.91 -8.41 56.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.115 172.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.613 ' CD2' HD22 ' A' ' 290' ' ' LEU . 44.7 tp -85.9 119.06 25.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.953 -177.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.01 -40.99 67.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -174.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.8 m -65.12 -50.13 67.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.829 -168.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.701 ' HB3' HG22 ' A' ' 302' ' ' VAL . 17.5 t80 -77.11 -28.62 54.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.953 -177.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -64.77 -38.98 92.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.915 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.31 -35.01 78.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.935 175.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -73.38 -41.33 63.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.952 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.619 HD13 ' HA ' ' A' ' 301' ' ' ALA . 77.2 mt -60.05 -31.87 70.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.884 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.54 -17.86 56.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.06 -19.64 66.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -90.9 121.73 67.67 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.624 0.726 . . . . 0.0 110.895 164.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -47.37 -28.05 7.88 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.737 2.291 . . . . 0.0 112.304 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -61.32 -30.96 70.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -172.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.474 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.1 mp -79.98 -30.23 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 -173.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.53 96.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.032 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.06 -44.1 77.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.023 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.624 ' HB ' ' HB1' ' A' ' 112' ' ' ALA . 82.6 p -65.43 -31.13 72.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 -171.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.9 mtp -65.49 -33.3 75.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -64.75 -47.19 79.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 -174.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.471 HD22 ' HB2' ' A' ' 112' ' ' ALA . 8.5 p-10 -82.97 -28.87 29.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.766 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.39 -52.31 62.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.033 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -65.86 -28.3 68.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.016 0.436 . . . . 0.0 110.984 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -109.63 -8.32 14.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.8 -168.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -89.88 -153.57 28.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.461 -166.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -146.1 140.81 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 0.0 110.919 -170.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 42.2 mm -60.31 121.37 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 -166.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 93.0 mtp . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 121.522 0.677 . . . . 0.0 110.902 179.34 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.8 0.333 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 54.7 mmm -80.13 -17.37 52.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.811 -170.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.5 m -60.82 -41.44 95.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.846 176.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.83 -35.64 59.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 6.4 m-30 -66.21 -42.37 88.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.964 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -56.51 -37.85 70.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.02 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -68.47 -41.22 80.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.17 -43.4 87.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.097 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 339' ' ' PHE . 20.4 m -73.4 -32.04 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.137 -177.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.0 tmt_? -64.93 -38.94 92.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.873 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.3 m -58.68 -36.68 74.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.173 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.05 -43.75 91.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.108 -174.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.751 ' HA ' HD11 ' A' ' 192' ' ' LEU . 8.2 m -73.17 -34.92 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.153 -175.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.471 HD13 HG21 ' A' ' 347' ' ' VAL . 1.5 mp -63.62 -47.27 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 173.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -63.59 -39.7 95.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.16 -45.51 60.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.025 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.29 -40.38 81.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.116 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 92.0 p -76.31 -10.91 59.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.09 16.61 74.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.46 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.03 -32.39 50.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 0.0 110.95 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -139.37 155.15 47.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.984 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 48.7 p -77.7 167.44 21.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 170.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.56 HG22 ' OG1' ' A' ' 193' ' ' THR . 54.8 t -55.89 -42.03 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.16 173.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -60.65 -46.88 88.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -69.11 -52.2 30.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -71.87 -49.39 38.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 -173.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.616 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 1.4 tm? -65.14 -46.87 79.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.968 -173.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.02 -53.44 53.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.847 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -67.14 -46.61 73.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -174.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.09 -41.8 94.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.091 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.616 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 68.0 mm-40 -77.74 -26.75 50.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.95 -177.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.2 m -64.44 -35.99 82.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.226 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.18 -30.4 68.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.971 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.451 HD13 HG22 ' A' ' 183' ' ' VAL . 70.0 mt -60.35 -38.49 77.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 173.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 60.8 p -93.45 -14.46 26.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.886 179.209 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.713 0.292 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . 0.405 HG21 ' HD2' ' A' ' 271' ' ' PRO . 76.4 mt -95.96 133.93 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.191 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -146.51 139.15 25.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -52.43 137.77 28.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.16 1.62 62.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.442 -173.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 64.4 pttt -164.53 149.85 10.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.74 0.305 . . . . 0.0 110.966 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.622 ' H ' HD21 ' A' ' 7' ' ' LEU . 1.2 pt? -147.67 158.07 43.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.947 -176.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 70.4 t -110.79 131.83 60.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.761 HG23 ' HB ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -119.94 132.08 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.149 -179.269 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.683 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 70.8 m95 -106.08 128.8 54.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.943 169.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.518 HD13 ' HB2' ' A' ' 20' ' ' LEU . 5.9 tt -109.41 149.96 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.157 -168.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -60.89 154.69 21.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -172.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.19 -21.3 31.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.495 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -72.93 -12.34 60.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.358 . . . . 0.0 110.812 -171.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.601 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -146.98 135.64 22.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 167.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.07 -79.91 1.06 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.599 -171.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -105.57 -44.93 4.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.958 0.409 . . . . 0.0 110.917 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -67.91 -52.92 30.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.864 -148.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 1.111 ' HA3' HG21 ' A' ' 293' ' ' VAL . . . -57.11 -51.95 54.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.498 -175.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.621 HD22 ' HB ' ' A' ' 9' ' ' ILE . 59.6 tp -57.87 -43.76 86.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 0.0 110.968 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.76 -40.05 59.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.991 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -69.71 -55.29 10.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 20' ' ' LEU . 22.0 m -69.83 -35.95 67.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.164 -175.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.419 ' HA3' HG22 ' A' ' 35' ' ' VAL . . . -62.83 -45.65 95.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.407 172.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -56.76 -30.2 63.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 110.996 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -57.55 -38.2 74.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 176.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 1.8 m-30 -56.22 -49.61 73.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.888 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.483 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 93.2 mt-10 -66.28 -35.41 80.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -69.3 -37.33 77.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -96.55 -47.99 5.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.918 0.39 . . . . 0.0 110.925 -169.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.8 p -114.73 -1.97 13.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.161 -169.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.88 8.73 82.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.417 166.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.88 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -99.46 133.0 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 111.121 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.483 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.6 mttt -75.17 139.75 42.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.852 -169.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.501 ' HB ' HD12 ' A' ' 9' ' ' ILE . 2.7 m -116.44 134.46 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.508 ' O ' HD13 ' A' ' 9' ' ' ILE . 98.3 m -105.12 127.54 52.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.136 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.595 HG13 HD21 ' A' ' 20' ' ' LEU . 54.5 t -91.53 127.05 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.155 175.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -119.14 147.01 44.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.828 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 63.6 t-80 -88.82 142.18 30.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.593 0.711 . . . . 0.0 110.887 -166.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.46 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 86.8 Cg_exo -54.9 -25.21 42.62 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.569 2.179 . . . . 0.0 112.379 -175.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -48.43 -56.79 7.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 -173.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -86.6 -4.07 59.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 8.1 tt -45.94 -53.81 9.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.896 -172.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.02 -35.48 80.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.846 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -67.37 -43.48 81.3 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.884 -173.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -80.47 -21.36 42.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.531 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 50.6 t80 -49.99 -51.51 60.98 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.564 0.697 . . . . 0.0 110.806 -165.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 61.6 Cg_endo -80.94 -29.68 2.0 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.615 2.21 . . . . 0.0 112.403 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -74.6 -40.33 61.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 -168.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 m -66.58 -27.68 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.121 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.795 ' HB2' HD23 ' A' ' 75' ' ' LEU . . . -67.61 -36.09 80.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.09 -31.38 70.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.024 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.8 p -93.0 -17.77 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.128 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.22 11.22 75.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.522 173.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -140.05 140.06 36.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.881 0.372 . . . . 0.0 110.827 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.96 -96.61 0.16 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.435 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.683 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 78.9 Cg_endo -80.08 148.79 19.54 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.728 2.286 . . . . 0.0 112.238 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -96.94 -35.99 10.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 165.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.761 ' HB ' HG23 ' A' ' 9' ' ' ILE . 46.6 mt -125.87 138.26 55.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.105 -176.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 tp -131.2 125.91 58.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.153 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -91.31 137.57 32.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 167.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.495 ' CZ2' ' HB3' ' A' ' 105' ' ' ALA . 31.2 p90 -140.5 162.62 34.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.017 172.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.46 -87.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.039 -167.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.51 ' NE2' ' HA3' ' A' ' 260' ' ' GLY . 10.8 m170 -128.17 -68.69 0.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -173.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -96.81 -10.92 25.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.811 -162.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -57.27 -14.28 4.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 -169.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.575 ' HB2' HD11 ' A' ' 104' ' ' ILE . 33.5 p90 -59.29 -29.41 67.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.9 -51.75 57.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.468 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.76 -36.55 92.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.522 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -55.45 -51.75 65.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 110.931 179.053 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.2 -43.11 58.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.16 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -56.86 -38.83 73.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 -175.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.419 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 61.8 m -84.8 -7.44 59.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.003 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.95 30.26 59.58 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.469 173.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.795 HD23 ' HB2' ' A' ' 51' ' ' ALA . 42.1 mt -89.35 -8.78 52.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.827 0.346 . . . . 0.0 110.886 -168.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -129.06 152.2 48.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -176.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.03 139.65 35.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.025 172.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.69 142.95 51.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.0 pt -104.15 154.53 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.9 m -90.67 123.85 64.0 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.672 0.749 . . . . 0.0 111.115 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.83 136.6 75.33 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.772 2.315 . . . . 0.0 112.395 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -105.05 111.79 24.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.16 -40.0 92.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.84 -176.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.39 97.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -71.97 -36.87 69.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.462 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.3 tt0 -51.73 -51.8 53.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.96 174.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -57.99 -37.07 73.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.802 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.38 -21.66 52.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.863 -174.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -105.06 -105.02 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.907 -172.04 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 27.7 t80 172.19 126.7 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.682 0.753 . . . . 0.0 110.963 -167.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 93.7 Cg_exo -54.66 -36.38 89.6 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.796 2.33 . . . . 0.0 112.407 -172.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -65.03 -35.1 80.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -172.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.1 p -76.72 -32.21 57.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.215 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.553 ' CE3' HD13 ' A' ' 103' ' ' LEU . 92.7 m95 -70.32 -29.09 65.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.002 173.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.07 -31.44 71.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 177.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.03 -24.04 64.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.092 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.529 HG23 ' HA ' ' A' ' 94' ' ' TRP . 17.9 m -106.35 15.95 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -99.98 131.5 45.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -129.37 117.45 20.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.7 t30 57.8 35.57 25.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.857 175.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.79 0.19 89.72 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.536 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -124.69 146.37 49.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 110.835 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.553 HD13 ' CE3' ' A' ' 94' ' ' TRP . 26.8 mt -88.56 135.35 33.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.799 -171.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.575 HD11 ' HB2' ' A' ' 67' ' ' PHE . 1.8 pp -121.87 -1.68 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.495 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . . . -158.8 161.43 36.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.086 -176.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.499 ' HB3' ' CD2' ' A' ' 285' ' ' LEU . 93.9 m-85 -110.27 138.25 20.82 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.662 0.744 . . . . 0.0 110.878 172.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.05 118.15 5.15 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.636 2.224 . . . . 0.0 112.303 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.919 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -103.24 -36.4 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -148.81 152.7 36.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 -172.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.54 130.71 73.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.112 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.481 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 92.0 mt-10 -129.74 128.57 42.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.791 ' HB2' HD22 ' A' ' 323' ' ' ASN . . . -150.8 152.26 33.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.126 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.533 ' HB2' ' CB ' ' A' ' 257' ' ' PRO . 5.1 mp -84.29 171.34 12.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.976 -161.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.1 p -156.02 154.7 31.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 -172.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.883 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -99.14 127.66 45.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.812 168.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.602 ' N ' HD23 ' A' ' 115' ' ' LEU . 5.3 mp -111.45 130.04 65.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.21 -175.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -131.34 148.46 52.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.928 -173.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -92.06 120.01 32.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.823 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.408 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.5 mttt -70.13 -25.74 63.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -174.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -86.59 -23.07 25.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.8 mp -75.02 -56.71 4.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.979 167.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.766 ' H ' HD21 ' A' ' 122' ' ' LEU . 1.1 pt? -140.02 127.89 12.87 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.589 0.709 . . . . 0.0 110.969 173.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.57 -7.84 16.9 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.592 2.194 . . . . 0.0 112.315 -175.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -147.27 96.71 4.18 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.648 0.737 . . . . 0.0 110.912 -176.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.64 155.04 71.7 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.636 2.224 . . . . 0.0 112.375 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.43 143.3 69.04 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.678 2.252 . . . . 0.0 112.274 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -84.86 -16.33 41.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.996 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.9 p -132.03 157.91 42.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.195 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.497 ' HA ' HG12 ' A' ' 132' ' ' ILE . 82.4 m95 -70.08 -20.79 63.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.88 -28.82 67.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -82.27 -8.14 59.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.881 -176.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.632 ' O ' HD13 ' A' ' 135' ' ' LEU . 46.8 mm -60.82 -53.14 67.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.576 0.703 . . . . 0.0 111.17 -173.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 21.6 Cg_endo -60.48 -39.88 61.92 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.566 2.177 . . . . 0.0 112.377 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.52 -61.14 2.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 1.153 HD23 ' C ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -70.88 -16.93 62.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.01 -175.628 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.527 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.9 t70 -63.54 -42.39 98.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.874 168.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.67 -30.43 68.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.963 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -69.98 -47.48 62.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.6 pp -87.22 -15.19 38.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.923 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.631 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.5 tttt -61.93 -33.86 75.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.012 175.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.41 -24.19 67.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.076 176.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -95.04 6.14 49.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.848 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.86 32.04 57.41 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.528 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -110.4 166.5 10.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 110.878 174.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.4 t -118.5 143.04 47.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 169.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.62 -44.13 71.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.132 -173.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -139.05 124.02 18.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.842 -174.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 62.1 tpp -113.4 132.57 55.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.81 -175.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -157.39 160.0 37.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.987 -175.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . 0.525 ' HB3' ' HA ' ' A' ' 209' ' ' ASP . 40.3 p-10 -99.21 -43.44 6.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -175.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 1.117 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.4 tm? 52.13 34.58 14.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -175.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -103.28 -11.61 17.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 -176.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 96.6 mt-10 -123.4 144.11 43.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.655 0.74 . . . . 0.0 110.924 -170.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 153' ' ' GLU . 73.1 Cg_exo -54.64 -32.75 76.64 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.634 2.222 . . . . 0.0 112.339 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -65.21 -29.96 70.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -79.89 -40.19 28.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.406 HG21 ' O ' ' A' ' 153' ' ' GLU . 39.3 p -62.79 -39.59 94.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.066 -175.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.61 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 32.0 t-105 -65.91 -50.14 54.56 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.63 0.728 . . . . 0.0 110.936 -164.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 78.4 Cg_exo -48.33 -46.55 22.73 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.702 2.268 . . . . 0.0 112.312 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.725 HD21 ' O ' ' A' ' 160' ' ' LEU . 6.4 tt -74.91 -40.35 60.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.957 -174.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.8 mt -69.13 -43.05 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.213 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.63 -24.71 61.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.91 -33.49 71.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.076 -178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -93.57 3.35 55.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.99 7.32 35.96 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.428 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.38 65.7 3.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -85.67 134.8 33.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.794 0.331 . . . . 0.0 110.989 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.53 1.57 16.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.091 -177.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -153.69 155.41 35.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.996 0.427 . . . . 0.0 110.853 -175.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -99.47 121.95 41.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 157.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -112.95 123.26 49.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -152.84 131.03 11.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.4 t30 55.07 44.89 27.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.985 173.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.29 15.69 78.84 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.485 173.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.01 139.84 50.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.794 0.331 . . . . 0.0 110.951 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -95.82 144.38 26.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.943 169.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -119.32 111.7 18.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 37.1 pt -78.18 -18.24 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -94.54 -8.99 36.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.817 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -123.45 92.8 3.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 24.9 m -118.72 164.26 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.081 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -108.46 22.38 26.7 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.541 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' A' ' 365' ' ' GLN . 1.5 m -108.8 -23.3 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 111.165 -173.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -91.79 24.03 3.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.793 174.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -118.88 176.25 5.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.877 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.09 -25.49 67.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.133 -177.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.09 -39.75 94.79 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.445 -172.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.711 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -65.48 -35.57 81.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.958 0.408 . . . . 0.0 111.124 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.582 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.7 mttt -59.69 -36.17 75.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 176.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.44 91.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.11 -48.16 67.32 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.496 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.539 HD11 ' HA ' ' A' ' 347' ' ' VAL . 19.0 tp -65.96 -33.2 75.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.927 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.415 ' OG1' HG22 ' A' ' 357' ' ' VAL . 88.3 m -65.98 -44.02 86.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.172 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.48 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 32.6 t80 -67.31 -46.52 73.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.864 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.585 ' C ' HD21 ' A' ' 195' ' ' LEU . 7.9 tt -51.12 -52.21 46.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -175.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 199' ' ' ILE . 27.6 m -64.03 -21.95 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 -173.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.9 m-20 -61.51 -33.06 73.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -80.33 -40.07 27.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -175.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.666 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.8 pp -74.94 -28.31 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.214 173.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -70.49 -39.08 74.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 174.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -78.29 2.15 19.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.876 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 66.55 40.9 3.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 166.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -78.11 -17.63 56.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.779 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.666 ' SD ' HG22 ' A' ' 199' ' ' ILE . 4.3 ppp? -143.33 158.09 43.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.899 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -92.21 153.6 19.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.817 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.7 -26.99 67.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.102 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -94.77 2.33 55.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 98.4 m -69.17 129.99 41.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.105 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.525 ' HA ' ' HB3' ' A' ' 150' ' ' ASN . 18.7 t0 -126.69 175.67 7.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.961 173.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -59.18 -35.78 74.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.01 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.7 p -68.4 -38.79 81.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 76.2 mt -67.46 -40.04 83.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.125 175.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.08 -35.52 80.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.001 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -61.4 -47.25 86.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.862 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.06 -41.23 99.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.11 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.9 -47.62 77.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.071 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -62.38 -41.86 98.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -63.96 -31.4 72.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.913 -177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.47 -19.3 28.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.836 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.37 22.43 31.94 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.453 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -80.96 -19.66 43.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.996 0.427 . . . . 0.0 110.9 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.7 t -128.76 137.47 51.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.153 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.459 ' HB2' HD22 ' A' ' 122' ' ' LEU . . . -66.34 -46.91 75.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.022 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.662 ' HB3' HD22 ' A' ' 115' ' ' LEU . 75.3 mtm -133.71 151.02 51.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.962 -168.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 66.1 p -138.69 156.9 47.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.161 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.4 mm -110.37 125.06 67.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -155.01 175.31 13.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -169.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.423 ' HA2' ' HG ' ' A' ' 113' ' ' LEU . . . -84.34 -164.17 37.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.419 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.481 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 36.5 Cg_endo -65.34 -23.78 58.48 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.685 2.257 . . . . 0.0 112.361 177.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -72.26 -30.79 65.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 45.37 45.09 9.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.104 174.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 29.7 m0 -63.68 -19.61 65.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.868 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -69.75 -14.88 63.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.855 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -78.45 -171.32 2.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 92.9 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.152 -178.933 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 71.7 t . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.826 0.346 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -82.99 139.13 33.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.408 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 39.0 p90 -150.02 156.6 41.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.927 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.7 163.86 26.46 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.431 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.0 p -135.53 135.93 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 111.127 -176.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 13.2 t -159.71 152.45 21.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 175.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 322' ' ' GLU . 28.2 m -59.2 163.26 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.288 -175.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.526 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 2.4 mp -67.02 153.66 94.07 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 110.985 -165.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.51 -178.17 2.12 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.777 2.318 . . . . 0.0 112.358 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 68.2 p -100.85 160.09 14.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.078 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -138.8 119.75 14.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.911 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 54.89 33.99 21.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 -173.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.78 9.92 73.66 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.558 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -126.17 139.94 35.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.619 0.723 . . . . 0.0 110.842 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -73.29 139.58 29.33 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.736 2.291 . . . . 0.0 112.298 -172.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 256' ' ' LYS . 73.8 m -85.33 1.5 48.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.845 168.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 99.0 mttt -38.4 118.06 0.99 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.569 0.7 . . . . 0.0 110.879 -175.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.533 ' CB ' ' HB2' ' A' ' 113' ' ' LEU . 53.0 Cg_exo -65.66 162.13 35.75 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.699 2.266 . . . . 0.0 112.33 -170.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -74.48 167.2 22.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.901 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.7 t -117.56 134.5 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.082 -165.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.51 ' HA3' ' NE2' ' A' ' 64' ' ' HIS . . . -116.7 135.52 12.07 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.469 176.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.2 t -124.96 118.24 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 111.197 174.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.41 HD21 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -66.28 123.06 18.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.3 m -126.49 133.45 51.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.789 -168.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.26 138.88 52.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.066 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.39 172.07 21.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.419 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . 0.494 HG13 ' HB2' ' A' ' 277' ' ' LYS . 29.1 mm -113.64 129.96 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 0.0 111.106 -173.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -61.85 128.74 37.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.465 ' HB3' ' C ' ' A' ' 76' ' ' LEU . . . -59.83 -29.19 68.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.099 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.82 -5.76 59.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.065 -173.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.5 t -73.14 121.0 83.99 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.654 0.74 . . . . 0.0 110.936 -173.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . 0.405 ' HD2' HG21 ' A' ' 2' ' ' ILE . 92.0 Cg_endo -68.04 -9.38 25.52 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.635 2.224 . . . . 0.0 112.353 168.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -108.66 19.72 19.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -53.97 -33.97 58.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.856 -171.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -67.55 -50.65 57.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -172.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.99 -32.08 39.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.45 -47.51 75.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.071 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . 0.494 ' HB2' HG13 ' A' ' 266' ' ' ILE . 37.3 ttpt -66.24 -42.41 88.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 176.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.46 -46.57 82.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -66.29 -43.2 87.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 284' ' ' LEU . 8.2 tt -55.83 -50.57 70.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 -176.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -72.4 -25.21 61.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -100.27 -11.15 20.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 -171.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.766 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 73.9 m-85 -122.91 -60.55 1.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 280' ' ' LEU . 1.4 mp -62.66 -32.49 73.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.908 -159.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.919 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.4 pp -123.22 38.07 4.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.96 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.483 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 64.0 p -124.68 163.47 21.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.454 ' HA ' HD11 ' A' ' 290' ' ' LEU . 38.7 t70 -45.63 -37.51 5.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -166.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -78.3 -41.63 33.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.766 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.52 -55.96 5.8 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.593 -170.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 291' ' ' GLU . 0.6 OUTLIER -67.2 -21.36 65.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 110.852 -178.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.6 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.9 tt0 -68.44 -47.6 66.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 172.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.63 -45.15 91.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -174.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 1.111 HG21 ' HA3' ' A' ' 19' ' ' GLY . 2.6 p -75.83 -34.56 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.176 -175.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.45 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 46.2 t30 -67.4 -28.24 67.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 173.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.09 -26.47 68.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -85.46 -41.76 15.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.992 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -145.36 131.78 9.78 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.572 0.701 . . . . 0.0 110.853 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.32 109.01 0.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.727 2.285 . . . . 0.0 112.358 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 59.4 mt -90.06 -19.6 24.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.97 -171.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 113.36 -59.46 0.38 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.461 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.677 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -171.37 169.63 6.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.807 0.337 . . . . 0.0 111.114 174.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.654 HG22 ' HB3' ' A' ' 307' ' ' TYR . 32.9 m -125.24 154.67 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.07 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.46 -10.71 60.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.077 171.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.583 ' CD2' HD22 ' A' ' 290' ' ' LEU . 54.1 tp -85.9 120.01 26.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -175.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -55.85 -40.45 72.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.883 -174.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.7 m -65.72 -50.02 66.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.849 -168.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.654 ' HB3' HG22 ' A' ' 302' ' ' VAL . 17.4 t80 -76.42 -28.63 56.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.979 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -64.8 -38.87 92.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.9 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.53 -34.76 77.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.909 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -75.02 -40.44 60.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.924 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.677 HD13 ' HA ' ' A' ' 301' ' ' ALA . 80.1 mt -61.23 -32.0 71.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.901 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.64 -18.64 60.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.06 -176.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.79 -19.37 65.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 173.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -91.4 122.7 65.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.608 0.718 . . . . 0.0 110.88 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -48.61 -28.69 12.73 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.668 2.245 . . . . 0.0 112.375 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -62.75 -27.25 69.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.888 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.4 mp -75.06 -32.88 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 -174.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.2 -46.03 91.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.046 -171.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.35 -39.3 89.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.169 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.634 HG21 ' HB1' ' A' ' 112' ' ' ALA . 21.6 m -59.32 -36.39 75.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.182 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.8 mmm -73.86 -34.24 64.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . 0.421 ' HB2' HG13 ' A' ' 246' ' ' VAL . 86.1 mt-10 -59.46 -44.14 93.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.942 -172.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.791 HD22 ' HB2' ' A' ' 112' ' ' ALA . 16.4 p-10 -87.83 -26.28 22.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -178.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.64 -45.31 92.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.133 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -62.46 -33.7 75.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.88 -177.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -107.62 -2.29 20.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.857 -173.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -90.17 -166.57 41.44 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.452 -164.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -144.94 143.0 30.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 110.962 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 47.0 mm -60.44 118.7 3.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 -171.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 47.6 tpp . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 121.561 0.696 . . . . 0.0 110.87 -178.537 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.79 0.328 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 66.1 mmm -80.03 -18.06 51.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 -168.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 95.0 p -63.8 -37.71 88.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.782 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -76.85 -35.13 57.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.14 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 343' ' ' VAL . 5.0 m-30 -67.61 -41.0 84.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.461 ' HA ' HG23 ' A' ' 343' ' ' VAL . 7.7 m0 -59.89 -34.64 73.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 174.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -69.43 -39.77 77.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.889 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.51 -43.22 85.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.109 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 339' ' ' PHE . 15.4 m -75.15 -28.58 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.098 -176.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.453 ' O ' HG23 ' A' ' 347' ' ' VAL . 49.3 ttt180 -58.62 -45.56 88.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.845 172.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 93.2 m -56.11 -36.25 67.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.148 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.64 -44.05 91.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.188 -174.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.539 ' HA ' HD11 ' A' ' 192' ' ' LEU . 3.0 m -74.88 -34.86 34.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.175 -174.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.453 HD13 HG21 ' A' ' 347' ' ' VAL . 1.4 mp -62.95 -52.18 62.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.196 173.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -62.5 -39.21 92.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.59 -45.71 61.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.111 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.72 -39.67 76.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.049 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 89.4 p -75.39 -10.56 59.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.921 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 82.02 17.13 70.5 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.414 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.72 -33.4 46.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 110.863 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -140.02 155.1 47.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.5 p -77.38 169.45 18.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.217 170.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.435 ' O ' ' CB ' ' A' ' 361' ' ' LEU . 53.8 t -56.17 -42.37 72.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.198 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -61.13 -46.58 89.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.828 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -70.09 -53.19 18.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -70.96 -48.04 55.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.146 -172.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.711 HD11 ' HB1' ' A' ' 188' ' ' ALA . 1.3 tm? -65.08 -41.76 94.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -174.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.73 -54.08 26.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -70.39 -48.35 56.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -171.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.34 85.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.175 -174.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.508 ' HB3' ' HB ' ' A' ' 183' ' ' VAL . 79.4 mm-40 -73.55 -34.79 65.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -175.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 26.9 m -60.17 -27.93 67.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.175 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -56.99 -30.11 63.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.804 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 365' ' ' GLN . 77.3 mt -60.6 -40.18 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.076 174.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 45.7 p -98.22 -11.38 22.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.019 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.955 175.938 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.835 0.35 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.6 mt -93.68 130.73 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.177 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -145.52 146.59 31.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.918 -176.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.22 137.15 35.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.27 6.13 63.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.458 -174.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.2 tttt -165.32 135.85 3.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.741 0.305 . . . . 0.0 110.961 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.417 HD21 ' HB3' ' A' ' 275' ' ' LEU . 0.5 OUTLIER -142.34 149.57 39.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 -178.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 78.3 t -107.62 133.76 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.726 HG23 ' HB ' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -119.92 133.87 65.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.12 -179.397 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.812 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 68.5 m95 -108.25 126.2 52.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.014 166.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.502 HD13 ' HG ' ' A' ' 20' ' ' LEU . 14.9 tt -110.55 150.06 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 -165.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.58 149.21 39.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -172.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.86 -17.84 23.3 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.459 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -73.5 -12.32 60.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.785 0.326 . . . . 0.0 110.826 -176.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -147.83 128.17 13.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 164.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.87 -77.25 1.0 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.443 -167.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -108.47 -44.91 3.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.923 0.392 . . . . 0.0 110.979 -175.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -67.47 -50.34 59.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.887 -152.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.662 ' HA3' HG21 ' A' ' 293' ' ' VAL . . . -54.95 -49.54 62.04 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.42 -173.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.519 HD22 HG21 ' A' ' 9' ' ' ILE . 3.2 mt -52.21 -54.43 31.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 0.0 110.913 170.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.96 -35.84 25.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -70.63 -59.22 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.971 0.415 . . . . 0.0 110.88 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.0 m -71.19 -37.77 67.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.127 -173.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.705 ' HA3' HG22 ' A' ' 35' ' ' VAL . . . -66.4 -45.88 82.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.426 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -57.43 -32.99 67.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 0.0 110.984 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -57.81 -37.83 74.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 176.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 6.0 m-30 -59.66 -44.61 93.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -64.81 -37.9 89.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.96 -40.62 75.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.867 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -97.54 -47.06 5.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.835 -166.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.6 p -108.13 -6.1 16.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.152 -173.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.91 3.83 90.53 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.432 169.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.836 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -100.13 133.17 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 0.0 111.177 -176.444 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.2 mttt -79.36 142.71 35.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.841 -172.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.705 HG22 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -120.01 133.79 65.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 178.359 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.481 ' O ' HD13 ' A' ' 9' ' ' ILE . 97.5 m -104.68 128.68 52.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.049 177.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.483 HG23 ' HB3' ' A' ' 20' ' ' LEU . 93.5 t -98.26 125.18 51.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.199 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -117.97 148.25 42.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 96.8 m-70 -86.75 148.3 45.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.597 0.713 . . . . 0.0 110.895 -165.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.469 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 50.7 Cg_exo -59.81 -24.96 77.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.69 2.26 . . . . 0.0 112.3 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -53.24 -50.09 65.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.937 -171.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.08 -3.83 56.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.836 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 7.7 tt -46.39 -52.63 12.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 -172.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -66.63 -36.45 82.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.767 176.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.38 -43.65 85.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.816 -172.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.4 -21.31 39.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.535 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 56.6 t80 -48.83 -51.17 56.51 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.614 0.721 . . . . 0.0 110.821 -167.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 63.1 Cg_endo -80.75 -29.46 2.2 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.731 2.287 . . . . 0.0 112.375 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -74.66 -39.65 61.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.929 -169.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.456 HG11 ' HD3' ' A' ' 57' ' ' PRO . 34.2 m -65.09 -27.83 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.031 -177.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.842 ' HB2' HD23 ' A' ' 75' ' ' LEU . . . -68.87 -37.01 78.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 177.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.11 -30.62 68.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.148 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.3 p -92.39 -15.37 27.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 176.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.48 10.22 78.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 175.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -141.05 133.28 28.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.38 -115.07 0.53 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.486 176.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.812 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 61.1 Cg_endo -75.28 152.57 39.64 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.723 2.282 . . . . 0.0 112.415 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.39 -34.99 17.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 159.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.726 ' HB ' HG23 ' A' ' 9' ' ' ILE . 30.5 mt -128.59 139.31 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 -175.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 tp -131.87 127.87 59.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -93.65 137.2 33.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 172.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.428 ' CZ2' ' HB3' ' A' ' 105' ' ' ALA . 30.0 p90 -144.66 165.03 29.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.932 171.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.81 -89.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.048 -169.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.423 ' CD2' ' HA2' ' A' ' 260' ' ' GLY . 18.0 m80 -105.47 -81.58 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.828 -171.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -103.88 -6.71 21.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.77 -154.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -52.15 -21.5 3.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -173.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.497 ' HB2' HD11 ' A' ' 104' ' ' ILE . 30.7 p90 -59.27 -28.96 67.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.815 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.62 -51.47 57.7 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.73 91.89 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.442 171.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.417 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -54.96 -51.68 65.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.981 0.42 . . . . 0.0 110.999 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.24 -42.6 45.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.113 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.5 tp60 -56.88 -38.62 73.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.87 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . 0.428 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 62.8 m -85.94 -6.9 58.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.847 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.73 30.78 59.26 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.561 174.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.842 HD23 ' HB2' ' A' ' 51' ' ' ALA . 39.0 mt -89.87 -10.07 46.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 0.0 110.972 -169.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.491 ' C ' ' HB3' ' A' ' 268' ' ' ALA . 0.2 OUTLIER -127.97 149.41 50.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 -176.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -77.36 141.11 40.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.124 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.8 136.48 45.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.957 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -105.1 156.86 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 98.8 m -100.7 130.32 25.69 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.606 0.717 . . . . 0.0 111.096 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 80' ' ' THR . 50.8 Cg_exo -54.44 134.57 62.15 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.738 2.292 . . . . 0.0 112.329 176.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -104.04 118.62 37.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.817 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.21 -41.96 98.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.897 -176.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.89 -45.05 87.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -74.88 -32.4 61.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.951 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . 0.481 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 66.9 tt0 -55.04 -50.87 68.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.901 175.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.03 -32.68 71.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 174.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -76.22 -21.32 56.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.7 -105.21 0.3 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.949 -172.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 30.3 t80 171.75 128.92 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.655 0.74 . . . . 0.0 110.92 -167.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -53.48 -37.03 81.98 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.746 2.297 . . . . 0.0 112.352 -173.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . 0.403 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 67.2 t80 -64.97 -35.72 82.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.785 -174.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.8 p -73.12 -30.97 64.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.186 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.537 ' HA ' HG23 ' A' ' 97' ' ' VAL . 86.3 m95 -67.47 -30.85 70.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 174.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.4 -30.75 70.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.852 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.96 -25.76 62.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.034 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.547 HG21 HD23 ' A' ' 103' ' ' LEU . 15.6 m -106.02 13.04 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 -174.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -100.04 129.74 46.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -123.68 115.03 20.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 172.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.8 t30 56.82 38.88 29.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 173.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.39 0.39 89.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.56 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -116.71 151.29 36.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.833 0.349 . . . . 0.0 110.805 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.547 HD23 HG21 ' A' ' 97' ' ' VAL . 15.1 mt -90.82 135.11 33.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.873 177.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.497 HD11 ' HB2' ' A' ' 67' ' ' PHE . 2.0 pp -125.68 3.9 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.037 -172.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.428 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . . . -163.03 165.47 24.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.162 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.46 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 92.4 m-85 -116.04 140.46 26.34 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.609 0.718 . . . . 0.0 110.993 172.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 11.4 Cg_exo -72.13 126.38 11.73 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.733 2.289 . . . . 0.0 112.391 172.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 1.068 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.5 mp -107.61 -39.98 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.213 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.59 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -144.02 152.09 40.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.162 -164.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.3 t -125.06 131.19 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.109 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . 0.522 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 92.5 mt-10 -133.89 132.31 40.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 175.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.778 ' HB2' HD22 ' A' ' 323' ' ' ASN . . . -154.18 152.73 30.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.119 176.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.36 169.65 16.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.941 -168.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 98.9 p -157.59 159.14 36.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.904 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -92.33 126.09 37.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 169.581 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.596 ' N ' HD23 ' A' ' 115' ' ' LEU . 65.7 mt -113.71 132.14 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -172.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -132.13 145.03 51.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.425 ' O ' HD21 ' A' ' 122' ' ' LEU . 54.8 t-20 -93.36 114.43 26.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.831 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.475 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.8 mttt -64.78 -18.43 65.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 -173.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -77.33 -29.98 53.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.865 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 mp -83.69 -49.51 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.647 ' H ' HD21 ' A' ' 122' ' ' LEU . 1.5 pt? -140.0 126.53 12.18 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.567 0.699 . . . . 0.0 110.89 176.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -79.16 -14.59 13.3 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.693 2.262 . . . . 0.0 112.377 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -142.23 97.16 6.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.564 0.697 . . . . 0.0 110.825 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.67 154.98 54.66 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.725 2.283 . . . . 0.0 112.282 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.39 146.23 74.21 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.624 2.216 . . . . 0.0 112.347 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -88.53 -18.16 28.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.988 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 69.6 p -132.27 158.72 41.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.166 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.559 ' HA ' HD11 ' A' ' 132' ' ' ILE . 58.7 m95 -69.66 -27.21 64.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.978 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.96 -24.6 67.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.14 -24.62 40.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.823 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.628 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -57.15 -49.68 92.53 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.586 0.708 . . . . 0.0 111.151 -172.034 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 40.0 Cg_endo -68.67 -38.02 11.32 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.67 2.247 . . . . 0.0 112.398 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.14 -60.73 3.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 176.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 1.209 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.96 -16.8 63.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 -175.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.511 ' N ' HD13 ' A' ' 135' ' ' LEU . 37.0 t70 -58.39 -39.63 80.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.821 168.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.52 -30.22 68.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.79 -47.6 52.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.032 0.444 . . . . 0.0 110.864 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.608 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.9 pp -85.62 -15.27 43.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.608 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.7 tttt -59.74 -33.45 71.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 173.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.03 -24.63 67.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 176.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -95.03 3.35 54.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.927 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.79 33.16 52.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.471 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -110.5 169.97 8.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.749 0.309 . . . . 0.0 110.909 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.0 t -118.93 142.13 48.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.996 0.427 . . . . 0.0 110.745 169.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -68.62 -39.87 80.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 -175.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -142.17 130.68 22.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 62.3 tpp -118.22 131.9 56.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.823 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -154.59 157.49 38.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.53 -51.56 5.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 1.11 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.4 tm? 48.04 33.37 3.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.891 -169.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -102.16 -2.76 28.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.936 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -127.97 153.68 78.32 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.683 0.754 . . . . 0.0 110.864 -174.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.457 ' HA ' ' HB ' ' A' ' 157' ' ' THR . 37.5 Cg_endo -61.81 -24.78 77.73 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.626 2.217 . . . . 0.0 112.362 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -66.68 -30.06 70.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -87.49 -39.39 15.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' THR . . . . . 0.457 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 20.5 m -61.18 -46.87 88.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.135 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.574 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 37.3 t-105 -58.81 -53.84 62.37 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.499 0.666 . . . . 0.0 110.833 -169.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 34.4 Cg_endo -66.12 -18.01 55.73 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.694 2.263 . . . . 0.0 112.255 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.781 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.6 tm? -81.61 -45.34 15.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.837 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.583 HG22 ' HA3' ' A' ' 166' ' ' GLY . 77.9 mt -74.24 -44.46 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.98 -20.95 63.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -60.66 -31.15 70.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.093 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.98 3.1 55.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.891 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 104.11 7.91 39.92 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.485 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.583 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -77.06 67.05 2.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.541 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -86.05 131.11 34.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.361 . . . . 0.0 110.89 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.54 13.48 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -174.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.426 ' HA ' HG12 ' A' ' 181' ' ' VAL . 52.9 p90 -153.43 154.4 34.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 86.8 tttt -101.48 127.5 48.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 158.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -116.22 125.81 52.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.983 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -153.55 130.39 10.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.0 t30 54.31 42.76 31.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.946 172.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.95 18.47 80.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -132.27 138.51 47.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.965 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -97.72 145.11 26.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.811 170.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -126.24 112.14 15.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.914 174.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . 0.609 ' O ' HD13 ' A' ' 178' ' ' ILE . 1.1 pp -79.43 -12.82 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -95.23 -10.1 31.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 -176.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 67.2 t0 -126.42 90.13 3.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 169.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 169' ' ' PHE . 29.3 m -113.55 164.07 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -173.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.11 22.59 32.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.519 -172.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.477 HG22 HD13 ' A' ' 368' ' ' ILE . 3.5 m -106.64 -17.91 7.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 111.046 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -87.68 21.23 2.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.829 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -120.05 -171.41 2.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.863 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.72 -30.38 71.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.128 -173.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.37 -40.51 94.57 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.434 -167.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.635 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -65.04 -38.36 90.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 111.107 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.547 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -61.92 -38.66 89.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.906 174.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.98 -38.79 92.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.05 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.516 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -65.75 -47.76 73.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.51 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.754 HD11 ' HA ' ' A' ' 347' ' ' VAL . 18.8 tp -67.33 -34.51 77.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.802 0.334 . . . . 0.0 110.845 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.481 ' OG1' HG22 ' A' ' 357' ' ' VAL . 89.2 m -64.98 -43.84 91.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.18 177.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 79.9 t80 -65.95 -48.58 70.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.881 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.71 ' C ' HD21 ' A' ' 195' ' ' LEU . 5.2 tt -50.98 -51.28 54.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.974 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 199' ' ' ILE . 27.5 m -64.5 -21.48 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.101 -173.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.3 m-20 -61.03 -33.13 72.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.808 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -80.86 -40.05 25.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.56 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.7 pp -74.37 -28.4 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 172.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.84 -37.66 79.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 173.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -80.04 2.17 24.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 66.41 40.18 3.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.802 166.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -78.98 -15.72 57.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.843 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.56 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.1 ppp? -141.33 155.53 45.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 178.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -94.63 150.04 20.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.26 68.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.044 -175.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -94.96 0.55 54.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.931 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 89.6 m -62.24 125.04 22.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.432 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 13.6 t0 -120.0 -179.65 3.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.844 177.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -64.1 -46.05 85.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.99 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.1 p -67.0 -37.09 83.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.82 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.432 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 80.9 mt -65.01 -43.9 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.088 174.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.41 84.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -63.49 -46.4 86.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 176.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.91 93.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.01 88.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.115 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -64.02 -42.08 97.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.963 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -66.28 -34.3 77.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -81.96 -23.34 36.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.884 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.43 27.03 26.2 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.448 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -83.46 -20.02 34.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.985 0.421 . . . . 0.0 110.9 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.7 t -131.22 137.54 48.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.133 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.586 ' HB3' HD23 ' A' ' 139' ' ' LEU . . . -67.37 -41.98 84.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.012 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 61.6 mtm -137.63 160.84 38.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -177.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.3 t -150.26 159.55 44.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.264 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.505 HD13 HD11 ' A' ' 247' ' ' LEU . 49.2 mm -109.24 126.23 66.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -154.97 174.4 15.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.861 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -81.64 -163.71 31.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.41 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.522 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 39.7 Cg_endo -68.61 -22.05 38.54 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.697 2.265 . . . . 0.0 112.281 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 54.1 m0 -70.09 -30.0 67.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.868 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 47.56 45.04 17.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.062 174.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 34.1 m0 -66.26 -16.12 63.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.88 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 74.3 m -53.01 -40.07 63.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.966 0.412 . . . . 0.0 110.875 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -86.36 -177.29 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -173.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 77.1 mt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.154 -174.876 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.763 0.316 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -104.51 140.01 38.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.86 175.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.475 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 42.8 p90 -150.01 154.78 38.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.31 160.7 25.13 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.538 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.2 p -138.6 137.34 43.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 0.0 111.154 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.1 t -154.09 146.19 23.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.14 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.6 m -61.33 167.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.936 HD21 ' HD3' ' A' ' 257' ' ' PRO . 3.1 mm? -64.65 144.88 98.8 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.546 0.689 . . . . 0.0 111.077 -163.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.11 -172.12 1.27 Allowed 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.753 2.302 . . . . 0.0 112.487 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 94.7 m -108.82 146.04 34.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.179 -173.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . 0.422 ' HB3' ' CD1' ' A' ' 129' ' ' TRP . 43.6 p90 -137.39 126.43 24.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 54.05 35.06 21.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.97 6.97 84.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.48 173.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -133.66 131.34 21.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.634 0.73 . . . . 0.0 110.859 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.47 137.42 25.41 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.674 2.249 . . . . 0.0 112.296 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.769 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 82.3 p -87.04 -1.07 57.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 173.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -39.31 132.99 1.23 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.567 0.699 . . . . 0.0 110.915 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.936 ' HD3' HD21 ' A' ' 247' ' ' LEU . 58.8 Cg_endo -83.22 157.94 15.03 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.607 2.205 . . . . 0.0 112.419 -169.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -75.77 167.24 22.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.865 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 45.5 t -111.24 136.37 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.203 -165.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . 0.423 ' HA2' ' CD2' ' A' ' 64' ' ' HIS . . . -114.41 131.98 10.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.38 172.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 83.7 t -125.08 115.38 43.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.774 0.321 . . . . 0.0 111.196 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.43 HD21 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -64.92 122.03 16.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.944 -177.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 42.6 m -127.53 133.25 49.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.839 -170.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -127.35 140.3 52.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.081 -172.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.41 170.77 22.17 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.479 -171.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.7 mm -112.36 128.22 69.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.745 0.307 . . . . 0.0 111.2 -172.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -63.31 128.24 34.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.973 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.491 ' HB3' ' C ' ' A' ' 76' ' ' LEU . . . -60.56 -28.65 68.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.121 -178.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.57 -6.74 59.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.104 -173.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.2 t -79.75 123.16 84.05 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.596 0.712 . . . . 0.0 110.903 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -69.53 -7.16 20.26 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.733 2.289 . . . . 0.0 112.396 169.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -102.1 21.97 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 -167.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -50.12 -36.28 29.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -173.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.3 -39.7 89.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.417 ' HB3' HD21 ' A' ' 7' ' ' LEU . 33.9 mt -66.79 -56.87 8.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 173.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.91 -50.99 36.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.991 -167.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -61.21 -40.64 94.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.955 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.9 tt0 -69.34 -47.75 63.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.944 -177.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 20.4 m-30 -66.53 -36.21 82.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 -178.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 284' ' ' LEU . 5.4 tt -59.17 -52.39 65.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -177.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . 0.414 ' HA ' HD22 ' A' ' 285' ' ' LEU . 24.4 pt-20 -78.66 -30.68 46.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.784 -174.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 63.7 m-80 -100.85 -13.96 18.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 -164.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.711 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 52.4 m-85 -126.7 -53.52 1.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.813 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.526 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.3 OUTLIER -61.66 -35.43 77.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.963 -167.363 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 1.068 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.9 pp -124.43 38.23 4.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -175.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.452 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 68.2 p -122.51 164.32 18.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.188 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.472 ' HA ' HD11 ' A' ' 290' ' ' LEU . 38.8 t70 -45.77 -38.0 6.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 -165.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -77.15 -42.57 37.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.954 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.711 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -71.98 -51.54 14.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 -170.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.569 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -74.07 -20.49 60.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.67 0.271 . . . . 0.0 110.892 -178.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.553 ' N ' HD12 ' A' ' 290' ' ' LEU . 35.8 tt0 -70.27 -46.45 64.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 171.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.97 -43.99 97.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.011 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.662 HG21 ' HA3' ' A' ' 19' ' ' GLY . 1.8 p -79.95 -30.55 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.236 -176.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . 0.408 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 39.0 t30 -68.09 -28.97 67.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.777 170.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.03 -24.81 68.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.944 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -77.02 -43.24 35.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -162.87 135.79 4.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.545 0.688 . . . . 0.0 110.976 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -45.43 114.66 0.76 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.745 2.297 . . . . 0.0 112.42 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 51.2 mt -89.98 -14.85 33.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.894 -175.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 114.92 -59.48 0.41 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.488 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.704 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -173.72 170.15 4.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 111.095 171.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.712 HG22 ' HB3' ' A' ' 307' ' ' TYR . 30.8 m -122.68 154.84 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.136 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.23 -10.49 59.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.023 171.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.569 ' CD2' HD22 ' A' ' 290' ' ' LEU . 40.1 tp -83.15 120.35 25.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.843 -177.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.16 -40.1 73.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.4 m -65.25 -50.14 66.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.882 -169.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.712 ' HB3' HG22 ' A' ' 302' ' ' VAL . 15.7 t80 -76.9 -29.13 55.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.973 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.09 -40.1 96.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.88 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.53 -35.29 78.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -74.47 -40.25 61.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.704 HD13 ' HA ' ' A' ' 301' ' ' ALA . 77.8 mt -60.91 -32.25 71.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 175.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.93 -19.8 61.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.022 0.439 . . . . 0.0 111.202 -177.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.57 -20.62 66.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.977 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -90.26 121.12 68.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.606 0.717 . . . . 0.0 110.88 166.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.81 -28.29 9.56 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.753 2.302 . . . . 0.0 112.355 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -60.24 -30.44 69.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.507 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.2 mp -79.99 -29.99 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.074 -176.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.71 85.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.047 -168.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.75 -47.64 62.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.067 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.579 HG21 ' HB1' ' A' ' 112' ' ' ALA . 26.9 m -61.09 -37.11 81.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.156 -174.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.6 ttp -65.22 -35.49 81.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -64.64 -47.76 77.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.835 -170.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.778 HD22 ' HB2' ' A' ' 112' ' ' ALA . 9.6 p-10 -83.43 -26.23 30.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 -178.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.64 -49.74 72.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.192 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -66.98 -29.86 69.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -109.74 -9.23 14.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -168.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.13 -148.87 23.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.458 -166.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -143.32 139.94 30.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.872 0.368 . . . . 0.0 110.824 -171.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 40.6 mm -65.52 122.4 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 59.0 ttm . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.575 0.702 . . . . 0.0 110.911 -179.701 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 . . . . . 0 N--CA 1.458 -0.054 0 CA-C-O 120.813 0.339 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 74.1 mmm -79.9 -19.05 49.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 -171.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.9 m -61.84 -41.73 98.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.773 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.32 -35.14 61.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.112 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.552 ' O ' HG13 ' A' ' 343' ' ' VAL . 8.2 m-30 -66.41 -40.42 89.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.47 ' HA ' HG23 ' A' ' 343' ' ' VAL . 18.6 m0 -59.01 -35.87 73.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.978 174.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -67.82 -41.88 82.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.95 -44.18 81.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.061 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.552 HG13 ' O ' ' A' ' 339' ' ' PHE . 16.7 m -74.38 -30.87 26.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 -176.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 347' ' ' VAL . 4.9 tmt_? -65.0 -39.38 93.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 175.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.7 m -58.36 -35.74 72.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.89 -43.62 95.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.189 -174.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.754 ' HA ' HD11 ' A' ' 192' ' ' LEU . 3.8 m -73.56 -33.7 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.237 -175.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.449 HD13 HG21 ' A' ' 347' ' ' VAL . 1.5 mp -63.8 -46.51 94.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.151 173.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -65.05 -39.85 93.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.53 62.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.079 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.61 -40.19 80.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.033 -175.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.8 p -75.43 -10.71 59.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.11 16.93 73.28 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.54 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.95 -32.82 45.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 0.0 110.854 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -139.59 154.87 47.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.0 p -77.63 168.91 19.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.096 169.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.481 HG22 ' OG1' ' A' ' 193' ' ' THR . 53.7 t -56.04 -42.09 70.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.205 172.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -61.29 -46.53 89.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.857 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -69.71 -53.23 19.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -70.75 -48.3 55.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.06 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.635 HD11 ' HB1' ' A' ' 188' ' ' ALA . 1.3 tm? -66.02 -45.63 80.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -173.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.67 -53.07 57.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.972 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -67.23 -47.11 71.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.1 -41.54 94.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.119 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 72.5 mm-40 -78.17 -26.79 47.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.014 -176.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.2 m -64.48 -36.03 82.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.161 171.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.01 -30.41 67.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.477 HD13 HG22 ' A' ' 183' ' ' VAL . 67.7 mt -60.4 -38.11 76.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.165 174.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 59.8 p -93.83 -14.85 25.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 178.728 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.73 0.3 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.7 mt -82.55 134.61 26.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.099 175.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -135.83 142.21 44.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.006 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -56.56 135.96 54.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.574 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 98.94 -0.17 57.54 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.518 -174.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 65.6 pttt -162.59 150.87 14.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.831 172.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.688 ' H ' HD21 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -147.23 156.72 43.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -176.559 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 91.2 t -113.92 131.12 66.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.095 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.917 ' HB ' HD22 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -119.97 126.82 75.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.12 -177.694 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.559 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 47.5 m0 -107.72 131.46 54.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.959 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.488 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 65.9 mt -117.75 142.41 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.078 173.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.413 ' O ' HG22 ' A' ' 11' ' ' ILE . 33.2 t30 -47.68 141.08 5.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 172.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.16 -13.03 13.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.569 -172.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -78.49 -15.22 58.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 0.0 110.844 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -130.99 112.07 12.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 167.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.75 -96.58 0.84 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.548 -153.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -102.97 -43.3 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.886 0.374 . . . . 0.0 110.931 -167.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.77 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 95.7 m-20 -62.49 -50.36 71.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 -157.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.718 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -57.8 -47.71 86.88 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 -175.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.917 HD22 ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -57.09 -61.02 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.76 0.314 . . . . 0.0 110.997 175.682 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.39 -40.94 37.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.14 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -65.03 -53.53 44.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.1 m -75.55 -36.06 33.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.179 -175.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.765 ' HA3' HG22 ' A' ' 35' ' ' VAL . . . -65.08 -47.22 84.16 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.98 -39.57 72.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.813 0.34 . . . . 0.0 110.861 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.67 -36.9 79.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -64.68 -41.56 95.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.57 -39.39 94.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.888 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -67.33 -33.84 76.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.879 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -89.32 -44.1 10.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.845 -170.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.566 ' OG1' HG13 ' A' ' 33' ' ' ILE . 66.6 p -110.73 -12.69 14.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.195 -171.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.53 7.23 87.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.589 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.858 HD13 ' O ' ' A' ' 33' ' ' ILE . 2.4 pp -99.01 133.51 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.078 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.6 mttt -82.62 140.28 33.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.96 -173.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.765 HG22 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -118.09 134.61 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.14 -177.411 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.403 ' O ' HD13 ' A' ' 9' ' ' ILE . 98.2 m -102.52 127.15 49.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.162 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.53 HG23 ' HG ' ' A' ' 20' ' ' LEU . 61.9 t -95.24 120.98 45.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.159 177.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.559 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 66.4 mm-40 -129.98 133.77 47.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.816 170.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -142.19 57.43 6.57 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.622 0.725 . . . . 0.0 110.873 174.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.01 -23.59 7.67 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.74 2.294 . . . . 0.0 112.369 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t0 62.63 20.77 12.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -170.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 45' ' ' GLU . 98.9 mttt -85.22 2.85 42.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.958 169.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 43' ' ' LEU . 11.3 mt -43.45 -47.86 7.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -171.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.86 -36.87 77.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 42' ' ' LYS . 89.0 tt0 -74.54 -36.38 63.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -78.95 -29.98 44.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.511 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 9.8 m-30 -45.16 -55.58 11.06 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.664 0.745 . . . . 0.0 110.851 -175.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.4 Cg_endo -68.68 -27.2 32.33 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.795 2.33 . . . . 0.0 112.317 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -79.4 -44.02 22.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.881 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.8 m -68.02 -30.52 48.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.154 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.37 79.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 172.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.42 -30.92 67.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.062 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.5 p -92.66 -12.33 31.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.169 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.45 15.27 81.31 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.462 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -161.08 154.21 21.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.862 0.363 . . . . 0.0 110.877 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.445 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . -162.76 -138.14 2.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.409 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.527 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 72.6 Cg_endo -68.62 155.88 67.4 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.621 2.214 . . . . 0.0 112.395 169.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.48 -38.03 26.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.747 ' HB ' HG23 ' A' ' 9' ' ' ILE . 4.1 mp -128.4 138.01 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.079 176.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.508 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 1.9 tp -130.36 129.06 64.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.169 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.576 ' CE2' HG13 ' A' ' 108' ' ' ILE . 2.5 m-85 -98.62 141.25 31.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.819 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.508 ' CZ2' HG23 ' A' ' 60' ' ' ILE . 8.6 m-90 -118.12 139.96 50.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.54 -83.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.198 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.422 ' HB3' ' SD ' ' A' ' 330' ' ' MET . 98.2 m-70 -128.0 -57.22 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.835 170.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -85.36 -26.61 26.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.778 -170.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.508 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 98.7 mtt180 -59.94 -29.97 68.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 -158.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -67.99 -28.31 67.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -169.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.12 -51.48 52.65 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.433 -172.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.85 -36.99 92.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.482 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 17.4 t80 -66.53 -37.74 85.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.879 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.54 -44.43 62.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -62.66 -33.31 74.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.5 p -80.33 -10.76 59.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.932 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.22 32.44 68.85 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.454 174.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 1.7 mp -86.34 1.24 51.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 0.0 110.905 -172.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.546 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.7 OUTLIER -131.93 159.86 37.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.949 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.711 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -68.36 130.63 43.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.034 174.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -69.99 123.35 21.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.937 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.6 pt -108.78 159.97 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.053 -172.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.1 p -103.49 146.64 32.86 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.604 0.716 . . . . 0.0 111.169 -171.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.73 146.87 30.61 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.747 2.298 . . . . 0.0 112.354 -177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -108.08 116.09 31.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.55 -35.86 61.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.18 95.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -70.03 -38.23 75.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.855 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -54.92 -48.03 73.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.02 -36.39 83.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.85 -20.09 58.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -104.02 -103.36 0.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -173.137 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 46.2 t80 -166.82 134.56 2.1 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.649 0.738 . . . . 0.0 110.883 -172.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 68.0 Cg_exo -52.29 -39.71 71.79 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.738 2.292 . . . . 0.0 112.393 -170.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -77.76 -30.62 51.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.96 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.3 m -69.63 -48.94 58.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 -165.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.47 ' HA ' HG23 ' A' ' 97' ' ' VAL . 53.8 p-90 -66.23 -28.74 68.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.888 178.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -71.33 -37.48 71.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.813 175.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.86 -25.1 64.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.119 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.541 HG21 HD23 ' A' ' 103' ' ' LEU . 21.5 m -101.16 16.36 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.135 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 67.9 ttt180 -101.52 132.58 47.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -148.15 130.56 15.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.1 t30 68.61 36.43 2.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.16 -4.6 66.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.464 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -140.04 164.34 30.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.853 0.359 . . . . 0.0 110.885 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.541 HD23 HG21 ' A' ' 97' ' ' VAL . 12.9 mt -73.83 146.49 44.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 -175.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.428 ' C ' HD13 ' A' ' 104' ' ' ILE . 2.0 pp -122.48 8.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.138 174.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.768 ' HB2' ' HB3' ' A' ' 263' ' ' SER . . . -168.45 158.54 9.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.02 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -125.15 151.24 69.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.722 0.773 . . . . 0.0 110.96 164.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.422 ' HB3' HG11 ' A' ' 261' ' ' VAL . 59.3 Cg_endo -72.39 121.1 7.18 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.648 2.232 . . . . 0.0 112.384 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.576 HG13 ' CE2' ' A' ' 61' ' ' PHE . 24.6 mm -98.1 -32.84 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.089 176.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -157.02 153.35 27.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 -177.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.1 t -117.51 133.76 63.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.14 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -119.5 129.24 54.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.934 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -149.84 158.82 44.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.748 HD21 ' HA3' ' A' ' 228' ' ' GLY . 59.3 mt -99.61 158.37 15.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.042 -173.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.0 p -153.53 160.01 42.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.872 HD13 ' O ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.8 124.16 44.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.955 175.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.622 ' N ' HD23 ' A' ' 115' ' ' LEU . 4.3 mp -106.28 133.71 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.163 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -133.15 147.77 52.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.957 -176.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -97.6 115.6 28.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.63 -16.37 63.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 21.5 t70 -80.16 -33.78 38.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.6 mp -88.67 -45.34 9.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.942 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 223' ' ' ALA . 3.0 mp -108.47 130.88 22.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.537 0.684 . . . . 0.0 110.894 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.44 -30.5 15.2 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.677 2.251 . . . . 0.0 112.345 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -153.87 89.93 3.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.56 0.695 . . . . 0.0 110.973 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.485 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 51.1 Cg_exo -58.21 139.56 90.95 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.678 2.252 . . . . 0.0 112.383 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 125' ' ' PRO . 62.6 Cg_exo -54.98 146.53 57.24 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.245 . . . . 0.0 112.327 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -100.65 -0.82 36.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 176.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.9 p -132.95 157.06 46.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.04 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -71.36 -25.32 62.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.967 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -66.36 -35.54 80.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -172.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -83.42 -9.98 58.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.618 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 47.0 mm -58.99 -52.64 73.42 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.628 0.728 . . . . 0.0 111.219 -172.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 28.6 Cg_endo -61.03 -38.85 64.98 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.737 2.291 . . . . 0.0 112.31 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.88 -60.51 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 1.184 HD23 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.53 -17.03 64.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -175.364 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.641 ' HA ' HD23 ' A' ' 139' ' ' LEU . 38.7 t70 -60.9 -38.47 85.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 168.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.81 -37.18 85.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.945 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.91 -49.72 23.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.674 HD21 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -75.14 -16.98 60.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -176.592 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.674 ' N ' HD21 ' A' ' 139' ' ' LEU . 87.6 tttt -57.46 -34.97 69.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.961 171.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.0 -24.53 67.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.121 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.8 7.89 44.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.87 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.01 28.62 62.11 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.509 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.441 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 46.9 mtmt -117.79 168.61 10.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.391 . . . . 0.0 110.821 174.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.9 t -129.46 137.38 50.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.82 176.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 136' ' ' ASP . . . -70.06 -57.67 4.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.087 -165.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -137.53 126.82 24.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.954 -167.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 92.7 mmm -103.25 126.16 50.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.809 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -155.65 165.04 37.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -126.22 144.21 50.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.905 171.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.478 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 48.3 tp -113.44 -2.59 13.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 -175.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -69.39 -10.06 56.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.26 151.74 51.45 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 121.704 0.764 . . . . 0.0 110.811 -175.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.535 ' HD3' ' HD2' ' A' ' 344' ' ' ARG . 30.4 Cg_endo -66.05 -18.5 56.86 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.634 2.223 . . . . 0.0 112.389 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -59.63 -39.49 84.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.957 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -83.76 -38.38 21.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.864 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.4 p -64.19 -38.89 92.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.121 -173.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.566 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 11.0 t-105 -63.6 -54.23 44.65 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.556 0.694 . . . . 0.0 110.943 -170.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 33.3 Cg_endo -68.48 -32.07 25.98 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.729 2.286 . . . . 0.0 112.385 -172.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.638 ' C ' HD21 ' A' ' 160' ' ' LEU . 7.1 tt -74.51 -40.78 61.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.639 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 75.9 mt -68.28 -40.16 82.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.141 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.54 -27.09 63.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.069 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.35 -33.02 70.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.024 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . 0.536 ' HA ' ' HD3' ' A' ' 251' ' ' LYS . 66.0 m-20 -91.3 -9.0 46.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.837 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.52 3.37 9.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.511 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.63 66.53 3.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.406 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -90.0 151.26 21.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 110.968 -174.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.491 ' HB1' ' SD ' ' A' ' 336' ' ' MET . . . -76.42 -6.89 53.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.003 -176.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -155.0 155.04 33.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.974 0.416 . . . . 0.0 110.873 -173.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -98.91 129.3 45.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 156.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -95.69 124.06 39.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -149.97 129.81 13.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.3 t30 57.1 44.98 21.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.908 171.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.41 7.82 73.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.408 172.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -132.91 140.92 48.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.831 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.427 ' N ' ' HD1' ' A' ' 176' ' ' TYR . 3.4 m-30 -79.29 132.94 36.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.991 166.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -94.12 105.01 17.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.6 tp -67.0 -19.23 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -95.13 -7.35 39.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -135.15 96.01 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.805 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.479 HG21 HG23 ' A' ' 183' ' ' VAL . 32.6 m -116.91 172.38 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -102.52 14.69 56.45 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.516 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.552 HG22 ' CD1' ' A' ' 368' ' ' ILE . 17.6 m -100.1 -17.05 6.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.83 0.347 . . . . 0.0 111.126 -175.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.498 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 57.9 p-10 -96.62 19.74 11.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.015 175.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -116.04 173.68 6.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.898 -174.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.39 -27.6 69.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.102 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.67 -40.27 90.31 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.551 -170.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.597 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -65.46 -41.19 93.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 111.041 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.51 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 91.9 mttt -60.8 -36.4 78.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.889 173.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.3 -37.05 86.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.01 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.639 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.51 -47.18 86.75 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.42 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.606 HD11 ' HA ' ' A' ' 347' ' ' VAL . 15.9 tp -68.19 -31.24 70.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.913 0.387 . . . . 0.0 110.99 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.437 ' O ' HG12 ' A' ' 196' ' ' VAL . 84.8 m -64.53 -42.87 95.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.04 176.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -67.05 -57.52 6.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.876 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.617 ' C ' HD12 ' A' ' 195' ' ' LEU . 3.6 pp -63.19 -27.8 69.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.926 -167.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.575 ' N ' HD12 ' A' ' 195' ' ' LEU . 1.3 p -74.27 -22.21 17.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.135 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -65.57 -58.34 6.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 1.018 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.66 -22.37 56.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -167.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.806 ' N ' HD23 ' A' ' 198' ' ' LEU . 2.2 pp -80.92 -33.53 13.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 172.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.38 -33.02 74.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 169.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -84.48 4.81 30.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.862 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 66.4 39.98 3.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -82.3 -11.17 58.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 172.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.5 ' CG ' HG22 ' A' ' 199' ' ' ILE . 5.1 ppp? -140.14 153.18 46.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 175.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -97.05 157.5 15.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 -177.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.21 -24.28 67.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.147 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -94.85 -1.81 52.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.1 m -64.02 131.7 48.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.204 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -149.25 174.22 12.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -177.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -79.76 -31.43 40.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.833 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 94.8 p -71.72 -39.46 70.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.871 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 36.6 pt -66.37 -22.28 29.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.135 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.65 -30.01 71.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.069 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -57.46 -44.02 84.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.847 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.02 -36.36 84.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.106 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.95 -36.44 81.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.097 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -64.09 -42.42 96.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -64.89 -33.79 76.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -89.18 -22.31 22.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.42 29.92 23.36 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.508 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.19 -30.12 16.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.383 . . . . 0.0 110.945 -171.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 52.8 m -110.08 125.35 52.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.093 -170.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.542 ' HB2' HD23 ' A' ' 122' ' ' LEU . . . -71.16 -48.97 48.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.149 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.424 ' HA ' ' O ' ' A' ' 116' ' ' ILE . 68.5 mtm -133.55 146.65 51.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -172.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.409 HG23 ' N ' ' A' ' 226' ' ' ILE . 80.7 m -145.01 152.37 40.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.126 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . 0.409 ' N ' HG23 ' A' ' 225' ' ' THR . 40.6 mm -111.52 120.33 61.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -161.87 170.52 19.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.798 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.748 ' HA3' HD21 ' A' ' 113' ' ' LEU . . . -130.26 -107.54 1.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.488 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.51 -16.48 42.96 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.728 2.285 . . . . 0.0 112.288 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -66.94 -30.03 70.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 54.02 49.59 18.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -66.1 -27.75 68.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.8 m -65.08 142.8 58.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 -175.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -100.0 -175.27 2.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 174.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.2 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.163 -178.3 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 240' ' ' VAL . 12.6 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.956 0.408 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 70.1 m-20 45.03 69.8 0.4 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -127.57 132.68 49.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.927 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.37 157.86 23.74 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.474 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.442 HG21 HG13 ' A' ' 116' ' ' ILE . 2.5 p -143.15 140.01 26.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.959 0.409 . . . . 0.0 111.067 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.3 t -153.93 150.11 27.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.561 HG11 ' HB2' ' A' ' 323' ' ' ASN . 31.3 m -61.92 168.87 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.626 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.9 mm? -61.15 145.4 89.91 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.742 0.782 . . . . 0.0 110.837 -160.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.37 -177.01 2.75 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.76 2.306 . . . . 0.0 112.392 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 63.6 p -109.14 160.05 16.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.03 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -145.26 128.24 16.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.865 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 251' ' ' LYS . 81.0 tttt 55.49 36.04 26.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 -177.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.06 8.36 82.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.536 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -134.68 139.37 32.23 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.58 0.705 . . . . 0.0 110.98 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.6 142.61 29.43 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.693 2.262 . . . . 0.0 112.343 -175.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.626 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 89.5 p -83.51 -5.02 59.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 169.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -41.95 125.69 2.6 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.522 0.677 . . . . 0.0 111.025 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.689 ' HG3' ' HB2' ' A' ' 113' ' ' LEU . 84.4 Cg_endo -86.94 164.91 8.78 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.704 2.269 . . . . 0.0 112.319 -174.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -75.01 170.03 16.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 175.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 324' ' ' ALA . 99.0 t -103.87 134.98 43.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.106 -170.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.54 140.69 15.47 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.536 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.422 HG11 ' HB3' ' A' ' 107' ' ' PRO . 90.4 t -126.64 126.94 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.868 0.366 . . . . 0.0 111.133 -176.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.433 HD21 ' N ' ' A' ' 263' ' ' SER . 2.0 tt -70.07 130.6 42.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.923 166.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.768 ' HB3' ' HB2' ' A' ' 105' ' ' ALA . 67.7 m -119.04 149.21 42.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.811 -175.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -133.81 139.62 46.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.087 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.505 ' HA3' ' HH2' ' A' ' 62' ' ' TRP . . . -142.31 171.52 24.61 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.508 -175.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 30.8 mm -113.33 130.39 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 111.089 -171.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -69.29 132.63 46.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.711 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -65.61 -24.99 67.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.048 -176.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.73 -11.96 58.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 -171.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.7 t -70.45 120.04 76.14 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.67 0.748 . . . . 0.0 110.929 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.72 -15.72 21.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.721 2.28 . . . . 0.0 112.305 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -114.74 30.93 7.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -61.67 -24.36 66.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -168.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -64.07 -40.55 96.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.798 -169.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.6 pp -78.81 -32.17 46.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.494 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -65.13 -45.9 83.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.018 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -69.53 -33.3 72.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.919 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.88 -50.06 73.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -172.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.482 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 1.9 p90 -68.64 -33.59 74.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 -176.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.428 ' C ' HD21 ' A' ' 280' ' ' LEU . 8.4 tt -62.66 -47.62 82.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.901 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.4 -39.52 67.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -99.93 -12.73 19.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -161.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.516 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 69.5 t80 -123.73 -51.33 1.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 2.1 mp -67.3 -46.01 74.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.849 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.34 48.75 1.32 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 169.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.449 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 80.5 m -146.47 145.27 30.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.194 176.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.452 ' HA ' HD11 ' A' ' 290' ' ' LEU . 49.5 t0 -42.57 -35.03 0.97 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.842 -175.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -74.69 -43.64 54.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.847 -174.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.97 -52.04 9.63 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.453 -171.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.695 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.7 OUTLIER -72.05 -22.54 61.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.336 . . . . 0.0 110.943 -177.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.52 ' N ' HD12 ' A' ' 290' ' ' LEU . 86.5 tt0 -67.13 -41.37 86.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 169.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.59 84.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.069 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.718 HG13 ' HA3' ' A' ' 19' ' ' GLY . 46.4 t -75.66 -45.54 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 -178.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -65.31 -35.09 79.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.98 -32.15 73.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 -173.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.77 ' HB3' ' HB3' ' A' ' 18' ' ' ASN . 63.8 m-20 -99.77 -35.19 9.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 -174.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.443 ' O ' HD13 ' A' ' 299' ' ' LEU . 46.9 tptt -129.11 124.45 22.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.563 0.697 . . . . 0.0 110.947 170.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -52.3 108.02 0.22 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.743 2.295 . . . . 0.0 112.281 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 297' ' ' LYS . 2.2 mp -92.26 -28.67 16.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 175.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.1 -55.9 1.81 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.466 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -174.27 168.53 3.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.0 111.094 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.591 ' CG2' ' HB3' ' A' ' 307' ' ' TYR . 32.2 m -135.0 161.84 39.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.126 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.44 -10.19 59.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.027 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.695 ' CD2' HD22 ' A' ' 290' ' ' LEU . 61.2 tp -79.75 129.43 34.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.866 -174.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -42.99 -31.93 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.899 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.436 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 70.6 m -47.83 -38.77 16.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.846 175.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.591 ' HB3' ' CG2' ' A' ' 302' ' ' VAL . 0.1 OUTLIER -58.99 -45.62 90.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.918 173.303 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.48 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 88.1 tt0 -56.96 -37.71 71.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.855 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -79.91 -64.1 1.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.833 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -85.01 -58.89 2.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -171.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 307' ' ' TYR . 56.0 mt -62.66 -32.62 73.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -168.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.1 -12.78 54.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.057 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.95 -18.31 64.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.838 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.515 ' HB3' HD13 ' A' ' 317' ' ' ILE . 58.2 t0 -78.88 121.23 83.18 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.616 0.722 . . . . 0.0 110.819 167.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.85 -36.4 15.19 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.647 2.231 . . . . 0.0 112.327 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 94.7 mtm-85 -73.12 -36.5 66.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.515 HD13 ' HB3' ' A' ' 314' ' ' ASP . 74.3 mt -77.07 -29.98 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.41 91.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.085 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.98 -48.56 73.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.076 175.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 68.9 p -67.58 -26.55 66.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.082 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 63.8 ttp -58.31 -37.28 74.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.866 173.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -67.36 -45.07 77.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.806 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.561 ' HB2' HG11 ' A' ' 246' ' ' VAL . 29.8 t30 -63.49 -36.53 84.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 176.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.428 ' HA ' HG22 ' A' ' 259' ' ' VAL . . . -65.03 -47.56 76.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.032 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -71.48 -34.17 69.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.7 -3.7 42.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.938 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -106.17 -162.25 22.74 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.465 -174.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -143.64 139.93 29.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.838 0.351 . . . . 0.0 110.779 -171.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.587 ' O ' ' C ' ' A' ' 330' ' ' MET . 41.2 mm -81.32 112.78 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.148 -172.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.587 ' C ' ' O ' ' A' ' 329' ' ' ILE . 71.6 mtm . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.583 0.706 . . . . 0.0 110.823 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.87 0.367 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' MET . . . . . 0.491 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 37.6 mmt -62.2 -26.04 68.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 -174.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.5 m -57.92 -36.86 73.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.814 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.59 -36.68 73.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.55 ' O ' HG13 ' A' ' 343' ' ' VAL . 45.5 m-85 -65.25 -44.23 88.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.814 174.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -64.96 -39.25 93.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.925 -176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -67.6 -47.39 69.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.72 -42.42 97.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 339' ' ' PHE . 7.7 m -80.98 -23.08 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.535 ' HD2' ' HD3' ' A' ' 154' ' ' PRO . 57.6 ttt180 -57.41 -56.56 20.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 81.5 p -60.68 -25.69 66.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.066 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -60.08 -41.13 91.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.606 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.5 m -73.11 -32.95 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.061 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 347' ' ' VAL . 1.6 mp -64.05 -45.24 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 173.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -64.35 -36.17 83.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.61 -46.15 60.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.113 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.38 88.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 -175.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 92.8 p -74.98 -10.79 59.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.904 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.4 15.02 81.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.549 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.85 -31.79 45.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.71 0.29 . . . . 0.0 110.761 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -138.25 154.78 49.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.895 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.7 p -79.73 167.53 20.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.184 169.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.439 ' HA ' HD21 ' A' ' 192' ' ' LEU . 55.6 t -54.98 -42.04 61.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -59.11 -46.43 88.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 177.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -71.7 -53.22 14.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.81 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -67.99 -43.75 78.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -171.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.597 HD11 ' HB1' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -67.54 -40.71 84.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 -178.58 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.82 -39.69 93.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 173.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.2 -38.9 90.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.865 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -63.44 -42.24 98.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 173.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.498 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 23.3 tm0? -64.47 -36.83 85.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.052 0.453 . . . . 0.0 110.885 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 370' ' ' LYS . 93.2 m -67.01 -40.44 87.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 177.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -67.51 -35.02 78.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.847 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.552 ' CD1' HG22 ' A' ' 183' ' ' VAL . 62.2 mt -63.38 -40.13 87.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.079 0.466 . . . . 0.0 111.229 176.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.8 p -93.81 -10.92 32.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.174 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 366' ' ' THR . 99.6 mttt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.9 mt -85.9 132.19 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -135.4 143.97 46.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.934 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -55.67 134.13 51.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.448 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 94.94 2.01 62.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.519 -176.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.5 tttt -164.97 138.2 4.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.947 0.403 . . . . 0.0 110.851 174.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.558 HD22 HG12 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -146.68 157.4 43.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.823 -173.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 86.6 t -114.5 133.47 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 -177.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.843 HD11 HD11 ' A' ' 20' ' ' LEU . 1.3 mp -119.28 125.81 74.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.606 ' CE3' ' HG3' ' A' ' 57' ' ' PRO . 45.1 m0 -106.02 128.97 54.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 178.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 12' ' ' ASN . 68.0 mt -122.1 141.45 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.168 172.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.427 ' O ' HG22 ' A' ' 11' ' ' ILE . 65.0 t30 -49.19 141.77 7.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 172.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.519 ' HA3' ' OD2' ' A' ' 41' ' ' ASP . . . -57.72 -11.14 7.32 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 -172.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -71.93 -17.07 62.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 110.868 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -129.92 111.2 12.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 161.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.98 -90.47 0.83 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.504 -159.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -101.71 -41.65 6.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.833 -172.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.791 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 85.2 m-20 -63.56 -53.58 49.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.804 -156.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.733 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -59.86 -48.07 87.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.503 -175.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.843 HD11 HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -55.35 -60.97 2.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.0 110.914 175.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.21 -41.37 60.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -176.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -65.17 -54.24 32.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.65 -35.7 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.444 ' HA3' HG22 ' A' ' 35' ' ' VAL . . . -65.04 -41.88 96.98 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 176.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.01 -41.26 82.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 110.892 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -64.39 -39.62 94.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.26 -45.81 89.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.953 178.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -68.44 -38.97 81.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.806 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.38 -37.05 82.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -82.1 -39.27 23.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -169.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.547 ' OG1' HG13 ' A' ' 33' ' ' ILE . 71.2 p -109.94 -11.17 14.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.178 -174.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.44 14.04 82.59 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.462 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 1.133 HD13 ' O ' ' A' ' 33' ' ' ILE . 2.0 pp -104.82 125.09 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.926 0.393 . . . . 0.0 111.029 -177.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.3 mttt -71.61 135.93 47.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 -168.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.558 HG12 HD22 ' A' ' 7' ' ' LEU . 8.4 m -110.7 135.45 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.046 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.415 ' HB ' HG23 ' A' ' 8' ' ' VAL . 97.7 m -107.62 128.54 54.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.186 176.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.549 HG23 ' HG ' ' A' ' 20' ' ' LEU . 71.0 t -96.76 120.79 46.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.585 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 68.3 mm-40 -130.53 144.62 51.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.841 172.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -156.71 58.61 1.66 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.543 0.687 . . . . 0.0 110.79 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 77.6 Cg_endo -81.84 -13.23 10.6 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.719 2.28 . . . . 0.0 112.382 -171.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.519 ' OD2' ' HA3' ' A' ' 13' ' ' GLY . 20.8 m-20 63.06 20.05 12.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -171.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 45' ' ' GLU . 98.0 mttt -91.06 0.96 57.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 174.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.2 mt -43.69 -50.15 7.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -170.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.16 -36.56 82.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 42' ' ' LYS . 99.1 mt-10 -74.96 -33.17 61.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 69.8 mmtt -82.57 -29.98 29.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.936 -175.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.522 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 11.6 m-30 -40.18 -56.01 3.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.626 0.727 . . . . 0.0 110.783 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 57.3 Cg_endo -69.13 -28.09 28.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.313 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -79.08 -43.62 23.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 -172.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.8 m -65.69 -30.6 50.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.75 -36.04 79.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 172.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.13 -31.25 68.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.966 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 p -93.02 -11.45 33.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.112 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.47 15.27 81.32 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.469 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -164.86 159.05 17.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.953 0.406 . . . . 0.0 110.812 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.7 -140.33 2.85 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.321 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.606 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 72.6 Cg_endo -67.8 148.57 77.33 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.664 2.243 . . . . 0.0 112.354 168.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -74.32 -39.07 63.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.65 ' HB ' HG23 ' A' ' 9' ' ' ILE . 3.7 mp -126.13 138.71 53.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 176.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.475 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 1.8 tp -131.39 130.06 62.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.09 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.524 ' CE2' HG13 ' A' ' 108' ' ' ILE . 4.3 m-85 -98.63 140.31 33.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.785 176.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.536 ' CH2' ' HA3' ' A' ' 265' ' ' GLY . 9.1 m-90 -116.99 140.09 49.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 262' ' ' LEU . . . -57.99 -82.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.129 -176.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -126.41 -58.21 1.35 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.989 166.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -86.11 -24.35 26.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.807 -167.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 97.0 mtt180 -59.87 -29.72 68.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.981 -160.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -68.08 -27.68 66.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.923 -170.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.32 -51.36 53.22 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.434 -172.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.7 -35.91 91.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.537 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.456 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 15.2 t80 -65.68 -38.12 88.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.866 0.365 . . . . 0.0 110.887 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.51 -44.03 58.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.085 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -62.39 -31.78 72.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -80.87 -11.95 59.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.99 176.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.8 32.08 64.24 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.515 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 1.8 mp -86.3 -3.04 58.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.829 0.347 . . . . 0.0 110.862 -172.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.55 ' C ' ' HB3' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -127.85 154.38 45.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 -177.381 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.643 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -73.94 136.86 43.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.127 175.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -71.02 131.37 43.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.903 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.477 HD13 ' CE2' ' A' ' 106' ' ' TYR . 33.6 pt -110.19 159.76 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 70.1 p -105.87 147.6 35.03 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.663 0.744 . . . . 0.0 111.087 -172.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.76 145.78 29.3 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.689 2.259 . . . . 0.0 112.301 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -112.96 112.03 23.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 170.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.58 -37.4 62.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.947 -178.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.95 94.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . 0.559 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 18.6 m-30 -68.8 -49.51 57.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.822 178.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -53.74 -40.08 65.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.913 -176.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -57.69 -32.29 67.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.07 -15.28 54.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 61.8 mt -105.0 -104.95 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -167.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 40.6 t80 -165.23 133.94 2.61 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.675 0.75 . . . . 0.0 110.953 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 71.3 Cg_exo -52.89 -39.91 76.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.748 2.299 . . . . 0.0 112.372 -171.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -80.08 -28.13 39.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.0 m -69.92 -48.31 59.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.086 -167.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.493 ' HA ' HG23 ' A' ' 97' ' ' VAL . 53.8 p-90 -66.96 -28.96 68.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.898 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -70.69 -35.97 73.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.74 -25.9 65.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.525 HG21 HD23 ' A' ' 103' ' ' LEU . 19.8 m -101.27 17.71 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.177 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 67.5 ttt180 -102.56 133.67 47.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.972 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -147.89 130.11 15.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.827 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.6 t30 67.16 35.68 4.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.928 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.78 -4.25 66.09 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.539 174.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -133.96 159.99 39.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.33 . . . . 0.0 110.943 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.525 HD23 HG21 ' A' ' 97' ' ' VAL . 13.8 mt -73.51 144.82 46.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pp -122.17 6.81 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.19 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.693 ' HB2' ' HB3' ' A' ' 263' ' ' SER . . . -167.83 159.3 11.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.051 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.477 ' CE2' HD13 ' A' ' 79' ' ' ILE . 62.1 m-85 -117.25 147.44 40.45 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.689 0.757 . . . . 0.0 110.928 164.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.53 ' HB3' HG11 ' A' ' 261' ' ' VAL . 59.6 Cg_endo -72.36 118.09 5.44 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.666 2.244 . . . . 0.0 112.358 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.524 HG13 ' CE2' ' A' ' 61' ' ' PHE . 30.8 mm -96.29 -36.88 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -151.93 154.67 36.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.083 -176.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.44 134.95 63.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.018 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -118.07 129.76 55.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.432 ' HB1' ' HB ' ' A' ' 320' ' ' THR . . . -150.92 157.12 42.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.113 177.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.645 ' HB2' ' HG3' ' A' ' 257' ' ' PRO . 7.4 mp -108.49 156.92 18.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 -172.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.1 p -150.39 161.19 42.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.929 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.905 HD13 ' O ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.22 124.3 44.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 175.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.727 HG13 HG21 ' A' ' 244' ' ' VAL . 4.6 mp -109.0 132.76 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.072 -174.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -133.08 148.28 52.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 -173.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -97.4 115.91 28.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.806 174.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -66.55 -15.84 63.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.781 172.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.556 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 22.8 t70 -80.87 -33.99 34.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.885 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 mp -87.9 -45.0 10.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.041 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.454 HD23 ' HB2' ' A' ' 223' ' ' ALA . 2.1 mp -106.08 127.62 27.97 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.545 0.688 . . . . 0.0 110.897 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.31 -30.09 16.14 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.732 2.288 . . . . 0.0 112.343 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -148.9 90.0 4.85 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.61 0.719 . . . . 0.0 110.944 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.51 144.97 90.84 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.668 2.245 . . . . 0.0 112.351 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.58 153.31 73.82 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.689 2.26 . . . . 0.0 112.336 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -107.72 -3.96 18.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.847 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.6 p -133.94 159.02 42.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.148 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.44 ' HA ' HG12 ' A' ' 132' ' ' ILE . 64.4 m95 -72.2 -24.65 61.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.4 -30.02 70.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.05 -19.31 60.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.85 -177.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.61 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 49.8 mm -61.49 -53.52 61.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.716 0.769 . . . . 0.0 111.138 -165.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 22.6 Cg_endo -61.7 -40.03 48.91 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.635 2.223 . . . . 0.0 112.276 -176.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.24 -60.67 2.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.065 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 1.185 HD23 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.52 -16.5 63.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.862 -174.462 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.643 ' HA ' HD23 ' A' ' 139' ' ' LEU . 38.7 t70 -61.74 -38.9 89.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.848 168.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.87 -36.44 82.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -73.6 -49.79 24.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.726 -174.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.67 HD21 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -74.97 -15.94 60.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -176.654 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.67 ' N ' HD21 ' A' ' 139' ' ' LEU . 87.8 tttt -56.43 -34.92 67.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.928 171.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.99 -23.75 67.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -94.32 7.99 43.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.95 27.41 64.6 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.415 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.43 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 45.5 mtmt -119.94 169.5 10.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.4 . . . . 0.0 110.863 173.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.535 ' HA ' HD22 ' A' ' 139' ' ' LEU . 33.5 t -133.1 143.95 49.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 172.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 224' ' ' MET . . . -71.98 -54.12 10.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.101 -162.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -139.65 125.47 19.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.948 -165.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 213' ' ' ALA . 57.6 ttm -106.28 129.22 54.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.891 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -154.71 164.24 39.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -122.81 142.92 50.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.942 171.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.5 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 50.8 tp -111.4 -0.13 16.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 -176.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -74.17 -6.04 45.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.936 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -119.73 150.18 49.85 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 121.679 0.752 . . . . 0.0 110.905 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.54 -18.82 64.13 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.632 2.221 . . . . 0.0 112.417 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -61.75 -37.21 83.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.927 -173.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -82.89 -40.17 20.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 23.6 p -63.77 -38.66 91.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.101 -175.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.586 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 22.2 t-105 -62.98 -54.44 46.56 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.567 0.699 . . . . 0.0 110.911 -168.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 28.5 Cg_endo -66.87 -32.19 36.75 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.696 2.264 . . . . 0.0 112.37 -172.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.71 HD21 ' O ' ' A' ' 160' ' ' LEU . 6.4 tt -74.69 -41.04 60.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.55 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 74.4 mt -70.48 -40.89 77.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.109 177.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.96 -26.14 63.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.45 -29.46 70.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.126 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -91.29 2.75 56.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 104.99 7.05 39.05 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.56 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.536 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -79.02 65.06 3.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.359 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -90.22 146.2 24.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.863 0.363 . . . . 0.0 110.911 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.42 -15.35 63.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.063 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -164.42 150.07 10.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.841 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -81.74 128.18 33.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.937 163.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -100.79 120.5 40.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.921 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -149.72 133.2 16.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.881 -173.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 61.9 t30 57.51 43.42 22.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.04 7.25 70.47 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.499 173.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -134.9 145.29 48.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.785 0.326 . . . . 0.0 110.888 -177.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -78.66 143.24 36.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 168.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -107.18 105.98 16.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.8 tp -71.28 -18.03 20.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.14 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -94.61 -8.99 36.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -177.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -129.56 93.05 3.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 172.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.9 m -114.01 167.62 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.128 -175.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.58 13.35 54.09 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.486 -171.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.521 HG11 ' CD1' ' A' ' 368' ' ' ILE . 33.7 m -104.85 -16.91 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.318 . . . . 0.0 111.096 -173.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.43 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 57.9 p-10 -95.09 18.07 12.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.934 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -115.91 172.86 6.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.88 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.21 -26.71 68.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.209 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.11 -41.28 92.68 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.526 -170.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.635 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -65.08 -40.6 94.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 111.02 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.502 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.1 mttt -60.83 -37.1 80.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 173.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.5 87.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.121 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.55 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.72 -46.02 91.06 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.421 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.605 HD11 ' HA ' ' A' ' 347' ' ' VAL . 22.6 tp -68.64 -34.8 76.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.922 0.391 . . . . 0.0 110.993 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.414 ' O ' HG12 ' A' ' 196' ' ' VAL . 85.4 m -61.83 -42.26 98.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -68.07 -56.99 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.681 ' C ' HD12 ' A' ' 195' ' ' LEU . 2.6 pp -63.64 -27.5 69.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 -165.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.56 ' N ' HD12 ' A' ' 195' ' ' LEU . 4.5 p -72.65 -22.85 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.182 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -66.03 -58.22 5.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -174.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 1.04 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.5 -24.25 56.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -167.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.809 ' N ' HD23 ' A' ' 198' ' ' LEU . 2.0 pp -77.46 -35.64 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.15 172.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.02 -30.36 70.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.8 168.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -84.65 5.37 28.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.878 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 66.07 40.06 4.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.94 170.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -82.12 -10.54 59.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.51 ' CG ' HG22 ' A' ' 199' ' ' ILE . 5.4 ppp? -141.08 154.26 45.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.848 175.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -99.0 156.13 17.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.89 -24.88 68.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.132 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.83 -2.59 50.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 88.7 m -64.38 131.49 47.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.227 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -147.23 173.39 12.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.926 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -78.66 -32.09 47.03 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.899 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 99.1 p -74.13 -38.84 63.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -172.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 39.5 pt -65.04 -20.11 26.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.105 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.436 ' HB2' HG22 ' A' ' 225' ' ' THR . . . -58.42 -32.45 68.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.19 -43.53 87.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.834 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.04 -36.82 85.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.147 174.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.1 79.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.065 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -65.08 -42.46 94.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.895 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -64.95 -33.94 77.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.896 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -92.51 -24.36 18.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.05 30.99 21.5 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.568 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -91.83 -31.61 15.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.85 0.357 . . . . 0.0 110.914 -168.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 96.9 m -115.89 127.58 55.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.089 -171.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.454 ' HB2' HD23 ' A' ' 122' ' ' LEU . . . -70.71 -44.97 65.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 -175.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.415 ' N ' ' O ' ' A' ' 146' ' ' ALA . 68.1 mtm -134.05 146.98 50.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 -172.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' THR . . . . . 0.436 HG22 ' HB2' ' A' ' 213' ' ' ALA . 43.3 p -140.01 161.64 37.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 177.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.2 mm -112.4 114.85 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.07 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . 0.464 ' HB2' HD11 ' A' ' 116' ' ' ILE . 63.8 m-80 -145.41 153.32 41.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -171.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.471 ' HA3' ' HG ' ' A' ' 113' ' ' LEU . . . -133.56 -123.3 2.38 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.5 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . 0.41 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 30.2 Cg_endo -61.97 -19.95 67.78 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.766 2.311 . . . . 0.0 112.269 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -65.19 -30.08 70.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.925 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 51.12 38.3 20.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.078 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -70.02 -27.87 65.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.046 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 72.7 m -53.22 117.95 3.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.86 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -74.86 -169.05 0.82 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 20.4 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 -178.442 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 240' ' ' VAL . 15.8 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.877 0.37 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.556 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 74.6 m-20 42.12 70.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -126.0 132.8 51.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 -172.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.97 158.33 24.17 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.508 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.727 HG21 HG13 ' A' ' 116' ' ' ILE . 3.2 p -145.46 139.94 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 0.0 111.156 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.0 t -155.37 151.82 28.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.075 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . 0.498 HG11 ' HB2' ' A' ' 323' ' ' ASN . 28.2 m -62.3 168.4 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.096 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.762 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.7 mm? -61.81 143.37 94.28 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.644 0.735 . . . . 0.0 110.921 -162.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.56 -176.52 3.17 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.649 2.233 . . . . 0.0 112.457 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 95.2 m -100.41 146.33 27.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.14 -171.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -139.02 119.12 13.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 54.97 37.13 28.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.96 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.09 -0.46 83.96 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -130.96 140.09 37.62 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.588 0.709 . . . . 0.0 110.914 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -70.93 141.23 39.98 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.669 2.246 . . . . 0.0 112.412 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.762 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 82.7 p -82.39 -3.47 55.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 172.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -40.48 129.69 1.77 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.555 0.693 . . . . 0.0 110.894 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.645 ' HG3' ' HB2' ' A' ' 113' ' ' LEU . 85.8 Cg_endo -86.32 164.82 9.67 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.731 2.287 . . . . 0.0 112.446 -171.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -75.0 169.96 16.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.863 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.14 132.29 57.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.114 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.52 143.9 16.23 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.458 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.53 HG11 ' HB3' ' A' ' 107' ' ' PRO . 97.9 t -128.66 126.51 65.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.986 0.422 . . . . 0.0 111.081 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 2.0 tt -71.86 136.34 46.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 171.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.693 ' HB3' ' HB2' ' A' ' 105' ' ' ALA . 74.7 m -118.9 148.97 42.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -174.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.483 ' HB2' HD11 ' A' ' 280' ' ' LEU . . . -133.78 137.53 45.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 174.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.536 ' HA3' ' CH2' ' A' ' 62' ' ' TRP . . . -140.76 170.14 24.61 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.549 -173.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 22.7 mm -114.22 132.37 63.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 111.136 -171.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -65.04 133.8 52.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -172.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.643 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -63.0 -29.79 71.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.115 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.38 -8.11 59.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.038 -172.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 24.2 t -69.98 120.14 75.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.698 0.761 . . . . 0.0 110.848 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.42 -16.23 19.41 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.733 2.289 . . . . 0.0 112.362 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.422 ' HB2' HD22 ' A' ' 275' ' ' LEU . 53.2 p-10 -114.16 29.97 7.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -177.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -61.48 -24.55 66.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 -169.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -63.65 -45.58 89.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.851 -169.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 272' ' ' ASN . 2.2 pp -75.8 -33.28 60.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -178.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.426 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -65.8 -50.24 65.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.056 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -65.95 -36.48 83.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.868 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -68.98 -45.36 70.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -59.08 -47.12 86.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.93 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 264' ' ' ALA . 8.0 tt -59.54 -52.24 66.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.889 -175.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -73.99 -25.72 60.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.953 -174.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -99.74 -14.18 18.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.942 -170.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.489 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 44.6 t80 -122.2 -56.54 1.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.4 OUTLIER -68.58 -39.69 80.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.854 -176.264 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.84 23.03 0.57 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 174.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 89.1 m -128.51 147.61 50.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.206 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.507 ' HA ' HD11 ' A' ' 290' ' ' LEU . 37.4 t70 -40.78 -38.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.774 -176.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.27 -42.57 68.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.856 -173.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.51 -52.03 8.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.445 -171.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.678 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -73.41 -21.97 60.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.815 0.34 . . . . 0.0 110.952 -177.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.487 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.4 tt0 -66.71 -42.69 85.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 169.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.93 -35.94 81.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.003 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.733 HG13 ' HA3' ' A' ' 19' ' ' GLY . 42.3 t -75.78 -44.27 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.166 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -65.05 -31.81 73.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.787 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.97 -32.2 72.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.932 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.791 ' HB3' ' HB3' ' A' ' 18' ' ' ASN . 63.7 m-20 -95.02 -29.64 14.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.834 -173.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.439 ' O ' HD13 ' A' ' 299' ' ' LEU . 77.3 tttt -146.1 135.47 11.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.626 0.727 . . . . 0.0 110.854 164.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.27 116.78 3.18 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.667 2.245 . . . . 0.0 112.33 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -90.08 -22.57 21.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 174.829 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.95 -55.79 1.85 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.531 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.441 ' HA ' HD21 ' A' ' 311' ' ' LEU . . . -177.71 161.87 1.7 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.868 0.366 . . . . 0.0 111.191 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.601 ' CG2' ' HB3' ' A' ' 307' ' ' TYR . 33.8 m -128.57 159.93 39.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.153 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.46 -2.07 30.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.678 ' CD2' HD22 ' A' ' 290' ' ' LEU . 60.3 tp -87.94 130.38 34.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 -175.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -44.55 -32.42 1.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.478 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 74.4 m -48.16 -39.2 20.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.601 ' HB3' ' CG2' ' A' ' 302' ' ' VAL . 0.1 OUTLIER -58.93 -45.41 90.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 173.477 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.463 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 84.4 tt0 -54.63 -34.34 61.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.808 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -79.85 -63.3 1.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.8 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -82.71 -58.27 2.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -170.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 311' ' ' LEU . 0.0 OUTLIER -60.14 -36.63 77.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -170.562 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.98 -14.42 53.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.41 -20.46 65.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.505 ' HB3' HD13 ' A' ' 317' ' ' ILE . 60.3 t0 -79.61 120.7 81.05 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.609 0.719 . . . . 0.0 110.921 167.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.68 -35.42 13.02 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.656 2.237 . . . . 0.0 112.351 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -70.81 -36.99 73.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.875 -176.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.505 HD13 ' HB3' ' A' ' 314' ' ' ASP . 70.7 mt -78.46 -30.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.182 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.48 -39.59 91.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.102 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.98 -47.24 78.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.118 174.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' THR . . . . . 0.432 ' HB ' ' HB1' ' A' ' 112' ' ' ALA . 74.1 p -67.55 -25.17 65.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.188 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -62.05 -38.03 87.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 174.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -65.02 -47.05 78.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.821 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.498 ' HB2' HG11 ' A' ' 246' ' ' VAL . 36.9 t30 -63.47 -38.17 90.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.73 -46.94 85.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.095 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -72.82 -30.98 64.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.37 -4.38 42.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.924 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -101.74 -161.78 26.88 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.465 -172.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -143.37 140.58 30.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.361 . . . . 0.0 110.825 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.584 ' O ' ' C ' ' A' ' 330' ' ' MET . 44.9 mm -82.51 106.63 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.17 -169.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.584 ' C ' ' O ' ' A' ' 329' ' ' ILE . 63.3 tpp . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 121.636 0.731 . . . . 0.0 110.874 175.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.8 0.333 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 22.8 mmt -77.9 -26.05 48.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 -175.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 62.1 p -65.27 -27.31 68.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.876 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -76.21 -36.06 58.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.168 173.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.408 ' N ' ' CD1' ' A' ' 339' ' ' PHE . 7.8 m-30 -61.16 -37.82 84.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.827 170.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -62.62 -32.7 73.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.021 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -72.87 -40.52 65.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.92 -40.08 91.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.106 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.46 ' O ' ' HB1' ' A' ' 346' ' ' ALA . 13.2 m -80.33 -24.01 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.142 177.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.564 ' O ' HG23 ' A' ' 347' ' ' VAL . 1.1 tmt_? -59.92 -50.24 74.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 171.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 56.1 m -57.88 -29.94 65.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.084 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 343' ' ' VAL . . . -56.33 -39.3 72.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.605 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.0 OUTLIER -72.6 -32.66 42.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 -176.402 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.35 -46.78 92.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.077 172.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -63.2 -34.66 78.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.98 -45.72 59.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.58 -40.51 88.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.155 -175.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.1 p -75.05 -12.08 60.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 110.891 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.16 14.95 82.06 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.579 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.27 -32.43 49.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.815 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -136.77 153.88 50.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.959 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.6 p -79.47 167.82 20.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.192 169.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.455 ' HA ' HD21 ' A' ' 192' ' ' LEU . 54.4 t -55.12 -41.99 62.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 172.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.35 -45.95 89.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.828 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -72.25 -53.18 13.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.831 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.11 -44.65 75.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.031 -171.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.635 HD11 ' HB1' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -66.98 -40.53 87.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.969 -178.142 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.98 -40.45 94.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.954 174.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.38 -39.72 94.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.75 98.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.43 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 16.8 tm0? -63.26 -38.44 91.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.958 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.9 m -65.01 -38.56 91.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.102 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 79.4 mtt-85 -67.25 -35.67 80.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.84 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.521 ' CD1' HG11 ' A' ' 183' ' ' VAL . 73.8 mt -66.47 -45.05 90.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.127 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 71.1 p -99.02 -8.63 25.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.158 -174.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.956 176.27 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.0 mt -82.82 129.93 36.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.159 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.44 143.48 43.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -56.35 134.98 53.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.592 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 97.61 -1.62 60.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.465 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 65.0 pttt -165.3 144.09 6.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.783 0.325 . . . . 0.0 110.902 172.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.545 HD23 HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -148.49 159.97 43.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.792 -175.019 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.417 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 90.3 t -113.78 132.94 61.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.161 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.833 HD11 HD11 ' A' ' 20' ' ' LEU . 1.2 mp -119.32 124.97 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.081 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.582 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 44.2 m0 -104.62 127.1 52.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.894 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -119.4 141.75 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.146 172.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -51.36 147.52 5.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.47 -12.8 9.69 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.501 -172.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -75.17 -17.05 60.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.856 0.36 . . . . 0.0 110.813 -174.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.1 mtmm -129.94 110.09 11.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 163.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.09 -91.53 0.81 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.443 -160.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -101.81 -42.37 6.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 110.856 -171.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . 0.777 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 86.0 m-20 -61.86 -52.08 65.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.843 -157.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.763 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -61.99 -48.55 82.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.516 -175.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.833 HD11 HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -56.52 -61.2 2.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.879 0.371 . . . . 0.0 110.922 177.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.66 -41.38 70.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 -174.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -65.05 -53.11 50.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -176.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 19' ' ' GLY . 18.7 m -74.89 -38.06 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.162 -175.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.633 ' HA3' HG22 ' A' ' 35' ' ' VAL . . . -65.12 -42.47 96.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.527 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.34 -41.33 88.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 110.927 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -63.21 -39.6 95.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.853 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -66.18 -36.95 84.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.839 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -62.12 -39.91 94.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 172.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -67.82 -33.98 75.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.911 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -86.76 -41.78 13.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -170.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.631 ' OG1' HG13 ' A' ' 33' ' ' ILE . 77.0 p -106.8 -14.86 14.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.212 -174.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.75 8.93 83.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.503 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.964 HD13 ' O ' ' A' ' 33' ' ' ILE . 2.2 pp -106.35 130.41 58.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 111.093 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.9 mttt -75.95 139.78 41.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -171.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.633 HG22 ' HA3' ' A' ' 24' ' ' GLY . 5.8 m -112.36 135.81 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.41 ' O ' HD13 ' A' ' 9' ' ' ILE . 99.3 m -105.93 128.31 53.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.083 176.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.549 HG23 ' HG ' ' A' ' 20' ' ' LEU . 80.9 t -96.57 120.0 45.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.105 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.582 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 68.3 mm-40 -130.31 145.2 51.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.891 171.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -156.1 58.3 1.71 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.599 0.714 . . . . 0.0 110.87 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.95 -27.43 5.8 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.762 2.308 . . . . 0.0 112.343 -172.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.0 t0 68.87 13.19 8.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.863 -167.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 45' ' ' GLU . 99.1 mttt -87.84 1.56 53.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.988 171.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.3 mt -44.37 -50.14 9.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.948 -168.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.9 -27.56 67.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 42' ' ' LYS . 98.3 mt-10 -79.01 -32.45 45.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.882 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 67.9 mmtt -81.84 -29.27 32.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.868 -174.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.548 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 14.4 m-30 -45.26 -54.4 14.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.635 0.731 . . . . 0.0 110.852 -175.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 53.1 Cg_endo -66.4 -27.3 47.3 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.656 2.237 . . . . 0.0 112.336 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -79.4 -42.98 24.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.915 -175.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.3 m -71.62 -28.03 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.106 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.23 -35.2 79.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.109 171.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.35 -31.99 71.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.132 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.9 p -92.47 -12.11 32.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.96 14.97 81.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.609 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -161.9 157.14 23.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.891 0.377 . . . . 0.0 110.842 176.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.44 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . -165.04 -141.08 3.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.437 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.558 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 69.9 Cg_endo -66.97 149.78 82.87 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.622 2.214 . . . . 0.0 112.376 169.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -75.49 -38.45 59.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.574 ' HB ' HG23 ' A' ' 9' ' ' ILE . 4.1 mp -126.61 138.82 53.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 177.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.543 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 2.2 tp -133.35 131.56 57.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.117 -178.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.513 ' CE2' HG13 ' A' ' 108' ' ' ILE . 3.1 m-85 -99.36 139.69 34.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.769 177.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.647 ' HH2' ' HA3' ' A' ' 265' ' ' GLY . 3.4 m-90 -120.06 140.09 51.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.829 174.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.49 -85.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.06 -178.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -116.26 -62.99 1.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.834 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -85.41 -30.46 23.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -167.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -62.1 -31.58 72.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.935 -158.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -67.77 -29.29 68.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -172.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.22 -52.33 41.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.439 -174.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.14 -39.93 98.55 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.507 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.561 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 28.8 t80 -66.08 -41.38 90.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 110.891 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.08 -44.29 63.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.096 176.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -55.02 -39.9 69.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.893 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.2 m -82.53 -8.12 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.65 35.06 59.31 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.519 174.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 mp -84.99 -2.16 57.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 0.0 110.907 -173.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.561 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -128.67 154.55 46.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -178.178 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.64 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -70.93 134.38 47.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 175.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -71.18 131.09 43.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.453 HD13 ' CE2' ' A' ' 106' ' ' TYR . 29.3 pt -110.12 160.0 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.99 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.2 p -105.17 148.34 36.04 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.565 0.697 . . . . 0.0 111.127 -172.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.15 142.66 31.07 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.774 2.316 . . . . 0.0 112.362 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -103.44 120.3 40.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 172.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.67 -38.67 69.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.47 91.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -72.87 -35.29 67.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.853 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -54.58 -46.72 73.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.84 176.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -65.83 -34.59 78.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.819 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -78.63 -24.01 45.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 -174.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -95.01 -96.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.957 -171.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.448 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 36.9 t80 -176.31 137.75 0.48 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.718 0.771 . . . . 0.0 110.833 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 86.9 Cg_exo -53.42 -39.28 82.35 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.331 -172.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -79.3 -30.27 42.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.448 ' OG1' ' HB3' ' A' ' 90' ' ' TYR . 55.7 m -70.0 -49.35 52.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.204 -165.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.445 ' HA ' HG23 ' A' ' 97' ' ' VAL . 51.7 p-90 -64.32 -29.98 71.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.46 -35.35 68.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.886 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.32 -25.01 64.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.756 ' HB ' ' HB1' ' A' ' 105' ' ' ALA . 19.6 m -101.8 17.92 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.172 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 63.7 ttt180 -101.13 133.3 45.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.957 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -144.25 129.45 18.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.4 t30 65.01 35.27 8.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.88 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.94 -4.77 73.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.476 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -132.55 158.59 41.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.816 0.341 . . . . 0.0 110.897 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.543 HD23 HG21 ' A' ' 97' ' ' VAL . 13.9 mt -72.98 147.52 45.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.1 pp -125.21 10.34 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.147 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.776 ' HB2' ' HB2' ' A' ' 263' ' ' SER . . . -163.26 151.32 13.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.041 -176.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.475 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 45.1 m-85 -115.02 136.28 22.58 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.659 0.742 . . . . 0.0 110.919 163.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 40.0 Cg_exo -60.23 118.17 5.01 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.664 2.243 . . . . 0.0 112.393 177.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.513 HG13 ' CE2' ' A' ' 61' ' ' PHE . 30.6 mm -99.38 -41.63 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.184 177.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -152.95 152.56 31.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.133 -175.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.7 p -123.91 134.18 67.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.082 -175.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.06 128.73 54.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.802 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.09 153.96 37.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.092 172.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.499 HD23 ' HG3' ' A' ' 257' ' ' PRO . 8.0 mp -104.72 158.87 16.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.86 -169.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.2 p -150.45 156.49 41.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.937 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.864 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -100.06 125.9 46.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 176.193 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.593 ' N ' HD23 ' A' ' 115' ' ' LEU . 3.7 mp -106.03 135.33 44.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 -175.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -136.7 149.89 48.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -92.95 119.83 32.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.793 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -67.47 -18.65 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 167.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 20.3 t70 -75.28 -32.42 61.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.908 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.2 mp -93.25 -44.98 8.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.965 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 21.6 mt -104.42 113.63 64.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.599 0.714 . . . . 0.0 110.872 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.84 -26.64 31.98 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.702 2.268 . . . . 0.0 112.378 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 56.5 t-20 -149.57 94.99 3.8 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.56 0.695 . . . . 0.0 110.871 172.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 37.8 Cg_endo -69.14 151.03 72.64 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 0.0 112.237 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.86 151.62 62.94 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.691 2.26 . . . . 0.0 112.33 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -108.54 -8.6 15.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.937 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 72.3 p -132.21 159.01 40.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -65.25 -31.35 72.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.03 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.85 -27.83 67.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.81 -12.7 59.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.631 ' O ' HD13 ' A' ' 135' ' ' LEU . 49.4 mm -64.98 -53.07 44.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.679 0.752 . . . . 0.0 111.19 -172.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 30.1 Cg_endo -61.74 -37.21 69.56 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.635 2.223 . . . . 0.0 112.347 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.65 -61.31 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.018 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 1.186 HD23 ' C ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -71.16 -18.34 62.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 -177.258 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.588 ' HA ' HD23 ' A' ' 139' ' ' LEU . 38.9 t70 -63.6 -40.94 98.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 169.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.85 -38.16 89.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.93 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.6 -50.66 23.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.631 HD21 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -75.73 -16.53 60.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.937 -175.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.631 ' N ' HD21 ' A' ' 139' ' ' LEU . 87.2 tttt -56.96 -34.41 68.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.97 172.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.78 -23.68 67.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -95.19 10.22 36.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.769 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.97 30.1 59.8 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.515 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.466 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 90.7 mttt -120.06 169.57 10.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 110.796 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.0 t -132.39 138.52 47.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 136' ' ' ASP . . . -71.75 -53.87 12.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 -165.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -137.36 131.72 32.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 -164.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' MET . . . . . 0.677 ' HG2' ' HB3' ' A' ' 213' ' ' ALA . 60.3 tpp -105.04 120.1 40.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -153.28 164.97 37.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -174.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -131.66 167.19 19.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 168.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.8 tp -116.26 -23.2 8.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -70.37 -4.07 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.851 -168.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -110.39 152.12 43.09 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.681 0.753 . . . . 0.0 110.819 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . 0.542 ' HD3' ' NE ' ' A' ' 344' ' ' ARG . 29.9 Cg_endo -67.55 -20.89 46.92 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.633 2.222 . . . . 0.0 112.304 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -59.19 -39.07 81.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.907 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -83.24 -42.97 16.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.786 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 41.9 p -65.37 -39.86 92.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.096 -170.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.578 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 17.5 t-105 -64.31 -53.86 43.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.589 0.709 . . . . 0.0 110.959 -169.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 36.2 Cg_endo -68.91 -32.24 22.77 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.596 2.198 . . . . 0.0 112.394 -172.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.725 HD21 ' O ' ' A' ' 160' ' ' LEU . 6.4 tt -72.74 -40.75 65.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.577 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 72.1 mt -69.77 -41.44 79.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.78 -27.67 63.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.034 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.56 -31.41 71.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -92.38 3.79 54.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 107.89 3.95 34.03 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.507 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.415 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -79.6 66.22 3.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.427 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . 0.441 ' O ' HG13 ' A' ' 183' ' ' VAL . 80.8 m-85 -90.02 145.41 25.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.853 0.359 . . . . 0.0 110.911 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.96 0.41 15.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.987 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -154.67 151.74 29.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.86 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -100.38 129.99 46.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.822 159.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -92.42 123.75 35.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -151.3 131.29 13.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.908 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.0 t30 57.57 43.6 22.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 171.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.65 77.41 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.54 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.88 144.26 47.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.877 -176.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -80.79 133.68 35.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 167.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -99.57 114.33 27.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.1 tp -72.91 -20.05 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.12 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.0 -10.25 36.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.908 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -127.57 95.02 4.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 169.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.4 m -112.01 163.11 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.1 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -97.64 13.29 64.17 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.486 -171.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.733 HG22 HD13 ' A' ' 368' ' ' ILE . 35.4 m -106.97 -13.43 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 111.058 -176.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -89.17 15.34 9.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -127.26 -171.27 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.26 -25.98 64.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.2 -173.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.93 -43.6 95.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.552 -167.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.733 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -67.57 -38.48 84.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 0.0 111.049 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.502 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.3 mttt -60.23 -35.29 75.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 174.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.29 -38.04 89.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.207 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -65.02 -45.75 91.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.365 177.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.619 HD11 ' HA ' ' A' ' 347' ' ' VAL . 17.8 tp -69.9 -32.99 71.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 0.0 110.964 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.46 ' O ' HG12 ' A' ' 196' ' ' VAL . 79.1 m -64.69 -42.11 95.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.169 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -70.55 -54.69 11.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.652 ' C ' HD12 ' A' ' 195' ' ' LEU . 3.6 pp -63.67 -23.91 67.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.989 -167.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.591 ' N ' HD12 ' A' ' 195' ' ' LEU . 1.2 p -74.54 -24.08 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.157 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.78 -55.41 19.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.837 -172.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 1.013 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.74 -24.6 56.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.943 -168.044 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.773 ' N ' HD23 ' A' ' 198' ' ' LEU . 2.0 pp -81.73 -33.88 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.077 173.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -65.26 -31.08 72.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -84.15 4.33 30.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.897 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 64.94 39.73 5.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.923 172.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -80.15 -11.71 59.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 174.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' MET . . . . . 0.438 ' CG ' HG22 ' A' ' 199' ' ' ILE . 5.3 ppp? -142.95 154.54 44.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.81 174.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -101.25 157.12 17.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.96 -28.37 70.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -97.44 -0.01 46.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.7 m -59.25 131.78 52.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.419 ' H ' HD12 ' A' ' 212' ' ' ILE . 23.1 t0 -144.17 171.55 14.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -82.42 -29.67 30.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.8 p -70.66 -38.54 73.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.925 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.419 HD12 ' H ' ' A' ' 209' ' ' ASP . 40.7 pt -67.48 -24.52 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.148 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . 0.677 ' HB3' ' HG2' ' A' ' 148' ' ' MET . . . -59.68 -37.44 78.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 -177.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -57.74 -40.66 80.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.0 93.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.52 91.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.153 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -65.55 -33.9 77.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.78 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.43 -31.97 70.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.01 -18.44 22.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.914 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.63 29.04 22.56 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.477 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -92.03 -27.02 18.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 110.889 -171.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 98.3 m -111.02 125.03 53.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.167 -176.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.28 -49.43 23.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.173 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.414 ' N ' ' O ' ' A' ' 146' ' ' ALA . 66.3 mtm -134.98 155.45 50.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -171.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.7 t -153.02 166.26 32.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.111 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 40.3 mm -113.49 124.03 69.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -142.29 153.16 43.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.824 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -135.0 -95.03 0.49 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.446 175.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.97 -24.02 24.62 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.759 2.306 . . . . 0.0 112.239 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -74.75 -37.79 62.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.872 -173.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 49.72 40.3 19.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 -175.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -70.76 -22.99 62.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.4 t -51.37 130.8 27.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.907 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -87.7 -167.78 2.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.95 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.7 mt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 -174.704 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.531 ' O ' HG12 ' A' ' 240' ' ' VAL . 14.9 t . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.911 0.386 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 74.4 m-20 42.31 69.97 0.33 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -127.09 133.07 50.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -174.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -133.69 155.09 21.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.446 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.409 HG21 HG13 ' A' ' 116' ' ' ILE . 3.4 p -145.61 138.97 21.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.907 0.384 . . . . 0.0 111.113 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -155.64 152.61 28.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.116 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.8 m -60.81 168.45 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.689 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.5 mm? -61.12 150.74 77.97 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.658 0.742 . . . . 0.0 110.907 -162.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.48 -178.23 4.44 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.631 2.221 . . . . 0.0 112.293 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.5 m -98.37 142.24 30.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.12 -174.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -132.84 114.87 14.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.825 -176.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 54.91 36.52 26.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.99 2.74 88.24 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.613 174.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -130.71 138.1 32.26 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.618 0.723 . . . . 0.0 110.954 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -68.5 137.45 39.45 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.706 2.271 . . . . 0.0 112.389 -174.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.689 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 98.8 p -79.19 -8.12 58.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.823 174.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -49.99 116.6 6.53 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.475 0.655 . . . . 0.0 110.888 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . 0.499 ' HG3' HD23 ' A' ' 113' ' ' LEU . 72.5 Cg_endo -80.44 167.75 18.88 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.689 2.259 . . . . 0.0 112.264 -176.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -66.89 169.89 7.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 80.5 t -106.86 133.16 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.089 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.5 139.6 15.22 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.551 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 97.5 t -125.6 120.07 56.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.916 0.388 . . . . 0.0 111.1 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.421 HD22 ' HB3' ' A' ' 61' ' ' PHE . 7.3 tt -78.98 129.13 34.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.989 168.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.776 ' HB2' ' HB2' ' A' ' 105' ' ' ALA . 96.5 p -132.39 160.76 35.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -170.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.62 143.04 50.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -175.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.647 ' HA3' ' HH2' ' A' ' 62' ' ' TRP . . . -139.64 172.53 23.27 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.47 -175.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 23.3 mm -113.53 131.0 66.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.847 0.356 . . . . 0.0 111.191 -171.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -65.28 133.59 51.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 -173.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.64 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -64.94 -27.2 68.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 -177.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.46 -8.58 59.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.996 -173.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.5 t -69.14 121.66 82.63 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.648 0.737 . . . . 0.0 110.948 -175.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.19 -17.79 18.86 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.311 172.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -112.05 29.29 8.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.963 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.02 -25.38 65.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -170.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -64.99 -43.38 92.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.822 -169.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.0 pp -76.93 -33.4 57.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.989 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.31 77.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.989 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -66.64 -35.01 79.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.921 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -69.4 -48.94 59.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.903 -173.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 0.6 OUTLIER -67.5 -31.24 71.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.922 -175.16 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 6.2 tt -64.61 -46.39 82.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.945 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -79.3 -24.88 42.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.887 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -97.61 -20.01 17.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.949 -168.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -119.97 -56.49 2.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.952 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 0.1 OUTLIER -65.68 -41.28 92.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.911 -176.085 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.66 48.21 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.922 169.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.44 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 74.2 m -145.52 146.69 31.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.112 173.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.446 ' HA ' HD11 ' A' ' 290' ' ' LEU . 35.8 t70 -40.0 -39.77 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.907 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.0 -41.69 64.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -172.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.83 -51.18 16.02 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.534 -172.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.7 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -75.49 -22.99 56.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.717 0.294 . . . . 0.0 110.89 -177.562 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.441 ' N ' HD12 ' A' ' 290' ' ' LEU . 86.6 tt0 -67.11 -40.6 86.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 169.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.95 -35.06 79.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.015 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.763 HG13 ' HA3' ' A' ' 19' ' ' GLY . 47.3 t -74.86 -43.68 46.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.14 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -63.28 -31.14 72.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.24 -32.34 73.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.807 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . 0.777 ' HB3' ' HB3' ' A' ' 18' ' ' ASN . 67.0 m-20 -94.99 -27.32 15.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 -173.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.41 ' O ' HD13 ' A' ' 299' ' ' LEU . 78.5 tttt -148.1 136.7 11.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.556 0.694 . . . . 0.0 110.857 168.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.33 111.87 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.687 2.258 . . . . 0.0 112.35 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 297' ' ' LYS . 0.4 OUTLIER -90.08 -28.58 18.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 174.697 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.06 -55.08 1.84 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.49 -176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.447 ' HA ' HD21 ' A' ' 311' ' ' LEU . . . -179.37 159.27 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.79 0.329 . . . . 0.0 111.067 -176.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.596 HG21 ' HB3' ' A' ' 307' ' ' TYR . 32.6 m -127.02 164.67 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.135 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -79.1 -4.22 49.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.066 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.7 ' CD2' HD22 ' A' ' 290' ' ' LEU . 58.9 tp -86.12 135.64 33.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.751 -172.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -47.3 -31.79 4.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.513 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 70.8 m -47.85 -39.99 20.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.843 173.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.596 ' HB3' HG21 ' A' ' 302' ' ' VAL . 0.0 OUTLIER -63.37 -46.1 88.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 173.556 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 32.9 tt0 -54.54 -36.78 64.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.736 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -80.76 -61.77 1.87 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.804 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -83.02 -58.3 2.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.938 -168.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 307' ' ' TYR . 0.0 OUTLIER -60.38 -36.44 78.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 -171.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.06 -14.97 58.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.077 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.26 -22.0 66.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.892 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.463 ' HB3' HD13 ' A' ' 317' ' ' ILE . 62.9 t0 -78.25 119.59 77.91 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.584 0.707 . . . . 0.0 110.938 167.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -45.65 -35.24 12.65 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.638 2.225 . . . . 0.0 112.323 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 -69.65 -37.54 76.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -176.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.463 HD13 ' HB3' ' A' ' 314' ' ' ASP . 66.0 mt -79.9 -29.91 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.087 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.63 -39.9 85.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.091 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.18 -47.27 74.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 174.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 78.9 p -65.07 -24.98 67.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.057 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 65.6 ttp -63.51 -40.57 97.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.937 174.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -65.01 -42.54 94.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.774 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -58.77 -44.64 90.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.928 173.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.91 90.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.052 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.84 -34.98 77.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.929 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -101.07 -3.73 28.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.939 -174.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -95.11 -163.59 34.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.43 -173.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.9 137.24 33.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.841 0.353 . . . . 0.0 110.835 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.59 ' O ' ' C ' ' A' ' 330' ' ' MET . 35.6 mm -81.06 109.83 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.191 -170.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.59 ' C ' ' O ' ' A' ' 329' ' ' ILE . 6.9 tpt . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 121.565 0.698 . . . . 0.0 110.899 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.775 0.322 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 17.4 mmt -74.6 -24.58 58.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.789 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.9 m -61.89 -33.71 74.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.879 177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.65 -35.72 67.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.167 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -64.25 -35.22 80.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 172.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . 0.418 ' HA ' HG23 ' A' ' 343' ' ' VAL . 52.5 m0 -63.86 -31.12 72.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 174.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -73.64 -37.07 65.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.08 96.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.133 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 340' ' ' TRP . 10.1 m -80.88 -23.44 10.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.137 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.542 ' NE ' ' HD3' ' A' ' 154' ' ' PRO . 64.9 ttt180 -57.43 -53.17 61.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 172.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 67.4 p -62.52 -25.96 68.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.141 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -58.21 -39.0 77.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.085 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.619 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.2 m -73.1 -31.86 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.194 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.39 -44.85 97.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.152 173.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -64.95 -34.96 79.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.86 -45.12 62.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.82 -39.56 87.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.129 -175.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.2 p -75.88 -12.81 60.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.799 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.2 14.86 82.13 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.588 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.52 -32.2 47.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.741 0.305 . . . . 0.0 110.873 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -136.4 153.68 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 46.0 p -79.85 167.65 20.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.133 170.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.441 ' HA ' HD21 ' A' ' 192' ' ' LEU . 53.8 t -55.4 -41.58 63.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.12 172.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -59.56 -45.03 93.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.929 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -72.84 -53.91 10.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.2 76.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.091 -171.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.733 HD11 ' HB1' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -67.08 -40.36 86.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.905 -178.105 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.09 -40.19 94.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.88 -39.91 93.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -63.39 -42.87 98.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 175.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -62.8 -39.05 93.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.821 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.4 m -64.38 -38.62 91.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.121 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -68.69 -35.11 76.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.733 HD13 HG22 ' A' ' 183' ' ' VAL . 75.2 mt -67.32 -45.32 86.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.099 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.6 p -101.71 -14.01 17.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.97 -179.558 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.71 0.291 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.55 131.81 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.095 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -135.59 144.27 46.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.937 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -56.14 135.14 53.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLY . . . . . 0.499 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 98.32 -1.85 59.06 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.492 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.3 tttt -166.29 137.34 3.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 174.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LEU . . . . . 0.624 HD23 HD11 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -143.48 157.54 44.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 -172.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.441 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 86.4 t -113.45 132.34 62.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.116 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.849 ' HB ' HD22 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -119.95 127.41 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.062 -178.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' TRP . . . . . 0.583 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 44.8 m0 -106.16 129.47 54.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 12' ' ' ASN . 60.7 mt -122.21 140.54 45.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.137 170.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.437 ' O ' HG22 ' A' ' 11' ' ' ILE . 64.2 t30 -50.15 141.74 10.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.906 172.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.411 ' HA3' ' OD2' ' A' ' 41' ' ' ASP . . . -58.06 -11.34 8.63 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.43 -172.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -73.32 -14.39 61.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.873 0.368 . . . . 0.0 110.923 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -136.94 109.99 7.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.957 158.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.36 -91.09 0.84 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.413 -154.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -104.7 -47.49 4.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.857 0.361 . . . . 0.0 110.849 -167.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -66.53 -46.86 74.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 -156.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.69 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -58.13 -47.06 91.6 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.512 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.849 HD22 ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -55.65 -60.97 2.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.792 0.329 . . . . 0.0 110.898 173.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.04 -39.28 55.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 -177.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -64.58 -52.83 55.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.3 m -75.69 -35.4 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.183 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.716 ' HA3' HG22 ' A' ' 35' ' ' VAL . . . -65.38 -44.57 93.13 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.481 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.67 -36.46 78.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.802 0.334 . . . . 0.0 110.832 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -61.6 -39.84 92.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.868 173.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PHE . . . . . 0.459 ' CD2' HD12 ' A' ' 33' ' ' ILE . 1.3 t80 -61.32 -44.82 96.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.0 -38.99 93.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.848 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.27 -31.85 73.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.13 -43.77 15.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -172.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . 0.536 ' OG1' HG13 ' A' ' 33' ' ' ILE . 53.8 p -113.85 -11.63 12.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.183 -171.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.87 14.0 81.46 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 1.152 HD13 ' O ' ' A' ' 33' ' ' ILE . 1.8 pp -104.55 126.83 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 0.0 111.137 -176.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.6 mttt -75.77 141.53 42.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -171.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.716 HG22 ' HA3' ' A' ' 24' ' ' GLY . 2.9 m -114.99 135.97 53.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.081 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . 0.441 ' O ' HD13 ' A' ' 9' ' ' ILE . 99.0 m -105.29 128.1 53.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.045 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . 0.535 HG23 ' HG ' ' A' ' 20' ' ' LEU . 58.4 t -96.24 121.38 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.145 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.583 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 69.2 mm-40 -130.09 144.61 51.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.837 172.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -156.82 58.78 1.68 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.585 0.707 . . . . 0.0 110.867 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 73.5 Cg_endo -80.71 -12.91 12.12 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.686 2.257 . . . . 0.0 112.296 -170.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 26.2 m-20 63.59 19.96 11.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -171.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 45' ' ' GLU . 98.6 mttt -93.67 0.25 56.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.966 174.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.1 mt -45.77 -51.77 12.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.951 -166.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.67 -26.53 66.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.95 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 42' ' ' LYS . 98.4 mt-10 -78.68 -33.1 47.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.993 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 69.0 mmtt -82.72 -30.22 29.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.9 -174.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' PHE . . . . . 0.519 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 14.1 m-30 -40.72 -56.07 4.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.637 0.732 . . . . 0.0 110.826 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 51.6 Cg_endo -67.34 -27.44 40.47 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.717 2.278 . . . . 0.0 112.307 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -79.65 -44.41 20.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.2 m -69.75 -27.49 33.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.152 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.91 78.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.101 170.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.28 -30.48 67.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.08 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.3 p -92.58 -12.1 32.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.217 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.69 15.12 81.48 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.42 175.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -163.78 157.31 18.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.91 0.386 . . . . 0.0 110.859 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.5 -138.81 2.49 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 -178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PRO . . . . . 0.499 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 73.6 Cg_endo -67.69 150.41 79.37 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.655 2.236 . . . . 0.0 112.401 168.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -76.32 -38.57 55.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.735 ' HB ' HG23 ' A' ' 9' ' ' ILE . 3.7 mp -126.4 138.66 53.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.207 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.521 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 2.2 tp -128.48 129.8 68.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.131 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.559 ' CE2' HG13 ' A' ' 108' ' ' ILE . 2.0 m-85 -98.53 142.68 29.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.831 175.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TRP . . . . . 0.559 ' HH2' ' HA3' ' A' ' 265' ' ' GLY . 6.1 m-90 -119.68 139.81 51.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.922 176.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 262' ' ' LEU . . . -59.65 -85.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.092 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -122.52 -61.46 1.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -84.56 -27.92 26.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.773 -167.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.468 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 89.4 mtt180 -60.07 -30.5 69.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.891 -158.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -67.8 -27.92 67.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -170.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.85 -51.84 47.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.515 -173.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.16 -36.27 92.74 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' TYR . . . . . 0.583 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 18.4 t80 -65.98 -38.31 88.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.932 0.396 . . . . 0.0 110.891 -178.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.14 -43.94 60.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -62.61 -32.06 73.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.2 m -80.48 -12.57 59.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 175.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.1 31.95 66.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.503 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.49 -1.26 56.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.79 0.329 . . . . 0.0 110.879 -172.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.583 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -130.99 156.94 44.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.975 -179.287 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.637 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -66.9 130.46 43.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.132 175.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -69.52 122.97 20.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -109.3 159.97 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.05 -171.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.6 p -103.23 146.5 32.56 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.629 0.728 . . . . 0.0 111.065 -171.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.84 146.25 29.56 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.682 2.255 . . . . 0.0 112.326 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -107.94 114.68 28.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -52.68 -35.92 56.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.828 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.08 -40.97 95.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -69.97 -38.25 76.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.862 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -54.95 -48.61 72.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.76 -36.39 83.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.845 175.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -75.78 -19.99 58.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -103.34 -103.52 0.29 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 -173.304 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 43.0 t80 -165.92 134.28 2.41 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.688 0.756 . . . . 0.0 110.933 -172.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 70.9 Cg_exo -52.51 -39.94 73.33 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.375 -170.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -78.44 -30.51 47.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.96 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.2 m -69.48 -48.7 59.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.196 -166.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TRP . . . . . 0.466 ' HA ' HG23 ' A' ' 97' ' ' VAL . 51.9 p-90 -66.57 -28.4 68.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.87 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -71.44 -37.59 71.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.855 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.98 -25.07 65.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.582 ' HB ' ' HB1' ' A' ' 105' ' ' ALA . 21.7 m -101.55 16.54 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.189 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 68.1 ttt180 -101.8 133.11 47.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.905 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -149.06 130.31 14.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.3 t30 68.69 36.26 2.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.12 -5.01 64.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.52 174.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -139.73 163.85 31.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LEU . . . . . 0.572 HD23 HG21 ' A' ' 97' ' ' VAL . 13.1 mt -73.07 146.09 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.002 -175.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.434 ' C ' HD13 ' A' ' 104' ' ' ILE . 1.9 pp -122.33 9.91 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.179 173.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.896 ' HB2' ' HB3' ' A' ' 263' ' ' SER . . . -168.09 156.68 9.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.045 -177.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' TYR . . . . . 0.45 ' HB3' HD22 ' A' ' 285' ' ' LEU . 21.4 m-85 -124.99 146.34 53.21 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.766 0.793 . . . . 0.0 110.905 163.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PRO . . . . . 0.664 ' HB3' HG11 ' A' ' 261' ' ' VAL . 42.9 Cg_endo -71.4 121.09 7.43 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.616 2.211 . . . . 0.0 112.359 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ILE . . . . . 0.559 HG13 ' CE2' ' A' ' 61' ' ' PHE . 25.1 mm -98.31 -32.28 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.137 177.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.04 151.34 26.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.403 HG23 HG23 ' A' ' 261' ' ' VAL . 75.6 t -115.02 132.99 62.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.079 178.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -112.88 131.72 55.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.83 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.08 154.49 40.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.966 176.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.439 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 11.0 mp -94.29 152.05 18.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.946 -174.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -148.22 157.59 43.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.82 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -99.23 125.2 44.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.85 174.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ILE . . . . . 0.589 ' N ' HD23 ' A' ' 115' ' ' LEU . 4.7 mp -107.54 132.1 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 -176.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -131.71 145.15 51.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.944 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -100.2 113.08 25.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.749 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 241' ' ' ASN . 99.5 mttt -64.78 -15.01 61.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.812 -176.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 15.1 t70 -80.47 -29.87 37.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 mp -88.83 -46.49 8.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.545 HD23 ' HB2' ' A' ' 223' ' ' ALA . 2.2 mp -111.24 124.94 31.53 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.587 0.708 . . . . 0.0 110.81 175.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -71.71 -26.71 19.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.652 2.234 . . . . 0.0 112.302 173.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -152.47 96.28 3.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.628 0.728 . . . . 0.0 110.921 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.78 153.99 68.2 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.687 2.258 . . . . 0.0 112.331 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.58 151.53 64.46 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.651 2.234 . . . . 0.0 112.38 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -113.62 -5.07 13.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.864 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 130' ' ' GLU . 11.8 m -127.9 146.08 50.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.106 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TRP . . . . . 0.469 ' HA ' HG12 ' A' ' 132' ' ' ILE . 63.1 m95 -66.39 -25.63 66.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.955 -177.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' GLU . . . . . 0.485 ' H ' HG23 ' A' ' 128' ' ' THR . 98.3 mt-10 -62.11 -30.32 70.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.15 -19.67 56.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 -175.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . 0.592 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 49.5 mm -62.0 -53.46 59.38 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.656 0.741 . . . . 0.0 111.133 -166.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 31.9 Cg_endo -62.75 -40.06 38.81 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.7 2.266 . . . . 0.0 112.339 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.0 -59.44 4.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LEU . . . . . 1.176 HD23 ' C ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.71 -17.67 63.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -175.257 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.649 ' HA ' HD23 ' A' ' 139' ' ' LEU . 39.0 t70 -63.49 -39.08 93.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 169.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.01 -36.72 82.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -73.16 -50.3 23.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -174.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LEU . . . . . 0.683 HD21 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -75.18 -15.2 60.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.892 -176.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.683 ' N ' HD21 ' A' ' 139' ' ' LEU . 87.8 tttt -56.28 -35.06 67.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 170.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.18 -23.84 67.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.129 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -94.9 8.64 42.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.816 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.22 27.51 63.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.425 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.446 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 46.0 mtmt -120.87 165.41 15.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.859 0.361 . . . . 0.0 110.862 173.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' SER . . . . . 0.533 ' HA ' HD22 ' A' ' 139' ' ' LEU . 37.1 t -128.56 146.69 50.77 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 170.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -72.04 -58.31 3.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.084 -164.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -138.64 128.87 25.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -161.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.1 mmm -105.91 128.64 53.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -153.77 162.38 41.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -123.89 142.95 50.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.429 ' HG ' HG22 ' A' ' 347' ' ' VAL . 54.4 tp -113.35 -9.73 13.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.975 -175.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -73.71 0.14 13.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -118.0 148.39 43.37 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 121.738 0.78 . . . . 0.0 110.828 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.77 -20.01 64.66 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.595 2.197 . . . . 0.0 112.327 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -62.37 -36.69 83.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -84.32 -37.69 21.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.4 p -64.09 -37.77 88.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' TRP . . . . . 0.568 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 12.4 t-105 -62.21 -55.13 43.27 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.621 0.724 . . . . 0.0 110.935 -172.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 26.4 Cg_endo -67.37 -32.48 32.4 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.68 2.253 . . . . 0.0 112.326 -171.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.711 HD21 ' O ' ' A' ' 160' ' ' LEU . 6.5 tt -74.48 -40.31 61.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.981 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ILE . . . . . 0.501 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 76.0 mt -69.74 -40.44 79.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.128 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.78 -26.72 64.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.142 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.59 -30.25 70.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -94.56 0.56 55.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 112.19 5.41 24.96 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.55 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.486 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -79.21 66.68 3.41 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.383 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -90.28 152.58 20.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.883 -174.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.68 -17.95 60.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.112 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -147.56 154.04 40.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.087 0.47 . . . . 0.0 110.813 -173.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -97.24 128.93 44.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.885 159.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -96.19 122.64 39.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.918 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -149.73 130.71 14.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.954 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.4 t30 56.9 44.28 23.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 172.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.14 6.43 74.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -132.71 142.39 49.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.858 0.361 . . . . 0.0 110.942 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -77.77 134.85 37.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.917 165.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -95.12 104.97 16.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.3 tp -65.76 -19.95 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.106 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -94.74 -8.43 37.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -132.63 95.58 3.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 174.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' VAL . . . . . 0.511 HG21 HG23 ' A' ' 183' ' ' VAL . 33.1 m -115.82 173.05 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.107 -177.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -99.95 12.13 60.7 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.442 -167.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' VAL . . . . . 0.572 HG22 ' CD1' ' A' ' 368' ' ' ILE . 17.9 m -101.62 -17.92 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 0.0 111.156 -172.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ASP . . . . . 0.459 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 57.5 p-10 -95.57 19.85 10.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.868 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -118.11 171.55 8.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.08 -24.46 67.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.069 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.05 -39.78 94.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.524 -172.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.651 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -65.5 -39.4 91.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 111.068 177.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' LYS . . . . . 0.519 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.2 mttt -59.73 -37.37 78.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 173.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.58 -38.11 89.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.121 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.0 -45.41 94.03 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.374 177.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' LEU . . . . . 0.605 HD11 ' HA ' ' A' ' 347' ' ' VAL . 18.7 tp -68.33 -33.31 74.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.928 0.394 . . . . 0.0 110.971 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' THR . . . . . 0.425 ' O ' HG12 ' A' ' 196' ' ' VAL . 89.5 m -63.06 -42.28 99.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.159 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -67.29 -58.03 5.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' LEU . . . . . 0.632 ' C ' HD12 ' A' ' 195' ' ' LEU . 3.4 pp -63.49 -27.78 69.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 -165.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' VAL . . . . . 0.571 ' N ' HD12 ' A' ' 195' ' ' LEU . 3.7 p -72.77 -22.55 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.11 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -66.06 -58.79 4.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.886 -174.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' LEU . . . . . 1.039 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.42 -24.54 57.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -167.404 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ILE . . . . . 0.813 ' N ' HD23 ' A' ' 198' ' ' LEU . 2.1 pp -77.35 -35.8 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.173 172.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.89 -30.71 71.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.919 169.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -85.55 5.79 29.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.843 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 67.26 40.02 2.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.904 170.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -82.8 -14.36 54.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 170.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 60.5 ttp -133.14 146.31 51.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -94.94 155.91 16.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.9 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.2 -25.03 68.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -95.09 -3.5 47.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 95.3 m -63.53 130.88 46.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.17 -175.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ASP . . . . . 0.507 ' H ' HD12 ' A' ' 212' ' ' ILE . 21.5 t0 -146.78 172.24 13.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 176.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -75.49 -34.38 60.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 -172.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 47.7 t -68.81 -48.3 63.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 -174.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ILE . . . . . 0.507 HD12 ' H ' ' A' ' 209' ' ' ASP . 29.8 pt -65.94 -24.85 34.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.123 176.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.97 -35.6 81.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.18 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -67.84 -35.96 79.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.809 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.16 -40.16 95.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.164 173.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.0 -40.49 95.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.136 174.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -65.09 -39.4 93.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.868 -177.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -63.64 -32.09 73.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.842 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.17 -10.87 48.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.979 -176.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.9 25.75 36.9 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.533 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -86.54 -26.23 24.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.898 0.38 . . . . 0.0 110.805 -175.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -125.45 134.51 52.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' ALA . . . . . 0.545 ' HB2' HD23 ' A' ' 122' ' ' LEU . . . -72.55 -35.74 68.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.085 -175.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 72.5 mtm -131.99 155.51 47.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 110.879 -176.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.6 t -149.01 160.12 43.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.7 mm -115.09 125.02 72.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.114 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -145.02 151.06 37.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -135.07 -97.51 0.55 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.457 174.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.93 -17.39 36.83 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.741 2.294 . . . . 0.0 112.329 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -67.38 -33.33 74.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.999 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 53.57 32.9 15.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.032 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 35.2 m0 -72.65 -34.58 67.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.035 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 19.2 t -55.52 112.77 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.868 -171.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ASN . . . . . 0.419 ' O ' ' HB ' ' A' ' 235' ' ' ILE . 44.7 p30 -95.47 -162.85 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.955 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 235' ' ' ILE . 47.6 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.157 -175.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 240' ' ' VAL . 11.6 t . . . . . 0 CA--C 1.523 -0.08 0 CA-C-O 120.904 0.383 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ASN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 77.4 m-20 37.27 70.0 0.2 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 169.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 242' ' ' TYR . 4.4 t80 -119.48 135.39 54.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.908 -171.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.07 158.47 24.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.428 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 319' ' ' ALA . 7.4 p -141.48 139.95 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.871 0.367 . . . . 0.0 111.11 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.3 t -153.02 148.92 27.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.162 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 18.9 m -61.76 168.94 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.096 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' LEU . . . . . 0.586 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.8 mm? -62.06 146.92 91.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.659 0.742 . . . . 0.0 110.895 -162.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -72.69 -177.42 2.81 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.65 2.233 . . . . 0.0 112.35 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.8 p -108.71 160.02 16.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.15 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -143.59 122.38 12.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 110.89 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 55.02 35.83 25.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.09 7.35 77.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.546 169.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -132.83 139.86 35.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.613 0.72 . . . . 0.0 110.905 176.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.87 140.9 36.03 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.741 2.294 . . . . 0.0 112.376 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' SER . . . . . 0.586 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 97.3 p -82.42 -5.87 58.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.865 170.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -49.93 113.33 3.31 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.545 0.688 . . . . 0.0 110.934 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.91 168.89 20.21 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.563 2.175 . . . . 0.0 112.426 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -72.9 171.75 12.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.883 -177.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.496 HG22 ' HA ' ' A' ' 324' ' ' ALA . 76.4 t -104.33 134.83 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.163 -170.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -109.77 137.91 14.51 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.502 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' VAL . . . . . 0.664 HG11 ' HB3' ' A' ' 107' ' ' PRO . 93.8 t -121.84 124.04 70.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.938 0.399 . . . . 0.0 111.168 -176.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 5.2 tt -72.09 128.82 36.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 168.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' SER . . . . . 0.896 ' HB3' ' HB2' ' A' ' 105' ' ' ALA . 58.5 m -121.31 153.89 37.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 -171.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ALA . . . . . 0.471 ' CB ' HD11 ' A' ' 280' ' ' LEU . . . -134.62 139.79 45.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 177.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' GLY . . . . . 0.559 ' HA3' ' HH2' ' A' ' 62' ' ' TRP . . . -142.41 172.22 24.37 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.518 -176.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 24.4 mm -112.87 134.31 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.333 . . . . 0.0 111.177 -169.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -64.55 132.07 48.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.936 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' ALA . . . . . 0.637 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -64.49 -30.21 71.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.1 -8.76 59.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.069 -172.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.3 t -68.21 121.66 81.11 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.639 0.733 . . . . 0.0 110.937 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.27 -16.95 19.35 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.71 2.273 . . . . 0.0 112.352 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 272' ' ' ASN . . . . . 0.453 ' HB2' HD22 ' A' ' 275' ' ' LEU . 53.1 p-10 -113.24 29.93 7.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.814 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -61.87 -25.29 67.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -169.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -65.65 -43.53 89.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 110.805 -168.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 275' ' ' LEU . . . . . 0.453 HD22 ' HB2' ' A' ' 272' ' ' ASN . 2.5 pp -74.75 -33.73 62.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 276' ' ' ALA . . . . . 0.455 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -65.81 -49.17 69.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -65.22 -35.13 80.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 94.0 mt-10 -68.62 -43.39 76.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.874 -177.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -60.12 -46.58 89.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' LEU . . . . . 0.471 HD11 ' CB ' ' A' ' 264' ' ' ALA . 7.6 tt -62.43 -46.56 87.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 -177.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.99 -38.81 72.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 -177.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 94.8 m-20 -102.28 -10.9 19.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -161.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' TYR . . . . . 0.434 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 53.5 t80 -122.46 -51.57 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' LEU . . . . . 0.437 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.5 OUTLIER -70.58 -43.22 69.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -176.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' A' ' 106' ' ' TYR . 4.5 mm? -81.69 44.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 169.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' THR . . . . . 0.439 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 89.6 m -145.77 145.37 30.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.168 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' ASP . . . . . 0.574 ' HA ' HD11 ' A' ' 290' ' ' LEU . 48.5 p-10 -50.11 -25.93 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -171.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -75.78 -45.89 33.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.71 -49.71 13.42 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 -169.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' LEU . . . . . 0.656 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.7 OUTLIER -73.06 -23.64 60.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.715 0.293 . . . . 0.0 110.877 -177.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' GLU . . . . . 0.526 ' N ' HD12 ' A' ' 290' ' ' LEU . 87.7 tt0 -68.71 -40.08 80.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 171.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.95 78.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.15 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' VAL . . . . . 0.69 HG13 ' HA3' ' A' ' 19' ' ' GLY . 39.9 t -77.89 -44.57 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.103 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -62.92 -29.66 70.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 177.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.01 -27.77 69.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -89.16 -36.77 15.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.819 -177.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' LYS . . . . . 0.433 ' O ' HD13 ' A' ' 299' ' ' LEU . 85.9 tttt -152.84 138.35 11.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.638 0.732 . . . . 0.0 110.864 175.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 297' ' ' LYS . 78.1 Cg_exo -51.78 112.72 0.9 Allowed 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.694 2.263 . . . . 0.0 112.329 175.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 297' ' ' LYS . 0.1 OUTLIER -88.98 -20.36 24.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 178.059 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 301' ' ' ALA . . . 102.18 -41.2 2.19 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.573 177.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 300' ' ' GLY . . . -179.86 175.92 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.884 0.373 . . . . 0.0 111.069 171.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' VAL . . . . . 0.629 ' CG2' ' HB3' ' A' ' 307' ' ' TYR . 22.3 m -135.85 160.06 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.136 162.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.27 -14.2 61.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.07 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' LEU . . . . . 0.656 ' CD2' HD22 ' A' ' 290' ' ' LEU . 60.4 tp -77.07 128.69 34.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -173.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -41.88 -33.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 -177.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' SER . . . . . 0.427 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 48.0 t -46.86 -38.66 10.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.866 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' TYR . . . . . 0.629 ' HB3' ' CG2' ' A' ' 302' ' ' VAL . 0.2 OUTLIER -57.36 -44.18 84.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 175.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' GLU . . . . . 0.472 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 88.7 tt0 -56.92 -39.99 75.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.786 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -80.01 -64.55 1.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.829 -174.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -85.81 -57.84 2.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.88 -171.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' LEU . . . . . 0.623 ' HB3' HD11 ' A' ' 317' ' ' ILE . 34.3 mt -59.34 -34.77 72.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 -169.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 318' ' ' ALA . . . -59.66 -18.19 39.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 -176.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -65.02 -23.01 67.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.767 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' ASP . . . . . 0.604 ' HB3' HD13 ' A' ' 317' ' ' ILE . 59.9 t0 -86.44 125.7 66.75 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.442 0.639 . . . . 0.0 110.876 173.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -49.23 -30.85 20.48 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.564 2.176 . . . . 0.0 112.334 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -65.11 -32.16 73.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' ILE . . . . . 0.623 HD11 ' HB3' ' A' ' 311' ' ' LEU . 6.9 mt -94.88 -36.07 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.082 -178.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 312' ' ' ALA . . . -53.82 -43.43 69.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.085 -174.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' ALA . . . . . 0.536 ' HB3' HG23 ' A' ' 244' ' ' VAL . . . -66.96 -44.62 80.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.091 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 64.2 p -64.7 -25.58 68.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.097 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 65.8 ttp -62.61 -38.6 90.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.911 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -66.82 -36.86 83.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.789 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 327' ' ' GLY . 63.7 t30 -78.88 -38.66 37.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.906 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' ALA . . . . . 0.496 ' HA ' HG22 ' A' ' 259' ' ' VAL . . . -64.92 -46.89 79.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.057 -175.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -70.36 -33.44 71.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 -177.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.66 -4.17 34.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -103.36 -160.2 25.13 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.443 -174.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -143.41 139.32 29.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.841 0.353 . . . . 0.0 110.837 -173.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' ILE . . . . . 0.582 ' O ' ' C ' ' A' ' 330' ' ' MET . 43.8 mm -82.35 112.33 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.189 -171.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' MET . . . . . 0.582 ' C ' ' O ' ' A' ' 329' ' ' ILE . 74.1 mtm . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 121.653 0.739 . . . . 0.0 110.892 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.817 0.342 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -57.57 -27.23 62.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.939 -173.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -35.97 79.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.34 -37.25 66.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.111 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 339' ' ' PHE . . . . . 0.455 ' HA ' HG12 ' A' ' 368' ' ' ILE . 35.4 m-85 -63.9 -49.02 74.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.8 174.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -64.89 -36.8 85.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.988 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -68.72 -47.23 66.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.71 89.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 343' ' ' VAL . . . . . 0.453 ' O ' ' HB1' ' A' ' 346' ' ' ALA . 13.9 m -80.6 -23.48 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 344' ' ' ARG . . . . . 0.53 ' O ' HG23 ' A' ' 347' ' ' VAL . 3.0 tmt_? -62.37 -47.39 84.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 81.4 p -60.85 -26.69 67.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.148 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 346' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -62.06 -41.91 98.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.044 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 347' ' ' VAL . . . . . 0.605 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.2 m -72.68 -32.83 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.072 -175.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.94 -45.97 95.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.194 172.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -63.8 -35.45 80.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.819 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.65 -45.76 61.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.096 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.0 89.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.185 -175.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 98.5 p -75.7 -9.99 59.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.947 -177.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.72 16.6 79.91 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.558 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.84 -32.77 40.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.719 0.295 . . . . 0.0 110.848 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -138.11 154.76 49.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.861 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.8 p -79.66 167.42 20.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.217 168.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 357' ' ' VAL . . . . . 0.479 ' HA ' HD21 ' A' ' 192' ' ' LEU . 55.1 t -54.72 -41.94 58.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.061 173.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -59.66 -45.76 91.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.858 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -72.55 -52.84 13.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.2 -43.64 77.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.053 -171.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 361' ' ' LEU . . . . . 0.651 HD11 ' HB1' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -67.52 -40.91 85.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 -178.471 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.9 -39.83 94.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.936 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -63.09 -38.53 91.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.841 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 364' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -63.58 -42.5 98.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.083 174.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 365' ' ' GLN . . . . . 0.459 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 23.1 tm0? -64.27 -36.79 85.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 177.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 366' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 370' ' ' LYS . 92.2 m -66.06 -40.22 90.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 176.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -67.59 -35.06 78.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 368' ' ' ILE . . . . . 0.572 ' CD1' HG22 ' A' ' 183' ' ' VAL . 68.3 mt -62.71 -40.88 90.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.061 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.3 p -94.68 -10.53 31.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 370' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 366' ' ' THR . 99.5 mttt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.778 0.323 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.7 mt -104.37 134.42 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -145.0 143.12 30.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -54.66 136.17 45.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.794 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.44 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 99.27 3.14 56.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.488 -173.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -166.34 149.83 7.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.797 0.332 . . . . 0.0 110.962 173.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.695 HD23 HD11 ' A' ' 33' ' ' ILE . 1.5 pt? -149.53 154.05 38.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.978 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.489 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 75.8 t -109.41 135.05 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.118 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.75 HG22 ' CG1' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -123.07 133.02 70.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.104 179.023 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.485 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 45.9 m0 -109.46 133.32 53.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.945 173.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.524 HD13 ' HB2' ' A' ' 20' ' ' LEU . 4.4 tt -109.99 149.79 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.136 -169.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -57.54 155.31 9.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.93 -14.47 16.94 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.531 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -76.46 -13.52 60.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.855 0.359 . . . . 0.0 110.843 -172.241 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HD2' ' HA ' ' A' ' 15' ' ' LYS . 26.1 mmmt -138.91 144.27 39.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 166.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.06 -84.11 1.01 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.452 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -112.99 -37.66 4.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.925 0.393 . . . . 0.0 110.895 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -66.33 -52.26 48.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.969 -144.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.7 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -62.92 -48.07 83.7 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.556 -176.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.677 HD22 HG13 ' A' ' 9' ' ' ILE . 10.9 tp -67.02 -35.87 80.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.947 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.74 84.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 173.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -65.07 -52.78 53.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.831 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.416 HG23 ' HA ' ' A' ' 20' ' ' LEU . 14.1 m -73.9 -35.58 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 -176.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.531 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -66.67 -44.39 89.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.519 176.723 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -64.95 -40.02 94.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -65.39 -38.88 91.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.424 ' CE2' HD12 ' A' ' 33' ' ' ILE . 73.6 t80 -66.14 -39.81 90.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.857 174.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -57.49 -39.98 77.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.2 -30.18 68.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -83.51 -38.96 21.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 -170.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.615 ' OG1' HG13 ' A' ' 33' ' ' ILE . 61.1 p -105.73 -12.93 15.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.41 5.91 89.09 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.519 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.836 HD13 ' O ' ' A' ' 33' ' ' ILE . 2.6 pp -99.29 133.96 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 0.0 111.159 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -70.47 129.25 38.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 -168.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.531 HG11 ' HA3' ' A' ' 24' ' ' GLY . 90.2 t -110.81 119.79 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.135 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.8 m -115.44 116.99 29.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.127 -173.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.46 HG23 ' HG ' ' A' ' 20' ' ' LEU . 79.0 t -98.77 139.29 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.485 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 73.9 mm-40 -121.25 161.83 21.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.888 176.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -84.78 141.04 37.98 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.612 0.72 . . . . 0.0 110.898 -171.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.43 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 85.6 Cg_exo -52.33 -30.72 43.96 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.724 2.282 . . . . 0.0 112.339 -177.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -49.34 -48.97 46.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.937 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.92 -19.31 48.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.875 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.618 ' C ' HD21 ' A' ' 43' ' ' LEU . 7.3 tt -52.4 -59.29 4.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.918 -171.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.06 -39.22 83.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.67 -42.7 57.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.845 -170.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -85.25 -29.27 24.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -171.565 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.553 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 91.2 t80 -47.72 -51.85 42.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.744 . . . . 0.0 110.885 -165.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.553 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 62.9 Cg_endo -69.04 -29.26 27.59 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 0.0 112.313 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -76.99 -43.4 35.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.6 m -72.29 -26.69 25.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.186 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.45 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . . . -65.65 -34.23 77.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 173.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.33 -29.64 70.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.077 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.2 p -92.38 -14.01 29.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.155 175.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.56 14.79 81.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.497 173.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -140.01 129.91 24.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.797 0.332 . . . . 0.0 110.916 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.85 -115.01 0.54 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.523 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.489 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 98.3 Cg_endo -72.84 151.41 51.1 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.658 2.239 . . . . 0.0 112.367 173.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.86 -35.49 15.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 168.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.75 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -138.51 150.03 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.054 177.073 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.587 HD12 HD22 ' A' ' 43' ' ' LEU . 4.1 tp -125.95 126.42 69.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.051 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.455 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 7.9 m-85 -108.07 123.35 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 177.521 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 16.7 t-105 -143.94 -172.81 3.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.3 -88.72 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.195 172.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -106.5 -54.64 2.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.82 -39.55 77.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 -159.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.58 -29.99 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 -174.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.819 ' O ' ' HD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -49.99 -52.95 29.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.934 -175.384 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.96 -41.33 97.4 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.495 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.97 -61.34 7.47 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.582 ' HD1' HD23 ' A' ' 76' ' ' LEU . 4.8 p90 -81.63 -25.52 35.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 110.929 -168.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.449 ' N ' ' CD1' ' A' ' 70' ' ' TYR . . . -70.22 -54.44 12.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.165 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -67.27 -34.14 76.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.845 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.6 m -84.77 -8.0 58.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 -173.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.39 31.75 63.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.481 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' A' ' 51' ' ' ALA . 2.5 mp -86.81 -4.63 59.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.929 0.395 . . . . 0.0 110.947 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.582 HD23 ' HD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -124.36 149.41 46.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.994 -175.002 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.01 140.53 37.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 169.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -71.63 135.35 46.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.909 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.872 HG13 ' HB3' ' A' ' 103' ' ' LEU . 42.5 pt -116.89 165.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 176.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 p -115.3 150.06 43.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.607 0.718 . . . . 0.0 111.122 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.32 144.99 47.3 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -103.14 119.96 39.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.61 -41.99 98.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.66 -46.46 82.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.16 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.455 ' HB3' ' HZ2' ' A' ' 94' ' ' TRP . 18.1 m-85 -73.55 -31.24 63.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.482 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.7 tt0 -53.5 -45.07 69.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.911 174.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -67.6 -33.9 75.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 175.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -77.84 -24.85 48.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.469 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 1.9 mp -104.98 -105.06 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 -174.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -169.26 128.1 0.9 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.637 0.732 . . . . 0.0 110.967 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -53.33 -36.51 78.85 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.586 2.19 . . . . 0.0 112.365 -171.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.62 -30.01 67.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.976 -173.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.4 p -76.66 -31.12 57.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.158 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.612 ' HA ' HG23 ' A' ' 97' ' ' VAL . 92.0 m95 -72.37 -27.51 62.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.932 171.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -72.78 -31.45 64.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 169.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . 0.429 ' CB ' HG21 ' A' ' 329' ' ' ILE . . . -65.03 -28.1 69.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.065 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.612 HG23 ' HA ' ' A' ' 94' ' ' TRP . 29.9 m -110.9 17.2 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.16 -171.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.444 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 72.3 ttt180 -112.46 138.06 49.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -143.05 125.24 15.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.4 t30 60.83 34.93 19.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.852 174.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.82 -6.44 74.29 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.499 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -122.53 145.31 48.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 0.0 110.915 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.872 ' HB3' HG13 ' A' ' 79' ' ' ILE . 3.6 tp -73.62 139.68 45.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -178.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.479 ' C ' HD13 ' A' ' 104' ' ' ILE . 2.5 pp -127.17 10.01 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 -173.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -173.26 169.63 4.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.093 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.491 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 89.4 m-85 -116.13 144.52 33.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.729 0.776 . . . . 0.0 110.88 166.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 15.0 Cg_exo -69.66 117.12 4.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.693 2.262 . . . . 0.0 112.316 172.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.49 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 29.7 mm -97.81 -47.01 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.14 154.98 38.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.108 -170.185 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.9 t -120.45 133.35 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 -178.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -120.83 134.19 55.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.63 161.78 41.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.06 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.6 ' HG ' ' HA3' ' A' ' 228' ' ' GLY . 6.0 mp -112.58 159.07 19.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.899 -173.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.9 p -154.37 162.92 40.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.854 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -93.64 123.72 37.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.953 176.836 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.553 ' N ' HD23 ' A' ' 115' ' ' LEU . 47.0 mt -108.44 132.06 57.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 -174.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -135.09 151.4 50.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 -175.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -96.33 117.86 31.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -66.91 -17.51 64.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -73.09 -29.61 63.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.837 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.546 HD22 ' O ' ' A' ' 220' ' ' GLY . 7.2 mp -99.94 -49.62 4.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 18.0 mt -102.25 125.55 36.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.608 0.718 . . . . 0.0 110.899 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.36 -23.5 23.87 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.643 2.229 . . . . 0.0 112.331 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -153.07 130.0 5.69 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.637 0.732 . . . . 0.0 110.873 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.1 153.6 77.11 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.71 2.273 . . . . 0.0 112.363 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.34 144.83 41.97 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.717 2.278 . . . . 0.0 112.324 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -94.01 -28.74 15.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.929 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 79.8 p -130.13 156.11 45.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.443 ' HA ' HD11 ' A' ' 132' ' ' ILE . 26.9 t-105 -68.76 -24.47 64.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.9 -23.95 63.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.899 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.55 -23.2 53.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.59 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.5 mp -62.32 -51.87 70.57 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.685 0.755 . . . . 0.0 111.173 -170.513 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.59 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 39.7 Cg_endo -71.57 -39.09 3.84 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.66 2.24 . . . . 0.0 112.378 -171.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.37 -39.69 85.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.195 173.263 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.8 tp -60.89 -44.53 96.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.538 ' OD1' ' HB1' ' A' ' 146' ' ' ALA . 40.5 m-20 -49.72 -35.01 20.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.821 178.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.14 -34.55 68.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 -178.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -74.61 -53.36 9.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -171.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.548 HD21 ' N ' ' A' ' 140' ' ' LYS . 0.9 OUTLIER -80.08 -10.96 59.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -175.79 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.548 ' N ' HD21 ' A' ' 139' ' ' LEU . 86.3 tttt -55.39 -31.22 61.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 168.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.74 -25.02 67.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.141 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -95.0 7.66 45.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.45 26.89 66.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.462 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.475 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 42.1 mmtm -116.83 162.7 17.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.839 0.352 . . . . 0.0 110.911 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.0 t -127.14 132.37 50.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.884 175.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.701 ' HA ' ' HB1' ' A' ' 223' ' ' ALA . . . -80.57 -38.3 29.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.084 -162.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -139.78 130.21 25.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.915 -174.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.786 ' SD ' ' HB3' ' A' ' 213' ' ' ALA . 56.8 ttm -117.04 130.15 56.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -177.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -151.04 157.2 42.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.8 -171.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -101.21 98.13 8.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.802 HD22 HD11 ' A' ' 195' ' ' LEU . 0.8 OUTLIER -69.24 -36.98 77.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -76.23 -3.77 38.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.891 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -99.87 148.92 35.45 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.624 0.726 . . . . 0.0 110.908 174.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.481 ' HD3' ' HD3' ' A' ' 344' ' ' ARG . 24.9 Cg_endo -63.0 -18.69 66.52 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.723 2.282 . . . . 0.0 112.379 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -64.33 -40.87 96.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.524 ' CD2' HD21 ' A' ' 151' ' ' LEU . 90.4 t80 -86.22 -37.8 18.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.875 -176.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 60.7 p -61.13 -36.95 81.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.226 -170.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.556 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 78.8 t90 -69.22 -53.65 13.12 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.504 0.669 . . . . 0.0 110.84 -174.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.556 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 44.0 Cg_endo -67.86 -17.17 46.82 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.647 2.231 . . . . 0.0 112.446 -176.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.844 HD13 ' O ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER -82.5 -48.49 10.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 172.962 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 68.0 mt -74.84 -40.03 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.97 65.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.136 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.479 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -63.34 -34.86 78.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.059 -168.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -91.87 2.6 56.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 120.08 3.41 11.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.503 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.54 60.6 4.8 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.488 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -79.84 134.45 36.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 110.969 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.42 5.29 18.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 -174.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -147.04 149.99 34.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.907 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 79.2 tttt -103.87 122.45 45.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 158.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -118.81 122.1 41.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.968 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -152.36 130.83 12.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 55.42 39.08 31.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.81 16.54 80.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.03 138.14 50.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 110.888 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -96.45 144.89 26.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -129.31 104.94 7.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.894 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.499 ' C ' HD13 ' A' ' 178' ' ' ILE . 1.4 pp -74.71 -11.21 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.204 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -97.56 -12.26 22.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 -174.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.54 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 51.4 t0 -124.3 62.54 1.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.11 174.9 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.167 -166.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -104.82 17.96 44.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.501 -164.143 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.41 HG22 HD13 ' A' ' 368' ' ' ILE . 2.5 m -100.2 -19.91 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 111.148 179.672 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -86.7 19.08 3.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -113.77 175.14 5.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.94 -25.28 67.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.89 -39.85 96.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.471 -172.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.669 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -68.77 -36.88 78.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 111.113 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.529 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 93.5 mttt -59.54 -33.25 71.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 174.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.0 69.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.152 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.19 -51.1 59.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.413 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.5 mt -64.51 -34.92 79.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.87 0.367 . . . . 0.0 110.916 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 94.9 m -56.81 -46.77 81.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.603 ' HD2' HD22 ' A' ' 160' ' ' LEU . 71.8 t80 -75.66 -44.89 40.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.802 HD11 HD22 ' A' ' 151' ' ' LEU . 7.7 tt -52.84 -44.41 66.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -171.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.405 ' HA ' HD12 ' A' ' 199' ' ' ILE . 34.9 m -70.45 -21.21 23.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.101 -177.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.649 ' HB3' HD13 ' A' ' 198' ' ' LEU . 38.8 t70 -56.96 -49.87 74.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 -166.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.764 HD13 ' N ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -87.09 -30.47 21.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 -170.587 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.534 ' H ' HD23 ' A' ' 198' ' ' LEU . 2.3 pp -78.33 -34.28 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.01 -27.6 68.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 168.314 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -83.94 4.68 28.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 174.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 65.11 39.31 5.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.901 172.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -77.43 -8.63 58.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 27.9 ptm -144.17 159.59 42.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.871 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -98.78 159.27 15.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.36 -26.3 68.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.049 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -93.76 -2.13 54.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.3 m -64.26 135.0 55.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -144.66 169.3 18.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -68.43 -34.59 76.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.854 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 91.6 p -67.47 -33.18 74.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.795 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 82.6 mt -63.48 -39.3 84.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.125 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.786 ' HB3' ' SD ' ' A' ' 148' ' ' MET . . . -62.43 -40.06 95.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 234' ' ' ASN . 92.9 mt-10 -63.1 -40.74 98.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -70.0 -38.95 76.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.089 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.45 -33.17 74.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.185 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -60.05 -30.69 69.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -62.01 -36.31 81.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.77 -19.01 19.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.546 ' O ' HD22 ' A' ' 121' ' ' LEU . . . 87.78 28.03 25.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.459 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -81.92 -28.61 32.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 0.0 110.901 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 93.1 m -119.24 131.36 55.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.701 ' HB1' ' HA ' ' A' ' 146' ' ' ALA . . . -75.82 -47.14 26.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.065 -174.047 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.455 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 61.0 mtm -134.97 158.95 43.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.853 -174.516 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 9.6 t -149.15 166.33 29.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 mm -109.46 124.23 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 172.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -155.33 171.8 19.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.835 -170.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.6 ' HA3' ' HG ' ' A' ' 113' ' ' LEU . . . -155.56 -115.71 0.53 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.504 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.3 -22.84 74.71 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.681 2.254 . . . . 0.0 112.317 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -78.26 -10.8 59.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.998 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.93 -16.57 61.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.092 -170.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 36.1 p-90 -54.94 -30.0 57.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.981 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.5 t -50.16 -56.34 11.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 214' ' ' GLU . 49.3 t30 -163.79 64.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 32.1 mm -131.79 112.78 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 167.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -171.32 160.05 5.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.883 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 96.7 m -120.44 108.67 14.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.156 -176.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 44.1 t -147.18 118.02 7.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.974 0.416 . . . . 0.0 110.923 172.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 60.35 35.45 20.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 29.0 m -149.3 171.11 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.138 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -112.8 82.09 1.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -117.99 148.59 42.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.82 162.17 25.52 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.552 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.801 HG11 ' O ' ' A' ' 315' ' ' PRO . 10.1 p -144.04 138.49 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.942 0.401 . . . . 0.0 111.169 -175.053 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.6 t -150.68 149.2 29.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.106 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 30.4 m -63.62 168.44 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.135 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.826 ' HB3' ' HB2' ' A' ' 255' ' ' SER . 3.9 mm? -63.27 137.01 96.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.569 0.7 . . . . 0.0 110.903 -162.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -72.04 -172.68 0.89 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.359 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 82.5 p -105.67 151.79 23.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.134 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.427 ' HD2' ' HB1' ' A' ' 163' ' ' ALA . 33.5 t80 -136.48 120.48 17.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 176.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 56.55 35.5 26.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.81 9.3 74.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.486 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -129.97 140.88 39.98 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.722 . . . . 0.0 110.877 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.2 142.17 33.57 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.672 2.248 . . . . 0.0 112.35 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.826 ' HB2' ' HB3' ' A' ' 247' ' ' LEU . 64.3 m -85.3 0.83 50.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.823 173.133 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -45.01 112.49 1.53 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.61 0.719 . . . . 0.0 110.935 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.11 162.0 32.03 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.724 2.282 . . . . 0.0 112.325 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -72.98 152.5 41.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 -172.554 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.13 134.99 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.112 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -112.48 135.19 12.51 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.44 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.3 t -125.88 128.4 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.884 0.373 . . . . 0.0 111.147 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.49 ' HB3' ' HB ' ' A' ' 108' ' ' ILE . 1.7 tt -69.99 130.13 41.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 77.3 p -122.23 135.92 54.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.825 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.472 ' HB2' HD11 ' A' ' 280' ' ' LEU . . . -124.8 127.53 47.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.12 -178.519 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.2 160.9 14.69 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.474 -170.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.428 ' HA ' HG22 ' A' ' 59' ' ' ILE . 20.6 mm -99.98 121.62 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.819 0.342 . . . . 0.0 111.129 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -66.68 129.5 40.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -175.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.429 ' HB3' ' C ' ' A' ' 76' ' ' LEU . . . -60.67 -27.72 68.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.083 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.83 -11.77 57.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.041 -173.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.8 t -75.48 121.25 84.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.719 . . . . 0.0 110.934 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -68.76 -10.42 29.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.658 2.239 . . . . 0.0 112.286 167.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -102.44 17.65 23.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.937 -171.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -48.78 -34.84 13.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.884 -172.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -70.37 -48.26 57.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 -170.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.0 pp -81.76 -30.38 32.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.51 -46.28 73.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.09 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -67.53 -34.47 77.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 89.2 tt0 -63.92 -52.28 60.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 -173.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.498 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.2 p90 -69.99 -34.18 73.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.473 HD22 HD12 ' A' ' 108' ' ' ILE . 4.3 tt -58.38 -50.99 71.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -80.11 -31.26 39.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 61.9 m-80 -101.4 -28.94 12.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.921 -165.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.564 ' O ' HG23 ' A' ' 286' ' ' THR . 85.4 t80 -110.25 -43.4 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 -169.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.2 mp -72.54 -47.07 51.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.414 HD11 ' HA ' ' A' ' 108' ' ' ILE . 1.2 mp -83.33 61.29 6.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 176.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.564 HG23 ' O ' ' A' ' 283' ' ' TYR . 14.5 t -153.1 155.72 37.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.16 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.508 ' HA ' HD11 ' A' ' 290' ' ' LEU . 39.1 p-10 -52.41 -27.25 15.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.857 -168.437 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -78.23 -46.02 21.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.92 -49.39 17.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.449 -168.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.605 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.4 OUTLIER -74.96 -21.56 59.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 0.0 110.908 -178.986 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.435 ' N ' HD12 ' A' ' 290' ' ' LEU . 83.1 tt0 -67.22 -40.91 86.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.95 170.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.31 76.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.129 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.7 HG13 ' HA3' ' A' ' 19' ' ' GLY . 19.7 t -80.22 -43.67 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.134 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.422 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 41.7 t30 -65.77 -28.78 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.926 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.55 -26.01 67.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -82.33 -45.21 15.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.838 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -153.51 135.52 9.09 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.583 0.706 . . . . 0.0 110.947 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -49.3 114.66 1.39 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.632 2.221 . . . . 0.0 112.414 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.422 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 40.1 mt -92.74 -19.04 22.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 -177.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 114.94 -60.48 0.39 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -176.4 168.43 2.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.815 0.34 . . . . 0.0 111.064 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 30.3 m -124.62 157.7 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.157 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.96 -17.28 61.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.605 ' CD2' HD22 ' A' ' 290' ' ' LEU . 58.4 tp -81.0 123.5 28.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.977 -174.208 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -61.44 -33.25 73.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.89 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.2 m -61.84 -47.67 84.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.815 -170.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.463 ' CD2' HD21 ' A' ' 311' ' ' LEU . 20.8 t80 -89.11 -28.66 19.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -57.78 -42.63 84.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.909 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.68 -34.96 79.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -73.02 -45.55 57.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.702 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.4 pp -73.43 -27.04 61.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.874 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.416 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.58 -11.23 57.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.34 -15.98 61.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -86.24 128.76 56.25 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.539 0.685 . . . . 0.0 110.882 169.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.801 ' O ' HG11 ' A' ' 244' ' ' VAL . 83.6 Cg_exo -52.6 -31.69 50.8 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.536 ' HG3' HG13 ' A' ' 317' ' ' ILE . 27.6 ptt-85 -66.3 -31.05 71.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -171.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.702 HG21 ' CD1' ' A' ' 311' ' ' LEU . 63.3 mt -95.12 -37.38 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 -176.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.53 -44.5 62.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 -168.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.97 -42.4 80.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.053 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 71.9 p -63.85 -28.22 69.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.408 ' HA ' ' HE3' ' A' ' 321' ' ' MET . 33.5 mmt -66.75 -31.91 72.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -66.06 -44.18 85.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 327' ' ' GLY . 40.9 t30 -64.46 -37.21 86.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 174.372 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.7 -45.05 95.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.1 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -73.78 -34.37 64.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.9 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -100.49 -0.0 38.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -96.57 -155.63 30.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.408 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.56 139.19 42.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 0.0 110.922 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.587 ' O ' ' C ' ' A' ' 330' ' ' MET . 42.6 mm -76.69 110.01 11.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.1 -173.59 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.587 ' C ' ' O ' ' A' ' 329' ' ' ILE . 99.3 mmm 22.88 60.03 0.33 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 170.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.413 ' N ' ' O ' ' A' ' 329' ' ' ILE . 36.4 Cg_endo -91.1 -10.02 2.92 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.716 2.277 . . . . 0.0 112.375 -170.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.556 ' O ' ' CG1' ' A' ' 333' ' ' ILE . 51.9 p-10 -94.86 9.87 37.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 -157.335 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.556 ' CG1' ' O ' ' A' ' 332' ' ' ASN . 31.6 pt 57.16 162.28 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.694 0.759 . . . . 0.0 111.099 162.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -57.6 -31.47 91.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.677 2.252 . . . . 0.0 112.342 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.16 -32.07 73.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.545 ' HG3' ' HB2' ' A' ' 332' ' ' ASN . 87.4 mmm -72.81 -26.12 61.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.953 -172.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.0 m -60.88 -41.43 95.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.4 -36.44 71.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -65.22 -37.73 88.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -61.04 -37.84 84.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -75.91 -35.26 59.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.92 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.417 ' HB2' ' HB2' ' A' ' 367' ' ' ARG . . . -62.68 -41.27 99.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.134 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.6 m -79.86 -25.17 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.481 ' HD3' ' HD3' ' A' ' 154' ' ' PRO . 54.5 ttp85 -61.3 -45.31 94.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.821 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 84.6 m -57.23 -36.63 71.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.131 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.751 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -60.58 -43.93 96.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.116 -175.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.467 HG23 ' O ' ' A' ' 344' ' ' ARG . 2.0 m -73.75 -32.69 35.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.171 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.74 -46.21 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.196 173.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.503 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 89.5 m-20 -69.13 -34.97 75.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.47 -45.35 65.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.01 -41.18 87.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 89.3 p -77.19 -11.96 59.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.836 -175.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.31 14.06 82.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.576 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.75 -29.85 56.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.755 0.312 . . . . 0.0 110.85 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.503 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 86.9 mt-30 -135.63 157.26 47.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 175.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.4 p -77.64 169.77 17.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.197 168.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.449 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 69.5 t -55.55 -42.83 70.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 170.462 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -59.87 -45.28 92.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -71.25 -52.78 17.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.838 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.24 -45.04 74.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 -173.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.669 HD11 ' HB1' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -66.75 -39.95 88.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.907 -176.85 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.546 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 87.9 tttt -64.68 -39.62 93.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 177.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.82 -37.91 89.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.751 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -64.75 -45.83 84.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.074 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.546 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 1.2 pp0? -73.82 -30.09 62.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 56.8 m -64.04 -41.54 97.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . 0.417 ' HB2' ' HB2' ' A' ' 342' ' ' ALA . 99.6 mtt180 -66.08 -39.07 89.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.41 HD13 HG22 ' A' ' 183' ' ' VAL . 70.4 mt -65.4 -37.86 81.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.209 178.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.3 p -92.37 -10.12 39.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.158 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.874 176.07 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.8 0.333 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 98.9 mt -91.44 125.03 44.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.132 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.31 146.07 36.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.855 -176.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.47 136.83 43.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.775 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.27 4.79 58.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.484 -174.299 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -169.89 153.22 4.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.869 0.366 . . . . 0.0 110.899 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.549 ' H ' HD21 ' A' ' 7' ' ' LEU . 1.0 OUTLIER -151.68 157.0 41.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.51 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 89.8 t -110.65 135.63 49.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.749 HG22 ' CG1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -122.98 132.01 72.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.075 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.454 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 41.9 m0 -108.77 125.75 52.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.936 171.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.468 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 14.8 tt -106.3 150.02 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.094 -170.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -59.21 151.46 22.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.91 -15.73 21.69 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.511 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -75.06 -11.14 60.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.845 -172.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -147.84 137.75 22.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.943 160.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.15 -83.26 1.04 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.443 -167.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -110.52 -45.67 3.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.013 0.435 . . . . 0.0 110.942 -172.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -68.22 -51.93 39.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.944 -151.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.536 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -60.09 -48.05 88.0 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.582 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.696 ' CD2' HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -58.13 -45.61 87.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.369 . . . . 0.0 110.884 176.452 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.99 76.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -64.86 -48.25 74.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 -177.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.0 m -74.38 -36.05 41.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.451 ' CA ' HG11 ' A' ' 35' ' ' VAL . . . -66.68 -48.34 62.55 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.576 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -65.45 -39.26 91.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.999 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -64.47 -41.58 96.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.467 ' CD2' HD12 ' A' ' 33' ' ' ILE . 63.1 t80 -65.42 -38.0 88.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.55 -41.76 99.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.89 -31.92 69.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.822 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -82.43 -40.48 21.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -171.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.641 ' OG1' HG13 ' A' ' 33' ' ' ILE . 60.8 p -102.61 -9.46 20.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.11 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.44 9.73 84.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.56 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 1.042 HD13 ' O ' ' A' ' 33' ' ' ILE . 2.0 pp -103.91 132.15 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.011 0.434 . . . . 0.0 111.07 -175.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -71.11 127.78 33.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.957 -168.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.489 HG23 HD22 ' A' ' 7' ' ' LEU . 99.2 t -110.67 122.06 64.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.086 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.474 ' HB ' HG23 ' A' ' 8' ' ' VAL . 99.7 m -111.57 117.94 34.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.146 -175.173 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.537 HG23 HD13 ' A' ' 20' ' ' LEU . 84.7 t -93.78 134.98 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.061 176.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.454 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 74.5 mm-40 -121.58 162.95 19.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.861 173.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.4 t-80 -84.9 139.73 37.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.615 0.722 . . . . 0.0 110.897 -167.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 70.9 Cg_exo -60.49 -16.85 44.71 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.754 2.303 . . . . 0.0 112.307 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -49.21 -56.37 9.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.936 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.407 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 73.1 mmtt -86.69 1.31 52.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -175.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.538 HD11 ' O ' ' A' ' 61' ' ' PHE . 9.4 tt -43.65 -53.34 5.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 -175.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -71.28 -43.8 66.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.21 -48.05 16.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.879 -161.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.467 ' HG2' HG13 ' A' ' 50' ' ' VAL . 84.3 tttt -84.58 -33.09 23.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -170.178 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.6 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 90.3 t80 -47.8 -53.54 30.61 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.69 0.757 . . . . 0.0 110.9 -172.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.6 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 31.5 Cg_endo -61.99 -29.31 81.62 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.612 2.208 . . . . 0.0 112.375 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -74.78 -43.47 54.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.467 HG13 ' HG2' ' A' ' 46' ' ' LYS . 35.7 m -74.97 -25.12 18.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.219 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.43 -33.9 74.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.13 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.18 -27.14 66.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.02 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.3 p -91.83 -13.6 31.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.164 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.26 14.27 82.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.478 170.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -145.89 137.29 24.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 0.0 110.876 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.454 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . 165.01 -131.2 2.34 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.466 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.51 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 54.1 Cg_endo -62.83 139.06 72.38 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.666 2.244 . . . . 0.0 112.372 171.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.461 ' HB2' HD11 ' A' ' 59' ' ' ILE . 2.6 m-20 -86.57 -35.03 19.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 171.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.749 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -132.51 148.12 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.134 177.622 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.7 tp -127.98 127.16 67.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.154 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.538 ' O ' HD11 ' A' ' 43' ' ' LEU . 9.1 m-85 -99.86 125.52 45.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.428 ' CG ' ' N ' ' A' ' 63' ' ' ALA . 41.6 t-105 -145.02 -175.81 4.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.928 169.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.428 ' N ' ' CG ' ' A' ' 62' ' ' TRP . . . -90.52 -87.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.136 173.73 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -126.23 -58.14 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.93 -44.4 96.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 -151.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -66.57 -28.52 68.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.836 -170.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -51.86 -42.9 62.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.868 -175.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.63 -49.66 74.26 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.531 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.84 -43.35 99.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.568 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -66.52 -46.97 74.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 110.874 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.91 -43.91 91.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.154 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.93 -34.96 79.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.016 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.5 m -84.91 -7.03 59.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.91 29.54 60.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.491 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.1 mp -84.13 -12.1 55.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.819 0.342 . . . . 0.0 110.837 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.615 HD11 HG22 ' A' ' 104' ' ' ILE . 4.4 pp -131.2 143.17 50.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.956 -177.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.447 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -79.65 144.94 33.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.45 134.2 48.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.864 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.821 HG13 ' HB3' ' A' ' 103' ' ' LEU . 36.4 pt -110.39 160.72 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.18 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.6 p -103.68 141.62 22.88 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.621 0.724 . . . . 0.0 111.065 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.79 145.19 31.99 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.728 2.285 . . . . 0.0 112.386 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -111.53 119.52 39.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.66 -41.63 98.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.897 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.45 89.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -73.43 -33.75 65.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.504 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.3 tt0 -53.6 -49.0 68.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.901 174.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -60.6 -34.98 75.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.01 -22.9 52.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.822 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -103.22 -109.43 0.25 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.813 -173.316 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -169.9 133.13 1.1 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.599 0.714 . . . . 0.0 110.992 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.8 -40.12 81.38 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.685 2.257 . . . . 0.0 112.303 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -69.13 -29.95 68.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -171.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.49 ' HB ' ' HB3' ' A' ' 107' ' ' PRO . 54.3 p -73.38 -31.36 63.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.112 -174.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.611 ' HA ' HG23 ' A' ' 97' ' ' VAL . 81.0 m95 -71.89 -25.47 61.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.042 174.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.53 -38.33 71.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.779 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.33 -26.98 63.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.611 HG23 ' HA ' ' A' ' 94' ' ' TRP . 19.7 m -100.01 15.44 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.132 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.418 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 34.8 ttp-105 -110.2 141.85 42.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.788 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -138.83 122.76 17.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.864 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 59.82 34.94 21.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.945 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.24 -2.64 84.08 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.451 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.56 144.52 48.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 0.0 110.912 174.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.821 ' HB3' HG13 ' A' ' 79' ' ' ILE . 4.9 tp -79.5 138.51 37.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.803 -173.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.615 HG22 HD11 ' A' ' 76' ' ' LEU . 2.5 pp -126.93 1.53 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 -171.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -167.14 168.41 13.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.457 ' CZ ' HD13 ' A' ' 79' ' ' ILE . 93.6 m-85 -114.52 139.91 24.56 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.676 0.751 . . . . 0.0 110.962 170.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.49 ' HB3' ' HB ' ' A' ' 93' ' ' THR . 74.1 Cg_endo -73.74 120.16 6.28 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.75 2.3 . . . . 0.0 112.368 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.6 mm -100.13 -56.13 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.604 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -142.16 154.87 45.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.162 -166.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.0 t -120.7 136.85 56.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.111 -169.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -126.34 131.1 51.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.433 ' HB1' ' HB ' ' A' ' 320' ' ' THR . . . -148.8 157.91 43.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.122 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.528 ' CD2' ' HA3' ' A' ' 228' ' ' GLY . 72.5 mt -102.02 168.76 9.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.89 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.8 p -155.93 158.15 37.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.938 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -96.26 127.74 42.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.889 172.594 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.562 ' N ' HD23 ' A' ' 115' ' ' LEU . 4.9 mp -110.95 133.05 57.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.066 -175.007 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -132.57 149.98 52.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.913 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -88.05 111.77 21.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.854 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.416 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 88.6 tttt -62.69 -22.9 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -76.54 -22.5 54.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.866 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.469 HD22 ' O ' ' A' ' 220' ' ' GLY . 7.0 mp -97.46 -49.23 4.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.823 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.521 HD11 ' HB2' ' A' ' 223' ' ' ALA . 22.8 mt -107.17 132.49 20.89 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 110.898 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.04 -20.68 28.57 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.632 2.221 . . . . 0.0 112.384 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.587 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 20.3 p30 -154.26 161.72 28.63 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.685 0.755 . . . . 0.0 110.805 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.587 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 58.8 Cg_endo -70.23 158.5 56.16 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 0.0 112.388 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.48 148.33 66.65 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.679 2.253 . . . . 0.0 112.306 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -103.54 -44.99 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.8 p -133.24 157.88 44.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.14 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.414 ' HA ' HD11 ' A' ' 132' ' ' ILE . 75.9 m95 -70.02 -24.89 63.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 177.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.92 -19.81 66.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -73.99 -30.13 62.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.492 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 1.4 mp -63.34 -47.76 83.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.63 0.728 . . . . 0.0 111.138 -167.236 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.492 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 85.3 Cg_exo -53.93 -51.62 10.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.569 2.179 . . . . 0.0 112.293 -176.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.6 -40.45 73.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.6 tp -54.55 -43.46 72.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.904 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.43 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . 1.8 m-20 -50.09 -44.29 51.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.816 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.77 -33.48 75.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 -176.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.8 -46.93 27.95 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 -173.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.43 ' CD2' ' HA ' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -90.53 -19.95 23.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.872 -173.026 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.456 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 85.8 tttt -61.81 -26.39 68.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.901 170.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.89 -24.94 67.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.111 171.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -95.37 8.88 41.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.81 28.08 65.68 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.501 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.456 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 89.3 mttt -117.26 170.03 9.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 110.908 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.4 t -131.53 142.23 49.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.803 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.443 ' HA ' ' HB1' ' A' ' 223' ' ' ALA . . . -73.14 -51.3 18.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.049 -170.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -139.24 130.78 27.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.91 -169.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 94.9 mtp -117.9 129.76 55.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.853 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -153.47 162.94 40.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.884 -169.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -95.81 104.37 16.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.027 169.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.765 HD22 HD11 ' A' ' 195' ' ' LEU . 0.7 OUTLIER -75.05 -35.96 61.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 177.271 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . 0.5 ' HA ' HD12 ' A' ' 348' ' ' ILE . 88.2 mt-30 -78.69 0.13 27.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.826 -175.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -106.82 150.44 39.72 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.635 0.731 . . . . 0.0 110.962 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.11 -20.31 69.39 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.691 2.26 . . . . 0.0 112.321 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -59.86 -44.07 94.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.011 -172.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -84.89 -39.99 17.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.863 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.0 p -64.02 -37.88 89.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.198 -169.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.574 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 19.9 t-105 -64.36 -55.47 30.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.583 0.706 . . . . 0.0 110.872 -173.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 23.6 Cg_endo -65.96 -30.74 48.03 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.616 2.211 . . . . 0.0 112.513 -171.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.7 HD21 ' O ' ' A' ' 160' ' ' LEU . 6.4 tt -72.89 -41.77 64.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.978 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 69.1 mt -73.81 -39.75 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.026 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.37 -33.17 67.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.17 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.494 ' HB1' ' HD2' ' A' ' 250' ' ' PHE . . . -61.7 -36.41 80.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.99 -168.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -89.12 1.03 56.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 121.84 1.22 10.73 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.49 169.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.36 64.99 3.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.446 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -86.71 132.88 33.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.868 0.366 . . . . 0.0 110.926 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.35 10.2 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.462 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.1 p90 -147.27 153.88 40.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -105.87 126.61 52.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 158.076 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -116.27 126.72 53.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.931 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -151.78 129.78 11.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.885 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.5 t30 55.07 44.55 27.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.04 14.0 82.19 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.484 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -129.92 139.62 51.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 110.887 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -99.98 145.96 27.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 170.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -121.26 110.1 15.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.839 171.128 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.517 ' C ' HD13 ' A' ' 178' ' ' ILE . 1.3 pp -80.0 -11.92 12.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.189 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.77 -12.71 19.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -123.33 88.17 2.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 169.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.462 HG12 ' HA ' ' A' ' 169' ' ' PHE . 33.5 m -116.58 170.96 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.177 -168.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.04 26.11 23.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.484 -168.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.529 HG22 HD13 ' A' ' 368' ' ' ILE . 12.6 m -109.9 -13.66 10.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.81 0.338 . . . . 0.0 111.145 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -85.07 20.04 2.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -112.81 -176.8 2.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.878 -175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.51 -25.09 63.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.425 ' O ' ' HB1' ' A' ' 190' ' ' ALA . . . -72.01 -42.43 51.94 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.492 -169.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.64 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -63.26 -36.75 84.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.353 . . . . 0.0 111.038 176.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.523 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.2 mttt -59.97 -34.09 72.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 173.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 187' ' ' GLY . . . -65.15 -31.85 73.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.091 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.64 -45.48 95.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.439 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.433 HD21 ' HA ' ' A' ' 192' ' ' LEU . 21.7 mt -64.98 -38.34 90.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.857 0.36 . . . . 0.0 110.902 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.9 m -57.56 -46.32 84.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.275 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -73.49 -47.75 38.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.765 HD11 HD22 ' A' ' 151' ' ' LEU . 6.8 tt -53.72 -47.14 70.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 -170.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 30.3 m -67.96 -18.82 24.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 -176.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -59.99 -58.08 10.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -171.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 1.044 ' H ' HD13 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.67 -23.73 56.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.908 -166.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.602 ' H ' HD23 ' A' ' 198' ' ' LEU . 2.0 pp -83.77 -36.41 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 174.826 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.36 -32.6 73.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 168.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -82.25 4.1 24.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 65.06 39.79 5.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 168.78 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -85.88 -14.94 43.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.784 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -146.64 161.85 39.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.926 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -99.88 150.5 22.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.849 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.59 -25.83 68.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.5 p-10 -93.78 5.34 51.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 59.7 m -62.55 129.99 43.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.086 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -137.45 169.83 17.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.957 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -63.91 -42.68 97.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.3 m -64.77 -39.45 93.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.11 -40.03 86.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.154 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.81 -37.34 87.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.086 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.417 ' HB3' ' HB3' ' A' ' 234' ' ' ASN . 94.1 mt-10 -63.17 -40.47 97.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.925 177.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.91 94.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 175.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.92 -38.25 90.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -61.58 -42.04 98.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -57.94 -32.31 67.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.799 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -89.39 -23.8 22.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.469 ' O ' HD22 ' A' ' 121' ' ' LEU . . . 90.51 25.78 24.81 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.504 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.59 -23.98 21.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.922 0.391 . . . . 0.0 110.877 -173.03 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 99.8 m -119.11 128.76 54.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 -176.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.521 ' HB2' HD11 ' A' ' 122' ' ' LEU . . . -65.58 -52.07 54.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.052 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.472 ' HB3' HD22 ' A' ' 115' ' ' LEU . 71.2 mtm -135.65 156.26 49.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.859 -169.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.3 t -150.82 161.56 42.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 44.6 mm -110.05 124.25 66.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.158 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.408 ' OD1' ' HB2' ' A' ' 230' ' ' TRP . 7.7 t-20 -154.34 170.63 20.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.804 -166.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.528 ' HA3' ' CD2' ' A' ' 113' ' ' LEU . . . -157.16 -113.69 0.41 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.522 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.419 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 40.4 Cg_endo -61.29 -22.34 74.32 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.618 2.212 . . . . 0.0 112.366 173.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.408 ' HB2' ' OD1' ' A' ' 227' ' ' ASN . 6.7 m-90 -78.89 -16.51 56.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.05 179.786 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.29 -23.7 67.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.057 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -60.04 -23.13 63.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.928 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 42.9 t -57.65 -59.64 4.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.417 ' HB3' ' HB3' ' A' ' 214' ' ' GLU . 66.1 t30 -152.03 45.56 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -173.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.0 mm -126.19 129.58 72.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.164 168.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -166.37 161.62 16.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 53.8 m -133.2 82.18 1.98 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.158 171.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 42.0 t -134.22 109.06 8.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.001 0.429 . . . . 0.0 110.808 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 60.1 30.96 20.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.939 -176.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.7 m -142.09 165.03 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -100.0 70.0 1.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.416 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 87.0 m-85 -130.91 146.67 52.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.019 174.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -130.95 155.66 21.36 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.498 HG11 ' HA ' ' A' ' 316' ' ' ARG . 3.3 p -134.79 134.88 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.961 0.41 . . . . 0.0 111.167 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.9 t -154.41 149.76 27.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.071 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 27.9 m -59.93 162.03 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.116 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.572 ' N ' HD12 ' A' ' 247' ' ' LEU . 5.5 mp -70.48 150.11 95.63 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.577 0.703 . . . . 0.0 110.906 -159.382 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.48 -179.24 2.66 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.706 2.271 . . . . 0.0 112.347 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 52.1 p -101.02 161.19 13.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.131 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.494 ' HD2' ' HB1' ' A' ' 163' ' ' ALA . 55.0 t80 -138.6 119.56 14.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 55.53 33.69 21.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.97 -169.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.15 9.77 72.77 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.529 171.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.486 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 86.1 mm-40 -132.66 129.46 21.33 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.651 0.738 . . . . 0.0 110.879 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 60.2 Cg_exo -59.59 144.8 99.34 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.577 2.185 . . . . 0.0 112.327 -175.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 65.2 p -88.65 16.69 6.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.809 171.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -43.05 112.34 1.17 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.634 0.731 . . . . 0.0 110.903 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.18 160.38 32.98 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.754 2.302 . . . . 0.0 112.326 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -72.51 161.55 30.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.801 -171.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 56.2 t -109.06 136.17 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.057 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -113.43 131.09 9.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.511 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.9 t -121.13 119.11 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 111.166 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.416 HD22 ' HB3' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -67.91 117.94 10.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 175.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 19.4 m -130.6 151.29 51.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 -170.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.06 129.79 44.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.15 -171.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -118.07 168.45 13.09 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.45 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.569 HD11 HG22 ' A' ' 59' ' ' ILE . 23.9 mm -99.68 126.84 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.0 111.183 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -68.36 129.3 39.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.853 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.447 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -66.2 -24.21 66.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.096 -176.228 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.91 -11.08 58.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.041 -171.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.6 t -75.97 120.28 80.98 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.642 0.734 . . . . 0.0 110.898 -176.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -69.0 -11.78 32.7 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.294 168.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -111.76 36.1 3.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.878 -171.012 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.85 -25.07 66.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 -167.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -71.32 -38.51 71.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 7' ' ' LEU . 37.8 tp -63.13 -48.65 77.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 173.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.634 ' HB2' HG23 ' A' ' 59' ' ' ILE . . . -69.05 -48.8 61.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.093 -173.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -63.82 -41.58 97.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -66.27 -54.57 23.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 -173.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.416 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -68.31 -34.0 75.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 -173.578 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.588 HD21 ' O ' ' A' ' 280' ' ' LEU . 4.8 tt -56.0 -45.54 79.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.875 176.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -72.93 -42.68 63.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -102.35 -9.3 20.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.889 -159.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.416 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 67.9 t80 -123.33 -48.65 1.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.528 HD12 ' HA ' ' A' ' 284' ' ' LEU . 0.0 OUTLIER -68.56 -46.59 69.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.495 ' HA ' HD13 ' A' ' 285' ' ' LEU . 0.8 OUTLIER -82.92 63.24 6.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 174.546 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.498 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 30.1 p -143.51 150.18 38.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.172 170.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.576 ' HA ' HD11 ' A' ' 290' ' ' LEU . 41.4 p-10 -53.19 -25.24 13.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -79.5 -44.08 21.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.49 -50.57 25.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.432 -170.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.576 HD11 ' HA ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -73.97 -21.27 60.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.438 ' N ' HD12 ' A' ' 290' ' ' LEU . 82.8 tt0 -66.07 -42.31 89.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 169.586 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.32 -34.77 75.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.536 HG13 ' HA3' ' A' ' 19' ' ' GLY . 21.6 t -76.83 -41.91 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.173 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.508 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 52.6 t30 -64.96 -25.42 67.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.981 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -66.83 -30.95 71.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.9 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -88.79 -40.87 12.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -141.97 130.05 11.79 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.514 0.673 . . . . 0.0 110.911 172.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.09 111.59 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.642 2.228 . . . . 0.0 112.376 174.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.508 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 43.0 mt -93.32 -13.1 28.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.016 -171.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.44 -53.71 1.0 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.433 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -173.77 166.15 4.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.795 0.331 . . . . 0.0 111.02 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.604 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 31.3 m -123.76 156.49 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.166 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . 0.434 ' O ' ' HA ' ' A' ' 89' ' ' LEU . . . -69.96 -17.16 63.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.018 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.457 ' HA ' HD12 ' A' ' 89' ' ' LEU . 57.6 tp -85.87 120.69 27.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.049 -171.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.2 -40.02 70.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.926 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.8 m -64.55 -50.33 67.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -167.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.495 ' HB3' HG22 ' A' ' 302' ' ' VAL . 38.2 t80 -81.13 -26.73 35.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.11 -42.28 94.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.4 -34.46 76.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.831 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -70.62 -48.53 54.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.669 HD13 HD11 ' A' ' 317' ' ' ILE . 4.6 pp -66.72 -28.81 68.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.856 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.467 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.95 -11.12 58.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.053 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.94 -15.57 62.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -79.78 128.66 73.61 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.633 0.73 . . . . 0.0 110.805 170.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -49.21 -38.37 41.17 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.678 2.252 . . . . 0.0 112.305 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.498 ' HA ' HG11 ' A' ' 244' ' ' VAL . 8.5 ptp85 -71.26 -24.83 62.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.918 -169.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.669 HD11 HD13 ' A' ' 311' ' ' LEU . 78.9 mt -92.26 -32.45 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.09 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.91 -34.95 63.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.059 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.497 ' CB ' HG23 ' A' ' 244' ' ' VAL . . . -65.01 -45.58 84.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.058 174.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.433 ' HB ' ' HB1' ' A' ' 112' ' ' ALA . 68.7 p -69.01 -24.38 64.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.162 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 87.6 mmm -58.84 -36.39 74.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -69.47 -46.92 65.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 327' ' ' GLY . 34.7 t30 -66.04 -36.01 82.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.995 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.28 84.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -72.62 -35.07 67.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -94.97 -1.83 51.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -100.01 -161.62 28.61 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.458 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.507 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 83.4 mt-10 -140.8 141.5 34.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 110.812 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.605 ' O ' ' C ' ' A' ' 330' ' ' MET . 18.8 mm -81.74 100.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.094 -169.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.605 ' C ' ' O ' ' A' ' 329' ' ' ILE . 95.3 mtp 20.52 60.43 0.25 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.55 0.691 . . . . 0.0 110.88 176.219 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.507 ' HG3' ' HB3' ' A' ' 328' ' ' GLU . 16.6 Cg_endo -95.1 -6.37 1.85 Allowed 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.766 2.311 . . . . 0.0 112.333 -170.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.526 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 52.7 p-10 -97.08 9.11 43.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 -147.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.575 HG22 ' H ' ' A' ' 335' ' ' GLN . 45.5 mm 78.81 130.42 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.689 0.757 . . . . 0.0 111.07 176.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -53.14 -25.46 29.49 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.623 2.215 . . . . 0.0 112.391 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.575 ' H ' HG22 ' A' ' 333' ' ' ILE . 99.3 mm-40 -62.63 -18.39 62.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.966 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 79.4 mmm -72.38 -24.0 61.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.8 m -63.59 -39.2 93.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -77.35 -35.4 54.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.136 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -62.66 -39.24 93.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.855 174.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -58.38 -36.28 73.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.809 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -75.9 -37.1 59.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.933 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.05 94.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.135 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.2 m -80.2 -25.46 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.177 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.497 ' O ' HG23 ' A' ' 347' ' ' VAL . 7.3 tmm_? -64.39 -43.33 94.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 173.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.5 m -58.67 -34.62 71.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.166 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.608 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -58.93 -42.22 89.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 -177.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 344' ' ' ARG . 1.3 m -74.08 -32.85 33.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -174.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.5 HD12 ' HA ' ' A' ' 152' ' ' GLN . 1.6 mp -62.01 -48.74 87.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.184 173.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.516 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 86.5 m-20 -65.6 -38.12 88.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.85 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.71 -46.22 63.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.188 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.15 -42.03 85.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.025 -176.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.6 p -76.5 -11.24 59.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.11 13.57 82.81 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.547 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.18 -31.36 58.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 110.883 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.516 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 90.9 mt-30 -136.33 159.53 41.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.4 p -78.45 169.75 17.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.131 168.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.465 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 72.9 t -55.52 -43.83 73.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.125 170.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -59.64 -44.79 93.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -70.44 -52.39 22.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.79 -45.93 70.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.079 -173.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.64 HD11 ' HB1' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -65.21 -40.01 93.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -177.404 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.569 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.0 tttt -65.3 -38.35 89.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 176.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -65.04 -38.91 92.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.795 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.608 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -64.79 -46.47 81.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.085 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.569 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 5.0 pp0? -70.55 -31.39 68.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.979 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 81.8 m -65.69 -42.63 91.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.199 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.29 -36.56 81.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.799 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.529 HD13 HG22 ' A' ' 183' ' ' VAL . 64.0 mt -64.96 -39.82 86.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.189 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.3 p -91.51 -11.05 38.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.195 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.917 176.71 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.806 0.336 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.404 HG21 ' HD2' ' A' ' 271' ' ' PRO . 83.6 mt -95.67 135.1 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.102 178.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -149.43 142.1 24.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -55.12 137.4 46.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.479 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 97.77 1.85 58.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.544 -172.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -166.1 149.16 7.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.837 0.351 . . . . 0.0 110.968 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.717 HD23 HD11 ' A' ' 33' ' ' ILE . 1.6 pt? -148.73 153.51 38.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.451 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 69.9 t -108.84 138.67 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.104 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.82 HG13 HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -122.21 132.55 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.001 177.018 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.487 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 45.2 m0 -108.82 127.81 54.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.887 172.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.565 ' HB ' HD23 ' A' ' 20' ' ' LEU . 7.2 tt -109.76 148.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.22 -168.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -57.28 146.86 27.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.888 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.89 -12.93 16.69 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.459 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -75.15 -10.29 59.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 110.842 -173.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -150.12 135.39 18.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 162.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.14 -84.71 1.0 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 -166.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -113.19 -45.65 3.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.923 0.392 . . . . 0.0 110.922 -170.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -68.05 -52.83 30.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.908 -149.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.647 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -63.17 -46.85 92.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.513 -176.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.82 HD22 HG13 ' A' ' 9' ' ' ILE . 17.7 tp -65.69 -39.94 91.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.839 0.352 . . . . 0.0 110.879 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.74 72.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.082 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -65.75 -48.23 72.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 m -75.36 -36.07 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.065 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.463 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -66.94 -46.41 73.95 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.444 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -65.58 -40.37 92.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.961 -176.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.94 -40.45 95.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.413 ' CE2' HD12 ' A' ' 33' ' ' ILE . 78.0 t80 -64.81 -39.34 93.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.05 -40.04 79.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.913 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -69.1 -30.02 68.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -84.42 -40.13 18.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.803 -170.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.61 ' OG1' HG13 ' A' ' 33' ' ' ILE . 62.3 p -103.79 -12.32 17.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.48 7.93 87.79 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.496 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.854 HD13 ' O ' ' A' ' 33' ' ' ILE . 2.6 pp -102.7 132.54 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 111.105 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -71.17 130.16 40.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 -168.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.534 HG23 HD22 ' A' ' 7' ' ' LEU . 90.0 t -110.57 120.17 60.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.402 ' HB ' HG23 ' A' ' 8' ' ' VAL . 99.5 m -113.62 118.03 33.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.159 -173.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.509 HG23 ' HG ' ' A' ' 20' ' ' LEU . 92.3 t -94.41 134.11 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.487 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 73.5 mm-40 -119.8 161.63 20.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.9 t-80 -83.41 139.38 41.51 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.626 0.727 . . . . 0.0 110.771 -168.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 75.6 Cg_exo -56.59 -25.09 57.39 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.768 2.312 . . . . 0.0 112.303 -176.216 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -47.64 -50.18 25.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -173.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -86.61 -8.56 57.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.494 HD11 ' O ' ' A' ' 61' ' ' PHE . 9.4 tt -46.73 -54.28 10.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.896 -167.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -75.03 -34.69 61.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -71.69 -48.87 44.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -168.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -87.2 -28.63 22.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 -170.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.562 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 91.5 t80 -47.49 -51.66 42.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.769 0.795 . . . . 0.0 110.922 -166.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.562 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 59.7 Cg_endo -68.3 -28.98 32.75 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.725 2.283 . . . . 0.0 112.296 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -76.56 -43.66 37.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.67 -24.96 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.127 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.86 -32.71 74.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.049 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.5 -27.65 67.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.03 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.2 p -94.61 -13.85 25.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.114 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.74 15.6 81.19 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.405 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -142.55 130.42 21.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.831 0.348 . . . . 0.0 110.998 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.69 -115.09 0.57 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.58 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.451 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 84.4 Cg_endo -70.32 146.48 56.83 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.306 168.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.401 ' HB2' HD11 ' A' ' 59' ' ' ILE . 1.4 m-20 -90.72 -36.34 14.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 169.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.7 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -138.46 150.04 24.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.175 176.989 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.0 tp -126.44 125.25 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 -169.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.54 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 4.8 m-85 -110.06 126.38 53.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 20.7 t-105 -143.1 -171.51 3.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 169.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.16 -89.53 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.119 171.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -106.55 -54.79 2.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.835 -172.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.49 -38.59 63.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.902 -158.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -74.46 -18.76 60.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 -169.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -39.99 -55.32 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.47 -38.43 44.72 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.493 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.32 -57.78 11.06 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 -171.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.603 ' HD1' HD23 ' A' ' 76' ' ' LEU . 8.8 p90 -85.79 -27.06 25.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.935 0.398 . . . . 0.0 110.93 -172.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.421 ' N ' ' CD1' ' A' ' 70' ' ' TYR . . . -71.62 -57.25 4.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.091 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -65.55 -32.02 73.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 -176.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.3 m -82.21 -7.88 59.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.58 30.42 68.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.503 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.457 ' HA ' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -87.45 -4.23 59.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.842 0.353 . . . . 0.0 110.835 -174.894 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.603 HD23 ' HD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -125.68 147.94 49.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -177.117 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.96 143.7 37.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.033 171.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -71.79 135.1 46.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.866 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.913 HG13 ' HB3' ' A' ' 103' ' ' LEU . 37.9 pt -117.31 164.97 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.087 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.2 p -115.81 150.03 44.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.543 0.687 . . . . 0.0 111.181 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.45 146.42 44.55 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.683 2.255 . . . . 0.0 112.32 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -105.65 119.92 40.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.828 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.03 -41.93 99.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.41 -45.02 89.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.555 ' HB3' ' HZ2' ' A' ' 94' ' ' TRP . 7.4 m-85 -72.4 -33.32 67.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.503 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.5 tt0 -52.1 -46.64 65.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.27 -36.14 82.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 174.411 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -78.86 -24.42 44.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.815 -173.438 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.3 OUTLIER -104.96 -105.04 0.31 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -172.164 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.476 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 39.7 t80 -164.6 129.63 1.97 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.671 0.748 . . . . 0.0 110.983 -174.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 96.9 Cg_exo -57.15 -43.03 56.98 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.62 2.213 . . . . 0.0 112.421 -169.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -72.44 -26.35 61.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.964 -173.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.652 ' CG2' ' HB3' ' A' ' 107' ' ' PRO . 96.7 m -69.75 -40.01 76.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.151 -174.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.599 ' HA ' HG23 ' A' ' 97' ' ' VAL . 92.2 m95 -65.68 -27.6 68.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.985 174.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -71.76 -35.24 70.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.54 -27.39 63.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.081 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.599 HG23 ' HA ' ' A' ' 94' ' ' TRP . 19.4 m -101.2 16.36 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.129 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.468 ' HB2' HD12 ' A' ' 103' ' ' LEU . 75.2 ttt180 -113.48 137.42 51.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -144.29 127.7 16.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.1 t30 62.19 34.78 15.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.899 174.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.82 -6.24 71.26 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.44 172.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -124.05 147.25 47.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.965 173.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.913 ' HB3' HG13 ' A' ' 79' ' ' ILE . 4.2 tp -73.28 139.99 46.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.924 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.465 ' C ' HD13 ' A' ' 104' ' ' ILE . 2.5 pp -126.28 10.01 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.012 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.583 ' HB2' ' HB2' ' A' ' 263' ' ' SER . . . -170.72 162.12 7.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -112.75 145.67 33.48 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.738 0.78 . . . . 0.0 110.914 164.455 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.652 ' HB3' ' CG2' ' A' ' 93' ' ' THR . 90.9 Cg_endo -75.63 118.52 5.13 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.668 2.246 . . . . 0.0 112.386 173.729 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.426 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 27.3 mm -94.75 -49.35 12.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.097 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.513 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.74 157.57 43.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.129 -170.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.401 HG23 HG23 ' A' ' 261' ' ' VAL . 79.7 t -121.46 134.64 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 -173.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -115.85 138.01 51.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.847 169.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.493 ' HB1' ' HB ' ' A' ' 320' ' ' THR . . . -151.48 160.04 43.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.023 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.435 ' HG ' ' HA3' ' A' ' 228' ' ' GLY . 7.0 mp -109.72 158.09 18.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 -170.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.5 p -154.82 161.9 41.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.925 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.937 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.98 128.19 46.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.996 176.157 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.578 ' N ' HD23 ' A' ' 115' ' ' LEU . 5.3 mp -109.64 130.97 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.099 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -133.17 153.42 51.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -93.02 116.69 29.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.877 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.04 -20.22 66.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.854 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.452 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 11.8 t70 -77.33 -29.89 53.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.841 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.673 HD22 ' O ' ' A' ' 220' ' ' GLY . 8.8 mp -95.17 -47.91 6.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.6 mt -102.28 115.02 65.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.535 0.683 . . . . 0.0 111.032 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.79 -27.09 21.99 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.646 2.231 . . . . 0.0 112.333 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.422 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 60.5 t-20 -145.95 102.47 4.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.587 0.708 . . . . 0.0 110.88 173.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.0 Cg_endo -71.02 146.17 51.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.677 2.251 . . . . 0.0 112.324 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 150.83 62.89 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.384 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -110.47 -6.34 14.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.971 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 79.1 p -131.15 157.4 43.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.226 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -66.74 -30.63 70.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.998 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.06 -26.14 68.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.928 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -78.96 -23.32 44.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.614 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.5 mp -60.94 -51.21 81.0 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.645 0.736 . . . . 0.0 111.153 -169.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.614 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.5 Cg_endo -71.18 -40.63 3.1 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.62 2.213 . . . . 0.0 112.439 -170.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.31 -41.93 80.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.956 HD21 ' O ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -56.8 -42.8 80.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.973 172.299 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.435 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . 24.7 t70 -54.39 -35.34 62.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.772 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.0 -34.31 75.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.819 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -76.29 -51.75 11.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.864 -172.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.582 HD21 ' N ' ' A' ' 140' ' ' LYS . 0.8 OUTLIER -80.04 -10.06 59.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.839 -176.088 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.582 ' N ' HD21 ' A' ' 139' ' ' LEU . 87.1 tttt -55.41 -31.99 62.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 167.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.66 -24.34 67.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.97 5.53 51.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.5 25.56 67.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.482 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.496 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 41.4 mmtm -118.35 165.81 13.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.886 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.6 t -126.67 142.03 51.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.831 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.405 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.17 -58.38 4.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.094 -166.367 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.421 HD13 ' C ' ' A' ' 147' ' ' LEU . 3.0 tm? -139.96 124.58 18.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.937 -168.125 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 58.0 ttm -109.93 128.82 55.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.4 ' HB2' ' CD2' ' A' ' 156' ' ' PHE . 18.1 p90 -155.83 157.18 36.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.832 -171.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -99.98 81.82 2.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.868 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.913 HD22 HD11 ' A' ' 195' ' ' LEU . 1.2 tm? -56.17 -32.52 64.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.876 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.37 9.53 3.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -108.73 145.01 30.76 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.597 0.713 . . . . 0.0 110.933 170.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.7 -24.91 68.88 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.706 2.271 . . . . 0.0 112.349 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -69.4 -32.11 70.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.4 ' CD2' ' HB2' ' A' ' 149' ' ' PHE . 68.7 m-85 -87.98 -30.82 19.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.87 -174.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 57.2 p -66.4 -32.46 73.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.233 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.591 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 29.8 t-105 -61.94 -55.57 40.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.903 -171.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 13.4 Cg_endo -61.13 -36.79 79.5 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.703 2.269 . . . . 0.0 112.481 -171.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.685 HD21 ' O ' ' A' ' 160' ' ' LEU . 6.3 tt -72.59 -43.0 63.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 73.3 mt -70.64 -40.04 76.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.66 -30.48 62.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.11 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.536 ' HB1' ' HD2' ' A' ' 250' ' ' PHE . . . -63.29 -34.48 77.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 -169.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -92.57 3.03 56.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.968 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.21 1.96 13.87 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.462 169.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.17 65.55 3.96 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.472 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -86.31 134.12 33.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.821 0.343 . . . . 0.0 110.964 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.61 7.14 10.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.106 -170.789 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.458 ' HA ' HG12 ' A' ' 181' ' ' VAL . 50.3 p90 -150.06 154.37 38.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.951 0.405 . . . . 0.0 110.931 -175.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -102.61 127.71 49.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.92 155.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -118.19 124.42 47.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.017 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -153.05 132.21 12.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.05 42.03 31.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.912 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.94 16.06 80.69 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.507 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -130.03 138.62 50.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.764 0.316 . . . . 0.0 110.923 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -95.78 143.42 27.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.863 169.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -121.39 109.83 15.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.932 172.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.634 ' O ' HD13 ' A' ' 178' ' ' ILE . 1.0 OUTLIER -79.24 -12.3 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.164 -178.225 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.7 -12.06 24.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.896 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -123.83 89.28 3.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.833 169.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.458 HG12 ' HA ' ' A' ' 169' ' ' PHE . 32.9 m -117.17 166.48 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.087 -171.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.01 24.0 29.3 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.514 -170.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.505 HG22 HD13 ' A' ' 368' ' ' ILE . 13.8 m -108.9 -15.4 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 111.112 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -85.26 19.92 2.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -112.14 -178.25 3.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.95 -24.86 63.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.999 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.407 ' O ' ' HB1' ' A' ' 190' ' ' ALA . . . -69.98 -40.5 73.45 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.438 -171.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.646 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -64.68 -37.32 87.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.872 0.367 . . . . 0.0 111.124 176.667 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.515 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.0 mttt -59.98 -34.21 72.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.953 173.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.407 ' HB1' ' O ' ' A' ' 187' ' ' GLY . . . -65.09 -30.9 71.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 174.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.42 93.9 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.458 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.434 HD11 ' HB2' ' A' ' 346' ' ' ALA . 24.9 mt -66.03 -37.52 86.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.952 0.406 . . . . 0.0 110.916 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.2 m -56.67 -45.27 81.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.226 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -75.26 -44.57 45.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.913 HD11 HD22 ' A' ' 151' ' ' LEU . 8.7 tt -56.99 -53.66 55.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.936 -172.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.545 ' HA ' HD11 ' A' ' 199' ' ' ILE . 13.6 m -64.96 -21.2 29.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.185 -176.111 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.33 -29.9 66.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.813 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -71.4 -48.88 47.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 177.053 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.814 ' H ' HD13 ' A' ' 199' ' ' ILE . 2.6 mp -64.23 -36.66 77.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.151 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.95 -39.84 94.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -90.47 -1.32 57.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.971 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.66 39.99 6.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -77.6 -14.31 59.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.834 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -139.31 154.34 47.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -100.22 151.32 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 -176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.89 -27.65 69.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.119 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -95.0 2.97 55.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.795 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.8 m -58.64 133.26 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.125 -177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -144.07 170.08 16.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 175.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -65.96 -35.78 81.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.906 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 97.4 p -65.65 -36.01 82.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.839 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 75.2 mt -65.06 -40.27 88.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.27 93.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.984 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.24 -39.5 86.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.868 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.01 -36.73 85.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.129 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.71 -32.71 71.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.131 -176.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -61.39 -32.08 72.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -61.32 -35.63 77.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -101.69 -21.61 14.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.673 ' O ' HD22 ' A' ' 121' ' ' LEU . . . 88.96 31.71 11.83 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.538 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -82.54 -30.67 29.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.881 0.372 . . . . 0.0 110.915 -171.231 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 93.0 m -116.62 127.28 54.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -69.86 -45.79 66.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.417 ' HB3' HD22 ' A' ' 115' ' ' LEU . 76.3 mtp -134.19 145.75 49.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 -175.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 30.6 p -142.35 161.87 36.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.203 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 31.0 mm -111.64 125.42 68.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.148 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.405 ' OD1' ' HB2' ' A' ' 230' ' ' TRP . 14.2 t-20 -154.33 158.08 39.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -174.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.435 ' HA3' ' HG ' ' A' ' 113' ' ' LEU . . . -137.53 -108.58 0.87 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.529 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.76 -17.28 47.35 Favored 'Trans proline' 0 C--O 1.23 0.096 0 C-N-CA 122.645 2.23 . . . . 0.0 112.359 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.405 ' HB2' ' OD1' ' A' ' 227' ' ' ASN . 97.5 m95 -80.25 -12.43 59.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.897 -179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -50.46 -39.0 46.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.017 -168.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -57.12 -24.38 53.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 27.8 t -50.08 -59.28 4.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.826 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -155.1 54.64 0.64 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.41 ' O ' ' HD3' ' A' ' 316' ' ' ARG . 29.2 mm -129.42 115.72 36.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 170.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -171.55 160.0 5.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.867 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.401 ' HB ' ' HG2' ' A' ' 315' ' ' PRO . 91.1 m -125.02 106.18 9.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.049 -179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 44.8 t -149.44 118.71 6.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.02 0.438 . . . . 0.0 110.879 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 60.15 35.02 21.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.873 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.2 m -145.69 173.88 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.144 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 74.4 m-80 -110.68 71.64 0.76 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.802 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -117.68 147.45 42.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -135.54 160.09 24.36 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.593 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.715 HG11 ' O ' ' A' ' 315' ' ' PRO . 5.8 p -140.82 138.23 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.928 0.394 . . . . 0.0 111.112 -176.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.1 t -152.86 152.19 31.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.118 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 24.4 m -60.02 167.4 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.085 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.471 HD13 ' HB2' ' A' ' 115' ' ' LEU . 3.5 mm? -63.2 141.09 97.76 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.608 0.718 . . . . 0.0 110.919 -159.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.97 167.68 19.18 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.641 2.228 . . . . 0.0 112.335 174.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 71.1 p -103.51 161.44 13.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.15 -170.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.536 ' HD2' ' HB1' ' A' ' 163' ' ' ALA . 30.7 t80 -143.18 121.06 11.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.864 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 57.25 34.98 25.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.89 10.32 79.09 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.462 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -126.44 145.06 51.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.651 0.739 . . . . 0.0 110.877 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -71.95 139.23 32.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.66 2.24 . . . . 0.0 112.309 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 70.2 m -84.95 0.14 52.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 171.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -46.18 110.16 1.14 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.658 0.742 . . . . 0.0 110.916 -176.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -76.7 161.09 34.11 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.783 2.322 . . . . 0.0 112.359 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -75.17 153.18 38.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -174.071 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.421 HG22 ' HA ' ' A' ' 324' ' ' ALA . 63.4 t -99.88 134.0 40.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.159 -170.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.21 133.62 11.75 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.438 -178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.401 HG23 HG23 ' A' ' 110' ' ' VAL . 86.0 t -124.91 131.44 72.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.936 0.398 . . . . 0.0 111.155 179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.426 ' HB3' ' HB ' ' A' ' 108' ' ' ILE . 2.5 tt -67.98 131.1 44.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 171.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.583 ' HB2' ' HB2' ' A' ' 105' ' ' ALA . 70.8 p -118.84 140.62 49.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.85 -176.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.561 ' HB2' HD11 ' A' ' 280' ' ' LEU . . . -127.87 130.17 48.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.089 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -122.52 163.19 16.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.495 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.485 ' HA ' HG22 ' A' ' 59' ' ' ILE . 15.7 mm -100.96 125.06 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 111.159 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -66.01 127.8 33.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.437 ' HB3' ' C ' ' A' ' 76' ' ' LEU . . . -60.92 -28.42 68.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.121 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.9 -10.9 56.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.061 -172.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.3 t -75.88 121.11 84.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.674 0.75 . . . . 0.0 110.865 -174.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.404 ' HD2' HG21 ' A' ' 2' ' ' ILE . 80.4 Cg_endo -67.23 -8.77 22.95 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 167.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -103.05 17.86 23.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 -173.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -52.72 -34.41 52.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 -168.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -71.38 -47.85 53.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.841 -170.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.3 pp -80.04 -31.02 39.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.966 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.481 ' HB2' HD13 ' A' ' 59' ' ' ILE . . . -67.84 -45.92 73.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -69.41 -34.05 73.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 89.2 tt0 -62.9 -52.93 61.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.483 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.2 p90 -69.9 -33.61 72.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.82 -176.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 264' ' ' ALA . 5.6 tt -56.93 -47.55 80.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -85.15 -32.11 22.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.511 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 69.4 m-20 -101.95 -14.01 17.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 -164.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.483 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 73.2 t80 -121.92 -49.49 2.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -175.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.515 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -64.39 -46.99 80.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 177.062 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.408 HD22 HD11 ' A' ' 108' ' ' ILE . 64.2 mt -85.98 59.98 5.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.984 -179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.491 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 47.5 p -139.18 150.42 45.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.065 172.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.546 ' HA ' HD11 ' A' ' 290' ' ' LEU . 42.4 p-10 -51.01 -26.4 6.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 -175.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -81.0 -43.9 18.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.834 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.05 -50.82 21.24 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.478 -169.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.565 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.4 OUTLIER -74.37 -20.85 59.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.894 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.433 ' N ' HD12 ' A' ' 290' ' ' LEU . 82.4 tt0 -67.12 -41.86 85.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.937 170.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.08 -34.37 74.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.145 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.647 HG13 ' HA3' ' A' ' 19' ' ' GLY . 21.1 t -79.4 -42.23 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.47 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 47.0 t30 -64.96 -27.4 68.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.944 177.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.82 -29.67 70.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -85.97 -39.99 16.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -150.87 133.77 8.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.584 0.707 . . . . 0.0 110.888 173.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.52 112.33 0.73 Allowed 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.662 2.242 . . . . 0.0 112.375 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.47 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 36.9 mt -91.05 -12.48 35.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.15 -58.98 0.49 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.43 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -175.01 167.28 3.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.846 0.355 . . . . 0.0 111.097 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.513 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 27.8 m -124.04 156.8 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.119 176.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -71.77 -17.73 62.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.983 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.565 ' CD2' HD22 ' A' ' 290' ' ' LEU . 58.6 tp -80.13 122.34 26.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.991 -173.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -56.09 -39.74 72.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -173.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.2 m -63.18 -48.47 78.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.825 -167.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.456 ' CD2' HD21 ' A' ' 311' ' ' LEU . 24.0 t80 -84.86 -28.31 26.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.74 -43.07 90.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.937 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.56 -37.9 89.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -72.32 -47.88 46.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.865 -176.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.719 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.5 pp -69.42 -27.76 65.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.959 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.44 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.0 -11.52 57.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.201 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.13 -15.02 61.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -81.2 130.09 64.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.503 0.668 . . . . 0.0 110.92 170.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.715 ' O ' HG11 ' A' ' 244' ' ' VAL . 87.1 Cg_exo -51.69 -35.21 56.9 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.272 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.54 ' HG3' HG13 ' A' ' 317' ' ' ILE . 23.3 ptt-85 -66.91 -32.61 73.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.838 -173.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.719 HG21 ' CD1' ' A' ' 311' ' ' LEU . 64.9 mt -93.35 -33.78 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.094 -175.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -52.47 -43.08 64.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -172.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.464 ' CB ' HG23 ' A' ' 244' ' ' VAL . . . -66.47 -43.1 86.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.493 ' HB ' ' HB1' ' A' ' 112' ' ' ALA . 72.4 p -65.3 -28.81 69.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.086 -174.702 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' MET . . . . . 0.41 ' HG2' HG22 ' A' ' 317' ' ' ILE . 34.6 mmt -68.72 -30.15 68.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 177.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -64.95 -44.41 89.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 327' ' ' GLY . 39.1 t30 -64.61 -36.88 85.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 174.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.421 ' HA ' HG22 ' A' ' 259' ' ' VAL . . . -62.14 -45.3 94.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -73.54 -34.5 65.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.54 -1.15 51.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -175.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -103.45 -157.3 24.76 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.431 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -141.17 142.09 34.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 0.0 110.952 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.577 ' O ' ' C ' ' A' ' 330' ' ' MET . 37.9 mm -81.69 110.6 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 -171.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.577 ' C ' ' O ' ' A' ' 329' ' ' ILE . 96.1 mmm 23.44 60.02 0.35 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.553 0.692 . . . . 0.0 110.782 174.167 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -88.48 -11.73 4.06 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.753 2.302 . . . . 0.0 112.302 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.564 ' HB2' ' HG3' ' A' ' 336' ' ' MET . 52.4 p-10 -99.28 15.15 27.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.964 -155.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.539 ' O ' ' O ' ' A' ' 332' ' ' ASN . 28.4 pt 58.41 161.68 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.747 0.784 . . . . 0.0 111.098 159.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -59.64 -30.54 92.51 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.706 2.271 . . . . 0.0 112.362 -174.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.01 -29.84 70.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -169.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.564 ' HG3' ' HB2' ' A' ' 332' ' ' ASN . 89.4 mmm -74.35 -24.59 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -172.013 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.7 m -64.13 -39.88 94.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.46 -36.7 65.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.045 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.411 ' O ' HG13 ' A' ' 343' ' ' VAL . 11.1 m-30 -65.04 -41.22 95.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -61.97 -35.42 78.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.764 177.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -69.3 -43.83 72.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.958 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.429 ' HB2' ' HB2' ' A' ' 367' ' ' ARG . . . -61.45 -40.5 94.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.221 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 339' ' ' PHE . 16.1 m -79.47 -24.86 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.121 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.407 ' O ' HG23 ' A' ' 347' ' ' VAL . 4.4 tmt_? -62.29 -45.44 93.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 175.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 87.2 m -57.28 -35.08 69.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.042 173.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -60.25 -44.42 95.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.057 -175.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.425 ' HA ' HD23 ' A' ' 192' ' ' LEU . 1.5 m -74.06 -33.63 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.124 -174.638 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.42 HD13 HG21 ' A' ' 347' ' ' VAL . 1.5 mp -63.5 -47.92 89.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.242 173.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.524 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 84.9 m-20 -67.02 -37.72 84.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.83 -47.9 49.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.154 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.21 -37.1 80.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.177 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.5 p -74.81 -13.92 60.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.823 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.53 12.2 84.5 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.436 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -81.74 -26.46 34.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.777 0.322 . . . . 0.0 110.91 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.524 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 93.3 mt-30 -133.43 159.4 40.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 170.078 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.2 p -80.42 169.54 17.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.249 170.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.432 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 69.7 t -56.48 -43.09 77.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.175 170.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -59.13 -45.09 91.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -70.1 -52.66 21.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.919 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.15 74.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.093 -173.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.646 HD11 ' HB1' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -67.05 -40.01 87.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.002 -176.185 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.557 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.0 tttt -65.1 -39.12 92.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.935 176.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -64.71 -37.08 86.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -63.95 -45.56 88.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.091 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.557 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -73.5 -30.04 62.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.073 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 67.9 m -64.6 -41.16 96.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.118 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . 0.429 ' HB2' ' HB2' ' A' ' 342' ' ' ALA . 99.7 mtt180 -66.75 -39.98 88.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.848 175.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.505 HD13 HG22 ' A' ' 183' ' ' VAL . 67.1 mt -65.93 -38.42 82.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.099 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 70.7 p -93.9 -8.95 38.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.168 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 173.713 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.74 0.305 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.8 mt -97.71 128.5 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.215 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -158.01 145.8 18.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -51.86 138.39 24.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.517 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 98.1 2.52 58.08 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.405 -173.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -170.35 152.38 4.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.609 HD23 HD11 ' A' ' 33' ' ' ILE . 1.3 pt? -153.51 155.37 36.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.984 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.498 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 71.4 t -109.92 135.8 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.159 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.691 HG22 ' CG1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -122.78 132.27 71.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.458 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 40.0 m0 -107.05 125.8 51.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.939 169.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.494 ' HB ' HD12 ' A' ' 20' ' ' LEU . 15.8 tt -107.74 149.71 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.194 -171.203 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -58.97 148.11 31.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.796 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.75 -14.64 37.66 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.476 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -73.84 -9.94 59.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.0 110.856 -174.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -150.23 133.76 16.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 159.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.91 -84.97 0.98 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.534 -163.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -106.69 -45.02 4.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.905 0.383 . . . . 0.0 110.921 -173.221 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -68.22 -52.46 33.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 -151.44 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.611 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -59.2 -48.04 87.89 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.556 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.608 ' CD1' HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -58.69 -46.38 87.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.933 176.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.65 -38.14 77.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -65.51 -49.4 69.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.8 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.6 m -73.36 -34.66 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.443 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -67.31 -43.22 88.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.87 -44.87 96.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.817 0.341 . . . . 0.0 110.932 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -67.33 -40.11 85.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.547 ' CE2' HD12 ' A' ' 33' ' ' ILE . 42.6 t80 -64.58 -38.85 92.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 176.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.93 -41.86 97.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.966 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.68 -36.4 82.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.842 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -81.49 -39.7 24.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.793 -170.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.636 ' OG1' HG13 ' A' ' 33' ' ' ILE . 63.9 p -103.62 -8.54 19.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.95 11.07 83.99 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.557 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 1.048 HD13 ' O ' ' A' ' 33' ' ' ILE . 2.0 pp -105.14 131.11 55.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.889 0.376 . . . . 0.0 111.168 -174.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -68.68 128.21 35.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.94 -168.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.479 HG23 HD22 ' A' ' 7' ' ' LEU . 95.8 t -110.42 119.97 60.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.476 ' HB ' HG23 ' A' ' 8' ' ' VAL . 99.8 m -111.12 116.71 31.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.516 HG23 HD13 ' A' ' 20' ' ' LEU . 87.9 t -92.82 133.51 33.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.12 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.458 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 74.0 mm-40 -120.02 160.88 21.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 174.658 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.423 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 64.7 t-80 -84.03 138.13 40.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 110.775 -167.948 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 58.8 Cg_exo -61.45 -17.42 53.52 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.717 2.278 . . . . 0.0 112.304 -174.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -47.39 -49.69 24.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 75.4 mmtt -90.88 -0.1 57.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.723 HD11 ' O ' ' A' ' 61' ' ' PHE . 9.8 tt -45.29 -56.93 4.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.954 -170.054 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -76.63 -38.42 54.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.879 -175.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -79.86 -44.84 19.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.896 -166.372 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 85.3 tttt -85.13 -36.02 21.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -171.18 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.601 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 84.0 t80 -49.23 -53.82 35.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.666 0.746 . . . . 0.0 110.989 -171.596 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 22.7 Cg_endo -59.17 -30.63 93.6 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.654 2.236 . . . . 0.0 112.325 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -74.46 -44.67 50.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.942 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.7 m -75.01 -24.71 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.168 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.65 -34.39 78.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.22 -31.0 71.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.071 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.5 p -89.99 -13.42 36.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.189 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.2 16.35 80.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.513 168.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -137.81 130.0 29.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.823 0.344 . . . . 0.0 110.821 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.3 -118.56 0.76 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.493 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.498 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 68.1 Cg_endo -70.54 153.22 65.51 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.711 2.274 . . . . 0.0 112.349 176.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.443 ' HB2' HD11 ' A' ' 59' ' ' ILE . 1.8 m-20 -86.4 -38.88 16.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.901 169.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.764 HG23 ' HB2' ' A' ' 276' ' ' ALA . 0.0 OUTLIER -133.81 149.69 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 178.803 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 tp -128.97 125.07 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.107 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.723 ' O ' HD11 ' A' ' 43' ' ' LEU . 2.3 m-85 -101.5 134.51 44.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.417 ' CH2' ' HB3' ' A' ' 105' ' ' ALA . 32.0 p90 -144.94 -178.74 6.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.948 175.385 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.96 -98.71 0.32 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -107.3 -55.1 2.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.822 -176.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.12 -34.35 73.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.872 -162.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.57 -20.01 54.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 -171.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -45.55 -53.14 9.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.928 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.42 -52.28 44.89 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.556 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.23 -49.93 73.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.576 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -70.93 -47.52 58.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.96 -172.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.3 -47.7 63.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.162 -173.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -64.45 -35.35 80.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.1 m -83.76 -7.48 59.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.814 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.26 33.48 61.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mp -84.0 -4.82 59.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 110.975 -176.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.756 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.8 pp -132.34 145.66 51.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.974 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.23 142.19 43.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.126 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -66.73 134.26 51.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.883 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.853 HG13 ' HB3' ' A' ' 103' ' ' LEU . 39.8 pt -111.58 160.71 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.137 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.9 m -101.46 130.06 25.53 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.627 0.727 . . . . 0.0 111.173 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.27 147.91 54.32 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.655 2.236 . . . . 0.0 112.33 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -114.46 120.06 38.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.15 -38.73 91.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.07 -44.77 83.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -71.44 -35.19 70.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.509 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 43.6 tt0 -53.32 -46.53 69.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.929 173.288 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.63 -34.55 75.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.905 174.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.26 -23.3 54.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.4 OUTLIER -108.09 -93.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.879 -171.676 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 39.3 t80 -169.98 129.18 0.87 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.631 0.729 . . . . 0.0 111.067 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 94.8 Cg_exo -56.2 -43.68 53.85 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.6 2.2 . . . . 0.0 112.291 -171.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 1.8 t80 -72.04 -32.78 67.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.994 -173.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.558 ' CG2' ' HB3' ' A' ' 107' ' ' PRO . 96.2 m -64.39 -34.77 78.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.011 -171.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.701 ' HA ' HG23 ' A' ' 97' ' ' VAL . 61.0 m95 -70.37 -21.61 62.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.986 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 92' ' ' PHE . 97.5 m-20 -72.99 -33.73 65.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.83 171.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.92 -27.7 64.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.701 HG23 ' HA ' ' A' ' 94' ' ' TRP . 15.7 m -100.38 15.51 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.09 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 70.8 ttt180 -110.4 136.48 49.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -140.12 126.59 20.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.975 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.4 t30 59.87 34.7 21.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.95 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.41 -3.0 83.77 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.528 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.14 147.41 49.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.707 0.289 . . . . 0.0 110.961 174.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.853 ' HB3' HG13 ' A' ' 79' ' ' ILE . 3.3 tp -76.87 140.1 40.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.857 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.437 HG22 HD11 ' A' ' 76' ' ' LEU . 2.0 pp -122.14 -6.16 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 -171.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.417 ' HB3' ' CH2' ' A' ' 62' ' ' TRP . . . -164.97 166.67 19.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.085 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.45 ' HB3' HD11 ' A' ' 285' ' ' LEU . 87.1 m-85 -112.93 146.42 35.09 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.696 0.76 . . . . 0.0 110.939 169.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.558 ' HB3' ' CG2' ' A' ' 93' ' ' THR . 72.0 Cg_endo -76.16 118.93 5.13 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.631 2.22 . . . . 0.0 112.426 176.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.446 HD11 HD22 ' A' ' 285' ' ' LEU . 27.2 mm -92.5 -55.26 6.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.43 160.48 43.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.08 -168.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.41 HG23 HG23 ' A' ' 261' ' ' VAL . 89.0 t -119.41 136.67 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.101 -172.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -121.33 140.14 52.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.907 171.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.47 ' HB2' HD21 ' A' ' 323' ' ' ASN . . . -150.45 159.27 44.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.436 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 8.8 mp -92.31 169.23 10.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.903 -173.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.5 p -157.05 157.86 35.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.904 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -100.03 126.06 46.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.021 171.162 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.578 ' N ' HD23 ' A' ' 115' ' ' LEU . 4.8 mp -110.2 133.3 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.177 -174.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -133.25 150.37 51.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -91.12 118.75 30.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.58 -20.71 66.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.939 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -77.76 -27.94 50.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.506 HD22 ' O ' ' A' ' 220' ' ' GLY . 6.7 mp -95.5 -44.76 7.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.946 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.414 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 24.6 mt -108.74 103.32 51.24 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.631 0.729 . . . . 0.0 110.89 177.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 122' ' ' LEU . 72.6 Cg_endo -67.7 -23.61 42.09 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.686 2.257 . . . . 0.0 112.358 171.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -147.16 94.02 4.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.621 0.724 . . . . 0.0 110.894 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.94 152.7 79.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.684 2.256 . . . . 0.0 112.364 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.37 144.9 63.57 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.65 2.234 . . . . 0.0 112.389 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.53 -13.62 27.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.0 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.4 p -130.22 155.88 45.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.079 -174.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.573 ' HA ' HD11 ' A' ' 132' ' ' ILE . 64.2 m95 -68.44 -29.27 67.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.958 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.53 -25.02 67.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 -176.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -78.74 -21.22 48.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.894 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.605 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.6 mp -60.43 -52.88 69.78 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.661 0.743 . . . . 0.0 111.065 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.605 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 27.7 Cg_endo -66.89 -40.04 13.16 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.623 2.215 . . . . 0.0 112.441 -171.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.18 -41.61 76.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.118 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.7 tp -55.14 -43.45 74.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.446 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . 1.5 m-20 -49.87 -42.37 47.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.95 -35.13 79.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.898 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -75.5 -46.17 33.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 -171.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.471 ' HG ' ' HB2' ' A' ' 144' ' ' LYS . 0.8 OUTLIER -89.94 -18.74 25.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.96 -174.218 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -53.67 -30.33 42.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.83 167.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.18 -25.08 67.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.12 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -95.0 7.01 47.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.865 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.16 24.91 72.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.464 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.471 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 26.5 mmtp -110.04 167.55 10.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.37 . . . . 0.0 110.904 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.0 t -130.64 137.95 49.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.899 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 224' ' ' MET . . . -72.94 -53.48 11.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.068 -166.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.463 HD23 ' H ' ' A' ' 148' ' ' MET . 1.9 tm? -138.24 138.12 38.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 -167.119 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.463 ' H ' HD23 ' A' ' 147' ' ' LEU . 98.7 mtp -125.14 133.27 52.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.852 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.416 ' HE2' HD21 ' A' ' 151' ' ' LEU . 22.0 p90 -159.98 161.69 34.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.823 179.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -95.47 90.05 5.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.843 HD22 HD11 ' A' ' 195' ' ' LEU . 1.2 tm? -66.44 -32.75 74.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.951 -173.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.29 0.07 23.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -100.4 142.87 25.44 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.586 0.707 . . . . 0.0 110.914 176.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.613 ' HG3' ' CE1' ' A' ' 341' ' ' TYR . 29.9 Cg_endo -64.32 -22.47 66.36 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.672 2.248 . . . . 0.0 112.429 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -69.26 -35.47 76.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.964 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -92.09 -29.97 16.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.836 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.2 p -65.68 -45.67 81.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.271 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.614 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 90.6 t90 -66.21 -46.83 61.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.521 0.677 . . . . 0.0 110.82 -166.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.614 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 96.9 Cg_exo -48.81 -45.39 28.5 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.685 2.257 . . . . 0.0 112.422 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.77 HD21 ' O ' ' A' ' 160' ' ' LEU . 6.2 tt -69.15 -39.11 79.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 67.2 mt -71.55 -40.5 71.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.73 -26.47 44.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -60.41 -33.68 72.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.046 -171.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -95.02 3.3 55.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.846 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.88 -1.06 13.52 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.45 171.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.3 67.14 3.11 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.422 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -87.76 132.38 34.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 0.0 110.928 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.07 13.98 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.424 ' HA ' HG12 ' A' ' 181' ' ' VAL . 49.1 p90 -147.47 151.45 36.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.868 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -103.21 129.62 50.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.836 158.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -120.88 125.03 46.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -151.99 129.81 11.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.994 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.09 41.78 31.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 172.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.02 15.35 81.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.525 173.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -129.97 139.03 51.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.739 0.304 . . . . 0.0 110.842 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -99.74 144.6 28.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 171.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -122.06 108.05 12.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.865 172.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.533 ' C ' HD13 ' A' ' 178' ' ' ILE . 1.4 pp -77.77 -11.99 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.134 -178.264 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.14 -11.44 22.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -176.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -130.01 85.08 2.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 172.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.424 HG12 ' HA ' ' A' ' 169' ' ' PHE . 30.6 m -113.84 173.08 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 -169.134 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -101.97 23.76 33.57 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.455 -166.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.547 HG22 HD13 ' A' ' 368' ' ' ILE . 31.3 m -114.41 -7.59 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 0.0 111.131 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.5 p-10 -85.5 18.07 2.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -125.74 -170.02 2.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.84 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.07 -27.64 68.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.111 -173.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.2 -44.76 74.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.479 -164.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.759 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -67.01 -36.01 81.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.81 0.338 . . . . 0.0 111.07 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.487 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.5 mttt -59.04 -33.7 71.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.898 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.13 -31.68 73.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.105 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.83 -45.22 96.16 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.481 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.482 HD11 ' HB2' ' A' ' 346' ' ' ALA . 22.7 mt -64.98 -38.63 91.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.9 0.381 . . . . 0.0 110.98 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.1 m -58.2 -44.99 88.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.244 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -75.88 -45.49 35.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.843 HD11 HD22 ' A' ' 151' ' ' LEU . 6.5 tt -54.39 -48.57 71.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.961 -170.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.431 ' HA ' HD12 ' A' ' 199' ' ' ILE . 23.0 m -70.1 -19.93 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 -174.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.458 ' HB3' HD13 ' A' ' 198' ' ' LEU . 38.6 t70 -56.52 -56.74 17.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 -168.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.97 ' H ' HD13 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.5 -26.6 58.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.928 -167.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.581 ' H ' HD23 ' A' ' 198' ' ' LEU . 1.8 pp -86.99 -34.52 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.176 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.74 -32.6 69.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.914 166.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -84.88 5.0 30.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 65.19 36.84 6.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -86.24 -14.44 43.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 57.9 ttp -138.08 153.27 49.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.962 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -97.7 150.16 21.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.81 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.97 -26.65 68.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.103 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -93.78 4.9 53.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.809 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 91.5 m -61.03 129.97 44.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -139.81 169.65 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.837 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -66.63 -36.19 81.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 99.5 p -66.08 -36.57 83.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.745 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 73.4 mt -64.94 -39.36 85.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.31 83.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.172 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.41 -45.73 93.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.949 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.03 -38.64 91.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.15 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.93 97.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.176 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -65.22 -36.91 85.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -61.35 -34.01 74.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -89.59 -22.59 22.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.506 ' O ' HD22 ' A' ' 121' ' ' LEU . . . 88.19 24.92 32.81 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.505 -178.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -87.91 -26.84 22.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.38 . . . . 0.0 110.861 -173.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . 0.451 HG22 ' SD ' ' A' ' 148' ' ' MET . 75.6 m -116.87 129.92 56.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 -173.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.92 -49.8 55.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.439 ' HB3' HD22 ' A' ' 115' ' ' LEU . 71.1 mtm -136.43 157.06 47.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -170.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.9 t -149.15 157.68 43.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.2 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.3 mm -112.81 121.26 64.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.119 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.561 ' HB3' ' HB3' ' A' ' 231' ' ' ALA . 9.4 t-20 -156.05 170.0 23.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -172.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -132.42 -100.32 0.77 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.571 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.26 -22.94 39.45 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.703 2.269 . . . . 0.0 112.306 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -83.56 -20.11 34.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.002 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . 0.561 ' HB3' ' HB3' ' A' ' 227' ' ' ASN . . . -55.6 -45.1 77.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.073 -166.089 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -63.14 -19.1 64.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 -171.734 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.1 p -54.05 -25.41 21.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.879 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -136.17 39.94 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.46 ' HB ' ' HG2' ' A' ' 316' ' ' ARG . 95.6 mt -119.43 128.46 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 170.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -165.06 162.55 20.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 73.6 p -135.07 54.64 1.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.083 176.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 43.4 t -138.4 110.55 7.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.02 0.438 . . . . 0.0 110.827 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 62.34 21.33 12.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 -174.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 30.8 m -145.25 163.1 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.089 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -123.41 82.49 2.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.836 176.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.03 147.88 47.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.868 171.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -127.67 153.09 19.12 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.542 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.54 HG23 ' CB ' ' A' ' 319' ' ' ALA . 5.0 p -137.8 134.07 45.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 111.166 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.8 t -155.78 147.86 23.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.105 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.4 m -60.66 168.87 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.068 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.662 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.8 mm? -64.09 149.13 94.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.615 0.721 . . . . 0.0 110.855 -159.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 32.1 Cg_exo -65.12 179.08 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.705 2.27 . . . . 0.0 112.254 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 97.3 m -101.04 146.41 27.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.189 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -136.79 119.42 16.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 56.14 35.05 24.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.51 3.33 86.64 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.478 171.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -133.7 142.73 44.85 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.683 0.754 . . . . 0.0 110.886 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.78 144.94 44.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.727 2.284 . . . . 0.0 112.315 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.662 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 70.0 p -87.03 10.28 16.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 173.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -43.07 112.21 1.16 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.648 0.737 . . . . 0.0 110.887 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.415 ' CD ' HD21 ' A' ' 247' ' ' LEU . 80.7 Cg_endo -78.5 164.63 26.0 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.654 2.236 . . . . 0.0 112.355 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -71.27 163.26 28.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -174.15 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 60.5 t -107.88 135.22 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 -172.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.12 135.98 13.17 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.455 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.41 HG23 HG23 ' A' ' 110' ' ' VAL . 89.6 t -122.8 132.13 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 111.114 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.4 HD21 ' N ' ' A' ' 263' ' ' SER . 2.4 tt -66.61 128.89 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 171.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.4 ' N ' HD21 ' A' ' 262' ' ' LEU . 59.7 p -123.11 132.17 53.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -177.871 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.484 ' HB2' HD11 ' A' ' 280' ' ' LEU . . . -124.92 127.75 47.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.163 -173.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.78 167.01 14.46 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.416 -171.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.418 HD11 HG22 ' A' ' 59' ' ' ILE . 12.6 mm -99.98 126.81 53.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 111.148 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -62.86 126.39 27.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.889 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.85 -25.11 68.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.083 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.59 -10.52 55.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.112 -173.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.3 t -75.61 120.37 81.33 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.581 0.705 . . . . 0.0 110.928 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -70.91 -12.24 30.45 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.631 2.221 . . . . 0.0 112.289 171.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -112.07 35.75 3.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.984 -170.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.05 -25.11 65.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -169.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.94 -39.07 76.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.802 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.412 HD21 ' HB3' ' A' ' 7' ' ' LEU . 43.1 tp -66.26 -48.21 71.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 173.051 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.764 ' HB2' HG23 ' A' ' 59' ' ' ILE . . . -68.0 -50.0 58.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.053 -172.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -62.97 -41.34 99.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -63.86 -53.46 50.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.954 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.472 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -70.05 -36.88 75.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -173.369 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.519 ' HA ' HD23 ' A' ' 284' ' ' LEU . 6.4 tt -58.53 -46.56 86.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -77.23 -40.31 45.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.832 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -102.8 -9.68 19.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 -160.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.472 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 75.7 t80 -122.48 -49.07 2.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.519 HD23 ' HA ' ' A' ' 280' ' ' LEU . 0.1 OUTLIER -64.43 -47.1 80.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 178.082 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 106' ' ' TYR . 64.6 mt -85.0 59.2 5.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.49 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 37.4 p -140.23 151.16 44.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.149 172.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.539 ' HA ' HD11 ' A' ' 290' ' ' LEU . 43.1 p-10 -51.12 -26.06 6.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.916 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -79.6 -44.93 20.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.801 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.88 -50.1 20.12 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.532 -168.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.539 HD11 ' HA ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -74.79 -20.9 59.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.737 0.303 . . . . 0.0 110.903 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.43 ' N ' HD12 ' A' ' 290' ' ' LEU . 82.4 tt0 -66.13 -40.43 90.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.931 169.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.68 -34.74 76.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.193 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.611 HG13 ' HA3' ' A' ' 19' ' ' GLY . 24.7 t -78.45 -45.23 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.182 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.415 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 48.3 t30 -65.53 -27.79 68.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.04 -27.31 69.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -85.99 -41.33 14.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.928 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -150.96 129.82 6.27 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.576 0.703 . . . . 0.0 110.906 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.8 110.35 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.396 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.415 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 55.8 mt -88.19 -17.81 30.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.98 -171.299 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.633 ' O ' HG23 ' A' ' 317' ' ' ILE . . . 105.13 -42.78 1.81 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.445 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.42 ' HB3' ' O ' ' A' ' 300' ' ' GLY . . . -176.04 173.17 2.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.861 0.362 . . . . 0.0 111.059 164.372 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.54 HG23 HD22 ' A' ' 311' ' ' LEU . 23.2 m -122.7 153.69 27.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.149 170.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -68.19 -18.8 64.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.041 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.472 ' HA ' HD12 ' A' ' 89' ' ' LEU . 52.6 tp -83.03 121.95 27.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.967 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -60.37 -34.99 74.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 -174.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.7 m -64.06 -50.21 69.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.844 -169.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.607 ' CD2' HD21 ' A' ' 311' ' ' LEU . 36.0 t80 -82.8 -26.93 31.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.954 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -55.71 -43.85 76.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.903 177.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.22 -36.89 85.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -77.62 -48.49 16.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.787 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.834 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.5 pp -65.68 -24.78 67.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.988 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.514 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -62.72 -18.74 63.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.094 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.36 -19.93 64.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -79.15 122.12 83.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.575 0.703 . . . . 0.0 110.903 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.511 ' O ' HG11 ' A' ' 244' ' ' VAL . 84.0 Cg_exo -48.58 -31.97 19.97 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.721 2.28 . . . . 0.0 112.241 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.46 ' HG2' ' HB ' ' A' ' 235' ' ' ILE . 99.1 mtt180 -59.01 -36.73 75.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.846 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.834 HG21 ' CD1' ' A' ' 311' ' ' LEU . 38.7 mt -99.97 -34.25 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -171.64 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.39 -41.52 20.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 -164.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.54 ' CB ' HG23 ' A' ' 244' ' ' VAL . . . -65.69 -44.49 86.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.013 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 317' ' ' ILE . 73.1 p -68.09 -29.7 68.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.074 -176.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -68.24 -38.17 81.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.894 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.1 -46.67 80.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.47 HD21 ' HB2' ' A' ' 112' ' ' ALA . 27.6 t30 -65.43 -35.49 81.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 176.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.79 -46.27 89.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -77.18 -32.96 56.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.05 -2.52 50.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -100.26 -156.63 27.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.449 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -137.36 143.08 41.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.585 ' O ' ' C ' ' A' ' 330' ' ' MET . 45.2 mm -78.79 104.79 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 -170.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.585 ' C ' ' O ' ' A' ' 329' ' ' ILE . 22.1 ptp 22.21 59.78 0.3 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.57 0.7 . . . . 0.0 110.846 174.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.41 -15.61 6.27 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.744 2.296 . . . . 0.0 112.388 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.557 ' HB2' ' HG3' ' A' ' 336' ' ' MET . 52.5 p-10 -98.09 20.52 12.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -151.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 332' ' ' ASN . 30.4 pt 60.17 160.05 0.11 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.647 0.737 . . . . 0.0 111.098 154.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.0 -32.46 92.35 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.73 2.287 . . . . 0.0 112.316 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.62 -25.45 67.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 -169.173 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.557 ' HG3' ' HB2' ' A' ' 332' ' ' ASN . 88.2 mmm -75.17 -23.18 57.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 -171.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.6 m -62.25 -42.25 99.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.08 -33.0 63.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.989 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -64.85 -38.78 92.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.869 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 154' ' ' PRO . 38.3 m0 -60.59 -35.33 75.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 175.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . 0.613 ' CE1' ' HG3' ' A' ' 154' ' ' PRO . 32.3 m-85 -73.61 -38.62 65.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.33 94.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.148 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.402 ' O ' ' HB1' ' A' ' 346' ' ' ALA . 17.1 m -80.4 -25.12 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 178.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.463 ' O ' HG23 ' A' ' 347' ' ' VAL . 7.9 tmm_? -62.12 -45.58 92.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 173.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 98.1 m -55.61 -34.74 65.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.206 173.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.528 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -61.34 -42.99 99.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 -176.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 344' ' ' ARG . 1.4 m -74.35 -33.72 34.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.138 -174.143 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.44 -47.04 94.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.204 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 95.1 m-20 -64.98 -39.67 93.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.29 -46.74 60.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.2 -42.66 88.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.6 p -76.04 -10.61 59.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.82 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.18 14.97 81.68 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.581 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.65 -31.29 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.684 0.278 . . . . 0.0 110.848 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.441 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 84.9 mm-40 -139.56 158.3 44.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 51.2 p -78.39 166.55 22.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.194 170.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.47 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 62.7 t -55.72 -42.46 69.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 172.431 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -60.16 -46.09 90.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -69.89 -52.5 24.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.848 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -67.66 -45.5 75.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.041 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.759 HD11 ' HB1' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -67.42 -39.78 85.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.001 -177.068 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.57 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 87.9 tttt -64.78 -38.42 90.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -63.96 -38.02 89.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 175.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.528 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -64.61 -45.97 84.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.016 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.57 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 1.1 pp0? -73.03 -30.91 64.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -177.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 73.9 m -65.62 -42.73 91.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.153 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -66.26 -37.11 84.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.547 HD13 HG22 ' A' ' 183' ' ' VAL . 62.9 mt -66.0 -39.9 85.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.186 177.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 72.0 p -90.36 -11.15 41.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.153 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.927 175.487 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.784 0.326 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.9 mt -102.11 127.77 55.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -152.4 144.08 23.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.6 137.65 30.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.784 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.415 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 97.66 3.15 58.44 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.505 -172.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -170.1 153.31 4.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.76 0.315 . . . . 0.0 110.983 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.562 HD23 HD11 ' A' ' 33' ' ' ILE . 1.3 pt? -153.17 155.97 37.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.472 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 78.1 t -110.62 137.87 41.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.128 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.937 HG13 HD22 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -122.09 132.76 70.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.095 -179.32 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.467 ' HB3' HD12 ' A' ' 43' ' ' LEU . 45.6 m0 -109.89 127.44 54.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 168.127 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.554 ' HB ' HD23 ' A' ' 20' ' ' LEU . 6.9 tt -108.18 145.6 15.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.137 -170.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -53.01 143.96 16.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.28 -13.53 21.99 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.418 -174.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -74.76 -10.29 59.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.861 0.363 . . . . 0.0 110.854 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -145.29 136.92 25.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 158.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.93 -83.86 1.01 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.537 -164.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -114.5 -45.0 3.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.951 0.405 . . . . 0.0 110.908 -173.219 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -68.6 -52.94 26.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.886 -149.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.608 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -60.27 -48.99 83.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 -175.67 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.937 HD22 HG13 ' A' ' 9' ' ' ILE . 18.0 tp -65.09 -41.41 95.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 110.978 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.23 67.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 173.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -67.17 -48.77 66.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.941 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.417 HG23 ' HA ' ' A' ' 20' ' ' LEU . 14.3 m -74.7 -34.47 34.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.503 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -65.53 -45.11 91.44 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.536 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -64.2 -38.93 92.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.84 0.352 . . . . 0.0 110.905 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -63.31 -42.65 99.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.974 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.475 ' CD2' HD12 ' A' ' 33' ' ' ILE . 56.3 t80 -65.06 -37.74 88.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.822 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.98 -41.55 98.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.974 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.96 -31.99 69.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.875 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -80.61 -41.53 23.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.83 -172.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.61 ' OG1' HG13 ' A' ' 33' ' ' ILE . 51.1 p -105.11 -8.44 18.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.031 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.71 10.0 84.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.555 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 1.004 HD13 ' O ' ' A' ' 33' ' ' ILE . 2.0 pp -103.29 132.51 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.943 0.401 . . . . 0.0 111.119 -174.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -70.61 126.94 31.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.911 -168.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.523 HG23 HD22 ' A' ' 7' ' ' LEU . 93.2 t -110.27 120.52 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.099 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.402 ' HB ' HG23 ' A' ' 8' ' ' VAL . 99.6 m -112.83 113.83 26.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.064 -174.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.492 HG23 ' HG ' ' A' ' 20' ' ' LEU . 96.1 t -93.22 132.62 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.149 176.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.4 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 94.9 mt-10 -126.06 155.15 42.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 177.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.3 t-80 -77.04 140.03 66.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.604 0.716 . . . . 0.0 110.841 -161.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 72.7 Cg_exo -56.76 -22.22 43.77 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.72 2.28 . . . . 0.0 112.332 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -47.1 -50.16 20.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 -173.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -86.98 -9.85 54.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.467 HD12 ' HB3' ' A' ' 10' ' ' TRP . 7.7 tt -46.93 -54.24 10.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 -167.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.05 -35.23 66.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.868 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -74.96 -47.2 30.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.906 -168.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -84.75 -33.66 23.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -170.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.595 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 94.4 t80 -48.22 -53.12 36.5 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.587 0.708 . . . . 0.0 110.966 -165.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.595 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 39.1 Cg_endo -62.8 -30.51 77.92 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.65 2.233 . . . . 0.0 112.443 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -76.7 -43.72 36.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.1 m -74.78 -25.05 18.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.208 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.83 -33.67 76.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.119 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.97 69.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.3 p -91.4 -13.85 31.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.17 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.14 15.27 81.76 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.499 170.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -138.92 130.04 26.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.884 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.09 -118.84 0.73 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.472 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 84.4 Cg_endo -72.8 154.11 53.75 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.756 2.304 . . . . 0.0 112.432 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.439 ' CB ' HD11 ' A' ' 59' ' ' ILE . 1.7 m-20 -87.15 -38.42 16.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 170.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.749 HG23 ' HB2' ' A' ' 276' ' ' ALA . 0.0 OUTLIER -134.05 150.05 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.077 179.155 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 tp -129.33 124.73 60.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.1 -174.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.461 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 2.4 m-85 -100.15 134.75 42.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.466 ' CH2' ' HB3' ' A' ' 105' ' ' ALA . 32.2 p90 -145.01 -177.82 5.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.842 174.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.75 -97.14 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.144 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -110.44 -55.43 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -58.83 -35.75 73.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -162.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.532 ' HD3' ' CZ ' ' A' ' 70' ' ' TYR . 4.4 mmp_? -74.56 -21.24 59.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 -172.613 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -45.95 -54.59 8.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.95 -53.58 36.42 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.45 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.69 -52.44 53.07 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.532 ' CZ ' ' HD3' ' A' ' 66' ' ' ARG . 15.8 m-30 -75.78 -41.98 51.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.919 0.39 . . . . 0.0 110.893 -168.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.34 -47.18 71.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.096 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -65.07 -34.93 79.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.8 m -81.7 -7.97 59.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.45 32.08 62.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.472 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mp -84.75 -4.5 59.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 110.978 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.746 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.2 pp -128.28 145.02 51.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.18 141.43 47.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.4 mp0 -69.27 132.33 46.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.909 HG13 ' HB3' ' A' ' 103' ' ' LEU . 37.7 pt -118.82 167.11 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.154 175.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.5 p -113.76 149.55 41.95 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.599 0.714 . . . . 0.0 111.118 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.08 146.82 41.93 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.691 2.261 . . . . 0.0 112.39 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -108.11 119.25 38.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.999 0.428 . . . . 0.0 110.789 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.14 -42.23 99.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.852 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.12 -46.52 80.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.142 -177.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.549 ' HB3' ' HZ2' ' A' ' 94' ' ' TRP . 9.1 m-85 -72.07 -33.86 68.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -177.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.458 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.6 tt0 -53.95 -48.07 70.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.933 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.6 -35.02 79.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.95 -23.26 55.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.978 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.584 HD21 ' HG2' ' A' ' 107' ' ' PRO . 1.4 mp -108.75 -92.3 0.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 -173.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.442 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 33.6 t80 -169.68 127.84 0.84 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.597 0.713 . . . . 0.0 110.996 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 87.3 Cg_exo -57.07 -42.66 61.47 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.646 2.23 . . . . 0.0 112.341 -170.645 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.599 ' O ' ' HD1' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -70.18 -33.27 71.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -174.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.642 ' CG2' ' HB3' ' A' ' 107' ' ' PRO . 88.3 m -67.56 -36.26 80.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 -173.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.612 ' HA ' HG23 ' A' ' 97' ' ' VAL . 68.5 m95 -67.83 -26.45 66.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.933 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -73.76 -32.17 63.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.82 171.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.11 -25.8 62.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.085 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.612 HG23 ' HA ' ' A' ' 94' ' ' TRP . 19.8 m -101.39 17.81 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.099 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.426 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 75.7 ttt180 -112.91 132.1 55.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.933 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -138.41 127.75 24.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 62.05 34.87 16.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.919 175.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.31 -4.17 78.34 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.578 173.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.42 150.05 48.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.353 . . . . 0.0 110.959 173.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.909 ' HB3' HG13 ' A' ' 79' ' ' ILE . 2.9 tp -74.42 140.4 44.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.563 HG22 HD11 ' A' ' 76' ' ' LEU . 2.0 pp -118.56 -7.35 11.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.091 -174.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.466 ' HB3' ' CH2' ' A' ' 62' ' ' TRP . . . -164.78 168.83 17.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.117 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.45 ' HB3' HD11 ' A' ' 285' ' ' LEU . 94.5 m-85 -112.22 146.41 34.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.714 0.769 . . . . 0.0 110.903 168.115 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.642 ' HB3' ' CG2' ' A' ' 93' ' ' THR . 73.9 Cg_endo -74.11 118.23 5.31 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.629 2.219 . . . . 0.0 112.381 172.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.423 HD12 HD22 ' A' ' 280' ' ' LEU . 29.7 mm -92.09 -54.97 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.147 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.89 158.63 44.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.059 -167.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.65 137.47 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.076 -172.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -122.01 139.07 54.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.543 ' HB2' HD21 ' A' ' 323' ' ' ASN . . . -152.1 160.16 43.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.063 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -94.56 168.68 10.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.852 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 100.0 p -154.87 152.92 30.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.819 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.966 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -100.03 128.38 46.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 169.316 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.518 ' N ' HD23 ' A' ' 115' ' ' LEU . 4.3 mp -111.07 137.01 45.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -133.75 149.58 51.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -86.45 110.98 20.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.461 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 88.9 tttt -62.1 -23.12 66.34 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -76.01 -24.19 55.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.893 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.537 HD22 ' O ' ' A' ' 220' ' ' GLY . 7.0 mp -94.76 -53.37 3.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.862 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.493 HD23 ' HB2' ' A' ' 223' ' ' ALA . 1.7 mp -105.07 132.31 20.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.678 0.751 . . . . 0.0 110.863 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.44 -16.99 24.21 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.686 2.257 . . . . 0.0 112.331 -175.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.585 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 20.8 p30 -154.33 161.62 28.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.614 0.721 . . . . 0.0 110.915 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.585 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 57.8 Cg_endo -69.59 155.12 67.38 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.646 2.231 . . . . 0.0 112.392 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.14 146.38 70.02 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.669 2.246 . . . . 0.0 112.299 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -100.12 -48.6 4.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 72.7 p -133.17 158.56 42.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 48.9 t-105 -64.2 -30.23 71.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 175.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.06 -23.67 65.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -174.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -72.75 -32.17 65.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.506 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 1.6 mp -66.03 -47.17 63.55 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.644 0.735 . . . . 0.0 111.085 -163.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.506 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 97.9 Cg_exo -53.31 -50.89 12.37 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.653 2.235 . . . . 0.0 112.267 -175.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.94 -39.21 69.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.134 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 30.3 tp -56.02 -45.32 79.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.406 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . 19.5 t70 -53.74 -34.97 60.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.837 -177.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.47 -36.76 79.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -73.44 -53.21 11.23 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -172.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.573 HD21 ' N ' ' A' ' 140' ' ' LYS . 0.8 OUTLIER -80.01 -10.64 59.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -175.804 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.573 ' N ' HD21 ' A' ' 139' ' ' LEU . 86.5 tttt -55.99 -31.61 63.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.943 166.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.87 -25.1 68.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -95.14 5.59 51.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.47 28.85 60.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.528 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -120.09 170.09 9.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.758 0.313 . . . . 0.0 110.904 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.3 t -131.25 141.25 49.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -70.42 -55.13 9.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.048 -166.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -141.97 131.05 23.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 -170.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.734 ' SD ' ' HB3' ' A' ' 213' ' ' ALA . 52.7 ttm -110.54 123.76 50.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -150.46 157.15 42.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -167.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -101.81 96.24 6.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.965 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.861 HD22 HD11 ' A' ' 195' ' ' LEU . 1.8 tm? -76.12 -18.29 59.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.973 172.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -80.36 -2.49 45.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.434 ' O ' HG21 ' A' ' 157' ' ' THR . 38.4 mt-10 -113.53 152.21 45.17 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.574 0.702 . . . . 0.0 110.909 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.541 ' HD3' ' CD ' ' A' ' 344' ' ' ARG . 30.5 Cg_endo -66.91 -19.82 51.97 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.68 2.254 . . . . 0.0 112.367 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -65.02 -40.66 95.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -172.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . 0.434 ' HD2' HD21 ' A' ' 151' ' ' LEU . 74.7 t80 -82.97 -36.04 25.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.807 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.434 HG21 ' O ' ' A' ' 153' ' ' GLU . 81.9 p -60.51 -46.7 89.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.189 -170.579 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.661 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 89.0 t90 -67.84 -48.17 41.53 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.502 0.667 . . . . 0.0 110.897 -167.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.661 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 78.5 Cg_exo -47.57 -46.37 20.86 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.666 2.244 . . . . 0.0 112.512 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.684 HD21 ' O ' ' A' ' 160' ' ' LEU . 6.5 tt -70.07 -39.87 75.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.965 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 71.0 mt -70.39 -41.02 78.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.014 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.63 -28.6 61.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.116 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.529 ' HB1' ' HD2' ' A' ' 250' ' ' PHE . . . -63.12 -34.96 78.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 -170.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -91.48 1.99 56.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.884 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.01 1.31 14.48 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.467 170.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.33 65.02 4.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.55 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -84.86 133.55 34.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.912 0.387 . . . . 0.0 110.893 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.25 5.43 10.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.076 -170.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.435 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.0 p90 -146.85 152.9 39.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.944 0.402 . . . . 0.0 110.956 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -103.78 126.15 50.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.98 156.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -115.69 126.28 53.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.857 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -151.58 130.07 12.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.913 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.1 t30 55.02 43.87 29.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 171.388 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.98 14.85 81.41 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.48 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.23 138.71 50.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 0.0 110.845 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -99.37 144.61 28.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 170.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -121.48 110.59 16.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.876 172.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.579 ' C ' HD13 ' A' ' 178' ' ' ILE . 1.2 pp -80.0 -12.64 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.082 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.96 -13.13 20.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -122.94 85.23 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.874 170.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.435 HG12 ' HA ' ' A' ' 169' ' ' PHE . 34.1 m -116.9 170.48 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.115 -169.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.63 24.42 29.84 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.45 -167.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.529 HG22 HD13 ' A' ' 368' ' ' ILE . 11.3 m -110.01 -15.45 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.0 111.112 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -85.92 19.61 2.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.786 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -110.32 -179.91 3.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.1 -24.6 64.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.097 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.413 ' O ' ' HB1' ' A' ' 190' ' ' ALA . . . -70.87 -40.63 63.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.456 -171.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.642 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -64.38 -35.35 80.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 111.115 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.546 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.1 mttt -59.05 -31.22 68.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 175.545 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.413 ' HB1' ' O ' ' A' ' 187' ' ' GLY . . . -65.51 -30.69 71.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.115 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.16 -47.46 84.9 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.379 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.514 HD11 ' HB2' ' A' ' 346' ' ' ALA . 19.7 mt -64.89 -38.91 92.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.883 0.373 . . . . 0.0 110.936 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.3 m -58.71 -45.12 90.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.21 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -77.28 -43.06 34.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.843 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.861 HD11 HD22 ' A' ' 151' ' ' LEU . 6.0 tt -55.57 -48.6 74.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 -171.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 24.8 m -68.58 -19.22 24.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -57.5 -54.87 41.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 -169.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 1.049 ' H ' HD13 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -76.1 -26.48 56.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.925 -168.021 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.609 ' H ' HD23 ' A' ' 198' ' ' LEU . 1.8 pp -86.65 -34.42 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.172 177.018 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.86 -31.81 68.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.856 165.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -85.86 6.06 29.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.861 177.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 65.0 39.94 5.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 170.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -84.54 -9.76 58.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 58.7 ttp -134.54 151.38 51.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -97.69 155.56 16.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.921 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.95 -27.76 69.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -95.25 4.25 53.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.903 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.409 ' CG2' ' HG3' ' A' ' 148' ' ' MET . 90.0 m -63.08 132.14 50.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.15 -176.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.427 ' H ' HD13 ' A' ' 212' ' ' ILE . 23.6 t0 -149.75 167.39 26.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.858 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -68.58 -34.01 75.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.0 p -63.57 -32.58 74.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.427 HD13 ' H ' ' A' ' 209' ' ' ASP . 79.7 mt -62.42 -36.56 75.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.08 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.734 ' HB3' ' SD ' ' A' ' 148' ' ' MET . . . -66.07 -42.22 89.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.081 -173.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -64.82 -39.24 93.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.986 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.32 -40.3 85.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.102 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.89 -34.59 78.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.121 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -59.95 -33.66 72.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.825 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -59.91 -34.98 73.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.954 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -96.45 -21.13 17.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.98 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . 0.537 ' O ' HD22 ' A' ' 121' ' ' LEU . . . 91.05 30.51 11.0 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.439 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -84.73 -27.75 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.876 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 94.9 m -116.96 131.1 57.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.216 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.493 ' HB2' HD23 ' A' ' 122' ' ' LEU . . . -66.26 -54.57 23.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.098 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.447 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 67.0 mtm -137.82 160.0 40.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.797 -168.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 10.4 t -149.76 164.17 36.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.7 mm -111.29 125.58 68.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.07 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -144.65 167.82 21.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.893 -169.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.407 ' HA3' ' HD2' ' A' ' 229' ' ' PRO . . . -118.52 -155.13 9.85 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.471 -174.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.407 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 30.7 Cg_endo -59.99 -22.53 69.49 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.725 2.283 . . . . 0.0 112.289 176.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.9 p90 -81.54 4.33 21.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.949 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -51.57 -29.24 16.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.0 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -53.54 -20.59 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 26.3 t -42.03 -57.81 2.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.808 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -150.65 40.36 0.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.482 HD13 HG21 ' A' ' 116' ' ' ILE . 46.5 mm -125.01 108.8 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.124 174.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -168.95 162.71 11.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 170.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 82.8 m -125.05 102.25 7.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.204 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 43.4 t -134.67 104.26 5.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.838 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 59.04 34.12 23.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.868 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.94 165.68 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.135 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -99.14 70.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -174.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.461 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 82.4 m-85 -130.03 145.58 51.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.004 172.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -128.26 153.13 19.36 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.509 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.643 HG23 ' HB3' ' A' ' 319' ' ' ALA . 6.7 p -138.53 135.96 43.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.381 . . . . 0.0 111.193 -177.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.2 t -153.44 149.89 28.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.416 ' CG1' ' HB2' ' A' ' 323' ' ' ASN . 25.1 m -60.76 167.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.674 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.3 mm? -64.77 146.19 98.62 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.586 0.708 . . . . 0.0 110.899 -160.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.85 -177.01 2.61 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.727 2.284 . . . . 0.0 112.285 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.2 p -106.76 162.63 13.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.143 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.529 ' HD2' ' HB1' ' A' ' 163' ' ' ALA . 44.7 t80 -146.03 123.43 11.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 176.2 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 55.33 35.25 24.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.84 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.53 12.12 70.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.531 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -137.05 140.37 31.19 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.56 0.695 . . . . 0.0 110.947 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.36 140.82 30.94 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.677 2.251 . . . . 0.0 112.407 -174.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.674 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 89.8 p -83.33 -5.1 59.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.798 169.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.401 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 50.9 mtmt -48.33 110.07 1.33 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.546 0.689 . . . . 0.0 110.901 -176.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 32.1 Cg_exo -66.0 163.53 30.83 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.623 2.216 . . . . 0.0 112.32 -177.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -73.66 174.82 7.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.828 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.5 t -108.39 132.32 56.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.048 -170.704 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -112.12 126.85 7.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.436 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 96.9 t -116.0 134.41 59.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.854 0.359 . . . . 0.0 111.098 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.416 HD21 ' N ' ' A' ' 263' ' ' SER . 2.6 tt -67.32 129.75 40.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.945 171.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.416 ' N ' HD21 ' A' ' 262' ' ' LEU . 64.3 p -124.63 131.82 53.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.899 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -125.25 125.87 44.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.137 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -119.75 170.34 14.08 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.424 -171.142 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.426 HD11 HG22 ' A' ' 59' ' ' ILE . 13.1 mm -99.96 127.93 52.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.768 0.318 . . . . 0.0 111.107 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -64.91 127.25 30.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.4 ' HB3' ' C ' ' A' ' 76' ' ' LEU . . . -64.9 -24.29 67.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.122 -177.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.65 -11.57 55.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.037 -172.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.6 t -77.67 122.38 85.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.632 0.73 . . . . 0.0 110.87 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.34 -11.57 30.31 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.591 2.194 . . . . 0.0 112.349 171.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -111.73 35.19 3.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.917 -169.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -59.31 -26.68 65.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.834 -170.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -69.03 -39.86 78.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.864 -172.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.38 -48.45 72.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.749 ' HB2' HG23 ' A' ' 59' ' ' ILE . . . -67.38 -48.17 68.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.153 -172.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -65.25 -37.46 87.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.426 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.5 tt0 -68.21 -53.7 22.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 -172.022 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.413 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.1 p90 -67.54 -35.13 78.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.837 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.484 ' HA ' HD23 ' A' ' 284' ' ' LEU . 4.8 tt -58.58 -50.04 75.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -79.95 -33.51 39.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.426 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 65.6 m-80 -100.01 -17.71 17.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 -164.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.413 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 40.0 t80 -121.33 -48.64 2.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.954 -172.059 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.484 HD23 ' HA ' ' A' ' 280' ' ' LEU . 0.3 OUTLIER -65.04 -46.39 81.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.82 176.228 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.45 HD11 ' HB3' ' A' ' 106' ' ' TYR . 64.8 mt -84.97 59.39 5.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.494 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 52.5 p -138.47 150.2 46.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.187 172.228 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.587 ' HA ' HD11 ' A' ' 290' ' ' LEU . 42.9 p-10 -51.56 -26.0 7.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.84 -174.057 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -78.65 -44.8 22.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.791 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.4 -51.07 13.68 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 -169.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.587 HD11 ' HA ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -73.31 -20.78 60.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 110.91 -179.251 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.436 ' N ' HD12 ' A' ' 290' ' ' LEU . 81.8 tt0 -66.06 -40.75 91.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.933 168.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.79 76.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.075 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.608 HG13 ' HA3' ' A' ' 19' ' ' GLY . 24.9 t -77.4 -44.62 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.143 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.438 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 49.8 t30 -65.03 -25.86 68.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.968 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.4 -28.96 70.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -87.01 -41.65 13.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.822 -176.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -147.69 132.8 9.08 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 121.515 0.674 . . . . 0.0 111.027 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -51.99 111.92 0.72 Allowed 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.628 2.219 . . . . 0.0 112.408 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.438 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 55.3 mt -90.98 -17.17 26.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -172.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.537 ' O ' HG23 ' A' ' 317' ' ' ILE . . . 102.96 -43.04 1.75 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.394 175.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -176.27 168.72 2.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.823 0.344 . . . . 0.0 110.974 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.526 HG23 HD22 ' A' ' 311' ' ' LEU . 23.9 m -122.6 154.29 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.199 170.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -69.44 -18.39 63.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.09 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.487 ' CD2' HD22 ' A' ' 290' ' ' LEU . 63.3 tp -83.63 122.62 28.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.014 -173.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -59.55 -36.33 75.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.787 -173.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.8 m -63.11 -49.87 72.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 -168.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.6 ' CD2' HD21 ' A' ' 311' ' ' LEU . 33.1 t80 -83.79 -26.97 29.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -56.43 -44.38 80.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.918 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.01 -36.23 83.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.875 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -76.01 -48.89 19.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.826 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.6 pp -66.72 -25.43 66.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.482 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -64.2 -17.37 63.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.061 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -67.3 -17.86 64.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.872 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -80.02 123.28 83.61 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.557 0.694 . . . . 0.0 110.904 173.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.562 ' O ' HG11 ' A' ' 244' ' ' VAL . 83.7 Cg_exo -52.85 -35.59 70.68 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.582 2.188 . . . . 0.0 112.319 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -64.79 -26.83 68.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.92 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.826 HG21 ' CD1' ' A' ' 311' ' ' LEU . 56.3 mt -96.75 -34.54 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.115 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.21 -39.41 13.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.012 -167.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.643 ' HB3' HG23 ' A' ' 244' ' ' VAL . . . -65.15 -44.32 88.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.05 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 317' ' ' ILE . 69.2 p -68.27 -29.9 68.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.128 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 18.0 tmm? -69.99 -40.13 75.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -65.69 -45.6 82.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.543 HD21 ' HB2' ' A' ' 112' ' ' ALA . 25.4 t30 -63.42 -36.3 83.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.967 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.79 -48.28 79.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.032 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -75.4 -32.69 60.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -94.75 -5.6 44.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.931 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -95.28 -157.73 32.43 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.496 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -140.02 142.73 36.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 110.925 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.581 ' O ' ' C ' ' A' ' 330' ' ' MET . 31.4 mm -79.91 108.47 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.215 -170.331 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.646 ' O ' ' HG3' ' A' ' 330' ' ' MET . 20.4 ptp 23.13 60.47 0.34 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.503 0.668 . . . . 0.0 110.848 174.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -90.05 -19.45 1.24 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.76 2.307 . . . . 0.0 112.264 -169.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.478 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 52.0 p-10 -97.17 6.88 47.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.93 -148.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.594 HG22 ' H ' ' A' ' 335' ' ' GLN . 39.0 mm 77.97 135.69 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.681 0.753 . . . . 0.0 111.111 174.151 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.89 -24.68 32.43 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.694 2.263 . . . . 0.0 112.303 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.594 ' H ' HG22 ' A' ' 333' ' ' ILE . 99.6 mm-40 -63.43 -21.26 66.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 79.7 mmm -71.33 -25.02 62.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.91 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.0 m -61.76 -40.06 93.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 176.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.88 -34.3 60.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.995 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -63.39 -37.97 89.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.891 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 154' ' ' PRO . 21.0 m0 -61.07 -34.5 75.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -76.79 -35.27 57.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . 0.438 ' HB2' ' HB2' ' A' ' 367' ' ' ARG . . . -63.2 -39.98 96.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.057 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.8 m -81.82 -24.2 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.091 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.541 ' CD ' ' HD3' ' A' ' 154' ' ' PRO . 52.9 ttt180 -55.63 -55.45 31.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.824 173.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 96.6 m -56.87 -33.0 66.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.131 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -56.94 -44.51 82.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.136 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.447 ' HA ' HD23 ' A' ' 192' ' ' LEU . 1.3 m -74.96 -33.1 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.179 -174.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.3 -47.21 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.22 173.163 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.577 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 84.5 m-20 -66.73 -37.01 83.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.52 -47.26 61.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.091 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.45 -39.87 92.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.094 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.5 p -74.86 -14.17 60.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.007 0.432 . . . . 0.0 110.85 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 76.67 10.61 85.83 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.505 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -79.77 -25.09 41.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.765 0.317 . . . . 0.0 110.844 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.577 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 87.5 mt-30 -133.15 158.26 43.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 169.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.5 p -79.37 171.01 15.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.154 168.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.435 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 67.1 t -55.88 -44.5 78.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.07 169.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -58.21 -44.93 88.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -70.84 -52.02 22.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -69.19 -44.66 71.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.132 -173.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.642 HD11 ' HB1' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -65.49 -39.99 92.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 -177.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . 0.574 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.0 tttt -64.91 -38.4 90.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.894 176.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -65.83 -36.89 84.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 177.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.654 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -63.92 -44.77 91.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.077 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.574 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -73.26 -30.38 63.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.942 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 68.5 m -64.34 -41.17 96.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . 0.438 ' HB2' ' HB2' ' A' ' 342' ' ' ALA . 99.6 mtt180 -67.74 -39.62 84.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.748 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.529 HD13 HG22 ' A' ' 183' ' ' VAL . 67.9 mt -65.6 -39.27 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.164 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.8 p -92.59 -9.04 42.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.064 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.99 173.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.733 0.301 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.475 HG21 ' HD2' ' A' ' 271' ' ' PRO . 87.1 mt -79.75 126.35 39.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -148.49 147.38 29.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.801 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.3 129.77 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.817 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.474 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 96.33 5.85 59.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.448 -174.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.445 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.0 tttt -164.71 139.86 5.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.779 0.324 . . . . 0.0 110.945 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.683 HD23 HD11 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -146.39 157.45 43.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.488 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 75.3 t -108.94 133.43 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.114 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.773 HG13 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -123.11 135.36 63.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 -178.493 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -109.07 160.87 15.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.572 HG21 ' HB2' ' A' ' 15' ' ' LYS . 87.9 mt -132.93 149.26 31.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.154 166.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.511 ' O ' HG22 ' A' ' 11' ' ' ILE . 62.0 t30 -58.26 159.81 5.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 174.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.51 -15.36 8.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.555 -174.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.91 -24.05 65.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 110.872 -172.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.572 ' HB2' HG21 ' A' ' 11' ' ' ILE . 35.4 mtmt -134.25 132.04 39.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.944 169.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.07 -94.07 0.76 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.459 -168.451 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -115.24 -46.67 2.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 110.943 -172.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -64.03 -47.85 78.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.963 -155.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.93 ' HA3' HG21 ' A' ' 293' ' ' VAL . . . -57.91 -45.66 93.39 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.431 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.773 HD11 HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -51.51 -50.73 59.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.872 0.368 . . . . 0.0 110.865 177.024 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.18 -39.37 63.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.167 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -70.1 -52.33 24.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.0 m -69.2 -36.33 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.574 ' HA3' HG22 ' A' ' 35' ' ' VAL . . . -66.72 -41.14 93.93 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.513 173.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -54.07 -46.06 71.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.889 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.9 -44.06 90.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.945 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.672 ' CE2' HD12 ' A' ' 33' ' ' ILE . 44.0 t80 -65.71 -38.09 88.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.812 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 34.7 tt0 -64.5 -42.94 95.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.841 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.6 -32.46 68.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -81.14 -39.35 25.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.872 -171.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.722 ' OG1' HG13 ' A' ' 33' ' ' ILE . 67.8 p -103.78 -10.21 18.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.42 7.39 85.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.453 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 1.085 HD13 ' O ' ' A' ' 33' ' ' ILE . 1.8 pp -104.08 132.51 50.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.882 0.372 . . . . 0.0 111.064 -175.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.445 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.8 mttt -70.41 136.74 49.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -171.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.574 HG22 ' HA3' ' A' ' 24' ' ' GLY . 3.0 m -111.99 133.07 58.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 174.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.409 ' HB ' HG23 ' A' ' 8' ' ' VAL . 94.6 m -110.1 125.66 53.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.102 179.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.595 HG23 ' HG ' ' A' ' 20' ' ' LEU . 60.9 t -89.66 126.29 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 178.772 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -112.91 148.88 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 175.018 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 64.8 t-80 -86.27 136.19 35.95 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.658 0.742 . . . . 0.0 110.883 -169.387 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 83.2 Cg_exo -56.04 -21.36 34.17 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.721 2.28 . . . . 0.0 112.322 -175.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -48.07 -53.99 14.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 43' ' ' LEU . 99.1 mttt -88.78 0.92 56.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -172.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 12' ' ' ASN . 16.4 tp -39.88 -54.73 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.975 -173.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.48 -35.27 68.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.844 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.19 -47.93 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 -166.475 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 79.1 tttt -78.6 -43.81 25.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 -171.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.563 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 83.6 t80 -50.87 -53.88 42.76 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.574 0.702 . . . . 0.0 110.851 -167.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 38.9 Cg_endo -65.98 -30.11 48.44 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.629 2.22 . . . . 0.0 112.351 -177.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -74.8 -41.99 58.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.44 HG22 ' HD3' ' A' ' 57' ' ' PRO . 24.9 m -75.48 -21.5 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.201 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 -31.69 72.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.057 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.15 -29.76 70.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.11 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.9 p -92.62 -15.19 27.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.199 170.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.98 18.38 79.64 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.432 171.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -140.2 143.85 36.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.863 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.48 -78.31 0.33 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.477 168.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.488 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 89.0 Cg_endo -78.52 140.99 17.35 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.727 2.284 . . . . 0.0 112.329 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.424 ' HB2' HD11 ' A' ' 59' ' ' ILE . 1.5 m-20 -101.41 -41.13 6.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.97 173.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.65 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -132.92 143.68 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.195 176.91 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.0 tp -136.08 128.06 44.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.174 -169.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.498 ' N ' ' HD1' ' A' ' 61' ' ' PHE . 2.0 m-30 -97.89 142.28 29.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.926 -175.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.483 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 80.3 m95 -140.72 159.74 41.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 174.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.17 -88.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.059 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.407 ' CG ' HG21 ' A' ' 329' ' ' ILE . 86.1 t60 -125.48 -62.54 1.19 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.874 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -75.39 -35.42 61.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 -161.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.483 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 9.4 mpt_? -54.66 -33.75 61.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.895 -168.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.577 ' HB3' HD11 ' A' ' 104' ' ' ILE . 51.0 m-85 -56.79 -38.71 72.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -172.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.06 -50.49 57.31 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.485 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.13 -42.35 99.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.515 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -74.66 -33.21 62.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.945 0.403 . . . . 0.0 110.985 -176.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.414 ' HA ' HD12 ' A' ' 76' ' ' LEU . . . -65.11 -38.71 91.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.074 170.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -63.97 -34.63 78.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 98.9 p -86.7 -10.14 54.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.886 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.54 28.97 62.41 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.554 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 mp -90.39 -17.2 27.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 -173.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 1.33 ' O ' HD13 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.09 121.17 37.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.826 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -64.73 137.83 58.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.084 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.21 137.05 56.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.452 HD13 ' CE2' ' A' ' 106' ' ' TYR . 37.2 pt -109.98 160.42 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.8 p -96.97 149.87 36.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.547 0.689 . . . . 0.0 111.214 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.13 137.93 29.8 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.74 2.294 . . . . 0.0 112.397 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -104.06 108.8 20.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.888 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.77 -41.78 91.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.969 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.38 -41.88 98.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.218 -176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.574 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 13.0 m-30 -74.35 -47.6 33.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -49.44 -42.53 43.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -57.35 -30.58 64.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.889 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.423 ' O ' ' HB2' ' A' ' 305' ' ' LYS . 84.9 mttt -87.45 -13.81 42.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.931 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.574 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 46.8 mt -104.93 -145.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.973 -170.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.97 140.69 37.11 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.743 0.782 . . . . 0.0 110.888 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.48 -28.78 38.31 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.628 2.218 . . . . 0.0 112.405 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -65.58 -42.81 91.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.522 HG23 HG22 ' A' ' 261' ' ' VAL . 81.2 p -78.25 -38.37 42.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.161 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -49.37 -46.97 47.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.931 169.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.42 -35.6 80.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.76 -24.94 65.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.024 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.49 HG21 HD11 ' A' ' 103' ' ' LEU . 31.7 m -112.46 20.77 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.206 -171.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.478 ' HB3' HD12 ' A' ' 103' ' ' LEU . 54.7 ptt85 -120.01 146.7 45.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.919 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -136.93 125.58 23.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.014 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.3 t30 60.01 37.05 21.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.73 1.07 90.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.517 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -117.46 150.15 39.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.758 0.314 . . . . 0.0 110.905 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.49 HD11 HG21 ' A' ' 97' ' ' VAL . 6.3 tp -81.68 136.79 35.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.577 HD11 ' HB3' ' A' ' 67' ' ' PHE . 2.1 pp -128.04 2.72 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.153 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.494 ' HB3' ' CE1' ' A' ' 67' ' ' PHE . . . -168.32 169.22 10.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.064 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 263' ' ' SER . 99.4 m-85 -120.1 139.67 28.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.682 0.753 . . . . 0.0 110.887 166.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.413 ' HD3' HG22 ' A' ' 97' ' ' VAL . 98.4 Cg_endo -78.52 122.99 5.75 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.586 2.19 . . . . 0.0 112.362 172.362 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.403 HD13 ' O ' ' A' ' 106' ' ' TYR . 2.2 mp -109.66 -42.92 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.039 -174.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.491 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -137.36 144.46 42.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 -165.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.27 131.49 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.17 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -117.6 125.37 50.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 176.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.519 ' HB1' ' CG2' ' A' ' 320' ' ' THR . . . -163.57 163.74 24.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.145 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.436 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 6.6 mp -101.03 170.93 7.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.917 -167.03 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 86.7 p -158.84 154.4 26.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 171.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.877 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -100.06 129.62 46.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.898 174.722 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.63 ' N ' HD23 ' A' ' 115' ' ' LEU . 5.2 mp -114.34 135.99 52.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 -177.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -135.8 154.93 51.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 -172.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -96.78 119.31 35.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.462 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 98.4 mttt -65.6 -18.98 65.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -83.38 -28.16 29.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.811 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.465 HD23 ' HA ' ' A' ' 223' ' ' ALA . 10.4 mp -88.09 -44.6 10.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.76 HD23 ' HB2' ' A' ' 223' ' ' ALA . 2.2 pt? -139.94 127.29 12.67 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.607 0.718 . . . . 0.0 110.907 168.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.73 -10.37 17.03 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.592 2.195 . . . . 0.0 112.412 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.448 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 61.0 t-20 -143.48 108.32 5.2 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.643 0.735 . . . . 0.0 110.881 -175.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.448 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 48.0 Cg_endo -68.03 148.61 76.04 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.728 2.286 . . . . 0.0 112.222 -178.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.17 142.7 56.57 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.721 2.281 . . . . 0.0 112.341 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -83.38 -27.93 29.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.4 p -127.15 154.54 44.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.106 -177.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.686 ' HA ' HD11 ' A' ' 132' ' ' ILE . 54.4 m95 -69.89 -23.96 63.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.29 -23.1 63.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -78.52 -22.59 47.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.686 HD11 ' HA ' ' A' ' 129' ' ' TRP . 1.4 mp -56.16 -51.13 83.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.677 0.751 . . . . 0.0 111.15 -170.057 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.611 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.6 Cg_endo -69.36 -41.25 4.97 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.621 2.214 . . . . 0.0 112.299 -172.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.0 -40.54 71.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.994 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 0.832 ' CD2' ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -58.35 -42.67 87.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.963 174.443 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.52 ' HA ' ' HB3' ' A' ' 146' ' ' ALA . 32.7 t70 -52.65 -37.24 58.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.09 -31.01 69.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.9 -56.39 5.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.842 -174.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.527 HD21 ' N ' ' A' ' 140' ' ' LYS . 1.0 OUTLIER -80.89 -10.06 59.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -175.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.527 ' N ' HD21 ' A' ' 139' ' ' LEU . 86.0 tttt -54.36 -30.77 52.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.804 165.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.82 -24.92 68.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.086 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -95.01 4.05 54.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.36 27.37 59.72 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.478 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.46 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 38.4 mmtm -116.48 155.52 28.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 0.0 110.891 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.9 t -100.73 147.53 25.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.834 173.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.52 ' HB3' ' HA ' ' A' ' 136' ' ' ASP . . . -67.25 -43.32 82.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.171 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.475 HD11 HG12 ' A' ' 226' ' ' ILE . 48.9 tp -141.4 152.6 44.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.843 -177.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 61.5 tpp -128.0 125.17 38.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.793 170.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -161.07 165.05 30.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -110.0 165.63 11.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 172.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.5 HD11 HD11 ' A' ' 195' ' ' LEU . 36.6 tp -130.15 -16.81 3.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.856 171.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -71.92 0.71 8.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.847 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.423 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 70.3 mm-40 -121.82 144.9 41.99 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.672 0.749 . . . . 0.0 110.882 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.446 ' HB3' ' HB3' ' A' ' 340' ' ' TRP . 53.9 Cg_exo -55.22 -28.74 63.33 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.789 2.326 . . . . 0.0 112.313 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -59.49 -42.29 91.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -86.47 -32.24 20.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.467 HG23 HG22 ' A' ' 347' ' ' VAL . 65.0 p -64.84 -37.47 87.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.225 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.572 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 42.7 t-105 -61.93 -54.52 49.92 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 121.597 0.713 . . . . 0.0 111.016 -173.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.572 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 33.2 Cg_endo -67.14 -27.6 41.56 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.699 2.266 . . . . 0.0 112.38 -174.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.673 ' C ' HD13 ' A' ' 160' ' ' LEU . 2.9 tm? -64.77 -41.85 95.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.581 HG22 ' HA3' ' A' ' 166' ' ' GLY . 2.9 mp -78.08 -41.91 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.23 176.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.32 -20.21 65.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.072 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.475 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -57.87 -34.17 69.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.985 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -101.51 5.37 41.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.864 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.33 9.21 24.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.379 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.581 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -75.09 65.79 2.25 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.344 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -95.69 134.81 38.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.885 0.374 . . . . 0.0 110.96 173.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.549 ' HB2' HG21 ' A' ' 368' ' ' ILE . . . -47.77 -31.0 4.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 -175.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.42 ' CD1' HG12 ' A' ' 181' ' ' VAL . 98.5 m-85 -138.48 148.03 43.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.911 174.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -69.11 127.66 33.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -102.04 119.95 39.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.933 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -150.83 130.61 13.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.809 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.3 t30 55.38 42.43 30.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.934 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.38 9.39 81.39 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.416 173.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.03 141.55 49.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.7 0.286 . . . . 0.0 110.892 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -94.11 135.33 35.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 172.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -95.92 105.41 17.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.907 -170.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.458 ' C ' HD13 ' A' ' 178' ' ' ILE . 2.4 pp -71.31 -6.52 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -100.89 -16.7 17.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -134.95 100.75 4.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' A' ' 168' ' ' ALA . 32.4 m -101.45 162.14 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.132 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -101.75 -0.1 52.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.527 -168.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.5 m -100.72 -20.03 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 0.0 111.128 -171.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -96.28 20.11 10.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -106.62 -175.08 2.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 -174.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.49 71.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.061 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -71.4 -41.25 58.96 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.461 -170.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.413 ' HB1' HD22 ' A' ' 361' ' ' LEU . . . -61.71 -34.68 76.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.775 0.321 . . . . 0.0 111.036 177.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -61.75 -40.87 96.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.969 174.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.06 76.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.025 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.512 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -58.68 -48.88 82.5 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.458 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.493 HD11 ' HB2' ' A' ' 346' ' ' ALA . 25.8 mt -66.41 -39.11 88.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.943 0.402 . . . . 0.0 110.967 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.9 m -58.55 -45.39 89.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.197 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.439 ' O ' HD23 ' A' ' 198' ' ' LEU . 82.3 t80 -68.91 -48.53 63.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 174.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.839 ' C ' HD21 ' A' ' 195' ' ' LEU . 3.2 tt -50.76 -51.79 46.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -174.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.516 ' HA ' HG23 ' A' ' 199' ' ' ILE . 34.7 m -63.52 -23.47 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.071 -175.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.54 -34.01 73.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.961 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 194' ' ' PHE . 0.6 OUTLIER -82.15 -40.02 22.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -174.952 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.551 ' O ' HG12 ' A' ' 199' ' ' ILE . 0.0 OUTLIER -75.23 -29.56 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 175.829 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . 0.435 ' N ' HD11 ' A' ' 199' ' ' ILE . 87.6 tttt -72.36 -46.54 54.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.901 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -90.16 5.75 45.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 67.27 37.72 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 170.474 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -83.04 -13.78 55.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.918 173.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -138.22 155.15 48.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.917 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -103.78 139.83 38.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.824 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.96 -22.24 64.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.071 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.72 -5.84 58.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.895 -172.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 86.7 m -60.03 137.98 57.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.457 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 20.9 t0 -139.25 175.41 9.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -60.82 -45.8 93.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.917 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 96.3 p -67.57 -35.97 80.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.457 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 85.8 mt -64.17 -41.61 92.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.145 175.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.76 -38.89 84.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.091 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -63.17 -45.86 89.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.803 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.14 95.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.159 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.67 97.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.02 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -66.78 -47.38 72.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.873 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -66.0 -30.52 71.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -86.02 -13.6 46.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.924 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.03 26.23 53.56 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.47 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -86.42 -28.62 23.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 0.0 110.911 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 15.3 t -119.79 134.38 55.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.109 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.76 ' HB2' HD23 ' A' ' 122' ' ' LEU . . . -78.45 -34.14 47.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.107 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.477 ' HB3' HD22 ' A' ' 115' ' ' LEU . 77.7 mtm -128.94 150.33 50.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.847 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.8 t -145.34 150.97 37.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.475 HG12 HD11 ' A' ' 147' ' ' LEU . 39.2 mm -107.04 122.22 60.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.11 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -140.98 149.39 41.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.436 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -127.24 -150.58 7.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.482 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.05 -20.36 71.22 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.658 2.239 . . . . 0.0 112.282 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -71.6 -24.47 61.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.905 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 55.09 54.92 8.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.079 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -60.27 -38.17 82.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.953 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 35.7 t -105.0 118.79 37.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 168.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -75.45 72.83 2.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.424 HD11 HG21 ' A' ' 116' ' ' ILE . 78.7 mt -85.56 111.24 20.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.155 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -125.05 -85.01 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 96.8 m -128.21 130.11 47.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.193 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 45.2 t -147.16 155.42 42.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.791 175.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.51 -24.09 63.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.891 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 25.5 m -72.33 165.01 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.134 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -92.71 121.06 33.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.897 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.462 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 31.3 p90 -143.53 152.56 41.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.937 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -143.01 167.8 26.23 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.606 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.435 HG21 HG13 ' A' ' 116' ' ' ILE . 7.7 p -132.27 139.5 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.966 0.412 . . . . 0.0 111.061 -172.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.0 t -144.92 147.16 32.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 168.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 16.6 m -56.92 156.45 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.133 168.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.483 ' N ' HD12 ' A' ' 247' ' ' LEU . 7.4 mp -66.76 148.99 98.61 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.514 0.673 . . . . 0.0 110.897 -157.109 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 48.1 Cg_exo -60.69 178.34 0.49 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.781 2.321 . . . . 0.0 112.369 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 82.1 p -99.96 153.98 18.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -135.31 117.05 15.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 54.77 35.17 23.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 89.11 5.7 72.73 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.472 171.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -124.36 140.54 35.35 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.606 0.717 . . . . 0.0 110.854 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.02 129.5 17.43 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.688 2.258 . . . . 0.0 112.326 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 68.0 m -78.81 -26.76 44.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.87 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -47.63 109.92 1.22 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.557 0.694 . . . . 0.0 110.91 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -58.72 161.31 15.33 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.731 2.287 . . . . 0.0 112.307 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -62.4 162.1 10.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 112' ' ' ALA . 3.5 p -108.3 134.03 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.11 -175.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.25 142.94 16.06 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.451 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.522 HG22 HG23 ' A' ' 93' ' ' THR . 73.3 t -127.65 122.54 59.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 111.194 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.643 HD21 ' N ' ' A' ' 263' ' ' SER . 1.6 tt -82.05 130.77 35.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 172.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.643 ' N ' HD21 ' A' ' 262' ' ' LEU . 62.2 m -132.32 158.16 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.902 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.18 138.98 50.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.063 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.76 178.27 18.23 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.46 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 77' ' ' ALA . 27.0 mm -103.6 137.06 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.908 0.385 . . . . 0.0 111.092 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -72.29 127.4 32.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.826 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -65.43 -23.06 66.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.1 -176.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.75 -11.72 55.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.054 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.7 t -77.16 120.84 83.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.66 0.743 . . . . 0.0 110.917 -173.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.475 ' HD2' HG21 ' A' ' 2' ' ' ILE . 77.7 Cg_endo -69.12 -10.57 29.42 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.707 2.271 . . . . 0.0 112.32 170.177 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -103.01 21.41 15.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 -170.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -52.97 -31.63 41.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 -170.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -66.18 -47.3 74.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.83 -170.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.04 -26.94 20.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.948 -177.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.582 ' HB2' HG23 ' A' ' 59' ' ' ILE . . . -63.14 -45.11 93.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.16 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -69.73 -33.95 73.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.987 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 92.4 mt-10 -66.43 -35.52 80.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.827 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.498 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 0.8 OUTLIER -56.27 -53.56 55.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.795 175.769 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.512 ' HB2' HD12 ' A' ' 284' ' ' LEU . 2.1 pp -79.06 -34.78 43.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.906 -170.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.22 -42.4 72.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 95.4 m-20 -97.56 -4.38 37.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 -164.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.624 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 47.3 m-85 -118.36 -54.4 2.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.033 173.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.567 ' O ' ' HB3' ' A' ' 290' ' ' LEU . 25.3 mt -81.17 -42.49 20.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.942 -169.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.486 HD21 HD12 ' A' ' 280' ' ' LEU . 4.0 mm? -81.58 19.94 0.97 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 169.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.638 ' O ' HD23 ' A' ' 290' ' ' LEU . 94.0 m -132.61 142.67 49.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.101 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 47.9 p-10 -51.44 -26.19 7.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -168.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -74.46 -46.8 37.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -175.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.624 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -80.62 -48.04 6.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 -165.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.722 HD21 ' N ' ' A' ' 291' ' ' GLU . 0.7 OUTLIER -70.21 -16.06 63.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 110.936 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.722 ' N ' HD21 ' A' ' 290' ' ' LEU . 83.2 tt0 -71.99 -47.33 52.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 167.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.81 -40.75 98.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.087 -172.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.93 HG21 ' HA3' ' A' ' 19' ' ' GLY . 3.3 p -70.75 -36.83 66.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -67.43 -25.21 65.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.784 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.84 -29.36 70.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -90.67 -43.11 10.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.419 ' O ' HD13 ' A' ' 299' ' ' LEU . 65.8 mttm -127.92 145.78 56.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.531 0.681 . . . . 0.0 110.902 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.7 107.14 1.59 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.748 2.298 . . . . 0.0 112.329 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.47 ' HG ' ' HD3' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -91.89 -19.21 22.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.944 -179.021 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.495 ' O ' HD12 ' A' ' 317' ' ' ILE . . . 88.58 -62.02 3.78 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.573 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -160.25 167.49 27.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 111.17 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.748 HG22 ' HB3' ' A' ' 307' ' ' TYR . 33.2 m -131.14 156.15 42.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.213 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.06 -14.82 60.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.077 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.463 ' HA ' HD21 ' A' ' 89' ' ' LEU . 50.4 tp -81.21 126.83 31.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -173.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . 0.423 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 87.2 tttt -55.41 -44.99 76.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 63.7 m -61.59 -52.18 65.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.802 -168.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.748 ' HB3' HG22 ' A' ' 302' ' ' VAL . 12.6 t80 -78.02 -32.67 51.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -62.91 -42.03 99.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.921 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -62.09 -38.99 90.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.894 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.69 -48.76 29.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.617 HD22 HG23 ' A' ' 302' ' ' VAL . 4.6 pp -69.13 -23.48 63.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.854 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.429 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.41 -14.96 63.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.14 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.45 -16.4 62.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.965 176.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.48 133.48 44.43 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.575 0.702 . . . . 0.0 110.864 169.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . 0.43 ' O ' HG11 ' A' ' 244' ' ' VAL . 90.5 Cg_exo -47.74 -35.74 24.3 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.673 2.249 . . . . 0.0 112.342 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -61.96 -27.64 68.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -167.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.495 HD12 ' O ' ' A' ' 300' ' ' GLY . 2.1 mp -100.03 -40.85 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.162 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.11 -47.24 61.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -162.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.25 -34.77 75.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.19 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.519 ' CG2' ' HB1' ' A' ' 112' ' ' ALA . 62.9 m -61.42 -37.01 81.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.058 -176.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.6 mtp -60.16 -30.46 69.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.896 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -65.45 -43.95 88.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -77.06 -39.75 48.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.36 -39.79 73.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.156 -168.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.3 -28.32 69.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -108.6 -1.68 19.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -86.16 -160.21 33.68 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.414 -168.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -140.93 154.75 46.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.987 0.422 . . . . 0.0 110.825 -173.174 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.407 HG21 ' CG ' ' A' ' 64' ' ' HIS . 40.6 mm -68.07 116.28 7.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.114 -171.192 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 63.3 ttp -60.09 140.18 90.85 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.515 0.674 . . . . 0.0 110.904 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.89 109.34 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.635 2.223 . . . . 0.0 112.383 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -107.02 10.17 30.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 42.0 pt -72.52 162.02 76.15 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.73 0.776 . . . . 0.0 111.138 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -53.07 -31.49 54.39 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.679 2.253 . . . . 0.0 112.347 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -66.58 -16.46 64.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.885 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.474 ' HA ' ' CD2' ' A' ' 339' ' ' PHE . 68.0 ttp -54.84 -34.88 63.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 95.9 p -65.14 -31.12 72.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.29 -35.54 63.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.163 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.56 ' HB3' ' CZ3' ' A' ' 158' ' ' TRP . 3.2 m-30 -56.34 -55.65 30.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 176.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 154' ' ' PRO . 52.5 m0 -62.79 -37.82 88.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.92 -172.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -69.71 -48.04 61.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.826 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.14 -42.36 93.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.168 -173.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.465 HG22 ' HA ' ' A' ' 158' ' ' TRP . 19.6 m -73.0 -28.0 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.065 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.401 ' O ' HG23 ' A' ' 347' ' ' VAL . 78.6 ttt-85 -62.71 -40.95 98.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.938 173.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 93.0 m -57.33 -36.07 70.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.157 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.493 ' HB2' HD11 ' A' ' 192' ' ' LEU . . . -65.41 -45.76 82.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.017 -175.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.467 HG22 HG23 ' A' ' 157' ' ' THR . 2.4 m -72.18 -34.42 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.132 -174.586 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.447 HD13 HG21 ' A' ' 347' ' ' VAL . 1.5 mp -63.18 -46.36 96.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.187 173.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -67.81 -39.49 83.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.924 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.59 -47.61 39.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.105 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.32 -37.43 80.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.12 -173.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.2 p -74.99 -9.1 58.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 75.51 11.66 84.2 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -78.77 -27.14 44.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.791 0.329 . . . . 0.0 110.893 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.409 ' HB2' ' HB3' ' A' ' 360' ' ' ALA . 82.4 mm-40 -139.67 156.23 46.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.939 173.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.6 p -77.15 164.96 25.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.194 170.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.7 t -51.91 -41.01 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 175.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.78 -48.94 76.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.994 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -76.82 -44.23 33.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.937 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.409 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . . . -63.56 -47.35 81.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.102 -177.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.413 HD22 ' HB1' ' A' ' 188' ' ' ALA . 13.5 tp -67.07 -52.86 36.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.957 -178.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -54.03 -46.8 71.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.939 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -72.23 -43.68 64.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.08 -47.07 54.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.168 -175.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -67.66 -30.77 70.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 24.9 m -55.14 -31.87 61.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.111 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -58.98 -29.84 67.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.549 HG21 ' HB2' ' A' ' 168' ' ' ALA . 77.9 mt -56.15 -40.11 62.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.113 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.6 p -100.99 -10.43 20.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.115 -174.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.882 179.643 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.718 0.294 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.2 mt -94.08 125.11 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -150.07 147.96 28.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -50.79 133.85 25.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.799 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.96 4.92 64.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.508 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.9 tttt -163.11 141.71 8.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 110.959 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.589 ' CD2' HD12 ' A' ' 33' ' ' ILE . 2.3 pt? -146.51 154.49 41.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.93 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 88.6 t -110.91 134.7 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.09 -177.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.672 HD12 ' HB ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -119.96 133.56 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 -178.994 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.73 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 65.2 m95 -106.59 124.19 49.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.942 164.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.519 HD13 ' HG ' ' A' ' 20' ' ' LEU . 12.1 tt -110.01 150.0 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.114 -165.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -62.74 148.18 47.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 -173.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.61 -17.69 21.02 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.454 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.88 -27.34 68.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -173.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 15' ' ' LYS . 35.7 mmtm -140.06 133.67 30.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 166.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.63 -80.77 0.95 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.497 -169.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -99.97 -38.7 8.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.839 0.352 . . . . 0.0 110.914 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -68.15 -51.91 40.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -151.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.11 -55.47 23.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.461 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.519 ' HG ' HD13 ' A' ' 11' ' ' ILE . 5.7 mt -53.82 -53.04 57.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.44 -40.21 7.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.082 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -72.12 -59.51 2.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.854 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 20' ' ' LEU . 20.7 m -70.33 -38.16 73.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 -172.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.78 ' HA3' HG22 ' A' ' 35' ' ' VAL . . . -66.98 -48.39 60.62 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.525 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -56.75 -35.0 68.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.846 0.355 . . . . 0.0 110.957 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -55.36 -39.62 70.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.987 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 5.6 m-30 -59.17 -46.32 88.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -65.0 -39.61 93.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -69.44 -38.23 77.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.853 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -94.95 -48.2 6.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -169.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.8 p -110.62 -1.47 16.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 -171.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.87 3.71 90.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.45 168.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 1.079 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -99.99 134.02 40.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.928 0.394 . . . . 0.0 111.124 -176.046 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.5 mttt -83.08 144.09 30.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.924 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.78 HG22 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -120.01 134.62 62.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 175.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.498 ' O ' HD13 ' A' ' 9' ' ' ILE . 97.0 m -102.21 129.09 48.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.145 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.468 HG23 ' HB3' ' A' ' 20' ' ' LEU . 87.2 t -99.57 125.86 53.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -115.06 149.9 36.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.4 t-80 -86.13 138.92 34.45 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.573 0.702 . . . . 0.0 110.928 -165.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 77.1 Cg_exo -56.49 -27.57 69.41 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.695 2.263 . . . . 0.0 112.291 -175.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -47.97 -50.55 26.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -172.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -88.79 -5.04 58.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.6 tt -46.11 -54.85 7.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.897 -169.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.32 -38.32 90.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.953 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.95 -40.82 95.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.899 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.437 ' HB3' HG13 ' A' ' 50' ' ' VAL . 75.3 mmtt -82.91 -20.01 36.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.581 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 84.4 t80 -49.29 -50.73 62.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.635 0.731 . . . . 0.0 110.799 -165.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 43.3 Cg_endo -82.85 -30.16 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.673 2.248 . . . . 0.0 112.385 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -74.86 -41.45 59.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 -167.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.494 HG22 ' HG3' ' A' ' 57' ' ' PRO . 32.1 m -67.58 -27.11 37.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 -175.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.505 ' CB ' ' HB3' ' A' ' 75' ' ' LEU . . . -69.33 -36.52 77.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.12 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.36 -33.49 75.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.147 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.8 p -94.46 -21.9 18.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.111 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.83 9.16 65.4 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.44 174.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -123.01 120.04 32.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.88 -95.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.427 172.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.73 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 64.5 Cg_endo -79.79 147.3 19.26 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.734 2.29 . . . . 0.0 112.394 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.04 -35.17 12.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.781 161.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.616 ' HB ' HG23 ' A' ' 9' ' ' ILE . 45.8 mt -125.24 136.87 59.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.141 -175.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.0 tp -132.88 126.41 53.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.187 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -92.22 138.98 31.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.857 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.492 ' CZ2' ' HB3' ' A' ' 105' ' ' ALA . 24.9 p90 -145.07 163.35 34.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.042 170.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.25 -90.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.039 -168.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.617 ' HB2' ' HB3' ' A' ' 332' ' ' ASN . 6.3 m170 -123.34 -68.04 0.9 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.868 -171.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -103.29 -12.36 17.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.844 -159.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 55.8 ttm-85 -51.05 -20.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 -174.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.486 ' HB2' HD11 ' A' ' 104' ' ' ILE . 32.6 p90 -59.21 -33.48 71.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.06 -50.45 65.97 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.46 -168.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.16 -37.65 94.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.5 174.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.642 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 9.3 t80 -69.01 -42.1 76.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.849 0.357 . . . . 0.0 110.89 -175.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.61 -42.95 70.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.095 175.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -58.24 -37.59 75.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.957 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.418 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 58.1 m -84.55 -5.01 59.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.795 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.01 30.27 59.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.464 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.505 ' HB3' ' CB ' ' A' ' 51' ' ' ALA . 46.1 mt -89.39 -10.04 48.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.867 0.365 . . . . 0.0 110.905 -168.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.642 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -131.03 153.27 49.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.877 -179.074 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -80.0 139.73 36.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.128 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.4 mp0 -65.68 137.34 57.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.3 pt -100.57 152.09 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.107 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.7 m -96.91 119.0 64.39 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.591 0.71 . . . . 0.0 111.085 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.63 ' HB3' HD12 ' A' ' 103' ' ' LEU . 73.1 Cg_endo -73.97 155.55 47.95 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.745 2.297 . . . . 0.0 112.324 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -105.52 117.86 35.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.842 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -52.87 -35.06 57.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.02 90.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.5 m-30 -75.87 -33.28 59.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.896 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.511 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 86.4 mt-30 -54.9 -51.93 64.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.71 -33.84 70.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -81.96 -18.43 43.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.841 -172.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.448 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -104.7 -105.02 0.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 -172.812 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.517 ' CG ' ' HD2' ' A' ' 91' ' ' PRO . 5.0 t80 -178.72 142.74 0.42 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.705 0.764 . . . . 0.0 110.956 -166.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.517 ' HD2' ' CG ' ' A' ' 90' ' ' TYR . 31.3 Cg_endo -68.25 -37.6 13.72 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.731 2.287 . . . . 0.0 112.337 -175.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -75.08 -29.28 60.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.9 p -72.68 -37.05 68.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.266 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.754 ' CE3' HD13 ' A' ' 103' ' ' LEU . 86.4 m95 -73.61 -26.43 60.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.893 173.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -73.02 -31.31 64.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.853 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.23 -23.88 63.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.07 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.605 HG23 ' HA ' ' A' ' 94' ' ' TRP . 17.9 m -106.16 16.4 6.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.075 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.3 ttp85 -100.97 126.31 47.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.974 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -125.82 115.8 20.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.7 t30 57.17 35.11 25.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.897 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.65 -0.97 89.18 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.558 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -120.97 143.55 48.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 110.862 174.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.754 HD13 ' CE3' ' A' ' 94' ' ' TRP . 41.5 mt -89.59 135.58 33.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 -172.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.486 HD11 ' HB2' ' A' ' 67' ' ' PHE . 2.1 pp -127.21 3.36 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 -166.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.492 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . . . -160.97 160.21 30.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.166 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.437 ' HB3' ' CD2' ' A' ' 285' ' ' LEU . 97.0 m-85 -108.53 139.57 20.94 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.582 0.706 . . . . 0.0 110.871 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -78.91 121.63 5.06 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.708 2.272 . . . . 0.0 112.327 170.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 1.06 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -105.59 -40.92 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.225 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.586 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -141.74 150.84 42.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.103 -164.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.6 t -115.65 123.91 71.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -112.92 122.34 47.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.648 ' HB2' HD22 ' A' ' 323' ' ' ASN . . . -150.18 144.8 25.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.065 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.5 ' HB2' ' HB3' ' A' ' 257' ' ' PRO . 7.1 mp -87.56 170.03 11.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -174.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.2 p -158.33 154.92 27.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.845 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.824 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -91.92 129.1 37.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 169.102 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.619 ' N ' HD23 ' A' ' 115' ' ' LEU . 4.9 mp -116.37 130.89 70.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.116 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -133.19 154.26 50.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 -171.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.46 ' O ' HD21 ' A' ' 122' ' ' LEU . 69.8 m-80 -88.0 119.57 28.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.862 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.434 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.6 mttt -64.82 -27.35 68.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -82.84 -24.13 33.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.819 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.0 mp -80.49 -54.43 5.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 172.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.703 ' H ' HD21 ' A' ' 122' ' ' LEU . 1.6 pt? -140.36 127.9 12.51 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.617 0.722 . . . . 0.0 110.952 176.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.44 -9.43 14.91 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.659 2.239 . . . . 0.0 112.436 -176.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -149.28 98.0 3.53 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.554 0.693 . . . . 0.0 110.871 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.27 157.08 63.36 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.623 2.215 . . . . 0.0 112.293 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -66.4 143.07 68.34 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.633 2.222 . . . . 0.0 112.36 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.1 -17.48 37.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.5 p -134.5 157.53 46.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.185 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.517 ' HA ' HD11 ' A' ' 132' ' ' ILE . 71.4 m95 -70.15 -23.15 62.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.967 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.02 -24.59 67.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -85.59 -18.38 33.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.901 -177.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.58 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -59.54 -42.87 94.32 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.686 0.755 . . . . 0.0 111.163 -170.382 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.58 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 92.9 Cg_endo -80.01 -37.83 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.664 2.243 . . . . 0.0 112.35 -173.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.88 -58.92 6.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.12 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 1.238 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.49 -17.08 64.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -176.038 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.556 ' N ' HD13 ' A' ' 135' ' ' LEU . 37.8 t70 -60.04 -41.39 92.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 168.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.72 -30.8 70.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.29 -47.29 61.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.88 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.637 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.1 pp -85.16 -14.61 46.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.888 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.637 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.8 tttt -60.36 -34.47 73.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.955 174.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.06 -23.4 67.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -95.03 4.23 54.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.935 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.06 32.6 56.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.369 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -111.09 169.96 8.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 0.0 110.836 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.8 t -120.82 139.4 53.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 167.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -67.64 -44.02 78.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 -171.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -138.88 131.46 28.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 52.2 ttm -117.11 130.85 56.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -153.62 155.13 35.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -174.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -86.17 -51.98 5.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.78 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 1.044 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.5 tm? 48.34 31.71 2.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.919 -169.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -102.11 -9.02 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 176.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -129.71 152.39 79.7 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 121.726 0.774 . . . . 0.0 110.818 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.419 ' HB3' ' HB3' ' A' ' 340' ' ' TRP . 51.8 Cg_exo -55.01 -29.62 65.75 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.675 2.25 . . . . 0.0 112.343 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -68.45 -30.0 68.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -79.91 -41.05 26.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 172.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.445 HG21 HG11 ' A' ' 347' ' ' VAL . 19.4 m -60.8 -52.45 65.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.132 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.581 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 15.1 t-105 -59.23 -48.75 95.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.488 0.661 . . . . 0.0 110.907 -161.338 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.581 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 90.8 Cg_exo -52.25 -44.71 44.36 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.694 2.262 . . . . 0.0 112.355 -177.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.609 ' C ' HD21 ' A' ' 160' ' ' LEU . 7.7 tt -71.26 -40.09 71.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.826 -171.237 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 83.0 mt -71.08 -43.44 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.71 -22.0 60.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.158 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.49 -28.57 68.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.107 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -99.11 1.77 45.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.856 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 108.5 5.65 31.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.478 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.59 67.97 2.52 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.541 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -83.83 132.68 34.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.895 0.379 . . . . 0.0 110.999 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.38 6.77 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.134 -174.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.445 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.3 p90 -149.73 155.01 39.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.912 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.404 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 87.3 tttt -104.97 124.69 49.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 157.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -116.26 124.42 50.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -153.91 130.63 10.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.02 43.04 30.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.75 17.29 80.06 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.518 173.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.63 138.58 48.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.71 0.29 . . . . 0.0 110.866 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -96.99 144.69 26.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 169.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -123.51 111.66 16.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.59 ' C ' HD13 ' A' ' 178' ' ' ILE . 1.1 pp -79.98 -12.74 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.55 -11.05 25.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.899 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.404 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 66.0 t0 -127.28 88.24 2.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 171.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 169' ' ' PHE . 32.7 m -116.13 166.92 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.063 -170.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.16 22.3 31.54 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.517 -170.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.494 HG22 HD13 ' A' ' 368' ' ' ILE . 1.5 m -105.47 -20.0 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.753 0.311 . . . . 0.0 111.083 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -86.48 21.16 2.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -104.96 -174.97 2.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 -175.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.9 -29.37 67.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.05 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.64 -40.18 77.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.437 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.511 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -62.57 -37.64 86.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.934 0.397 . . . . 0.0 111.162 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.607 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 88.6 mttt -62.92 -37.97 89.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 174.073 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.13 -36.99 85.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.079 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.42 -47.57 62.39 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.507 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.792 HD11 ' HA ' ' A' ' 347' ' ' VAL . 20.6 tp -66.41 -34.25 77.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 0.0 110.841 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.521 ' OG1' HG22 ' A' ' 357' ' ' VAL . 91.5 m -63.69 -40.68 97.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.227 174.555 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.483 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 61.8 t80 -67.15 -49.27 65.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.62 ' C ' HD21 ' A' ' 195' ' ' LEU . 7.2 tt -50.43 -51.69 44.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.884 -175.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 199' ' ' ILE . 35.2 m -63.9 -22.48 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.145 -174.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.5 m-20 -61.8 -34.58 76.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.42 HD23 ' O ' ' A' ' 194' ' ' PHE . 0.9 OUTLIER -80.95 -40.15 24.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -173.996 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.61 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.7 pp -72.98 -29.76 30.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 172.545 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.91 -37.59 79.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.917 173.31 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -80.09 2.31 24.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 68.16 38.57 2.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.773 168.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -78.99 -17.33 55.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.823 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.61 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.2 ppp? -145.2 158.14 43.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.864 176.57 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -94.94 148.87 21.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.87 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.89 -25.75 67.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.169 -175.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -95.9 1.72 53.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 94.7 m -62.48 124.97 22.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.196 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.43 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 14.5 t0 -119.93 177.68 4.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -64.89 -37.38 87.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.035 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 96.1 p -70.32 -38.37 74.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.43 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 77.7 mt -65.09 -42.66 95.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.105 174.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.16 -36.18 83.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.046 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -61.5 -47.26 86.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.836 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.48 89.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.004 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.0 -44.87 87.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.141 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -62.75 -44.48 96.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.992 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -64.77 -31.86 73.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.885 -177.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -83.72 -15.82 47.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.55 26.43 30.1 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.551 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -84.83 -21.79 29.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 110.84 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.1 t -123.91 137.47 54.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.615 ' HB3' HD23 ' A' ' 139' ' ' LEU . . . -62.74 -48.57 78.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.009 177.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.772 ' HB3' HD22 ' A' ' 115' ' ' LEU . 71.7 mtm -134.19 160.01 39.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 -172.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.4 t -151.33 157.16 42.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.199 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 48.4 mm -111.55 129.14 67.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.164 -175.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -155.05 175.02 14.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -81.74 -159.15 23.6 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.449 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.82 -24.92 24.28 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.584 2.189 . . . . 0.0 112.348 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 51.5 m0 -75.0 -29.44 60.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.961 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 47.4 45.52 17.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 174.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -65.62 -17.63 64.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.964 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 91.1 p -74.93 -9.41 58.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.961 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -76.8 -171.31 1.88 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.4 mt -104.98 125.45 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 -173.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -101.11 -40.11 7.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.915 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 39.5 m -134.66 89.98 2.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.221 -174.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 14.7 t -176.48 165.59 2.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.879 175.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -87.3 -1.77 58.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.912 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 88.9 t -71.22 125.46 29.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.144 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -79.95 139.92 36.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.434 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 45.1 p90 -144.95 158.65 43.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.881 176.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.65 166.67 26.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.496 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.1 p -135.02 135.16 53.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.888 0.375 . . . . 0.0 111.125 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.639 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 9.5 t -159.37 142.53 14.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.082 175.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.0 m -63.89 168.31 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.065 -169.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 2.1 mp -68.71 155.55 92.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.562 0.696 . . . . 0.0 110.942 -161.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -77.93 -176.22 3.12 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.739 2.293 . . . . 0.0 112.353 -173.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.443 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 93.9 m -85.93 145.13 27.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.225 -173.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -130.56 113.33 14.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.799 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 54.94 34.63 22.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.81 -0.54 86.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.471 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -127.54 127.54 24.08 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.598 0.713 . . . . 0.0 110.863 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 249' ' ' THR . 81.2 Cg_exo -54.73 131.05 43.68 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.662 2.242 . . . . 0.0 112.351 -176.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 256' ' ' LYS . 96.0 p -83.77 1.36 43.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 172.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.457 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 97.8 mttt -37.09 130.2 0.76 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.512 0.672 . . . . 0.0 110.832 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.5 ' HB3' ' HB2' ' A' ' 113' ' ' LEU . 74.0 Cg_exo -61.56 155.91 50.38 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.66 2.24 . . . . 0.0 112.378 -169.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -74.98 165.15 25.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.845 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.88 126.76 69.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.192 -168.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -112.28 137.35 14.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.454 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 62.5 t -125.04 116.03 45.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 111.13 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.17 123.42 19.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.941 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 47.4 m -127.59 130.39 48.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.803 -168.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.01 136.17 52.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 -171.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.88 169.35 16.85 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.403 -171.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.925 HG13 ' HG2' ' A' ' 277' ' ' LYS . 31.2 mm -112.69 130.16 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 111.082 -174.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -63.37 126.02 26.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.532 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -60.6 -28.24 68.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.144 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.0 -6.52 59.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.074 -170.097 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.4 t -75.08 122.91 88.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.644 0.735 . . . . 0.0 110.868 -173.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -68.59 -12.59 35.14 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.727 2.285 . . . . 0.0 112.373 166.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.449 HD22 HD23 ' A' ' 275' ' ' LEU . 55.5 t30 -111.12 31.27 6.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.919 -168.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -60.84 -29.78 69.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -57.52 -40.11 78.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.706 HD21 HG13 ' A' ' 33' ' ' ILE . 8.6 mp -75.16 -45.67 39.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.963 174.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -62.7 -56.22 19.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.058 -171.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.925 ' HG2' HG13 ' A' ' 266' ' ' ILE . 91.7 mttt -60.92 -40.26 92.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.922 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.7 tt0 -71.0 -49.26 47.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.834 -173.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -67.16 -34.11 76.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.501 ' HA ' HD23 ' A' ' 284' ' ' LEU . 4.6 tt -62.46 -51.39 67.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.965 -175.123 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -77.88 -33.33 52.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 67.7 m-80 -98.72 -11.19 22.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -163.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.864 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 77.5 m-85 -129.67 -52.32 1.16 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.873 177.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.501 HD23 ' HA ' ' A' ' 280' ' ' LEU . 0.5 OUTLIER -62.81 -35.69 80.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -168.852 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 1.06 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.5 pp -123.96 37.76 4.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.885 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.435 ' CG2' ' N ' ' A' ' 287' ' ' ASP . 8.2 m -117.97 153.7 33.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.109 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.47 ' HA ' HD11 ' A' ' 290' ' ' LEU . 31.0 t70 -43.45 -36.38 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.85 -166.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -79.36 -40.62 29.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.864 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.14 -56.73 5.56 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.446 -171.628 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.657 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.1 -21.08 66.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 0.0 110.98 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.601 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.0 tt0 -66.74 -45.87 77.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.788 171.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.2 -46.64 88.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.102 -174.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -46.06 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.172 -175.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.529 ' HB2' HD23 ' A' ' 299' ' ' LEU . 43.2 t30 -63.38 -27.89 69.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.21 -27.59 68.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -91.14 -47.64 7.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.943 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -136.31 145.46 51.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.545 0.688 . . . . 0.0 110.93 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.6 110.08 1.78 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.729 2.286 . . . . 0.0 112.402 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.529 HD23 ' HB2' ' A' ' 294' ' ' ASN . 0.8 OUTLIER -82.02 -27.67 32.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 176.309 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 103.69 -58.55 0.52 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.419 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.614 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -169.25 165.02 10.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.915 0.388 . . . . 0.0 111.129 174.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.586 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 26.1 m -125.92 153.93 34.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.02 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.39 -10.88 60.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.143 173.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.657 ' CD2' HD22 ' A' ' 290' ' ' LEU . 51.4 tp -85.23 120.27 26.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.31 -39.96 76.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.948 -172.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 41.3 t -64.75 -51.36 62.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 -168.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.507 ' HB3' HG22 ' A' ' 302' ' ' VAL . 19.0 t80 -76.73 -29.04 56.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -64.34 -38.46 91.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.16 -37.24 82.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.91 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -74.25 -39.93 62.71 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.93 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.614 HD13 ' HA ' ' A' ' 301' ' ' ALA . 77.4 mt -60.05 -33.01 71.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 175.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.31 -19.58 61.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.08 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.73 -20.32 66.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -90.12 123.59 65.49 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.664 0.745 . . . . 0.0 110.807 167.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -47.93 -28.86 10.78 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.649 2.232 . . . . 0.0 112.377 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -61.75 -32.58 72.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.95 -173.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.597 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.4 mp -80.07 -35.53 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.082 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.1 -39.63 72.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.085 -174.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.16 75.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.051 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 82.6 p -59.82 -28.38 67.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.147 -174.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.3 mmm -66.36 -33.11 74.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.86 174.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -62.52 -47.43 83.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 -175.437 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.648 HD22 ' HB2' ' A' ' 112' ' ' ALA . 14.4 p-10 -83.42 -25.92 30.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.06 -43.96 97.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -67.4 -35.03 78.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.84 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -106.03 -4.48 20.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.829 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.94 -170.02 39.89 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.534 -167.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -139.91 149.39 43.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.881 0.372 . . . . 0.0 110.805 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 42.9 mm -63.85 117.7 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.082 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 59.6 ttm -64.21 134.79 96.08 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.463 0.649 . . . . 0.0 110.982 -176.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.54 128.02 17.44 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.713 2.275 . . . . 0.0 112.382 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.617 ' HB3' ' HB2' ' A' ' 64' ' ' HIS . 1.8 t-20 -133.56 20.17 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 -176.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 49.5 pt -70.58 153.66 94.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.584 0.707 . . . . 0.0 111.151 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -54.69 -35.99 88.79 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.615 2.21 . . . . 0.0 112.408 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -69.06 -24.99 64.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 40.4 tpp -73.6 -26.89 61.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.854 -170.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.0 m -57.37 -37.95 73.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.846 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.96 -36.12 59.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.011 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.532 ' O ' HG13 ' A' ' 343' ' ' VAL . 4.7 m-30 -66.87 -46.98 73.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.455 ' HA ' HG23 ' A' ' 343' ' ' VAL . 28.1 m0 -61.07 -32.5 72.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -66.92 -47.09 72.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.03 -40.36 94.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.163 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.532 HG13 ' O ' ' A' ' 339' ' ' PHE . 17.9 m -74.1 -30.83 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.128 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.5 ' O ' HG23 ' A' ' 347' ' ' VAL . 4.9 tmt_? -65.0 -38.98 92.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.2 m -58.22 -36.19 72.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.194 173.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.57 95.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.189 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.792 ' HA ' HD11 ' A' ' 192' ' ' LEU . 5.8 m -73.99 -35.01 40.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.191 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.472 HD13 HG21 ' A' ' 347' ' ' VAL . 1.5 mp -62.44 -47.94 90.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.191 174.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -63.91 -39.18 93.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.05 -45.55 60.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.098 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.37 -39.86 77.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.0 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.8 p -75.58 -10.7 59.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.911 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.96 17.25 72.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.449 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.25 -33.29 43.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 0.0 110.907 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -138.63 154.4 48.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.4 p -77.19 169.89 17.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.18 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.521 HG22 ' OG1' ' A' ' 193' ' ' THR . 53.5 t -56.53 -42.34 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 173.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -62.09 -45.62 92.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -69.94 -51.59 31.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -75.4 -51.79 12.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.188 -173.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.607 ' HG ' ' HA ' ' A' ' 189' ' ' LYS . 1.9 tm? -65.04 -48.97 71.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 -171.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.51 -52.83 61.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 -173.286 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -67.94 -48.65 65.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.808 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.25 85.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.156 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.595 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 66.3 mm-40 -78.04 -29.03 49.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.907 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 89.5 m -65.92 -33.96 77.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.178 170.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -56.39 -31.95 64.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.854 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.494 HD13 HG22 ' A' ' 183' ' ' VAL . 62.0 mt -59.02 -34.93 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.951 0.405 . . . . 0.0 111.191 173.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 69.9 p -95.07 -14.34 24.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 89.7 mttt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 177.096 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.729 0.3 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.467 HG21 ' HD2' ' A' ' 271' ' ' PRO . 60.1 mt -97.81 139.96 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.181 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -140.13 145.03 37.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.822 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.29 133.5 39.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 177.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.83 11.58 61.63 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.494 -175.061 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.414 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.2 tttt -165.07 134.77 3.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.834 0.349 . . . . 0.0 110.944 177.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.595 ' CD2' HD12 ' A' ' 33' ' ' ILE . 1.6 pt? -144.0 152.71 41.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.94 -173.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 87.2 t -110.76 137.67 42.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.02 -177.288 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.728 HD12 HG13 ' A' ' 35' ' ' VAL . 1.1 mp -119.79 134.47 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.094 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.62 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 76.6 m95 -103.69 124.66 49.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 164.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.511 HD13 ' HG ' ' A' ' 20' ' ' LEU . 11.5 tt -108.83 150.04 11.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.052 -163.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -58.43 153.2 16.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 -174.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.38 -15.97 40.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.416 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -79.2 -13.28 59.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.866 0.365 . . . . 0.0 110.897 -172.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 15' ' ' LYS . 11.0 mmmm -139.96 129.2 23.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 163.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.52 -70.72 1.29 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.469 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -109.92 -39.19 5.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.958 0.409 . . . . 0.0 110.98 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -67.37 -52.28 41.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.871 -150.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.442 ' CA ' HG21 ' A' ' 293' ' ' VAL . . . -54.1 -50.35 55.78 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.565 -175.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.516 ' HB3' HG23 ' A' ' 37' ' ' VAL . 6.0 mt -55.08 -52.57 62.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.699 0.285 . . . . 0.0 110.933 171.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.48 -35.92 21.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.125 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -72.45 -59.99 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.427 HG23 ' HA ' ' A' ' 20' ' ' LEU . 21.5 m -71.64 -38.15 65.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.158 -172.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.561 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -65.64 -47.84 73.25 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.422 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -54.73 -35.65 63.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -57.93 -39.12 77.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.039 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 4.8 m-30 -62.9 -45.42 92.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.426 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 99.8 mt-10 -60.7 -36.96 80.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -71.24 -41.17 70.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.898 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -94.52 -47.81 6.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.889 -164.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.3 p -109.1 -7.83 15.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.18 -172.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.65 8.12 87.97 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.514 167.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 1.0 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.52 133.86 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 111.085 -179.074 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.426 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.2 mttt -72.02 136.0 46.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 -169.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.728 HG13 HD12 ' A' ' 9' ' ' ILE . 99.2 t -115.87 125.01 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.061 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.57 ' O ' HD13 ' A' ' 9' ' ' ILE . 95.5 m -109.93 130.02 55.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.067 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.516 HG23 ' HB3' ' A' ' 20' ' ' LEU . 87.4 t -103.58 131.17 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.159 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -119.36 154.09 34.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.404 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.3 t-80 -88.25 139.93 30.41 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.694 0.759 . . . . 0.0 110.863 -167.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 87.3 Cg_exo -55.02 -29.86 66.99 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.758 2.305 . . . . 0.0 112.335 -175.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -49.03 -52.62 24.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.873 -172.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -90.07 0.68 57.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.832 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.433 ' C ' HD21 ' A' ' 43' ' ' LEU . 10.5 tt -45.86 -51.09 13.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.937 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -74.44 -40.37 61.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.862 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -80.44 -51.88 8.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.956 -164.335 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -83.33 -38.39 22.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.919 -170.283 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.61 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 83.9 t80 -49.83 -53.39 42.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.684 0.754 . . . . 0.0 110.872 -169.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 29.4 Cg_endo -61.19 -30.83 89.3 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.668 2.245 . . . . 0.0 112.331 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -73.08 -44.18 60.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.425 HG22 ' HD3' ' A' ' 57' ' ' PRO . 21.2 m -75.56 -24.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.112 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.13 78.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.054 174.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.11 -29.74 70.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.099 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.0 p -88.36 -14.54 37.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.11 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.44 14.72 81.72 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.477 168.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -135.39 129.39 33.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 110.816 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.47 -92.34 0.14 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.497 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.62 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 67.6 Cg_endo -79.36 148.0 20.71 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.68 2.253 . . . . 0.0 112.375 -177.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -107.52 -32.09 7.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.798 165.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.564 ' HB ' HG23 ' A' ' 9' ' ' ILE . 57.6 mt -128.11 137.53 57.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.169 -176.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.5 HD13 ' HB2' ' A' ' 10' ' ' TRP . 6.3 tp -132.64 127.13 55.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -92.55 128.21 38.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.771 170.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -114.38 145.15 42.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.994 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.58 -83.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.036 -168.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.441 ' HB2' ' HB3' ' A' ' 332' ' ' ASN . 16.0 m170 -120.81 -65.85 1.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.835 174.547 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -99.98 -16.54 17.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.84 -167.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -61.36 -6.31 2.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -165.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 70' ' ' TYR . 31.5 p90 -59.08 -25.58 63.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 173.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.47 -48.36 86.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.46 -174.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.04 -32.16 83.25 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.515 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.721 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 2.3 t80 -54.96 -51.71 65.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.857 0.36 . . . . 0.0 110.931 175.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.92 -42.98 56.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.164 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -56.1 -38.94 71.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.967 -175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.404 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 63.0 m -83.68 -7.65 59.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 179.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.93 31.1 58.39 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.582 172.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.404 ' HG ' ' HB2' ' A' ' 73' ' ' SER . 63.4 mt -88.86 -5.01 58.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.859 0.362 . . . . 0.0 110.972 -165.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.721 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -128.01 154.3 45.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.912 -171.779 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.19 144.58 29.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.086 167.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -65.1 136.18 56.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.884 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.413 HD13 ' CZ ' ' A' ' 106' ' ' TYR . 42.3 pt -100.12 151.54 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.09 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.5 m -96.15 126.5 44.06 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.585 0.707 . . . . 0.0 111.09 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.07 134.06 61.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.637 2.225 . . . . 0.0 112.349 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -103.22 119.71 39.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.99 -41.66 99.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.794 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.73 -44.75 89.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.1 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -75.0 -32.3 61.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.484 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 67.0 tt0 -53.48 -49.71 66.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.936 174.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.35 -32.63 72.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.894 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.39 -20.3 54.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.828 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.483 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.86 -106.54 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -172.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.483 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 29.2 t80 171.52 129.51 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.687 0.756 . . . . 0.0 110.973 -168.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -52.82 -36.01 72.16 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.762 2.308 . . . . 0.0 112.39 -173.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -64.91 -36.5 84.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -173.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.2 p -73.83 -30.35 62.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.17 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.598 ' HA ' HG23 ' A' ' 97' ' ' VAL . 80.7 m95 -67.27 -30.03 69.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 173.719 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.62 -31.31 68.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.827 174.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.07 -24.27 61.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.106 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.598 HG23 ' HA ' ' A' ' 94' ' ' TRP . 20.0 m -107.8 16.01 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.143 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -101.56 136.25 41.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -136.43 117.35 14.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 173.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 60.56 36.05 19.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.868 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.49 2.19 89.03 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.51 172.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -127.97 149.87 50.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.825 0.345 . . . . 0.0 110.875 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.529 HD23 HG21 ' A' ' 97' ' ' VAL . 15.3 mt -86.01 135.49 33.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.838 -175.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 67' ' ' PHE . 1.8 pp -122.15 -1.52 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.026 -170.111 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.407 ' N ' HD13 ' A' ' 104' ' ' ILE . . . -164.89 165.86 20.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 -176.102 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.413 ' CZ ' HD13 ' A' ' 79' ' ' ILE . 97.1 m-85 -114.35 145.05 32.92 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.604 0.716 . . . . 0.0 110.926 170.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.21 125.23 7.0 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.686 2.257 . . . . 0.0 112.304 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 1.081 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp -106.29 -39.91 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.194 177.08 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.596 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -143.19 150.9 40.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.11 -167.002 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.3 t -114.69 130.89 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.164 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -120.53 119.89 34.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.553 ' HB1' ' HB ' ' A' ' 320' ' ' THR . . . -150.06 144.95 26.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.068 -173.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.6 mp -89.88 170.04 10.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.973 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.0 p -158.81 157.98 32.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.915 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.88 127.03 46.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.924 170.822 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.575 ' N ' HD23 ' A' ' 115' ' ' LEU . 5.2 mp -110.3 130.32 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.14 -175.054 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -128.39 146.52 50.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -92.75 115.0 27.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.806 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.426 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.9 mttt -65.66 -23.26 66.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.917 -175.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -78.68 -25.23 44.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.811 -175.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.7 mp -84.26 -49.24 8.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.871 174.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.649 ' H ' HD21 ' A' ' 122' ' ' LEU . 1.7 pt? -143.67 128.5 9.61 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.743 0.782 . . . . 0.0 110.832 174.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.72 -9.03 15.89 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.634 2.223 . . . . 0.0 112.366 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.408 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 59.7 t-20 -143.19 97.01 5.75 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.64 0.733 . . . . 0.0 110.812 -174.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 64.4 Cg_endo -70.26 156.04 62.92 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.746 2.297 . . . . 0.0 112.365 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.43 144.95 63.34 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.748 2.299 . . . . 0.0 112.314 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.18 -17.16 28.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.89 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 71.5 p -130.71 157.68 42.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.192 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.515 ' HA ' HD11 ' A' ' 132' ' ' ILE . 57.0 m95 -68.83 -28.94 67.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.951 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.04 -22.13 66.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.85 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.84 -24.25 41.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.627 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -55.88 -50.05 89.44 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.676 0.751 . . . . 0.0 111.197 -172.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.627 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.8 Cg_endo -68.24 -39.11 10.74 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.622 2.215 . . . . 0.0 112.376 -173.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.02 -60.15 3.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 1.265 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.28 -17.01 63.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.989 -175.732 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.521 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.8 t70 -58.47 -40.42 82.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.848 168.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.07 -30.75 69.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.49 -46.42 54.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.773 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.647 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.0 pp -84.86 -14.35 48.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.964 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.647 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.7 tttt -61.15 -34.41 74.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.955 174.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.95 -23.44 67.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -94.96 3.62 54.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.921 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.48 33.16 53.45 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.56 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -111.75 169.95 8.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 0.0 110.867 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.0 t -121.12 140.22 52.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.917 168.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.441 ' HA ' HD22 ' A' ' 139' ' ' LEU . . . -66.69 -40.37 88.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.112 -172.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -144.53 130.59 19.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 55.2 ttm -118.18 132.92 56.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -153.53 157.35 39.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -173.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -84.93 -54.64 4.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.94 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.825 HD13 ' O ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER 49.28 30.72 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.022 -168.362 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -103.45 -4.35 24.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -129.91 156.53 78.88 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.59 0.71 . . . . 0.0 110.952 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.422 ' HD3' ' HD2' ' A' ' 344' ' ' ARG . 40.3 Cg_endo -60.76 -24.37 78.7 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.684 2.256 . . . . 0.0 112.321 174.282 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -68.23 -30.02 68.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.822 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -84.27 -38.31 20.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.844 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.443 HG21 HG11 ' A' ' 347' ' ' VAL . 23.0 m -61.11 -47.23 87.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.979 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.584 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 39.2 t-105 -56.96 -54.58 52.96 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.534 0.683 . . . . 0.0 110.949 -169.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.584 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 31.2 Cg_endo -65.83 -19.63 58.78 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.731 2.287 . . . . 0.0 112.41 -174.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.723 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.3 tm? -81.63 -45.29 16.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.513 HG22 ' HA3' ' A' ' 166' ' ' GLY . 80.1 mt -74.23 -43.3 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.116 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.9 -22.57 64.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.099 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.549 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -58.87 -32.28 69.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.172 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -100.87 1.13 39.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 112.29 5.48 24.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.492 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.513 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -77.2 69.6 2.48 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.509 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -87.36 132.64 33.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.86 0.362 . . . . 0.0 110.98 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.75 10.34 9.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.154 -171.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.45 ' HA ' HG12 ' A' ' 181' ' ' VAL . 52.8 p90 -158.13 152.34 24.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -93.28 128.38 39.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.816 159.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -118.08 121.57 40.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.827 172.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.02 130.05 11.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.901 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.02 41.83 31.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.842 174.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.37 17.52 79.75 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.533 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.01 139.35 51.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.768 0.318 . . . . 0.0 110.86 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -98.88 145.01 27.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -128.32 108.95 11.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.874 174.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.578 ' C ' HD13 ' A' ' 178' ' ' ILE . 1.3 pp -79.1 -8.52 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.131 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -100.27 -12.31 19.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 -177.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -119.49 85.81 2.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 170.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.45 HG12 ' HA ' ' A' ' 169' ' ' PHE . 27.4 m -114.28 161.3 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 -170.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.02 22.66 32.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.495 -172.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.527 HG22 HD13 ' A' ' 368' ' ' ILE . 6.8 m -107.37 -17.05 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.772 0.32 . . . . 0.0 111.112 -178.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -87.04 20.47 2.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -119.97 -171.51 2.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.91 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.29 -29.71 69.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.106 -173.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.7 -41.41 95.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.484 -167.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.625 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -65.24 -38.06 89.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.972 0.415 . . . . 0.0 111.093 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.589 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 96.8 mttt -62.04 -37.82 86.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.943 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.07 -37.91 89.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.074 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.424 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -66.2 -46.47 79.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.576 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.678 HD11 ' HA ' ' A' ' 347' ' ' VAL . 27.3 tp -65.08 -35.92 82.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 110.855 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.416 ' OG1' HG22 ' A' ' 357' ' ' VAL . 90.0 m -64.52 -41.17 96.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.151 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 65.0 t80 -66.32 -47.94 71.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.861 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.677 ' C ' HD21 ' A' ' 195' ' ' LEU . 5.2 tt -50.32 -51.56 44.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.963 -175.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.437 ' HA ' ' CG1' ' A' ' 199' ' ' ILE . 27.9 m -65.04 -21.61 29.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.075 -173.583 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.0 m-20 -62.59 -33.92 75.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.802 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 194' ' ' PHE . 0.9 OUTLIER -81.21 -39.9 24.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.959 -174.635 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.585 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.6 pp -73.95 -26.99 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.07 172.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.25 -38.23 84.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 170.273 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -80.95 2.92 24.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 176.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 66.53 37.68 4.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 56.0 m170 -77.58 -18.94 56.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.819 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.585 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.1 ppp? -144.14 156.95 44.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -95.02 152.0 18.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.14 -26.93 68.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -95.5 1.73 54.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.813 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.1 m -63.84 126.08 26.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.101 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.429 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 16.9 t0 -120.05 174.28 6.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.843 177.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -64.98 -37.0 86.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.969 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.8 p -70.45 -37.52 74.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.429 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 80.3 mt -65.01 -42.48 94.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.077 173.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.68 81.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.06 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.0 -45.04 94.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.865 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.8 -41.44 95.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.096 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.86 -42.86 97.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.058 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -63.8 -39.67 94.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.936 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -64.33 -35.73 81.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -83.59 -20.02 34.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.982 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.84 25.83 33.71 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.418 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -84.79 -21.65 29.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.976 0.417 . . . . 0.0 110.902 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.2 t -124.45 136.81 54.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.076 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.603 ' HB3' HD23 ' A' ' 139' ' ' LEU . . . -65.03 -47.68 76.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.061 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.534 ' HB3' HD22 ' A' ' 115' ' ' LEU . 71.8 mtm -134.49 158.32 44.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -174.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 60.8 p -139.73 161.29 37.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.171 172.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.412 HD13 HD11 ' A' ' 247' ' ' LEU . 50.2 mm -110.75 127.18 67.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.03 175.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -154.95 175.04 14.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.957 -172.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -88.64 -156.87 31.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.523 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -22.26 32.28 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.66 2.24 . . . . 0.0 112.384 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -78.36 -24.93 46.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 48.76 51.95 14.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.175 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -60.04 -23.94 64.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 61.3 m -50.05 -43.95 51.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -87.0 176.7 7.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 -172.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.7 mp -122.13 123.39 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.211 -171.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.51 -35.11 75.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 -174.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 87.3 m -125.03 101.82 7.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.166 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 29.2 t -174.35 159.75 3.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.53 -14.83 57.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.9 m -59.98 153.53 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.129 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -108.29 128.28 54.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.426 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 50.2 p90 -145.21 158.21 43.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.92 162.35 25.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.387 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.1 p -135.72 135.32 51.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 111.142 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.7 t -154.39 148.75 26.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.9 167.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.173 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 1.036 HD21 ' HD3' ' A' ' 257' ' ' PRO . 2.6 mm? -63.1 149.53 90.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.575 0.702 . . . . 0.0 110.961 -164.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.84 -176.33 3.11 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.691 2.261 . . . . 0.0 112.382 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.421 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 96.8 m -92.47 145.17 24.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.057 -172.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -130.91 113.26 13.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.933 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 55.0 36.59 27.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.815 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.43 2.79 84.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.494 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -131.36 130.62 22.61 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.539 0.685 . . . . 0.0 110.843 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' A' ' 249' ' ' THR . 22.9 Cg_endo -65.42 133.93 36.7 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.715 2.277 . . . . 0.0 112.324 -173.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.611 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 97.0 p -84.52 0.19 50.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.766 173.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -37.4 135.02 0.73 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.522 0.677 . . . . 0.0 110.9 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 1.036 ' HD3' HD21 ' A' ' 247' ' ' LEU . 38.0 Cg_endo -80.05 157.85 23.66 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.729 2.286 . . . . 0.0 112.336 -166.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -75.09 169.67 17.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.53 129.67 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 -166.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.96 137.7 14.48 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.369 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 76.9 t -125.36 117.11 48.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.806 0.336 . . . . 0.0 111.207 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.434 HD21 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -65.27 119.73 11.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 178.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.9 m -126.4 126.61 44.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.79 -167.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -125.67 137.07 53.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.041 -171.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -131.42 171.44 21.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.486 -170.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.858 HG13 ' HG2' ' A' ' 277' ' ' LYS . 25.0 mm -113.41 126.17 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.81 0.338 . . . . 0.0 111.297 -171.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -61.27 131.12 49.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.472 ' HB3' ' C ' ' A' ' 76' ' ' LEU . . . -59.81 -26.17 65.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.125 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.21 -8.49 57.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 -173.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.8 t -70.81 127.16 92.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.674 0.75 . . . . 0.0 110.913 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.467 ' HD2' HG21 ' A' ' 2' ' ' ILE . 74.1 Cg_endo -72.87 -10.46 24.83 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.658 2.239 . . . . 0.0 112.401 165.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -104.04 19.09 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -169.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -54.09 -34.91 61.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.925 -171.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.14 -52.43 63.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.6 pp -84.36 -27.97 27.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.924 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.81 -50.51 56.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.06 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.858 ' HG2' HG13 ' A' ' 266' ' ' ILE . 96.1 mttt -59.74 -38.49 81.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.839 173.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.547 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.7 tt0 -68.45 -48.25 65.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -175.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -67.59 -35.37 78.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.512 ' HA ' HD23 ' A' ' 284' ' ' LEU . 7.3 tt -61.8 -51.96 66.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.892 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -78.15 -31.5 49.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.836 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.547 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 63.8 m-80 -99.46 -11.61 20.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.848 -165.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.929 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 66.6 m-85 -129.95 -52.82 1.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.512 HD23 ' HA ' ' A' ' 280' ' ' LEU . 0.6 OUTLIER -62.73 -36.74 83.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.912 -169.425 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 1.081 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.6 pp -124.27 37.63 4.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.979 176.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.457 ' CG2' ' N ' ' A' ' 287' ' ' ASP . 4.1 m -116.08 154.91 29.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.099 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.517 ' HA ' HD11 ' A' ' 290' ' ' LEU . 33.0 t70 -42.93 -37.42 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.796 -167.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -78.03 -40.81 37.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.971 -176.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.929 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.06 -57.16 5.37 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 -172.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.594 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.1 -21.17 66.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.34 . . . . 0.0 110.974 -178.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.59 ' N ' HD12 ' A' ' 290' ' ' LEU . 84.6 tt0 -67.44 -45.1 77.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 170.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.81 95.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.131 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.442 HG21 ' CA ' ' A' ' 19' ' ' GLY . 1.4 p -80.03 -30.0 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.11 -174.498 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -70.12 -27.17 64.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 172.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.32 -25.79 67.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.927 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.95 -51.28 8.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -143.2 152.7 58.47 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 121.615 0.722 . . . . 0.0 110.847 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -62.17 116.4 3.46 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.771 2.314 . . . . 0.0 112.298 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 299' ' ' LEU . 0.2 OUTLIER -87.55 -18.58 29.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 176.194 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 103.64 -58.55 0.52 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.525 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.656 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -170.73 164.76 8.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 111.138 175.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.596 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 21.7 m -124.23 156.08 31.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.101 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.22 -11.02 59.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.109 172.574 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.594 ' CD2' HD22 ' A' ' 290' ' ' LEU . 47.3 tp -83.2 122.06 27.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -175.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.32 -39.15 75.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 46.5 t -64.73 -49.95 68.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.881 -168.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.487 ' HB3' HG22 ' A' ' 302' ' ' VAL . 18.4 t80 -81.62 -29.07 33.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -61.95 -39.73 93.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.831 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -59.39 -38.21 79.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -73.7 -38.49 64.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.656 HD13 ' HA ' ' A' ' 301' ' ' ALA . 78.5 mt -62.82 -32.91 74.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.26 -18.83 62.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.113 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.06 -20.07 66.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 174.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -91.34 121.07 68.11 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.636 0.731 . . . . 0.0 110.87 166.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.98 -26.76 7.91 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.756 2.304 . . . . 0.0 112.313 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -61.76 -35.63 78.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.873 -175.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.555 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.1 mp -80.12 -32.6 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.076 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.4 -40.09 85.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 -172.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.17 -46.25 74.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.108 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.553 ' HB ' ' HB1' ' A' ' 112' ' ' ALA . 81.2 p -64.97 -29.21 70.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.066 -174.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.5 mtp -63.7 -34.38 77.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.6 tp10 -64.75 -47.7 77.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -173.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.515 HD22 ' HB2' ' A' ' 112' ' ' ALA . 8.9 p-10 -82.14 -28.01 32.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.864 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.01 -50.24 67.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.011 -175.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -69.25 -29.92 67.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.922 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -108.2 -8.55 15.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 -169.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.13 -153.55 29.99 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.43 -166.749 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -147.33 143.69 28.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.796 0.332 . . . . 0.0 110.902 -170.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 44.4 mm -61.76 124.01 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.092 -167.482 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 95.5 mtp -50.3 156.91 1.3 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.49 0.662 . . . . 0.0 110.969 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.472 ' HG3' ' CE2' ' A' ' 158' ' ' TRP . 89.6 Cg_endo -77.63 72.26 6.13 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.693 2.262 . . . . 0.0 112.379 174.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.441 ' HB3' ' HB2' ' A' ' 64' ' ' HIS . 12.7 t-20 -101.49 13.37 35.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 -172.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 45.7 pt -77.81 157.51 79.19 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.539 0.685 . . . . 0.0 111.207 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -56.48 -37.04 98.03 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.757 2.305 . . . . 0.0 112.254 -173.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -67.62 -29.7 69.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.402 ' HB3' ' HE3' ' A' ' 336' ' ' MET . 69.1 mmm -80.01 -17.83 51.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.826 -172.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 47.6 t -62.18 -41.99 98.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.831 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.49 -37.04 63.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.156 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.437 ' O ' HG13 ' A' ' 343' ' ' VAL . 7.4 m-30 -66.28 -36.29 82.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -54.93 -37.9 66.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.982 172.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -71.79 -38.05 70.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.939 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.92 -42.81 80.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.105 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.437 HG13 ' O ' ' A' ' 339' ' ' PHE . 21.4 m -72.72 -31.36 36.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.184 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.434 ' O ' HG23 ' A' ' 347' ' ' VAL . 74.0 ttt-85 -61.67 -40.93 96.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 175.604 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.0 m -55.76 -36.14 66.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.186 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.13 -46.19 81.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.084 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.678 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.4 m -75.55 -34.78 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.199 -172.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.462 HD13 HG21 ' A' ' 347' ' ' VAL . 1.5 mp -62.42 -48.01 90.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.21 -37.94 88.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.32 -46.61 60.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.66 81.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.053 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.2 p -75.74 -11.88 60.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.981 0.419 . . . . 0.0 110.927 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.57 18.02 69.46 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.424 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.83 -32.95 46.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.757 0.313 . . . . 0.0 110.848 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -140.08 157.01 46.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 50.0 p -77.27 165.76 24.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.159 169.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.416 HG22 ' OG1' ' A' ' 193' ' ' THR . 55.4 t -54.94 -42.7 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.167 174.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.04 -44.13 96.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.832 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -69.38 -54.0 16.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -69.37 -47.78 63.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.625 HD11 ' HB1' ' A' ' 188' ' ' ALA . 1.5 tm? -64.95 -45.03 87.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.96 -174.449 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -65.41 -53.04 48.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.945 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -69.64 -45.68 67.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -173.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.23 -42.87 83.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.075 -174.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.461 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 85.6 mm-40 -72.49 -30.96 64.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.979 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 55.5 m -59.01 -32.59 69.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.093 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -57.11 -29.94 63.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.527 HD13 HG22 ' A' ' 183' ' ' VAL . 69.8 mt -59.72 -39.6 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 175.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.3 p -94.78 -14.98 24.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.808 179.074 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.745 0.307 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.474 HG21 ' HD2' ' A' ' 271' ' ' PRO . 83.2 mt -97.54 133.05 40.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.179 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -144.97 146.8 32.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.97 132.99 48.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.1 7.74 63.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.406 -176.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.527 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.1 tttt -164.44 134.67 4.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.744 0.306 . . . . 0.0 110.959 176.355 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.676 HD23 HD12 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -141.72 154.81 45.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.956 -172.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.434 HG23 ' HB ' ' A' ' 36' ' ' THR . 77.3 t -113.59 135.74 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.133 -177.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.649 HG23 ' HB ' ' A' ' 59' ' ' ILE . 1.4 mp -119.65 133.97 64.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.744 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 74.9 m95 -105.18 124.24 49.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.943 166.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.497 HD13 ' HG ' ' A' ' 20' ' ' LEU . 13.6 tt -110.35 149.97 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.146 -167.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -64.52 158.63 23.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.756 -171.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.36 -16.07 26.43 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.511 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -68.25 -29.9 68.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.883 0.373 . . . . 0.0 110.853 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -139.18 130.02 26.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.845 166.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.16 -80.14 1.01 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.468 -172.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -96.72 -42.36 8.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.941 0.401 . . . . 0.0 110.97 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -67.59 -49.93 60.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.837 -153.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.12 -56.97 20.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.407 -176.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.564 ' HB3' HG23 ' A' ' 37' ' ' VAL . 5.5 mt -51.72 -46.48 63.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.797 0.332 . . . . 0.0 110.923 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.04 -37.48 45.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.061 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -75.68 -60.04 2.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.972 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.407 HG23 ' HA ' ' A' ' 20' ' ' LEU . 20.3 m -71.94 -36.61 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.171 -172.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.46 -40.84 99.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.477 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -61.04 -31.24 70.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.928 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -50.0 -39.94 42.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.919 172.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 0.9 OUTLIER -54.97 -49.24 71.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 176.818 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -71.75 -34.92 69.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.899 -174.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.23 -37.99 84.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.958 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -95.2 -47.29 6.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 -168.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.8 p -115.1 -5.96 12.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.197 -169.48 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.53 4.9 85.44 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.377 169.108 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.995 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -89.73 132.36 34.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.826 0.346 . . . . 0.0 111.078 -179.202 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.4 mttt -70.03 136.73 50.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 -170.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.506 HG21 HD12 ' A' ' 9' ' ' ILE . 9.8 p -112.76 134.32 55.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.067 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.511 ' O ' HD13 ' A' ' 9' ' ' ILE . 99.3 m -113.19 129.24 56.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.124 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.564 HG23 ' HB3' ' A' ' 20' ' ' LEU . 84.8 t -102.41 128.43 55.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.204 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -120.12 152.0 38.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.919 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -91.64 150.62 41.32 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.566 0.698 . . . . 0.0 110.823 -166.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.558 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 37.1 Cg_endo -68.92 -19.62 39.97 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.611 2.207 . . . . 0.0 112.39 -175.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -54.13 -49.02 70.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -174.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -89.58 -9.1 51.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.592 ' C ' HD21 ' A' ' 43' ' ' LEU . 8.3 tt -48.64 -53.86 16.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 -168.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.77 -35.37 80.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.852 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -70.13 -36.4 74.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.857 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.411 ' O ' HG23 ' A' ' 50' ' ' VAL . 74.7 mmtt -80.64 -24.54 38.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.591 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 86.3 t80 -49.45 -50.6 64.53 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 0.0 110.877 -163.031 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.591 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 46.2 Cg_endo -82.58 -32.08 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.648 2.232 . . . . 0.0 112.391 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -77.22 -44.17 30.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.867 -165.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.528 HG22 ' HG3' ' A' ' 57' ' ' PRO . 24.8 m -70.31 -27.72 32.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.075 -173.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.638 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . . . -71.85 -35.19 69.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.042 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.48 -32.56 73.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.106 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.7 p -89.13 -18.87 26.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.11 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.94 8.77 78.79 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.49 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -128.18 130.01 47.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 110.827 174.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.97 -91.57 0.13 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.554 169.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.744 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 77.4 Cg_endo -80.07 146.92 18.41 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.349 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -94.25 -35.03 12.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.777 161.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.649 ' HB ' HG23 ' A' ' 9' ' ' ILE . 29.4 mt -127.03 138.48 54.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.173 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 tp -133.23 127.39 54.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.101 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -87.94 140.7 29.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.516 ' CZ2' ' HB3' ' A' ' 105' ' ' ALA . 24.2 p90 -145.11 160.83 40.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.001 170.316 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.73 -87.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.113 -166.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -127.19 -68.41 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -171.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.453 ' HB2' ' HB2' ' A' ' 332' ' ' ASN . 69.2 m-20 -99.33 -10.65 22.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.839 -162.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -56.11 -19.07 11.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -169.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.535 ' HB2' HD11 ' A' ' 104' ' ' ILE . 36.0 p90 -57.67 -31.45 66.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.851 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.76 -52.32 53.13 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.572 -171.416 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.92 -35.99 85.64 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.528 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.625 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 11.1 t80 -66.87 -41.73 86.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.726 0.298 . . . . 0.0 110.902 -176.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -39.87 67.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 174.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -58.51 -35.9 72.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.928 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.426 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 64.5 m -87.67 -5.01 58.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.01 31.25 58.05 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.526 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.638 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 53.6 mt -87.73 -12.06 46.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -169.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.625 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -129.08 151.66 49.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.934 -178.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.431 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -78.95 140.83 37.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.021 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -74.16 141.43 45.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.836 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.411 HD13 ' CZ ' ' A' ' 106' ' ' TYR . 42.7 pt -110.45 162.84 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.125 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 p -107.25 149.91 39.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 111.119 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.14 141.22 35.7 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.624 2.216 . . . . 0.0 112.417 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -105.26 120.02 40.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.928 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.22 -42.0 98.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.841 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.9 91.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.154 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -74.3 -32.89 63.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.47 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 65.1 tt0 -54.88 -50.09 69.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.043 176.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.36 -30.33 70.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.751 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -78.86 -20.03 50.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.491 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.18 -104.92 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -172.925 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.491 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 22.4 t80 172.12 129.47 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.704 0.764 . . . . 0.0 110.885 -169.679 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.63 -37.59 83.58 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.647 2.231 . . . . 0.0 112.356 -174.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -65.22 -34.06 77.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -173.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.9 p -75.5 -31.01 60.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.079 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.585 ' HA ' HG23 ' A' ' 97' ' ' VAL . 88.6 m95 -65.54 -30.01 70.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.935 173.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -69.56 -32.07 70.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.55 -26.24 62.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.645 HG21 HD23 ' A' ' 103' ' ' LEU . 18.5 m -108.28 16.88 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 -175.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -104.71 135.76 45.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -132.45 117.47 18.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.7 t30 58.68 35.07 24.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.818 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.62 -0.85 89.19 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.588 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.11 145.11 50.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.356 . . . . 0.0 110.843 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.645 HD23 HG21 ' A' ' 97' ' ' VAL . 28.8 mt -80.86 139.14 36.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -172.545 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 67' ' ' PHE . 1.8 pp -123.46 -2.7 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.096 -174.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.516 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . . . -161.74 165.29 28.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.152 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.411 ' CZ ' HD13 ' A' ' 79' ' ' ILE . 90.2 m-85 -114.31 144.47 31.77 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.646 0.736 . . . . 0.0 110.93 170.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.57 122.26 5.45 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.606 2.204 . . . . 0.0 112.326 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 1.027 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -106.49 -36.64 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.205 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -144.44 150.86 38.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.183 -169.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.6 t -120.33 134.91 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.134 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -124.97 136.78 54.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.845 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.625 ' HB2' HD22 ' A' ' 323' ' ' ASN . . . -151.89 145.78 25.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 176.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -85.57 164.16 17.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.7 p -157.22 154.86 29.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.918 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -95.92 127.04 41.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.96 169.545 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.614 ' N ' HD23 ' A' ' 115' ' ' LEU . 5.2 mp -110.02 133.17 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -133.63 148.85 51.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -90.92 115.14 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.861 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.497 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.3 mttt -63.06 -22.75 67.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.979 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.34 -25.42 51.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -88.33 -52.9 4.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.679 ' H ' HD21 ' A' ' 122' ' ' LEU . 1.7 pt? -141.74 126.13 10.26 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.725 0.774 . . . . 0.0 110.844 174.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -81.92 -2.32 11.27 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.671 2.247 . . . . 0.0 112.293 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -150.78 102.6 3.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.61 0.719 . . . . 0.0 110.812 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.64 156.74 60.46 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.667 2.245 . . . . 0.0 112.375 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -66.45 145.08 75.91 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.663 2.242 . . . . 0.0 112.251 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -81.27 -18.28 46.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.8 p -133.92 159.0 42.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.2 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.412 ' HE1' ' HG ' ' A' ' 255' ' ' SER . 69.6 m95 -72.08 -29.95 64.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.405 ' O ' ' HD2' ' A' ' 133' ' ' PRO . 97.5 mt-10 -65.85 -20.35 66.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.864 -179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -77.69 -27.24 50.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.56 ' HA ' HD12 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -55.24 -47.22 99.07 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.57 0.7 . . . . 0.0 111.152 -169.455 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.471 ' N ' HG22 ' A' ' 132' ' ' ILE . 81.9 Cg_exo -51.15 -49.31 17.5 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.695 2.263 . . . . 0.0 112.377 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.67 -58.39 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.149 -176.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 1.253 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.34 -17.64 64.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 -173.955 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.584 ' N ' HD13 ' A' ' 135' ' ' LEU . 34.3 t70 -60.28 -41.83 94.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.869 168.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.38 -30.83 69.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -70.4 -47.39 61.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.658 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.9 pp -85.0 -14.38 47.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.658 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.9 tttt -61.75 -34.7 76.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 174.633 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.96 -23.2 67.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.06 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -95.03 5.0 53.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.918 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 31.89 57.32 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.463 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -110.36 170.14 8.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.857 0.361 . . . . 0.0 110.832 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.6 t -123.29 140.41 53.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 166.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -65.62 -41.24 92.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.144 -172.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -144.45 128.4 17.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 98.3 mmm -106.73 134.43 49.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -157.82 161.92 38.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 -175.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -96.64 -47.61 5.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 1.16 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.1 tm? 46.17 33.47 1.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 -168.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -99.43 -7.75 25.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -118.86 153.82 52.71 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.7 0.762 . . . . 0.0 110.917 -174.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.26 -24.46 50.88 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.669 2.246 . . . . 0.0 112.354 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -75.53 -29.88 59.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.832 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -83.04 -31.53 27.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.843 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.6 m -58.48 -43.29 88.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.046 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.574 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 43.9 t-105 -58.14 -55.63 43.37 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.532 0.682 . . . . 0.0 110.85 -171.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.606 ' O ' ' HB3' ' A' ' 163' ' ' ALA . 23.7 Cg_endo -64.23 -18.64 64.08 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.682 2.255 . . . . 0.0 112.416 -174.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.718 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.7 tm? -82.3 -45.55 14.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.897 177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.589 HG22 ' HA3' ' A' ' 166' ' ' GLY . 85.4 mt -75.48 -44.65 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.052 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.17 -23.35 60.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.05 -173.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.606 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -58.98 -35.27 72.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -171.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.7 p30 -103.06 8.42 38.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 118.52 3.76 14.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.442 171.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.589 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -76.78 65.87 2.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.507 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -89.32 135.01 33.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.855 0.36 . . . . 0.0 110.945 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.23 0.45 36.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.223 -174.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.403 ' HA ' ' CE1' ' A' ' 176' ' ' TYR . 51.6 p90 -152.13 141.65 21.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -176.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.506 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 37.9 tptt -72.68 135.69 45.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.998 156.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -124.69 116.38 22.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.922 164.549 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -147.77 118.47 7.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 53.51 38.17 27.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.35 23.96 74.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.519 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -127.26 139.22 53.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.854 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.403 ' CE1' ' HA ' ' A' ' 169' ' ' PHE . 1.7 t80 -97.47 120.61 38.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 171.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -110.86 105.13 13.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.845 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.4 tp -63.51 -17.34 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.063 -174.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.95 -7.54 48.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.941 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 48.8 t0 -130.87 60.35 1.65 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 29.0 m -107.93 167.56 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.115 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -102.61 5.22 51.15 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.562 -166.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.534 ' HB ' ' HB3' ' A' ' 365' ' ' GLN . 0.8 OUTLIER -101.25 -25.49 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 111.096 -168.728 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -93.65 24.96 3.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 173.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -116.71 176.12 5.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.15 -27.25 68.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.047 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.87 -40.69 97.44 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.521 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.606 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -64.05 -37.85 88.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.997 0.427 . . . . 0.0 111.19 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.601 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 90.5 mttt -62.38 -37.62 86.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.813 175.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.07 89.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.099 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.493 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -66.99 -47.99 62.66 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.535 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.532 HD11 ' HA ' ' A' ' 347' ' ' VAL . 27.4 tp -65.95 -35.25 80.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.904 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.538 ' OG1' HG22 ' A' ' 357' ' ' VAL . 93.4 m -64.97 -43.29 93.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.186 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.488 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 91.4 t80 -67.81 -47.12 69.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.73 ' C ' HD21 ' A' ' 195' ' ' LEU . 4.7 tt -50.39 -50.38 51.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.432 ' O ' HG13 ' A' ' 199' ' ' ILE . 35.7 m -65.04 -22.45 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.15 -174.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.488 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.9 m-20 -61.86 -33.14 73.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.438 HD23 ' O ' ' A' ' 194' ' ' PHE . 0.8 OUTLIER -81.16 -40.07 24.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.876 -173.829 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.432 HG13 ' O ' ' A' ' 196' ' ' VAL . 1.6 pp -72.65 -29.76 31.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 171.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -68.22 -38.14 81.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -82.67 3.67 28.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.847 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 66.36 40.22 3.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.832 170.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -76.73 -14.93 59.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.767 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -142.0 154.58 45.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.865 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -94.6 155.0 17.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.902 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.86 -27.71 68.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.044 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -96.04 0.14 51.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.817 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.2 m -63.26 135.06 56.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.061 -176.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -142.62 174.41 10.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.991 176.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -61.94 -41.58 98.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.975 0.416 . . . . 0.0 111.014 -175.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.0 m -62.25 -40.45 96.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.883 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 66.3 mt -64.94 -43.66 96.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.122 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.86 -34.24 77.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -61.83 -47.79 83.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.928 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.59 95.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.088 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.67 -44.27 90.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -64.81 -39.9 94.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -64.83 -34.2 77.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -86.29 -16.77 36.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.828 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.85 28.31 29.3 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.502 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -84.07 -22.77 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.923 0.392 . . . . 0.0 110.861 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 67.4 p -130.91 144.02 51.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.519 ' HB3' HD23 ' A' ' 139' ' ' LEU . . . -66.55 -60.99 2.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.058 -173.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.534 ' HB3' HD22 ' A' ' 115' ' ' LEU . 59.4 mtm -134.62 158.5 43.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 -166.409 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.4 t -150.43 157.29 42.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.26 126.98 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.182 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -154.62 174.26 15.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -172.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -85.11 -158.29 29.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.52 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.87 -23.66 40.98 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.677 2.251 . . . . 0.0 112.404 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -78.04 -30.38 49.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.914 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 45.69 49.91 11.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -59.98 -24.0 64.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.6 p -79.01 -5.22 53.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -81.03 -174.95 5.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.426 HG21 ' HB3' ' A' ' 238' ' ' SER . 89.5 mt -98.01 130.89 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.172 -177.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -92.01 -53.68 4.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 85.7 m -132.95 112.98 12.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.188 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' SER . . . . . 0.426 ' HB3' HG21 ' A' ' 235' ' ' ILE . 33.8 t -175.11 164.58 3.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.838 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -83.83 -4.65 58.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.895 171.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 99.6 t -81.3 124.42 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.12 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -88.09 147.91 24.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.497 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 49.3 p90 -145.9 163.23 35.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.967 178.41 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -128.78 158.0 21.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.446 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.39 135.28 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 111.111 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.4 t -153.73 149.86 27.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.132 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.2 m -61.23 163.4 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.157 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.487 ' N ' HD12 ' A' ' 247' ' ' LEU . 3.9 mp -69.1 150.01 97.55 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.59 0.71 . . . . 0.0 111.049 -164.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.56 -176.4 2.95 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.809 2.339 . . . . 0.0 112.366 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.4 m -84.25 143.15 29.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.161 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -130.08 112.79 13.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 55.16 35.78 25.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.41 0.97 84.17 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.534 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.423 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 91.4 mm-40 -125.73 125.82 24.93 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.496 0.665 . . . . 0.0 110.914 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 73.0 Cg_exo -54.54 132.82 53.4 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.736 2.291 . . . . 0.0 112.312 -178.566 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.412 ' HG ' ' HE1' ' A' ' 129' ' ' TRP . 66.7 m -81.14 -4.97 57.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.862 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -39.69 129.45 1.47 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.547 0.689 . . . . 0.0 110.874 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -82.19 164.16 17.33 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.758 2.305 . . . . 0.0 112.287 -164.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -74.96 170.04 16.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 29.2 t -114.46 134.4 57.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.207 -168.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -115.18 135.09 12.02 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.416 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.8 t -125.64 117.43 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.773 0.321 . . . . 0.0 111.19 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.423 HD21 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -66.13 122.92 18.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.914 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 45.2 m -125.43 132.26 52.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 -168.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.92 137.5 53.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.118 -174.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.9 173.99 21.31 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.377 -171.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.2 mm -113.3 130.68 66.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.702 0.287 . . . . 0.0 111.166 -172.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -62.36 129.48 40.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.453 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -59.58 -29.33 67.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.9 -6.07 59.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.081 -174.012 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.8 t -75.33 122.14 86.66 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.579 0.704 . . . . 0.0 110.88 -175.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.474 ' HD2' HG21 ' A' ' 2' ' ' ILE . 89.5 Cg_endo -68.88 -6.99 19.45 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.695 2.263 . . . . 0.0 112.437 167.154 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -102.92 14.38 32.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -51.73 -35.0 41.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.798 -168.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -72.15 -47.68 49.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.989 -171.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.0 pp -79.97 -33.68 39.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.906 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.73 -48.77 70.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.071 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -66.81 -34.42 77.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.14 -45.39 88.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.955 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -70.28 -36.12 74.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.786 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.693 HD21 ' O ' ' A' ' 280' ' ' LEU . 4.5 tt -59.4 -47.1 86.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -177.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -78.75 -28.53 44.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.03 -17.71 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -161.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.87 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 14.7 m-30 -121.18 -46.42 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.842 -178.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.515 HD23 ' HA ' ' A' ' 280' ' ' LEU . 1.0 OUTLIER -63.94 -44.11 93.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -171.502 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 1.027 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.7 pp -124.42 37.95 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -166.716 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.485 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 82.0 p -121.46 162.25 20.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.16 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.424 ' HA ' HD11 ' A' ' 290' ' ' LEU . 36.1 p-10 -47.84 -35.06 9.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.806 -167.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -80.18 -40.32 27.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.87 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -71.6 -58.64 5.28 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 -171.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.66 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.11 -22.23 66.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.719 0.295 . . . . 0.0 110.907 -178.488 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.585 ' N ' HD12 ' A' ' 290' ' ' LEU . 87.9 tt0 -68.19 -46.25 71.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.819 172.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.94 -46.32 89.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.052 -174.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.492 HG12 ' O ' ' A' ' 289' ' ' GLY . 0.2 OUTLIER -70.04 -44.82 78.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 178.297 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.548 ' HB2' HD23 ' A' ' 299' ' ' LEU . 29.0 t30 -55.54 -31.46 62.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.853 175.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.76 -26.82 68.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.974 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -83.75 -40.76 18.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -161.41 139.89 7.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.576 0.703 . . . . 0.0 110.861 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -48.86 126.52 15.01 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.68 2.253 . . . . 0.0 112.295 -174.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.548 HD23 ' HB2' ' A' ' 294' ' ' ASN . 0.1 OUTLIER -87.67 -19.11 28.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 173.764 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.37 -67.18 1.43 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.663 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.598 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -157.9 144.98 18.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.933 0.397 . . . . 0.0 111.082 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.546 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 24.8 m -125.55 159.93 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.041 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.59 -13.24 60.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.021 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.66 ' CD2' HD22 ' A' ' 290' ' ' LEU . 43.2 tp -81.3 125.21 30.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.887 -174.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -61.58 -36.04 79.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.876 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.3 m -60.7 -50.07 74.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -170.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.565 ' CE2' HD22 ' A' ' 311' ' ' LEU . 23.0 t80 -77.1 -35.25 56.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.987 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.68 ' HA ' HD12 ' A' ' 311' ' ' LEU . 87.3 tt0 -53.37 -39.88 64.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.885 175.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -52.11 -38.69 58.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.905 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -79.85 -34.37 39.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.68 HD12 ' HA ' ' A' ' 308' ' ' GLU . 54.2 mt -64.1 -30.66 71.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 -175.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.84 -22.36 47.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.216 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.67 -20.57 65.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.003 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -89.3 122.64 68.38 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.695 0.76 . . . . 0.0 110.88 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -48.44 -30.2 15.19 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.754 2.303 . . . . 0.0 112.317 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -62.62 -30.72 71.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 -172.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.541 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.3 mp -74.9 -30.09 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.037 -173.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.14 -41.63 93.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 -170.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.66 -43.63 68.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.451 ' HB ' ' HB1' ' A' ' 112' ' ' ALA . 76.5 p -63.86 -31.27 72.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.093 -171.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 38.4 mmt -70.35 -31.43 68.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -64.38 -49.17 72.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 -175.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.625 HD22 ' HB2' ' A' ' 112' ' ' ALA . 10.2 p-10 -80.35 -25.6 39.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.807 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.37 -50.58 69.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.143 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.72 -34.7 77.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.952 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -104.13 -5.03 22.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -170.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -96.53 -156.35 30.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.448 -168.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -151.12 148.08 27.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.832 0.349 . . . . 0.0 110.843 -171.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 44.3 mm -60.85 124.94 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.132 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 96.9 mtp -51.6 142.28 23.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.5 0.667 . . . . 0.0 110.962 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.07 100.8 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 0.0 112.307 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.453 ' HB2' ' HB2' ' A' ' 65' ' ' ASP . 25.9 m-80 -120.64 18.69 11.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 -175.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 48.7 pt -77.15 159.44 78.1 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.636 0.731 . . . . 0.0 111.131 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -54.97 -33.42 82.82 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.72 2.28 . . . . 0.0 112.292 -174.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.23 -27.74 69.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.782 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 87.2 mmm -69.62 -28.27 65.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.837 -168.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.9 m -52.13 -42.76 63.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.821 -171.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.65 -36.28 73.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.99 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 2.5 m-30 -64.91 -42.7 94.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.851 -175.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -54.67 -42.69 71.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -70.72 -43.24 69.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.3 95.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.122 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 339' ' ' PHE . 17.7 m -73.8 -31.56 31.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.436 ' O ' HG23 ' A' ' 347' ' ' VAL . 55.2 ttt180 -62.9 -41.82 99.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 90.8 m -57.19 -38.05 73.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.145 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.71 91.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 -173.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.532 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.5 m -74.53 -34.9 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.16 -174.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.46 HD13 HG21 ' A' ' 347' ' ' VAL . 1.4 mp -63.52 -49.14 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.209 174.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 82.4 m-20 -65.36 -39.1 91.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.926 -176.105 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.17 -45.55 59.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.109 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.83 -39.57 79.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.138 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.6 p -76.38 -10.44 59.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.881 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.8 17.2 70.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.39 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.12 -33.46 44.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.934 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.411 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 93.9 mt-30 -140.06 155.45 47.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.7 p -77.82 169.16 18.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 170.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.538 HG22 ' OG1' ' A' ' 193' ' ' THR . 53.3 t -56.82 -41.34 75.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -62.06 -45.96 91.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -70.0 -52.92 20.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -72.64 -49.73 29.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.048 -172.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.606 HD11 ' HB1' ' A' ' 188' ' ' ALA . 1.6 tm? -65.1 -47.7 76.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.75 -50.79 63.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.49 -49.97 55.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.47 -43.64 84.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.134 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.534 ' HB3' ' HB ' ' A' ' 183' ' ' VAL . 78.8 mm-40 -71.7 -35.01 70.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.974 -175.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 31.1 m -60.31 -28.08 67.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.243 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -56.83 -30.78 64.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.401 ' HB ' ' O ' ' A' ' 365' ' ' GLN . 78.3 mt -59.09 -40.57 81.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.162 173.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 63.5 p -97.99 -13.54 21.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.227 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.9 tttt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.817 177.313 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.729 0.299 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.401 HG21 ' HD2' ' A' ' 271' ' ' PRO . 86.7 mt -94.48 139.83 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.155 178.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.92 138.95 53.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.856 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.97 134.57 43.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.35 8.02 71.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.492 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -160.37 140.61 11.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.757 0.313 . . . . 0.0 110.901 171.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.656 ' H ' HD21 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -143.02 156.39 44.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 -167.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.498 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 69.7 t -112.33 136.43 48.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.705 HD12 HG13 ' A' ' 35' ' ' VAL . 1.1 mp -118.4 131.46 71.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.182 175.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.787 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 73.0 m95 -104.37 126.04 51.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 165.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.522 HD13 ' HG ' ' A' ' 20' ' ' LEU . 13.3 tt -109.49 150.32 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.06 -166.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -58.14 155.05 11.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.808 -170.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.04 -17.51 23.2 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.472 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -78.16 -15.08 59.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.318 . . . . 0.0 110.843 -173.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.429 ' HE3' ' HB3' ' A' ' 15' ' ' LYS . 28.8 mmmt -135.0 136.04 41.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 171.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.0 -84.25 1.0 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.495 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -110.25 -38.08 5.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 110.891 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -65.56 -50.97 63.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -150.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.07 -59.98 9.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.443 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.522 ' HG ' HD13 ' A' ' 11' ' ' ILE . 2.0 mt -45.53 -49.95 13.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.952 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.68 -38.01 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.044 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -70.61 -54.42 12.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.853 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.0 m -74.44 -37.74 45.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.186 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.498 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -63.03 -46.76 92.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.443 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -56.88 -30.04 63.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.938 0.399 . . . . 0.0 110.898 -177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -58.35 -37.41 75.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.955 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 1.5 m-30 -60.71 -48.82 80.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.929 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.12 -34.91 78.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -72.18 -37.26 69.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -94.78 -50.0 5.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 -167.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.2 p -116.42 -3.25 11.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.155 -171.581 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.48 14.2 82.21 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.427 166.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.824 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -98.25 133.27 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.352 . . . . 0.0 111.107 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -74.54 134.18 42.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -166.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.705 HG13 HD12 ' A' ' 9' ' ' ILE . 94.5 t -113.45 127.12 70.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.138 -172.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.589 ' O ' HD13 ' A' ' 9' ' ' ILE . 97.2 m -110.85 128.01 55.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.096 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.403 HG23 ' HB3' ' A' ' 20' ' ' LEU . 81.6 t -102.24 132.16 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.195 177.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -118.67 155.17 31.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.936 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.1 t-80 -89.09 140.11 28.92 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.543 0.687 . . . . 0.0 110.945 -170.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 85.6 Cg_exo -55.02 -27.97 57.52 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.603 2.202 . . . . 0.0 112.406 -174.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -48.39 -51.11 28.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 -171.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.23 -1.19 57.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.984 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 tt -46.64 -53.03 12.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.048 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -67.39 -39.41 85.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.963 175.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -63.8 -40.54 96.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.914 -171.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -80.85 -22.93 39.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.558 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 75.9 t80 -48.32 -50.47 56.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 0.0 110.883 -166.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 60.0 Cg_endo -80.59 -28.68 2.66 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.721 2.281 . . . . 0.0 112.343 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -74.5 -37.6 63.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 -170.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.607 HG11 ' HD3' ' A' ' 57' ' ' PRO . 33.6 m -65.9 -26.86 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.03 78.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 173.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.06 68.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.0 p -87.3 -12.23 47.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.135 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.98 11.11 84.07 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.525 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -164.46 156.97 16.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.753 0.311 . . . . 0.0 110.934 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.91 -114.99 0.53 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.505 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.787 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 89.6 Cg_endo -77.6 150.67 28.07 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.739 2.293 . . . . 0.0 112.318 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.25 -35.3 21.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.805 163.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.538 ' HB ' HG23 ' A' ' 9' ' ' ILE . 40.5 mt -126.5 136.33 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.108 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 tp -132.12 125.84 55.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.119 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -89.81 139.56 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.805 166.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.446 ' CH2' ' HB3' ' A' ' 105' ' ' ALA . 35.2 p90 -141.12 163.0 34.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.936 171.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.53 -85.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.09 -168.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.543 ' NE2' ' HA3' ' A' ' 260' ' ' GLY . 11.3 m170 -126.89 -68.2 0.81 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.469 ' HB3' HG22 ' A' ' 333' ' ' ILE . 99.7 m-20 -100.65 -10.01 21.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 -158.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -51.83 -20.0 2.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.85 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.496 ' HB2' HD11 ' A' ' 104' ' ' ILE . 34.3 p90 -55.92 -28.88 58.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.53 -51.08 59.95 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.24 -36.7 90.21 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.425 172.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 1.4 t80 -55.83 -51.73 66.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.811 0.338 . . . . 0.0 110.913 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.32 -42.26 59.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.131 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -56.9 -37.98 72.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.938 -175.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.416 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 62.3 m -84.9 -6.42 59.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.949 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.96 30.47 59.24 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.591 173.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.416 ' HG ' ' HB2' ' A' ' 73' ' ' SER . 52.6 mt -89.04 -12.18 42.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.829 -167.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.457 ' HA ' ' H ' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -128.94 151.39 49.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 -173.246 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -77.07 142.21 39.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.118 175.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.94 135.89 48.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.903 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -104.22 153.7 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.255 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 99.2 m -96.39 126.74 42.65 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 111.112 -179.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 80' ' ' THR . 51.2 Cg_exo -54.98 134.79 65.56 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.653 2.236 . . . . 0.0 112.347 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -104.93 120.1 40.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.85 -39.84 94.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.88 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.13 -45.27 85.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.059 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -75.31 -31.75 60.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.499 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 65.4 tt0 -53.94 -51.18 64.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.52 -32.18 70.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 174.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -76.66 -22.01 54.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.51 -105.36 0.3 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.952 -171.413 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.487 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 25.0 t80 171.94 130.02 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.624 0.726 . . . . 0.0 110.966 -168.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -52.79 -37.68 76.73 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.727 2.285 . . . . 0.0 112.359 -175.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -66.57 -34.78 78.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.852 -172.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.5 p -73.93 -30.01 62.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.17 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.511 ' HA ' HG23 ' A' ' 97' ' ' VAL . 75.8 m95 -65.82 -31.99 73.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.931 173.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.66 -32.33 72.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.812 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.72 -23.9 62.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.518 HG21 HD23 ' A' ' 103' ' ' LEU . 19.5 m -107.27 14.06 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 -177.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -100.02 130.12 46.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.823 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -126.07 113.71 17.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.2 t30 58.99 38.31 24.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.839 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.36 0.64 89.46 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.502 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -118.9 151.62 37.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.878 0.37 . . . . 0.0 110.843 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.518 HD23 HG21 ' A' ' 97' ' ' VAL . 14.6 mt -89.93 133.53 34.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.496 HD11 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -124.0 4.15 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 -172.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.446 ' HB3' ' CH2' ' A' ' 62' ' ' TRP . . . -163.47 164.58 24.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.106 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -114.11 142.21 27.59 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.575 0.702 . . . . 0.0 110.923 171.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.93 122.16 5.25 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.625 2.216 . . . . 0.0 112.296 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 1.074 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp -104.22 -37.69 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.61 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -146.48 154.09 41.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.034 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.4 t -115.49 129.86 71.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.089 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -109.96 129.28 55.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.522 ' HB1' ' HB ' ' A' ' 320' ' ' THR . . . -154.93 143.67 20.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.06 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.407 ' HB2' ' CB ' ' A' ' 257' ' ' PRO . 7.2 mp -89.97 169.0 11.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.95 -177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.7 p -157.31 156.37 32.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.898 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -100.06 128.58 46.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.902 169.451 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.624 ' N ' HD23 ' A' ' 115' ' ' LEU . 4.9 mp -110.07 133.14 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.102 -175.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -131.01 145.28 52.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -93.5 113.9 26.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.856 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.33 -20.79 66.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -175.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -79.5 -28.46 41.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.895 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.19 -49.61 11.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 175.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.653 ' H ' HD21 ' A' ' 122' ' ' LEU . 1.7 pt? -141.71 133.76 13.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.564 0.697 . . . . 0.0 110.831 175.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.44 -14.38 14.55 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.625 2.217 . . . . 0.0 112.352 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -143.72 98.35 5.32 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.564 0.697 . . . . 0.0 110.879 -173.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.45 156.5 61.41 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.684 2.256 . . . . 0.0 112.357 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.44 143.83 59.15 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.664 2.243 . . . . 0.0 112.321 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -89.89 -13.84 35.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.404 HG23 ' HB ' ' A' ' 249' ' ' THR . 63.6 p -132.44 158.38 42.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.132 -179.077 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -68.64 -30.04 68.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.56 -19.97 65.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.953 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -79.99 -26.97 39.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.851 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.478 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -56.7 -46.94 99.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.613 0.721 . . . . 0.0 111.303 -169.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 86.7 Cg_exo -52.58 -50.78 12.87 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.657 2.238 . . . . 0.0 112.374 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.71 -57.68 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 -174.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 1.161 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.37 -17.26 63.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 -173.18 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.58 ' N ' HD13 ' A' ' 135' ' ' LEU . 36.2 t70 -61.17 -40.16 92.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 168.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.16 -30.89 71.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.879 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.8 -46.24 58.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.842 -177.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.641 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.0 pp -84.11 -13.9 51.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.641 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.7 tttt -58.77 -34.92 71.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.93 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.72 -24.14 67.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.057 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -95.0 3.4 54.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.888 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.75 32.32 54.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.445 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -110.65 171.76 7.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 110.911 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.6 t -124.63 140.17 53.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.753 168.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.451 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -67.28 -42.95 82.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.168 -170.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -138.54 128.79 25.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 63.2 tpp -110.81 129.32 55.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -153.22 155.18 36.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -88.57 -50.94 5.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.845 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 1.085 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.8 tm? 48.47 31.12 2.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -170.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -103.06 -7.36 21.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.977 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -129.99 152.52 80.12 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-O 121.652 0.739 . . . . 0.0 110.882 -174.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.49 -32.51 53.36 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.752 2.301 . . . . 0.0 112.315 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -69.7 -30.05 67.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -80.01 -39.64 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.835 172.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.405 HG21 HG11 ' A' ' 347' ' ' VAL . 17.8 m -60.1 -52.3 65.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.124 -179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.593 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 22.7 t-105 -60.7 -48.65 92.56 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.598 0.713 . . . . 0.0 110.889 -160.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 84.3 Cg_exo -50.82 -44.43 41.33 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.62 2.213 . . . . 0.0 112.276 -176.34 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.637 ' C ' HD21 ' A' ' 160' ' ' LEU . 7.0 tt -72.92 -39.99 65.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 -171.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.17 -42.07 66.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.136 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.14 -23.32 60.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.126 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.26 -35.02 71.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.111 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.6 p30 -104.29 9.44 35.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.877 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.44 4.75 23.32 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.472 169.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.37 68.89 2.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.531 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -92.62 133.53 35.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.771 0.32 . . . . 0.0 110.944 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.453 ' HB2' HD11 ' A' ' 368' ' ' ILE . . . -83.94 12.61 5.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 -173.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.501 ' HD1' ' HE2' ' A' ' 336' ' ' MET . 53.1 p90 -151.52 153.32 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.911 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -99.79 122.29 42.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 156.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -112.72 122.31 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.872 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -152.2 130.58 12.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.2 t30 54.99 43.96 29.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.77 15.46 79.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.602 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.38 139.75 50.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.867 -176.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -96.99 145.0 26.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 170.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -126.03 110.15 13.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.87 172.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.559 ' C ' HD13 ' A' ' 178' ' ' ILE . 1.6 pp -80.04 -9.02 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -98.2 -11.93 22.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -121.93 89.14 3.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 169.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.414 HG12 ' HA ' ' A' ' 169' ' ' PHE . 26.0 m -116.61 164.55 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.082 -172.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -107.45 24.78 23.4 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.574 -173.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.438 HG22 HD13 ' A' ' 368' ' ' ILE . 2.5 m -109.24 -21.05 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.811 0.338 . . . . 0.0 111.055 -176.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -90.96 28.9 1.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.794 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -125.12 -170.04 2.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.893 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.85 -29.09 68.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.88 -41.71 95.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.477 -168.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.66 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -64.03 -37.04 85.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.942 0.401 . . . . 0.0 111.156 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.594 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -61.83 -38.13 87.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.868 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.14 -38.07 89.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.136 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.09 -47.73 63.38 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.505 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.556 HD11 ' HA ' ' A' ' 347' ' ' VAL . 22.6 tp -67.39 -34.8 78.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.912 0.387 . . . . 0.0 110.901 -177.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.499 ' OG1' HG22 ' A' ' 357' ' ' VAL . 93.1 m -65.09 -41.43 94.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.148 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 59.8 t80 -67.33 -47.02 71.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.903 177.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.619 ' C ' HD21 ' A' ' 195' ' ' LEU . 7.4 tt -51.6 -51.42 55.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 -175.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.408 ' O ' HG13 ' A' ' 199' ' ' ILE . 31.2 m -64.01 -22.67 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.0 m-20 -61.59 -34.43 75.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.946 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 194' ' ' PHE . 0.8 OUTLIER -81.28 -39.91 24.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.922 -173.92 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.526 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.8 pp -73.46 -29.3 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.135 172.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.6 -37.29 79.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -80.82 2.6 25.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.885 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 67.1 39.74 3.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.799 170.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -77.32 -17.94 57.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.91 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.526 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.2 ppp? -146.11 157.12 43.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.885 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -94.09 150.09 20.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.844 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.97 -25.88 67.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.075 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -95.4 0.99 54.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 94.0 m -63.55 127.18 30.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.095 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.42 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 14.7 t0 -120.02 177.36 5.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.853 177.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -65.01 -36.96 86.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.94 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.3 p -70.48 -38.03 74.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.911 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.42 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 78.7 mt -65.83 -43.12 93.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.072 175.652 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.31 87.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.209 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -61.6 -46.8 88.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.88 -40.77 97.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.056 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.91 -49.11 76.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.124 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -64.7 -41.1 96.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.966 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -63.51 -31.58 72.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.903 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.24 -13.17 44.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.962 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.14 25.01 35.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.556 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -85.87 -21.18 28.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 110.907 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.8 t -125.63 138.48 53.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.592 ' HB3' HD23 ' A' ' 139' ' ' LEU . . . -63.08 -48.84 76.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.012 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.504 ' HB3' HD22 ' A' ' 115' ' ' LEU . 69.9 mtm -133.3 159.89 38.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.949 -173.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.4 t -149.07 155.66 41.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.237 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.0 mm -111.47 130.05 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.178 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -155.77 174.63 15.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.5 -151.48 9.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.441 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.69 -26.18 28.16 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.621 2.214 . . . . 0.0 112.337 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -74.32 -32.06 62.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.942 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 43.19 45.04 4.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.151 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 35.6 m0 -69.45 -16.77 63.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 66.6 m -65.03 -26.42 68.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.528 ' HB3' HG21 ' A' ' 116' ' ' ILE . 39.1 p30 -82.62 -179.1 7.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 -172.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.8 mt -97.57 122.51 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.125 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.95 -60.0 2.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.821 -173.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 86.2 m -129.28 118.38 22.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.227 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 29.8 t -175.01 162.2 3.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -68.71 -19.69 64.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.93 170.382 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 87.9 t -65.16 124.97 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.081 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -79.05 140.11 37.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.29 151.52 38.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.72 161.93 26.23 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 173.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.1 p -137.03 138.47 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.418 . . . . 0.0 111.025 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.4 t -155.72 150.97 26.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.176 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 30.7 m -59.97 167.08 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.119 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.964 HD21 ' HD3' ' A' ' 257' ' ' PRO . 2.8 mm? -59.24 149.82 66.25 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.519 0.676 . . . . 0.0 110.946 -168.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.23 -176.58 2.76 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.786 2.324 . . . . 0.0 112.406 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' THR . . . . . 0.404 ' HB ' HG23 ' A' ' 128' ' ' THR . 99.3 m -88.92 144.03 26.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.108 -173.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -131.34 110.96 11.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 54.92 36.16 26.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.988 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 89.81 -0.16 79.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.449 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -128.78 139.16 34.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.543 0.687 . . . . 0.0 110.843 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -67.38 138.28 45.9 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.734 2.289 . . . . 0.0 112.375 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.454 ' HB2' ' HB3' ' A' ' 247' ' ' LEU . 75.6 m -81.48 -4.81 56.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 173.5 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 255' ' ' SER . 91.3 mttt -37.41 130.93 0.82 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.494 0.664 . . . . 0.0 110.878 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.964 ' HD3' HD21 ' A' ' 247' ' ' LEU . 37.8 Cg_endo -84.24 168.07 11.94 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.7 2.266 . . . . 0.0 112.278 -159.97 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -60.36 166.83 2.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.4 t -117.88 130.23 73.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.152 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.543 ' HA3' ' NE2' ' A' ' 64' ' ' HIS . . . -117.93 139.72 14.98 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.438 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 83.8 t -124.77 116.95 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.756 0.312 . . . . 0.0 111.189 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.441 HD21 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -65.14 119.97 11.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.961 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.3 m -123.8 130.88 53.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.809 -167.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.93 138.69 52.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.049 -174.421 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.6 170.82 22.21 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.43 -171.548 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.588 HG13 ' HB3' ' A' ' 277' ' ' LYS . 23.1 mm -114.96 127.64 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 0.0 111.198 -173.201 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -63.24 129.56 40.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 -175.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.467 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -58.68 -29.94 67.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.16 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.92 -6.34 59.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 -172.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 18.2 t -70.66 123.47 89.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.557 0.694 . . . . 0.0 110.981 -173.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.401 ' HD2' HG21 ' A' ' 2' ' ' ILE . 97.0 Cg_endo -68.47 -8.34 22.84 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.669 2.246 . . . . 0.0 112.388 167.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.402 ' O ' ' HG ' ' A' ' 275' ' ' LEU . 74.2 m-80 -106.35 11.12 31.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.907 -176.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -47.58 -37.52 12.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 -168.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.54 -47.18 61.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.875 -171.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 272' ' ' ASN . 2.1 pp -81.02 -30.7 34.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.945 -176.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.35 -49.55 68.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.071 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.588 ' HB3' HG13 ' A' ' 266' ' ' ILE . 57.9 pttt -69.33 -34.1 74.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.56 -45.82 81.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.822 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -67.75 -38.88 84.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.797 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 7.5 tt -58.55 -50.73 72.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 -175.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -72.2 -26.7 62.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -100.02 -11.06 20.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.967 -169.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.877 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 79.1 m-85 -128.33 -55.27 1.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 3.5 mp -66.13 -34.88 79.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 -165.395 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 1.074 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.2 pp -123.82 37.45 4.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.97 175.501 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 287' ' ' ASP . 9.3 m -115.53 153.86 30.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.108 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.581 ' HA ' HD11 ' A' ' 290' ' ' LEU . 28.7 t70 -45.7 -34.82 3.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -166.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -78.49 -41.09 33.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.877 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.04 -56.53 5.72 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.472 -171.686 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.582 HD12 ' N ' ' A' ' 291' ' ' GLU . 0.5 OUTLIER -66.42 -21.26 66.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.908 -179.157 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.582 ' N ' HD12 ' A' ' 290' ' ' LEU . 84.4 tt0 -68.29 -46.94 68.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.798 171.254 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.91 -42.87 99.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.071 -174.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 4.0 m -79.59 -36.31 17.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.182 -174.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -64.97 -28.73 69.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.934 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.79 -26.72 68.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -87.95 -41.96 12.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -146.13 135.53 11.47 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.541 0.686 . . . . 0.0 110.902 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -53.12 113.9 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.655 2.236 . . . . 0.0 112.394 175.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.419 ' HA ' HD12 ' A' ' 299' ' ' LEU . 0.7 OUTLIER -86.45 -24.94 25.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.949 177.77 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 103.63 -57.01 0.56 Allowed Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.506 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.596 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -168.18 161.83 12.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.384 . . . . 0.0 111.036 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.624 HG22 ' HB3' ' A' ' 307' ' ' TYR . 32.6 m -124.33 155.55 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.099 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.02 -9.99 59.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.034 173.405 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.567 ' CD2' HD22 ' A' ' 290' ' ' LEU . 45.0 tp -86.5 119.95 27.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.858 -176.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.61 -38.64 72.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.945 -174.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 42.7 t -64.56 -50.32 67.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.916 -169.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.624 ' HB3' HG22 ' A' ' 302' ' ' VAL . 16.9 t80 -78.52 -29.13 46.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -64.74 -37.76 88.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.37 -37.9 85.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.939 173.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -72.81 -39.8 66.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.963 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.596 HD13 ' HA ' ' A' ' 301' ' ' ALA . 79.2 mt -61.93 -32.64 73.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.928 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.26 -17.52 58.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.8 -19.12 65.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.978 173.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -91.63 121.74 66.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.746 0.784 . . . . 0.0 110.852 164.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -48.2 -26.93 8.73 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.679 2.252 . . . . 0.0 112.344 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -61.26 -29.64 69.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -172.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 1.2 mp -76.84 -29.86 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.188 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.51 85.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.046 -170.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.21 -43.74 77.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.522 ' HB ' ' HB1' ' A' ' 112' ' ' ALA . 80.8 p -63.78 -30.99 72.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -171.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.5 mmm -70.91 -32.86 69.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.85 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -64.46 -46.68 82.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.869 -173.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.456 ' OD1' ' HB2' ' A' ' 112' ' ' ALA . 7.5 p-10 -80.08 -27.07 39.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.728 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.13 -49.21 73.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.116 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -68.0 -34.98 77.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -105.51 -6.54 19.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.823 -169.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -93.18 -159.6 34.94 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.435 -170.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -142.22 148.53 38.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 0.0 110.92 -172.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 41.7 mm -65.13 122.3 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.083 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 36.2 ttp -52.46 139.64 37.7 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.574 0.702 . . . . 0.0 110.913 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.441 ' HB2' ' HG3' ' A' ' 336' ' ' MET . 58.5 Cg_endo -67.7 84.33 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.728 2.285 . . . . 0.0 112.348 176.53 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.433 ' CG ' ' O ' ' A' ' 332' ' ' ASN . 10.6 t-20 -106.51 16.52 24.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 -170.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.469 HG22 ' HB3' ' A' ' 65' ' ' ASP . 48.2 pt -83.22 159.98 60.96 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.614 0.721 . . . . 0.0 111.217 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -57.17 -36.32 99.09 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.736 2.291 . . . . 0.0 112.315 -172.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -71.16 -28.1 64.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.858 -175.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.501 ' HE2' ' HD1' ' A' ' 169' ' ' PHE . 85.1 mmm -79.99 -22.76 42.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 -173.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.5 m -55.52 -39.95 71.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.806 -171.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -68.71 -33.48 74.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.031 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 1.5 m-30 -67.51 -37.33 82.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -54.98 -42.04 71.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -78.28 -36.18 47.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.774 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.12 -38.44 90.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.043 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.428 HG13 ' O ' ' A' ' 339' ' ' PHE . 19.3 m -74.72 -31.32 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.071 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.495 ' O ' HG23 ' A' ' 347' ' ' VAL . 4.9 tmt_? -64.16 -37.33 87.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.863 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.9 m -57.27 -36.73 71.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.212 174.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.89 -42.54 94.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.183 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.556 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.9 m -74.26 -34.57 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.202 -174.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.465 HD13 HG21 ' A' ' 347' ' ' VAL . 1.4 mp -63.37 -47.91 89.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.119 173.856 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.97 -40.29 97.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.26 -46.39 41.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.105 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.33 78.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.039 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.2 p -75.26 -10.73 59.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.3 18.31 69.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.484 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.87 -33.32 45.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.764 0.316 . . . . 0.0 110.938 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.51 ' HB2' ' HB3' ' A' ' 360' ' ' ALA . 90.3 mm-40 -140.58 156.44 46.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 52.3 p -77.48 166.59 22.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.183 171.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.499 HG22 ' OG1' ' A' ' 193' ' ' THR . 53.2 t -56.19 -41.92 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.226 173.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.52 -46.85 88.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.951 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -70.49 -56.42 6.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.51 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . . . -68.45 -48.42 64.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.11 -172.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.66 HD11 ' HB1' ' A' ' 188' ' ' ALA . 1.8 tm? -65.0 -45.85 83.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -175.035 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.34 -53.76 50.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 -176.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . 0.417 ' O ' ' HG3' ' A' ' 367' ' ' ARG . 32.1 t70 -68.07 -50.08 57.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 -174.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -64.06 -38.29 90.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 -172.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 75.5 mm-40 -78.08 -32.34 50.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 40.9 m -66.21 -29.13 69.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.172 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . 0.417 ' HG3' ' O ' ' A' ' 363' ' ' ASP . 79.6 mtt180 -56.9 -32.16 65.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 174.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 365' ' ' GLN . 71.4 mt -59.89 -40.72 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 41.6 p -97.1 -11.07 24.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.189 -175.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.812 175.363 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.755 0.312 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.441 HG21 ' HD2' ' A' ' 271' ' ' PRO . 62.3 mt -99.45 140.06 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.154 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -143.9 145.0 31.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -54.34 138.24 39.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 176.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.15 8.35 68.88 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.538 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.43 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.2 tttt -166.09 131.09 2.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.827 0.346 . . . . 0.0 110.91 176.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.618 HD23 HD12 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -141.76 155.97 45.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.963 -172.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 69.3 t -114.45 135.43 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.18 -175.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.727 HD12 HG13 ' A' ' 35' ' ' VAL . 0.9 OUTLIER -120.0 134.88 62.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.047 176.603 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.87 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 60.5 m95 -108.62 124.46 50.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 163.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.531 HD13 ' HG ' ' A' ' 20' ' ' LEU . 12.1 tt -109.75 151.77 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.074 -163.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -54.75 148.28 13.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.807 -172.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.99 -16.85 41.87 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.504 -175.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -80.61 -14.12 58.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.854 0.359 . . . . 0.0 110.888 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 15' ' ' LYS . 33.0 mmtm -140.0 128.09 22.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 166.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.1 -78.13 1.07 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.49 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -104.88 -35.92 7.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -67.33 -52.47 39.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.862 -150.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.403 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -54.32 -52.62 43.16 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.508 -177.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.542 HD23 HD11 ' A' ' 9' ' ' ILE . 5.8 mt -55.09 -53.44 55.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.359 . . . . 0.0 110.907 174.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.29 -39.02 6.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.133 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -71.47 -57.99 3.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 178.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.48 HG23 ' HA ' ' A' ' 20' ' ' LEU . 20.9 m -74.29 -36.19 42.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.199 -170.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.565 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -63.6 -45.62 94.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.489 174.895 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -54.33 -36.49 63.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.878 0.37 . . . . 0.0 110.831 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -58.92 -41.12 86.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.967 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 4.7 m-30 -62.34 -47.03 86.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.441 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 98.1 mt-10 -61.27 -36.05 78.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -75.42 -40.18 58.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.924 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -91.24 -49.84 6.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 -166.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.6 p -108.66 -7.55 15.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.174 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.13 8.83 87.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.369 167.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.934 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.8 133.66 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 111.219 -178.39 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.441 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.7 mttt -69.97 136.18 50.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.853 -172.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.727 HG13 HD12 ' A' ' 9' ' ' ILE . 92.1 t -114.7 125.02 71.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.007 -175.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.575 ' O ' HD13 ' A' ' 9' ' ' ILE . 98.6 m -108.91 125.66 52.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.098 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.434 HG23 ' HB3' ' A' ' 20' ' ' LEU . 84.8 t -102.43 130.91 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.138 177.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -118.13 154.27 32.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.958 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.463 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 65.8 t-80 -87.13 138.61 32.48 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.558 0.694 . . . . 0.0 110.884 -169.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 81.4 Cg_exo -57.34 -25.51 65.88 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.652 2.235 . . . . 0.0 112.303 -173.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -48.36 -51.1 27.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.838 -173.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.94 -0.82 57.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 -175.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.442 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 8.1 tt -46.56 -52.71 12.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -174.642 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -65.01 -40.81 95.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.81 -40.89 97.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.865 -172.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -81.55 -21.14 38.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.538 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 53.2 t80 -50.06 -51.16 64.45 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.696 0.76 . . . . 0.0 110.816 -165.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.538 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 55.5 Cg_endo -81.69 -30.06 1.55 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.656 2.238 . . . . 0.0 112.405 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -75.12 -40.05 60.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -167.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.51 -27.69 41.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.032 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.723 ' HB2' HD23 ' A' ' 75' ' ' LEU . . . -68.08 -36.21 79.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.096 177.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.81 -32.08 71.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.051 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.2 p -92.18 -15.7 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.135 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.76 10.89 80.64 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.403 173.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -140.2 132.62 28.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 0.0 110.811 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.439 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . 170.69 -127.76 1.51 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.474 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.87 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 35.0 Cg_endo -64.18 149.01 91.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.713 2.275 . . . . 0.0 112.399 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -92.1 -33.2 14.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.826 161.251 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.692 ' HB ' HG23 ' A' ' 9' ' ' ILE . 38.7 mt -124.16 136.09 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.114 -177.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 tp -131.44 127.56 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.157 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -93.77 136.7 33.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.802 170.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.489 ' CH2' ' HB3' ' A' ' 105' ' ' ALA . 33.0 p90 -140.89 167.17 22.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.969 171.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.59 -82.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.016 -167.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -127.32 -73.42 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.881 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.455 ' H ' ' HB3' ' A' ' 332' ' ' ASN . 70.1 m-20 -99.96 -10.73 21.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -159.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -51.25 -22.34 2.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.527 ' HB2' HD11 ' A' ' 104' ' ' ILE . 32.9 p90 -56.8 -31.77 65.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.807 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.89 -50.99 60.91 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.447 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.73 -35.98 90.56 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.533 171.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.452 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -55.1 -51.63 65.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 0.0 110.946 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.73 -44.07 51.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.072 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -57.04 -38.86 73.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.982 -174.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.414 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 63.4 m -85.02 -7.15 59.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.77 30.3 59.9 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.545 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.723 HD23 ' HB2' ' A' ' 51' ' ' ALA . 35.5 mt -88.83 -9.35 52.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.808 0.337 . . . . 0.0 110.904 -170.012 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.467 ' HA ' ' H ' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -128.61 152.11 48.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 -178.161 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.43 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -80.37 142.82 34.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.069 175.695 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -73.12 135.38 44.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.836 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 pt -105.06 155.87 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.109 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.9 m -97.65 130.04 30.08 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.536 0.684 . . . . 0.0 111.08 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.42 135.55 66.2 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.669 2.246 . . . . 0.0 112.335 176.428 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -103.39 117.85 35.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 175.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.31 -41.34 98.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.849 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.25 87.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.002 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.435 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 16.5 m-85 -75.84 -31.75 59.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.857 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.448 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 66.8 tt0 -53.4 -50.84 64.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.949 173.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.76 -32.99 72.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.435 ' HB2' ' HA ' ' A' ' 85' ' ' PHE . 93.7 mttt -75.87 -21.04 57.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -174.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.465 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -104.76 -105.08 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -171.528 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.465 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 26.9 t80 171.66 128.33 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.68 0.752 . . . . 0.0 110.956 -167.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -52.77 -36.78 74.69 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.406 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 62.9 t80 -65.19 -35.11 80.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.4 p -73.79 -31.08 63.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.168 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.665 ' HA ' HG23 ' A' ' 97' ' ' VAL . 79.6 m95 -67.95 -29.72 68.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 173.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.04 -31.48 72.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.95 -23.84 58.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.665 HG23 ' HA ' ' A' ' 94' ' ' TRP . 17.7 m -111.51 19.28 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 -173.146 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.1 ttp-105 -111.95 136.5 51.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.842 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -135.39 121.89 20.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.952 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.2 t30 58.91 35.39 24.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.96 0.76 89.78 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.57 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -118.29 151.0 38.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 110.853 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.625 HD23 HG21 ' A' ' 97' ' ' VAL . 22.2 mt -86.58 135.27 33.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.951 177.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.527 HD11 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -124.79 3.6 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.065 -173.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.489 ' HB3' ' CH2' ' A' ' 62' ' ' TRP . . . -163.46 165.83 23.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.196 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.473 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 90.2 m-85 -114.87 140.57 25.64 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.618 0.723 . . . . 0.0 110.976 170.653 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.473 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 12.0 Cg_exo -70.07 123.63 10.19 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.603 2.202 . . . . 0.0 112.294 170.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 1.021 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -106.98 -39.83 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 175.039 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.6 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -144.51 153.78 42.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 -166.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.8 t -118.68 129.86 74.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.135 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -119.89 127.78 53.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.615 ' HB2' HD22 ' A' ' 323' ' ' ASN . . . -155.02 146.42 23.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.036 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.6 mp -85.71 170.01 12.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.996 -175.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.4 p -154.75 153.63 31.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.988 0.423 . . . . 0.0 110.853 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.883 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -94.89 126.79 40.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 169.411 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.602 ' N ' HD23 ' A' ' 115' ' ' LEU . 5.1 mp -111.63 131.73 62.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 -175.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -132.47 147.93 52.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 -175.091 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -92.37 115.49 28.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.872 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.474 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.2 mttt -66.56 -22.12 66.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -77.94 -23.35 48.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 -176.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.8 mp -85.29 -57.5 3.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 168.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.734 ' H ' HD21 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -144.32 125.89 8.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.696 0.76 . . . . 0.0 110.785 177.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.46 -0.76 10.66 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.594 2.196 . . . . 0.0 112.41 -176.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -147.93 101.87 3.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.654 0.74 . . . . 0.0 110.761 -174.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.52 155.06 50.39 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.755 2.303 . . . . 0.0 112.401 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.452 ' HD2' ' SD ' ' A' ' 224' ' ' MET . 52.4 Cg_exo -55.28 143.06 77.56 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.699 2.266 . . . . 0.0 112.294 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -78.87 -22.03 46.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 52.9 p -135.62 159.95 40.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.202 -177.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.441 ' HA ' HD11 ' A' ' 132' ' ' ILE . 77.8 m95 -70.82 -28.13 64.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.09 -19.41 65.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -84.07 -20.63 32.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.559 ' O ' HD13 ' A' ' 135' ' ' LEU . 0.7 OUTLIER -57.36 -45.35 99.9 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.635 0.731 . . . . 0.0 111.133 -171.865 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 82.0 Cg_exo -51.27 -47.67 24.81 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.612 2.208 . . . . 0.0 112.335 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.84 -59.84 3.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.054 -174.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 1.122 HD23 ' C ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.99 -16.8 63.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.866 -173.328 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.549 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.4 t70 -61.3 -40.1 92.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 168.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.36 -30.07 69.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.7 -47.95 57.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.832 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.61 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.1 pp -87.42 -16.69 34.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.924 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.61 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.4 tttt -59.45 -32.86 70.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.41 -25.13 68.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.983 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -95.36 7.04 47.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.919 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.9 30.96 58.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.531 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -109.7 169.99 8.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 0.0 110.887 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.5 t -125.63 142.22 51.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 174.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.428 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.63 -42.48 74.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.124 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -139.3 127.78 22.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.945 -175.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 63.3 tpp -105.25 129.14 53.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 -174.342 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.18 158.33 38.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.929 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -98.63 -42.87 7.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.82 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 1.032 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.5 tm? 48.46 31.2 2.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 -170.205 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -103.73 -6.76 21.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.887 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -137.67 156.5 74.63 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.645 0.736 . . . . 0.0 110.901 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.495 ' HA ' ' HB ' ' A' ' 157' ' ' THR . 67.7 Cg_exo -52.37 -26.39 27.6 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.671 2.247 . . . . 0.0 112.339 176.176 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -63.22 -38.49 91.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -85.85 -37.19 19.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.495 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 20.0 m -58.87 -52.13 67.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.116 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.589 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 23.6 t-105 -62.54 -49.23 84.21 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.561 0.696 . . . . 0.0 110.893 -163.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.589 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 81.6 Cg_exo -50.07 -48.26 20.42 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.724 2.283 . . . . 0.0 112.392 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.7 HD21 ' O ' ' A' ' 160' ' ' LEU . 6.8 tt -72.0 -39.91 68.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 -170.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.3 mt -71.12 -42.41 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.119 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.38 -25.86 59.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.425 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -60.66 -35.03 75.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -169.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.409 ' HB3' ' CD2' ' A' ' 250' ' ' PHE . 59.6 p30 -97.53 3.48 50.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.76 2.15 13.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.415 173.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.89 64.78 3.0 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.563 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -87.08 136.02 33.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.916 0.388 . . . . 0.0 110.987 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.49 -0.33 22.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.791 ' CE1' ' HG3' ' A' ' 331' ' ' PRO . 49.6 p90 -154.05 154.82 34.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.909 -175.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -97.22 121.96 39.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.952 157.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -109.76 123.14 49.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.882 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -152.69 131.52 12.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.3 t30 55.74 44.97 25.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 172.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.92 15.29 78.34 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.463 173.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.89 139.11 50.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.0 110.864 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -98.75 140.43 32.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 172.711 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -122.33 109.94 15.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.534 ' C ' HD13 ' A' ' 178' ' ' ILE . 2.1 pp -83.4 -6.2 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.071 -177.581 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -99.67 -16.92 18.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -117.01 88.74 2.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.834 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.484 HG12 ' HA ' ' A' ' 169' ' ' PHE . 22.9 m -117.82 165.03 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.094 -169.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -109.96 25.71 15.86 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.509 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.52 ' HB ' ' HB3' ' A' ' 365' ' ' GLN . 1.2 m -106.6 -23.06 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.821 0.344 . . . . 0.0 111.06 -176.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -92.09 24.15 3.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -107.72 -174.97 2.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.8 -28.31 63.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.11 -40.43 92.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.524 -171.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.599 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -60.45 -38.39 84.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 111.099 177.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.604 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.6 mttt -61.67 -37.3 83.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.9 176.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.77 88.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.042 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.0 -46.62 71.39 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.564 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.565 HD11 ' HA ' ' A' ' 347' ' ' VAL . 20.2 tp -67.56 -33.63 75.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.958 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.527 ' OG1' HG22 ' A' ' 357' ' ' VAL . 91.8 m -65.57 -42.02 92.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.24 176.511 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.475 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 92.3 t80 -69.4 -44.68 70.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.638 ' C ' HD21 ' A' ' 195' ' ' LEU . 6.9 tt -51.13 -51.6 51.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.932 -175.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.403 ' O ' HG13 ' A' ' 199' ' ' ILE . 35.1 m -63.89 -22.48 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 -174.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.475 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.0 m-20 -62.25 -34.18 76.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.843 -177.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.465 HD23 ' O ' ' A' ' 194' ' ' PHE . 0.7 OUTLIER -82.02 -39.96 22.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.959 -173.444 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.403 HG13 ' O ' ' A' ' 196' ' ' VAL . 1.8 pp -72.02 -29.96 34.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.151 172.212 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -67.47 -37.73 83.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 171.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -82.72 2.54 33.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.925 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 66.86 39.94 3.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.829 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -75.96 -15.66 60.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.811 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -144.1 156.1 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.842 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -94.19 152.61 18.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.58 -27.11 68.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -94.1 2.67 55.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -177.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.9 m -65.62 134.92 54.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -138.36 171.73 13.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.918 176.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.07 -46.04 82.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 -176.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.8 m -60.37 -40.61 91.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.95 -42.25 94.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.178 173.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.98 -36.91 85.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.136 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . 0.414 ' HG2' ' HA ' ' A' ' 233' ' ' SER . 93.8 mt-10 -65.04 -44.24 89.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.874 177.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.96 -39.56 93.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.087 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.18 -45.02 95.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.099 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -64.25 -38.67 91.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.22 -34.7 76.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.0 -19.26 27.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.39 26.1 26.48 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -82.07 -19.96 39.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.928 0.395 . . . . 0.0 110.915 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.9 t -123.89 134.76 53.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 174.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.527 ' HB2' HD22 ' A' ' 122' ' ' LEU . . . -66.8 -47.38 72.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.996 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.64 ' HB3' HD22 ' A' ' 115' ' ' LEU . 72.9 mtm -133.86 153.78 51.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -171.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 10.1 t -151.04 155.81 39.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.213 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.2 mm -109.69 124.76 66.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.185 -175.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -153.51 174.64 14.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 -170.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.41 -164.13 34.17 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.435 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.2 -20.9 49.1 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.662 2.241 . . . . 0.0 112.341 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -78.16 -25.52 47.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 49.4 53.52 12.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.115 178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -60.0 -23.61 63.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 -177.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.414 ' HA ' ' HG2' ' A' ' 214' ' ' GLU . 65.2 m -57.09 -40.69 77.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.89 -176.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -85.91 179.19 7.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 69.8 mt -120.47 127.32 75.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 -167.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -95.38 -9.91 31.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 65.2 p -130.59 71.41 1.46 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 31.5 t -168.26 163.94 13.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.926 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.24 -3.03 51.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 34.9 m -57.85 156.47 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.122 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -106.15 124.25 49.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.474 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 52.5 p90 -143.82 155.97 44.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.89 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -135.84 160.16 24.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.512 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.38 135.12 54.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.938 0.399 . . . . 0.0 111.061 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.8 t -153.8 149.14 27.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.36 162.07 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 3.1 mp -68.05 151.58 97.09 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.539 0.685 . . . . 0.0 110.919 -162.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.09 -173.6 1.85 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.663 2.242 . . . . 0.0 112.327 -174.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 99.5 m -89.03 143.01 27.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 -171.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.409 ' CD2' ' HB3' ' A' ' 164' ' ' ASP . 11.1 t80 -132.17 113.13 12.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -176.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 56.22 35.46 25.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.37 1.89 83.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.583 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.425 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 90.0 mm-40 -126.86 127.94 24.32 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 121.555 0.693 . . . . 0.0 110.887 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 78.1 Cg_exo -55.12 133.24 57.0 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.631 2.221 . . . . 0.0 112.375 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 256' ' ' LYS . 69.4 m -78.81 -9.61 59.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.855 173.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 85.7 mttt -39.8 128.61 1.53 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.539 0.685 . . . . 0.0 110.861 -173.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 71.2 Cg_exo -63.51 156.25 57.77 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.648 2.232 . . . . 0.0 112.377 -167.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -70.75 166.6 20.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 173.048 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.83 131.68 61.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.146 -167.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.95 135.13 12.09 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.436 173.111 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 96.4 t -123.53 115.91 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 0.0 111.159 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.453 HD21 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -64.17 120.71 12.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.992 -178.525 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 48.4 m -124.74 131.63 53.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.835 -169.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.84 138.89 52.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.105 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -135.04 172.85 21.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.463 -170.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 23.4 mm -111.39 127.91 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.759 0.314 . . . . 0.0 111.244 -173.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -62.48 132.03 51.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.988 -176.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.467 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -60.13 -28.48 67.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.113 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.7 -5.15 59.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.8 t -74.79 120.06 79.75 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.675 0.75 . . . . 0.0 110.917 -174.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.441 ' HD2' HG21 ' A' ' 2' ' ' ILE . 92.0 Cg_endo -70.4 -7.1 20.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.637 2.225 . . . . 0.0 112.389 164.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -101.11 14.93 30.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 -171.022 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -51.87 -40.18 60.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.898 -169.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.3 -52.4 58.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 -172.018 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.4 pp -80.51 -33.65 36.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.004 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.62 -47.43 69.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.018 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -61.48 -41.75 97.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.854 173.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.592 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.8 tt0 -61.38 -47.32 86.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.42 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 17.9 m-30 -68.4 -36.56 79.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.813 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.537 ' HA ' HD23 ' A' ' 284' ' ' LEU . 5.8 tt -59.37 -52.4 65.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.873 -177.005 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -77.91 -33.5 51.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 -176.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.592 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 61.7 m-80 -99.97 -13.19 19.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.845 -163.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.771 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 59.2 m-85 -127.36 -50.49 1.41 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.537 HD23 ' HA ' ' A' ' 280' ' ' LEU . 0.5 OUTLIER -63.85 -39.36 94.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -170.523 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 1.021 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.7 pp -124.38 38.2 4.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 -175.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.484 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 5.9 t -115.66 162.73 16.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.088 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.438 ' HA ' HD11 ' A' ' 290' ' ' LEU . 28.4 t70 -48.51 -34.12 10.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -169.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -80.24 -41.09 25.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.859 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.771 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.77 -57.24 5.48 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.452 -170.224 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.558 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -66.42 -21.47 66.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.0 110.973 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.545 ' N ' HD12 ' A' ' 290' ' ' LEU . 83.9 tt0 -67.06 -46.49 74.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.825 171.135 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.67 -37.66 88.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.403 HG13 ' HA3' ' A' ' 19' ' ' GLY . 61.0 t -74.61 -46.33 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.086 -177.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -65.81 -30.09 70.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.797 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.05 -27.8 67.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.95 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -87.41 -49.92 6.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.83 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 74.1 mmtt -138.6 139.15 23.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.57 0.7 . . . . 0.0 110.865 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 297' ' ' LYS . 80.1 Cg_exo -55.03 115.83 2.71 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.66 2.24 . . . . 0.0 112.381 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 299' ' ' LEU . 0.3 OUTLIER -84.41 -22.54 30.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 173.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 96.8 -59.71 1.22 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.516 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.676 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -167.53 160.23 12.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.814 0.34 . . . . 0.0 111.231 174.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.706 HG22 ' HB3' ' A' ' 307' ' ' TYR . 22.1 m -120.84 153.3 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.87 -9.58 58.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.061 173.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.558 ' CD2' HD22 ' A' ' 290' ' ' LEU . 44.0 tp -83.48 121.1 26.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.886 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.58 -38.61 75.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.86 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.7 t -64.46 -50.0 69.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.847 -169.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.706 ' HB3' HG22 ' A' ' 302' ' ' VAL . 13.6 t80 -77.26 -31.32 54.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.91 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.93 -39.15 93.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -58.67 -38.01 77.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -75.05 -38.78 61.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.979 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.676 HD13 ' HA ' ' A' ' 301' ' ' ALA . 80.3 mt -61.84 -34.25 75.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.98 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.38 -18.05 63.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.055 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.12 -19.56 66.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.934 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -93.14 121.43 65.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.6 0.715 . . . . 0.0 110.865 166.024 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -47.9 -26.65 7.56 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.66 2.24 . . . . 0.0 112.396 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -62.91 -34.88 78.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 -175.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.546 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.0 OUTLIER -81.5 -35.95 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.2 90.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.118 -170.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.92 -47.96 73.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.035 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.545 ' HB ' ' HB1' ' A' ' 112' ' ' ALA . 75.6 p -67.84 -27.16 66.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.086 -176.09 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.5 ttp -62.48 -34.96 77.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -62.31 -51.37 67.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.84 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.615 HD22 ' HB2' ' A' ' 112' ' ' ALA . 12.3 p-10 -80.06 -26.48 39.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.77 -177.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.41 -51.62 62.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.095 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -69.33 -29.77 67.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.88 -8.13 16.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.824 -168.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -91.39 -153.24 29.33 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.436 -168.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.0 144.83 37.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.856 0.36 . . . . 0.0 110.895 -172.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 36.0 mm -63.78 119.54 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.089 -172.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 60.2 ttm -62.54 135.93 95.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.517 0.675 . . . . 0.0 110.89 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.791 ' HG3' ' CE1' ' A' ' 169' ' ' PHE . 32.0 Cg_endo -67.89 126.21 14.26 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.678 2.252 . . . . 0.0 112.312 -177.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.455 ' HB3' ' H ' ' A' ' 65' ' ' ASP . 61.0 t30 -117.58 21.84 12.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.895 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 50.4 pt -79.78 153.53 75.51 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.677 0.751 . . . . 0.0 111.128 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -54.11 -30.97 62.94 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.717 2.278 . . . . 0.0 112.315 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.418 ' HB3' ' CZ ' ' A' ' 339' ' ' PHE . 99.4 mm-40 -67.03 -24.55 66.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.83 -173.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 88.4 mmm -64.96 -28.64 69.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.871 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.1 m -58.07 -39.91 79.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.767 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.07 -39.39 63.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 3.8 m-30 -63.17 -46.74 85.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -60.14 -37.71 80.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.901 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -69.63 -39.67 77.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.2 -43.01 83.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.104 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.41 HG13 ' O ' ' A' ' 339' ' ' PHE . 19.7 m -73.91 -33.17 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.133 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.462 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.0 tmt_? -65.2 -38.68 91.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 86.1 m -58.53 -38.6 78.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.76 94.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.565 ' HA ' HD11 ' A' ' 192' ' ' LEU . 12.4 m -73.97 -35.51 42.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.084 -174.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.453 HD13 HG21 ' A' ' 347' ' ' VAL . 1.4 mp -63.68 -47.01 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.221 173.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.02 -40.98 99.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.891 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.96 -45.94 47.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.11 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.01 -40.17 78.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.7 p -75.67 -10.11 59.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.32 18.67 68.43 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.375 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.13 -32.85 44.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 0.0 110.911 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -140.88 157.72 44.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.6 p -77.21 169.11 18.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.288 170.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.527 HG22 ' OG1' ' A' ' 193' ' ' THR . 53.0 t -57.56 -43.07 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.14 172.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.65 -47.04 88.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -69.52 -55.3 10.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.5 -47.7 66.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.084 -172.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.604 ' HG ' ' HA ' ' A' ' 189' ' ' LYS . 1.6 tm? -65.08 -44.96 87.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -174.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.46 -53.71 38.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.949 -177.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.01 -47.07 66.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 -172.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.07 -43.92 81.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 -174.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.52 ' HB3' ' HB ' ' A' ' 183' ' ' VAL . 86.9 mm-40 -73.36 -32.98 64.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.933 -175.032 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 35.9 m -61.76 -28.23 69.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.172 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.88 -30.11 65.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.435 ' HB ' ' O ' ' A' ' 365' ' ' GLN . 74.5 mt -60.9 -37.7 77.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.233 174.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 43.4 p -98.01 -12.01 22.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.174 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 176.539 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.752 0.31 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.6 mt -108.96 138.16 37.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -121.37 136.13 55.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.83 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -54.32 134.92 45.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.843 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.24 9.4 67.32 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.475 -174.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 39.2 ttpt -160.07 129.97 5.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.363 . . . . 0.0 110.936 173.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.672 ' H ' HD21 ' A' ' 7' ' ' LEU . 1.1 pt? -136.24 152.77 51.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.93 -169.326 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 74.5 t -112.64 135.22 52.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.189 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.643 HD12 HG21 ' A' ' 35' ' ' VAL . 1.1 mp -118.64 132.69 67.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 177.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.819 ' HD1' ' HB3' ' A' ' 57' ' ' PRO . 78.7 m95 -104.45 125.77 50.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.929 164.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.535 HD13 ' HG ' ' A' ' 20' ' ' LEU . 10.4 tt -110.88 150.03 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.096 -166.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -58.99 150.09 25.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -173.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.83 -16.62 12.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.417 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -72.68 -15.21 61.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.917 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -139.98 137.85 35.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.899 167.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.97 -81.56 1.07 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.504 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -109.99 -37.13 5.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.932 0.396 . . . . 0.0 110.946 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -66.9 -50.01 63.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.92 -151.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.757 ' HA3' HG21 ' A' ' 293' ' ' VAL . . . -54.67 -53.6 38.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.537 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.535 ' HG ' HD13 ' A' ' 11' ' ' ILE . 8.1 mt -55.01 -48.07 73.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.783 0.325 . . . . 0.0 110.926 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.73 -34.77 12.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.11 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -78.66 -60.13 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.848 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.473 HG23 ' HA ' ' A' ' 20' ' ' LEU . 26.4 m -74.55 -42.1 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 -169.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.47 ' N ' HG21 ' A' ' 23' ' ' VAL . . . -64.99 -40.61 97.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -59.04 -29.95 67.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.908 0.385 . . . . 0.0 110.88 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -56.99 -33.08 66.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.026 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 2.5 m-30 -56.6 -47.76 78.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.895 177.278 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -70.36 -41.42 73.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.07 -34.85 79.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.846 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -92.63 -48.94 6.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.908 0.385 . . . . 0.0 110.853 -170.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.1 p -116.56 -0.72 12.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.213 -169.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.04 11.72 85.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.429 167.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.967 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.02 133.86 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.868 0.366 . . . . 0.0 111.11 -179.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 73.4 mmtt -74.13 140.62 45.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.844 -171.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.643 HG21 HD12 ' A' ' 9' ' ' ILE . 13.1 p -122.72 128.1 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.065 -174.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.631 ' O ' HD13 ' A' ' 9' ' ' ILE . 96.9 m -111.94 129.08 56.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.093 -174.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.478 HG23 ' HB3' ' A' ' 20' ' ' LEU . 91.6 t -104.48 131.51 53.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.125 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -117.18 155.02 30.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.44 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.0 t-80 -85.07 138.96 36.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.683 0.754 . . . . 0.0 110.837 -170.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 86.6 Cg_exo -54.98 -29.39 64.34 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.627 2.218 . . . . 0.0 112.303 -175.361 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -48.28 -51.34 26.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 -172.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.03 -0.85 57.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.885 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.2 tt -47.06 -53.12 13.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -68.69 -38.45 80.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.7 -41.35 96.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 -171.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -81.66 -21.43 38.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.54 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 65.9 t80 -48.6 -50.71 57.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.624 0.726 . . . . 0.0 110.84 -167.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.54 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 66.3 Cg_endo -80.06 -28.48 3.13 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.596 2.198 . . . . 0.0 112.352 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -74.43 -39.16 62.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 -171.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.444 HG11 ' HD3' ' A' ' 57' ' ' PRO . 33.5 m -67.88 -27.97 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.13 -177.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.591 ' HB2' HD23 ' A' ' 75' ' ' LEU . . . -68.29 -37.77 80.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.057 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.19 -32.11 72.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.076 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.8 p -92.89 -14.92 27.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.56 10.79 79.95 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.407 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -142.79 136.2 28.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.776 0.322 . . . . 0.0 110.766 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.95 -114.95 0.52 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.514 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.819 ' HB3' ' HD1' ' A' ' 10' ' ' TRP . 61.2 Cg_endo -73.97 154.54 47.89 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.709 2.273 . . . . 0.0 112.285 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.67 -32.77 13.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 160.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.624 ' HB ' HG23 ' A' ' 9' ' ' ILE . 39.0 mt -127.63 137.77 56.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.229 -177.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 tp -131.38 126.84 59.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.193 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -88.97 141.6 28.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 167.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.589 ' CZ2' ' HB3' ' A' ' 67' ' ' PHE . 1.8 p90 -138.41 160.9 38.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.968 172.002 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.43 -82.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.164 -169.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.544 ' CD2' ' HA3' ' A' ' 260' ' ' GLY . 40.5 m170 -121.88 -71.07 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -170.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.95 -11.78 16.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.815 -164.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -56.78 -17.07 7.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -158.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.589 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . 27.9 p90 -61.77 -23.23 66.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.826 -173.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.55 -48.81 63.53 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.404 -174.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.43 -36.77 92.03 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.474 171.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.505 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 1.5 t80 -55.17 -51.23 67.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.897 0.38 . . . . 0.0 110.874 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.99 -41.91 40.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.119 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -59.19 -36.18 74.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.41 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 67.0 m -85.06 -7.69 59.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 178.289 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.28 31.73 58.95 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.591 HD23 ' HB2' ' A' ' 51' ' ' ALA . 52.1 mt -88.12 -9.62 52.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.812 0.339 . . . . 0.0 110.884 -167.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.549 HD11 ' HB ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -128.42 152.95 47.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -172.254 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.446 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -79.18 141.25 37.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.091 175.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -70.74 137.85 50.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 173.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.436 HD13 ' CZ ' ' A' ' 106' ' ' TYR . 39.3 pt -103.88 156.64 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.143 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.9 m -92.08 130.04 39.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.536 0.684 . . . . 0.0 111.088 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.428 ' HB3' HD12 ' A' ' 103' ' ' LEU . 50.0 Cg_endo -67.41 141.14 55.03 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.687 2.258 . . . . 0.0 112.328 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -110.14 118.75 37.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.94 -36.78 73.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.25 -45.17 92.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.178 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -75.64 -32.44 60.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.494 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.5 tt0 -51.51 -49.1 62.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -66.35 -32.89 74.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.799 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.02 -23.26 52.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 -172.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.416 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -104.96 -104.64 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.993 -169.392 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 t80 174.94 107.98 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.668 0.747 . . . . 0.0 111.036 -160.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.0 -32.17 30.0 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.725 2.283 . . . . 0.0 112.329 -177.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.99 -36.93 85.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.2 p -78.3 -31.52 48.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.591 ' HA ' HG23 ' A' ' 97' ' ' VAL . 86.2 m95 -63.16 -29.99 71.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 171.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -69.46 -32.15 70.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.792 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.73 -23.01 61.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.08 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.591 HG23 ' HA ' ' A' ' 94' ' ' TRP . 19.8 m -110.7 17.98 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.134 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -107.57 132.93 52.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.817 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -126.2 119.22 26.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 174.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.2 t30 57.57 37.04 27.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.868 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.64 1.12 90.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.482 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -121.83 148.75 44.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.843 0.354 . . . . 0.0 110.852 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.584 HD23 HG21 ' A' ' 97' ' ' VAL . 16.8 mt -86.03 133.79 33.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -176.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.549 ' HB ' HD11 ' A' ' 76' ' ' LEU . 1.2 pp -114.84 -9.29 12.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.095 -172.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.571 ' HB1' ' HH2' ' A' ' 62' ' ' TRP . . . -169.44 173.4 6.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.183 -173.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.459 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 99.2 m-85 -115.88 140.17 25.86 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.671 0.748 . . . . 0.0 110.925 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 12.2 Cg_exo -70.82 127.85 14.29 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.705 2.27 . . . . 0.0 112.323 172.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.913 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -108.9 -39.93 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.117 177.074 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.607 ' HB1' ' HB3' ' A' ' 262' ' ' LEU . . . -143.29 154.17 43.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.149 -171.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.2 t -116.15 127.28 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.204 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -110.62 125.23 53.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.467 ' HB1' ' HB ' ' A' ' 320' ' ' THR . . . -146.36 141.05 26.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.9 mp -89.66 167.12 13.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.004 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.5 p -156.27 154.99 31.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.845 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.879 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -92.27 123.48 35.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 168.335 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.564 ' N ' HD23 ' A' ' 115' ' ' LEU . 5.0 mp -109.94 131.56 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.177 -175.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -132.35 148.41 52.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 -173.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -91.06 113.97 26.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.909 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.11 -25.41 68.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -173.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -83.47 -22.15 32.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 -173.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 mp -81.23 -55.51 4.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.857 169.11 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.7 ' H ' HD21 ' A' ' 122' ' ' LEU . 1.7 pt? -141.05 127.34 11.5 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.554 0.693 . . . . 0.0 110.888 173.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.18 -5.54 13.64 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.663 2.242 . . . . 0.0 112.365 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -149.27 102.43 3.32 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.621 0.725 . . . . 0.0 110.793 -175.037 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -72.01 156.92 55.49 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.769 2.312 . . . . 0.0 112.321 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.14 144.84 82.98 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.737 2.291 . . . . 0.0 112.247 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.02 -17.97 44.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.977 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 56.8 p -135.06 159.51 41.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.21 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.536 ' HA ' HD11 ' A' ' 132' ' ' ILE . 64.7 m95 -70.76 -28.35 64.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.039 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.99 -22.78 67.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.807 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -82.34 -21.96 35.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.791 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.643 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -56.76 -48.73 96.76 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.67 0.747 . . . . 0.0 111.2 -173.6 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.643 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 41.8 Cg_endo -69.07 -37.41 10.87 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.669 2.246 . . . . 0.0 112.332 -174.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.89 -60.74 2.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.081 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 1.278 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.23 -16.95 64.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -175.99 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.512 ' N ' HD13 ' A' ' 135' ' ' LEU . 34.5 t70 -57.79 -40.4 79.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.039 0.447 . . . . 0.0 110.866 168.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.25 -30.66 69.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -70.97 -47.69 57.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.812 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.9 pp -84.91 -14.47 47.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.627 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.8 tttt -60.87 -34.01 73.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.968 174.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.73 -24.05 67.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.085 175.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -95.12 4.35 53.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.877 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.02 32.13 56.96 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -110.22 170.72 7.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.932 173.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.9 t -124.14 138.73 54.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 168.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -65.4 -43.69 89.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 -170.236 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -143.11 127.87 18.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 63.5 tpp -107.55 132.58 53.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -153.57 158.44 41.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -172.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -90.11 -51.08 5.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.851 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 1.071 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.6 tm? 48.04 32.36 2.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.03 -167.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -101.2 -6.16 24.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.866 175.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.36 155.02 80.72 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.638 0.732 . . . . 0.0 110.939 -174.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.06 -25.95 77.9 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.743 2.295 . . . . 0.0 112.391 177.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -72.26 -27.48 62.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -80.01 -38.88 31.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.848 170.507 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.414 HG21 HG11 ' A' ' 347' ' ' VAL . 22.5 m -63.15 -45.66 90.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.07 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.596 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 46.2 t-105 -54.95 -54.55 48.66 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.609 0.719 . . . . 0.0 110.931 -169.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.596 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 22.1 Cg_endo -63.99 -19.92 67.15 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.634 2.222 . . . . 0.0 112.38 -173.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.712 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.7 tm? -82.77 -45.87 13.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.858 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.542 HG22 ' HA3' ' A' ' 166' ' ' GLY . 85.3 mt -75.3 -44.77 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.143 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.11 -23.65 61.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 -173.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.593 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -59.59 -35.95 75.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.104 -170.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 58.9 p30 -102.51 8.39 39.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.94 2.01 12.81 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.501 170.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.542 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -77.34 65.49 3.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.498 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -88.23 134.57 33.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.865 0.364 . . . . 0.0 111.035 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.6 2.1 17.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.135 -174.271 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.46 ' HA ' HG12 ' A' ' 181' ' ' VAL . 44.3 p90 -159.45 154.74 25.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 -175.632 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -93.67 123.13 36.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.847 160.367 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -114.95 120.58 40.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.987 175.116 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -151.93 130.13 11.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -173.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.04 41.41 31.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.955 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.21 17.81 79.67 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.536 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.32 138.5 50.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.853 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -99.24 144.98 27.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -126.39 110.0 12.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.832 174.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.7 pt -77.48 -15.73 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.105 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.95 -9.52 33.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -121.78 84.17 2.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.833 172.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.46 HG12 ' HA ' ' A' ' 169' ' ' PHE . 27.6 m -112.75 160.44 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 -172.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -104.53 19.06 43.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.516 -174.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.407 HG22 ' CD1' ' A' ' 368' ' ' ILE . 2.3 m -102.6 -20.65 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 0.0 111.098 -175.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -87.61 21.71 2.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.788 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -117.13 175.01 5.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.81 -24.95 67.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.076 -175.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.99 -40.61 97.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.491 -173.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.611 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -64.86 -37.77 88.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 111.055 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.577 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -61.14 -38.5 86.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 174.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.08 89.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.078 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.5 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -66.52 -47.74 67.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.5 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.732 HD11 ' HA ' ' A' ' 347' ' ' VAL . 20.3 tp -66.67 -34.72 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.954 0.406 . . . . 0.0 110.926 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.554 ' OG1' HG22 ' A' ' 357' ' ' VAL . 91.7 m -64.84 -42.64 94.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.11 177.516 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 91.5 t80 -68.06 -47.75 67.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.705 ' C ' HD21 ' A' ' 195' ' ' LEU . 5.3 tt -50.83 -50.66 56.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.91 -174.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 35.0 m -64.38 -22.7 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.111 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.478 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.3 m-20 -62.45 -33.95 75.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.918 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 194' ' ' PHE . 0.6 OUTLIER -81.66 -39.86 23.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.966 -173.368 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.423 ' H ' HG13 ' A' ' 199' ' ' ILE . 1.7 pp -72.05 -29.77 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.15 171.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.93 -36.82 83.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 171.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -83.65 4.03 30.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.952 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 66.23 39.9 4.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.835 170.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -75.73 -17.87 59.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -143.01 154.93 44.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.892 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -94.39 154.56 17.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.01 -26.85 68.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.151 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -95.03 0.42 54.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 97.1 m -66.17 128.82 37.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.153 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 19.7 t0 -122.0 173.6 7.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -62.77 -40.96 98.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.6 p -68.28 -37.37 80.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.862 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 79.9 mt -65.03 -42.22 94.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.081 174.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.1 93.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.078 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.26 -41.92 89.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.04 90.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.076 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.85 -39.11 93.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.129 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -63.68 -39.64 94.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.914 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -61.27 -33.19 73.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.3 -13.93 48.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.867 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.16 25.15 41.32 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.483 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -85.45 -22.16 28.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.952 0.406 . . . . 0.0 110.893 -175.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.9 t -129.57 139.95 51.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.582 ' HB3' HD23 ' A' ' 139' ' ' LEU . . . -65.05 -54.23 33.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.05 -174.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.674 ' HB3' HD22 ' A' ' 115' ' ' LEU . 67.8 mtm -134.42 153.2 52.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 -170.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 68.8 p -139.37 161.64 36.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.185 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 44.9 mm -108.94 126.21 65.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -154.75 175.05 14.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 -171.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -85.93 -159.98 33.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.411 -174.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.26 -23.52 33.0 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.679 2.253 . . . . 0.0 112.391 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -75.92 -24.88 55.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 48.05 50.08 16.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.153 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -59.98 -20.49 57.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 70.0 m -48.78 -50.1 35.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.865 174.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -85.02 179.33 7.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -172.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.2 mt -124.25 131.7 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.158 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -69.97 -39.62 75.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 -174.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 91.4 m -124.69 109.97 13.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.055 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 27.3 t -172.1 150.13 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.98 -26.83 67.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 173.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.22 134.31 30.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -90.95 132.02 36.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -127.29 147.65 50.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.846 176.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -129.6 156.81 21.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.489 170.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.468 HG11 ' HA ' ' A' ' 316' ' ' ARG . 3.1 p -135.72 135.17 51.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.962 0.411 . . . . 0.0 111.086 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.6 t -154.62 150.95 28.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.2 m -61.04 164.75 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.17 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 2.5 mp -71.26 152.75 94.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.583 0.706 . . . . 0.0 110.95 -163.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.62 -176.44 3.22 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.28 . . . . 0.0 112.479 -171.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.2 m -86.02 143.84 27.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.196 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -129.85 111.78 12.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.957 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 54.99 36.84 27.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.53 0.78 84.05 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.462 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . 0.42 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 91.2 mm-40 -126.5 125.89 24.53 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 121.576 0.703 . . . . 0.0 110.862 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 77.3 Cg_exo -54.43 128.58 30.71 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.736 2.29 . . . . 0.0 112.338 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 82.4 p -84.32 0.41 49.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.024 0.44 . . . . 0.0 110.9 174.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -37.71 134.95 0.79 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.54 0.686 . . . . 0.0 110.825 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.465 ' HD3' HD13 ' A' ' 247' ' ' LEU . 30.3 Cg_endo -79.05 156.66 26.57 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.657 2.238 . . . . 0.0 112.385 -163.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . 0.559 ' HB2' ' SD ' ' A' ' 330' ' ' MET . 10.4 m-85 -75.46 167.19 22.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.885 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 42.6 t -114.49 132.77 62.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.181 -167.167 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.544 ' HA3' ' CD2' ' A' ' 64' ' ' HIS . . . -115.2 141.78 17.21 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.41 173.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 81.4 t -121.42 112.08 33.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.767 0.318 . . . . 0.0 111.122 -176.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.607 ' HB3' ' HB1' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -75.82 114.51 14.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -176.57 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.424 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . 19.1 m -131.62 154.11 49.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.777 -164.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -132.61 133.56 43.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.123 -176.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.01 171.24 16.3 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.459 -174.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.648 HG13 ' HB3' ' A' ' 277' ' ' LYS . 37.5 mm -113.31 124.99 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.246 -170.698 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -62.97 130.68 45.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 -176.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.479 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -59.26 -29.36 67.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.2 -177.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.03 -8.19 58.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.001 -172.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.4 t -67.39 123.56 86.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.58 0.705 . . . . 0.0 110.866 -172.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -69.71 -11.49 31.02 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.576 2.184 . . . . 0.0 112.408 168.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -103.92 14.1 31.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -51.82 -35.25 43.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 -167.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . 0.42 ' HA ' ' HE3' ' A' ' 277' ' ' LYS . 72.0 mm-40 -70.08 -49.4 51.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.006 -174.024 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.94 -30.33 39.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.901 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.83 -50.53 66.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.648 ' HB3' HG13 ' A' ' 266' ' ' ILE . 13.7 pttp -71.96 -34.07 68.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.915 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -63.39 -46.62 85.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 177.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -69.7 -36.33 75.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.884 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.455 ' HA ' HD23 ' A' ' 284' ' ' LEU . 5.9 tt -55.73 -51.32 67.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.922 -178.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -75.79 -26.35 57.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.816 -177.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -100.28 -13.25 18.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.78 -166.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.856 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 63.0 m-85 -120.15 -59.77 1.75 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.813 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.455 HD23 ' HA ' ' A' ' 280' ' ' LEU . 1.6 mp -62.37 -34.23 76.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.951 -161.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.913 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.3 pp -124.77 37.52 4.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.483 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 66.7 p -118.59 160.6 21.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.176 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.586 ' HA ' HD11 ' A' ' 290' ' ' LEU . 42.2 p-10 -51.12 -28.51 10.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.778 -167.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -78.93 -45.0 21.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 175.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.856 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.27 -56.8 6.0 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.497 -169.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.6 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.5 -21.63 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.766 0.317 . . . . 0.0 110.976 -178.884 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.59 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.1 tt0 -69.34 -49.31 56.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 172.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.65 96.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.077 -172.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.757 HG21 ' HA3' ' A' ' 19' ' ' GLY . 1.5 p -79.78 -29.89 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.435 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 27.7 t30 -63.9 -29.79 70.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 174.262 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.58 -20.76 66.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.935 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -82.17 -39.96 22.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.917 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -161.89 138.37 6.09 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.424 0.631 . . . . 0.0 110.935 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -45.82 115.94 1.23 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.685 2.256 . . . . 0.0 112.448 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.435 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 49.4 mt -93.49 -12.15 30.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 98.33 -61.7 0.89 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.528 171.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.624 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -167.1 159.55 13.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.844 0.354 . . . . 0.0 111.141 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.602 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 19.3 m -124.95 159.85 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.212 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.81 -14.44 61.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 172.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.6 ' CD2' HD22 ' A' ' 290' ' ' LEU . 49.9 tp -83.74 121.01 26.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -172.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -59.4 -33.79 71.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.944 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.9 m -61.34 -47.53 85.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.775 -172.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.526 ' HB3' HG22 ' A' ' 302' ' ' VAL . 4.5 t80 -78.78 -32.69 46.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.933 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.27 -40.89 62.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.849 173.618 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -55.14 -40.19 70.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.877 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -78.12 -37.83 45.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 177.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.624 HD13 ' HA ' ' A' ' 301' ' ' ALA . 83.4 mt -63.68 -33.03 74.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.58 -20.26 59.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.05 -20.22 66.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -93.09 121.28 65.94 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.65 0.738 . . . . 0.0 110.899 168.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.97 -25.13 11.81 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 0.0 112.373 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.468 ' HA ' HG11 ' A' ' 244' ' ' VAL . 78.3 mtt85 -62.25 -29.87 70.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.935 -175.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.578 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.2 mp -75.3 -28.67 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.81 87.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.031 -171.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.26 -45.32 73.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.145 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.467 ' HB ' ' HB1' ' A' ' 112' ' ' ALA . 67.0 p -64.47 -29.61 70.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.151 -173.43 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 61.9 tpp -68.63 -35.66 77.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.791 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -65.03 -47.75 76.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -173.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 327' ' ' GLY . 8.2 p-10 -79.94 -24.78 40.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.39 -42.79 92.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.93 -38.84 86.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.925 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.47 -4.14 15.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.818 -166.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.87 -162.7 36.99 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.526 -166.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -150.31 147.11 27.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 -171.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 36.8 mm -59.85 123.14 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.115 -170.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.559 ' SD ' ' HB2' ' A' ' 258' ' ' PHE . 74.4 mmm -42.0 134.42 2.38 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 121.554 0.692 . . . . 0.0 110.917 178.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.452 ' HG3' ' CE2' ' A' ' 158' ' ' TRP . 74.5 Cg_endo -75.22 80.64 2.43 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.666 2.244 . . . . 0.0 112.294 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -111.07 22.59 15.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 46.3 pt -74.77 159.71 82.52 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 121.642 0.734 . . . . 0.0 111.114 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -54.44 -35.11 84.0 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.64 2.226 . . . . 0.0 112.292 -174.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -67.21 -28.05 67.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.989 -177.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.409 ' HG3' ' HB2' ' A' ' 331' ' ' PRO . 80.8 mmm -75.43 -18.36 59.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.812 -171.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.4 m -58.4 -42.17 86.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.774 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.0 -39.45 63.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.528 ' O ' HG13 ' A' ' 343' ' ' VAL . 4.2 m-30 -67.3 -45.42 76.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -174.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.473 ' HA ' HG23 ' A' ' 343' ' ' VAL . 6.9 m0 -59.7 -37.32 78.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.955 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -63.6 -45.18 91.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.23 79.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.106 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.528 HG13 ' O ' ' A' ' 339' ' ' PHE . 18.4 m -73.49 -32.46 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -175.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.451 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.1 tmt_? -66.05 -39.04 89.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 175.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.2 m -58.74 -36.96 75.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 173.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.85 91.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -174.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.732 ' HA ' HD11 ' A' ' 192' ' ' LEU . 8.5 m -73.01 -34.79 46.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.211 -175.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.471 HD13 HG21 ' A' ' 347' ' ' VAL . 1.5 mp -64.22 -46.78 92.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.09 174.025 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -67.9 -37.18 81.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.815 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.86 -44.93 65.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.18 85.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.062 -176.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.6 p -77.7 -10.16 59.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.09 17.07 73.01 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.45 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.02 -31.12 50.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.74 0.305 . . . . 0.0 110.881 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . 0.569 ' HB2' ' HB3' ' A' ' 360' ' ' ALA . 77.8 mt-30 -139.98 155.07 47.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.901 176.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 57.2 p -78.81 166.04 22.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 169.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.554 HG22 ' OG1' ' A' ' 193' ' ' THR . 53.8 t -56.12 -41.95 70.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.116 174.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -60.9 -48.13 83.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.854 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -69.58 -54.96 11.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.947 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . 0.569 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . . . -68.61 -47.75 65.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.115 -172.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.611 HD11 ' HB1' ' A' ' 188' ' ' ALA . 1.5 tm? -65.46 -44.63 86.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.964 -174.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.45 -53.12 53.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.986 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -67.5 -45.89 74.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.54 85.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.57 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 78.4 mm-40 -76.02 -25.73 55.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.001 -176.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 53.5 m -62.39 -35.08 78.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.086 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -59.94 -30.23 68.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.893 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.407 ' CD1' HG22 ' A' ' 183' ' ' VAL . 71.4 mt -60.46 -37.6 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.088 174.246 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 60.9 p -94.56 -15.0 24.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.168 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 179.252 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.726 0.298 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.432 HG21 ' HD2' ' A' ' 271' ' ' PRO . 49.4 mt -100.47 141.26 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.144 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -139.13 144.86 38.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.8 133.74 37.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.79 10.6 64.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.46 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.417 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.2 tttt -163.78 130.79 3.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.91 176.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.624 ' CD2' HD12 ' A' ' 33' ' ' ILE . 1.4 pt? -141.58 151.89 43.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.974 -169.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 80.4 t -110.48 135.97 47.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.091 -176.327 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.669 HD12 HG13 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -120.03 134.08 64.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.159 176.626 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.793 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 72.4 m95 -103.75 128.05 51.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 163.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.455 HD13 ' HG ' ' A' ' 20' ' ' LEU . 13.8 tt -108.52 149.95 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.193 -165.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.67 153.16 13.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.795 -173.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.17 -22.45 29.22 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.509 -177.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -72.42 -17.11 61.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.359 . . . . 0.0 110.924 -169.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.4 ' HA ' ' HD2' ' A' ' 15' ' ' LYS . 11.5 mmmm -140.07 131.87 27.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 168.213 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.93 -71.96 1.23 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.544 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -109.08 -40.15 5.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -66.9 -52.44 43.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.866 -149.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.421 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -52.96 -51.61 44.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.425 -176.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.481 ' HB3' HG23 ' A' ' 37' ' ' VAL . 3.9 mt -54.98 -57.35 12.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.775 0.321 . . . . 0.0 110.919 173.139 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.85 -37.4 13.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 -176.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.56 -55.69 9.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.3 m -73.79 -35.27 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.187 -173.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.581 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -66.66 -46.67 73.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.482 176.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -53.42 -36.64 61.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 110.898 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -56.22 -42.8 77.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.904 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -64.0 -43.49 95.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.833 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.44 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 98.8 mt-10 -61.23 -37.64 83.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.944 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.77 -41.49 68.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.886 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -94.46 -46.96 6.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.944 -164.441 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.7 p -108.57 -7.87 15.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.111 -172.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.81 8.3 87.84 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.436 168.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 1.045 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.64 134.69 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.807 0.337 . . . . 0.0 111.168 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.44 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.1 mttt -73.34 135.69 44.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.959 -170.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.669 HG13 HD12 ' A' ' 9' ' ' ILE . 96.6 t -115.74 126.34 73.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.989 0.423 . . . . 0.0 111.075 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.565 ' O ' HD13 ' A' ' 9' ' ' ILE . 96.7 m -108.47 127.9 54.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.126 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.481 HG23 ' HB3' ' A' ' 20' ' ' LEU . 94.2 t -103.1 130.07 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -119.38 152.01 37.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.835 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 64.9 t-80 -90.72 141.66 27.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.612 0.72 . . . . 0.0 110.902 -167.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.477 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 86.2 Cg_exo -55.11 -26.66 51.72 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.676 2.25 . . . . 0.0 112.386 -175.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -49.72 -55.72 12.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.96 -1.74 58.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.853 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.477 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 8.8 tt -46.9 -53.33 12.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.901 -175.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -67.81 -38.31 83.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.869 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.21 -42.21 89.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.843 -171.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -83.63 -21.56 32.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.536 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 62.1 t80 -47.11 -50.27 47.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.669 0.747 . . . . 0.0 110.832 -169.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.536 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 69.7 Cg_endo -79.89 -28.82 3.05 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.25 . . . . 0.0 112.347 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -73.86 -40.01 63.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -172.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.45 HG11 ' HD3' ' A' ' 57' ' ' PRO . 33.7 m -67.91 -28.12 40.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.197 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.679 ' HB2' HD23 ' A' ' 75' ' ' LEU . . . -70.38 -38.06 74.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.055 175.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.57 -33.86 75.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.164 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 p -90.11 -15.97 30.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.224 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.44 9.15 77.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.395 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -139.96 132.25 28.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 110.815 177.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.02 -114.95 0.52 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.51 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.793 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 61.2 Cg_endo -74.75 149.06 37.39 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.677 2.251 . . . . 0.0 112.282 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -86.97 -32.89 19.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 158.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.611 ' HB ' HG23 ' A' ' 9' ' ' ILE . 40.7 mt -128.19 137.77 56.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.116 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 tp -131.78 126.1 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -89.79 139.65 30.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 169.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.522 ' CZ2' ' HB3' ' A' ' 105' ' ' ALA . 35.6 p90 -142.61 165.04 28.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.966 171.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.9 -88.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.034 -163.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.493 ' NE2' ' HA3' ' A' ' 260' ' ' GLY . 27.4 m170 -111.65 -75.72 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.861 -174.671 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -103.69 -3.89 24.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 -161.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -56.52 -16.89 6.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 -169.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.514 ' HB2' HD11 ' A' ' 104' ' ' ILE . 37.6 p90 -57.42 -28.52 63.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -177.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.41 -50.6 63.55 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.493 -173.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.12 -38.06 94.86 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.56 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.459 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 1.6 t80 -57.22 -48.22 79.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 0.0 110.93 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.37 -43.79 31.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.053 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -56.58 -38.85 72.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.9 -175.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.424 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 60.3 m -83.72 -6.75 59.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.878 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.46 30.52 60.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.452 173.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.679 HD23 ' HB2' ' A' ' 51' ' ' ALA . 52.8 mt -88.01 -9.74 52.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.905 0.384 . . . . 0.0 110.914 -167.472 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.483 ' HA ' ' H ' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -130.15 153.16 48.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -172.891 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.83 144.93 31.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.081 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.28 139.22 54.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 175.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.6 pt -105.05 153.92 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.067 -173.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.5 m -108.66 125.15 32.39 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.577 0.704 . . . . 0.0 111.104 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.65 156.0 53.89 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.631 2.22 . . . . 0.0 112.328 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -105.96 122.51 46.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 175.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.23 -35.02 48.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.807 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.05 -37.92 89.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.098 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -88.29 -25.47 22.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -54.9 -45.27 74.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 -176.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -68.11 -23.81 64.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.831 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.55 -19.63 22.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.976 -167.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.598 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -99.67 -32.44 11.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.956 -168.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.598 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 11.7 m-30 92.42 144.45 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.638 0.733 . . . . 0.0 110.947 175.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.32 -40.0 87.58 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 0.0 112.406 -174.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -71.34 -23.17 61.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.949 -171.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.4 p -80.17 -37.67 32.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.231 173.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.538 ' HA ' HG23 ' A' ' 97' ' ' VAL . 55.7 m95 -65.03 -29.21 70.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.996 171.037 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -71.13 -34.62 71.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 177.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.14 -24.77 63.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.585 HG21 HD23 ' A' ' 103' ' ' LEU . 18.4 m -106.96 15.64 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.164 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -101.34 131.62 47.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -130.94 116.03 17.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 174.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 t30 58.65 35.95 24.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.77 0.26 89.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.511 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -118.17 148.07 42.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 110.818 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.585 HD23 HG21 ' A' ' 97' ' ' VAL . 32.6 mt -88.74 134.42 33.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.514 HD11 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -125.81 3.42 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.033 -169.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.522 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . . . -163.7 162.71 24.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.184 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.506 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 94.0 m-85 -111.12 138.13 21.14 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.563 0.697 . . . . 0.0 110.941 173.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 15.1 Cg_exo -68.09 121.35 8.34 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.654 2.236 . . . . 0.0 112.362 170.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 1.051 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp -104.72 -40.02 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 173.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.617 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -145.72 154.86 42.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.064 -167.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.7 t -114.95 125.57 72.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.177 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -104.02 124.48 49.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.949 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.554 ' HB1' ' HB ' ' A' ' 320' ' ' THR . . . -149.07 141.41 24.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.147 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.8 mp -90.91 168.65 11.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.7 p -156.67 154.74 30.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.868 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -93.68 124.45 37.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 168.441 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.558 ' N ' HD23 ' A' ' 115' ' ' LEU . 5.1 mp -110.15 131.46 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.067 -175.726 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -131.31 145.28 51.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -94.49 114.37 26.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.825 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.416 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.7 mttt -66.03 -19.42 65.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.847 -173.354 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -84.67 -25.35 28.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.831 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.0 mp -82.17 -52.55 6.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.547 ' H ' HD21 ' A' ' 122' ' ' LEU . 2.0 pt? -140.03 128.55 13.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.621 0.724 . . . . 0.0 110.878 173.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -77.8 -11.97 16.59 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.709 2.272 . . . . 0.0 112.349 -173.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.407 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 61.1 t-20 -144.46 102.84 4.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.6 0.714 . . . . 0.0 110.895 -175.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.407 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 70.6 Cg_endo -71.27 153.84 61.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.618 2.212 . . . . 0.0 112.364 177.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.07 143.02 70.31 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.654 2.236 . . . . 0.0 112.314 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.0 -18.73 42.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.8 p -135.05 159.66 40.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.178 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.436 ' HA ' HD11 ' A' ' 132' ' ' ILE . 79.9 m95 -69.77 -28.14 65.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.994 177.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.68 -22.32 66.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.817 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -82.26 -24.63 34.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.869 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.478 HG22 ' N ' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -57.15 -46.95 99.8 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.564 0.697 . . . . 0.0 111.243 -171.073 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.478 ' N ' HG22 ' A' ' 132' ' ' ILE . 84.0 Cg_exo -51.92 -49.25 17.91 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.613 2.209 . . . . 0.0 112.457 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.76 -59.08 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 -174.269 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 1.133 HD23 ' C ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -70.09 -16.15 63.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -172.02 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.536 ' N ' HD13 ' A' ' 135' ' ' LEU . 32.2 t70 -61.32 -38.61 87.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.879 168.504 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.76 -30.5 71.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.05 -48.01 47.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -177.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.654 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.4 pp -84.96 -13.24 51.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.654 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.2 tttt -57.99 -34.46 70.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 170.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.48 -24.83 67.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.078 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -94.97 3.67 54.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.912 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.27 30.74 56.52 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.439 177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -109.68 171.19 7.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.914 0.387 . . . . 0.0 110.824 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.6 t -124.49 140.13 53.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 168.366 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.459 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -68.09 -43.47 78.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.09 -170.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -143.21 127.36 17.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 57.5 ttm -110.49 132.75 53.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -152.9 158.27 41.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.896 -173.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -84.87 -59.15 2.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.972 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 1.151 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.1 tm? 48.27 30.49 2.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 -163.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -103.06 -6.8 21.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.99 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.404 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 97.5 mt-10 -129.7 152.36 79.64 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.656 0.741 . . . . 0.0 110.921 -175.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.459 ' HB3' ' HB3' ' A' ' 340' ' ' TRP . 53.9 Cg_exo -56.48 -32.21 88.61 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.694 2.262 . . . . 0.0 112.317 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -70.6 -27.47 64.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -79.67 -41.18 27.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.823 171.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.465 HG21 HG11 ' A' ' 347' ' ' VAL . 15.7 m -61.64 -49.58 75.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.121 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.58 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 17.4 t-105 -59.56 -48.65 95.1 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.471 0.653 . . . . 0.0 110.903 -161.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.58 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 94.5 Cg_exo -51.26 -44.78 40.96 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.812 2.341 . . . . 0.0 112.329 -176.6 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.718 HD21 ' O ' ' A' ' 160' ' ' LEU . 6.7 tt -72.16 -39.33 68.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -171.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.43 -41.59 73.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.149 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.15 -23.91 59.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.068 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.47 -35.24 71.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.188 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -103.58 10.05 37.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.973 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.88 4.7 22.62 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 169.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.38 67.87 3.02 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.46 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -89.86 133.15 34.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.858 0.361 . . . . 0.0 110.978 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.45 10.18 7.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.08 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -152.21 154.48 35.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -99.75 123.37 43.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 157.042 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -112.42 121.76 45.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.959 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -152.64 130.07 11.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -174.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 54.89 43.67 29.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 174.373 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.14 16.77 78.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.572 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.86 138.73 49.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.773 0.321 . . . . 0.0 110.862 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.87 144.25 27.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 170.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -125.51 112.42 16.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.569 ' C ' HD13 ' A' ' 178' ' ' ILE . 1.2 pp -79.53 -12.02 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -177.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.96 -12.08 22.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -119.43 87.85 2.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.866 169.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.7 m -115.88 161.08 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -171.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.02 25.47 25.17 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.464 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.494 HG22 HD13 ' A' ' 368' ' ' ILE . 3.4 m -109.44 -19.01 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.838 0.351 . . . . 0.0 111.032 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -87.29 19.88 3.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -177.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -122.19 -170.06 2.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.019 -178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.36 -29.55 70.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 -172.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.64 -42.99 95.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.529 -167.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.618 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -64.99 -37.23 86.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.988 0.423 . . . . 0.0 111.107 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.572 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -62.3 -38.25 88.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.825 175.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.9 -37.99 89.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.138 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.09 -46.3 81.44 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.521 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.716 HD11 ' HA ' ' A' ' 347' ' ' VAL . 19.7 tp -68.63 -34.23 75.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.87 0.367 . . . . 0.0 110.826 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.492 ' OG1' HG22 ' A' ' 357' ' ' VAL . 90.7 m -64.3 -42.77 96.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.197 176.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 74.8 t80 -68.43 -47.0 68.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.841 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.629 HD11 HD22 ' A' ' 151' ' ' LEU . 7.3 tt -50.45 -51.47 46.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 -174.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.402 ' O ' HG13 ' A' ' 199' ' ' ILE . 30.9 m -63.95 -23.06 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.126 -174.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.3 m-20 -62.14 -33.39 74.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.946 -177.496 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.449 HD23 ' O ' ' A' ' 194' ' ' PHE . 0.8 OUTLIER -81.49 -39.99 23.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.847 -173.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.415 ' H ' HG13 ' A' ' 199' ' ' ILE . 1.8 pp -73.53 -28.81 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.175 171.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.54 -37.61 80.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -79.22 -0.32 31.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 65.3 40.72 4.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 169.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -76.06 -16.11 59.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.782 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -144.71 157.99 43.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.873 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -95.44 152.01 18.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.871 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.02 -26.26 68.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -94.96 1.79 55.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.7 m -66.31 128.34 35.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -121.57 171.38 8.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -66.05 -36.85 84.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.029 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 97.2 p -68.76 -37.33 79.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.852 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.03 -41.0 90.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.052 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.99 -38.29 90.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.004 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -65.26 -43.52 91.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.927 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.37 95.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.132 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.66 -41.59 98.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.203 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -64.07 -39.56 94.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.939 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -63.97 -33.63 76.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.895 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -85.08 -17.38 37.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.969 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.66 24.44 46.13 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.545 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.39 -22.45 28.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 110.895 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.8 t -128.3 137.42 51.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.187 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.492 ' HB3' HD23 ' A' ' 139' ' ' LEU . . . -64.07 -52.14 60.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.128 -175.39 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.57 ' HB3' HD22 ' A' ' 115' ' ' LEU . 61.8 mtm -135.82 155.1 50.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.765 -172.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 65.3 p -139.64 162.21 35.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.239 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.7 mm -110.41 126.92 67.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.136 174.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -153.0 174.68 13.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.913 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -87.14 -156.27 29.25 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.471 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.3 -21.94 26.02 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.645 2.23 . . . . 0.0 112.341 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . 0.658 ' HD1' ' O ' ' A' ' 230' ' ' TRP . 4.9 t90 -67.37 -30.01 69.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 48.74 44.96 21.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -65.07 -20.82 66.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -173.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 67.6 m -47.75 -41.1 22.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.913 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 49.8 p30 -85.02 -178.86 6.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.881 -171.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.446 HG22 ' H ' ' A' ' 237' ' ' THR . 77.7 mt -117.7 120.27 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.228 -168.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 55.9 p30 -89.52 -2.62 58.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 -175.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' THR . . . . . 0.446 ' H ' HG22 ' A' ' 235' ' ' ILE . 24.1 m -136.83 74.95 1.51 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.205 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 35.9 t -174.72 162.67 3.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -96.33 -0.43 49.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.3 m -59.91 159.99 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.102 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -104.28 128.73 52.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 -176.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.416 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 37.8 p90 -148.13 154.25 39.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.27 160.73 24.79 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.444 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.424 HG11 ' HA ' ' A' ' 316' ' ' ARG . 2.8 p -134.52 135.13 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.967 0.413 . . . . 0.0 111.099 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.3 t -154.13 149.88 27.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.136 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.5 m -60.54 165.57 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.09 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 1.4 mp -66.16 152.29 94.23 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.521 0.676 . . . . 0.0 111.047 -164.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -75.78 -176.41 2.99 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.747 2.298 . . . . 0.0 112.358 -173.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 94.9 m -86.9 145.43 26.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.07 -171.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -130.99 111.4 12.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 54.85 35.3 23.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.927 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.94 2.62 80.86 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -126.59 126.2 24.52 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.566 0.698 . . . . 0.0 110.844 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.01 134.98 66.74 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.654 2.236 . . . . 0.0 112.306 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 256' ' ' LYS . 73.1 m -82.52 -1.48 50.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.046 0.451 . . . . 0.0 110.844 174.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 255' ' ' SER . 90.9 mttt -37.28 130.0 0.8 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.605 0.717 . . . . 0.0 110.881 -178.113 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -78.16 163.17 28.13 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.632 2.221 . . . . 0.0 112.333 -163.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -74.52 163.97 27.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.842 -175.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 47.7 t -111.45 127.49 68.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.181 -168.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.493 ' HA3' ' NE2' ' A' ' 64' ' ' HIS . . . -112.85 141.49 16.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.426 174.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 89.2 t -124.7 116.98 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.746 0.308 . . . . 0.0 111.183 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.33 119.97 11.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.881 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.7 m -126.18 131.1 52.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.785 -167.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.58 139.07 51.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.093 -175.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.67 170.13 21.21 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.432 -169.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.708 HG13 ' HG2' ' A' ' 277' ' ' LYS . 24.7 mm -111.23 125.03 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 -174.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -63.14 130.79 46.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.483 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -58.17 -28.56 64.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.123 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.17 -7.0 58.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.019 -173.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 22.3 t -67.31 119.04 62.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.649 0.738 . . . . 0.0 110.915 -172.62 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.432 ' HD2' HG21 ' A' ' 2' ' ' ILE . 83.8 Cg_endo -71.26 -10.47 27.23 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.587 2.192 . . . . 0.0 112.327 168.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -103.4 12.88 34.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.824 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -49.33 -35.89 19.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -167.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -68.49 -47.52 66.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.969 -171.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.3 pp -81.47 -27.47 34.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.24 -46.89 75.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.054 173.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.708 ' HG2' HG13 ' A' ' 266' ' ' ILE . 50.3 mtmt -58.08 -41.73 84.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.902 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.545 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 95.6 mt-10 -69.87 -40.66 75.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.898 -177.238 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.444 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 15.9 m-30 -67.63 -39.5 84.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.545 ' HA ' HD23 ' A' ' 284' ' ' LEU . 4.0 tt -65.29 -53.26 46.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.977 -172.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.447 ' HA ' HD22 ' A' ' 285' ' ' LEU . 40.3 tt0 -75.19 -35.6 61.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -175.646 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.545 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 82.8 m-20 -103.57 -12.77 16.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.846 -160.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.654 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 62.3 m-85 -128.55 -48.6 1.28 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -177.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.545 HD23 ' HA ' ' A' ' 280' ' ' LEU . 0.7 OUTLIER -64.39 -36.56 84.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.98 -174.061 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 1.051 ' HB3' HG13 ' A' ' 108' ' ' ILE . 2.4 pp -124.71 38.27 4.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -175.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.461 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 6.6 t -114.25 163.65 14.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 286' ' ' THR . 16.4 p-10 -40.15 -43.88 1.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -175.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -74.85 -41.42 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.893 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.654 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.75 -53.9 7.84 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.516 -169.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.562 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -72.63 -20.1 61.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.725 0.298 . . . . 0.0 110.9 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.511 ' N ' HD12 ' A' ' 290' ' ' LEU . 86.5 tt0 -67.16 -45.56 76.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.813 169.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.93 -38.77 92.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.071 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.421 HG13 ' HA3' ' A' ' 19' ' ' GLY . 59.9 t -75.18 -46.8 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.116 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -64.97 -28.89 69.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.62 -25.95 68.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.826 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -82.23 -48.14 11.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.935 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.414 ' O ' HD13 ' A' ' 299' ' ' LEU . 85.7 tttt -151.03 138.94 12.49 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.511 0.672 . . . . 0.0 110.942 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -50.66 116.76 2.76 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.769 2.312 . . . . 0.0 112.363 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.483 HD12 ' HA ' ' A' ' 299' ' ' LEU . 0.2 OUTLIER -85.98 -19.99 29.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.005 174.275 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 98.49 -57.7 0.99 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.442 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.624 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -168.19 155.33 7.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.787 0.327 . . . . 0.0 111.165 175.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.822 HG22 ' HB3' ' A' ' 307' ' ' TYR . 18.4 m -115.89 154.58 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.03 -15.62 61.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.103 173.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.562 ' CD2' HD22 ' A' ' 290' ' ' LEU . 39.9 tp -80.92 121.93 26.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.936 -174.116 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -53.91 -41.88 68.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.935 -177.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 48.3 t -62.99 -49.98 72.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -169.169 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.822 ' HB3' HG22 ' A' ' 302' ' ' VAL . 10.9 t80 -76.5 -30.71 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.987 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -60.73 -40.67 93.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 176.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.33 -36.94 76.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.65 -39.33 57.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 176.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.624 HD13 ' HA ' ' A' ' 301' ' ' ALA . 76.7 mt -61.19 -34.57 75.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.11 -19.12 61.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 -176.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -64.89 -21.12 66.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.005 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -93.17 121.86 64.57 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.663 0.744 . . . . 0.0 110.916 167.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.29 -25.41 9.84 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.776 2.318 . . . . 0.0 112.35 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . 0.424 ' HA ' HG11 ' A' ' 244' ' ' VAL . 82.7 mtt85 -60.91 -33.38 73.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -176.188 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.595 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.1 mp -81.19 -26.98 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.088 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.83 -40.41 79.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.07 -172.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.9 81.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.088 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.554 ' HB ' ' HB1' ' A' ' 112' ' ' ALA . 58.1 p -64.18 -29.55 70.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 -173.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.6 mtp -67.92 -34.87 77.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -65.64 -47.07 76.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.842 -172.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.404 ' O ' ' N ' ' A' ' 327' ' ' GLY . 8.7 p-10 -80.0 -25.69 40.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.797 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.44 -49.18 74.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.103 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -70.72 -37.18 73.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.89 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -105.44 -7.55 18.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 -168.107 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -90.94 -159.92 36.09 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.481 -172.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -139.9 147.78 41.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.776 0.322 . . . . 0.0 111.03 -175.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 40.7 mm -64.74 123.2 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.136 -171.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 50.2 tpp -46.58 132.3 8.12 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.565 0.697 . . . . 0.0 110.898 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.561 ' HG3' ' CZ2' ' A' ' 158' ' ' TRP . 79.6 Cg_endo -72.01 68.6 3.17 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.763 2.309 . . . . 0.0 112.359 173.048 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -97.55 25.05 6.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -172.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 47.7 pt -77.1 160.7 75.46 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.719 . . . . 0.0 111.203 -175.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -55.59 -38.22 94.39 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.718 2.279 . . . . 0.0 112.234 -173.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -68.66 -28.14 66.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.889 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.453 ' HG3' ' HB2' ' A' ' 331' ' ' PRO . 73.9 mmm -80.07 -17.5 52.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -172.299 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.6 m -61.94 -40.97 97.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.825 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.62 -37.05 60.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.558 ' O ' HG13 ' A' ' 343' ' ' VAL . 3.6 m-30 -65.12 -41.27 95.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.812 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.459 ' HB3' ' HB3' ' A' ' 154' ' ' PRO . 12.2 m0 -60.03 -35.66 75.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 176.06 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -68.06 -41.85 81.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.25 -44.1 84.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.004 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.558 HG13 ' O ' ' A' ' 339' ' ' PHE . 16.9 m -74.07 -31.03 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 -176.094 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.495 ' O ' HG23 ' A' ' 347' ' ' VAL . 4.9 tmt_? -65.6 -39.65 91.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 175.027 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 87.4 m -58.72 -35.39 72.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 174.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.78 -43.63 95.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 -175.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.716 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.0 m -74.17 -34.13 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.169 -174.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.454 HD13 HG21 ' A' ' 347' ' ' VAL . 1.5 mp -63.34 -47.1 93.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 174.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -64.85 -39.51 93.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.26 -44.42 62.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.114 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.33 -39.9 77.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.086 -175.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.2 p -75.69 -11.09 59.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.838 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.21 16.56 74.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.463 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.21 -32.45 44.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.318 . . . . 0.0 110.883 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -138.78 155.35 48.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.1 p -76.74 171.43 14.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 170.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.492 HG22 ' OG1' ' A' ' 193' ' ' THR . 53.1 t -57.51 -43.22 82.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.124 171.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -61.44 -45.71 93.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.863 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -69.64 -52.41 26.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -72.3 -48.25 43.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.121 -173.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.618 HD11 ' HB1' ' A' ' 188' ' ' ALA . 1.4 tm? -65.59 -45.02 84.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -173.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.82 -53.57 48.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.965 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -68.09 -46.03 72.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -173.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.71 -42.31 91.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 -174.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.58 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 79.0 mm-40 -76.81 -27.93 55.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.97 -176.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 53.3 m -61.73 -34.99 76.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.225 171.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -58.77 -30.09 67.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.494 HD13 HG22 ' A' ' 183' ' ' VAL . 70.3 mt -60.85 -38.14 78.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.151 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.0 p -94.64 -14.98 24.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.154 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.831 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.773 0.32 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.445 HG21 ' HD2' ' A' ' 271' ' ' PRO . 74.8 mt -100.46 131.81 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 177.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -148.15 139.81 23.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -51.93 136.47 28.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.792 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.74 2.69 62.88 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.529 -173.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.457 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 64.3 pttt -165.03 146.96 7.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 0.0 110.954 171.36 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.556 HD23 HD12 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -147.68 160.01 43.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -177.231 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.426 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 71.2 t -111.98 134.05 55.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.081 -177.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.743 HG23 ' HB ' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -120.02 131.56 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.082 179.094 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.726 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 65.2 m95 -107.51 128.25 54.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.952 168.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.47 ' HB ' HD23 ' A' ' 20' ' ' LEU . 7.2 tt -109.59 149.86 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.076 -166.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -58.1 155.35 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -173.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.35 -22.76 24.06 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.378 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -73.78 -14.12 61.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.877 0.37 . . . . 0.0 110.906 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.422 ' HD2' ' HD3' ' A' ' 297' ' ' LYS . 24.0 mmmt -134.3 137.25 44.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.924 171.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.02 -85.08 0.98 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.466 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -110.04 -44.91 3.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.904 0.383 . . . . 0.0 110.92 -176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -68.16 -51.87 40.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 -148.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.999 ' HA3' HG21 ' A' ' 293' ' ' VAL . . . -57.74 -49.82 70.83 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.516 -176.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.613 HD22 ' HB ' ' A' ' 9' ' ' ILE . 55.1 tp -57.24 -41.94 80.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.827 0.346 . . . . 0.0 110.914 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.82 -38.61 67.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.071 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.455 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 67.2 mm-40 -70.57 -50.4 37.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.807 -176.381 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.422 HG23 ' HA ' ' A' ' 20' ' ' LEU . 17.7 m -72.53 -36.54 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.185 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.42 ' HA3' HG22 ' A' ' 35' ' ' VAL . . . -64.34 -49.34 66.33 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.494 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.455 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 57.7 pttt -59.47 -24.71 63.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.924 0.392 . . . . 0.0 110.956 -175.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -59.88 -37.11 78.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 1.2 m-30 -56.75 -47.73 79.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.482 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 88.7 mt-10 -66.6 -35.96 81.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.981 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.53 -35.49 73.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.85 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -94.8 -50.04 5.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.811 -170.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.2 p -115.86 -1.08 12.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 -169.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.41 9.92 84.48 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.421 167.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.866 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -99.36 132.93 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 111.159 -177.783 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.482 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.8 mttt -74.21 140.36 45.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 -171.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.558 ' HB ' HD12 ' A' ' 9' ' ' ILE . 2.9 m -116.72 134.34 60.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.113 177.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.523 ' O ' HD13 ' A' ' 9' ' ' ILE . 99.6 m -103.94 127.8 51.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 176.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.608 HG13 HD21 ' A' ' 20' ' ' LEU . 54.8 t -93.07 126.66 45.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.201 175.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -119.93 145.74 46.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.974 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -88.95 141.14 29.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.528 0.68 . . . . 0.0 110.929 -168.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 85.2 Cg_exo -56.62 -26.29 64.0 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.736 2.291 . . . . 0.0 112.251 -174.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -47.34 -51.28 19.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 -171.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.84 -8.92 55.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.456 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 9.8 tt -47.85 -55.26 10.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 -170.049 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -64.76 -35.83 82.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.36 -39.52 92.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.416 ' O ' HG23 ' A' ' 50' ' ' VAL . 75.1 mmtt -80.44 -23.84 39.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.583 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 83.9 t80 -50.87 -50.26 75.25 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.665 0.745 . . . . 0.0 110.807 -160.637 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.583 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 44.4 Cg_endo -82.72 -32.32 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.685 2.256 . . . . 0.0 112.306 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -75.89 -46.41 30.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 -165.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.52 HG22 ' HG3' ' A' ' 57' ' ' PRO . 21.0 m -72.36 -27.16 25.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.04 -171.702 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.728 ' HB2' ' HB3' ' A' ' 75' ' ' LEU . . . -70.28 -35.78 73.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.098 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.11 -33.2 74.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.124 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.9 p -90.58 -20.25 22.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.2 8.35 69.73 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.542 172.788 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -118.35 116.84 27.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.35 . . . . 0.0 110.87 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.94 -92.75 0.13 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.502 171.075 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.726 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 71.2 Cg_endo -79.42 146.79 19.7 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.68 2.254 . . . . 0.0 112.362 -177.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -97.53 -35.06 10.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.777 163.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.743 ' HB ' HG23 ' A' ' 9' ' ' ILE . 35.4 mt -124.79 137.37 57.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.106 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.3 tp -132.77 125.22 52.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -88.34 140.11 29.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.731 168.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.47 ' CZ2' ' HB3' ' A' ' 105' ' ' ALA . 21.9 p90 -142.85 163.39 32.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.979 171.145 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.83 -90.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 -164.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.675 ' CE1' ' HA3' ' A' ' 260' ' ' GLY . 23.2 m170 -130.56 -64.63 0.83 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 -173.058 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -95.13 -13.92 24.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -167.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.78 -14.49 14.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.997 -165.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.567 ' HB2' HD11 ' A' ' 104' ' ' ILE . 30.5 p90 -57.42 -32.43 66.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.875 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.77 -51.21 60.05 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.492 -170.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.59 -36.96 92.15 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.576 175.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.697 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 13.6 t80 -66.56 -41.94 87.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 -176.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.85 -40.98 68.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.169 174.419 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -57.58 -37.54 73.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.414 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 59.9 m -85.47 -4.98 59.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.982 -179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.32 30.07 59.21 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.492 174.292 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.728 ' HB3' ' HB2' ' A' ' 51' ' ' ALA . 58.9 mt -87.17 -10.07 53.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.919 0.39 . . . . 0.0 110.929 -167.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.697 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -130.95 153.77 48.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.924 -176.808 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.464 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -81.4 142.12 33.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 174.462 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.81 142.3 49.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.442 HD13 ' CZ ' ' A' ' 106' ' ' TYR . 36.9 pt -106.52 155.41 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 -177.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.6 m -96.1 130.57 30.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.666 0.746 . . . . 0.0 111.064 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.36 142.31 65.6 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.673 2.248 . . . . 0.0 112.326 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -113.92 114.78 26.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.21 -36.02 60.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.78 -43.47 98.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.021 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -74.54 -32.98 62.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.875 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.478 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 85.6 mt-30 -54.94 -51.49 65.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -57.6 -34.71 69.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.781 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.27 -24.53 57.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 -175.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.479 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.97 -104.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 -170.573 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.479 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 33.9 t80 172.66 128.84 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.739 0.781 . . . . 0.0 110.903 -169.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -52.31 -36.26 67.5 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.345 -173.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -65.14 -35.19 80.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 -173.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.3 p -73.47 -29.7 62.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.169 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.638 ' HA ' HG23 ' A' ' 97' ' ' VAL . 92.5 m95 -67.88 -30.55 69.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.972 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -69.25 -30.17 68.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.943 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.14 -26.04 62.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.038 175.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.638 HG23 ' HA ' ' A' ' 94' ' ' TRP . 16.3 m -109.96 20.7 5.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.14 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -113.8 132.52 55.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -132.1 119.45 20.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.5 t30 58.4 35.29 24.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.918 176.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.21 -0.41 89.74 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.449 175.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.25 149.42 42.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 0.0 110.861 175.589 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.614 HD23 HG21 ' A' ' 97' ' ' VAL . 18.4 mt -84.03 136.0 34.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.567 HD11 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -123.11 -2.3 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.051 -175.053 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.47 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . . . -161.15 164.45 30.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.12 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.442 ' CZ ' HD13 ' A' ' 79' ' ' ILE . 89.9 m-85 -112.27 143.26 28.49 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.626 0.727 . . . . 0.0 110.948 170.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.33 121.42 5.24 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.669 2.246 . . . . 0.0 112.336 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.936 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -104.25 -36.72 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.177 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -146.0 153.12 40.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 -170.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.3 t -117.96 130.42 72.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.5 mp0 -110.64 131.98 54.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.806 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.624 ' HB1' ' HB ' ' A' ' 320' ' ' THR . . . -153.09 144.66 23.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.119 177.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.6 mp -89.0 160.25 17.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.972 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.9 p -151.49 152.44 33.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.86 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.874 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -93.76 128.88 40.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 171.043 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.636 ' N ' HD23 ' A' ' 115' ' ' LEU . 4.7 mp -111.39 132.04 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.236 -174.855 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -131.81 146.97 52.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.988 0.423 . . . . 0.0 110.86 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -91.88 117.4 29.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.893 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.91 -25.92 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.964 -172.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -84.68 -20.82 30.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 -172.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.9 mp -80.08 -54.03 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 169.63 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.754 ' H ' HD21 ' A' ' 122' ' ' LEU . 1.3 pt? -140.32 127.23 12.23 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.564 0.697 . . . . 0.0 110.921 173.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.42 -7.06 14.87 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.665 2.244 . . . . 0.0 112.348 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.435 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 56.3 t-20 -147.22 95.27 4.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.725 0.774 . . . . 0.0 110.839 -176.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.435 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 58.6 Cg_endo -68.23 155.68 68.48 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.64 2.227 . . . . 0.0 112.376 177.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.52 143.67 76.4 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.64 2.226 . . . . 0.0 112.423 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -86.72 -15.76 38.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 80.6 p -133.68 156.75 47.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.426 ' HA ' HD11 ' A' ' 132' ' ' ILE . 74.1 m95 -70.77 -27.98 64.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.982 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.21 -19.58 65.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.843 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -80.3 -25.53 39.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.488 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -57.56 -46.27 99.79 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.567 0.698 . . . . 0.0 111.184 -169.249 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 86.4 Cg_exo -52.93 -50.74 13.02 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.712 2.274 . . . . 0.0 112.385 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.95 -59.49 4.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 1.165 HD23 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.41 -16.24 63.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -172.711 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.585 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.7 t70 -61.88 -41.69 98.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 167.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.66 -30.59 69.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.923 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.1 -46.86 60.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.84 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.621 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.1 pp -85.08 -14.32 47.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.965 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.621 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.6 tttt -60.98 -33.99 74.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.95 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.32 -24.03 67.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.993 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -94.98 4.3 53.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.942 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.03 31.98 57.11 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.572 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -110.24 170.14 8.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 0.0 110.885 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.7 t -121.04 140.94 51.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.827 168.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -67.67 -40.6 84.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.144 -174.647 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.404 HD23 ' H ' ' A' ' 148' ' ' MET . 2.1 tm? -140.78 133.48 28.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.958 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.404 ' H ' HD23 ' A' ' 147' ' ' LEU . 53.2 ttm -119.22 131.35 55.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.844 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -153.99 155.64 35.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 -174.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -86.27 -53.37 5.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -177.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.993 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.3 tm? 48.01 32.81 3.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.909 -169.085 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -100.24 -7.15 24.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.887 175.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.65 154.92 80.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.68 0.753 . . . . 0.0 110.922 -172.29 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.41 ' HA ' ' HB ' ' A' ' 157' ' ' THR . 38.5 Cg_endo -59.94 -25.07 78.48 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.673 2.248 . . . . 0.0 112.38 173.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -71.62 -29.41 64.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.84 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -81.43 -39.79 24.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 171.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.42 HG21 HG11 ' A' ' 347' ' ' VAL . 22.1 m -60.35 -48.34 82.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.589 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 40.5 t-105 -57.07 -54.42 54.78 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.444 0.64 . . . . 0.0 110.81 -168.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 24.3 Cg_endo -63.99 -20.04 67.31 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.544 2.163 . . . . 0.0 112.388 -174.113 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.779 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.7 tm? -81.6 -44.92 16.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.52 HG22 ' HA3' ' A' ' 166' ' ' GLY . 79.2 mt -74.98 -43.78 45.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.84 -24.7 66.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.972 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.537 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -58.26 -30.87 66.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.56 3.59 42.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 104.63 8.32 37.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.547 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.52 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -75.7 67.41 2.3 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.435 177.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -80.5 132.2 35.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.772 0.32 . . . . 0.0 110.939 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.86 6.36 11.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.127 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.559 ' CE1' ' HB3' ' A' ' 331' ' ' PRO . 51.2 p90 -154.0 155.81 36.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.906 -175.601 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -99.99 127.4 46.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.915 156.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -114.19 120.6 41.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -153.26 130.03 10.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -171.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 54.97 42.2 31.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.19 16.09 78.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.526 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.97 139.95 50.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.698 0.285 . . . . 0.0 110.93 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -96.47 144.94 26.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.923 170.72 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -128.06 111.97 14.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.885 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.567 ' C ' HD13 ' A' ' 178' ' ' ILE . 1.2 pp -80.06 -11.38 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -96.9 -10.16 27.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -125.51 85.97 2.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.471 HG12 ' HA ' ' A' ' 169' ' ' PHE . 31.1 m -113.97 164.79 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.056 -170.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.8 25.55 22.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.562 -173.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.451 HG22 HD13 ' A' ' 368' ' ' ILE . 2.1 m -106.53 -19.99 6.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.904 0.383 . . . . 0.0 111.156 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -87.39 21.79 2.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.799 -176.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -109.31 -176.32 2.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.927 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.52 -28.34 66.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.071 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.53 -40.08 78.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.492 -169.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.529 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -59.88 -40.08 87.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 111.11 175.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.59 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.2 mttt -62.23 -39.04 91.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.979 175.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.0 86.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.196 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.448 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -67.15 -46.02 76.02 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.516 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.751 HD11 ' HA ' ' A' ' 347' ' ' VAL . 22.8 tp -66.62 -35.5 80.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 110.821 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.56 ' OG1' HG22 ' A' ' 357' ' ' VAL . 94.3 m -65.07 -41.48 95.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 176.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.477 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 51.8 t80 -66.03 -49.68 66.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 177.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.708 ' C ' HD21 ' A' ' 195' ' ' LEU . 5.4 tt -50.72 -51.11 52.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.884 -174.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.412 ' O ' HG13 ' A' ' 199' ' ' ILE . 31.2 m -64.25 -22.47 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.177 -174.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.2 m-20 -62.27 -33.53 74.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 0.439 HD23 ' O ' ' A' ' 194' ' ' PHE . 0.9 OUTLIER -80.69 -40.09 26.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -174.556 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.555 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.8 pp -73.7 -28.67 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.234 172.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -68.57 -37.63 80.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -80.63 2.79 24.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 68.0 38.51 2.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 169.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -78.28 -17.04 57.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.555 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.2 ppp? -145.3 157.18 44.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.934 174.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -94.63 150.65 20.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.4 -26.22 67.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -96.59 1.52 51.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.936 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 94.1 m -64.0 125.05 23.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.07 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.415 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 17.3 t0 -120.45 174.98 6.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.905 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -62.82 -40.41 97.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.999 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 98.6 p -67.58 -38.05 83.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.823 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.415 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 76.6 mt -65.05 -42.32 94.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.14 174.348 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.47 -35.6 80.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.107 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.27 -48.1 82.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.49 -42.36 95.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.111 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.05 -49.03 71.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.2 -43.39 98.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.911 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -63.18 -29.61 70.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.861 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -85.92 -16.74 37.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.24 25.04 29.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.431 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -83.28 -21.28 33.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 110.916 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.8 t -126.16 136.37 52.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.25 178.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.608 ' HB3' HD23 ' A' ' 139' ' ' LEU . . . -62.18 -48.8 78.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.024 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.602 ' HB3' HD22 ' A' ' 115' ' ' LEU . 66.9 mtm -135.0 160.06 39.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 -173.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.0 t -150.44 157.34 42.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.183 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 mm -111.58 129.42 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 -176.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -155.42 173.71 16.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -83.73 -153.37 15.64 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.395 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.11 -26.4 36.69 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.736 2.29 . . . . 0.0 112.328 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -76.01 -29.18 58.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 43.79 44.96 5.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.169 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 32.1 m0 -66.11 -20.63 66.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 63.6 m -71.22 -18.1 62.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -81.2 -175.37 5.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -174.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 87.9 mt -93.82 125.78 46.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -80.09 -57.85 3.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.81 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 88.4 m -145.17 122.79 11.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.149 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 27.5 t -174.77 163.08 3.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.887 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.4 -20.96 66.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.963 171.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 97.9 t -69.18 125.59 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.07 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -77.77 140.98 39.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.33 149.93 38.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.3 161.73 26.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.503 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.08 139.4 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.932 0.396 . . . . 0.0 111.1 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.3 t -153.4 149.08 27.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.161 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 22.4 m -59.95 163.51 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.153 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 3.8 mp -67.7 153.3 95.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.625 0.726 . . . . 0.0 111.029 -159.232 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 47.5 Cg_exo -63.75 178.92 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.699 2.266 . . . . 0.0 112.393 -175.036 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.0 m -92.52 145.71 24.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.21 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -131.26 112.2 12.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.952 -172.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 54.65 34.97 22.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.943 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.1 1.59 81.74 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.565 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -128.38 127.03 23.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.582 0.706 . . . . 0.0 110.896 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -55.28 136.9 75.56 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.673 2.249 . . . . 0.0 112.337 -176.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 256' ' ' LYS . 67.7 m -80.06 -5.05 55.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.798 170.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 255' ' ' SER . 97.3 mttt -38.31 129.05 1.05 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.514 0.673 . . . . 0.0 110.912 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -83.09 163.11 15.52 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.666 2.244 . . . . 0.0 112.384 -163.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -72.99 164.95 25.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.4 t -110.89 132.29 59.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.173 -168.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.675 ' HA3' ' CE1' ' A' ' 64' ' ' HIS . . . -114.85 138.92 15.19 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.443 176.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 74.0 t -126.13 116.54 46.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 111.24 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.421 ' HA ' HD21 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -66.28 122.52 17.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.984 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 51.0 m -124.11 131.11 53.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 -166.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.99 133.88 50.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.02 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.55 172.5 20.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.455 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.403 HG13 ' HB3' ' A' ' 277' ' ' LYS . 34.9 mm -113.99 130.48 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.785 0.326 . . . . 0.0 111.178 -173.388 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -61.86 128.99 38.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.984 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.471 ' HB3' ' C ' ' A' ' 76' ' ' LEU . . . -58.85 -30.93 68.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.165 -178.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.28 -5.21 59.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.033 -172.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 15.6 t -71.51 120.23 78.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.68 0.752 . . . . 0.0 110.951 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.445 ' HD2' HG21 ' A' ' 2' ' ' ILE . 97.8 Cg_endo -67.49 -9.89 26.85 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.623 2.215 . . . . 0.0 112.342 167.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -109.06 16.89 22.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -55.79 -32.93 63.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -170.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.67 -47.48 63.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.958 0.409 . . . . 0.0 110.896 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.0 pp -78.69 -31.03 46.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.9 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.77 -48.74 68.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.064 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.403 ' HB3' HG13 ' A' ' 266' ' ' ILE . 46.8 pttt -65.97 -34.98 79.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.115 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.51 -40.98 73.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 19.0 m-30 -66.97 -38.73 86.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 176.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.446 ' HA ' HD23 ' A' ' 284' ' ' LEU . 5.3 tt -57.62 -51.5 69.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 -176.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -75.31 -27.98 59.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -98.68 -13.5 20.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -167.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.763 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 69.0 m-85 -121.19 -60.13 1.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.446 HD23 ' HA ' ' A' ' 280' ' ' LEU . 1.4 mp -61.44 -33.68 74.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.937 -161.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.936 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.2 pp -123.78 37.88 4.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.994 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.468 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 67.9 p -121.25 162.36 20.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 177.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.447 ' HA ' HD11 ' A' ' 290' ' ' LEU . 38.7 t70 -45.66 -36.29 4.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 -167.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -78.73 -42.02 29.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.984 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.763 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.9 -52.9 8.57 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.505 -170.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.613 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -72.62 -20.08 61.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.754 0.312 . . . . 0.0 110.965 -178.457 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.571 ' N ' HD12 ' A' ' 290' ' ' LEU . 35.3 tt0 -70.62 -47.93 57.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.774 172.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.65 97.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.098 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.999 HG21 ' HA3' ' A' ' 19' ' ' GLY . 2.8 p -78.71 -32.17 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 -176.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.407 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 48.3 t30 -68.78 -27.72 66.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.785 171.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.62 -25.05 67.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -88.39 -40.12 13.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.422 ' HD3' ' HD2' ' A' ' 15' ' ' LYS . 85.2 tttt -146.06 135.17 11.26 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.475 0.655 . . . . 0.0 110.951 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -58.28 109.03 0.44 Allowed 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.744 2.296 . . . . 0.0 112.289 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.407 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 61.6 mt -89.89 -18.59 25.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.978 -171.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 109.49 -59.49 0.35 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.525 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.619 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -169.37 165.24 10.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.359 . . . . 0.0 111.095 175.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.701 HG22 ' HB3' ' A' ' 307' ' ' TYR . 29.8 m -124.9 153.92 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.02 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.91 -8.41 56.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.115 172.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.613 ' CD2' HD22 ' A' ' 290' ' ' LEU . 44.7 tp -85.9 119.06 25.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.953 -177.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.01 -40.99 67.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -174.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.8 m -65.12 -50.13 67.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.829 -168.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.701 ' HB3' HG22 ' A' ' 302' ' ' VAL . 17.5 t80 -77.11 -28.62 54.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.953 -177.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -64.77 -38.98 92.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.915 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.31 -35.01 78.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.935 175.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -73.38 -41.33 63.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.952 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.619 HD13 ' HA ' ' A' ' 301' ' ' ALA . 77.2 mt -60.05 -31.87 70.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.884 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.54 -17.86 56.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.06 -19.64 66.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -90.9 121.73 67.67 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.624 0.726 . . . . 0.0 110.895 164.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -47.37 -28.05 7.88 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.737 2.291 . . . . 0.0 112.304 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -61.32 -30.96 70.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -172.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.474 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.1 mp -79.98 -30.23 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 -173.079 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.53 96.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.032 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.06 -44.1 77.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.023 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.624 ' HB ' ' HB1' ' A' ' 112' ' ' ALA . 82.6 p -65.43 -31.13 72.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 -171.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.9 mtp -65.49 -33.3 75.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -64.75 -47.19 79.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 -174.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.471 HD22 ' HB2' ' A' ' 112' ' ' ALA . 8.5 p-10 -82.97 -28.87 29.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.766 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.39 -52.31 62.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.033 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -65.86 -28.3 68.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.016 0.436 . . . . 0.0 110.984 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -109.63 -8.32 14.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.8 -168.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -89.88 -153.57 28.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.461 -166.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -146.1 140.81 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 0.0 110.919 -170.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 42.2 mm -60.31 121.37 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 -166.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 93.0 mtp -49.34 143.89 9.25 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.522 0.677 . . . . 0.0 110.902 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.559 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 70.7 Cg_endo -77.85 84.89 1.9 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.688 2.259 . . . . 0.0 112.274 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.535 ' ND2' ' ND1' ' A' ' 64' ' ' HIS . 44.7 m-80 -111.8 21.77 15.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 -173.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 48.4 pt -75.44 159.39 81.99 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 0.0 111.114 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -55.74 -38.1 94.76 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.706 2.271 . . . . 0.0 112.317 -174.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -67.68 -27.46 66.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.908 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.464 ' HG3' ' HB2' ' A' ' 331' ' ' PRO . 54.7 mmm -80.13 -17.37 52.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.811 -170.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.5 m -60.82 -41.44 95.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.846 176.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.83 -35.64 59.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 6.4 m-30 -66.21 -42.37 88.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.964 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -56.51 -37.85 70.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.02 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -68.47 -41.22 80.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.17 -43.4 87.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.097 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.432 HG13 ' O ' ' A' ' 339' ' ' PHE . 20.4 m -73.4 -32.04 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.137 -177.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 347' ' ' VAL . 5.0 tmt_? -64.93 -38.94 92.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.873 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.3 m -58.68 -36.68 74.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.173 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.05 -43.75 91.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.108 -174.225 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.751 ' HA ' HD11 ' A' ' 192' ' ' LEU . 8.2 m -73.17 -34.92 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.153 -175.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.471 HD13 HG21 ' A' ' 347' ' ' VAL . 1.5 mp -63.62 -47.27 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 173.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -63.59 -39.7 95.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.16 -45.51 60.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.025 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.29 -40.38 81.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.116 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 92.0 p -76.31 -10.91 59.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.09 16.61 74.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.46 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.03 -32.39 50.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 0.0 110.95 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -139.37 155.15 47.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.984 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 48.7 p -77.7 167.44 21.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 170.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.56 HG22 ' OG1' ' A' ' 193' ' ' THR . 54.8 t -55.89 -42.03 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.16 173.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -60.65 -46.88 88.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -69.11 -52.2 30.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -71.87 -49.39 38.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 -173.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.616 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 1.4 tm? -65.14 -46.87 79.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.968 -173.259 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.02 -53.44 53.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.847 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -67.14 -46.61 73.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -174.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.09 -41.8 94.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.091 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.616 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 68.0 mm-40 -77.74 -26.75 50.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.95 -177.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.2 m -64.44 -35.99 82.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.226 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.18 -30.4 68.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.971 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.451 HD13 HG22 ' A' ' 183' ' ' VAL . 70.0 mt -60.35 -38.49 77.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 173.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 60.8 p -93.45 -14.46 26.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.886 179.209 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.713 0.292 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.405 HG21 ' HD2' ' A' ' 271' ' ' PRO . 76.4 mt -95.96 133.93 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.191 -178.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -146.51 139.15 25.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -52.43 137.77 28.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.16 1.62 62.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.442 -173.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 64.4 pttt -164.53 149.85 10.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.74 0.305 . . . . 0.0 110.966 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.622 ' H ' HD21 ' A' ' 7' ' ' LEU . 1.2 pt? -147.67 158.07 43.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.947 -176.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.476 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 70.4 t -110.79 131.83 60.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.761 HG23 ' HB ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -119.94 132.08 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.149 -179.269 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.683 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 70.8 m95 -106.08 128.8 54.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.943 169.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.518 HD13 ' HB2' ' A' ' 20' ' ' LEU . 5.9 tt -109.41 149.96 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.157 -168.541 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -60.89 154.69 21.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -172.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.19 -21.3 31.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.495 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -72.93 -12.34 60.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.358 . . . . 0.0 110.812 -171.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.601 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -146.98 135.64 22.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 167.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.07 -79.91 1.06 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.599 -171.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -105.57 -44.93 4.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.958 0.409 . . . . 0.0 110.917 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -67.91 -52.92 30.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.864 -148.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 1.111 ' HA3' HG21 ' A' ' 293' ' ' VAL . . . -57.11 -51.95 54.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.498 -175.675 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.621 HD22 ' HB ' ' A' ' 9' ' ' ILE . 59.6 tp -57.87 -43.76 86.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 0.0 110.968 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.76 -40.05 59.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.991 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -69.71 -55.29 10.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.469 HG23 ' HA ' ' A' ' 20' ' ' LEU . 22.0 m -69.83 -35.95 67.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.164 -175.387 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.419 ' HA3' HG22 ' A' ' 35' ' ' VAL . . . -62.83 -45.65 95.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.407 172.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -56.76 -30.2 63.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 110.996 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -57.55 -38.2 74.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 176.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 1.8 m-30 -56.22 -49.61 73.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.888 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.483 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 93.2 mt-10 -66.28 -35.41 80.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -69.3 -37.33 77.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -96.55 -47.99 5.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.918 0.39 . . . . 0.0 110.925 -169.792 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.8 p -114.73 -1.97 13.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.161 -169.344 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.88 8.73 82.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.417 166.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.88 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -99.46 133.0 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 111.121 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.483 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.6 mttt -75.17 139.75 42.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.852 -169.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.501 ' HB ' HD12 ' A' ' 9' ' ' ILE . 2.7 m -116.44 134.46 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.508 ' O ' HD13 ' A' ' 9' ' ' ILE . 98.3 m -105.12 127.54 52.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.136 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.595 HG13 HD21 ' A' ' 20' ' ' LEU . 54.5 t -91.53 127.05 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.155 175.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -119.14 147.01 44.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.828 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.427 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 63.6 t-80 -88.82 142.18 30.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.593 0.711 . . . . 0.0 110.887 -166.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.46 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 86.8 Cg_exo -54.9 -25.21 42.62 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.569 2.179 . . . . 0.0 112.379 -175.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -48.43 -56.79 7.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 -173.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -86.6 -4.07 59.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 8.1 tt -45.94 -53.81 9.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.896 -172.046 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.02 -35.48 80.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.846 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -67.37 -43.48 81.3 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.884 -173.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -80.47 -21.36 42.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.531 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 50.6 t80 -49.99 -51.51 60.98 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.564 0.697 . . . . 0.0 110.806 -165.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 61.6 Cg_endo -80.94 -29.68 2.0 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.615 2.21 . . . . 0.0 112.403 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -74.6 -40.33 61.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 -168.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 m -66.58 -27.68 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.121 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.795 ' HB2' HD23 ' A' ' 75' ' ' LEU . . . -67.61 -36.09 80.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.09 -31.38 70.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.024 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.8 p -93.0 -17.77 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.128 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.22 11.22 75.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.522 173.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -140.05 140.06 36.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.881 0.372 . . . . 0.0 110.827 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.96 -96.61 0.16 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.435 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.683 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 78.9 Cg_endo -80.08 148.79 19.54 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.728 2.286 . . . . 0.0 112.238 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -96.94 -35.99 10.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 165.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.761 ' HB ' HG23 ' A' ' 9' ' ' ILE . 46.6 mt -125.87 138.26 55.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.105 -176.14 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 tp -131.2 125.91 58.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.153 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -91.31 137.57 32.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 167.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.495 ' CZ2' ' HB3' ' A' ' 105' ' ' ALA . 31.2 p90 -140.5 162.62 34.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.017 172.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.46 -87.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.039 -167.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.515 ' ND1' ' ND2' ' A' ' 332' ' ' ASN . 10.8 m170 -128.17 -68.69 0.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -173.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -96.81 -10.92 25.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.811 -162.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -57.27 -14.28 4.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 -169.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.575 ' HB2' HD11 ' A' ' 104' ' ' ILE . 33.5 p90 -59.29 -29.41 67.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.9 -51.75 57.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.468 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.76 -36.55 92.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.522 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -55.45 -51.75 65.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 110.931 179.053 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.2 -43.11 58.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.16 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -56.86 -38.83 73.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 -175.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.419 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 61.8 m -84.8 -7.44 59.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.003 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.95 30.26 59.58 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.469 173.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.795 HD23 ' HB2' ' A' ' 51' ' ' ALA . 42.1 mt -89.35 -8.78 52.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.827 0.346 . . . . 0.0 110.886 -168.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.488 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -129.06 152.2 48.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -176.458 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.03 139.65 35.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.025 172.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.69 142.95 51.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.0 pt -104.15 154.53 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.9 m -90.67 123.85 64.0 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.672 0.749 . . . . 0.0 111.115 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.83 136.6 75.33 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.772 2.315 . . . . 0.0 112.395 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -105.05 111.79 24.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.16 -40.0 92.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.84 -176.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.39 97.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -71.97 -36.87 69.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.462 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.3 tt0 -51.73 -51.8 53.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.96 174.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -57.99 -37.07 73.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.802 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.38 -21.66 52.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.863 -174.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.515 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -105.06 -105.02 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.907 -172.04 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 27.7 t80 172.19 126.7 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.682 0.753 . . . . 0.0 110.963 -167.557 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 93.7 Cg_exo -54.66 -36.38 89.6 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.796 2.33 . . . . 0.0 112.407 -172.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -65.03 -35.1 80.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -172.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.1 p -76.72 -32.21 57.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.215 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.553 ' CE3' HD13 ' A' ' 103' ' ' LEU . 92.7 m95 -70.32 -29.09 65.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.002 173.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.07 -31.44 71.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 177.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.03 -24.04 64.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.092 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.529 HG23 ' HA ' ' A' ' 94' ' ' TRP . 17.9 m -106.35 15.95 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -99.98 131.5 45.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -129.37 117.45 20.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.7 t30 57.8 35.57 25.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.857 175.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.79 0.19 89.72 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.536 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -124.69 146.37 49.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 110.835 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.553 HD13 ' CE3' ' A' ' 94' ' ' TRP . 26.8 mt -88.56 135.35 33.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.799 -171.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.575 HD11 ' HB2' ' A' ' 67' ' ' PHE . 1.8 pp -121.87 -1.68 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.495 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . . . -158.8 161.43 36.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.086 -176.288 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.499 ' HB3' ' CD2' ' A' ' 285' ' ' LEU . 93.9 m-85 -110.27 138.25 20.82 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.662 0.744 . . . . 0.0 110.878 172.434 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.05 118.15 5.15 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.636 2.224 . . . . 0.0 112.303 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.919 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -103.24 -36.4 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.531 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -148.81 152.7 36.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 -172.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.54 130.71 73.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.112 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.481 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 92.0 mt-10 -129.74 128.57 42.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.791 ' HB2' HD22 ' A' ' 323' ' ' ASN . . . -150.8 152.26 33.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.126 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.533 ' HB2' ' CB ' ' A' ' 257' ' ' PRO . 5.1 mp -84.29 171.34 12.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.976 -161.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.1 p -156.02 154.7 31.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 -172.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.883 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -99.14 127.66 45.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.812 168.639 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.602 ' N ' HD23 ' A' ' 115' ' ' LEU . 5.3 mp -111.45 130.04 65.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.21 -175.22 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -131.34 148.46 52.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.928 -173.371 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -92.06 120.01 32.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.823 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.408 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.5 mttt -70.13 -25.74 63.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -174.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -86.59 -23.07 25.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.8 mp -75.02 -56.71 4.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.979 167.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.766 ' H ' HD21 ' A' ' 122' ' ' LEU . 1.1 pt? -140.02 127.89 12.87 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.589 0.709 . . . . 0.0 110.969 173.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.57 -7.84 16.9 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.592 2.194 . . . . 0.0 112.315 -175.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -147.27 96.71 4.18 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.648 0.737 . . . . 0.0 110.912 -176.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.64 155.04 71.7 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.636 2.224 . . . . 0.0 112.375 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.43 143.3 69.04 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.678 2.252 . . . . 0.0 112.274 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -84.86 -16.33 41.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.996 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.9 p -132.03 157.91 42.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.195 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.497 ' HA ' HG12 ' A' ' 132' ' ' ILE . 82.4 m95 -70.08 -20.79 63.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.88 -28.82 67.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -82.27 -8.14 59.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.881 -176.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.632 ' O ' HD13 ' A' ' 135' ' ' LEU . 46.8 mm -60.82 -53.14 67.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.576 0.703 . . . . 0.0 111.17 -173.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 21.6 Cg_endo -60.48 -39.88 61.92 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.566 2.177 . . . . 0.0 112.377 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.52 -61.14 2.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 1.153 HD23 ' C ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -70.88 -16.93 62.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.01 -175.628 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.527 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.9 t70 -63.54 -42.39 98.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.874 168.458 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.67 -30.43 68.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.963 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -69.98 -47.48 62.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.6 pp -87.22 -15.19 38.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.923 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.631 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.5 tttt -61.93 -33.86 75.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.012 175.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.41 -24.19 67.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.076 176.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -95.04 6.14 49.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.848 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.86 32.04 57.41 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.528 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -110.4 166.5 10.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 110.878 174.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.4 t -118.5 143.04 47.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 169.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.62 -44.13 71.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.132 -173.73 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -139.05 124.02 18.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.842 -174.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 62.1 tpp -113.4 132.57 55.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.81 -175.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -157.39 160.0 37.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.987 -175.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . 0.525 ' HB3' ' HA ' ' A' ' 209' ' ' ASP . 40.3 p-10 -99.21 -43.44 6.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -175.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 1.117 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.4 tm? 52.13 34.58 14.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -175.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -103.28 -11.61 17.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 -176.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 96.6 mt-10 -123.4 144.11 43.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.655 0.74 . . . . 0.0 110.924 -170.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 153' ' ' GLU . 73.1 Cg_exo -54.64 -32.75 76.64 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.634 2.222 . . . . 0.0 112.339 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -65.21 -29.96 70.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -79.89 -40.19 28.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.406 HG21 ' O ' ' A' ' 153' ' ' GLU . 39.3 p -62.79 -39.59 94.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.066 -175.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.61 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 32.0 t-105 -65.91 -50.14 54.56 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.63 0.728 . . . . 0.0 110.936 -164.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.61 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 78.4 Cg_exo -48.33 -46.55 22.73 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.702 2.268 . . . . 0.0 112.312 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.725 HD21 ' O ' ' A' ' 160' ' ' LEU . 6.4 tt -74.91 -40.35 60.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.957 -174.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.8 mt -69.13 -43.05 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.213 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.63 -24.71 61.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.91 -33.49 71.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.076 -178.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -93.57 3.35 55.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.99 7.32 35.96 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.428 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.38 65.7 3.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -85.67 134.8 33.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.794 0.331 . . . . 0.0 110.989 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.53 1.57 16.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.091 -177.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -153.69 155.41 35.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.996 0.427 . . . . 0.0 110.853 -175.087 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -99.47 121.95 41.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 157.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -112.95 123.26 49.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -152.84 131.03 11.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.4 t30 55.07 44.89 27.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.985 173.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.29 15.69 78.84 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.485 173.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.01 139.84 50.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.794 0.331 . . . . 0.0 110.951 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -95.82 144.38 26.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.943 169.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -119.32 111.7 18.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 37.1 pt -78.18 -18.24 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -94.54 -8.99 36.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.817 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -123.45 92.8 3.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 24.9 m -118.72 164.26 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.081 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -108.46 22.38 26.7 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.541 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.508 ' HB ' ' HB3' ' A' ' 365' ' ' GLN . 1.5 m -108.8 -23.3 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 111.165 -173.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -91.79 24.03 3.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.793 174.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -118.88 176.25 5.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.877 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.09 -25.49 67.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.133 -177.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.09 -39.75 94.79 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.445 -172.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.711 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -65.48 -35.57 81.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.958 0.408 . . . . 0.0 111.124 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.582 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.7 mttt -59.69 -36.17 75.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 176.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.44 91.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.11 -48.16 67.32 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.496 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.539 HD11 ' HA ' ' A' ' 347' ' ' VAL . 19.0 tp -65.96 -33.2 75.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.927 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.415 ' OG1' HG22 ' A' ' 357' ' ' VAL . 88.3 m -65.98 -44.02 86.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.172 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.48 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 32.6 t80 -67.31 -46.52 73.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.864 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.585 ' C ' HD21 ' A' ' 195' ' ' LEU . 7.9 tt -51.12 -52.21 46.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -175.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.434 ' O ' HG13 ' A' ' 199' ' ' ILE . 27.6 m -64.03 -21.95 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 -173.853 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.48 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.9 m-20 -61.51 -33.06 73.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -80.33 -40.07 27.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -175.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.666 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.8 pp -74.94 -28.31 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.214 173.05 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -70.49 -39.08 74.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 174.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -78.29 2.15 19.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.876 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 66.55 40.9 3.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 166.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -78.11 -17.63 56.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.779 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.666 ' SD ' HG22 ' A' ' 199' ' ' ILE . 4.3 ppp? -143.33 158.09 43.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.899 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -92.21 153.6 19.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.817 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.7 -26.99 67.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.102 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -94.77 2.33 55.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 98.4 m -69.17 129.99 41.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.105 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.525 ' HA ' ' HB3' ' A' ' 150' ' ' ASN . 18.7 t0 -126.69 175.67 7.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.961 173.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -59.18 -35.78 74.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.01 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.7 p -68.4 -38.79 81.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 76.2 mt -67.46 -40.04 83.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.125 175.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.08 -35.52 80.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.001 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -61.4 -47.25 86.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.862 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.06 -41.23 99.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.11 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.9 -47.62 77.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.071 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -62.38 -41.86 98.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -63.96 -31.4 72.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.913 -177.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.47 -19.3 28.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.836 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.37 22.43 31.94 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.453 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -80.96 -19.66 43.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.996 0.427 . . . . 0.0 110.9 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.7 t -128.76 137.47 51.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.153 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.459 ' HB2' HD22 ' A' ' 122' ' ' LEU . . . -66.34 -46.91 75.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.022 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.662 ' HB3' HD22 ' A' ' 115' ' ' LEU . 75.3 mtm -133.71 151.02 51.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.962 -168.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 66.1 p -138.69 156.9 47.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.161 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.4 mm -110.37 125.06 67.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -155.01 175.31 13.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -169.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.423 ' HA2' ' HG ' ' A' ' 113' ' ' LEU . . . -84.34 -164.17 37.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.419 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.481 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 36.5 Cg_endo -65.34 -23.78 58.48 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.685 2.257 . . . . 0.0 112.361 177.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -72.26 -30.79 65.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 45.37 45.09 9.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.104 174.535 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 29.7 m0 -63.68 -19.61 65.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.868 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -69.75 -14.88 63.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.855 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -78.45 -171.32 2.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.498 HG21 ' HB3' ' A' ' 238' ' ' SER . 92.9 mt -96.28 140.06 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.152 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -92.03 -49.49 6.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 86.3 m -144.85 119.9 10.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.185 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' SER . . . . . 0.498 ' HB3' HG21 ' A' ' 235' ' ' ILE . 29.2 t -178.75 164.37 1.54 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -79.14 -10.44 59.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 172.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.09 130.96 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.056 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -82.99 139.13 33.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.408 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 39.0 p90 -150.02 156.6 41.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.927 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.7 163.86 26.46 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.431 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.0 p -135.53 135.93 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 111.127 -176.235 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 13.2 t -159.71 152.45 21.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 175.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.421 HG13 ' HB2' ' A' ' 322' ' ' GLU . 28.2 m -59.2 163.26 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.288 -175.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.526 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 2.4 mp -67.02 153.66 94.07 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 110.985 -165.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.51 -178.17 2.12 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.777 2.318 . . . . 0.0 112.358 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 68.2 p -100.85 160.09 14.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.078 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -138.8 119.75 14.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.911 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 54.89 33.99 21.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 -173.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.78 9.92 73.66 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.558 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -126.17 139.94 35.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.619 0.723 . . . . 0.0 110.842 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -73.29 139.58 29.33 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.736 2.291 . . . . 0.0 112.298 -172.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 256' ' ' LYS . 73.8 m -85.33 1.5 48.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.845 168.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . 0.428 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 99.0 mttt -38.4 118.06 0.99 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.569 0.7 . . . . 0.0 110.879 -175.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.533 ' CB ' ' HB2' ' A' ' 113' ' ' LEU . 53.0 Cg_exo -65.66 162.13 35.75 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.699 2.266 . . . . 0.0 112.33 -170.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -74.48 167.2 22.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.901 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.7 t -117.56 134.5 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.082 -165.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.51 ' HA3' ' NE2' ' A' ' 64' ' ' HIS . . . -116.7 135.52 12.07 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.469 176.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.2 t -124.96 118.24 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 111.197 174.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.41 HD21 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -66.28 123.06 18.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.3 m -126.49 133.45 51.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.789 -168.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.26 138.88 52.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.066 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.39 172.07 21.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.419 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.494 HG13 ' HB2' ' A' ' 277' ' ' LYS . 29.1 mm -113.64 129.96 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 0.0 111.106 -173.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -61.85 128.74 37.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.465 ' HB3' ' C ' ' A' ' 76' ' ' LEU . . . -59.83 -29.19 68.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.099 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.82 -5.76 59.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.065 -173.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.5 t -73.14 121.0 83.99 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.654 0.74 . . . . 0.0 110.936 -173.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . 0.405 ' HD2' HG21 ' A' ' 2' ' ' ILE . 92.0 Cg_endo -68.04 -9.38 25.52 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.635 2.224 . . . . 0.0 112.353 168.032 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -108.66 19.72 19.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -53.97 -33.97 58.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.856 -171.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -67.55 -50.65 57.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -172.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.99 -32.08 39.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.45 -47.51 75.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.071 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . 0.494 ' HB2' HG13 ' A' ' 266' ' ' ILE . 37.3 ttpt -66.24 -42.41 88.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 176.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.46 -46.57 82.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -66.29 -43.2 87.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 284' ' ' LEU . 8.2 tt -55.83 -50.57 70.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 -176.427 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -72.4 -25.21 61.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -100.27 -11.15 20.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 -171.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.766 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 73.9 m-85 -122.91 -60.55 1.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.448 HD23 ' HA ' ' A' ' 280' ' ' LEU . 1.4 mp -62.66 -32.49 73.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.908 -159.56 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.919 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.4 pp -123.22 38.07 4.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.96 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.483 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 64.0 p -124.68 163.47 21.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.454 ' HA ' HD11 ' A' ' 290' ' ' LEU . 38.7 t70 -45.63 -37.51 5.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -166.044 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -78.3 -41.63 33.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.766 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.52 -55.96 5.8 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.593 -170.685 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 291' ' ' GLU . 0.6 OUTLIER -67.2 -21.36 65.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 110.852 -178.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.6 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.9 tt0 -68.44 -47.6 66.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 172.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.63 -45.15 91.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -174.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 1.111 HG21 ' HA3' ' A' ' 19' ' ' GLY . 2.6 p -75.83 -34.56 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.176 -175.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.45 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 46.2 t30 -67.4 -28.24 67.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 173.352 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.09 -26.47 68.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -85.46 -41.76 15.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.992 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -145.36 131.78 9.78 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.572 0.701 . . . . 0.0 110.853 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.32 109.01 0.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.727 2.285 . . . . 0.0 112.358 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.45 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 59.4 mt -90.06 -19.6 24.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.97 -171.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 113.36 -59.46 0.38 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.461 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.677 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -171.37 169.63 6.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.807 0.337 . . . . 0.0 111.114 174.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.654 HG22 ' HB3' ' A' ' 307' ' ' TYR . 32.9 m -125.24 154.67 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.07 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.46 -10.71 60.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.077 171.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.583 ' CD2' HD22 ' A' ' 290' ' ' LEU . 54.1 tp -85.9 120.01 26.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -175.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -55.85 -40.45 72.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.883 -174.065 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.7 m -65.72 -50.02 66.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.849 -168.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.654 ' HB3' HG22 ' A' ' 302' ' ' VAL . 17.4 t80 -76.42 -28.63 56.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.979 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -64.8 -38.87 92.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.9 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.53 -34.76 77.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.909 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -75.02 -40.44 60.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.924 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.677 HD13 ' HA ' ' A' ' 301' ' ' ALA . 80.1 mt -61.23 -32.0 71.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.901 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.64 -18.64 60.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.06 -176.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.79 -19.37 65.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 173.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -91.4 122.7 65.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.608 0.718 . . . . 0.0 110.88 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -48.61 -28.69 12.73 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.668 2.245 . . . . 0.0 112.375 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -62.75 -27.25 69.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.888 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.414 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.4 mp -75.06 -32.88 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 -174.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.2 -46.03 91.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.046 -171.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.35 -39.3 89.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.169 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.634 HG21 ' HB1' ' A' ' 112' ' ' ALA . 21.6 m -59.32 -36.39 75.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.182 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.8 mmm -73.86 -34.24 64.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . 0.421 ' HB2' HG13 ' A' ' 246' ' ' VAL . 86.1 mt-10 -59.46 -44.14 93.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.942 -172.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.791 HD22 ' HB2' ' A' ' 112' ' ' ALA . 16.4 p-10 -87.83 -26.28 22.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -178.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.64 -45.31 92.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.133 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -62.46 -33.7 75.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.88 -177.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -107.62 -2.29 20.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.857 -173.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -90.17 -166.57 41.44 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.452 -164.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -144.94 143.0 30.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 110.962 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 47.0 mm -60.44 118.7 3.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 -171.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 47.6 tpp -54.28 130.22 60.69 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.561 0.696 . . . . 0.0 110.87 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.543 ' HB2' ' HG3' ' A' ' 336' ' ' MET . 43.0 Cg_endo -70.95 99.9 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.692 2.261 . . . . 0.0 112.321 -175.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.515 ' ND2' ' ND1' ' A' ' 64' ' ' HIS . 23.3 m-80 -120.58 23.29 10.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -174.263 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 51.0 pt -75.8 160.13 79.55 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.626 0.727 . . . . 0.0 111.129 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -54.81 -38.25 92.14 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.775 2.317 . . . . 0.0 112.301 -173.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -67.68 -29.18 68.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.543 ' HG3' ' HB2' ' A' ' 331' ' ' PRO . 66.1 mmm -80.03 -18.06 51.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 -168.902 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 95.0 p -63.8 -37.71 88.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.782 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -76.85 -35.13 57.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.14 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.556 ' O ' HG13 ' A' ' 343' ' ' VAL . 5.0 m-30 -67.61 -41.0 84.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.461 ' HA ' HG23 ' A' ' 343' ' ' VAL . 7.7 m0 -59.89 -34.64 73.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 174.367 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -69.43 -39.77 77.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.889 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.51 -43.22 85.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.109 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.556 HG13 ' O ' ' A' ' 339' ' ' PHE . 15.4 m -75.15 -28.58 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.098 -176.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.453 ' O ' HG23 ' A' ' 347' ' ' VAL . 49.3 ttt180 -58.62 -45.56 88.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.845 172.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 93.2 m -56.11 -36.25 67.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.148 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.64 -44.05 91.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.188 -174.347 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.539 ' HA ' HD11 ' A' ' 192' ' ' LEU . 3.0 m -74.88 -34.86 34.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.175 -174.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.453 HD13 HG21 ' A' ' 347' ' ' VAL . 1.4 mp -62.95 -52.18 62.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.196 173.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -62.5 -39.21 92.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.59 -45.71 61.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.111 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.72 -39.67 76.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.049 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 89.4 p -75.39 -10.56 59.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.921 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 82.02 17.13 70.5 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.414 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.72 -33.4 46.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 110.863 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -140.02 155.1 47.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.5 p -77.38 169.45 18.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.217 170.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.435 ' O ' ' CB ' ' A' ' 361' ' ' LEU . 53.8 t -56.17 -42.37 72.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.198 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -61.13 -46.58 89.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.828 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -70.09 -53.19 18.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -70.96 -48.04 55.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.146 -172.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.711 HD11 ' HB1' ' A' ' 188' ' ' ALA . 1.3 tm? -65.08 -41.76 94.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -174.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.73 -54.08 26.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -70.39 -48.35 56.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -171.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.34 85.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.175 -174.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.508 ' HB3' ' HB ' ' A' ' 183' ' ' VAL . 79.4 mm-40 -73.55 -34.79 65.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -175.868 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 26.9 m -60.17 -27.93 67.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.175 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -56.99 -30.11 63.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.804 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.427 ' HB ' ' O ' ' A' ' 365' ' ' GLN . 77.3 mt -60.6 -40.18 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.076 174.657 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 45.7 p -98.22 -11.38 22.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.019 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.955 175.938 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.835 0.35 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.6 mt -93.68 130.73 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.177 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -145.52 146.59 31.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.918 -176.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.22 137.15 35.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.27 6.13 63.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.458 -174.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.476 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.2 tttt -165.32 135.85 3.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.741 0.305 . . . . 0.0 110.961 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.417 HD21 ' HB3' ' A' ' 275' ' ' LEU . 0.5 OUTLIER -142.34 149.57 39.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 -178.804 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 78.3 t -107.62 133.76 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.726 HG23 ' HB ' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -119.92 133.87 65.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.12 -179.397 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.812 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 68.5 m95 -108.25 126.2 52.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.014 166.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.502 HD13 ' HG ' ' A' ' 20' ' ' LEU . 14.9 tt -110.55 150.06 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 -165.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.58 149.21 39.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -172.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.86 -17.84 23.3 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.459 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -73.5 -12.32 60.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.785 0.326 . . . . 0.0 110.826 -176.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -147.83 128.17 13.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 164.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.87 -77.25 1.0 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.443 -167.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -108.47 -44.91 3.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.923 0.392 . . . . 0.0 110.979 -175.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -67.47 -50.34 59.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.887 -152.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.662 ' HA3' HG21 ' A' ' 293' ' ' VAL . . . -54.95 -49.54 62.04 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.42 -173.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.519 HD22 HG21 ' A' ' 9' ' ' ILE . 3.2 mt -52.21 -54.43 31.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 0.0 110.913 170.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.96 -35.84 25.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -70.63 -59.22 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.971 0.415 . . . . 0.0 110.88 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.0 m -71.19 -37.77 67.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.127 -173.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.705 ' HA3' HG22 ' A' ' 35' ' ' VAL . . . -66.4 -45.88 82.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.426 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -57.43 -32.99 67.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 0.0 110.984 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -57.81 -37.83 74.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 176.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 6.0 m-30 -59.66 -44.61 93.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -64.81 -37.9 89.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.96 -40.62 75.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.867 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -97.54 -47.06 5.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.835 -166.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.6 p -108.13 -6.1 16.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.152 -173.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.91 3.83 90.53 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.432 169.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.836 HD11 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -100.13 133.17 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 0.0 111.177 -176.444 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.2 mttt -79.36 142.71 35.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.841 -172.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.705 HG22 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -120.01 133.79 65.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 178.359 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.481 ' O ' HD13 ' A' ' 9' ' ' ILE . 97.5 m -104.68 128.68 52.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.049 177.202 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.483 HG23 ' HB3' ' A' ' 20' ' ' LEU . 93.5 t -98.26 125.18 51.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.199 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -117.97 148.25 42.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 96.8 m-70 -86.75 148.3 45.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.597 0.713 . . . . 0.0 110.895 -165.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.469 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 50.7 Cg_exo -59.81 -24.96 77.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.69 2.26 . . . . 0.0 112.3 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -53.24 -50.09 65.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.937 -171.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.08 -3.83 56.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.836 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.469 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 7.7 tt -46.39 -52.63 12.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 -172.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -66.63 -36.45 82.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.767 176.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.38 -43.65 85.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.816 -172.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.4 -21.31 39.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.535 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 56.6 t80 -48.83 -51.17 56.51 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.614 0.721 . . . . 0.0 110.821 -167.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.535 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 63.1 Cg_endo -80.75 -29.46 2.2 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.731 2.287 . . . . 0.0 112.375 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -74.66 -39.65 61.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.929 -169.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.456 HG11 ' HD3' ' A' ' 57' ' ' PRO . 34.2 m -65.09 -27.83 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.031 -177.354 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.842 ' HB2' HD23 ' A' ' 75' ' ' LEU . . . -68.87 -37.01 78.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 177.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.11 -30.62 68.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.148 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.3 p -92.39 -15.37 27.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 176.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.48 10.22 78.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 175.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -141.05 133.28 28.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.38 -115.07 0.53 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.486 176.752 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.812 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 61.1 Cg_endo -75.28 152.57 39.64 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.723 2.282 . . . . 0.0 112.415 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.39 -34.99 17.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 159.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.726 ' HB ' HG23 ' A' ' 9' ' ' ILE . 30.5 mt -128.59 139.31 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 -175.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 tp -131.87 127.87 59.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -93.65 137.2 33.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 172.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.428 ' CZ2' ' HB3' ' A' ' 105' ' ' ALA . 30.0 p90 -144.66 165.03 29.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.932 171.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.81 -89.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.048 -169.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.423 ' CD2' ' HA2' ' A' ' 260' ' ' GLY . 18.0 m80 -105.47 -81.58 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.828 -171.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.573 ' H ' ' HB3' ' A' ' 332' ' ' ASN . 70.0 m-20 -103.88 -6.71 21.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.77 -154.227 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -52.15 -21.5 3.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -173.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.497 ' HB2' HD11 ' A' ' 104' ' ' ILE . 30.7 p90 -59.27 -28.96 67.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.815 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.62 -51.47 57.7 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.73 91.89 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.442 171.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.417 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -54.96 -51.68 65.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.981 0.42 . . . . 0.0 110.999 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.24 -42.6 45.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.113 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.5 tp60 -56.88 -38.62 73.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.87 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . 0.428 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 62.8 m -85.94 -6.9 58.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.847 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.73 30.78 59.26 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.561 174.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.842 HD23 ' HB2' ' A' ' 51' ' ' ALA . 39.0 mt -89.87 -10.07 46.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 0.0 110.972 -169.218 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.491 ' C ' ' HB3' ' A' ' 268' ' ' ALA . 0.2 OUTLIER -127.97 149.41 50.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 -176.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -77.36 141.11 40.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.124 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.8 136.48 45.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.957 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -105.1 156.86 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 81' ' ' PRO . 98.8 m -100.7 130.32 25.69 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.606 0.717 . . . . 0.0 111.096 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 80' ' ' THR . 50.8 Cg_exo -54.44 134.57 62.15 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.738 2.292 . . . . 0.0 112.329 176.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -104.04 118.62 37.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.817 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.21 -41.96 98.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.897 -176.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.89 -45.05 87.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -74.88 -32.4 61.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.951 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . 0.481 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 66.9 tt0 -55.04 -50.87 68.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.901 175.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.03 -32.68 71.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 174.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -76.22 -21.32 56.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.466 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.7 -105.21 0.3 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.949 -172.461 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.466 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 30.3 t80 171.75 128.92 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.655 0.74 . . . . 0.0 110.92 -167.752 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -53.48 -37.03 81.98 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.746 2.297 . . . . 0.0 112.352 -173.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . 0.403 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 67.2 t80 -64.97 -35.72 82.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.785 -174.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.8 p -73.12 -30.97 64.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.186 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.537 ' HA ' HG23 ' A' ' 97' ' ' VAL . 86.3 m95 -67.47 -30.85 70.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 174.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.4 -30.75 70.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.852 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.96 -25.76 62.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.034 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.547 HG21 HD23 ' A' ' 103' ' ' LEU . 15.6 m -106.02 13.04 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 -174.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -100.04 129.74 46.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -123.68 115.03 20.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 172.592 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.8 t30 56.82 38.88 29.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 173.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.39 0.39 89.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.56 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -116.71 151.29 36.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.833 0.349 . . . . 0.0 110.805 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.547 HD23 HG21 ' A' ' 97' ' ' VAL . 15.1 mt -90.82 135.11 33.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.873 177.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.497 HD11 ' HB2' ' A' ' 67' ' ' PHE . 2.0 pp -125.68 3.9 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.037 -172.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.428 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . . . -163.03 165.47 24.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.162 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.46 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 92.4 m-85 -116.04 140.46 26.34 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.609 0.718 . . . . 0.0 110.993 172.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 11.4 Cg_exo -72.13 126.38 11.73 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.733 2.289 . . . . 0.0 112.391 172.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 1.068 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.5 mp -107.61 -39.98 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.213 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.59 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -144.02 152.09 40.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.162 -164.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.3 t -125.06 131.19 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.109 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . 0.522 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 92.5 mt-10 -133.89 132.31 40.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 175.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.778 ' HB2' HD22 ' A' ' 323' ' ' ASN . . . -154.18 152.73 30.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.119 176.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.36 169.65 16.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.941 -168.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 98.9 p -157.59 159.14 36.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.904 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -92.33 126.09 37.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 169.581 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.596 ' N ' HD23 ' A' ' 115' ' ' LEU . 65.7 mt -113.71 132.14 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -172.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -132.13 145.03 51.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.425 ' O ' HD21 ' A' ' 122' ' ' LEU . 54.8 t-20 -93.36 114.43 26.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.831 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.475 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.8 mttt -64.78 -18.43 65.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 -173.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -77.33 -29.98 53.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.865 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 mp -83.69 -49.51 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.647 ' H ' HD21 ' A' ' 122' ' ' LEU . 1.5 pt? -140.0 126.53 12.18 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.567 0.699 . . . . 0.0 110.89 176.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -79.16 -14.59 13.3 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.693 2.262 . . . . 0.0 112.377 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -142.23 97.16 6.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.564 0.697 . . . . 0.0 110.825 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.67 154.98 54.66 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.725 2.283 . . . . 0.0 112.282 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.39 146.23 74.21 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.624 2.216 . . . . 0.0 112.347 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -88.53 -18.16 28.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.988 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 69.6 p -132.27 158.72 41.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.166 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.559 ' HA ' HD11 ' A' ' 132' ' ' ILE . 58.7 m95 -69.66 -27.21 64.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.978 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.96 -24.6 67.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.14 -24.62 40.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.823 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.628 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -57.15 -49.68 92.53 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.586 0.708 . . . . 0.0 111.151 -172.034 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.628 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 40.0 Cg_endo -68.67 -38.02 11.32 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.67 2.247 . . . . 0.0 112.398 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.14 -60.73 3.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 176.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 1.209 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.96 -16.8 63.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 -175.708 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.511 ' N ' HD13 ' A' ' 135' ' ' LEU . 37.0 t70 -58.39 -39.63 80.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.821 168.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.52 -30.22 68.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.79 -47.6 52.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.032 0.444 . . . . 0.0 110.864 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.608 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.9 pp -85.62 -15.27 43.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.608 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.7 tttt -59.74 -33.45 71.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 173.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.03 -24.63 67.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 176.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -95.03 3.35 54.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.927 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.79 33.16 52.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.471 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -110.5 169.97 8.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.749 0.309 . . . . 0.0 110.909 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.0 t -118.93 142.13 48.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.996 0.427 . . . . 0.0 110.745 169.033 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -68.62 -39.87 80.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 -175.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -142.17 130.68 22.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 62.3 tpp -118.22 131.9 56.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.823 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -154.59 157.49 38.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.53 -51.56 5.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 1.11 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.4 tm? 48.04 33.37 3.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.891 -169.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -102.16 -2.76 28.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.936 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -127.97 153.68 78.32 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.683 0.754 . . . . 0.0 110.864 -174.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.457 ' HA ' ' HB ' ' A' ' 157' ' ' THR . 37.5 Cg_endo -61.81 -24.78 77.73 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.626 2.217 . . . . 0.0 112.362 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -66.68 -30.06 70.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -87.49 -39.39 15.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' THR . . . . . 0.457 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 20.5 m -61.18 -46.87 88.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.135 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.574 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 37.3 t-105 -58.81 -53.84 62.37 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.499 0.666 . . . . 0.0 110.833 -169.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 34.4 Cg_endo -66.12 -18.01 55.73 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.694 2.263 . . . . 0.0 112.255 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.781 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.6 tm? -81.61 -45.34 15.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.837 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.583 HG22 ' HA3' ' A' ' 166' ' ' GLY . 77.9 mt -74.24 -44.46 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.98 -20.95 63.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . 0.463 ' HB3' ' O ' ' A' ' 159' ' ' PRO . . . -60.66 -31.15 70.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.093 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.98 3.1 55.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.891 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 104.11 7.91 39.92 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.485 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.583 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -77.06 67.05 2.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.541 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -86.05 131.11 34.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.361 . . . . 0.0 110.89 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.54 13.48 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -174.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.426 ' HA ' HG12 ' A' ' 181' ' ' VAL . 52.9 p90 -153.43 154.4 34.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.415 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 86.8 tttt -101.48 127.5 48.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 158.273 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -116.22 125.81 52.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.983 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -153.55 130.39 10.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.0 t30 54.31 42.76 31.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.946 172.573 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.95 18.47 80.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -132.27 138.51 47.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.965 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -97.72 145.11 26.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.811 170.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -126.24 112.14 15.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.914 174.183 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . 0.609 ' O ' HD13 ' A' ' 178' ' ' ILE . 1.1 pp -79.43 -12.82 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -95.23 -10.1 31.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 -176.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . 0.415 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 67.2 t0 -126.42 90.13 3.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 169.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.426 HG12 ' HA ' ' A' ' 169' ' ' PHE . 29.3 m -113.55 164.07 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -173.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.11 22.59 32.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.519 -172.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.477 HG22 HD13 ' A' ' 368' ' ' ILE . 3.5 m -106.64 -17.91 7.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 111.046 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -87.68 21.23 2.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.829 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -120.05 -171.41 2.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.863 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.72 -30.38 71.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.128 -173.227 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.37 -40.51 94.57 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.434 -167.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.635 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -65.04 -38.36 90.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 111.107 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.547 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -61.92 -38.66 89.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.906 174.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.98 -38.79 92.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.05 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.516 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -65.75 -47.76 73.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.51 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.754 HD11 ' HA ' ' A' ' 347' ' ' VAL . 18.8 tp -67.33 -34.51 77.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.802 0.334 . . . . 0.0 110.845 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.481 ' OG1' HG22 ' A' ' 357' ' ' VAL . 89.2 m -64.98 -43.84 91.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.18 177.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 79.9 t80 -65.95 -48.58 70.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.881 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.71 ' C ' HD21 ' A' ' 195' ' ' LEU . 5.2 tt -50.98 -51.28 54.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.974 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.424 ' O ' HG13 ' A' ' 199' ' ' ILE . 27.5 m -64.5 -21.48 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.101 -173.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.3 m-20 -61.03 -33.13 72.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.808 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -80.86 -40.05 25.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.56 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.7 pp -74.37 -28.4 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 172.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.84 -37.66 79.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 173.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -80.04 2.17 24.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 66.41 40.18 3.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.802 166.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -78.98 -15.72 57.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.843 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.56 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.1 ppp? -141.33 155.53 45.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 178.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -94.63 150.04 20.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.26 68.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.044 -175.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -94.96 0.55 54.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.931 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 89.6 m -62.24 125.04 22.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.432 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 13.6 t0 -120.0 -179.65 3.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.844 177.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -64.1 -46.05 85.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.99 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.1 p -67.0 -37.09 83.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.82 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.432 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 80.9 mt -65.01 -43.9 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.088 174.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.41 84.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -63.49 -46.4 86.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 176.142 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.91 93.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.01 88.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.115 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -64.02 -42.08 97.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.963 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -66.28 -34.3 77.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -81.96 -23.34 36.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.884 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.43 27.03 26.2 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.448 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -83.46 -20.02 34.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.985 0.421 . . . . 0.0 110.9 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.7 t -131.22 137.54 48.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.133 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.586 ' HB3' HD23 ' A' ' 139' ' ' LEU . . . -67.37 -41.98 84.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.012 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.476 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 61.6 mtm -137.63 160.84 38.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -177.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.3 t -150.26 159.55 44.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.264 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.505 HD13 HD11 ' A' ' 247' ' ' LEU . 49.2 mm -109.24 126.23 66.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -154.97 174.4 15.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.861 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -81.64 -163.71 31.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.41 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.522 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 39.7 Cg_endo -68.61 -22.05 38.54 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.697 2.265 . . . . 0.0 112.281 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 54.1 m0 -70.09 -30.0 67.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.868 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 47.56 45.04 17.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.062 174.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 34.1 m0 -66.26 -16.12 63.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.88 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 74.3 m -53.01 -40.07 63.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.966 0.412 . . . . 0.0 110.875 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -86.36 -177.29 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -173.692 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 77.1 mt -120.08 125.76 74.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.154 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -70.12 -38.73 75.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.773 -175.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 86.7 m -124.96 106.2 9.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 27.9 t -174.06 162.98 3.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 177.319 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -77.8 -19.23 55.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.851 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 23.3 m -60.19 150.67 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.158 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -104.51 140.01 38.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.86 175.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.475 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 42.8 p90 -150.01 154.78 38.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.31 160.7 25.13 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.538 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.2 p -138.6 137.34 43.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 0.0 111.154 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.1 t -154.09 146.19 23.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.14 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.6 m -61.33 167.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.936 HD21 ' HD3' ' A' ' 257' ' ' PRO . 3.1 mm? -64.65 144.88 98.8 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.546 0.689 . . . . 0.0 111.077 -163.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.11 -172.12 1.27 Allowed 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.753 2.302 . . . . 0.0 112.487 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 94.7 m -108.82 146.04 34.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.179 -173.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . 0.422 ' HB3' ' CD1' ' A' ' 129' ' ' TRP . 43.6 p90 -137.39 126.43 24.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 54.05 35.06 21.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.97 6.97 84.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.48 173.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -133.66 131.34 21.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.634 0.73 . . . . 0.0 110.859 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.47 137.42 25.41 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.674 2.249 . . . . 0.0 112.296 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.769 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 82.3 p -87.04 -1.07 57.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 173.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -39.31 132.99 1.23 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.567 0.699 . . . . 0.0 110.915 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.936 ' HD3' HD21 ' A' ' 247' ' ' LEU . 58.8 Cg_endo -83.22 157.94 15.03 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.607 2.205 . . . . 0.0 112.419 -169.037 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -75.77 167.24 22.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.865 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 45.5 t -111.24 136.37 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.203 -165.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . 0.423 ' HA2' ' CD2' ' A' ' 64' ' ' HIS . . . -114.41 131.98 10.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.38 172.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 83.7 t -125.08 115.38 43.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.774 0.321 . . . . 0.0 111.196 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.43 HD21 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -64.92 122.03 16.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.944 -177.749 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 42.6 m -127.53 133.25 49.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.839 -170.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -127.35 140.3 52.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.081 -172.221 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.41 170.77 22.17 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.479 -171.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.7 mm -112.36 128.22 69.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.745 0.307 . . . . 0.0 111.2 -172.134 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -63.31 128.24 34.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.973 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.491 ' HB3' ' C ' ' A' ' 76' ' ' LEU . . . -60.56 -28.65 68.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.121 -178.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.57 -6.74 59.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.104 -173.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.2 t -79.75 123.16 84.05 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.596 0.712 . . . . 0.0 110.903 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -69.53 -7.16 20.26 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.733 2.289 . . . . 0.0 112.396 169.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -102.1 21.97 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 -167.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -50.12 -36.28 29.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -173.214 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.3 -39.7 89.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.417 ' HB3' HD21 ' A' ' 7' ' ' LEU . 33.9 mt -66.79 -56.87 8.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 173.455 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.91 -50.99 36.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.991 -167.583 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -61.21 -40.64 94.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.955 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.9 tt0 -69.34 -47.75 63.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.944 -177.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.401 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 20.4 m-30 -66.53 -36.21 82.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 -178.243 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.508 ' HA ' HD23 ' A' ' 284' ' ' LEU . 5.4 tt -59.17 -52.39 65.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -177.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . 0.414 ' HA ' HD22 ' A' ' 285' ' ' LEU . 24.4 pt-20 -78.66 -30.68 46.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.784 -174.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.484 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 63.7 m-80 -100.85 -13.96 18.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 -164.759 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.711 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 52.4 m-85 -126.7 -53.52 1.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.813 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.526 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.3 OUTLIER -61.66 -35.43 77.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.963 -167.363 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 1.068 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.9 pp -124.43 38.23 4.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -175.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.452 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 68.2 p -122.51 164.32 18.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.188 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.472 ' HA ' HD11 ' A' ' 290' ' ' LEU . 38.8 t70 -45.77 -38.0 6.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 -165.275 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -77.15 -42.57 37.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.954 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.711 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -71.98 -51.54 14.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 -170.316 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.569 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -74.07 -20.49 60.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.67 0.271 . . . . 0.0 110.892 -178.349 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.553 ' N ' HD12 ' A' ' 290' ' ' LEU . 35.8 tt0 -70.27 -46.45 64.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 171.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.97 -43.99 97.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.011 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.662 HG21 ' HA3' ' A' ' 19' ' ' GLY . 1.8 p -79.95 -30.55 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.236 -176.04 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . 0.408 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 39.0 t30 -68.09 -28.97 67.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.777 170.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.03 -24.81 68.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.944 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -77.02 -43.24 35.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -162.87 135.79 4.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.545 0.688 . . . . 0.0 110.976 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -45.43 114.66 0.76 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.745 2.297 . . . . 0.0 112.42 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.408 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 51.2 mt -89.98 -14.85 33.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.894 -175.34 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 114.92 -59.48 0.41 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.488 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.704 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -173.72 170.15 4.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 111.095 171.678 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.712 HG22 ' HB3' ' A' ' 307' ' ' TYR . 30.8 m -122.68 154.84 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.136 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.23 -10.49 59.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.023 171.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.569 ' CD2' HD22 ' A' ' 290' ' ' LEU . 40.1 tp -83.15 120.35 25.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.843 -177.107 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.16 -40.1 73.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.4 m -65.25 -50.14 66.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.882 -169.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.712 ' HB3' HG22 ' A' ' 302' ' ' VAL . 15.7 t80 -76.9 -29.13 55.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.973 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.09 -40.1 96.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.88 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.53 -35.29 78.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -74.47 -40.25 61.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.704 HD13 ' HA ' ' A' ' 301' ' ' ALA . 77.8 mt -60.91 -32.25 71.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 175.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.93 -19.8 61.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.022 0.439 . . . . 0.0 111.202 -177.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.57 -20.62 66.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.977 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -90.26 121.12 68.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.606 0.717 . . . . 0.0 110.88 166.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.81 -28.29 9.56 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.753 2.302 . . . . 0.0 112.355 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -60.24 -30.44 69.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.507 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.2 mp -79.99 -29.99 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.074 -176.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.71 85.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.047 -168.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.75 -47.64 62.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.067 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.579 HG21 ' HB1' ' A' ' 112' ' ' ALA . 26.9 m -61.09 -37.11 81.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.156 -174.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.6 ttp -65.22 -35.49 81.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -64.64 -47.76 77.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.835 -170.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.778 HD22 ' HB2' ' A' ' 112' ' ' ALA . 9.6 p-10 -83.43 -26.23 30.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 -178.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.64 -49.74 72.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.192 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -66.98 -29.86 69.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -109.74 -9.23 14.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -168.24 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.13 -148.87 23.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.458 -166.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -143.32 139.94 30.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.872 0.368 . . . . 0.0 110.824 -171.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 40.6 mm -65.52 122.4 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 59.0 ttm -64.57 137.27 97.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.575 0.702 . . . . 0.0 110.911 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.437 ' HB2' ' HG3' ' A' ' 336' ' ' MET . 34.3 Cg_endo -67.38 128.52 18.46 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.641 2.227 . . . . 0.0 112.3 -176.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.573 ' HB3' ' H ' ' A' ' 65' ' ' ASP . 63.8 t30 -135.91 24.28 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 40.7 pt -78.67 157.0 77.52 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.627 0.727 . . . . 0.0 111.171 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -55.18 -36.18 92.6 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.747 2.298 . . . . 0.0 112.309 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -71.31 -30.56 66.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.904 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.437 ' HG3' ' HB2' ' A' ' 331' ' ' PRO . 74.1 mmm -79.9 -19.05 49.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 -171.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.9 m -61.84 -41.73 98.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.773 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.32 -35.14 61.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.112 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.552 ' O ' HG13 ' A' ' 343' ' ' VAL . 8.2 m-30 -66.41 -40.42 89.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.47 ' HA ' HG23 ' A' ' 343' ' ' VAL . 18.6 m0 -59.01 -35.87 73.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.978 174.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -67.82 -41.88 82.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.95 -44.18 81.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.061 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.552 HG13 ' O ' ' A' ' 339' ' ' PHE . 16.7 m -74.38 -30.87 26.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 -176.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.483 ' O ' HG23 ' A' ' 347' ' ' VAL . 4.9 tmt_? -65.0 -39.38 93.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 175.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.7 m -58.36 -35.74 72.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.89 -43.62 95.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.189 -174.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.754 ' HA ' HD11 ' A' ' 192' ' ' LEU . 3.8 m -73.56 -33.7 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.237 -175.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.449 HD13 HG21 ' A' ' 347' ' ' VAL . 1.5 mp -63.8 -46.51 94.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.151 173.018 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -65.05 -39.85 93.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.53 62.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.079 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.61 -40.19 80.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.033 -175.627 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.8 p -75.43 -10.71 59.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.11 16.93 73.28 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.54 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.95 -32.82 45.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 0.0 110.854 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -139.59 154.87 47.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.0 p -77.63 168.91 19.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.096 169.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.481 HG22 ' OG1' ' A' ' 193' ' ' THR . 53.7 t -56.04 -42.09 70.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.205 172.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -61.29 -46.53 89.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.857 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -69.71 -53.23 19.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -70.75 -48.3 55.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.06 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.635 HD11 ' HB1' ' A' ' 188' ' ' ALA . 1.3 tm? -66.02 -45.63 80.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -173.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.67 -53.07 57.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.972 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -67.23 -47.11 71.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.1 -41.54 94.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.119 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.617 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 72.5 mm-40 -78.17 -26.79 47.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.014 -176.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.2 m -64.48 -36.03 82.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.161 171.167 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.01 -30.41 67.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.477 HD13 HG22 ' A' ' 183' ' ' VAL . 67.7 mt -60.4 -38.11 76.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.165 174.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 59.8 p -93.83 -14.85 25.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 178.728 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.73 0.3 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.7 mt -82.55 134.61 26.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.099 175.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -135.83 142.21 44.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.006 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -56.56 135.96 54.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.574 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 98.94 -0.17 57.54 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.518 -174.518 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 65.6 pttt -162.59 150.87 14.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.831 172.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.688 ' H ' HD21 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -147.23 156.72 43.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -176.559 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 91.2 t -113.92 131.12 66.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.095 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.917 ' HB ' HD22 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -119.97 126.82 75.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.12 -177.694 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.559 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 47.5 m0 -107.72 131.46 54.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.959 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.488 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 65.9 mt -117.75 142.41 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.078 173.053 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.413 ' O ' HG22 ' A' ' 11' ' ' ILE . 33.2 t30 -47.68 141.08 5.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 172.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.16 -13.03 13.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.569 -172.385 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -78.49 -15.22 58.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 0.0 110.844 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -130.99 112.07 12.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 167.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.75 -96.58 0.84 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.548 -153.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -102.97 -43.3 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.886 0.374 . . . . 0.0 110.931 -167.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.77 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 95.7 m-20 -62.49 -50.36 71.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 -157.144 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.718 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -57.8 -47.71 86.88 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 -175.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.917 HD22 ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -57.09 -61.02 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.76 0.314 . . . . 0.0 110.997 175.682 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.39 -40.94 37.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.14 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -65.03 -53.53 44.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.1 m -75.55 -36.06 33.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.179 -175.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.765 ' HA3' HG22 ' A' ' 35' ' ' VAL . . . -65.08 -47.22 84.16 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.98 -39.57 72.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.813 0.34 . . . . 0.0 110.861 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.67 -36.9 79.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -64.68 -41.56 95.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.57 -39.39 94.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.888 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -67.33 -33.84 76.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.879 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -89.32 -44.1 10.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.845 -170.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.566 ' OG1' HG13 ' A' ' 33' ' ' ILE . 66.6 p -110.73 -12.69 14.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.195 -171.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.53 7.23 87.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.589 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.858 HD13 ' O ' ' A' ' 33' ' ' ILE . 2.4 pp -99.01 133.51 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.078 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.6 mttt -82.62 140.28 33.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.96 -173.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.765 HG22 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -118.09 134.61 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.14 -177.411 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.403 ' O ' HD13 ' A' ' 9' ' ' ILE . 98.2 m -102.52 127.15 49.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.162 179.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.53 HG23 ' HG ' ' A' ' 20' ' ' LEU . 61.9 t -95.24 120.98 45.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.159 177.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.559 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 66.4 mm-40 -129.98 133.77 47.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.816 170.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -142.19 57.43 6.57 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.622 0.725 . . . . 0.0 110.873 174.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.01 -23.59 7.67 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.74 2.294 . . . . 0.0 112.369 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t0 62.63 20.77 12.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -170.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 45' ' ' GLU . 98.9 mttt -85.22 2.85 42.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.958 169.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . 0.414 ' HG ' ' H ' ' A' ' 43' ' ' LEU . 11.3 mt -43.45 -47.86 7.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -171.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.86 -36.87 77.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 42' ' ' LYS . 89.0 tt0 -74.54 -36.38 63.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -78.95 -29.98 44.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.511 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 9.8 m-30 -45.16 -55.58 11.06 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.664 0.745 . . . . 0.0 110.851 -175.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.511 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.4 Cg_endo -68.68 -27.2 32.33 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.795 2.33 . . . . 0.0 112.317 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -79.4 -44.02 22.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.881 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.8 m -68.02 -30.52 48.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.154 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.37 79.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 172.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.42 -30.92 67.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.062 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.5 p -92.66 -12.33 31.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.169 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.45 15.27 81.31 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.462 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -161.08 154.21 21.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.862 0.363 . . . . 0.0 110.877 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.445 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . -162.76 -138.14 2.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.409 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.527 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 72.6 Cg_endo -68.62 155.88 67.4 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.621 2.214 . . . . 0.0 112.395 169.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.48 -38.03 26.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.747 ' HB ' HG23 ' A' ' 9' ' ' ILE . 4.1 mp -128.4 138.01 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.079 176.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.508 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 1.9 tp -130.36 129.06 64.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.169 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.576 ' CE2' HG13 ' A' ' 108' ' ' ILE . 2.5 m-85 -98.62 141.25 31.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.819 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.508 ' CZ2' HG23 ' A' ' 60' ' ' ILE . 8.6 m-90 -118.12 139.96 50.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.54 -83.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.198 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.422 ' HB3' ' SD ' ' A' ' 330' ' ' MET . 98.2 m-70 -128.0 -57.22 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.835 170.088 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -85.36 -26.61 26.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.778 -170.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.508 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 98.7 mtt180 -59.94 -29.97 68.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 -158.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -67.99 -28.31 67.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -169.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.12 -51.48 52.65 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.433 -172.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.85 -36.99 92.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.482 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.546 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 17.4 t80 -66.53 -37.74 85.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.879 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.54 -44.43 62.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -62.66 -33.31 74.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.5 p -80.33 -10.76 59.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.932 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.22 32.44 68.85 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.454 174.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.411 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 1.7 mp -86.34 1.24 51.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 0.0 110.905 -172.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.546 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.7 OUTLIER -131.93 159.86 37.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.949 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.711 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -68.36 130.63 43.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.034 174.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -69.99 123.35 21.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.937 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.6 pt -108.78 159.97 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.053 -172.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.1 p -103.49 146.64 32.86 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.604 0.716 . . . . 0.0 111.169 -171.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.73 146.87 30.61 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.747 2.298 . . . . 0.0 112.354 -177.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -108.08 116.09 31.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.55 -35.86 61.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.18 95.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -70.03 -38.23 75.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.855 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -54.92 -48.03 73.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.02 -36.39 83.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.85 -20.09 58.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -104.02 -103.36 0.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -173.137 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 46.2 t80 -166.82 134.56 2.1 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.649 0.738 . . . . 0.0 110.883 -172.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 68.0 Cg_exo -52.29 -39.71 71.79 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.738 2.292 . . . . 0.0 112.393 -170.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -77.76 -30.62 51.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.96 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.3 m -69.63 -48.94 58.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 -165.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.47 ' HA ' HG23 ' A' ' 97' ' ' VAL . 53.8 p-90 -66.23 -28.74 68.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.888 178.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -71.33 -37.48 71.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.813 175.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.86 -25.1 64.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.119 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.541 HG21 HD23 ' A' ' 103' ' ' LEU . 21.5 m -101.16 16.36 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.135 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.47 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 67.9 ttt180 -101.52 132.58 47.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -148.15 130.56 15.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.1 t30 68.61 36.43 2.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.16 -4.6 66.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.464 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -140.04 164.34 30.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.853 0.359 . . . . 0.0 110.885 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.541 HD23 HG21 ' A' ' 97' ' ' VAL . 12.9 mt -73.83 146.49 44.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 -175.938 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.428 ' C ' HD13 ' A' ' 104' ' ' ILE . 2.0 pp -122.48 8.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.138 174.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.768 ' HB2' ' HB3' ' A' ' 263' ' ' SER . . . -168.45 158.54 9.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.02 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -125.15 151.24 69.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.722 0.773 . . . . 0.0 110.96 164.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.422 ' HB3' HG11 ' A' ' 261' ' ' VAL . 59.3 Cg_endo -72.39 121.1 7.18 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.648 2.232 . . . . 0.0 112.384 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.576 HG13 ' CE2' ' A' ' 61' ' ' PHE . 24.6 mm -98.1 -32.84 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.089 176.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.41 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -157.02 153.35 27.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 -177.304 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.1 t -117.51 133.76 63.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.14 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -119.5 129.24 54.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.934 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -149.84 158.82 44.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.748 HD21 ' HA3' ' A' ' 228' ' ' GLY . 59.3 mt -99.61 158.37 15.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.042 -173.227 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.0 p -153.53 160.01 42.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.872 HD13 ' O ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.8 124.16 44.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.955 175.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.622 ' N ' HD23 ' A' ' 115' ' ' LEU . 4.3 mp -106.28 133.71 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.163 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -133.15 147.77 52.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.957 -176.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -97.6 115.6 28.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.63 -16.37 63.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.526 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 21.5 t70 -80.16 -33.78 38.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.6 mp -88.67 -45.34 9.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.942 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.542 HD23 ' HB2' ' A' ' 223' ' ' ALA . 3.0 mp -108.47 130.88 22.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.537 0.684 . . . . 0.0 110.894 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.44 -30.5 15.2 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.677 2.251 . . . . 0.0 112.345 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -153.87 89.93 3.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.56 0.695 . . . . 0.0 110.973 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.485 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 51.1 Cg_exo -58.21 139.56 90.95 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.678 2.252 . . . . 0.0 112.383 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 125' ' ' PRO . 62.6 Cg_exo -54.98 146.53 57.24 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.245 . . . . 0.0 112.327 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -100.65 -0.82 36.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 176.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.9 p -132.95 157.06 46.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.04 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -71.36 -25.32 62.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.967 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -66.36 -35.54 80.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -172.218 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -83.42 -9.98 58.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.618 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 47.0 mm -58.99 -52.64 73.42 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.628 0.728 . . . . 0.0 111.219 -172.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.618 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 28.6 Cg_endo -61.03 -38.85 64.98 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.737 2.291 . . . . 0.0 112.31 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.88 -60.51 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 1.184 HD23 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.53 -17.03 64.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -175.364 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.641 ' HA ' HD23 ' A' ' 139' ' ' LEU . 38.7 t70 -60.9 -38.47 85.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 168.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.81 -37.18 85.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.945 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.91 -49.72 23.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.674 HD21 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -75.14 -16.98 60.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -176.592 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.674 ' N ' HD21 ' A' ' 139' ' ' LEU . 87.6 tttt -57.46 -34.97 69.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.961 171.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.0 -24.53 67.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.121 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.8 7.89 44.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.87 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.01 28.62 62.11 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.509 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.441 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 46.9 mtmt -117.79 168.61 10.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.391 . . . . 0.0 110.821 174.301 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.9 t -129.46 137.38 50.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.82 176.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.455 ' HB3' ' HA ' ' A' ' 136' ' ' ASP . . . -70.06 -57.67 4.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.087 -165.181 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -137.53 126.82 24.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.954 -167.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 92.7 mmm -103.25 126.16 50.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.809 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -155.65 165.04 37.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -126.22 144.21 50.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.905 171.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.478 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 48.3 tp -113.44 -2.59 13.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 -175.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -69.39 -10.06 56.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.26 151.74 51.45 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 121.704 0.764 . . . . 0.0 110.811 -175.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.535 ' HD3' ' HD2' ' A' ' 344' ' ' ARG . 30.4 Cg_endo -66.05 -18.5 56.86 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.634 2.223 . . . . 0.0 112.389 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -59.63 -39.49 84.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.957 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -83.76 -38.38 21.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.864 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.4 p -64.19 -38.89 92.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.121 -173.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.566 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 11.0 t-105 -63.6 -54.23 44.65 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.556 0.694 . . . . 0.0 110.943 -170.479 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.566 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 33.3 Cg_endo -68.48 -32.07 25.98 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.729 2.286 . . . . 0.0 112.385 -172.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.638 ' C ' HD21 ' A' ' 160' ' ' LEU . 7.1 tt -74.51 -40.78 61.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.639 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 75.9 mt -68.28 -40.16 82.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.141 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.54 -27.09 63.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.069 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.35 -33.02 70.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.024 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . 0.536 ' HA ' ' HD3' ' A' ' 251' ' ' LYS . 66.0 m-20 -91.3 -9.0 46.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.837 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.52 3.37 9.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.511 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.63 66.53 3.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.406 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -90.0 151.26 21.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 110.968 -174.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.491 ' HB1' ' SD ' ' A' ' 336' ' ' MET . . . -76.42 -6.89 53.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.003 -176.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -155.0 155.04 33.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.974 0.416 . . . . 0.0 110.873 -173.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -98.91 129.3 45.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 156.536 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -95.69 124.06 39.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -149.97 129.81 13.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.3 t30 57.1 44.98 21.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.908 171.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.41 7.82 73.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.408 172.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -132.91 140.92 48.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.831 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.427 ' N ' ' HD1' ' A' ' 176' ' ' TYR . 3.4 m-30 -79.29 132.94 36.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.991 166.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -94.12 105.01 17.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.6 tp -67.0 -19.23 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -95.13 -7.35 39.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -135.15 96.01 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.805 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.479 HG21 HG23 ' A' ' 183' ' ' VAL . 32.6 m -116.91 172.38 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -102.52 14.69 56.45 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.516 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.552 HG22 ' CD1' ' A' ' 368' ' ' ILE . 17.6 m -100.1 -17.05 6.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.83 0.347 . . . . 0.0 111.126 -175.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.498 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 57.9 p-10 -96.62 19.74 11.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.015 175.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -116.04 173.68 6.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.898 -174.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.39 -27.6 69.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.102 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.67 -40.27 90.31 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.551 -170.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.597 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -65.46 -41.19 93.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 111.041 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.51 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 91.9 mttt -60.8 -36.4 78.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.889 173.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.3 -37.05 86.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.01 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.639 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.51 -47.18 86.75 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.42 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.606 HD11 ' HA ' ' A' ' 347' ' ' VAL . 15.9 tp -68.19 -31.24 70.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.913 0.387 . . . . 0.0 110.99 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.437 ' O ' HG12 ' A' ' 196' ' ' VAL . 84.8 m -64.53 -42.87 95.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.04 176.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -67.05 -57.52 6.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.876 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.617 ' C ' HD12 ' A' ' 195' ' ' LEU . 3.6 pp -63.19 -27.8 69.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.926 -167.523 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.575 ' N ' HD12 ' A' ' 195' ' ' LEU . 1.3 p -74.27 -22.21 17.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.135 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -65.57 -58.34 6.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 1.018 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.66 -22.37 56.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -167.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.806 ' N ' HD23 ' A' ' 198' ' ' LEU . 2.2 pp -80.92 -33.53 13.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 172.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.38 -33.02 74.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 169.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -84.48 4.81 30.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.862 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 66.4 39.98 3.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -82.3 -11.17 58.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 172.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.5 ' CG ' HG22 ' A' ' 199' ' ' ILE . 5.1 ppp? -140.14 153.18 46.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 175.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -97.05 157.5 15.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 -177.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.21 -24.28 67.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.147 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -94.85 -1.81 52.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.1 m -64.02 131.7 48.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.204 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -149.25 174.22 12.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -177.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -79.76 -31.43 40.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.833 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 94.8 p -71.72 -39.46 70.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.871 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 36.6 pt -66.37 -22.28 29.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.135 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.65 -30.01 71.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.069 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -57.46 -44.02 84.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.847 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.02 -36.36 84.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.106 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.95 -36.44 81.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.097 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -64.09 -42.42 96.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -64.89 -33.79 76.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -89.18 -22.31 22.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.42 29.92 23.36 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.508 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.19 -30.12 16.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.383 . . . . 0.0 110.945 -171.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 52.8 m -110.08 125.35 52.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.093 -170.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.542 ' HB2' HD23 ' A' ' 122' ' ' LEU . . . -71.16 -48.97 48.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.149 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.424 ' HA ' ' O ' ' A' ' 116' ' ' ILE . 68.5 mtm -133.55 146.65 51.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -172.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.409 HG23 ' N ' ' A' ' 226' ' ' ILE . 80.7 m -145.01 152.37 40.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.126 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . 0.409 ' N ' HG23 ' A' ' 225' ' ' THR . 40.6 mm -111.52 120.33 61.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -161.87 170.52 19.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.798 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.748 ' HA3' HD21 ' A' ' 113' ' ' LEU . . . -130.26 -107.54 1.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.488 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.51 -16.48 42.96 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.728 2.285 . . . . 0.0 112.288 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -66.94 -30.03 70.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 54.02 49.59 18.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -66.1 -27.75 68.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.8 m -65.08 142.8 58.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 -175.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -100.0 -175.27 2.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 174.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.2 mt 59.96 74.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.163 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -54.72 -46.85 74.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 52.8 p -85.59 175.82 8.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.154 -174.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 96.3 p -75.66 -6.09 48.75 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.88 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -59.68 167.6 2.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.888 177.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.523 ' O ' HG12 ' A' ' 240' ' ' VAL . 12.6 t 55.0 38.63 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 -173.906 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 70.1 m-20 45.03 69.8 0.4 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -127.57 132.68 49.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.927 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.37 157.86 23.74 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.474 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.442 HG21 HG13 ' A' ' 116' ' ' ILE . 2.5 p -143.15 140.01 26.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.959 0.409 . . . . 0.0 111.067 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.3 t -153.93 150.11 27.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.561 HG11 ' HB2' ' A' ' 323' ' ' ASN . 31.3 m -61.92 168.87 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.626 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.9 mm? -61.15 145.4 89.91 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.742 0.782 . . . . 0.0 110.837 -160.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.37 -177.01 2.75 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.76 2.306 . . . . 0.0 112.392 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 63.6 p -109.14 160.05 16.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.03 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -145.26 128.24 16.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.865 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . 0.676 ' HG2' ' O ' ' A' ' 251' ' ' LYS . 81.0 tttt 55.49 36.04 26.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 -177.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.06 8.36 82.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.536 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -134.68 139.37 32.23 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.58 0.705 . . . . 0.0 110.98 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.6 142.61 29.43 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.693 2.262 . . . . 0.0 112.343 -175.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.626 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 89.5 p -83.51 -5.02 59.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 169.502 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -41.95 125.69 2.6 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.522 0.677 . . . . 0.0 111.025 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.689 ' HG3' ' HB2' ' A' ' 113' ' ' LEU . 84.4 Cg_endo -86.94 164.91 8.78 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.704 2.269 . . . . 0.0 112.319 -174.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -75.01 170.03 16.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 175.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.428 HG22 ' HA ' ' A' ' 324' ' ' ALA . 99.0 t -103.87 134.98 43.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.106 -170.072 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.54 140.69 15.47 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.536 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.422 HG11 ' HB3' ' A' ' 107' ' ' PRO . 90.4 t -126.64 126.94 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.868 0.366 . . . . 0.0 111.133 -176.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.433 HD21 ' N ' ' A' ' 263' ' ' SER . 2.0 tt -70.07 130.6 42.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.923 166.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.768 ' HB3' ' HB2' ' A' ' 105' ' ' ALA . 67.7 m -119.04 149.21 42.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.811 -175.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -133.81 139.62 46.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.087 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.505 ' HA3' ' HH2' ' A' ' 62' ' ' TRP . . . -142.31 171.52 24.61 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.508 -175.737 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 30.8 mm -113.33 130.39 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 111.089 -171.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -69.29 132.63 46.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.711 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -65.61 -24.99 67.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.048 -176.24 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.73 -11.96 58.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 -171.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.7 t -70.45 120.04 76.14 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.67 0.748 . . . . 0.0 110.929 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.72 -15.72 21.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.721 2.28 . . . . 0.0 112.305 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -114.74 30.93 7.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -61.67 -24.36 66.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -168.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -64.07 -40.55 96.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.798 -169.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.6 pp -78.81 -32.17 46.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.494 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -65.13 -45.9 83.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.018 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -69.53 -33.3 72.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.919 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.88 -50.06 73.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -172.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.482 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 1.9 p90 -68.64 -33.59 74.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 -176.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.428 ' C ' HD21 ' A' ' 280' ' ' LEU . 8.4 tt -62.66 -47.62 82.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.901 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.4 -39.52 67.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -99.93 -12.73 19.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -161.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.516 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 69.5 t80 -123.73 -51.33 1.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.421 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 2.1 mp -67.3 -46.01 74.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.849 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.34 48.75 1.32 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 169.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.449 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 80.5 m -146.47 145.27 30.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.194 176.233 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.452 ' HA ' HD11 ' A' ' 290' ' ' LEU . 49.5 t0 -42.57 -35.03 0.97 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.842 -175.788 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -74.69 -43.64 54.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.847 -174.221 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.97 -52.04 9.63 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.453 -171.015 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.695 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.7 OUTLIER -72.05 -22.54 61.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.336 . . . . 0.0 110.943 -177.869 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.52 ' N ' HD12 ' A' ' 290' ' ' LEU . 86.5 tt0 -67.13 -41.37 86.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 169.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.59 84.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.069 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.718 HG13 ' HA3' ' A' ' 19' ' ' GLY . 46.4 t -75.66 -45.54 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 -178.403 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -65.31 -35.09 79.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.98 -32.15 73.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 -173.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.77 ' HB3' ' HB3' ' A' ' 18' ' ' ASN . 63.8 m-20 -99.77 -35.19 9.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 -174.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.443 ' O ' HD13 ' A' ' 299' ' ' LEU . 46.9 tptt -129.11 124.45 22.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.563 0.697 . . . . 0.0 110.947 170.018 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -52.3 108.02 0.22 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.743 2.295 . . . . 0.0 112.281 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.443 HD13 ' O ' ' A' ' 297' ' ' LYS . 2.2 mp -92.26 -28.67 16.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 175.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.1 -55.9 1.81 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.466 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -174.27 168.53 3.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.0 111.094 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.591 ' CG2' ' HB3' ' A' ' 307' ' ' TYR . 32.2 m -135.0 161.84 39.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.126 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.44 -10.19 59.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.027 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.695 ' CD2' HD22 ' A' ' 290' ' ' LEU . 61.2 tp -79.75 129.43 34.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.866 -174.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -42.99 -31.93 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.899 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.436 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 70.6 m -47.83 -38.77 16.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.846 175.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.591 ' HB3' ' CG2' ' A' ' 302' ' ' VAL . 0.1 OUTLIER -58.99 -45.62 90.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.918 173.303 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.48 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 88.1 tt0 -56.96 -37.71 71.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.855 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -79.91 -64.1 1.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.833 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -85.01 -58.89 2.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -171.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 307' ' ' TYR . 56.0 mt -62.66 -32.62 73.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -168.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.1 -12.78 54.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.057 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.95 -18.31 64.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.838 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.515 ' HB3' HD13 ' A' ' 317' ' ' ILE . 58.2 t0 -78.88 121.23 83.18 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.616 0.722 . . . . 0.0 110.819 167.734 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.85 -36.4 15.19 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.647 2.231 . . . . 0.0 112.327 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 94.7 mtm-85 -73.12 -36.5 66.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.515 HD13 ' HB3' ' A' ' 314' ' ' ASP . 74.3 mt -77.07 -29.98 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.41 91.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.085 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.98 -48.56 73.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.076 175.373 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 68.9 p -67.58 -26.55 66.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.082 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 63.8 ttp -58.31 -37.28 74.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.866 173.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -67.36 -45.07 77.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.806 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.561 ' HB2' HG11 ' A' ' 246' ' ' VAL . 29.8 t30 -63.49 -36.53 84.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 176.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.428 ' HA ' HG22 ' A' ' 259' ' ' VAL . . . -65.03 -47.56 76.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.032 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -71.48 -34.17 69.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.7 -3.7 42.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.938 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -106.17 -162.25 22.74 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.465 -174.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.68 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 94.9 mt-10 -143.64 139.93 29.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.838 0.351 . . . . 0.0 110.779 -171.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.587 ' O ' ' C ' ' A' ' 330' ' ' MET . 41.2 mm -81.32 112.78 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.148 -172.287 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.587 ' C ' ' O ' ' A' ' 329' ' ' ILE . 71.6 mtm 23.89 56.68 0.31 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.583 0.706 . . . . 0.0 110.823 174.369 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.68 ' HG3' ' HB3' ' A' ' 328' ' ' GLU . 42.8 Cg_endo -96.59 -7.3 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.658 2.239 . . . . 0.0 112.339 -169.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.604 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 90.2 m-20 -95.0 2.05 55.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.941 -155.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.622 HG22 ' H ' ' A' ' 335' ' ' GLN . 45.7 mm 87.56 133.23 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.62 0.724 . . . . 0.0 111.128 173.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.07 -22.48 73.4 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.686 2.257 . . . . 0.0 112.396 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.622 ' H ' HG22 ' A' ' 333' ' ' ILE . 99.2 mm-40 -60.65 -17.72 49.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.491 ' SD ' ' HB1' ' A' ' 168' ' ' ALA . 37.6 mmt -62.2 -26.04 68.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 -174.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.5 m -57.92 -36.86 73.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.814 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.59 -36.68 73.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.55 ' O ' HG13 ' A' ' 343' ' ' VAL . 45.5 m-85 -65.25 -44.23 88.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.814 174.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -64.96 -39.25 93.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.925 -176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -67.6 -47.39 69.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.72 -42.42 97.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 339' ' ' PHE . 7.7 m -80.98 -23.08 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.535 ' HD2' ' HD3' ' A' ' 154' ' ' PRO . 57.6 ttt180 -57.41 -56.56 20.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 81.5 p -60.68 -25.69 66.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.066 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -60.08 -41.13 91.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.606 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.5 m -73.11 -32.95 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.061 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . 0.406 HD13 HG21 ' A' ' 347' ' ' VAL . 1.6 mp -64.05 -45.24 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 173.539 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -64.35 -36.17 83.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.61 -46.15 60.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.113 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.38 88.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 -175.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 92.8 p -74.98 -10.79 59.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.904 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.4 15.02 81.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.549 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.85 -31.79 45.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.71 0.29 . . . . 0.0 110.761 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -138.25 154.78 49.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.895 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.7 p -79.73 167.53 20.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.184 169.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.439 ' HA ' HD21 ' A' ' 192' ' ' LEU . 55.6 t -54.98 -42.04 61.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -59.11 -46.43 88.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 177.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -71.7 -53.22 14.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.81 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -67.99 -43.75 78.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -171.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.597 HD11 ' HB1' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -67.54 -40.71 84.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 -178.58 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.82 -39.69 93.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 173.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.2 -38.9 90.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.865 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.53 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -63.44 -42.24 98.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 173.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.498 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 23.3 tm0? -64.47 -36.83 85.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.052 0.453 . . . . 0.0 110.885 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 370' ' ' LYS . 93.2 m -67.01 -40.44 87.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 177.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -67.51 -35.02 78.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.847 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.552 ' CD1' HG22 ' A' ' 183' ' ' VAL . 62.2 mt -63.38 -40.13 87.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.079 0.466 . . . . 0.0 111.229 176.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.8 p -93.81 -10.92 32.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.174 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 366' ' ' THR . 99.6 mttt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.9 mt -85.9 132.19 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -135.4 143.97 46.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.934 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -55.67 134.13 51.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.448 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 94.94 2.01 62.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.519 -176.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.5 tttt -164.97 138.2 4.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.947 0.403 . . . . 0.0 110.851 174.308 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.558 HD22 HG12 ' A' ' 35' ' ' VAL . 0.7 OUTLIER -146.68 157.4 43.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.823 -173.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.477 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 86.6 t -114.5 133.47 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 -177.287 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.843 HD11 HD11 ' A' ' 20' ' ' LEU . 1.3 mp -119.28 125.81 74.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.606 ' CE3' ' HG3' ' A' ' 57' ' ' PRO . 45.1 m0 -106.02 128.97 54.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 178.202 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.427 HG22 ' O ' ' A' ' 12' ' ' ASN . 68.0 mt -122.1 141.45 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.168 172.223 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.427 ' O ' HG22 ' A' ' 11' ' ' ILE . 65.0 t30 -49.19 141.77 7.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 172.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.519 ' HA3' ' OD2' ' A' ' 41' ' ' ASP . . . -57.72 -11.14 7.32 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 -172.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -71.93 -17.07 62.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 110.868 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -129.92 111.2 12.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 161.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.98 -90.47 0.83 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.504 -159.472 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -101.71 -41.65 6.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.833 -172.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.791 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 85.2 m-20 -63.56 -53.58 49.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.804 -156.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.733 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -59.86 -48.07 87.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.503 -175.326 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.843 HD11 HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -55.35 -60.97 2.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.0 110.914 175.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.21 -41.37 60.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -176.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -65.17 -54.24 32.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.65 -35.7 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.444 ' HA3' HG22 ' A' ' 35' ' ' VAL . . . -65.04 -41.88 96.98 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 176.458 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.01 -41.26 82.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 110.892 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -64.39 -39.62 94.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.26 -45.81 89.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.953 178.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -68.44 -38.97 81.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.806 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.38 -37.05 82.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -82.1 -39.27 23.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -169.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.547 ' OG1' HG13 ' A' ' 33' ' ' ILE . 71.2 p -109.94 -11.17 14.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.178 -174.598 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.44 14.04 82.59 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.462 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 1.133 HD13 ' O ' ' A' ' 33' ' ' ILE . 2.0 pp -104.82 125.09 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.926 0.393 . . . . 0.0 111.029 -177.014 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.3 mttt -71.61 135.93 47.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 -168.31 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.558 HG12 HD22 ' A' ' 7' ' ' LEU . 8.4 m -110.7 135.45 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.046 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.415 ' HB ' HG23 ' A' ' 8' ' ' VAL . 97.7 m -107.62 128.54 54.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.186 176.802 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.549 HG23 ' HG ' ' A' ' 20' ' ' LEU . 71.0 t -96.76 120.79 46.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.585 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 68.3 mm-40 -130.53 144.62 51.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.841 172.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -156.71 58.61 1.66 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.543 0.687 . . . . 0.0 110.79 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 77.6 Cg_endo -81.84 -13.23 10.6 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.719 2.28 . . . . 0.0 112.382 -171.01 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.519 ' OD2' ' HA3' ' A' ' 13' ' ' GLY . 20.8 m-20 63.06 20.05 12.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -171.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 45' ' ' GLU . 98.0 mttt -91.06 0.96 57.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 174.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.2 mt -43.69 -50.15 7.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -170.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.16 -36.56 82.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 42' ' ' LYS . 99.1 mt-10 -74.96 -33.17 61.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.424 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 69.8 mmtt -82.57 -29.98 29.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.936 -175.204 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.522 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 11.6 m-30 -40.18 -56.01 3.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.626 0.727 . . . . 0.0 110.783 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.522 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 57.3 Cg_endo -69.13 -28.09 28.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.313 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -79.08 -43.62 23.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 -172.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.8 m -65.69 -30.6 50.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.75 -36.04 79.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 172.398 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.13 -31.25 68.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.966 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 p -93.02 -11.45 33.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.112 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.47 15.27 81.32 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.469 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -164.86 159.05 17.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.953 0.406 . . . . 0.0 110.812 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.7 -140.33 2.85 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.321 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.606 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 72.6 Cg_endo -67.8 148.57 77.33 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.664 2.243 . . . . 0.0 112.354 168.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -74.32 -39.07 63.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.65 ' HB ' HG23 ' A' ' 9' ' ' ILE . 3.7 mp -126.13 138.71 53.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 176.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.475 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 1.8 tp -131.39 130.06 62.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.09 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.524 ' CE2' HG13 ' A' ' 108' ' ' ILE . 4.3 m-85 -98.63 140.31 33.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.785 176.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.536 ' CH2' ' HA3' ' A' ' 265' ' ' GLY . 9.1 m-90 -116.99 140.09 49.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 262' ' ' LEU . . . -57.99 -82.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.129 -176.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -126.41 -58.21 1.35 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.989 166.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -86.11 -24.35 26.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.807 -167.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.499 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 97.0 mtt180 -59.87 -29.72 68.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.981 -160.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -68.08 -27.68 66.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.923 -170.65 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.32 -51.36 53.22 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.434 -172.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.7 -35.91 91.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.537 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.456 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 15.2 t80 -65.68 -38.12 88.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.866 0.365 . . . . 0.0 110.887 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.51 -44.03 58.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.085 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -62.39 -31.78 72.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -80.87 -11.95 59.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.99 176.055 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.8 32.08 64.24 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.515 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.413 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 1.8 mp -86.3 -3.04 58.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.829 0.347 . . . . 0.0 110.862 -172.63 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.55 ' C ' ' HB3' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -127.85 154.38 45.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 -177.381 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.643 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -73.94 136.86 43.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.127 175.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -71.02 131.37 43.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.903 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.477 HD13 ' CE2' ' A' ' 106' ' ' TYR . 33.6 pt -110.19 159.76 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 70.1 p -105.87 147.6 35.03 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.663 0.744 . . . . 0.0 111.087 -172.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.76 145.78 29.3 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.689 2.259 . . . . 0.0 112.301 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -112.96 112.03 23.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 170.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.58 -37.4 62.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.947 -178.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.95 94.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.559 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 18.6 m-30 -68.8 -49.51 57.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.822 178.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -53.74 -40.08 65.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.913 -176.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -57.69 -32.29 67.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.07 -15.28 54.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 61.8 mt -105.0 -104.95 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -167.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.416 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 40.6 t80 -165.23 133.94 2.61 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.675 0.75 . . . . 0.0 110.953 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 71.3 Cg_exo -52.89 -39.91 76.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.748 2.299 . . . . 0.0 112.372 -171.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -80.08 -28.13 39.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.0 m -69.92 -48.31 59.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.086 -167.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.493 ' HA ' HG23 ' A' ' 97' ' ' VAL . 53.8 p-90 -66.96 -28.96 68.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.898 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -70.69 -35.97 73.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.74 -25.9 65.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.525 HG21 HD23 ' A' ' 103' ' ' LEU . 19.8 m -101.27 17.71 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.177 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.458 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 67.5 ttt180 -102.56 133.67 47.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.972 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -147.89 130.11 15.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.827 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.6 t30 67.16 35.68 4.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.928 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.78 -4.25 66.09 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.539 174.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -133.96 159.99 39.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.33 . . . . 0.0 110.943 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.525 HD23 HG21 ' A' ' 97' ' ' VAL . 13.8 mt -73.51 144.82 46.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pp -122.17 6.81 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.19 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.693 ' HB2' ' HB3' ' A' ' 263' ' ' SER . . . -167.83 159.3 11.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.051 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.477 ' CE2' HD13 ' A' ' 79' ' ' ILE . 62.1 m-85 -117.25 147.44 40.45 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.689 0.757 . . . . 0.0 110.928 164.064 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.53 ' HB3' HG11 ' A' ' 261' ' ' VAL . 59.6 Cg_endo -72.36 118.09 5.44 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.666 2.244 . . . . 0.0 112.358 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.524 HG13 ' CE2' ' A' ' 61' ' ' PHE . 30.8 mm -96.29 -36.88 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.551 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -151.93 154.67 36.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.083 -176.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.44 134.95 63.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.018 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -118.07 129.76 55.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.432 ' HB1' ' HB ' ' A' ' 320' ' ' THR . . . -150.92 157.12 42.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.113 177.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.645 ' HB2' ' HG3' ' A' ' 257' ' ' PRO . 7.4 mp -108.49 156.92 18.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 -172.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.1 p -150.39 161.19 42.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.929 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.905 HD13 ' O ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.22 124.3 44.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 175.922 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.727 HG13 HG21 ' A' ' 244' ' ' VAL . 4.6 mp -109.0 132.76 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.072 -174.605 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -133.08 148.28 52.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 -173.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -97.4 115.91 28.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.806 174.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -66.55 -15.84 63.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.781 172.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.556 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 22.8 t70 -80.87 -33.99 34.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.885 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 mp -87.9 -45.0 10.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.041 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.454 HD23 ' HB2' ' A' ' 223' ' ' ALA . 2.1 mp -106.08 127.62 27.97 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.545 0.688 . . . . 0.0 110.897 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.31 -30.09 16.14 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.732 2.288 . . . . 0.0 112.343 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -148.9 90.0 4.85 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.61 0.719 . . . . 0.0 110.944 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.51 144.97 90.84 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.668 2.245 . . . . 0.0 112.351 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.58 153.31 73.82 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.689 2.26 . . . . 0.0 112.336 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -107.72 -3.96 18.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.847 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.6 p -133.94 159.02 42.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.148 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.44 ' HA ' HG12 ' A' ' 132' ' ' ILE . 64.4 m95 -72.2 -24.65 61.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.4 -30.02 70.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.05 -19.31 60.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.85 -177.471 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.61 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 49.8 mm -61.49 -53.52 61.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.716 0.769 . . . . 0.0 111.138 -165.346 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 22.6 Cg_endo -61.7 -40.03 48.91 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.635 2.223 . . . . 0.0 112.276 -176.233 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.24 -60.67 2.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.065 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 1.185 HD23 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.52 -16.5 63.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.862 -174.462 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.643 ' HA ' HD23 ' A' ' 139' ' ' LEU . 38.7 t70 -61.74 -38.9 89.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.848 168.163 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.87 -36.44 82.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -73.6 -49.79 24.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.726 -174.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.67 HD21 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -74.97 -15.94 60.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -176.654 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.67 ' N ' HD21 ' A' ' 139' ' ' LEU . 87.8 tttt -56.43 -34.92 67.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.928 171.148 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.99 -23.75 67.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -94.32 7.99 43.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.95 27.41 64.6 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.415 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.43 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 45.5 mtmt -119.94 169.5 10.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.4 . . . . 0.0 110.863 173.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.535 ' HA ' HD22 ' A' ' 139' ' ' LEU . 33.5 t -133.1 143.95 49.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 172.065 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 224' ' ' MET . . . -71.98 -54.12 10.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.101 -162.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -139.65 125.47 19.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.948 -165.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.427 ' SD ' ' HB3' ' A' ' 213' ' ' ALA . 57.6 ttm -106.28 129.22 54.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.891 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -154.71 164.24 39.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -122.81 142.92 50.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.942 171.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.5 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 50.8 tp -111.4 -0.13 16.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 -176.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -74.17 -6.04 45.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.936 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -119.73 150.18 49.85 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 121.679 0.752 . . . . 0.0 110.905 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.54 -18.82 64.13 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.632 2.221 . . . . 0.0 112.417 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -61.75 -37.21 83.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.927 -173.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -82.89 -40.17 20.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 23.6 p -63.77 -38.66 91.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.101 -175.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.586 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 22.2 t-105 -62.98 -54.44 46.56 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.567 0.699 . . . . 0.0 110.911 -168.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.586 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 28.5 Cg_endo -66.87 -32.19 36.75 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.696 2.264 . . . . 0.0 112.37 -172.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.71 HD21 ' O ' ' A' ' 160' ' ' LEU . 6.4 tt -74.69 -41.04 60.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.55 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 74.4 mt -70.48 -40.89 77.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.109 177.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.96 -26.14 63.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.45 -29.46 70.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.126 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -91.29 2.75 56.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 104.99 7.05 39.05 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.56 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.536 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -79.02 65.06 3.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.359 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -90.22 146.2 24.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.863 0.363 . . . . 0.0 110.911 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.42 -15.35 63.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.063 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -164.42 150.07 10.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.841 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -81.74 128.18 33.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.937 163.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -100.79 120.5 40.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.921 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -149.72 133.2 16.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.881 -173.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 61.9 t30 57.51 43.42 22.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.04 7.25 70.47 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.499 173.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -134.9 145.29 48.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.785 0.326 . . . . 0.0 110.888 -177.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -78.66 143.24 36.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 168.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -107.18 105.98 16.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.8 tp -71.28 -18.03 20.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.14 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -94.61 -8.99 36.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -177.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -129.56 93.05 3.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 172.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.9 m -114.01 167.62 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.128 -175.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.58 13.35 54.09 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.486 -171.441 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.521 HG11 ' CD1' ' A' ' 368' ' ' ILE . 33.7 m -104.85 -16.91 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.318 . . . . 0.0 111.096 -173.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.43 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 57.9 p-10 -95.09 18.07 12.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.934 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -115.91 172.86 6.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.88 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.21 -26.71 68.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.209 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.11 -41.28 92.68 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.526 -170.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.635 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -65.08 -40.6 94.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 111.02 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.502 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.1 mttt -60.83 -37.1 80.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 173.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.5 87.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.121 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.55 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.72 -46.02 91.06 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.421 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.605 HD11 ' HA ' ' A' ' 347' ' ' VAL . 22.6 tp -68.64 -34.8 76.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.922 0.391 . . . . 0.0 110.993 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.414 ' O ' HG12 ' A' ' 196' ' ' VAL . 85.4 m -61.83 -42.26 98.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -68.07 -56.99 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.681 ' C ' HD12 ' A' ' 195' ' ' LEU . 2.6 pp -63.64 -27.5 69.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 -165.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.56 ' N ' HD12 ' A' ' 195' ' ' LEU . 4.5 p -72.65 -22.85 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.182 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -66.03 -58.22 5.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -174.096 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 1.04 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.5 -24.25 56.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -167.474 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.809 ' N ' HD23 ' A' ' 198' ' ' LEU . 2.0 pp -77.46 -35.64 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.15 172.432 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.02 -30.36 70.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.8 168.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -84.65 5.37 28.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.878 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 66.07 40.06 4.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.94 170.209 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -82.12 -10.54 59.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.51 ' CG ' HG22 ' A' ' 199' ' ' ILE . 5.4 ppp? -141.08 154.26 45.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.848 175.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -99.0 156.13 17.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.89 -24.88 68.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.132 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.83 -2.59 50.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 88.7 m -64.38 131.49 47.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.227 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -147.23 173.39 12.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.926 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -78.66 -32.09 47.03 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.899 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 99.1 p -74.13 -38.84 63.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -172.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 39.5 pt -65.04 -20.11 26.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.105 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.436 ' HB2' HG22 ' A' ' 225' ' ' THR . . . -58.42 -32.45 68.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.19 -43.53 87.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.834 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.04 -36.82 85.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.147 174.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.1 79.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.065 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -65.08 -42.46 94.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.895 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -64.95 -33.94 77.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.896 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -92.51 -24.36 18.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.05 30.99 21.5 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.568 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -91.83 -31.61 15.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.85 0.357 . . . . 0.0 110.914 -168.96 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 96.9 m -115.89 127.58 55.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.089 -171.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.454 ' HB2' HD23 ' A' ' 122' ' ' LEU . . . -70.71 -44.97 65.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 -175.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.415 ' N ' ' O ' ' A' ' 146' ' ' ALA . 68.1 mtm -134.05 146.98 50.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 -172.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' THR . . . . . 0.436 HG22 ' HB2' ' A' ' 213' ' ' ALA . 43.3 p -140.01 161.64 37.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 177.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.2 mm -112.4 114.85 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.07 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . 0.464 ' HB2' HD11 ' A' ' 116' ' ' ILE . 63.8 m-80 -145.41 153.32 41.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -171.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.471 ' HA3' ' HG ' ' A' ' 113' ' ' LEU . . . -133.56 -123.3 2.38 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.5 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . 0.41 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 30.2 Cg_endo -61.97 -19.95 67.78 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.766 2.311 . . . . 0.0 112.269 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -65.19 -30.08 70.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.925 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 51.12 38.3 20.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.078 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -70.02 -27.87 65.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.046 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 72.7 m -53.22 117.95 3.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.86 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -74.86 -169.05 0.82 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 20.4 mt 57.07 75.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -56.53 -47.6 79.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 -171.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 46.1 p -90.18 178.01 6.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.071 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 95.8 p -76.34 -5.06 45.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.919 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.11 167.9 2.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.876 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 240' ' ' VAL . 15.8 t 54.95 41.82 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.046 -172.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.556 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 74.6 m-20 42.12 70.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -126.0 132.8 51.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 -172.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.97 158.33 24.17 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.508 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.727 HG21 HG13 ' A' ' 116' ' ' ILE . 3.2 p -145.46 139.94 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 0.0 111.156 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.0 t -155.37 151.82 28.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.075 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . 0.498 HG11 ' HB2' ' A' ' 323' ' ' ASN . 28.2 m -62.3 168.4 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.096 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.762 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.7 mm? -61.81 143.37 94.28 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.644 0.735 . . . . 0.0 110.921 -162.198 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.56 -176.52 3.17 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.649 2.233 . . . . 0.0 112.457 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 95.2 m -100.41 146.33 27.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.14 -171.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -139.02 119.12 13.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 54.97 37.13 28.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.96 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.09 -0.46 83.96 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -130.96 140.09 37.62 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.588 0.709 . . . . 0.0 110.914 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -70.93 141.23 39.98 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.669 2.246 . . . . 0.0 112.412 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.762 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 82.7 p -82.39 -3.47 55.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 172.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -40.48 129.69 1.77 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.555 0.693 . . . . 0.0 110.894 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.645 ' HG3' ' HB2' ' A' ' 113' ' ' LEU . 85.8 Cg_endo -86.32 164.82 9.67 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.731 2.287 . . . . 0.0 112.446 -171.462 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -75.0 169.96 16.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.863 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.14 132.29 57.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.114 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.52 143.9 16.23 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.458 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.53 HG11 ' HB3' ' A' ' 107' ' ' PRO . 97.9 t -128.66 126.51 65.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.986 0.422 . . . . 0.0 111.081 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 2.0 tt -71.86 136.34 46.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 171.185 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.693 ' HB3' ' HB2' ' A' ' 105' ' ' ALA . 74.7 m -118.9 148.97 42.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -174.232 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.483 ' HB2' HD11 ' A' ' 280' ' ' LEU . . . -133.78 137.53 45.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 174.151 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.536 ' HA3' ' CH2' ' A' ' 62' ' ' TRP . . . -140.76 170.14 24.61 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.549 -173.493 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 22.7 mm -114.22 132.37 63.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 111.136 -171.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -65.04 133.8 52.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -172.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.643 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -63.0 -29.79 71.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.115 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.38 -8.11 59.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.038 -172.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 24.2 t -69.98 120.14 75.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.698 0.761 . . . . 0.0 110.848 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.42 -16.23 19.41 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.733 2.289 . . . . 0.0 112.362 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.422 ' HB2' HD22 ' A' ' 275' ' ' LEU . 53.2 p-10 -114.16 29.97 7.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -177.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -61.48 -24.55 66.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 -169.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -63.65 -45.58 89.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.851 -169.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.422 HD22 ' HB2' ' A' ' 272' ' ' ASN . 2.2 pp -75.8 -33.28 60.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -178.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.426 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -65.8 -50.24 65.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.056 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -65.95 -36.48 83.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.868 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -68.98 -45.36 70.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -59.08 -47.12 86.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.93 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.483 HD11 ' HB2' ' A' ' 264' ' ' ALA . 8.0 tt -59.54 -52.24 66.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.889 -175.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -73.99 -25.72 60.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.953 -174.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -99.74 -14.18 18.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.942 -170.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.489 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 44.6 t80 -122.2 -56.54 1.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.4 OUTLIER -68.58 -39.69 80.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.854 -176.264 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.84 23.03 0.57 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 174.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 89.1 m -128.51 147.61 50.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.206 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.507 ' HA ' HD11 ' A' ' 290' ' ' LEU . 37.4 t70 -40.78 -38.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.774 -176.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.27 -42.57 68.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.856 -173.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.489 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.51 -52.03 8.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.445 -171.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.678 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -73.41 -21.97 60.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.815 0.34 . . . . 0.0 110.952 -177.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.487 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.4 tt0 -66.71 -42.69 85.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 169.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.93 -35.94 81.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.003 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.733 HG13 ' HA3' ' A' ' 19' ' ' GLY . 42.3 t -75.78 -44.27 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.166 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -65.05 -31.81 73.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.787 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.97 -32.2 72.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.932 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.791 ' HB3' ' HB3' ' A' ' 18' ' ' ASN . 63.7 m-20 -95.02 -29.64 14.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.834 -173.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.439 ' O ' HD13 ' A' ' 299' ' ' LEU . 77.3 tttt -146.1 135.47 11.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.626 0.727 . . . . 0.0 110.854 164.952 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.27 116.78 3.18 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.667 2.245 . . . . 0.0 112.33 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.439 HD13 ' O ' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -90.08 -22.57 21.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 174.829 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.95 -55.79 1.85 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.531 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.441 ' HA ' HD21 ' A' ' 311' ' ' LEU . . . -177.71 161.87 1.7 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.868 0.366 . . . . 0.0 111.191 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.601 ' CG2' ' HB3' ' A' ' 307' ' ' TYR . 33.8 m -128.57 159.93 39.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.153 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.46 -2.07 30.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.678 ' CD2' HD22 ' A' ' 290' ' ' LEU . 60.3 tp -87.94 130.38 34.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 -175.736 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -44.55 -32.42 1.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.478 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 74.4 m -48.16 -39.2 20.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.601 ' HB3' ' CG2' ' A' ' 302' ' ' VAL . 0.1 OUTLIER -58.93 -45.41 90.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 173.477 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.463 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 84.4 tt0 -54.63 -34.34 61.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.808 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -79.85 -63.3 1.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.8 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -82.71 -58.27 2.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -170.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.487 HD12 ' HA ' ' A' ' 311' ' ' LEU . 0.0 OUTLIER -60.14 -36.63 77.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -170.562 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.98 -14.42 53.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.41 -20.46 65.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.505 ' HB3' HD13 ' A' ' 317' ' ' ILE . 60.3 t0 -79.61 120.7 81.05 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.609 0.719 . . . . 0.0 110.921 167.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.68 -35.42 13.02 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.656 2.237 . . . . 0.0 112.351 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -70.81 -36.99 73.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.875 -176.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.505 HD13 ' HB3' ' A' ' 314' ' ' ASP . 70.7 mt -78.46 -30.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.182 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.48 -39.59 91.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.102 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.98 -47.24 78.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.118 174.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' THR . . . . . 0.432 ' HB ' ' HB1' ' A' ' 112' ' ' ALA . 74.1 p -67.55 -25.17 65.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.188 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -62.05 -38.03 87.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 174.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -65.02 -47.05 78.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.821 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.498 ' HB2' HG11 ' A' ' 246' ' ' VAL . 36.9 t30 -63.47 -38.17 90.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.73 -46.94 85.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.095 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -72.82 -30.98 64.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.37 -4.38 42.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.924 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -101.74 -161.78 26.88 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.465 -172.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.731 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 95.4 mt-10 -143.37 140.58 30.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.361 . . . . 0.0 110.825 -172.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.584 ' O ' ' C ' ' A' ' 330' ' ' MET . 44.9 mm -82.51 106.63 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.17 -169.657 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.584 ' C ' ' O ' ' A' ' 329' ' ' ILE . 63.3 tpp 22.88 57.5 0.28 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.636 0.731 . . . . 0.0 110.874 175.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.731 ' HG3' ' HB3' ' A' ' 328' ' ' GLU . 46.2 Cg_endo -94.3 -5.79 2.33 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.67 2.247 . . . . 0.0 112.346 -172.164 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.554 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 74.5 m-20 -100.02 12.55 36.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.917 -158.421 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.554 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 47.9 mm 86.35 132.13 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.634 0.73 . . . . 0.0 111.124 162.081 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.23 -27.67 28.72 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.663 2.242 . . . . 0.0 112.392 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.445 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.7 mt-30 -72.35 -26.23 61.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.926 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' MET . . . . . 0.461 ' CG ' ' HB ' ' A' ' 333' ' ' ILE . 22.8 mmt -77.9 -26.05 48.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 -175.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 62.1 p -65.27 -27.31 68.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.876 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -76.21 -36.06 58.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.168 173.258 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.408 ' N ' ' CD1' ' A' ' 339' ' ' PHE . 7.8 m-30 -61.16 -37.82 84.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.827 170.864 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -62.62 -32.7 73.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.021 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -72.87 -40.52 65.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.92 -40.08 91.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.106 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.46 ' O ' ' HB1' ' A' ' 346' ' ' ALA . 13.2 m -80.33 -24.01 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.142 177.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.564 ' O ' HG23 ' A' ' 347' ' ' VAL . 1.1 tmt_? -59.92 -50.24 74.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 171.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 56.1 m -57.88 -29.94 65.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.084 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.46 ' HB1' ' O ' ' A' ' 343' ' ' VAL . . . -56.33 -39.3 72.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.605 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.0 OUTLIER -72.6 -32.66 42.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 -176.402 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.35 -46.78 92.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.077 172.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -63.2 -34.66 78.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.98 -45.72 59.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.58 -40.51 88.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.155 -175.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.1 p -75.05 -12.08 60.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 110.891 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.16 14.95 82.06 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.579 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.27 -32.43 49.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.815 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -136.77 153.88 50.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.959 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.6 p -79.47 167.82 20.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.192 169.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.455 ' HA ' HD21 ' A' ' 192' ' ' LEU . 54.4 t -55.12 -41.99 62.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 172.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.35 -45.95 89.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.828 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -72.25 -53.18 13.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.831 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.11 -44.65 75.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.031 -171.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.635 HD11 ' HB1' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -66.98 -40.53 87.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.969 -178.142 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.98 -40.45 94.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.954 174.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.38 -39.72 94.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.75 98.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.43 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 16.8 tm0? -63.26 -38.44 91.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.958 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.9 m -65.01 -38.56 91.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.102 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 79.4 mtt-85 -67.25 -35.67 80.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.84 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.521 ' CD1' HG11 ' A' ' 183' ' ' VAL . 73.8 mt -66.47 -45.05 90.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.127 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 71.1 p -99.02 -8.63 25.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.158 -174.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.956 176.27 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.0 mt -82.82 129.93 36.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.159 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.44 143.48 43.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -56.35 134.98 53.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.592 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 97.61 -1.62 60.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.465 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.41 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 65.0 pttt -165.3 144.09 6.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.783 0.325 . . . . 0.0 110.902 172.794 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.545 HD23 HD11 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -148.49 159.97 43.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.792 -175.019 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.417 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 90.3 t -113.78 132.94 61.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.161 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.833 HD11 HD11 ' A' ' 20' ' ' LEU . 1.2 mp -119.32 124.97 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.081 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.582 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 44.2 m0 -104.62 127.1 52.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.894 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -119.4 141.75 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.146 172.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -51.36 147.52 5.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.47 -12.8 9.69 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.501 -172.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -75.17 -17.05 60.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.856 0.36 . . . . 0.0 110.813 -174.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.1 mtmm -129.94 110.09 11.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 163.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.09 -91.53 0.81 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.443 -160.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -101.81 -42.37 6.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 110.856 -171.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . 0.777 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 86.0 m-20 -61.86 -52.08 65.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.843 -157.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.763 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -61.99 -48.55 82.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.516 -175.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.833 HD11 HD11 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -56.52 -61.2 2.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.879 0.371 . . . . 0.0 110.922 177.824 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.66 -41.38 70.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 -174.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -65.05 -53.11 50.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -176.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 19' ' ' GLY . 18.7 m -74.89 -38.06 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.162 -175.768 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.633 ' HA3' HG22 ' A' ' 35' ' ' VAL . . . -65.12 -42.47 96.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.527 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.34 -41.33 88.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 110.927 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -63.21 -39.6 95.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.853 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -66.18 -36.95 84.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.839 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -62.12 -39.91 94.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 172.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -67.82 -33.98 75.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.911 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -86.76 -41.78 13.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -170.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.631 ' OG1' HG13 ' A' ' 33' ' ' ILE . 77.0 p -106.8 -14.86 14.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.212 -174.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.75 8.93 83.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.503 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.964 HD13 ' O ' ' A' ' 33' ' ' ILE . 2.2 pp -106.35 130.41 58.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 111.093 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.41 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.9 mttt -75.95 139.78 41.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -171.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.633 HG22 ' HA3' ' A' ' 24' ' ' GLY . 5.8 m -112.36 135.81 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.41 ' O ' HD13 ' A' ' 9' ' ' ILE . 99.3 m -105.93 128.31 53.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.083 176.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.549 HG23 ' HG ' ' A' ' 20' ' ' LEU . 80.9 t -96.57 120.0 45.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.105 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.582 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 68.3 mm-40 -130.31 145.2 51.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.891 171.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -156.1 58.3 1.71 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.599 0.714 . . . . 0.0 110.87 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.95 -27.43 5.8 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.762 2.308 . . . . 0.0 112.343 -172.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.0 t0 68.87 13.19 8.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.863 -167.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 45' ' ' GLU . 99.1 mttt -87.84 1.56 53.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.988 171.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.3 mt -44.37 -50.14 9.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.948 -168.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.9 -27.56 67.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 42' ' ' LYS . 98.3 mt-10 -79.01 -32.45 45.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.882 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.411 ' HA ' ' HD3' ' A' ' 46' ' ' LYS . 67.9 mmtt -81.84 -29.27 32.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.868 -174.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.548 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 14.4 m-30 -45.26 -54.4 14.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.635 0.731 . . . . 0.0 110.852 -175.248 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 53.1 Cg_endo -66.4 -27.3 47.3 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.656 2.237 . . . . 0.0 112.336 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -79.4 -42.98 24.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.915 -175.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.3 m -71.62 -28.03 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.106 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.23 -35.2 79.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.109 171.101 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.35 -31.99 71.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.132 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.9 p -92.47 -12.11 32.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.96 14.97 81.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.609 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -161.9 157.14 23.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.891 0.377 . . . . 0.0 110.842 176.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.44 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . -165.04 -141.08 3.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.437 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.558 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 69.9 Cg_endo -66.97 149.78 82.87 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.622 2.214 . . . . 0.0 112.376 169.8 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -75.49 -38.45 59.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.574 ' HB ' HG23 ' A' ' 9' ' ' ILE . 4.1 mp -126.61 138.82 53.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 177.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.543 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 2.2 tp -133.35 131.56 57.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.117 -178.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.513 ' CE2' HG13 ' A' ' 108' ' ' ILE . 3.1 m-85 -99.36 139.69 34.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.769 177.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.647 ' HH2' ' HA3' ' A' ' 265' ' ' GLY . 3.4 m-90 -120.06 140.09 51.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.829 174.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.49 -85.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.06 -178.298 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -116.26 -62.99 1.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.834 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -85.41 -30.46 23.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -167.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -62.1 -31.58 72.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.935 -158.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -67.77 -29.29 68.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -172.562 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.22 -52.33 41.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.439 -174.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.14 -39.93 98.55 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.507 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.561 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 28.8 t80 -66.08 -41.38 90.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 110.891 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.08 -44.29 63.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.096 176.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -55.02 -39.9 69.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.893 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.2 m -82.53 -8.12 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.65 35.06 59.31 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.519 174.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 mp -84.99 -2.16 57.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 0.0 110.907 -173.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.561 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -128.67 154.55 46.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -178.178 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.64 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -70.93 134.38 47.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 175.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -71.18 131.09 43.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.453 HD13 ' CE2' ' A' ' 106' ' ' TYR . 29.3 pt -110.12 160.0 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.99 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.2 p -105.17 148.34 36.04 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.565 0.697 . . . . 0.0 111.127 -172.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.15 142.66 31.07 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.774 2.316 . . . . 0.0 112.362 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -103.44 120.3 40.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 172.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.67 -38.67 69.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.47 91.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -72.87 -35.29 67.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.853 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -54.58 -46.72 73.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.84 176.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -65.83 -34.59 78.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.819 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -78.63 -24.01 45.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 -174.663 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.467 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -95.01 -96.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.957 -171.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.448 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 36.9 t80 -176.31 137.75 0.48 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.718 0.771 . . . . 0.0 110.833 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 86.9 Cg_exo -53.42 -39.28 82.35 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.331 -172.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -79.3 -30.27 42.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.448 ' OG1' ' HB3' ' A' ' 90' ' ' TYR . 55.7 m -70.0 -49.35 52.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.204 -165.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.445 ' HA ' HG23 ' A' ' 97' ' ' VAL . 51.7 p-90 -64.32 -29.98 71.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.46 -35.35 68.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.886 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.32 -25.01 64.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.756 ' HB ' ' HB1' ' A' ' 105' ' ' ALA . 19.6 m -101.8 17.92 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.172 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 63.7 ttt180 -101.13 133.3 45.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.957 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -144.25 129.45 18.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.4 t30 65.01 35.27 8.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.88 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.94 -4.77 73.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.476 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -132.55 158.59 41.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.816 0.341 . . . . 0.0 110.897 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.543 HD23 HG21 ' A' ' 97' ' ' VAL . 13.9 mt -72.98 147.52 45.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.1 pp -125.21 10.34 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.147 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.776 ' HB2' ' HB2' ' A' ' 263' ' ' SER . . . -163.26 151.32 13.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.041 -176.672 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.475 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 45.1 m-85 -115.02 136.28 22.58 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.659 0.742 . . . . 0.0 110.919 163.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 40.0 Cg_exo -60.23 118.17 5.01 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.664 2.243 . . . . 0.0 112.393 177.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.513 HG13 ' CE2' ' A' ' 61' ' ' PHE . 30.6 mm -99.38 -41.63 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.184 177.063 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . 0.562 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -152.95 152.56 31.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.133 -175.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.7 p -123.91 134.18 67.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.082 -175.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.06 128.73 54.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.802 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.09 153.96 37.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.092 172.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.499 HD23 ' HG3' ' A' ' 257' ' ' PRO . 8.0 mp -104.72 158.87 16.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.86 -169.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.2 p -150.45 156.49 41.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.937 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.864 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -100.06 125.9 46.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 176.193 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.593 ' N ' HD23 ' A' ' 115' ' ' LEU . 3.7 mp -106.03 135.33 44.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 -175.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -136.7 149.89 48.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -92.95 119.83 32.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.793 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -67.47 -18.65 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 167.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 20.3 t70 -75.28 -32.42 61.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.908 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.2 mp -93.25 -44.98 8.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.965 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 21.6 mt -104.42 113.63 64.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.599 0.714 . . . . 0.0 110.872 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.84 -26.64 31.98 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.702 2.268 . . . . 0.0 112.378 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.433 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 56.5 t-20 -149.57 94.99 3.8 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.56 0.695 . . . . 0.0 110.871 172.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . 0.433 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 37.8 Cg_endo -69.14 151.03 72.64 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 0.0 112.237 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.86 151.62 62.94 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.691 2.26 . . . . 0.0 112.33 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -108.54 -8.6 15.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.937 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 72.3 p -132.21 159.01 40.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -65.25 -31.35 72.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.03 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.85 -27.83 67.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.81 -12.7 59.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.631 ' O ' HD13 ' A' ' 135' ' ' LEU . 49.4 mm -64.98 -53.07 44.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.679 0.752 . . . . 0.0 111.19 -172.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 30.1 Cg_endo -61.74 -37.21 69.56 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.635 2.223 . . . . 0.0 112.347 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.65 -61.31 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.018 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 1.186 HD23 ' C ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -71.16 -18.34 62.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 -177.258 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.588 ' HA ' HD23 ' A' ' 139' ' ' LEU . 38.9 t70 -63.6 -40.94 98.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 169.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.85 -38.16 89.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.93 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.6 -50.66 23.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.631 HD21 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -75.73 -16.53 60.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.937 -175.893 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.631 ' N ' HD21 ' A' ' 139' ' ' LEU . 87.2 tttt -56.96 -34.41 68.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.97 172.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.78 -23.68 67.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -95.19 10.22 36.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.769 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.97 30.1 59.8 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.515 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.466 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 90.7 mttt -120.06 169.57 10.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 110.796 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.0 t -132.39 138.52 47.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.532 ' HB3' ' HA ' ' A' ' 136' ' ' ASP . . . -71.75 -53.87 12.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 -165.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -137.36 131.72 32.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 -164.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' MET . . . . . 0.677 ' HG2' ' HB3' ' A' ' 213' ' ' ALA . 60.3 tpp -105.04 120.1 40.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -153.28 164.97 37.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -174.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -131.66 167.19 19.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 168.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.8 tp -116.26 -23.2 8.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -70.37 -4.07 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.851 -168.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -110.39 152.12 43.09 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.681 0.753 . . . . 0.0 110.819 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . 0.542 ' HD3' ' NE ' ' A' ' 344' ' ' ARG . 29.9 Cg_endo -67.55 -20.89 46.92 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.633 2.222 . . . . 0.0 112.304 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -59.19 -39.07 81.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.907 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -83.24 -42.97 16.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.786 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 41.9 p -65.37 -39.86 92.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.096 -170.081 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.578 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 17.5 t-105 -64.31 -53.86 43.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.589 0.709 . . . . 0.0 110.959 -169.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 36.2 Cg_endo -68.91 -32.24 22.77 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.596 2.198 . . . . 0.0 112.394 -172.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.725 HD21 ' O ' ' A' ' 160' ' ' LEU . 6.4 tt -72.74 -40.75 65.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.577 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 72.1 mt -69.77 -41.44 79.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.78 -27.67 63.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.034 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.56 -31.41 71.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -92.38 3.79 54.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 107.89 3.95 34.03 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.507 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.415 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -79.6 66.22 3.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.427 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . 0.441 ' O ' HG13 ' A' ' 183' ' ' VAL . 80.8 m-85 -90.02 145.41 25.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.853 0.359 . . . . 0.0 110.911 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.96 0.41 15.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.987 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -154.67 151.74 29.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.86 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -100.38 129.99 46.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.822 159.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -92.42 123.75 35.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -151.3 131.29 13.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.908 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.0 t30 57.57 43.6 22.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 171.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.65 77.41 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.54 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.88 144.26 47.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.877 -176.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -80.79 133.68 35.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 167.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -99.57 114.33 27.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.1 tp -72.91 -20.05 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.12 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.0 -10.25 36.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.908 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -127.57 95.02 4.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 169.282 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.4 m -112.01 163.11 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.1 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -97.64 13.29 64.17 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.486 -171.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.733 HG22 HD13 ' A' ' 368' ' ' ILE . 35.4 m -106.97 -13.43 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 111.058 -176.202 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -89.17 15.34 9.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -127.26 -171.27 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.26 -25.98 64.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.2 -173.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.93 -43.6 95.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.552 -167.41 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.733 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -67.57 -38.48 84.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 0.0 111.049 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.502 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.3 mttt -60.23 -35.29 75.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 174.785 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.29 -38.04 89.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.207 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.577 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -65.02 -45.75 91.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.365 177.466 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.619 HD11 ' HA ' ' A' ' 347' ' ' VAL . 17.8 tp -69.9 -32.99 71.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 0.0 110.964 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.46 ' O ' HG12 ' A' ' 196' ' ' VAL . 79.1 m -64.69 -42.11 95.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.169 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -70.55 -54.69 11.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.652 ' C ' HD12 ' A' ' 195' ' ' LEU . 3.6 pp -63.67 -23.91 67.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.989 -167.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.591 ' N ' HD12 ' A' ' 195' ' ' LEU . 1.2 p -74.54 -24.08 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.157 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.78 -55.41 19.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.837 -172.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 1.013 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.74 -24.6 56.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.943 -168.044 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.773 ' N ' HD23 ' A' ' 198' ' ' LEU . 2.0 pp -81.73 -33.88 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.077 173.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -65.26 -31.08 72.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -84.15 4.33 30.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.897 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 64.94 39.73 5.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.923 172.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -80.15 -11.71 59.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 174.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' MET . . . . . 0.438 ' CG ' HG22 ' A' ' 199' ' ' ILE . 5.3 ppp? -142.95 154.54 44.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.81 174.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -101.25 157.12 17.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.96 -28.37 70.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -97.44 -0.01 46.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.7 m -59.25 131.78 52.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.419 ' H ' HD12 ' A' ' 212' ' ' ILE . 23.1 t0 -144.17 171.55 14.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -82.42 -29.67 30.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.8 p -70.66 -38.54 73.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.925 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.419 HD12 ' H ' ' A' ' 209' ' ' ASP . 40.7 pt -67.48 -24.52 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.148 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . 0.677 ' HB3' ' HG2' ' A' ' 148' ' ' MET . . . -59.68 -37.44 78.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 -177.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -57.74 -40.66 80.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.0 93.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.52 91.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.153 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -65.55 -33.9 77.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.78 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.43 -31.97 70.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.01 -18.44 22.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.914 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.63 29.04 22.56 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.477 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -92.03 -27.02 18.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 110.889 -171.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 98.3 m -111.02 125.03 53.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.167 -176.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.28 -49.43 23.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.173 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.414 ' N ' ' O ' ' A' ' 146' ' ' ALA . 66.3 mtm -134.98 155.45 50.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -171.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.7 t -153.02 166.26 32.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.111 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 40.3 mm -113.49 124.03 69.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -142.29 153.16 43.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.824 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -135.0 -95.03 0.49 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.446 175.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.97 -24.02 24.62 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.759 2.306 . . . . 0.0 112.239 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -74.75 -37.79 62.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.872 -173.546 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 49.72 40.3 19.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 -175.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -70.76 -22.99 62.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.4 t -51.37 130.8 27.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.907 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -87.7 -167.78 2.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.95 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.7 mt 55.11 75.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 -174.704 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -52.73 -45.67 67.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.916 -174.01 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 49.3 p -89.8 -178.97 5.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.11 -174.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 93.3 p -79.26 -5.02 53.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.944 176.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.81 171.8 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.531 ' O ' HG12 ' A' ' 240' ' ' VAL . 14.9 t 54.88 41.09 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.164 -174.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.498 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 74.4 m-20 42.31 69.97 0.33 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -127.09 133.07 50.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -174.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -133.69 155.09 21.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.446 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.409 HG21 HG13 ' A' ' 116' ' ' ILE . 3.4 p -145.61 138.97 21.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.907 0.384 . . . . 0.0 111.113 178.45 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -155.64 152.61 28.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.116 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.8 m -60.81 168.45 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.689 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.5 mm? -61.12 150.74 77.97 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.658 0.742 . . . . 0.0 110.907 -162.249 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.48 -178.23 4.44 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.631 2.221 . . . . 0.0 112.293 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.5 m -98.37 142.24 30.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.12 -174.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -132.84 114.87 14.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.825 -176.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 54.91 36.52 26.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.99 2.74 88.24 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.613 174.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -130.71 138.1 32.26 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.618 0.723 . . . . 0.0 110.954 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -68.5 137.45 39.45 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.706 2.271 . . . . 0.0 112.389 -174.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.689 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 98.8 p -79.19 -8.12 58.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.823 174.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -49.99 116.6 6.53 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.475 0.655 . . . . 0.0 110.888 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . 0.499 ' HG3' HD23 ' A' ' 113' ' ' LEU . 72.5 Cg_endo -80.44 167.75 18.88 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.689 2.259 . . . . 0.0 112.264 -176.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -66.89 169.89 7.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 80.5 t -106.86 133.16 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.089 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.5 139.6 15.22 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.551 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 97.5 t -125.6 120.07 56.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.916 0.388 . . . . 0.0 111.1 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.421 HD22 ' HB3' ' A' ' 61' ' ' PHE . 7.3 tt -78.98 129.13 34.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.989 168.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.776 ' HB2' ' HB2' ' A' ' 105' ' ' ALA . 96.5 p -132.39 160.76 35.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -170.622 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.62 143.04 50.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -175.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.647 ' HA3' ' HH2' ' A' ' 62' ' ' TRP . . . -139.64 172.53 23.27 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.47 -175.58 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 23.3 mm -113.53 131.0 66.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.847 0.356 . . . . 0.0 111.191 -171.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -65.28 133.59 51.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 -173.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.64 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -64.94 -27.2 68.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 -177.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.46 -8.58 59.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.996 -173.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.5 t -69.14 121.66 82.63 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.648 0.737 . . . . 0.0 110.948 -175.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.19 -17.79 18.86 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.311 172.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -112.05 29.29 8.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.963 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.02 -25.38 65.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -170.129 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -64.99 -43.38 92.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.822 -169.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.0 pp -76.93 -33.4 57.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.989 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.31 77.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.989 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -66.64 -35.01 79.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.921 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -69.4 -48.94 59.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.903 -173.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 0.6 OUTLIER -67.5 -31.24 71.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.922 -175.16 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.448 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 6.2 tt -64.61 -46.39 82.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.945 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -79.3 -24.88 42.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.887 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -97.61 -20.01 17.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.949 -168.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -119.97 -56.49 2.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.952 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 0.1 OUTLIER -65.68 -41.28 92.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.911 -176.085 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.66 48.21 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.922 169.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.44 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 74.2 m -145.52 146.69 31.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.112 173.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.446 ' HA ' HD11 ' A' ' 290' ' ' LEU . 35.8 t70 -40.0 -39.77 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.907 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.0 -41.69 64.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -172.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.83 -51.18 16.02 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.534 -172.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.7 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -75.49 -22.99 56.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.717 0.294 . . . . 0.0 110.89 -177.562 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.441 ' N ' HD12 ' A' ' 290' ' ' LEU . 86.6 tt0 -67.11 -40.6 86.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 169.747 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.95 -35.06 79.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.015 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.763 HG13 ' HA3' ' A' ' 19' ' ' GLY . 47.3 t -74.86 -43.68 46.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.14 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -63.28 -31.14 72.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.24 -32.34 73.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.807 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . 0.777 ' HB3' ' HB3' ' A' ' 18' ' ' ASN . 67.0 m-20 -94.99 -27.32 15.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 -173.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.41 ' O ' HD13 ' A' ' 299' ' ' LEU . 78.5 tttt -148.1 136.7 11.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.556 0.694 . . . . 0.0 110.857 168.136 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.33 111.87 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.687 2.258 . . . . 0.0 112.35 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 297' ' ' LYS . 0.4 OUTLIER -90.08 -28.58 18.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 174.697 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.06 -55.08 1.84 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.49 -176.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.447 ' HA ' HD21 ' A' ' 311' ' ' LEU . . . -179.37 159.27 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.79 0.329 . . . . 0.0 111.067 -176.164 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.596 HG21 ' HB3' ' A' ' 307' ' ' TYR . 32.6 m -127.02 164.67 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.135 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -79.1 -4.22 49.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.066 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.7 ' CD2' HD22 ' A' ' 290' ' ' LEU . 58.9 tp -86.12 135.64 33.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.751 -172.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -47.3 -31.79 4.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.513 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 70.8 m -47.85 -39.99 20.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.843 173.635 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.596 ' HB3' HG21 ' A' ' 302' ' ' VAL . 0.0 OUTLIER -63.37 -46.1 88.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 173.556 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 32.9 tt0 -54.54 -36.78 64.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.736 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -80.76 -61.77 1.87 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.804 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -83.02 -58.3 2.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.938 -168.375 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 307' ' ' TYR . 0.0 OUTLIER -60.38 -36.44 78.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 -171.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.06 -14.97 58.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.077 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.26 -22.0 66.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.892 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.463 ' HB3' HD13 ' A' ' 317' ' ' ILE . 62.9 t0 -78.25 119.59 77.91 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.584 0.707 . . . . 0.0 110.938 167.247 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -45.65 -35.24 12.65 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.638 2.225 . . . . 0.0 112.323 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 -69.65 -37.54 76.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -176.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.463 HD13 ' HB3' ' A' ' 314' ' ' ASP . 66.0 mt -79.9 -29.91 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.087 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.63 -39.9 85.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.091 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.18 -47.27 74.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 174.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 78.9 p -65.07 -24.98 67.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.057 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 65.6 ttp -63.51 -40.57 97.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.937 174.12 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -65.01 -42.54 94.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.774 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -58.77 -44.64 90.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.928 173.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.91 90.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.052 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.84 -34.98 77.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.929 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -101.07 -3.73 28.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.939 -174.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -95.11 -163.59 34.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.43 -173.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.629 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 95.7 mt-10 -140.9 137.24 33.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.841 0.353 . . . . 0.0 110.835 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.59 ' O ' ' C ' ' A' ' 330' ' ' MET . 35.6 mm -81.06 109.83 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.191 -170.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.59 ' C ' ' O ' ' A' ' 329' ' ' ILE . 6.9 tpt 23.03 57.71 0.29 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.565 0.698 . . . . 0.0 110.899 174.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.629 ' HG3' ' HB3' ' A' ' 328' ' ' GLU . 44.5 Cg_endo -90.87 -4.6 4.54 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.639 2.226 . . . . 0.0 112.287 -176.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.577 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 94.6 m-20 -101.51 4.96 41.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.869 -161.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.577 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 45.7 mm 86.06 132.93 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.654 0.74 . . . . 0.0 111.086 162.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -68.07 -28.72 34.52 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.692 2.261 . . . . 0.0 112.398 -175.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.462 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.7 mt-30 -69.98 -27.27 64.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 176.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 17.4 mmt -74.6 -24.58 58.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.789 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.9 m -61.89 -33.71 74.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.879 177.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.65 -35.72 67.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.167 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -64.25 -35.22 80.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 172.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . 0.418 ' HA ' HG23 ' A' ' 343' ' ' VAL . 52.5 m0 -63.86 -31.12 72.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 174.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -73.64 -37.07 65.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.08 96.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.133 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.418 HG23 ' HA ' ' A' ' 340' ' ' TRP . 10.1 m -80.88 -23.44 10.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.137 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.542 ' NE ' ' HD3' ' A' ' 154' ' ' PRO . 64.9 ttt180 -57.43 -53.17 61.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 172.099 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 67.4 p -62.52 -25.96 68.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.141 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -58.21 -39.0 77.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.085 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.619 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.2 m -73.1 -31.86 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.194 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.39 -44.85 97.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.152 173.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -64.95 -34.96 79.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.86 -45.12 62.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.82 -39.56 87.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.129 -175.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.2 p -75.88 -12.81 60.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.799 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.2 14.86 82.13 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.588 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.52 -32.2 47.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.741 0.305 . . . . 0.0 110.873 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -136.4 153.68 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 46.0 p -79.85 167.65 20.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.133 170.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.441 ' HA ' HD21 ' A' ' 192' ' ' LEU . 53.8 t -55.4 -41.58 63.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.12 172.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -59.56 -45.03 93.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.929 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -72.84 -53.91 10.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.2 76.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.091 -171.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.733 HD11 ' HB1' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -67.08 -40.36 86.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.905 -178.105 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.09 -40.19 94.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.88 -39.91 93.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.425 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -63.39 -42.87 98.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 175.028 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -62.8 -39.05 93.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.821 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.4 m -64.38 -38.62 91.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.121 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -68.69 -35.11 76.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.733 HD13 HG22 ' A' ' 183' ' ' VAL . 75.2 mt -67.32 -45.32 86.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.099 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.6 p -101.71 -14.01 17.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.97 -179.558 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.71 0.291 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.55 131.81 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.095 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -135.59 144.27 46.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.937 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -56.14 135.14 53.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . 0.499 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 98.32 -1.85 59.06 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.492 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.3 tttt -166.29 137.34 3.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 174.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.624 HD23 HD11 ' A' ' 33' ' ' ILE . 0.7 OUTLIER -143.48 157.54 44.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 -172.745 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.441 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 86.4 t -113.45 132.34 62.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.116 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.849 ' HB ' HD22 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -119.95 127.41 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.062 -178.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' TRP . . . . . 0.583 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 44.8 m0 -106.16 129.47 54.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . 0.437 HG22 ' O ' ' A' ' 12' ' ' ASN . 60.7 mt -122.21 140.54 45.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.137 170.6 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.437 ' O ' HG22 ' A' ' 11' ' ' ILE . 64.2 t30 -50.15 141.74 10.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.906 172.023 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.411 ' HA3' ' OD2' ' A' ' 41' ' ' ASP . . . -58.06 -11.34 8.63 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.43 -172.582 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -73.32 -14.39 61.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.873 0.368 . . . . 0.0 110.923 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -136.94 109.99 7.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.957 158.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.36 -91.09 0.84 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.413 -154.562 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -104.7 -47.49 4.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.857 0.361 . . . . 0.0 110.849 -167.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -66.53 -46.86 74.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 -156.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.69 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -58.13 -47.06 91.6 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.512 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.849 HD22 ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -55.65 -60.97 2.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.792 0.329 . . . . 0.0 110.898 173.834 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.04 -39.28 55.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 -177.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -64.58 -52.83 55.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.3 m -75.69 -35.4 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.183 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.716 ' HA3' HG22 ' A' ' 35' ' ' VAL . . . -65.38 -44.57 93.13 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.481 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.67 -36.46 78.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.802 0.334 . . . . 0.0 110.832 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -61.6 -39.84 92.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.868 173.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PHE . . . . . 0.459 ' CD2' HD12 ' A' ' 33' ' ' ILE . 1.3 t80 -61.32 -44.82 96.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.0 -38.99 93.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.848 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.27 -31.85 73.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.13 -43.77 15.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -172.368 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . 0.536 ' OG1' HG13 ' A' ' 33' ' ' ILE . 53.8 p -113.85 -11.63 12.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.183 -171.292 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.87 14.0 81.46 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 1.152 HD13 ' O ' ' A' ' 33' ' ' ILE . 1.8 pp -104.55 126.83 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 0.0 111.137 -176.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.6 mttt -75.77 141.53 42.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -171.005 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.716 HG22 ' HA3' ' A' ' 24' ' ' GLY . 2.9 m -114.99 135.97 53.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.081 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . 0.441 ' O ' HD13 ' A' ' 9' ' ' ILE . 99.0 m -105.29 128.1 53.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.045 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . 0.535 HG23 ' HG ' ' A' ' 20' ' ' LEU . 58.4 t -96.24 121.38 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.145 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.583 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 69.2 mm-40 -130.09 144.61 51.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.837 172.159 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -156.82 58.78 1.68 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.585 0.707 . . . . 0.0 110.867 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . 0.479 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 73.5 Cg_endo -80.71 -12.91 12.12 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.686 2.257 . . . . 0.0 112.296 -170.752 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 26.2 m-20 63.59 19.96 11.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -171.192 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 45' ' ' GLU . 98.6 mttt -93.67 0.25 56.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.966 174.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.1 mt -45.77 -51.77 12.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.951 -166.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.67 -26.53 66.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.95 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 42' ' ' LYS . 98.4 mt-10 -78.68 -33.1 47.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.993 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.43 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 69.0 mmtt -82.72 -30.22 29.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.9 -174.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' PHE . . . . . 0.519 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 14.1 m-30 -40.72 -56.07 4.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.637 0.732 . . . . 0.0 110.826 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . 0.519 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 51.6 Cg_endo -67.34 -27.44 40.47 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.717 2.278 . . . . 0.0 112.307 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -79.65 -44.41 20.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.2 m -69.75 -27.49 33.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.152 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.91 78.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.101 170.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.28 -30.48 67.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.08 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.3 p -92.58 -12.1 32.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.217 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.69 15.12 81.48 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.42 175.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -163.78 157.31 18.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.91 0.386 . . . . 0.0 110.859 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.5 -138.81 2.49 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 -178.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PRO . . . . . 0.499 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 73.6 Cg_endo -67.69 150.41 79.37 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.655 2.236 . . . . 0.0 112.401 168.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -76.32 -38.57 55.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.735 ' HB ' HG23 ' A' ' 9' ' ' ILE . 3.7 mp -126.4 138.66 53.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.207 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.521 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 2.2 tp -128.48 129.8 68.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.131 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.559 ' CE2' HG13 ' A' ' 108' ' ' ILE . 2.0 m-85 -98.53 142.68 29.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.831 175.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TRP . . . . . 0.559 ' HH2' ' HA3' ' A' ' 265' ' ' GLY . 6.1 m-90 -119.68 139.81 51.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.922 176.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.416 ' O ' ' HA ' ' A' ' 262' ' ' LEU . . . -59.65 -85.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.092 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -122.52 -61.46 1.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -84.56 -27.92 26.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.773 -167.046 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.468 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 89.4 mtt180 -60.07 -30.5 69.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.891 -158.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -67.8 -27.92 67.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -170.284 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.85 -51.84 47.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.515 -173.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.16 -36.27 92.74 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' TYR . . . . . 0.583 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 18.4 t80 -65.98 -38.31 88.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.932 0.396 . . . . 0.0 110.891 -178.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.14 -43.94 60.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -62.61 -32.06 73.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.2 m -80.48 -12.57 59.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 175.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.1 31.95 66.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.503 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.49 -1.26 56.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.79 0.329 . . . . 0.0 110.879 -172.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.583 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -130.99 156.94 44.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.975 -179.287 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.637 ' HB3' ' HA ' ' A' ' 268' ' ' ALA . . . -66.9 130.46 43.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.132 175.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -69.52 122.97 20.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -109.3 159.97 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.05 -171.82 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.6 p -103.23 146.5 32.56 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.629 0.728 . . . . 0.0 111.065 -171.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.84 146.25 29.56 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.682 2.255 . . . . 0.0 112.326 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -107.94 114.68 28.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -52.68 -35.92 56.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.828 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.08 -40.97 95.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -69.97 -38.25 76.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.862 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -54.95 -48.61 72.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.76 -36.39 83.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.845 175.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -75.78 -19.99 58.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.468 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -103.34 -103.52 0.29 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 -173.304 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 43.0 t80 -165.92 134.28 2.41 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.688 0.756 . . . . 0.0 110.933 -172.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 70.9 Cg_exo -52.51 -39.94 73.33 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.375 -170.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -78.44 -30.51 47.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.96 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.2 m -69.48 -48.7 59.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.196 -166.382 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TRP . . . . . 0.466 ' HA ' HG23 ' A' ' 97' ' ' VAL . 51.9 p-90 -66.57 -28.4 68.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.87 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -71.44 -37.59 71.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.855 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.98 -25.07 65.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.582 ' HB ' ' HB1' ' A' ' 105' ' ' ALA . 21.7 m -101.55 16.54 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.189 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ARG . . . . . 0.464 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 68.1 ttt180 -101.8 133.11 47.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.905 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -149.06 130.31 14.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.3 t30 68.69 36.26 2.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.12 -5.01 64.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.52 174.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -139.73 163.85 31.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LEU . . . . . 0.572 HD23 HG21 ' A' ' 97' ' ' VAL . 13.1 mt -73.07 146.09 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.002 -175.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.434 ' C ' HD13 ' A' ' 104' ' ' ILE . 1.9 pp -122.33 9.91 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.179 173.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.896 ' HB2' ' HB3' ' A' ' 263' ' ' SER . . . -168.09 156.68 9.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.045 -177.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' TYR . . . . . 0.45 ' HB3' HD22 ' A' ' 285' ' ' LEU . 21.4 m-85 -124.99 146.34 53.21 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.766 0.793 . . . . 0.0 110.905 163.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.664 ' HB3' HG11 ' A' ' 261' ' ' VAL . 42.9 Cg_endo -71.4 121.09 7.43 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.616 2.211 . . . . 0.0 112.359 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ILE . . . . . 0.559 HG13 ' CE2' ' A' ' 61' ' ' PHE . 25.1 mm -98.31 -32.28 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.137 177.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.04 151.34 26.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.403 HG23 HG23 ' A' ' 261' ' ' VAL . 75.6 t -115.02 132.99 62.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.079 178.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -112.88 131.72 55.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.83 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.08 154.49 40.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.966 176.5 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.439 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 11.0 mp -94.29 152.05 18.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.946 -174.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -148.22 157.59 43.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.82 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -99.23 125.2 44.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.85 174.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ILE . . . . . 0.589 ' N ' HD23 ' A' ' 115' ' ' LEU . 4.7 mp -107.54 132.1 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 -176.14 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -131.71 145.15 51.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.944 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -100.2 113.08 25.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.749 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 241' ' ' ASN . 99.5 mttt -64.78 -15.01 61.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.812 -176.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASP . . . . . 0.472 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 15.1 t70 -80.47 -29.87 37.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 mp -88.83 -46.49 8.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.545 HD23 ' HB2' ' A' ' 223' ' ' ALA . 2.2 mp -111.24 124.94 31.53 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.587 0.708 . . . . 0.0 110.81 175.331 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -71.71 -26.71 19.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.652 2.234 . . . . 0.0 112.302 173.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -152.47 96.28 3.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.628 0.728 . . . . 0.0 110.921 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.78 153.99 68.2 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.687 2.258 . . . . 0.0 112.331 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.58 151.53 64.46 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.651 2.234 . . . . 0.0 112.38 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -113.62 -5.07 13.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.864 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' THR . . . . . 0.485 HG23 ' H ' ' A' ' 130' ' ' GLU . 11.8 m -127.9 146.08 50.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.106 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TRP . . . . . 0.469 ' HA ' HG12 ' A' ' 132' ' ' ILE . 63.1 m95 -66.39 -25.63 66.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.955 -177.314 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . 0.485 ' H ' HG23 ' A' ' 128' ' ' THR . 98.3 mt-10 -62.11 -30.32 70.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.15 -19.67 56.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 -175.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . 0.592 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 49.5 mm -62.0 -53.46 59.38 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.656 0.741 . . . . 0.0 111.133 -166.206 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PRO . . . . . 0.592 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 31.9 Cg_endo -62.75 -40.06 38.81 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.7 2.266 . . . . 0.0 112.339 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.0 -59.44 4.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LEU . . . . . 1.176 HD23 ' C ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.71 -17.67 63.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -175.257 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.649 ' HA ' HD23 ' A' ' 139' ' ' LEU . 39.0 t70 -63.49 -39.08 93.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 169.027 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.01 -36.72 82.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -73.16 -50.3 23.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -174.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LEU . . . . . 0.683 HD21 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -75.18 -15.2 60.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.892 -176.524 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.683 ' N ' HD21 ' A' ' 139' ' ' LEU . 87.8 tttt -56.28 -35.06 67.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 170.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.18 -23.84 67.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.129 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -94.9 8.64 42.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.816 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.22 27.51 63.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.425 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.446 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 46.0 mtmt -120.87 165.41 15.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.859 0.361 . . . . 0.0 110.862 173.174 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . 0.533 ' HA ' HD22 ' A' ' 139' ' ' LEU . 37.1 t -128.56 146.69 50.77 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 170.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -72.04 -58.31 3.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.084 -164.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -138.64 128.87 25.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -161.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.1 mmm -105.91 128.64 53.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -153.77 162.38 41.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -123.89 142.95 50.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.429 ' HG ' HG22 ' A' ' 347' ' ' VAL . 54.4 tp -113.35 -9.73 13.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.975 -175.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -73.71 0.14 13.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -118.0 148.39 43.37 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 121.738 0.78 . . . . 0.0 110.828 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.77 -20.01 64.66 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.595 2.197 . . . . 0.0 112.327 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -62.37 -36.69 83.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -84.32 -37.69 21.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.4 p -64.09 -37.77 88.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' TRP . . . . . 0.568 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 12.4 t-105 -62.21 -55.13 43.27 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.621 0.724 . . . . 0.0 110.935 -172.033 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' PRO . . . . . 0.568 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 26.4 Cg_endo -67.37 -32.48 32.4 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.68 2.253 . . . . 0.0 112.326 -171.375 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.711 HD21 ' O ' ' A' ' 160' ' ' LEU . 6.5 tt -74.48 -40.31 61.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.981 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.501 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 76.0 mt -69.74 -40.44 79.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.128 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.78 -26.72 64.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.142 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.59 -30.25 70.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -94.56 0.56 55.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 112.19 5.41 24.96 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.55 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.486 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -79.21 66.68 3.41 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.383 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -90.28 152.58 20.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.883 -174.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.68 -17.95 60.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.112 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -147.56 154.04 40.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.087 0.47 . . . . 0.0 110.813 -173.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -97.24 128.93 44.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.885 159.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -96.19 122.64 39.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.918 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -149.73 130.71 14.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.954 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.4 t30 56.9 44.28 23.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 172.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.14 6.43 74.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -132.71 142.39 49.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.858 0.361 . . . . 0.0 110.942 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -77.77 134.85 37.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.917 165.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -95.12 104.97 16.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.3 tp -65.76 -19.95 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.106 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -94.74 -8.43 37.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -132.63 95.58 3.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 174.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' VAL . . . . . 0.511 HG21 HG23 ' A' ' 183' ' ' VAL . 33.1 m -115.82 173.05 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.107 -177.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -99.95 12.13 60.7 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.442 -167.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' VAL . . . . . 0.572 HG22 ' CD1' ' A' ' 368' ' ' ILE . 17.9 m -101.62 -17.92 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 0.0 111.156 -172.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ASP . . . . . 0.459 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 57.5 p-10 -95.57 19.85 10.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.868 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -118.11 171.55 8.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.08 -24.46 67.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.069 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.05 -39.78 94.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.524 -172.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.651 ' HB1' HD11 ' A' ' 361' ' ' LEU . . . -65.5 -39.4 91.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 111.068 177.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' LYS . . . . . 0.519 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.2 mttt -59.73 -37.37 78.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 173.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.58 -38.11 89.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.121 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.0 -45.41 94.03 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.374 177.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' LEU . . . . . 0.605 HD11 ' HA ' ' A' ' 347' ' ' VAL . 18.7 tp -68.33 -33.31 74.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.928 0.394 . . . . 0.0 110.971 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' THR . . . . . 0.425 ' O ' HG12 ' A' ' 196' ' ' VAL . 89.5 m -63.06 -42.28 99.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.159 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -67.29 -58.03 5.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' LEU . . . . . 0.632 ' C ' HD12 ' A' ' 195' ' ' LEU . 3.4 pp -63.49 -27.78 69.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 -165.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' VAL . . . . . 0.571 ' N ' HD12 ' A' ' 195' ' ' LEU . 3.7 p -72.77 -22.55 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.11 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -66.06 -58.79 4.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.886 -174.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' LEU . . . . . 1.039 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.42 -24.54 57.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -167.404 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ILE . . . . . 0.813 ' N ' HD23 ' A' ' 198' ' ' LEU . 2.1 pp -77.35 -35.8 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.173 172.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.89 -30.71 71.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.919 169.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -85.55 5.79 29.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.843 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 67.26 40.02 2.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.904 170.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -82.8 -14.36 54.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 170.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 60.5 ttp -133.14 146.31 51.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -94.94 155.91 16.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.9 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.2 -25.03 68.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -95.09 -3.5 47.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 95.3 m -63.53 130.88 46.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.17 -175.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ASP . . . . . 0.507 ' H ' HD12 ' A' ' 212' ' ' ILE . 21.5 t0 -146.78 172.24 13.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 176.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -75.49 -34.38 60.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 -172.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 47.7 t -68.81 -48.3 63.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 -174.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ILE . . . . . 0.507 HD12 ' H ' ' A' ' 209' ' ' ASP . 29.8 pt -65.94 -24.85 34.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.123 176.201 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.97 -35.6 81.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.18 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -67.84 -35.96 79.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.809 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.16 -40.16 95.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.164 173.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.0 -40.49 95.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.136 174.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -65.09 -39.4 93.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.868 -177.134 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -63.64 -32.09 73.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.842 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.17 -10.87 48.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.979 -176.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.9 25.75 36.9 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.533 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -86.54 -26.23 24.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.898 0.38 . . . . 0.0 110.805 -175.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -125.45 134.51 52.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' ALA . . . . . 0.545 ' HB2' HD23 ' A' ' 122' ' ' LEU . . . -72.55 -35.74 68.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.085 -175.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' MET . . . . . 0.415 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 72.5 mtm -131.99 155.51 47.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 110.879 -176.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.6 t -149.01 160.12 43.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.7 mm -115.09 125.02 72.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.114 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -145.02 151.06 37.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . 0.439 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -135.07 -97.51 0.55 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.457 174.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.93 -17.39 36.83 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.741 2.294 . . . . 0.0 112.329 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -67.38 -33.33 74.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.999 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 53.57 32.9 15.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.032 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 35.2 m0 -72.65 -34.58 67.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.035 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 19.2 t -55.52 112.77 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.868 -171.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ASN . . . . . 0.419 ' O ' ' HB ' ' A' ' 235' ' ' ILE . 44.7 p30 -95.47 -162.85 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.955 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ILE . . . . . 0.532 HG22 ' O ' ' A' ' 235' ' ' ILE . 47.6 mt 69.86 54.54 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.157 -175.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -60.03 -29.99 68.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.913 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 72.3 p -82.14 169.23 16.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.032 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 97.2 p -76.16 -6.11 49.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.973 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -61.03 160.56 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.923 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 240' ' ' VAL . 11.6 t 55.99 35.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.174 -178.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ASN . . . . . 0.472 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 77.4 m-20 37.27 70.0 0.2 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 169.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 242' ' ' TYR . 4.4 t80 -119.48 135.39 54.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.908 -171.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.07 158.47 24.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.428 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' VAL . . . . . 0.536 HG23 ' HB3' ' A' ' 319' ' ' ALA . 7.4 p -141.48 139.95 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.871 0.367 . . . . 0.0 111.11 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.3 t -153.02 148.92 27.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.162 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 18.9 m -61.76 168.94 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.096 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' LEU . . . . . 0.586 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.8 mm? -62.06 146.92 91.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.659 0.742 . . . . 0.0 110.895 -162.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -72.69 -177.42 2.81 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.65 2.233 . . . . 0.0 112.35 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.8 p -108.71 160.02 16.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.15 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -143.59 122.38 12.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 110.89 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 55.02 35.83 25.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.09 7.35 77.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.546 169.93 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -132.83 139.86 35.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.613 0.72 . . . . 0.0 110.905 176.285 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.87 140.9 36.03 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.741 2.294 . . . . 0.0 112.376 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' SER . . . . . 0.586 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 97.3 p -82.42 -5.87 58.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.865 170.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -49.93 113.33 3.31 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.545 0.688 . . . . 0.0 110.934 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.91 168.89 20.21 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.563 2.175 . . . . 0.0 112.426 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -72.9 171.75 12.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.883 -177.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.496 HG22 ' HA ' ' A' ' 324' ' ' ALA . 76.4 t -104.33 134.83 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.163 -170.413 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -109.77 137.91 14.51 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.502 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' VAL . . . . . 0.664 HG11 ' HB3' ' A' ' 107' ' ' PRO . 93.8 t -121.84 124.04 70.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.938 0.399 . . . . 0.0 111.168 -176.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.416 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 5.2 tt -72.09 128.82 36.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 168.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' SER . . . . . 0.896 ' HB3' ' HB2' ' A' ' 105' ' ' ALA . 58.5 m -121.31 153.89 37.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 -171.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ALA . . . . . 0.471 ' CB ' HD11 ' A' ' 280' ' ' LEU . . . -134.62 139.79 45.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 177.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' GLY . . . . . 0.559 ' HA3' ' HH2' ' A' ' 62' ' ' TRP . . . -142.41 172.22 24.37 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.518 -176.392 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 24.4 mm -112.87 134.31 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.333 . . . . 0.0 111.177 -169.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -64.55 132.07 48.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.936 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' ALA . . . . . 0.637 ' HA ' ' HB3' ' A' ' 77' ' ' ALA . . . -64.49 -30.21 71.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.1 -8.76 59.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.069 -172.065 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.3 t -68.21 121.66 81.11 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.639 0.733 . . . . 0.0 110.937 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.27 -16.95 19.35 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.71 2.273 . . . . 0.0 112.352 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ASN . . . . . 0.453 ' HB2' HD22 ' A' ' 275' ' ' LEU . 53.1 p-10 -113.24 29.93 7.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.814 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -61.87 -25.29 67.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -169.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -65.65 -43.53 89.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 110.805 -168.331 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' LEU . . . . . 0.453 HD22 ' HB2' ' A' ' 272' ' ' ASN . 2.5 pp -74.75 -33.73 62.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' ALA . . . . . 0.455 ' HB2' HD12 ' A' ' 59' ' ' ILE . . . -65.81 -49.17 69.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -65.22 -35.13 80.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 94.0 mt-10 -68.62 -43.39 76.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.874 -177.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -60.12 -46.58 89.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' LEU . . . . . 0.471 HD11 ' CB ' ' A' ' 264' ' ' ALA . 7.6 tt -62.43 -46.56 87.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 -177.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.99 -38.81 72.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 -177.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' ASN . . . . . 0.427 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 94.8 m-20 -102.28 -10.9 19.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -161.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' TYR . . . . . 0.434 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 53.5 t80 -122.46 -51.57 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' LEU . . . . . 0.437 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.5 OUTLIER -70.58 -43.22 69.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -176.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' LEU . . . . . 0.45 HD22 ' HB3' ' A' ' 106' ' ' TYR . 4.5 mm? -81.69 44.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 169.183 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' THR . . . . . 0.439 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 89.6 m -145.77 145.37 30.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.168 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' ASP . . . . . 0.574 ' HA ' HD11 ' A' ' 290' ' ' LEU . 48.5 p-10 -50.11 -25.93 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -171.203 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -75.78 -45.89 33.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.71 -49.71 13.42 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 -169.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' LEU . . . . . 0.656 HD22 ' CD2' ' A' ' 304' ' ' LEU . 0.7 OUTLIER -73.06 -23.64 60.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.715 0.293 . . . . 0.0 110.877 -177.841 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' GLU . . . . . 0.526 ' N ' HD12 ' A' ' 290' ' ' LEU . 87.7 tt0 -68.71 -40.08 80.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 171.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.95 78.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.15 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' VAL . . . . . 0.69 HG13 ' HA3' ' A' ' 19' ' ' GLY . 39.9 t -77.89 -44.57 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.103 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -62.92 -29.66 70.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 177.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.01 -27.77 69.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -89.16 -36.77 15.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.819 -177.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' LYS . . . . . 0.433 ' O ' HD13 ' A' ' 299' ' ' LEU . 85.9 tttt -152.84 138.35 11.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.638 0.732 . . . . 0.0 110.864 175.191 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 297' ' ' LYS . 78.1 Cg_exo -51.78 112.72 0.9 Allowed 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.694 2.263 . . . . 0.0 112.329 175.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 297' ' ' LYS . 0.1 OUTLIER -88.98 -20.36 24.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 178.059 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 301' ' ' ALA . . . 102.18 -41.2 2.19 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.573 177.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 300' ' ' GLY . . . -179.86 175.92 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.884 0.373 . . . . 0.0 111.069 171.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' VAL . . . . . 0.629 ' CG2' ' HB3' ' A' ' 307' ' ' TYR . 22.3 m -135.85 160.06 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.136 162.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.27 -14.2 61.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.07 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' LEU . . . . . 0.656 ' CD2' HD22 ' A' ' 290' ' ' LEU . 60.4 tp -77.07 128.69 34.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -173.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -41.88 -33.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 -177.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' SER . . . . . 0.427 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 48.0 t -46.86 -38.66 10.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.866 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' TYR . . . . . 0.629 ' HB3' ' CG2' ' A' ' 302' ' ' VAL . 0.2 OUTLIER -57.36 -44.18 84.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 175.313 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' GLU . . . . . 0.472 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 88.7 tt0 -56.92 -39.99 75.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.786 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -80.01 -64.55 1.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.829 -174.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -85.81 -57.84 2.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.88 -171.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' LEU . . . . . 0.623 ' HB3' HD11 ' A' ' 317' ' ' ILE . 34.3 mt -59.34 -34.77 72.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 -169.63 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' ALA . . . . . 0.457 ' O ' ' HB3' ' A' ' 318' ' ' ALA . . . -59.66 -18.19 39.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 -176.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -65.02 -23.01 67.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.767 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' ASP . . . . . 0.604 ' HB3' HD13 ' A' ' 317' ' ' ILE . 59.9 t0 -86.44 125.7 66.75 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.442 0.639 . . . . 0.0 110.876 173.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -49.23 -30.85 20.48 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.564 2.176 . . . . 0.0 112.334 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -65.11 -32.16 73.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' ILE . . . . . 0.623 HD11 ' HB3' ' A' ' 311' ' ' LEU . 6.9 mt -94.88 -36.07 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.082 -178.278 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' ALA . . . . . 0.457 ' HB3' ' O ' ' A' ' 312' ' ' ALA . . . -53.82 -43.43 69.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.085 -174.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' ALA . . . . . 0.536 ' HB3' HG23 ' A' ' 244' ' ' VAL . . . -66.96 -44.62 80.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.091 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 64.2 p -64.7 -25.58 68.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.097 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 65.8 ttp -62.61 -38.6 90.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.911 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -66.82 -36.86 83.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.789 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 327' ' ' GLY . 63.7 t30 -78.88 -38.66 37.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.906 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' ALA . . . . . 0.496 ' HA ' HG22 ' A' ' 259' ' ' VAL . . . -64.92 -46.89 79.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.057 -175.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -70.36 -33.44 71.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 -177.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.66 -4.17 34.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -103.36 -160.2 25.13 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.443 -174.2 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' GLU . . . . . 0.657 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 94.8 mt-10 -143.41 139.32 29.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.841 0.353 . . . . 0.0 110.837 -173.118 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' ILE . . . . . 0.582 ' O ' ' C ' ' A' ' 330' ' ' MET . 43.8 mm -82.35 112.33 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.189 -171.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' MET . . . . . 0.582 ' C ' ' O ' ' A' ' 329' ' ' ILE . 74.1 mtm 23.69 56.96 0.31 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.653 0.739 . . . . 0.0 110.892 175.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' PRO . . . . . 0.657 ' HG3' ' HB3' ' A' ' 328' ' ' GLU . 45.0 Cg_endo -93.14 -8.75 2.23 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.596 2.197 . . . . 0.0 112.287 -173.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' ASN . . . . . 0.555 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 8.5 t-20 -98.0 11.42 37.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.84 -160.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' ILE . . . . . 0.608 HG22 ' H ' ' A' ' 335' ' ' GLN . 50.1 mm 86.38 132.34 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.69 0.757 . . . . 0.0 111.055 164.785 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.41 -24.83 76.31 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.662 2.241 . . . . 0.0 112.371 -176.06 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' GLN . . . . . 0.608 ' H ' HG22 ' A' ' 333' ' ' ILE . 99.2 mm-40 -61.93 -17.54 57.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.96 174.74 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -57.57 -27.23 62.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.939 -173.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -35.97 79.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.34 -37.25 66.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.111 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 339' ' ' PHE . . . . . 0.455 ' HA ' HG12 ' A' ' 368' ' ' ILE . 35.4 m-85 -63.9 -49.02 74.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.8 174.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -64.89 -36.8 85.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.988 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -68.72 -47.23 66.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.71 89.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 343' ' ' VAL . . . . . 0.453 ' O ' ' HB1' ' A' ' 346' ' ' ALA . 13.9 m -80.6 -23.48 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 344' ' ' ARG . . . . . 0.53 ' O ' HG23 ' A' ' 347' ' ' VAL . 3.0 tmt_? -62.37 -47.39 84.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 81.4 p -60.85 -26.69 67.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.148 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 346' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 364' ' ' ALA . . . -62.06 -41.91 98.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.044 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 347' ' ' VAL . . . . . 0.605 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.2 m -72.68 -32.83 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.072 -175.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.94 -45.97 95.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.194 172.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -63.8 -35.45 80.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.819 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.65 -45.76 61.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.096 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.0 89.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.185 -175.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 98.5 p -75.7 -9.99 59.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.947 -177.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.72 16.6 79.91 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.558 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.84 -32.77 40.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.719 0.295 . . . . 0.0 110.848 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -138.11 154.76 49.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.861 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.8 p -79.66 167.42 20.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.217 168.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 357' ' ' VAL . . . . . 0.479 ' HA ' HD21 ' A' ' 192' ' ' LEU . 55.1 t -54.72 -41.94 58.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.061 173.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -59.66 -45.76 91.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.858 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -72.55 -52.84 13.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.2 -43.64 77.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.053 -171.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 361' ' ' LEU . . . . . 0.651 HD11 ' HB1' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -67.52 -40.91 85.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 -178.471 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.9 -39.83 94.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.936 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -63.09 -38.53 91.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.841 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 364' ' ' ALA . . . . . 0.554 ' HB3' ' HB3' ' A' ' 346' ' ' ALA . . . -63.58 -42.5 98.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.083 174.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 365' ' ' GLN . . . . . 0.459 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 23.1 tm0? -64.27 -36.79 85.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 177.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 366' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 370' ' ' LYS . 92.2 m -66.06 -40.22 90.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 176.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -67.59 -35.06 78.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 368' ' ' ILE . . . . . 0.572 ' CD1' HG22 ' A' ' 183' ' ' VAL . 68.3 mt -62.71 -40.88 90.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.061 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.3 p -94.68 -10.53 31.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 370' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 366' ' ' THR . 99.5 mttt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.778 0.323 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.7 mt -104.37 134.42 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -145.0 143.12 30.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -54.66 136.17 45.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.794 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.424 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 99.27 3.14 56.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.488 -173.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -166.34 149.83 7.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.797 0.332 . . . . 0.0 110.962 173.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.68 HD22 HD13 ' A' ' 33' ' ' ILE . 1.5 pt? -149.53 154.05 38.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.978 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 75.8 t -109.41 135.05 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.118 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.739 HG22 ' CG1' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -123.07 133.02 70.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.104 179.023 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.476 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 45.9 m0 -109.46 133.32 53.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.945 173.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.509 HD12 ' HB2' ' A' ' 20' ' ' LEU . 4.4 tt -109.99 149.79 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.136 -169.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -57.54 155.31 9.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.93 -14.47 16.94 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.531 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -76.46 -13.52 60.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.855 0.359 . . . . 0.0 110.843 -172.241 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -138.91 144.27 39.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.06 -84.11 1.01 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.452 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -112.99 -37.66 4.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.925 0.393 . . . . 0.0 110.895 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -66.33 -52.26 48.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.969 -144.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.68 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -62.92 -48.07 83.7 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.556 -176.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.67 HD21 HG13 ' A' ' 9' ' ' ILE . 10.9 tp -67.02 -35.87 80.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.947 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.74 84.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 173.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -65.07 -52.78 53.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.831 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 20' ' ' LEU . 14.1 m -73.9 -35.58 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 -176.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.517 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -66.67 -44.39 89.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.519 176.723 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -64.95 -40.02 94.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -65.39 -38.88 91.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.415 ' CE2' HD11 ' A' ' 33' ' ' ILE . 73.6 t80 -66.14 -39.81 90.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.857 174.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -57.49 -39.98 77.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.2 -30.18 68.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -83.51 -38.96 21.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 -170.287 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.609 ' OG1' HG13 ' A' ' 33' ' ' ILE . 61.1 p -105.73 -12.93 15.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.41 5.91 89.09 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.519 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.828 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.6 pp -99.29 133.96 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 0.0 111.159 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -70.47 129.25 38.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 -168.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.517 HG11 ' HA3' ' A' ' 24' ' ' GLY . 90.2 t -110.81 119.79 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.135 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.8 m -115.44 116.99 29.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.127 -173.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.446 HG22 ' HG ' ' A' ' 20' ' ' LEU . 79.0 t -98.77 139.29 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.476 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 73.9 mm-40 -121.25 161.83 21.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.888 176.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -84.78 141.04 37.98 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.612 0.72 . . . . 0.0 110.898 -171.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 85.6 Cg_exo -52.33 -30.72 43.96 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.724 2.282 . . . . 0.0 112.339 -177.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -49.34 -48.97 46.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.937 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.92 -19.31 48.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.875 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.612 HD23 ' C ' ' A' ' 43' ' ' LEU . 7.3 tt -52.4 -59.29 4.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.918 -171.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.06 -39.22 83.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.67 -42.7 57.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.845 -170.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -85.25 -29.27 24.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -171.565 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.549 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 91.2 t80 -47.72 -51.85 42.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.744 . . . . 0.0 110.885 -165.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 62.9 Cg_endo -69.04 -29.26 27.59 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 0.0 112.313 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -76.99 -43.4 35.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.6 m -72.29 -26.69 25.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.186 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.437 ' HB1' ' HG ' ' A' ' 75' ' ' LEU . . . -65.65 -34.23 77.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 173.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.33 -29.64 70.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.077 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.2 p -92.38 -14.01 29.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.155 175.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.56 14.79 81.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.497 173.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -140.01 129.91 24.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.797 0.332 . . . . 0.0 110.916 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.85 -115.01 0.54 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.523 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.473 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 98.3 Cg_endo -72.84 151.41 51.1 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.658 2.239 . . . . 0.0 112.367 173.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.86 -35.49 15.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 168.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.739 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -138.51 150.03 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.054 177.073 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.573 HD11 HD21 ' A' ' 43' ' ' LEU . 4.1 tp -125.95 126.42 69.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.051 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.439 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 7.9 m-85 -108.07 123.35 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 177.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 16.7 t-105 -143.94 -172.81 3.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.3 -88.72 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.195 172.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -106.5 -54.64 2.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.82 -39.55 77.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 -159.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.58 -29.99 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 -174.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.801 ' O ' ' HD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -49.99 -52.95 29.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.934 -175.384 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.96 -41.33 97.4 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.495 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.97 -61.34 7.47 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.557 ' HD1' HD22 ' A' ' 76' ' ' LEU . 4.8 p90 -81.63 -25.52 35.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 110.929 -168.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.449 ' N ' ' CD1' ' A' ' 70' ' ' TYR . . . -70.22 -54.44 12.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.165 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -67.27 -34.14 76.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.845 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.6 m -84.77 -8.0 58.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 -173.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.39 31.75 63.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.481 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.437 ' HG ' ' HB1' ' A' ' 51' ' ' ALA . 2.5 mp -86.81 -4.63 59.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.929 0.395 . . . . 0.0 110.947 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.557 HD22 ' HD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -124.36 149.41 46.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.994 -175.002 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.01 140.53 37.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 169.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -71.63 135.35 46.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.909 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.854 HG13 ' HB3' ' A' ' 103' ' ' LEU . 42.5 pt -116.89 165.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 176.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 p -115.3 150.06 43.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.607 0.718 . . . . 0.0 111.122 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.32 144.99 47.3 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -103.14 119.96 39.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.61 -41.99 98.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.66 -46.46 82.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.16 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.43 ' HB3' ' HZ2' ' A' ' 94' ' ' TRP . 18.1 m-85 -73.55 -31.24 63.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.473 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.7 tt0 -53.5 -45.07 69.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.911 174.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -67.6 -33.9 75.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 175.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -77.84 -24.85 48.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.478 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 1.9 mp -104.98 -105.06 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 -174.019 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -169.26 128.1 0.9 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.637 0.732 . . . . 0.0 110.967 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -53.33 -36.51 78.85 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.586 2.19 . . . . 0.0 112.365 -171.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.62 -30.01 67.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.976 -173.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.4 p -76.66 -31.12 57.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.158 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.601 ' HA ' HG22 ' A' ' 97' ' ' VAL . 92.0 m95 -72.37 -27.51 62.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.932 171.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -72.78 -31.45 64.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 169.094 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ALA . . . . . 0.42 ' CB ' HG21 ' A' ' 329' ' ' ILE . . . -65.03 -28.1 69.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.065 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.601 HG22 ' HA ' ' A' ' 94' ' ' TRP . 29.9 m -110.9 17.2 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.16 -171.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 72.3 ttt180 -112.46 138.06 49.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -143.05 125.24 15.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.4 t30 60.83 34.93 19.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.852 174.341 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.82 -6.44 74.29 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.499 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -122.53 145.31 48.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 0.0 110.915 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.854 ' HB3' HG13 ' A' ' 79' ' ' ILE . 3.6 tp -73.62 139.68 45.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -178.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.475 HD12 ' C ' ' A' ' 104' ' ' ILE . 2.5 pp -127.17 10.01 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 -173.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -173.26 169.63 4.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.093 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.483 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 89.4 m-85 -116.13 144.52 33.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.729 0.776 . . . . 0.0 110.88 166.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 15.0 Cg_exo -69.66 117.12 4.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.693 2.262 . . . . 0.0 112.316 172.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 29.7 mm -97.81 -47.01 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.14 154.98 38.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.108 -170.185 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.9 t -120.45 133.35 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 -178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -120.83 134.19 55.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.63 161.78 41.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.06 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.589 ' HG ' ' HA3' ' A' ' 228' ' ' GLY . 6.0 mp -112.58 159.07 19.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.899 -173.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.9 p -154.37 162.92 40.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.848 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -93.64 123.72 37.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.953 176.836 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.545 ' N ' HD22 ' A' ' 115' ' ' LEU . 47.0 mt -108.44 132.06 57.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 -174.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -135.09 151.4 50.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 -175.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -96.33 117.86 31.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -66.91 -17.51 64.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -73.09 -29.61 63.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.837 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.537 HD21 ' O ' ' A' ' 220' ' ' GLY . 7.2 mp -99.94 -49.62 4.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 18.0 mt -102.25 125.55 36.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.608 0.718 . . . . 0.0 110.899 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.36 -23.5 23.87 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.643 2.229 . . . . 0.0 112.331 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -153.07 130.0 5.69 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.637 0.732 . . . . 0.0 110.873 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.1 153.6 77.11 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.71 2.273 . . . . 0.0 112.363 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.34 144.83 41.97 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.717 2.278 . . . . 0.0 112.324 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -94.01 -28.74 15.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.929 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 79.8 p -130.13 156.11 45.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.426 ' HA ' HD13 ' A' ' 132' ' ' ILE . 26.9 t-105 -68.76 -24.47 64.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.9 -23.95 63.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.899 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.55 -23.2 53.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.585 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.5 mp -62.32 -51.87 70.57 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.685 0.755 . . . . 0.0 111.173 -170.513 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 39.7 Cg_endo -71.57 -39.09 3.84 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.66 2.24 . . . . 0.0 112.378 -171.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.37 -39.69 85.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.195 173.263 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.8 tp -60.89 -44.53 96.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.531 ' OD1' ' HB3' ' A' ' 146' ' ' ALA . 40.5 m-20 -49.72 -35.01 20.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.821 178.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.14 -34.55 68.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 -178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -74.61 -53.36 9.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -171.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.541 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.9 OUTLIER -80.08 -10.96 59.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -175.79 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.541 ' N ' HD23 ' A' ' 139' ' ' LEU . 86.3 tttt -55.39 -31.22 61.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 168.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.74 -25.02 67.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.141 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -95.0 7.66 45.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.45 26.89 66.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.462 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.463 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 42.1 mmtm -116.83 162.7 17.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.839 0.352 . . . . 0.0 110.911 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.0 t -127.14 132.37 50.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.884 175.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.687 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -80.57 -38.3 29.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.084 -162.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -139.78 130.21 25.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.915 -174.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.777 ' SD ' ' HB2' ' A' ' 213' ' ' ALA . 56.8 ttm -117.04 130.15 56.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -177.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -151.04 157.2 42.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.8 -171.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -101.21 98.13 8.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.787 HD21 HD11 ' A' ' 195' ' ' LEU . 0.8 OUTLIER -69.24 -36.98 77.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -76.23 -3.77 38.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.891 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -99.87 148.92 35.45 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.624 0.726 . . . . 0.0 110.908 174.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.469 ' HD3' ' HD3' ' A' ' 344' ' ' ARG . 24.9 Cg_endo -63.0 -18.69 66.52 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.723 2.282 . . . . 0.0 112.379 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -64.33 -40.87 96.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.514 ' CD2' HD23 ' A' ' 151' ' ' LEU . 90.4 t80 -86.22 -37.8 18.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.875 -176.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 60.7 p -61.13 -36.95 81.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.226 -170.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.551 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 78.8 t90 -69.22 -53.65 13.12 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.504 0.669 . . . . 0.0 110.84 -174.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 44.0 Cg_endo -67.86 -17.17 46.82 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.647 2.231 . . . . 0.0 112.446 -176.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.836 HD13 ' O ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER -82.5 -48.49 10.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 172.962 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 68.0 mt -74.84 -40.03 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.97 65.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.136 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -63.34 -34.86 78.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.059 -168.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -91.87 2.6 56.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 120.08 3.41 11.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.503 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.54 60.6 4.8 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.488 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -79.84 134.45 36.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 110.969 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.42 5.29 18.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 -174.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -147.04 149.99 34.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.907 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 79.2 tttt -103.87 122.45 45.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 158.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -118.81 122.1 41.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.968 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -152.36 130.83 12.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 55.42 39.08 31.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.81 16.54 80.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.03 138.14 50.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 110.888 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -96.45 144.89 26.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -129.31 104.94 7.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.894 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.496 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.4 pp -74.71 -11.21 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.204 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -97.56 -12.26 22.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 -174.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 51.4 t0 -124.3 62.54 1.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.11 174.9 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.167 -166.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -104.82 17.96 44.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.501 -164.143 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.5 m -100.2 -19.91 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 111.148 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -86.7 19.08 3.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -113.77 175.14 5.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.94 -25.28 67.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.89 -39.85 96.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.471 -172.65 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.656 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -68.77 -36.88 78.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 111.113 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.516 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 93.5 mttt -59.54 -33.25 71.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 174.831 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.0 69.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.152 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.19 -51.1 59.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.413 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.5 mt -64.51 -34.92 79.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.87 0.367 . . . . 0.0 110.916 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 94.9 m -56.81 -46.77 81.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.582 ' HD2' HD21 ' A' ' 160' ' ' LEU . 71.8 t80 -75.66 -44.89 40.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.787 HD11 HD21 ' A' ' 151' ' ' LEU . 7.7 tt -52.84 -44.41 66.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -171.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 34.9 m -70.45 -21.21 23.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.101 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.636 ' HB3' HD13 ' A' ' 198' ' ' LEU . 38.8 t70 -56.96 -49.87 74.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 -166.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.758 HD13 ' N ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -87.09 -30.47 21.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 -170.587 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.541 ' H ' HD22 ' A' ' 198' ' ' LEU . 2.3 pp -78.33 -34.28 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.01 -27.6 68.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 168.314 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -83.94 4.68 28.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 174.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 65.11 39.31 5.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.901 172.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -77.43 -8.63 58.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 27.9 ptm -144.17 159.59 42.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.871 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -98.78 159.27 15.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.36 -26.3 68.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.049 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -93.76 -2.13 54.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.3 m -64.26 135.0 55.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -144.66 169.3 18.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -68.43 -34.59 76.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.854 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 91.6 p -67.47 -33.18 74.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.795 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 82.6 mt -63.48 -39.3 84.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.125 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.777 ' HB2' ' SD ' ' A' ' 148' ' ' MET . . . -62.43 -40.06 95.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 234' ' ' ASN . 92.9 mt-10 -63.1 -40.74 98.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -70.0 -38.95 76.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.089 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.45 -33.17 74.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.185 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -60.05 -30.69 69.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -62.01 -36.31 81.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.77 -19.01 19.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.537 ' O ' HD21 ' A' ' 121' ' ' LEU . . . 87.78 28.03 25.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.459 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -81.92 -28.61 32.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 0.0 110.901 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 93.1 m -119.24 131.36 55.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.687 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -75.82 -47.14 26.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.065 -174.047 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 61.0 mtm -134.97 158.95 43.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.853 -174.516 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 9.6 t -149.15 166.33 29.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 mm -109.46 124.23 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 172.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -155.33 171.8 19.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.835 -170.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.589 ' HA3' ' HG ' ' A' ' 113' ' ' LEU . . . -155.56 -115.71 0.53 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.504 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.3 -22.84 74.71 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.681 2.254 . . . . 0.0 112.317 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -78.26 -10.8 59.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.998 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.93 -16.57 61.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.092 -170.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 36.1 p-90 -54.94 -30.0 57.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.981 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.5 t -50.16 -56.34 11.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 214' ' ' GLU . 49.3 t30 -163.79 64.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 32.1 mm . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 167.918 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.898 0.38 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -112.8 82.09 1.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -117.99 148.59 42.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.82 162.17 25.52 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.552 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.79 HG11 ' O ' ' A' ' 315' ' ' PRO . 10.1 p -144.04 138.49 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.942 0.401 . . . . 0.0 111.169 -175.053 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.6 t -150.68 149.2 29.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.106 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 30.4 m -63.62 168.44 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.135 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.809 ' HB3' ' HB2' ' A' ' 255' ' ' SER . 3.9 mm? -63.27 137.01 96.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.569 0.7 . . . . 0.0 110.903 -162.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -72.04 -172.68 0.89 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.359 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 82.5 p -105.67 151.79 23.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.134 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.402 ' HD2' ' HB3' ' A' ' 163' ' ' ALA . 33.5 t80 -136.48 120.48 17.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 176.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 56.55 35.5 26.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.81 9.3 74.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.486 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -129.97 140.88 39.98 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.722 . . . . 0.0 110.877 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.2 142.17 33.57 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.672 2.248 . . . . 0.0 112.35 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.809 ' HB2' ' HB3' ' A' ' 247' ' ' LEU . 64.3 m -85.3 0.83 50.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.823 173.133 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -45.01 112.49 1.53 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.61 0.719 . . . . 0.0 110.935 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.11 162.0 32.03 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.724 2.282 . . . . 0.0 112.325 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -72.98 152.5 41.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 -172.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.13 134.99 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.112 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -112.48 135.19 12.51 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.44 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.3 t -125.88 128.4 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.884 0.373 . . . . 0.0 111.147 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 108' ' ' ILE . 1.7 tt -69.99 130.13 41.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 77.3 p -122.23 135.92 54.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.825 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.458 ' HB1' HD11 ' A' ' 280' ' ' LEU . . . -124.8 127.53 47.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.12 -178.519 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.2 160.9 14.69 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.474 -170.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.41 ' HA ' HG22 ' A' ' 59' ' ' ILE . 20.6 mm -99.98 121.62 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.819 0.342 . . . . 0.0 111.129 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -66.68 129.5 40.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -175.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.42 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -60.67 -27.72 68.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.083 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.83 -11.77 57.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.041 -173.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.8 t -75.48 121.25 84.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.719 . . . . 0.0 110.934 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -68.76 -10.42 29.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.658 2.239 . . . . 0.0 112.286 167.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -102.44 17.65 23.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.937 -171.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -48.78 -34.84 13.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.884 -172.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -70.37 -48.26 57.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 -170.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.0 pp -81.76 -30.38 32.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.51 -46.28 73.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.09 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -67.53 -34.47 77.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 89.2 tt0 -63.92 -52.28 60.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 -173.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.491 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.2 p90 -69.99 -34.18 73.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.458 HD11 ' HB1' ' A' ' 264' ' ' ALA . 4.3 tt -58.38 -50.99 71.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -80.11 -31.26 39.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 61.9 m-80 -101.4 -28.94 12.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.921 -165.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.555 ' O ' HG22 ' A' ' 286' ' ' THR . 85.4 t80 -110.25 -43.4 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 -169.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.2 mp -72.54 -47.07 51.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.2 mp -83.33 61.29 6.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 283' ' ' TYR . 14.5 t -153.1 155.72 37.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.16 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.492 ' HA ' HD11 ' A' ' 290' ' ' LEU . 39.1 p-10 -52.41 -27.25 15.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.857 -168.437 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -78.23 -46.02 21.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.92 -49.39 17.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.449 -168.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.595 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.4 OUTLIER -74.96 -21.56 59.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 0.0 110.908 -178.986 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.427 ' N ' HD12 ' A' ' 290' ' ' LEU . 83.1 tt0 -67.22 -40.91 86.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.95 170.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.31 76.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.129 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.68 HG13 ' HA3' ' A' ' 19' ' ' GLY . 19.7 t -80.22 -43.67 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.134 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.405 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 41.7 t30 -65.77 -28.78 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.926 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.55 -26.01 67.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -82.33 -45.21 15.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.838 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -153.51 135.52 9.09 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.583 0.706 . . . . 0.0 110.947 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -49.3 114.66 1.39 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.632 2.221 . . . . 0.0 112.414 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 40.1 mt -92.74 -19.04 22.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 -177.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 114.94 -60.48 0.39 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -176.4 168.43 2.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.815 0.34 . . . . 0.0 111.064 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 30.3 m -124.62 157.7 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.157 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.96 -17.28 61.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.595 ' CD2' HD21 ' A' ' 290' ' ' LEU . 58.4 tp -81.0 123.5 28.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.977 -174.208 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -61.44 -33.25 73.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.89 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.2 m -61.84 -47.67 84.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.815 -170.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.454 ' CD2' HD23 ' A' ' 311' ' ' LEU . 20.8 t80 -89.11 -28.66 19.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -57.78 -42.63 84.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.909 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.68 -34.96 79.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -73.02 -45.55 57.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.692 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.4 pp -73.43 -27.04 61.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.874 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.41 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.58 -11.23 57.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.34 -15.98 61.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -86.24 128.76 56.25 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.539 0.685 . . . . 0.0 110.882 169.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.79 ' O ' HG11 ' A' ' 244' ' ' VAL . 83.6 Cg_exo -52.6 -31.69 50.8 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.518 ' HG3' HG13 ' A' ' 317' ' ' ILE . 27.6 ptt-85 -66.3 -31.05 71.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -171.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.692 HG21 ' CD1' ' A' ' 311' ' ' LEU . 63.3 mt -95.12 -37.38 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 -176.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.53 -44.5 62.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 -168.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.97 -42.4 80.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.053 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 71.9 p -63.85 -28.22 69.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' MET . . . . . 0.411 ' HE2' ' HA ' ' A' ' 321' ' ' MET . 33.5 mmt -66.75 -31.91 72.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -66.06 -44.18 85.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 327' ' ' GLY . 40.9 t30 -64.46 -37.21 86.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 174.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.7 -45.05 95.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.1 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -73.78 -34.37 64.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.9 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -100.49 -0.0 38.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -96.57 -155.63 30.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.408 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.56 139.19 42.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 0.0 110.922 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.587 ' O ' ' C ' ' A' ' 330' ' ' MET . 42.6 mm -76.69 110.01 11.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.1 -173.59 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.587 ' C ' ' O ' ' A' ' 329' ' ' ILE . 99.3 mmm . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 170.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.765 0.317 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 87.4 mmm -72.81 -26.12 61.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.953 -172.061 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.0 m -60.88 -41.43 95.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.4 -36.44 71.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -65.22 -37.73 88.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -61.04 -37.84 84.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -75.91 -35.26 59.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.92 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 367' ' ' ARG . . . -62.68 -41.27 99.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.134 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.6 m -79.86 -25.17 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.469 ' HD3' ' HD3' ' A' ' 154' ' ' PRO . 54.5 ttp85 -61.3 -45.31 94.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.821 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 84.6 m -57.23 -36.63 71.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.131 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.735 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -60.58 -43.93 96.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.116 -175.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 344' ' ' ARG . 2.0 m -73.75 -32.69 35.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.171 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.74 -46.21 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.196 173.087 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.489 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 89.5 m-20 -69.13 -34.97 75.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.47 -45.35 65.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.01 -41.18 87.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 89.3 p -77.19 -11.96 59.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.836 -175.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.31 14.06 82.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.576 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.75 -29.85 56.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.755 0.312 . . . . 0.0 110.85 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 86.9 mt-30 -135.63 157.26 47.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 175.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.4 p -77.64 169.77 17.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.197 168.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 69.5 t -55.55 -42.83 70.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 170.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -59.87 -45.28 92.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -71.25 -52.78 17.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.838 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.24 -45.04 74.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 -173.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -66.75 -39.95 88.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.907 -176.85 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.537 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 87.9 tttt -64.68 -39.62 93.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 177.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.82 -37.91 89.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.735 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -64.75 -45.83 84.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.074 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.537 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 1.2 pp0? -73.82 -30.09 62.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 56.8 m -64.04 -41.54 97.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.404 ' HB2' ' HB1' ' A' ' 342' ' ' ALA . 99.6 mtt180 -66.08 -39.07 89.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 70.4 mt -65.4 -37.86 81.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.209 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.3 p -92.37 -10.12 39.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.158 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.874 176.07 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.8 0.333 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 98.9 mt -91.44 125.03 44.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.132 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.31 146.07 36.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.855 -176.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.47 136.83 43.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.775 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.27 4.79 58.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.484 -174.299 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -169.89 153.22 4.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.869 0.366 . . . . 0.0 110.899 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.551 HD23 ' H ' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -151.68 157.0 41.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.495 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 89.8 t -110.65 135.63 49.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.738 HG22 ' CG1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -122.98 132.01 72.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.075 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.445 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 41.9 m0 -108.77 125.75 52.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.936 171.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 14.8 tt -106.3 150.02 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.094 -170.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -59.21 151.46 22.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.91 -15.73 21.69 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.511 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -75.06 -11.14 60.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.845 -172.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -147.84 137.75 22.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.943 160.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.15 -83.26 1.04 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.443 -167.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -110.52 -45.67 3.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.013 0.435 . . . . 0.0 110.942 -172.027 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -68.22 -51.93 39.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.944 -151.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.518 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -60.09 -48.05 88.0 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.582 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.686 ' CD2' HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -58.13 -45.61 87.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.369 . . . . 0.0 110.884 176.452 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.99 76.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -64.86 -48.25 74.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 -177.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.0 m -74.38 -36.05 41.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.442 ' CA ' HG11 ' A' ' 35' ' ' VAL . . . -66.68 -48.34 62.55 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.576 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -65.45 -39.26 91.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.999 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -64.47 -41.58 96.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.457 ' CD2' HD11 ' A' ' 33' ' ' ILE . 63.1 t80 -65.42 -38.0 88.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.55 -41.76 99.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.89 -31.92 69.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.822 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -82.43 -40.48 21.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -171.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.636 ' OG1' HG13 ' A' ' 33' ' ' ILE . 60.8 p -102.61 -9.46 20.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.11 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.44 9.73 84.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.56 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.036 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 pp -103.91 132.15 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.011 0.434 . . . . 0.0 111.07 -175.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -71.11 127.78 33.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.957 -168.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.474 HG22 HD21 ' A' ' 7' ' ' LEU . 99.2 t -110.67 122.06 64.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.086 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.457 ' HB ' HG22 ' A' ' 8' ' ' VAL . 99.7 m -111.57 117.94 34.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.146 -175.173 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.522 HG22 HD13 ' A' ' 20' ' ' LEU . 84.7 t -93.78 134.98 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.061 176.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.445 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 74.5 mm-40 -121.58 162.95 19.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.861 173.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.4 t-80 -84.9 139.73 37.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.615 0.722 . . . . 0.0 110.897 -167.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 70.9 Cg_exo -60.49 -16.85 44.71 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.754 2.303 . . . . 0.0 112.307 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -49.21 -56.37 9.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.936 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -86.69 1.31 52.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -175.295 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.53 HD11 ' O ' ' A' ' 61' ' ' PHE . 9.4 tt -43.65 -53.34 5.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 -175.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -71.28 -43.8 66.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.21 -48.05 16.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.879 -161.588 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HG2' HG13 ' A' ' 50' ' ' VAL . 84.3 tttt -84.58 -33.09 23.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -170.178 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 90.3 t80 -47.8 -53.54 30.61 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.69 0.757 . . . . 0.0 110.9 -172.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 31.5 Cg_endo -61.99 -29.31 81.62 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.612 2.208 . . . . 0.0 112.375 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -74.78 -43.47 54.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.456 HG13 ' HG2' ' A' ' 46' ' ' LYS . 35.7 m -74.97 -25.12 18.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.219 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.43 -33.9 74.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.13 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.18 -27.14 66.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.02 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.3 p -91.83 -13.6 31.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.164 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.26 14.27 82.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.478 170.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -145.89 137.29 24.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 0.0 110.876 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.446 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . 165.01 -131.2 2.34 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.466 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.495 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 54.1 Cg_endo -62.83 139.06 72.38 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.666 2.244 . . . . 0.0 112.372 171.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.449 ' HB2' HD13 ' A' ' 59' ' ' ILE . 2.6 m-20 -86.57 -35.03 19.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 171.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.738 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -132.51 148.12 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.134 177.622 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.7 tp -127.98 127.16 67.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.154 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.53 ' O ' HD11 ' A' ' 43' ' ' LEU . 9.1 m-85 -99.86 125.52 45.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.428 ' CG ' ' N ' ' A' ' 63' ' ' ALA . 41.6 t-105 -145.02 -175.81 4.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.928 169.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.428 ' N ' ' CG ' ' A' ' 62' ' ' TRP . . . -90.52 -87.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.136 173.73 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -126.23 -58.14 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.93 -44.4 96.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 -151.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -66.57 -28.52 68.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.836 -170.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -51.86 -42.9 62.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.868 -175.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.63 -49.66 74.26 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.531 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.84 -43.35 99.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.568 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -66.52 -46.97 74.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 110.874 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.91 -43.91 91.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.154 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.93 -34.96 79.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.016 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.5 m -84.91 -7.03 59.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.91 29.54 60.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.491 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.1 mp -84.13 -12.1 55.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.819 0.342 . . . . 0.0 110.837 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.598 HD11 HG22 ' A' ' 104' ' ' ILE . 4.4 pp -131.2 143.17 50.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.956 -177.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -79.65 144.94 33.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.45 134.2 48.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.864 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.802 HG13 ' HB3' ' A' ' 103' ' ' LEU . 36.4 pt -110.39 160.72 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.18 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.6 p -103.68 141.62 22.88 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.621 0.724 . . . . 0.0 111.065 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.79 145.19 31.99 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.728 2.285 . . . . 0.0 112.386 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -111.53 119.52 39.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.66 -41.63 98.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.897 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.45 89.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -73.43 -33.75 65.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.495 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.3 tt0 -53.6 -49.0 68.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.901 174.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -60.6 -34.98 75.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.01 -22.9 52.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.822 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -103.22 -109.43 0.25 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.813 -173.316 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -169.9 133.13 1.1 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.599 0.714 . . . . 0.0 110.992 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.8 -40.12 81.38 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.685 2.257 . . . . 0.0 112.303 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -69.13 -29.95 68.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -171.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 107' ' ' PRO . 54.3 p -73.38 -31.36 63.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.112 -174.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.598 ' HA ' HG22 ' A' ' 97' ' ' VAL . 81.0 m95 -71.89 -25.47 61.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.042 174.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.53 -38.33 71.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.779 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.33 -26.98 63.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 94' ' ' TRP . 19.7 m -100.01 15.44 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.132 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 34.8 ttp-105 -110.2 141.85 42.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.788 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -138.83 122.76 17.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.864 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 59.82 34.94 21.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.945 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.24 -2.64 84.08 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.451 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.56 144.52 48.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 0.0 110.912 174.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.802 ' HB3' HG13 ' A' ' 79' ' ' ILE . 4.9 tp -79.5 138.51 37.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.803 -173.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.598 HG22 HD11 ' A' ' 76' ' ' LEU . 2.5 pp -126.93 1.53 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 -171.511 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -167.14 168.41 13.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.448 ' CZ ' HD12 ' A' ' 79' ' ' ILE . 93.6 m-85 -114.52 139.91 24.56 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.676 0.751 . . . . 0.0 110.962 170.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.476 ' HB3' ' HB ' ' A' ' 93' ' ' THR . 74.1 Cg_endo -73.74 120.16 6.28 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.75 2.3 . . . . 0.0 112.368 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.6 mm -100.13 -56.13 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.587 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -142.16 154.87 45.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.162 -166.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.0 t -120.7 136.85 56.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.111 -169.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -126.34 131.1 51.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -148.8 157.91 43.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.122 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.519 ' CD2' ' HA3' ' A' ' 228' ' ' GLY . 72.5 mt -102.02 168.76 9.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.89 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.8 p -155.93 158.15 37.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.931 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -96.26 127.74 42.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.889 172.594 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.554 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.9 mp -110.95 133.05 57.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.066 -175.007 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -132.57 149.98 52.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.913 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -88.05 111.77 21.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.854 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.427 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 88.6 tttt -62.69 -22.9 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -76.54 -22.5 54.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.866 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.459 HD21 ' O ' ' A' ' 220' ' ' GLY . 7.0 mp -97.46 -49.23 4.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.823 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.509 HD11 ' HB1' ' A' ' 223' ' ' ALA . 22.8 mt -107.17 132.49 20.89 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 110.898 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.04 -20.68 28.57 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.632 2.221 . . . . 0.0 112.384 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.573 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 20.3 p30 -154.26 161.72 28.63 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.685 0.755 . . . . 0.0 110.805 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.573 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 58.8 Cg_endo -70.23 158.5 56.16 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 0.0 112.388 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.48 148.33 66.65 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.679 2.253 . . . . 0.0 112.306 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -103.54 -44.99 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.8 p -133.24 157.88 44.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.14 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -70.02 -24.89 63.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.92 -19.81 66.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -73.99 -30.13 62.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.483 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 1.4 mp -63.34 -47.76 83.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.63 0.728 . . . . 0.0 111.138 -167.236 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.483 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 85.3 Cg_exo -53.93 -51.62 10.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.569 2.179 . . . . 0.0 112.293 -176.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.6 -40.45 73.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.6 tp -54.55 -43.46 72.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.904 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.422 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . 1.8 m-20 -50.09 -44.29 51.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.816 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.77 -33.48 75.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 -176.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.8 -46.93 27.95 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 -173.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.422 ' CD2' ' HA ' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -90.53 -19.95 23.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.872 -173.026 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 85.8 tttt -61.81 -26.39 68.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.901 170.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.89 -24.94 67.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.111 171.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -95.37 8.88 41.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.81 28.08 65.68 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.501 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 89.3 mttt -117.26 170.03 9.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 110.908 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.4 t -131.53 142.23 49.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.803 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -73.14 -51.3 18.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.049 -170.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -139.24 130.78 27.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.91 -169.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.415 ' SD ' ' OG1' ' A' ' 222' ' ' THR . 94.9 mtp -117.9 129.76 55.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.853 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -153.47 162.94 40.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.884 -169.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -95.81 104.37 16.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.027 169.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.752 HD21 HD11 ' A' ' 195' ' ' LEU . 0.7 OUTLIER -75.05 -35.96 61.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 177.271 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLN . . . . . 0.484 ' HA ' HD11 ' A' ' 348' ' ' ILE . 88.2 mt-30 -78.69 0.13 27.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.826 -175.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -106.82 150.44 39.72 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.635 0.731 . . . . 0.0 110.962 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.11 -20.31 69.39 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.691 2.26 . . . . 0.0 112.321 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -59.86 -44.07 94.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.011 -172.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -84.89 -39.99 17.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.863 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.0 p -64.02 -37.88 89.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.198 -169.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.569 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 19.9 t-105 -64.36 -55.47 30.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.583 0.706 . . . . 0.0 110.872 -173.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 23.6 Cg_endo -65.96 -30.74 48.03 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.616 2.211 . . . . 0.0 112.513 -171.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.692 HD23 ' O ' ' A' ' 160' ' ' LEU . 6.4 tt -72.89 -41.77 64.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.978 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 69.1 mt -73.81 -39.75 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.026 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.37 -33.17 67.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.17 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.468 ' HB3' ' HD2' ' A' ' 250' ' ' PHE . . . -61.7 -36.41 80.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.99 -168.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -89.12 1.03 56.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 121.84 1.22 10.73 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.49 169.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.36 64.99 3.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.446 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -86.71 132.88 33.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.868 0.366 . . . . 0.0 110.926 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.35 10.2 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.445 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.1 p90 -147.27 153.88 40.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -105.87 126.61 52.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 158.076 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -116.27 126.72 53.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.931 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -151.78 129.78 11.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.885 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.5 t30 55.07 44.55 27.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.04 14.0 82.19 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.484 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -129.92 139.62 51.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 110.887 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -99.98 145.96 27.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 170.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -121.26 110.1 15.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.839 171.128 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.512 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.3 pp -80.0 -11.92 12.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.189 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.77 -12.71 19.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -123.33 88.17 2.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 169.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 169' ' ' PHE . 33.5 m -116.58 170.96 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.177 -168.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.04 26.11 23.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.484 -168.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.511 HG21 HD12 ' A' ' 368' ' ' ILE . 12.6 m -109.9 -13.66 10.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.81 0.338 . . . . 0.0 111.145 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -85.07 20.04 2.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -112.81 -176.8 2.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.878 -175.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.51 -25.09 63.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 190' ' ' ALA . . . -72.01 -42.43 51.94 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.492 -169.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.624 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -63.26 -36.75 84.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.353 . . . . 0.0 111.038 176.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.511 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.2 mttt -59.97 -34.09 72.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 173.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 187' ' ' GLY . . . -65.15 -31.85 73.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.091 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.64 -45.48 95.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.439 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 192' ' ' LEU . 21.7 mt -64.98 -38.34 90.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.857 0.36 . . . . 0.0 110.902 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.9 m -57.56 -46.32 84.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.275 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -73.49 -47.75 38.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.752 HD11 HD21 ' A' ' 151' ' ' LEU . 6.8 tt -53.72 -47.14 70.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 -170.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 30.3 m -67.96 -18.82 24.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 -176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -59.99 -58.08 10.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -171.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 1.049 ' H ' HD13 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.67 -23.73 56.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.908 -166.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.603 ' H ' HD22 ' A' ' 198' ' ' LEU . 2.0 pp -83.77 -36.41 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 174.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.36 -32.6 73.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 168.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -82.25 4.1 24.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 65.06 39.79 5.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 168.78 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -85.88 -14.94 43.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.784 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -146.64 161.85 39.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.926 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -99.88 150.5 22.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.849 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.59 -25.83 68.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.5 p-10 -93.78 5.34 51.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 59.7 m -62.55 129.99 43.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.086 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -137.45 169.83 17.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.957 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -63.91 -42.68 97.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.3 m -64.77 -39.45 93.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.11 -40.03 86.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.154 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.81 -37.34 87.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.086 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -63.17 -40.47 97.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.925 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.91 94.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 175.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.92 -38.25 90.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -61.58 -42.04 98.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -57.94 -32.31 67.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.799 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -89.39 -23.8 22.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.459 ' O ' HD21 ' A' ' 121' ' ' LEU . . . 90.51 25.78 24.81 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.504 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.59 -23.98 21.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.922 0.391 . . . . 0.0 110.877 -173.03 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.415 ' OG1' ' SD ' ' A' ' 148' ' ' MET . 99.8 m -119.11 128.76 54.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 -176.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.509 ' HB1' HD11 ' A' ' 122' ' ' LEU . . . -65.58 -52.07 54.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.052 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.455 ' HB3' HD21 ' A' ' 115' ' ' LEU . 71.2 mtm -135.65 156.26 49.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.859 -169.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.3 t -150.82 161.56 42.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 44.6 mm -110.05 124.25 66.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.158 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -154.34 170.63 20.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.804 -166.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.519 ' HA3' ' CD2' ' A' ' 113' ' ' LEU . . . -157.16 -113.69 0.41 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.522 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.411 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 40.4 Cg_endo -61.29 -22.34 74.32 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.618 2.212 . . . . 0.0 112.366 173.888 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -78.89 -16.51 56.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.05 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.29 -23.7 67.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.057 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -60.04 -23.13 63.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.928 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 42.9 t -57.65 -59.64 4.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -152.03 45.56 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -173.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.0 mm . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.164 168.646 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.909 0.385 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -100.0 70.0 1.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.427 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 87.0 m-85 -130.91 146.67 52.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.019 174.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -130.95 155.66 21.36 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.487 HG22 ' CB ' ' A' ' 319' ' ' ALA . 3.3 p -134.79 134.88 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.961 0.41 . . . . 0.0 111.167 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.9 t -154.41 149.76 27.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.071 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 27.9 m -59.93 162.03 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.116 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 247' ' ' LEU . 5.5 mp -70.48 150.11 95.63 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.577 0.703 . . . . 0.0 110.906 -159.382 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.48 -179.24 2.66 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.706 2.271 . . . . 0.0 112.347 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 52.1 p -101.02 161.19 13.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.131 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.468 ' HD2' ' HB3' ' A' ' 163' ' ' ALA . 55.0 t80 -138.6 119.56 14.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 55.53 33.69 21.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.97 -169.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.15 9.77 72.77 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.529 171.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.478 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 86.1 mm-40 -132.66 129.46 21.33 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.651 0.738 . . . . 0.0 110.879 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 60.2 Cg_exo -59.59 144.8 99.34 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.577 2.185 . . . . 0.0 112.327 -175.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 65.2 p -88.65 16.69 6.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.809 171.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -43.05 112.34 1.17 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.634 0.731 . . . . 0.0 110.903 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.18 160.38 32.98 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.754 2.302 . . . . 0.0 112.326 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -72.51 161.55 30.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.801 -171.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 56.2 t -109.06 136.17 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.057 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -113.43 131.09 9.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.511 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.9 t -121.13 119.11 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 111.166 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.401 ' C ' ' CD2' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -67.91 117.94 10.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 175.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 19.4 m -130.6 151.29 51.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 -170.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.06 129.79 44.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.15 -171.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -118.07 168.45 13.09 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.45 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.553 HD13 HG22 ' A' ' 59' ' ' ILE . 23.9 mm -99.68 126.84 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.0 111.183 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -68.36 129.3 39.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.853 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.429 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -66.2 -24.21 66.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.096 -176.228 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.91 -11.08 58.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.041 -171.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.6 t -75.97 120.28 80.98 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.642 0.734 . . . . 0.0 110.898 -176.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -69.0 -11.78 32.7 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.294 168.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -111.76 36.1 3.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.878 -171.012 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.85 -25.07 66.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 -167.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -71.32 -38.51 71.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' A' ' 7' ' ' LEU . 37.8 tp -63.13 -48.65 77.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 173.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.615 ' HB1' HG23 ' A' ' 59' ' ' ILE . . . -69.05 -48.8 61.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.093 -173.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -63.82 -41.58 97.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -66.27 -54.57 23.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 -173.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.411 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -68.31 -34.0 75.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 -173.578 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 280' ' ' LEU . 4.8 tt -56.0 -45.54 79.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.875 176.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -72.93 -42.68 63.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -102.35 -9.3 20.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.889 -159.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 67.9 t80 -123.33 -48.65 1.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.0 OUTLIER -68.56 -46.59 69.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.487 ' HA ' HD13 ' A' ' 285' ' ' LEU . 0.8 OUTLIER -82.92 63.24 6.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 174.546 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.491 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 30.1 p -143.51 150.18 38.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.172 170.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.561 ' HA ' HD11 ' A' ' 290' ' ' LEU . 41.4 p-10 -53.19 -25.24 13.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -79.5 -44.08 21.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.49 -50.57 25.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.432 -170.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.561 HD11 ' HA ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -73.97 -21.27 60.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.43 ' N ' HD12 ' A' ' 290' ' ' LEU . 82.8 tt0 -66.07 -42.31 89.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 169.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.32 -34.77 75.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.518 HG13 ' HA3' ' A' ' 19' ' ' GLY . 21.6 t -76.83 -41.91 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.173 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.49 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 52.6 t30 -64.96 -25.42 67.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.981 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -66.83 -30.95 71.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.9 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -88.79 -40.87 12.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -141.97 130.05 11.79 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.514 0.673 . . . . 0.0 110.911 172.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.09 111.59 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.642 2.228 . . . . 0.0 112.376 174.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.49 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 43.0 mt -93.32 -13.1 28.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.016 -171.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.44 -53.71 1.0 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.433 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -173.77 166.15 4.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.795 0.331 . . . . 0.0 111.02 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.587 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 31.3 m -123.76 156.49 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.166 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 89' ' ' LEU . . . -69.96 -17.16 63.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.018 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' A' ' 89' ' ' LEU . 57.6 tp -85.87 120.69 27.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.049 -171.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.2 -40.02 70.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.926 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.8 m -64.55 -50.33 67.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -167.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.477 ' HB3' HG21 ' A' ' 302' ' ' VAL . 38.2 t80 -81.13 -26.73 35.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.11 -42.28 94.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.4 -34.46 76.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.831 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -70.62 -48.53 54.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.652 HD13 HD13 ' A' ' 317' ' ' ILE . 4.6 pp -66.72 -28.81 68.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.856 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.461 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.95 -11.12 58.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.053 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.94 -15.57 62.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -79.78 128.66 73.61 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.633 0.73 . . . . 0.0 110.805 170.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -49.21 -38.37 41.17 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.678 2.252 . . . . 0.0 112.305 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.482 ' HA ' HG11 ' A' ' 244' ' ' VAL . 8.5 ptp85 -71.26 -24.83 62.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.918 -169.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.652 HD13 HD13 ' A' ' 311' ' ' LEU . 78.9 mt -92.26 -32.45 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.09 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.91 -34.95 63.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.059 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.487 ' CB ' HG22 ' A' ' 244' ' ' VAL . . . -65.01 -45.58 84.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.058 174.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 68.7 p -69.01 -24.38 64.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.162 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 87.6 mmm -58.84 -36.39 74.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -69.47 -46.92 65.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 327' ' ' GLY . 34.7 t30 -66.04 -36.01 82.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.995 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.28 84.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -72.62 -35.07 67.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -94.97 -1.83 51.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -100.01 -161.62 28.61 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.458 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -140.8 141.5 34.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 110.812 -176.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.605 ' O ' ' C ' ' A' ' 330' ' ' MET . 18.8 mm -81.74 100.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.094 -169.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.605 ' C ' ' O ' ' A' ' 329' ' ' ILE . 95.3 mtp . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.55 0.691 . . . . 0.0 110.88 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.751 0.31 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 79.4 mmm -72.38 -24.0 61.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.8 m -63.59 -39.2 93.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -77.35 -35.4 54.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.136 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -62.66 -39.24 93.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.855 174.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -58.38 -36.28 73.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.809 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -75.9 -37.1 59.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.933 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.05 94.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.135 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.2 m -80.2 -25.46 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.177 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 347' ' ' VAL . 7.3 tmm_? -64.39 -43.33 94.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 173.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.5 m -58.67 -34.62 71.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.166 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -58.93 -42.22 89.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 -177.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 344' ' ' ARG . 1.3 m -74.08 -32.85 33.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -174.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 152' ' ' GLN . 1.6 mp -62.01 -48.74 87.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.184 173.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 86.5 m-20 -65.6 -38.12 88.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.85 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.71 -46.22 63.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.188 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.15 -42.03 85.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.025 -176.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.6 p -76.5 -11.24 59.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.11 13.57 82.81 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.547 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.18 -31.36 58.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 110.883 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.498 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 90.9 mt-30 -136.33 159.53 41.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.4 p -78.45 169.75 17.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.131 168.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 72.9 t -55.52 -43.83 73.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.125 170.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -59.64 -44.79 93.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -70.44 -52.39 22.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.79 -45.93 70.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.079 -173.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.624 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -65.21 -40.01 93.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -177.404 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.0 tttt -65.3 -38.35 89.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 176.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -65.04 -38.91 92.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.795 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -64.79 -46.47 81.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.085 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 5.0 pp0? -70.55 -31.39 68.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.979 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 81.8 m -65.69 -42.63 91.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.199 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.29 -36.56 81.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.799 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.511 HD12 HG21 ' A' ' 183' ' ' VAL . 64.0 mt -64.96 -39.82 86.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.189 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.3 p -91.51 -11.05 38.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.195 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.917 176.71 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.806 0.336 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 83.6 mt -95.67 135.1 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.102 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -149.43 142.1 24.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -55.12 137.4 46.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.463 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 97.77 1.85 58.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.544 -172.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -166.1 149.16 7.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.837 0.351 . . . . 0.0 110.968 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.703 HD22 HD13 ' A' ' 33' ' ' ILE . 1.6 pt? -148.73 153.51 38.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 69.9 t -108.84 138.67 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.104 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.813 HG13 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -122.21 132.55 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.001 177.018 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.479 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 45.2 m0 -108.82 127.81 54.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.887 172.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.551 ' HB ' HD22 ' A' ' 20' ' ' LEU . 7.2 tt -109.76 148.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.22 -168.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -57.28 146.86 27.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.888 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.89 -12.93 16.69 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.459 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -75.15 -10.29 59.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 110.842 -173.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -150.12 135.39 18.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 162.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.14 -84.71 1.0 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 -166.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -113.19 -45.65 3.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.923 0.392 . . . . 0.0 110.922 -170.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -68.05 -52.83 30.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.908 -149.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.63 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -63.17 -46.85 92.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.513 -176.359 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.813 HD21 HG13 ' A' ' 9' ' ' ILE . 17.7 tp -65.69 -39.94 91.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.839 0.352 . . . . 0.0 110.879 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.74 72.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.082 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -65.75 -48.23 72.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 m -75.36 -36.07 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.065 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.455 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -66.94 -46.41 73.95 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.444 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -65.58 -40.37 92.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.961 -176.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.94 -40.45 95.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.404 ' CE2' HD11 ' A' ' 33' ' ' ILE . 78.0 t80 -64.81 -39.34 93.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.05 -40.04 79.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.913 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -69.1 -30.02 68.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -84.42 -40.13 18.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.803 -170.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.604 ' OG1' HG13 ' A' ' 33' ' ' ILE . 62.3 p -103.79 -12.32 17.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.48 7.93 87.79 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.496 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.849 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.6 pp -102.7 132.54 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 111.105 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -71.17 130.16 40.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 -168.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.517 HG22 HD21 ' A' ' 7' ' ' LEU . 90.0 t -110.57 120.17 60.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.5 m -113.62 118.03 33.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.159 -173.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.497 HG22 ' HG ' ' A' ' 20' ' ' LEU . 92.3 t -94.41 134.11 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.479 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 73.5 mm-40 -119.8 161.63 20.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.9 t-80 -83.41 139.38 41.51 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.626 0.727 . . . . 0.0 110.771 -168.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 75.6 Cg_exo -56.59 -25.09 57.39 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.768 2.312 . . . . 0.0 112.303 -176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -47.64 -50.18 25.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -173.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -86.61 -8.56 57.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.487 HD11 ' O ' ' A' ' 61' ' ' PHE . 9.4 tt -46.73 -54.28 10.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.896 -167.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -75.03 -34.69 61.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -71.69 -48.87 44.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -168.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -87.2 -28.63 22.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 -170.207 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.559 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 91.5 t80 -47.49 -51.66 42.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.769 0.795 . . . . 0.0 110.922 -166.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 59.7 Cg_endo -68.3 -28.98 32.75 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.725 2.283 . . . . 0.0 112.296 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -76.56 -43.66 37.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.67 -24.96 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.127 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.86 -32.71 74.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.049 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.5 -27.65 67.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.03 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.2 p -94.61 -13.85 25.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.114 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.74 15.6 81.19 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.405 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -142.55 130.42 21.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.831 0.348 . . . . 0.0 110.998 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.69 -115.09 0.57 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.58 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.437 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 84.4 Cg_endo -70.32 146.48 56.83 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.306 168.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -90.72 -36.34 14.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 169.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.691 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -138.46 150.04 24.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.175 176.989 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.0 tp -126.44 125.25 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 -169.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.523 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 4.8 m-85 -110.06 126.38 53.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 20.7 t-105 -143.1 -171.51 3.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 169.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.16 -89.53 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.119 171.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -106.55 -54.79 2.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.835 -172.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.49 -38.59 63.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.902 -158.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -74.46 -18.76 60.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 -169.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -39.99 -55.32 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.47 -38.43 44.72 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.493 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.32 -57.78 11.06 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 -171.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.579 ' HD1' HD22 ' A' ' 76' ' ' LEU . 8.8 p90 -85.79 -27.06 25.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.935 0.398 . . . . 0.0 110.93 -172.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.421 ' N ' ' CD1' ' A' ' 70' ' ' TYR . . . -71.62 -57.25 4.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.091 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -65.55 -32.02 73.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 -176.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.3 m -82.21 -7.88 59.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.58 30.42 68.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.503 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.447 ' HA ' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -87.45 -4.23 59.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.842 0.353 . . . . 0.0 110.835 -174.894 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.579 HD22 ' HD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -125.68 147.94 49.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -177.117 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.96 143.7 37.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.033 171.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -71.79 135.1 46.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.866 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.894 HG13 ' HB3' ' A' ' 103' ' ' LEU . 37.9 pt -117.31 164.97 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.087 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.2 p -115.81 150.03 44.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.543 0.687 . . . . 0.0 111.181 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.45 146.42 44.55 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.683 2.255 . . . . 0.0 112.32 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -105.65 119.92 40.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.828 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.03 -41.93 99.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.41 -45.02 89.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.53 ' HB3' ' HZ2' ' A' ' 94' ' ' TRP . 7.4 m-85 -72.4 -33.32 67.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.494 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.5 tt0 -52.1 -46.64 65.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.27 -36.14 82.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 174.411 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -78.86 -24.42 44.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.815 -173.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.3 OUTLIER -104.96 -105.04 0.31 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -172.164 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.467 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 39.7 t80 -164.6 129.63 1.97 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.671 0.748 . . . . 0.0 110.983 -174.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 96.9 Cg_exo -57.15 -43.03 56.98 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.62 2.213 . . . . 0.0 112.421 -169.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -72.44 -26.35 61.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.964 -173.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.645 ' CG2' ' HB3' ' A' ' 107' ' ' PRO . 96.7 m -69.75 -40.01 76.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.151 -174.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.587 ' HA ' HG22 ' A' ' 97' ' ' VAL . 92.2 m95 -65.68 -27.6 68.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.985 174.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -71.76 -35.24 70.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.54 -27.39 63.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.081 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.587 HG22 ' HA ' ' A' ' 94' ' ' TRP . 19.4 m -101.2 16.36 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.129 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.455 ' HB2' HD12 ' A' ' 103' ' ' LEU . 75.2 ttt180 -113.48 137.42 51.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -144.29 127.7 16.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.1 t30 62.19 34.78 15.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.899 174.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.82 -6.24 71.26 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.44 172.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -124.05 147.25 47.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.965 173.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.894 ' HB3' HG13 ' A' ' 79' ' ' ILE . 4.2 tp -73.28 139.99 46.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.924 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.46 HD12 ' C ' ' A' ' 104' ' ' ILE . 2.5 pp -126.28 10.01 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.012 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -170.72 162.12 7.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -112.75 145.67 33.48 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.738 0.78 . . . . 0.0 110.914 164.455 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.645 ' HB3' ' CG2' ' A' ' 93' ' ' THR . 90.9 Cg_endo -75.63 118.52 5.13 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.668 2.246 . . . . 0.0 112.386 173.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 27.3 mm -94.75 -49.35 12.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.097 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.74 157.57 43.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.129 -170.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.7 t -121.46 134.64 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 -173.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -115.85 138.01 51.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.847 169.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -151.48 160.04 43.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.023 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.424 ' HG ' ' HA3' ' A' ' 228' ' ' GLY . 7.0 mp -109.72 158.09 18.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 -170.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.5 p -154.82 161.9 41.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.925 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.93 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.98 128.19 46.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.996 176.157 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.569 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.3 mp -109.64 130.97 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.099 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -133.17 153.42 51.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.525 HD22 ' HD1' ' A' ' 217' ' ' PHE . 31.6 m120 -93.02 116.69 29.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.877 176.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.04 -20.22 66.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.854 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 11.8 t70 -77.33 -29.89 53.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.841 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.664 HD21 ' O ' ' A' ' 220' ' ' GLY . 8.8 mp -95.17 -47.91 6.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.6 mt -102.28 115.02 65.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.535 0.683 . . . . 0.0 111.032 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.79 -27.09 21.99 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.646 2.231 . . . . 0.0 112.333 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 60.5 t-20 -145.95 102.47 4.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.587 0.708 . . . . 0.0 110.88 173.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.0 Cg_endo -71.02 146.17 51.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.677 2.251 . . . . 0.0 112.324 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 150.83 62.89 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.384 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -110.47 -6.34 14.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.971 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 79.1 p -131.15 157.4 43.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.226 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -66.74 -30.63 70.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.998 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.06 -26.14 68.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.928 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -78.96 -23.32 44.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.61 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.5 mp -60.94 -51.21 81.0 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.645 0.736 . . . . 0.0 111.153 -169.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.5 Cg_endo -71.18 -40.63 3.1 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.62 2.213 . . . . 0.0 112.439 -170.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.31 -41.93 80.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.954 HD23 ' O ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -56.8 -42.8 80.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.973 172.299 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.427 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . 24.7 t70 -54.39 -35.34 62.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.772 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.0 -34.31 75.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.819 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -76.29 -51.75 11.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.864 -172.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.575 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.8 OUTLIER -80.04 -10.06 59.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.839 -176.088 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.575 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.1 tttt -55.41 -31.99 62.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 167.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.66 -24.34 67.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.97 5.53 51.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.5 25.56 67.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.482 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.481 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 41.4 mmtm -118.35 165.81 13.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.886 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.6 t -126.67 142.03 51.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.831 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.17 -58.38 4.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.094 -166.367 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.415 HD13 ' C ' ' A' ' 147' ' ' LEU . 3.0 tm? -139.96 124.58 18.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.937 -168.125 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 58.0 ttm -109.93 128.82 55.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -155.83 157.18 36.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.832 -171.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -99.98 81.82 2.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.868 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.902 HD21 HD11 ' A' ' 195' ' ' LEU . 1.2 tm? -56.17 -32.52 64.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.876 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.37 9.53 3.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -108.73 145.01 30.76 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.597 0.713 . . . . 0.0 110.933 170.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.7 -24.91 68.88 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.706 2.271 . . . . 0.0 112.349 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -69.4 -32.11 70.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -87.98 -30.82 19.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.87 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 57.2 p -66.4 -32.46 73.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.233 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.587 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 29.8 t-105 -61.94 -55.57 40.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.903 -171.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 13.4 Cg_endo -61.13 -36.79 79.5 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.703 2.269 . . . . 0.0 112.481 -171.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 160' ' ' LEU . 6.3 tt -72.59 -43.0 63.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 73.3 mt -70.64 -40.04 76.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.66 -30.48 62.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.11 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.514 ' HB3' ' HD2' ' A' ' 250' ' ' PHE . . . -63.29 -34.48 77.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 -169.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -92.57 3.03 56.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.968 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.21 1.96 13.87 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.462 169.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.17 65.55 3.96 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.472 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -86.31 134.12 33.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.821 0.343 . . . . 0.0 110.964 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.61 7.14 10.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.106 -170.789 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.44 ' HA ' HG12 ' A' ' 181' ' ' VAL . 50.3 p90 -150.06 154.37 38.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.951 0.405 . . . . 0.0 110.931 -175.496 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -102.61 127.71 49.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.92 155.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -118.19 124.42 47.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.017 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -153.05 132.21 12.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.05 42.03 31.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.912 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.94 16.06 80.69 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.507 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -130.03 138.62 50.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.764 0.316 . . . . 0.0 110.923 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -95.78 143.42 27.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.863 169.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -121.39 109.83 15.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.932 172.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.626 HD12 ' O ' ' A' ' 178' ' ' ILE . 1.0 OUTLIER -79.24 -12.3 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.164 -178.225 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.7 -12.06 24.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.896 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -123.83 89.28 3.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.833 169.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 169' ' ' PHE . 32.9 m -117.17 166.48 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.087 -171.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.01 24.0 29.3 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.514 -170.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.492 HG21 HD12 ' A' ' 368' ' ' ILE . 13.8 m -108.9 -15.4 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 111.112 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -85.26 19.92 2.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -112.14 -178.25 3.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.95 -24.86 63.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.999 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.98 -40.5 73.45 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.438 -171.003 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.633 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.68 -37.32 87.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.872 0.367 . . . . 0.0 111.124 176.667 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.504 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.0 mttt -59.98 -34.21 72.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.953 173.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.09 -30.9 71.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.42 93.9 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.458 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 347' ' ' VAL . 24.9 mt -66.03 -37.52 86.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.952 0.406 . . . . 0.0 110.916 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.2 m -56.67 -45.27 81.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.226 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -75.26 -44.57 45.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.902 HD11 HD21 ' A' ' 151' ' ' LEU . 8.7 tt -56.99 -53.66 55.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.936 -172.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.526 ' HA ' HD13 ' A' ' 199' ' ' ILE . 13.6 m -64.96 -21.2 29.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.185 -176.111 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.33 -29.9 66.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.813 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -71.4 -48.88 47.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 177.053 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.823 ' H ' HD12 ' A' ' 199' ' ' ILE . 2.6 mp -64.23 -36.66 77.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.151 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.95 -39.84 94.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -90.47 -1.32 57.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.971 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.66 39.99 6.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -77.6 -14.31 59.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.834 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -139.31 154.34 47.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -100.22 151.32 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 -176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.89 -27.65 69.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.119 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -95.0 2.97 55.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.795 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.8 m -58.64 133.26 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.125 -177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -144.07 170.08 16.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 175.381 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -65.96 -35.78 81.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.906 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 97.4 p -65.65 -36.01 82.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.839 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 75.2 mt -65.06 -40.27 88.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.27 93.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.984 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.24 -39.5 86.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.868 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.01 -36.73 85.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.129 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.71 -32.71 71.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.131 -176.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.525 ' HD1' HD22 ' A' ' 118' ' ' ASN . 22.5 m-85 -61.39 -32.08 72.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -61.32 -35.63 77.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -101.69 -21.61 14.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.664 ' O ' HD21 ' A' ' 121' ' ' LEU . . . 88.96 31.71 11.83 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.538 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -82.54 -30.67 29.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.881 0.372 . . . . 0.0 110.915 -171.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 93.0 m -116.62 127.28 54.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -69.86 -45.79 66.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.401 ' HB3' HD21 ' A' ' 115' ' ' LEU . 76.3 mtp -134.19 145.75 49.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 -175.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 30.6 p -142.35 161.87 36.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.203 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 31.0 mm -111.64 125.42 68.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.148 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -154.33 158.08 39.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.424 ' HA3' ' HG ' ' A' ' 113' ' ' LEU . . . -137.53 -108.58 0.87 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.529 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.76 -17.28 47.35 Favored 'Trans proline' 0 C--O 1.23 0.096 0 C-N-CA 122.645 2.23 . . . . 0.0 112.359 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -80.25 -12.43 59.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.897 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -50.46 -39.0 46.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.017 -168.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -57.12 -24.38 53.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 27.8 t -50.08 -59.28 4.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.826 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -155.1 54.64 0.64 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.4 ' O ' ' HD3' ' A' ' 316' ' ' ARG . 29.2 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 170.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 74.4 m-80 -110.68 71.64 0.76 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.802 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -117.68 147.45 42.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -135.54 160.09 24.36 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.593 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.705 HG11 ' O ' ' A' ' 315' ' ' PRO . 5.8 p -140.82 138.23 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.928 0.394 . . . . 0.0 111.112 -176.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.1 t -152.86 152.19 31.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.118 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 24.4 m -60.02 167.4 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.085 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 247' ' ' LEU . 3.5 mm? -63.2 141.09 97.76 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.608 0.718 . . . . 0.0 110.919 -159.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.97 167.68 19.18 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.641 2.228 . . . . 0.0 112.335 174.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 71.1 p -103.51 161.44 13.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.15 -170.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.514 ' HD2' ' HB3' ' A' ' 163' ' ' ALA . 30.7 t80 -143.18 121.06 11.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.864 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 57.25 34.98 25.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.89 10.32 79.09 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.462 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -126.44 145.06 51.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.651 0.739 . . . . 0.0 110.877 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -71.95 139.23 32.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.66 2.24 . . . . 0.0 112.309 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 70.2 m -84.95 0.14 52.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 171.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -46.18 110.16 1.14 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.658 0.742 . . . . 0.0 110.916 -176.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -76.7 161.09 34.11 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.783 2.322 . . . . 0.0 112.359 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -75.17 153.18 38.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -174.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.408 HG21 ' HA ' ' A' ' 324' ' ' ALA . 63.4 t -99.88 134.0 40.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.159 -170.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.21 133.62 11.75 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.438 -178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 86.0 t -124.91 131.44 72.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.936 0.398 . . . . 0.0 111.155 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.407 ' HB3' ' HB ' ' A' ' 108' ' ' ILE . 2.5 tt -67.98 131.1 44.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 171.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.569 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 70.8 p -118.84 140.62 49.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.85 -176.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.545 ' HB1' HD11 ' A' ' 280' ' ' LEU . . . -127.87 130.17 48.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.089 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -122.52 163.19 16.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.495 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.466 ' HA ' HG22 ' A' ' 59' ' ' ILE . 15.7 mm -100.96 125.06 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 111.159 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -66.01 127.8 33.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.428 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -60.92 -28.42 68.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.121 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.9 -10.9 56.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.061 -172.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.3 t -75.88 121.11 84.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.674 0.75 . . . . 0.0 110.865 -174.512 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -67.23 -8.77 22.95 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 167.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -103.05 17.86 23.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 -173.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -52.72 -34.41 52.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 -168.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -71.38 -47.85 53.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.841 -170.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.3 pp -80.04 -31.02 39.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.966 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.464 ' HB1' HD12 ' A' ' 59' ' ' ILE . . . -67.84 -45.92 73.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -69.41 -34.05 73.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 89.2 tt0 -62.9 -52.93 61.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.477 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.2 p90 -69.9 -33.61 72.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.82 -176.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.545 HD11 ' HB1' ' A' ' 264' ' ' ALA . 5.6 tt -56.93 -47.55 80.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -85.15 -32.11 22.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 69.4 m-20 -101.95 -14.01 17.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 -164.584 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 73.2 t80 -121.92 -49.49 2.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -175.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.506 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -64.39 -46.99 80.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 177.062 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 64.2 mt -85.98 59.98 5.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.984 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.484 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 47.5 p -139.18 150.42 45.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.065 172.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.531 ' HA ' HD11 ' A' ' 290' ' ' LEU . 42.4 p-10 -51.01 -26.4 6.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 -175.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -81.0 -43.9 18.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.834 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.05 -50.82 21.24 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.478 -169.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.555 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.4 OUTLIER -74.37 -20.85 59.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.894 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.426 ' N ' HD12 ' A' ' 290' ' ' LEU . 82.4 tt0 -67.12 -41.86 85.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.937 170.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.08 -34.37 74.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.145 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.63 HG13 ' HA3' ' A' ' 19' ' ' GLY . 21.1 t -79.4 -42.23 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.453 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 47.0 t30 -64.96 -27.4 68.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.944 177.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.82 -29.67 70.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -85.97 -39.99 16.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -150.87 133.77 8.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.584 0.707 . . . . 0.0 110.888 173.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.52 112.33 0.73 Allowed 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.662 2.242 . . . . 0.0 112.375 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.453 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 36.9 mt -91.05 -12.48 35.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.15 -58.98 0.49 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.43 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -175.01 167.28 3.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.846 0.355 . . . . 0.0 111.097 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 27.8 m -124.04 156.8 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.119 176.603 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -71.77 -17.73 62.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.983 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.555 ' CD2' HD21 ' A' ' 290' ' ' LEU . 58.6 tp -80.13 122.34 26.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.991 -173.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -56.09 -39.74 72.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -173.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.2 m -63.18 -48.47 78.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.825 -167.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.447 ' CD2' HD23 ' A' ' 311' ' ' LEU . 24.0 t80 -84.86 -28.31 26.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.74 -43.07 90.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.937 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.56 -37.9 89.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -72.32 -47.88 46.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.865 -176.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.709 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.5 pp -69.42 -27.76 65.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.959 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.433 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.0 -11.52 57.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.201 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.13 -15.02 61.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -81.2 130.09 64.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.503 0.668 . . . . 0.0 110.92 170.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.705 ' O ' HG11 ' A' ' 244' ' ' VAL . 87.1 Cg_exo -51.69 -35.21 56.9 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.272 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.522 ' HG3' HG13 ' A' ' 317' ' ' ILE . 23.3 ptt-85 -66.91 -32.61 73.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.838 -173.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.709 HG21 ' CD1' ' A' ' 311' ' ' LEU . 64.9 mt -93.35 -33.78 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.094 -175.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -52.47 -43.08 64.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -172.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.457 ' CB ' HG22 ' A' ' 244' ' ' VAL . . . -66.47 -43.1 86.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 72.4 p -65.3 -28.81 69.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.086 -174.702 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 34.6 mmt -68.72 -30.15 68.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -64.95 -44.41 89.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 327' ' ' GLY . 39.1 t30 -64.61 -36.88 85.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 174.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.408 ' HA ' HG21 ' A' ' 259' ' ' VAL . . . -62.14 -45.3 94.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -73.54 -34.5 65.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.54 -1.15 51.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -175.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -103.45 -157.3 24.76 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.431 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -141.17 142.09 34.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 0.0 110.952 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.577 ' O ' ' C ' ' A' ' 330' ' ' MET . 37.9 mm -81.69 110.6 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 -171.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.577 ' C ' ' O ' ' A' ' 329' ' ' ILE . 96.1 mmm . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 121.553 0.692 . . . . 0.0 110.782 174.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.812 0.339 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 89.4 mmm -74.35 -24.59 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -172.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.7 m -64.13 -39.88 94.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.46 -36.7 65.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.045 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.401 ' O ' HG13 ' A' ' 343' ' ' VAL . 11.1 m-30 -65.04 -41.22 95.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -61.97 -35.42 78.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.764 177.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -69.3 -43.83 72.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.958 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 367' ' ' ARG . . . -61.45 -40.5 94.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.221 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 339' ' ' PHE . 16.1 m -79.47 -24.86 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.121 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -62.29 -45.44 93.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 87.2 m -57.28 -35.08 69.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.042 173.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.636 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -60.25 -44.42 95.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.057 -175.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.414 ' HA ' HD22 ' A' ' 192' ' ' LEU . 1.5 m -74.06 -33.63 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.124 -174.638 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -63.5 -47.92 89.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.242 173.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 84.9 m-20 -67.02 -37.72 84.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.83 -47.9 49.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.154 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.21 -37.1 80.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.177 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.5 p -74.81 -13.92 60.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.823 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.53 12.2 84.5 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.436 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -81.74 -26.46 34.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.777 0.322 . . . . 0.0 110.91 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 93.3 mt-30 -133.43 159.4 40.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 170.078 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.2 p -80.42 169.54 17.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.249 170.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 69.7 t -56.48 -43.09 77.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.175 170.342 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -59.13 -45.09 91.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -70.1 -52.66 21.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.919 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.15 74.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.093 -173.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.633 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -67.05 -40.01 87.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.002 -176.185 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.547 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.0 tttt -65.1 -39.12 92.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.935 176.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -64.71 -37.08 86.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.636 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -63.95 -45.56 88.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.091 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -73.5 -30.04 62.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.073 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 67.9 m -64.6 -41.16 96.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.118 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.413 ' HB2' ' HB1' ' A' ' 342' ' ' ALA . 99.7 mtt180 -66.75 -39.98 88.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.848 175.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.492 HD12 HG21 ' A' ' 183' ' ' VAL . 67.1 mt -65.93 -38.42 82.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.099 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 70.7 p -93.9 -8.95 38.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.168 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 173.713 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.74 0.305 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.8 mt -97.71 128.5 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.215 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -158.01 145.8 18.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -51.86 138.39 24.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.501 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 98.1 2.52 58.08 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.405 -173.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -170.35 152.38 4.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.597 HD22 HD13 ' A' ' 33' ' ' ILE . 1.3 pt? -153.51 155.37 36.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.984 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 71.4 t -109.92 135.8 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.159 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.681 HG22 ' CG1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -122.78 132.27 71.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.449 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 40.0 m0 -107.05 125.8 51.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.939 169.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.485 ' HB ' HD12 ' A' ' 20' ' ' LEU . 15.8 tt -107.74 149.71 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.194 -171.203 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -58.97 148.11 31.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.796 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.75 -14.64 37.66 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.476 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -73.84 -9.94 59.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.0 110.856 -174.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -150.23 133.76 16.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 159.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.91 -84.97 0.98 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.534 -163.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -106.69 -45.02 4.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.905 0.383 . . . . 0.0 110.921 -173.221 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -68.22 -52.46 33.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 -151.44 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.596 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -59.2 -48.04 87.89 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.556 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.602 ' CD1' HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -58.69 -46.38 87.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.933 176.713 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.65 -38.14 77.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -65.51 -49.4 69.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.8 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.6 m -73.36 -34.66 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -67.31 -43.22 88.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.87 -44.87 96.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.817 0.341 . . . . 0.0 110.932 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -67.33 -40.11 85.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 33' ' ' ILE . 42.6 t80 -64.58 -38.85 92.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 176.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.93 -41.86 97.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.966 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.68 -36.4 82.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.842 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -81.49 -39.7 24.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.793 -170.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.631 ' OG1' HG13 ' A' ' 33' ' ' ILE . 63.9 p -103.62 -8.54 19.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.95 11.07 83.99 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.557 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.038 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 pp -105.14 131.11 55.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.889 0.376 . . . . 0.0 111.168 -174.401 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -68.68 128.21 35.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.94 -168.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.463 HG22 HD21 ' A' ' 7' ' ' LEU . 95.8 t -110.42 119.97 60.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.458 ' HB ' HG22 ' A' ' 8' ' ' VAL . 99.8 m -111.12 116.71 31.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.501 HG22 HD13 ' A' ' 20' ' ' LEU . 87.9 t -92.82 133.51 33.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.12 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.449 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 74.0 mm-40 -120.02 160.88 21.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 174.658 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 64.7 t-80 -84.03 138.13 40.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 110.775 -167.948 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 58.8 Cg_exo -61.45 -17.42 53.52 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.717 2.278 . . . . 0.0 112.304 -174.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -47.39 -49.69 24.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 75.4 mmtt -90.88 -0.1 57.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.714 HD11 ' O ' ' A' ' 61' ' ' PHE . 9.8 tt -45.29 -56.93 4.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.954 -170.054 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -76.63 -38.42 54.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.879 -175.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -79.86 -44.84 19.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.896 -166.372 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 85.3 tttt -85.13 -36.02 21.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -171.18 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.597 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 84.0 t80 -49.23 -53.82 35.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.666 0.746 . . . . 0.0 110.989 -171.596 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 22.7 Cg_endo -59.17 -30.63 93.6 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.654 2.236 . . . . 0.0 112.325 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -74.46 -44.67 50.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.942 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.7 m -75.01 -24.71 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.168 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.65 -34.39 78.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.22 -31.0 71.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.071 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.5 p -89.99 -13.42 36.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.189 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.2 16.35 80.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.513 168.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -137.81 130.0 29.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.823 0.344 . . . . 0.0 110.821 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.3 -118.56 0.76 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.493 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.48 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 68.1 Cg_endo -70.54 153.22 65.51 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.711 2.274 . . . . 0.0 112.349 176.204 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.432 ' HB2' HD13 ' A' ' 59' ' ' ILE . 1.8 m-20 -86.4 -38.88 16.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.901 169.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.752 HG23 ' HB1' ' A' ' 276' ' ' ALA . 0.0 OUTLIER -133.81 149.69 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 178.803 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 tp -128.97 125.07 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.107 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.714 ' O ' HD11 ' A' ' 43' ' ' LEU . 2.3 m-85 -101.5 134.51 44.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.409 ' CH2' ' HB2' ' A' ' 105' ' ' ALA . 32.0 p90 -144.94 -178.74 6.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.948 175.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.96 -98.71 0.32 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -107.3 -55.1 2.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.822 -176.697 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.12 -34.35 73.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.872 -162.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.57 -20.01 54.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 -171.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -45.55 -53.14 9.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.928 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.42 -52.28 44.89 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.556 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.23 -49.93 73.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.576 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -70.93 -47.52 58.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.96 -172.494 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.3 -47.7 63.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.162 -173.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -64.45 -35.35 80.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.1 m -83.76 -7.48 59.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.814 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.26 33.48 61.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mp -84.0 -4.82 59.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 110.975 -176.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.746 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.8 pp -132.34 145.66 51.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.974 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.23 142.19 43.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.126 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -66.73 134.26 51.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.883 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.835 HG13 ' HB3' ' A' ' 103' ' ' LEU . 39.8 pt -111.58 160.71 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.137 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.9 m -101.46 130.06 25.53 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.627 0.727 . . . . 0.0 111.173 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.27 147.91 54.32 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.655 2.236 . . . . 0.0 112.33 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -114.46 120.06 38.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.15 -38.73 91.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.07 -44.77 83.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -71.44 -35.19 70.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.501 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 43.6 tt0 -53.32 -46.53 69.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.929 173.288 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.63 -34.55 75.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.905 174.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.26 -23.3 54.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.4 OUTLIER -108.09 -93.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.879 -171.676 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -169.98 129.18 0.87 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.631 0.729 . . . . 0.0 111.067 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -56.2 -43.68 53.85 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.6 2.2 . . . . 0.0 112.291 -171.102 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 1.8 t80 -72.04 -32.78 67.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.994 -173.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.551 ' CG2' ' HB3' ' A' ' 107' ' ' PRO . 96.2 m -64.39 -34.77 78.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.011 -171.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.69 ' HA ' HG22 ' A' ' 97' ' ' VAL . 61.0 m95 -70.37 -21.61 62.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.986 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 92' ' ' PHE . 97.5 m-20 -72.99 -33.73 65.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.83 171.403 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.92 -27.7 64.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.69 HG22 ' HA ' ' A' ' 94' ' ' TRP . 15.7 m -100.38 15.51 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.09 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 70.8 ttt180 -110.4 136.48 49.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -140.12 126.59 20.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.975 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.4 t30 59.87 34.7 21.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.95 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.41 -3.0 83.77 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.528 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.14 147.41 49.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.707 0.289 . . . . 0.0 110.961 174.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.835 ' HB3' HG13 ' A' ' 79' ' ' ILE . 3.3 tp -76.87 140.1 40.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.857 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 76' ' ' LEU . 2.0 pp -122.14 -6.16 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 -171.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.409 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . . . -164.97 166.67 19.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.085 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.433 ' HB3' HD11 ' A' ' 285' ' ' LEU . 87.1 m-85 -112.93 146.42 35.09 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.696 0.76 . . . . 0.0 110.939 169.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.551 ' HB3' ' CG2' ' A' ' 93' ' ' THR . 72.0 Cg_endo -76.16 118.93 5.13 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.631 2.22 . . . . 0.0 112.426 176.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.431 HD13 HD21 ' A' ' 285' ' ' LEU . 27.2 mm -92.5 -55.26 6.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.43 160.48 43.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.08 -168.498 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.0 t -119.41 136.67 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.101 -172.866 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -121.33 140.14 52.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.907 171.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.481 ' HB1' HD22 ' A' ' 323' ' ' ASN . . . -150.45 159.27 44.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.419 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 8.8 mp -92.31 169.23 10.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.903 -173.149 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.5 p -157.05 157.86 35.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.899 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -100.03 126.06 46.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.021 171.162 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.569 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.8 mp -110.2 133.3 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.177 -174.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -133.25 150.37 51.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -91.12 118.75 30.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.58 -20.71 66.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.939 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -77.76 -27.94 50.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.497 HD21 ' O ' ' A' ' 220' ' ' GLY . 6.7 mp -95.5 -44.76 7.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.946 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 24.6 mt -108.74 103.32 51.24 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.631 0.729 . . . . 0.0 110.89 177.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 122' ' ' LEU . 72.6 Cg_endo -67.7 -23.61 42.09 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.686 2.257 . . . . 0.0 112.358 171.026 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -147.16 94.02 4.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.621 0.724 . . . . 0.0 110.894 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.94 152.7 79.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.684 2.256 . . . . 0.0 112.364 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.37 144.9 63.57 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.65 2.234 . . . . 0.0 112.389 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.53 -13.62 27.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.0 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.4 p -130.22 155.88 45.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.079 -174.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.558 ' HA ' HD13 ' A' ' 132' ' ' ILE . 64.2 m95 -68.44 -29.27 67.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.958 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.53 -25.02 67.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 -176.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -78.74 -21.22 48.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.894 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.598 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.6 mp -60.43 -52.88 69.78 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.661 0.743 . . . . 0.0 111.065 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 27.7 Cg_endo -66.89 -40.04 13.16 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.623 2.215 . . . . 0.0 112.441 -171.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.18 -41.61 76.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.118 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.7 tp -55.14 -43.45 74.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.437 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . 1.5 m-20 -49.87 -42.37 47.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.95 -35.13 79.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.898 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -75.5 -46.17 33.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 -171.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.46 ' HG ' ' HB2' ' A' ' 144' ' ' LYS . 0.8 OUTLIER -89.94 -18.74 25.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.96 -174.218 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -53.67 -30.33 42.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.83 167.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.18 -25.08 67.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.12 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -95.0 7.01 47.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.865 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.16 24.91 72.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.464 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.46 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 26.5 mmtp -110.04 167.55 10.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.37 . . . . 0.0 110.904 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.0 t -130.64 137.95 49.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.899 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 224' ' ' MET . . . -72.94 -53.48 11.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.068 -166.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.461 HD22 ' H ' ' A' ' 148' ' ' MET . 1.9 tm? -138.24 138.12 38.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 -167.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.461 ' H ' HD22 ' A' ' 147' ' ' LEU . 98.7 mtp -125.14 133.27 52.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.852 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -159.98 161.69 34.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.823 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -95.47 90.05 5.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.829 HD21 HD11 ' A' ' 195' ' ' LEU . 1.2 tm? -66.44 -32.75 74.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.951 -173.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.29 0.07 23.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -100.4 142.87 25.44 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.586 0.707 . . . . 0.0 110.914 176.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.604 ' HG3' ' CE1' ' A' ' 341' ' ' TYR . 29.9 Cg_endo -64.32 -22.47 66.36 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.672 2.248 . . . . 0.0 112.429 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -69.26 -35.47 76.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.964 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -92.09 -29.97 16.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.836 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.2 p -65.68 -45.67 81.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.271 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.598 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 90.6 t90 -66.21 -46.83 61.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.521 0.677 . . . . 0.0 110.82 -166.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 96.9 Cg_exo -48.81 -45.39 28.5 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.685 2.257 . . . . 0.0 112.422 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 160' ' ' LEU . 6.2 tt -69.15 -39.11 79.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 67.2 mt -71.55 -40.5 71.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.73 -26.47 44.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -60.41 -33.68 72.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.046 -171.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -95.02 3.3 55.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.846 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.88 -1.06 13.52 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.45 171.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.3 67.14 3.11 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.422 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -87.76 132.38 34.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 0.0 110.928 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.07 13.98 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.409 ' HA ' HG12 ' A' ' 181' ' ' VAL . 49.1 p90 -147.47 151.45 36.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.868 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -103.21 129.62 50.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.836 158.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -120.88 125.03 46.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -151.99 129.81 11.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.994 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.09 41.78 31.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 172.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.02 15.35 81.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.525 173.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -129.97 139.03 51.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.739 0.304 . . . . 0.0 110.842 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -99.74 144.6 28.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 171.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -122.06 108.05 12.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.865 172.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.528 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.4 pp -77.77 -11.99 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.134 -178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.14 -11.44 22.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -176.296 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -130.01 85.08 2.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 172.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 169' ' ' PHE . 30.6 m -113.84 173.08 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 -169.134 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -101.97 23.76 33.57 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.455 -166.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.534 HG21 HD12 ' A' ' 368' ' ' ILE . 31.3 m -114.41 -7.59 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 0.0 111.131 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.5 p-10 -85.5 18.07 2.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -125.74 -170.02 2.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.84 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.07 -27.64 68.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.111 -173.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.2 -44.76 74.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.479 -164.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.747 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -67.01 -36.01 81.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.81 0.338 . . . . 0.0 111.07 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.476 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.5 mttt -59.04 -33.7 71.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.898 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.13 -31.68 73.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.105 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.83 -45.22 96.16 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.481 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.463 HD11 ' HB1' ' A' ' 346' ' ' ALA . 22.7 mt -64.98 -38.63 91.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.9 0.381 . . . . 0.0 110.98 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.1 m -58.2 -44.99 88.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.244 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -75.88 -45.49 35.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.829 HD11 HD21 ' A' ' 151' ' ' LEU . 6.5 tt -54.39 -48.57 71.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.961 -170.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.418 ' HA ' HD11 ' A' ' 199' ' ' ILE . 23.0 m -70.1 -19.93 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 -174.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.443 ' HB3' HD13 ' A' ' 198' ' ' LEU . 38.6 t70 -56.52 -56.74 17.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 -168.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.985 ' H ' HD13 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.5 -26.6 58.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.928 -167.582 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.581 ' H ' HD22 ' A' ' 198' ' ' LEU . 1.8 pp -86.99 -34.52 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.176 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.74 -32.6 69.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.914 166.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -84.88 5.0 30.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 65.19 36.84 6.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -86.24 -14.44 43.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 57.9 ttp -138.08 153.27 49.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.962 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -97.7 150.16 21.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.81 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.97 -26.65 68.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.103 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -93.78 4.9 53.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.809 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 91.5 m -61.03 129.97 44.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -139.81 169.65 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.837 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -66.63 -36.19 81.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 99.5 p -66.08 -36.57 83.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.745 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 73.4 mt -64.94 -39.36 85.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.31 83.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.172 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.41 -45.73 93.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.949 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.03 -38.64 91.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.15 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.93 97.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.176 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -65.22 -36.91 85.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -61.35 -34.01 74.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -89.59 -22.59 22.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.497 ' O ' HD21 ' A' ' 121' ' ' LEU . . . 88.19 24.92 32.81 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.505 -178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -87.91 -26.84 22.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.38 . . . . 0.0 110.861 -173.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . 0.443 HG21 ' SD ' ' A' ' 148' ' ' MET . 75.6 m -116.87 129.92 56.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 -173.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.92 -49.8 55.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.428 ' N ' ' O ' ' A' ' 146' ' ' ALA . 71.1 mtm -136.43 157.06 47.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -170.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.9 t -149.15 157.68 43.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.2 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.3 mm -112.81 121.26 64.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.119 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.545 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 9.4 t-20 -156.05 170.0 23.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -172.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -132.42 -100.32 0.77 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.571 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.26 -22.94 39.45 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.703 2.269 . . . . 0.0 112.306 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -83.56 -20.11 34.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.002 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -55.6 -45.1 77.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.073 -166.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -63.14 -19.1 64.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 -171.734 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.1 p -54.05 -25.41 21.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.879 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -136.17 39.94 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.442 ' HB ' ' HG2' ' A' ' 316' ' ' ARG . 95.6 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 170.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 CA--C 1.524 -0.026 0 CA-C-O 120.907 0.384 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -123.41 82.49 2.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.836 176.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.03 147.88 47.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.868 171.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -127.67 153.09 19.12 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.542 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.532 HG22 ' CB ' ' A' ' 319' ' ' ALA . 5.0 p -137.8 134.07 45.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 111.166 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.8 t -155.78 147.86 23.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.105 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.4 m -60.66 168.87 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.068 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.656 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.8 mm? -64.09 149.13 94.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.615 0.721 . . . . 0.0 110.855 -159.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 32.1 Cg_exo -65.12 179.08 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.705 2.27 . . . . 0.0 112.254 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 97.3 m -101.04 146.41 27.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.189 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -136.79 119.42 16.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 56.14 35.05 24.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.51 3.33 86.64 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.478 171.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -133.7 142.73 44.85 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.683 0.754 . . . . 0.0 110.886 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.78 144.94 44.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.727 2.284 . . . . 0.0 112.315 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.656 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 70.0 p -87.03 10.28 16.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 173.717 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -43.07 112.21 1.16 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.648 0.737 . . . . 0.0 110.887 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.408 ' CD ' HD23 ' A' ' 247' ' ' LEU . 80.7 Cg_endo -78.5 164.63 26.0 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.654 2.236 . . . . 0.0 112.355 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -71.27 163.26 28.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -174.15 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 60.5 t -107.88 135.22 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 -172.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.12 135.98 13.17 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.455 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 89.6 t -122.8 132.13 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 111.114 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.4 tt -66.61 128.89 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 171.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 59.7 p -123.11 132.17 53.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 280' ' ' LEU . . . -124.92 127.75 47.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.163 -173.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.78 167.01 14.46 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.416 -171.56 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.406 HD13 HG22 ' A' ' 59' ' ' ILE . 12.6 mm -99.98 126.81 53.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 111.148 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -62.86 126.39 27.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.889 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.85 -25.11 68.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.083 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.59 -10.52 55.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.112 -173.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.3 t -75.61 120.37 81.33 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.581 0.705 . . . . 0.0 110.928 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -70.91 -12.24 30.45 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.631 2.221 . . . . 0.0 112.289 171.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -112.07 35.75 3.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.984 -170.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.05 -25.11 65.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -169.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.94 -39.07 76.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.802 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 43.1 tp -66.26 -48.21 71.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 173.051 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.752 ' HB1' HG23 ' A' ' 59' ' ' ILE . . . -68.0 -50.0 58.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.053 -172.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -62.97 -41.34 99.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -63.86 -53.46 50.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.954 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -70.05 -36.88 75.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -173.369 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 280' ' ' LEU . 6.4 tt -58.53 -46.56 86.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -77.23 -40.31 45.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.832 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -102.8 -9.68 19.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 -160.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 75.7 t80 -122.48 -49.07 2.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.502 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.1 OUTLIER -64.43 -47.1 80.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 178.082 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 106' ' ' TYR . 64.6 mt -85.0 59.2 5.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.483 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 37.4 p -140.23 151.16 44.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.149 172.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.524 ' HA ' HD11 ' A' ' 290' ' ' LEU . 43.1 p-10 -51.12 -26.06 6.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.916 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -79.6 -44.93 20.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.801 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.88 -50.1 20.12 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.532 -168.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -74.79 -20.9 59.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.737 0.303 . . . . 0.0 110.903 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.421 ' N ' HD12 ' A' ' 290' ' ' LEU . 82.4 tt0 -66.13 -40.43 90.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.931 169.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.68 -34.74 76.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.193 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.596 HG13 ' HA3' ' A' ' 19' ' ' GLY . 24.7 t -78.45 -45.23 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.182 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.4 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 48.3 t30 -65.53 -27.79 68.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.04 -27.31 69.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -85.99 -41.33 14.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.928 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -150.96 129.82 6.27 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.576 0.703 . . . . 0.0 110.906 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.8 110.35 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.396 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.4 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 55.8 mt -88.19 -17.81 30.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.98 -171.299 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.626 ' O ' HG23 ' A' ' 317' ' ' ILE . . . 105.13 -42.78 1.81 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.445 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 300' ' ' GLY . . . -176.04 173.17 2.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.861 0.362 . . . . 0.0 111.059 164.372 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.523 HG22 HD21 ' A' ' 311' ' ' LEU . 23.2 m -122.7 153.69 27.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.149 170.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -68.19 -18.8 64.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.041 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.453 ' HA ' HD12 ' A' ' 89' ' ' LEU . 52.6 tp -83.03 121.95 27.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.967 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -60.37 -34.99 74.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 -174.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.7 m -64.06 -50.21 69.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.844 -169.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.597 ' CD2' HD23 ' A' ' 311' ' ' LEU . 36.0 t80 -82.8 -26.93 31.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.954 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -55.71 -43.85 76.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.903 177.592 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.22 -36.89 85.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -77.62 -48.49 16.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.787 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.825 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.5 pp -65.68 -24.78 67.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.988 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.506 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -62.72 -18.74 63.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.094 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.36 -19.93 64.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -79.15 122.12 83.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.575 0.703 . . . . 0.0 110.903 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.504 ' O ' HG11 ' A' ' 244' ' ' VAL . 84.0 Cg_exo -48.58 -31.97 19.97 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.721 2.28 . . . . 0.0 112.241 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.442 ' HG2' ' HB ' ' A' ' 235' ' ' ILE . 99.1 mtt180 -59.01 -36.73 75.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.846 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.825 HG21 ' CD1' ' A' ' 311' ' ' LEU . 38.7 mt -99.97 -34.25 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -171.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.39 -41.52 20.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 -164.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.532 ' CB ' HG22 ' A' ' 244' ' ' VAL . . . -65.69 -44.49 86.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.013 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 317' ' ' ILE . 73.1 p -68.09 -29.7 68.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.074 -176.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -68.24 -38.17 81.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.894 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.1 -46.67 80.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.481 HD22 ' HB1' ' A' ' 112' ' ' ALA . 27.6 t30 -65.43 -35.49 81.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 176.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.79 -46.27 89.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -77.18 -32.96 56.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.05 -2.52 50.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -100.26 -156.63 27.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.449 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -137.36 143.08 41.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.585 ' O ' ' C ' ' A' ' 330' ' ' MET . 45.2 mm -78.79 104.79 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 -170.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.585 ' C ' ' O ' ' A' ' 329' ' ' ILE . 22.1 ptp . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 121.57 0.7 . . . . 0.0 110.846 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.846 0.355 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 88.2 mmm -75.17 -23.18 57.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 -171.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.6 m -62.25 -42.25 99.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.08 -33.0 63.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.989 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -64.85 -38.78 92.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.869 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 154' ' ' PRO . 38.3 m0 -60.59 -35.33 75.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 175.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 341' ' ' TYR . . . . . 0.604 ' CE1' ' HG3' ' A' ' 154' ' ' PRO . 32.3 m-85 -73.61 -38.62 65.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.33 94.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.148 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.1 m -80.4 -25.12 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.453 ' O ' HG22 ' A' ' 347' ' ' VAL . 7.9 tmm_? -62.12 -45.58 92.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 173.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 98.1 m -55.61 -34.74 65.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.206 173.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -61.34 -42.99 99.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 -176.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 344' ' ' ARG . 1.4 m -74.35 -33.72 34.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.138 -174.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.44 -47.04 94.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.204 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 95.1 m-20 -64.98 -39.67 93.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.29 -46.74 60.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.2 -42.66 88.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.6 p -76.04 -10.61 59.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.82 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.18 14.97 81.68 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.581 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.65 -31.29 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.684 0.278 . . . . 0.0 110.848 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 84.9 mm-40 -139.56 158.3 44.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 51.2 p -78.39 166.55 22.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.194 170.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 62.7 t -55.72 -42.46 69.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 172.431 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -60.16 -46.09 90.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -69.89 -52.5 24.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.848 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -67.66 -45.5 75.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.041 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.747 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -67.42 -39.78 85.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.001 -177.068 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 87.9 tttt -64.78 -38.42 90.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -63.96 -38.02 89.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 175.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -64.61 -45.97 84.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.016 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 1.1 pp0? -73.03 -30.91 64.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -177.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 73.9 m -65.62 -42.73 91.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.153 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -66.26 -37.11 84.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.534 HD12 HG21 ' A' ' 183' ' ' VAL . 62.9 mt -66.0 -39.9 85.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.186 177.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 72.0 p -90.36 -11.15 41.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.153 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.927 175.487 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.784 0.326 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.9 mt -102.11 127.77 55.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -152.4 144.08 23.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.6 137.65 30.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.784 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 97.66 3.15 58.44 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.505 -172.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -170.1 153.31 4.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.76 0.315 . . . . 0.0 110.983 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.549 HD22 HD13 ' A' ' 33' ' ' ILE . 1.3 pt? -153.17 155.97 37.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 78.1 t -110.62 137.87 41.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.128 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.927 HG13 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -122.09 132.76 70.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.095 -179.32 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.453 ' HB3' HD12 ' A' ' 43' ' ' LEU . 45.6 m0 -109.89 127.44 54.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 168.127 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.542 ' HB ' HD22 ' A' ' 20' ' ' LEU . 6.9 tt -108.18 145.6 15.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.137 -170.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -53.01 143.96 16.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.28 -13.53 21.99 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.418 -174.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -74.76 -10.29 59.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.861 0.363 . . . . 0.0 110.854 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -145.29 136.92 25.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 158.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.93 -83.86 1.01 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.537 -164.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -114.5 -45.0 3.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.951 0.405 . . . . 0.0 110.908 -173.219 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -68.6 -52.94 26.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.886 -149.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.592 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -60.27 -48.99 83.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 -175.67 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.927 HD21 HG13 ' A' ' 9' ' ' ILE . 18.0 tp -65.09 -41.41 95.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 110.978 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.23 67.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 173.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -67.17 -48.77 66.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.941 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.402 HG22 ' HA ' ' A' ' 20' ' ' LEU . 14.3 m -74.7 -34.47 34.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.491 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -65.53 -45.11 91.44 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.536 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -64.2 -38.93 92.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.84 0.352 . . . . 0.0 110.905 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -63.31 -42.65 99.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.974 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.466 ' CD2' HD11 ' A' ' 33' ' ' ILE . 56.3 t80 -65.06 -37.74 88.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.822 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.98 -41.55 98.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.974 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.96 -31.99 69.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.875 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -80.61 -41.53 23.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.83 -172.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.603 ' OG1' HG13 ' A' ' 33' ' ' ILE . 51.1 p -105.11 -8.44 18.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.031 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.71 10.0 84.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.555 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.997 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 pp -103.29 132.51 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.943 0.401 . . . . 0.0 111.119 -174.101 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -70.61 126.94 31.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.911 -168.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.506 HG22 HD21 ' A' ' 7' ' ' LEU . 93.2 t -110.27 120.52 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.099 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.6 m -112.83 113.83 26.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.064 -174.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.482 HG22 ' HG ' ' A' ' 20' ' ' LEU . 96.1 t -93.22 132.62 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.149 176.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -126.06 155.15 42.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.3 t-80 -77.04 140.03 66.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.604 0.716 . . . . 0.0 110.841 -161.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 72.7 Cg_exo -56.76 -22.22 43.77 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.72 2.28 . . . . 0.0 112.332 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -47.1 -50.16 20.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 -173.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -86.98 -9.85 54.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 10' ' ' TRP . 7.7 tt -46.93 -54.24 10.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 -167.506 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.05 -35.23 66.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.868 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -74.96 -47.2 30.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.906 -168.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -84.75 -33.66 23.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -170.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.589 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 94.4 t80 -48.22 -53.12 36.5 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.587 0.708 . . . . 0.0 110.966 -165.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 39.1 Cg_endo -62.8 -30.51 77.92 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.65 2.233 . . . . 0.0 112.443 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -76.7 -43.72 36.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.1 m -74.78 -25.05 18.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.208 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.83 -33.67 76.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.119 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.97 69.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.3 p -91.4 -13.85 31.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.17 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.14 15.27 81.76 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.499 170.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -138.92 130.04 26.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.884 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.09 -118.84 0.73 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.454 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 84.4 Cg_endo -72.8 154.11 53.75 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.756 2.304 . . . . 0.0 112.432 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.431 ' CB ' HD13 ' A' ' 59' ' ' ILE . 1.7 m-20 -87.15 -38.42 16.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 170.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.732 HG23 ' HB1' ' A' ' 276' ' ' ALA . 0.0 OUTLIER -134.05 150.05 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.077 179.155 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 tp -129.33 124.73 60.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.1 -174.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.448 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 2.4 m-85 -100.15 134.75 42.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.457 ' CH2' ' HB2' ' A' ' 105' ' ' ALA . 32.2 p90 -145.01 -177.82 5.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.842 174.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.75 -97.14 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.144 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -110.44 -55.43 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -58.83 -35.75 73.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -162.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.523 ' HD3' ' CZ ' ' A' ' 70' ' ' TYR . 4.4 mmp_? -74.56 -21.24 59.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 -172.613 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -45.95 -54.59 8.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.95 -53.58 36.42 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.45 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.69 -52.44 53.07 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.523 ' CZ ' ' HD3' ' A' ' 66' ' ' ARG . 15.8 m-30 -75.78 -41.98 51.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.919 0.39 . . . . 0.0 110.893 -168.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.34 -47.18 71.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.096 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -65.07 -34.93 79.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.8 m -81.7 -7.97 59.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.45 32.08 62.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.472 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mp -84.75 -4.5 59.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 110.978 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.737 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.2 pp -128.28 145.02 51.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.18 141.43 47.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.4 mp0 -69.27 132.33 46.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.89 HG13 ' HB3' ' A' ' 103' ' ' LEU . 37.7 pt -118.82 167.11 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.154 175.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.5 p -113.76 149.55 41.95 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.599 0.714 . . . . 0.0 111.118 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.08 146.82 41.93 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.691 2.261 . . . . 0.0 112.39 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -108.11 119.25 38.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.999 0.428 . . . . 0.0 110.789 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.14 -42.23 99.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.852 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.12 -46.52 80.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.142 -177.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.524 ' HB3' ' HZ2' ' A' ' 94' ' ' TRP . 9.1 m-85 -72.07 -33.86 68.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -177.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.449 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.6 tt0 -53.95 -48.07 70.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.933 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.6 -35.02 79.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.95 -23.26 55.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.978 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.566 HD23 ' HG2' ' A' ' 107' ' ' PRO . 1.4 mp -108.75 -92.3 0.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 -173.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 33.6 t80 -169.68 127.84 0.84 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.597 0.713 . . . . 0.0 110.996 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 87.3 Cg_exo -57.07 -42.66 61.47 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.646 2.23 . . . . 0.0 112.341 -170.645 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.589 ' O ' ' HD1' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -70.18 -33.27 71.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -174.289 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.634 ' CG2' ' HB3' ' A' ' 107' ' ' PRO . 88.3 m -67.56 -36.26 80.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 -173.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.598 ' HA ' HG22 ' A' ' 97' ' ' VAL . 68.5 m95 -67.83 -26.45 66.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.933 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -73.76 -32.17 63.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.82 171.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.11 -25.8 62.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.085 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 94' ' ' TRP . 19.8 m -101.39 17.81 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.099 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 75.7 ttt180 -112.91 132.1 55.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.933 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -138.41 127.75 24.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 62.05 34.87 16.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.919 175.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.31 -4.17 78.34 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.578 173.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.42 150.05 48.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.353 . . . . 0.0 110.959 173.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.89 ' HB3' HG13 ' A' ' 79' ' ' ILE . 2.9 tp -74.42 140.4 44.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.548 HG22 HD11 ' A' ' 76' ' ' LEU . 2.0 pp -118.56 -7.35 11.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.091 -174.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.457 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . . . -164.78 168.83 17.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.117 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.433 ' HB3' HD11 ' A' ' 285' ' ' LEU . 94.5 m-85 -112.22 146.41 34.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.714 0.769 . . . . 0.0 110.903 168.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.634 ' HB3' ' CG2' ' A' ' 93' ' ' THR . 73.9 Cg_endo -74.11 118.23 5.31 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.629 2.219 . . . . 0.0 112.381 172.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.409 HD11 HD21 ' A' ' 280' ' ' LEU . 29.7 mm -92.09 -54.97 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.147 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.89 158.63 44.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.059 -167.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.65 137.47 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.076 -172.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -122.01 139.07 54.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.551 ' HB1' HD22 ' A' ' 323' ' ' ASN . . . -152.1 160.16 43.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.063 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -94.56 168.68 10.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.852 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 100.0 p -154.87 152.92 30.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.819 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.961 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -100.03 128.38 46.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 169.316 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.511 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.3 mp -111.07 137.01 45.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -133.75 149.58 51.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -86.45 110.98 20.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.471 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 88.9 tttt -62.1 -23.12 66.34 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -76.01 -24.19 55.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.893 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.528 HD21 ' O ' ' A' ' 220' ' ' GLY . 7.0 mp -94.76 -53.37 3.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.862 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.477 HD22 ' HB1' ' A' ' 223' ' ' ALA . 1.7 mp -105.07 132.31 20.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.678 0.751 . . . . 0.0 110.863 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.44 -16.99 24.21 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.686 2.257 . . . . 0.0 112.331 -175.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.571 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 20.8 p30 -154.33 161.62 28.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.614 0.721 . . . . 0.0 110.915 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.571 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 57.8 Cg_endo -69.59 155.12 67.38 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.646 2.231 . . . . 0.0 112.392 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.14 146.38 70.02 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.669 2.246 . . . . 0.0 112.299 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -100.12 -48.6 4.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 72.7 p -133.17 158.56 42.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 48.9 t-105 -64.2 -30.23 71.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 175.043 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.06 -23.67 65.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -174.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -72.75 -32.17 65.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.494 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 1.6 mp -66.03 -47.17 63.55 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.644 0.735 . . . . 0.0 111.085 -163.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 97.9 Cg_exo -53.31 -50.89 12.37 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.653 2.235 . . . . 0.0 112.267 -175.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.94 -39.21 69.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.134 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 30.3 tp -56.02 -45.32 79.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -53.74 -34.97 60.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.837 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.47 -36.76 79.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -73.44 -53.21 11.23 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -172.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.8 OUTLIER -80.01 -10.64 59.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -175.804 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.566 ' N ' HD23 ' A' ' 139' ' ' LEU . 86.5 tttt -55.99 -31.61 63.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.943 166.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.87 -25.1 68.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -95.14 5.59 51.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.47 28.85 60.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.528 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -120.09 170.09 9.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.758 0.313 . . . . 0.0 110.904 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.3 t -131.25 141.25 49.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -70.42 -55.13 9.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.048 -166.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -141.97 131.05 23.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 -170.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.726 ' SD ' ' HB2' ' A' ' 213' ' ' ALA . 52.7 ttm -110.54 123.76 50.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -150.46 157.15 42.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -167.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -101.81 96.24 6.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.965 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.844 HD21 HD11 ' A' ' 195' ' ' LEU . 1.8 tm? -76.12 -18.29 59.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.973 172.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -80.36 -2.49 45.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.425 ' O ' HG23 ' A' ' 157' ' ' THR . 38.4 mt-10 -113.53 152.21 45.17 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.574 0.702 . . . . 0.0 110.909 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.532 ' HD3' ' CD ' ' A' ' 344' ' ' ARG . 30.5 Cg_endo -66.91 -19.82 51.97 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.68 2.254 . . . . 0.0 112.367 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -65.02 -40.66 95.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -172.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' PHE . . . . . 0.411 ' HD2' HD23 ' A' ' 151' ' ' LEU . 74.7 t80 -82.97 -36.04 25.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.807 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 153' ' ' GLU . 81.9 p -60.51 -46.7 89.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.189 -170.579 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.645 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 89.0 t90 -67.84 -48.17 41.53 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.502 0.667 . . . . 0.0 110.897 -167.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 78.5 Cg_exo -47.57 -46.37 20.86 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.666 2.244 . . . . 0.0 112.512 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 160' ' ' LEU . 6.5 tt -70.07 -39.87 75.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.965 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 71.0 mt -70.39 -41.02 78.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.014 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.63 -28.6 61.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.116 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.504 ' HB3' ' HD2' ' A' ' 250' ' ' PHE . . . -63.12 -34.96 78.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 -170.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -91.48 1.99 56.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.884 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.01 1.31 14.48 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.467 170.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.33 65.02 4.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.55 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -84.86 133.55 34.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.912 0.387 . . . . 0.0 110.893 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.25 5.43 10.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.076 -170.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.421 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.0 p90 -146.85 152.9 39.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.944 0.402 . . . . 0.0 110.956 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -103.78 126.15 50.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.98 156.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -115.69 126.28 53.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.857 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -151.58 130.07 12.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.913 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.1 t30 55.02 43.87 29.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 171.388 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.98 14.85 81.41 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.48 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.23 138.71 50.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 0.0 110.845 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -99.37 144.61 28.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 170.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -121.48 110.59 16.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.876 172.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.572 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.2 pp -80.0 -12.64 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.082 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.96 -13.13 20.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -122.94 85.23 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.874 170.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 169' ' ' PHE . 34.1 m -116.9 170.48 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.115 -169.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.63 24.42 29.84 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.45 -167.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.516 HG21 HD12 ' A' ' 368' ' ' ILE . 11.3 m -110.01 -15.45 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.0 111.112 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -85.92 19.61 2.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.786 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -110.32 -179.91 3.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.1 -24.6 64.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.097 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 190' ' ' ALA . . . -70.87 -40.63 63.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.456 -171.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.631 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.38 -35.35 80.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 111.115 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.534 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.1 mttt -59.05 -31.22 68.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 175.545 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 190' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 187' ' ' GLY . . . -65.51 -30.69 71.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.115 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.16 -47.46 84.9 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.379 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.495 HD11 ' HB1' ' A' ' 346' ' ' ALA . 19.7 mt -64.89 -38.91 92.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.883 0.373 . . . . 0.0 110.936 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.3 m -58.71 -45.12 90.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.21 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -77.28 -43.06 34.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.843 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.844 HD11 HD21 ' A' ' 151' ' ' LEU . 6.0 tt -55.57 -48.6 74.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 -171.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 24.8 m -68.58 -19.22 24.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -57.5 -54.87 41.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 -169.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 1.045 ' H ' HD13 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -76.1 -26.48 56.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.925 -168.021 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.613 ' H ' HD22 ' A' ' 198' ' ' LEU . 1.8 pp -86.65 -34.42 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.172 177.018 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.86 -31.81 68.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.856 165.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -85.86 6.06 29.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.861 177.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 65.0 39.94 5.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 170.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -84.54 -9.76 58.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 58.7 ttp -134.54 151.38 51.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -97.69 155.56 16.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.921 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.95 -27.76 69.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -95.25 4.25 53.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.903 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.402 ' CG2' ' HG3' ' A' ' 148' ' ' MET . 90.0 m -63.08 132.14 50.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.15 -176.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.432 ' H ' HD12 ' A' ' 212' ' ' ILE . 23.6 t0 -149.75 167.39 26.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.858 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -68.58 -34.01 75.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.0 p -63.57 -32.58 74.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.432 HD12 ' H ' ' A' ' 209' ' ' ASP . 79.7 mt -62.42 -36.56 75.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.08 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.726 ' HB2' ' SD ' ' A' ' 148' ' ' MET . . . -66.07 -42.22 89.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.081 -173.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -64.82 -39.24 93.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.986 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.32 -40.3 85.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.102 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.89 -34.59 78.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.121 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -59.95 -33.66 72.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.825 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -59.91 -34.98 73.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.954 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -96.45 -21.13 17.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.98 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLY . . . . . 0.528 ' O ' HD21 ' A' ' 121' ' ' LEU . . . 91.05 30.51 11.0 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.439 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -84.73 -27.75 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.876 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 94.9 m -116.96 131.1 57.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.216 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.477 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -66.26 -54.57 23.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.098 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.441 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 67.0 mtm -137.82 160.0 40.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.797 -168.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 10.4 t -149.76 164.17 36.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.7 mm -111.29 125.58 68.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.07 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -144.65 167.82 21.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.893 -169.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -118.52 -155.13 9.85 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.471 -174.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -59.99 -22.53 69.49 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.725 2.283 . . . . 0.0 112.289 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.9 p90 -81.54 4.33 21.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.949 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -51.57 -29.24 16.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.0 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -53.54 -20.59 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 26.3 t -42.03 -57.81 2.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.808 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -150.65 40.36 0.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.465 HD12 HG21 ' A' ' 116' ' ' ILE . 46.5 mm . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.124 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.828 0.347 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -99.14 70.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -174.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.471 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 82.4 m-85 -130.03 145.58 51.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.004 172.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -128.26 153.13 19.36 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.509 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.628 HG22 ' HB2' ' A' ' 319' ' ' ALA . 6.7 p -138.53 135.96 43.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.381 . . . . 0.0 111.193 -177.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.2 t -153.44 149.89 28.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.408 ' CG1' ' HB2' ' A' ' 323' ' ' ASN . 25.1 m -60.76 167.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.666 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.3 mm? -64.77 146.19 98.62 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.586 0.708 . . . . 0.0 110.899 -160.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.85 -177.01 2.61 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.727 2.284 . . . . 0.0 112.285 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.2 p -106.76 162.63 13.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.143 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.504 ' HD2' ' HB3' ' A' ' 163' ' ' ALA . 44.7 t80 -146.03 123.43 11.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 176.2 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 55.33 35.25 24.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.84 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.53 12.12 70.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.531 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -137.05 140.37 31.19 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.56 0.695 . . . . 0.0 110.947 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.36 140.82 30.94 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.677 2.251 . . . . 0.0 112.407 -174.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.666 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 89.8 p -83.33 -5.1 59.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.798 169.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -48.33 110.07 1.33 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.546 0.689 . . . . 0.0 110.901 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.0 163.53 30.83 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.623 2.216 . . . . 0.0 112.32 -177.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -73.66 174.82 7.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.828 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.5 t -108.39 132.32 56.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.048 -170.704 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -112.12 126.85 7.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.436 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 96.9 t -116.0 134.41 59.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.854 0.359 . . . . 0.0 111.098 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 263' ' ' SER . 2.6 tt -67.32 129.75 40.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.945 171.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.406 ' N ' HD23 ' A' ' 262' ' ' LEU . 64.3 p -124.63 131.82 53.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.899 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -125.25 125.87 44.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.137 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -119.75 170.34 14.08 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.424 -171.142 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 59' ' ' ILE . 13.1 mm -99.96 127.93 52.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.768 0.318 . . . . 0.0 111.107 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -64.91 127.25 30.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.9 -24.29 67.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.122 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.65 -11.57 55.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.037 -172.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.6 t -77.67 122.38 85.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.632 0.73 . . . . 0.0 110.87 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.34 -11.57 30.31 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.591 2.194 . . . . 0.0 112.349 171.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -111.73 35.19 3.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.917 -169.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -59.31 -26.68 65.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.834 -170.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -69.03 -39.86 78.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.864 -172.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.38 -48.45 72.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.732 ' HB1' HG23 ' A' ' 59' ' ' ILE . . . -67.38 -48.17 68.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.153 -172.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -65.25 -37.46 87.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.5 tt0 -68.21 -53.7 22.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 -172.022 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.1 p90 -67.54 -35.13 78.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.837 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 4.8 tt -58.58 -50.04 75.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -79.95 -33.51 39.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 65.6 m-80 -100.01 -17.71 17.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 -164.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.407 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 40.0 t80 -121.33 -48.64 2.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.954 -172.059 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 0.3 OUTLIER -65.04 -46.39 81.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.82 176.228 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 106' ' ' TYR . 64.8 mt -84.97 59.39 5.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.486 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 52.5 p -138.47 150.2 46.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.187 172.228 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.57 ' HA ' HD11 ' A' ' 290' ' ' LEU . 42.9 p-10 -51.56 -26.0 7.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.84 -174.057 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -78.65 -44.8 22.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.791 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.4 -51.07 13.68 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 -169.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.57 HD11 ' HA ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -73.31 -20.78 60.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 110.91 -179.251 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.426 ' N ' HD12 ' A' ' 290' ' ' LEU . 81.8 tt0 -66.06 -40.75 91.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.933 168.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.79 76.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.075 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.592 HG13 ' HA3' ' A' ' 19' ' ' GLY . 24.9 t -77.4 -44.62 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.143 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.42 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 49.8 t30 -65.03 -25.86 68.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.968 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.4 -28.96 70.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -87.01 -41.65 13.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.822 -176.97 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -147.69 132.8 9.08 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 121.515 0.674 . . . . 0.0 111.027 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -51.99 111.92 0.72 Allowed 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.628 2.219 . . . . 0.0 112.408 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.42 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 55.3 mt -90.98 -17.17 26.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -172.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.528 ' O ' HG23 ' A' ' 317' ' ' ILE . . . 102.96 -43.04 1.75 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.394 175.793 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -176.27 168.72 2.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.823 0.344 . . . . 0.0 110.974 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.51 HG22 HD21 ' A' ' 311' ' ' LEU . 23.9 m -122.6 154.29 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.199 170.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -69.44 -18.39 63.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.09 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.477 ' CD2' HD21 ' A' ' 290' ' ' LEU . 63.3 tp -83.63 122.62 28.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.014 -173.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -59.55 -36.33 75.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.787 -173.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.8 m -63.11 -49.87 72.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 -168.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.591 ' CD2' HD23 ' A' ' 311' ' ' LEU . 33.1 t80 -83.79 -26.97 29.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -56.43 -44.38 80.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.918 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.01 -36.23 83.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.875 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -76.01 -48.89 19.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.815 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.6 pp -66.72 -25.43 66.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -64.2 -17.37 63.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.061 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -67.3 -17.86 64.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.872 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -80.02 123.28 83.61 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.557 0.694 . . . . 0.0 110.904 173.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.554 ' O ' HG11 ' A' ' 244' ' ' VAL . 83.7 Cg_exo -52.85 -35.59 70.68 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.582 2.188 . . . . 0.0 112.319 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -64.79 -26.83 68.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.92 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.815 HG21 ' CD1' ' A' ' 311' ' ' LEU . 56.3 mt -96.75 -34.54 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.115 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.21 -39.41 13.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.012 -167.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.628 ' HB2' HG22 ' A' ' 244' ' ' VAL . . . -65.15 -44.32 88.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.05 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 317' ' ' ILE . 69.2 p -68.27 -29.9 68.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.128 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 18.0 tmm? -69.99 -40.13 75.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -65.69 -45.6 82.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.551 HD22 ' HB1' ' A' ' 112' ' ' ALA . 25.4 t30 -63.42 -36.3 83.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.967 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.79 -48.28 79.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.032 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -75.4 -32.69 60.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -94.75 -5.6 44.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.931 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -95.28 -157.73 32.43 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.496 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -140.02 142.73 36.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 110.925 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.581 ' O ' ' C ' ' A' ' 330' ' ' MET . 31.4 mm -79.91 108.47 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.215 -170.331 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.643 ' O ' ' HG3' ' A' ' 330' ' ' MET . 20.4 ptp . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.503 0.668 . . . . 0.0 110.848 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.804 0.335 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 79.7 mmm -71.33 -25.02 62.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.91 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.0 m -61.76 -40.06 93.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 176.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.88 -34.3 60.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.995 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -63.39 -37.97 89.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.891 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 154' ' ' PRO . 21.0 m0 -61.07 -34.5 75.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -76.79 -35.27 57.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 342' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 367' ' ' ARG . . . -63.2 -39.98 96.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.057 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.8 m -81.82 -24.2 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.091 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.532 ' CD ' ' HD3' ' A' ' 154' ' ' PRO . 52.9 ttt180 -55.63 -55.45 31.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.824 173.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 96.6 m -56.87 -33.0 66.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.131 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.637 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -56.94 -44.51 82.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.136 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.432 ' HA ' HD22 ' A' ' 192' ' ' LEU . 1.3 m -74.96 -33.1 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.179 -174.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.3 -47.21 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.22 173.163 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 349' ' ' ASN . . . . . 0.561 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 84.5 m-20 -66.73 -37.01 83.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.52 -47.26 61.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.091 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.45 -39.87 92.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.094 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.5 p -74.86 -14.17 60.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.007 0.432 . . . . 0.0 110.85 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 76.67 10.61 85.83 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.505 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -79.77 -25.09 41.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.765 0.317 . . . . 0.0 110.844 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 87.5 mt-30 -133.15 158.26 43.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 169.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.5 p -79.37 171.01 15.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.154 168.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 67.1 t -55.88 -44.5 78.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.07 169.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -58.21 -44.93 88.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -70.84 -52.02 22.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -69.19 -44.66 71.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.132 -173.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -65.49 -39.99 92.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 -177.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 362' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.0 tttt -64.91 -38.4 90.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.894 176.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -65.83 -36.89 84.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.637 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -63.92 -44.77 91.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.077 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -73.26 -30.38 63.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.942 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 68.5 m -64.34 -41.17 96.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.422 ' HB2' ' HB1' ' A' ' 342' ' ' ALA . 99.6 mtt180 -67.74 -39.62 84.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.748 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.516 HD12 HG21 ' A' ' 183' ' ' VAL . 67.9 mt -65.6 -39.27 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.164 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.8 p -92.59 -9.04 42.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.064 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.99 173.966 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.733 0.301 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.458 HG21 ' HD2' ' A' ' 271' ' ' PRO . 87.1 mt -79.75 126.35 39.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -148.49 147.38 29.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.801 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.3 129.77 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.817 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.458 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 96.33 5.85 59.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.448 -174.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.0 tttt -164.71 139.86 5.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.779 0.324 . . . . 0.0 110.945 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.669 HD22 HD13 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -146.39 157.45 43.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 75.3 t -108.94 133.43 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.114 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.762 HG13 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -123.11 135.36 63.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 -178.493 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -109.07 160.87 15.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.553 HG21 ' HB2' ' A' ' 15' ' ' LYS . 87.9 mt -132.93 149.26 31.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.154 166.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.501 ' O ' HG22 ' A' ' 11' ' ' ILE . 62.0 t30 -58.26 159.81 5.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 174.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.51 -15.36 8.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.555 -174.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.91 -24.05 65.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 110.872 -172.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.553 ' HB2' HG21 ' A' ' 11' ' ' ILE . 35.4 mtmt -134.25 132.04 39.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.944 169.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.07 -94.07 0.76 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.459 -168.451 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -115.24 -46.67 2.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 110.943 -172.707 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -64.03 -47.85 78.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.963 -155.464 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.916 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -57.91 -45.66 93.39 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.431 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.762 HD11 HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -51.51 -50.73 59.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.872 0.368 . . . . 0.0 110.865 177.024 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.18 -39.37 63.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.167 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -70.1 -52.33 24.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.0 m -69.2 -36.33 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.56 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -66.72 -41.14 93.93 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.513 173.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -54.07 -46.06 71.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.889 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.9 -44.06 90.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.945 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.663 ' CE2' HD11 ' A' ' 33' ' ' ILE . 44.0 t80 -65.71 -38.09 88.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.812 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 34.7 tt0 -64.5 -42.94 95.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.841 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.6 -32.46 68.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -81.14 -39.35 25.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.872 -171.227 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.715 ' OG1' HG13 ' A' ' 33' ' ' ILE . 67.8 p -103.78 -10.21 18.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.42 7.39 85.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.453 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.076 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.8 pp -104.08 132.51 50.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.882 0.372 . . . . 0.0 111.064 -175.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.8 mttt -70.41 136.74 49.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -171.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.56 HG21 ' HA3' ' A' ' 24' ' ' GLY . 3.0 m -111.99 133.07 58.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 174.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.6 m -110.1 125.66 53.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.102 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.584 HG22 ' HG ' ' A' ' 20' ' ' LEU . 60.9 t -89.66 126.29 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 178.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -112.91 148.88 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 175.018 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 64.8 t-80 -86.27 136.19 35.95 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.658 0.742 . . . . 0.0 110.883 -169.387 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 83.2 Cg_exo -56.04 -21.36 34.17 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.721 2.28 . . . . 0.0 112.322 -175.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -48.07 -53.99 14.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 43' ' ' LEU . 99.1 mttt -88.78 0.92 56.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -172.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 42' ' ' LYS . 16.4 tp -39.88 -54.73 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.975 -173.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.48 -35.27 68.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.844 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.19 -47.93 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 -166.475 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -78.6 -43.81 25.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 -171.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.557 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 83.6 t80 -50.87 -53.88 42.76 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.574 0.702 . . . . 0.0 110.851 -167.662 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 38.9 Cg_endo -65.98 -30.11 48.44 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.629 2.22 . . . . 0.0 112.351 -177.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -74.8 -41.99 58.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.428 HG21 ' HD3' ' A' ' 57' ' ' PRO . 24.9 m -75.48 -21.5 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.201 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 -31.69 72.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.057 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.15 -29.76 70.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.11 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.9 p -92.62 -15.19 27.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.199 170.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.98 18.38 79.64 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.432 171.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -140.2 143.85 36.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.863 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.48 -78.31 0.33 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.477 168.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 89.0 Cg_endo -78.52 140.99 17.35 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.727 2.284 . . . . 0.0 112.329 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.413 ' HB2' HD13 ' A' ' 59' ' ' ILE . 1.5 m-20 -101.41 -41.13 6.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.97 173.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.64 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -132.92 143.68 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.195 176.91 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.0 tp -136.08 128.06 44.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.174 -169.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.486 ' N ' ' HD1' ' A' ' 61' ' ' PHE . 2.0 m-30 -97.89 142.28 29.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.926 -175.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 80.3 m95 -140.72 159.74 41.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 174.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.17 -88.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.059 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -125.48 -62.54 1.19 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.874 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -75.39 -35.42 61.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 -161.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.467 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 9.4 mpt_? -54.66 -33.75 61.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.895 -168.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.563 ' HB3' HD13 ' A' ' 104' ' ' ILE . 51.0 m-85 -56.79 -38.71 72.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -172.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.06 -50.49 57.31 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.485 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.13 -42.35 99.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.515 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -74.66 -33.21 62.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.945 0.403 . . . . 0.0 110.985 -176.123 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' A' ' 76' ' ' LEU . . . -65.11 -38.71 91.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.074 170.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -63.97 -34.63 78.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 98.9 p -86.7 -10.14 54.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.886 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.54 28.97 62.41 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.554 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 mp -90.39 -17.2 27.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 -173.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 1.328 ' O ' HD13 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.09 121.17 37.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.807 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -64.73 137.83 58.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.084 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.21 137.05 56.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.446 HD12 ' CE2' ' A' ' 106' ' ' TYR . 37.2 pt -109.98 160.42 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.8 p -96.97 149.87 36.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.547 0.689 . . . . 0.0 111.214 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.13 137.93 29.8 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.74 2.294 . . . . 0.0 112.397 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -104.06 108.8 20.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.888 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.77 -41.78 91.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.969 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.38 -41.88 98.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.218 -176.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.565 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 13.0 m-30 -74.35 -47.6 33.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -49.44 -42.53 43.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -57.35 -30.58 64.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.889 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 305' ' ' LYS . 84.9 mttt -87.45 -13.81 42.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.931 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 46.8 mt -104.93 -145.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.973 -170.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.97 140.69 37.11 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.743 0.782 . . . . 0.0 110.888 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.48 -28.78 38.31 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.628 2.218 . . . . 0.0 112.405 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -65.58 -42.81 91.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.506 HG22 HG21 ' A' ' 261' ' ' VAL . 81.2 p -78.25 -38.37 42.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.161 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -49.37 -46.97 47.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.931 169.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.42 -35.6 80.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.76 -24.94 65.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.024 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.479 HG23 HD11 ' A' ' 103' ' ' LEU . 31.7 m -112.46 20.77 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.206 -171.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.464 ' HB3' HD12 ' A' ' 103' ' ' LEU . 54.7 ptt85 -120.01 146.7 45.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.919 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -136.93 125.58 23.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.014 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.3 t30 60.01 37.05 21.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.73 1.07 90.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.517 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -117.46 150.15 39.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.758 0.314 . . . . 0.0 110.905 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.479 HD11 HG23 ' A' ' 97' ' ' VAL . 6.3 tp -81.68 136.79 35.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.563 HD13 ' HB3' ' A' ' 67' ' ' PHE . 2.1 pp -128.04 2.72 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.153 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.486 ' HB2' ' CE1' ' A' ' 67' ' ' PHE . . . -168.32 169.22 10.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.064 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 263' ' ' SER . 99.4 m-85 -120.1 139.67 28.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.682 0.753 . . . . 0.0 110.887 166.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.52 122.99 5.75 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.586 2.19 . . . . 0.0 112.362 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.2 mp -109.66 -42.92 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.039 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -137.36 144.46 42.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 -165.943 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.27 131.49 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.17 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -117.6 125.37 50.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.511 ' HB3' ' CG2' ' A' ' 320' ' ' THR . . . -163.57 163.74 24.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.145 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.421 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 6.6 mp -101.03 170.93 7.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.917 -167.03 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 86.7 p -158.84 154.4 26.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 171.822 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.872 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -100.06 129.62 46.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.898 174.722 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.623 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.2 mp -114.34 135.99 52.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 -177.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -135.8 154.93 51.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 -172.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -96.78 119.31 35.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.471 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 98.4 mttt -65.6 -18.98 65.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -83.38 -28.16 29.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.811 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 223' ' ' ALA . 10.4 mp -88.09 -44.6 10.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.744 HD22 ' HB1' ' A' ' 223' ' ' ALA . 2.2 pt? -139.94 127.29 12.67 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.607 0.718 . . . . 0.0 110.907 168.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.73 -10.37 17.03 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.592 2.195 . . . . 0.0 112.412 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -143.48 108.32 5.2 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.643 0.735 . . . . 0.0 110.881 -175.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.03 148.61 76.04 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.728 2.286 . . . . 0.0 112.222 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.17 142.7 56.57 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.721 2.281 . . . . 0.0 112.341 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -83.38 -27.93 29.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.4 p -127.15 154.54 44.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.106 -177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.667 ' HA ' HD13 ' A' ' 132' ' ' ILE . 54.4 m95 -69.89 -23.96 63.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.29 -23.1 63.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -78.52 -22.59 47.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.667 HD13 ' HA ' ' A' ' 129' ' ' TRP . 1.4 mp -56.16 -51.13 83.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.677 0.751 . . . . 0.0 111.15 -170.057 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.6 Cg_endo -69.36 -41.25 4.97 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.621 2.214 . . . . 0.0 112.299 -172.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.0 -40.54 71.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.994 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 0.832 ' CD2' ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -58.35 -42.67 87.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.963 174.443 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.512 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 32.7 t70 -52.65 -37.24 58.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.09 -31.01 69.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.9 -56.39 5.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.842 -174.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 140' ' ' LYS . 1.0 OUTLIER -80.89 -10.06 59.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -175.61 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.52 ' N ' HD23 ' A' ' 139' ' ' LEU . 86.0 tttt -54.36 -30.77 52.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.804 165.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.82 -24.92 68.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.086 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -95.01 4.05 54.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.36 27.37 59.72 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.478 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.447 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 38.4 mmtm -116.48 155.52 28.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 0.0 110.891 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.9 t -100.73 147.53 25.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.834 173.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.512 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -67.25 -43.32 82.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.171 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.459 HD11 HG12 ' A' ' 226' ' ' ILE . 48.9 tp -141.4 152.6 44.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.843 -177.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 61.5 tpp -128.0 125.17 38.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.793 170.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -161.07 165.05 30.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -110.0 165.63 11.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 172.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.486 HD11 HD11 ' A' ' 195' ' ' LEU . 36.6 tp -130.15 -16.81 3.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.856 171.283 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -71.92 0.71 8.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.847 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 70.3 mm-40 -121.82 144.9 41.99 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.672 0.749 . . . . 0.0 110.882 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' A' ' 340' ' ' TRP . 53.9 Cg_exo -55.22 -28.74 63.33 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.789 2.326 . . . . 0.0 112.313 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -59.49 -42.29 91.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -86.47 -32.24 20.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.452 HG22 HG21 ' A' ' 347' ' ' VAL . 65.0 p -64.84 -37.47 87.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.225 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.567 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 42.7 t-105 -61.93 -54.52 49.92 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 121.597 0.713 . . . . 0.0 111.016 -173.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 33.2 Cg_endo -67.14 -27.6 41.56 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.699 2.266 . . . . 0.0 112.38 -174.648 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.668 ' C ' HD13 ' A' ' 160' ' ' LEU . 2.9 tm? -64.77 -41.85 95.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.572 HG22 ' HA3' ' A' ' 166' ' ' GLY . 2.9 mp -78.08 -41.91 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.23 176.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.32 -20.21 65.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.072 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -57.87 -34.17 69.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.985 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -101.51 5.37 41.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.864 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.33 9.21 24.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.379 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.572 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -75.09 65.79 2.25 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.344 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -95.69 134.81 38.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.885 0.374 . . . . 0.0 110.96 173.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.533 ' HB1' HG21 ' A' ' 368' ' ' ILE . . . -47.77 -31.0 4.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 -175.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.411 ' CD1' HG12 ' A' ' 181' ' ' VAL . 98.5 m-85 -138.48 148.03 43.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.911 174.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -69.11 127.66 33.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -102.04 119.95 39.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.933 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -150.83 130.61 13.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.809 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.3 t30 55.38 42.43 30.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.934 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.38 9.39 81.39 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.416 173.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.03 141.55 49.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.7 0.286 . . . . 0.0 110.892 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -94.11 135.33 35.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 172.338 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -95.92 105.41 17.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.907 -170.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.454 ' C ' HD12 ' A' ' 178' ' ' ILE . 2.4 pp -71.31 -6.52 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -100.89 -16.7 17.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -134.95 100.75 4.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 168' ' ' ALA . 32.4 m -101.45 162.14 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.132 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -101.75 -0.1 52.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.527 -168.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.5 m -100.72 -20.03 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 0.0 111.128 -171.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -96.28 20.11 10.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -106.62 -175.08 2.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 -174.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.49 71.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.061 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -71.4 -41.25 58.96 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.461 -170.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.71 -34.68 76.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.775 0.321 . . . . 0.0 111.036 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -61.75 -40.87 96.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.969 174.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.06 76.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.025 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.504 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -58.68 -48.88 82.5 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.458 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.475 HD11 ' HB1' ' A' ' 346' ' ' ALA . 25.8 mt -66.41 -39.11 88.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.943 0.402 . . . . 0.0 110.967 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.9 m -58.55 -45.39 89.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.197 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.433 ' O ' HD22 ' A' ' 198' ' ' LEU . 82.3 t80 -68.91 -48.53 63.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 174.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.835 HD23 ' C ' ' A' ' 195' ' ' LEU . 3.2 tt -50.76 -51.79 46.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -174.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.504 ' HA ' HG23 ' A' ' 199' ' ' ILE . 34.7 m -63.52 -23.47 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.071 -175.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.54 -34.01 73.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.961 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.6 OUTLIER -82.15 -40.02 22.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -174.952 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.543 ' O ' HG12 ' A' ' 199' ' ' ILE . 0.0 OUTLIER -75.23 -29.56 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 175.829 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LYS . . . . . 0.428 ' N ' HD13 ' A' ' 199' ' ' ILE . 87.6 tttt -72.36 -46.54 54.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.901 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -90.16 5.75 45.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 67.27 37.72 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 170.474 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -83.04 -13.78 55.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.918 173.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -138.22 155.15 48.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.917 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -103.78 139.83 38.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.824 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.96 -22.24 64.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.071 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.72 -5.84 58.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.895 -172.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 86.7 m -60.03 137.98 57.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.469 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 20.9 t0 -139.25 175.41 9.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -60.82 -45.8 93.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.917 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 96.3 p -67.57 -35.97 80.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.469 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 85.8 mt -64.17 -41.61 92.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.145 175.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.76 -38.89 84.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.091 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -63.17 -45.86 89.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.803 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.14 95.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.159 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.67 97.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.02 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -66.78 -47.38 72.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.873 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -66.0 -30.52 71.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -86.02 -13.6 46.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.924 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.03 26.23 53.56 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.47 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -86.42 -28.62 23.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 0.0 110.911 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 15.3 t -119.79 134.38 55.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.109 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.744 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -78.45 -34.14 47.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.107 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.46 ' HB3' HD21 ' A' ' 115' ' ' LEU . 77.7 mtm -128.94 150.33 50.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.847 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.8 t -145.34 150.97 37.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.459 HG12 HD11 ' A' ' 147' ' ' LEU . 39.2 mm -107.04 122.22 60.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.11 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -140.98 149.39 41.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -127.24 -150.58 7.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.482 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.05 -20.36 71.22 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.658 2.239 . . . . 0.0 112.282 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -71.6 -24.47 61.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.905 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 55.09 54.92 8.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.079 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -60.27 -38.17 82.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.953 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 35.7 t -105.0 118.79 37.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 168.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -75.45 72.83 2.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 116' ' ' ILE . 78.7 mt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.155 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 25.5 m . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -92.71 121.06 33.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.897 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.471 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 31.3 p90 -143.53 152.56 41.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.937 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -143.01 167.8 26.23 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.606 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 315' ' ' PRO . 7.7 p -132.27 139.5 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.966 0.412 . . . . 0.0 111.061 -172.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.0 t -144.92 147.16 32.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 168.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 16.6 m -56.92 156.45 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.133 168.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.48 ' N ' HD12 ' A' ' 247' ' ' LEU . 7.4 mp -66.76 148.99 98.61 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.514 0.673 . . . . 0.0 110.897 -157.109 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 48.1 Cg_exo -60.69 178.34 0.49 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.781 2.321 . . . . 0.0 112.369 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 82.1 p -99.96 153.98 18.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -135.31 117.05 15.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 54.77 35.17 23.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 89.11 5.7 72.73 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.472 171.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -124.36 140.54 35.35 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.606 0.717 . . . . 0.0 110.854 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.02 129.5 17.43 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.688 2.258 . . . . 0.0 112.326 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 68.0 m -78.81 -26.76 44.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.87 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -47.63 109.92 1.22 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.557 0.694 . . . . 0.0 110.91 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -58.72 161.31 15.33 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.731 2.287 . . . . 0.0 112.307 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -62.4 162.1 10.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.456 HG23 ' HB2' ' A' ' 112' ' ' ALA . 3.5 p -108.3 134.03 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.11 -175.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.25 142.94 16.06 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.451 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.506 HG21 HG22 ' A' ' 93' ' ' THR . 73.3 t -127.65 122.54 59.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 111.194 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 263' ' ' SER . 1.6 tt -82.05 130.77 35.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 172.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.637 ' N ' HD23 ' A' ' 262' ' ' LEU . 62.2 m -132.32 158.16 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.902 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.18 138.98 50.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.063 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.76 178.27 18.23 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.46 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 77' ' ' ALA . 27.0 mm -103.6 137.06 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.908 0.385 . . . . 0.0 111.092 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -72.29 127.4 32.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.807 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -65.43 -23.06 66.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.1 -176.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.75 -11.72 55.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.054 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.7 t -77.16 120.84 83.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.66 0.743 . . . . 0.0 110.917 -173.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.458 ' HD2' HG21 ' A' ' 2' ' ' ILE . 77.7 Cg_endo -69.12 -10.57 29.42 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.707 2.271 . . . . 0.0 112.32 170.177 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -103.01 21.41 15.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 -170.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -52.97 -31.63 41.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 -170.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -66.18 -47.3 74.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.83 -170.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.04 -26.94 20.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.948 -177.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.567 ' HB1' HG23 ' A' ' 59' ' ' ILE . . . -63.14 -45.11 93.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.16 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -69.73 -33.95 73.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.987 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 92.4 mt-10 -66.43 -35.52 80.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.827 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.498 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 0.8 OUTLIER -56.27 -53.56 55.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.795 175.769 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.495 ' HB2' HD12 ' A' ' 284' ' ' LEU . 2.1 pp -79.06 -34.78 43.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.906 -170.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.22 -42.4 72.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 95.4 m-20 -97.56 -4.38 37.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 -164.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.621 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 47.3 m-85 -118.36 -54.4 2.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.033 173.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.558 ' O ' ' HB3' ' A' ' 290' ' ' LEU . 25.3 mt -81.17 -42.49 20.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.942 -169.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.469 HD23 HD12 ' A' ' 280' ' ' LEU . 4.0 mm? -81.58 19.94 0.97 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 169.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.63 ' O ' HD22 ' A' ' 290' ' ' LEU . 94.0 m -132.61 142.67 49.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.101 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 47.9 p-10 -51.44 -26.19 7.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -168.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -74.46 -46.8 37.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -175.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -80.62 -48.04 6.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 -165.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 291' ' ' GLU . 0.7 OUTLIER -70.21 -16.06 63.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 110.936 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.713 ' N ' HD23 ' A' ' 290' ' ' LEU . 83.2 tt0 -71.99 -47.33 52.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 167.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.81 -40.75 98.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.087 -172.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.916 HG23 ' HA3' ' A' ' 19' ' ' GLY . 3.3 p -70.75 -36.83 66.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -67.43 -25.21 65.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.784 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.84 -29.36 70.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -90.67 -43.11 10.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.409 ' O ' HD13 ' A' ' 299' ' ' LEU . 65.8 mttm -127.92 145.78 56.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.531 0.681 . . . . 0.0 110.902 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.7 107.14 1.59 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.748 2.298 . . . . 0.0 112.329 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.455 ' HG ' ' HD3' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -91.89 -19.21 22.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.944 -179.021 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.488 ' O ' HD11 ' A' ' 317' ' ' ILE . . . 88.58 -62.02 3.78 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.573 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -160.25 167.49 27.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 111.17 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.73 HG21 ' HB3' ' A' ' 307' ' ' TYR . 33.2 m -131.14 156.15 42.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.213 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.06 -14.82 60.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.077 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' A' ' 89' ' ' LEU . 50.4 tp -81.21 126.83 31.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -173.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 87.2 tttt -55.41 -44.99 76.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 63.7 m -61.59 -52.18 65.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.802 -168.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.73 ' HB3' HG21 ' A' ' 302' ' ' VAL . 12.6 t80 -78.02 -32.67 51.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -62.91 -42.03 99.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.921 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -62.09 -38.99 90.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.894 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.69 -48.76 29.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.601 HD21 HG22 ' A' ' 302' ' ' VAL . 4.6 pp -69.13 -23.48 63.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.854 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.422 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.41 -14.96 63.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.14 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.45 -16.4 62.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.965 176.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.48 133.48 44.43 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.575 0.702 . . . . 0.0 110.864 169.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' PRO . . . . . 0.423 ' O ' HG11 ' A' ' 244' ' ' VAL . 90.5 Cg_exo -47.74 -35.74 24.3 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.673 2.249 . . . . 0.0 112.342 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -61.96 -27.64 68.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -167.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.488 HD11 ' O ' ' A' ' 300' ' ' GLY . 2.1 mp -100.03 -40.85 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.162 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.11 -47.24 61.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -162.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.25 -34.77 75.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.19 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.511 ' CG2' ' HB3' ' A' ' 112' ' ' ALA . 62.9 m -61.42 -37.01 81.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.058 -176.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.6 mtp -60.16 -30.46 69.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.896 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -65.45 -43.95 88.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -77.06 -39.75 48.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.36 -39.79 73.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.156 -168.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.3 -28.32 69.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -108.6 -1.68 19.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -86.16 -160.21 33.68 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.414 -168.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -140.93 154.75 46.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.987 0.422 . . . . 0.0 110.825 -173.174 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 40.6 mm -68.07 116.28 7.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.114 -171.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 63.3 ttp . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 121.515 0.674 . . . . 0.0 110.904 174.784 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.8 0.333 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.465 ' HA ' ' CD2' ' A' ' 339' ' ' PHE . 68.0 ttp -54.84 -34.88 63.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 95.9 p -65.14 -31.12 72.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.29 -35.54 63.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.163 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.55 ' HB3' ' CZ3' ' A' ' 158' ' ' TRP . 3.2 m-30 -56.34 -55.65 30.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 176.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.429 ' HB3' ' HB3' ' A' ' 154' ' ' PRO . 52.5 m0 -62.79 -37.82 88.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.92 -172.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -69.71 -48.04 61.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.826 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.14 -42.36 93.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.168 -173.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.449 HG21 ' HA ' ' A' ' 158' ' ' TRP . 19.6 m -73.0 -28.0 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.065 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -62.71 -40.95 98.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.938 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 93.0 m -57.33 -36.07 70.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.157 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.475 ' HB1' HD11 ' A' ' 192' ' ' LEU . . . -65.41 -45.76 82.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.017 -175.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.452 HG21 HG22 ' A' ' 157' ' ' THR . 2.4 m -72.18 -34.42 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.132 -174.586 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.433 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -63.18 -46.36 96.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.187 173.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -67.81 -39.49 83.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.924 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.59 -47.61 39.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.105 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.32 -37.43 80.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.12 -173.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.2 p -74.99 -9.1 58.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 75.51 11.66 84.2 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -78.77 -27.14 44.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.791 0.329 . . . . 0.0 110.893 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -139.67 156.23 46.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.939 173.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.6 p -77.15 164.96 25.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.194 170.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.7 t -51.91 -41.01 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 175.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.78 -48.94 76.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.994 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -76.82 -44.23 33.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.937 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.56 -47.35 81.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.102 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 13.5 tp -67.07 -52.86 36.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.957 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -54.03 -46.8 71.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.939 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -72.23 -43.68 64.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.08 -47.07 54.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.168 -175.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -67.66 -30.77 70.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 24.9 m -55.14 -31.87 61.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.111 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -58.98 -29.84 67.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.533 HG21 ' HB1' ' A' ' 168' ' ' ALA . 77.9 mt -56.15 -40.11 62.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.113 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.6 p -100.99 -10.43 20.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.115 -174.757 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.882 179.643 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.718 0.294 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.2 mt -94.08 125.11 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -150.07 147.96 28.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -50.79 133.85 25.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.799 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.96 4.92 64.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.508 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.9 tttt -163.11 141.71 8.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 110.959 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.581 ' CD2' HD11 ' A' ' 33' ' ' ILE . 2.3 pt? -146.51 154.49 41.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.93 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.501 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 88.6 t -110.91 134.7 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.09 -177.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.654 HD11 ' HB ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -119.96 133.56 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 -178.994 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.72 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 65.2 m95 -106.59 124.19 49.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.942 164.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.501 HD12 ' HG ' ' A' ' 20' ' ' LEU . 12.1 tt -110.01 150.0 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.114 -165.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -62.74 148.18 47.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 -173.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.61 -17.69 21.02 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.454 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.88 -27.34 68.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -173.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 15' ' ' LYS . 35.7 mmtm -140.06 133.67 30.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 166.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.63 -80.77 0.95 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.497 -169.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -99.97 -38.7 8.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.839 0.352 . . . . 0.0 110.914 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -68.15 -51.91 40.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -151.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.11 -55.47 23.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.461 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.501 ' HG ' HD12 ' A' ' 11' ' ' ILE . 5.7 mt -53.82 -53.04 57.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.44 -40.21 7.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.082 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -72.12 -59.51 2.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.854 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 20' ' ' LEU . 20.7 m -70.33 -38.16 73.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 -172.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.767 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -66.98 -48.39 60.62 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.525 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -56.75 -35.0 68.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.846 0.355 . . . . 0.0 110.957 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -55.36 -39.62 70.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.987 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 5.6 m-30 -59.17 -46.32 88.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -65.0 -39.61 93.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -69.44 -38.23 77.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.853 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -94.95 -48.2 6.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -169.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.8 p -110.62 -1.47 16.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 -171.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.87 3.71 90.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.45 168.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.07 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -99.99 134.02 40.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.928 0.394 . . . . 0.0 111.124 -176.046 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.5 mttt -83.08 144.09 30.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.924 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.767 HG21 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -120.01 134.62 62.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 175.822 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.488 ' O ' HD12 ' A' ' 9' ' ' ILE . 97.0 m -102.21 129.09 48.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.145 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 20' ' ' LEU . 87.2 t -99.57 125.86 53.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -115.06 149.9 36.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.4 t-80 -86.13 138.92 34.45 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.573 0.702 . . . . 0.0 110.928 -165.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 77.1 Cg_exo -56.49 -27.57 69.41 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.695 2.263 . . . . 0.0 112.291 -175.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -47.97 -50.55 26.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -172.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -88.79 -5.04 58.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.6 tt -46.11 -54.85 7.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.897 -169.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.32 -38.32 90.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.953 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.95 -40.82 95.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.899 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HB3' HG13 ' A' ' 50' ' ' VAL . 75.3 mmtt -82.91 -20.01 36.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.57 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 84.4 t80 -49.29 -50.73 62.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.635 0.731 . . . . 0.0 110.799 -165.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 43.3 Cg_endo -82.85 -30.16 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.673 2.248 . . . . 0.0 112.385 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -74.86 -41.45 59.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 -167.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.479 HG21 ' HG3' ' A' ' 57' ' ' PRO . 32.1 m -67.58 -27.11 37.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 -175.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.496 ' CB ' ' HB3' ' A' ' 75' ' ' LEU . . . -69.33 -36.52 77.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.12 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.36 -33.49 75.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.147 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.8 p -94.46 -21.9 18.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.111 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.83 9.16 65.4 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.44 174.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -123.01 120.04 32.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.88 -95.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.427 172.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.72 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 64.5 Cg_endo -79.79 147.3 19.26 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.734 2.29 . . . . 0.0 112.394 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.04 -35.17 12.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.781 161.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.603 ' HB ' HG23 ' A' ' 9' ' ' ILE . 45.8 mt -125.24 136.87 59.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.141 -175.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.0 tp -132.88 126.41 53.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.187 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -92.22 138.98 31.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.857 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.484 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 24.9 p90 -145.07 163.35 34.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.042 170.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.25 -90.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.039 -168.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -123.34 -68.04 0.9 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.868 -171.572 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -103.29 -12.36 17.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.844 -159.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 55.8 ttm-85 -51.05 -20.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 -174.09 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.475 ' HB2' HD13 ' A' ' 104' ' ' ILE . 32.6 p90 -59.21 -33.48 71.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.06 -50.45 65.97 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.46 -168.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.16 -37.65 94.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.5 174.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.633 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 9.3 t80 -69.01 -42.1 76.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.849 0.357 . . . . 0.0 110.89 -175.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.61 -42.95 70.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.095 175.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -58.24 -37.59 75.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.957 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.407 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 58.1 m -84.55 -5.01 59.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.795 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.01 30.27 59.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.464 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.496 ' HB3' ' CB ' ' A' ' 51' ' ' ALA . 46.1 mt -89.39 -10.04 48.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.867 0.365 . . . . 0.0 110.905 -168.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.633 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -131.03 153.27 49.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.877 -179.074 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -80.0 139.73 36.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.128 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.4 mp0 -65.68 137.34 57.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.3 pt -100.57 152.09 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.107 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.7 m -96.91 119.0 64.39 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.591 0.71 . . . . 0.0 111.085 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.616 ' HB3' HD12 ' A' ' 103' ' ' LEU . 73.1 Cg_endo -73.97 155.55 47.95 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.745 2.297 . . . . 0.0 112.324 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -105.52 117.86 35.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.842 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -52.87 -35.06 57.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.02 90.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.5 m-30 -75.87 -33.28 59.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.896 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.511 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 86.4 mt-30 -54.9 -51.93 64.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.71 -33.84 70.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -81.96 -18.43 43.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.841 -172.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -104.7 -105.02 0.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 -172.812 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.509 ' CG ' ' HD2' ' A' ' 91' ' ' PRO . 5.0 t80 -178.72 142.74 0.42 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.705 0.764 . . . . 0.0 110.956 -166.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.509 ' HD2' ' CG ' ' A' ' 90' ' ' TYR . 31.3 Cg_endo -68.25 -37.6 13.72 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.731 2.287 . . . . 0.0 112.337 -175.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -75.08 -29.28 60.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.9 p -72.68 -37.05 68.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.266 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.745 ' CE3' HD13 ' A' ' 103' ' ' LEU . 86.4 m95 -73.61 -26.43 60.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.893 173.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -73.02 -31.31 64.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.853 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.23 -23.88 63.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.07 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.59 HG22 ' HA ' ' A' ' 94' ' ' TRP . 17.9 m -106.16 16.4 6.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.075 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.3 ttp85 -100.97 126.31 47.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.974 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -125.82 115.8 20.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.7 t30 57.17 35.11 25.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.897 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.65 -0.97 89.18 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.558 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -120.97 143.55 48.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 110.862 174.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.745 HD13 ' CE3' ' A' ' 94' ' ' TRP . 41.5 mt -89.59 135.58 33.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 -172.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.475 HD13 ' HB2' ' A' ' 67' ' ' PHE . 2.1 pp -127.21 3.36 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 -166.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.484 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -160.97 160.21 30.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.166 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.429 ' HB3' ' CD2' ' A' ' 285' ' ' LEU . 97.0 m-85 -108.53 139.57 20.94 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.582 0.706 . . . . 0.0 110.871 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -78.91 121.63 5.06 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.708 2.272 . . . . 0.0 112.327 170.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.072 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -105.59 -40.92 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.225 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -141.74 150.84 42.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.103 -164.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.6 t -115.65 123.91 71.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -112.92 122.34 47.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.656 ' HB1' HD21 ' A' ' 323' ' ' ASN . . . -150.18 144.8 25.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.065 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 257' ' ' PRO . 7.1 mp -87.56 170.03 11.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -174.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.2 p -158.33 154.92 27.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.845 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.817 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -91.92 129.1 37.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 169.102 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.611 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.9 mp -116.37 130.89 70.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.116 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -133.19 154.26 50.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 -171.815 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.451 ' O ' HD23 ' A' ' 122' ' ' LEU . 69.8 m-80 -88.0 119.57 28.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.862 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.44 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.6 mttt -64.82 -27.35 68.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -82.84 -24.13 33.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.819 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.0 mp -80.49 -54.43 5.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 172.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.706 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.6 pt? -140.36 127.9 12.51 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.617 0.722 . . . . 0.0 110.952 176.802 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.44 -9.43 14.91 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.659 2.239 . . . . 0.0 112.436 -176.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -149.28 98.0 3.53 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.554 0.693 . . . . 0.0 110.871 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.27 157.08 63.36 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.623 2.215 . . . . 0.0 112.293 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -66.4 143.07 68.34 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.633 2.222 . . . . 0.0 112.36 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.1 -17.48 37.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.5 p -134.5 157.53 46.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.185 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.497 ' HA ' HD13 ' A' ' 132' ' ' ILE . 71.4 m95 -70.15 -23.15 62.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.967 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.02 -24.59 67.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -85.59 -18.38 33.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.901 -177.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.576 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -59.54 -42.87 94.32 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.686 0.755 . . . . 0.0 111.163 -170.382 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 92.9 Cg_endo -80.01 -37.83 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.664 2.243 . . . . 0.0 112.35 -173.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.88 -58.92 6.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.12 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.236 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.49 -17.08 64.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -176.038 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.549 ' N ' HD13 ' A' ' 135' ' ' LEU . 37.8 t70 -60.04 -41.39 92.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 168.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.72 -30.8 70.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.29 -47.29 61.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.88 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.1 pp -85.16 -14.61 46.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.888 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.627 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.8 tttt -60.36 -34.47 73.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.955 174.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.06 -23.4 67.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -95.03 4.23 54.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.935 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.06 32.6 56.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.369 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -111.09 169.96 8.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 0.0 110.836 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.8 t -120.82 139.4 53.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 167.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -67.64 -44.02 78.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 -171.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -138.88 131.46 28.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 52.2 ttm -117.11 130.85 56.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -153.62 155.13 35.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -174.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -86.17 -51.98 5.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.78 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.038 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.5 tm? 48.34 31.71 2.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.919 -169.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -102.11 -9.02 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -129.71 152.39 79.7 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 121.726 0.774 . . . . 0.0 110.818 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.409 ' HB3' ' HB3' ' A' ' 340' ' ' TRP . 51.8 Cg_exo -55.01 -29.62 65.75 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.675 2.25 . . . . 0.0 112.343 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -68.45 -30.0 68.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -79.91 -41.05 26.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 172.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.435 HG23 HG11 ' A' ' 347' ' ' VAL . 19.4 m -60.8 -52.45 65.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.132 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.568 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 15.1 t-105 -59.23 -48.75 95.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.488 0.661 . . . . 0.0 110.907 -161.338 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 90.8 Cg_exo -52.25 -44.71 44.36 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.694 2.262 . . . . 0.0 112.355 -177.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.604 HD23 ' C ' ' A' ' 160' ' ' LEU . 7.7 tt -71.26 -40.09 71.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.826 -171.237 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 83.0 mt -71.08 -43.44 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.71 -22.0 60.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.158 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.49 -28.57 68.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.107 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -99.11 1.77 45.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.856 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 108.5 5.65 31.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.478 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.59 67.97 2.52 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.541 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -83.83 132.68 34.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.895 0.379 . . . . 0.0 110.999 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.38 6.77 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.134 -174.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.427 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.3 p90 -149.73 155.01 39.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.912 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 87.3 tttt -104.97 124.69 49.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 157.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -116.26 124.42 50.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -153.91 130.63 10.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.02 43.04 30.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.75 17.29 80.06 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.518 173.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.63 138.58 48.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.71 0.29 . . . . 0.0 110.866 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -96.99 144.69 26.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 169.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -123.51 111.66 16.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.583 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.1 pp -79.98 -12.74 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.55 -11.05 25.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.899 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 66.0 t0 -127.28 88.24 2.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 171.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 169' ' ' PHE . 32.7 m -116.13 166.92 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.063 -170.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.16 22.3 31.54 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.517 -170.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.479 HG21 HD12 ' A' ' 368' ' ' ILE . 1.5 m -105.47 -20.0 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.753 0.311 . . . . 0.0 111.083 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -86.48 21.16 2.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -104.96 -174.97 2.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 -175.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.9 -29.37 67.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.05 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.64 -40.18 77.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.437 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.499 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -62.57 -37.64 86.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.934 0.397 . . . . 0.0 111.162 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.593 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 88.6 mttt -62.92 -37.97 89.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 174.073 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.13 -36.99 85.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.079 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.42 -47.57 62.39 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.507 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.775 HD11 ' HA ' ' A' ' 347' ' ' VAL . 20.6 tp -66.41 -34.25 77.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 0.0 110.841 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.512 ' OG1' HG21 ' A' ' 357' ' ' VAL . 91.5 m -63.69 -40.68 97.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.227 174.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 61.8 t80 -67.15 -49.27 65.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 195' ' ' LEU . 7.2 tt -50.43 -51.69 44.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.884 -175.262 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 199' ' ' ILE . 35.2 m -63.9 -22.48 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.145 -174.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.5 m-20 -61.8 -34.58 76.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.412 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.9 OUTLIER -80.95 -40.15 24.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -173.996 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.6 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.7 pp -72.98 -29.76 30.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 172.545 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.91 -37.59 79.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.917 173.31 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -80.09 2.31 24.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 68.16 38.57 2.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.773 168.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -78.99 -17.33 55.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.823 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.6 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.2 ppp? -145.2 158.14 43.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.864 176.57 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -94.94 148.87 21.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.87 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.89 -25.75 67.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.169 -175.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -95.9 1.72 53.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 94.7 m -62.48 124.97 22.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.196 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.439 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 14.5 t0 -119.93 177.68 4.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -64.89 -37.38 87.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.035 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 96.1 p -70.32 -38.37 74.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.439 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 77.7 mt -65.09 -42.66 95.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.105 174.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.16 -36.18 83.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.046 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -61.5 -47.26 86.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.836 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.48 89.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.004 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.0 -44.87 87.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.141 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -62.75 -44.48 96.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.992 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -64.77 -31.86 73.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.885 -177.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -83.72 -15.82 47.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.55 26.43 30.1 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.551 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -84.83 -21.79 29.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 110.84 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.1 t -123.91 137.47 54.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.598 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -62.74 -48.57 78.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.009 177.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.752 ' HB3' HD21 ' A' ' 115' ' ' LEU . 71.7 mtm -134.19 160.01 39.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 -172.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.4 t -151.33 157.16 42.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.199 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 48.4 mm -111.55 129.14 67.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.164 -175.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -155.05 175.02 14.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -81.74 -159.15 23.6 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.449 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.82 -24.92 24.28 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.584 2.189 . . . . 0.0 112.348 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 51.5 m0 -75.0 -29.44 60.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.961 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 47.4 45.52 17.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 174.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -65.62 -17.63 64.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.964 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 91.1 p -74.93 -9.41 58.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.961 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -76.8 -171.31 1.88 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.4 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 -173.821 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 88.9 t . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.858 0.361 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -79.95 139.92 36.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.44 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 45.1 p90 -144.95 158.65 43.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.881 176.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.65 166.67 26.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.496 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.1 p -135.02 135.16 53.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.888 0.375 . . . . 0.0 111.125 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.63 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 9.5 t -159.37 142.53 14.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.082 175.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.0 m -63.89 168.31 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.065 -169.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 2.1 mp -68.71 155.55 92.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.562 0.696 . . . . 0.0 110.942 -161.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -77.93 -176.22 3.12 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.739 2.293 . . . . 0.0 112.353 -173.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 93.9 m -85.93 145.13 27.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.225 -173.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -130.56 113.33 14.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.799 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 54.94 34.63 22.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.81 -0.54 86.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.471 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -127.54 127.54 24.08 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.598 0.713 . . . . 0.0 110.863 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 249' ' ' THR . 81.2 Cg_exo -54.73 131.05 43.68 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.662 2.242 . . . . 0.0 112.351 -176.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 256' ' ' LYS . 96.0 p -83.77 1.36 43.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 172.153 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 97.8 mttt -37.09 130.2 0.76 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.512 0.672 . . . . 0.0 110.832 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.486 ' HB3' ' HB2' ' A' ' 113' ' ' LEU . 74.0 Cg_exo -61.56 155.91 50.38 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.66 2.24 . . . . 0.0 112.378 -169.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -74.98 165.15 25.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.845 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.88 126.76 69.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.192 -168.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -112.28 137.35 14.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.454 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 62.5 t -125.04 116.03 45.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 111.13 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.17 123.42 19.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.941 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 47.4 m -127.59 130.39 48.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.803 -168.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.01 136.17 52.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 -171.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.88 169.35 16.85 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.403 -171.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.908 HG13 ' HG2' ' A' ' 277' ' ' LYS . 31.2 mm -112.69 130.16 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 111.082 -174.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -63.37 126.02 26.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -60.6 -28.24 68.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.144 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.0 -6.52 59.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.074 -170.097 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.4 t -75.08 122.91 88.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.644 0.735 . . . . 0.0 110.868 -173.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -68.59 -12.59 35.14 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.727 2.285 . . . . 0.0 112.373 166.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.46 HD21 HD22 ' A' ' 275' ' ' LEU . 55.5 t30 -111.12 31.27 6.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.919 -168.041 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -60.84 -29.78 69.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -57.52 -40.11 78.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.692 HD23 HG13 ' A' ' 33' ' ' ILE . 8.6 mp -75.16 -45.67 39.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.963 174.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -62.7 -56.22 19.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.058 -171.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.908 ' HG2' HG13 ' A' ' 266' ' ' ILE . 91.7 mttt -60.92 -40.26 92.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.922 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.7 tt0 -71.0 -49.26 47.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.834 -173.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -67.16 -34.11 76.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.483 ' HA ' HD22 ' A' ' 284' ' ' LEU . 4.6 tt -62.46 -51.39 67.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.965 -175.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -77.88 -33.33 52.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 67.7 m-80 -98.72 -11.19 22.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -163.516 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.856 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 77.5 m-85 -129.67 -52.32 1.16 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.873 177.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.5 OUTLIER -62.81 -35.69 80.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -168.852 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 1.072 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.5 pp -123.96 37.76 4.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.885 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.435 ' CG2' ' N ' ' A' ' 287' ' ' ASP . 8.2 m -117.97 153.7 33.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.109 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.454 ' HA ' HD11 ' A' ' 290' ' ' LEU . 31.0 t70 -43.45 -36.38 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.85 -166.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -79.36 -40.62 29.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.856 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.14 -56.73 5.56 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.446 -171.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.647 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.1 -21.08 66.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 0.0 110.98 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.593 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.0 tt0 -66.74 -45.87 77.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.788 171.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.2 -46.64 88.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.102 -174.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -46.06 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.172 -175.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.511 ' HB2' HD22 ' A' ' 299' ' ' LEU . 43.2 t30 -63.38 -27.89 69.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.21 -27.59 68.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -91.14 -47.64 7.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.943 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -136.31 145.46 51.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.545 0.688 . . . . 0.0 110.93 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.6 110.08 1.78 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.729 2.286 . . . . 0.0 112.402 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.511 HD22 ' HB2' ' A' ' 294' ' ' ASN . 0.8 OUTLIER -82.02 -27.67 32.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 176.309 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 103.69 -58.55 0.52 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.419 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.598 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -169.25 165.02 10.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.915 0.388 . . . . 0.0 111.129 174.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 26.1 m -125.92 153.93 34.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.02 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.39 -10.88 60.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.143 173.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.647 ' CD2' HD21 ' A' ' 290' ' ' LEU . 51.4 tp -85.23 120.27 26.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.31 -39.96 76.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.948 -172.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 41.3 t -64.75 -51.36 62.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 -168.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.489 ' HB3' HG21 ' A' ' 302' ' ' VAL . 19.0 t80 -76.73 -29.04 56.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -64.34 -38.46 91.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.16 -37.24 82.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.91 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -74.25 -39.93 62.71 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.93 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.598 HD13 ' HA ' ' A' ' 301' ' ' ALA . 77.4 mt -60.05 -33.01 71.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 175.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.31 -19.58 61.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.08 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.73 -20.32 66.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -90.12 123.59 65.49 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.664 0.745 . . . . 0.0 110.807 167.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -47.93 -28.86 10.78 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.649 2.232 . . . . 0.0 112.377 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -61.75 -32.58 72.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.95 -173.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.585 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.4 mp -80.07 -35.53 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.082 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.1 -39.63 72.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.085 -174.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.16 75.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.051 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 82.6 p -59.82 -28.38 67.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.147 -174.672 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.3 mmm -66.36 -33.11 74.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.86 174.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -62.52 -47.43 83.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 -175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.656 HD21 ' HB1' ' A' ' 112' ' ' ALA . 14.4 p-10 -83.42 -25.92 30.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.06 -43.96 97.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -67.4 -35.03 78.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.84 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -106.03 -4.48 20.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.829 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.94 -170.02 39.89 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.534 -167.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -139.91 149.39 43.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.881 0.372 . . . . 0.0 110.805 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 42.9 mm -63.85 117.7 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.082 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 59.6 ttm . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 121.463 0.649 . . . . 0.0 110.982 -176.033 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.806 0.336 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 40.4 tpp -73.6 -26.89 61.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.854 -170.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.0 m -57.37 -37.95 73.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.846 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.96 -36.12 59.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.011 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.524 ' O ' HG13 ' A' ' 343' ' ' VAL . 4.7 m-30 -66.87 -46.98 73.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.446 ' HA ' HG22 ' A' ' 343' ' ' VAL . 28.1 m0 -61.07 -32.5 72.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -66.92 -47.09 72.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.03 -40.36 94.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.163 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 339' ' ' PHE . 17.9 m -74.1 -30.83 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.128 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.491 ' O ' HG22 ' A' ' 347' ' ' VAL . 4.9 tmt_? -65.0 -38.98 92.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.2 m -58.22 -36.19 72.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.194 173.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.57 95.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.189 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.775 ' HA ' HD11 ' A' ' 192' ' ' LEU . 5.8 m -73.99 -35.01 40.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.191 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.458 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -62.44 -47.94 90.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.191 174.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -63.91 -39.18 93.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.05 -45.55 60.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.098 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.37 -39.86 77.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.0 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.8 p -75.58 -10.7 59.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.911 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.96 17.25 72.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.449 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.25 -33.29 43.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 0.0 110.907 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -138.63 154.4 48.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.4 p -77.19 169.89 17.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.18 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.512 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.5 t -56.53 -42.34 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 173.383 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -62.09 -45.62 92.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -69.94 -51.59 31.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -75.4 -51.79 12.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.188 -173.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.593 ' HG ' ' HA ' ' A' ' 189' ' ' LYS . 1.9 tm? -65.04 -48.97 71.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 -171.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.51 -52.83 61.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 -173.286 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -67.94 -48.65 65.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.808 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.25 85.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.156 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 66.3 mm-40 -78.04 -29.03 49.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.907 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 89.5 m -65.92 -33.96 77.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.178 170.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -56.39 -31.95 64.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.854 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.479 HD12 HG21 ' A' ' 183' ' ' VAL . 62.0 mt -59.02 -34.93 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.951 0.405 . . . . 0.0 111.191 173.214 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 69.9 p -95.07 -14.34 24.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 89.7 mttt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 177.096 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.729 0.3 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.455 HG21 ' HD2' ' A' ' 271' ' ' PRO . 60.1 mt -97.81 139.96 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.181 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -140.13 145.03 37.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.822 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.29 133.5 39.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.83 11.58 61.63 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.494 -175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.2 tttt -165.07 134.77 3.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.834 0.349 . . . . 0.0 110.944 177.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.585 ' CD2' HD11 ' A' ' 33' ' ' ILE . 1.6 pt? -144.0 152.71 41.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.94 -173.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 87.2 t -110.76 137.67 42.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.02 -177.288 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.716 HD11 HG13 ' A' ' 35' ' ' VAL . 1.1 mp -119.79 134.47 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.094 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.61 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 76.6 m95 -103.69 124.66 49.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 164.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.494 HD12 ' HG ' ' A' ' 20' ' ' LEU . 11.5 tt -108.83 150.04 11.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.052 -163.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -58.43 153.2 16.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 -174.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.38 -15.97 40.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.416 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -79.2 -13.28 59.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.866 0.365 . . . . 0.0 110.897 -172.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -139.96 129.2 23.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 163.027 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.52 -70.72 1.29 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.469 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -109.92 -39.19 5.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.958 0.409 . . . . 0.0 110.98 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -67.37 -52.28 41.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.871 -150.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.436 ' CA ' HG23 ' A' ' 293' ' ' VAL . . . -54.1 -50.35 55.78 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.565 -175.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.502 ' HB3' HG22 ' A' ' 37' ' ' VAL . 6.0 mt -55.08 -52.57 62.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.699 0.285 . . . . 0.0 110.933 171.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.48 -35.92 21.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.125 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -72.45 -59.99 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.413 HG22 ' HA ' ' A' ' 20' ' ' LEU . 21.5 m -71.64 -38.15 65.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.158 -172.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.55 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -65.64 -47.84 73.25 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.422 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -54.73 -35.65 63.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -57.93 -39.12 77.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.039 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 4.8 m-30 -62.9 -45.42 92.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 99.8 mt-10 -60.7 -36.96 80.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -71.24 -41.17 70.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.898 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -94.52 -47.81 6.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.889 -164.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.3 p -109.1 -7.83 15.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.18 -172.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.65 8.12 87.97 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.514 167.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.994 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.52 133.86 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 111.085 -179.074 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.2 mttt -72.02 136.0 46.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 -169.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.716 HG13 HD11 ' A' ' 9' ' ' ILE . 99.2 t -115.87 125.01 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.061 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.56 ' O ' HD12 ' A' ' 9' ' ' ILE . 95.5 m -109.93 130.02 55.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.067 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 20' ' ' LEU . 87.4 t -103.58 131.17 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.159 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -119.36 154.09 34.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 66.3 t-80 -88.25 139.93 30.41 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.694 0.759 . . . . 0.0 110.863 -167.453 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -55.02 -29.86 66.99 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.758 2.305 . . . . 0.0 112.335 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -49.03 -52.62 24.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.873 -172.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -90.07 0.68 57.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.832 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 43' ' ' LEU . 10.5 tt -45.86 -51.09 13.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.937 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -74.44 -40.37 61.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.862 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -80.44 -51.88 8.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.956 -164.335 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -83.33 -38.39 22.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.919 -170.283 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.606 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 83.9 t80 -49.83 -53.39 42.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.684 0.754 . . . . 0.0 110.872 -169.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 29.4 Cg_endo -61.19 -30.83 89.3 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.668 2.245 . . . . 0.0 112.331 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -73.08 -44.18 60.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.414 HG21 ' HD3' ' A' ' 57' ' ' PRO . 21.2 m -75.56 -24.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.112 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.13 78.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.054 174.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.11 -29.74 70.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.099 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.0 p -88.36 -14.54 37.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.11 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.44 14.72 81.72 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.477 168.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -135.39 129.39 33.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 110.816 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.47 -92.34 0.14 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.497 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.61 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 67.6 Cg_endo -79.36 148.0 20.71 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.68 2.253 . . . . 0.0 112.375 -177.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -107.52 -32.09 7.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.798 165.721 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.55 ' HB ' HG23 ' A' ' 9' ' ' ILE . 57.6 mt -128.11 137.53 57.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.169 -176.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 10' ' ' TRP . 6.3 tp -132.64 127.13 55.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -92.55 128.21 38.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.771 170.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -114.38 145.15 42.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.994 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.58 -83.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.036 -168.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -120.81 -65.85 1.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.835 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -99.98 -16.54 17.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.84 -167.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -61.36 -6.31 2.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -165.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.461 ' O ' ' HB3' ' A' ' 70' ' ' TYR . 31.5 p90 -59.08 -25.58 63.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 173.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.47 -48.36 86.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.46 -174.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.04 -32.16 83.25 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.515 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.716 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 2.3 t80 -54.96 -51.71 65.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.857 0.36 . . . . 0.0 110.931 175.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.92 -42.98 56.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.164 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -56.1 -38.94 71.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.967 -175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.0 m -83.68 -7.65 59.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.93 31.1 58.39 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.582 172.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 63.4 mt -88.86 -5.01 58.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.859 0.362 . . . . 0.0 110.972 -165.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.716 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -128.01 154.3 45.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.912 -171.779 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.19 144.58 29.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.086 167.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -65.1 136.18 56.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.884 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.405 HD12 ' CZ ' ' A' ' 106' ' ' TYR . 42.3 pt -100.12 151.54 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.09 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.5 m -96.15 126.5 44.06 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.585 0.707 . . . . 0.0 111.09 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.07 134.06 61.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.637 2.225 . . . . 0.0 112.349 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -103.22 119.71 39.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.99 -41.66 99.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.794 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.73 -44.75 89.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.1 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -75.0 -32.3 61.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.486 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 67.0 tt0 -53.48 -49.71 66.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.936 174.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.35 -32.63 72.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.894 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.39 -20.3 54.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.828 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.86 -106.54 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -172.367 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 29.2 t80 171.52 129.51 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.687 0.756 . . . . 0.0 110.973 -168.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -52.82 -36.01 72.16 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.762 2.308 . . . . 0.0 112.39 -173.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -64.91 -36.5 84.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -173.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.2 p -73.83 -30.35 62.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.17 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.588 ' HA ' HG22 ' A' ' 97' ' ' VAL . 80.7 m95 -67.27 -30.03 69.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 173.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.62 -31.31 68.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.827 174.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.07 -24.27 61.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.106 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.588 HG22 ' HA ' ' A' ' 94' ' ' TRP . 20.0 m -107.8 16.01 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.143 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -101.56 136.25 41.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -136.43 117.35 14.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 173.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 60.56 36.05 19.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.868 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.49 2.19 89.03 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.51 172.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -127.97 149.87 50.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.825 0.345 . . . . 0.0 110.875 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.51 HD22 HG23 ' A' ' 97' ' ' VAL . 15.3 mt -86.01 135.49 33.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.838 -175.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -122.15 -1.52 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.026 -170.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.89 165.86 20.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.405 ' CZ ' HD12 ' A' ' 79' ' ' ILE . 97.1 m-85 -114.35 145.05 32.92 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.604 0.716 . . . . 0.0 110.926 170.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.21 125.23 7.0 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.686 2.257 . . . . 0.0 112.304 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.092 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp -106.29 -39.91 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.194 177.08 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -143.19 150.9 40.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.11 -167.002 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.3 t -114.69 130.89 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.164 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -120.53 119.89 34.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -150.06 144.95 26.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.068 -173.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.6 mp -89.88 170.04 10.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.973 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.0 p -158.81 157.98 32.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.91 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.88 127.03 46.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.924 170.822 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.566 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.2 mp -110.3 130.32 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.14 -175.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -128.39 146.52 50.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -92.75 115.0 27.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.806 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.435 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.9 mttt -65.66 -23.26 66.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.917 -175.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -78.68 -25.23 44.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.811 -175.211 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.7 mp -84.26 -49.24 8.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.871 174.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.643 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -143.67 128.5 9.61 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.743 0.782 . . . . 0.0 110.832 174.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.72 -9.03 15.89 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.634 2.223 . . . . 0.0 112.366 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -143.19 97.01 5.75 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.64 0.733 . . . . 0.0 110.812 -174.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.26 156.04 62.92 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.746 2.297 . . . . 0.0 112.365 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.43 144.95 63.34 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.748 2.299 . . . . 0.0 112.314 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.18 -17.16 28.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.89 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 71.5 p -130.71 157.68 42.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.192 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.498 ' HA ' HD13 ' A' ' 132' ' ' ILE . 57.0 m95 -68.83 -28.94 67.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.951 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.04 -22.13 66.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.85 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.84 -24.25 41.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.624 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -55.88 -50.05 89.44 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.676 0.751 . . . . 0.0 111.197 -172.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.8 Cg_endo -68.24 -39.11 10.74 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.622 2.215 . . . . 0.0 112.376 -173.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.02 -60.15 3.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.263 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.28 -17.01 63.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.989 -175.732 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.513 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.8 t70 -58.47 -40.42 82.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.848 168.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.07 -30.75 69.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.49 -46.42 54.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.773 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.638 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.0 pp -84.86 -14.35 48.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.964 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.638 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.7 tttt -61.15 -34.41 74.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.955 174.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.95 -23.44 67.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -94.96 3.62 54.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.921 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.48 33.16 53.45 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.56 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -111.75 169.95 8.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 0.0 110.867 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.0 t -121.12 140.22 52.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.917 168.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.429 ' HA ' HD21 ' A' ' 139' ' ' LEU . . . -66.69 -40.37 88.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.112 -172.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -144.53 130.59 19.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 55.2 ttm -118.18 132.92 56.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -153.53 157.35 39.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -173.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -84.93 -54.64 4.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.94 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.819 HD13 ' O ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER 49.28 30.72 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.022 -168.362 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -103.45 -4.35 24.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -129.91 156.53 78.88 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.59 0.71 . . . . 0.0 110.952 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.406 ' HD3' ' HD2' ' A' ' 344' ' ' ARG . 40.3 Cg_endo -60.76 -24.37 78.7 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.684 2.256 . . . . 0.0 112.321 174.282 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -68.23 -30.02 68.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.822 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -84.27 -38.31 20.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.844 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.433 HG23 HG11 ' A' ' 347' ' ' VAL . 23.0 m -61.11 -47.23 87.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.979 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.579 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 39.2 t-105 -56.96 -54.58 52.96 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.534 0.683 . . . . 0.0 110.949 -169.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 31.2 Cg_endo -65.83 -19.63 58.78 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.731 2.287 . . . . 0.0 112.41 -174.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.718 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.3 tm? -81.63 -45.29 16.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.505 HG22 ' HA3' ' A' ' 166' ' ' GLY . 80.1 mt -74.23 -43.3 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.116 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.9 -22.57 64.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.099 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -58.87 -32.28 69.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.172 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -100.87 1.13 39.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 112.29 5.48 24.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.492 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.505 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -77.2 69.6 2.48 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.509 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -87.36 132.64 33.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.86 0.362 . . . . 0.0 110.98 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.75 10.34 9.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.154 -171.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.433 ' HA ' HG12 ' A' ' 181' ' ' VAL . 52.8 p90 -158.13 152.34 24.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -93.28 128.38 39.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.816 159.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -118.08 121.57 40.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.827 172.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.02 130.05 11.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.901 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.02 41.83 31.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.842 174.545 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.37 17.52 79.75 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.533 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.01 139.35 51.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.768 0.318 . . . . 0.0 110.86 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -98.88 145.01 27.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -128.32 108.95 11.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.874 174.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.572 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.3 pp -79.1 -8.52 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.131 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -100.27 -12.31 19.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 -177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -119.49 85.81 2.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 170.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 169' ' ' PHE . 27.4 m -114.28 161.3 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 -170.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.02 22.66 32.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.495 -172.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.515 HG21 HD12 ' A' ' 368' ' ' ILE . 6.8 m -107.37 -17.05 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.772 0.32 . . . . 0.0 111.112 -178.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -87.04 20.47 2.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -119.97 -171.51 2.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.91 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.29 -29.71 69.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.106 -173.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.7 -41.41 95.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.484 -167.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.611 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.24 -38.06 89.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.972 0.415 . . . . 0.0 111.093 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.577 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 96.8 mttt -62.04 -37.82 86.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.943 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.07 -37.91 89.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.074 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.415 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -66.2 -46.47 79.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.576 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.664 HD11 ' HA ' ' A' ' 347' ' ' VAL . 27.3 tp -65.08 -35.92 82.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 110.855 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.408 ' OG1' HG21 ' A' ' 357' ' ' VAL . 90.0 m -64.52 -41.17 96.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.151 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 65.0 t80 -66.32 -47.94 71.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.861 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.673 HD23 ' C ' ' A' ' 195' ' ' LEU . 5.2 tt -50.32 -51.56 44.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.963 -175.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.431 ' HA ' ' CG1' ' A' ' 199' ' ' ILE . 27.9 m -65.04 -21.61 29.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.075 -173.583 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.0 m-20 -62.59 -33.92 75.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.802 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.9 OUTLIER -81.21 -39.9 24.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.959 -174.635 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.576 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.6 pp -73.95 -26.99 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.07 172.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.25 -38.23 84.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 170.273 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -80.95 2.92 24.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 176.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 66.53 37.68 4.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 56.0 m170 -77.58 -18.94 56.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.819 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.576 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.1 ppp? -144.14 156.95 44.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -95.02 152.0 18.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.14 -26.93 68.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -95.5 1.73 54.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.813 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.1 m -63.84 126.08 26.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.101 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.438 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 16.9 t0 -120.05 174.28 6.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.843 177.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -64.98 -37.0 86.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.969 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.8 p -70.45 -37.52 74.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.438 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 80.3 mt -65.01 -42.48 94.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.077 173.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.68 81.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.06 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.0 -45.04 94.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.865 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.8 -41.44 95.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.096 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.86 -42.86 97.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.058 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -63.8 -39.67 94.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.936 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -64.33 -35.73 81.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -83.59 -20.02 34.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.982 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.84 25.83 33.71 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.418 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -84.79 -21.65 29.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.976 0.417 . . . . 0.0 110.902 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.2 t -124.45 136.81 54.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.076 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.588 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -65.03 -47.68 76.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.061 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.522 ' HB3' HD21 ' A' ' 115' ' ' LEU . 71.8 mtm -134.49 158.32 44.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -174.326 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 60.8 p -139.73 161.29 37.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.171 172.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.2 mm -110.75 127.18 67.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.03 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -154.95 175.04 14.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.957 -172.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -88.64 -156.87 31.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.523 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -22.26 32.28 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.66 2.24 . . . . 0.0 112.384 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -78.36 -24.93 46.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 48.76 51.95 14.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.175 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -60.04 -23.94 64.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 61.3 m -50.05 -43.95 51.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -87.0 176.7 7.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 -172.48 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.211 -171.698 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.834 0.35 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -108.29 128.28 54.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.435 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 50.2 p90 -145.21 158.21 43.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.92 162.35 25.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.387 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.1 p -135.72 135.32 51.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 111.142 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.7 t -154.39 148.75 26.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.9 167.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.173 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 1.022 HD23 ' HD3' ' A' ' 257' ' ' PRO . 2.6 mm? -63.1 149.53 90.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.575 0.702 . . . . 0.0 110.961 -164.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.84 -176.33 3.11 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.691 2.261 . . . . 0.0 112.382 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 96.8 m -92.47 145.17 24.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.057 -172.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -130.91 113.26 13.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.933 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 55.0 36.59 27.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.815 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.43 2.79 84.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.494 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -131.36 130.62 22.61 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.539 0.685 . . . . 0.0 110.843 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 249' ' ' THR . 22.9 Cg_endo -65.42 133.93 36.7 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.715 2.277 . . . . 0.0 112.324 -173.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.604 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 97.0 p -84.52 0.19 50.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.766 173.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -37.4 135.02 0.73 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.522 0.677 . . . . 0.0 110.9 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 1.022 ' HD3' HD23 ' A' ' 247' ' ' LEU . 38.0 Cg_endo -80.05 157.85 23.66 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.729 2.286 . . . . 0.0 112.336 -166.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -75.09 169.67 17.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.53 129.67 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 -166.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.96 137.7 14.48 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.369 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 76.9 t -125.36 117.11 48.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.806 0.336 . . . . 0.0 111.207 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -65.27 119.73 11.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 178.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.9 m -126.4 126.61 44.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.79 -167.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -125.67 137.07 53.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.041 -171.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -131.42 171.44 21.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.486 -170.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.846 HG13 ' HG2' ' A' ' 277' ' ' LYS . 25.0 mm -113.41 126.17 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.81 0.338 . . . . 0.0 111.297 -171.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -61.27 131.12 49.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.464 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -59.81 -26.17 65.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.125 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.21 -8.49 57.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 -173.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.8 t -70.81 127.16 92.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.674 0.75 . . . . 0.0 110.913 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.455 ' HD2' HG21 ' A' ' 2' ' ' ILE . 74.1 Cg_endo -72.87 -10.46 24.83 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.658 2.239 . . . . 0.0 112.401 165.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -104.04 19.09 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -169.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -54.09 -34.91 61.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.925 -171.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.14 -52.43 63.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.6 pp -84.36 -27.97 27.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.924 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.81 -50.51 56.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.06 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.846 ' HG2' HG13 ' A' ' 266' ' ' ILE . 96.1 mttt -59.74 -38.49 81.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.839 173.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.7 tt0 -68.45 -48.25 65.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -175.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -67.59 -35.37 78.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.497 ' HA ' HD22 ' A' ' 284' ' ' LEU . 7.3 tt -61.8 -51.96 66.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.892 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -78.15 -31.5 49.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.836 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 63.8 m-80 -99.46 -11.61 20.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.848 -165.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.918 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 66.6 m-85 -129.95 -52.82 1.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.497 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.6 OUTLIER -62.73 -36.74 83.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.912 -169.425 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 1.092 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.6 pp -124.27 37.63 4.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.979 176.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.457 ' CG2' ' N ' ' A' ' 287' ' ' ASP . 4.1 m -116.08 154.91 29.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.099 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.501 ' HA ' HD11 ' A' ' 290' ' ' LEU . 33.0 t70 -42.93 -37.42 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.796 -167.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -78.03 -40.81 37.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.971 -176.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.918 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.06 -57.16 5.37 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 -172.007 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.584 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.1 -21.17 66.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.34 . . . . 0.0 110.974 -178.754 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.581 ' N ' HD12 ' A' ' 290' ' ' LEU . 84.6 tt0 -67.44 -45.1 77.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 170.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.81 95.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.131 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.436 HG23 ' CA ' ' A' ' 19' ' ' GLY . 1.4 p -80.03 -30.0 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.11 -174.498 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -70.12 -27.17 64.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 172.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.32 -25.79 67.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.927 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.95 -51.28 8.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -143.2 152.7 58.47 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 121.615 0.722 . . . . 0.0 110.847 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -62.17 116.4 3.46 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.771 2.314 . . . . 0.0 112.298 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 299' ' ' LEU . 0.2 OUTLIER -87.55 -18.58 29.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 176.194 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 103.64 -58.55 0.52 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.525 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.639 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -170.73 164.76 8.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 111.138 175.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 21.7 m -124.23 156.08 31.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.101 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.22 -11.02 59.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.109 172.574 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.584 ' CD2' HD21 ' A' ' 290' ' ' LEU . 47.3 tp -83.2 122.06 27.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -175.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.32 -39.15 75.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 46.5 t -64.73 -49.95 68.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.881 -168.314 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.468 ' HB3' HG21 ' A' ' 302' ' ' VAL . 18.4 t80 -81.62 -29.07 33.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -61.95 -39.73 93.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.831 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -59.39 -38.21 79.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -73.7 -38.49 64.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.639 HD13 ' HA ' ' A' ' 301' ' ' ALA . 78.5 mt -62.82 -32.91 74.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.26 -18.83 62.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.113 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.06 -20.07 66.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 174.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -91.34 121.07 68.11 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.636 0.731 . . . . 0.0 110.87 166.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.98 -26.76 7.91 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.756 2.304 . . . . 0.0 112.313 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -61.76 -35.63 78.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.873 -175.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.545 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.1 mp -80.12 -32.6 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.076 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.4 -40.09 85.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 -172.288 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.17 -46.25 74.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.108 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 81.2 p -64.97 -29.21 70.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.066 -174.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.5 mtp -63.7 -34.38 77.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.6 tp10 -64.75 -47.7 77.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -173.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.522 HD21 ' HB1' ' A' ' 112' ' ' ALA . 8.9 p-10 -82.14 -28.01 32.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.864 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.01 -50.24 67.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.011 -175.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -69.25 -29.92 67.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.922 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -108.2 -8.55 15.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 -169.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.13 -153.55 29.99 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.43 -166.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -147.33 143.69 28.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.796 0.332 . . . . 0.0 110.902 -170.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 44.4 mm -61.76 124.01 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.092 -167.482 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 95.5 mtp . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.49 0.662 . . . . 0.0 110.969 -177.838 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.804 0.335 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 69.1 mmm -80.01 -17.83 51.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.826 -172.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 47.6 t -62.18 -41.99 98.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.831 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.49 -37.04 63.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.156 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.429 ' O ' HG13 ' A' ' 343' ' ' VAL . 7.4 m-30 -66.28 -36.29 82.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -54.93 -37.9 66.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.982 172.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -71.79 -38.05 70.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.939 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.92 -42.81 80.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.105 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 339' ' ' PHE . 21.4 m -72.72 -31.36 36.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.184 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.425 ' O ' HG22 ' A' ' 347' ' ' VAL . 74.0 ttt-85 -61.67 -40.93 96.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 175.604 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.0 m -55.76 -36.14 66.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.186 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.13 -46.19 81.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.084 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.664 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.4 m -75.55 -34.78 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.199 -172.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.448 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -62.42 -48.01 90.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.21 -37.94 88.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.32 -46.61 60.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.66 81.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.053 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.2 p -75.74 -11.88 60.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.981 0.419 . . . . 0.0 110.927 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.57 18.02 69.46 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.424 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.83 -32.95 46.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.757 0.313 . . . . 0.0 110.848 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -140.08 157.01 46.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 50.0 p -77.27 165.76 24.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.159 169.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.408 HG21 ' OG1' ' A' ' 193' ' ' THR . 55.4 t -54.94 -42.7 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.167 174.105 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.04 -44.13 96.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.832 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -69.38 -54.0 16.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -69.37 -47.78 63.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.5 tm? -64.95 -45.03 87.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.96 -174.449 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -65.41 -53.04 48.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.945 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -69.64 -45.68 67.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -173.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.23 -42.87 83.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.075 -174.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 85.6 mm-40 -72.49 -30.96 64.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.979 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 55.5 m -59.01 -32.59 69.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.093 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -57.11 -29.94 63.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.515 HD12 HG21 ' A' ' 183' ' ' VAL . 69.8 mt -59.72 -39.6 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 175.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.3 p -94.78 -14.98 24.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.808 179.074 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.745 0.307 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.459 HG21 ' HD2' ' A' ' 271' ' ' PRO . 83.2 mt -97.54 133.05 40.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.179 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -144.97 146.8 32.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.97 132.99 48.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.1 7.74 63.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.406 -176.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.1 tttt -164.44 134.67 4.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.744 0.306 . . . . 0.0 110.959 176.355 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.663 HD22 HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -141.72 154.81 45.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.956 -172.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.424 HG22 ' HB ' ' A' ' 36' ' ' THR . 77.3 t -113.59 135.74 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.133 -177.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.635 HG23 ' HB ' ' A' ' 59' ' ' ILE . 1.4 mp -119.65 133.97 64.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.735 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 74.9 m95 -105.18 124.24 49.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.943 166.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.484 HD12 ' HG ' ' A' ' 20' ' ' LEU . 13.6 tt -110.35 149.97 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.146 -167.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -64.52 158.63 23.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.756 -171.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.36 -16.07 26.43 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.511 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -68.25 -29.9 68.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.883 0.373 . . . . 0.0 110.853 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -139.18 130.02 26.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.845 166.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.16 -80.14 1.01 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.468 -172.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -96.72 -42.36 8.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.941 0.401 . . . . 0.0 110.97 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -67.59 -49.93 60.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.837 -153.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.12 -56.97 20.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.407 -176.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.545 ' HB3' HG22 ' A' ' 37' ' ' VAL . 5.5 mt -51.72 -46.48 63.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.797 0.332 . . . . 0.0 110.923 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.04 -37.48 45.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.061 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -75.68 -60.04 2.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.972 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 m -71.94 -36.61 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.171 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.46 -40.84 99.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.477 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -61.04 -31.24 70.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.928 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -50.0 -39.94 42.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.919 172.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 0.9 OUTLIER -54.97 -49.24 71.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 176.818 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -71.75 -34.92 69.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.899 -174.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.23 -37.99 84.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.958 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -95.2 -47.29 6.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 -168.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.8 p -115.1 -5.96 12.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.197 -169.48 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.53 4.9 85.44 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.377 169.108 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.989 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -89.73 132.36 34.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.826 0.346 . . . . 0.0 111.078 -179.202 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.4 mttt -70.03 136.73 50.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 -170.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.494 HG23 HD11 ' A' ' 9' ' ' ILE . 9.8 p -112.76 134.32 55.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.067 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.501 ' O ' HD12 ' A' ' 9' ' ' ILE . 99.3 m -113.19 129.24 56.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.124 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 20' ' ' LEU . 84.8 t -102.41 128.43 55.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.204 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -120.12 152.0 38.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.919 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -91.64 150.62 41.32 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.566 0.698 . . . . 0.0 110.823 -166.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.544 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 37.1 Cg_endo -68.92 -19.62 39.97 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.611 2.207 . . . . 0.0 112.39 -175.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -54.13 -49.02 70.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -174.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -89.58 -9.1 51.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 43' ' ' LEU . 8.3 tt -48.64 -53.86 16.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 -168.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.77 -35.37 80.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.852 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -70.13 -36.4 74.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.857 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.403 ' O ' HG22 ' A' ' 50' ' ' VAL . 74.7 mmtt -80.64 -24.54 38.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.579 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 86.3 t80 -49.45 -50.6 64.53 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 0.0 110.877 -163.031 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 46.2 Cg_endo -82.58 -32.08 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.648 2.232 . . . . 0.0 112.391 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -77.22 -44.17 30.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.867 -165.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.517 HG21 ' HG3' ' A' ' 57' ' ' PRO . 24.8 m -70.31 -27.72 32.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.075 -173.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.624 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -71.85 -35.19 69.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.042 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.48 -32.56 73.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.106 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.7 p -89.13 -18.87 26.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.11 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.94 8.77 78.79 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.49 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -128.18 130.01 47.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 110.827 174.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.97 -91.57 0.13 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.554 169.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.735 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 77.4 Cg_endo -80.07 146.92 18.41 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.349 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -94.25 -35.03 12.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.777 161.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.635 ' HB ' HG23 ' A' ' 9' ' ' ILE . 29.4 mt -127.03 138.48 54.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.173 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 tp -133.23 127.39 54.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.101 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -87.94 140.7 29.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.508 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 24.2 p90 -145.11 160.83 40.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.001 170.316 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.73 -87.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.113 -166.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -127.19 -68.41 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -171.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -99.33 -10.65 22.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.839 -162.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -56.11 -19.07 11.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -169.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.522 ' HB2' HD13 ' A' ' 104' ' ' ILE . 36.0 p90 -57.67 -31.45 66.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.851 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.76 -52.32 53.13 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.572 -171.416 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.92 -35.99 85.64 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.528 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.617 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 11.1 t80 -66.87 -41.73 86.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.726 0.298 . . . . 0.0 110.902 -176.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -39.87 67.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 174.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -58.51 -35.9 72.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.928 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.415 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 64.5 m -87.67 -5.01 58.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.01 31.25 58.05 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.526 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.624 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 53.6 mt -87.73 -12.06 46.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -169.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.617 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -129.08 151.66 49.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.934 -178.25 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.415 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -78.95 140.83 37.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.021 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -74.16 141.43 45.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.836 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.402 HD12 ' CZ ' ' A' ' 106' ' ' TYR . 42.7 pt -110.45 162.84 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.125 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 p -107.25 149.91 39.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 111.119 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.14 141.22 35.7 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.624 2.216 . . . . 0.0 112.417 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -105.26 120.02 40.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.928 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.22 -42.0 98.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.841 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.9 91.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.154 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -74.3 -32.89 63.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.471 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 65.1 tt0 -54.88 -50.09 69.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.043 176.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.36 -30.33 70.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.751 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -78.86 -20.03 50.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.18 -104.92 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -172.925 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 22.4 t80 172.12 129.47 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.704 0.764 . . . . 0.0 110.885 -169.679 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.63 -37.59 83.58 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.647 2.231 . . . . 0.0 112.356 -174.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -65.22 -34.06 77.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -173.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.9 p -75.5 -31.01 60.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.079 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.575 ' HA ' HG22 ' A' ' 97' ' ' VAL . 88.6 m95 -65.54 -30.01 70.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.935 173.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -69.56 -32.07 70.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.55 -26.24 62.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.626 HG23 HD22 ' A' ' 103' ' ' LEU . 18.5 m -108.28 16.88 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 -175.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -104.71 135.76 45.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -132.45 117.47 18.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.7 t30 58.68 35.07 24.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.818 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.62 -0.85 89.19 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.588 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.11 145.11 50.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.356 . . . . 0.0 110.843 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.626 HD22 HG23 ' A' ' 97' ' ' VAL . 28.8 mt -80.86 139.14 36.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -172.545 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.522 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.8 pp -123.46 -2.7 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.096 -174.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.508 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -161.74 165.29 28.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.152 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.402 ' CZ ' HD12 ' A' ' 79' ' ' ILE . 90.2 m-85 -114.31 144.47 31.77 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.646 0.736 . . . . 0.0 110.93 170.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.57 122.26 5.45 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.606 2.204 . . . . 0.0 112.326 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.009 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -106.49 -36.64 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.205 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -144.44 150.86 38.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.183 -169.588 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.6 t -120.33 134.91 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.134 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -124.97 136.78 54.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.845 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.628 ' HB1' HD21 ' A' ' 323' ' ' ASN . . . -151.89 145.78 25.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 176.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -85.57 164.16 17.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.7 p -157.22 154.86 29.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.913 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -95.92 127.04 41.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.96 169.545 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.605 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.2 mp -110.02 133.17 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -133.63 148.85 51.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -90.92 115.14 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.861 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.508 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.3 mttt -63.06 -22.75 67.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.979 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.34 -25.42 51.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -88.33 -52.9 4.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.674 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -141.74 126.13 10.26 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.725 0.774 . . . . 0.0 110.844 174.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -81.92 -2.32 11.27 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.671 2.247 . . . . 0.0 112.293 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -150.78 102.6 3.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.61 0.719 . . . . 0.0 110.812 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.64 156.74 60.46 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.667 2.245 . . . . 0.0 112.375 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -66.45 145.08 75.91 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.663 2.242 . . . . 0.0 112.251 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -81.27 -18.28 46.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.8 p -133.92 159.0 42.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.2 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.442 ' HE1' ' HG ' ' A' ' 255' ' ' SER . 69.6 m95 -72.08 -29.95 64.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.85 -20.35 66.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.864 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -77.69 -27.24 50.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.547 ' HA ' HD12 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -55.24 -47.22 99.07 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.57 0.7 . . . . 0.0 111.152 -169.455 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.466 ' N ' HG22 ' A' ' 132' ' ' ILE . 81.9 Cg_exo -51.15 -49.31 17.5 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.695 2.263 . . . . 0.0 112.377 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.67 -58.39 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.149 -176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.247 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.34 -17.64 64.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 -173.955 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.575 ' N ' HD13 ' A' ' 135' ' ' LEU . 34.3 t70 -60.28 -41.83 94.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.869 168.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.38 -30.83 69.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -70.4 -47.39 61.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.65 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.9 pp -85.0 -14.38 47.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.65 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.9 tttt -61.75 -34.7 76.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 174.633 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.96 -23.2 67.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.06 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -95.03 5.0 53.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.918 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 31.89 57.32 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.463 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -110.36 170.14 8.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.857 0.361 . . . . 0.0 110.832 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.6 t -123.29 140.41 53.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 166.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -65.62 -41.24 92.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.144 -172.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -144.45 128.4 17.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 98.3 mmm -106.73 134.43 49.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -157.82 161.92 38.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 -175.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -96.64 -47.61 5.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.154 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.1 tm? 46.17 33.47 1.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 -168.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -99.43 -7.75 25.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -118.86 153.82 52.71 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.7 0.762 . . . . 0.0 110.917 -174.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.26 -24.46 50.88 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.669 2.246 . . . . 0.0 112.354 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -75.53 -29.88 59.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.832 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -83.04 -31.53 27.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.843 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.6 m -58.48 -43.29 88.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.046 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.568 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 43.9 t-105 -58.14 -55.63 43.37 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.532 0.682 . . . . 0.0 110.85 -171.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.598 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 23.7 Cg_endo -64.23 -18.64 64.08 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.682 2.255 . . . . 0.0 112.416 -174.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.713 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.7 tm? -82.3 -45.55 14.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.897 177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.579 HG22 ' HA3' ' A' ' 166' ' ' GLY . 85.4 mt -75.48 -44.65 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.052 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.17 -23.35 60.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.05 -173.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -58.98 -35.27 72.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -171.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.7 p30 -103.06 8.42 38.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 118.52 3.76 14.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.442 171.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.579 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -76.78 65.87 2.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.507 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -89.32 135.01 33.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.855 0.36 . . . . 0.0 110.945 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.23 0.45 36.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.223 -174.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -152.13 141.65 21.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -176.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 37.9 tptt -72.68 135.69 45.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.998 156.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -124.69 116.38 22.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.922 164.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -147.77 118.47 7.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 53.51 38.17 27.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.35 23.96 74.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.519 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -127.26 139.22 53.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.854 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -97.47 120.61 38.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 171.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -110.86 105.13 13.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.845 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.4 tp -63.51 -17.34 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.063 -174.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.95 -7.54 48.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.941 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 48.8 t0 -130.87 60.35 1.65 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 29.0 m -107.93 167.56 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.115 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -102.61 5.22 51.15 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.562 -166.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' A' ' 365' ' ' GLN . 0.8 OUTLIER -101.25 -25.49 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 111.096 -168.728 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -93.65 24.96 3.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 173.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -116.71 176.12 5.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.15 -27.25 68.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.047 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.87 -40.69 97.44 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.521 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.59 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.05 -37.85 88.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.997 0.427 . . . . 0.0 111.19 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.586 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 90.5 mttt -62.38 -37.62 86.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.813 175.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.07 89.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.099 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.484 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -66.99 -47.99 62.66 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.535 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.518 HD11 ' HA ' ' A' ' 347' ' ' VAL . 27.4 tp -65.95 -35.25 80.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.904 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.528 ' OG1' HG21 ' A' ' 357' ' ' VAL . 93.4 m -64.97 -43.29 93.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.186 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 91.4 t80 -67.81 -47.12 69.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.723 HD23 ' C ' ' A' ' 195' ' ' LEU . 4.7 tt -50.39 -50.38 51.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 199' ' ' ILE . 35.7 m -65.04 -22.45 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.15 -174.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.9 m-20 -61.86 -33.14 73.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.431 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.8 OUTLIER -81.16 -40.07 24.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.876 -173.829 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 196' ' ' VAL . 1.6 pp -72.65 -29.76 31.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 171.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -68.22 -38.14 81.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -82.67 3.67 28.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.847 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 66.36 40.22 3.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.832 170.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -76.73 -14.93 59.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.767 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -142.0 154.58 45.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.865 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -94.6 155.0 17.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.902 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.86 -27.71 68.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.044 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -96.04 0.14 51.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.817 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.2 m -63.26 135.06 56.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.061 -176.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -142.62 174.41 10.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.991 176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -61.94 -41.58 98.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.975 0.416 . . . . 0.0 111.014 -175.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.0 m -62.25 -40.45 96.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.883 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 66.3 mt -64.94 -43.66 96.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.122 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.86 -34.24 77.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -61.83 -47.79 83.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.928 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.59 95.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.088 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.67 -44.27 90.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -64.81 -39.9 94.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -64.83 -34.2 77.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -86.29 -16.77 36.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.828 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.85 28.31 29.3 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.502 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -84.07 -22.77 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.923 0.392 . . . . 0.0 110.861 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 67.4 p -130.91 144.02 51.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.503 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -66.55 -60.99 2.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.058 -173.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.516 ' HB3' HD21 ' A' ' 115' ' ' LEU . 59.4 mtm -134.62 158.5 43.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 -166.409 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.4 t -150.43 157.29 42.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.26 126.98 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.182 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -154.62 174.26 15.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -172.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -85.11 -158.29 29.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.52 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.87 -23.66 40.98 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.677 2.251 . . . . 0.0 112.404 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -78.04 -30.38 49.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.914 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 45.69 49.91 11.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -59.98 -24.0 64.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.6 p -79.01 -5.22 53.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -81.03 -174.95 5.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 89.5 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.172 -177.897 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 99.6 t . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.822 0.344 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -88.09 147.91 24.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.508 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 49.3 p90 -145.9 163.23 35.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.967 178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -128.78 158.0 21.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.446 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.39 135.28 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 111.111 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.4 t -153.73 149.86 27.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.132 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.2 m -61.23 163.4 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.157 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 247' ' ' LEU . 3.9 mp -69.1 150.01 97.55 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.59 0.71 . . . . 0.0 111.049 -164.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.56 -176.4 2.95 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.809 2.339 . . . . 0.0 112.366 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.4 m -84.25 143.15 29.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.161 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -130.08 112.79 13.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 55.16 35.78 25.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.41 0.97 84.17 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.534 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.414 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 91.4 mm-40 -125.73 125.82 24.93 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.496 0.665 . . . . 0.0 110.914 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 73.0 Cg_exo -54.54 132.82 53.4 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.736 2.291 . . . . 0.0 112.312 -178.566 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.442 ' HG ' ' HE1' ' A' ' 129' ' ' TRP . 66.7 m -81.14 -4.97 57.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.862 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -39.69 129.45 1.47 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.547 0.689 . . . . 0.0 110.874 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -82.19 164.16 17.33 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.758 2.305 . . . . 0.0 112.287 -164.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -74.96 170.04 16.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 29.2 t -114.46 134.4 57.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.207 -168.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -115.18 135.09 12.02 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.416 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.8 t -125.64 117.43 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.773 0.321 . . . . 0.0 111.19 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -66.13 122.92 18.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.914 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 45.2 m -125.43 132.26 52.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 -168.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.92 137.5 53.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.118 -174.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.9 173.99 21.31 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.377 -171.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.2 mm -113.3 130.68 66.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.702 0.287 . . . . 0.0 111.166 -172.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -62.36 129.48 40.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.456 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -59.58 -29.33 67.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.9 -6.07 59.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.081 -174.012 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.8 t -75.33 122.14 86.66 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.579 0.704 . . . . 0.0 110.88 -175.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.459 ' HD2' HG21 ' A' ' 2' ' ' ILE . 89.5 Cg_endo -68.88 -6.99 19.45 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.695 2.263 . . . . 0.0 112.437 167.154 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -102.92 14.38 32.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -51.73 -35.0 41.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.798 -168.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -72.15 -47.68 49.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.989 -171.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.0 pp -79.97 -33.68 39.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.906 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.73 -48.77 70.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.071 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -66.81 -34.42 77.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.14 -45.39 88.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.955 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -70.28 -36.12 74.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.786 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.684 HD23 ' O ' ' A' ' 280' ' ' LEU . 4.5 tt -59.4 -47.1 86.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -177.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -78.75 -28.53 44.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.03 -17.71 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -161.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.86 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 14.7 m-30 -121.18 -46.42 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.842 -178.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 1.0 OUTLIER -63.94 -44.11 93.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -171.502 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 1.009 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.7 pp -124.42 37.95 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -166.716 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 82.0 p -121.46 162.25 20.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.16 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.408 ' HA ' HD11 ' A' ' 290' ' ' LEU . 36.1 p-10 -47.84 -35.06 9.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.806 -167.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -80.18 -40.32 27.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.86 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -71.6 -58.64 5.28 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 -171.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.65 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.11 -22.23 66.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.719 0.295 . . . . 0.0 110.907 -178.488 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.576 ' N ' HD12 ' A' ' 290' ' ' LEU . 87.9 tt0 -68.19 -46.25 71.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.819 172.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.94 -46.32 89.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.052 -174.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 289' ' ' GLY . 0.2 OUTLIER -70.04 -44.82 78.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 178.297 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.53 ' HB2' HD22 ' A' ' 299' ' ' LEU . 29.0 t30 -55.54 -31.46 62.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.853 175.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.76 -26.82 68.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.974 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -83.75 -40.76 18.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -161.41 139.89 7.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.576 0.703 . . . . 0.0 110.861 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -48.86 126.52 15.01 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.68 2.253 . . . . 0.0 112.295 -174.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.53 HD22 ' HB2' ' A' ' 294' ' ' ASN . 0.1 OUTLIER -87.67 -19.11 28.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 173.764 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.37 -67.18 1.43 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.663 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.583 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -157.9 144.98 18.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.933 0.397 . . . . 0.0 111.082 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 24.8 m -125.55 159.93 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.041 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.59 -13.24 60.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.021 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.65 ' CD2' HD21 ' A' ' 290' ' ' LEU . 43.2 tp -81.3 125.21 30.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.887 -174.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -61.58 -36.04 79.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.876 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.3 m -60.7 -50.07 74.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -170.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.558 ' CE2' HD21 ' A' ' 311' ' ' LEU . 23.0 t80 -77.1 -35.25 56.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.987 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.665 ' HA ' HD12 ' A' ' 311' ' ' LEU . 87.3 tt0 -53.37 -39.88 64.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.885 175.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -52.11 -38.69 58.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.905 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -79.85 -34.37 39.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 308' ' ' GLU . 54.2 mt -64.1 -30.66 71.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 -175.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.84 -22.36 47.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.216 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.67 -20.57 65.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.003 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -89.3 122.64 68.38 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.695 0.76 . . . . 0.0 110.88 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -48.44 -30.2 15.19 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.754 2.303 . . . . 0.0 112.317 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -62.62 -30.72 71.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 -172.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.531 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.3 mp -74.9 -30.09 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.037 -173.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.14 -41.63 93.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 -170.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.66 -43.63 68.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 76.5 p -63.86 -31.27 72.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.093 -171.613 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 38.4 mmt -70.35 -31.43 68.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -64.38 -49.17 72.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 -175.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.628 HD21 ' HB1' ' A' ' 112' ' ' ALA . 10.2 p-10 -80.35 -25.6 39.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.807 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.37 -50.58 69.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.143 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.72 -34.7 77.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.952 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -104.13 -5.03 22.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -170.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -96.53 -156.35 30.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.448 -168.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -151.12 148.08 27.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.832 0.349 . . . . 0.0 110.843 -171.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 44.3 mm -60.85 124.94 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.132 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 96.9 mtp . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 121.5 0.667 . . . . 0.0 110.962 -178.405 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.671 0.272 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 87.2 mmm -69.62 -28.27 65.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.837 -168.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.9 m -52.13 -42.76 63.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.821 -171.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.65 -36.28 73.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.99 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 2.5 m-30 -64.91 -42.7 94.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.851 -175.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -54.67 -42.69 71.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -70.72 -43.24 69.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.3 95.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.122 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 339' ' ' PHE . 17.7 m -73.8 -31.56 31.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.426 ' O ' HG22 ' A' ' 347' ' ' VAL . 55.2 ttt180 -62.9 -41.82 99.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 90.8 m -57.19 -38.05 73.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.145 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.71 91.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 -173.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.518 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.5 m -74.53 -34.9 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.16 -174.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.447 HD12 HG23 ' A' ' 347' ' ' VAL . 1.4 mp -63.52 -49.14 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.209 174.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -65.36 -39.1 91.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.926 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.17 -45.55 59.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.109 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.83 -39.57 79.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.138 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.6 p -76.38 -10.44 59.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.881 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.8 17.2 70.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.39 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.12 -33.46 44.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.934 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -140.06 155.45 47.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.7 p -77.82 169.16 18.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 170.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.528 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.3 t -56.82 -41.34 75.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -62.06 -45.96 91.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -70.0 -52.92 20.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -72.64 -49.73 29.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.048 -172.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.6 tm? -65.1 -47.7 76.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.75 -50.79 63.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.49 -49.97 55.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.47 -43.64 84.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.134 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.518 ' HB3' ' HB ' ' A' ' 183' ' ' VAL . 78.8 mm-40 -71.7 -35.01 70.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.974 -175.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 31.1 m -60.31 -28.08 67.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.243 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -56.83 -30.78 64.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 78.3 mt -59.09 -40.57 81.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.162 173.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 63.5 p -97.99 -13.54 21.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.227 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.9 tttt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.817 177.313 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.729 0.299 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.7 mt -94.48 139.83 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.155 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.92 138.95 53.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.856 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.97 134.57 43.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.35 8.02 71.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.492 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -160.37 140.61 11.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.757 0.313 . . . . 0.0 110.901 171.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.66 HD23 ' H ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -143.02 156.39 44.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 -167.599 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 69.7 t -112.33 136.43 48.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.693 HD11 HG13 ' A' ' 35' ' ' VAL . 1.1 mp -118.4 131.46 71.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.182 175.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.779 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 73.0 m95 -104.37 126.04 51.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 165.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.507 HD12 ' HG ' ' A' ' 20' ' ' LEU . 13.3 tt -109.49 150.32 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.06 -166.522 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -58.14 155.05 11.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.808 -170.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.04 -17.51 23.2 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.472 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -78.16 -15.08 59.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.318 . . . . 0.0 110.843 -173.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' A' ' 15' ' ' LYS . 28.8 mmmt -135.0 136.04 41.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 171.888 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.0 -84.25 1.0 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.495 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -110.25 -38.08 5.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 110.891 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -65.56 -50.97 63.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -150.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.07 -59.98 9.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.443 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.507 ' HG ' HD12 ' A' ' 11' ' ' ILE . 2.0 mt -45.53 -49.95 13.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.952 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.68 -38.01 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.044 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -70.61 -54.42 12.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.853 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.0 m -74.44 -37.74 45.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.186 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.485 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -63.03 -46.76 92.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.443 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -56.88 -30.04 63.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.938 0.399 . . . . 0.0 110.898 -177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -58.35 -37.41 75.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.955 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 1.5 m-30 -60.71 -48.82 80.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.929 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.12 -34.91 78.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -72.18 -37.26 69.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -94.78 -50.0 5.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 -167.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.2 p -116.42 -3.25 11.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.155 -171.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.48 14.2 82.21 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.427 166.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.818 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -98.25 133.27 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.352 . . . . 0.0 111.107 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -74.54 134.18 42.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -166.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.693 HG13 HD11 ' A' ' 9' ' ' ILE . 94.5 t -113.45 127.12 70.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.138 -172.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.578 ' O ' HD12 ' A' ' 9' ' ' ILE . 97.2 m -110.85 128.01 55.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.096 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 81.6 t -102.24 132.16 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.195 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -118.67 155.17 31.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.936 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.1 t-80 -89.09 140.11 28.92 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.543 0.687 . . . . 0.0 110.945 -170.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 85.6 Cg_exo -55.02 -27.97 57.52 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.603 2.202 . . . . 0.0 112.406 -174.629 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -48.39 -51.11 28.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 -171.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.23 -1.19 57.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.984 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 tt -46.64 -53.03 12.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.048 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -67.39 -39.41 85.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.963 175.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -63.8 -40.54 96.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.914 -171.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -80.85 -22.93 39.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.547 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 75.9 t80 -48.32 -50.47 56.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 0.0 110.883 -166.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 60.0 Cg_endo -80.59 -28.68 2.66 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.721 2.281 . . . . 0.0 112.343 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -74.5 -37.6 63.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 -170.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.592 HG11 ' HD3' ' A' ' 57' ' ' PRO . 33.6 m -65.9 -26.86 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.03 78.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 173.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.06 68.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.0 p -87.3 -12.23 47.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.135 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.98 11.11 84.07 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.525 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -164.46 156.97 16.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.753 0.311 . . . . 0.0 110.934 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.91 -114.99 0.53 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.505 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.779 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 89.6 Cg_endo -77.6 150.67 28.07 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.739 2.293 . . . . 0.0 112.318 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.25 -35.3 21.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.805 163.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.521 ' HB ' HG23 ' A' ' 9' ' ' ILE . 40.5 mt -126.5 136.33 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.108 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 tp -132.12 125.84 55.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.119 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -89.81 139.56 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.805 166.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.438 ' CH2' ' HB2' ' A' ' 105' ' ' ALA . 35.2 p90 -141.12 163.0 34.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.936 171.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.53 -85.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.09 -168.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.537 ' NE2' ' HA3' ' A' ' 260' ' ' GLY . 11.3 m170 -126.89 -68.2 0.81 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -100.65 -10.01 21.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 -158.029 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -51.83 -20.0 2.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.85 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.482 ' HB2' HD13 ' A' ' 104' ' ' ILE . 34.3 p90 -55.92 -28.88 58.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.53 -51.08 59.95 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.24 -36.7 90.21 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.425 172.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 1.4 t80 -55.83 -51.73 66.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.811 0.338 . . . . 0.0 110.913 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.32 -42.26 59.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.131 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -56.9 -37.98 72.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.938 -175.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.404 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 62.3 m -84.9 -6.42 59.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.949 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.96 30.47 59.24 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.591 173.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.404 ' HG ' ' HB2' ' A' ' 73' ' ' SER . 52.6 mt -89.04 -12.18 42.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.829 -167.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.461 ' HA ' ' H ' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -128.94 151.39 49.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 -173.246 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -77.07 142.21 39.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.118 175.05 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.94 135.89 48.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.903 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -104.22 153.7 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.255 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.2 m -96.39 126.74 42.65 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 111.112 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.98 134.79 65.56 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.653 2.236 . . . . 0.0 112.347 176.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -104.93 120.1 40.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.85 -39.84 94.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.88 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.13 -45.27 85.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.059 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -75.31 -31.75 60.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.501 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 65.4 tt0 -53.94 -51.18 64.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.52 -32.18 70.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 174.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -76.66 -22.01 54.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.51 -105.36 0.3 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.952 -171.413 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 25.0 t80 171.94 130.02 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.624 0.726 . . . . 0.0 110.966 -168.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -52.79 -37.68 76.73 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.727 2.285 . . . . 0.0 112.359 -175.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -66.57 -34.78 78.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.852 -172.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.5 p -73.93 -30.01 62.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.17 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.501 ' HA ' HG22 ' A' ' 97' ' ' VAL . 75.8 m95 -65.82 -31.99 73.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.931 173.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.66 -32.33 72.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.812 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.72 -23.9 62.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.501 HG22 ' HA ' ' A' ' 94' ' ' TRP . 19.5 m -107.27 14.06 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 -177.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -100.02 130.12 46.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.823 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -126.07 113.71 17.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.2 t30 58.99 38.31 24.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.839 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.36 0.64 89.46 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.502 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -118.9 151.62 37.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.878 0.37 . . . . 0.0 110.843 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.499 HD22 HG23 ' A' ' 97' ' ' VAL . 14.6 mt -89.93 133.53 34.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -124.0 4.15 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 -172.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.438 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . . . -163.47 164.58 24.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.106 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -114.11 142.21 27.59 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.575 0.702 . . . . 0.0 110.923 171.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.93 122.16 5.25 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.625 2.216 . . . . 0.0 112.296 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.062 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp -104.22 -37.69 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -146.48 154.09 41.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.034 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.4 t -115.49 129.86 71.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.089 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -109.96 129.28 55.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -154.93 143.67 20.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.06 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.97 169.0 11.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.95 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.7 p -157.31 156.37 32.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.893 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -100.06 128.58 46.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.902 169.451 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.614 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.9 mp -110.07 133.14 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.102 -175.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -131.01 145.28 52.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -93.5 113.9 26.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.856 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.33 -20.79 66.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -175.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -79.5 -28.46 41.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.895 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.19 -49.61 11.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 175.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -141.71 133.76 13.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.564 0.697 . . . . 0.0 110.831 175.641 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.44 -14.38 14.55 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.625 2.217 . . . . 0.0 112.352 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -143.72 98.35 5.32 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.564 0.697 . . . . 0.0 110.879 -173.013 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.45 156.5 61.41 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.684 2.256 . . . . 0.0 112.357 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.44 143.83 59.15 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.664 2.243 . . . . 0.0 112.321 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -89.89 -13.84 35.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.6 p -132.44 158.38 42.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.132 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -68.64 -30.04 68.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.56 -19.97 65.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.953 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -79.99 -26.97 39.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.851 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.478 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -56.7 -46.94 99.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.613 0.721 . . . . 0.0 111.303 -169.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 86.7 Cg_exo -52.58 -50.78 12.87 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.657 2.238 . . . . 0.0 112.374 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.71 -57.68 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 -174.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.156 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.37 -17.26 63.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 -173.18 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.572 ' N ' HD13 ' A' ' 135' ' ' LEU . 36.2 t70 -61.17 -40.16 92.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 168.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.16 -30.89 71.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.879 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.8 -46.24 58.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.842 -177.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.0 pp -84.11 -13.9 51.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.631 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.7 tttt -58.77 -34.92 71.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.93 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.72 -24.14 67.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.057 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -95.0 3.4 54.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.888 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.75 32.32 54.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.445 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -110.65 171.76 7.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 110.911 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.6 t -124.63 140.17 53.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.753 168.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -67.28 -42.95 82.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.168 -170.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -138.54 128.79 25.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 63.2 tpp -110.81 129.32 55.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -153.22 155.18 36.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -88.57 -50.94 5.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.845 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.076 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.8 tm? 48.47 31.12 2.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -170.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -103.06 -7.36 21.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.977 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -129.99 152.52 80.12 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-O 121.652 0.739 . . . . 0.0 110.882 -174.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.49 -32.51 53.36 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.752 2.301 . . . . 0.0 112.315 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -69.7 -30.05 67.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -80.01 -39.64 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.835 172.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.8 m -60.1 -52.3 65.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.124 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.578 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 22.7 t-105 -60.7 -48.65 92.56 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.598 0.713 . . . . 0.0 110.889 -160.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 84.3 Cg_exo -50.82 -44.43 41.33 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.62 2.213 . . . . 0.0 112.276 -176.34 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 160' ' ' LEU . 7.0 tt -72.92 -39.99 65.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 -171.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.17 -42.07 66.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.136 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.14 -23.32 60.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.126 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.26 -35.02 71.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.111 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.6 p30 -104.29 9.44 35.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.877 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.44 4.75 23.32 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.472 169.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.37 68.89 2.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.531 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -92.62 133.53 35.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.771 0.32 . . . . 0.0 110.944 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.44 ' HB1' HD13 ' A' ' 368' ' ' ILE . . . -83.94 12.61 5.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 -173.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -151.52 153.32 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.911 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -99.79 122.29 42.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 156.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -112.72 122.31 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.872 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -152.2 130.58 12.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.2 t30 54.99 43.96 29.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.77 15.46 79.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.602 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.38 139.75 50.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.867 -176.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -96.99 145.0 26.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 170.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -126.03 110.15 13.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.87 172.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.554 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.6 pp -80.04 -9.02 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -98.2 -11.93 22.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -121.93 89.14 3.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 169.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 26.0 m -116.61 164.55 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.082 -172.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -107.45 24.78 23.4 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.574 -173.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.423 HG21 HD12 ' A' ' 368' ' ' ILE . 2.5 m -109.24 -21.05 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.811 0.338 . . . . 0.0 111.055 -176.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -90.96 28.9 1.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.794 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -125.12 -170.04 2.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.893 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.85 -29.09 68.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.88 -41.71 95.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.477 -168.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.644 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.03 -37.04 85.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.942 0.401 . . . . 0.0 111.156 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.582 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -61.83 -38.13 87.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.868 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.14 -38.07 89.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.136 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.09 -47.73 63.38 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.505 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 347' ' ' VAL . 22.6 tp -67.39 -34.8 78.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.912 0.387 . . . . 0.0 110.901 -177.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.49 ' OG1' HG21 ' A' ' 357' ' ' VAL . 93.1 m -65.09 -41.43 94.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.148 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.461 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 59.8 t80 -67.33 -47.02 71.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.903 177.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 195' ' ' LEU . 7.4 tt -51.6 -51.42 55.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 -175.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 199' ' ' ILE . 31.2 m -64.01 -22.67 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.0 m-20 -61.59 -34.43 75.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.946 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.43 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.8 OUTLIER -81.28 -39.91 24.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.922 -173.92 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.516 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.8 pp -73.46 -29.3 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.135 172.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.6 -37.29 79.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -80.82 2.6 25.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.885 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 67.1 39.74 3.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.799 170.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -77.32 -17.94 57.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.91 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.516 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.2 ppp? -146.11 157.12 43.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.885 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -94.09 150.09 20.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.844 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.97 -25.88 67.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.075 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -95.4 0.99 54.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 94.0 m -63.55 127.18 30.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.095 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.429 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 14.7 t0 -120.02 177.36 5.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.853 177.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -65.01 -36.96 86.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.94 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.3 p -70.48 -38.03 74.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.911 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.429 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 78.7 mt -65.83 -43.12 93.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.072 175.652 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.31 87.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.209 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -61.6 -46.8 88.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.88 -40.77 97.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.056 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.91 -49.11 76.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.124 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -64.7 -41.1 96.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.966 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -63.51 -31.58 72.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.903 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.24 -13.17 44.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.962 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.14 25.01 35.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.556 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -85.87 -21.18 28.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 110.907 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.8 t -125.63 138.48 53.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.576 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -63.08 -48.84 76.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.012 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.489 ' HB3' HD21 ' A' ' 115' ' ' LEU . 69.9 mtm -133.3 159.89 38.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.949 -173.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.4 t -149.07 155.66 41.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.237 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.0 mm -111.47 130.05 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.178 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -155.77 174.63 15.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.5 -151.48 9.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.441 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.69 -26.18 28.16 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.621 2.214 . . . . 0.0 112.337 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -74.32 -32.06 62.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.942 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 43.19 45.04 4.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.151 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 35.6 m0 -69.45 -16.77 63.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 66.6 m -65.03 -26.42 68.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.514 ' HB3' HG21 ' A' ' 116' ' ' ILE . 39.1 p30 -82.62 -179.1 7.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 -172.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.8 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.125 -177.254 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 87.9 t . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.781 0.324 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -79.05 140.11 37.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.29 151.52 38.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.72 161.93 26.23 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 173.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.1 p -137.03 138.47 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.418 . . . . 0.0 111.025 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.4 t -155.72 150.97 26.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.176 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 30.7 m -59.97 167.08 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.119 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.946 HD23 ' HD3' ' A' ' 257' ' ' PRO . 2.8 mm? -59.24 149.82 66.25 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.519 0.676 . . . . 0.0 110.946 -168.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.23 -176.58 2.76 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.786 2.324 . . . . 0.0 112.406 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 99.3 m -88.92 144.03 26.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.108 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -131.34 110.96 11.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 54.92 36.16 26.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.988 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 89.81 -0.16 79.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.449 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -128.78 139.16 34.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.543 0.687 . . . . 0.0 110.843 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -67.38 138.28 45.9 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.734 2.289 . . . . 0.0 112.375 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 247' ' ' LEU . 75.6 m -81.48 -4.81 56.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 173.5 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 255' ' ' SER . 91.3 mttt -37.41 130.93 0.82 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.494 0.664 . . . . 0.0 110.878 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.946 ' HD3' HD23 ' A' ' 247' ' ' LEU . 37.8 Cg_endo -84.24 168.07 11.94 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.7 2.266 . . . . 0.0 112.278 -159.97 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -60.36 166.83 2.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.4 t -117.88 130.23 73.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.152 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.537 ' HA3' ' NE2' ' A' ' 64' ' ' HIS . . . -117.93 139.72 14.98 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.438 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 83.8 t -124.77 116.95 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.756 0.312 . . . . 0.0 111.189 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -65.14 119.97 11.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.961 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.3 m -123.8 130.88 53.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.809 -167.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.93 138.69 52.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.049 -174.421 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.6 170.82 22.21 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.43 -171.548 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.576 HG13 ' HB3' ' A' ' 277' ' ' LYS . 23.1 mm -114.96 127.64 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 0.0 111.198 -173.201 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -63.24 129.56 40.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 -175.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.461 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -58.68 -29.94 67.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.16 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.92 -6.34 59.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 -172.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 18.2 t -70.66 123.47 89.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.557 0.694 . . . . 0.0 110.981 -173.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -68.47 -8.34 22.84 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.669 2.246 . . . . 0.0 112.388 167.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -106.35 11.12 31.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.907 -176.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -47.58 -37.52 12.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 -168.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.54 -47.18 61.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.875 -171.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.1 pp -81.02 -30.7 34.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.945 -176.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.35 -49.55 68.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.071 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.576 ' HB3' HG13 ' A' ' 266' ' ' ILE . 57.9 pttt -69.33 -34.1 74.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.56 -45.82 81.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.822 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -67.75 -38.88 84.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.797 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 7.5 tt -58.55 -50.73 72.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 -175.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -72.2 -26.7 62.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -100.02 -11.06 20.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.967 -169.166 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.868 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 79.1 m-85 -128.33 -55.27 1.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 3.5 mp -66.13 -34.88 79.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 -165.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 1.062 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.2 pp -123.82 37.45 4.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.97 175.501 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 287' ' ' ASP . 9.3 m -115.53 153.86 30.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.108 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.566 ' HA ' HD11 ' A' ' 290' ' ' LEU . 28.7 t70 -45.7 -34.82 3.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -166.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -78.49 -41.09 33.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.868 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.04 -56.53 5.72 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.472 -171.686 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.573 HD12 ' N ' ' A' ' 291' ' ' GLU . 0.5 OUTLIER -66.42 -21.26 66.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.908 -179.157 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.573 ' N ' HD12 ' A' ' 290' ' ' LEU . 84.4 tt0 -68.29 -46.94 68.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.798 171.254 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.91 -42.87 99.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.071 -174.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 4.0 m -79.59 -36.31 17.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.182 -174.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -64.97 -28.73 69.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.934 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.79 -26.72 68.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -87.95 -41.96 12.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -146.13 135.53 11.47 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.541 0.686 . . . . 0.0 110.902 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -53.12 113.9 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.655 2.236 . . . . 0.0 112.394 175.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.411 ' HA ' HD12 ' A' ' 299' ' ' LEU . 0.7 OUTLIER -86.45 -24.94 25.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.949 177.77 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 103.63 -57.01 0.56 Allowed Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.506 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.577 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -168.18 161.83 12.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.384 . . . . 0.0 111.036 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.606 HG21 ' HB3' ' A' ' 307' ' ' TYR . 32.6 m -124.33 155.55 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.099 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.02 -9.99 59.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.034 173.405 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.557 ' CD2' HD21 ' A' ' 290' ' ' LEU . 45.0 tp -86.5 119.95 27.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.858 -176.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.61 -38.64 72.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.945 -174.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 42.7 t -64.56 -50.32 67.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.916 -169.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.606 ' HB3' HG21 ' A' ' 302' ' ' VAL . 16.9 t80 -78.52 -29.13 46.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -64.74 -37.76 88.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.37 -37.9 85.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.939 173.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -72.81 -39.8 66.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.963 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.577 HD13 ' HA ' ' A' ' 301' ' ' ALA . 79.2 mt -61.93 -32.64 73.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.928 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.26 -17.52 58.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.8 -19.12 65.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.978 173.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -91.63 121.74 66.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.746 0.784 . . . . 0.0 110.852 164.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -48.2 -26.93 8.73 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.679 2.252 . . . . 0.0 112.344 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -61.26 -29.64 69.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -172.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 1.2 mp -76.84 -29.86 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.188 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.51 85.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.046 -170.314 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.21 -43.74 77.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 80.8 p -63.78 -30.99 72.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -171.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.5 mmm -70.91 -32.86 69.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.85 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -64.46 -46.68 82.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.869 -173.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.447 ' OD1' ' HB1' ' A' ' 112' ' ' ALA . 7.5 p-10 -80.08 -27.07 39.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.728 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.13 -49.21 73.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.116 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -68.0 -34.98 77.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -105.51 -6.54 19.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.823 -169.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -93.18 -159.6 34.94 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.435 -170.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -142.22 148.53 38.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 0.0 110.92 -172.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 41.7 mm -65.13 122.3 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.083 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 36.2 ttp . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.574 0.702 . . . . 0.0 110.913 -179.639 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 . . . . . 0 C--O 1.23 0.04 0 CA-C-O 120.704 0.287 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 85.1 mmm -79.99 -22.76 42.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 -173.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.5 m -55.52 -39.95 71.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.806 -171.792 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -68.71 -33.48 74.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.031 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 1.5 m-30 -67.51 -37.33 82.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -54.98 -42.04 71.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -78.28 -36.18 47.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.774 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.12 -38.44 90.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.043 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 339' ' ' PHE . 19.3 m -74.72 -31.32 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.071 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 347' ' ' VAL . 4.9 tmt_? -64.16 -37.33 87.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.863 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.9 m -57.27 -36.73 71.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.212 174.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.89 -42.54 94.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.183 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.541 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.9 m -74.26 -34.57 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.202 -174.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.452 HD12 HG23 ' A' ' 347' ' ' VAL . 1.4 mp -63.37 -47.91 89.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.119 173.856 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.97 -40.29 97.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.26 -46.39 41.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.105 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.33 78.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.039 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.2 p -75.26 -10.73 59.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.3 18.31 69.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.484 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.87 -33.32 45.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.764 0.316 . . . . 0.0 110.938 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.494 ' HB2' ' HB2' ' A' ' 360' ' ' ALA . 90.3 mm-40 -140.58 156.44 46.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 52.3 p -77.48 166.59 22.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.183 171.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.49 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.2 t -56.19 -41.92 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.226 173.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.52 -46.85 88.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.951 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -70.49 -56.42 6.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' A' ' 355' ' ' GLN . . . -68.45 -48.42 64.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.11 -172.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.644 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.8 tm? -65.0 -45.85 83.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -175.035 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.34 -53.76 50.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 -176.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 363' ' ' ASP . . . . . 0.409 ' O ' ' HG3' ' A' ' 367' ' ' ARG . 32.1 t70 -68.07 -50.08 57.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 -174.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -64.06 -38.29 90.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 -172.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 75.5 mm-40 -78.08 -32.34 50.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 40.9 m -66.21 -29.13 69.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.172 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 367' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 363' ' ' ASP . 79.6 mtt180 -56.9 -32.16 65.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 174.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 365' ' ' GLN . 71.4 mt -59.89 -40.72 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 41.6 p -97.1 -11.07 24.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.189 -175.736 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.812 175.363 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.755 0.312 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.425 HG21 ' HD2' ' A' ' 271' ' ' PRO . 62.3 mt -99.45 140.06 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.154 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -143.9 145.0 31.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -54.34 138.24 39.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 176.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.15 8.35 68.88 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.538 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.2 tttt -166.09 131.09 2.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.827 0.346 . . . . 0.0 110.91 176.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.611 HD22 HD11 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -141.76 155.97 45.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.963 -172.454 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 69.3 t -114.45 135.43 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.18 -175.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.712 HD11 HG13 ' A' ' 35' ' ' VAL . 0.9 OUTLIER -120.0 134.88 62.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.047 176.603 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.859 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 60.5 m95 -108.62 124.46 50.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 163.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.513 HD12 ' HG ' ' A' ' 20' ' ' LEU . 12.1 tt -109.75 151.77 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.074 -163.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -54.75 148.28 13.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.807 -172.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.99 -16.85 41.87 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.504 -175.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -80.61 -14.12 58.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.854 0.359 . . . . 0.0 110.888 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 15' ' ' LYS . 33.0 mmtm -140.0 128.09 22.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 166.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.1 -78.13 1.07 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.49 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -104.88 -35.92 7.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -67.33 -52.47 39.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.862 -150.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.32 -52.62 43.16 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.508 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.526 HD22 HD13 ' A' ' 9' ' ' ILE . 5.8 mt -55.09 -53.44 55.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.359 . . . . 0.0 110.907 174.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.29 -39.02 6.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.133 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -71.47 -57.99 3.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 178.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 20' ' ' LEU . 20.9 m -74.29 -36.19 42.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.199 -170.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.55 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -63.6 -45.62 94.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.489 174.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -54.33 -36.49 63.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.878 0.37 . . . . 0.0 110.831 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -58.92 -41.12 86.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.967 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 4.7 m-30 -62.34 -47.03 86.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 98.1 mt-10 -61.27 -36.05 78.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -75.42 -40.18 58.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.924 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -91.24 -49.84 6.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 -166.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.6 p -108.66 -7.55 15.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.174 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.13 8.83 87.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.369 167.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.927 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.8 133.66 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 111.219 -178.39 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.7 mttt -69.97 136.18 50.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.853 -172.059 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.712 HG13 HD11 ' A' ' 9' ' ' ILE . 92.1 t -114.7 125.02 71.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.007 -175.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.565 ' O ' HD12 ' A' ' 9' ' ' ILE . 98.6 m -108.91 125.66 52.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.098 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.422 HG22 ' HB3' ' A' ' 20' ' ' LEU . 84.8 t -102.43 130.91 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.138 177.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -118.13 154.27 32.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.958 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 65.8 t-80 -87.13 138.61 32.48 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.558 0.694 . . . . 0.0 110.884 -169.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 81.4 Cg_exo -57.34 -25.51 65.88 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.652 2.235 . . . . 0.0 112.303 -173.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -48.36 -51.1 27.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.838 -173.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.94 -0.82 57.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 -175.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 8.1 tt -46.56 -52.71 12.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -174.642 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -65.01 -40.81 95.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.81 -40.89 97.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.865 -172.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -81.55 -21.14 38.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.526 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 53.2 t80 -50.06 -51.16 64.45 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.696 0.76 . . . . 0.0 110.816 -165.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 55.5 Cg_endo -81.69 -30.06 1.55 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.656 2.238 . . . . 0.0 112.405 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -75.12 -40.05 60.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -167.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.51 -27.69 41.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.032 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.706 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -68.08 -36.21 79.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.096 177.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.81 -32.08 71.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.051 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.2 p -92.18 -15.7 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.135 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.76 10.89 80.64 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.403 173.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -140.2 132.62 28.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 0.0 110.811 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.434 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . 170.69 -127.76 1.51 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.474 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.859 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 35.0 Cg_endo -64.18 149.01 91.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.713 2.275 . . . . 0.0 112.399 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -92.1 -33.2 14.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.826 161.251 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.68 ' HB ' HG23 ' A' ' 9' ' ' ILE . 38.7 mt -124.16 136.09 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.114 -177.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 tp -131.44 127.56 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.157 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -93.77 136.7 33.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.802 170.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.479 ' CH2' ' HB2' ' A' ' 105' ' ' ALA . 33.0 p90 -140.89 167.17 22.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.969 171.349 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.59 -82.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.016 -167.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -127.32 -73.42 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.881 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -99.96 -10.73 21.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -159.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -51.25 -22.34 2.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.516 ' HB2' HD13 ' A' ' 104' ' ' ILE . 32.9 p90 -56.8 -31.77 65.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.807 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.89 -50.99 60.91 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.447 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.73 -35.98 90.56 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.533 171.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -55.1 -51.63 65.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 0.0 110.946 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.73 -44.07 51.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.072 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -57.04 -38.86 73.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.982 -174.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.4 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 63.4 m -85.02 -7.15 59.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.77 30.3 59.9 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.545 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.706 HD22 ' HB1' ' A' ' 51' ' ' ALA . 35.5 mt -88.83 -9.35 52.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.808 0.337 . . . . 0.0 110.904 -170.012 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.467 ' HA ' ' H ' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -128.61 152.11 48.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 -178.161 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.413 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -80.37 142.82 34.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.069 175.695 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -73.12 135.38 44.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.836 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 pt -105.06 155.87 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.109 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.9 m -97.65 130.04 30.08 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.536 0.684 . . . . 0.0 111.08 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.42 135.55 66.2 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.669 2.246 . . . . 0.0 112.335 176.428 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -103.39 117.85 35.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 175.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.31 -41.34 98.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.849 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.25 87.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.002 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.42 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 16.5 m-85 -75.84 -31.75 59.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.857 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.45 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 66.8 tt0 -53.4 -50.84 64.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.949 173.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.76 -32.99 72.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 85' ' ' PHE . 93.7 mttt -75.87 -21.04 57.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -174.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -104.76 -105.08 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -171.528 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 26.9 t80 171.66 128.33 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.68 0.752 . . . . 0.0 110.956 -167.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -52.77 -36.78 74.69 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PHE . . . . . 0.4 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 62.9 t80 -65.19 -35.11 80.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.4 p -73.79 -31.08 63.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.168 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.65 ' HA ' HG22 ' A' ' 97' ' ' VAL . 79.6 m95 -67.95 -29.72 68.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 173.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.04 -31.48 72.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.95 -23.84 58.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.65 HG22 ' HA ' ' A' ' 94' ' ' TRP . 17.7 m -111.51 19.28 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 -173.146 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.1 ttp-105 -111.95 136.5 51.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.842 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -135.39 121.89 20.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.952 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.2 t30 58.91 35.39 24.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.96 0.76 89.78 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.57 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -118.29 151.0 38.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 110.853 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.606 HD22 HG23 ' A' ' 97' ' ' VAL . 22.2 mt -86.58 135.27 33.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.951 177.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.516 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -124.79 3.6 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.065 -173.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.479 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . . . -163.46 165.83 23.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.196 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.463 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 90.2 m-85 -114.87 140.57 25.64 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.618 0.723 . . . . 0.0 110.976 170.653 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 12.0 Cg_exo -70.07 123.63 10.19 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.603 2.202 . . . . 0.0 112.294 170.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.014 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -106.98 -39.83 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 175.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -144.51 153.78 42.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 -166.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.8 t -118.68 129.86 74.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.135 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -119.89 127.78 53.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.621 ' HB1' HD21 ' A' ' 323' ' ' ASN . . . -155.02 146.42 23.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.036 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.6 mp -85.71 170.01 12.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.996 -175.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.4 p -154.75 153.63 31.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.988 0.423 . . . . 0.0 110.853 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.878 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -94.89 126.79 40.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 169.411 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.592 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.1 mp -111.63 131.73 62.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 -175.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -132.47 147.93 52.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 -175.091 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -92.37 115.49 28.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.872 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.483 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.2 mttt -66.56 -22.12 66.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -77.94 -23.35 48.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 -176.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.8 mp -85.29 -57.5 3.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 168.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.726 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -144.32 125.89 8.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.696 0.76 . . . . 0.0 110.785 177.76 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.46 -0.76 10.66 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.594 2.196 . . . . 0.0 112.41 -176.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -147.93 101.87 3.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.654 0.74 . . . . 0.0 110.761 -174.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.52 155.06 50.39 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.755 2.303 . . . . 0.0 112.401 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.444 ' HD2' ' SD ' ' A' ' 224' ' ' MET . 52.4 Cg_exo -55.28 143.06 77.56 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.699 2.266 . . . . 0.0 112.294 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -78.87 -22.03 46.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 52.9 p -135.62 159.95 40.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.202 -177.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.428 ' HA ' HD13 ' A' ' 132' ' ' ILE . 77.8 m95 -70.82 -28.13 64.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.09 -19.41 65.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -84.07 -20.63 32.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.554 ' O ' HD13 ' A' ' 135' ' ' LEU . 0.7 OUTLIER -57.36 -45.35 99.9 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.635 0.731 . . . . 0.0 111.133 -171.865 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 82.0 Cg_exo -51.27 -47.67 24.81 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.612 2.208 . . . . 0.0 112.335 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.84 -59.84 3.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.054 -174.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.113 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.99 -16.8 63.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.866 -173.328 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.542 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.4 t70 -61.3 -40.1 92.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 168.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.36 -30.07 69.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.7 -47.95 57.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.832 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.1 pp -87.42 -16.69 34.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.924 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.602 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.4 tttt -59.45 -32.86 70.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.41 -25.13 68.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.983 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -95.36 7.04 47.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.919 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.9 30.96 58.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.531 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -109.7 169.99 8.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 0.0 110.887 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.5 t -125.63 142.22 51.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 174.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.63 -42.48 74.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.124 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -139.3 127.78 22.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.945 -175.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 63.3 tpp -105.25 129.14 53.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 -174.342 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.18 158.33 38.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.929 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -98.63 -42.87 7.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.82 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.026 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.5 tm? 48.46 31.2 2.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 -170.205 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -103.73 -6.76 21.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.887 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -137.67 156.5 74.63 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.645 0.736 . . . . 0.0 110.901 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.476 ' HA ' ' HB ' ' A' ' 157' ' ' THR . 67.7 Cg_exo -52.37 -26.39 27.6 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.671 2.247 . . . . 0.0 112.339 176.176 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -63.22 -38.49 91.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -85.85 -37.19 19.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 20.0 m -58.87 -52.13 67.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.116 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.574 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 23.6 t-105 -62.54 -49.23 84.21 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.561 0.696 . . . . 0.0 110.893 -163.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 81.6 Cg_exo -50.07 -48.26 20.42 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.724 2.283 . . . . 0.0 112.392 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 160' ' ' LEU . 6.8 tt -72.0 -39.91 68.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 -170.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.3 mt -71.12 -42.41 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.119 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.38 -25.86 59.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -60.66 -35.03 75.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -169.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.4 ' HB3' ' CD2' ' A' ' 250' ' ' PHE . 59.6 p30 -97.53 3.48 50.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.76 2.15 13.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.415 173.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.89 64.78 3.0 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.563 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -87.08 136.02 33.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.916 0.388 . . . . 0.0 110.987 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.49 -0.33 22.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.466 ' HA ' HG12 ' A' ' 181' ' ' VAL . 49.6 p90 -154.05 154.82 34.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.909 -175.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -97.22 121.96 39.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.952 157.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -109.76 123.14 49.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.882 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -152.69 131.52 12.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.3 t30 55.74 44.97 25.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 172.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.92 15.29 78.34 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.463 173.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.89 139.11 50.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.0 110.864 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -98.75 140.43 32.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 172.711 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -122.33 109.94 15.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.528 ' C ' HD12 ' A' ' 178' ' ' ILE . 2.1 pp -83.4 -6.2 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.071 -177.581 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -99.67 -16.92 18.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -117.01 88.74 2.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.834 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 169' ' ' PHE . 22.9 m -117.82 165.03 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.094 -169.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -109.96 25.71 15.86 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.509 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 365' ' ' GLN . 1.2 m -106.6 -23.06 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.821 0.344 . . . . 0.0 111.06 -176.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -92.09 24.15 3.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -107.72 -174.97 2.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.8 -28.31 63.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.11 -40.43 92.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.524 -171.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.583 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -60.45 -38.39 84.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 111.099 177.319 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.589 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.6 mttt -61.67 -37.3 83.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.9 176.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.77 88.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.042 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.0 -46.62 71.39 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.564 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.549 HD11 ' HA ' ' A' ' 347' ' ' VAL . 20.2 tp -67.56 -33.63 75.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.958 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.516 ' OG1' HG21 ' A' ' 357' ' ' VAL . 91.8 m -65.57 -42.02 92.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.24 176.511 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 92.3 t80 -69.4 -44.68 70.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 195' ' ' LEU . 6.9 tt -51.13 -51.6 51.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.932 -175.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 35.1 m -63.89 -22.48 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.0 m-20 -62.25 -34.18 76.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.843 -177.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.457 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.7 OUTLIER -82.02 -39.96 22.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.959 -173.444 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.8 pp -72.02 -29.96 34.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.151 172.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -67.47 -37.73 83.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 171.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -82.72 2.54 33.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.925 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 66.86 39.94 3.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.829 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -75.96 -15.66 60.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.811 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -144.1 156.1 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.842 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -94.19 152.61 18.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.58 -27.11 68.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -94.1 2.67 55.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -177.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.9 m -65.62 134.92 54.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -138.36 171.73 13.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.918 176.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.07 -46.04 82.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 -176.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.8 m -60.37 -40.61 91.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.95 -42.25 94.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.178 173.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.98 -36.91 85.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.136 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' GLU . . . . . 0.402 ' HG2' ' HA ' ' A' ' 233' ' ' SER . 93.8 mt-10 -65.04 -44.24 89.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.874 177.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.96 -39.56 93.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.087 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.18 -45.02 95.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.099 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -64.25 -38.67 91.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.22 -34.7 76.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.0 -19.26 27.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.39 26.1 26.48 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -82.07 -19.96 39.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.928 0.395 . . . . 0.0 110.915 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.9 t -123.89 134.76 53.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 174.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.514 ' HB1' HD21 ' A' ' 122' ' ' LEU . . . -66.8 -47.38 72.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.996 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.626 ' HB3' HD21 ' A' ' 115' ' ' LEU . 72.9 mtm -133.86 153.78 51.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -171.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 10.1 t -151.04 155.81 39.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.213 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.2 mm -109.69 124.76 66.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.185 -175.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -153.51 174.64 14.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 -170.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.41 -164.13 34.17 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.435 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.2 -20.9 49.1 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.662 2.241 . . . . 0.0 112.341 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -78.16 -25.52 47.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 49.4 53.52 12.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.115 178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -60.0 -23.61 63.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 -177.243 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.402 ' HA ' ' HG2' ' A' ' 214' ' ' GLU . 65.2 m -57.09 -40.69 77.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.89 -176.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -85.91 179.19 7.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 69.8 mt . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 -167.543 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.809 0.338 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -106.15 124.25 49.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.483 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 52.5 p90 -143.82 155.97 44.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.89 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -135.84 160.16 24.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.512 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.38 135.12 54.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.938 0.399 . . . . 0.0 111.061 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.8 t -153.8 149.14 27.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.36 162.07 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 3.1 mp -68.05 151.58 97.09 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.539 0.685 . . . . 0.0 110.919 -162.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.09 -173.6 1.85 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.663 2.242 . . . . 0.0 112.327 -174.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 99.5 m -89.03 143.01 27.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 -171.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 164' ' ' ASP . 11.1 t80 -132.17 113.13 12.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -176.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 56.22 35.46 25.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.37 1.89 83.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.583 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 90.0 mm-40 -126.86 127.94 24.32 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 121.555 0.693 . . . . 0.0 110.887 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 78.1 Cg_exo -55.12 133.24 57.0 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.631 2.221 . . . . 0.0 112.375 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 256' ' ' LYS . 69.4 m -78.81 -9.61 59.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.855 173.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 85.7 mttt -39.8 128.61 1.53 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.539 0.685 . . . . 0.0 110.861 -173.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 71.2 Cg_exo -63.51 156.25 57.77 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.648 2.232 . . . . 0.0 112.377 -167.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -70.75 166.6 20.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 173.048 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.83 131.68 61.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.146 -167.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.95 135.13 12.09 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.436 173.111 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 96.4 t -123.53 115.91 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 0.0 111.159 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -64.17 120.71 12.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.992 -178.525 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 48.4 m -124.74 131.63 53.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.835 -169.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.84 138.89 52.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.105 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -135.04 172.85 21.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.463 -170.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 23.4 mm -111.39 127.91 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.759 0.314 . . . . 0.0 111.244 -173.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -62.48 132.03 51.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.988 -176.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.467 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -60.13 -28.48 67.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.113 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.7 -5.15 59.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.8 t -74.79 120.06 79.75 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.675 0.75 . . . . 0.0 110.917 -174.326 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.425 ' HD2' HG21 ' A' ' 2' ' ' ILE . 92.0 Cg_endo -70.4 -7.1 20.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.637 2.225 . . . . 0.0 112.389 164.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -101.11 14.93 30.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 -171.022 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -51.87 -40.18 60.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.898 -169.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.3 -52.4 58.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 -172.018 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.4 pp -80.51 -33.65 36.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.004 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.62 -47.43 69.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.018 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -61.48 -41.75 97.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.854 173.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.8 tt0 -61.38 -47.32 86.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 17.9 m-30 -68.4 -36.56 79.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.813 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.52 ' HA ' HD22 ' A' ' 284' ' ' LEU . 5.8 tt -59.37 -52.4 65.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.873 -177.005 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -77.91 -33.5 51.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 -176.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.584 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 61.7 m-80 -99.97 -13.19 19.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.845 -163.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.762 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 59.2 m-85 -127.36 -50.49 1.41 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.52 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.5 OUTLIER -63.85 -39.36 94.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -170.523 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 1.014 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.7 pp -124.38 38.2 4.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 -175.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.477 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 5.9 t -115.66 162.73 16.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.088 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.423 ' HA ' HD11 ' A' ' 290' ' ' LEU . 28.4 t70 -48.51 -34.12 10.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -169.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -80.24 -41.09 25.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.859 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.762 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.77 -57.24 5.48 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.452 -170.224 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.549 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -66.42 -21.47 66.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.0 110.973 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.537 ' N ' HD12 ' A' ' 290' ' ' LEU . 83.9 tt0 -67.06 -46.49 74.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.825 171.135 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.67 -37.66 88.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.61 -46.33 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.086 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -65.81 -30.09 70.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.797 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.05 -27.8 67.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.95 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -87.41 -49.92 6.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.83 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 74.1 mmtt -138.6 139.15 23.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.57 0.7 . . . . 0.0 110.865 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 298' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 297' ' ' LYS . 80.1 Cg_exo -55.03 115.83 2.71 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.66 2.24 . . . . 0.0 112.381 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 299' ' ' LEU . 0.3 OUTLIER -84.41 -22.54 30.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 173.694 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 96.8 -59.71 1.22 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.516 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.659 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -167.53 160.23 12.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.814 0.34 . . . . 0.0 111.231 174.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.691 HG21 ' HB3' ' A' ' 307' ' ' TYR . 22.1 m -120.84 153.3 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.87 -9.58 58.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.061 173.213 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.549 ' CD2' HD21 ' A' ' 290' ' ' LEU . 44.0 tp -83.48 121.1 26.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.886 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.58 -38.61 75.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.86 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.7 t -64.46 -50.0 69.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.847 -169.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.691 ' HB3' HG21 ' A' ' 302' ' ' VAL . 13.6 t80 -77.26 -31.32 54.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.91 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.93 -39.15 93.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -58.67 -38.01 77.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -75.05 -38.78 61.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.979 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.659 HD13 ' HA ' ' A' ' 301' ' ' ALA . 80.3 mt -61.84 -34.25 75.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.98 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.38 -18.05 63.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.055 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.12 -19.56 66.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.934 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -93.14 121.43 65.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.6 0.715 . . . . 0.0 110.865 166.024 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -47.9 -26.65 7.56 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.66 2.24 . . . . 0.0 112.396 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -62.91 -34.88 78.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 -175.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.531 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.0 OUTLIER -81.5 -35.95 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.2 90.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.118 -170.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.92 -47.96 73.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.035 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 75.6 p -67.84 -27.16 66.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.086 -176.09 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.5 ttp -62.48 -34.96 77.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -62.31 -51.37 67.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.84 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.621 HD21 ' HB1' ' A' ' 112' ' ' ALA . 12.3 p-10 -80.06 -26.48 39.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.77 -177.107 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.41 -51.62 62.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.095 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -69.33 -29.77 67.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.88 -8.13 16.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.824 -168.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -91.39 -153.24 29.33 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.436 -168.383 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.0 144.83 37.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.856 0.36 . . . . 0.0 110.895 -172.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 36.0 mm -63.78 119.54 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.089 -172.426 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 60.2 ttm . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.517 0.675 . . . . 0.0 110.89 178.058 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 335' ' ' GLN . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 339' ' ' PHE . 99.4 mm-40 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.73 0.3 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 88.4 mmm -64.96 -28.64 69.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.871 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.1 m -58.07 -39.91 79.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.767 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.07 -39.39 63.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 3.8 m-30 -63.17 -46.74 85.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -60.14 -37.71 80.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.901 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -69.63 -39.67 77.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.2 -43.01 83.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.104 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 339' ' ' PHE . 19.7 m -73.91 -33.17 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.133 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.454 ' O ' HG22 ' A' ' 347' ' ' VAL . 5.0 tmt_? -65.2 -38.68 91.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 86.1 m -58.53 -38.6 78.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.76 94.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.549 ' HA ' HD11 ' A' ' 192' ' ' LEU . 12.4 m -73.97 -35.51 42.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.084 -174.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 347' ' ' VAL . 1.4 mp -63.68 -47.01 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.221 173.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.02 -40.98 99.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.891 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.96 -45.94 47.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.11 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.01 -40.17 78.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.7 p -75.67 -10.11 59.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.32 18.67 68.43 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.375 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.13 -32.85 44.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 0.0 110.911 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -140.88 157.72 44.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.6 p -77.21 169.11 18.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.288 170.713 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.516 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.0 t -57.56 -43.07 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.14 172.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.65 -47.04 88.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -69.52 -55.3 10.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.5 -47.7 66.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.084 -172.889 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.589 ' HG ' ' HA ' ' A' ' 189' ' ' LYS . 1.6 tm? -65.08 -44.96 87.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -174.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.46 -53.71 38.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.949 -177.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.01 -47.07 66.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 -172.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.07 -43.92 81.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 -174.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.502 ' HB3' ' HB ' ' A' ' 183' ' ' VAL . 86.9 mm-40 -73.36 -32.98 64.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.933 -175.032 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 35.9 m -61.76 -28.23 69.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.172 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.88 -30.11 65.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 365' ' ' GLN . 74.5 mt -60.9 -37.7 77.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.233 174.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 43.4 p -98.01 -12.01 22.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.174 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 176.539 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.752 0.31 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.6 mt -108.96 138.16 37.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -121.37 136.13 55.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.83 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -54.32 134.92 45.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.843 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.24 9.4 67.32 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.475 -174.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 39.2 ttpt -160.07 129.97 5.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.363 . . . . 0.0 110.936 173.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.675 HD23 ' H ' ' A' ' 7' ' ' LEU . 1.1 pt? -136.24 152.77 51.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.93 -169.326 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 74.5 t -112.64 135.22 52.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.189 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.631 HD11 HG23 ' A' ' 35' ' ' VAL . 1.1 mp -118.64 132.69 67.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 177.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.799 ' HD1' ' HB3' ' A' ' 57' ' ' PRO . 78.7 m95 -104.45 125.77 50.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.929 164.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.518 HD12 ' HG ' ' A' ' 20' ' ' LEU . 10.4 tt -110.88 150.03 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.096 -166.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -58.99 150.09 25.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -173.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.83 -16.62 12.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.417 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -72.68 -15.21 61.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.917 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -139.98 137.85 35.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.899 167.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.97 -81.56 1.07 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.504 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -109.99 -37.13 5.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.932 0.396 . . . . 0.0 110.946 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -66.9 -50.01 63.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.92 -151.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.754 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -54.67 -53.6 38.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.537 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.518 ' HG ' HD12 ' A' ' 11' ' ' ILE . 8.1 mt -55.01 -48.07 73.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.783 0.325 . . . . 0.0 110.926 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.73 -34.77 12.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.11 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -78.66 -60.13 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.848 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 24' ' ' GLY . 26.4 m -74.55 -42.1 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 -169.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.465 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -64.99 -40.61 97.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -59.04 -29.95 67.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.908 0.385 . . . . 0.0 110.88 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -56.99 -33.08 66.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.026 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 2.5 m-30 -56.6 -47.76 78.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.895 177.278 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -70.36 -41.42 73.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.07 -34.85 79.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.846 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -92.63 -48.94 6.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.908 0.385 . . . . 0.0 110.853 -170.476 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.1 p -116.56 -0.72 12.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.213 -169.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.04 11.72 85.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.429 167.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.959 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.02 133.86 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.868 0.366 . . . . 0.0 111.11 -179.706 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 73.4 mmtt -74.13 140.62 45.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.844 -171.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.631 HG23 HD11 ' A' ' 9' ' ' ILE . 13.1 p -122.72 128.1 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.065 -174.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.621 ' O ' HD12 ' A' ' 9' ' ' ILE . 96.9 m -111.94 129.08 56.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.093 -174.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 20' ' ' LEU . 91.6 t -104.48 131.51 53.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.125 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -117.18 155.02 30.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.0 t-80 -85.07 138.96 36.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.683 0.754 . . . . 0.0 110.837 -170.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 86.6 Cg_exo -54.98 -29.39 64.34 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.627 2.218 . . . . 0.0 112.303 -175.361 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -48.28 -51.34 26.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 -172.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.03 -0.85 57.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.885 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.2 tt -47.06 -53.12 13.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -68.69 -38.45 80.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.7 -41.35 96.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 -171.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -81.66 -21.43 38.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.528 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 65.9 t80 -48.6 -50.71 57.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.624 0.726 . . . . 0.0 110.84 -167.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 66.3 Cg_endo -80.06 -28.48 3.13 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.596 2.198 . . . . 0.0 112.352 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -74.43 -39.16 62.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 -171.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.428 HG11 ' HD3' ' A' ' 57' ' ' PRO . 33.5 m -67.88 -27.97 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.13 -177.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.575 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -68.29 -37.77 80.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.057 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.19 -32.11 72.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.076 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.8 p -92.89 -14.92 27.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.56 10.79 79.95 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.407 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -142.79 136.2 28.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.776 0.322 . . . . 0.0 110.766 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.95 -114.95 0.52 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.514 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.799 ' HB3' ' HD1' ' A' ' 10' ' ' TRP . 61.2 Cg_endo -73.97 154.54 47.89 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.709 2.273 . . . . 0.0 112.285 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.67 -32.77 13.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 160.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.608 ' HB ' HG23 ' A' ' 9' ' ' ILE . 39.0 mt -127.63 137.77 56.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.229 -177.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 tp -131.38 126.84 59.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.193 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -88.97 141.6 28.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 167.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.579 ' CZ2' ' HB3' ' A' ' 67' ' ' PHE . 1.8 p90 -138.41 160.9 38.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.968 172.002 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.43 -82.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.164 -169.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.537 ' CD2' ' HA3' ' A' ' 260' ' ' GLY . 40.5 m170 -121.88 -71.07 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -170.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.95 -11.78 16.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.815 -164.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -56.78 -17.07 7.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -158.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.579 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . 27.9 p90 -61.77 -23.23 66.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.826 -173.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.55 -48.81 63.53 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.404 -174.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.43 -36.77 92.03 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.474 171.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 1.5 t80 -55.17 -51.23 67.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.897 0.38 . . . . 0.0 110.874 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.99 -41.91 40.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.119 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -59.19 -36.18 74.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.0 m -85.06 -7.69 59.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.28 31.73 58.95 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.575 HD22 ' HB1' ' A' ' 51' ' ' ALA . 52.1 mt -88.12 -9.62 52.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.812 0.339 . . . . 0.0 110.884 -167.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.538 HD11 ' HB ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -128.42 152.95 47.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -172.254 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -79.18 141.25 37.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.091 175.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -70.74 137.85 50.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 173.638 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.427 HD12 ' CZ ' ' A' ' 106' ' ' TYR . 39.3 pt -103.88 156.64 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.143 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.9 m -92.08 130.04 39.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.536 0.684 . . . . 0.0 111.088 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PRO . . . . . 0.412 ' HB3' HD12 ' A' ' 103' ' ' LEU . 50.0 Cg_endo -67.41 141.14 55.03 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.687 2.258 . . . . 0.0 112.328 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -110.14 118.75 37.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.94 -36.78 73.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.25 -45.17 92.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.178 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -75.64 -32.44 60.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.483 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.5 tt0 -51.51 -49.1 62.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -66.35 -32.89 74.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.799 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.02 -23.26 52.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 -172.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.96 -104.64 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.993 -169.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 t80 174.94 107.98 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.668 0.747 . . . . 0.0 111.036 -160.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.0 -32.17 30.0 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.725 2.283 . . . . 0.0 112.329 -177.968 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.99 -36.93 85.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.2 p -78.3 -31.52 48.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.579 ' HA ' HG22 ' A' ' 97' ' ' VAL . 86.2 m95 -63.16 -29.99 71.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 171.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -69.46 -32.15 70.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.792 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.73 -23.01 61.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.08 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 94' ' ' TRP . 19.8 m -110.7 17.98 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.134 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -107.57 132.93 52.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.817 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -126.2 119.22 26.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 174.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.2 t30 57.57 37.04 27.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.868 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.64 1.12 90.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.482 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -121.83 148.75 44.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.843 0.354 . . . . 0.0 110.852 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.564 HD22 HG23 ' A' ' 97' ' ' VAL . 16.8 mt -86.03 133.79 33.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -176.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.538 ' HB ' HD11 ' A' ' 76' ' ' LEU . 1.2 pp -114.84 -9.29 12.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.095 -172.704 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.55 ' HB3' ' HH2' ' A' ' 62' ' ' TRP . . . -169.44 173.4 6.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.183 -173.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 99.2 m-85 -115.88 140.17 25.86 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.671 0.748 . . . . 0.0 110.925 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 12.2 Cg_exo -70.82 127.85 14.29 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.705 2.27 . . . . 0.0 112.323 172.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.898 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -108.9 -39.93 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.117 177.074 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 262' ' ' LEU . . . -143.29 154.17 43.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.149 -171.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.2 t -116.15 127.28 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.204 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -110.62 125.23 53.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.452 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -146.36 141.05 26.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.9 mp -89.66 167.12 13.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.004 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.5 p -156.27 154.99 31.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.845 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.874 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -92.27 123.48 35.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 168.335 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.555 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.0 mp -109.94 131.56 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.177 -175.122 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -132.35 148.41 52.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 -173.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -91.06 113.97 26.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.909 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.11 -25.41 68.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -173.653 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -83.47 -22.15 32.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 -173.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 mp -81.23 -55.51 4.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.857 169.11 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.696 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -141.05 127.34 11.5 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.554 0.693 . . . . 0.0 110.888 173.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.18 -5.54 13.64 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.663 2.242 . . . . 0.0 112.365 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -149.27 102.43 3.32 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.621 0.725 . . . . 0.0 110.793 -175.037 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -72.01 156.92 55.49 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.769 2.312 . . . . 0.0 112.321 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.14 144.84 82.98 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.737 2.291 . . . . 0.0 112.247 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.02 -17.97 44.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.977 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 56.8 p -135.06 159.51 41.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.21 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.519 ' HA ' HD13 ' A' ' 132' ' ' ILE . 64.7 m95 -70.76 -28.35 64.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.039 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.99 -22.78 67.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.807 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -82.34 -21.96 35.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.791 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.638 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -56.76 -48.73 96.76 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.67 0.747 . . . . 0.0 111.2 -173.6 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 41.8 Cg_endo -69.07 -37.41 10.87 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.669 2.246 . . . . 0.0 112.332 -174.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.89 -60.74 2.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.081 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.272 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.23 -16.95 64.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -175.99 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.504 ' N ' HD13 ' A' ' 135' ' ' LEU . 34.5 t70 -57.79 -40.4 79.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.039 0.447 . . . . 0.0 110.866 168.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.25 -30.66 69.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -70.97 -47.69 57.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.812 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.9 pp -84.91 -14.47 47.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.618 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.8 tttt -60.87 -34.01 73.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.968 174.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.73 -24.05 67.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.085 175.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -95.12 4.35 53.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.877 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.02 32.13 56.96 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -110.22 170.72 7.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.932 173.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.9 t -124.14 138.73 54.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 168.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -65.4 -43.69 89.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 -170.236 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -143.11 127.87 18.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 63.5 tpp -107.55 132.58 53.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -153.57 158.44 41.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -172.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -90.11 -51.08 5.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.851 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.064 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.6 tm? 48.04 32.36 2.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.03 -167.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -101.2 -6.16 24.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.866 175.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.36 155.02 80.72 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.638 0.732 . . . . 0.0 110.939 -174.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.06 -25.95 77.9 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.743 2.295 . . . . 0.0 112.391 177.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -72.26 -27.48 62.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -80.01 -38.88 31.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.848 170.507 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.405 HG23 HG11 ' A' ' 347' ' ' VAL . 22.5 m -63.15 -45.66 90.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.07 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.591 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 46.2 t-105 -54.95 -54.55 48.66 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.609 0.719 . . . . 0.0 110.931 -169.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 22.1 Cg_endo -63.99 -19.92 67.15 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.634 2.222 . . . . 0.0 112.38 -173.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.706 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.7 tm? -82.77 -45.87 13.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.858 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.532 HG22 ' HA3' ' A' ' 166' ' ' GLY . 85.3 mt -75.3 -44.77 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.143 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.11 -23.65 61.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 -173.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -59.59 -35.95 75.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.104 -170.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 58.9 p30 -102.51 8.39 39.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.94 2.01 12.81 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.501 170.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.532 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -77.34 65.49 3.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.498 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -88.23 134.57 33.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.865 0.364 . . . . 0.0 111.035 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.6 2.1 17.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.135 -174.271 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.442 ' HA ' HG12 ' A' ' 181' ' ' VAL . 44.3 p90 -159.45 154.74 25.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 -175.632 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -93.67 123.13 36.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.847 160.367 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -114.95 120.58 40.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.987 175.116 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -151.93 130.13 11.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -173.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.04 41.41 31.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.955 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.21 17.81 79.67 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.536 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.32 138.5 50.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.853 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -99.24 144.98 27.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -126.39 110.0 12.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.832 174.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.7 pt -77.48 -15.73 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.105 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.95 -9.52 33.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -121.78 84.17 2.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.833 172.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 169' ' ' PHE . 27.6 m -112.75 160.44 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 -172.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -104.53 19.06 43.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.516 -174.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.3 m -102.6 -20.65 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 0.0 111.098 -175.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -87.61 21.71 2.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.788 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -117.13 175.01 5.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.81 -24.95 67.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.076 -175.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.99 -40.61 97.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.491 -173.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.594 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.86 -37.77 88.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 111.055 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.562 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -61.14 -38.5 86.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 174.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.08 89.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.078 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.491 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -66.52 -47.74 67.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.5 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.717 HD11 ' HA ' ' A' ' 347' ' ' VAL . 20.3 tp -66.67 -34.72 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.954 0.406 . . . . 0.0 110.926 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.545 ' OG1' HG21 ' A' ' 357' ' ' VAL . 91.7 m -64.84 -42.64 94.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.11 177.516 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 91.5 t80 -68.06 -47.75 67.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.699 HD23 ' C ' ' A' ' 195' ' ' LEU . 5.3 tt -50.83 -50.66 56.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.91 -174.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 35.0 m -64.38 -22.7 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.111 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.3 m-20 -62.45 -33.95 75.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.918 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.462 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.6 OUTLIER -81.66 -39.86 23.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.966 -173.368 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.424 ' H ' HG13 ' A' ' 199' ' ' ILE . 1.7 pp -72.05 -29.77 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.15 171.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.93 -36.82 83.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 171.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -83.65 4.03 30.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.952 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 66.23 39.9 4.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.835 170.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -75.73 -17.87 59.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -143.01 154.93 44.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.892 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -94.39 154.56 17.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.01 -26.85 68.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.151 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -95.03 0.42 54.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 97.1 m -66.17 128.82 37.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.153 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.401 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 19.7 t0 -122.0 173.6 7.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 173.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -62.77 -40.96 98.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.6 p -68.28 -37.37 80.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.862 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.401 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 79.9 mt -65.03 -42.22 94.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.081 174.428 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.1 93.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.078 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.26 -41.92 89.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.04 90.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.076 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.85 -39.11 93.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.129 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -63.68 -39.64 94.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.914 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -61.27 -33.19 73.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.3 -13.93 48.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.867 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.16 25.15 41.32 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.483 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -85.45 -22.16 28.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.952 0.406 . . . . 0.0 110.893 -175.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.9 t -129.57 139.95 51.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.566 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -65.05 -54.23 33.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.05 -174.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.656 ' HB3' HD21 ' A' ' 115' ' ' LEU . 67.8 mtm -134.42 153.2 52.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 -170.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 68.8 p -139.37 161.64 36.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.185 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 44.9 mm -108.94 126.21 65.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -154.75 175.05 14.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 -171.579 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -85.93 -159.98 33.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.411 -174.35 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.26 -23.52 33.0 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.679 2.253 . . . . 0.0 112.391 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -75.92 -24.88 55.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 48.05 50.08 16.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.153 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -59.98 -20.49 57.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 70.0 m -48.78 -50.1 35.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.865 174.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -85.02 179.33 7.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -172.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.2 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.158 -176.607 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 87.5 t . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.85 0.357 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -90.95 132.02 36.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -127.29 147.65 50.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.846 176.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -129.6 156.81 21.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.489 170.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 316' ' ' ARG . 3.1 p -135.72 135.17 51.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.962 0.411 . . . . 0.0 111.086 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.6 t -154.62 150.95 28.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.2 m -61.04 164.75 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.17 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 2.5 mp -71.26 152.75 94.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.583 0.706 . . . . 0.0 110.95 -163.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.62 -176.44 3.22 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.28 . . . . 0.0 112.479 -171.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.2 m -86.02 143.84 27.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.196 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -129.85 111.78 12.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.957 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 54.99 36.84 27.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.53 0.78 84.05 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.462 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' GLN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 91.2 mm-40 -126.5 125.89 24.53 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 121.576 0.703 . . . . 0.0 110.862 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 77.3 Cg_exo -54.43 128.58 30.71 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.736 2.29 . . . . 0.0 112.338 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 82.4 p -84.32 0.41 49.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.024 0.44 . . . . 0.0 110.9 174.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -37.71 134.95 0.79 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.54 0.686 . . . . 0.0 110.825 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.452 ' HD3' HD13 ' A' ' 247' ' ' LEU . 30.3 Cg_endo -79.05 156.66 26.57 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.657 2.238 . . . . 0.0 112.385 -163.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 258' ' ' PHE . . . . . 0.552 ' HB2' ' SD ' ' A' ' 330' ' ' MET . 10.4 m-85 -75.46 167.19 22.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.885 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 42.6 t -114.49 132.77 62.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.181 -167.167 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.537 ' HA3' ' CD2' ' A' ' 64' ' ' HIS . . . -115.2 141.78 17.21 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.41 173.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 81.4 t -121.42 112.08 33.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.767 0.318 . . . . 0.0 111.122 -176.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -75.82 114.51 14.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -176.57 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.417 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . 19.1 m -131.62 154.11 49.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.777 -164.133 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.421 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -132.61 133.56 43.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.123 -176.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.01 171.24 16.3 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.459 -174.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.636 HG13 ' HB3' ' A' ' 277' ' ' LYS . 37.5 mm -113.31 124.99 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.246 -170.698 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -62.97 130.68 45.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 -176.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.479 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -59.26 -29.36 67.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.2 -177.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.03 -8.19 58.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.001 -172.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.4 t -67.39 123.56 86.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.58 0.705 . . . . 0.0 110.866 -172.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -69.71 -11.49 31.02 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.576 2.184 . . . . 0.0 112.408 168.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -103.92 14.1 31.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -51.82 -35.25 43.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 -167.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 274' ' ' GLU . . . . . 0.405 ' HA ' ' HE3' ' A' ' 277' ' ' LYS . 72.0 mm-40 -70.08 -49.4 51.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.006 -174.024 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.94 -30.33 39.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.901 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.83 -50.53 66.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.636 ' HB3' HG13 ' A' ' 266' ' ' ILE . 13.7 pttp -71.96 -34.07 68.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.915 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -63.39 -46.62 85.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 177.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -69.7 -36.33 75.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.884 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.437 ' HA ' HD22 ' A' ' 284' ' ' LEU . 5.9 tt -55.73 -51.32 67.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.922 -178.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -75.79 -26.35 57.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.816 -177.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -100.28 -13.25 18.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.78 -166.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.846 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 63.0 m-85 -120.15 -59.77 1.75 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.813 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 280' ' ' LEU . 1.6 mp -62.37 -34.23 76.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.951 -161.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.898 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.3 pp -124.77 37.52 4.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.475 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 66.7 p -118.59 160.6 21.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.176 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.569 ' HA ' HD11 ' A' ' 290' ' ' LEU . 42.2 p-10 -51.12 -28.51 10.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.778 -167.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -78.93 -45.0 21.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 175.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.846 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.27 -56.8 6.0 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.497 -169.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.59 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.5 -21.63 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.766 0.317 . . . . 0.0 110.976 -178.884 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.581 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.1 tt0 -69.34 -49.31 56.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 172.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.65 96.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.077 -172.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.754 HG23 ' HA3' ' A' ' 19' ' ' GLY . 1.5 p -79.78 -29.89 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.417 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 27.7 t30 -63.9 -29.79 70.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 174.262 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.58 -20.76 66.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.935 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -82.17 -39.96 22.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.917 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -161.89 138.37 6.09 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.424 0.631 . . . . 0.0 110.935 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -45.82 115.94 1.23 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.685 2.256 . . . . 0.0 112.448 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.417 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 49.4 mt -93.49 -12.15 30.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 98.33 -61.7 0.89 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.528 171.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.607 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -167.1 159.55 13.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.844 0.354 . . . . 0.0 111.141 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 19.3 m -124.95 159.85 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.212 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.81 -14.44 61.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 172.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.59 ' CD2' HD21 ' A' ' 290' ' ' LEU . 49.9 tp -83.74 121.01 26.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -172.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -59.4 -33.79 71.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.944 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.9 m -61.34 -47.53 85.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.775 -172.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.512 ' HB3' HG21 ' A' ' 302' ' ' VAL . 4.5 t80 -78.78 -32.69 46.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.933 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.27 -40.89 62.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.849 173.618 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -55.14 -40.19 70.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.877 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -78.12 -37.83 45.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 177.257 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.607 HD13 ' HA ' ' A' ' 301' ' ' ALA . 83.4 mt -63.68 -33.03 74.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.58 -20.26 59.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.05 -20.22 66.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -93.09 121.28 65.94 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.65 0.738 . . . . 0.0 110.899 168.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.97 -25.13 11.81 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 0.0 112.373 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.451 ' HA ' HG11 ' A' ' 244' ' ' VAL . 78.3 mtt85 -62.25 -29.87 70.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.935 -175.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.565 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.2 mp -75.3 -28.67 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.81 87.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.031 -171.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.26 -45.32 73.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.145 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 67.0 p -64.47 -29.61 70.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.151 -173.43 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 61.9 tpp -68.63 -35.66 77.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.791 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -65.03 -47.75 76.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -173.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 327' ' ' GLY . 8.2 p-10 -79.94 -24.78 40.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.39 -42.79 92.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.93 -38.84 86.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.925 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.47 -4.14 15.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.818 -166.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.87 -162.7 36.99 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.526 -166.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -150.31 147.11 27.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 -171.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 36.8 mm -59.85 123.14 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.115 -170.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 258' ' ' PHE . 74.4 mmm . . . . . 0 C--N 1.331 -0.222 0 CA-C-O 121.554 0.692 . . . . 0.0 110.917 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.949 0.404 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 80.8 mmm -75.43 -18.36 59.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.812 -171.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.4 m -58.4 -42.17 86.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.774 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.0 -39.45 63.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.519 ' O ' HG13 ' A' ' 343' ' ' VAL . 4.2 m-30 -67.3 -45.42 76.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -174.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.461 ' HA ' HG22 ' A' ' 343' ' ' VAL . 6.9 m0 -59.7 -37.32 78.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.955 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -63.6 -45.18 91.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.23 79.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.106 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 339' ' ' PHE . 18.4 m -73.49 -32.46 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -175.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.442 ' O ' HG22 ' A' ' 347' ' ' VAL . 5.1 tmt_? -66.05 -39.04 89.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 175.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.2 m -58.74 -36.96 75.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 173.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.85 91.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -174.043 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.717 ' HA ' HD11 ' A' ' 192' ' ' LEU . 8.5 m -73.01 -34.79 46.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.211 -175.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.457 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -64.22 -46.78 92.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.09 174.025 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -67.9 -37.18 81.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.815 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.86 -44.93 65.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.18 85.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.062 -176.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.6 p -77.7 -10.16 59.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.09 17.07 73.01 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.45 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.02 -31.12 50.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.74 0.305 . . . . 0.0 110.881 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 355' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 360' ' ' ALA . 77.8 mt-30 -139.98 155.07 47.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.901 176.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 57.2 p -78.81 166.04 22.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 169.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.545 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.8 t -56.12 -41.95 70.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.116 174.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -60.9 -48.13 83.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.854 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -69.58 -54.96 11.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.947 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 360' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 355' ' ' GLN . . . -68.61 -47.75 65.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.115 -172.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.594 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.5 tm? -65.46 -44.63 86.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.964 -174.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.45 -53.12 53.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.986 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -67.5 -45.89 74.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.54 85.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.565 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 78.4 mm-40 -76.02 -25.73 55.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.001 -176.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 53.5 m -62.39 -35.08 78.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.086 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -59.94 -30.23 68.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.893 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 71.4 mt -60.46 -37.6 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.088 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 60.9 p -94.56 -15.0 24.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.168 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 179.252 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.726 0.298 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.421 HG21 ' HD2' ' A' ' 271' ' ' PRO . 49.4 mt -100.47 141.26 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.144 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -139.13 144.86 38.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.8 133.74 37.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.79 10.6 64.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.46 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.2 tttt -163.78 130.79 3.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.91 176.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.615 ' CD2' HD11 ' A' ' 33' ' ' ILE . 1.4 pt? -141.58 151.89 43.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.974 -169.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.515 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 80.4 t -110.48 135.97 47.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.091 -176.327 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.656 HD11 HG13 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -120.03 134.08 64.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.159 176.626 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.784 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 72.4 m95 -103.75 128.05 51.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 163.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.441 HD12 ' HG ' ' A' ' 20' ' ' LEU . 13.8 tt -108.52 149.95 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.193 -165.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.67 153.16 13.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.795 -173.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.17 -22.45 29.22 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.509 -177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -72.42 -17.11 61.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.359 . . . . 0.0 110.924 -169.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -140.07 131.87 27.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 168.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.93 -71.96 1.23 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.544 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -109.08 -40.15 5.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -66.9 -52.44 43.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.866 -149.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.411 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -52.96 -51.61 44.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.425 -176.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.468 ' HB3' HG22 ' A' ' 37' ' ' VAL . 3.9 mt -54.98 -57.35 12.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.775 0.321 . . . . 0.0 110.919 173.139 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.85 -37.4 13.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 -176.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.56 -55.69 9.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.3 m -73.79 -35.27 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.187 -173.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.566 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -66.66 -46.67 73.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.482 176.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -53.42 -36.64 61.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 110.898 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -56.22 -42.8 77.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.904 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -64.0 -43.49 95.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.833 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 98.8 mt-10 -61.23 -37.64 83.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.944 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.77 -41.49 68.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.886 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -94.46 -46.96 6.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.944 -164.441 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.7 p -108.57 -7.87 15.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.111 -172.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.81 8.3 87.84 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.436 168.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.035 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.64 134.69 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.807 0.337 . . . . 0.0 111.168 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.1 mttt -73.34 135.69 44.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.959 -170.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.656 HG13 HD11 ' A' ' 9' ' ' ILE . 96.6 t -115.74 126.34 73.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.989 0.423 . . . . 0.0 111.075 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.555 ' O ' HD12 ' A' ' 9' ' ' ILE . 96.7 m -108.47 127.9 54.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.126 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 20' ' ' LEU . 94.2 t -103.1 130.07 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -119.38 152.01 37.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.835 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 64.9 t-80 -90.72 141.66 27.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.612 0.72 . . . . 0.0 110.902 -167.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.462 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 86.2 Cg_exo -55.11 -26.66 51.72 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.676 2.25 . . . . 0.0 112.386 -175.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -49.72 -55.72 12.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.96 -1.74 58.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.853 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 8.8 tt -46.9 -53.33 12.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.901 -175.516 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -67.81 -38.31 83.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.869 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.21 -42.21 89.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.843 -171.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -83.63 -21.56 32.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.523 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 62.1 t80 -47.11 -50.27 47.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.669 0.747 . . . . 0.0 110.832 -169.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 69.7 Cg_endo -79.89 -28.82 3.05 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.25 . . . . 0.0 112.347 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -73.86 -40.01 63.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -172.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.435 HG11 ' HD3' ' A' ' 57' ' ' PRO . 33.7 m -67.91 -28.12 40.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.197 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.664 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -70.38 -38.06 74.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.055 175.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.57 -33.86 75.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.164 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 p -90.11 -15.97 30.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.224 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.44 9.15 77.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.395 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -139.96 132.25 28.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 110.815 177.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.02 -114.95 0.52 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.51 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.784 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 61.2 Cg_endo -74.75 149.06 37.39 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.677 2.251 . . . . 0.0 112.282 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -86.97 -32.89 19.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 158.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.595 ' HB ' HG23 ' A' ' 9' ' ' ILE . 40.7 mt -128.19 137.77 56.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.116 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 tp -131.78 126.1 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -89.79 139.65 30.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 169.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.514 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 35.6 p90 -142.61 165.04 28.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.966 171.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.9 -88.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.034 -163.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.484 ' NE2' ' HA3' ' A' ' 260' ' ' GLY . 27.4 m170 -111.65 -75.72 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.861 -174.671 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -103.69 -3.89 24.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 -161.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -56.52 -16.89 6.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 -169.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.502 ' HB2' HD13 ' A' ' 104' ' ' ILE . 37.6 p90 -57.42 -28.52 63.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -177.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.41 -50.6 63.55 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.493 -173.347 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.12 -38.06 94.86 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.56 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 1.6 t80 -57.22 -48.22 79.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 0.0 110.93 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.37 -43.79 31.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.053 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -56.58 -38.85 72.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.9 -175.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.412 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 60.3 m -83.72 -6.75 59.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.878 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.46 30.52 60.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.452 173.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.664 HD22 ' HB1' ' A' ' 51' ' ' ALA . 52.8 mt -88.01 -9.74 52.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.905 0.384 . . . . 0.0 110.914 -167.472 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.486 ' HA ' ' H ' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -130.15 153.16 48.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -172.891 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.83 144.93 31.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.081 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.28 139.22 54.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 175.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.6 pt -105.05 153.92 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.067 -173.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.5 m -108.66 125.15 32.39 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.577 0.704 . . . . 0.0 111.104 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.65 156.0 53.89 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.631 2.22 . . . . 0.0 112.328 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -105.96 122.51 46.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 175.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.23 -35.02 48.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.807 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.05 -37.92 89.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.098 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -88.29 -25.47 22.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.4 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 66.5 tt0 -54.9 -45.27 74.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -68.11 -23.81 64.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.831 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.55 -19.63 22.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.976 -167.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.597 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -99.67 -32.44 11.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.956 -168.839 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.597 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 11.7 m-30 92.42 144.45 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.638 0.733 . . . . 0.0 110.947 175.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.32 -40.0 87.58 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 0.0 112.406 -174.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -71.34 -23.17 61.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.949 -171.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.4 p -80.17 -37.67 32.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.231 173.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.525 ' HA ' HG22 ' A' ' 97' ' ' VAL . 55.7 m95 -65.03 -29.21 70.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.996 171.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -71.13 -34.62 71.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 177.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.14 -24.77 63.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.566 HG23 HD22 ' A' ' 103' ' ' LEU . 18.4 m -106.96 15.64 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.164 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -101.34 131.62 47.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -130.94 116.03 17.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 174.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 t30 58.65 35.95 24.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.77 0.26 89.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.511 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -118.17 148.07 42.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 110.818 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.566 HD22 HG23 ' A' ' 97' ' ' VAL . 32.6 mt -88.74 134.42 33.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.502 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -125.81 3.42 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.033 -169.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.514 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -163.7 162.71 24.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.184 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.497 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 94.0 m-85 -111.12 138.13 21.14 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.563 0.697 . . . . 0.0 110.941 173.176 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 15.1 Cg_exo -68.09 121.35 8.34 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.654 2.236 . . . . 0.0 112.362 170.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.044 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp -104.72 -40.02 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 173.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -145.72 154.86 42.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.064 -167.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.7 t -114.95 125.57 72.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.177 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -104.02 124.48 49.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.949 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.541 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -149.07 141.41 24.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.147 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.8 mp -90.91 168.65 11.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.7 p -156.67 154.74 30.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.864 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -93.68 124.45 37.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 168.441 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.549 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.1 mp -110.15 131.46 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.067 -175.726 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -131.31 145.28 51.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -94.49 114.37 26.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.825 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.426 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.7 mttt -66.03 -19.42 65.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.847 -173.354 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -84.67 -25.35 28.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.831 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.0 mp -82.17 -52.55 6.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.549 ' H ' HD23 ' A' ' 122' ' ' LEU . 2.0 pt? -140.03 128.55 13.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.621 0.724 . . . . 0.0 110.878 173.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -77.8 -11.97 16.59 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.709 2.272 . . . . 0.0 112.349 -173.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -144.46 102.84 4.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.6 0.714 . . . . 0.0 110.895 -175.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -71.27 153.84 61.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.618 2.212 . . . . 0.0 112.364 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.07 143.02 70.31 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.654 2.236 . . . . 0.0 112.314 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.0 -18.73 42.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.8 p -135.05 159.66 40.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.178 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.419 ' HA ' HD13 ' A' ' 132' ' ' ILE . 79.9 m95 -69.77 -28.14 65.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.994 177.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.68 -22.32 66.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.817 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -82.26 -24.63 34.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.869 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.475 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -57.15 -46.95 99.8 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.564 0.697 . . . . 0.0 111.243 -171.073 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 84.0 Cg_exo -51.92 -49.25 17.91 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.613 2.209 . . . . 0.0 112.457 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.76 -59.08 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 -174.269 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.131 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -70.09 -16.15 63.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -172.02 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.528 ' N ' HD13 ' A' ' 135' ' ' LEU . 32.2 t70 -61.32 -38.61 87.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.879 168.504 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.76 -30.5 71.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.05 -48.01 47.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -177.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.645 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.4 pp -84.96 -13.24 51.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.645 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.2 tttt -57.99 -34.46 70.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 170.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.48 -24.83 67.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.078 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -94.97 3.67 54.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.912 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.27 30.74 56.52 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.439 177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -109.68 171.19 7.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.914 0.387 . . . . 0.0 110.824 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.6 t -124.49 140.13 53.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 168.366 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -68.09 -43.47 78.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.09 -170.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -143.21 127.36 17.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 57.5 ttm -110.49 132.75 53.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -152.9 158.27 41.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.896 -173.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -84.87 -59.15 2.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.972 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.143 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.1 tm? 48.27 30.49 2.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 -163.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -103.06 -6.8 21.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.99 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.7 152.36 79.64 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.656 0.741 . . . . 0.0 110.921 -175.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.446 ' HB3' ' HB3' ' A' ' 340' ' ' TRP . 53.9 Cg_exo -56.48 -32.21 88.61 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.694 2.262 . . . . 0.0 112.317 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -70.6 -27.47 64.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -79.67 -41.18 27.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.823 171.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.455 HG23 HG11 ' A' ' 347' ' ' VAL . 15.7 m -61.64 -49.58 75.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.121 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.567 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 17.4 t-105 -59.56 -48.65 95.1 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.471 0.653 . . . . 0.0 110.903 -161.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.567 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 94.5 Cg_exo -51.26 -44.78 40.96 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.812 2.341 . . . . 0.0 112.329 -176.6 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 160' ' ' LEU . 6.7 tt -72.16 -39.33 68.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -171.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.43 -41.59 73.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.149 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.15 -23.91 59.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.068 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.47 -35.24 71.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.188 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -103.58 10.05 37.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.973 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.88 4.7 22.62 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 169.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.38 67.87 3.02 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.46 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -89.86 133.15 34.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.858 0.361 . . . . 0.0 110.978 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.45 10.18 7.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.08 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -152.21 154.48 35.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -99.75 123.37 43.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 157.042 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -112.42 121.76 45.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.959 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -152.64 130.07 11.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -174.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 54.89 43.67 29.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 174.373 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.14 16.77 78.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.572 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.86 138.73 49.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.773 0.321 . . . . 0.0 110.862 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.87 144.25 27.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 170.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -125.51 112.42 16.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.562 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.2 pp -79.53 -12.02 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -177.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.96 -12.08 22.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -119.43 87.85 2.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.866 169.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.7 m -115.88 161.08 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -171.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.02 25.47 25.17 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.464 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.482 HG21 HD12 ' A' ' 368' ' ' ILE . 3.4 m -109.44 -19.01 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.838 0.351 . . . . 0.0 111.032 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -87.29 19.88 3.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -177.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -122.19 -170.06 2.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.019 -178.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.36 -29.55 70.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 -172.541 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.64 -42.99 95.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.529 -167.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.6 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.99 -37.23 86.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.988 0.423 . . . . 0.0 111.107 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.555 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -62.3 -38.25 88.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.825 175.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.9 -37.99 89.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.138 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.09 -46.3 81.44 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.521 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.701 HD11 ' HA ' ' A' ' 347' ' ' VAL . 19.7 tp -68.63 -34.23 75.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.87 0.367 . . . . 0.0 110.826 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.482 ' OG1' HG21 ' A' ' 357' ' ' VAL . 90.7 m -64.3 -42.77 96.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.197 176.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 74.8 t80 -68.43 -47.0 68.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.841 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.616 HD11 HD21 ' A' ' 151' ' ' LEU . 7.3 tt -50.45 -51.47 46.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 -174.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.95 -23.06 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.126 -174.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.3 m-20 -62.14 -33.39 74.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.946 -177.496 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.442 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.8 OUTLIER -81.49 -39.99 23.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.847 -173.883 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.414 ' H ' HG13 ' A' ' 199' ' ' ILE . 1.8 pp -73.53 -28.81 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.175 171.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.54 -37.61 80.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -79.22 -0.32 31.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 65.3 40.72 4.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 169.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -76.06 -16.11 59.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.782 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -144.71 157.99 43.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.873 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -95.44 152.01 18.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.871 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.02 -26.26 68.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -94.96 1.79 55.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.7 m -66.31 128.34 35.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -121.57 171.38 8.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -66.05 -36.85 84.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.029 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 97.2 p -68.76 -37.33 79.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.852 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.03 -41.0 90.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.052 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.99 -38.29 90.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.004 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -65.26 -43.52 91.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.927 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.37 95.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.132 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.66 -41.59 98.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.203 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -64.07 -39.56 94.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.939 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -63.97 -33.63 76.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.895 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -85.08 -17.38 37.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.969 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.66 24.44 46.13 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.545 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.39 -22.45 28.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 110.895 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.8 t -128.3 137.42 51.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.187 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.478 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -64.07 -52.14 60.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.128 -175.39 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.557 ' HB3' HD21 ' A' ' 115' ' ' LEU . 61.8 mtm -135.82 155.1 50.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.765 -172.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 65.3 p -139.64 162.21 35.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.239 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.7 mm -110.41 126.92 67.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.136 174.494 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -153.0 174.68 13.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.913 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -87.14 -156.27 29.25 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.471 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.3 -21.94 26.02 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.645 2.23 . . . . 0.0 112.341 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' TRP . . . . . 0.643 ' HD1' ' O ' ' A' ' 230' ' ' TRP . 4.9 t90 -67.37 -30.01 69.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 48.74 44.96 21.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -65.07 -20.82 66.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -173.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 67.6 m -47.75 -41.1 22.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.913 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 49.8 p30 -85.02 -178.86 6.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.881 -171.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 77.7 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.228 -168.364 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.84 0.353 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -104.28 128.73 52.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 -176.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.426 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 37.8 p90 -148.13 154.25 39.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.27 160.73 24.79 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.444 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' A' ' 316' ' ' ARG . 2.8 p -134.52 135.13 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.967 0.413 . . . . 0.0 111.099 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.3 t -154.13 149.88 27.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.136 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.5 m -60.54 165.57 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.09 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 1.4 mp -66.16 152.29 94.23 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.521 0.676 . . . . 0.0 111.047 -164.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -75.78 -176.41 2.99 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.747 2.298 . . . . 0.0 112.358 -173.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 94.9 m -86.9 145.43 26.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.07 -171.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -130.99 111.4 12.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 54.85 35.3 23.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.927 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.94 2.62 80.86 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -126.59 126.2 24.52 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.566 0.698 . . . . 0.0 110.844 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.01 134.98 66.74 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.654 2.236 . . . . 0.0 112.306 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 256' ' ' LYS . 73.1 m -82.52 -1.48 50.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.046 0.451 . . . . 0.0 110.844 174.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 255' ' ' SER . 90.9 mttt -37.28 130.0 0.8 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.605 0.717 . . . . 0.0 110.881 -178.113 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -78.16 163.17 28.13 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.632 2.221 . . . . 0.0 112.333 -163.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -74.52 163.97 27.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.842 -175.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 47.7 t -111.45 127.49 68.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.181 -168.806 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.484 ' HA3' ' NE2' ' A' ' 64' ' ' HIS . . . -112.85 141.49 16.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.426 174.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 89.2 t -124.7 116.98 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.746 0.308 . . . . 0.0 111.183 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.33 119.97 11.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.881 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.7 m -126.18 131.1 52.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.785 -167.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.58 139.07 51.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.093 -175.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.67 170.13 21.21 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.432 -169.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.696 HG13 ' HG2' ' A' ' 277' ' ' LYS . 24.7 mm -111.23 125.03 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 -174.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -63.14 130.79 46.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.486 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -58.17 -28.56 64.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.123 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.17 -7.0 58.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.019 -173.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 22.3 t -67.31 119.04 62.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.649 0.738 . . . . 0.0 110.915 -172.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.421 ' HD2' HG21 ' A' ' 2' ' ' ILE . 83.8 Cg_endo -71.26 -10.47 27.23 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.587 2.192 . . . . 0.0 112.327 168.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -103.4 12.88 34.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.824 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -49.33 -35.89 19.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -167.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -68.49 -47.52 66.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.969 -171.75 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.3 pp -81.47 -27.47 34.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.24 -46.89 75.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.054 173.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.696 ' HG2' HG13 ' A' ' 266' ' ' ILE . 50.3 mtmt -58.08 -41.73 84.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.902 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 95.6 mt-10 -69.87 -40.66 75.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.898 -177.238 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 15.9 m-30 -67.63 -39.5 84.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.529 ' HA ' HD22 ' A' ' 284' ' ' LEU . 4.0 tt -65.29 -53.26 46.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.977 -172.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.431 ' HA ' HD21 ' A' ' 285' ' ' LEU . 40.3 tt0 -75.19 -35.6 61.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -175.646 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 82.8 m-20 -103.57 -12.77 16.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.846 -160.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.644 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 62.3 m-85 -128.55 -48.6 1.28 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -177.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.529 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.7 OUTLIER -64.39 -36.56 84.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.98 -174.061 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 1.044 ' HB3' HG13 ' A' ' 108' ' ' ILE . 2.4 pp -124.71 38.27 4.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -175.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.455 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 6.6 t -114.25 163.65 14.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 286' ' ' THR . 16.4 p-10 -40.15 -43.88 1.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -175.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -74.85 -41.42 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.893 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.644 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.75 -53.9 7.84 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.516 -169.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.553 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -72.63 -20.1 61.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.725 0.298 . . . . 0.0 110.9 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.503 ' N ' HD12 ' A' ' 290' ' ' LEU . 86.5 tt0 -67.16 -45.56 76.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.813 169.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.93 -38.77 92.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.071 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.411 HG13 ' HA3' ' A' ' 19' ' ' GLY . 59.9 t -75.18 -46.8 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.116 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -64.97 -28.89 69.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.62 -25.95 68.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.826 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -82.23 -48.14 11.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.935 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.404 ' O ' HD13 ' A' ' 299' ' ' LEU . 85.7 tttt -151.03 138.94 12.49 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.511 0.672 . . . . 0.0 110.942 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -50.66 116.76 2.76 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.769 2.312 . . . . 0.0 112.363 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 299' ' ' LEU . 0.2 OUTLIER -85.98 -19.99 29.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.005 174.275 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 98.49 -57.7 0.99 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.442 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.608 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -168.19 155.33 7.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.787 0.327 . . . . 0.0 111.165 175.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.805 HG21 ' HB3' ' A' ' 307' ' ' TYR . 18.4 m -115.89 154.58 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.03 -15.62 61.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.103 173.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.553 ' CD2' HD21 ' A' ' 290' ' ' LEU . 39.9 tp -80.92 121.93 26.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.936 -174.116 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -53.91 -41.88 68.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.935 -177.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 48.3 t -62.99 -49.98 72.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -169.169 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.805 ' HB3' HG21 ' A' ' 302' ' ' VAL . 10.9 t80 -76.5 -30.71 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.987 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -60.73 -40.67 93.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 176.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.33 -36.94 76.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.65 -39.33 57.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 176.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.608 HD13 ' HA ' ' A' ' 301' ' ' ALA . 76.7 mt -61.19 -34.57 75.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.11 -19.12 61.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 -176.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -64.89 -21.12 66.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.005 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -93.17 121.86 64.57 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.663 0.744 . . . . 0.0 110.916 167.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.29 -25.41 9.84 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.776 2.318 . . . . 0.0 112.35 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' ARG . . . . . 0.405 ' HA ' HG11 ' A' ' 244' ' ' VAL . 82.7 mtt85 -60.91 -33.38 73.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -176.188 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.586 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.1 mp -81.19 -26.98 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.088 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.83 -40.41 79.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.07 -172.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.9 81.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.088 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 58.1 p -64.18 -29.55 70.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 -173.547 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.6 mtp -67.92 -34.87 77.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -65.64 -47.07 76.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.842 -172.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.404 ' O ' ' N ' ' A' ' 327' ' ' GLY . 8.7 p-10 -80.0 -25.69 40.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.797 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.44 -49.18 74.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.103 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -70.72 -37.18 73.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.89 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -105.44 -7.55 18.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 -168.107 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -90.94 -159.92 36.09 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.481 -172.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -139.9 147.78 41.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.776 0.322 . . . . 0.0 111.03 -175.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 40.7 mm -64.74 123.2 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.136 -171.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 50.2 tpp . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.565 0.697 . . . . 0.0 110.898 -178.786 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.741 0.305 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 73.9 mmm -80.07 -17.5 52.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -172.299 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.6 m -61.94 -40.97 97.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.825 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.62 -37.05 60.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.549 ' O ' HG13 ' A' ' 343' ' ' VAL . 3.6 m-30 -65.12 -41.27 95.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.812 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 154' ' ' PRO . 12.2 m0 -60.03 -35.66 75.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 176.06 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -68.06 -41.85 81.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.25 -44.1 84.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.004 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 339' ' ' PHE . 16.9 m -74.07 -31.03 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 -176.094 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 347' ' ' VAL . 4.9 tmt_? -65.6 -39.65 91.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 175.027 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 87.4 m -58.72 -35.39 72.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 174.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.78 -43.63 95.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 -175.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.701 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.0 m -74.17 -34.13 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.169 -174.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.439 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -63.34 -47.1 93.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 174.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -64.85 -39.51 93.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.26 -44.42 62.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.114 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.33 -39.9 77.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.086 -175.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.2 p -75.69 -11.09 59.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.838 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.21 16.56 74.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.463 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.21 -32.45 44.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.318 . . . . 0.0 110.883 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -138.78 155.35 48.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.1 p -76.74 171.43 14.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 170.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.482 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.1 t -57.51 -43.22 82.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.124 171.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -61.44 -45.71 93.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.863 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -69.64 -52.41 26.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -72.3 -48.25 43.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.121 -173.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.6 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.4 tm? -65.59 -45.02 84.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -173.378 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.82 -53.57 48.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.965 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -68.09 -46.03 72.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -173.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.71 -42.31 91.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 -174.981 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 79.0 mm-40 -76.81 -27.93 55.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.97 -176.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 53.3 m -61.73 -34.99 76.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.225 171.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -58.77 -30.09 67.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.482 HD12 HG21 ' A' ' 183' ' ' VAL . 70.3 mt -60.85 -38.14 78.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.151 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.0 p -94.64 -14.98 24.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.154 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.831 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.773 0.32 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ILE . . . . . 0.431 HG21 ' HD2' ' A' ' 271' ' ' PRO . 74.8 mt -100.46 131.81 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 177.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -148.15 139.81 23.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -51.93 136.47 28.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.792 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.74 2.69 62.88 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.529 -173.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 64.3 pttt -165.03 146.96 7.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 0.0 110.954 171.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.543 HD22 HD11 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -147.68 160.01 43.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -177.231 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.409 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 71.2 t -111.98 134.05 55.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.081 -177.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.729 HG23 ' HB ' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -120.02 131.56 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.082 179.094 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.716 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 65.2 m95 -107.51 128.25 54.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.952 168.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.452 ' HB ' HD22 ' A' ' 20' ' ' LEU . 7.2 tt -109.59 149.86 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.076 -166.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -58.1 155.35 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -173.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.35 -22.76 24.06 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.378 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -73.78 -14.12 61.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.877 0.37 . . . . 0.0 110.906 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HD2' ' HD3' ' A' ' 297' ' ' LYS . 24.0 mmmt -134.3 137.25 44.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.924 171.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.02 -85.08 0.98 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.466 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -110.04 -44.91 3.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.904 0.383 . . . . 0.0 110.92 -176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -68.16 -51.87 40.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 -148.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 1.008 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -57.74 -49.82 70.83 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.516 -176.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.596 HD21 ' HB ' ' A' ' 9' ' ' ILE . 55.1 tp -57.24 -41.94 80.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.827 0.346 . . . . 0.0 110.914 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.82 -38.61 67.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.071 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 67.2 mm-40 -70.57 -50.4 37.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.807 -176.381 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 20' ' ' LEU . 17.7 m -72.53 -36.54 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.185 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.407 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -64.34 -49.34 66.33 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.494 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 57.7 pttt -59.47 -24.71 63.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.924 0.392 . . . . 0.0 110.956 -175.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -59.88 -37.11 78.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 1.2 m-30 -56.75 -47.73 79.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.472 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 88.7 mt-10 -66.6 -35.96 81.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.981 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.53 -35.49 73.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.85 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -94.8 -50.04 5.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.811 -170.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.2 p -115.86 -1.08 12.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 -169.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.41 9.92 84.48 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.421 167.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.858 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -99.36 132.93 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 111.159 -177.783 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.8 mttt -74.21 140.36 45.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 -171.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.542 ' HB ' HD11 ' A' ' 9' ' ' ILE . 2.9 m -116.72 134.34 60.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.113 177.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.514 ' O ' HD12 ' A' ' 9' ' ' ILE . 99.6 m -103.94 127.8 51.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 176.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.59 HG13 HD23 ' A' ' 20' ' ' LEU . 54.8 t -93.07 126.66 45.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.201 175.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -119.93 145.74 46.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.974 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -88.95 141.14 29.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.528 0.68 . . . . 0.0 110.929 -168.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.439 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 85.2 Cg_exo -56.62 -26.29 64.0 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.736 2.291 . . . . 0.0 112.251 -174.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -47.34 -51.28 19.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 -171.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.84 -8.92 55.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 9.8 tt -47.85 -55.26 10.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 -170.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -64.76 -35.83 82.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.36 -39.52 92.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 50' ' ' VAL . 75.1 mmtt -80.44 -23.84 39.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.57 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 83.9 t80 -50.87 -50.26 75.25 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.665 0.745 . . . . 0.0 110.807 -160.637 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 44.4 Cg_endo -82.72 -32.32 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.685 2.256 . . . . 0.0 112.306 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -75.89 -46.41 30.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 -165.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.508 HG21 ' HG3' ' A' ' 57' ' ' PRO . 21.0 m -72.36 -27.16 25.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.04 -171.702 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.714 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -70.28 -35.78 73.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.098 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.11 -33.2 74.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.124 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.9 p -90.58 -20.25 22.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.2 8.35 69.73 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.542 172.788 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -118.35 116.84 27.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.35 . . . . 0.0 110.87 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.94 -92.75 0.13 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.502 171.075 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.716 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 71.2 Cg_endo -79.42 146.79 19.7 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.68 2.254 . . . . 0.0 112.362 -177.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -97.53 -35.06 10.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.777 163.27 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.729 ' HB ' HG23 ' A' ' 9' ' ' ILE . 35.4 mt -124.79 137.37 57.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.106 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.3 tp -132.77 125.22 52.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -88.34 140.11 29.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.731 168.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.463 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 21.9 p90 -142.85 163.39 32.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.979 171.145 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.83 -90.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 -164.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.669 ' CE1' ' HA3' ' A' ' 260' ' ' GLY . 23.2 m170 -130.56 -64.63 0.83 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 -173.058 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -95.13 -13.92 24.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -167.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.78 -14.49 14.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.997 -165.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.556 ' HB2' HD13 ' A' ' 104' ' ' ILE . 30.5 p90 -57.42 -32.43 66.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.875 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.77 -51.21 60.05 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.492 -170.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.59 -36.96 92.15 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.576 175.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.689 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 13.6 t80 -66.56 -41.94 87.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 -176.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.85 -40.98 68.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.169 174.419 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -57.58 -37.54 73.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.9 m -85.47 -4.98 59.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.982 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.32 30.07 59.21 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.492 174.292 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.714 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 58.9 mt -87.17 -10.07 53.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.919 0.39 . . . . 0.0 110.929 -167.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.689 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -130.95 153.77 48.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.924 -176.808 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -81.4 142.12 33.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 174.462 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.81 142.3 49.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.433 HD12 ' CZ ' ' A' ' 106' ' ' TYR . 36.9 pt -106.52 155.41 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 -177.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.6 m -96.1 130.57 30.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.666 0.746 . . . . 0.0 111.064 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.36 142.31 65.6 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.673 2.248 . . . . 0.0 112.326 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -113.92 114.78 26.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.21 -36.02 60.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.78 -43.47 98.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.021 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -74.54 -32.98 62.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.875 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.478 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 85.6 mt-30 -54.94 -51.49 65.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -57.6 -34.71 69.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.781 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.27 -24.53 57.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 -175.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.97 -104.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 -170.573 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 33.9 t80 172.66 128.84 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.739 0.781 . . . . 0.0 110.903 -169.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -52.31 -36.26 67.5 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.345 -173.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -65.14 -35.19 80.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 -173.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.3 p -73.47 -29.7 62.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.169 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.625 ' HA ' HG22 ' A' ' 97' ' ' VAL . 92.5 m95 -67.88 -30.55 69.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.972 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -69.25 -30.17 68.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.943 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.14 -26.04 62.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.038 175.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.625 HG22 ' HA ' ' A' ' 94' ' ' TRP . 16.3 m -109.96 20.7 5.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.14 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -113.8 132.52 55.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -132.1 119.45 20.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.5 t30 58.4 35.29 24.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.918 176.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.21 -0.41 89.74 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.449 175.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.25 149.42 42.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 0.0 110.861 175.589 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.596 HD22 HG23 ' A' ' 97' ' ' VAL . 18.4 mt -84.03 136.0 34.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.556 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -123.11 -2.3 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.051 -175.053 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.463 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -161.15 164.45 30.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.12 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.433 ' CZ ' HD12 ' A' ' 79' ' ' ILE . 89.9 m-85 -112.27 143.26 28.49 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.626 0.727 . . . . 0.0 110.948 170.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.33 121.42 5.24 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.669 2.246 . . . . 0.0 112.336 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.926 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -104.25 -36.72 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.177 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -146.0 153.12 40.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 -170.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.3 t -117.96 130.42 72.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.5 mp0 -110.64 131.98 54.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.806 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -153.09 144.66 23.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.119 177.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.6 mp -89.0 160.25 17.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.972 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.9 p -151.49 152.44 33.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.86 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.869 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -93.76 128.88 40.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 171.043 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.626 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.7 mp -111.39 132.04 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.236 -174.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -131.81 146.97 52.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.988 0.423 . . . . 0.0 110.86 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -91.88 117.4 29.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.893 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.91 -25.92 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.964 -172.571 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -84.68 -20.82 30.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 -172.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.9 mp -80.08 -54.03 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 169.63 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.747 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.3 pt? -140.32 127.23 12.23 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.564 0.697 . . . . 0.0 110.921 173.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.42 -7.06 14.87 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.665 2.244 . . . . 0.0 112.348 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.426 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 56.3 t-20 -147.22 95.27 4.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.725 0.774 . . . . 0.0 110.839 -176.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 58.6 Cg_endo -68.23 155.68 68.48 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.64 2.227 . . . . 0.0 112.376 177.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.52 143.67 76.4 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.64 2.226 . . . . 0.0 112.423 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -86.72 -15.76 38.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 80.6 p -133.68 156.75 47.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.409 ' HA ' HD13 ' A' ' 132' ' ' ILE . 74.1 m95 -70.77 -27.98 64.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.982 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.21 -19.58 65.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.843 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -80.3 -25.53 39.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.488 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -57.56 -46.27 99.79 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.567 0.698 . . . . 0.0 111.184 -169.249 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 86.4 Cg_exo -52.93 -50.74 13.02 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.712 2.274 . . . . 0.0 112.385 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.95 -59.49 4.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.158 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.41 -16.24 63.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -172.711 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.576 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.7 t70 -61.88 -41.69 98.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 167.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.66 -30.59 69.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.923 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.1 -46.86 60.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.84 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.1 pp -85.08 -14.32 47.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.965 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.612 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.6 tttt -60.98 -33.99 74.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.95 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.32 -24.03 67.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.993 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -94.98 4.3 53.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.942 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.03 31.98 57.11 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.572 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -110.24 170.14 8.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 0.0 110.885 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.7 t -121.04 140.94 51.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.827 168.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -67.67 -40.6 84.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.144 -174.647 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.406 HD22 ' H ' ' A' ' 148' ' ' MET . 2.1 tm? -140.78 133.48 28.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.958 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.406 ' H ' HD22 ' A' ' 147' ' ' LEU . 53.2 ttm -119.22 131.35 55.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.844 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -153.99 155.64 35.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 -174.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -86.27 -53.37 5.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -177.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.987 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.3 tm? 48.01 32.81 3.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.909 -169.085 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -100.24 -7.15 24.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.887 175.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.65 154.92 80.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.68 0.753 . . . . 0.0 110.922 -172.29 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -59.94 -25.07 78.48 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.673 2.248 . . . . 0.0 112.38 173.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -71.62 -29.41 64.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.84 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -81.43 -39.79 24.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 171.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.411 HG23 HG11 ' A' ' 347' ' ' VAL . 22.1 m -60.35 -48.34 82.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.585 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 40.5 t-105 -57.07 -54.42 54.78 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.444 0.64 . . . . 0.0 110.81 -168.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 24.3 Cg_endo -63.99 -20.04 67.31 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.544 2.163 . . . . 0.0 112.388 -174.113 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.774 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.7 tm? -81.6 -44.92 16.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.507 HG22 ' HA3' ' A' ' 166' ' ' GLY . 79.2 mt -74.98 -43.78 45.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.84 -24.7 66.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.972 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -58.26 -30.87 66.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.56 3.59 42.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 104.63 8.32 37.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.547 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.507 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -75.7 67.41 2.3 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.435 177.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -80.5 132.2 35.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.772 0.32 . . . . 0.0 110.939 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.86 6.36 11.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.127 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.452 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.2 p90 -154.0 155.81 36.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.906 -175.601 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -99.99 127.4 46.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.915 156.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -114.19 120.6 41.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -153.26 130.03 10.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -171.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 54.97 42.2 31.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.19 16.09 78.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.526 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.97 139.95 50.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.698 0.285 . . . . 0.0 110.93 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -96.47 144.94 26.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.923 170.72 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -128.06 111.97 14.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.885 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.562 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.2 pp -80.06 -11.38 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -96.9 -10.16 27.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -125.51 85.97 2.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 169' ' ' PHE . 31.1 m -113.97 164.79 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.056 -170.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.8 25.55 22.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.562 -173.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.439 HG21 HD12 ' A' ' 368' ' ' ILE . 2.1 m -106.53 -19.99 6.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.904 0.383 . . . . 0.0 111.156 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -87.39 21.79 2.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.799 -176.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -109.31 -176.32 2.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.927 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.52 -28.34 66.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.071 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.53 -40.08 78.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.492 -169.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.514 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -59.88 -40.08 87.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 111.11 175.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.574 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.2 mttt -62.23 -39.04 91.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.979 175.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.0 86.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.196 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.438 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -67.15 -46.02 76.02 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.516 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.736 HD11 ' HA ' ' A' ' 347' ' ' VAL . 22.8 tp -66.62 -35.5 80.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 110.821 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.55 ' OG1' HG21 ' A' ' 357' ' ' VAL . 94.3 m -65.07 -41.48 95.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 176.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 51.8 t80 -66.03 -49.68 66.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 177.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.701 HD23 ' C ' ' A' ' 195' ' ' LEU . 5.4 tt -50.72 -51.11 52.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.884 -174.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 199' ' ' ILE . 31.2 m -64.25 -22.47 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.177 -174.131 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.2 m-20 -62.27 -33.53 74.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 0.43 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.9 OUTLIER -80.69 -40.09 26.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -174.556 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.548 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.8 pp -73.7 -28.67 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.234 172.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -68.57 -37.63 80.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -80.63 2.79 24.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 68.0 38.51 2.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 169.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -78.28 -17.04 57.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.548 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.2 ppp? -145.3 157.18 44.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.934 174.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -94.63 150.65 20.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.4 -26.22 67.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -96.59 1.52 51.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.936 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 94.1 m -64.0 125.05 23.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.07 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.425 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 17.3 t0 -120.45 174.98 6.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.905 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -62.82 -40.41 97.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.999 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 98.6 p -67.58 -38.05 83.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.823 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.425 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 76.6 mt -65.05 -42.32 94.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.14 174.348 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.47 -35.6 80.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.107 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.27 -48.1 82.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.49 -42.36 95.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.111 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.05 -49.03 71.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.2 -43.39 98.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.911 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -63.18 -29.61 70.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.861 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -85.92 -16.74 37.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.24 25.04 29.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.431 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -83.28 -21.28 33.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 110.916 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.8 t -126.16 136.37 52.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.25 178.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.594 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -62.18 -48.8 78.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.024 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.586 ' HB3' HD21 ' A' ' 115' ' ' LEU . 66.9 mtm -135.0 160.06 39.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 -173.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.0 t -150.44 157.34 42.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.183 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 mm -111.58 129.42 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 -176.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -155.42 173.71 16.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -83.73 -153.37 15.64 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.395 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.11 -26.4 36.69 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.736 2.29 . . . . 0.0 112.328 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -76.01 -29.18 58.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 43.79 44.96 5.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.169 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 32.1 m0 -66.11 -20.63 66.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 63.6 m -71.22 -18.1 62.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -81.2 -175.37 5.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -174.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 87.9 mt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 176.561 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 97.9 t . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.892 0.377 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -77.77 140.98 39.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.33 149.93 38.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.3 161.73 26.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.503 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.08 139.4 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.932 0.396 . . . . 0.0 111.1 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.3 t -153.4 149.08 27.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.161 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 22.4 m -59.95 163.51 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.153 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 3.8 mp -67.7 153.3 95.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.625 0.726 . . . . 0.0 111.029 -159.232 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 47.5 Cg_exo -63.75 178.92 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.699 2.266 . . . . 0.0 112.393 -175.036 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.0 m -92.52 145.71 24.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.21 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -131.26 112.2 12.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.952 -172.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 54.65 34.97 22.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.943 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.1 1.59 81.74 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.565 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -128.38 127.03 23.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.582 0.706 . . . . 0.0 110.896 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -55.28 136.9 75.56 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.673 2.249 . . . . 0.0 112.337 -176.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 256' ' ' LYS . 67.7 m -80.06 -5.05 55.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.798 170.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 255' ' ' SER . 97.3 mttt -38.31 129.05 1.05 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.514 0.673 . . . . 0.0 110.912 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -83.09 163.11 15.52 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.666 2.244 . . . . 0.0 112.384 -163.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -72.99 164.95 25.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.4 t -110.89 132.29 59.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.173 -168.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.669 ' HA3' ' CE1' ' A' ' 64' ' ' HIS . . . -114.85 138.92 15.19 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.443 176.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 74.0 t -126.13 116.54 46.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 111.24 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -66.28 122.52 17.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.984 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 51.0 m -124.11 131.11 53.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 -166.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.99 133.88 50.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.02 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.55 172.5 20.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.455 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 34.9 mm -113.99 130.48 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.785 0.326 . . . . 0.0 111.178 -173.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -61.86 128.99 38.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.984 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.469 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -58.85 -30.93 68.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.165 -178.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.28 -5.21 59.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.033 -172.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 15.6 t -71.51 120.23 78.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.68 0.752 . . . . 0.0 110.951 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 271' ' ' PRO . . . . . 0.431 ' HD2' HG21 ' A' ' 2' ' ' ILE . 97.8 Cg_endo -67.49 -9.89 26.85 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.623 2.215 . . . . 0.0 112.342 167.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -109.06 16.89 22.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -55.79 -32.93 63.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -170.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.67 -47.48 63.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.958 0.409 . . . . 0.0 110.896 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.0 pp -78.69 -31.03 46.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.9 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.77 -48.74 68.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.064 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -65.97 -34.98 79.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.51 -40.98 73.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 19.0 m-30 -66.97 -38.73 86.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 176.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.427 ' HA ' HD22 ' A' ' 284' ' ' LEU . 5.3 tt -57.62 -51.5 69.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 -176.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -75.31 -27.98 59.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -98.68 -13.5 20.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -167.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.754 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 69.0 m-85 -121.19 -60.13 1.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 280' ' ' LEU . 1.4 mp -61.44 -33.68 74.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.937 -161.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.926 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.2 pp -123.78 37.88 4.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.994 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.462 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 67.9 p -121.25 162.36 20.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 177.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.432 ' HA ' HD11 ' A' ' 290' ' ' LEU . 38.7 t70 -45.66 -36.29 4.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 -167.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -78.73 -42.02 29.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.984 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.754 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.9 -52.9 8.57 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.505 -170.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.604 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -72.62 -20.08 61.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.754 0.312 . . . . 0.0 110.965 -178.457 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.563 ' N ' HD12 ' A' ' 290' ' ' LEU . 35.3 tt0 -70.62 -47.93 57.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.774 172.009 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.65 97.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.098 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 1.008 HG23 ' HA3' ' A' ' 19' ' ' GLY . 2.8 p -78.71 -32.17 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 -176.093 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -68.78 -27.72 66.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.785 171.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.62 -25.05 67.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -88.39 -40.12 13.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.404 ' HD3' ' HD2' ' A' ' 15' ' ' LYS . 85.2 tttt -146.06 135.17 11.26 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.475 0.655 . . . . 0.0 110.951 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -58.28 109.03 0.44 Allowed 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.744 2.296 . . . . 0.0 112.289 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 61.6 mt -89.89 -18.59 25.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.978 -171.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 109.49 -59.49 0.35 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.525 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.6 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -169.37 165.24 10.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.359 . . . . 0.0 111.095 175.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.681 HG21 ' HB3' ' A' ' 307' ' ' TYR . 29.8 m -124.9 153.92 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.02 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.91 -8.41 56.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.115 172.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.604 ' CD2' HD21 ' A' ' 290' ' ' LEU . 44.7 tp -85.9 119.06 25.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.953 -177.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.01 -40.99 67.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -174.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.8 m -65.12 -50.13 67.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.829 -168.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.681 ' HB3' HG21 ' A' ' 302' ' ' VAL . 17.5 t80 -77.11 -28.62 54.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.953 -177.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -64.77 -38.98 92.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.915 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.31 -35.01 78.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.935 175.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -73.38 -41.33 63.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.952 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.6 HD13 ' HA ' ' A' ' 301' ' ' ALA . 77.2 mt -60.05 -31.87 70.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.884 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.54 -17.86 56.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.06 -19.64 66.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -90.9 121.73 67.67 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.624 0.726 . . . . 0.0 110.895 164.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -47.37 -28.05 7.88 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.737 2.291 . . . . 0.0 112.304 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -61.32 -30.96 70.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -172.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.467 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.1 mp -79.98 -30.23 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 -173.079 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.53 96.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.032 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.06 -44.1 77.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.023 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 82.6 p -65.43 -31.13 72.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 -171.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.9 mtp -65.49 -33.3 75.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -64.75 -47.19 79.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 -174.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.477 HD21 ' HB1' ' A' ' 112' ' ' ALA . 8.5 p-10 -82.97 -28.87 29.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.766 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.39 -52.31 62.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.033 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -65.86 -28.3 68.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.016 0.436 . . . . 0.0 110.984 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -109.63 -8.32 14.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.8 -168.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -89.88 -153.57 28.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.461 -166.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -146.1 140.81 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 0.0 110.919 -170.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 42.2 mm -60.31 121.37 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 -166.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 93.0 mtp . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 121.522 0.677 . . . . 0.0 110.902 179.34 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.8 0.333 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 54.7 mmm -80.13 -17.37 52.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.811 -170.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.5 m -60.82 -41.44 95.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.846 176.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.83 -35.64 59.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 6.4 m-30 -66.21 -42.37 88.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.964 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -56.51 -37.85 70.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.02 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -68.47 -41.22 80.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.17 -43.4 87.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.097 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 339' ' ' PHE . 20.4 m -73.4 -32.04 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.137 -177.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.451 ' O ' HG22 ' A' ' 347' ' ' VAL . 5.0 tmt_? -64.93 -38.94 92.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.873 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.3 m -58.68 -36.68 74.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.173 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.05 -43.75 91.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.108 -174.225 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.736 ' HA ' HD11 ' A' ' 192' ' ' LEU . 8.2 m -73.17 -34.92 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.153 -175.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.455 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -63.62 -47.27 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 173.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -63.59 -39.7 95.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.16 -45.51 60.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.025 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.29 -40.38 81.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.116 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 92.0 p -76.31 -10.91 59.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.09 16.61 74.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.46 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.03 -32.39 50.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 0.0 110.95 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -139.37 155.15 47.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.984 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 48.7 p -77.7 167.44 21.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 170.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.55 HG21 ' OG1' ' A' ' 193' ' ' THR . 54.8 t -55.89 -42.03 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.16 173.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -60.65 -46.88 88.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -69.11 -52.2 30.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -71.87 -49.39 38.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 -173.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.608 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 1.4 tm? -65.14 -46.87 79.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.968 -173.259 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.02 -53.44 53.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.847 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -67.14 -46.61 73.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -174.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.09 -41.8 94.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.091 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 68.0 mm-40 -77.74 -26.75 50.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.95 -177.12 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.2 m -64.44 -35.99 82.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.226 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.18 -30.4 68.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.971 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.439 HD12 HG21 ' A' ' 183' ' ' VAL . 70.0 mt -60.35 -38.49 77.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 173.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 60.8 p -93.45 -14.46 26.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.886 179.209 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.713 0.292 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 76.4 mt -95.96 133.93 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.191 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -146.51 139.15 25.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -52.43 137.77 28.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.16 1.62 62.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.442 -173.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 64.4 pttt -164.53 149.85 10.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.74 0.305 . . . . 0.0 110.966 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.628 HD23 ' H ' ' A' ' 7' ' ' LEU . 1.2 pt? -147.67 158.07 43.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.947 -176.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 70.4 t -110.79 131.83 60.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.743 HG23 ' HB ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -119.94 132.08 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.149 -179.269 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.673 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 70.8 m95 -106.08 128.8 54.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.943 169.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 20' ' ' LEU . 5.9 tt -109.41 149.96 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.157 -168.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -60.89 154.69 21.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -172.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.19 -21.3 31.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.495 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -72.93 -12.34 60.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.358 . . . . 0.0 110.812 -171.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.588 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -146.98 135.64 22.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 167.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.07 -79.91 1.06 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.599 -171.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -105.57 -44.93 4.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.958 0.409 . . . . 0.0 110.917 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -67.91 -52.92 30.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.864 -148.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 1.117 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -57.11 -51.95 54.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.498 -175.675 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.603 HD21 ' HB ' ' A' ' 9' ' ' ILE . 59.6 tp -57.87 -43.76 86.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 0.0 110.968 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.76 -40.05 59.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.991 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -69.71 -55.29 10.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 20' ' ' LEU . 22.0 m -69.83 -35.95 67.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.164 -175.387 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.406 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -62.83 -45.65 95.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.407 172.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -56.76 -30.2 63.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 110.996 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -57.55 -38.2 74.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 176.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 1.8 m-30 -56.22 -49.61 73.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.888 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 93.2 mt-10 -66.28 -35.41 80.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -69.3 -37.33 77.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -96.55 -47.99 5.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.918 0.39 . . . . 0.0 110.925 -169.792 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.8 p -114.73 -1.97 13.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.161 -169.344 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.88 8.73 82.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.417 166.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -99.46 133.0 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 111.121 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.6 mttt -75.17 139.75 42.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.852 -169.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.486 ' HB ' HD11 ' A' ' 9' ' ' ILE . 2.7 m -116.44 134.46 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.498 ' O ' HD12 ' A' ' 9' ' ' ILE . 98.3 m -105.12 127.54 52.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.136 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.578 HG13 HD23 ' A' ' 20' ' ' LEU . 54.5 t -91.53 127.05 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.155 175.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -119.14 147.01 44.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.828 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 63.6 t-80 -88.82 142.18 30.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.593 0.711 . . . . 0.0 110.887 -166.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 86.8 Cg_exo -54.9 -25.21 42.62 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.569 2.179 . . . . 0.0 112.379 -175.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -48.43 -56.79 7.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 -173.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -86.6 -4.07 59.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 8.1 tt -45.94 -53.81 9.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.896 -172.046 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.02 -35.48 80.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.846 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -67.37 -43.48 81.3 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.884 -173.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -80.47 -21.36 42.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 50.6 t80 -49.99 -51.51 60.98 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.564 0.697 . . . . 0.0 110.806 -165.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 61.6 Cg_endo -80.94 -29.68 2.0 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.615 2.21 . . . . 0.0 112.403 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -74.6 -40.33 61.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 -168.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 m -66.58 -27.68 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.121 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.782 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -67.61 -36.09 80.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.09 -31.38 70.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.024 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.8 p -93.0 -17.77 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.128 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.22 11.22 75.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.522 173.899 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -140.05 140.06 36.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.881 0.372 . . . . 0.0 110.827 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.96 -96.61 0.16 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.435 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.673 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 78.9 Cg_endo -80.08 148.79 19.54 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.728 2.286 . . . . 0.0 112.238 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -96.94 -35.99 10.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 165.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.743 ' HB ' HG23 ' A' ' 9' ' ' ILE . 46.6 mt -125.87 138.26 55.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.105 -176.14 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 tp -131.2 125.91 58.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.153 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -91.31 137.57 32.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 167.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.489 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 31.2 p90 -140.5 162.62 34.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.017 172.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.46 -87.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.039 -167.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.504 ' NE2' ' HA3' ' A' ' 260' ' ' GLY . 10.8 m170 -128.17 -68.69 0.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -173.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -96.81 -10.92 25.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.811 -162.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -57.27 -14.28 4.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 -169.085 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.564 ' HB2' HD13 ' A' ' 104' ' ' ILE . 33.5 p90 -59.29 -29.41 67.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.9 -51.75 57.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.468 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.76 -36.55 92.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.522 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -55.45 -51.75 65.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 110.931 179.053 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.2 -43.11 58.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.16 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -56.86 -38.83 73.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 -175.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.404 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 61.8 m -84.8 -7.44 59.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.003 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.95 30.26 59.58 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.469 173.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.782 HD22 ' HB1' ' A' ' 51' ' ' ALA . 42.1 mt -89.35 -8.78 52.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.827 0.346 . . . . 0.0 110.886 -168.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -129.06 152.2 48.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -176.458 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.03 139.65 35.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.025 172.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.69 142.95 51.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.0 pt -104.15 154.53 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.9 m -90.67 123.85 64.0 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.672 0.749 . . . . 0.0 111.115 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.83 136.6 75.33 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.772 2.315 . . . . 0.0 112.395 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -105.05 111.79 24.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.16 -40.0 92.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.84 -176.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.39 97.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -71.97 -36.87 69.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.454 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 66.3 tt0 -51.73 -51.8 53.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.96 174.198 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -57.99 -37.07 73.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.802 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.38 -21.66 52.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.863 -174.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -105.06 -105.02 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.907 -172.04 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 27.7 t80 172.19 126.7 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.682 0.753 . . . . 0.0 110.963 -167.557 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 93.7 Cg_exo -54.66 -36.38 89.6 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.796 2.33 . . . . 0.0 112.407 -172.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -65.03 -35.1 80.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -172.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.1 p -76.72 -32.21 57.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.215 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.545 ' CE3' HD13 ' A' ' 103' ' ' LEU . 92.7 m95 -70.32 -29.09 65.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.002 173.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.07 -31.44 71.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 177.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.03 -24.04 64.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.092 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' A' ' 94' ' ' TRP . 17.9 m -106.35 15.95 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -99.98 131.5 45.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -129.37 117.45 20.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.7 t30 57.8 35.57 25.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.857 175.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.79 0.19 89.72 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.536 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -124.69 146.37 49.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 110.835 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.545 HD13 ' CE3' ' A' ' 94' ' ' TRP . 26.8 mt -88.56 135.35 33.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.799 -171.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.564 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.8 pp -121.87 -1.68 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.489 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -158.8 161.43 36.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.086 -176.288 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.491 ' HB3' ' CD2' ' A' ' 285' ' ' LEU . 93.9 m-85 -110.27 138.25 20.82 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.662 0.744 . . . . 0.0 110.878 172.434 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.05 118.15 5.15 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.636 2.224 . . . . 0.0 112.303 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.898 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -103.24 -36.4 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -148.81 152.7 36.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 -172.544 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.54 130.71 73.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.112 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.469 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 92.0 mt-10 -129.74 128.57 42.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.801 ' HB1' HD21 ' A' ' 323' ' ' ASN . . . -150.8 152.26 33.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.126 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.522 ' HB2' ' CB ' ' A' ' 257' ' ' PRO . 5.1 mp -84.29 171.34 12.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.976 -161.323 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.1 p -156.02 154.7 31.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 -172.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.876 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -99.14 127.66 45.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.812 168.639 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.594 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.3 mp -111.45 130.04 65.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.21 -175.22 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -131.34 148.46 52.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.928 -173.371 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -92.06 120.01 32.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.823 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.416 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.5 mttt -70.13 -25.74 63.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -174.896 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -86.59 -23.07 25.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.8 mp -75.02 -56.71 4.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.979 167.321 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.765 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.1 pt? -140.02 127.89 12.87 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.589 0.709 . . . . 0.0 110.969 173.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.57 -7.84 16.9 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.592 2.194 . . . . 0.0 112.315 -175.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -147.27 96.71 4.18 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.648 0.737 . . . . 0.0 110.912 -176.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.64 155.04 71.7 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.636 2.224 . . . . 0.0 112.375 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.43 143.3 69.04 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.678 2.252 . . . . 0.0 112.274 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -84.86 -16.33 41.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.996 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.9 p -132.03 157.91 42.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.195 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.488 ' HA ' HG12 ' A' ' 132' ' ' ILE . 82.4 m95 -70.08 -20.79 63.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.88 -28.82 67.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -82.27 -8.14 59.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.881 -176.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.627 ' O ' HD13 ' A' ' 135' ' ' LEU . 46.8 mm -60.82 -53.14 67.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.576 0.703 . . . . 0.0 111.17 -173.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 21.6 Cg_endo -60.48 -39.88 61.92 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.566 2.177 . . . . 0.0 112.377 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.52 -61.14 2.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.147 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -70.88 -16.93 62.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.01 -175.628 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.52 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.9 t70 -63.54 -42.39 98.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.874 168.458 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.67 -30.43 68.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.963 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -69.98 -47.48 62.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.623 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.6 pp -87.22 -15.19 38.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.923 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.623 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.5 tttt -61.93 -33.86 75.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.012 175.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.41 -24.19 67.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.076 176.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -95.04 6.14 49.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.848 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.86 32.04 57.41 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.528 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -110.4 166.5 10.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 110.878 174.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.4 t -118.5 143.04 47.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 169.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.62 -44.13 71.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.132 -173.73 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -139.05 124.02 18.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.842 -174.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 62.1 tpp -113.4 132.57 55.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.81 -175.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -157.39 160.0 37.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.987 -175.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' ASN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 209' ' ' ASP . 40.3 p-10 -99.21 -43.44 6.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -175.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.108 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.4 tm? 52.13 34.58 14.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -175.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -103.28 -11.61 17.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 -176.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 96.6 mt-10 -123.4 144.11 43.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.655 0.74 . . . . 0.0 110.924 -170.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 153' ' ' GLU . 73.1 Cg_exo -54.64 -32.75 76.64 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.634 2.222 . . . . 0.0 112.339 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -65.21 -29.96 70.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -79.89 -40.19 28.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 39.3 p -62.79 -39.59 94.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.066 -175.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.596 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 32.0 t-105 -65.91 -50.14 54.56 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.63 0.728 . . . . 0.0 110.936 -164.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 78.4 Cg_exo -48.33 -46.55 22.73 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.702 2.268 . . . . 0.0 112.312 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.716 HD23 ' O ' ' A' ' 160' ' ' LEU . 6.4 tt -74.91 -40.35 60.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.957 -174.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.8 mt -69.13 -43.05 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.213 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.63 -24.71 61.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.91 -33.49 71.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.076 -178.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -93.57 3.35 55.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.99 7.32 35.96 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.428 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.38 65.7 3.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -85.67 134.8 33.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.794 0.331 . . . . 0.0 110.989 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.53 1.57 16.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.091 -177.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -153.69 155.41 35.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.996 0.427 . . . . 0.0 110.853 -175.087 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -99.47 121.95 41.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 157.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -112.95 123.26 49.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -152.84 131.03 11.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.4 t30 55.07 44.89 27.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.985 173.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.29 15.69 78.84 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.485 173.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.01 139.84 50.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.794 0.331 . . . . 0.0 110.951 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -95.82 144.38 26.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.943 169.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -119.32 111.7 18.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 37.1 pt -78.18 -18.24 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -94.54 -8.99 36.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.817 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -123.45 92.8 3.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 24.9 m -118.72 164.26 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.081 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -108.46 22.38 26.7 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.541 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 365' ' ' GLN . 1.5 m -108.8 -23.3 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 111.165 -173.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -91.79 24.03 3.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.793 174.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -118.88 176.25 5.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.877 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.09 -25.49 67.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.133 -177.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.09 -39.75 94.79 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.445 -172.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.693 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.48 -35.57 81.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.958 0.408 . . . . 0.0 111.124 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.566 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.7 mttt -59.69 -36.17 75.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 176.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.44 91.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.11 -48.16 67.32 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.496 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.526 HD11 ' HA ' ' A' ' 347' ' ' VAL . 19.0 tp -65.96 -33.2 75.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.927 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 357' ' ' VAL . 88.3 m -65.98 -44.02 86.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.172 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 32.6 t80 -67.31 -46.52 73.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.864 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.579 HD23 ' C ' ' A' ' 195' ' ' LEU . 7.9 tt -51.12 -52.21 46.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -175.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 199' ' ' ILE . 27.6 m -64.03 -21.95 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 -173.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.9 m-20 -61.51 -33.06 73.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -80.33 -40.07 27.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -175.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.658 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.8 pp -74.94 -28.31 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.214 173.05 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -70.49 -39.08 74.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 174.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -78.29 2.15 19.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.876 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 66.55 40.9 3.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 166.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -78.11 -17.63 56.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.779 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.658 ' SD ' HG22 ' A' ' 199' ' ' ILE . 4.3 ppp? -143.33 158.09 43.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.899 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -92.21 153.6 19.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.817 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.7 -26.99 67.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.102 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -94.77 2.33 55.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 98.4 m -69.17 129.99 41.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.105 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.514 ' HA ' ' HB3' ' A' ' 150' ' ' ASN . 18.7 t0 -126.69 175.67 7.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.961 173.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -59.18 -35.78 74.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.01 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.7 p -68.4 -38.79 81.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 76.2 mt -67.46 -40.04 83.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.125 175.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.08 -35.52 80.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.001 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -61.4 -47.25 86.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.862 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.06 -41.23 99.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.11 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.9 -47.62 77.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.071 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -62.38 -41.86 98.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -63.96 -31.4 72.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.913 -177.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.47 -19.3 28.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.836 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.37 22.43 31.94 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.453 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -80.96 -19.66 43.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.996 0.427 . . . . 0.0 110.9 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.7 t -128.76 137.47 51.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.153 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.444 ' HB1' HD21 ' A' ' 122' ' ' LEU . . . -66.34 -46.91 75.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.022 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.645 ' HB3' HD21 ' A' ' 115' ' ' LEU . 75.3 mtm -133.71 151.02 51.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.962 -168.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 66.1 p -138.69 156.9 47.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.161 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.4 mm -110.37 125.06 67.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -155.01 175.31 13.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -169.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.409 ' HA2' ' HG ' ' A' ' 113' ' ' LEU . . . -84.34 -164.17 37.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.419 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.469 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 36.5 Cg_endo -65.34 -23.78 58.48 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.685 2.257 . . . . 0.0 112.361 177.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -72.26 -30.79 65.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 45.37 45.09 9.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.104 174.535 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 29.7 m0 -63.68 -19.61 65.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.868 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -69.75 -14.88 63.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.855 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -78.45 -171.32 2.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 92.9 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.152 -178.933 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 71.7 t . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.826 0.346 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -82.99 139.13 33.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.416 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 39.0 p90 -150.02 156.6 41.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.927 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.7 163.86 26.46 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.431 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.0 p -135.53 135.93 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 111.127 -176.235 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 13.2 t -159.71 152.45 21.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 175.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 322' ' ' GLU . 28.2 m -59.2 163.26 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.288 -175.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.526 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 2.4 mp -67.02 153.66 94.07 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 110.985 -165.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.51 -178.17 2.12 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.777 2.318 . . . . 0.0 112.358 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 68.2 p -100.85 160.09 14.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.078 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -138.8 119.75 14.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.911 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 54.89 33.99 21.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 -173.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.78 9.92 73.66 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.558 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -126.17 139.94 35.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.619 0.723 . . . . 0.0 110.842 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -73.29 139.58 29.33 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.736 2.291 . . . . 0.0 112.298 -172.375 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 256' ' ' LYS . 73.8 m -85.33 1.5 48.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.845 168.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 255' ' ' SER . 99.0 mttt -38.4 118.06 0.99 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.569 0.7 . . . . 0.0 110.879 -175.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.522 ' CB ' ' HB2' ' A' ' 113' ' ' LEU . 53.0 Cg_exo -65.66 162.13 35.75 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.699 2.266 . . . . 0.0 112.33 -170.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -74.48 167.2 22.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.901 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.7 t -117.56 134.5 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.082 -165.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.504 ' HA3' ' NE2' ' A' ' 64' ' ' HIS . . . -116.7 135.52 12.07 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.469 176.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.2 t -124.96 118.24 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 111.197 174.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -66.28 123.06 18.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.3 m -126.49 133.45 51.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.789 -168.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.26 138.88 52.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.066 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.39 172.07 21.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.419 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.479 HG13 ' HB2' ' A' ' 277' ' ' LYS . 29.1 mm -113.64 129.96 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 0.0 111.106 -173.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -61.85 128.74 37.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.455 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -59.83 -29.19 68.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.099 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.82 -5.76 59.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.065 -173.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.5 t -73.14 121.0 83.99 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.654 0.74 . . . . 0.0 110.936 -173.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -68.04 -9.38 25.52 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.635 2.224 . . . . 0.0 112.353 168.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -108.66 19.72 19.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -53.97 -33.97 58.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.856 -171.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -67.55 -50.65 57.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -172.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.99 -32.08 39.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.45 -47.51 75.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.071 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 277' ' ' LYS . . . . . 0.479 ' HB2' HG13 ' A' ' 266' ' ' ILE . 37.3 ttpt -66.24 -42.41 88.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 176.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.46 -46.57 82.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -66.29 -43.2 87.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 284' ' ' LEU . 8.2 tt -55.83 -50.57 70.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 -176.427 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -72.4 -25.21 61.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -100.27 -11.15 20.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 -171.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.756 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 73.9 m-85 -122.91 -60.55 1.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 280' ' ' LEU . 1.4 mp -62.66 -32.49 73.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.908 -159.56 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.898 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.4 pp -123.22 38.07 4.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.96 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.474 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 64.0 p -124.68 163.47 21.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.438 ' HA ' HD11 ' A' ' 290' ' ' LEU . 38.7 t70 -45.63 -37.51 5.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -166.044 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -78.3 -41.63 33.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.756 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.52 -55.96 5.8 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.593 -170.685 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 291' ' ' GLU . 0.6 OUTLIER -67.2 -21.36 65.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 110.852 -178.971 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.592 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.9 tt0 -68.44 -47.6 66.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 172.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.63 -45.15 91.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -174.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 1.117 HG23 ' HA3' ' A' ' 19' ' ' GLY . 2.6 p -75.83 -34.56 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.176 -175.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 294' ' ' ASN . . . . . 0.434 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 46.2 t30 -67.4 -28.24 67.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 173.352 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.09 -26.47 68.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -85.46 -41.76 15.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.992 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -145.36 131.78 9.78 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.572 0.701 . . . . 0.0 110.853 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.32 109.01 0.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.727 2.285 . . . . 0.0 112.358 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.434 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 59.4 mt -90.06 -19.6 24.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.97 -171.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 113.36 -59.46 0.38 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.461 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.658 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -171.37 169.63 6.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.807 0.337 . . . . 0.0 111.114 174.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.635 HG21 ' HB3' ' A' ' 307' ' ' TYR . 32.9 m -125.24 154.67 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.07 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.46 -10.71 60.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.077 171.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.574 ' CD2' HD21 ' A' ' 290' ' ' LEU . 54.1 tp -85.9 120.01 26.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -175.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -55.85 -40.45 72.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.883 -174.065 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.7 m -65.72 -50.02 66.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.849 -168.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.635 ' HB3' HG21 ' A' ' 302' ' ' VAL . 17.4 t80 -76.42 -28.63 56.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.979 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -64.8 -38.87 92.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.9 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.53 -34.76 77.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.909 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -75.02 -40.44 60.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.924 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.658 HD13 ' HA ' ' A' ' 301' ' ' ALA . 80.1 mt -61.23 -32.0 71.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.901 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.64 -18.64 60.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.06 -176.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.79 -19.37 65.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 173.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -91.4 122.7 65.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.608 0.718 . . . . 0.0 110.88 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -48.61 -28.69 12.73 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.668 2.245 . . . . 0.0 112.375 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -62.75 -27.25 69.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.888 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.405 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.4 mp -75.06 -32.88 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 -174.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.2 -46.03 91.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.046 -171.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.35 -39.3 89.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.169 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.619 HG23 ' HB3' ' A' ' 112' ' ' ALA . 21.6 m -59.32 -36.39 75.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.182 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.8 mmm -73.86 -34.24 64.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 322' ' ' GLU . . . . . 0.408 ' HB2' HG13 ' A' ' 246' ' ' VAL . 86.1 mt-10 -59.46 -44.14 93.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.942 -172.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.801 HD21 ' HB1' ' A' ' 112' ' ' ALA . 16.4 p-10 -87.83 -26.28 22.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.64 -45.31 92.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.133 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -62.46 -33.7 75.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.88 -177.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -107.62 -2.29 20.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.857 -173.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -90.17 -166.57 41.44 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.452 -164.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -144.94 143.0 30.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 110.962 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 47.0 mm -60.44 118.7 3.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 -171.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 47.6 tpp . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 121.561 0.696 . . . . 0.0 110.87 -178.537 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.79 0.328 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 66.1 mmm -80.03 -18.06 51.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 -168.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 95.0 p -63.8 -37.71 88.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.782 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -76.85 -35.13 57.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.14 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.547 ' O ' HG13 ' A' ' 343' ' ' VAL . 5.0 m-30 -67.61 -41.0 84.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.451 ' HA ' HG22 ' A' ' 343' ' ' VAL . 7.7 m0 -59.89 -34.64 73.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 174.367 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -69.43 -39.77 77.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.889 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.51 -43.22 85.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.109 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 339' ' ' PHE . 15.4 m -75.15 -28.58 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.098 -176.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.445 ' O ' HG22 ' A' ' 347' ' ' VAL . 49.3 ttt180 -58.62 -45.56 88.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.845 172.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 93.2 m -56.11 -36.25 67.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.148 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.64 -44.05 91.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.188 -174.347 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.526 ' HA ' HD11 ' A' ' 192' ' ' LEU . 3.0 m -74.88 -34.86 34.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.175 -174.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 347' ' ' VAL . 1.4 mp -62.95 -52.18 62.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.196 173.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -62.5 -39.21 92.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.59 -45.71 61.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.111 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.72 -39.67 76.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.049 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 89.4 p -75.39 -10.56 59.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.921 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 82.02 17.13 70.5 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.414 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.72 -33.4 46.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 110.863 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -140.02 155.1 47.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.5 p -77.38 169.45 18.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.217 170.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.435 ' O ' ' CB ' ' A' ' 361' ' ' LEU . 53.8 t -56.17 -42.37 72.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.198 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -61.13 -46.58 89.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.828 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -70.09 -53.19 18.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -70.96 -48.04 55.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.146 -172.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.3 tm? -65.08 -41.76 94.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -174.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.73 -54.08 26.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -70.39 -48.35 56.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -171.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.34 85.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.175 -174.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.493 ' HB3' ' HB ' ' A' ' 183' ' ' VAL . 79.4 mm-40 -73.55 -34.79 65.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -175.868 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 26.9 m -60.17 -27.93 67.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.175 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -56.99 -30.11 63.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.804 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 365' ' ' GLN . 77.3 mt -60.6 -40.18 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.076 174.657 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 45.7 p -98.22 -11.38 22.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.019 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.955 175.938 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.835 0.35 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.6 mt -93.68 130.73 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.177 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -145.52 146.59 31.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.918 -176.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.22 137.15 35.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.27 6.13 63.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.458 -174.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.2 tttt -165.32 135.85 3.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.741 0.305 . . . . 0.0 110.961 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.406 HD23 ' HB3' ' A' ' 275' ' ' LEU . 0.5 OUTLIER -142.34 149.57 39.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 -178.804 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 78.3 t -107.62 133.76 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.712 HG23 ' HB ' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -119.92 133.87 65.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.12 -179.397 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.803 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 68.5 m95 -108.25 126.2 52.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.014 166.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.485 HD12 ' HG ' ' A' ' 20' ' ' LEU . 14.9 tt -110.55 150.06 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 -165.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.58 149.21 39.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -172.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.86 -17.84 23.3 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.459 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -73.5 -12.32 60.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.785 0.326 . . . . 0.0 110.826 -176.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -147.83 128.17 13.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 164.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.87 -77.25 1.0 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.443 -167.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -108.47 -44.91 3.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.923 0.392 . . . . 0.0 110.979 -175.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -67.47 -50.34 59.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.887 -152.601 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.653 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -54.95 -49.54 62.04 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.42 -173.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 9' ' ' ILE . 3.2 mt -52.21 -54.43 31.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 0.0 110.913 170.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.96 -35.84 25.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -70.63 -59.22 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.971 0.415 . . . . 0.0 110.88 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.0 m -71.19 -37.77 67.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.127 -173.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.69 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -66.4 -45.88 82.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.426 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -57.43 -32.99 67.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 0.0 110.984 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -57.81 -37.83 74.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 176.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 6.0 m-30 -59.66 -44.61 93.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -64.81 -37.9 89.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.96 -40.62 75.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.867 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -97.54 -47.06 5.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.835 -166.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.6 p -108.13 -6.1 16.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.152 -173.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.91 3.83 90.53 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.432 169.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.829 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -100.13 133.17 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 0.0 111.177 -176.444 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.2 mttt -79.36 142.71 35.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.841 -172.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.69 HG21 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -120.01 133.79 65.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 178.359 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.471 ' O ' HD12 ' A' ' 9' ' ' ILE . 97.5 m -104.68 128.68 52.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.049 177.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 20' ' ' LEU . 93.5 t -98.26 125.18 51.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.199 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -117.97 148.25 42.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' HIS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 96.8 m-70 -86.75 148.3 45.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.597 0.713 . . . . 0.0 110.895 -165.083 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.452 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 50.7 Cg_exo -59.81 -24.96 77.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.69 2.26 . . . . 0.0 112.3 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -53.24 -50.09 65.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.937 -171.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.08 -3.83 56.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.836 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 7.7 tt -46.39 -52.63 12.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 -172.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -66.63 -36.45 82.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.767 176.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.38 -43.65 85.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.816 -172.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.4 -21.31 39.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 56.6 t80 -48.83 -51.17 56.51 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.614 0.721 . . . . 0.0 110.821 -167.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 63.1 Cg_endo -80.75 -29.46 2.2 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.731 2.287 . . . . 0.0 112.375 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -74.66 -39.65 61.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.929 -169.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.439 HG11 ' HD3' ' A' ' 57' ' ' PRO . 34.2 m -65.09 -27.83 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.031 -177.354 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.826 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -68.87 -37.01 78.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 177.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.11 -30.62 68.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.148 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.3 p -92.39 -15.37 27.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 176.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.48 10.22 78.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 175.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -141.05 133.28 28.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.38 -115.07 0.53 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.486 176.752 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.803 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 61.1 Cg_endo -75.28 152.57 39.64 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.723 2.282 . . . . 0.0 112.415 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.39 -34.99 17.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 159.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.712 ' HB ' HG23 ' A' ' 9' ' ' ILE . 30.5 mt -128.59 139.31 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 -175.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 tp -131.87 127.87 59.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -93.65 137.2 33.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 172.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.422 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 30.0 p90 -144.66 165.03 29.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.932 171.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.81 -89.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.048 -169.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.414 ' CD2' ' HA2' ' A' ' 260' ' ' GLY . 18.0 m80 -105.47 -81.58 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.828 -171.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -103.88 -6.71 21.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.77 -154.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -52.15 -21.5 3.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -173.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.483 ' HB2' HD13 ' A' ' 104' ' ' ILE . 30.7 p90 -59.27 -28.96 67.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.815 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.62 -51.47 57.7 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.73 91.89 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.442 171.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.408 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -54.96 -51.68 65.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.981 0.42 . . . . 0.0 110.999 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.24 -42.6 45.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.113 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.5 tp60 -56.88 -38.62 73.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.87 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.415 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 62.8 m -85.94 -6.9 58.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.847 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.73 30.78 59.26 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.561 174.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.826 HD22 ' HB1' ' A' ' 51' ' ' ALA . 39.0 mt -89.87 -10.07 46.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 0.0 110.972 -169.218 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.483 ' C ' ' HB2' ' A' ' 268' ' ' ALA . 0.2 OUTLIER -127.97 149.41 50.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 -176.38 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -77.36 141.11 40.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.124 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.8 136.48 45.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.957 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -105.1 156.86 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.8 m -100.7 130.32 25.69 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.606 0.717 . . . . 0.0 111.096 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.44 134.57 62.15 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.738 2.292 . . . . 0.0 112.329 176.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -104.04 118.62 37.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.817 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.21 -41.96 98.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.897 -176.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.89 -45.05 87.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -74.88 -32.4 61.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.951 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLN . . . . . 0.483 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 66.9 tt0 -55.04 -50.87 68.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.901 175.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.03 -32.68 71.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 174.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -76.22 -21.32 56.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.7 -105.21 0.3 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.949 -172.461 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 30.3 t80 171.75 128.92 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.655 0.74 . . . . 0.0 110.92 -167.752 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -53.48 -37.03 81.98 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.746 2.297 . . . . 0.0 112.352 -173.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -64.97 -35.72 82.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.785 -174.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.8 p -73.12 -30.97 64.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.186 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.527 ' HA ' HG22 ' A' ' 97' ' ' VAL . 86.3 m95 -67.47 -30.85 70.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 174.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.4 -30.75 70.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.852 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.96 -25.76 62.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.034 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.528 HG23 HD22 ' A' ' 103' ' ' LEU . 15.6 m -106.02 13.04 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 -174.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -100.04 129.74 46.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -123.68 115.03 20.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 172.592 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.8 t30 56.82 38.88 29.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 173.017 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.39 0.39 89.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.56 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -116.71 151.29 36.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.833 0.349 . . . . 0.0 110.805 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.528 HD22 HG23 ' A' ' 97' ' ' VAL . 15.1 mt -90.82 135.11 33.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.873 177.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.483 HD13 ' HB2' ' A' ' 67' ' ' PHE . 2.0 pp -125.68 3.9 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.037 -172.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.422 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -163.03 165.47 24.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.162 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 92.4 m-85 -116.04 140.46 26.34 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.609 0.718 . . . . 0.0 110.993 172.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 11.4 Cg_exo -72.13 126.38 11.73 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.733 2.289 . . . . 0.0 112.391 172.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 1.076 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.5 mp -107.61 -39.98 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.213 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -144.02 152.09 40.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.162 -164.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.3 t -125.06 131.19 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.109 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLU . . . . . 0.508 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 92.5 mt-10 -133.89 132.31 40.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 175.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.563 ' HB3' HG23 ' A' ' 320' ' ' THR . . . -154.18 152.73 30.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.119 176.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.36 169.65 16.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.941 -168.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 98.9 p -157.59 159.14 36.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.897 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -92.33 126.09 37.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 169.581 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.587 ' N ' HD22 ' A' ' 115' ' ' LEU . 65.7 mt -113.71 132.14 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -172.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -132.13 145.03 51.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.418 ' O ' HD23 ' A' ' 122' ' ' LEU . 54.8 t-20 -93.36 114.43 26.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.831 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.484 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.8 mttt -64.78 -18.43 65.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 -173.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -77.33 -29.98 53.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.865 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 mp -83.69 -49.51 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.653 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.5 pt? -140.0 126.53 12.18 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.567 0.699 . . . . 0.0 110.89 176.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -79.16 -14.59 13.3 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.693 2.262 . . . . 0.0 112.377 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -142.23 97.16 6.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.564 0.697 . . . . 0.0 110.825 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.67 154.98 54.66 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.725 2.283 . . . . 0.0 112.282 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.39 146.23 74.21 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.624 2.216 . . . . 0.0 112.347 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -88.53 -18.16 28.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.988 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 69.6 p -132.27 158.72 41.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.166 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.541 ' HA ' HD13 ' A' ' 132' ' ' ILE . 58.7 m95 -69.66 -27.21 64.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.978 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.96 -24.6 67.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.14 -24.62 40.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.823 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.624 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -57.15 -49.68 92.53 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.586 0.708 . . . . 0.0 111.151 -172.034 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 40.0 Cg_endo -68.67 -38.02 11.32 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.67 2.247 . . . . 0.0 112.398 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.14 -60.73 3.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 176.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.205 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.96 -16.8 63.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 -175.708 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.504 ' N ' HD13 ' A' ' 135' ' ' LEU . 37.0 t70 -58.39 -39.63 80.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.821 168.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.52 -30.22 68.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.79 -47.6 52.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.032 0.444 . . . . 0.0 110.864 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.9 pp -85.62 -15.27 43.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.6 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.7 tttt -59.74 -33.45 71.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 173.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.03 -24.63 67.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 176.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -95.03 3.35 54.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.927 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.79 33.16 52.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.471 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -110.5 169.97 8.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.749 0.309 . . . . 0.0 110.909 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.0 t -118.93 142.13 48.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.996 0.427 . . . . 0.0 110.745 169.033 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -68.62 -39.87 80.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 -175.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -142.17 130.68 22.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 62.3 tpp -118.22 131.9 56.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.823 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -154.59 157.49 38.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.53 -51.56 5.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.104 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.4 tm? 48.04 33.37 3.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.891 -169.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -102.16 -2.76 28.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.936 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -127.97 153.68 78.32 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.683 0.754 . . . . 0.0 110.864 -174.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.44 ' HA ' ' HB ' ' A' ' 157' ' ' THR . 37.5 Cg_endo -61.81 -24.78 77.73 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.626 2.217 . . . . 0.0 112.362 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -66.68 -30.06 70.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -87.49 -39.39 15.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' THR . . . . . 0.44 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 20.5 m -61.18 -46.87 88.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.135 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.571 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 37.3 t-105 -58.81 -53.84 62.37 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.499 0.666 . . . . 0.0 110.833 -169.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 34.4 Cg_endo -66.12 -18.01 55.73 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.694 2.263 . . . . 0.0 112.255 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.775 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.6 tm? -81.61 -45.34 15.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.837 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.569 HG22 ' HA3' ' A' ' 166' ' ' GLY . 77.9 mt -74.24 -44.46 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.98 -20.95 63.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -60.66 -31.15 70.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.093 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.98 3.1 55.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.891 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 104.11 7.91 39.92 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.485 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.569 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -77.06 67.05 2.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.541 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -86.05 131.11 34.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.361 . . . . 0.0 110.89 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.54 13.48 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -174.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.409 ' HA ' HG12 ' A' ' 181' ' ' VAL . 52.9 p90 -153.43 154.4 34.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 86.8 tttt -101.48 127.5 48.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 158.273 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -116.22 125.81 52.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.983 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -153.55 130.39 10.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.0 t30 54.31 42.76 31.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.946 172.573 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.95 18.47 80.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -132.27 138.51 47.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.965 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -97.72 145.11 26.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.811 170.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -126.24 112.14 15.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.914 174.183 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 178' ' ' ILE . 1.1 pp -79.43 -12.82 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -95.23 -10.1 31.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 -176.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 67.2 t0 -126.42 90.13 3.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 169.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 169' ' ' PHE . 29.3 m -113.55 164.07 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -173.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.11 22.59 32.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.519 -172.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 368' ' ' ILE . 3.5 m -106.64 -17.91 7.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 111.046 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -87.68 21.23 2.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.829 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -120.05 -171.41 2.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.863 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.72 -30.38 71.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.128 -173.227 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.37 -40.51 94.57 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.434 -167.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.618 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.04 -38.36 90.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 111.107 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.531 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -61.92 -38.66 89.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.906 174.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.98 -38.79 92.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.05 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.506 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -65.75 -47.76 73.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.51 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.738 HD11 ' HA ' ' A' ' 347' ' ' VAL . 18.8 tp -67.33 -34.51 77.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.802 0.334 . . . . 0.0 110.845 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.471 ' OG1' HG21 ' A' ' 357' ' ' VAL . 89.2 m -64.98 -43.84 91.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.18 177.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 79.9 t80 -65.95 -48.58 70.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.881 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.705 HD23 ' C ' ' A' ' 195' ' ' LEU . 5.2 tt -50.98 -51.28 54.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.974 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 199' ' ' ILE . 27.5 m -64.5 -21.48 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.101 -173.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.3 m-20 -61.03 -33.13 72.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.808 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -80.86 -40.05 25.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.551 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.7 pp -74.37 -28.4 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 172.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.84 -37.66 79.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 173.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -80.04 2.17 24.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 66.41 40.18 3.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.802 166.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -78.98 -15.72 57.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.843 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.551 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.1 ppp? -141.33 155.53 45.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 178.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -94.63 150.04 20.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.26 68.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.044 -175.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -94.96 0.55 54.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.931 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 89.6 m -62.24 125.04 22.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.441 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 13.6 t0 -120.0 -179.65 3.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.844 177.288 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -64.1 -46.05 85.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.99 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.1 p -67.0 -37.09 83.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.82 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.441 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 80.9 mt -65.01 -43.9 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.088 174.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.41 84.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -63.49 -46.4 86.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 176.142 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.91 93.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.01 88.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.115 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -64.02 -42.08 97.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.963 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -66.28 -34.3 77.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -81.96 -23.34 36.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.884 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.43 27.03 26.2 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.448 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -83.46 -20.02 34.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.985 0.421 . . . . 0.0 110.9 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.7 t -131.22 137.54 48.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.133 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.571 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -67.37 -41.98 84.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.012 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 61.6 mtm -137.63 160.84 38.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -177.612 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.3 t -150.26 159.55 44.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.264 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.489 HD12 HD11 ' A' ' 247' ' ' LEU . 49.2 mm -109.24 126.23 66.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -154.97 174.4 15.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.861 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -81.64 -163.71 31.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.41 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.508 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 39.7 Cg_endo -68.61 -22.05 38.54 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.697 2.265 . . . . 0.0 112.281 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 54.1 m0 -70.09 -30.0 67.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.868 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 47.56 45.04 17.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.062 174.343 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 34.1 m0 -66.26 -16.12 63.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.88 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 74.3 m -53.01 -40.07 63.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.966 0.412 . . . . 0.0 110.875 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -86.36 -177.29 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -173.692 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 77.1 mt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.154 -174.876 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.763 0.316 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -104.51 140.01 38.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.86 175.171 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.484 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 42.8 p90 -150.01 154.78 38.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.31 160.7 25.13 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.538 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.2 p -138.6 137.34 43.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 0.0 111.154 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.1 t -154.09 146.19 23.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.14 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.6 m -61.33 167.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.929 HD23 ' HD3' ' A' ' 257' ' ' PRO . 3.1 mm? -64.65 144.88 98.8 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.546 0.689 . . . . 0.0 111.077 -163.224 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.11 -172.12 1.27 Allowed 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.753 2.302 . . . . 0.0 112.487 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 94.7 m -108.82 146.04 34.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.179 -173.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' PHE . . . . . 0.412 ' HB3' ' CD1' ' A' ' 129' ' ' TRP . 43.6 p90 -137.39 126.43 24.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 54.05 35.06 21.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.97 6.97 84.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.48 173.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -133.66 131.34 21.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.634 0.73 . . . . 0.0 110.859 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.47 137.42 25.41 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.674 2.249 . . . . 0.0 112.296 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.76 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 82.3 p -87.04 -1.07 57.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 173.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -39.31 132.99 1.23 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.567 0.699 . . . . 0.0 110.915 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.929 ' HD3' HD23 ' A' ' 247' ' ' LEU . 58.8 Cg_endo -83.22 157.94 15.03 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.607 2.205 . . . . 0.0 112.419 -169.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -75.77 167.24 22.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.865 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 45.5 t -111.24 136.37 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.203 -165.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' GLY . . . . . 0.414 ' HA2' ' CD2' ' A' ' 64' ' ' HIS . . . -114.41 131.98 10.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.38 172.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 83.7 t -125.08 115.38 43.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.774 0.321 . . . . 0.0 111.196 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -64.92 122.03 16.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.944 -177.749 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 42.6 m -127.53 133.25 49.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.839 -170.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -127.35 140.3 52.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.081 -172.221 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.41 170.77 22.17 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.479 -171.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.7 mm -112.36 128.22 69.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.745 0.307 . . . . 0.0 111.2 -172.134 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -63.31 128.24 34.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.973 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.483 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -60.56 -28.65 68.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.121 -178.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.57 -6.74 59.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.104 -173.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.2 t -79.75 123.16 84.05 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.596 0.712 . . . . 0.0 110.903 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -69.53 -7.16 20.26 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.733 2.289 . . . . 0.0 112.396 169.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -102.1 21.97 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 -167.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -50.12 -36.28 29.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -173.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.3 -39.7 89.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.406 ' HB3' HD23 ' A' ' 7' ' ' LEU . 33.9 mt -66.79 -56.87 8.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 173.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.91 -50.99 36.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.991 -167.583 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -61.21 -40.64 94.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.955 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.9 tt0 -69.34 -47.75 63.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.944 -177.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -66.53 -36.21 82.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.491 ' HA ' HD22 ' A' ' 284' ' ' LEU . 5.4 tt -59.17 -52.39 65.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -177.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 281' ' ' GLU . . . . . 0.4 ' HA ' HD21 ' A' ' 285' ' ' LEU . 24.4 pt-20 -78.66 -30.68 46.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.784 -174.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 63.7 m-80 -100.85 -13.96 18.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 -164.759 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.702 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 52.4 m-85 -126.7 -53.52 1.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.813 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.517 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.3 OUTLIER -61.66 -35.43 77.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.963 -167.363 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 1.076 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.9 pp -124.43 38.23 4.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -175.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.444 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 68.2 p -122.51 164.32 18.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.188 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.458 ' HA ' HD11 ' A' ' 290' ' ' LEU . 38.8 t70 -45.77 -38.0 6.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 -165.275 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -77.15 -42.57 37.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.954 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -71.98 -51.54 14.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 -170.316 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.56 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -74.07 -20.49 60.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.67 0.271 . . . . 0.0 110.892 -178.349 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.544 ' N ' HD12 ' A' ' 290' ' ' LEU . 35.8 tt0 -70.27 -46.45 64.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 171.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.97 -43.99 97.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.011 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.653 HG23 ' HA3' ' A' ' 19' ' ' GLY . 1.8 p -79.95 -30.55 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.236 -176.04 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -68.09 -28.97 67.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.777 170.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.03 -24.81 68.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.944 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -77.02 -43.24 35.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -162.87 135.79 4.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.545 0.688 . . . . 0.0 110.976 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -45.43 114.66 0.76 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.745 2.297 . . . . 0.0 112.42 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 51.2 mt -89.98 -14.85 33.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.894 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 114.92 -59.48 0.41 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.488 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.687 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -173.72 170.15 4.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 111.095 171.678 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.693 HG21 ' HB3' ' A' ' 307' ' ' TYR . 30.8 m -122.68 154.84 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.136 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.23 -10.49 59.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.023 171.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.56 ' CD2' HD21 ' A' ' 290' ' ' LEU . 40.1 tp -83.15 120.35 25.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.843 -177.107 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.16 -40.1 73.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.4 m -65.25 -50.14 66.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.882 -169.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.693 ' HB3' HG21 ' A' ' 302' ' ' VAL . 15.7 t80 -76.9 -29.13 55.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.973 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.09 -40.1 96.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.88 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.53 -35.29 78.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -74.47 -40.25 61.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.687 HD13 ' HA ' ' A' ' 301' ' ' ALA . 77.8 mt -60.91 -32.25 71.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 175.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.93 -19.8 61.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.022 0.439 . . . . 0.0 111.202 -177.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.57 -20.62 66.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.977 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -90.26 121.12 68.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.606 0.717 . . . . 0.0 110.88 166.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.81 -28.29 9.56 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.753 2.302 . . . . 0.0 112.355 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -60.24 -30.44 69.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.2 mp -79.99 -29.99 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.074 -176.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.71 85.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.047 -168.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.75 -47.64 62.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.067 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.563 HG23 ' HB3' ' A' ' 112' ' ' ALA . 26.9 m -61.09 -37.11 81.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.156 -174.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.6 ttp -65.22 -35.49 81.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -64.64 -47.76 77.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.835 -170.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.495 ' H ' HD21 ' A' ' 323' ' ' ASN . 0.1 OUTLIER -83.43 -26.23 30.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 -178.35 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.64 -49.74 72.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.192 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -66.98 -29.86 69.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -109.74 -9.23 14.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -168.24 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.13 -148.87 23.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.458 -166.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -143.32 139.94 30.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.872 0.368 . . . . 0.0 110.824 -171.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 40.6 mm -65.52 122.4 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 59.0 ttm . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.575 0.702 . . . . 0.0 110.911 -179.701 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 . . . . . 0 N--CA 1.458 -0.054 0 CA-C-O 120.813 0.339 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 74.1 mmm -79.9 -19.05 49.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 -171.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.9 m -61.84 -41.73 98.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.773 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.32 -35.14 61.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.112 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.544 ' O ' HG13 ' A' ' 343' ' ' VAL . 8.2 m-30 -66.41 -40.42 89.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.458 ' HA ' HG22 ' A' ' 343' ' ' VAL . 18.6 m0 -59.01 -35.87 73.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.978 174.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -67.82 -41.88 82.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.95 -44.18 81.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.061 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 339' ' ' PHE . 16.7 m -74.38 -30.87 26.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 -176.03 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.474 ' O ' HG22 ' A' ' 347' ' ' VAL . 4.9 tmt_? -65.0 -39.38 93.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 175.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.7 m -58.36 -35.74 72.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.89 -43.62 95.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.189 -174.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.738 ' HA ' HD11 ' A' ' 192' ' ' LEU . 3.8 m -73.56 -33.7 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.237 -175.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 348' ' ' ILE . . . . . 0.434 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -63.8 -46.51 94.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.151 173.018 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -65.05 -39.85 93.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.53 62.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.079 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.61 -40.19 80.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.033 -175.627 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.8 p -75.43 -10.71 59.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.11 16.93 73.28 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.54 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.95 -32.82 45.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 0.0 110.854 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -139.59 154.87 47.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.0 p -77.63 168.91 19.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.096 169.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.471 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.7 t -56.04 -42.09 70.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.205 172.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -61.29 -46.53 89.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.857 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -69.71 -53.23 19.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -70.75 -48.3 55.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.06 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.618 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.3 tm? -66.02 -45.63 80.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -173.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.67 -53.07 57.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.972 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -67.23 -47.11 71.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.1 -41.54 94.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.119 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 72.5 mm-40 -78.17 -26.79 47.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.014 -176.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.2 m -64.48 -36.03 82.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.161 171.167 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.01 -30.41 67.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.464 HD12 HG21 ' A' ' 183' ' ' VAL . 67.7 mt -60.4 -38.11 76.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.165 174.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 59.8 p -93.83 -14.85 25.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 178.728 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.73 0.3 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.7 mt -82.55 134.61 26.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.099 175.644 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -135.83 142.21 44.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.006 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -56.56 135.96 54.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.554 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 98.94 -0.17 57.54 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.518 -174.518 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -162.59 150.87 14.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.831 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.691 HD23 ' H ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -147.23 156.72 43.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -176.559 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 91.2 t -113.92 131.12 66.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.095 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.901 ' HB ' HD21 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -119.97 126.82 75.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.12 -177.694 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.548 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 47.5 m0 -107.72 131.46 54.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.959 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.47 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 65.9 mt -117.75 142.41 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.078 173.053 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.403 ' O ' HG22 ' A' ' 11' ' ' ILE . 33.2 t30 -47.68 141.08 5.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 172.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.16 -13.03 13.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.569 -172.385 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -78.49 -15.22 58.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 0.0 110.844 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -130.99 112.07 12.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 167.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.75 -96.58 0.84 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.548 -153.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -102.97 -43.3 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.886 0.374 . . . . 0.0 110.931 -167.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.752 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 95.7 m-20 -62.49 -50.36 71.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 -157.144 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.7 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -57.8 -47.71 86.88 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 -175.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.901 HD21 ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -57.09 -61.02 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.76 0.314 . . . . 0.0 110.997 175.682 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.39 -40.94 37.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.14 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -65.03 -53.53 44.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.1 m -75.55 -36.06 33.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.179 -175.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.747 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -65.08 -47.22 84.16 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.98 -39.57 72.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.813 0.34 . . . . 0.0 110.861 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.67 -36.9 79.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -64.68 -41.56 95.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.57 -39.39 94.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.888 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -67.33 -33.84 76.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.879 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -89.32 -44.1 10.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.845 -170.735 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.559 ' OG1' HG13 ' A' ' 33' ' ' ILE . 66.6 p -110.73 -12.69 14.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.195 -171.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.53 7.23 87.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.589 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.849 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.4 pp -99.01 133.51 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.078 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -82.62 140.28 33.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.96 -173.027 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.747 HG21 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -118.09 134.61 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.14 -177.411 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.2 m -102.52 127.15 49.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.162 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.521 HG22 ' HG ' ' A' ' 20' ' ' LEU . 61.9 t -95.24 120.98 45.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.159 177.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.548 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 66.4 mm-40 -129.98 133.77 47.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.816 170.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -142.19 57.43 6.57 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.622 0.725 . . . . 0.0 110.873 174.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.01 -23.59 7.67 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.74 2.294 . . . . 0.0 112.369 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t0 62.63 20.77 12.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -170.528 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 45' ' ' GLU . 98.9 mttt -85.22 2.85 42.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.958 169.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.3 mt -43.45 -47.86 7.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -171.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.86 -36.87 77.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 42' ' ' LYS . 89.0 tt0 -74.54 -36.38 63.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -78.95 -29.98 44.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.506 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 9.8 m-30 -45.16 -55.58 11.06 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.664 0.745 . . . . 0.0 110.851 -175.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.4 Cg_endo -68.68 -27.2 32.33 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.795 2.33 . . . . 0.0 112.317 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -79.4 -44.02 22.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.881 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.8 m -68.02 -30.52 48.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.154 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.37 79.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 172.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.42 -30.92 67.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.062 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.5 p -92.66 -12.33 31.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.169 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.45 15.27 81.31 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.462 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -161.08 154.21 21.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.862 0.363 . . . . 0.0 110.877 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.436 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . -162.76 -138.14 2.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.409 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.518 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 72.6 Cg_endo -68.62 155.88 67.4 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.621 2.214 . . . . 0.0 112.395 169.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.48 -38.03 26.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.729 ' HB ' HG23 ' A' ' 9' ' ' ILE . 4.1 mp -128.4 138.01 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.079 176.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.5 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 1.9 tp -130.36 129.06 64.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.169 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.567 ' CE2' HG13 ' A' ' 108' ' ' ILE . 2.5 m-85 -98.62 141.25 31.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.819 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.5 ' CZ2' HG23 ' A' ' 60' ' ' ILE . 8.6 m-90 -118.12 139.96 50.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.54 -83.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.198 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.414 ' HB3' ' SD ' ' A' ' 330' ' ' MET . 98.2 m-70 -128.0 -57.22 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.835 170.088 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -85.36 -26.61 26.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.778 -170.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.492 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 98.7 mtt180 -59.94 -29.97 68.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 -158.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -67.99 -28.31 67.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -169.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.12 -51.48 52.65 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.433 -172.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.85 -36.99 92.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.482 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.536 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 17.4 t80 -66.53 -37.74 85.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.879 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.54 -44.43 62.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -62.66 -33.31 74.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.5 p -80.33 -10.76 59.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.932 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.22 32.44 68.85 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.454 174.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 1.7 mp -86.34 1.24 51.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 0.0 110.905 -172.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.536 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.7 OUTLIER -131.93 159.86 37.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.949 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -68.36 130.63 43.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.034 174.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -69.99 123.35 21.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.937 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.6 pt -108.78 159.97 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.053 -172.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.1 p -103.49 146.64 32.86 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.604 0.716 . . . . 0.0 111.169 -171.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.73 146.87 30.61 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.747 2.298 . . . . 0.0 112.354 -177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -108.08 116.09 31.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.55 -35.86 61.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.18 95.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -70.03 -38.23 75.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.855 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -54.92 -48.03 73.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.02 -36.39 83.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.85 -20.09 58.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -104.02 -103.36 0.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -173.137 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 46.2 t80 -166.82 134.56 2.1 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.649 0.738 . . . . 0.0 110.883 -172.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 68.0 Cg_exo -52.29 -39.71 71.79 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.738 2.292 . . . . 0.0 112.393 -170.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -77.76 -30.62 51.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.96 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.3 m -69.63 -48.94 58.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 -165.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.46 ' HA ' HG22 ' A' ' 97' ' ' VAL . 53.8 p-90 -66.23 -28.74 68.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.888 178.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -71.33 -37.48 71.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.813 175.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.86 -25.1 64.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.119 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.523 HG23 HD22 ' A' ' 103' ' ' LEU . 21.5 m -101.16 16.36 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.135 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 67.9 ttt180 -101.52 132.58 47.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -148.15 130.56 15.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.1 t30 68.61 36.43 2.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.16 -4.6 66.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.464 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -140.04 164.34 30.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.853 0.359 . . . . 0.0 110.885 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.523 HD22 HG23 ' A' ' 97' ' ' VAL . 12.9 mt -73.83 146.49 44.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 -175.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.424 HD12 ' C ' ' A' ' 104' ' ' ILE . 2.0 pp -122.48 8.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.138 174.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.753 ' HB1' ' HB3' ' A' ' 263' ' ' SER . . . -168.45 158.54 9.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.02 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -125.15 151.24 69.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.722 0.773 . . . . 0.0 110.96 164.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.408 ' HB3' HG11 ' A' ' 261' ' ' VAL . 59.3 Cg_endo -72.39 121.1 7.18 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.648 2.232 . . . . 0.0 112.384 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.567 HG13 ' CE2' ' A' ' 61' ' ' PHE . 24.6 mm -98.1 -32.84 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.089 176.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.02 153.35 27.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 -177.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.1 t -117.51 133.76 63.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.14 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -119.5 129.24 54.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.934 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -149.84 158.82 44.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.732 HD23 ' HA3' ' A' ' 228' ' ' GLY . 59.3 mt -99.61 158.37 15.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.042 -173.227 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.0 p -153.53 160.01 42.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.865 HD13 ' O ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.8 124.16 44.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.955 175.578 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.614 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.3 mp -106.28 133.71 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.163 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -133.15 147.77 52.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.957 -176.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -97.6 115.6 28.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.63 -16.37 63.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 21.5 t70 -80.16 -33.78 38.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.6 mp -88.67 -45.34 9.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.942 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.529 HD22 ' HB1' ' A' ' 223' ' ' ALA . 3.0 mp -108.47 130.88 22.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.537 0.684 . . . . 0.0 110.894 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.44 -30.5 15.2 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.677 2.251 . . . . 0.0 112.345 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -153.87 89.93 3.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.56 0.695 . . . . 0.0 110.973 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.479 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 51.1 Cg_exo -58.21 139.56 90.95 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.678 2.252 . . . . 0.0 112.383 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 125' ' ' PRO . 62.6 Cg_exo -54.98 146.53 57.24 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.245 . . . . 0.0 112.327 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -100.65 -0.82 36.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 176.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.9 p -132.95 157.06 46.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.04 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -71.36 -25.32 62.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.967 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -66.36 -35.54 80.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -172.218 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -83.42 -9.98 58.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.612 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 47.0 mm -58.99 -52.64 73.42 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.628 0.728 . . . . 0.0 111.219 -172.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 28.6 Cg_endo -61.03 -38.85 64.98 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.737 2.291 . . . . 0.0 112.31 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.88 -60.51 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.177 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.53 -17.03 64.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -175.364 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.626 ' HA ' HD22 ' A' ' 139' ' ' LEU . 38.7 t70 -60.9 -38.47 85.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 168.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.81 -37.18 85.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.945 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.91 -49.72 23.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -75.14 -16.98 60.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -176.592 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.667 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.6 tttt -57.46 -34.97 69.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.961 171.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.0 -24.53 67.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.121 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.8 7.89 44.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.87 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.01 28.62 62.11 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.509 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.427 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 46.9 mtmt -117.79 168.61 10.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.391 . . . . 0.0 110.821 174.301 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.9 t -129.46 137.38 50.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.82 176.733 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.441 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -70.06 -57.67 4.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.087 -165.181 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -137.53 126.82 24.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.954 -167.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 92.7 mmm -103.25 126.16 50.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.809 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -155.65 165.04 37.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -126.22 144.21 50.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.905 171.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 48.3 tp -113.44 -2.59 13.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 -175.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -69.39 -10.06 56.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.26 151.74 51.45 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 121.704 0.764 . . . . 0.0 110.811 -175.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.526 ' HD3' ' HD2' ' A' ' 344' ' ' ARG . 30.4 Cg_endo -66.05 -18.5 56.86 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.634 2.223 . . . . 0.0 112.389 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -59.63 -39.49 84.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.957 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -83.76 -38.38 21.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.864 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.4 p -64.19 -38.89 92.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.121 -173.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.561 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 11.0 t-105 -63.6 -54.23 44.65 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.556 0.694 . . . . 0.0 110.943 -170.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 33.3 Cg_endo -68.48 -32.07 25.98 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.729 2.286 . . . . 0.0 112.385 -172.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 160' ' ' LEU . 7.1 tt -74.51 -40.78 61.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.619 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 75.9 mt -68.28 -40.16 82.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.141 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.54 -27.09 63.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.069 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.35 -33.02 70.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.024 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASP . . . . . 0.518 ' HA ' ' HD3' ' A' ' 251' ' ' LYS . 66.0 m-20 -91.3 -9.0 46.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.837 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.52 3.37 9.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.511 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.63 66.53 3.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.406 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -90.0 151.26 21.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 110.968 -174.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . 0.485 ' HB3' ' SD ' ' A' ' 336' ' ' MET . . . -76.42 -6.89 53.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.003 -176.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -155.0 155.04 33.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.974 0.416 . . . . 0.0 110.873 -173.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -98.91 129.3 45.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 156.536 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -95.69 124.06 39.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -149.97 129.81 13.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.3 t30 57.1 44.98 21.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.908 171.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.41 7.82 73.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.408 172.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -132.91 140.92 48.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.831 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.415 ' N ' ' HD1' ' A' ' 176' ' ' TYR . 3.4 m-30 -79.29 132.94 36.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.991 166.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -94.12 105.01 17.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.6 tp -67.0 -19.23 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -95.13 -7.35 39.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -135.15 96.01 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.805 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.468 HG23 HG22 ' A' ' 183' ' ' VAL . 32.6 m -116.91 172.38 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -102.52 14.69 56.45 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.516 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.542 HG21 ' CD1' ' A' ' 368' ' ' ILE . 17.6 m -100.1 -17.05 6.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.83 0.347 . . . . 0.0 111.126 -175.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.487 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 57.9 p-10 -96.62 19.74 11.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.015 175.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -116.04 173.68 6.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.898 -174.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.39 -27.6 69.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.102 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.67 -40.27 90.31 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.551 -170.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.587 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.46 -41.19 93.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 111.041 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.496 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 91.9 mttt -60.8 -36.4 78.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.889 173.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.3 -37.05 86.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.01 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.619 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.51 -47.18 86.75 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.42 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.592 HD11 ' HA ' ' A' ' 347' ' ' VAL . 15.9 tp -68.19 -31.24 70.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.913 0.387 . . . . 0.0 110.99 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.426 ' O ' HG12 ' A' ' 196' ' ' VAL . 84.8 m -64.53 -42.87 95.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.04 176.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -67.05 -57.52 6.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.876 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.61 ' C ' HD12 ' A' ' 195' ' ' LEU . 3.6 pp -63.19 -27.8 69.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.926 -167.523 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.568 ' N ' HD12 ' A' ' 195' ' ' LEU . 1.3 p -74.27 -22.21 17.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.135 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -65.57 -58.34 6.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 1.034 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.66 -22.37 56.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -167.889 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.798 ' N ' HD22 ' A' ' 198' ' ' LEU . 2.2 pp -80.92 -33.53 13.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 172.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.38 -33.02 74.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 169.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -84.48 4.81 30.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.862 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 66.4 39.98 3.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -82.3 -11.17 58.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 172.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.489 ' CG ' HG22 ' A' ' 199' ' ' ILE . 5.1 ppp? -140.14 153.18 46.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 175.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -97.05 157.5 15.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 -177.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.21 -24.28 67.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.147 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -94.85 -1.81 52.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.1 m -64.02 131.7 48.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.204 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -149.25 174.22 12.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -177.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -79.76 -31.43 40.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.833 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 94.8 p -71.72 -39.46 70.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.871 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 36.6 pt -66.37 -22.28 29.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.135 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.65 -30.01 71.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.069 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -57.46 -44.02 84.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.847 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.02 -36.36 84.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.106 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.95 -36.44 81.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.097 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -64.09 -42.42 96.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -64.89 -33.79 76.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -89.18 -22.31 22.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.42 29.92 23.36 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.508 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.19 -30.12 16.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.383 . . . . 0.0 110.945 -171.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 52.8 m -110.08 125.35 52.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.093 -170.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.529 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -71.16 -48.97 48.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.149 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' A' ' 116' ' ' ILE . 68.5 mtm -133.55 146.65 51.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -172.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 226' ' ' ILE . 80.7 m -145.01 152.37 40.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.126 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' ILE . . . . . 0.406 ' N ' HG22 ' A' ' 225' ' ' THR . 40.6 mm -111.52 120.33 61.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -161.87 170.52 19.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.798 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.732 ' HA3' HD23 ' A' ' 113' ' ' LEU . . . -130.26 -107.54 1.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.488 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.51 -16.48 42.96 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.728 2.285 . . . . 0.0 112.288 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -66.94 -30.03 70.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 54.02 49.59 18.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -66.1 -27.75 68.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.8 m -65.08 142.8 58.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 -175.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -100.0 -175.27 2.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 174.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.2 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.163 -178.3 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 240' ' ' VAL . 12.6 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.956 0.408 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.508 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 70.1 m-20 45.03 69.8 0.4 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -127.57 132.68 49.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.927 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.37 157.86 23.74 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.474 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.429 HG23 HG13 ' A' ' 116' ' ' ILE . 2.5 p -143.15 140.01 26.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.959 0.409 . . . . 0.0 111.067 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.3 t -153.93 150.11 27.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.544 HG11 ' HB2' ' A' ' 323' ' ' ASN . 31.3 m -61.92 168.87 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.617 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.9 mm? -61.15 145.4 89.91 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.742 0.782 . . . . 0.0 110.837 -160.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.37 -177.01 2.75 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.76 2.306 . . . . 0.0 112.392 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 63.6 p -109.14 160.05 16.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.03 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -145.26 128.24 16.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.865 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' LYS . . . . . 0.67 ' HG2' ' O ' ' A' ' 251' ' ' LYS . 81.0 tttt 55.49 36.04 26.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 -177.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.06 8.36 82.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.536 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -134.68 139.37 32.23 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.58 0.705 . . . . 0.0 110.98 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.6 142.61 29.43 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.693 2.262 . . . . 0.0 112.343 -175.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.617 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 89.5 p -83.51 -5.02 59.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 169.502 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -41.95 125.69 2.6 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.522 0.677 . . . . 0.0 111.025 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.673 ' HG3' ' HB2' ' A' ' 113' ' ' LEU . 84.4 Cg_endo -86.94 164.91 8.78 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.704 2.269 . . . . 0.0 112.319 -174.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -75.01 170.03 16.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 175.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.412 HG21 ' HA ' ' A' ' 324' ' ' ALA . 99.0 t -103.87 134.98 43.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.106 -170.072 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.54 140.69 15.47 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.536 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.408 HG11 ' HB3' ' A' ' 107' ' ' PRO . 90.4 t -126.64 126.94 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.868 0.366 . . . . 0.0 111.133 -176.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.424 HD23 ' N ' ' A' ' 263' ' ' SER . 2.0 tt -70.07 130.6 42.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.923 166.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.753 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 67.7 m -119.04 149.21 42.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.811 -175.335 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -133.81 139.62 46.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.087 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.485 ' HA3' ' HH2' ' A' ' 62' ' ' TRP . . . -142.31 171.52 24.61 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.508 -175.737 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 30.8 mm -113.33 130.39 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 111.089 -171.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -69.29 132.63 46.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -65.61 -24.99 67.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.048 -176.24 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.73 -11.96 58.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 -171.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.7 t -70.45 120.04 76.14 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.67 0.748 . . . . 0.0 110.929 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.72 -15.72 21.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.721 2.28 . . . . 0.0 112.305 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -114.74 30.93 7.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -61.67 -24.36 66.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -168.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -64.07 -40.55 96.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.798 -169.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.6 pp -78.81 -32.17 46.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 59' ' ' ILE . . . -65.13 -45.9 83.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.018 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -69.53 -33.3 72.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.919 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.88 -50.06 73.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -172.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.482 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 1.9 p90 -68.64 -33.59 74.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 -176.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 280' ' ' LEU . 8.4 tt -62.66 -47.62 82.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.901 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.4 -39.52 67.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -99.93 -12.73 19.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -161.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.509 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 69.5 t80 -123.73 -51.33 1.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 2.1 mp -67.3 -46.01 74.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.849 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.34 48.75 1.32 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 169.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.439 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 80.5 m -146.47 145.27 30.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.194 176.233 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.435 ' HA ' HD11 ' A' ' 290' ' ' LEU . 49.5 t0 -42.57 -35.03 0.97 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.842 -175.788 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -74.69 -43.64 54.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.847 -174.221 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.97 -52.04 9.63 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.453 -171.015 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.685 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.7 OUTLIER -72.05 -22.54 61.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.336 . . . . 0.0 110.943 -177.869 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.512 ' N ' HD12 ' A' ' 290' ' ' LEU . 86.5 tt0 -67.13 -41.37 86.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 169.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.59 84.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.069 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.7 HG13 ' HA3' ' A' ' 19' ' ' GLY . 46.4 t -75.66 -45.54 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 -178.403 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -65.31 -35.09 79.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.98 -32.15 73.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 -173.424 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.752 ' HB3' ' HB3' ' A' ' 18' ' ' ASN . 63.8 m-20 -99.77 -35.19 9.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 -174.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.435 ' O ' HD13 ' A' ' 299' ' ' LEU . 46.9 tptt -129.11 124.45 22.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.563 0.697 . . . . 0.0 110.947 170.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -52.3 108.02 0.22 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.743 2.295 . . . . 0.0 112.281 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 297' ' ' LYS . 2.2 mp -92.26 -28.67 16.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 175.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.1 -55.9 1.81 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.466 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -174.27 168.53 3.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.0 111.094 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.586 ' CG2' ' HB3' ' A' ' 307' ' ' TYR . 32.2 m -135.0 161.84 39.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.126 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.44 -10.19 59.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.027 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.685 ' CD2' HD21 ' A' ' 290' ' ' LEU . 61.2 tp -79.75 129.43 34.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.866 -174.246 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -42.99 -31.93 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.899 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.443 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 70.6 m -47.83 -38.77 16.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.846 175.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.586 ' HB3' ' CG2' ' A' ' 302' ' ' VAL . 0.1 OUTLIER -58.99 -45.62 90.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.918 173.303 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.48 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 88.1 tt0 -56.96 -37.71 71.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.855 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -79.91 -64.1 1.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.833 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -85.01 -58.89 2.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -171.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 307' ' ' TYR . 56.0 mt -62.66 -32.62 73.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -168.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.1 -12.78 54.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.057 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.95 -18.31 64.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.838 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.498 ' HB3' HD12 ' A' ' 317' ' ' ILE . 58.2 t0 -78.88 121.23 83.18 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.616 0.722 . . . . 0.0 110.819 167.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.85 -36.4 15.19 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.647 2.231 . . . . 0.0 112.327 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 94.7 mtm-85 -73.12 -36.5 66.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.498 HD12 ' HB3' ' A' ' 314' ' ' ASP . 74.3 mt -77.07 -29.98 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.41 91.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.085 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.98 -48.56 73.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.076 175.373 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 68.9 p -67.58 -26.55 66.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.082 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 63.8 ttp -58.31 -37.28 74.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.866 173.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -67.36 -45.07 77.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.806 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.544 ' HB2' HG11 ' A' ' 246' ' ' VAL . 29.8 t30 -63.49 -36.53 84.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 176.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' A' ' 259' ' ' VAL . . . -65.03 -47.56 76.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.032 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -71.48 -34.17 69.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.7 -3.7 42.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.938 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -106.17 -162.25 22.74 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.465 -174.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -143.64 139.93 29.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.838 0.351 . . . . 0.0 110.779 -171.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.587 ' O ' ' C ' ' A' ' 330' ' ' MET . 41.2 mm -81.32 112.78 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.148 -172.287 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.587 ' C ' ' O ' ' A' ' 329' ' ' ILE . 71.6 mtm . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.583 0.706 . . . . 0.0 110.823 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.87 0.367 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 336' ' ' MET . . . . . 0.485 ' SD ' ' HB3' ' A' ' 168' ' ' ALA . 37.6 mmt -62.2 -26.04 68.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 -174.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.5 m -57.92 -36.86 73.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.814 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.59 -36.68 73.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.542 ' O ' HG13 ' A' ' 343' ' ' VAL . 45.5 m-85 -65.25 -44.23 88.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.814 174.83 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -64.96 -39.25 93.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.925 -176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -67.6 -47.39 69.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.72 -42.42 97.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 339' ' ' PHE . 7.7 m -80.98 -23.08 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.526 ' HD2' ' HD3' ' A' ' 154' ' ' PRO . 57.6 ttt180 -57.41 -56.56 20.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 81.5 p -60.68 -25.69 66.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.066 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.511 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -60.08 -41.13 91.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.592 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.5 m -73.11 -32.95 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.061 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.05 -45.24 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -64.35 -36.17 83.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.61 -46.15 60.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.113 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.38 88.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 -175.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 92.8 p -74.98 -10.79 59.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.904 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.4 15.02 81.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.549 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.85 -31.79 45.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.71 0.29 . . . . 0.0 110.761 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -138.25 154.78 49.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.895 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.7 p -79.73 167.53 20.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.184 169.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.421 ' HA ' HD23 ' A' ' 192' ' ' LEU . 55.6 t -54.98 -42.04 61.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -59.11 -46.43 88.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 177.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -71.7 -53.22 14.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.81 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -67.99 -43.75 78.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -171.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -67.54 -40.71 84.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 -178.58 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.82 -39.69 93.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 173.185 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.2 -38.9 90.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.865 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.511 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -63.44 -42.24 98.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 173.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.487 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 23.3 tm0? -64.47 -36.83 85.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.052 0.453 . . . . 0.0 110.885 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 370' ' ' LYS . 93.2 m -67.01 -40.44 87.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 177.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -67.51 -35.02 78.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.847 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.542 ' CD1' HG21 ' A' ' 183' ' ' VAL . 62.2 mt -63.38 -40.13 87.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.079 0.466 . . . . 0.0 111.229 176.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.8 p -93.81 -10.92 32.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.174 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 366' ' ' THR . 99.6 mttt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.9 mt -85.9 132.19 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -135.4 143.97 46.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.934 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -55.67 134.13 51.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.431 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 94.94 2.01 62.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.519 -176.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.5 tttt -164.97 138.2 4.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.947 0.403 . . . . 0.0 110.851 174.308 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -146.68 157.4 43.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.823 -173.821 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 86.6 t -114.5 133.47 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 -177.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.825 HD13 HD11 ' A' ' 20' ' ' LEU . 1.3 mp -119.28 125.81 74.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.596 ' CE3' ' HG3' ' A' ' 57' ' ' PRO . 45.1 m0 -106.02 128.97 54.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 178.202 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 12' ' ' ASN . 68.0 mt -122.1 141.45 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.168 172.223 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.417 ' O ' HG22 ' A' ' 11' ' ' ILE . 65.0 t30 -49.19 141.77 7.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 172.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.51 ' HA3' ' OD2' ' A' ' 41' ' ' ASP . . . -57.72 -11.14 7.32 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 -172.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -71.93 -17.07 62.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 110.868 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -129.92 111.2 12.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 161.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.98 -90.47 0.83 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.504 -159.472 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -101.71 -41.65 6.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.833 -172.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.78 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 85.2 m-20 -63.56 -53.58 49.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.804 -156.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.717 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -59.86 -48.07 87.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.503 -175.326 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.825 HD11 HD13 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -55.35 -60.97 2.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.0 110.914 175.66 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.21 -41.37 60.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -176.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -65.17 -54.24 32.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.65 -35.7 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.429 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -65.04 -41.88 96.98 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 176.458 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.01 -41.26 82.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 110.892 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -64.39 -39.62 94.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.26 -45.81 89.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.953 178.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -68.44 -38.97 81.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.806 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.38 -37.05 82.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -82.1 -39.27 23.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -169.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.539 ' OG1' HG13 ' A' ' 33' ' ' ILE . 71.2 p -109.94 -11.17 14.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.178 -174.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.44 14.04 82.59 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.462 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.127 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 pp -104.82 125.09 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.926 0.393 . . . . 0.0 111.029 -177.014 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.3 mttt -71.61 135.93 47.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 -168.31 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.539 HG12 HD21 ' A' ' 7' ' ' LEU . 8.4 m -110.7 135.45 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.046 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.405 ' O ' HD12 ' A' ' 9' ' ' ILE . 97.7 m -107.62 128.54 54.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.186 176.802 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.535 HG22 ' HG ' ' A' ' 20' ' ' LEU . 71.0 t -96.76 120.79 46.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.577 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 68.3 mm-40 -130.53 144.62 51.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.841 172.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -156.71 58.61 1.66 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.543 0.687 . . . . 0.0 110.79 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.462 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 77.6 Cg_endo -81.84 -13.23 10.6 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.719 2.28 . . . . 0.0 112.382 -171.01 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.51 ' OD2' ' HA3' ' A' ' 13' ' ' GLY . 20.8 m-20 63.06 20.05 12.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -171.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 45' ' ' GLU . 98.0 mttt -91.06 0.96 57.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 174.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.2 mt -43.69 -50.15 7.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -170.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.16 -36.56 82.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 42' ' ' LYS . 99.1 mt-10 -74.96 -33.17 61.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 69.8 mmtt -82.57 -29.98 29.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.936 -175.204 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.511 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 11.6 m-30 -40.18 -56.01 3.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.626 0.727 . . . . 0.0 110.783 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 57.3 Cg_endo -69.13 -28.09 28.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.313 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -79.08 -43.62 23.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 -172.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.8 m -65.69 -30.6 50.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.75 -36.04 79.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 172.398 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.13 -31.25 68.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.966 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 p -93.02 -11.45 33.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.112 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.47 15.27 81.32 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.469 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -164.86 159.05 17.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.953 0.406 . . . . 0.0 110.812 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.7 -140.33 2.85 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.321 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.596 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 72.6 Cg_endo -67.8 148.57 77.33 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.664 2.243 . . . . 0.0 112.354 168.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -74.32 -39.07 63.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.63 ' HB ' HG23 ' A' ' 9' ' ' ILE . 3.7 mp -126.13 138.71 53.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 176.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.47 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 1.8 tp -131.39 130.06 62.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.09 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.515 ' CE2' HG13 ' A' ' 108' ' ' ILE . 4.3 m-85 -98.63 140.31 33.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.785 176.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.529 ' CH2' ' HA3' ' A' ' 265' ' ' GLY . 9.1 m-90 -116.99 140.09 49.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 262' ' ' LEU . . . -57.99 -82.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.129 -176.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -126.41 -58.21 1.35 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.989 166.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -86.11 -24.35 26.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.807 -167.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 97.0 mtt180 -59.87 -29.72 68.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.981 -160.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -68.08 -27.68 66.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.923 -170.65 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.32 -51.36 53.22 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.434 -172.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.7 -35.91 91.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.537 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 15.2 t80 -65.68 -38.12 88.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.866 0.365 . . . . 0.0 110.887 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.51 -44.03 58.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.085 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -62.39 -31.78 72.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -80.87 -11.95 59.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.99 176.055 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.8 32.08 64.24 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.515 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 1.8 mp -86.3 -3.04 58.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.829 0.347 . . . . 0.0 110.862 -172.63 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.541 ' C ' ' HB2' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -127.85 154.38 45.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 -177.381 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.627 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -73.94 136.86 43.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.127 175.131 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -71.02 131.37 43.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.903 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.468 HD12 ' CE2' ' A' ' 106' ' ' TYR . 33.6 pt -110.19 159.76 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 70.1 p -105.87 147.6 35.03 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.663 0.744 . . . . 0.0 111.087 -172.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.76 145.78 29.3 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.689 2.259 . . . . 0.0 112.301 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -112.96 112.03 23.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 170.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.58 -37.4 62.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.947 -178.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.95 94.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PHE . . . . . 0.549 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 18.6 m-30 -68.8 -49.51 57.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.822 178.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -53.74 -40.08 65.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.913 -176.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -57.69 -32.29 67.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.07 -15.28 54.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 61.8 mt -105.0 -104.95 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -167.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 40.6 t80 -165.23 133.94 2.61 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.675 0.75 . . . . 0.0 110.953 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 71.3 Cg_exo -52.89 -39.91 76.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.748 2.299 . . . . 0.0 112.372 -171.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -80.08 -28.13 39.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.0 m -69.92 -48.31 59.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.086 -167.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.479 ' HA ' HG22 ' A' ' 97' ' ' VAL . 53.8 p-90 -66.96 -28.96 68.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.898 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -70.69 -35.97 73.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.74 -25.9 65.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.506 HG23 HD22 ' A' ' 103' ' ' LEU . 19.8 m -101.27 17.71 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.177 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 67.5 ttt180 -102.56 133.67 47.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.972 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -147.89 130.11 15.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.827 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.6 t30 67.16 35.68 4.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.928 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.78 -4.25 66.09 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.539 174.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -133.96 159.99 39.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.33 . . . . 0.0 110.943 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.506 HD22 HG23 ' A' ' 97' ' ' VAL . 13.8 mt -73.51 144.82 46.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pp -122.17 6.81 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.19 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.678 ' HB1' ' HB3' ' A' ' 263' ' ' SER . . . -167.83 159.3 11.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.051 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.468 ' CE2' HD12 ' A' ' 79' ' ' ILE . 62.1 m-85 -117.25 147.44 40.45 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.689 0.757 . . . . 0.0 110.928 164.064 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.516 ' HB3' HG11 ' A' ' 261' ' ' VAL . 59.6 Cg_endo -72.36 118.09 5.44 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.666 2.244 . . . . 0.0 112.358 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.515 HG13 ' CE2' ' A' ' 61' ' ' PHE . 30.8 mm -96.29 -36.88 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -151.93 154.67 36.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.083 -176.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.44 134.95 63.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.018 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -118.07 129.76 55.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -150.92 157.12 42.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.113 177.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.635 ' HB2' ' HG3' ' A' ' 257' ' ' PRO . 7.4 mp -108.49 156.92 18.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 -172.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.1 p -150.39 161.19 42.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.929 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.899 HD13 ' O ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.22 124.3 44.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 175.922 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.71 HG13 HG23 ' A' ' 244' ' ' VAL . 4.6 mp -109.0 132.76 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.072 -174.605 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -133.08 148.28 52.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 -173.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -97.4 115.91 28.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.806 174.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -66.55 -15.84 63.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.781 172.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.537 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 22.8 t70 -80.87 -33.99 34.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.885 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 mp -87.9 -45.0 10.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.041 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.439 HD22 ' HB1' ' A' ' 223' ' ' ALA . 2.1 mp -106.08 127.62 27.97 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.545 0.688 . . . . 0.0 110.897 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.31 -30.09 16.14 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.732 2.288 . . . . 0.0 112.343 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -148.9 90.0 4.85 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.61 0.719 . . . . 0.0 110.944 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.51 144.97 90.84 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.668 2.245 . . . . 0.0 112.351 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.58 153.31 73.82 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.689 2.26 . . . . 0.0 112.336 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -107.72 -3.96 18.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.847 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.6 p -133.94 159.02 42.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.148 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.428 ' HA ' HG12 ' A' ' 132' ' ' ILE . 64.4 m95 -72.2 -24.65 61.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.4 -30.02 70.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.05 -19.31 60.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.85 -177.471 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.604 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 49.8 mm -61.49 -53.52 61.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.716 0.769 . . . . 0.0 111.138 -165.346 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 22.6 Cg_endo -61.7 -40.03 48.91 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.635 2.223 . . . . 0.0 112.276 -176.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.24 -60.67 2.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.065 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.178 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.52 -16.5 63.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.862 -174.462 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.629 ' HA ' HD22 ' A' ' 139' ' ' LEU . 38.7 t70 -61.74 -38.9 89.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.848 168.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.87 -36.44 82.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -73.6 -49.79 24.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.726 -174.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.662 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -74.97 -15.94 60.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -176.654 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.662 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.8 tttt -56.43 -34.92 67.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.928 171.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.99 -23.75 67.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -94.32 7.99 43.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.95 27.41 64.6 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.415 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.417 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 45.5 mtmt -119.94 169.5 10.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.4 . . . . 0.0 110.863 173.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.52 ' HA ' HD21 ' A' ' 139' ' ' LEU . 33.5 t -133.1 143.95 49.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 172.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 224' ' ' MET . . . -71.98 -54.12 10.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.101 -162.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -139.65 125.47 19.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.948 -165.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.422 ' SD ' ' HB2' ' A' ' 213' ' ' ALA . 57.6 ttm -106.28 129.22 54.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.891 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -154.71 164.24 39.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -122.81 142.92 50.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.942 171.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.495 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 50.8 tp -111.4 -0.13 16.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 -176.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -74.17 -6.04 45.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.936 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -119.73 150.18 49.85 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 121.679 0.752 . . . . 0.0 110.905 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.54 -18.82 64.13 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.632 2.221 . . . . 0.0 112.417 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -61.75 -37.21 83.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.927 -173.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -82.89 -40.17 20.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 23.6 p -63.77 -38.66 91.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.101 -175.269 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.581 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 22.2 t-105 -62.98 -54.44 46.56 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.567 0.699 . . . . 0.0 110.911 -168.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 28.5 Cg_endo -66.87 -32.19 36.75 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.696 2.264 . . . . 0.0 112.37 -172.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 160' ' ' LEU . 6.4 tt -74.69 -41.04 60.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.53 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 74.4 mt -70.48 -40.89 77.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.109 177.909 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.96 -26.14 63.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.45 -29.46 70.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.126 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -91.29 2.75 56.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 104.99 7.05 39.05 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.56 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -79.02 65.06 3.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.359 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -90.22 146.2 24.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.863 0.363 . . . . 0.0 110.911 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.42 -15.35 63.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.063 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -164.42 150.07 10.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.841 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -81.74 128.18 33.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.937 163.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -100.79 120.5 40.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.921 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -149.72 133.2 16.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.881 -173.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 61.9 t30 57.51 43.42 22.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.04 7.25 70.47 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.499 173.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -134.9 145.29 48.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.785 0.326 . . . . 0.0 110.888 -177.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -78.66 143.24 36.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 168.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -107.18 105.98 16.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.8 tp -71.28 -18.03 20.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.14 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -94.61 -8.99 36.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -177.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -129.56 93.05 3.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 172.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.9 m -114.01 167.62 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.128 -175.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.58 13.35 54.09 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.486 -171.441 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.512 HG11 ' CD1' ' A' ' 368' ' ' ILE . 33.7 m -104.85 -16.91 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.318 . . . . 0.0 111.096 -173.211 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.42 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 57.9 p-10 -95.09 18.07 12.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.934 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -115.91 172.86 6.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.88 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.21 -26.71 68.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.209 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.11 -41.28 92.68 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.526 -170.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.625 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.08 -40.6 94.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 111.02 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.49 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.1 mttt -60.83 -37.1 80.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 173.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.5 87.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.121 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.72 -46.02 91.06 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.421 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.591 HD11 ' HA ' ' A' ' 347' ' ' VAL . 22.6 tp -68.64 -34.8 76.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.922 0.391 . . . . 0.0 110.993 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.406 ' O ' HG12 ' A' ' 196' ' ' VAL . 85.4 m -61.83 -42.26 98.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -68.07 -56.99 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.676 ' C ' HD12 ' A' ' 195' ' ' LEU . 2.6 pp -63.64 -27.5 69.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 -165.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.553 ' N ' HD12 ' A' ' 195' ' ' LEU . 4.5 p -72.65 -22.85 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.182 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -66.03 -58.22 5.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -174.096 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 1.057 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.5 -24.25 56.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -167.474 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.801 ' N ' HD22 ' A' ' 198' ' ' LEU . 2.0 pp -77.46 -35.64 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.15 172.432 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.02 -30.36 70.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.8 168.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -84.65 5.37 28.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.878 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 66.07 40.06 4.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.94 170.209 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -82.12 -10.54 59.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.5 ' CG ' HG22 ' A' ' 199' ' ' ILE . 5.4 ppp? -141.08 154.26 45.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.848 175.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -99.0 156.13 17.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.89 -24.88 68.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.132 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.83 -2.59 50.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 88.7 m -64.38 131.49 47.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.227 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -147.23 173.39 12.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.926 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -78.66 -32.09 47.03 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.899 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 99.1 p -74.13 -38.84 63.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -172.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 39.5 pt -65.04 -20.11 26.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.105 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.422 ' HB2' ' SD ' ' A' ' 148' ' ' MET . . . -58.42 -32.45 68.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.19 -43.53 87.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.834 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.04 -36.82 85.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.147 174.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.1 79.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.065 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -65.08 -42.46 94.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.895 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -64.95 -33.94 77.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.896 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -92.51 -24.36 18.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.05 30.99 21.5 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.568 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -91.83 -31.61 15.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.85 0.357 . . . . 0.0 110.914 -168.96 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 96.9 m -115.89 127.58 55.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.089 -171.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.439 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -70.71 -44.97 65.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 -175.795 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.415 ' N ' ' O ' ' A' ' 146' ' ' ALA . 68.1 mtm -134.05 146.98 50.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 -172.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' THR . . . . . 0.421 HG21 ' HB1' ' A' ' 213' ' ' ALA . 43.3 p -140.01 161.64 37.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 177.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.2 mm -112.4 114.85 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.07 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' ASN . . . . . 0.451 ' HB2' HD13 ' A' ' 116' ' ' ILE . 31.3 m120 -145.41 153.32 41.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -171.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.456 ' HA3' ' HG ' ' A' ' 113' ' ' LEU . . . -133.56 -123.3 2.38 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.5 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' PRO . . . . . 0.404 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 30.2 Cg_endo -61.97 -19.95 67.78 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.766 2.311 . . . . 0.0 112.269 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -65.19 -30.08 70.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.925 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 51.12 38.3 20.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.078 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -70.02 -27.87 65.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.046 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 72.7 m -53.22 117.95 3.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.86 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -74.86 -169.05 0.82 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 20.4 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 -178.442 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 240' ' ' VAL . 15.8 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.877 0.37 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.537 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 74.6 m-20 42.12 70.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -126.0 132.8 51.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 -172.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.97 158.33 24.17 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.508 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.71 HG23 HG13 ' A' ' 116' ' ' ILE . 3.2 p -145.46 139.94 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 0.0 111.156 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.0 t -155.37 151.82 28.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.075 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' VAL . . . . . 0.485 HG11 ' HB2' ' A' ' 323' ' ' ASN . 28.2 m -62.3 168.4 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.096 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.753 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.7 mm? -61.81 143.37 94.28 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.644 0.735 . . . . 0.0 110.921 -162.198 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.56 -176.52 3.17 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.649 2.233 . . . . 0.0 112.457 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 95.2 m -100.41 146.33 27.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.14 -171.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -139.02 119.12 13.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 54.97 37.13 28.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.96 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.09 -0.46 83.96 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -130.96 140.09 37.62 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.588 0.709 . . . . 0.0 110.914 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -70.93 141.23 39.98 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.669 2.246 . . . . 0.0 112.412 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.753 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 82.7 p -82.39 -3.47 55.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 172.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -40.48 129.69 1.77 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.555 0.693 . . . . 0.0 110.894 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.635 ' HG3' ' HB2' ' A' ' 113' ' ' LEU . 85.8 Cg_endo -86.32 164.82 9.67 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.731 2.287 . . . . 0.0 112.446 -171.462 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -75.0 169.96 16.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.863 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.14 132.29 57.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.114 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.52 143.9 16.23 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.458 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' A' ' 107' ' ' PRO . 97.9 t -128.66 126.51 65.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.986 0.422 . . . . 0.0 111.081 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 2.0 tt -71.86 136.34 46.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 171.185 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.678 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 74.7 m -118.9 148.97 42.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -174.232 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.471 ' HB1' HD11 ' A' ' 280' ' ' LEU . . . -133.78 137.53 45.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 174.151 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.529 ' HA3' ' CH2' ' A' ' 62' ' ' TRP . . . -140.76 170.14 24.61 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.549 -173.493 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 22.7 mm -114.22 132.37 63.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 111.136 -171.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -65.04 133.8 52.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -172.771 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.627 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -63.0 -29.79 71.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.115 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.38 -8.11 59.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.038 -172.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 24.2 t -69.98 120.14 75.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.698 0.761 . . . . 0.0 110.848 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.42 -16.23 19.41 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.733 2.289 . . . . 0.0 112.362 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.405 ' HB2' HD21 ' A' ' 275' ' ' LEU . 53.2 p-10 -114.16 29.97 7.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -177.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -61.48 -24.55 66.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 -169.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -63.65 -45.58 89.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.851 -169.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 272' ' ' ASN . 2.2 pp -75.8 -33.28 60.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -178.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.413 ' HB1' HD11 ' A' ' 59' ' ' ILE . . . -65.8 -50.24 65.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.056 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -65.95 -36.48 83.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.868 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -68.98 -45.36 70.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -59.08 -47.12 86.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.93 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.471 HD11 ' HB1' ' A' ' 264' ' ' ALA . 8.0 tt -59.54 -52.24 66.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.889 -175.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -73.99 -25.72 60.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.953 -174.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -99.74 -14.18 18.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.942 -170.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.484 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 44.6 t80 -122.2 -56.54 1.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.404 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.4 OUTLIER -68.58 -39.69 80.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.854 -176.264 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.84 23.03 0.57 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 174.071 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 89.1 m -128.51 147.61 50.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.206 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.493 ' HA ' HD11 ' A' ' 290' ' ' LEU . 37.4 t70 -40.78 -38.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.774 -176.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.27 -42.57 68.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.856 -173.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.51 -52.03 8.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.445 -171.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.669 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -73.41 -21.97 60.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.815 0.34 . . . . 0.0 110.952 -177.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.478 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.4 tt0 -66.71 -42.69 85.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 169.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.93 -35.94 81.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.003 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.717 HG13 ' HA3' ' A' ' 19' ' ' GLY . 42.3 t -75.78 -44.27 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.166 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -65.05 -31.81 73.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.787 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.97 -32.2 72.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.932 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.78 ' HB3' ' HB3' ' A' ' 18' ' ' ASN . 63.7 m-20 -95.02 -29.64 14.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.834 -173.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.431 ' O ' HD13 ' A' ' 299' ' ' LEU . 77.3 tttt -146.1 135.47 11.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.626 0.727 . . . . 0.0 110.854 164.952 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.27 116.78 3.18 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.667 2.245 . . . . 0.0 112.33 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.431 HD13 ' O ' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -90.08 -22.57 21.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 174.829 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.95 -55.79 1.85 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.531 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.427 ' HA ' HD23 ' A' ' 311' ' ' LEU . . . -177.71 161.87 1.7 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.868 0.366 . . . . 0.0 111.191 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.594 ' CG2' ' HB3' ' A' ' 307' ' ' TYR . 33.8 m -128.57 159.93 39.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.153 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.46 -2.07 30.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.669 ' CD2' HD21 ' A' ' 290' ' ' LEU . 60.3 tp -87.94 130.38 34.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 -175.736 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -44.55 -32.42 1.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.484 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 74.4 m -48.16 -39.2 20.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.594 ' HB3' ' CG2' ' A' ' 302' ' ' VAL . 0.1 OUTLIER -58.93 -45.41 90.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 173.477 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.463 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 84.4 tt0 -54.63 -34.34 61.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.808 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -79.85 -63.3 1.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.8 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -82.71 -58.27 2.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -170.787 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 311' ' ' LEU . 0.0 OUTLIER -60.14 -36.63 77.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -170.562 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.98 -14.42 53.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.41 -20.46 65.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.491 ' HB3' HD12 ' A' ' 317' ' ' ILE . 60.3 t0 -79.61 120.7 81.05 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.609 0.719 . . . . 0.0 110.921 167.234 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.68 -35.42 13.02 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.656 2.237 . . . . 0.0 112.351 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -70.81 -36.99 73.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.875 -176.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.491 HD12 ' HB3' ' A' ' 314' ' ' ASP . 70.7 mt -78.46 -30.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.182 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.48 -39.59 91.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.102 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.98 -47.24 78.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.118 174.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 320' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 74.1 p -67.55 -25.17 65.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.188 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -62.05 -38.03 87.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 174.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -65.02 -47.05 78.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.821 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.485 ' HB2' HG11 ' A' ' 246' ' ' VAL . 36.9 t30 -63.47 -38.17 90.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.73 -46.94 85.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.095 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -72.82 -30.98 64.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.37 -4.38 42.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.924 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -101.74 -161.78 26.88 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.465 -172.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -143.37 140.58 30.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.361 . . . . 0.0 110.825 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.584 ' O ' ' C ' ' A' ' 330' ' ' MET . 44.9 mm -82.51 106.63 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.17 -169.657 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.584 ' C ' ' O ' ' A' ' 329' ' ' ILE . 63.3 tpp . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 121.636 0.731 . . . . 0.0 110.874 175.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.8 0.333 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 22.8 mmt -77.9 -26.05 48.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 -175.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 62.1 p -65.27 -27.31 68.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.876 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -76.21 -36.06 58.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.168 173.258 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.408 ' N ' ' CD1' ' A' ' 339' ' ' PHE . 7.8 m-30 -61.16 -37.82 84.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.827 170.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -62.62 -32.7 73.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.021 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -72.87 -40.52 65.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.92 -40.08 91.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.106 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 346' ' ' ALA . 13.2 m -80.33 -24.01 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.142 177.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.555 ' O ' HG22 ' A' ' 347' ' ' VAL . 1.1 tmt_? -59.92 -50.24 74.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 171.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 56.1 m -57.88 -29.94 65.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.084 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 343' ' ' VAL . . . -56.33 -39.3 72.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.591 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.0 OUTLIER -72.6 -32.66 42.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 -176.402 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.35 -46.78 92.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.077 172.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -63.2 -34.66 78.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.98 -45.72 59.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.58 -40.51 88.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.155 -175.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.1 p -75.05 -12.08 60.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 110.891 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.16 14.95 82.06 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.579 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.27 -32.43 49.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.815 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -136.77 153.88 50.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.959 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.6 p -79.47 167.82 20.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.192 169.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.441 ' HA ' HD23 ' A' ' 192' ' ' LEU . 54.4 t -55.12 -41.99 62.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 172.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.35 -45.95 89.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.828 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -72.25 -53.18 13.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.831 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.11 -44.65 75.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.031 -171.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.625 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -66.98 -40.53 87.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.969 -178.142 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.98 -40.45 94.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.954 174.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.38 -39.72 94.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.75 98.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.42 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 1.1 tm0? -63.26 -38.44 91.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.958 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.9 m -65.01 -38.56 91.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.102 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 79.4 mtt-85 -67.25 -35.67 80.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.84 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.512 ' CD1' HG11 ' A' ' 183' ' ' VAL . 73.8 mt -66.47 -45.05 90.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.127 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 71.1 p -99.02 -8.63 25.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.158 -174.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.956 176.27 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.0 mt -82.82 129.93 36.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.159 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.44 143.48 43.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -56.35 134.98 53.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.575 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 97.61 -1.62 60.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.465 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 65.0 pttt -165.3 144.09 6.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.783 0.325 . . . . 0.0 110.902 172.794 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.533 HD22 HD13 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -148.49 159.97 43.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.792 -175.019 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 90.3 t -113.78 132.94 61.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.161 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.814 HD13 HD11 ' A' ' 20' ' ' LEU . 1.2 mp -119.32 124.97 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.081 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.574 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 44.2 m0 -104.62 127.1 52.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.894 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -119.4 141.75 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.146 172.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -51.36 147.52 5.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.47 -12.8 9.69 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.501 -172.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -75.17 -17.05 60.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.856 0.36 . . . . 0.0 110.813 -174.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.1 mtmm -129.94 110.09 11.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 163.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.09 -91.53 0.81 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.443 -160.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -101.81 -42.37 6.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 110.856 -171.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASN . . . . . 0.76 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 86.0 m-20 -61.86 -52.08 65.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.843 -157.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.746 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -61.99 -48.55 82.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.516 -175.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.814 HD11 HD13 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -56.52 -61.2 2.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.879 0.371 . . . . 0.0 110.922 177.824 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.66 -41.38 70.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 -174.484 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -65.05 -53.11 50.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -176.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 19' ' ' GLY . 18.7 m -74.89 -38.06 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.162 -175.768 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.617 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -65.12 -42.47 96.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.527 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.34 -41.33 88.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 110.927 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -63.21 -39.6 95.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.853 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -66.18 -36.95 84.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.839 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -62.12 -39.91 94.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 172.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -67.82 -33.98 75.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.911 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -86.76 -41.78 13.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -170.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.625 ' OG1' HG13 ' A' ' 33' ' ' ILE . 77.0 p -106.8 -14.86 14.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.212 -174.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.75 8.93 83.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.503 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.96 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.2 pp -106.35 130.41 58.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 111.093 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.9 mttt -75.95 139.78 41.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -171.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.617 HG21 ' HA3' ' A' ' 24' ' ' GLY . 5.8 m -112.36 135.81 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.402 ' O ' HD12 ' A' ' 9' ' ' ILE . 99.3 m -105.93 128.31 53.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.083 176.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.539 HG22 ' HG ' ' A' ' 20' ' ' LEU . 80.9 t -96.57 120.0 45.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.105 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.574 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 68.3 mm-40 -130.31 145.2 51.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.891 171.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -156.1 58.3 1.71 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.599 0.714 . . . . 0.0 110.87 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.95 -27.43 5.8 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.762 2.308 . . . . 0.0 112.343 -172.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.0 t0 68.87 13.19 8.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.863 -167.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 45' ' ' GLU . 99.1 mttt -87.84 1.56 53.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.988 171.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.3 mt -44.37 -50.14 9.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.948 -168.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.9 -27.56 67.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 42' ' ' LYS . 98.3 mt-10 -79.01 -32.45 45.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.882 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -81.84 -29.27 32.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.868 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.544 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 14.4 m-30 -45.26 -54.4 14.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.635 0.731 . . . . 0.0 110.852 -175.248 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 53.1 Cg_endo -66.4 -27.3 47.3 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.656 2.237 . . . . 0.0 112.336 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -79.4 -42.98 24.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.915 -175.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.3 m -71.62 -28.03 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.106 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.23 -35.2 79.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.109 171.101 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.35 -31.99 71.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.132 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.9 p -92.47 -12.11 32.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.96 14.97 81.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.609 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -161.9 157.14 23.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.891 0.377 . . . . 0.0 110.842 176.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.431 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . -165.04 -141.08 3.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.437 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.55 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 69.9 Cg_endo -66.97 149.78 82.87 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.622 2.214 . . . . 0.0 112.376 169.8 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -75.49 -38.45 59.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.56 ' HB ' HG23 ' A' ' 9' ' ' ILE . 4.1 mp -126.61 138.82 53.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 177.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.534 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 2.2 tp -133.35 131.56 57.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.117 -178.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.503 ' CE2' HG13 ' A' ' 108' ' ' ILE . 3.1 m-85 -99.36 139.69 34.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.769 177.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.627 ' HH2' ' HA3' ' A' ' 265' ' ' GLY . 3.4 m-90 -120.06 140.09 51.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.829 174.376 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.49 -85.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.06 -178.298 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -116.26 -62.99 1.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.834 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -85.41 -30.46 23.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -167.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -62.1 -31.58 72.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.935 -158.309 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -67.77 -29.29 68.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -172.562 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.22 -52.33 41.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.439 -174.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.14 -39.93 98.55 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.507 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.552 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 28.8 t80 -66.08 -41.38 90.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 110.891 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.08 -44.29 63.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.096 176.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -55.02 -39.9 69.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.893 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.2 m -82.53 -8.12 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.65 35.06 59.31 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.519 174.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 mp -84.99 -2.16 57.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 0.0 110.907 -173.911 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.552 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -128.67 154.55 46.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -178.178 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.623 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -70.93 134.38 47.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 175.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -71.18 131.09 43.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.445 HD12 ' CE2' ' A' ' 106' ' ' TYR . 29.3 pt -110.12 160.0 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.99 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.2 p -105.17 148.34 36.04 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.565 0.697 . . . . 0.0 111.127 -172.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.15 142.66 31.07 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.774 2.316 . . . . 0.0 112.362 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -103.44 120.3 40.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 172.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.67 -38.67 69.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.47 91.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -72.87 -35.29 67.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.853 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -54.58 -46.72 73.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.84 176.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -65.83 -34.59 78.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.819 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -78.63 -24.01 45.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 -174.663 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -95.01 -96.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.957 -171.392 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.439 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 36.9 t80 -176.31 137.75 0.48 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.718 0.771 . . . . 0.0 110.833 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -53.42 -39.28 82.35 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.331 -172.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -79.3 -30.27 42.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.439 ' OG1' ' HB3' ' A' ' 90' ' ' TYR . 55.7 m -70.0 -49.35 52.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.204 -165.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.434 ' HA ' HG22 ' A' ' 97' ' ' VAL . 51.7 p-90 -64.32 -29.98 71.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.46 -35.35 68.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.886 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.32 -25.01 64.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.741 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 19.6 m -101.8 17.92 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.172 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 63.7 ttt180 -101.13 133.3 45.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.957 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -144.25 129.45 18.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.4 t30 65.01 35.27 8.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.88 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.94 -4.77 73.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.476 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -132.55 158.59 41.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.816 0.341 . . . . 0.0 110.897 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.523 HD22 HG23 ' A' ' 97' ' ' VAL . 13.9 mt -72.98 147.52 45.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.1 pp -125.21 10.34 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.147 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.761 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -163.26 151.32 13.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.041 -176.672 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 45.1 m-85 -115.02 136.28 22.58 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.659 0.742 . . . . 0.0 110.919 163.988 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 40.0 Cg_exo -60.23 118.17 5.01 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.664 2.243 . . . . 0.0 112.393 177.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.503 HG13 ' CE2' ' A' ' 61' ' ' PHE . 30.6 mm -99.38 -41.63 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.184 177.063 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -152.95 152.56 31.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.133 -175.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.7 p -123.91 134.18 67.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.082 -175.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.06 128.73 54.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.802 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.09 153.96 37.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.092 172.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.482 HD22 ' HG3' ' A' ' 257' ' ' PRO . 8.0 mp -104.72 158.87 16.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.86 -169.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.2 p -150.45 156.49 41.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.937 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.859 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -100.06 125.9 46.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 176.193 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.584 ' N ' HD22 ' A' ' 115' ' ' LEU . 3.7 mp -106.03 135.33 44.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 -175.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -136.7 149.89 48.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -92.95 119.83 32.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.793 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -67.47 -18.65 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 167.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.484 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 20.3 t70 -75.28 -32.42 61.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.908 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.2 mp -93.25 -44.98 8.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.965 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 21.6 mt -104.42 113.63 64.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.599 0.714 . . . . 0.0 110.872 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.84 -26.64 31.98 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.702 2.268 . . . . 0.0 112.378 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.424 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 56.5 t-20 -149.57 94.99 3.8 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.56 0.695 . . . . 0.0 110.871 172.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 37.8 Cg_endo -69.14 151.03 72.64 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 0.0 112.237 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.86 151.62 62.94 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.691 2.26 . . . . 0.0 112.33 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -108.54 -8.6 15.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.937 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 72.3 p -132.21 159.01 40.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -65.25 -31.35 72.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.03 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.85 -27.83 67.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.81 -12.7 59.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.625 ' O ' HD13 ' A' ' 135' ' ' LEU . 49.4 mm -64.98 -53.07 44.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.679 0.752 . . . . 0.0 111.19 -172.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 30.1 Cg_endo -61.74 -37.21 69.56 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.635 2.223 . . . . 0.0 112.347 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.65 -61.31 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.018 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.181 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -71.16 -18.34 62.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 -177.258 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.577 ' HA ' HD22 ' A' ' 139' ' ' LEU . 38.9 t70 -63.6 -40.94 98.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 169.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.85 -38.16 89.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.93 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.6 -50.66 23.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -75.73 -16.53 60.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.937 -175.893 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.623 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.2 tttt -56.96 -34.41 68.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.97 172.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.78 -23.68 67.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -95.19 10.22 36.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.769 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.97 30.1 59.8 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.515 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.453 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 90.7 mttt -120.06 169.57 10.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 110.796 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.0 t -132.39 138.52 47.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.518 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -71.75 -53.87 12.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 -165.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -137.36 131.72 32.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 -164.132 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' MET . . . . . 0.658 ' HG2' ' HB2' ' A' ' 213' ' ' ALA . 60.3 tpp -105.04 120.1 40.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -153.28 164.97 37.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -174.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -131.66 167.19 19.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 168.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.8 tp -116.26 -23.2 8.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -70.37 -4.07 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.851 -168.11 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -110.39 152.12 43.09 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.681 0.753 . . . . 0.0 110.819 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' PRO . . . . . 0.533 ' HD3' ' NE ' ' A' ' 344' ' ' ARG . 29.9 Cg_endo -67.55 -20.89 46.92 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.633 2.222 . . . . 0.0 112.304 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -59.19 -39.07 81.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.907 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -83.24 -42.97 16.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.786 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 41.9 p -65.37 -39.86 92.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.096 -170.081 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.574 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 17.5 t-105 -64.31 -53.86 43.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.589 0.709 . . . . 0.0 110.959 -169.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 36.2 Cg_endo -68.91 -32.24 22.77 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.596 2.198 . . . . 0.0 112.394 -172.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.717 HD23 ' O ' ' A' ' 160' ' ' LEU . 6.4 tt -72.74 -40.75 65.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.561 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 72.1 mt -69.77 -41.44 79.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.78 -27.67 63.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.034 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.56 -31.41 71.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -92.38 3.79 54.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 107.89 3.95 34.03 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.507 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.404 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -79.6 66.22 3.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.427 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' TYR . . . . . 0.432 ' O ' HG13 ' A' ' 183' ' ' VAL . 80.8 m-85 -90.02 145.41 25.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.853 0.359 . . . . 0.0 110.911 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.96 0.41 15.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.987 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -154.67 151.74 29.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.86 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -100.38 129.99 46.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.822 159.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -92.42 123.75 35.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -151.3 131.29 13.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.908 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.0 t30 57.57 43.6 22.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 171.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.65 77.41 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.54 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.88 144.26 47.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.877 -176.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -80.79 133.68 35.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 167.412 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -99.57 114.33 27.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.1 tp -72.91 -20.05 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.12 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.0 -10.25 36.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.908 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -127.57 95.02 4.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 169.282 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.4 m -112.01 163.11 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.1 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -97.64 13.29 64.17 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.486 -171.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.719 HG21 HD12 ' A' ' 368' ' ' ILE . 35.4 m -106.97 -13.43 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 111.058 -176.202 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -89.17 15.34 9.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -127.26 -171.27 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.26 -25.98 64.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.2 -173.657 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.93 -43.6 95.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.552 -167.41 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.718 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -67.57 -38.48 84.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 0.0 111.049 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.487 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.3 mttt -60.23 -35.29 75.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 174.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.29 -38.04 89.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.207 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -65.02 -45.75 91.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.365 177.466 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.604 HD11 ' HA ' ' A' ' 347' ' ' VAL . 17.8 tp -69.9 -32.99 71.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 0.0 110.964 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.45 ' O ' HG12 ' A' ' 196' ' ' VAL . 79.1 m -64.69 -42.11 95.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.169 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -70.55 -54.69 11.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.648 ' C ' HD12 ' A' ' 195' ' ' LEU . 3.6 pp -63.67 -23.91 67.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.989 -167.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.582 ' N ' HD12 ' A' ' 195' ' ' LEU . 1.2 p -74.54 -24.08 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.157 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.78 -55.41 19.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.837 -172.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 1.03 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.74 -24.6 56.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.943 -168.044 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.764 ' N ' HD22 ' A' ' 198' ' ' LEU . 2.0 pp -81.73 -33.88 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.077 173.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -65.26 -31.08 72.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -84.15 4.33 30.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.897 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 64.94 39.73 5.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.923 172.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -80.15 -11.71 59.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 174.406 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' MET . . . . . 0.428 ' CG ' HG22 ' A' ' 199' ' ' ILE . 5.3 ppp? -142.95 154.54 44.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.81 174.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -101.25 157.12 17.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.96 -28.37 70.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -97.44 -0.01 46.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.7 m -59.25 131.78 52.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.435 ' H ' HD11 ' A' ' 212' ' ' ILE . 23.1 t0 -144.17 171.55 14.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -82.42 -29.67 30.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.8 p -70.66 -38.54 73.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.925 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.435 HD11 ' H ' ' A' ' 209' ' ' ASP . 40.7 pt -67.48 -24.52 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.148 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ALA . . . . . 0.658 ' HB2' ' HG2' ' A' ' 148' ' ' MET . . . -59.68 -37.44 78.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 -177.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -57.74 -40.66 80.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.0 93.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.52 91.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.153 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -65.55 -33.9 77.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.78 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.43 -31.97 70.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.01 -18.44 22.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.914 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.63 29.04 22.56 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.477 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -92.03 -27.02 18.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 110.889 -171.755 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 98.3 m -111.02 125.03 53.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.167 -176.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.28 -49.43 23.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.173 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.414 ' N ' ' O ' ' A' ' 146' ' ' ALA . 66.3 mtm -134.98 155.45 50.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -171.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.7 t -153.02 166.26 32.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.111 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 40.3 mm -113.49 124.03 69.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -142.29 153.16 43.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.824 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -135.0 -95.03 0.49 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.446 175.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.97 -24.02 24.62 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.759 2.306 . . . . 0.0 112.239 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -74.75 -37.79 62.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.872 -173.546 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 49.72 40.3 19.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 -175.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -70.76 -22.99 62.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.4 t -51.37 130.8 27.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.907 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -87.7 -167.78 2.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.95 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.7 mt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 -174.704 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 240' ' ' VAL . 14.9 t . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.911 0.386 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 74.4 m-20 42.31 69.97 0.33 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -127.09 133.07 50.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -174.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -133.69 155.09 21.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.446 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.4 p -145.61 138.97 21.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.907 0.384 . . . . 0.0 111.113 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -155.64 152.61 28.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.116 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.8 m -60.81 168.45 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.681 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.5 mm? -61.12 150.74 77.97 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.658 0.742 . . . . 0.0 110.907 -162.249 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.48 -178.23 4.44 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.631 2.221 . . . . 0.0 112.293 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.5 m -98.37 142.24 30.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.12 -174.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -132.84 114.87 14.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.825 -176.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 54.91 36.52 26.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.99 2.74 88.24 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.613 174.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -130.71 138.1 32.26 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.618 0.723 . . . . 0.0 110.954 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -68.5 137.45 39.45 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.706 2.271 . . . . 0.0 112.389 -174.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.681 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 98.8 p -79.19 -8.12 58.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.823 174.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -49.99 116.6 6.53 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.475 0.655 . . . . 0.0 110.888 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' PRO . . . . . 0.482 ' HG3' HD22 ' A' ' 113' ' ' LEU . 72.5 Cg_endo -80.44 167.75 18.88 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.689 2.259 . . . . 0.0 112.264 -176.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -66.89 169.89 7.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 80.5 t -106.86 133.16 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.089 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.5 139.6 15.22 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.551 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 97.5 t -125.6 120.07 56.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.916 0.388 . . . . 0.0 111.1 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.407 HD23 ' C ' ' A' ' 262' ' ' LEU . 7.3 tt -78.98 129.13 34.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.989 168.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.761 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 96.5 p -132.39 160.76 35.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -170.622 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.62 143.04 50.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -175.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.627 ' HA3' ' HH2' ' A' ' 62' ' ' TRP . . . -139.64 172.53 23.27 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.47 -175.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 23.3 mm -113.53 131.0 66.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.847 0.356 . . . . 0.0 111.191 -171.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -65.28 133.59 51.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 -173.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.623 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -64.94 -27.2 68.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 -177.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.46 -8.58 59.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.996 -173.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.5 t -69.14 121.66 82.63 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.648 0.737 . . . . 0.0 110.948 -175.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.19 -17.79 18.86 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.311 172.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -112.05 29.29 8.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.963 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.02 -25.38 65.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -170.129 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -64.99 -43.38 92.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.822 -169.373 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.0 pp -76.93 -33.4 57.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.989 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.31 77.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.989 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -66.64 -35.01 79.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.921 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -69.4 -48.94 59.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.903 -173.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 0.6 OUTLIER -67.5 -31.24 71.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.922 -175.16 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 6.2 tt -64.61 -46.39 82.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.945 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -79.3 -24.88 42.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.887 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -97.61 -20.01 17.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.949 -168.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -119.97 -56.49 2.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.952 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 0.1 OUTLIER -65.68 -41.28 92.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.911 -176.085 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.66 48.21 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.922 169.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.432 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 74.2 m -145.52 146.69 31.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.112 173.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.431 ' HA ' HD11 ' A' ' 290' ' ' LEU . 35.8 t70 -40.0 -39.77 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.907 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.0 -41.69 64.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -172.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.83 -51.18 16.02 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.534 -172.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.69 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -75.49 -22.99 56.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.717 0.294 . . . . 0.0 110.89 -177.562 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.433 ' N ' HD12 ' A' ' 290' ' ' LEU . 86.6 tt0 -67.11 -40.6 86.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 169.747 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.95 -35.06 79.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.015 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.746 HG13 ' HA3' ' A' ' 19' ' ' GLY . 47.3 t -74.86 -43.68 46.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.14 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -63.28 -31.14 72.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.24 -32.34 73.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.807 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' ASP . . . . . 0.76 ' HB3' ' HB3' ' A' ' 18' ' ' ASN . 67.0 m-20 -94.99 -27.32 15.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 -173.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.401 ' O ' HD13 ' A' ' 299' ' ' LEU . 78.5 tttt -148.1 136.7 11.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.556 0.694 . . . . 0.0 110.857 168.136 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.33 111.87 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.687 2.258 . . . . 0.0 112.35 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 297' ' ' LYS . 0.4 OUTLIER -90.08 -28.58 18.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 174.697 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.06 -55.08 1.84 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.49 -176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.436 ' HA ' HD23 ' A' ' 311' ' ' LEU . . . -179.37 159.27 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.79 0.329 . . . . 0.0 111.067 -176.164 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.584 HG23 ' HB3' ' A' ' 307' ' ' TYR . 32.6 m -127.02 164.67 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.135 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -79.1 -4.22 49.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.066 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.69 ' CD2' HD21 ' A' ' 290' ' ' LEU . 58.9 tp -86.12 135.64 33.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.751 -172.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -47.3 -31.79 4.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.521 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 70.8 m -47.85 -39.99 20.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.843 173.635 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.584 ' HB3' HG23 ' A' ' 302' ' ' VAL . 0.0 OUTLIER -63.37 -46.1 88.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 173.556 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 32.9 tt0 -54.54 -36.78 64.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.736 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -80.76 -61.77 1.87 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.804 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -83.02 -58.3 2.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.938 -168.375 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 311' ' ' LEU . 0.0 OUTLIER -60.38 -36.44 78.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 -171.874 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.06 -14.97 58.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.077 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.26 -22.0 66.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.892 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.446 ' HB3' HD12 ' A' ' 317' ' ' ILE . 62.9 t0 -78.25 119.59 77.91 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.584 0.707 . . . . 0.0 110.938 167.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -45.65 -35.24 12.65 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.638 2.225 . . . . 0.0 112.323 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 -69.65 -37.54 76.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -176.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 314' ' ' ASP . 66.0 mt -79.9 -29.91 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.087 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.63 -39.9 85.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.091 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.18 -47.27 74.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 174.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 78.9 p -65.07 -24.98 67.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.057 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 65.6 ttp -63.51 -40.57 97.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.937 174.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -65.01 -42.54 94.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.774 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -58.77 -44.64 90.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.928 173.87 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.91 90.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.052 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.84 -34.98 77.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.929 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -101.07 -3.73 28.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.939 -174.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -95.11 -163.59 34.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.43 -173.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.9 137.24 33.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.841 0.353 . . . . 0.0 110.835 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.59 ' O ' ' C ' ' A' ' 330' ' ' MET . 35.6 mm -81.06 109.83 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.191 -170.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.59 ' C ' ' O ' ' A' ' 329' ' ' ILE . 6.9 tpt . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 121.565 0.698 . . . . 0.0 110.899 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.775 0.322 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 17.4 mmt -74.6 -24.58 58.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.789 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.9 m -61.89 -33.71 74.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.879 177.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.65 -35.72 67.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.167 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -64.25 -35.22 80.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 172.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 340' ' ' TRP . . . . . 0.407 ' HA ' HG22 ' A' ' 343' ' ' VAL . 52.5 m0 -63.86 -31.12 72.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 174.25 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -73.64 -37.07 65.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.08 96.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.133 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 340' ' ' TRP . 10.1 m -80.88 -23.44 10.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.137 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.533 ' NE ' ' HD3' ' A' ' 154' ' ' PRO . 64.9 ttt180 -57.43 -53.17 61.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 172.099 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 67.4 p -62.52 -25.96 68.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.141 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -58.21 -39.0 77.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.085 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.604 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.2 m -73.1 -31.86 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.194 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.39 -44.85 97.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.152 173.56 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -64.95 -34.96 79.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.86 -45.12 62.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.82 -39.56 87.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.129 -175.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.2 p -75.88 -12.81 60.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.799 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.2 14.86 82.13 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.588 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.52 -32.2 47.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.741 0.305 . . . . 0.0 110.873 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -136.4 153.68 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 46.0 p -79.85 167.65 20.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.133 170.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.424 ' HA ' HD23 ' A' ' 192' ' ' LEU . 53.8 t -55.4 -41.58 63.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.12 172.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -59.56 -45.03 93.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.929 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -72.84 -53.91 10.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.2 76.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.091 -171.554 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -67.08 -40.36 86.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.905 -178.105 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.09 -40.19 94.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.88 -39.91 93.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -63.39 -42.87 98.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 175.028 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -62.8 -39.05 93.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.821 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.4 m -64.38 -38.62 91.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.121 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -68.69 -35.11 76.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.719 HD12 HG21 ' A' ' 183' ' ' VAL . 75.2 mt -67.32 -45.32 86.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.099 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.6 p -101.71 -14.01 17.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.97 -179.558 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.71 0.291 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.55 131.81 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.095 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -135.59 144.27 46.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.937 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -56.14 135.14 53.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLY . . . . . 0.483 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 98.32 -1.85 59.06 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.492 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.3 tttt -166.29 137.34 3.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 174.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -143.48 157.54 44.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 -172.745 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 86.4 t -113.45 132.34 62.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.116 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.836 ' HB ' HD21 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -119.95 127.41 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.062 -178.928 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' TRP . . . . . 0.573 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 44.8 m0 -106.16 129.47 54.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 12' ' ' ASN . 60.7 mt -122.21 140.54 45.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.137 170.6 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.426 ' O ' HG22 ' A' ' 11' ' ' ILE . 64.2 t30 -50.15 141.74 10.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.906 172.023 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.403 ' HA3' ' OD2' ' A' ' 41' ' ' ASP . . . -58.06 -11.34 8.63 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.43 -172.582 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -73.32 -14.39 61.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.873 0.368 . . . . 0.0 110.923 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -136.94 109.99 7.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.957 158.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.36 -91.09 0.84 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.413 -154.562 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -104.7 -47.49 4.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.857 0.361 . . . . 0.0 110.849 -167.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -66.53 -46.86 74.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 -156.412 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.672 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -58.13 -47.06 91.6 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.512 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.836 HD21 ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -55.65 -60.97 2.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.792 0.329 . . . . 0.0 110.898 173.834 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.04 -39.28 55.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 -177.47 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -64.58 -52.83 55.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.3 m -75.69 -35.4 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.183 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.702 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -65.38 -44.57 93.13 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.481 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.67 -36.46 78.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.802 0.334 . . . . 0.0 110.832 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -61.6 -39.84 92.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.868 173.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PHE . . . . . 0.448 ' CD2' HD11 ' A' ' 33' ' ' ILE . 1.3 t80 -61.32 -44.82 96.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.0 -38.99 93.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.848 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.27 -31.85 73.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.13 -43.77 15.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -172.368 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . 0.53 ' OG1' HG13 ' A' ' 33' ' ' ILE . 53.8 p -113.85 -11.63 12.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.183 -171.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.87 14.0 81.46 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.142 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.8 pp -104.55 126.83 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 0.0 111.137 -176.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.6 mttt -75.77 141.53 42.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -171.005 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.702 HG21 ' HA3' ' A' ' 24' ' ' GLY . 2.9 m -114.99 135.97 53.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.081 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.432 ' O ' HD12 ' A' ' 9' ' ' ILE . 99.0 m -105.29 128.1 53.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.045 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . 0.523 HG22 ' HG ' ' A' ' 20' ' ' LEU . 58.4 t -96.24 121.38 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.145 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.573 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 69.2 mm-40 -130.09 144.61 51.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.837 172.159 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -156.82 58.78 1.68 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.585 0.707 . . . . 0.0 110.867 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 73.5 Cg_endo -80.71 -12.91 12.12 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.686 2.257 . . . . 0.0 112.296 -170.752 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 26.2 m-20 63.59 19.96 11.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -171.192 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 45' ' ' GLU . 98.6 mttt -93.67 0.25 56.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.966 174.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 43' ' ' LEU . 14.1 mt -45.77 -51.77 12.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.951 -166.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.67 -26.53 66.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.95 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 42' ' ' LYS . 98.4 mt-10 -78.68 -33.1 47.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.993 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 69.0 mmtt -82.72 -30.22 29.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.9 -174.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' PHE . . . . . 0.51 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 14.1 m-30 -40.72 -56.07 4.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.637 0.732 . . . . 0.0 110.826 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 51.6 Cg_endo -67.34 -27.44 40.47 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.717 2.278 . . . . 0.0 112.307 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -79.65 -44.41 20.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.2 m -69.75 -27.49 33.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.152 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.91 78.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.101 170.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.28 -30.48 67.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.08 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.3 p -92.58 -12.1 32.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.217 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.69 15.12 81.48 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.42 175.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -163.78 157.31 18.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.91 0.386 . . . . 0.0 110.859 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.5 -138.81 2.49 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 -178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PRO . . . . . 0.491 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 73.6 Cg_endo -67.69 150.41 79.37 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.655 2.236 . . . . 0.0 112.401 168.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -76.32 -38.57 55.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.716 ' HB ' HG23 ' A' ' 9' ' ' ILE . 3.7 mp -126.4 138.66 53.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.207 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.514 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 2.2 tp -128.48 129.8 68.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.131 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.549 ' CE2' HG13 ' A' ' 108' ' ' ILE . 2.0 m-85 -98.53 142.68 29.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.831 175.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TRP . . . . . 0.535 ' HH2' ' HA3' ' A' ' 265' ' ' GLY . 6.1 m-90 -119.68 139.81 51.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.922 176.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 262' ' ' LEU . . . -59.65 -85.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.092 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -122.52 -61.46 1.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -84.56 -27.92 26.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.773 -167.046 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.452 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 89.4 mtt180 -60.07 -30.5 69.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.891 -158.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -67.8 -27.92 67.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -170.284 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.85 -51.84 47.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.515 -173.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.16 -36.27 92.74 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' TYR . . . . . 0.574 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 18.4 t80 -65.98 -38.31 88.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.932 0.396 . . . . 0.0 110.891 -178.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.14 -43.94 60.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -62.61 -32.06 73.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.2 m -80.48 -12.57 59.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 175.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.1 31.95 66.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.503 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.49 -1.26 56.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.79 0.329 . . . . 0.0 110.879 -172.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.574 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -130.99 156.94 44.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.975 -179.287 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -66.9 130.46 43.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.132 175.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -69.52 122.97 20.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -109.3 159.97 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.05 -171.82 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.6 p -103.23 146.5 32.56 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.629 0.728 . . . . 0.0 111.065 -171.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.84 146.25 29.56 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.682 2.255 . . . . 0.0 112.326 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -107.94 114.68 28.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -52.68 -35.92 56.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.828 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.08 -40.97 95.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -69.97 -38.25 76.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.862 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -54.95 -48.61 72.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.76 -36.39 83.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.845 175.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -75.78 -19.99 58.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -103.34 -103.52 0.29 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 -173.304 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 43.0 t80 -165.92 134.28 2.41 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.688 0.756 . . . . 0.0 110.933 -172.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 70.9 Cg_exo -52.51 -39.94 73.33 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.375 -170.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -78.44 -30.51 47.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.96 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.2 m -69.48 -48.7 59.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.196 -166.382 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TRP . . . . . 0.454 ' HA ' HG22 ' A' ' 97' ' ' VAL . 51.9 p-90 -66.57 -28.4 68.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.87 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -71.44 -37.59 71.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.855 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.98 -25.07 65.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 21.7 m -101.55 16.54 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.189 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 68.1 ttt180 -101.8 133.11 47.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.905 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -149.06 130.31 14.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.3 t30 68.69 36.26 2.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.12 -5.01 64.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.52 174.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -139.73 163.85 31.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LEU . . . . . 0.553 HD22 HG23 ' A' ' 97' ' ' VAL . 13.1 mt -73.07 146.09 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.002 -175.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.431 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.9 pp -122.33 9.91 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.179 173.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.876 ' HB1' ' HB3' ' A' ' 263' ' ' SER . . . -168.09 156.68 9.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.045 -177.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' TYR . . . . . 0.436 ' HB3' HD21 ' A' ' 285' ' ' LEU . 21.4 m-85 -124.99 146.34 53.21 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.766 0.793 . . . . 0.0 110.905 163.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PRO . . . . . 0.65 ' HB3' HG11 ' A' ' 261' ' ' VAL . 42.9 Cg_endo -71.4 121.09 7.43 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.616 2.211 . . . . 0.0 112.359 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ILE . . . . . 0.549 HG13 ' CE2' ' A' ' 61' ' ' PHE . 25.1 mm -98.31 -32.28 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.137 177.372 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.04 151.34 26.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.6 t -115.02 132.99 62.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.079 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -112.88 131.72 55.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.83 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.08 154.49 40.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.966 176.5 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.425 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 11.0 mp -94.29 152.05 18.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.946 -174.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -148.22 157.59 43.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.813 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -99.23 125.2 44.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.85 174.524 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ILE . . . . . 0.58 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.7 mp -107.54 132.1 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 -176.14 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -131.71 145.15 51.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.944 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -100.2 113.08 25.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.749 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 241' ' ' ASN . 99.5 mttt -64.78 -15.01 61.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.812 -176.52 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 15.1 t70 -80.47 -29.87 37.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 mp -88.83 -46.49 8.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.533 HD22 ' HB1' ' A' ' 223' ' ' ALA . 2.2 mp -111.24 124.94 31.53 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.587 0.708 . . . . 0.0 110.81 175.331 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -71.71 -26.71 19.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.652 2.234 . . . . 0.0 112.302 173.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -152.47 96.28 3.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.628 0.728 . . . . 0.0 110.921 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.78 153.99 68.2 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.687 2.258 . . . . 0.0 112.331 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.58 151.53 64.46 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.651 2.234 . . . . 0.0 112.38 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -113.62 -5.07 13.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.864 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 130' ' ' GLU . 11.8 m -127.9 146.08 50.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.106 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TRP . . . . . 0.458 ' HA ' HG12 ' A' ' 132' ' ' ILE . 63.1 m95 -66.39 -25.63 66.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.955 -177.314 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' GLU . . . . . 0.495 ' H ' HG22 ' A' ' 128' ' ' THR . 98.3 mt-10 -62.11 -30.32 70.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.15 -19.67 56.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 -175.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.587 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 49.5 mm -62.0 -53.46 59.38 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.656 0.741 . . . . 0.0 111.133 -166.206 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 31.9 Cg_endo -62.75 -40.06 38.81 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.7 2.266 . . . . 0.0 112.339 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.0 -59.44 4.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LEU . . . . . 1.17 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.71 -17.67 63.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -175.257 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.637 ' HA ' HD22 ' A' ' 139' ' ' LEU . 39.0 t70 -63.49 -39.08 93.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 169.027 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.01 -36.72 82.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -73.16 -50.3 23.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -174.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -75.18 -15.2 60.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.892 -176.524 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.675 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.8 tttt -56.28 -35.06 67.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 170.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.18 -23.84 67.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.129 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -94.9 8.64 42.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.816 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.22 27.51 63.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.425 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.434 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 46.0 mtmt -120.87 165.41 15.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.859 0.361 . . . . 0.0 110.862 173.174 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' SER . . . . . 0.52 ' HA ' HD21 ' A' ' 139' ' ' LEU . 37.1 t -128.56 146.69 50.77 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 170.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -72.04 -58.31 3.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.084 -164.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -138.64 128.87 25.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -161.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.1 mmm -105.91 128.64 53.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -153.77 162.38 41.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -123.89 142.95 50.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.421 ' HG ' HG21 ' A' ' 347' ' ' VAL . 54.4 tp -113.35 -9.73 13.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.975 -175.586 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -73.71 0.14 13.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -118.0 148.39 43.37 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 121.738 0.78 . . . . 0.0 110.828 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.77 -20.01 64.66 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.595 2.197 . . . . 0.0 112.327 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -62.37 -36.69 83.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -84.32 -37.69 21.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.4 p -64.09 -37.77 88.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' TRP . . . . . 0.561 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 12.4 t-105 -62.21 -55.13 43.27 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.621 0.724 . . . . 0.0 110.935 -172.033 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 26.4 Cg_endo -67.37 -32.48 32.4 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.68 2.253 . . . . 0.0 112.326 -171.375 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 160' ' ' LEU . 6.5 tt -74.48 -40.31 61.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.981 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ILE . . . . . 0.481 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 76.0 mt -69.74 -40.44 79.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.128 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.78 -26.72 64.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.142 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.59 -30.25 70.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -94.56 0.56 55.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 112.19 5.41 24.96 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.55 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.473 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -79.21 66.68 3.41 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.383 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -90.28 152.58 20.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.883 -174.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.68 -17.95 60.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.112 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -147.56 154.04 40.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.087 0.47 . . . . 0.0 110.813 -173.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -97.24 128.93 44.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.885 159.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -96.19 122.64 39.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.918 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -149.73 130.71 14.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.954 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.4 t30 56.9 44.28 23.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 172.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.14 6.43 74.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -132.71 142.39 49.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.858 0.361 . . . . 0.0 110.942 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -77.77 134.85 37.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.917 165.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -95.12 104.97 16.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.3 tp -65.76 -19.95 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.106 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -94.74 -8.43 37.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -132.63 95.58 3.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 174.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' VAL . . . . . 0.501 HG23 HG22 ' A' ' 183' ' ' VAL . 33.1 m -115.82 173.05 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.107 -177.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -99.95 12.13 60.7 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.442 -167.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' VAL . . . . . 0.563 HG21 ' CD1' ' A' ' 368' ' ' ILE . 17.9 m -101.62 -17.92 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 0.0 111.156 -172.981 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ASP . . . . . 0.449 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 57.5 p-10 -95.57 19.85 10.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.868 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -118.11 171.55 8.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.08 -24.46 67.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.069 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.05 -39.78 94.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.524 -172.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.637 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.5 -39.4 91.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 111.068 177.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' LYS . . . . . 0.505 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.2 mttt -59.73 -37.37 78.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 173.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.58 -38.11 89.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.121 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.0 -45.41 94.03 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.374 177.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' LEU . . . . . 0.593 HD11 ' HA ' ' A' ' 347' ' ' VAL . 18.7 tp -68.33 -33.31 74.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.928 0.394 . . . . 0.0 110.971 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' THR . . . . . 0.415 ' O ' HG12 ' A' ' 196' ' ' VAL . 89.5 m -63.06 -42.28 99.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.159 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -67.29 -58.03 5.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' LEU . . . . . 0.626 ' C ' HD12 ' A' ' 195' ' ' LEU . 3.4 pp -63.49 -27.78 69.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 -165.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' VAL . . . . . 0.563 ' N ' HD12 ' A' ' 195' ' ' LEU . 3.7 p -72.77 -22.55 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.11 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -66.06 -58.79 4.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.886 -174.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' LEU . . . . . 1.055 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.42 -24.54 57.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -167.404 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ILE . . . . . 0.804 ' N ' HD22 ' A' ' 198' ' ' LEU . 2.1 pp -77.35 -35.8 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.173 172.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.89 -30.71 71.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.919 169.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -85.55 5.79 29.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.843 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 67.26 40.02 2.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.904 170.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -82.8 -14.36 54.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 170.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 60.5 ttp -133.14 146.31 51.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -94.94 155.91 16.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.9 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.2 -25.03 68.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -95.09 -3.5 47.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 95.3 m -63.53 130.88 46.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.17 -175.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ASP . . . . . 0.514 ' H ' HD11 ' A' ' 212' ' ' ILE . 21.5 t0 -146.78 172.24 13.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 176.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -75.49 -34.38 60.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 -172.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 47.7 t -68.81 -48.3 63.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 -174.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ILE . . . . . 0.514 HD11 ' H ' ' A' ' 209' ' ' ASP . 29.8 pt -65.94 -24.85 34.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.123 176.201 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.97 -35.6 81.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.18 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -67.84 -35.96 79.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.809 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.16 -40.16 95.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.164 173.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.0 -40.49 95.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.136 174.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -65.09 -39.4 93.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.868 -177.134 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -63.64 -32.09 73.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.842 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.17 -10.87 48.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.979 -176.569 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.9 25.75 36.9 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.533 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -86.54 -26.23 24.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.898 0.38 . . . . 0.0 110.805 -175.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -125.45 134.51 52.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' ALA . . . . . 0.533 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -72.55 -35.74 68.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.085 -175.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 72.5 mtm -131.99 155.51 47.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 110.879 -176.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.6 t -149.01 160.12 43.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.7 mm -115.09 125.02 72.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.114 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -145.02 151.06 37.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -135.07 -97.51 0.55 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.457 174.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.93 -17.39 36.83 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.741 2.294 . . . . 0.0 112.329 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -67.38 -33.33 74.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.999 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 53.57 32.9 15.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.032 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 35.2 m0 -72.65 -34.58 67.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.035 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 19.2 t -55.52 112.77 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.868 -171.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ASN . . . . . 0.413 ' O ' ' HB ' ' A' ' 235' ' ' ILE . 44.7 p30 -95.47 -162.85 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.955 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 235' ' ' ILE . 47.6 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.157 -175.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 240' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 240' ' ' VAL . 11.6 t . . . . . 0 CA--C 1.523 -0.08 0 CA-C-O 120.904 0.383 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ASN . . . . . 0.46 ' C ' ' O ' ' A' ' 240' ' ' VAL . 77.4 m-20 37.27 70.0 0.2 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 169.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 242' ' ' TYR . 4.4 t80 -119.48 135.39 54.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.908 -171.811 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.07 158.47 24.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.428 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' VAL . . . . . 0.526 HG22 ' HB2' ' A' ' 319' ' ' ALA . 7.4 p -141.48 139.95 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.871 0.367 . . . . 0.0 111.11 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.3 t -153.02 148.92 27.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.162 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 18.9 m -61.76 168.94 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.096 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' LEU . . . . . 0.578 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.8 mm? -62.06 146.92 91.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.659 0.742 . . . . 0.0 110.895 -162.118 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -72.69 -177.42 2.81 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.65 2.233 . . . . 0.0 112.35 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.8 p -108.71 160.02 16.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.15 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -143.59 122.38 12.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 110.89 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 55.02 35.83 25.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.09 7.35 77.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.546 169.93 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -132.83 139.86 35.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.613 0.72 . . . . 0.0 110.905 176.285 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.87 140.9 36.03 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.741 2.294 . . . . 0.0 112.376 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 255' ' ' SER . . . . . 0.578 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 97.3 p -82.42 -5.87 58.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.865 170.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -49.93 113.33 3.31 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.545 0.688 . . . . 0.0 110.934 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.91 168.89 20.21 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.563 2.175 . . . . 0.0 112.426 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -72.9 171.75 12.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.883 -177.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.478 HG21 ' HA ' ' A' ' 324' ' ' ALA . 76.4 t -104.33 134.83 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.163 -170.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -109.77 137.91 14.51 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.502 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' A' ' 107' ' ' PRO . 93.8 t -121.84 124.04 70.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.938 0.399 . . . . 0.0 111.168 -176.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 5.2 tt -72.09 128.82 36.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 168.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' SER . . . . . 0.876 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 58.5 m -121.31 153.89 37.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 -171.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ALA . . . . . 0.461 ' CB ' HD11 ' A' ' 280' ' ' LEU . . . -134.62 139.79 45.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 177.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' GLY . . . . . 0.535 ' HA3' ' HH2' ' A' ' 62' ' ' TRP . . . -142.41 172.22 24.37 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.518 -176.392 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 24.4 mm -112.87 134.31 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.333 . . . . 0.0 111.177 -169.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -64.55 132.07 48.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.936 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' ALA . . . . . 0.62 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -64.49 -30.21 71.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.1 -8.76 59.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.069 -172.065 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.3 t -68.21 121.66 81.11 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.639 0.733 . . . . 0.0 110.937 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.27 -16.95 19.35 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.71 2.273 . . . . 0.0 112.352 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 272' ' ' ASN . . . . . 0.439 ' HB2' HD21 ' A' ' 275' ' ' LEU . 53.1 p-10 -113.24 29.93 7.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.814 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -61.87 -25.29 67.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -169.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -65.65 -43.53 89.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 110.805 -168.331 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 275' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 272' ' ' ASN . 2.5 pp -74.75 -33.73 62.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 276' ' ' ALA . . . . . 0.444 ' HB1' HD11 ' A' ' 59' ' ' ILE . . . -65.81 -49.17 69.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -65.22 -35.13 80.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 278' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 94.0 mt-10 -68.62 -43.39 76.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.874 -177.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -60.12 -46.58 89.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' LEU . . . . . 0.461 HD11 ' CB ' ' A' ' 264' ' ' ALA . 7.6 tt -62.43 -46.56 87.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 -177.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.99 -38.81 72.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 -177.894 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 94.8 m-20 -102.28 -10.9 19.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -161.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' TYR . . . . . 0.426 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 53.5 t80 -122.46 -51.57 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 284' ' ' LEU . . . . . 0.429 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.5 OUTLIER -70.58 -43.22 69.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -176.724 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 285' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 106' ' ' TYR . 4.5 mm? -81.69 44.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 169.183 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 286' ' ' THR . . . . . 0.431 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 89.6 m -145.77 145.37 30.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.168 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 287' ' ' ASP . . . . . 0.556 ' HA ' HD11 ' A' ' 290' ' ' LEU . 48.5 p-10 -50.11 -25.93 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -171.203 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -75.78 -45.89 33.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 289' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.71 -49.71 13.42 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 -169.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 290' ' ' LEU . . . . . 0.646 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.7 OUTLIER -73.06 -23.64 60.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.715 0.293 . . . . 0.0 110.877 -177.841 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 291' ' ' GLU . . . . . 0.516 ' N ' HD12 ' A' ' 290' ' ' LEU . 87.7 tt0 -68.71 -40.08 80.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 171.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.95 78.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.15 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 293' ' ' VAL . . . . . 0.672 HG13 ' HA3' ' A' ' 19' ' ' GLY . 39.9 t -77.89 -44.57 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.103 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -62.92 -29.66 70.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 177.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.01 -27.77 69.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -89.16 -36.77 15.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.819 -177.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' LYS . . . . . 0.423 ' O ' HD13 ' A' ' 299' ' ' LEU . 85.9 tttt -152.84 138.35 11.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.638 0.732 . . . . 0.0 110.864 175.191 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.78 112.72 0.9 Allowed 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.694 2.263 . . . . 0.0 112.329 175.279 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 297' ' ' LYS . 0.1 OUTLIER -88.98 -20.36 24.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 178.059 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 300' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 301' ' ' ALA . . . 102.18 -41.2 2.19 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.573 177.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 301' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 300' ' ' GLY . . . -179.86 175.92 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.884 0.373 . . . . 0.0 111.069 171.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 302' ' ' VAL . . . . . 0.621 ' CG2' ' HB3' ' A' ' 307' ' ' TYR . 22.3 m -135.85 160.06 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.136 162.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.27 -14.2 61.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.07 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 304' ' ' LEU . . . . . 0.646 ' CD2' HD21 ' A' ' 290' ' ' LEU . 60.4 tp -77.07 128.69 34.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -173.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -41.88 -33.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 -177.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' SER . . . . . 0.432 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 48.0 t -46.86 -38.66 10.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.866 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' TYR . . . . . 0.621 ' HB3' ' CG2' ' A' ' 302' ' ' VAL . 0.2 OUTLIER -57.36 -44.18 84.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 175.313 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 308' ' ' GLU . . . . . 0.472 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 88.7 tt0 -56.92 -39.99 75.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.786 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -80.01 -64.55 1.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.829 -174.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -85.81 -57.84 2.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.88 -171.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' LEU . . . . . 0.609 ' HB3' HD13 ' A' ' 317' ' ' ILE . 34.3 mt -59.34 -34.77 72.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 -169.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 312' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 318' ' ' ALA . . . -59.66 -18.19 39.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 -176.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -65.02 -23.01 67.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.767 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 314' ' ' ASP . . . . . 0.585 ' HB3' HD12 ' A' ' 317' ' ' ILE . 59.9 t0 -86.44 125.7 66.75 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.442 0.639 . . . . 0.0 110.876 173.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -49.23 -30.85 20.48 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.564 2.176 . . . . 0.0 112.334 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -65.11 -32.16 73.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 317' ' ' ILE . . . . . 0.609 HD13 ' HB3' ' A' ' 311' ' ' LEU . 6.9 mt -94.88 -36.07 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.082 -178.278 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 318' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 312' ' ' ALA . . . -53.82 -43.43 69.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.085 -174.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' ALA . . . . . 0.526 ' HB2' HG22 ' A' ' 244' ' ' VAL . . . -66.96 -44.62 80.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.091 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 64.2 p -64.7 -25.58 68.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.097 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 65.8 ttp -62.61 -38.6 90.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.911 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -66.82 -36.86 83.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.789 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 323' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 327' ' ' GLY . 63.7 t30 -78.88 -38.66 37.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.906 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 324' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 259' ' ' VAL . . . -64.92 -46.89 79.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.057 -175.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -70.36 -33.44 71.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 -177.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.66 -4.17 34.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 327' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -103.36 -160.2 25.13 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.443 -174.2 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -143.41 139.32 29.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.841 0.353 . . . . 0.0 110.837 -173.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 329' ' ' ILE . . . . . 0.582 ' O ' ' C ' ' A' ' 330' ' ' MET . 43.8 mm -82.35 112.33 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.189 -171.74 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 330' ' ' MET . . . . . 0.582 ' C ' ' O ' ' A' ' 329' ' ' ILE . 74.1 mtm . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 121.653 0.739 . . . . 0.0 110.892 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.817 0.342 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -57.57 -27.23 62.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.939 -173.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -35.97 79.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.34 -37.25 66.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.111 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 339' ' ' PHE . . . . . 0.437 ' HA ' HG12 ' A' ' 368' ' ' ILE . 35.4 m-85 -63.9 -49.02 74.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.8 174.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -64.89 -36.8 85.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.988 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -68.72 -47.23 66.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.71 89.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 343' ' ' VAL . . . . . 0.444 ' O ' ' HB3' ' A' ' 346' ' ' ALA . 13.9 m -80.6 -23.48 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 344' ' ' ARG . . . . . 0.52 ' O ' HG22 ' A' ' 347' ' ' VAL . 3.0 tmt_? -62.37 -47.39 84.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 81.4 p -60.85 -26.69 67.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.148 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 346' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -62.06 -41.91 98.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.044 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 347' ' ' VAL . . . . . 0.593 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.2 m -72.68 -32.83 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.072 -175.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.94 -45.97 95.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.194 172.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -63.8 -35.45 80.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.819 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.65 -45.76 61.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.096 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.0 89.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.185 -175.76 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 98.5 p -75.7 -9.99 59.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.947 -177.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.72 16.6 79.91 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.558 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.84 -32.77 40.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.719 0.295 . . . . 0.0 110.848 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -138.11 154.76 49.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.861 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.8 p -79.66 167.42 20.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.217 168.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 357' ' ' VAL . . . . . 0.463 ' HA ' HD23 ' A' ' 192' ' ' LEU . 55.1 t -54.72 -41.94 58.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.061 173.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -59.66 -45.76 91.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.858 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -72.55 -52.84 13.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.2 -43.64 77.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.053 -171.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 361' ' ' LEU . . . . . 0.637 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -67.52 -40.91 85.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 -178.471 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.9 -39.83 94.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.936 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -63.09 -38.53 91.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.841 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 364' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -63.58 -42.5 98.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.083 174.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 365' ' ' GLN . . . . . 0.449 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 23.1 tm0? -64.27 -36.79 85.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 177.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 366' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 370' ' ' LYS . 92.2 m -66.06 -40.22 90.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 176.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -67.59 -35.06 78.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 368' ' ' ILE . . . . . 0.563 ' CD1' HG21 ' A' ' 183' ' ' VAL . 68.3 mt -62.71 -40.88 90.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.061 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.3 p -94.68 -10.53 31.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 370' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 366' ' ' THR . 99.5 mttt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.778 0.323 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.7 mt -104.37 134.42 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -145.0 143.12 30.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -54.66 136.17 45.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.794 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.424 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 99.27 3.14 56.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.488 -173.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -166.34 149.83 7.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.797 0.332 . . . . 0.0 110.962 173.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.68 HD22 HD13 ' A' ' 33' ' ' ILE . 1.5 pt? -149.53 154.05 38.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.978 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 75.8 t -109.41 135.05 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.118 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.739 HG22 ' CG1' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -123.07 133.02 70.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.104 179.023 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.476 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 45.9 m0 -109.46 133.32 53.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.945 173.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.509 HD12 ' HB2' ' A' ' 20' ' ' LEU . 4.4 tt -109.99 149.79 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.136 -169.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -57.54 155.31 9.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.93 -14.47 16.94 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.531 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -76.46 -13.52 60.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.855 0.359 . . . . 0.0 110.843 -172.241 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -138.91 144.27 39.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.06 -84.11 1.01 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.452 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -112.99 -37.66 4.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.925 0.393 . . . . 0.0 110.895 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -66.33 -52.26 48.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.969 -144.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.68 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -62.92 -48.07 83.7 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.556 -176.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.67 HD21 HG13 ' A' ' 9' ' ' ILE . 10.9 tp -67.02 -35.87 80.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.947 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.74 84.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 173.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -65.07 -52.78 53.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.831 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 20' ' ' LEU . 14.1 m -73.9 -35.58 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 -176.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.517 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -66.67 -44.39 89.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.519 176.723 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -64.95 -40.02 94.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -65.39 -38.88 91.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.415 ' CE2' HD11 ' A' ' 33' ' ' ILE . 73.6 t80 -66.14 -39.81 90.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.857 174.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -57.49 -39.98 77.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.2 -30.18 68.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -83.51 -38.96 21.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 -170.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.609 ' OG1' HG13 ' A' ' 33' ' ' ILE . 61.1 p -105.73 -12.93 15.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.41 5.91 89.09 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.519 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.828 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.6 pp -99.29 133.96 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 0.0 111.159 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -70.47 129.25 38.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 -168.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.517 HG11 ' HA3' ' A' ' 24' ' ' GLY . 90.2 t -110.81 119.79 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.135 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.8 m -115.44 116.99 29.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.127 -173.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.446 HG22 ' HG ' ' A' ' 20' ' ' LEU . 79.0 t -98.77 139.29 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.476 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 73.9 mm-40 -121.25 161.83 21.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.888 176.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -84.78 141.04 37.98 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.612 0.72 . . . . 0.0 110.898 -171.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 85.6 Cg_exo -52.33 -30.72 43.96 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.724 2.282 . . . . 0.0 112.339 -177.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -49.34 -48.97 46.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.937 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.92 -19.31 48.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.875 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.612 HD23 ' C ' ' A' ' 43' ' ' LEU . 7.3 tt -52.4 -59.29 4.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.918 -171.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.06 -39.22 83.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.67 -42.7 57.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.845 -170.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -85.25 -29.27 24.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -171.565 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.549 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 91.2 t80 -47.72 -51.85 42.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.744 . . . . 0.0 110.885 -165.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 62.9 Cg_endo -69.04 -29.26 27.59 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 0.0 112.313 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -76.99 -43.4 35.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.6 m -72.29 -26.69 25.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.186 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.437 ' HB1' ' HG ' ' A' ' 75' ' ' LEU . . . -65.65 -34.23 77.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 173.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.33 -29.64 70.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.077 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.2 p -92.38 -14.01 29.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.155 175.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.56 14.79 81.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.497 173.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -140.01 129.91 24.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.797 0.332 . . . . 0.0 110.916 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.85 -115.01 0.54 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.523 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.473 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 98.3 Cg_endo -72.84 151.41 51.1 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.658 2.239 . . . . 0.0 112.367 173.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.86 -35.49 15.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 168.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.739 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -138.51 150.03 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.054 177.073 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.573 HD11 HD21 ' A' ' 43' ' ' LEU . 4.1 tp -125.95 126.42 69.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.051 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.439 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 7.9 m-85 -108.07 123.35 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 177.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 16.7 t-105 -143.94 -172.81 3.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.3 -88.72 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.195 172.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -106.5 -54.64 2.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.82 -39.55 77.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 -159.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.58 -29.99 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 -174.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.801 ' O ' ' HD1' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -49.99 -52.95 29.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.934 -175.384 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.96 -41.33 97.4 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.495 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.97 -61.34 7.47 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.557 ' HD1' HD22 ' A' ' 76' ' ' LEU . 4.8 p90 -81.63 -25.52 35.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 110.929 -168.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.449 ' N ' ' CD1' ' A' ' 70' ' ' TYR . . . -70.22 -54.44 12.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.165 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -67.27 -34.14 76.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.845 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.6 m -84.77 -8.0 58.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 -173.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.39 31.75 63.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.481 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.437 ' HG ' ' HB1' ' A' ' 51' ' ' ALA . 2.5 mp -86.81 -4.63 59.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.929 0.395 . . . . 0.0 110.947 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.557 HD22 ' HD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -124.36 149.41 46.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.994 -175.002 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.01 140.53 37.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 169.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -71.63 135.35 46.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.909 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.854 HG13 ' HB3' ' A' ' 103' ' ' LEU . 42.5 pt -116.89 165.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 176.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 p -115.3 150.06 43.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.607 0.718 . . . . 0.0 111.122 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.32 144.99 47.3 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -103.14 119.96 39.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.61 -41.99 98.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.66 -46.46 82.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.16 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.43 ' HB3' ' HZ2' ' A' ' 94' ' ' TRP . 18.1 m-85 -73.55 -31.24 63.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.473 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.7 tt0 -53.5 -45.07 69.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.911 174.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -67.6 -33.9 75.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 175.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -77.84 -24.85 48.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.478 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 1.9 mp -104.98 -105.06 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 -174.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -169.26 128.1 0.9 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.637 0.732 . . . . 0.0 110.967 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -53.33 -36.51 78.85 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.586 2.19 . . . . 0.0 112.365 -171.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.62 -30.01 67.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.976 -173.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.4 p -76.66 -31.12 57.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.158 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.601 ' HA ' HG22 ' A' ' 97' ' ' VAL . 92.0 m95 -72.37 -27.51 62.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.932 171.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -72.78 -31.45 64.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 169.094 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ALA . . . . . 0.42 ' CB ' HG21 ' A' ' 329' ' ' ILE . . . -65.03 -28.1 69.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.065 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.601 HG22 ' HA ' ' A' ' 94' ' ' TRP . 29.9 m -110.9 17.2 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.16 -171.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 72.3 ttt180 -112.46 138.06 49.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -143.05 125.24 15.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.4 t30 60.83 34.93 19.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.852 174.341 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.82 -6.44 74.29 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.499 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -122.53 145.31 48.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 0.0 110.915 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.854 ' HB3' HG13 ' A' ' 79' ' ' ILE . 3.6 tp -73.62 139.68 45.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -178.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.475 HD12 ' C ' ' A' ' 104' ' ' ILE . 2.5 pp -127.17 10.01 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 -173.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -173.26 169.63 4.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.093 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.483 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 89.4 m-85 -116.13 144.52 33.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.729 0.776 . . . . 0.0 110.88 166.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 15.0 Cg_exo -69.66 117.12 4.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.693 2.262 . . . . 0.0 112.316 172.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 29.7 mm -97.81 -47.01 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.14 154.98 38.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.108 -170.185 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.9 t -120.45 133.35 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 -178.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -120.83 134.19 55.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.63 161.78 41.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.06 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.589 ' HG ' ' HA3' ' A' ' 228' ' ' GLY . 6.0 mp -112.58 159.07 19.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.899 -173.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.9 p -154.37 162.92 40.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.848 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -93.64 123.72 37.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.953 176.836 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.545 ' N ' HD22 ' A' ' 115' ' ' LEU . 47.0 mt -108.44 132.06 57.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 -174.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -135.09 151.4 50.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 -175.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -96.33 117.86 31.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -66.91 -17.51 64.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -73.09 -29.61 63.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.837 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.537 HD21 ' O ' ' A' ' 220' ' ' GLY . 7.2 mp -99.94 -49.62 4.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 18.0 mt -102.25 125.55 36.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.608 0.718 . . . . 0.0 110.899 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.36 -23.5 23.87 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.643 2.229 . . . . 0.0 112.331 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -153.07 130.0 5.69 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.637 0.732 . . . . 0.0 110.873 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.1 153.6 77.11 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.71 2.273 . . . . 0.0 112.363 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.34 144.83 41.97 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.717 2.278 . . . . 0.0 112.324 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -94.01 -28.74 15.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.929 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 79.8 p -130.13 156.11 45.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.426 ' HA ' HD13 ' A' ' 132' ' ' ILE . 26.9 t-105 -68.76 -24.47 64.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.9 -23.95 63.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.899 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.55 -23.2 53.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.585 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.5 mp -62.32 -51.87 70.57 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.685 0.755 . . . . 0.0 111.173 -170.513 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 39.7 Cg_endo -71.57 -39.09 3.84 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.66 2.24 . . . . 0.0 112.378 -171.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.37 -39.69 85.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.195 173.263 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.8 tp -60.89 -44.53 96.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.531 ' OD1' ' HB3' ' A' ' 146' ' ' ALA . 40.5 m-20 -49.72 -35.01 20.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.821 178.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.14 -34.55 68.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 -178.398 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -74.61 -53.36 9.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -171.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.541 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.9 OUTLIER -80.08 -10.96 59.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -175.79 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.541 ' N ' HD23 ' A' ' 139' ' ' LEU . 86.3 tttt -55.39 -31.22 61.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 168.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.74 -25.02 67.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.141 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -95.0 7.66 45.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.45 26.89 66.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.462 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.463 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 42.1 mmtm -116.83 162.7 17.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.839 0.352 . . . . 0.0 110.911 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.0 t -127.14 132.37 50.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.884 175.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.687 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -80.57 -38.3 29.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.084 -162.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -139.78 130.21 25.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.915 -174.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.777 ' SD ' ' HB2' ' A' ' 213' ' ' ALA . 56.8 ttm -117.04 130.15 56.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -177.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -151.04 157.2 42.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.8 -171.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -101.21 98.13 8.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.787 HD21 HD11 ' A' ' 195' ' ' LEU . 0.8 OUTLIER -69.24 -36.98 77.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -76.23 -3.77 38.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.891 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -99.87 148.92 35.45 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.624 0.726 . . . . 0.0 110.908 174.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.469 ' HD3' ' HD3' ' A' ' 344' ' ' ARG . 24.9 Cg_endo -63.0 -18.69 66.52 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.723 2.282 . . . . 0.0 112.379 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -64.33 -40.87 96.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.514 ' CD2' HD23 ' A' ' 151' ' ' LEU . 90.4 t80 -86.22 -37.8 18.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.875 -176.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 60.7 p -61.13 -36.95 81.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.226 -170.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.551 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 78.8 t90 -69.22 -53.65 13.12 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.504 0.669 . . . . 0.0 110.84 -174.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 44.0 Cg_endo -67.86 -17.17 46.82 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.647 2.231 . . . . 0.0 112.446 -176.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.836 HD13 ' O ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER -82.5 -48.49 10.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 172.962 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 68.0 mt -74.84 -40.03 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.97 65.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.136 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -63.34 -34.86 78.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.059 -168.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -91.87 2.6 56.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 120.08 3.41 11.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.503 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.54 60.6 4.8 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.488 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -79.84 134.45 36.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 110.969 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.42 5.29 18.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 -174.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -147.04 149.99 34.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.907 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 79.2 tttt -103.87 122.45 45.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 158.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -118.81 122.1 41.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.968 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -152.36 130.83 12.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 55.42 39.08 31.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.81 16.54 80.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.03 138.14 50.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 110.888 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -96.45 144.89 26.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -129.31 104.94 7.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.894 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.496 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.4 pp -74.71 -11.21 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.204 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -97.56 -12.26 22.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 -174.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 51.4 t0 -124.3 62.54 1.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.11 174.9 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.167 -166.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -104.82 17.96 44.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.501 -164.143 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.5 m -100.2 -19.91 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 111.148 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -86.7 19.08 3.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -113.77 175.14 5.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.94 -25.28 67.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.89 -39.85 96.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.471 -172.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.656 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -68.77 -36.88 78.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 111.113 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.516 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 93.5 mttt -59.54 -33.25 71.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 174.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.0 69.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.152 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.19 -51.1 59.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.413 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.5 mt -64.51 -34.92 79.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.87 0.367 . . . . 0.0 110.916 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 94.9 m -56.81 -46.77 81.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.582 ' HD2' HD21 ' A' ' 160' ' ' LEU . 71.8 t80 -75.66 -44.89 40.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.787 HD11 HD21 ' A' ' 151' ' ' LEU . 7.7 tt -52.84 -44.41 66.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -171.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 34.9 m -70.45 -21.21 23.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.101 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.636 ' HB3' HD13 ' A' ' 198' ' ' LEU . 38.8 t70 -56.96 -49.87 74.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 -166.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.758 HD13 ' N ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -87.09 -30.47 21.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 -170.587 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.541 ' H ' HD22 ' A' ' 198' ' ' LEU . 2.3 pp -78.33 -34.28 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.01 -27.6 68.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 168.314 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -83.94 4.68 28.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 174.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 65.11 39.31 5.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.901 172.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -77.43 -8.63 58.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 27.9 ptm -144.17 159.59 42.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.871 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -98.78 159.27 15.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.36 -26.3 68.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.049 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -93.76 -2.13 54.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.3 m -64.26 135.0 55.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -144.66 169.3 18.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -68.43 -34.59 76.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.854 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 91.6 p -67.47 -33.18 74.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.795 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 82.6 mt -63.48 -39.3 84.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.125 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.777 ' HB2' ' SD ' ' A' ' 148' ' ' MET . . . -62.43 -40.06 95.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 234' ' ' ASN . 92.9 mt-10 -63.1 -40.74 98.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -70.0 -38.95 76.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.089 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.45 -33.17 74.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.185 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -60.05 -30.69 69.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -62.01 -36.31 81.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.77 -19.01 19.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.537 ' O ' HD21 ' A' ' 121' ' ' LEU . . . 87.78 28.03 25.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.459 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -81.92 -28.61 32.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 0.0 110.901 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 93.1 m -119.24 131.36 55.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.687 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -75.82 -47.14 26.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.065 -174.047 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 61.0 mtm -134.97 158.95 43.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.853 -174.516 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 9.6 t -149.15 166.33 29.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 mm -109.46 124.23 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 172.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -155.33 171.8 19.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.835 -170.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.589 ' HA3' ' HG ' ' A' ' 113' ' ' LEU . . . -155.56 -115.71 0.53 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.504 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.3 -22.84 74.71 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.681 2.254 . . . . 0.0 112.317 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -78.26 -10.8 59.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.998 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.93 -16.57 61.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.092 -170.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 36.1 p-90 -54.94 -30.0 57.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.981 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.5 t -50.16 -56.34 11.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 214' ' ' GLU . 49.3 t30 -163.79 64.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 32.1 mm -131.79 112.78 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 167.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -171.32 160.05 5.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.883 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 96.7 m -120.44 108.67 14.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.156 -176.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 44.1 t -147.18 118.02 7.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.974 0.416 . . . . 0.0 110.923 172.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 60.35 35.45 20.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 29.0 m -149.3 171.11 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.138 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -112.8 82.09 1.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -117.99 148.59 42.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.82 162.17 25.52 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.552 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.79 HG11 ' O ' ' A' ' 315' ' ' PRO . 10.1 p -144.04 138.49 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.942 0.401 . . . . 0.0 111.169 -175.053 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.6 t -150.68 149.2 29.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.106 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 30.4 m -63.62 168.44 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.135 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.809 ' HB3' ' HB2' ' A' ' 255' ' ' SER . 3.9 mm? -63.27 137.01 96.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.569 0.7 . . . . 0.0 110.903 -162.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -72.04 -172.68 0.89 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.359 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 82.5 p -105.67 151.79 23.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.134 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.402 ' HD2' ' HB3' ' A' ' 163' ' ' ALA . 33.5 t80 -136.48 120.48 17.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 176.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 56.55 35.5 26.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.81 9.3 74.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.486 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -129.97 140.88 39.98 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.722 . . . . 0.0 110.877 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.2 142.17 33.57 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.672 2.248 . . . . 0.0 112.35 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.809 ' HB2' ' HB3' ' A' ' 247' ' ' LEU . 64.3 m -85.3 0.83 50.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.823 173.133 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -45.01 112.49 1.53 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.61 0.719 . . . . 0.0 110.935 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.11 162.0 32.03 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.724 2.282 . . . . 0.0 112.325 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -72.98 152.5 41.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 -172.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.13 134.99 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.112 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -112.48 135.19 12.51 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.44 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.3 t -125.88 128.4 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.884 0.373 . . . . 0.0 111.147 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 108' ' ' ILE . 1.7 tt -69.99 130.13 41.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 77.3 p -122.23 135.92 54.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.825 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.458 ' HB1' HD11 ' A' ' 280' ' ' LEU . . . -124.8 127.53 47.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.12 -178.519 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.2 160.9 14.69 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.474 -170.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.41 ' HA ' HG22 ' A' ' 59' ' ' ILE . 20.6 mm -99.98 121.62 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.819 0.342 . . . . 0.0 111.129 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -66.68 129.5 40.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -175.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.42 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -60.67 -27.72 68.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.083 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.83 -11.77 57.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.041 -173.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.8 t -75.48 121.25 84.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.719 . . . . 0.0 110.934 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -68.76 -10.42 29.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.658 2.239 . . . . 0.0 112.286 167.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -102.44 17.65 23.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.937 -171.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -48.78 -34.84 13.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.884 -172.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -70.37 -48.26 57.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 -170.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.0 pp -81.76 -30.38 32.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.51 -46.28 73.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.09 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -67.53 -34.47 77.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 89.2 tt0 -63.92 -52.28 60.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 -173.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.491 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.2 p90 -69.99 -34.18 73.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.458 HD11 ' HB1' ' A' ' 264' ' ' ALA . 4.3 tt -58.38 -50.99 71.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -80.11 -31.26 39.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 61.9 m-80 -101.4 -28.94 12.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.921 -165.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.555 ' O ' HG22 ' A' ' 286' ' ' THR . 85.4 t80 -110.25 -43.4 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 -169.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.2 mp -72.54 -47.07 51.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.2 mp -83.33 61.29 6.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 283' ' ' TYR . 14.5 t -153.1 155.72 37.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.16 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.492 ' HA ' HD11 ' A' ' 290' ' ' LEU . 39.1 p-10 -52.41 -27.25 15.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.857 -168.437 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -78.23 -46.02 21.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.92 -49.39 17.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.449 -168.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.595 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.4 OUTLIER -74.96 -21.56 59.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 0.0 110.908 -178.986 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.427 ' N ' HD12 ' A' ' 290' ' ' LEU . 83.1 tt0 -67.22 -40.91 86.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.95 170.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.31 76.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.129 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.68 HG13 ' HA3' ' A' ' 19' ' ' GLY . 19.7 t -80.22 -43.67 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.134 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.405 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 41.7 t30 -65.77 -28.78 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.926 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.55 -26.01 67.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -82.33 -45.21 15.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.838 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -153.51 135.52 9.09 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.583 0.706 . . . . 0.0 110.947 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -49.3 114.66 1.39 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.632 2.221 . . . . 0.0 112.414 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 40.1 mt -92.74 -19.04 22.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 -177.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 114.94 -60.48 0.39 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -176.4 168.43 2.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.815 0.34 . . . . 0.0 111.064 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 30.3 m -124.62 157.7 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.157 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.96 -17.28 61.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.595 ' CD2' HD21 ' A' ' 290' ' ' LEU . 58.4 tp -81.0 123.5 28.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.977 -174.208 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -61.44 -33.25 73.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.89 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.2 m -61.84 -47.67 84.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.815 -170.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.454 ' CD2' HD23 ' A' ' 311' ' ' LEU . 20.8 t80 -89.11 -28.66 19.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -57.78 -42.63 84.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.909 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.68 -34.96 79.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -73.02 -45.55 57.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.692 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.4 pp -73.43 -27.04 61.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.874 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.41 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.58 -11.23 57.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.34 -15.98 61.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -86.24 128.76 56.25 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.539 0.685 . . . . 0.0 110.882 169.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.79 ' O ' HG11 ' A' ' 244' ' ' VAL . 83.6 Cg_exo -52.6 -31.69 50.8 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.518 ' HG3' HG13 ' A' ' 317' ' ' ILE . 27.6 ptt-85 -66.3 -31.05 71.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -171.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.692 HG21 ' CD1' ' A' ' 311' ' ' LEU . 63.3 mt -95.12 -37.38 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 -176.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.53 -44.5 62.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 -168.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.97 -42.4 80.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.053 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 71.9 p -63.85 -28.22 69.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' MET . . . . . 0.411 ' HE2' ' HA ' ' A' ' 321' ' ' MET . 33.5 mmt -66.75 -31.91 72.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -66.06 -44.18 85.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 327' ' ' GLY . 40.9 t30 -64.46 -37.21 86.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 174.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.7 -45.05 95.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.1 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -73.78 -34.37 64.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.9 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -100.49 -0.0 38.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -96.57 -155.63 30.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.408 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.56 139.19 42.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 0.0 110.922 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.587 ' O ' ' C ' ' A' ' 330' ' ' MET . 42.6 mm -76.69 110.01 11.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.1 -173.59 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.587 ' C ' ' O ' ' A' ' 329' ' ' ILE . 99.3 mmm 22.88 60.03 0.33 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 170.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.413 ' N ' ' O ' ' A' ' 329' ' ' ILE . 36.4 Cg_endo -91.1 -10.02 2.92 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.716 2.277 . . . . 0.0 112.375 -170.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.556 ' O ' ' CG1' ' A' ' 333' ' ' ILE . 51.9 p-10 -94.86 9.87 37.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 -157.335 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.556 ' CG1' ' O ' ' A' ' 332' ' ' ASN . 31.6 pt 57.16 162.28 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.694 0.759 . . . . 0.0 111.099 162.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -57.6 -31.47 91.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.677 2.252 . . . . 0.0 112.342 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.16 -32.07 73.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.527 ' HG3' ' HB2' ' A' ' 332' ' ' ASN . 87.4 mmm -72.81 -26.12 61.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.953 -172.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.0 m -60.88 -41.43 95.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.4 -36.44 71.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -65.22 -37.73 88.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -61.04 -37.84 84.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -75.91 -35.26 59.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.92 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 367' ' ' ARG . . . -62.68 -41.27 99.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.134 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.6 m -79.86 -25.17 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.469 ' HD3' ' HD3' ' A' ' 154' ' ' PRO . 54.5 ttp85 -61.3 -45.31 94.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.821 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 84.6 m -57.23 -36.63 71.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.131 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.735 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -60.58 -43.93 96.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.116 -175.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 344' ' ' ARG . 2.0 m -73.75 -32.69 35.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.171 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.74 -46.21 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.196 173.087 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.489 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 89.5 m-20 -69.13 -34.97 75.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.47 -45.35 65.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.01 -41.18 87.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 89.3 p -77.19 -11.96 59.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.836 -175.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.31 14.06 82.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.576 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.75 -29.85 56.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.755 0.312 . . . . 0.0 110.85 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 86.9 mt-30 -135.63 157.26 47.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 175.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.4 p -77.64 169.77 17.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.197 168.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 69.5 t -55.55 -42.83 70.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 170.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -59.87 -45.28 92.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -71.25 -52.78 17.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.838 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.24 -45.04 74.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 -173.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -66.75 -39.95 88.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.907 -176.85 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.537 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 87.9 tttt -64.68 -39.62 93.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 177.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.82 -37.91 89.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.735 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -64.75 -45.83 84.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.074 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.537 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 1.2 pp0? -73.82 -30.09 62.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 56.8 m -64.04 -41.54 97.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.404 ' HB2' ' HB1' ' A' ' 342' ' ' ALA . 99.6 mtt180 -66.08 -39.07 89.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 70.4 mt -65.4 -37.86 81.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.209 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.3 p -92.37 -10.12 39.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.158 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.874 176.07 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.8 0.333 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 98.9 mt -91.44 125.03 44.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.132 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.31 146.07 36.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.855 -176.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.47 136.83 43.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.775 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.27 4.79 58.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.484 -174.299 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -169.89 153.22 4.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.869 0.366 . . . . 0.0 110.899 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.551 HD23 ' H ' ' A' ' 7' ' ' LEU . 1.0 OUTLIER -151.68 157.0 41.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.495 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 89.8 t -110.65 135.63 49.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.738 HG22 ' CG1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -122.98 132.01 72.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.075 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.445 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 41.9 m0 -108.77 125.75 52.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.936 171.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 14.8 tt -106.3 150.02 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.094 -170.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -59.21 151.46 22.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.91 -15.73 21.69 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.511 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -75.06 -11.14 60.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.845 -172.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -147.84 137.75 22.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.943 160.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.15 -83.26 1.04 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.443 -167.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -110.52 -45.67 3.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.013 0.435 . . . . 0.0 110.942 -172.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -68.22 -51.93 39.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.944 -151.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.518 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -60.09 -48.05 88.0 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.582 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.686 ' CD2' HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -58.13 -45.61 87.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.369 . . . . 0.0 110.884 176.452 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.99 76.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -64.86 -48.25 74.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 -177.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.0 m -74.38 -36.05 41.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.442 ' CA ' HG11 ' A' ' 35' ' ' VAL . . . -66.68 -48.34 62.55 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.576 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -65.45 -39.26 91.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.999 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -64.47 -41.58 96.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.457 ' CD2' HD11 ' A' ' 33' ' ' ILE . 63.1 t80 -65.42 -38.0 88.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.55 -41.76 99.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.89 -31.92 69.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.822 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -82.43 -40.48 21.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -171.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.636 ' OG1' HG13 ' A' ' 33' ' ' ILE . 60.8 p -102.61 -9.46 20.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.11 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.44 9.73 84.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.56 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.036 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 pp -103.91 132.15 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.011 0.434 . . . . 0.0 111.07 -175.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -71.11 127.78 33.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.957 -168.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.474 HG22 HD21 ' A' ' 7' ' ' LEU . 99.2 t -110.67 122.06 64.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.086 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.457 ' HB ' HG22 ' A' ' 8' ' ' VAL . 99.7 m -111.57 117.94 34.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.146 -175.173 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.522 HG22 HD13 ' A' ' 20' ' ' LEU . 84.7 t -93.78 134.98 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.061 176.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.445 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 74.5 mm-40 -121.58 162.95 19.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.861 173.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.4 t-80 -84.9 139.73 37.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.615 0.722 . . . . 0.0 110.897 -167.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 70.9 Cg_exo -60.49 -16.85 44.71 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.754 2.303 . . . . 0.0 112.307 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -49.21 -56.37 9.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.936 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -86.69 1.31 52.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -175.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.53 HD11 ' O ' ' A' ' 61' ' ' PHE . 9.4 tt -43.65 -53.34 5.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 -175.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -71.28 -43.8 66.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.21 -48.05 16.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.879 -161.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HG2' HG13 ' A' ' 50' ' ' VAL . 84.3 tttt -84.58 -33.09 23.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -170.178 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 90.3 t80 -47.8 -53.54 30.61 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.69 0.757 . . . . 0.0 110.9 -172.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 31.5 Cg_endo -61.99 -29.31 81.62 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.612 2.208 . . . . 0.0 112.375 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -74.78 -43.47 54.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.456 HG13 ' HG2' ' A' ' 46' ' ' LYS . 35.7 m -74.97 -25.12 18.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.219 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.43 -33.9 74.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.13 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.18 -27.14 66.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.02 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.3 p -91.83 -13.6 31.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.164 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.26 14.27 82.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.478 170.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -145.89 137.29 24.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 0.0 110.876 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.446 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . 165.01 -131.2 2.34 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.466 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.495 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 54.1 Cg_endo -62.83 139.06 72.38 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.666 2.244 . . . . 0.0 112.372 171.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.449 ' HB2' HD13 ' A' ' 59' ' ' ILE . 2.6 m-20 -86.57 -35.03 19.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 171.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.738 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -132.51 148.12 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.134 177.622 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.7 tp -127.98 127.16 67.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.154 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.53 ' O ' HD11 ' A' ' 43' ' ' LEU . 9.1 m-85 -99.86 125.52 45.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.428 ' CG ' ' N ' ' A' ' 63' ' ' ALA . 41.6 t-105 -145.02 -175.81 4.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.928 169.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.428 ' N ' ' CG ' ' A' ' 62' ' ' TRP . . . -90.52 -87.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.136 173.73 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -126.23 -58.14 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.93 -44.4 96.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 -151.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -66.57 -28.52 68.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.836 -170.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -51.86 -42.9 62.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.868 -175.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.63 -49.66 74.26 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.531 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.84 -43.35 99.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.568 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -66.52 -46.97 74.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 110.874 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.91 -43.91 91.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.154 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.93 -34.96 79.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.016 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.5 m -84.91 -7.03 59.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.91 29.54 60.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.491 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.1 mp -84.13 -12.1 55.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.819 0.342 . . . . 0.0 110.837 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.598 HD11 HG22 ' A' ' 104' ' ' ILE . 4.4 pp -131.2 143.17 50.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.956 -177.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -79.65 144.94 33.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.45 134.2 48.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.864 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.802 HG13 ' HB3' ' A' ' 103' ' ' LEU . 36.4 pt -110.39 160.72 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.18 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.6 p -103.68 141.62 22.88 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.621 0.724 . . . . 0.0 111.065 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.79 145.19 31.99 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.728 2.285 . . . . 0.0 112.386 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -111.53 119.52 39.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.66 -41.63 98.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.897 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.45 89.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -73.43 -33.75 65.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.495 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.3 tt0 -53.6 -49.0 68.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.901 174.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -60.6 -34.98 75.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.01 -22.9 52.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.822 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -103.22 -109.43 0.25 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.813 -173.316 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -169.9 133.13 1.1 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.599 0.714 . . . . 0.0 110.992 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.8 -40.12 81.38 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.685 2.257 . . . . 0.0 112.303 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -69.13 -29.95 68.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -171.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 107' ' ' PRO . 54.3 p -73.38 -31.36 63.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.112 -174.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.598 ' HA ' HG22 ' A' ' 97' ' ' VAL . 81.0 m95 -71.89 -25.47 61.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.042 174.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.53 -38.33 71.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.779 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.33 -26.98 63.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 94' ' ' TRP . 19.7 m -100.01 15.44 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.132 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 34.8 ttp-105 -110.2 141.85 42.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.788 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -138.83 122.76 17.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.864 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 59.82 34.94 21.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.945 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.24 -2.64 84.08 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.451 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.56 144.52 48.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 0.0 110.912 174.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.802 ' HB3' HG13 ' A' ' 79' ' ' ILE . 4.9 tp -79.5 138.51 37.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.803 -173.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.598 HG22 HD11 ' A' ' 76' ' ' LEU . 2.5 pp -126.93 1.53 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 -171.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -167.14 168.41 13.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.448 ' CZ ' HD12 ' A' ' 79' ' ' ILE . 93.6 m-85 -114.52 139.91 24.56 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.676 0.751 . . . . 0.0 110.962 170.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.476 ' HB3' ' HB ' ' A' ' 93' ' ' THR . 74.1 Cg_endo -73.74 120.16 6.28 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.75 2.3 . . . . 0.0 112.368 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.6 mm -100.13 -56.13 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.587 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -142.16 154.87 45.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.162 -166.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.0 t -120.7 136.85 56.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.111 -169.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -126.34 131.1 51.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -148.8 157.91 43.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.122 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.519 ' CD2' ' HA3' ' A' ' 228' ' ' GLY . 72.5 mt -102.02 168.76 9.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.89 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.8 p -155.93 158.15 37.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.931 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -96.26 127.74 42.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.889 172.594 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.554 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.9 mp -110.95 133.05 57.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.066 -175.007 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -132.57 149.98 52.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.913 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -88.05 111.77 21.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.854 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.427 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 88.6 tttt -62.69 -22.9 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -76.54 -22.5 54.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.866 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.459 HD21 ' O ' ' A' ' 220' ' ' GLY . 7.0 mp -97.46 -49.23 4.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.823 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.509 HD11 ' HB1' ' A' ' 223' ' ' ALA . 22.8 mt -107.17 132.49 20.89 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 110.898 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.04 -20.68 28.57 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.632 2.221 . . . . 0.0 112.384 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.573 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 20.3 p30 -154.26 161.72 28.63 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.685 0.755 . . . . 0.0 110.805 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.573 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 58.8 Cg_endo -70.23 158.5 56.16 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 0.0 112.388 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.48 148.33 66.65 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.679 2.253 . . . . 0.0 112.306 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -103.54 -44.99 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.8 p -133.24 157.88 44.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.14 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -70.02 -24.89 63.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.92 -19.81 66.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -73.99 -30.13 62.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.483 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 1.4 mp -63.34 -47.76 83.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.63 0.728 . . . . 0.0 111.138 -167.236 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.483 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 85.3 Cg_exo -53.93 -51.62 10.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.569 2.179 . . . . 0.0 112.293 -176.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.6 -40.45 73.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.6 tp -54.55 -43.46 72.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.904 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.422 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . 1.8 m-20 -50.09 -44.29 51.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.816 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.77 -33.48 75.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 -176.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.8 -46.93 27.95 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 -173.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.422 ' CD2' ' HA ' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -90.53 -19.95 23.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.872 -173.026 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 85.8 tttt -61.81 -26.39 68.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.901 170.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.89 -24.94 67.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.111 171.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -95.37 8.88 41.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.81 28.08 65.68 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.501 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 89.3 mttt -117.26 170.03 9.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 110.908 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.4 t -131.53 142.23 49.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.803 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -73.14 -51.3 18.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.049 -170.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -139.24 130.78 27.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.91 -169.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.415 ' SD ' ' OG1' ' A' ' 222' ' ' THR . 94.9 mtp -117.9 129.76 55.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.853 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -153.47 162.94 40.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.884 -169.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -95.81 104.37 16.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.027 169.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.752 HD21 HD11 ' A' ' 195' ' ' LEU . 0.7 OUTLIER -75.05 -35.96 61.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 177.271 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLN . . . . . 0.484 ' HA ' HD11 ' A' ' 348' ' ' ILE . 88.2 mt-30 -78.69 0.13 27.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.826 -175.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -106.82 150.44 39.72 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.635 0.731 . . . . 0.0 110.962 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.11 -20.31 69.39 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.691 2.26 . . . . 0.0 112.321 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -59.86 -44.07 94.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.011 -172.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -84.89 -39.99 17.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.863 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.0 p -64.02 -37.88 89.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.198 -169.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.569 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 19.9 t-105 -64.36 -55.47 30.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.583 0.706 . . . . 0.0 110.872 -173.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 23.6 Cg_endo -65.96 -30.74 48.03 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.616 2.211 . . . . 0.0 112.513 -171.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.692 HD23 ' O ' ' A' ' 160' ' ' LEU . 6.4 tt -72.89 -41.77 64.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.978 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 69.1 mt -73.81 -39.75 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.026 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.37 -33.17 67.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.17 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.468 ' HB3' ' HD2' ' A' ' 250' ' ' PHE . . . -61.7 -36.41 80.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.99 -168.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -89.12 1.03 56.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 121.84 1.22 10.73 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.49 169.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.36 64.99 3.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.446 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -86.71 132.88 33.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.868 0.366 . . . . 0.0 110.926 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.35 10.2 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.445 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.1 p90 -147.27 153.88 40.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -105.87 126.61 52.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 158.076 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -116.27 126.72 53.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.931 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -151.78 129.78 11.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.885 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.5 t30 55.07 44.55 27.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.04 14.0 82.19 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.484 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -129.92 139.62 51.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 110.887 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -99.98 145.96 27.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 170.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -121.26 110.1 15.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.839 171.128 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.512 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.3 pp -80.0 -11.92 12.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.189 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.77 -12.71 19.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -123.33 88.17 2.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 169.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 169' ' ' PHE . 33.5 m -116.58 170.96 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.177 -168.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.04 26.11 23.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.484 -168.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.511 HG21 HD12 ' A' ' 368' ' ' ILE . 12.6 m -109.9 -13.66 10.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.81 0.338 . . . . 0.0 111.145 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -85.07 20.04 2.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -112.81 -176.8 2.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.878 -175.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.51 -25.09 63.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 190' ' ' ALA . . . -72.01 -42.43 51.94 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.492 -169.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.624 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -63.26 -36.75 84.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.353 . . . . 0.0 111.038 176.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.511 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.2 mttt -59.97 -34.09 72.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 173.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 187' ' ' GLY . . . -65.15 -31.85 73.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.091 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.64 -45.48 95.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.439 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 192' ' ' LEU . 21.7 mt -64.98 -38.34 90.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.857 0.36 . . . . 0.0 110.902 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.9 m -57.56 -46.32 84.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.275 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -73.49 -47.75 38.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.752 HD11 HD21 ' A' ' 151' ' ' LEU . 6.8 tt -53.72 -47.14 70.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 -170.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 30.3 m -67.96 -18.82 24.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 -176.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -59.99 -58.08 10.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -171.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 1.049 ' H ' HD13 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.67 -23.73 56.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.908 -166.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.603 ' H ' HD22 ' A' ' 198' ' ' LEU . 2.0 pp -83.77 -36.41 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 174.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.36 -32.6 73.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 168.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -82.25 4.1 24.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 65.06 39.79 5.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 168.78 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -85.88 -14.94 43.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.784 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -146.64 161.85 39.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.926 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -99.88 150.5 22.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.849 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.59 -25.83 68.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.5 p-10 -93.78 5.34 51.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 59.7 m -62.55 129.99 43.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.086 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -137.45 169.83 17.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.957 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -63.91 -42.68 97.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.3 m -64.77 -39.45 93.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.11 -40.03 86.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.154 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.81 -37.34 87.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.086 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -63.17 -40.47 97.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.925 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.91 94.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 175.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.92 -38.25 90.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -61.58 -42.04 98.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -57.94 -32.31 67.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.799 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -89.39 -23.8 22.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.459 ' O ' HD21 ' A' ' 121' ' ' LEU . . . 90.51 25.78 24.81 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.504 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.59 -23.98 21.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.922 0.391 . . . . 0.0 110.877 -173.03 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.415 ' OG1' ' SD ' ' A' ' 148' ' ' MET . 99.8 m -119.11 128.76 54.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 -176.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.509 ' HB1' HD11 ' A' ' 122' ' ' LEU . . . -65.58 -52.07 54.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.052 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.455 ' HB3' HD21 ' A' ' 115' ' ' LEU . 71.2 mtm -135.65 156.26 49.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.859 -169.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.3 t -150.82 161.56 42.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 44.6 mm -110.05 124.25 66.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.158 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -154.34 170.63 20.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.804 -166.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.519 ' HA3' ' CD2' ' A' ' 113' ' ' LEU . . . -157.16 -113.69 0.41 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.522 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.411 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 40.4 Cg_endo -61.29 -22.34 74.32 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.618 2.212 . . . . 0.0 112.366 173.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -78.89 -16.51 56.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.05 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.29 -23.7 67.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.057 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -60.04 -23.13 63.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.928 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 42.9 t -57.65 -59.64 4.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -152.03 45.56 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -173.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.0 mm -126.19 129.58 72.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.164 168.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -166.37 161.62 16.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 53.8 m -133.2 82.18 1.98 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.158 171.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 42.0 t -134.22 109.06 8.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.001 0.429 . . . . 0.0 110.808 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 60.1 30.96 20.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.939 -176.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.7 m -142.09 165.03 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -100.0 70.0 1.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.427 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 87.0 m-85 -130.91 146.67 52.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.019 174.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -130.95 155.66 21.36 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.487 HG22 ' CB ' ' A' ' 319' ' ' ALA . 3.3 p -134.79 134.88 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.961 0.41 . . . . 0.0 111.167 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.9 t -154.41 149.76 27.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.071 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 27.9 m -59.93 162.03 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.116 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.57 ' N ' HD12 ' A' ' 247' ' ' LEU . 5.5 mp -70.48 150.11 95.63 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.577 0.703 . . . . 0.0 110.906 -159.382 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.48 -179.24 2.66 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.706 2.271 . . . . 0.0 112.347 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 52.1 p -101.02 161.19 13.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.131 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.468 ' HD2' ' HB3' ' A' ' 163' ' ' ALA . 55.0 t80 -138.6 119.56 14.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 55.53 33.69 21.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.97 -169.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.15 9.77 72.77 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.529 171.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.478 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 86.1 mm-40 -132.66 129.46 21.33 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.651 0.738 . . . . 0.0 110.879 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 60.2 Cg_exo -59.59 144.8 99.34 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.577 2.185 . . . . 0.0 112.327 -175.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 65.2 p -88.65 16.69 6.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.809 171.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -43.05 112.34 1.17 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.634 0.731 . . . . 0.0 110.903 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.18 160.38 32.98 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.754 2.302 . . . . 0.0 112.326 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -72.51 161.55 30.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.801 -171.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 56.2 t -109.06 136.17 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.057 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -113.43 131.09 9.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.511 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.9 t -121.13 119.11 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 111.166 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.401 ' C ' ' CD2' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -67.91 117.94 10.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 175.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 19.4 m -130.6 151.29 51.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 -170.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.06 129.79 44.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.15 -171.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -118.07 168.45 13.09 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.45 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.553 HD13 HG22 ' A' ' 59' ' ' ILE . 23.9 mm -99.68 126.84 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.0 111.183 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -68.36 129.3 39.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.853 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.429 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -66.2 -24.21 66.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.096 -176.228 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.91 -11.08 58.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.041 -171.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.6 t -75.97 120.28 80.98 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.642 0.734 . . . . 0.0 110.898 -176.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -69.0 -11.78 32.7 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.294 168.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -111.76 36.1 3.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.878 -171.012 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.85 -25.07 66.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 -167.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -71.32 -38.51 71.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' A' ' 7' ' ' LEU . 37.8 tp -63.13 -48.65 77.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 173.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.615 ' HB1' HG23 ' A' ' 59' ' ' ILE . . . -69.05 -48.8 61.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.093 -173.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -63.82 -41.58 97.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -66.27 -54.57 23.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 -173.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.411 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -68.31 -34.0 75.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 -173.578 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.578 HD23 ' O ' ' A' ' 280' ' ' LEU . 4.8 tt -56.0 -45.54 79.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.875 176.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -72.93 -42.68 63.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -102.35 -9.3 20.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.889 -159.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 67.9 t80 -123.33 -48.65 1.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.0 OUTLIER -68.56 -46.59 69.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.487 ' HA ' HD13 ' A' ' 285' ' ' LEU . 0.8 OUTLIER -82.92 63.24 6.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 174.546 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.491 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 30.1 p -143.51 150.18 38.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.172 170.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.561 ' HA ' HD11 ' A' ' 290' ' ' LEU . 41.4 p-10 -53.19 -25.24 13.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -79.5 -44.08 21.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.49 -50.57 25.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.432 -170.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.561 HD11 ' HA ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -73.97 -21.27 60.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.43 ' N ' HD12 ' A' ' 290' ' ' LEU . 82.8 tt0 -66.07 -42.31 89.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 169.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.32 -34.77 75.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.518 HG13 ' HA3' ' A' ' 19' ' ' GLY . 21.6 t -76.83 -41.91 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.173 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.49 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 52.6 t30 -64.96 -25.42 67.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.981 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -66.83 -30.95 71.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.9 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -88.79 -40.87 12.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -141.97 130.05 11.79 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.514 0.673 . . . . 0.0 110.911 172.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.09 111.59 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.642 2.228 . . . . 0.0 112.376 174.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.49 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 43.0 mt -93.32 -13.1 28.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.016 -171.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.44 -53.71 1.0 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.433 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -173.77 166.15 4.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.795 0.331 . . . . 0.0 111.02 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.587 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 31.3 m -123.76 156.49 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.166 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 89' ' ' LEU . . . -69.96 -17.16 63.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.018 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' A' ' 89' ' ' LEU . 57.6 tp -85.87 120.69 27.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.049 -171.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.2 -40.02 70.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.926 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.8 m -64.55 -50.33 67.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -167.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.477 ' HB3' HG21 ' A' ' 302' ' ' VAL . 38.2 t80 -81.13 -26.73 35.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.11 -42.28 94.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.4 -34.46 76.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.831 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -70.62 -48.53 54.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.652 HD13 HD13 ' A' ' 317' ' ' ILE . 4.6 pp -66.72 -28.81 68.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.856 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.461 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.95 -11.12 58.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.053 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.94 -15.57 62.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -79.78 128.66 73.61 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.633 0.73 . . . . 0.0 110.805 170.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -49.21 -38.37 41.17 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.678 2.252 . . . . 0.0 112.305 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.482 ' HA ' HG11 ' A' ' 244' ' ' VAL . 8.5 ptp85 -71.26 -24.83 62.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.918 -169.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.652 HD13 HD13 ' A' ' 311' ' ' LEU . 78.9 mt -92.26 -32.45 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.09 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.91 -34.95 63.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.059 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.487 ' CB ' HG22 ' A' ' 244' ' ' VAL . . . -65.01 -45.58 84.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.058 174.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 68.7 p -69.01 -24.38 64.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.162 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 87.6 mmm -58.84 -36.39 74.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -69.47 -46.92 65.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 327' ' ' GLY . 34.7 t30 -66.04 -36.01 82.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.995 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.28 84.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -72.62 -35.07 67.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -94.97 -1.83 51.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -100.01 -161.62 28.61 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.458 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.494 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 83.4 mt-10 -140.8 141.5 34.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 110.812 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.605 ' O ' ' C ' ' A' ' 330' ' ' MET . 18.8 mm -81.74 100.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.094 -169.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.605 ' C ' ' O ' ' A' ' 329' ' ' ILE . 95.3 mtp 20.52 60.43 0.25 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.55 0.691 . . . . 0.0 110.88 176.219 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.494 ' HG3' ' HB3' ' A' ' 328' ' ' GLU . 16.6 Cg_endo -95.1 -6.37 1.85 Allowed 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.766 2.311 . . . . 0.0 112.333 -170.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.522 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 52.7 p-10 -97.08 9.11 43.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 -147.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.587 HG22 ' H ' ' A' ' 335' ' ' GLN . 45.5 mm 78.81 130.42 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.689 0.757 . . . . 0.0 111.07 176.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -53.14 -25.46 29.49 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.623 2.215 . . . . 0.0 112.391 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.587 ' H ' HG22 ' A' ' 333' ' ' ILE . 99.3 mm-40 -62.63 -18.39 62.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.966 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 79.4 mmm -72.38 -24.0 61.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.8 m -63.59 -39.2 93.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -77.35 -35.4 54.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.136 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -62.66 -39.24 93.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.855 174.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -58.38 -36.28 73.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.809 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -75.9 -37.1 59.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.933 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.05 94.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.135 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.2 m -80.2 -25.46 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.177 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 347' ' ' VAL . 7.3 tmm_? -64.39 -43.33 94.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 173.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.5 m -58.67 -34.62 71.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.166 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -58.93 -42.22 89.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 -177.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 344' ' ' ARG . 1.3 m -74.08 -32.85 33.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -174.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 152' ' ' GLN . 1.6 mp -62.01 -48.74 87.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.184 173.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 86.5 m-20 -65.6 -38.12 88.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.85 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.71 -46.22 63.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.188 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.15 -42.03 85.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.025 -176.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.6 p -76.5 -11.24 59.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.11 13.57 82.81 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.547 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.18 -31.36 58.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 110.883 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.498 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 90.9 mt-30 -136.33 159.53 41.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.4 p -78.45 169.75 17.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.131 168.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 72.9 t -55.52 -43.83 73.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.125 170.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -59.64 -44.79 93.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -70.44 -52.39 22.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.79 -45.93 70.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.079 -173.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.624 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -65.21 -40.01 93.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -177.404 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.0 tttt -65.3 -38.35 89.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 176.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -65.04 -38.91 92.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.795 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -64.79 -46.47 81.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.085 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 5.0 pp0? -70.55 -31.39 68.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.979 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 81.8 m -65.69 -42.63 91.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.199 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.29 -36.56 81.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.799 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.511 HD12 HG21 ' A' ' 183' ' ' VAL . 64.0 mt -64.96 -39.82 86.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.189 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.3 p -91.51 -11.05 38.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.195 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.917 176.71 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.806 0.336 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 83.6 mt -95.67 135.1 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.102 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -149.43 142.1 24.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -55.12 137.4 46.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.463 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 97.77 1.85 58.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.544 -172.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -166.1 149.16 7.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.837 0.351 . . . . 0.0 110.968 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.703 HD22 HD13 ' A' ' 33' ' ' ILE . 1.6 pt? -148.73 153.51 38.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 69.9 t -108.84 138.67 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.104 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.813 HG13 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -122.21 132.55 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.001 177.018 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.479 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 45.2 m0 -108.82 127.81 54.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.887 172.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.551 ' HB ' HD22 ' A' ' 20' ' ' LEU . 7.2 tt -109.76 148.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.22 -168.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -57.28 146.86 27.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.888 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.89 -12.93 16.69 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.459 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -75.15 -10.29 59.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 110.842 -173.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -150.12 135.39 18.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 162.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.14 -84.71 1.0 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 -166.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -113.19 -45.65 3.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.923 0.392 . . . . 0.0 110.922 -170.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -68.05 -52.83 30.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.908 -149.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.63 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -63.17 -46.85 92.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.513 -176.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.813 HD21 HG13 ' A' ' 9' ' ' ILE . 17.7 tp -65.69 -39.94 91.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.839 0.352 . . . . 0.0 110.879 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.74 72.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.082 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -65.75 -48.23 72.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 m -75.36 -36.07 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.065 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.455 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -66.94 -46.41 73.95 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.444 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -65.58 -40.37 92.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.961 -176.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.94 -40.45 95.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.404 ' CE2' HD11 ' A' ' 33' ' ' ILE . 78.0 t80 -64.81 -39.34 93.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.05 -40.04 79.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.913 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -69.1 -30.02 68.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -84.42 -40.13 18.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.803 -170.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.604 ' OG1' HG13 ' A' ' 33' ' ' ILE . 62.3 p -103.79 -12.32 17.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.48 7.93 87.79 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.496 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.849 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.6 pp -102.7 132.54 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 111.105 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -71.17 130.16 40.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 -168.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.517 HG22 HD21 ' A' ' 7' ' ' LEU . 90.0 t -110.57 120.17 60.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.5 m -113.62 118.03 33.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.159 -173.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.497 HG22 ' HG ' ' A' ' 20' ' ' LEU . 92.3 t -94.41 134.11 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.479 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 73.5 mm-40 -119.8 161.63 20.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.9 t-80 -83.41 139.38 41.51 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.626 0.727 . . . . 0.0 110.771 -168.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 75.6 Cg_exo -56.59 -25.09 57.39 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.768 2.312 . . . . 0.0 112.303 -176.216 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -47.64 -50.18 25.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -173.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -86.61 -8.56 57.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.487 HD11 ' O ' ' A' ' 61' ' ' PHE . 9.4 tt -46.73 -54.28 10.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.896 -167.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -75.03 -34.69 61.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -71.69 -48.87 44.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -168.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -87.2 -28.63 22.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 -170.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.559 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 91.5 t80 -47.49 -51.66 42.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.769 0.795 . . . . 0.0 110.922 -166.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 59.7 Cg_endo -68.3 -28.98 32.75 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.725 2.283 . . . . 0.0 112.296 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -76.56 -43.66 37.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.67 -24.96 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.127 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.86 -32.71 74.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.049 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.5 -27.65 67.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.03 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.2 p -94.61 -13.85 25.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.114 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.74 15.6 81.19 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.405 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -142.55 130.42 21.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.831 0.348 . . . . 0.0 110.998 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.69 -115.09 0.57 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.58 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.437 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 84.4 Cg_endo -70.32 146.48 56.83 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.306 168.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -90.72 -36.34 14.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 169.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.691 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -138.46 150.04 24.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.175 176.989 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.0 tp -126.44 125.25 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 -169.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.523 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 4.8 m-85 -110.06 126.38 53.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 20.7 t-105 -143.1 -171.51 3.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 169.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.16 -89.53 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.119 171.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -106.55 -54.79 2.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.835 -172.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.49 -38.59 63.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.902 -158.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -74.46 -18.76 60.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 -169.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -39.99 -55.32 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.47 -38.43 44.72 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.493 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.32 -57.78 11.06 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 -171.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.579 ' HD1' HD22 ' A' ' 76' ' ' LEU . 8.8 p90 -85.79 -27.06 25.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.935 0.398 . . . . 0.0 110.93 -172.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.421 ' N ' ' CD1' ' A' ' 70' ' ' TYR . . . -71.62 -57.25 4.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.091 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -65.55 -32.02 73.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 -176.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.3 m -82.21 -7.88 59.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.58 30.42 68.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.503 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.447 ' HA ' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -87.45 -4.23 59.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.842 0.353 . . . . 0.0 110.835 -174.894 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.579 HD22 ' HD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -125.68 147.94 49.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -177.117 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.96 143.7 37.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.033 171.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -71.79 135.1 46.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.866 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.894 HG13 ' HB3' ' A' ' 103' ' ' LEU . 37.9 pt -117.31 164.97 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.087 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.2 p -115.81 150.03 44.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.543 0.687 . . . . 0.0 111.181 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.45 146.42 44.55 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.683 2.255 . . . . 0.0 112.32 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -105.65 119.92 40.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.828 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.03 -41.93 99.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.41 -45.02 89.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.53 ' HB3' ' HZ2' ' A' ' 94' ' ' TRP . 7.4 m-85 -72.4 -33.32 67.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.494 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.5 tt0 -52.1 -46.64 65.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.27 -36.14 82.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 174.411 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -78.86 -24.42 44.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.815 -173.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.3 OUTLIER -104.96 -105.04 0.31 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -172.164 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.467 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 39.7 t80 -164.6 129.63 1.97 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.671 0.748 . . . . 0.0 110.983 -174.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 96.9 Cg_exo -57.15 -43.03 56.98 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.62 2.213 . . . . 0.0 112.421 -169.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -72.44 -26.35 61.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.964 -173.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.645 ' CG2' ' HB3' ' A' ' 107' ' ' PRO . 96.7 m -69.75 -40.01 76.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.151 -174.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.587 ' HA ' HG22 ' A' ' 97' ' ' VAL . 92.2 m95 -65.68 -27.6 68.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.985 174.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -71.76 -35.24 70.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.54 -27.39 63.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.081 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.587 HG22 ' HA ' ' A' ' 94' ' ' TRP . 19.4 m -101.2 16.36 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.129 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.455 ' HB2' HD12 ' A' ' 103' ' ' LEU . 75.2 ttt180 -113.48 137.42 51.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -144.29 127.7 16.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.1 t30 62.19 34.78 15.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.899 174.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.82 -6.24 71.26 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.44 172.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -124.05 147.25 47.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.965 173.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.894 ' HB3' HG13 ' A' ' 79' ' ' ILE . 4.2 tp -73.28 139.99 46.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.924 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.46 HD12 ' C ' ' A' ' 104' ' ' ILE . 2.5 pp -126.28 10.01 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.012 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -170.72 162.12 7.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -112.75 145.67 33.48 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.738 0.78 . . . . 0.0 110.914 164.455 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.645 ' HB3' ' CG2' ' A' ' 93' ' ' THR . 90.9 Cg_endo -75.63 118.52 5.13 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.668 2.246 . . . . 0.0 112.386 173.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 27.3 mm -94.75 -49.35 12.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.097 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.74 157.57 43.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.129 -170.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.7 t -121.46 134.64 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 -173.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -115.85 138.01 51.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.847 169.371 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -151.48 160.04 43.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.023 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.424 ' HG ' ' HA3' ' A' ' 228' ' ' GLY . 7.0 mp -109.72 158.09 18.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 -170.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.5 p -154.82 161.9 41.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.925 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.93 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.98 128.19 46.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.996 176.157 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.569 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.3 mp -109.64 130.97 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.099 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -133.17 153.42 51.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.525 HD22 ' HD1' ' A' ' 217' ' ' PHE . 31.6 m120 -93.02 116.69 29.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.877 176.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.04 -20.22 66.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.854 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 11.8 t70 -77.33 -29.89 53.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.841 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.664 HD21 ' O ' ' A' ' 220' ' ' GLY . 8.8 mp -95.17 -47.91 6.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.6 mt -102.28 115.02 65.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.535 0.683 . . . . 0.0 111.032 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.79 -27.09 21.99 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.646 2.231 . . . . 0.0 112.333 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 60.5 t-20 -145.95 102.47 4.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.587 0.708 . . . . 0.0 110.88 173.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.0 Cg_endo -71.02 146.17 51.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.677 2.251 . . . . 0.0 112.324 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 150.83 62.89 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.384 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -110.47 -6.34 14.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.971 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 79.1 p -131.15 157.4 43.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.226 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -66.74 -30.63 70.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.998 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.06 -26.14 68.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.928 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -78.96 -23.32 44.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.61 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.5 mp -60.94 -51.21 81.0 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.645 0.736 . . . . 0.0 111.153 -169.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.5 Cg_endo -71.18 -40.63 3.1 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.62 2.213 . . . . 0.0 112.439 -170.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.31 -41.93 80.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.954 HD23 ' O ' ' A' ' 135' ' ' LEU . 0.2 OUTLIER -56.8 -42.8 80.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.973 172.299 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.427 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . 24.7 t70 -54.39 -35.34 62.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.772 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.0 -34.31 75.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.819 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -76.29 -51.75 11.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.864 -172.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.575 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.8 OUTLIER -80.04 -10.06 59.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.839 -176.088 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.575 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.1 tttt -55.41 -31.99 62.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 167.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.66 -24.34 67.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.97 5.53 51.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.5 25.56 67.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.482 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.481 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 41.4 mmtm -118.35 165.81 13.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.886 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.6 t -126.67 142.03 51.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.831 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.17 -58.38 4.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.094 -166.367 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.415 HD13 ' C ' ' A' ' 147' ' ' LEU . 3.0 tm? -139.96 124.58 18.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.937 -168.125 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 58.0 ttm -109.93 128.82 55.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -155.83 157.18 36.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.832 -171.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -99.98 81.82 2.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.868 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.902 HD21 HD11 ' A' ' 195' ' ' LEU . 1.2 tm? -56.17 -32.52 64.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.876 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.37 9.53 3.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -108.73 145.01 30.76 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.597 0.713 . . . . 0.0 110.933 170.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.7 -24.91 68.88 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.706 2.271 . . . . 0.0 112.349 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -69.4 -32.11 70.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -87.98 -30.82 19.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.87 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 57.2 p -66.4 -32.46 73.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.233 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.587 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 29.8 t-105 -61.94 -55.57 40.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.903 -171.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 13.4 Cg_endo -61.13 -36.79 79.5 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.703 2.269 . . . . 0.0 112.481 -171.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.677 HD23 ' O ' ' A' ' 160' ' ' LEU . 6.3 tt -72.59 -43.0 63.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 73.3 mt -70.64 -40.04 76.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.66 -30.48 62.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.11 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.514 ' HB3' ' HD2' ' A' ' 250' ' ' PHE . . . -63.29 -34.48 77.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 -169.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -92.57 3.03 56.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.968 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.21 1.96 13.87 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.462 169.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.17 65.55 3.96 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.472 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -86.31 134.12 33.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.821 0.343 . . . . 0.0 110.964 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.61 7.14 10.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.106 -170.789 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.44 ' HA ' HG12 ' A' ' 181' ' ' VAL . 50.3 p90 -150.06 154.37 38.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.951 0.405 . . . . 0.0 110.931 -175.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -102.61 127.71 49.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.92 155.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -118.19 124.42 47.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.017 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -153.05 132.21 12.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.05 42.03 31.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.912 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.94 16.06 80.69 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.507 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -130.03 138.62 50.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.764 0.316 . . . . 0.0 110.923 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -95.78 143.42 27.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.863 169.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -121.39 109.83 15.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.932 172.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.626 HD12 ' O ' ' A' ' 178' ' ' ILE . 1.0 OUTLIER -79.24 -12.3 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.164 -178.225 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.7 -12.06 24.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.896 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -123.83 89.28 3.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.833 169.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 169' ' ' PHE . 32.9 m -117.17 166.48 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.087 -171.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.01 24.0 29.3 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.514 -170.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.492 HG21 HD12 ' A' ' 368' ' ' ILE . 13.8 m -108.9 -15.4 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 111.112 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -85.26 19.92 2.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -112.14 -178.25 3.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.95 -24.86 63.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.999 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.98 -40.5 73.45 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.438 -171.003 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.633 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.68 -37.32 87.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.872 0.367 . . . . 0.0 111.124 176.667 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.504 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.0 mttt -59.98 -34.21 72.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.953 173.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.09 -30.9 71.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.42 93.9 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.458 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 347' ' ' VAL . 24.9 mt -66.03 -37.52 86.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.952 0.406 . . . . 0.0 110.916 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.2 m -56.67 -45.27 81.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.226 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -75.26 -44.57 45.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.902 HD11 HD21 ' A' ' 151' ' ' LEU . 8.7 tt -56.99 -53.66 55.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.936 -172.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.526 ' HA ' HD13 ' A' ' 199' ' ' ILE . 13.6 m -64.96 -21.2 29.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.185 -176.111 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.33 -29.9 66.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.813 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -71.4 -48.88 47.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 177.053 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.823 ' H ' HD12 ' A' ' 199' ' ' ILE . 2.6 mp -64.23 -36.66 77.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.151 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.95 -39.84 94.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -90.47 -1.32 57.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.971 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.66 39.99 6.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -77.6 -14.31 59.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.834 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -139.31 154.34 47.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -100.22 151.32 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 -176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.89 -27.65 69.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.119 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -95.0 2.97 55.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.795 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.8 m -58.64 133.26 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.125 -177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -144.07 170.08 16.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 175.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -65.96 -35.78 81.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.906 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 97.4 p -65.65 -36.01 82.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.839 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 75.2 mt -65.06 -40.27 88.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.27 93.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.984 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.24 -39.5 86.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.868 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.01 -36.73 85.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.129 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.71 -32.71 71.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.131 -176.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.525 ' HD1' HD22 ' A' ' 118' ' ' ASN . 22.5 m-85 -61.39 -32.08 72.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -61.32 -35.63 77.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -101.69 -21.61 14.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.664 ' O ' HD21 ' A' ' 121' ' ' LEU . . . 88.96 31.71 11.83 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.538 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -82.54 -30.67 29.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.881 0.372 . . . . 0.0 110.915 -171.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 93.0 m -116.62 127.28 54.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -69.86 -45.79 66.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.401 ' HB3' HD21 ' A' ' 115' ' ' LEU . 76.3 mtp -134.19 145.75 49.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 -175.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 30.6 p -142.35 161.87 36.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.203 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 31.0 mm -111.64 125.42 68.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.148 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -154.33 158.08 39.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.424 ' HA3' ' HG ' ' A' ' 113' ' ' LEU . . . -137.53 -108.58 0.87 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.529 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.76 -17.28 47.35 Favored 'Trans proline' 0 C--O 1.23 0.096 0 C-N-CA 122.645 2.23 . . . . 0.0 112.359 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -80.25 -12.43 59.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.897 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -50.46 -39.0 46.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.017 -168.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -57.12 -24.38 53.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 27.8 t -50.08 -59.28 4.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.826 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -155.1 54.64 0.64 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.4 ' O ' ' HD3' ' A' ' 316' ' ' ARG . 29.2 mm -129.42 115.72 36.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 170.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -171.55 160.0 5.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.867 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 91.1 m -125.02 106.18 9.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.049 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 44.8 t -149.44 118.71 6.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.02 0.438 . . . . 0.0 110.879 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 60.15 35.02 21.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.873 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.2 m -145.69 173.88 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.144 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 74.4 m-80 -110.68 71.64 0.76 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.802 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -117.68 147.45 42.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -135.54 160.09 24.36 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.593 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.705 HG11 ' O ' ' A' ' 315' ' ' PRO . 5.8 p -140.82 138.23 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.928 0.394 . . . . 0.0 111.112 -176.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.1 t -152.86 152.19 31.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.118 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 24.4 m -60.02 167.4 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.085 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.465 HD22 ' N ' ' A' ' 247' ' ' LEU . 3.5 mm? -63.2 141.09 97.76 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.608 0.718 . . . . 0.0 110.919 -159.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.97 167.68 19.18 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.641 2.228 . . . . 0.0 112.335 174.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 71.1 p -103.51 161.44 13.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.15 -170.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.514 ' HD2' ' HB3' ' A' ' 163' ' ' ALA . 30.7 t80 -143.18 121.06 11.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.864 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 57.25 34.98 25.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.89 10.32 79.09 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.462 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -126.44 145.06 51.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.651 0.739 . . . . 0.0 110.877 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -71.95 139.23 32.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.66 2.24 . . . . 0.0 112.309 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 70.2 m -84.95 0.14 52.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 171.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -46.18 110.16 1.14 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.658 0.742 . . . . 0.0 110.916 -176.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -76.7 161.09 34.11 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.783 2.322 . . . . 0.0 112.359 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -75.17 153.18 38.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -174.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.408 HG21 ' HA ' ' A' ' 324' ' ' ALA . 63.4 t -99.88 134.0 40.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.159 -170.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.21 133.62 11.75 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.438 -178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 86.0 t -124.91 131.44 72.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.936 0.398 . . . . 0.0 111.155 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.407 ' HB3' ' HB ' ' A' ' 108' ' ' ILE . 2.5 tt -67.98 131.1 44.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 171.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.569 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 70.8 p -118.84 140.62 49.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.85 -176.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.545 ' HB1' HD11 ' A' ' 280' ' ' LEU . . . -127.87 130.17 48.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.089 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -122.52 163.19 16.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.495 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.466 ' HA ' HG22 ' A' ' 59' ' ' ILE . 15.7 mm -100.96 125.06 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 111.159 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -66.01 127.8 33.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.428 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -60.92 -28.42 68.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.121 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.9 -10.9 56.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.061 -172.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.3 t -75.88 121.11 84.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.674 0.75 . . . . 0.0 110.865 -174.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -67.23 -8.77 22.95 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 167.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -103.05 17.86 23.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 -173.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -52.72 -34.41 52.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 -168.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -71.38 -47.85 53.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.841 -170.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.3 pp -80.04 -31.02 39.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.966 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.464 ' HB1' HD12 ' A' ' 59' ' ' ILE . . . -67.84 -45.92 73.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -69.41 -34.05 73.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 89.2 tt0 -62.9 -52.93 61.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.477 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.2 p90 -69.9 -33.61 72.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.82 -176.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.545 HD11 ' HB1' ' A' ' 264' ' ' ALA . 5.6 tt -56.93 -47.55 80.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -85.15 -32.11 22.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 69.4 m-20 -101.95 -14.01 17.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 -164.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 73.2 t80 -121.92 -49.49 2.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -175.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.506 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -64.39 -46.99 80.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 177.062 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 64.2 mt -85.98 59.98 5.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.984 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.484 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 47.5 p -139.18 150.42 45.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.065 172.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.531 ' HA ' HD11 ' A' ' 290' ' ' LEU . 42.4 p-10 -51.01 -26.4 6.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 -175.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -81.0 -43.9 18.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.834 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.05 -50.82 21.24 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.478 -169.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.555 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.4 OUTLIER -74.37 -20.85 59.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.894 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.426 ' N ' HD12 ' A' ' 290' ' ' LEU . 82.4 tt0 -67.12 -41.86 85.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.937 170.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.08 -34.37 74.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.145 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.63 HG13 ' HA3' ' A' ' 19' ' ' GLY . 21.1 t -79.4 -42.23 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.453 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 47.0 t30 -64.96 -27.4 68.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.944 177.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.82 -29.67 70.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -85.97 -39.99 16.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -150.87 133.77 8.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.584 0.707 . . . . 0.0 110.888 173.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.52 112.33 0.73 Allowed 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.662 2.242 . . . . 0.0 112.375 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.453 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 36.9 mt -91.05 -12.48 35.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.15 -58.98 0.49 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.43 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -175.01 167.28 3.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.846 0.355 . . . . 0.0 111.097 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 27.8 m -124.04 156.8 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.119 176.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -71.77 -17.73 62.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.983 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.555 ' CD2' HD21 ' A' ' 290' ' ' LEU . 58.6 tp -80.13 122.34 26.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.991 -173.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -56.09 -39.74 72.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -173.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.2 m -63.18 -48.47 78.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.825 -167.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.447 ' CD2' HD23 ' A' ' 311' ' ' LEU . 24.0 t80 -84.86 -28.31 26.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.74 -43.07 90.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.937 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.56 -37.9 89.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -72.32 -47.88 46.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.865 -176.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.709 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.5 pp -69.42 -27.76 65.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.959 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.433 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.0 -11.52 57.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.201 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.13 -15.02 61.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -81.2 130.09 64.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.503 0.668 . . . . 0.0 110.92 170.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.705 ' O ' HG11 ' A' ' 244' ' ' VAL . 87.1 Cg_exo -51.69 -35.21 56.9 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.272 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.522 ' HG3' HG13 ' A' ' 317' ' ' ILE . 23.3 ptt-85 -66.91 -32.61 73.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.838 -173.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.709 HG21 ' CD1' ' A' ' 311' ' ' LEU . 64.9 mt -93.35 -33.78 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.094 -175.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -52.47 -43.08 64.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -172.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.457 ' CB ' HG22 ' A' ' 244' ' ' VAL . . . -66.47 -43.1 86.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 72.4 p -65.3 -28.81 69.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.086 -174.702 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 34.6 mmt -68.72 -30.15 68.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -64.95 -44.41 89.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 327' ' ' GLY . 39.1 t30 -64.61 -36.88 85.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 174.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.408 ' HA ' HG21 ' A' ' 259' ' ' VAL . . . -62.14 -45.3 94.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -73.54 -34.5 65.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.54 -1.15 51.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -175.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -103.45 -157.3 24.76 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.431 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -141.17 142.09 34.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 0.0 110.952 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.577 ' O ' ' C ' ' A' ' 330' ' ' MET . 37.9 mm -81.69 110.6 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 -171.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.577 ' C ' ' O ' ' A' ' 329' ' ' ILE . 96.1 mmm 23.44 60.02 0.35 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.553 0.692 . . . . 0.0 110.782 174.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -88.48 -11.73 4.06 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.753 2.302 . . . . 0.0 112.302 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.547 ' HB2' ' HG3' ' A' ' 336' ' ' MET . 52.4 p-10 -99.28 15.15 27.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.964 -155.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.539 ' O ' ' O ' ' A' ' 332' ' ' ASN . 28.4 pt 58.41 161.68 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.747 0.784 . . . . 0.0 111.098 159.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -59.64 -30.54 92.51 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.706 2.271 . . . . 0.0 112.362 -174.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.01 -29.84 70.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -169.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.547 ' HG3' ' HB2' ' A' ' 332' ' ' ASN . 89.4 mmm -74.35 -24.59 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -172.013 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.7 m -64.13 -39.88 94.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.46 -36.7 65.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.045 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.401 ' O ' HG13 ' A' ' 343' ' ' VAL . 11.1 m-30 -65.04 -41.22 95.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -61.97 -35.42 78.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.764 177.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -69.3 -43.83 72.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.958 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 367' ' ' ARG . . . -61.45 -40.5 94.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.221 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 339' ' ' PHE . 16.1 m -79.47 -24.86 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.121 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -62.29 -45.44 93.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 87.2 m -57.28 -35.08 69.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.042 173.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.636 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -60.25 -44.42 95.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.057 -175.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.414 ' HA ' HD22 ' A' ' 192' ' ' LEU . 1.5 m -74.06 -33.63 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.124 -174.638 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -63.5 -47.92 89.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.242 173.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 84.9 m-20 -67.02 -37.72 84.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.83 -47.9 49.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.154 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.21 -37.1 80.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.177 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.5 p -74.81 -13.92 60.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.823 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.53 12.2 84.5 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.436 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -81.74 -26.46 34.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.777 0.322 . . . . 0.0 110.91 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 93.3 mt-30 -133.43 159.4 40.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 170.078 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.2 p -80.42 169.54 17.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.249 170.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 69.7 t -56.48 -43.09 77.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.175 170.342 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -59.13 -45.09 91.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -70.1 -52.66 21.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.919 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.15 74.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.093 -173.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.633 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -67.05 -40.01 87.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.002 -176.185 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.547 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.0 tttt -65.1 -39.12 92.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.935 176.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -64.71 -37.08 86.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.636 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -63.95 -45.56 88.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.091 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -73.5 -30.04 62.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.073 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 67.9 m -64.6 -41.16 96.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.118 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.413 ' HB2' ' HB1' ' A' ' 342' ' ' ALA . 99.7 mtt180 -66.75 -39.98 88.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.848 175.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.492 HD12 HG21 ' A' ' 183' ' ' VAL . 67.1 mt -65.93 -38.42 82.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.099 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 70.7 p -93.9 -8.95 38.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.168 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 173.713 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.74 0.305 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.8 mt -97.71 128.5 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.215 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -158.01 145.8 18.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -51.86 138.39 24.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.501 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 98.1 2.52 58.08 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.405 -173.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -170.35 152.38 4.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.597 HD22 HD13 ' A' ' 33' ' ' ILE . 1.3 pt? -153.51 155.37 36.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.984 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 71.4 t -109.92 135.8 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.159 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.681 HG22 ' CG1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -122.78 132.27 71.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.449 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 40.0 m0 -107.05 125.8 51.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.939 169.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.485 ' HB ' HD12 ' A' ' 20' ' ' LEU . 15.8 tt -107.74 149.71 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.194 -171.203 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -58.97 148.11 31.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.796 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.75 -14.64 37.66 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.476 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -73.84 -9.94 59.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.0 110.856 -174.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -150.23 133.76 16.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 159.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.91 -84.97 0.98 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.534 -163.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -106.69 -45.02 4.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.905 0.383 . . . . 0.0 110.921 -173.221 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -68.22 -52.46 33.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 -151.44 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.596 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -59.2 -48.04 87.89 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.556 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.602 ' CD1' HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -58.69 -46.38 87.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.933 176.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.65 -38.14 77.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -65.51 -49.4 69.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.8 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.6 m -73.36 -34.66 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -67.31 -43.22 88.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.87 -44.87 96.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.817 0.341 . . . . 0.0 110.932 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -67.33 -40.11 85.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 33' ' ' ILE . 42.6 t80 -64.58 -38.85 92.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 176.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.93 -41.86 97.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.966 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.68 -36.4 82.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.842 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -81.49 -39.7 24.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.793 -170.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.631 ' OG1' HG13 ' A' ' 33' ' ' ILE . 63.9 p -103.62 -8.54 19.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.95 11.07 83.99 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.557 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.038 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 pp -105.14 131.11 55.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.889 0.376 . . . . 0.0 111.168 -174.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -68.68 128.21 35.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.94 -168.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.463 HG22 HD21 ' A' ' 7' ' ' LEU . 95.8 t -110.42 119.97 60.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.458 ' HB ' HG22 ' A' ' 8' ' ' VAL . 99.8 m -111.12 116.71 31.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.501 HG22 HD13 ' A' ' 20' ' ' LEU . 87.9 t -92.82 133.51 33.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.12 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.449 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 74.0 mm-40 -120.02 160.88 21.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 174.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 64.7 t-80 -84.03 138.13 40.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 110.775 -167.948 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 58.8 Cg_exo -61.45 -17.42 53.52 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.717 2.278 . . . . 0.0 112.304 -174.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -47.39 -49.69 24.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 75.4 mmtt -90.88 -0.1 57.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.714 HD11 ' O ' ' A' ' 61' ' ' PHE . 9.8 tt -45.29 -56.93 4.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.954 -170.054 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -76.63 -38.42 54.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.879 -175.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -79.86 -44.84 19.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.896 -166.372 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 85.3 tttt -85.13 -36.02 21.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -171.18 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.597 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 84.0 t80 -49.23 -53.82 35.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.666 0.746 . . . . 0.0 110.989 -171.596 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 22.7 Cg_endo -59.17 -30.63 93.6 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.654 2.236 . . . . 0.0 112.325 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -74.46 -44.67 50.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.942 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.7 m -75.01 -24.71 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.168 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.65 -34.39 78.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.22 -31.0 71.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.071 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.5 p -89.99 -13.42 36.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.189 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.2 16.35 80.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.513 168.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -137.81 130.0 29.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.823 0.344 . . . . 0.0 110.821 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.3 -118.56 0.76 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.493 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.48 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 68.1 Cg_endo -70.54 153.22 65.51 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.711 2.274 . . . . 0.0 112.349 176.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.432 ' HB2' HD13 ' A' ' 59' ' ' ILE . 1.8 m-20 -86.4 -38.88 16.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.901 169.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.752 HG23 ' HB1' ' A' ' 276' ' ' ALA . 0.0 OUTLIER -133.81 149.69 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 178.803 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 tp -128.97 125.07 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.107 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.714 ' O ' HD11 ' A' ' 43' ' ' LEU . 2.3 m-85 -101.5 134.51 44.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.409 ' CH2' ' HB2' ' A' ' 105' ' ' ALA . 32.0 p90 -144.94 -178.74 6.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.948 175.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.96 -98.71 0.32 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -107.3 -55.1 2.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.822 -176.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.12 -34.35 73.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.872 -162.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.57 -20.01 54.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 -171.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -45.55 -53.14 9.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.928 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.42 -52.28 44.89 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.556 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.23 -49.93 73.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.576 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -70.93 -47.52 58.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.96 -172.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.3 -47.7 63.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.162 -173.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -64.45 -35.35 80.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.1 m -83.76 -7.48 59.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.814 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.26 33.48 61.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mp -84.0 -4.82 59.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 110.975 -176.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.746 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.8 pp -132.34 145.66 51.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.974 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.23 142.19 43.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.126 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -66.73 134.26 51.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.883 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.835 HG13 ' HB3' ' A' ' 103' ' ' LEU . 39.8 pt -111.58 160.71 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.137 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.9 m -101.46 130.06 25.53 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.627 0.727 . . . . 0.0 111.173 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.27 147.91 54.32 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.655 2.236 . . . . 0.0 112.33 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -114.46 120.06 38.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.15 -38.73 91.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.07 -44.77 83.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -71.44 -35.19 70.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.501 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 43.6 tt0 -53.32 -46.53 69.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.929 173.288 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.63 -34.55 75.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.905 174.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.26 -23.3 54.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.4 OUTLIER -108.09 -93.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.879 -171.676 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -169.98 129.18 0.87 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.631 0.729 . . . . 0.0 111.067 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -56.2 -43.68 53.85 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.6 2.2 . . . . 0.0 112.291 -171.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 1.8 t80 -72.04 -32.78 67.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.994 -173.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.551 ' CG2' ' HB3' ' A' ' 107' ' ' PRO . 96.2 m -64.39 -34.77 78.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.011 -171.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.69 ' HA ' HG22 ' A' ' 97' ' ' VAL . 61.0 m95 -70.37 -21.61 62.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.986 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 92' ' ' PHE . 97.5 m-20 -72.99 -33.73 65.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.83 171.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.92 -27.7 64.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.69 HG22 ' HA ' ' A' ' 94' ' ' TRP . 15.7 m -100.38 15.51 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.09 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 70.8 ttt180 -110.4 136.48 49.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -140.12 126.59 20.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.975 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.4 t30 59.87 34.7 21.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.95 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.41 -3.0 83.77 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.528 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.14 147.41 49.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.707 0.289 . . . . 0.0 110.961 174.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.835 ' HB3' HG13 ' A' ' 79' ' ' ILE . 3.3 tp -76.87 140.1 40.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.857 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 76' ' ' LEU . 2.0 pp -122.14 -6.16 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 -171.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.409 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . . . -164.97 166.67 19.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.085 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.433 ' HB3' HD11 ' A' ' 285' ' ' LEU . 87.1 m-85 -112.93 146.42 35.09 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.696 0.76 . . . . 0.0 110.939 169.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.551 ' HB3' ' CG2' ' A' ' 93' ' ' THR . 72.0 Cg_endo -76.16 118.93 5.13 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.631 2.22 . . . . 0.0 112.426 176.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.431 HD13 HD21 ' A' ' 285' ' ' LEU . 27.2 mm -92.5 -55.26 6.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.43 160.48 43.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.08 -168.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.0 t -119.41 136.67 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.101 -172.866 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -121.33 140.14 52.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.907 171.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.481 ' HB1' HD22 ' A' ' 323' ' ' ASN . . . -150.45 159.27 44.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.419 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 8.8 mp -92.31 169.23 10.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.903 -173.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.5 p -157.05 157.86 35.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.899 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -100.03 126.06 46.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.021 171.162 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.569 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.8 mp -110.2 133.3 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.177 -174.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -133.25 150.37 51.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -91.12 118.75 30.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.58 -20.71 66.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.939 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -77.76 -27.94 50.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.497 HD21 ' O ' ' A' ' 220' ' ' GLY . 6.7 mp -95.5 -44.76 7.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.946 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 24.6 mt -108.74 103.32 51.24 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.631 0.729 . . . . 0.0 110.89 177.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 122' ' ' LEU . 72.6 Cg_endo -67.7 -23.61 42.09 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.686 2.257 . . . . 0.0 112.358 171.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -147.16 94.02 4.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.621 0.724 . . . . 0.0 110.894 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.94 152.7 79.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.684 2.256 . . . . 0.0 112.364 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.37 144.9 63.57 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.65 2.234 . . . . 0.0 112.389 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.53 -13.62 27.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.0 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.4 p -130.22 155.88 45.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.079 -174.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.558 ' HA ' HD13 ' A' ' 132' ' ' ILE . 64.2 m95 -68.44 -29.27 67.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.958 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.53 -25.02 67.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 -176.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -78.74 -21.22 48.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.894 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.598 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.6 mp -60.43 -52.88 69.78 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.661 0.743 . . . . 0.0 111.065 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 27.7 Cg_endo -66.89 -40.04 13.16 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.623 2.215 . . . . 0.0 112.441 -171.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.18 -41.61 76.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.118 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.7 tp -55.14 -43.45 74.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.437 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . 1.5 m-20 -49.87 -42.37 47.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.95 -35.13 79.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.898 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -75.5 -46.17 33.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 -171.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.46 ' HG ' ' HB2' ' A' ' 144' ' ' LYS . 0.8 OUTLIER -89.94 -18.74 25.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.96 -174.218 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -53.67 -30.33 42.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.83 167.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.18 -25.08 67.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.12 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -95.0 7.01 47.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.865 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.16 24.91 72.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.464 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.46 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 26.5 mmtp -110.04 167.55 10.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.37 . . . . 0.0 110.904 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.0 t -130.64 137.95 49.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.899 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 224' ' ' MET . . . -72.94 -53.48 11.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.068 -166.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.461 HD22 ' H ' ' A' ' 148' ' ' MET . 1.9 tm? -138.24 138.12 38.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 -167.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.461 ' H ' HD22 ' A' ' 147' ' ' LEU . 98.7 mtp -125.14 133.27 52.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.852 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -159.98 161.69 34.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.823 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -95.47 90.05 5.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.829 HD21 HD11 ' A' ' 195' ' ' LEU . 1.2 tm? -66.44 -32.75 74.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.951 -173.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.29 0.07 23.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -100.4 142.87 25.44 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.586 0.707 . . . . 0.0 110.914 176.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.604 ' HG3' ' CE1' ' A' ' 341' ' ' TYR . 29.9 Cg_endo -64.32 -22.47 66.36 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.672 2.248 . . . . 0.0 112.429 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -69.26 -35.47 76.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.964 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -92.09 -29.97 16.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.836 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.2 p -65.68 -45.67 81.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.271 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.598 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 90.6 t90 -66.21 -46.83 61.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.521 0.677 . . . . 0.0 110.82 -166.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 96.9 Cg_exo -48.81 -45.39 28.5 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.685 2.257 . . . . 0.0 112.422 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.761 HD23 ' O ' ' A' ' 160' ' ' LEU . 6.2 tt -69.15 -39.11 79.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 67.2 mt -71.55 -40.5 71.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.73 -26.47 44.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -60.41 -33.68 72.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.046 -171.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -95.02 3.3 55.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.846 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.88 -1.06 13.52 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.45 171.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.3 67.14 3.11 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.422 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -87.76 132.38 34.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 0.0 110.928 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.07 13.98 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.409 ' HA ' HG12 ' A' ' 181' ' ' VAL . 49.1 p90 -147.47 151.45 36.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.868 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -103.21 129.62 50.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.836 158.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -120.88 125.03 46.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -151.99 129.81 11.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.994 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.09 41.78 31.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 172.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.02 15.35 81.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.525 173.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -129.97 139.03 51.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.739 0.304 . . . . 0.0 110.842 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -99.74 144.6 28.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 171.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -122.06 108.05 12.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.865 172.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.528 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.4 pp -77.77 -11.99 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.134 -178.264 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.14 -11.44 22.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -176.296 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -130.01 85.08 2.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 172.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 169' ' ' PHE . 30.6 m -113.84 173.08 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 -169.134 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -101.97 23.76 33.57 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.455 -166.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.534 HG21 HD12 ' A' ' 368' ' ' ILE . 31.3 m -114.41 -7.59 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 0.0 111.131 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.5 p-10 -85.5 18.07 2.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -125.74 -170.02 2.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.84 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.07 -27.64 68.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.111 -173.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.2 -44.76 74.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.479 -164.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.747 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -67.01 -36.01 81.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.81 0.338 . . . . 0.0 111.07 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.476 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.5 mttt -59.04 -33.7 71.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.898 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.13 -31.68 73.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.105 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.83 -45.22 96.16 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.481 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.463 HD11 ' HB1' ' A' ' 346' ' ' ALA . 22.7 mt -64.98 -38.63 91.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.9 0.381 . . . . 0.0 110.98 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.1 m -58.2 -44.99 88.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.244 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -75.88 -45.49 35.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.829 HD11 HD21 ' A' ' 151' ' ' LEU . 6.5 tt -54.39 -48.57 71.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.961 -170.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.418 ' HA ' HD11 ' A' ' 199' ' ' ILE . 23.0 m -70.1 -19.93 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 -174.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.443 ' HB3' HD13 ' A' ' 198' ' ' LEU . 38.6 t70 -56.52 -56.74 17.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 -168.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.985 ' H ' HD13 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.5 -26.6 58.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.928 -167.582 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.581 ' H ' HD22 ' A' ' 198' ' ' LEU . 1.8 pp -86.99 -34.52 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.176 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.74 -32.6 69.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.914 166.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -84.88 5.0 30.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 65.19 36.84 6.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -86.24 -14.44 43.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 57.9 ttp -138.08 153.27 49.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.962 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -97.7 150.16 21.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.81 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.97 -26.65 68.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.103 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -93.78 4.9 53.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.809 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 91.5 m -61.03 129.97 44.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -139.81 169.65 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.837 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -66.63 -36.19 81.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 99.5 p -66.08 -36.57 83.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.745 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 73.4 mt -64.94 -39.36 85.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.31 83.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.172 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.41 -45.73 93.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.949 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.03 -38.64 91.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.15 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.93 97.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.176 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -65.22 -36.91 85.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -61.35 -34.01 74.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -89.59 -22.59 22.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.497 ' O ' HD21 ' A' ' 121' ' ' LEU . . . 88.19 24.92 32.81 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.505 -178.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -87.91 -26.84 22.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.38 . . . . 0.0 110.861 -173.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . 0.443 HG21 ' SD ' ' A' ' 148' ' ' MET . 75.6 m -116.87 129.92 56.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 -173.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.92 -49.8 55.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.428 ' N ' ' O ' ' A' ' 146' ' ' ALA . 71.1 mtm -136.43 157.06 47.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -170.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.9 t -149.15 157.68 43.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.2 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.3 mm -112.81 121.26 64.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.119 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.545 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 9.4 t-20 -156.05 170.0 23.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -172.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -132.42 -100.32 0.77 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.571 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.26 -22.94 39.45 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.703 2.269 . . . . 0.0 112.306 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -83.56 -20.11 34.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.002 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -55.6 -45.1 77.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.073 -166.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -63.14 -19.1 64.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 -171.734 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.1 p -54.05 -25.41 21.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.879 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -136.17 39.94 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.442 ' HB ' ' HG2' ' A' ' 316' ' ' ARG . 95.6 mt -119.43 128.46 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 170.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -165.06 162.55 20.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 73.6 p -135.07 54.64 1.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.083 176.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 43.4 t -138.4 110.55 7.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.02 0.438 . . . . 0.0 110.827 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 62.34 21.33 12.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 -174.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 30.8 m -145.25 163.1 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.089 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -123.41 82.49 2.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.836 176.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.03 147.88 47.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.868 171.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -127.67 153.09 19.12 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.542 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.532 HG22 ' CB ' ' A' ' 319' ' ' ALA . 5.0 p -137.8 134.07 45.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 111.166 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.8 t -155.78 147.86 23.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.105 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.4 m -60.66 168.87 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.068 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.656 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.8 mm? -64.09 149.13 94.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.615 0.721 . . . . 0.0 110.855 -159.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 32.1 Cg_exo -65.12 179.08 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.705 2.27 . . . . 0.0 112.254 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 97.3 m -101.04 146.41 27.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.189 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -136.79 119.42 16.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 56.14 35.05 24.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.51 3.33 86.64 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.478 171.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -133.7 142.73 44.85 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.683 0.754 . . . . 0.0 110.886 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.78 144.94 44.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.727 2.284 . . . . 0.0 112.315 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.656 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 70.0 p -87.03 10.28 16.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 173.717 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -43.07 112.21 1.16 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.648 0.737 . . . . 0.0 110.887 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.408 ' CD ' HD23 ' A' ' 247' ' ' LEU . 80.7 Cg_endo -78.5 164.63 26.0 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.654 2.236 . . . . 0.0 112.355 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -71.27 163.26 28.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -174.15 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 60.5 t -107.88 135.22 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 -172.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.12 135.98 13.17 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.455 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 89.6 t -122.8 132.13 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 111.114 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.4 tt -66.61 128.89 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 171.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 59.7 p -123.11 132.17 53.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 280' ' ' LEU . . . -124.92 127.75 47.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.163 -173.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.78 167.01 14.46 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.416 -171.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.406 HD13 HG22 ' A' ' 59' ' ' ILE . 12.6 mm -99.98 126.81 53.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 111.148 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -62.86 126.39 27.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.889 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.85 -25.11 68.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.083 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.59 -10.52 55.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.112 -173.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.3 t -75.61 120.37 81.33 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.581 0.705 . . . . 0.0 110.928 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -70.91 -12.24 30.45 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.631 2.221 . . . . 0.0 112.289 171.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -112.07 35.75 3.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.984 -170.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.05 -25.11 65.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -169.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.94 -39.07 76.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.802 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 43.1 tp -66.26 -48.21 71.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 173.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.752 ' HB1' HG23 ' A' ' 59' ' ' ILE . . . -68.0 -50.0 58.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.053 -172.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -62.97 -41.34 99.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -63.86 -53.46 50.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.954 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -70.05 -36.88 75.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -173.369 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.509 HD23 ' O ' ' A' ' 280' ' ' LEU . 6.4 tt -58.53 -46.56 86.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -77.23 -40.31 45.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.832 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -102.8 -9.68 19.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 -160.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 75.7 t80 -122.48 -49.07 2.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.502 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.1 OUTLIER -64.43 -47.1 80.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 178.082 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 106' ' ' TYR . 64.6 mt -85.0 59.2 5.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.483 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 37.4 p -140.23 151.16 44.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.149 172.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.524 ' HA ' HD11 ' A' ' 290' ' ' LEU . 43.1 p-10 -51.12 -26.06 6.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.916 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -79.6 -44.93 20.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.801 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.88 -50.1 20.12 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.532 -168.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -74.79 -20.9 59.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.737 0.303 . . . . 0.0 110.903 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.421 ' N ' HD12 ' A' ' 290' ' ' LEU . 82.4 tt0 -66.13 -40.43 90.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.931 169.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.68 -34.74 76.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.193 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.596 HG13 ' HA3' ' A' ' 19' ' ' GLY . 24.7 t -78.45 -45.23 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.182 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.4 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 48.3 t30 -65.53 -27.79 68.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.04 -27.31 69.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -85.99 -41.33 14.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.928 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -150.96 129.82 6.27 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.576 0.703 . . . . 0.0 110.906 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.8 110.35 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.396 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.4 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 55.8 mt -88.19 -17.81 30.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.98 -171.299 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.626 ' O ' HG23 ' A' ' 317' ' ' ILE . . . 105.13 -42.78 1.81 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.445 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 300' ' ' GLY . . . -176.04 173.17 2.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.861 0.362 . . . . 0.0 111.059 164.372 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.523 HG22 HD21 ' A' ' 311' ' ' LEU . 23.2 m -122.7 153.69 27.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.149 170.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -68.19 -18.8 64.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.041 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.453 ' HA ' HD12 ' A' ' 89' ' ' LEU . 52.6 tp -83.03 121.95 27.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.967 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -60.37 -34.99 74.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 -174.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.7 m -64.06 -50.21 69.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.844 -169.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.597 ' CD2' HD23 ' A' ' 311' ' ' LEU . 36.0 t80 -82.8 -26.93 31.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.954 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -55.71 -43.85 76.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.903 177.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.22 -36.89 85.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -77.62 -48.49 16.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.787 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.825 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.5 pp -65.68 -24.78 67.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.988 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.506 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -62.72 -18.74 63.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.094 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.36 -19.93 64.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -79.15 122.12 83.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.575 0.703 . . . . 0.0 110.903 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.504 ' O ' HG11 ' A' ' 244' ' ' VAL . 84.0 Cg_exo -48.58 -31.97 19.97 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.721 2.28 . . . . 0.0 112.241 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.442 ' HG2' ' HB ' ' A' ' 235' ' ' ILE . 99.1 mtt180 -59.01 -36.73 75.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.846 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.825 HG21 ' CD1' ' A' ' 311' ' ' LEU . 38.7 mt -99.97 -34.25 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -171.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.39 -41.52 20.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 -164.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.532 ' CB ' HG22 ' A' ' 244' ' ' VAL . . . -65.69 -44.49 86.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.013 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 317' ' ' ILE . 73.1 p -68.09 -29.7 68.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.074 -176.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -68.24 -38.17 81.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.894 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.1 -46.67 80.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.481 HD22 ' HB1' ' A' ' 112' ' ' ALA . 27.6 t30 -65.43 -35.49 81.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 176.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.79 -46.27 89.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -77.18 -32.96 56.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.05 -2.52 50.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -100.26 -156.63 27.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.449 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -137.36 143.08 41.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.585 ' O ' ' C ' ' A' ' 330' ' ' MET . 45.2 mm -78.79 104.79 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 -170.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.585 ' C ' ' O ' ' A' ' 329' ' ' ILE . 22.1 ptp 22.21 59.78 0.3 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.57 0.7 . . . . 0.0 110.846 174.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.41 -15.61 6.27 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.744 2.296 . . . . 0.0 112.388 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.555 ' O ' ' O ' ' A' ' 333' ' ' ILE . 52.5 p-10 -98.09 20.52 12.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -151.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 332' ' ' ASN . 30.4 pt 60.17 160.05 0.11 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.647 0.737 . . . . 0.0 111.098 154.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.0 -32.46 92.35 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.73 2.287 . . . . 0.0 112.316 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.62 -25.45 67.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 -169.173 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.539 ' HG3' ' HB2' ' A' ' 332' ' ' ASN . 88.2 mmm -75.17 -23.18 57.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 -171.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.6 m -62.25 -42.25 99.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.08 -33.0 63.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.989 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -64.85 -38.78 92.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.869 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 154' ' ' PRO . 38.3 m0 -60.59 -35.33 75.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 175.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 341' ' ' TYR . . . . . 0.604 ' CE1' ' HG3' ' A' ' 154' ' ' PRO . 32.3 m-85 -73.61 -38.62 65.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.33 94.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.148 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.1 m -80.4 -25.12 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.453 ' O ' HG22 ' A' ' 347' ' ' VAL . 7.9 tmm_? -62.12 -45.58 92.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 173.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 98.1 m -55.61 -34.74 65.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.206 173.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -61.34 -42.99 99.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 -176.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 344' ' ' ARG . 1.4 m -74.35 -33.72 34.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.138 -174.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.44 -47.04 94.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.204 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 95.1 m-20 -64.98 -39.67 93.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.29 -46.74 60.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.2 -42.66 88.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.6 p -76.04 -10.61 59.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.82 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.18 14.97 81.68 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.581 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.65 -31.29 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.684 0.278 . . . . 0.0 110.848 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 84.9 mm-40 -139.56 158.3 44.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 51.2 p -78.39 166.55 22.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.194 170.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 62.7 t -55.72 -42.46 69.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 172.431 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -60.16 -46.09 90.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -69.89 -52.5 24.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.848 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -67.66 -45.5 75.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.041 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.747 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -67.42 -39.78 85.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.001 -177.068 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 87.9 tttt -64.78 -38.42 90.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -63.96 -38.02 89.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 175.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -64.61 -45.97 84.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.016 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 1.1 pp0? -73.03 -30.91 64.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -177.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 73.9 m -65.62 -42.73 91.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.153 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -66.26 -37.11 84.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.534 HD12 HG21 ' A' ' 183' ' ' VAL . 62.9 mt -66.0 -39.9 85.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.186 177.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 72.0 p -90.36 -11.15 41.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.153 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.927 175.487 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.784 0.326 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.9 mt -102.11 127.77 55.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -152.4 144.08 23.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.6 137.65 30.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.784 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 97.66 3.15 58.44 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.505 -172.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -170.1 153.31 4.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.76 0.315 . . . . 0.0 110.983 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.549 HD22 HD13 ' A' ' 33' ' ' ILE . 1.3 pt? -153.17 155.97 37.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 78.1 t -110.62 137.87 41.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.128 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.927 HG13 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -122.09 132.76 70.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.095 -179.32 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.453 ' HB3' HD12 ' A' ' 43' ' ' LEU . 45.6 m0 -109.89 127.44 54.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 168.127 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.542 ' HB ' HD22 ' A' ' 20' ' ' LEU . 6.9 tt -108.18 145.6 15.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.137 -170.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -53.01 143.96 16.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.28 -13.53 21.99 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.418 -174.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -74.76 -10.29 59.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.861 0.363 . . . . 0.0 110.854 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -145.29 136.92 25.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 158.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.93 -83.86 1.01 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.537 -164.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -114.5 -45.0 3.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.951 0.405 . . . . 0.0 110.908 -173.219 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -68.6 -52.94 26.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.886 -149.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.592 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -60.27 -48.99 83.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 -175.67 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.927 HD21 HG13 ' A' ' 9' ' ' ILE . 18.0 tp -65.09 -41.41 95.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 110.978 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.23 67.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 173.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -67.17 -48.77 66.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.941 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.402 HG22 ' HA ' ' A' ' 20' ' ' LEU . 14.3 m -74.7 -34.47 34.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.491 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -65.53 -45.11 91.44 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.536 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -64.2 -38.93 92.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.84 0.352 . . . . 0.0 110.905 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -63.31 -42.65 99.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.974 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.466 ' CD2' HD11 ' A' ' 33' ' ' ILE . 56.3 t80 -65.06 -37.74 88.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.822 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.98 -41.55 98.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.974 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.96 -31.99 69.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.875 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -80.61 -41.53 23.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.83 -172.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.603 ' OG1' HG13 ' A' ' 33' ' ' ILE . 51.1 p -105.11 -8.44 18.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.031 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.71 10.0 84.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.555 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.997 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 pp -103.29 132.51 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.943 0.401 . . . . 0.0 111.119 -174.101 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -70.61 126.94 31.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.911 -168.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.506 HG22 HD21 ' A' ' 7' ' ' LEU . 93.2 t -110.27 120.52 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.099 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.6 m -112.83 113.83 26.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.064 -174.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.482 HG22 ' HG ' ' A' ' 20' ' ' LEU . 96.1 t -93.22 132.62 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.149 176.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -126.06 155.15 42.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.3 t-80 -77.04 140.03 66.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.604 0.716 . . . . 0.0 110.841 -161.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 72.7 Cg_exo -56.76 -22.22 43.77 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.72 2.28 . . . . 0.0 112.332 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -47.1 -50.16 20.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 -173.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -86.98 -9.85 54.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 10' ' ' TRP . 7.7 tt -46.93 -54.24 10.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 -167.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.05 -35.23 66.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.868 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -74.96 -47.2 30.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.906 -168.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -84.75 -33.66 23.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -170.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.589 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 94.4 t80 -48.22 -53.12 36.5 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.587 0.708 . . . . 0.0 110.966 -165.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 39.1 Cg_endo -62.8 -30.51 77.92 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.65 2.233 . . . . 0.0 112.443 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -76.7 -43.72 36.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.1 m -74.78 -25.05 18.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.208 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.83 -33.67 76.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.119 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.97 69.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.3 p -91.4 -13.85 31.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.17 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.14 15.27 81.76 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.499 170.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -138.92 130.04 26.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.884 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.09 -118.84 0.73 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.454 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 84.4 Cg_endo -72.8 154.11 53.75 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.756 2.304 . . . . 0.0 112.432 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.431 ' CB ' HD13 ' A' ' 59' ' ' ILE . 1.7 m-20 -87.15 -38.42 16.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 170.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.732 HG23 ' HB1' ' A' ' 276' ' ' ALA . 0.0 OUTLIER -134.05 150.05 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.077 179.155 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 tp -129.33 124.73 60.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.1 -174.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.448 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 2.4 m-85 -100.15 134.75 42.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.457 ' CH2' ' HB2' ' A' ' 105' ' ' ALA . 32.2 p90 -145.01 -177.82 5.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.842 174.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.75 -97.14 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.144 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -110.44 -55.43 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -58.83 -35.75 73.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -162.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.523 ' HD3' ' CZ ' ' A' ' 70' ' ' TYR . 4.4 mmp_? -74.56 -21.24 59.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 -172.613 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -45.95 -54.59 8.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.95 -53.58 36.42 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.45 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.69 -52.44 53.07 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.523 ' CZ ' ' HD3' ' A' ' 66' ' ' ARG . 15.8 m-30 -75.78 -41.98 51.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.919 0.39 . . . . 0.0 110.893 -168.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.34 -47.18 71.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.096 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -65.07 -34.93 79.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.8 m -81.7 -7.97 59.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.45 32.08 62.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.472 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mp -84.75 -4.5 59.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 110.978 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.737 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.2 pp -128.28 145.02 51.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.18 141.43 47.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.4 mp0 -69.27 132.33 46.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.89 HG13 ' HB3' ' A' ' 103' ' ' LEU . 37.7 pt -118.82 167.11 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.154 175.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.5 p -113.76 149.55 41.95 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.599 0.714 . . . . 0.0 111.118 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.08 146.82 41.93 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.691 2.261 . . . . 0.0 112.39 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -108.11 119.25 38.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.999 0.428 . . . . 0.0 110.789 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.14 -42.23 99.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.852 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.12 -46.52 80.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.142 -177.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.524 ' HB3' ' HZ2' ' A' ' 94' ' ' TRP . 9.1 m-85 -72.07 -33.86 68.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -177.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.449 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.6 tt0 -53.95 -48.07 70.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.933 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.6 -35.02 79.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.95 -23.26 55.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.978 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.566 HD23 ' HG2' ' A' ' 107' ' ' PRO . 1.4 mp -108.75 -92.3 0.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 -173.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 33.6 t80 -169.68 127.84 0.84 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.597 0.713 . . . . 0.0 110.996 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 87.3 Cg_exo -57.07 -42.66 61.47 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.646 2.23 . . . . 0.0 112.341 -170.645 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.589 ' O ' ' HD1' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -70.18 -33.27 71.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -174.289 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.634 ' CG2' ' HB3' ' A' ' 107' ' ' PRO . 88.3 m -67.56 -36.26 80.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 -173.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.598 ' HA ' HG22 ' A' ' 97' ' ' VAL . 68.5 m95 -67.83 -26.45 66.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.933 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -73.76 -32.17 63.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.82 171.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.11 -25.8 62.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.085 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 94' ' ' TRP . 19.8 m -101.39 17.81 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.099 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 75.7 ttt180 -112.91 132.1 55.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.933 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -138.41 127.75 24.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 62.05 34.87 16.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.919 175.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.31 -4.17 78.34 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.578 173.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.42 150.05 48.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.353 . . . . 0.0 110.959 173.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.89 ' HB3' HG13 ' A' ' 79' ' ' ILE . 2.9 tp -74.42 140.4 44.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.548 HG22 HD11 ' A' ' 76' ' ' LEU . 2.0 pp -118.56 -7.35 11.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.091 -174.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.457 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . . . -164.78 168.83 17.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.117 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.433 ' HB3' HD11 ' A' ' 285' ' ' LEU . 94.5 m-85 -112.22 146.41 34.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.714 0.769 . . . . 0.0 110.903 168.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.634 ' HB3' ' CG2' ' A' ' 93' ' ' THR . 73.9 Cg_endo -74.11 118.23 5.31 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.629 2.219 . . . . 0.0 112.381 172.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.409 HD11 HD21 ' A' ' 280' ' ' LEU . 29.7 mm -92.09 -54.97 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.147 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.89 158.63 44.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.059 -167.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.65 137.47 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.076 -172.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -122.01 139.07 54.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.551 ' HB1' HD22 ' A' ' 323' ' ' ASN . . . -152.1 160.16 43.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.063 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -94.56 168.68 10.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.852 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 100.0 p -154.87 152.92 30.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.819 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.961 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -100.03 128.38 46.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 169.316 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.511 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.3 mp -111.07 137.01 45.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -133.75 149.58 51.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -86.45 110.98 20.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.471 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 88.9 tttt -62.1 -23.12 66.34 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -76.01 -24.19 55.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.893 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.528 HD21 ' O ' ' A' ' 220' ' ' GLY . 7.0 mp -94.76 -53.37 3.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.862 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.477 HD22 ' HB1' ' A' ' 223' ' ' ALA . 1.7 mp -105.07 132.31 20.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.678 0.751 . . . . 0.0 110.863 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.44 -16.99 24.21 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.686 2.257 . . . . 0.0 112.331 -175.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.571 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 20.8 p30 -154.33 161.62 28.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.614 0.721 . . . . 0.0 110.915 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.571 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 57.8 Cg_endo -69.59 155.12 67.38 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.646 2.231 . . . . 0.0 112.392 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.14 146.38 70.02 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.669 2.246 . . . . 0.0 112.299 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -100.12 -48.6 4.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 72.7 p -133.17 158.56 42.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 48.9 t-105 -64.2 -30.23 71.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 175.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.06 -23.67 65.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -174.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -72.75 -32.17 65.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.494 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 1.6 mp -66.03 -47.17 63.55 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.644 0.735 . . . . 0.0 111.085 -163.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 97.9 Cg_exo -53.31 -50.89 12.37 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.653 2.235 . . . . 0.0 112.267 -175.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.94 -39.21 69.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.134 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 30.3 tp -56.02 -45.32 79.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -53.74 -34.97 60.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.837 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.47 -36.76 79.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -73.44 -53.21 11.23 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -172.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.8 OUTLIER -80.01 -10.64 59.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -175.804 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.566 ' N ' HD23 ' A' ' 139' ' ' LEU . 86.5 tttt -55.99 -31.61 63.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.943 166.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.87 -25.1 68.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -95.14 5.59 51.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.47 28.85 60.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.528 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -120.09 170.09 9.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.758 0.313 . . . . 0.0 110.904 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.3 t -131.25 141.25 49.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -70.42 -55.13 9.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.048 -166.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -141.97 131.05 23.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 -170.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.726 ' SD ' ' HB2' ' A' ' 213' ' ' ALA . 52.7 ttm -110.54 123.76 50.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -150.46 157.15 42.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -167.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -101.81 96.24 6.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.965 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.844 HD21 HD11 ' A' ' 195' ' ' LEU . 1.8 tm? -76.12 -18.29 59.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.973 172.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -80.36 -2.49 45.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.425 ' O ' HG23 ' A' ' 157' ' ' THR . 38.4 mt-10 -113.53 152.21 45.17 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.574 0.702 . . . . 0.0 110.909 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.532 ' HD3' ' CD ' ' A' ' 344' ' ' ARG . 30.5 Cg_endo -66.91 -19.82 51.97 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.68 2.254 . . . . 0.0 112.367 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -65.02 -40.66 95.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -172.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' PHE . . . . . 0.411 ' HD2' HD23 ' A' ' 151' ' ' LEU . 74.7 t80 -82.97 -36.04 25.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.807 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 153' ' ' GLU . 81.9 p -60.51 -46.7 89.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.189 -170.579 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.645 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 89.0 t90 -67.84 -48.17 41.53 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.502 0.667 . . . . 0.0 110.897 -167.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 78.5 Cg_exo -47.57 -46.37 20.86 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.666 2.244 . . . . 0.0 112.512 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.674 HD23 ' O ' ' A' ' 160' ' ' LEU . 6.5 tt -70.07 -39.87 75.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.965 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 71.0 mt -70.39 -41.02 78.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.014 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.63 -28.6 61.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.116 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.504 ' HB3' ' HD2' ' A' ' 250' ' ' PHE . . . -63.12 -34.96 78.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 -170.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -91.48 1.99 56.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.884 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.01 1.31 14.48 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.467 170.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.33 65.02 4.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.55 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -84.86 133.55 34.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.912 0.387 . . . . 0.0 110.893 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.25 5.43 10.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.076 -170.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.421 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.0 p90 -146.85 152.9 39.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.944 0.402 . . . . 0.0 110.956 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -103.78 126.15 50.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.98 156.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -115.69 126.28 53.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.857 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -151.58 130.07 12.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.913 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.1 t30 55.02 43.87 29.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 171.388 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.98 14.85 81.41 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.48 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.23 138.71 50.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 0.0 110.845 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -99.37 144.61 28.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 170.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -121.48 110.59 16.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.876 172.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.572 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.2 pp -80.0 -12.64 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.082 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.96 -13.13 20.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -122.94 85.23 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.874 170.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 169' ' ' PHE . 34.1 m -116.9 170.48 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.115 -169.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.63 24.42 29.84 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.45 -167.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.516 HG21 HD12 ' A' ' 368' ' ' ILE . 11.3 m -110.01 -15.45 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.0 111.112 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -85.92 19.61 2.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.786 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -110.32 -179.91 3.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.1 -24.6 64.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.097 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 190' ' ' ALA . . . -70.87 -40.63 63.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.456 -171.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.631 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.38 -35.35 80.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 111.115 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.534 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.1 mttt -59.05 -31.22 68.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 175.545 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 187' ' ' GLY . . . -65.51 -30.69 71.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.115 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.16 -47.46 84.9 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.379 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.495 HD11 ' HB1' ' A' ' 346' ' ' ALA . 19.7 mt -64.89 -38.91 92.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.883 0.373 . . . . 0.0 110.936 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.3 m -58.71 -45.12 90.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.21 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -77.28 -43.06 34.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.843 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.844 HD11 HD21 ' A' ' 151' ' ' LEU . 6.0 tt -55.57 -48.6 74.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 -171.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 24.8 m -68.58 -19.22 24.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -57.5 -54.87 41.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 -169.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 1.045 ' H ' HD13 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -76.1 -26.48 56.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.925 -168.021 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.613 ' H ' HD22 ' A' ' 198' ' ' LEU . 1.8 pp -86.65 -34.42 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.172 177.018 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.86 -31.81 68.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.856 165.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -85.86 6.06 29.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.861 177.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 65.0 39.94 5.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 170.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -84.54 -9.76 58.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 58.7 ttp -134.54 151.38 51.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -97.69 155.56 16.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.921 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.95 -27.76 69.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -95.25 4.25 53.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.903 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.402 ' CG2' ' HG3' ' A' ' 148' ' ' MET . 90.0 m -63.08 132.14 50.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.15 -176.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.432 ' H ' HD12 ' A' ' 212' ' ' ILE . 23.6 t0 -149.75 167.39 26.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.858 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -68.58 -34.01 75.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.0 p -63.57 -32.58 74.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.432 HD12 ' H ' ' A' ' 209' ' ' ASP . 79.7 mt -62.42 -36.56 75.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.08 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.726 ' HB2' ' SD ' ' A' ' 148' ' ' MET . . . -66.07 -42.22 89.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.081 -173.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -64.82 -39.24 93.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.986 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.32 -40.3 85.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.102 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.89 -34.59 78.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.121 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -59.95 -33.66 72.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.825 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -59.91 -34.98 73.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.954 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -96.45 -21.13 17.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.98 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLY . . . . . 0.528 ' O ' HD21 ' A' ' 121' ' ' LEU . . . 91.05 30.51 11.0 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.439 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -84.73 -27.75 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.876 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 94.9 m -116.96 131.1 57.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.216 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.477 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -66.26 -54.57 23.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.098 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.441 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 67.0 mtm -137.82 160.0 40.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.797 -168.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 10.4 t -149.76 164.17 36.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.7 mm -111.29 125.58 68.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.07 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -144.65 167.82 21.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.893 -169.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -118.52 -155.13 9.85 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.471 -174.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -59.99 -22.53 69.49 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.725 2.283 . . . . 0.0 112.289 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.9 p90 -81.54 4.33 21.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.949 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -51.57 -29.24 16.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.0 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -53.54 -20.59 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 26.3 t -42.03 -57.81 2.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.808 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -150.65 40.36 0.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.465 HD12 HG21 ' A' ' 116' ' ' ILE . 46.5 mm -125.01 108.8 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.124 174.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -168.95 162.71 11.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 170.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 82.8 m -125.05 102.25 7.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.204 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 43.4 t -134.67 104.26 5.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.838 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 59.04 34.12 23.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.868 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.94 165.68 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.135 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -99.14 70.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -174.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.471 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 82.4 m-85 -130.03 145.58 51.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.004 172.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -128.26 153.13 19.36 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.509 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.628 HG22 ' HB2' ' A' ' 319' ' ' ALA . 6.7 p -138.53 135.96 43.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.381 . . . . 0.0 111.193 -177.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.2 t -153.44 149.89 28.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.408 ' CG1' ' HB2' ' A' ' 323' ' ' ASN . 25.1 m -60.76 167.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.666 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.3 mm? -64.77 146.19 98.62 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.586 0.708 . . . . 0.0 110.899 -160.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.85 -177.01 2.61 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.727 2.284 . . . . 0.0 112.285 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.2 p -106.76 162.63 13.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.143 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.504 ' HD2' ' HB3' ' A' ' 163' ' ' ALA . 44.7 t80 -146.03 123.43 11.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 176.2 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 55.33 35.25 24.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.84 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.53 12.12 70.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.531 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -137.05 140.37 31.19 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.56 0.695 . . . . 0.0 110.947 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.36 140.82 30.94 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.677 2.251 . . . . 0.0 112.407 -174.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.666 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 89.8 p -83.33 -5.1 59.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.798 169.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -48.33 110.07 1.33 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.546 0.689 . . . . 0.0 110.901 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.0 163.53 30.83 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.623 2.216 . . . . 0.0 112.32 -177.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -73.66 174.82 7.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.828 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.5 t -108.39 132.32 56.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.048 -170.704 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -112.12 126.85 7.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.436 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 96.9 t -116.0 134.41 59.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.854 0.359 . . . . 0.0 111.098 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 263' ' ' SER . 2.6 tt -67.32 129.75 40.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.945 171.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.406 ' N ' HD23 ' A' ' 262' ' ' LEU . 64.3 p -124.63 131.82 53.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.899 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -125.25 125.87 44.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.137 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -119.75 170.34 14.08 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.424 -171.142 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 59' ' ' ILE . 13.1 mm -99.96 127.93 52.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.768 0.318 . . . . 0.0 111.107 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -64.91 127.25 30.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.9 -24.29 67.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.122 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.65 -11.57 55.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.037 -172.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.6 t -77.67 122.38 85.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.632 0.73 . . . . 0.0 110.87 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.34 -11.57 30.31 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.591 2.194 . . . . 0.0 112.349 171.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -111.73 35.19 3.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.917 -169.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -59.31 -26.68 65.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.834 -170.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -69.03 -39.86 78.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.864 -172.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.38 -48.45 72.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.732 ' HB1' HG23 ' A' ' 59' ' ' ILE . . . -67.38 -48.17 68.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.153 -172.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -65.25 -37.46 87.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.5 tt0 -68.21 -53.7 22.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 -172.022 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.1 p90 -67.54 -35.13 78.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.837 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 4.8 tt -58.58 -50.04 75.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -79.95 -33.51 39.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 65.6 m-80 -100.01 -17.71 17.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 -164.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.407 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 40.0 t80 -121.33 -48.64 2.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.954 -172.059 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 0.3 OUTLIER -65.04 -46.39 81.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.82 176.228 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 106' ' ' TYR . 64.8 mt -84.97 59.39 5.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.486 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 52.5 p -138.47 150.2 46.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.187 172.228 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.57 ' HA ' HD11 ' A' ' 290' ' ' LEU . 42.9 p-10 -51.56 -26.0 7.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.84 -174.057 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -78.65 -44.8 22.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.791 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.4 -51.07 13.68 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 -169.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.57 HD11 ' HA ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -73.31 -20.78 60.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 110.91 -179.251 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.426 ' N ' HD12 ' A' ' 290' ' ' LEU . 81.8 tt0 -66.06 -40.75 91.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.933 168.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.79 76.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.075 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.592 HG13 ' HA3' ' A' ' 19' ' ' GLY . 24.9 t -77.4 -44.62 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.143 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.42 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 49.8 t30 -65.03 -25.86 68.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.968 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.4 -28.96 70.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -87.01 -41.65 13.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.822 -176.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -147.69 132.8 9.08 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 121.515 0.674 . . . . 0.0 111.027 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -51.99 111.92 0.72 Allowed 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.628 2.219 . . . . 0.0 112.408 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.42 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 55.3 mt -90.98 -17.17 26.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -172.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.528 ' O ' HG23 ' A' ' 317' ' ' ILE . . . 102.96 -43.04 1.75 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.394 175.793 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -176.27 168.72 2.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.823 0.344 . . . . 0.0 110.974 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.51 HG22 HD21 ' A' ' 311' ' ' LEU . 23.9 m -122.6 154.29 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.199 170.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -69.44 -18.39 63.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.09 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.477 ' CD2' HD21 ' A' ' 290' ' ' LEU . 63.3 tp -83.63 122.62 28.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.014 -173.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -59.55 -36.33 75.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.787 -173.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.8 m -63.11 -49.87 72.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 -168.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.591 ' CD2' HD23 ' A' ' 311' ' ' LEU . 33.1 t80 -83.79 -26.97 29.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -56.43 -44.38 80.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.918 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.01 -36.23 83.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.875 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -76.01 -48.89 19.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.815 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.6 pp -66.72 -25.43 66.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -64.2 -17.37 63.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.061 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -67.3 -17.86 64.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.872 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -80.02 123.28 83.61 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.557 0.694 . . . . 0.0 110.904 173.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.554 ' O ' HG11 ' A' ' 244' ' ' VAL . 83.7 Cg_exo -52.85 -35.59 70.68 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.582 2.188 . . . . 0.0 112.319 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -64.79 -26.83 68.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.92 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.815 HG21 ' CD1' ' A' ' 311' ' ' LEU . 56.3 mt -96.75 -34.54 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.115 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.21 -39.41 13.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.012 -167.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.628 ' HB2' HG22 ' A' ' 244' ' ' VAL . . . -65.15 -44.32 88.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.05 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 317' ' ' ILE . 69.2 p -68.27 -29.9 68.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.128 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 18.0 tmm? -69.99 -40.13 75.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -65.69 -45.6 82.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.551 HD22 ' HB1' ' A' ' 112' ' ' ALA . 25.4 t30 -63.42 -36.3 83.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.967 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.79 -48.28 79.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.032 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -75.4 -32.69 60.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -94.75 -5.6 44.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.931 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -95.28 -157.73 32.43 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.496 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -140.02 142.73 36.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 110.925 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.581 ' O ' ' C ' ' A' ' 330' ' ' MET . 31.4 mm -79.91 108.47 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.215 -170.331 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.643 ' O ' ' HG3' ' A' ' 330' ' ' MET . 20.4 ptp 23.13 60.47 0.34 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.503 0.668 . . . . 0.0 110.848 174.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -90.05 -19.45 1.24 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.76 2.307 . . . . 0.0 112.264 -169.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.474 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 52.0 p-10 -97.17 6.88 47.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.93 -148.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.605 HG22 ' H ' ' A' ' 335' ' ' GLN . 39.0 mm 77.97 135.69 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.681 0.753 . . . . 0.0 111.111 174.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.89 -24.68 32.43 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.694 2.263 . . . . 0.0 112.303 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.605 ' H ' HG22 ' A' ' 333' ' ' ILE . 99.6 mm-40 -63.43 -21.26 66.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 79.7 mmm -71.33 -25.02 62.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.91 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.0 m -61.76 -40.06 93.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 176.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.88 -34.3 60.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.995 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -63.39 -37.97 89.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.891 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 154' ' ' PRO . 21.0 m0 -61.07 -34.5 75.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -76.79 -35.27 57.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 342' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 367' ' ' ARG . . . -63.2 -39.98 96.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.057 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.8 m -81.82 -24.2 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.091 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.532 ' CD ' ' HD3' ' A' ' 154' ' ' PRO . 52.9 ttt180 -55.63 -55.45 31.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.824 173.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 96.6 m -56.87 -33.0 66.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.131 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.637 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -56.94 -44.51 82.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.136 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.432 ' HA ' HD22 ' A' ' 192' ' ' LEU . 1.3 m -74.96 -33.1 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.179 -174.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.3 -47.21 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.22 173.163 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 349' ' ' ASN . . . . . 0.561 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 84.5 m-20 -66.73 -37.01 83.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.52 -47.26 61.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.091 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.45 -39.87 92.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.094 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.5 p -74.86 -14.17 60.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.007 0.432 . . . . 0.0 110.85 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 76.67 10.61 85.83 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.505 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -79.77 -25.09 41.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.765 0.317 . . . . 0.0 110.844 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 87.5 mt-30 -133.15 158.26 43.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 169.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.5 p -79.37 171.01 15.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.154 168.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 67.1 t -55.88 -44.5 78.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.07 169.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -58.21 -44.93 88.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -70.84 -52.02 22.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -69.19 -44.66 71.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.132 -173.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -65.49 -39.99 92.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 -177.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 362' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.0 tttt -64.91 -38.4 90.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.894 176.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -65.83 -36.89 84.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 177.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.637 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -63.92 -44.77 91.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.077 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -73.26 -30.38 63.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.942 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 68.5 m -64.34 -41.17 96.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.422 ' HB2' ' HB1' ' A' ' 342' ' ' ALA . 99.6 mtt180 -67.74 -39.62 84.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.748 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.516 HD12 HG21 ' A' ' 183' ' ' VAL . 67.9 mt -65.6 -39.27 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.164 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.8 p -92.59 -9.04 42.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.064 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.99 173.966 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.733 0.301 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.458 HG21 ' HD2' ' A' ' 271' ' ' PRO . 87.1 mt -79.75 126.35 39.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -148.49 147.38 29.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.801 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.3 129.77 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.817 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.458 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 96.33 5.85 59.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.448 -174.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.0 tttt -164.71 139.86 5.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.779 0.324 . . . . 0.0 110.945 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.669 HD22 HD13 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -146.39 157.45 43.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 75.3 t -108.94 133.43 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.114 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.762 HG13 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -123.11 135.36 63.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 -178.493 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -109.07 160.87 15.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.553 HG21 ' HB2' ' A' ' 15' ' ' LYS . 87.9 mt -132.93 149.26 31.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.154 166.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.501 ' O ' HG22 ' A' ' 11' ' ' ILE . 62.0 t30 -58.26 159.81 5.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 174.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.51 -15.36 8.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.555 -174.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.91 -24.05 65.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 110.872 -172.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.553 ' HB2' HG21 ' A' ' 11' ' ' ILE . 35.4 mtmt -134.25 132.04 39.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.944 169.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.07 -94.07 0.76 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.459 -168.451 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -115.24 -46.67 2.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 110.943 -172.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -64.03 -47.85 78.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.963 -155.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.916 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -57.91 -45.66 93.39 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.431 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.762 HD11 HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -51.51 -50.73 59.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.872 0.368 . . . . 0.0 110.865 177.024 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.18 -39.37 63.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.167 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -70.1 -52.33 24.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.0 m -69.2 -36.33 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.56 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -66.72 -41.14 93.93 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.513 173.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -54.07 -46.06 71.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.889 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.9 -44.06 90.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.945 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.663 ' CE2' HD11 ' A' ' 33' ' ' ILE . 44.0 t80 -65.71 -38.09 88.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.812 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 34.7 tt0 -64.5 -42.94 95.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.841 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.6 -32.46 68.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -81.14 -39.35 25.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.872 -171.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.715 ' OG1' HG13 ' A' ' 33' ' ' ILE . 67.8 p -103.78 -10.21 18.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.42 7.39 85.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.453 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.076 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.8 pp -104.08 132.51 50.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.882 0.372 . . . . 0.0 111.064 -175.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.8 mttt -70.41 136.74 49.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -171.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.56 HG21 ' HA3' ' A' ' 24' ' ' GLY . 3.0 m -111.99 133.07 58.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 174.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.6 m -110.1 125.66 53.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.102 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.584 HG22 ' HG ' ' A' ' 20' ' ' LEU . 60.9 t -89.66 126.29 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 178.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -112.91 148.88 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 175.018 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 64.8 t-80 -86.27 136.19 35.95 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.658 0.742 . . . . 0.0 110.883 -169.387 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 83.2 Cg_exo -56.04 -21.36 34.17 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.721 2.28 . . . . 0.0 112.322 -175.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -48.07 -53.99 14.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 43' ' ' LEU . 99.1 mttt -88.78 0.92 56.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -172.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 42' ' ' LYS . 16.4 tp -39.88 -54.73 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.975 -173.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.48 -35.27 68.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.844 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.19 -47.93 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 -166.475 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -78.6 -43.81 25.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 -171.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.557 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 83.6 t80 -50.87 -53.88 42.76 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.574 0.702 . . . . 0.0 110.851 -167.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 38.9 Cg_endo -65.98 -30.11 48.44 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.629 2.22 . . . . 0.0 112.351 -177.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -74.8 -41.99 58.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.428 HG21 ' HD3' ' A' ' 57' ' ' PRO . 24.9 m -75.48 -21.5 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.201 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 -31.69 72.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.057 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.15 -29.76 70.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.11 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.9 p -92.62 -15.19 27.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.199 170.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.98 18.38 79.64 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.432 171.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -140.2 143.85 36.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.863 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.48 -78.31 0.33 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.477 168.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 89.0 Cg_endo -78.52 140.99 17.35 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.727 2.284 . . . . 0.0 112.329 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.413 ' HB2' HD13 ' A' ' 59' ' ' ILE . 1.5 m-20 -101.41 -41.13 6.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.97 173.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.64 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -132.92 143.68 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.195 176.91 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.0 tp -136.08 128.06 44.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.174 -169.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.486 ' N ' ' HD1' ' A' ' 61' ' ' PHE . 2.0 m-30 -97.89 142.28 29.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.926 -175.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 80.3 m95 -140.72 159.74 41.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 174.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.17 -88.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.059 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -125.48 -62.54 1.19 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.874 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -75.39 -35.42 61.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 -161.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.467 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 9.4 mpt_? -54.66 -33.75 61.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.895 -168.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.563 ' HB3' HD13 ' A' ' 104' ' ' ILE . 51.0 m-85 -56.79 -38.71 72.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -172.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.06 -50.49 57.31 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.485 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.13 -42.35 99.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.515 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -74.66 -33.21 62.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.945 0.403 . . . . 0.0 110.985 -176.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' A' ' 76' ' ' LEU . . . -65.11 -38.71 91.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.074 170.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -63.97 -34.63 78.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 98.9 p -86.7 -10.14 54.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.886 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.54 28.97 62.41 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.554 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 mp -90.39 -17.2 27.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 -173.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 1.328 ' O ' HD13 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.09 121.17 37.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.807 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -64.73 137.83 58.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.084 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.21 137.05 56.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.446 HD12 ' CE2' ' A' ' 106' ' ' TYR . 37.2 pt -109.98 160.42 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.8 p -96.97 149.87 36.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.547 0.689 . . . . 0.0 111.214 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.13 137.93 29.8 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.74 2.294 . . . . 0.0 112.397 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -104.06 108.8 20.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.888 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.77 -41.78 91.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.969 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.38 -41.88 98.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.218 -176.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.565 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 13.0 m-30 -74.35 -47.6 33.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -49.44 -42.53 43.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -57.35 -30.58 64.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.889 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 305' ' ' LYS . 84.9 mttt -87.45 -13.81 42.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.931 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 46.8 mt -104.93 -145.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.973 -170.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.97 140.69 37.11 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.743 0.782 . . . . 0.0 110.888 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.48 -28.78 38.31 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.628 2.218 . . . . 0.0 112.405 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -65.58 -42.81 91.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.506 HG22 HG21 ' A' ' 261' ' ' VAL . 81.2 p -78.25 -38.37 42.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.161 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -49.37 -46.97 47.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.931 169.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.42 -35.6 80.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.76 -24.94 65.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.024 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.479 HG23 HD11 ' A' ' 103' ' ' LEU . 31.7 m -112.46 20.77 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.206 -171.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.464 ' HB3' HD12 ' A' ' 103' ' ' LEU . 54.7 ptt85 -120.01 146.7 45.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.919 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -136.93 125.58 23.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.014 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.3 t30 60.01 37.05 21.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.73 1.07 90.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.517 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -117.46 150.15 39.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.758 0.314 . . . . 0.0 110.905 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.479 HD11 HG23 ' A' ' 97' ' ' VAL . 6.3 tp -81.68 136.79 35.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.563 HD13 ' HB3' ' A' ' 67' ' ' PHE . 2.1 pp -128.04 2.72 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.153 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.486 ' HB2' ' CE1' ' A' ' 67' ' ' PHE . . . -168.32 169.22 10.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.064 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 263' ' ' SER . 99.4 m-85 -120.1 139.67 28.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.682 0.753 . . . . 0.0 110.887 166.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.52 122.99 5.75 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.586 2.19 . . . . 0.0 112.362 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.2 mp -109.66 -42.92 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.039 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -137.36 144.46 42.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 -165.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.27 131.49 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.17 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -117.6 125.37 50.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 176.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.511 ' HB3' ' CG2' ' A' ' 320' ' ' THR . . . -163.57 163.74 24.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.145 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.421 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 6.6 mp -101.03 170.93 7.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.917 -167.03 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 86.7 p -158.84 154.4 26.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 171.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.872 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -100.06 129.62 46.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.898 174.722 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.623 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.2 mp -114.34 135.99 52.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 -177.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -135.8 154.93 51.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 -172.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -96.78 119.31 35.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.471 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 98.4 mttt -65.6 -18.98 65.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -83.38 -28.16 29.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.811 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 223' ' ' ALA . 10.4 mp -88.09 -44.6 10.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.744 HD22 ' HB1' ' A' ' 223' ' ' ALA . 2.2 pt? -139.94 127.29 12.67 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.607 0.718 . . . . 0.0 110.907 168.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.73 -10.37 17.03 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.592 2.195 . . . . 0.0 112.412 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -143.48 108.32 5.2 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.643 0.735 . . . . 0.0 110.881 -175.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.03 148.61 76.04 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.728 2.286 . . . . 0.0 112.222 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.17 142.7 56.57 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.721 2.281 . . . . 0.0 112.341 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -83.38 -27.93 29.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.4 p -127.15 154.54 44.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.106 -177.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.667 ' HA ' HD13 ' A' ' 132' ' ' ILE . 54.4 m95 -69.89 -23.96 63.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.29 -23.1 63.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -78.52 -22.59 47.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.667 HD13 ' HA ' ' A' ' 129' ' ' TRP . 1.4 mp -56.16 -51.13 83.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.677 0.751 . . . . 0.0 111.15 -170.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.6 Cg_endo -69.36 -41.25 4.97 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.621 2.214 . . . . 0.0 112.299 -172.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.0 -40.54 71.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.994 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 0.832 ' CD2' ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -58.35 -42.67 87.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.963 174.443 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.512 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 32.7 t70 -52.65 -37.24 58.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.09 -31.01 69.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.9 -56.39 5.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.842 -174.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 140' ' ' LYS . 1.0 OUTLIER -80.89 -10.06 59.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -175.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.52 ' N ' HD23 ' A' ' 139' ' ' LEU . 86.0 tttt -54.36 -30.77 52.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.804 165.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.82 -24.92 68.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.086 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -95.01 4.05 54.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.36 27.37 59.72 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.478 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.447 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 38.4 mmtm -116.48 155.52 28.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 0.0 110.891 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.9 t -100.73 147.53 25.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.834 173.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.512 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -67.25 -43.32 82.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.171 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.459 HD11 HG12 ' A' ' 226' ' ' ILE . 48.9 tp -141.4 152.6 44.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.843 -177.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 61.5 tpp -128.0 125.17 38.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.793 170.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -161.07 165.05 30.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -110.0 165.63 11.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 172.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.486 HD11 HD11 ' A' ' 195' ' ' LEU . 36.6 tp -130.15 -16.81 3.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.856 171.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -71.92 0.71 8.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.847 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 70.3 mm-40 -121.82 144.9 41.99 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.672 0.749 . . . . 0.0 110.882 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' A' ' 340' ' ' TRP . 53.9 Cg_exo -55.22 -28.74 63.33 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.789 2.326 . . . . 0.0 112.313 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -59.49 -42.29 91.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -86.47 -32.24 20.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.452 HG22 HG21 ' A' ' 347' ' ' VAL . 65.0 p -64.84 -37.47 87.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.225 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.567 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 42.7 t-105 -61.93 -54.52 49.92 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 121.597 0.713 . . . . 0.0 111.016 -173.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 33.2 Cg_endo -67.14 -27.6 41.56 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.699 2.266 . . . . 0.0 112.38 -174.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.668 ' C ' HD13 ' A' ' 160' ' ' LEU . 2.9 tm? -64.77 -41.85 95.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.572 HG22 ' HA3' ' A' ' 166' ' ' GLY . 2.9 mp -78.08 -41.91 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.23 176.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.32 -20.21 65.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.072 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -57.87 -34.17 69.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.985 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -101.51 5.37 41.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.864 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.33 9.21 24.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.379 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.572 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -75.09 65.79 2.25 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.344 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -95.69 134.81 38.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.885 0.374 . . . . 0.0 110.96 173.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.533 ' HB1' HG21 ' A' ' 368' ' ' ILE . . . -47.77 -31.0 4.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 -175.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.411 ' CD1' HG12 ' A' ' 181' ' ' VAL . 98.5 m-85 -138.48 148.03 43.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.911 174.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -69.11 127.66 33.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -102.04 119.95 39.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.933 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -150.83 130.61 13.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.809 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.3 t30 55.38 42.43 30.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.934 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.38 9.39 81.39 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.416 173.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.03 141.55 49.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.7 0.286 . . . . 0.0 110.892 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -94.11 135.33 35.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 172.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -95.92 105.41 17.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.907 -170.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.454 ' C ' HD12 ' A' ' 178' ' ' ILE . 2.4 pp -71.31 -6.52 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -100.89 -16.7 17.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -134.95 100.75 4.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 168' ' ' ALA . 32.4 m -101.45 162.14 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.132 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -101.75 -0.1 52.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.527 -168.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.5 m -100.72 -20.03 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 0.0 111.128 -171.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -96.28 20.11 10.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -106.62 -175.08 2.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 -174.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.49 71.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.061 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -71.4 -41.25 58.96 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.461 -170.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.71 -34.68 76.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.775 0.321 . . . . 0.0 111.036 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -61.75 -40.87 96.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.969 174.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.06 76.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.025 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.504 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -58.68 -48.88 82.5 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.458 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.475 HD11 ' HB1' ' A' ' 346' ' ' ALA . 25.8 mt -66.41 -39.11 88.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.943 0.402 . . . . 0.0 110.967 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.9 m -58.55 -45.39 89.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.197 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.433 ' O ' HD22 ' A' ' 198' ' ' LEU . 82.3 t80 -68.91 -48.53 63.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 174.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.835 HD23 ' C ' ' A' ' 195' ' ' LEU . 3.2 tt -50.76 -51.79 46.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -174.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.504 ' HA ' HG23 ' A' ' 199' ' ' ILE . 34.7 m -63.52 -23.47 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.071 -175.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.54 -34.01 73.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.961 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.6 OUTLIER -82.15 -40.02 22.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -174.952 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.543 ' O ' HG12 ' A' ' 199' ' ' ILE . 0.0 OUTLIER -75.23 -29.56 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 175.829 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LYS . . . . . 0.428 ' N ' HD13 ' A' ' 199' ' ' ILE . 87.6 tttt -72.36 -46.54 54.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.901 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -90.16 5.75 45.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 67.27 37.72 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 170.474 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -83.04 -13.78 55.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.918 173.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -138.22 155.15 48.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.917 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -103.78 139.83 38.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.824 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.96 -22.24 64.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.071 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.72 -5.84 58.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.895 -172.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 86.7 m -60.03 137.98 57.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.469 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 20.9 t0 -139.25 175.41 9.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -60.82 -45.8 93.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.917 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 96.3 p -67.57 -35.97 80.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.469 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 85.8 mt -64.17 -41.61 92.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.145 175.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.76 -38.89 84.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.091 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -63.17 -45.86 89.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.803 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.14 95.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.159 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.67 97.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.02 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -66.78 -47.38 72.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.873 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -66.0 -30.52 71.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -86.02 -13.6 46.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.924 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.03 26.23 53.56 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.47 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -86.42 -28.62 23.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 0.0 110.911 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 15.3 t -119.79 134.38 55.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.109 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.744 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -78.45 -34.14 47.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.107 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.46 ' HB3' HD21 ' A' ' 115' ' ' LEU . 77.7 mtm -128.94 150.33 50.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.847 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.8 t -145.34 150.97 37.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.459 HG12 HD11 ' A' ' 147' ' ' LEU . 39.2 mm -107.04 122.22 60.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.11 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -140.98 149.39 41.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -127.24 -150.58 7.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.482 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.05 -20.36 71.22 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.658 2.239 . . . . 0.0 112.282 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -71.6 -24.47 61.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.905 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 55.09 54.92 8.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.079 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -60.27 -38.17 82.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.953 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 35.7 t -105.0 118.79 37.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 168.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -75.45 72.83 2.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 116' ' ' ILE . 78.7 mt -85.56 111.24 20.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.155 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -125.05 -85.01 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 96.8 m -128.21 130.11 47.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.193 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 45.2 t -147.16 155.42 42.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.791 175.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.51 -24.09 63.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.891 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 25.5 m -72.33 165.01 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.134 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -92.71 121.06 33.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.897 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.471 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 31.3 p90 -143.53 152.56 41.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.937 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -143.01 167.8 26.23 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.606 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 315' ' ' PRO . 7.7 p -132.27 139.5 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.966 0.412 . . . . 0.0 111.061 -172.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.0 t -144.92 147.16 32.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 168.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 16.6 m -56.92 156.45 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.133 168.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.48 ' N ' HD12 ' A' ' 247' ' ' LEU . 7.4 mp -66.76 148.99 98.61 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.514 0.673 . . . . 0.0 110.897 -157.109 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 48.1 Cg_exo -60.69 178.34 0.49 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.781 2.321 . . . . 0.0 112.369 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 82.1 p -99.96 153.98 18.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -135.31 117.05 15.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 54.77 35.17 23.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 89.11 5.7 72.73 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.472 171.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -124.36 140.54 35.35 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.606 0.717 . . . . 0.0 110.854 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.02 129.5 17.43 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.688 2.258 . . . . 0.0 112.326 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 68.0 m -78.81 -26.76 44.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.87 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -47.63 109.92 1.22 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.557 0.694 . . . . 0.0 110.91 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -58.72 161.31 15.33 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.731 2.287 . . . . 0.0 112.307 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -62.4 162.1 10.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.456 HG23 ' HB2' ' A' ' 112' ' ' ALA . 3.5 p -108.3 134.03 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.11 -175.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.25 142.94 16.06 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.451 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.506 HG21 HG22 ' A' ' 93' ' ' THR . 73.3 t -127.65 122.54 59.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 111.194 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 263' ' ' SER . 1.6 tt -82.05 130.77 35.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 172.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.637 ' N ' HD23 ' A' ' 262' ' ' LEU . 62.2 m -132.32 158.16 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.902 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.18 138.98 50.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.063 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.76 178.27 18.23 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.46 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 77' ' ' ALA . 27.0 mm -103.6 137.06 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.908 0.385 . . . . 0.0 111.092 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -72.29 127.4 32.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.807 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -65.43 -23.06 66.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.1 -176.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.75 -11.72 55.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.054 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.7 t -77.16 120.84 83.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.66 0.743 . . . . 0.0 110.917 -173.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.458 ' HD2' HG21 ' A' ' 2' ' ' ILE . 77.7 Cg_endo -69.12 -10.57 29.42 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.707 2.271 . . . . 0.0 112.32 170.177 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -103.01 21.41 15.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 -170.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -52.97 -31.63 41.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 -170.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -66.18 -47.3 74.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.83 -170.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.04 -26.94 20.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.948 -177.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.567 ' HB1' HG23 ' A' ' 59' ' ' ILE . . . -63.14 -45.11 93.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.16 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -69.73 -33.95 73.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.987 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 92.4 mt-10 -66.43 -35.52 80.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.827 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.498 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 0.8 OUTLIER -56.27 -53.56 55.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.795 175.769 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.495 ' HB2' HD12 ' A' ' 284' ' ' LEU . 2.1 pp -79.06 -34.78 43.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.906 -170.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.22 -42.4 72.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 95.4 m-20 -97.56 -4.38 37.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 -164.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.621 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 47.3 m-85 -118.36 -54.4 2.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.033 173.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.558 ' O ' ' HB3' ' A' ' 290' ' ' LEU . 25.3 mt -81.17 -42.49 20.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.942 -169.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.469 HD23 HD12 ' A' ' 280' ' ' LEU . 4.0 mm? -81.58 19.94 0.97 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 169.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.63 ' O ' HD22 ' A' ' 290' ' ' LEU . 94.0 m -132.61 142.67 49.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.101 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 47.9 p-10 -51.44 -26.19 7.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -168.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -74.46 -46.8 37.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -175.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -80.62 -48.04 6.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 -165.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 291' ' ' GLU . 0.7 OUTLIER -70.21 -16.06 63.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 110.936 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.713 ' N ' HD23 ' A' ' 290' ' ' LEU . 83.2 tt0 -71.99 -47.33 52.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 167.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.81 -40.75 98.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.087 -172.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.916 HG23 ' HA3' ' A' ' 19' ' ' GLY . 3.3 p -70.75 -36.83 66.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -67.43 -25.21 65.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.784 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.84 -29.36 70.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -90.67 -43.11 10.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.409 ' O ' HD13 ' A' ' 299' ' ' LEU . 65.8 mttm -127.92 145.78 56.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.531 0.681 . . . . 0.0 110.902 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.7 107.14 1.59 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.748 2.298 . . . . 0.0 112.329 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.455 ' HG ' ' HD3' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -91.89 -19.21 22.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.944 -179.021 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.488 ' O ' HD11 ' A' ' 317' ' ' ILE . . . 88.58 -62.02 3.78 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.573 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -160.25 167.49 27.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 111.17 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.73 HG21 ' HB3' ' A' ' 307' ' ' TYR . 33.2 m -131.14 156.15 42.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.213 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.06 -14.82 60.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.077 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' A' ' 89' ' ' LEU . 50.4 tp -81.21 126.83 31.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -173.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 87.2 tttt -55.41 -44.99 76.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 63.7 m -61.59 -52.18 65.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.802 -168.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.73 ' HB3' HG21 ' A' ' 302' ' ' VAL . 12.6 t80 -78.02 -32.67 51.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -62.91 -42.03 99.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.921 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -62.09 -38.99 90.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.894 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.69 -48.76 29.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.601 HD21 HG22 ' A' ' 302' ' ' VAL . 4.6 pp -69.13 -23.48 63.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.854 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.422 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.41 -14.96 63.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.14 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.45 -16.4 62.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.965 176.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.48 133.48 44.43 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.575 0.702 . . . . 0.0 110.864 169.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' PRO . . . . . 0.423 ' O ' HG11 ' A' ' 244' ' ' VAL . 90.5 Cg_exo -47.74 -35.74 24.3 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.673 2.249 . . . . 0.0 112.342 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -61.96 -27.64 68.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -167.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.488 HD11 ' O ' ' A' ' 300' ' ' GLY . 2.1 mp -100.03 -40.85 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.162 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.11 -47.24 61.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -162.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.25 -34.77 75.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.19 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.511 ' CG2' ' HB3' ' A' ' 112' ' ' ALA . 62.9 m -61.42 -37.01 81.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.058 -176.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.6 mtp -60.16 -30.46 69.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.896 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -65.45 -43.95 88.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -77.06 -39.75 48.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.36 -39.79 73.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.156 -168.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.3 -28.32 69.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -108.6 -1.68 19.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -86.16 -160.21 33.68 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.414 -168.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -140.93 154.75 46.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.987 0.422 . . . . 0.0 110.825 -173.174 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 40.6 mm -68.07 116.28 7.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.114 -171.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 63.3 ttp -60.09 140.18 90.85 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.515 0.674 . . . . 0.0 110.904 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.89 109.34 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.635 2.223 . . . . 0.0 112.383 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -107.02 10.17 30.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 42.0 pt -72.52 162.02 76.15 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.73 0.776 . . . . 0.0 111.138 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -53.07 -31.49 54.39 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.679 2.253 . . . . 0.0 112.347 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -66.58 -16.46 64.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.885 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.465 ' HA ' ' CD2' ' A' ' 339' ' ' PHE . 68.0 ttp -54.84 -34.88 63.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 95.9 p -65.14 -31.12 72.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.29 -35.54 63.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.163 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.55 ' HB3' ' CZ3' ' A' ' 158' ' ' TRP . 3.2 m-30 -56.34 -55.65 30.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 176.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.429 ' HB3' ' HB3' ' A' ' 154' ' ' PRO . 52.5 m0 -62.79 -37.82 88.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.92 -172.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -69.71 -48.04 61.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.826 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.14 -42.36 93.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.168 -173.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.449 HG21 ' HA ' ' A' ' 158' ' ' TRP . 19.6 m -73.0 -28.0 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.065 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -62.71 -40.95 98.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.938 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 93.0 m -57.33 -36.07 70.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.157 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.475 ' HB1' HD11 ' A' ' 192' ' ' LEU . . . -65.41 -45.76 82.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.017 -175.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.452 HG21 HG22 ' A' ' 157' ' ' THR . 2.4 m -72.18 -34.42 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.132 -174.586 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.433 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -63.18 -46.36 96.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.187 173.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -67.81 -39.49 83.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.924 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.59 -47.61 39.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.105 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.32 -37.43 80.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.12 -173.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.2 p -74.99 -9.1 58.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 75.51 11.66 84.2 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -78.77 -27.14 44.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.791 0.329 . . . . 0.0 110.893 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -139.67 156.23 46.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.939 173.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.6 p -77.15 164.96 25.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.194 170.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.7 t -51.91 -41.01 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 175.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.78 -48.94 76.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.994 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -76.82 -44.23 33.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.937 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.56 -47.35 81.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.102 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 13.5 tp -67.07 -52.86 36.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.957 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -54.03 -46.8 71.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.939 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -72.23 -43.68 64.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.08 -47.07 54.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.168 -175.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -67.66 -30.77 70.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 24.9 m -55.14 -31.87 61.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.111 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -58.98 -29.84 67.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.533 HG21 ' HB1' ' A' ' 168' ' ' ALA . 77.9 mt -56.15 -40.11 62.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.113 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.6 p -100.99 -10.43 20.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.115 -174.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.882 179.643 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.718 0.294 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.2 mt -94.08 125.11 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -150.07 147.96 28.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -50.79 133.85 25.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.799 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.96 4.92 64.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.508 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.9 tttt -163.11 141.71 8.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 110.959 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.581 ' CD2' HD11 ' A' ' 33' ' ' ILE . 2.3 pt? -146.51 154.49 41.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.93 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.501 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 88.6 t -110.91 134.7 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.09 -177.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.654 HD11 ' HB ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -119.96 133.56 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 -178.994 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.72 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 65.2 m95 -106.59 124.19 49.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.942 164.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.501 HD12 ' HG ' ' A' ' 20' ' ' LEU . 12.1 tt -110.01 150.0 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.114 -165.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -62.74 148.18 47.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 -173.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.61 -17.69 21.02 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.454 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.88 -27.34 68.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -173.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 15' ' ' LYS . 35.7 mmtm -140.06 133.67 30.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 166.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.63 -80.77 0.95 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.497 -169.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -99.97 -38.7 8.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.839 0.352 . . . . 0.0 110.914 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -68.15 -51.91 40.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -151.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.11 -55.47 23.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.461 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.501 ' HG ' HD12 ' A' ' 11' ' ' ILE . 5.7 mt -53.82 -53.04 57.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.44 -40.21 7.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.082 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -72.12 -59.51 2.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.854 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 20' ' ' LEU . 20.7 m -70.33 -38.16 73.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 -172.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.767 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -66.98 -48.39 60.62 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.525 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -56.75 -35.0 68.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.846 0.355 . . . . 0.0 110.957 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -55.36 -39.62 70.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.987 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 5.6 m-30 -59.17 -46.32 88.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -65.0 -39.61 93.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -69.44 -38.23 77.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.853 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -94.95 -48.2 6.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -169.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.8 p -110.62 -1.47 16.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 -171.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.87 3.71 90.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.45 168.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.07 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -99.99 134.02 40.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.928 0.394 . . . . 0.0 111.124 -176.046 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.5 mttt -83.08 144.09 30.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.924 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.767 HG21 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -120.01 134.62 62.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 175.822 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.488 ' O ' HD12 ' A' ' 9' ' ' ILE . 97.0 m -102.21 129.09 48.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.145 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 20' ' ' LEU . 87.2 t -99.57 125.86 53.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -115.06 149.9 36.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.4 t-80 -86.13 138.92 34.45 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.573 0.702 . . . . 0.0 110.928 -165.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 77.1 Cg_exo -56.49 -27.57 69.41 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.695 2.263 . . . . 0.0 112.291 -175.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -47.97 -50.55 26.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -172.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -88.79 -5.04 58.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.6 tt -46.11 -54.85 7.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.897 -169.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.32 -38.32 90.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.953 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.95 -40.82 95.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.899 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HB3' HG13 ' A' ' 50' ' ' VAL . 75.3 mmtt -82.91 -20.01 36.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.57 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 84.4 t80 -49.29 -50.73 62.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.635 0.731 . . . . 0.0 110.799 -165.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 43.3 Cg_endo -82.85 -30.16 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.673 2.248 . . . . 0.0 112.385 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -74.86 -41.45 59.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 -167.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.479 HG21 ' HG3' ' A' ' 57' ' ' PRO . 32.1 m -67.58 -27.11 37.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 -175.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.496 ' CB ' ' HB3' ' A' ' 75' ' ' LEU . . . -69.33 -36.52 77.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.12 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.36 -33.49 75.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.147 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.8 p -94.46 -21.9 18.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.111 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.83 9.16 65.4 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.44 174.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -123.01 120.04 32.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.88 -95.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.427 172.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.72 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 64.5 Cg_endo -79.79 147.3 19.26 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.734 2.29 . . . . 0.0 112.394 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.04 -35.17 12.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.781 161.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.603 ' HB ' HG23 ' A' ' 9' ' ' ILE . 45.8 mt -125.24 136.87 59.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.141 -175.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.0 tp -132.88 126.41 53.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.187 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -92.22 138.98 31.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.857 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.484 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 24.9 p90 -145.07 163.35 34.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.042 170.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.25 -90.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.039 -168.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.6 ' HB2' ' HB3' ' A' ' 332' ' ' ASN . 6.3 m170 -123.34 -68.04 0.9 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.868 -171.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -103.29 -12.36 17.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.844 -159.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 55.8 ttm-85 -51.05 -20.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 -174.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.475 ' HB2' HD13 ' A' ' 104' ' ' ILE . 32.6 p90 -59.21 -33.48 71.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.06 -50.45 65.97 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.46 -168.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.16 -37.65 94.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.5 174.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.633 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 9.3 t80 -69.01 -42.1 76.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.849 0.357 . . . . 0.0 110.89 -175.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.61 -42.95 70.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.095 175.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -58.24 -37.59 75.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.957 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.407 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 58.1 m -84.55 -5.01 59.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.795 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.01 30.27 59.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.464 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.496 ' HB3' ' CB ' ' A' ' 51' ' ' ALA . 46.1 mt -89.39 -10.04 48.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.867 0.365 . . . . 0.0 110.905 -168.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.633 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -131.03 153.27 49.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.877 -179.074 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -80.0 139.73 36.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.128 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.4 mp0 -65.68 137.34 57.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.3 pt -100.57 152.09 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.107 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.7 m -96.91 119.0 64.39 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.591 0.71 . . . . 0.0 111.085 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.616 ' HB3' HD12 ' A' ' 103' ' ' LEU . 73.1 Cg_endo -73.97 155.55 47.95 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.745 2.297 . . . . 0.0 112.324 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -105.52 117.86 35.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.842 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -52.87 -35.06 57.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.02 90.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.5 m-30 -75.87 -33.28 59.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.896 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.511 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 86.4 mt-30 -54.9 -51.93 64.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.71 -33.84 70.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -81.96 -18.43 43.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.841 -172.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -104.7 -105.02 0.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 -172.812 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.509 ' CG ' ' HD2' ' A' ' 91' ' ' PRO . 5.0 t80 -178.72 142.74 0.42 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.705 0.764 . . . . 0.0 110.956 -166.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.509 ' HD2' ' CG ' ' A' ' 90' ' ' TYR . 31.3 Cg_endo -68.25 -37.6 13.72 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.731 2.287 . . . . 0.0 112.337 -175.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -75.08 -29.28 60.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.9 p -72.68 -37.05 68.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.266 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.745 ' CE3' HD13 ' A' ' 103' ' ' LEU . 86.4 m95 -73.61 -26.43 60.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.893 173.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -73.02 -31.31 64.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.853 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.23 -23.88 63.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.07 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.59 HG22 ' HA ' ' A' ' 94' ' ' TRP . 17.9 m -106.16 16.4 6.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.075 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.3 ttp85 -100.97 126.31 47.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.974 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -125.82 115.8 20.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.7 t30 57.17 35.11 25.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.897 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.65 -0.97 89.18 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.558 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -120.97 143.55 48.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 110.862 174.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.745 HD13 ' CE3' ' A' ' 94' ' ' TRP . 41.5 mt -89.59 135.58 33.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 -172.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.475 HD13 ' HB2' ' A' ' 67' ' ' PHE . 2.1 pp -127.21 3.36 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 -166.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.484 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -160.97 160.21 30.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.166 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.429 ' HB3' ' CD2' ' A' ' 285' ' ' LEU . 97.0 m-85 -108.53 139.57 20.94 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.582 0.706 . . . . 0.0 110.871 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -78.91 121.63 5.06 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.708 2.272 . . . . 0.0 112.327 170.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.072 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -105.59 -40.92 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.225 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -141.74 150.84 42.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.103 -164.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.6 t -115.65 123.91 71.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -112.92 122.34 47.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.656 ' HB1' HD21 ' A' ' 323' ' ' ASN . . . -150.18 144.8 25.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.065 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 257' ' ' PRO . 7.1 mp -87.56 170.03 11.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -174.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.2 p -158.33 154.92 27.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.845 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.817 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.5 OUTLIER -91.92 129.1 37.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 169.102 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.611 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.9 mp -116.37 130.89 70.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.116 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -133.19 154.26 50.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 -171.815 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.451 ' O ' HD23 ' A' ' 122' ' ' LEU . 69.8 m-80 -88.0 119.57 28.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.862 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.44 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.6 mttt -64.82 -27.35 68.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -82.84 -24.13 33.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.819 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.0 mp -80.49 -54.43 5.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 172.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.706 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.6 pt? -140.36 127.9 12.51 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.617 0.722 . . . . 0.0 110.952 176.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.44 -9.43 14.91 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.659 2.239 . . . . 0.0 112.436 -176.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -149.28 98.0 3.53 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.554 0.693 . . . . 0.0 110.871 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.27 157.08 63.36 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.623 2.215 . . . . 0.0 112.293 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -66.4 143.07 68.34 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.633 2.222 . . . . 0.0 112.36 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.1 -17.48 37.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.5 p -134.5 157.53 46.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.185 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.497 ' HA ' HD13 ' A' ' 132' ' ' ILE . 71.4 m95 -70.15 -23.15 62.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.967 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.02 -24.59 67.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -85.59 -18.38 33.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.901 -177.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.576 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -59.54 -42.87 94.32 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.686 0.755 . . . . 0.0 111.163 -170.382 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 92.9 Cg_endo -80.01 -37.83 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.664 2.243 . . . . 0.0 112.35 -173.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.88 -58.92 6.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.12 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.236 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.49 -17.08 64.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -176.038 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.549 ' N ' HD13 ' A' ' 135' ' ' LEU . 37.8 t70 -60.04 -41.39 92.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 168.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.72 -30.8 70.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.29 -47.29 61.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.88 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.1 pp -85.16 -14.61 46.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.888 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.627 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.8 tttt -60.36 -34.47 73.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.955 174.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.06 -23.4 67.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -95.03 4.23 54.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.935 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.06 32.6 56.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.369 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -111.09 169.96 8.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 0.0 110.836 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.8 t -120.82 139.4 53.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 167.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -67.64 -44.02 78.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 -171.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -138.88 131.46 28.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 52.2 ttm -117.11 130.85 56.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -153.62 155.13 35.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -174.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -86.17 -51.98 5.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.78 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.038 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.5 tm? 48.34 31.71 2.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.919 -169.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -102.11 -9.02 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 176.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -129.71 152.39 79.7 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 121.726 0.774 . . . . 0.0 110.818 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.409 ' HB3' ' HB3' ' A' ' 340' ' ' TRP . 51.8 Cg_exo -55.01 -29.62 65.75 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.675 2.25 . . . . 0.0 112.343 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -68.45 -30.0 68.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -79.91 -41.05 26.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 172.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.435 HG23 HG11 ' A' ' 347' ' ' VAL . 19.4 m -60.8 -52.45 65.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.132 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.568 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 15.1 t-105 -59.23 -48.75 95.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.488 0.661 . . . . 0.0 110.907 -161.338 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 90.8 Cg_exo -52.25 -44.71 44.36 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.694 2.262 . . . . 0.0 112.355 -177.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.604 HD23 ' C ' ' A' ' 160' ' ' LEU . 7.7 tt -71.26 -40.09 71.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.826 -171.237 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 83.0 mt -71.08 -43.44 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.71 -22.0 60.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.158 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.49 -28.57 68.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.107 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -99.11 1.77 45.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.856 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 108.5 5.65 31.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.478 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.59 67.97 2.52 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.541 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -83.83 132.68 34.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.895 0.379 . . . . 0.0 110.999 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.38 6.77 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.134 -174.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.427 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.3 p90 -149.73 155.01 39.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.912 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 87.3 tttt -104.97 124.69 49.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 157.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -116.26 124.42 50.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -153.91 130.63 10.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.02 43.04 30.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.75 17.29 80.06 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.518 173.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.63 138.58 48.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.71 0.29 . . . . 0.0 110.866 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -96.99 144.69 26.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 169.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -123.51 111.66 16.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.583 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.1 pp -79.98 -12.74 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.55 -11.05 25.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.899 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 66.0 t0 -127.28 88.24 2.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 171.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 169' ' ' PHE . 32.7 m -116.13 166.92 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.063 -170.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.16 22.3 31.54 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.517 -170.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.479 HG21 HD12 ' A' ' 368' ' ' ILE . 1.5 m -105.47 -20.0 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.753 0.311 . . . . 0.0 111.083 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -86.48 21.16 2.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -104.96 -174.97 2.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 -175.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.9 -29.37 67.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.05 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.64 -40.18 77.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.437 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.499 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -62.57 -37.64 86.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.934 0.397 . . . . 0.0 111.162 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.593 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 88.6 mttt -62.92 -37.97 89.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 174.073 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.13 -36.99 85.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.079 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.42 -47.57 62.39 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.507 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.775 HD11 ' HA ' ' A' ' 347' ' ' VAL . 20.6 tp -66.41 -34.25 77.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 0.0 110.841 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.512 ' OG1' HG21 ' A' ' 357' ' ' VAL . 91.5 m -63.69 -40.68 97.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.227 174.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 61.8 t80 -67.15 -49.27 65.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 195' ' ' LEU . 7.2 tt -50.43 -51.69 44.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.884 -175.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 199' ' ' ILE . 35.2 m -63.9 -22.48 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.145 -174.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.5 m-20 -61.8 -34.58 76.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.412 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.9 OUTLIER -80.95 -40.15 24.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -173.996 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.6 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.7 pp -72.98 -29.76 30.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 172.545 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.91 -37.59 79.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.917 173.31 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -80.09 2.31 24.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 68.16 38.57 2.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.773 168.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -78.99 -17.33 55.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.823 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.6 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.2 ppp? -145.2 158.14 43.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.864 176.57 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -94.94 148.87 21.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.87 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.89 -25.75 67.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.169 -175.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -95.9 1.72 53.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 94.7 m -62.48 124.97 22.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.196 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.439 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 14.5 t0 -119.93 177.68 4.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -64.89 -37.38 87.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.035 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 96.1 p -70.32 -38.37 74.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.439 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 77.7 mt -65.09 -42.66 95.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.105 174.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.16 -36.18 83.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.046 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -61.5 -47.26 86.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.836 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.48 89.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.004 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.0 -44.87 87.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.141 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -62.75 -44.48 96.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.992 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -64.77 -31.86 73.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.885 -177.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -83.72 -15.82 47.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.55 26.43 30.1 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.551 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -84.83 -21.79 29.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 110.84 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.1 t -123.91 137.47 54.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.598 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -62.74 -48.57 78.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.009 177.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.752 ' HB3' HD21 ' A' ' 115' ' ' LEU . 71.7 mtm -134.19 160.01 39.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 -172.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.4 t -151.33 157.16 42.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.199 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 48.4 mm -111.55 129.14 67.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.164 -175.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -155.05 175.02 14.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -81.74 -159.15 23.6 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.449 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.82 -24.92 24.28 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.584 2.189 . . . . 0.0 112.348 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 51.5 m0 -75.0 -29.44 60.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.961 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 47.4 45.52 17.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 174.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -65.62 -17.63 64.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.964 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 91.1 p -74.93 -9.41 58.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.961 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -76.8 -171.31 1.88 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.4 mt -104.98 125.45 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 -173.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -101.11 -40.11 7.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.915 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 39.5 m -134.66 89.98 2.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.221 -174.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 14.7 t -176.48 165.59 2.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.879 175.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -87.3 -1.77 58.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.912 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 88.9 t -71.22 125.46 29.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.144 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -79.95 139.92 36.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.44 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 45.1 p90 -144.95 158.65 43.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.881 176.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.65 166.67 26.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.496 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.1 p -135.02 135.16 53.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.888 0.375 . . . . 0.0 111.125 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.63 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 9.5 t -159.37 142.53 14.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.082 175.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.0 m -63.89 168.31 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.065 -169.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 2.1 mp -68.71 155.55 92.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.562 0.696 . . . . 0.0 110.942 -161.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -77.93 -176.22 3.12 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.739 2.293 . . . . 0.0 112.353 -173.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 93.9 m -85.93 145.13 27.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.225 -173.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -130.56 113.33 14.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.799 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 54.94 34.63 22.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.81 -0.54 86.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.471 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -127.54 127.54 24.08 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.598 0.713 . . . . 0.0 110.863 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 249' ' ' THR . 81.2 Cg_exo -54.73 131.05 43.68 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.662 2.242 . . . . 0.0 112.351 -176.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 256' ' ' LYS . 96.0 p -83.77 1.36 43.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 172.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 97.8 mttt -37.09 130.2 0.76 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.512 0.672 . . . . 0.0 110.832 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.486 ' HB3' ' HB2' ' A' ' 113' ' ' LEU . 74.0 Cg_exo -61.56 155.91 50.38 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.66 2.24 . . . . 0.0 112.378 -169.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -74.98 165.15 25.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.845 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.88 126.76 69.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.192 -168.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -112.28 137.35 14.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.454 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 62.5 t -125.04 116.03 45.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 111.13 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.17 123.42 19.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.941 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 47.4 m -127.59 130.39 48.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.803 -168.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.01 136.17 52.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 -171.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.88 169.35 16.85 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.403 -171.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.908 HG13 ' HG2' ' A' ' 277' ' ' LYS . 31.2 mm -112.69 130.16 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 111.082 -174.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -63.37 126.02 26.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -60.6 -28.24 68.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.144 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.0 -6.52 59.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.074 -170.097 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.4 t -75.08 122.91 88.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.644 0.735 . . . . 0.0 110.868 -173.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -68.59 -12.59 35.14 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.727 2.285 . . . . 0.0 112.373 166.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.46 HD21 HD22 ' A' ' 275' ' ' LEU . 55.5 t30 -111.12 31.27 6.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.919 -168.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -60.84 -29.78 69.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -57.52 -40.11 78.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.692 HD23 HG13 ' A' ' 33' ' ' ILE . 8.6 mp -75.16 -45.67 39.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.963 174.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -62.7 -56.22 19.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.058 -171.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.908 ' HG2' HG13 ' A' ' 266' ' ' ILE . 91.7 mttt -60.92 -40.26 92.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.922 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.7 tt0 -71.0 -49.26 47.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.834 -173.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -67.16 -34.11 76.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.483 ' HA ' HD22 ' A' ' 284' ' ' LEU . 4.6 tt -62.46 -51.39 67.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.965 -175.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -77.88 -33.33 52.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 67.7 m-80 -98.72 -11.19 22.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -163.516 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.856 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 77.5 m-85 -129.67 -52.32 1.16 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.873 177.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.5 OUTLIER -62.81 -35.69 80.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -168.852 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 1.072 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.5 pp -123.96 37.76 4.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.885 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.435 ' CG2' ' N ' ' A' ' 287' ' ' ASP . 8.2 m -117.97 153.7 33.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.109 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.454 ' HA ' HD11 ' A' ' 290' ' ' LEU . 31.0 t70 -43.45 -36.38 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.85 -166.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -79.36 -40.62 29.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.856 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.14 -56.73 5.56 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.446 -171.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.647 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.1 -21.08 66.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 0.0 110.98 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.593 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.0 tt0 -66.74 -45.87 77.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.788 171.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.2 -46.64 88.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.102 -174.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -46.06 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.172 -175.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.511 ' HB2' HD22 ' A' ' 299' ' ' LEU . 43.2 t30 -63.38 -27.89 69.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.21 -27.59 68.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -91.14 -47.64 7.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.943 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -136.31 145.46 51.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.545 0.688 . . . . 0.0 110.93 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.6 110.08 1.78 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.729 2.286 . . . . 0.0 112.402 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.511 HD22 ' HB2' ' A' ' 294' ' ' ASN . 0.8 OUTLIER -82.02 -27.67 32.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 176.309 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 103.69 -58.55 0.52 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.419 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.598 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -169.25 165.02 10.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.915 0.388 . . . . 0.0 111.129 174.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 26.1 m -125.92 153.93 34.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.02 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.39 -10.88 60.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.143 173.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.647 ' CD2' HD21 ' A' ' 290' ' ' LEU . 51.4 tp -85.23 120.27 26.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.31 -39.96 76.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.948 -172.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 41.3 t -64.75 -51.36 62.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 -168.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.489 ' HB3' HG21 ' A' ' 302' ' ' VAL . 19.0 t80 -76.73 -29.04 56.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -64.34 -38.46 91.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.16 -37.24 82.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.91 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -74.25 -39.93 62.71 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.93 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.598 HD13 ' HA ' ' A' ' 301' ' ' ALA . 77.4 mt -60.05 -33.01 71.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 175.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.31 -19.58 61.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.08 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.73 -20.32 66.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -90.12 123.59 65.49 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.664 0.745 . . . . 0.0 110.807 167.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -47.93 -28.86 10.78 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.649 2.232 . . . . 0.0 112.377 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -61.75 -32.58 72.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.95 -173.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.585 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.4 mp -80.07 -35.53 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.082 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.1 -39.63 72.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.085 -174.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.16 75.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.051 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 82.6 p -59.82 -28.38 67.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.147 -174.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.3 mmm -66.36 -33.11 74.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.86 174.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -62.52 -47.43 83.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 -175.437 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.656 HD21 ' HB1' ' A' ' 112' ' ' ALA . 14.4 p-10 -83.42 -25.92 30.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.06 -43.96 97.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -67.4 -35.03 78.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.84 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -106.03 -4.48 20.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.829 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.94 -170.02 39.89 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.534 -167.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -139.91 149.39 43.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.881 0.372 . . . . 0.0 110.805 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 42.9 mm -63.85 117.7 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.082 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 59.6 ttm -64.21 134.79 96.08 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.463 0.649 . . . . 0.0 110.982 -176.033 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.54 128.02 17.44 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.713 2.275 . . . . 0.0 112.382 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.607 ' CG ' ' O ' ' A' ' 332' ' ' ASN . 1.8 t-20 -133.56 20.17 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 -176.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 49.5 pt -70.58 153.66 94.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.584 0.707 . . . . 0.0 111.151 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -54.69 -35.99 88.79 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.615 2.21 . . . . 0.0 112.408 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -69.06 -24.99 64.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 40.4 tpp -73.6 -26.89 61.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.854 -170.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.0 m -57.37 -37.95 73.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.846 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.96 -36.12 59.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.011 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.524 ' O ' HG13 ' A' ' 343' ' ' VAL . 4.7 m-30 -66.87 -46.98 73.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.446 ' HA ' HG22 ' A' ' 343' ' ' VAL . 28.1 m0 -61.07 -32.5 72.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -66.92 -47.09 72.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.03 -40.36 94.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.163 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 339' ' ' PHE . 17.9 m -74.1 -30.83 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.128 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.491 ' O ' HG22 ' A' ' 347' ' ' VAL . 4.9 tmt_? -65.0 -38.98 92.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.2 m -58.22 -36.19 72.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.194 173.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.57 95.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.189 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.775 ' HA ' HD11 ' A' ' 192' ' ' LEU . 5.8 m -73.99 -35.01 40.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.191 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.458 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -62.44 -47.94 90.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.191 174.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -63.91 -39.18 93.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.05 -45.55 60.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.098 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.37 -39.86 77.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.0 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.8 p -75.58 -10.7 59.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.911 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.96 17.25 72.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.449 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.25 -33.29 43.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 0.0 110.907 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -138.63 154.4 48.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.4 p -77.19 169.89 17.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.18 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.512 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.5 t -56.53 -42.34 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 173.383 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -62.09 -45.62 92.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -69.94 -51.59 31.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -75.4 -51.79 12.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.188 -173.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.593 ' HG ' ' HA ' ' A' ' 189' ' ' LYS . 1.9 tm? -65.04 -48.97 71.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 -171.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.51 -52.83 61.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 -173.286 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -67.94 -48.65 65.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.808 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.25 85.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.156 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 66.3 mm-40 -78.04 -29.03 49.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.907 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 89.5 m -65.92 -33.96 77.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.178 170.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -56.39 -31.95 64.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.854 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.479 HD12 HG21 ' A' ' 183' ' ' VAL . 62.0 mt -59.02 -34.93 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.951 0.405 . . . . 0.0 111.191 173.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 69.9 p -95.07 -14.34 24.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 89.7 mttt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 177.096 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.729 0.3 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.455 HG21 ' HD2' ' A' ' 271' ' ' PRO . 60.1 mt -97.81 139.96 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.181 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -140.13 145.03 37.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.822 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.29 133.5 39.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 177.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.83 11.58 61.63 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.494 -175.061 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.2 tttt -165.07 134.77 3.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.834 0.349 . . . . 0.0 110.944 177.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.585 ' CD2' HD11 ' A' ' 33' ' ' ILE . 1.6 pt? -144.0 152.71 41.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.94 -173.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 87.2 t -110.76 137.67 42.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.02 -177.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.716 HD11 HG13 ' A' ' 35' ' ' VAL . 1.1 mp -119.79 134.47 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.094 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.61 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 76.6 m95 -103.69 124.66 49.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 164.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.494 HD12 ' HG ' ' A' ' 20' ' ' LEU . 11.5 tt -108.83 150.04 11.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.052 -163.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -58.43 153.2 16.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 -174.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.38 -15.97 40.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.416 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -79.2 -13.28 59.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.866 0.365 . . . . 0.0 110.897 -172.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -139.96 129.2 23.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 163.027 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.52 -70.72 1.29 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.469 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -109.92 -39.19 5.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.958 0.409 . . . . 0.0 110.98 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -67.37 -52.28 41.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.871 -150.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.436 ' CA ' HG23 ' A' ' 293' ' ' VAL . . . -54.1 -50.35 55.78 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.565 -175.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.502 ' HB3' HG22 ' A' ' 37' ' ' VAL . 6.0 mt -55.08 -52.57 62.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.699 0.285 . . . . 0.0 110.933 171.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.48 -35.92 21.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.125 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -72.45 -59.99 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.413 HG22 ' HA ' ' A' ' 20' ' ' LEU . 21.5 m -71.64 -38.15 65.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.158 -172.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.55 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -65.64 -47.84 73.25 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.422 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -54.73 -35.65 63.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -57.93 -39.12 77.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.039 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 4.8 m-30 -62.9 -45.42 92.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 99.8 mt-10 -60.7 -36.96 80.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -71.24 -41.17 70.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.898 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -94.52 -47.81 6.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.889 -164.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.3 p -109.1 -7.83 15.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.18 -172.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.65 8.12 87.97 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.514 167.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.994 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.52 133.86 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 111.085 -179.074 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.2 mttt -72.02 136.0 46.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 -169.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.716 HG13 HD11 ' A' ' 9' ' ' ILE . 99.2 t -115.87 125.01 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.061 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.56 ' O ' HD12 ' A' ' 9' ' ' ILE . 95.5 m -109.93 130.02 55.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.067 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 20' ' ' LEU . 87.4 t -103.58 131.17 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.159 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -119.36 154.09 34.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 66.3 t-80 -88.25 139.93 30.41 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.694 0.759 . . . . 0.0 110.863 -167.453 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -55.02 -29.86 66.99 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.758 2.305 . . . . 0.0 112.335 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -49.03 -52.62 24.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.873 -172.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -90.07 0.68 57.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.832 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.427 HD23 ' C ' ' A' ' 43' ' ' LEU . 10.5 tt -45.86 -51.09 13.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.937 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -74.44 -40.37 61.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.862 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -80.44 -51.88 8.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.956 -164.335 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -83.33 -38.39 22.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.919 -170.283 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.606 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 83.9 t80 -49.83 -53.39 42.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.684 0.754 . . . . 0.0 110.872 -169.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 29.4 Cg_endo -61.19 -30.83 89.3 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.668 2.245 . . . . 0.0 112.331 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -73.08 -44.18 60.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.414 HG21 ' HD3' ' A' ' 57' ' ' PRO . 21.2 m -75.56 -24.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.112 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.13 78.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.054 174.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.11 -29.74 70.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.099 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.0 p -88.36 -14.54 37.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.11 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.44 14.72 81.72 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.477 168.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -135.39 129.39 33.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 110.816 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.47 -92.34 0.14 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.497 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.61 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 67.6 Cg_endo -79.36 148.0 20.71 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.68 2.253 . . . . 0.0 112.375 -177.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -107.52 -32.09 7.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.798 165.721 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.55 ' HB ' HG23 ' A' ' 9' ' ' ILE . 57.6 mt -128.11 137.53 57.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.169 -176.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 10' ' ' TRP . 6.3 tp -132.64 127.13 55.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -92.55 128.21 38.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.771 170.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -114.38 145.15 42.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.994 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.58 -83.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.036 -168.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 332' ' ' ASN . 16.0 m170 -120.81 -65.85 1.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.835 174.547 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -99.98 -16.54 17.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.84 -167.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -61.36 -6.31 2.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -165.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.461 ' O ' ' HB3' ' A' ' 70' ' ' TYR . 31.5 p90 -59.08 -25.58 63.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 173.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.47 -48.36 86.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.46 -174.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.04 -32.16 83.25 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.515 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.716 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 2.3 t80 -54.96 -51.71 65.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.857 0.36 . . . . 0.0 110.931 175.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.92 -42.98 56.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.164 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -56.1 -38.94 71.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.967 -175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.0 m -83.68 -7.65 59.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.93 31.1 58.39 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.582 172.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 63.4 mt -88.86 -5.01 58.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.859 0.362 . . . . 0.0 110.972 -165.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.716 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -128.01 154.3 45.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.912 -171.779 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.19 144.58 29.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.086 167.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -65.1 136.18 56.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.884 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.405 HD12 ' CZ ' ' A' ' 106' ' ' TYR . 42.3 pt -100.12 151.54 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.09 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.5 m -96.15 126.5 44.06 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.585 0.707 . . . . 0.0 111.09 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.07 134.06 61.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.637 2.225 . . . . 0.0 112.349 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -103.22 119.71 39.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.99 -41.66 99.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.794 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.73 -44.75 89.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.1 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -75.0 -32.3 61.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.486 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 67.0 tt0 -53.48 -49.71 66.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.936 174.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.35 -32.63 72.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.894 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.39 -20.3 54.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.828 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.86 -106.54 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -172.367 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 29.2 t80 171.52 129.51 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.687 0.756 . . . . 0.0 110.973 -168.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -52.82 -36.01 72.16 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.762 2.308 . . . . 0.0 112.39 -173.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -64.91 -36.5 84.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -173.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.2 p -73.83 -30.35 62.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.17 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.588 ' HA ' HG22 ' A' ' 97' ' ' VAL . 80.7 m95 -67.27 -30.03 69.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 173.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.62 -31.31 68.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.827 174.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.07 -24.27 61.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.106 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.588 HG22 ' HA ' ' A' ' 94' ' ' TRP . 20.0 m -107.8 16.01 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.143 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -101.56 136.25 41.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -136.43 117.35 14.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 173.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 60.56 36.05 19.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.868 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.49 2.19 89.03 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.51 172.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -127.97 149.87 50.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.825 0.345 . . . . 0.0 110.875 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.51 HD22 HG23 ' A' ' 97' ' ' VAL . 15.3 mt -86.01 135.49 33.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.838 -175.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -122.15 -1.52 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.026 -170.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.89 165.86 20.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.405 ' CZ ' HD12 ' A' ' 79' ' ' ILE . 97.1 m-85 -114.35 145.05 32.92 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.604 0.716 . . . . 0.0 110.926 170.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.21 125.23 7.0 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.686 2.257 . . . . 0.0 112.304 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.092 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp -106.29 -39.91 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.194 177.08 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -143.19 150.9 40.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.11 -167.002 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.3 t -114.69 130.89 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.164 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -120.53 119.89 34.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -150.06 144.95 26.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.068 -173.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.6 mp -89.88 170.04 10.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.973 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.0 p -158.81 157.98 32.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.91 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.88 127.03 46.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.924 170.822 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.566 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.2 mp -110.3 130.32 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.14 -175.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -128.39 146.52 50.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -92.75 115.0 27.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.806 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.435 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.9 mttt -65.66 -23.26 66.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.917 -175.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -78.68 -25.23 44.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.811 -175.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.7 mp -84.26 -49.24 8.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.871 174.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.643 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -143.67 128.5 9.61 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.743 0.782 . . . . 0.0 110.832 174.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.72 -9.03 15.89 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.634 2.223 . . . . 0.0 112.366 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -143.19 97.01 5.75 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.64 0.733 . . . . 0.0 110.812 -174.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.26 156.04 62.92 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.746 2.297 . . . . 0.0 112.365 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.43 144.95 63.34 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.748 2.299 . . . . 0.0 112.314 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.18 -17.16 28.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.89 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 71.5 p -130.71 157.68 42.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.192 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.498 ' HA ' HD13 ' A' ' 132' ' ' ILE . 57.0 m95 -68.83 -28.94 67.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.951 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.04 -22.13 66.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.85 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.84 -24.25 41.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.624 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -55.88 -50.05 89.44 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.676 0.751 . . . . 0.0 111.197 -172.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.8 Cg_endo -68.24 -39.11 10.74 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.622 2.215 . . . . 0.0 112.376 -173.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.02 -60.15 3.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.263 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.28 -17.01 63.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.989 -175.732 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.513 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.8 t70 -58.47 -40.42 82.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.848 168.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.07 -30.75 69.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.49 -46.42 54.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.773 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.638 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.0 pp -84.86 -14.35 48.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.964 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.638 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.7 tttt -61.15 -34.41 74.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.955 174.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.95 -23.44 67.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -94.96 3.62 54.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.921 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.48 33.16 53.45 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.56 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -111.75 169.95 8.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 0.0 110.867 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.0 t -121.12 140.22 52.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.917 168.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.429 ' HA ' HD21 ' A' ' 139' ' ' LEU . . . -66.69 -40.37 88.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.112 -172.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -144.53 130.59 19.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 55.2 ttm -118.18 132.92 56.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -153.53 157.35 39.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -173.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -84.93 -54.64 4.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.94 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.819 HD13 ' O ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER 49.28 30.72 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.022 -168.362 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -103.45 -4.35 24.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -129.91 156.53 78.88 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.59 0.71 . . . . 0.0 110.952 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.406 ' HD3' ' HD2' ' A' ' 344' ' ' ARG . 40.3 Cg_endo -60.76 -24.37 78.7 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.684 2.256 . . . . 0.0 112.321 174.282 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -68.23 -30.02 68.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.822 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -84.27 -38.31 20.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.844 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.433 HG23 HG11 ' A' ' 347' ' ' VAL . 23.0 m -61.11 -47.23 87.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.979 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.579 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 39.2 t-105 -56.96 -54.58 52.96 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.534 0.683 . . . . 0.0 110.949 -169.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 31.2 Cg_endo -65.83 -19.63 58.78 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.731 2.287 . . . . 0.0 112.41 -174.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.718 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.3 tm? -81.63 -45.29 16.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.505 HG22 ' HA3' ' A' ' 166' ' ' GLY . 80.1 mt -74.23 -43.3 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.116 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.9 -22.57 64.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.099 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -58.87 -32.28 69.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.172 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -100.87 1.13 39.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 112.29 5.48 24.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.492 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.505 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -77.2 69.6 2.48 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.509 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -87.36 132.64 33.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.86 0.362 . . . . 0.0 110.98 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.75 10.34 9.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.154 -171.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.433 ' HA ' HG12 ' A' ' 181' ' ' VAL . 52.8 p90 -158.13 152.34 24.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -93.28 128.38 39.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.816 159.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -118.08 121.57 40.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.827 172.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.02 130.05 11.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.901 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.02 41.83 31.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.842 174.545 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.37 17.52 79.75 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.533 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.01 139.35 51.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.768 0.318 . . . . 0.0 110.86 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -98.88 145.01 27.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -128.32 108.95 11.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.874 174.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.572 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.3 pp -79.1 -8.52 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.131 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -100.27 -12.31 19.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 -177.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -119.49 85.81 2.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 170.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 169' ' ' PHE . 27.4 m -114.28 161.3 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 -170.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.02 22.66 32.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.495 -172.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.515 HG21 HD12 ' A' ' 368' ' ' ILE . 6.8 m -107.37 -17.05 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.772 0.32 . . . . 0.0 111.112 -178.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -87.04 20.47 2.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -119.97 -171.51 2.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.91 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.29 -29.71 69.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.106 -173.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.7 -41.41 95.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.484 -167.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.611 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.24 -38.06 89.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.972 0.415 . . . . 0.0 111.093 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.577 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 96.8 mttt -62.04 -37.82 86.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.943 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.07 -37.91 89.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.074 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.415 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -66.2 -46.47 79.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.576 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.664 HD11 ' HA ' ' A' ' 347' ' ' VAL . 27.3 tp -65.08 -35.92 82.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 110.855 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.408 ' OG1' HG21 ' A' ' 357' ' ' VAL . 90.0 m -64.52 -41.17 96.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.151 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 65.0 t80 -66.32 -47.94 71.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.861 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.673 HD23 ' C ' ' A' ' 195' ' ' LEU . 5.2 tt -50.32 -51.56 44.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.963 -175.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.431 ' HA ' ' CG1' ' A' ' 199' ' ' ILE . 27.9 m -65.04 -21.61 29.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.075 -173.583 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.0 m-20 -62.59 -33.92 75.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.802 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.9 OUTLIER -81.21 -39.9 24.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.959 -174.635 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.576 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.6 pp -73.95 -26.99 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.07 172.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.25 -38.23 84.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 170.273 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -80.95 2.92 24.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 176.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 66.53 37.68 4.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 56.0 m170 -77.58 -18.94 56.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.819 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.576 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.1 ppp? -144.14 156.95 44.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -95.02 152.0 18.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.14 -26.93 68.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -95.5 1.73 54.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.813 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.1 m -63.84 126.08 26.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.101 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.438 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 16.9 t0 -120.05 174.28 6.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.843 177.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -64.98 -37.0 86.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.969 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.8 p -70.45 -37.52 74.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.438 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 80.3 mt -65.01 -42.48 94.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.077 173.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.68 81.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.06 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.0 -45.04 94.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.865 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.8 -41.44 95.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.096 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.86 -42.86 97.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.058 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -63.8 -39.67 94.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.936 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -64.33 -35.73 81.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -83.59 -20.02 34.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.982 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.84 25.83 33.71 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.418 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -84.79 -21.65 29.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.976 0.417 . . . . 0.0 110.902 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.2 t -124.45 136.81 54.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.076 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.588 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -65.03 -47.68 76.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.061 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.522 ' HB3' HD21 ' A' ' 115' ' ' LEU . 71.8 mtm -134.49 158.32 44.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -174.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 60.8 p -139.73 161.29 37.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.171 172.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.2 mm -110.75 127.18 67.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.03 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -154.95 175.04 14.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.957 -172.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -88.64 -156.87 31.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.523 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -22.26 32.28 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.66 2.24 . . . . 0.0 112.384 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -78.36 -24.93 46.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 48.76 51.95 14.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.175 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -60.04 -23.94 64.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 61.3 m -50.05 -43.95 51.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -87.0 176.7 7.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 -172.48 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.7 mp -122.13 123.39 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.211 -171.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.51 -35.11 75.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 -174.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 87.3 m -125.03 101.82 7.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.166 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 29.2 t -174.35 159.75 3.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.53 -14.83 57.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.9 m -59.98 153.53 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.129 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -108.29 128.28 54.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.435 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 50.2 p90 -145.21 158.21 43.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.92 162.35 25.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.387 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.1 p -135.72 135.32 51.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 111.142 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.7 t -154.39 148.75 26.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.9 167.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.173 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 1.022 HD23 ' HD3' ' A' ' 257' ' ' PRO . 2.6 mm? -63.1 149.53 90.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.575 0.702 . . . . 0.0 110.961 -164.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.84 -176.33 3.11 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.691 2.261 . . . . 0.0 112.382 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 96.8 m -92.47 145.17 24.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.057 -172.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -130.91 113.26 13.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.933 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 55.0 36.59 27.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.815 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.43 2.79 84.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.494 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -131.36 130.62 22.61 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.539 0.685 . . . . 0.0 110.843 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 249' ' ' THR . 22.9 Cg_endo -65.42 133.93 36.7 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.715 2.277 . . . . 0.0 112.324 -173.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.604 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 97.0 p -84.52 0.19 50.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.766 173.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -37.4 135.02 0.73 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.522 0.677 . . . . 0.0 110.9 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 1.022 ' HD3' HD23 ' A' ' 247' ' ' LEU . 38.0 Cg_endo -80.05 157.85 23.66 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.729 2.286 . . . . 0.0 112.336 -166.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -75.09 169.67 17.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.53 129.67 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 -166.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.96 137.7 14.48 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.369 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 76.9 t -125.36 117.11 48.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.806 0.336 . . . . 0.0 111.207 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -65.27 119.73 11.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 178.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.9 m -126.4 126.61 44.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.79 -167.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -125.67 137.07 53.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.041 -171.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -131.42 171.44 21.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.486 -170.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.846 HG13 ' HG2' ' A' ' 277' ' ' LYS . 25.0 mm -113.41 126.17 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.81 0.338 . . . . 0.0 111.297 -171.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -61.27 131.12 49.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.464 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -59.81 -26.17 65.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.125 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.21 -8.49 57.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 -173.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.8 t -70.81 127.16 92.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.674 0.75 . . . . 0.0 110.913 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.455 ' HD2' HG21 ' A' ' 2' ' ' ILE . 74.1 Cg_endo -72.87 -10.46 24.83 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.658 2.239 . . . . 0.0 112.401 165.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -104.04 19.09 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -169.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -54.09 -34.91 61.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.925 -171.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.14 -52.43 63.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.6 pp -84.36 -27.97 27.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.924 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.81 -50.51 56.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.06 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.846 ' HG2' HG13 ' A' ' 266' ' ' ILE . 96.1 mttt -59.74 -38.49 81.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.839 173.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.7 tt0 -68.45 -48.25 65.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -175.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -67.59 -35.37 78.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.497 ' HA ' HD22 ' A' ' 284' ' ' LEU . 7.3 tt -61.8 -51.96 66.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.892 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -78.15 -31.5 49.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.836 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 63.8 m-80 -99.46 -11.61 20.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.848 -165.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.918 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 66.6 m-85 -129.95 -52.82 1.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.497 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.6 OUTLIER -62.73 -36.74 83.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.912 -169.425 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 1.092 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.6 pp -124.27 37.63 4.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.979 176.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.457 ' CG2' ' N ' ' A' ' 287' ' ' ASP . 4.1 m -116.08 154.91 29.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.099 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.501 ' HA ' HD11 ' A' ' 290' ' ' LEU . 33.0 t70 -42.93 -37.42 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.796 -167.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -78.03 -40.81 37.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.971 -176.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.918 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.06 -57.16 5.37 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 -172.007 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.584 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.1 -21.17 66.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.34 . . . . 0.0 110.974 -178.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.581 ' N ' HD12 ' A' ' 290' ' ' LEU . 84.6 tt0 -67.44 -45.1 77.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 170.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.81 95.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.131 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.436 HG23 ' CA ' ' A' ' 19' ' ' GLY . 1.4 p -80.03 -30.0 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.11 -174.498 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -70.12 -27.17 64.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 172.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.32 -25.79 67.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.927 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.95 -51.28 8.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -143.2 152.7 58.47 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 121.615 0.722 . . . . 0.0 110.847 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -62.17 116.4 3.46 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.771 2.314 . . . . 0.0 112.298 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 299' ' ' LEU . 0.2 OUTLIER -87.55 -18.58 29.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 176.194 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 103.64 -58.55 0.52 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.525 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.639 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -170.73 164.76 8.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 111.138 175.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 21.7 m -124.23 156.08 31.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.101 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.22 -11.02 59.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.109 172.574 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.584 ' CD2' HD21 ' A' ' 290' ' ' LEU . 47.3 tp -83.2 122.06 27.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -175.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.32 -39.15 75.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 46.5 t -64.73 -49.95 68.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.881 -168.314 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.468 ' HB3' HG21 ' A' ' 302' ' ' VAL . 18.4 t80 -81.62 -29.07 33.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -61.95 -39.73 93.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.831 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -59.39 -38.21 79.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -73.7 -38.49 64.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.639 HD13 ' HA ' ' A' ' 301' ' ' ALA . 78.5 mt -62.82 -32.91 74.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.26 -18.83 62.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.113 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.06 -20.07 66.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 174.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -91.34 121.07 68.11 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.636 0.731 . . . . 0.0 110.87 166.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.98 -26.76 7.91 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.756 2.304 . . . . 0.0 112.313 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -61.76 -35.63 78.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.873 -175.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.545 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.1 mp -80.12 -32.6 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.076 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.4 -40.09 85.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 -172.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.17 -46.25 74.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.108 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 81.2 p -64.97 -29.21 70.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.066 -174.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.5 mtp -63.7 -34.38 77.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.6 tp10 -64.75 -47.7 77.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -173.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.522 HD21 ' HB1' ' A' ' 112' ' ' ALA . 8.9 p-10 -82.14 -28.01 32.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.864 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.01 -50.24 67.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.011 -175.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -69.25 -29.92 67.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.922 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -108.2 -8.55 15.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 -169.326 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.13 -153.55 29.99 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.43 -166.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -147.33 143.69 28.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.796 0.332 . . . . 0.0 110.902 -170.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 44.4 mm -61.76 124.01 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.092 -167.482 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 95.5 mtp -50.3 156.91 1.3 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.49 0.662 . . . . 0.0 110.969 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.464 ' HG3' ' CE2' ' A' ' 158' ' ' TRP . 89.6 Cg_endo -77.63 72.26 6.13 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.693 2.262 . . . . 0.0 112.379 174.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.428 ' HB3' ' HB2' ' A' ' 64' ' ' HIS . 12.7 t-20 -101.49 13.37 35.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 -172.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 45.7 pt -77.81 157.51 79.19 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.539 0.685 . . . . 0.0 111.207 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -56.48 -37.04 98.03 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.757 2.305 . . . . 0.0 112.254 -173.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -67.62 -29.7 69.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.416 ' HE2' ' HB3' ' A' ' 336' ' ' MET . 69.1 mmm -80.01 -17.83 51.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.826 -172.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 47.6 t -62.18 -41.99 98.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.831 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.49 -37.04 63.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.156 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.429 ' O ' HG13 ' A' ' 343' ' ' VAL . 7.4 m-30 -66.28 -36.29 82.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -54.93 -37.9 66.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.982 172.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -71.79 -38.05 70.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.939 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.92 -42.81 80.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.105 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 339' ' ' PHE . 21.4 m -72.72 -31.36 36.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.184 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.425 ' O ' HG22 ' A' ' 347' ' ' VAL . 74.0 ttt-85 -61.67 -40.93 96.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 175.604 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.0 m -55.76 -36.14 66.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.186 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.13 -46.19 81.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.084 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.664 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.4 m -75.55 -34.78 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.199 -172.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.448 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -62.42 -48.01 90.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.21 -37.94 88.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.32 -46.61 60.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.66 81.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.053 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.2 p -75.74 -11.88 60.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.981 0.419 . . . . 0.0 110.927 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.57 18.02 69.46 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.424 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.83 -32.95 46.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.757 0.313 . . . . 0.0 110.848 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -140.08 157.01 46.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 50.0 p -77.27 165.76 24.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.159 169.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.408 HG21 ' OG1' ' A' ' 193' ' ' THR . 55.4 t -54.94 -42.7 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.167 174.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.04 -44.13 96.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.832 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -69.38 -54.0 16.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -69.37 -47.78 63.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.5 tm? -64.95 -45.03 87.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.96 -174.449 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -65.41 -53.04 48.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.945 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -69.64 -45.68 67.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -173.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.23 -42.87 83.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.075 -174.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 85.6 mm-40 -72.49 -30.96 64.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.979 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 55.5 m -59.01 -32.59 69.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.093 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -57.11 -29.94 63.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.515 HD12 HG21 ' A' ' 183' ' ' VAL . 69.8 mt -59.72 -39.6 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 175.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.3 p -94.78 -14.98 24.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.808 179.074 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.745 0.307 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.459 HG21 ' HD2' ' A' ' 271' ' ' PRO . 83.2 mt -97.54 133.05 40.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.179 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -144.97 146.8 32.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.97 132.99 48.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.1 7.74 63.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.406 -176.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.1 tttt -164.44 134.67 4.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.744 0.306 . . . . 0.0 110.959 176.355 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.663 HD22 HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -141.72 154.81 45.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.956 -172.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.424 HG22 ' HB ' ' A' ' 36' ' ' THR . 77.3 t -113.59 135.74 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.133 -177.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.635 HG23 ' HB ' ' A' ' 59' ' ' ILE . 1.4 mp -119.65 133.97 64.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.735 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 74.9 m95 -105.18 124.24 49.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.943 166.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.484 HD12 ' HG ' ' A' ' 20' ' ' LEU . 13.6 tt -110.35 149.97 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.146 -167.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -64.52 158.63 23.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.756 -171.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.36 -16.07 26.43 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.511 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -68.25 -29.9 68.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.883 0.373 . . . . 0.0 110.853 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -139.18 130.02 26.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.845 166.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.16 -80.14 1.01 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.468 -172.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -96.72 -42.36 8.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.941 0.401 . . . . 0.0 110.97 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -67.59 -49.93 60.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.837 -153.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.12 -56.97 20.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.407 -176.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.545 ' HB3' HG22 ' A' ' 37' ' ' VAL . 5.5 mt -51.72 -46.48 63.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.797 0.332 . . . . 0.0 110.923 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.04 -37.48 45.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.061 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -75.68 -60.04 2.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.972 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 m -71.94 -36.61 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.171 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.46 -40.84 99.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.477 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -61.04 -31.24 70.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.928 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -50.0 -39.94 42.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.919 172.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 0.9 OUTLIER -54.97 -49.24 71.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 176.818 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -71.75 -34.92 69.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.899 -174.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.23 -37.99 84.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.958 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -95.2 -47.29 6.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 -168.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.8 p -115.1 -5.96 12.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.197 -169.48 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.53 4.9 85.44 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.377 169.108 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.989 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -89.73 132.36 34.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.826 0.346 . . . . 0.0 111.078 -179.202 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.4 mttt -70.03 136.73 50.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 -170.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.494 HG23 HD11 ' A' ' 9' ' ' ILE . 9.8 p -112.76 134.32 55.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.067 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.501 ' O ' HD12 ' A' ' 9' ' ' ILE . 99.3 m -113.19 129.24 56.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.124 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 20' ' ' LEU . 84.8 t -102.41 128.43 55.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.204 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -120.12 152.0 38.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.919 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -91.64 150.62 41.32 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.566 0.698 . . . . 0.0 110.823 -166.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.544 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 37.1 Cg_endo -68.92 -19.62 39.97 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.611 2.207 . . . . 0.0 112.39 -175.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -54.13 -49.02 70.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -174.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -89.58 -9.1 51.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.586 HD23 ' C ' ' A' ' 43' ' ' LEU . 8.3 tt -48.64 -53.86 16.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 -168.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.77 -35.37 80.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.852 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -70.13 -36.4 74.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.857 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.403 ' O ' HG22 ' A' ' 50' ' ' VAL . 74.7 mmtt -80.64 -24.54 38.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.579 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 86.3 t80 -49.45 -50.6 64.53 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 0.0 110.877 -163.031 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 46.2 Cg_endo -82.58 -32.08 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.648 2.232 . . . . 0.0 112.391 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -77.22 -44.17 30.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.867 -165.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.517 HG21 ' HG3' ' A' ' 57' ' ' PRO . 24.8 m -70.31 -27.72 32.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.075 -173.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.624 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -71.85 -35.19 69.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.042 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.48 -32.56 73.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.106 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.7 p -89.13 -18.87 26.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.11 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.94 8.77 78.79 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.49 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -128.18 130.01 47.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 110.827 174.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.97 -91.57 0.13 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.554 169.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.735 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 77.4 Cg_endo -80.07 146.92 18.41 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.349 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -94.25 -35.03 12.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.777 161.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.635 ' HB ' HG23 ' A' ' 9' ' ' ILE . 29.4 mt -127.03 138.48 54.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.173 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 tp -133.23 127.39 54.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.101 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -87.94 140.7 29.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.508 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 24.2 p90 -145.11 160.83 40.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.001 170.316 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.73 -87.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.113 -166.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -127.19 -68.41 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -171.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 332' ' ' ASN . 69.2 m-20 -99.33 -10.65 22.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.839 -162.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -56.11 -19.07 11.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -169.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.522 ' HB2' HD13 ' A' ' 104' ' ' ILE . 36.0 p90 -57.67 -31.45 66.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.851 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.76 -52.32 53.13 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.572 -171.416 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.92 -35.99 85.64 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.528 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.617 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 11.1 t80 -66.87 -41.73 86.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.726 0.298 . . . . 0.0 110.902 -176.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -39.87 67.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 174.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -58.51 -35.9 72.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.928 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.415 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 64.5 m -87.67 -5.01 58.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.01 31.25 58.05 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.526 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.624 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 53.6 mt -87.73 -12.06 46.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -169.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.617 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -129.08 151.66 49.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.934 -178.25 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.415 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -78.95 140.83 37.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.021 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -74.16 141.43 45.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.836 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.402 HD12 ' CZ ' ' A' ' 106' ' ' TYR . 42.7 pt -110.45 162.84 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.125 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 p -107.25 149.91 39.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 111.119 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.14 141.22 35.7 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.624 2.216 . . . . 0.0 112.417 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -105.26 120.02 40.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.928 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.22 -42.0 98.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.841 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.9 91.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.154 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -74.3 -32.89 63.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.471 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 65.1 tt0 -54.88 -50.09 69.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.043 176.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.36 -30.33 70.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.751 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -78.86 -20.03 50.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.18 -104.92 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -172.925 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 22.4 t80 172.12 129.47 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.704 0.764 . . . . 0.0 110.885 -169.679 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.63 -37.59 83.58 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.647 2.231 . . . . 0.0 112.356 -174.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -65.22 -34.06 77.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -173.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.9 p -75.5 -31.01 60.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.079 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.575 ' HA ' HG22 ' A' ' 97' ' ' VAL . 88.6 m95 -65.54 -30.01 70.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.935 173.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -69.56 -32.07 70.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.55 -26.24 62.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.626 HG23 HD22 ' A' ' 103' ' ' LEU . 18.5 m -108.28 16.88 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 -175.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -104.71 135.76 45.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -132.45 117.47 18.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.7 t30 58.68 35.07 24.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.818 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.62 -0.85 89.19 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.588 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.11 145.11 50.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.356 . . . . 0.0 110.843 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.626 HD22 HG23 ' A' ' 97' ' ' VAL . 28.8 mt -80.86 139.14 36.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -172.545 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.522 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.8 pp -123.46 -2.7 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.096 -174.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.508 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -161.74 165.29 28.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.152 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.402 ' CZ ' HD12 ' A' ' 79' ' ' ILE . 90.2 m-85 -114.31 144.47 31.77 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.646 0.736 . . . . 0.0 110.93 170.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.57 122.26 5.45 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.606 2.204 . . . . 0.0 112.326 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.009 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -106.49 -36.64 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.205 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -144.44 150.86 38.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.183 -169.588 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.6 t -120.33 134.91 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.134 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -124.97 136.78 54.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.845 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.628 ' HB1' HD21 ' A' ' 323' ' ' ASN . . . -151.89 145.78 25.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 176.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -85.57 164.16 17.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.7 p -157.22 154.86 29.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.913 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -95.92 127.04 41.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.96 169.545 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.605 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.2 mp -110.02 133.17 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -133.63 148.85 51.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -90.92 115.14 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.861 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.508 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.3 mttt -63.06 -22.75 67.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.979 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.34 -25.42 51.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -88.33 -52.9 4.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.674 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -141.74 126.13 10.26 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.725 0.774 . . . . 0.0 110.844 174.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -81.92 -2.32 11.27 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.671 2.247 . . . . 0.0 112.293 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -150.78 102.6 3.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.61 0.719 . . . . 0.0 110.812 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.64 156.74 60.46 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.667 2.245 . . . . 0.0 112.375 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -66.45 145.08 75.91 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.663 2.242 . . . . 0.0 112.251 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -81.27 -18.28 46.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.8 p -133.92 159.0 42.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.2 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.442 ' HE1' ' HG ' ' A' ' 255' ' ' SER . 69.6 m95 -72.08 -29.95 64.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.85 -20.35 66.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.864 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -77.69 -27.24 50.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.547 ' HA ' HD12 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -55.24 -47.22 99.07 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.57 0.7 . . . . 0.0 111.152 -169.455 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.466 ' N ' HG22 ' A' ' 132' ' ' ILE . 81.9 Cg_exo -51.15 -49.31 17.5 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.695 2.263 . . . . 0.0 112.377 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.67 -58.39 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.149 -176.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.247 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.34 -17.64 64.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 -173.955 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.575 ' N ' HD13 ' A' ' 135' ' ' LEU . 34.3 t70 -60.28 -41.83 94.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.869 168.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.38 -30.83 69.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -70.4 -47.39 61.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.65 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.9 pp -85.0 -14.38 47.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.65 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.9 tttt -61.75 -34.7 76.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 174.633 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.96 -23.2 67.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.06 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -95.03 5.0 53.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.918 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 31.89 57.32 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.463 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -110.36 170.14 8.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.857 0.361 . . . . 0.0 110.832 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.6 t -123.29 140.41 53.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 166.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -65.62 -41.24 92.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.144 -172.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -144.45 128.4 17.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 98.3 mmm -106.73 134.43 49.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -157.82 161.92 38.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 -175.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -96.64 -47.61 5.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.154 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.1 tm? 46.17 33.47 1.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 -168.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -99.43 -7.75 25.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -118.86 153.82 52.71 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.7 0.762 . . . . 0.0 110.917 -174.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.26 -24.46 50.88 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.669 2.246 . . . . 0.0 112.354 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -75.53 -29.88 59.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.832 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -83.04 -31.53 27.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.843 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.6 m -58.48 -43.29 88.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.046 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.568 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 43.9 t-105 -58.14 -55.63 43.37 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.532 0.682 . . . . 0.0 110.85 -171.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.598 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 23.7 Cg_endo -64.23 -18.64 64.08 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.682 2.255 . . . . 0.0 112.416 -174.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.713 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.7 tm? -82.3 -45.55 14.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.897 177.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.579 HG22 ' HA3' ' A' ' 166' ' ' GLY . 85.4 mt -75.48 -44.65 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.052 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.17 -23.35 60.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.05 -173.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -58.98 -35.27 72.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -171.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.7 p30 -103.06 8.42 38.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 118.52 3.76 14.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.442 171.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.579 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -76.78 65.87 2.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.507 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -89.32 135.01 33.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.855 0.36 . . . . 0.0 110.945 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.23 0.45 36.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.223 -174.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -152.13 141.65 21.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -176.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 37.9 tptt -72.68 135.69 45.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.998 156.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -124.69 116.38 22.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.922 164.549 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -147.77 118.47 7.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 53.51 38.17 27.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.35 23.96 74.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.519 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -127.26 139.22 53.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.854 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -97.47 120.61 38.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 171.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -110.86 105.13 13.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.845 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.4 tp -63.51 -17.34 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.063 -174.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.95 -7.54 48.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.941 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 48.8 t0 -130.87 60.35 1.65 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 29.0 m -107.93 167.56 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.115 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -102.61 5.22 51.15 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.562 -166.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' A' ' 365' ' ' GLN . 0.8 OUTLIER -101.25 -25.49 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 111.096 -168.728 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -93.65 24.96 3.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 173.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -116.71 176.12 5.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.15 -27.25 68.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.047 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.87 -40.69 97.44 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.521 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.59 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.05 -37.85 88.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.997 0.427 . . . . 0.0 111.19 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.586 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 90.5 mttt -62.38 -37.62 86.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.813 175.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.07 89.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.099 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.484 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -66.99 -47.99 62.66 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.535 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.518 HD11 ' HA ' ' A' ' 347' ' ' VAL . 27.4 tp -65.95 -35.25 80.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.904 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.528 ' OG1' HG21 ' A' ' 357' ' ' VAL . 93.4 m -64.97 -43.29 93.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.186 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 91.4 t80 -67.81 -47.12 69.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.723 HD23 ' C ' ' A' ' 195' ' ' LEU . 4.7 tt -50.39 -50.38 51.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 199' ' ' ILE . 35.7 m -65.04 -22.45 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.15 -174.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.9 m-20 -61.86 -33.14 73.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.431 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.8 OUTLIER -81.16 -40.07 24.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.876 -173.829 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 196' ' ' VAL . 1.6 pp -72.65 -29.76 31.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 171.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -68.22 -38.14 81.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -82.67 3.67 28.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.847 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 66.36 40.22 3.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.832 170.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -76.73 -14.93 59.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.767 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -142.0 154.58 45.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.865 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -94.6 155.0 17.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.902 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.86 -27.71 68.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.044 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -96.04 0.14 51.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.817 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.2 m -63.26 135.06 56.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.061 -176.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -142.62 174.41 10.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.991 176.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -61.94 -41.58 98.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.975 0.416 . . . . 0.0 111.014 -175.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.0 m -62.25 -40.45 96.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.883 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 66.3 mt -64.94 -43.66 96.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.122 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.86 -34.24 77.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -61.83 -47.79 83.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.928 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.59 95.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.088 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.67 -44.27 90.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -64.81 -39.9 94.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -64.83 -34.2 77.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -86.29 -16.77 36.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.828 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.85 28.31 29.3 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.502 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -84.07 -22.77 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.923 0.392 . . . . 0.0 110.861 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 67.4 p -130.91 144.02 51.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.503 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -66.55 -60.99 2.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.058 -173.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.516 ' HB3' HD21 ' A' ' 115' ' ' LEU . 59.4 mtm -134.62 158.5 43.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 -166.409 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.4 t -150.43 157.29 42.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.26 126.98 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.182 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -154.62 174.26 15.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -172.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -85.11 -158.29 29.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.52 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.87 -23.66 40.98 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.677 2.251 . . . . 0.0 112.404 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -78.04 -30.38 49.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.914 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 45.69 49.91 11.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -59.98 -24.0 64.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.6 p -79.01 -5.22 53.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -81.03 -174.95 5.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.414 HG21 ' HB3' ' A' ' 238' ' ' SER . 89.5 mt -98.01 130.89 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.172 -177.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -92.01 -53.68 4.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 85.7 m -132.95 112.98 12.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.188 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' SER . . . . . 0.414 ' HB3' HG21 ' A' ' 235' ' ' ILE . 33.8 t -175.11 164.58 3.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.838 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -83.83 -4.65 58.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.895 171.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 99.6 t -81.3 124.42 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.12 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -88.09 147.91 24.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.508 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 49.3 p90 -145.9 163.23 35.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.967 178.41 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -128.78 158.0 21.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.446 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.39 135.28 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 111.111 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.4 t -153.73 149.86 27.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.132 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.2 m -61.23 163.4 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.157 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.484 ' N ' HD12 ' A' ' 247' ' ' LEU . 3.9 mp -69.1 150.01 97.55 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.59 0.71 . . . . 0.0 111.049 -164.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.56 -176.4 2.95 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.809 2.339 . . . . 0.0 112.366 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.4 m -84.25 143.15 29.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.161 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -130.08 112.79 13.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 55.16 35.78 25.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.41 0.97 84.17 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.534 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.414 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 91.4 mm-40 -125.73 125.82 24.93 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.496 0.665 . . . . 0.0 110.914 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 73.0 Cg_exo -54.54 132.82 53.4 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.736 2.291 . . . . 0.0 112.312 -178.566 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.442 ' HG ' ' HE1' ' A' ' 129' ' ' TRP . 66.7 m -81.14 -4.97 57.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.862 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -39.69 129.45 1.47 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.547 0.689 . . . . 0.0 110.874 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -82.19 164.16 17.33 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.758 2.305 . . . . 0.0 112.287 -164.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -74.96 170.04 16.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 29.2 t -114.46 134.4 57.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.207 -168.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -115.18 135.09 12.02 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.416 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.8 t -125.64 117.43 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.773 0.321 . . . . 0.0 111.19 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -66.13 122.92 18.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.914 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 45.2 m -125.43 132.26 52.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 -168.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.92 137.5 53.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.118 -174.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.9 173.99 21.31 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.377 -171.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.2 mm -113.3 130.68 66.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.702 0.287 . . . . 0.0 111.166 -172.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -62.36 129.48 40.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.456 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -59.58 -29.33 67.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.9 -6.07 59.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.081 -174.012 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.8 t -75.33 122.14 86.66 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.579 0.704 . . . . 0.0 110.88 -175.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.459 ' HD2' HG21 ' A' ' 2' ' ' ILE . 89.5 Cg_endo -68.88 -6.99 19.45 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.695 2.263 . . . . 0.0 112.437 167.154 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -102.92 14.38 32.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -51.73 -35.0 41.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.798 -168.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -72.15 -47.68 49.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.989 -171.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.0 pp -79.97 -33.68 39.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.906 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.73 -48.77 70.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.071 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -66.81 -34.42 77.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.14 -45.39 88.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.955 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -70.28 -36.12 74.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.786 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.684 HD23 ' O ' ' A' ' 280' ' ' LEU . 4.5 tt -59.4 -47.1 86.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -177.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -78.75 -28.53 44.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.03 -17.71 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -161.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.86 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 14.7 m-30 -121.18 -46.42 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.842 -178.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 1.0 OUTLIER -63.94 -44.11 93.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -171.502 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 1.009 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.7 pp -124.42 37.95 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -166.716 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 82.0 p -121.46 162.25 20.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.16 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.408 ' HA ' HD11 ' A' ' 290' ' ' LEU . 36.1 p-10 -47.84 -35.06 9.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.806 -167.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -80.18 -40.32 27.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.86 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -71.6 -58.64 5.28 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 -171.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.65 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.11 -22.23 66.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.719 0.295 . . . . 0.0 110.907 -178.488 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.576 ' N ' HD12 ' A' ' 290' ' ' LEU . 87.9 tt0 -68.19 -46.25 71.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.819 172.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.94 -46.32 89.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.052 -174.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 289' ' ' GLY . 0.2 OUTLIER -70.04 -44.82 78.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 178.297 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.53 ' HB2' HD22 ' A' ' 299' ' ' LEU . 29.0 t30 -55.54 -31.46 62.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.853 175.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.76 -26.82 68.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.974 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -83.75 -40.76 18.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -161.41 139.89 7.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.576 0.703 . . . . 0.0 110.861 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -48.86 126.52 15.01 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.68 2.253 . . . . 0.0 112.295 -174.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.53 HD22 ' HB2' ' A' ' 294' ' ' ASN . 0.1 OUTLIER -87.67 -19.11 28.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 173.764 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.37 -67.18 1.43 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.663 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.583 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -157.9 144.98 18.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.933 0.397 . . . . 0.0 111.082 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 24.8 m -125.55 159.93 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.041 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.59 -13.24 60.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.021 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.65 ' CD2' HD21 ' A' ' 290' ' ' LEU . 43.2 tp -81.3 125.21 30.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.887 -174.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -61.58 -36.04 79.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.876 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.3 m -60.7 -50.07 74.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -170.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.558 ' CE2' HD21 ' A' ' 311' ' ' LEU . 23.0 t80 -77.1 -35.25 56.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.987 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.665 ' HA ' HD12 ' A' ' 311' ' ' LEU . 87.3 tt0 -53.37 -39.88 64.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.885 175.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -52.11 -38.69 58.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.905 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -79.85 -34.37 39.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 308' ' ' GLU . 54.2 mt -64.1 -30.66 71.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 -175.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.84 -22.36 47.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.216 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.67 -20.57 65.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.003 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -89.3 122.64 68.38 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.695 0.76 . . . . 0.0 110.88 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -48.44 -30.2 15.19 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.754 2.303 . . . . 0.0 112.317 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -62.62 -30.72 71.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 -172.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.531 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.3 mp -74.9 -30.09 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.037 -173.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.14 -41.63 93.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 -170.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.66 -43.63 68.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 76.5 p -63.86 -31.27 72.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.093 -171.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 38.4 mmt -70.35 -31.43 68.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -64.38 -49.17 72.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 -175.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.628 HD21 ' HB1' ' A' ' 112' ' ' ALA . 10.2 p-10 -80.35 -25.6 39.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.807 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.37 -50.58 69.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.143 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.72 -34.7 77.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.952 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -104.13 -5.03 22.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -170.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -96.53 -156.35 30.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.448 -168.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -151.12 148.08 27.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.832 0.349 . . . . 0.0 110.843 -171.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 44.3 mm -60.85 124.94 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.132 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 96.9 mtp -51.6 142.28 23.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.5 0.667 . . . . 0.0 110.962 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.07 100.8 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 0.0 112.307 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 65' ' ' ASP . 18.2 m120 -120.64 18.69 11.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 -175.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 48.7 pt -77.15 159.44 78.1 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.636 0.731 . . . . 0.0 111.131 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -54.97 -33.42 82.82 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.72 2.28 . . . . 0.0 112.292 -174.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.23 -27.74 69.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.782 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 87.2 mmm -69.62 -28.27 65.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.837 -168.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.9 m -52.13 -42.76 63.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.821 -171.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.65 -36.28 73.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.99 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 2.5 m-30 -64.91 -42.7 94.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.851 -175.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -54.67 -42.69 71.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -70.72 -43.24 69.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.3 95.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.122 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 339' ' ' PHE . 17.7 m -73.8 -31.56 31.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.426 ' O ' HG22 ' A' ' 347' ' ' VAL . 55.2 ttt180 -62.9 -41.82 99.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 90.8 m -57.19 -38.05 73.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.145 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.71 91.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 -173.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.518 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.5 m -74.53 -34.9 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.16 -174.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.447 HD12 HG23 ' A' ' 347' ' ' VAL . 1.4 mp -63.52 -49.14 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.209 174.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -65.36 -39.1 91.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.926 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.17 -45.55 59.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.109 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.83 -39.57 79.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.138 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.6 p -76.38 -10.44 59.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.881 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.8 17.2 70.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.39 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.12 -33.46 44.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.934 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -140.06 155.45 47.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.7 p -77.82 169.16 18.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 170.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.528 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.3 t -56.82 -41.34 75.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -62.06 -45.96 91.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -70.0 -52.92 20.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -72.64 -49.73 29.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.048 -172.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.6 tm? -65.1 -47.7 76.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.75 -50.79 63.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.49 -49.97 55.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.47 -43.64 84.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.134 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.518 ' HB3' ' HB ' ' A' ' 183' ' ' VAL . 78.8 mm-40 -71.7 -35.01 70.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.974 -175.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 31.1 m -60.31 -28.08 67.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.243 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -56.83 -30.78 64.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 78.3 mt -59.09 -40.57 81.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.162 173.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 63.5 p -97.99 -13.54 21.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.227 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.9 tttt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.817 177.313 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.729 0.299 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.7 mt -94.48 139.83 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.155 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.92 138.95 53.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.856 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.97 134.57 43.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.35 8.02 71.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.492 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -160.37 140.61 11.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.757 0.313 . . . . 0.0 110.901 171.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.66 HD23 ' H ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -143.02 156.39 44.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 -167.599 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 69.7 t -112.33 136.43 48.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.693 HD11 HG13 ' A' ' 35' ' ' VAL . 1.1 mp -118.4 131.46 71.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.182 175.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.779 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 73.0 m95 -104.37 126.04 51.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 165.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.507 HD12 ' HG ' ' A' ' 20' ' ' LEU . 13.3 tt -109.49 150.32 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.06 -166.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -58.14 155.05 11.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.808 -170.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.04 -17.51 23.2 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.472 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -78.16 -15.08 59.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.318 . . . . 0.0 110.843 -173.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' A' ' 15' ' ' LYS . 28.8 mmmt -135.0 136.04 41.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 171.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.0 -84.25 1.0 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.495 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -110.25 -38.08 5.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 110.891 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -65.56 -50.97 63.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -150.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.07 -59.98 9.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.443 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.507 ' HG ' HD12 ' A' ' 11' ' ' ILE . 2.0 mt -45.53 -49.95 13.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.952 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.68 -38.01 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.044 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -70.61 -54.42 12.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.853 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.0 m -74.44 -37.74 45.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.186 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.485 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -63.03 -46.76 92.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.443 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -56.88 -30.04 63.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.938 0.399 . . . . 0.0 110.898 -177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -58.35 -37.41 75.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.955 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 1.5 m-30 -60.71 -48.82 80.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.929 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.12 -34.91 78.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -72.18 -37.26 69.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -94.78 -50.0 5.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 -167.323 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.2 p -116.42 -3.25 11.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.155 -171.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.48 14.2 82.21 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.427 166.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.818 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -98.25 133.27 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.352 . . . . 0.0 111.107 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -74.54 134.18 42.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -166.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.693 HG13 HD11 ' A' ' 9' ' ' ILE . 94.5 t -113.45 127.12 70.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.138 -172.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.578 ' O ' HD12 ' A' ' 9' ' ' ILE . 97.2 m -110.85 128.01 55.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.096 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 81.6 t -102.24 132.16 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.195 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -118.67 155.17 31.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.936 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.1 t-80 -89.09 140.11 28.92 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.543 0.687 . . . . 0.0 110.945 -170.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 85.6 Cg_exo -55.02 -27.97 57.52 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.603 2.202 . . . . 0.0 112.406 -174.629 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -48.39 -51.11 28.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 -171.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.23 -1.19 57.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.984 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 tt -46.64 -53.03 12.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.048 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -67.39 -39.41 85.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.963 175.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -63.8 -40.54 96.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.914 -171.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -80.85 -22.93 39.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.547 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 75.9 t80 -48.32 -50.47 56.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 0.0 110.883 -166.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 60.0 Cg_endo -80.59 -28.68 2.66 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.721 2.281 . . . . 0.0 112.343 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -74.5 -37.6 63.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 -170.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.592 HG11 ' HD3' ' A' ' 57' ' ' PRO . 33.6 m -65.9 -26.86 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.03 78.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 173.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.06 68.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.0 p -87.3 -12.23 47.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.135 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.98 11.11 84.07 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.525 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -164.46 156.97 16.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.753 0.311 . . . . 0.0 110.934 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.91 -114.99 0.53 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.505 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.779 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 89.6 Cg_endo -77.6 150.67 28.07 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.739 2.293 . . . . 0.0 112.318 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.25 -35.3 21.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.805 163.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.521 ' HB ' HG23 ' A' ' 9' ' ' ILE . 40.5 mt -126.5 136.33 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.108 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 tp -132.12 125.84 55.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.119 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -89.81 139.56 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.805 166.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.438 ' CH2' ' HB2' ' A' ' 105' ' ' ALA . 35.2 p90 -141.12 163.0 34.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.936 171.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.53 -85.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.09 -168.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.537 ' NE2' ' HA3' ' A' ' 260' ' ' GLY . 11.3 m170 -126.89 -68.2 0.81 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.456 ' HB3' HG22 ' A' ' 333' ' ' ILE . 99.7 m-20 -100.65 -10.01 21.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 -158.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -51.83 -20.0 2.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.85 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.482 ' HB2' HD13 ' A' ' 104' ' ' ILE . 34.3 p90 -55.92 -28.88 58.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.53 -51.08 59.95 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.24 -36.7 90.21 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.425 172.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 1.4 t80 -55.83 -51.73 66.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.811 0.338 . . . . 0.0 110.913 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.32 -42.26 59.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.131 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -56.9 -37.98 72.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.938 -175.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.404 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 62.3 m -84.9 -6.42 59.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.949 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.96 30.47 59.24 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.591 173.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.404 ' HG ' ' HB2' ' A' ' 73' ' ' SER . 52.6 mt -89.04 -12.18 42.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.829 -167.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.461 ' HA ' ' H ' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -128.94 151.39 49.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 -173.246 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -77.07 142.21 39.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.118 175.05 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.94 135.89 48.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.903 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -104.22 153.7 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.255 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.2 m -96.39 126.74 42.65 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 111.112 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.98 134.79 65.56 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.653 2.236 . . . . 0.0 112.347 176.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -104.93 120.1 40.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.85 -39.84 94.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.88 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.13 -45.27 85.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.059 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -75.31 -31.75 60.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.501 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 65.4 tt0 -53.94 -51.18 64.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.52 -32.18 70.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 174.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -76.66 -22.01 54.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.51 -105.36 0.3 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.952 -171.413 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 25.0 t80 171.94 130.02 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.624 0.726 . . . . 0.0 110.966 -168.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -52.79 -37.68 76.73 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.727 2.285 . . . . 0.0 112.359 -175.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -66.57 -34.78 78.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.852 -172.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.5 p -73.93 -30.01 62.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.17 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.501 ' HA ' HG22 ' A' ' 97' ' ' VAL . 75.8 m95 -65.82 -31.99 73.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.931 173.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.66 -32.33 72.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.812 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.72 -23.9 62.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.501 HG22 ' HA ' ' A' ' 94' ' ' TRP . 19.5 m -107.27 14.06 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 -177.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -100.02 130.12 46.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.823 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -126.07 113.71 17.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.2 t30 58.99 38.31 24.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.839 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.36 0.64 89.46 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.502 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -118.9 151.62 37.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.878 0.37 . . . . 0.0 110.843 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.499 HD22 HG23 ' A' ' 97' ' ' VAL . 14.6 mt -89.93 133.53 34.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -124.0 4.15 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 -172.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.438 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . . . -163.47 164.58 24.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.106 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -114.11 142.21 27.59 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.575 0.702 . . . . 0.0 110.923 171.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.93 122.16 5.25 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.625 2.216 . . . . 0.0 112.296 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.062 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp -104.22 -37.69 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -146.48 154.09 41.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.034 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.4 t -115.49 129.86 71.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.089 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -109.96 129.28 55.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -154.93 143.67 20.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.06 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.97 169.0 11.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.95 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.7 p -157.31 156.37 32.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.893 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -100.06 128.58 46.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.902 169.451 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.614 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.9 mp -110.07 133.14 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.102 -175.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -131.01 145.28 52.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -93.5 113.9 26.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.856 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.33 -20.79 66.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -175.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -79.5 -28.46 41.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.895 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.19 -49.61 11.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 175.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -141.71 133.76 13.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.564 0.697 . . . . 0.0 110.831 175.641 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.44 -14.38 14.55 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.625 2.217 . . . . 0.0 112.352 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -143.72 98.35 5.32 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.564 0.697 . . . . 0.0 110.879 -173.013 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.45 156.5 61.41 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.684 2.256 . . . . 0.0 112.357 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.44 143.83 59.15 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.664 2.243 . . . . 0.0 112.321 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -89.89 -13.84 35.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.6 p -132.44 158.38 42.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.132 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -68.64 -30.04 68.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.56 -19.97 65.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.953 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -79.99 -26.97 39.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.851 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.478 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -56.7 -46.94 99.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.613 0.721 . . . . 0.0 111.303 -169.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 86.7 Cg_exo -52.58 -50.78 12.87 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.657 2.238 . . . . 0.0 112.374 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.71 -57.68 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 -174.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.156 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.37 -17.26 63.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 -173.18 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.572 ' N ' HD13 ' A' ' 135' ' ' LEU . 36.2 t70 -61.17 -40.16 92.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 168.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.16 -30.89 71.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.879 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.8 -46.24 58.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.842 -177.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.0 pp -84.11 -13.9 51.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.631 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.7 tttt -58.77 -34.92 71.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.93 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.72 -24.14 67.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.057 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -95.0 3.4 54.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.888 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.75 32.32 54.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.445 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -110.65 171.76 7.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 110.911 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.6 t -124.63 140.17 53.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.753 168.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -67.28 -42.95 82.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.168 -170.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -138.54 128.79 25.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 63.2 tpp -110.81 129.32 55.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -153.22 155.18 36.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -88.57 -50.94 5.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.845 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.076 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.8 tm? 48.47 31.12 2.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -170.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -103.06 -7.36 21.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.977 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -129.99 152.52 80.12 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-O 121.652 0.739 . . . . 0.0 110.882 -174.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.49 -32.51 53.36 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.752 2.301 . . . . 0.0 112.315 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -69.7 -30.05 67.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -80.01 -39.64 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.835 172.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.8 m -60.1 -52.3 65.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.124 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.578 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 22.7 t-105 -60.7 -48.65 92.56 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.598 0.713 . . . . 0.0 110.889 -160.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 84.3 Cg_exo -50.82 -44.43 41.33 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.62 2.213 . . . . 0.0 112.276 -176.34 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 160' ' ' LEU . 7.0 tt -72.92 -39.99 65.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 -171.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.17 -42.07 66.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.136 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.14 -23.32 60.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.126 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.26 -35.02 71.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.111 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.6 p30 -104.29 9.44 35.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.877 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.44 4.75 23.32 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.472 169.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.37 68.89 2.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.531 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -92.62 133.53 35.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.771 0.32 . . . . 0.0 110.944 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.44 ' HB1' HD13 ' A' ' 368' ' ' ILE . . . -83.94 12.61 5.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 -173.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.449 ' HD1' ' HE1' ' A' ' 336' ' ' MET . 53.1 p90 -151.52 153.32 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.911 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -99.79 122.29 42.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 156.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -112.72 122.31 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.872 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -152.2 130.58 12.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.2 t30 54.99 43.96 29.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.77 15.46 79.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.602 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.38 139.75 50.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.867 -176.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -96.99 145.0 26.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 170.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -126.03 110.15 13.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.87 172.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.554 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.6 pp -80.04 -9.02 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -98.2 -11.93 22.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -121.93 89.14 3.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 169.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 26.0 m -116.61 164.55 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.082 -172.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -107.45 24.78 23.4 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.574 -173.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.423 HG21 HD12 ' A' ' 368' ' ' ILE . 2.5 m -109.24 -21.05 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.811 0.338 . . . . 0.0 111.055 -176.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -90.96 28.9 1.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.794 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -125.12 -170.04 2.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.893 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.85 -29.09 68.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.88 -41.71 95.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.477 -168.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.644 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.03 -37.04 85.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.942 0.401 . . . . 0.0 111.156 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.582 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -61.83 -38.13 87.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.868 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.14 -38.07 89.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.136 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.09 -47.73 63.38 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.505 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 347' ' ' VAL . 22.6 tp -67.39 -34.8 78.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.912 0.387 . . . . 0.0 110.901 -177.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.49 ' OG1' HG21 ' A' ' 357' ' ' VAL . 93.1 m -65.09 -41.43 94.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.148 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.461 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 59.8 t80 -67.33 -47.02 71.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.903 177.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 195' ' ' LEU . 7.4 tt -51.6 -51.42 55.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 -175.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 199' ' ' ILE . 31.2 m -64.01 -22.67 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.0 m-20 -61.59 -34.43 75.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.946 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.43 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.8 OUTLIER -81.28 -39.91 24.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.922 -173.92 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.516 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.8 pp -73.46 -29.3 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.135 172.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.6 -37.29 79.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -80.82 2.6 25.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.885 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 67.1 39.74 3.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.799 170.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -77.32 -17.94 57.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.91 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.516 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.2 ppp? -146.11 157.12 43.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.885 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -94.09 150.09 20.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.844 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.97 -25.88 67.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.075 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -95.4 0.99 54.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 94.0 m -63.55 127.18 30.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.095 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.429 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 14.7 t0 -120.02 177.36 5.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.853 177.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -65.01 -36.96 86.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.94 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.3 p -70.48 -38.03 74.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.911 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.429 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 78.7 mt -65.83 -43.12 93.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.072 175.652 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.31 87.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.209 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -61.6 -46.8 88.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.88 -40.77 97.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.056 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.91 -49.11 76.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.124 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -64.7 -41.1 96.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.966 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -63.51 -31.58 72.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.903 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.24 -13.17 44.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.962 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.14 25.01 35.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.556 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -85.87 -21.18 28.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 110.907 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.8 t -125.63 138.48 53.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.576 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -63.08 -48.84 76.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.012 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.489 ' HB3' HD21 ' A' ' 115' ' ' LEU . 69.9 mtm -133.3 159.89 38.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.949 -173.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.4 t -149.07 155.66 41.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.237 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.0 mm -111.47 130.05 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.178 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -155.77 174.63 15.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.5 -151.48 9.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.441 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.69 -26.18 28.16 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.621 2.214 . . . . 0.0 112.337 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -74.32 -32.06 62.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.942 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 43.19 45.04 4.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.151 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 35.6 m0 -69.45 -16.77 63.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 66.6 m -65.03 -26.42 68.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.514 ' HB3' HG21 ' A' ' 116' ' ' ILE . 39.1 p30 -82.62 -179.1 7.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 -172.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.8 mt -97.57 122.51 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.125 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.95 -60.0 2.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.821 -173.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 86.2 m -129.28 118.38 22.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.227 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 29.8 t -175.01 162.2 3.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -68.71 -19.69 64.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.93 170.382 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 87.9 t -65.16 124.97 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.081 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -79.05 140.11 37.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.29 151.52 38.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.72 161.93 26.23 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 173.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.1 p -137.03 138.47 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.418 . . . . 0.0 111.025 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.4 t -155.72 150.97 26.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.176 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 30.7 m -59.97 167.08 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.119 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.946 HD23 ' HD3' ' A' ' 257' ' ' PRO . 2.8 mm? -59.24 149.82 66.25 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.519 0.676 . . . . 0.0 110.946 -168.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.23 -176.58 2.76 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.786 2.324 . . . . 0.0 112.406 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 99.3 m -88.92 144.03 26.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.108 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -131.34 110.96 11.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 54.92 36.16 26.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.988 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 89.81 -0.16 79.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.449 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -128.78 139.16 34.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.543 0.687 . . . . 0.0 110.843 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -67.38 138.28 45.9 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.734 2.289 . . . . 0.0 112.375 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 247' ' ' LEU . 75.6 m -81.48 -4.81 56.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 173.5 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 255' ' ' SER . 91.3 mttt -37.41 130.93 0.82 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.494 0.664 . . . . 0.0 110.878 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.946 ' HD3' HD23 ' A' ' 247' ' ' LEU . 37.8 Cg_endo -84.24 168.07 11.94 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.7 2.266 . . . . 0.0 112.278 -159.97 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -60.36 166.83 2.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.4 t -117.88 130.23 73.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.152 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.537 ' HA3' ' NE2' ' A' ' 64' ' ' HIS . . . -117.93 139.72 14.98 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.438 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 83.8 t -124.77 116.95 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.756 0.312 . . . . 0.0 111.189 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -65.14 119.97 11.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.961 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.3 m -123.8 130.88 53.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.809 -167.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.93 138.69 52.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.049 -174.421 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.6 170.82 22.21 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.43 -171.548 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.576 HG13 ' HB3' ' A' ' 277' ' ' LYS . 23.1 mm -114.96 127.64 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 0.0 111.198 -173.201 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -63.24 129.56 40.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 -175.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.461 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -58.68 -29.94 67.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.16 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.92 -6.34 59.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 -172.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 18.2 t -70.66 123.47 89.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.557 0.694 . . . . 0.0 110.981 -173.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -68.47 -8.34 22.84 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.669 2.246 . . . . 0.0 112.388 167.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -106.35 11.12 31.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.907 -176.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -47.58 -37.52 12.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 -168.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.54 -47.18 61.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.875 -171.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.1 pp -81.02 -30.7 34.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.945 -176.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.35 -49.55 68.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.071 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.576 ' HB3' HG13 ' A' ' 266' ' ' ILE . 57.9 pttt -69.33 -34.1 74.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.56 -45.82 81.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.822 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -67.75 -38.88 84.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.797 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 7.5 tt -58.55 -50.73 72.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 -175.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -72.2 -26.7 62.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -100.02 -11.06 20.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.967 -169.166 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.868 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 79.1 m-85 -128.33 -55.27 1.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 3.5 mp -66.13 -34.88 79.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 -165.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 1.062 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.2 pp -123.82 37.45 4.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.97 175.501 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 287' ' ' ASP . 9.3 m -115.53 153.86 30.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.108 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.566 ' HA ' HD11 ' A' ' 290' ' ' LEU . 28.7 t70 -45.7 -34.82 3.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -166.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -78.49 -41.09 33.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.868 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.04 -56.53 5.72 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.472 -171.686 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.573 HD12 ' N ' ' A' ' 291' ' ' GLU . 0.5 OUTLIER -66.42 -21.26 66.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.908 -179.157 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.573 ' N ' HD12 ' A' ' 290' ' ' LEU . 84.4 tt0 -68.29 -46.94 68.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.798 171.254 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.91 -42.87 99.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.071 -174.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 4.0 m -79.59 -36.31 17.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.182 -174.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -64.97 -28.73 69.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.934 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.79 -26.72 68.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -87.95 -41.96 12.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -146.13 135.53 11.47 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.541 0.686 . . . . 0.0 110.902 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -53.12 113.9 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.655 2.236 . . . . 0.0 112.394 175.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.411 ' HA ' HD12 ' A' ' 299' ' ' LEU . 0.7 OUTLIER -86.45 -24.94 25.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.949 177.77 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 103.63 -57.01 0.56 Allowed Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.506 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.577 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -168.18 161.83 12.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.384 . . . . 0.0 111.036 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.606 HG21 ' HB3' ' A' ' 307' ' ' TYR . 32.6 m -124.33 155.55 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.099 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.02 -9.99 59.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.034 173.405 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.557 ' CD2' HD21 ' A' ' 290' ' ' LEU . 45.0 tp -86.5 119.95 27.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.858 -176.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.61 -38.64 72.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.945 -174.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 42.7 t -64.56 -50.32 67.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.916 -169.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.606 ' HB3' HG21 ' A' ' 302' ' ' VAL . 16.9 t80 -78.52 -29.13 46.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -64.74 -37.76 88.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.37 -37.9 85.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.939 173.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -72.81 -39.8 66.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.963 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.577 HD13 ' HA ' ' A' ' 301' ' ' ALA . 79.2 mt -61.93 -32.64 73.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.928 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.26 -17.52 58.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.8 -19.12 65.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.978 173.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -91.63 121.74 66.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.746 0.784 . . . . 0.0 110.852 164.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -48.2 -26.93 8.73 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.679 2.252 . . . . 0.0 112.344 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -61.26 -29.64 69.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -172.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 1.2 mp -76.84 -29.86 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.188 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.51 85.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.046 -170.314 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.21 -43.74 77.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 80.8 p -63.78 -30.99 72.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -171.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.5 mmm -70.91 -32.86 69.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.85 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -64.46 -46.68 82.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.869 -173.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.447 ' OD1' ' HB1' ' A' ' 112' ' ' ALA . 7.5 p-10 -80.08 -27.07 39.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.728 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.13 -49.21 73.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.116 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -68.0 -34.98 77.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -105.51 -6.54 19.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.823 -169.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -93.18 -159.6 34.94 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.435 -170.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -142.22 148.53 38.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 0.0 110.92 -172.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 41.7 mm -65.13 122.3 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.083 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 36.2 ttp -52.46 139.64 37.7 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.574 0.702 . . . . 0.0 110.913 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.457 ' HB2' ' HE2' ' A' ' 336' ' ' MET . 58.5 Cg_endo -67.7 84.33 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.728 2.285 . . . . 0.0 112.348 176.53 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.433 ' CG ' ' O ' ' A' ' 332' ' ' ASN . 10.6 t-20 -106.51 16.52 24.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 -170.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.456 HG22 ' HB3' ' A' ' 65' ' ' ASP . 48.2 pt -83.22 159.98 60.96 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.614 0.721 . . . . 0.0 111.217 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -57.17 -36.32 99.09 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.736 2.291 . . . . 0.0 112.315 -172.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -71.16 -28.1 64.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.858 -175.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.457 ' HE2' ' HB2' ' A' ' 331' ' ' PRO . 85.1 mmm -79.99 -22.76 42.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 -173.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.5 m -55.52 -39.95 71.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.806 -171.792 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -68.71 -33.48 74.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.031 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 1.5 m-30 -67.51 -37.33 82.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -54.98 -42.04 71.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -78.28 -36.18 47.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.774 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.12 -38.44 90.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.043 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 339' ' ' PHE . 19.3 m -74.72 -31.32 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.071 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 347' ' ' VAL . 4.9 tmt_? -64.16 -37.33 87.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.863 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.9 m -57.27 -36.73 71.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.212 174.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.89 -42.54 94.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.183 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.541 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.9 m -74.26 -34.57 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.202 -174.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.452 HD12 HG23 ' A' ' 347' ' ' VAL . 1.4 mp -63.37 -47.91 89.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.119 173.856 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.97 -40.29 97.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.26 -46.39 41.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.105 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.33 78.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.039 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.2 p -75.26 -10.73 59.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.3 18.31 69.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.484 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.87 -33.32 45.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.764 0.316 . . . . 0.0 110.938 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.494 ' HB2' ' HB2' ' A' ' 360' ' ' ALA . 90.3 mm-40 -140.58 156.44 46.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 52.3 p -77.48 166.59 22.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.183 171.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.49 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.2 t -56.19 -41.92 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.226 173.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.52 -46.85 88.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.951 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -70.49 -56.42 6.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' A' ' 355' ' ' GLN . . . -68.45 -48.42 64.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.11 -172.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.644 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.8 tm? -65.0 -45.85 83.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -175.035 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.34 -53.76 50.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 -176.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 363' ' ' ASP . . . . . 0.409 ' O ' ' HG3' ' A' ' 367' ' ' ARG . 32.1 t70 -68.07 -50.08 57.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 -174.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -64.06 -38.29 90.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 -172.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 75.5 mm-40 -78.08 -32.34 50.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 40.9 m -66.21 -29.13 69.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.172 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 367' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 363' ' ' ASP . 79.6 mtt180 -56.9 -32.16 65.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 174.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 365' ' ' GLN . 71.4 mt -59.89 -40.72 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 41.6 p -97.1 -11.07 24.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.189 -175.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.812 175.363 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.755 0.312 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.425 HG21 ' HD2' ' A' ' 271' ' ' PRO . 62.3 mt -99.45 140.06 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.154 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -143.9 145.0 31.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -54.34 138.24 39.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 176.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.15 8.35 68.88 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.538 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.2 tttt -166.09 131.09 2.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.827 0.346 . . . . 0.0 110.91 176.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.611 HD22 HD11 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -141.76 155.97 45.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.963 -172.454 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 69.3 t -114.45 135.43 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.18 -175.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.712 HD11 HG13 ' A' ' 35' ' ' VAL . 0.9 OUTLIER -120.0 134.88 62.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.047 176.603 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.859 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 60.5 m95 -108.62 124.46 50.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 163.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.513 HD12 ' HG ' ' A' ' 20' ' ' LEU . 12.1 tt -109.75 151.77 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.074 -163.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -54.75 148.28 13.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.807 -172.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.99 -16.85 41.87 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.504 -175.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -80.61 -14.12 58.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.854 0.359 . . . . 0.0 110.888 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 15' ' ' LYS . 33.0 mmtm -140.0 128.09 22.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 166.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.1 -78.13 1.07 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.49 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -104.88 -35.92 7.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -67.33 -52.47 39.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.862 -150.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.32 -52.62 43.16 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.508 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.526 HD22 HD13 ' A' ' 9' ' ' ILE . 5.8 mt -55.09 -53.44 55.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.359 . . . . 0.0 110.907 174.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.29 -39.02 6.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.133 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -71.47 -57.99 3.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 178.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 20' ' ' LEU . 20.9 m -74.29 -36.19 42.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.199 -170.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.55 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -63.6 -45.62 94.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.489 174.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -54.33 -36.49 63.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.878 0.37 . . . . 0.0 110.831 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -58.92 -41.12 86.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.967 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 4.7 m-30 -62.34 -47.03 86.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 98.1 mt-10 -61.27 -36.05 78.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -75.42 -40.18 58.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.924 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -91.24 -49.84 6.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 -166.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.6 p -108.66 -7.55 15.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.174 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.13 8.83 87.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.369 167.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.927 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.8 133.66 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 111.219 -178.39 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.7 mttt -69.97 136.18 50.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.853 -172.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.712 HG13 HD11 ' A' ' 9' ' ' ILE . 92.1 t -114.7 125.02 71.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.007 -175.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.565 ' O ' HD12 ' A' ' 9' ' ' ILE . 98.6 m -108.91 125.66 52.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.098 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.422 HG22 ' HB3' ' A' ' 20' ' ' LEU . 84.8 t -102.43 130.91 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.138 177.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -118.13 154.27 32.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.958 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 65.8 t-80 -87.13 138.61 32.48 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.558 0.694 . . . . 0.0 110.884 -169.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 81.4 Cg_exo -57.34 -25.51 65.88 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.652 2.235 . . . . 0.0 112.303 -173.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -48.36 -51.1 27.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.838 -173.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.94 -0.82 57.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 -175.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 8.1 tt -46.56 -52.71 12.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -174.642 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -65.01 -40.81 95.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.81 -40.89 97.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.865 -172.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -81.55 -21.14 38.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.526 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 53.2 t80 -50.06 -51.16 64.45 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.696 0.76 . . . . 0.0 110.816 -165.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 55.5 Cg_endo -81.69 -30.06 1.55 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.656 2.238 . . . . 0.0 112.405 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -75.12 -40.05 60.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -167.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.51 -27.69 41.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.032 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.706 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -68.08 -36.21 79.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.096 177.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.81 -32.08 71.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.051 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.2 p -92.18 -15.7 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.135 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.76 10.89 80.64 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.403 173.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -140.2 132.62 28.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 0.0 110.811 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.434 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . 170.69 -127.76 1.51 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.474 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.859 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 35.0 Cg_endo -64.18 149.01 91.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.713 2.275 . . . . 0.0 112.399 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -92.1 -33.2 14.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.826 161.251 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.68 ' HB ' HG23 ' A' ' 9' ' ' ILE . 38.7 mt -124.16 136.09 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.114 -177.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 tp -131.44 127.56 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.157 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -93.77 136.7 33.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.802 170.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.479 ' CH2' ' HB2' ' A' ' 105' ' ' ALA . 33.0 p90 -140.89 167.17 22.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.969 171.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.59 -82.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.016 -167.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -127.32 -73.42 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.881 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.467 ' H ' ' HB3' ' A' ' 332' ' ' ASN . 70.1 m-20 -99.96 -10.73 21.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -159.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -51.25 -22.34 2.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.516 ' HB2' HD13 ' A' ' 104' ' ' ILE . 32.9 p90 -56.8 -31.77 65.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.807 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.89 -50.99 60.91 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.447 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.73 -35.98 90.56 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.533 171.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -55.1 -51.63 65.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 0.0 110.946 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.73 -44.07 51.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.072 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -57.04 -38.86 73.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.982 -174.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.4 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 63.4 m -85.02 -7.15 59.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.77 30.3 59.9 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.545 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.706 HD22 ' HB1' ' A' ' 51' ' ' ALA . 35.5 mt -88.83 -9.35 52.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.808 0.337 . . . . 0.0 110.904 -170.012 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.467 ' HA ' ' H ' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -128.61 152.11 48.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 -178.161 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -80.37 142.82 34.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.069 175.695 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -73.12 135.38 44.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.836 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 pt -105.06 155.87 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.109 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.9 m -97.65 130.04 30.08 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.536 0.684 . . . . 0.0 111.08 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.42 135.55 66.2 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.669 2.246 . . . . 0.0 112.335 176.428 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -103.39 117.85 35.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 175.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.31 -41.34 98.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.849 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.25 87.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.002 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.42 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 16.5 m-85 -75.84 -31.75 59.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.857 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.45 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 66.8 tt0 -53.4 -50.84 64.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.949 173.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.76 -32.99 72.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 85' ' ' PHE . 93.7 mttt -75.87 -21.04 57.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -174.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -104.76 -105.08 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -171.528 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 26.9 t80 171.66 128.33 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.68 0.752 . . . . 0.0 110.956 -167.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -52.77 -36.78 74.69 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PHE . . . . . 0.4 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 62.9 t80 -65.19 -35.11 80.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.4 p -73.79 -31.08 63.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.168 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.65 ' HA ' HG22 ' A' ' 97' ' ' VAL . 79.6 m95 -67.95 -29.72 68.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 173.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.04 -31.48 72.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.95 -23.84 58.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.65 HG22 ' HA ' ' A' ' 94' ' ' TRP . 17.7 m -111.51 19.28 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 -173.146 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.1 ttp-105 -111.95 136.5 51.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.842 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -135.39 121.89 20.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.952 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.2 t30 58.91 35.39 24.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.96 0.76 89.78 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.57 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -118.29 151.0 38.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 110.853 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.606 HD22 HG23 ' A' ' 97' ' ' VAL . 22.2 mt -86.58 135.27 33.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.951 177.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.516 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -124.79 3.6 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.065 -173.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.479 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . . . -163.46 165.83 23.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.196 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.463 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 90.2 m-85 -114.87 140.57 25.64 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.618 0.723 . . . . 0.0 110.976 170.653 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 12.0 Cg_exo -70.07 123.63 10.19 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.603 2.202 . . . . 0.0 112.294 170.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.014 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -106.98 -39.83 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 175.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -144.51 153.78 42.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 -166.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.8 t -118.68 129.86 74.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.135 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -119.89 127.78 53.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.621 ' HB1' HD21 ' A' ' 323' ' ' ASN . . . -155.02 146.42 23.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.036 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.6 mp -85.71 170.01 12.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.996 -175.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.4 p -154.75 153.63 31.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.988 0.423 . . . . 0.0 110.853 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.878 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -94.89 126.79 40.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 169.411 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.592 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.1 mp -111.63 131.73 62.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 -175.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -132.47 147.93 52.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 -175.091 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -92.37 115.49 28.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.872 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.483 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.2 mttt -66.56 -22.12 66.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -77.94 -23.35 48.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 -176.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.8 mp -85.29 -57.5 3.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 168.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.726 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -144.32 125.89 8.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.696 0.76 . . . . 0.0 110.785 177.76 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.46 -0.76 10.66 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.594 2.196 . . . . 0.0 112.41 -176.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -147.93 101.87 3.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.654 0.74 . . . . 0.0 110.761 -174.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.52 155.06 50.39 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.755 2.303 . . . . 0.0 112.401 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.444 ' HD2' ' SD ' ' A' ' 224' ' ' MET . 52.4 Cg_exo -55.28 143.06 77.56 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.699 2.266 . . . . 0.0 112.294 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -78.87 -22.03 46.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 52.9 p -135.62 159.95 40.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.202 -177.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.428 ' HA ' HD13 ' A' ' 132' ' ' ILE . 77.8 m95 -70.82 -28.13 64.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.09 -19.41 65.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -84.07 -20.63 32.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.554 ' O ' HD13 ' A' ' 135' ' ' LEU . 0.7 OUTLIER -57.36 -45.35 99.9 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.635 0.731 . . . . 0.0 111.133 -171.865 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 82.0 Cg_exo -51.27 -47.67 24.81 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.612 2.208 . . . . 0.0 112.335 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.84 -59.84 3.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.054 -174.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.113 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.99 -16.8 63.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.866 -173.328 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.542 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.4 t70 -61.3 -40.1 92.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 168.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.36 -30.07 69.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.7 -47.95 57.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.832 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.1 pp -87.42 -16.69 34.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.924 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.602 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.4 tttt -59.45 -32.86 70.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.41 -25.13 68.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.983 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -95.36 7.04 47.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.919 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.9 30.96 58.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.531 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -109.7 169.99 8.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 0.0 110.887 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.5 t -125.63 142.22 51.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 174.132 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.63 -42.48 74.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.124 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -139.3 127.78 22.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.945 -175.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 63.3 tpp -105.25 129.14 53.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 -174.342 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.18 158.33 38.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.929 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -98.63 -42.87 7.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.82 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.026 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.5 tm? 48.46 31.2 2.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 -170.205 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -103.73 -6.76 21.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.887 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -137.67 156.5 74.63 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.645 0.736 . . . . 0.0 110.901 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.476 ' HA ' ' HB ' ' A' ' 157' ' ' THR . 67.7 Cg_exo -52.37 -26.39 27.6 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.671 2.247 . . . . 0.0 112.339 176.176 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -63.22 -38.49 91.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -85.85 -37.19 19.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 20.0 m -58.87 -52.13 67.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.116 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.574 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 23.6 t-105 -62.54 -49.23 84.21 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.561 0.696 . . . . 0.0 110.893 -163.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 81.6 Cg_exo -50.07 -48.26 20.42 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.724 2.283 . . . . 0.0 112.392 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.691 HD23 ' O ' ' A' ' 160' ' ' LEU . 6.8 tt -72.0 -39.91 68.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 -170.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.3 mt -71.12 -42.41 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.119 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.38 -25.86 59.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -60.66 -35.03 75.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -169.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.4 ' HB3' ' CD2' ' A' ' 250' ' ' PHE . 59.6 p30 -97.53 3.48 50.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.76 2.15 13.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.415 173.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.89 64.78 3.0 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.563 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -87.08 136.02 33.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.916 0.388 . . . . 0.0 110.987 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.49 -0.33 22.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.781 ' CE1' ' HG3' ' A' ' 331' ' ' PRO . 49.6 p90 -154.05 154.82 34.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.909 -175.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -97.22 121.96 39.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.952 157.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -109.76 123.14 49.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.882 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -152.69 131.52 12.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.3 t30 55.74 44.97 25.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 172.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.92 15.29 78.34 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.463 173.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.89 139.11 50.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.0 110.864 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -98.75 140.43 32.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 172.711 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -122.33 109.94 15.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.528 ' C ' HD12 ' A' ' 178' ' ' ILE . 2.1 pp -83.4 -6.2 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.071 -177.581 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -99.67 -16.92 18.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -117.01 88.74 2.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.834 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 169' ' ' PHE . 22.9 m -117.82 165.03 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.094 -169.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -109.96 25.71 15.86 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.509 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 365' ' ' GLN . 1.2 m -106.6 -23.06 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.821 0.344 . . . . 0.0 111.06 -176.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -92.09 24.15 3.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -107.72 -174.97 2.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.8 -28.31 63.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.11 -40.43 92.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.524 -171.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.583 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -60.45 -38.39 84.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 111.099 177.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.589 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.6 mttt -61.67 -37.3 83.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.9 176.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.77 88.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.042 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.0 -46.62 71.39 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.564 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.549 HD11 ' HA ' ' A' ' 347' ' ' VAL . 20.2 tp -67.56 -33.63 75.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.958 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.516 ' OG1' HG21 ' A' ' 357' ' ' VAL . 91.8 m -65.57 -42.02 92.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.24 176.511 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 92.3 t80 -69.4 -44.68 70.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 195' ' ' LEU . 6.9 tt -51.13 -51.6 51.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.932 -175.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 35.1 m -63.89 -22.48 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.0 m-20 -62.25 -34.18 76.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.843 -177.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.457 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.7 OUTLIER -82.02 -39.96 22.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.959 -173.444 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.8 pp -72.02 -29.96 34.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.151 172.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -67.47 -37.73 83.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 171.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -82.72 2.54 33.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.925 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 66.86 39.94 3.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.829 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -75.96 -15.66 60.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.811 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -144.1 156.1 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.842 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -94.19 152.61 18.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.58 -27.11 68.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -94.1 2.67 55.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -177.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.9 m -65.62 134.92 54.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -138.36 171.73 13.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.918 176.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.07 -46.04 82.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 -176.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.8 m -60.37 -40.61 91.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.95 -42.25 94.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.178 173.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.98 -36.91 85.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.136 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' GLU . . . . . 0.402 ' HG2' ' HA ' ' A' ' 233' ' ' SER . 93.8 mt-10 -65.04 -44.24 89.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.874 177.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.96 -39.56 93.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.087 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.18 -45.02 95.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.099 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -64.25 -38.67 91.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.22 -34.7 76.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.0 -19.26 27.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.39 26.1 26.48 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -82.07 -19.96 39.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.928 0.395 . . . . 0.0 110.915 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.9 t -123.89 134.76 53.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 174.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.514 ' HB1' HD21 ' A' ' 122' ' ' LEU . . . -66.8 -47.38 72.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.996 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.626 ' HB3' HD21 ' A' ' 115' ' ' LEU . 72.9 mtm -133.86 153.78 51.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -171.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 10.1 t -151.04 155.81 39.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.213 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.2 mm -109.69 124.76 66.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.185 -175.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -153.51 174.64 14.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 -170.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.41 -164.13 34.17 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.435 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.2 -20.9 49.1 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.662 2.241 . . . . 0.0 112.341 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -78.16 -25.52 47.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 49.4 53.52 12.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.115 178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -60.0 -23.61 63.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 -177.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.402 ' HA ' ' HG2' ' A' ' 214' ' ' GLU . 65.2 m -57.09 -40.69 77.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.89 -176.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -85.91 179.19 7.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 69.8 mt -120.47 127.32 75.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 -167.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -95.38 -9.91 31.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 65.2 p -130.59 71.41 1.46 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 31.5 t -168.26 163.94 13.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.926 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.24 -3.03 51.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 34.9 m -57.85 156.47 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.122 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -106.15 124.25 49.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.483 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 52.5 p90 -143.82 155.97 44.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.89 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -135.84 160.16 24.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.512 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.38 135.12 54.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.938 0.399 . . . . 0.0 111.061 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.8 t -153.8 149.14 27.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.36 162.07 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 3.1 mp -68.05 151.58 97.09 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.539 0.685 . . . . 0.0 110.919 -162.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.09 -173.6 1.85 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.663 2.242 . . . . 0.0 112.327 -174.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 99.5 m -89.03 143.01 27.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 -171.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 164' ' ' ASP . 11.1 t80 -132.17 113.13 12.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -176.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 56.22 35.46 25.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.37 1.89 83.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.583 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 90.0 mm-40 -126.86 127.94 24.32 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 121.555 0.693 . . . . 0.0 110.887 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 78.1 Cg_exo -55.12 133.24 57.0 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.631 2.221 . . . . 0.0 112.375 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 256' ' ' LYS . 69.4 m -78.81 -9.61 59.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.855 173.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 85.7 mttt -39.8 128.61 1.53 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.539 0.685 . . . . 0.0 110.861 -173.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 71.2 Cg_exo -63.51 156.25 57.77 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.648 2.232 . . . . 0.0 112.377 -167.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -70.75 166.6 20.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 173.048 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.83 131.68 61.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.146 -167.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.95 135.13 12.09 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.436 173.111 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 96.4 t -123.53 115.91 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 0.0 111.159 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -64.17 120.71 12.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.992 -178.525 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 48.4 m -124.74 131.63 53.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.835 -169.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.84 138.89 52.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.105 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -135.04 172.85 21.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.463 -170.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 23.4 mm -111.39 127.91 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.759 0.314 . . . . 0.0 111.244 -173.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -62.48 132.03 51.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.988 -176.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.467 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -60.13 -28.48 67.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.113 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.7 -5.15 59.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.8 t -74.79 120.06 79.75 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.675 0.75 . . . . 0.0 110.917 -174.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.425 ' HD2' HG21 ' A' ' 2' ' ' ILE . 92.0 Cg_endo -70.4 -7.1 20.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.637 2.225 . . . . 0.0 112.389 164.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -101.11 14.93 30.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 -171.022 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -51.87 -40.18 60.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.898 -169.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.3 -52.4 58.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 -172.018 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.4 pp -80.51 -33.65 36.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.004 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.62 -47.43 69.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.018 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -61.48 -41.75 97.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.854 173.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.8 tt0 -61.38 -47.32 86.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 17.9 m-30 -68.4 -36.56 79.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.813 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.52 ' HA ' HD22 ' A' ' 284' ' ' LEU . 5.8 tt -59.37 -52.4 65.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.873 -177.005 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -77.91 -33.5 51.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 -176.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.584 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 61.7 m-80 -99.97 -13.19 19.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.845 -163.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.762 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 59.2 m-85 -127.36 -50.49 1.41 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.52 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.5 OUTLIER -63.85 -39.36 94.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -170.523 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 1.014 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.7 pp -124.38 38.2 4.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 -175.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.477 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 5.9 t -115.66 162.73 16.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.088 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.423 ' HA ' HD11 ' A' ' 290' ' ' LEU . 28.4 t70 -48.51 -34.12 10.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -169.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -80.24 -41.09 25.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.859 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.762 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.77 -57.24 5.48 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.452 -170.224 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.549 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -66.42 -21.47 66.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.0 110.973 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.537 ' N ' HD12 ' A' ' 290' ' ' LEU . 83.9 tt0 -67.06 -46.49 74.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.825 171.135 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.67 -37.66 88.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.61 -46.33 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.086 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -65.81 -30.09 70.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.797 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.05 -27.8 67.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.95 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -87.41 -49.92 6.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.83 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 74.1 mmtt -138.6 139.15 23.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.57 0.7 . . . . 0.0 110.865 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 298' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 297' ' ' LYS . 80.1 Cg_exo -55.03 115.83 2.71 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.66 2.24 . . . . 0.0 112.381 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 299' ' ' LEU . 0.3 OUTLIER -84.41 -22.54 30.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 173.694 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 96.8 -59.71 1.22 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.516 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.659 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -167.53 160.23 12.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.814 0.34 . . . . 0.0 111.231 174.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.691 HG21 ' HB3' ' A' ' 307' ' ' TYR . 22.1 m -120.84 153.3 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.87 -9.58 58.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.061 173.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.549 ' CD2' HD21 ' A' ' 290' ' ' LEU . 44.0 tp -83.48 121.1 26.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.886 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.58 -38.61 75.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.86 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.7 t -64.46 -50.0 69.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.847 -169.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.691 ' HB3' HG21 ' A' ' 302' ' ' VAL . 13.6 t80 -77.26 -31.32 54.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.91 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.93 -39.15 93.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -58.67 -38.01 77.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -75.05 -38.78 61.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.979 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.659 HD13 ' HA ' ' A' ' 301' ' ' ALA . 80.3 mt -61.84 -34.25 75.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.98 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.38 -18.05 63.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.055 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.12 -19.56 66.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.934 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -93.14 121.43 65.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.6 0.715 . . . . 0.0 110.865 166.024 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -47.9 -26.65 7.56 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.66 2.24 . . . . 0.0 112.396 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -62.91 -34.88 78.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 -175.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.531 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.0 OUTLIER -81.5 -35.95 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.2 90.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.118 -170.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.92 -47.96 73.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.035 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 75.6 p -67.84 -27.16 66.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.086 -176.09 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.5 ttp -62.48 -34.96 77.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -62.31 -51.37 67.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.84 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.621 HD21 ' HB1' ' A' ' 112' ' ' ALA . 12.3 p-10 -80.06 -26.48 39.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.77 -177.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.41 -51.62 62.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.095 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -69.33 -29.77 67.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.88 -8.13 16.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.824 -168.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -91.39 -153.24 29.33 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.436 -168.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.0 144.83 37.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.856 0.36 . . . . 0.0 110.895 -172.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 36.0 mm -63.78 119.54 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.089 -172.426 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 60.2 ttm -62.54 135.93 95.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.517 0.675 . . . . 0.0 110.89 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.781 ' HG3' ' CE1' ' A' ' 169' ' ' PHE . 32.0 Cg_endo -67.89 126.21 14.26 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.678 2.252 . . . . 0.0 112.312 -177.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.467 ' HB3' ' H ' ' A' ' 65' ' ' ASP . 61.0 t30 -117.58 21.84 12.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.895 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 50.4 pt -79.78 153.53 75.51 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.677 0.751 . . . . 0.0 111.128 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -54.11 -30.97 62.94 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.717 2.278 . . . . 0.0 112.315 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 339' ' ' PHE . 99.4 mm-40 -67.03 -24.55 66.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.83 -173.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 88.4 mmm -64.96 -28.64 69.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.871 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.1 m -58.07 -39.91 79.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.767 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.07 -39.39 63.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 3.8 m-30 -63.17 -46.74 85.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -60.14 -37.71 80.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.901 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -69.63 -39.67 77.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.2 -43.01 83.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.104 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 339' ' ' PHE . 19.7 m -73.91 -33.17 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.133 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.454 ' O ' HG22 ' A' ' 347' ' ' VAL . 5.0 tmt_? -65.2 -38.68 91.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 86.1 m -58.53 -38.6 78.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.76 94.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.549 ' HA ' HD11 ' A' ' 192' ' ' LEU . 12.4 m -73.97 -35.51 42.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.084 -174.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 347' ' ' VAL . 1.4 mp -63.68 -47.01 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.221 173.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.02 -40.98 99.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.891 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.96 -45.94 47.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.11 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.01 -40.17 78.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.7 p -75.67 -10.11 59.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.32 18.67 68.43 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.375 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.13 -32.85 44.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 0.0 110.911 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -140.88 157.72 44.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.6 p -77.21 169.11 18.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.288 170.713 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.516 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.0 t -57.56 -43.07 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.14 172.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.65 -47.04 88.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -69.52 -55.3 10.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.5 -47.7 66.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.084 -172.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.589 ' HG ' ' HA ' ' A' ' 189' ' ' LYS . 1.6 tm? -65.08 -44.96 87.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -174.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.46 -53.71 38.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.949 -177.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.01 -47.07 66.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 -172.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.07 -43.92 81.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 -174.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.502 ' HB3' ' HB ' ' A' ' 183' ' ' VAL . 86.9 mm-40 -73.36 -32.98 64.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.933 -175.032 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 35.9 m -61.76 -28.23 69.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.172 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.88 -30.11 65.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 365' ' ' GLN . 74.5 mt -60.9 -37.7 77.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.233 174.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 43.4 p -98.01 -12.01 22.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.174 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 176.539 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.752 0.31 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.6 mt -108.96 138.16 37.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -121.37 136.13 55.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.83 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -54.32 134.92 45.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.843 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.24 9.4 67.32 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.475 -174.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 39.2 ttpt -160.07 129.97 5.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.363 . . . . 0.0 110.936 173.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.675 HD23 ' H ' ' A' ' 7' ' ' LEU . 1.1 pt? -136.24 152.77 51.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.93 -169.326 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 74.5 t -112.64 135.22 52.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.189 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.631 HD11 HG23 ' A' ' 35' ' ' VAL . 1.1 mp -118.64 132.69 67.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 177.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.799 ' HD1' ' HB3' ' A' ' 57' ' ' PRO . 78.7 m95 -104.45 125.77 50.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.929 164.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.518 HD12 ' HG ' ' A' ' 20' ' ' LEU . 10.4 tt -110.88 150.03 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.096 -166.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -58.99 150.09 25.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -173.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.83 -16.62 12.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.417 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -72.68 -15.21 61.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.917 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -139.98 137.85 35.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.899 167.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.97 -81.56 1.07 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.504 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -109.99 -37.13 5.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.932 0.396 . . . . 0.0 110.946 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -66.9 -50.01 63.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.92 -151.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.754 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -54.67 -53.6 38.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.537 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.518 ' HG ' HD12 ' A' ' 11' ' ' ILE . 8.1 mt -55.01 -48.07 73.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.783 0.325 . . . . 0.0 110.926 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.73 -34.77 12.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.11 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -78.66 -60.13 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.848 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 24' ' ' GLY . 26.4 m -74.55 -42.1 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 -169.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.465 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -64.99 -40.61 97.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -59.04 -29.95 67.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.908 0.385 . . . . 0.0 110.88 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -56.99 -33.08 66.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.026 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 2.5 m-30 -56.6 -47.76 78.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.895 177.278 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -70.36 -41.42 73.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.07 -34.85 79.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.846 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -92.63 -48.94 6.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.908 0.385 . . . . 0.0 110.853 -170.476 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.1 p -116.56 -0.72 12.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.213 -169.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.04 11.72 85.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.429 167.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.959 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.02 133.86 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.868 0.366 . . . . 0.0 111.11 -179.706 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 73.4 mmtt -74.13 140.62 45.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.844 -171.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.631 HG23 HD11 ' A' ' 9' ' ' ILE . 13.1 p -122.72 128.1 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.065 -174.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.621 ' O ' HD12 ' A' ' 9' ' ' ILE . 96.9 m -111.94 129.08 56.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.093 -174.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 20' ' ' LEU . 91.6 t -104.48 131.51 53.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.125 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -117.18 155.02 30.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.0 t-80 -85.07 138.96 36.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.683 0.754 . . . . 0.0 110.837 -170.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 86.6 Cg_exo -54.98 -29.39 64.34 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.627 2.218 . . . . 0.0 112.303 -175.361 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -48.28 -51.34 26.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 -172.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.03 -0.85 57.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.885 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.2 tt -47.06 -53.12 13.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -68.69 -38.45 80.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.7 -41.35 96.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 -171.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -81.66 -21.43 38.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.528 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 65.9 t80 -48.6 -50.71 57.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.624 0.726 . . . . 0.0 110.84 -167.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 66.3 Cg_endo -80.06 -28.48 3.13 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.596 2.198 . . . . 0.0 112.352 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -74.43 -39.16 62.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 -171.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.428 HG11 ' HD3' ' A' ' 57' ' ' PRO . 33.5 m -67.88 -27.97 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.13 -177.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.575 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -68.29 -37.77 80.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.057 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.19 -32.11 72.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.076 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.8 p -92.89 -14.92 27.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.56 10.79 79.95 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.407 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -142.79 136.2 28.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.776 0.322 . . . . 0.0 110.766 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.95 -114.95 0.52 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.514 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.799 ' HB3' ' HD1' ' A' ' 10' ' ' TRP . 61.2 Cg_endo -73.97 154.54 47.89 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.709 2.273 . . . . 0.0 112.285 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.67 -32.77 13.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 160.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.608 ' HB ' HG23 ' A' ' 9' ' ' ILE . 39.0 mt -127.63 137.77 56.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.229 -177.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 tp -131.38 126.84 59.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.193 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -88.97 141.6 28.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 167.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.579 ' CZ2' ' HB3' ' A' ' 67' ' ' PHE . 1.8 p90 -138.41 160.9 38.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.968 172.002 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.43 -82.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.164 -169.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.537 ' CD2' ' HA3' ' A' ' 260' ' ' GLY . 40.5 m170 -121.88 -71.07 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -170.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.95 -11.78 16.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.815 -164.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -56.78 -17.07 7.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -158.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.579 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . 27.9 p90 -61.77 -23.23 66.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.826 -173.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.55 -48.81 63.53 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.404 -174.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.43 -36.77 92.03 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.474 171.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 1.5 t80 -55.17 -51.23 67.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.897 0.38 . . . . 0.0 110.874 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.99 -41.91 40.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.119 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -59.19 -36.18 74.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.0 m -85.06 -7.69 59.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.28 31.73 58.95 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.575 HD22 ' HB1' ' A' ' 51' ' ' ALA . 52.1 mt -88.12 -9.62 52.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.812 0.339 . . . . 0.0 110.884 -167.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.538 HD11 ' HB ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -128.42 152.95 47.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -172.254 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -79.18 141.25 37.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.091 175.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -70.74 137.85 50.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 173.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.427 HD12 ' CZ ' ' A' ' 106' ' ' TYR . 39.3 pt -103.88 156.64 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.143 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.9 m -92.08 130.04 39.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.536 0.684 . . . . 0.0 111.088 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PRO . . . . . 0.412 ' HB3' HD12 ' A' ' 103' ' ' LEU . 50.0 Cg_endo -67.41 141.14 55.03 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.687 2.258 . . . . 0.0 112.328 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -110.14 118.75 37.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.94 -36.78 73.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.25 -45.17 92.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.178 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -75.64 -32.44 60.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.483 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.5 tt0 -51.51 -49.1 62.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -66.35 -32.89 74.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.799 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.02 -23.26 52.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 -172.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.96 -104.64 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.993 -169.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 t80 174.94 107.98 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.668 0.747 . . . . 0.0 111.036 -160.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.0 -32.17 30.0 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.725 2.283 . . . . 0.0 112.329 -177.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.99 -36.93 85.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.2 p -78.3 -31.52 48.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.579 ' HA ' HG22 ' A' ' 97' ' ' VAL . 86.2 m95 -63.16 -29.99 71.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 171.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -69.46 -32.15 70.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.792 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.73 -23.01 61.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.08 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 94' ' ' TRP . 19.8 m -110.7 17.98 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.134 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -107.57 132.93 52.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.817 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -126.2 119.22 26.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 174.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.2 t30 57.57 37.04 27.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.868 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.64 1.12 90.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.482 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -121.83 148.75 44.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.843 0.354 . . . . 0.0 110.852 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.564 HD22 HG23 ' A' ' 97' ' ' VAL . 16.8 mt -86.03 133.79 33.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -176.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.538 ' HB ' HD11 ' A' ' 76' ' ' LEU . 1.2 pp -114.84 -9.29 12.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.095 -172.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.55 ' HB3' ' HH2' ' A' ' 62' ' ' TRP . . . -169.44 173.4 6.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.183 -173.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 99.2 m-85 -115.88 140.17 25.86 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.671 0.748 . . . . 0.0 110.925 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 12.2 Cg_exo -70.82 127.85 14.29 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.705 2.27 . . . . 0.0 112.323 172.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.898 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -108.9 -39.93 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.117 177.074 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 262' ' ' LEU . . . -143.29 154.17 43.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.149 -171.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.2 t -116.15 127.28 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.204 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -110.62 125.23 53.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.452 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -146.36 141.05 26.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.9 mp -89.66 167.12 13.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.004 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.5 p -156.27 154.99 31.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.845 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.874 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -92.27 123.48 35.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 168.335 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.555 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.0 mp -109.94 131.56 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.177 -175.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -132.35 148.41 52.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 -173.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -91.06 113.97 26.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.909 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.11 -25.41 68.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -173.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -83.47 -22.15 32.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 -173.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 mp -81.23 -55.51 4.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.857 169.11 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.696 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -141.05 127.34 11.5 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.554 0.693 . . . . 0.0 110.888 173.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.18 -5.54 13.64 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.663 2.242 . . . . 0.0 112.365 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -149.27 102.43 3.32 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.621 0.725 . . . . 0.0 110.793 -175.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -72.01 156.92 55.49 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.769 2.312 . . . . 0.0 112.321 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.14 144.84 82.98 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.737 2.291 . . . . 0.0 112.247 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.02 -17.97 44.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.977 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 56.8 p -135.06 159.51 41.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.21 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.519 ' HA ' HD13 ' A' ' 132' ' ' ILE . 64.7 m95 -70.76 -28.35 64.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.039 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.99 -22.78 67.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.807 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -82.34 -21.96 35.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.791 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.638 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -56.76 -48.73 96.76 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.67 0.747 . . . . 0.0 111.2 -173.6 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 41.8 Cg_endo -69.07 -37.41 10.87 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.669 2.246 . . . . 0.0 112.332 -174.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.89 -60.74 2.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.081 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.272 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.23 -16.95 64.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -175.99 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.504 ' N ' HD13 ' A' ' 135' ' ' LEU . 34.5 t70 -57.79 -40.4 79.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.039 0.447 . . . . 0.0 110.866 168.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.25 -30.66 69.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -70.97 -47.69 57.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.812 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.9 pp -84.91 -14.47 47.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.618 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.8 tttt -60.87 -34.01 73.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.968 174.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.73 -24.05 67.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.085 175.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -95.12 4.35 53.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.877 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.02 32.13 56.96 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -110.22 170.72 7.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.932 173.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.9 t -124.14 138.73 54.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 168.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -65.4 -43.69 89.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 -170.236 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -143.11 127.87 18.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 63.5 tpp -107.55 132.58 53.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -153.57 158.44 41.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -172.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -90.11 -51.08 5.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.851 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.064 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.6 tm? 48.04 32.36 2.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.03 -167.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -101.2 -6.16 24.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.866 175.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.36 155.02 80.72 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.638 0.732 . . . . 0.0 110.939 -174.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.06 -25.95 77.9 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.743 2.295 . . . . 0.0 112.391 177.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -72.26 -27.48 62.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -80.01 -38.88 31.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.848 170.507 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.405 HG23 HG11 ' A' ' 347' ' ' VAL . 22.5 m -63.15 -45.66 90.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.07 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.591 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 46.2 t-105 -54.95 -54.55 48.66 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.609 0.719 . . . . 0.0 110.931 -169.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 22.1 Cg_endo -63.99 -19.92 67.15 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.634 2.222 . . . . 0.0 112.38 -173.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.706 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.7 tm? -82.77 -45.87 13.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.858 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.532 HG22 ' HA3' ' A' ' 166' ' ' GLY . 85.3 mt -75.3 -44.77 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.143 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.11 -23.65 61.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 -173.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -59.59 -35.95 75.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.104 -170.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 58.9 p30 -102.51 8.39 39.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.94 2.01 12.81 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.501 170.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.532 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -77.34 65.49 3.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.498 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -88.23 134.57 33.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.865 0.364 . . . . 0.0 111.035 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.6 2.1 17.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.135 -174.271 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.442 ' HA ' HG12 ' A' ' 181' ' ' VAL . 44.3 p90 -159.45 154.74 25.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 -175.632 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -93.67 123.13 36.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.847 160.367 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -114.95 120.58 40.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.987 175.116 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -151.93 130.13 11.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -173.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.04 41.41 31.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.955 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.21 17.81 79.67 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.536 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.32 138.5 50.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.853 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -99.24 144.98 27.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -126.39 110.0 12.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.832 174.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.7 pt -77.48 -15.73 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.105 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.95 -9.52 33.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -121.78 84.17 2.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.833 172.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 169' ' ' PHE . 27.6 m -112.75 160.44 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 -172.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -104.53 19.06 43.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.516 -174.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.3 m -102.6 -20.65 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 0.0 111.098 -175.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -87.61 21.71 2.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.788 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -117.13 175.01 5.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.81 -24.95 67.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.076 -175.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.99 -40.61 97.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.491 -173.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.594 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.86 -37.77 88.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 111.055 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.562 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -61.14 -38.5 86.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 174.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.08 89.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.078 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.491 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -66.52 -47.74 67.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.5 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.717 HD11 ' HA ' ' A' ' 347' ' ' VAL . 20.3 tp -66.67 -34.72 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.954 0.406 . . . . 0.0 110.926 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.545 ' OG1' HG21 ' A' ' 357' ' ' VAL . 91.7 m -64.84 -42.64 94.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.11 177.516 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 91.5 t80 -68.06 -47.75 67.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.699 HD23 ' C ' ' A' ' 195' ' ' LEU . 5.3 tt -50.83 -50.66 56.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.91 -174.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 35.0 m -64.38 -22.7 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.111 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.3 m-20 -62.45 -33.95 75.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.918 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.462 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.6 OUTLIER -81.66 -39.86 23.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.966 -173.368 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.424 ' H ' HG13 ' A' ' 199' ' ' ILE . 1.7 pp -72.05 -29.77 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.15 171.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.93 -36.82 83.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 171.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -83.65 4.03 30.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.952 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 66.23 39.9 4.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.835 170.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -75.73 -17.87 59.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -143.01 154.93 44.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.892 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -94.39 154.56 17.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.01 -26.85 68.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.151 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -95.03 0.42 54.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 97.1 m -66.17 128.82 37.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.153 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.401 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 19.7 t0 -122.0 173.6 7.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 173.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -62.77 -40.96 98.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.6 p -68.28 -37.37 80.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.862 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.401 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 79.9 mt -65.03 -42.22 94.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.081 174.428 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.1 93.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.078 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.26 -41.92 89.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.04 90.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.076 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.85 -39.11 93.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.129 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -63.68 -39.64 94.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.914 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -61.27 -33.19 73.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.3 -13.93 48.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.867 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.16 25.15 41.32 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.483 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -85.45 -22.16 28.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.952 0.406 . . . . 0.0 110.893 -175.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.9 t -129.57 139.95 51.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.566 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -65.05 -54.23 33.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.05 -174.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.656 ' HB3' HD21 ' A' ' 115' ' ' LEU . 67.8 mtm -134.42 153.2 52.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 -170.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 68.8 p -139.37 161.64 36.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.185 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 44.9 mm -108.94 126.21 65.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -154.75 175.05 14.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 -171.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -85.93 -159.98 33.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.411 -174.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.26 -23.52 33.0 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.679 2.253 . . . . 0.0 112.391 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -75.92 -24.88 55.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 48.05 50.08 16.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.153 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -59.98 -20.49 57.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 70.0 m -48.78 -50.1 35.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.865 174.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -85.02 179.33 7.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -172.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.2 mt -124.25 131.7 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.158 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -69.97 -39.62 75.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 -174.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 91.4 m -124.69 109.97 13.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.055 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 27.3 t -172.1 150.13 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.98 -26.83 67.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 173.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.22 134.31 30.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -90.95 132.02 36.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -127.29 147.65 50.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.846 176.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -129.6 156.81 21.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.489 170.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 316' ' ' ARG . 3.1 p -135.72 135.17 51.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.962 0.411 . . . . 0.0 111.086 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.6 t -154.62 150.95 28.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.2 m -61.04 164.75 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.17 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 2.5 mp -71.26 152.75 94.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.583 0.706 . . . . 0.0 110.95 -163.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.62 -176.44 3.22 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.28 . . . . 0.0 112.479 -171.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.2 m -86.02 143.84 27.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.196 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -129.85 111.78 12.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.957 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 54.99 36.84 27.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.53 0.78 84.05 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.462 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' GLN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 91.2 mm-40 -126.5 125.89 24.53 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 121.576 0.703 . . . . 0.0 110.862 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 77.3 Cg_exo -54.43 128.58 30.71 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.736 2.29 . . . . 0.0 112.338 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 82.4 p -84.32 0.41 49.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.024 0.44 . . . . 0.0 110.9 174.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -37.71 134.95 0.79 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.54 0.686 . . . . 0.0 110.825 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.452 ' HD3' HD13 ' A' ' 247' ' ' LEU . 30.3 Cg_endo -79.05 156.66 26.57 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.657 2.238 . . . . 0.0 112.385 -163.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 258' ' ' PHE . . . . . 0.552 ' HB2' ' SD ' ' A' ' 330' ' ' MET . 10.4 m-85 -75.46 167.19 22.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.885 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 42.6 t -114.49 132.77 62.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.181 -167.167 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.537 ' HA3' ' CD2' ' A' ' 64' ' ' HIS . . . -115.2 141.78 17.21 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.41 173.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 81.4 t -121.42 112.08 33.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.767 0.318 . . . . 0.0 111.122 -176.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -75.82 114.51 14.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -176.57 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.417 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . 19.1 m -131.62 154.11 49.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.777 -164.133 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.421 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -132.61 133.56 43.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.123 -176.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.01 171.24 16.3 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.459 -174.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.636 HG13 ' HB3' ' A' ' 277' ' ' LYS . 37.5 mm -113.31 124.99 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.246 -170.698 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -62.97 130.68 45.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 -176.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.479 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -59.26 -29.36 67.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.2 -177.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.03 -8.19 58.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.001 -172.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.4 t -67.39 123.56 86.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.58 0.705 . . . . 0.0 110.866 -172.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -69.71 -11.49 31.02 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.576 2.184 . . . . 0.0 112.408 168.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -103.92 14.1 31.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -51.82 -35.25 43.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 -167.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLU . . . . . 0.405 ' HA ' ' HE3' ' A' ' 277' ' ' LYS . 72.0 mm-40 -70.08 -49.4 51.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.006 -174.024 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.94 -30.33 39.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.901 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.83 -50.53 66.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.636 ' HB3' HG13 ' A' ' 266' ' ' ILE . 13.7 pttp -71.96 -34.07 68.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.915 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -63.39 -46.62 85.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 177.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -69.7 -36.33 75.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.884 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.437 ' HA ' HD22 ' A' ' 284' ' ' LEU . 5.9 tt -55.73 -51.32 67.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.922 -178.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -75.79 -26.35 57.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.816 -177.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -100.28 -13.25 18.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.78 -166.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.846 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 63.0 m-85 -120.15 -59.77 1.75 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.813 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 280' ' ' LEU . 1.6 mp -62.37 -34.23 76.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.951 -161.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.898 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.3 pp -124.77 37.52 4.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.475 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 66.7 p -118.59 160.6 21.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.176 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.569 ' HA ' HD11 ' A' ' 290' ' ' LEU . 42.2 p-10 -51.12 -28.51 10.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.778 -167.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -78.93 -45.0 21.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 175.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.846 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.27 -56.8 6.0 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.497 -169.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.59 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.5 -21.63 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.766 0.317 . . . . 0.0 110.976 -178.884 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.581 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.1 tt0 -69.34 -49.31 56.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 172.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.65 96.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.077 -172.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.754 HG23 ' HA3' ' A' ' 19' ' ' GLY . 1.5 p -79.78 -29.89 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.417 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 27.7 t30 -63.9 -29.79 70.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 174.262 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.58 -20.76 66.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.935 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -82.17 -39.96 22.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.917 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -161.89 138.37 6.09 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.424 0.631 . . . . 0.0 110.935 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -45.82 115.94 1.23 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.685 2.256 . . . . 0.0 112.448 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.417 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 49.4 mt -93.49 -12.15 30.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 98.33 -61.7 0.89 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.528 171.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.607 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -167.1 159.55 13.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.844 0.354 . . . . 0.0 111.141 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 19.3 m -124.95 159.85 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.212 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.81 -14.44 61.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 172.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.59 ' CD2' HD21 ' A' ' 290' ' ' LEU . 49.9 tp -83.74 121.01 26.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -172.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -59.4 -33.79 71.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.944 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.9 m -61.34 -47.53 85.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.775 -172.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.512 ' HB3' HG21 ' A' ' 302' ' ' VAL . 4.5 t80 -78.78 -32.69 46.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.933 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.27 -40.89 62.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.849 173.618 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -55.14 -40.19 70.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.877 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -78.12 -37.83 45.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 177.257 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.607 HD13 ' HA ' ' A' ' 301' ' ' ALA . 83.4 mt -63.68 -33.03 74.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.58 -20.26 59.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.05 -20.22 66.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -93.09 121.28 65.94 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.65 0.738 . . . . 0.0 110.899 168.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.97 -25.13 11.81 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 0.0 112.373 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.451 ' HA ' HG11 ' A' ' 244' ' ' VAL . 78.3 mtt85 -62.25 -29.87 70.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.935 -175.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.565 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.2 mp -75.3 -28.67 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.81 87.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.031 -171.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.26 -45.32 73.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.145 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 67.0 p -64.47 -29.61 70.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.151 -173.43 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 61.9 tpp -68.63 -35.66 77.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.791 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -65.03 -47.75 76.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -173.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 327' ' ' GLY . 8.2 p-10 -79.94 -24.78 40.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.39 -42.79 92.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.93 -38.84 86.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.925 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.47 -4.14 15.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.818 -166.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.87 -162.7 36.99 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.526 -166.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -150.31 147.11 27.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 -171.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 36.8 mm -59.85 123.14 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.115 -170.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 258' ' ' PHE . 74.4 mmm -42.0 134.42 2.38 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 121.554 0.692 . . . . 0.0 110.917 178.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.444 ' HG3' ' CE2' ' A' ' 158' ' ' TRP . 74.5 Cg_endo -75.22 80.64 2.43 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.666 2.244 . . . . 0.0 112.294 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 33.3 m120 -111.07 22.59 15.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 46.3 pt -74.77 159.71 82.52 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 121.642 0.734 . . . . 0.0 111.114 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -54.44 -35.11 84.0 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.64 2.226 . . . . 0.0 112.292 -174.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -67.21 -28.05 67.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.989 -177.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 80.8 mmm -75.43 -18.36 59.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.812 -171.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.4 m -58.4 -42.17 86.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.774 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.0 -39.45 63.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.519 ' O ' HG13 ' A' ' 343' ' ' VAL . 4.2 m-30 -67.3 -45.42 76.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -174.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.461 ' HA ' HG22 ' A' ' 343' ' ' VAL . 6.9 m0 -59.7 -37.32 78.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.955 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -63.6 -45.18 91.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.23 79.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.106 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 339' ' ' PHE . 18.4 m -73.49 -32.46 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -175.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.442 ' O ' HG22 ' A' ' 347' ' ' VAL . 5.1 tmt_? -66.05 -39.04 89.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 175.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.2 m -58.74 -36.96 75.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 173.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.85 91.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -174.043 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.717 ' HA ' HD11 ' A' ' 192' ' ' LEU . 8.5 m -73.01 -34.79 46.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.211 -175.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.457 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -64.22 -46.78 92.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.09 174.025 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -67.9 -37.18 81.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.815 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.86 -44.93 65.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.18 85.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.062 -176.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.6 p -77.7 -10.16 59.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.09 17.07 73.01 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.45 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.02 -31.12 50.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.74 0.305 . . . . 0.0 110.881 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 355' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 360' ' ' ALA . 77.8 mt-30 -139.98 155.07 47.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.901 176.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 57.2 p -78.81 166.04 22.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 169.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.545 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.8 t -56.12 -41.95 70.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.116 174.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -60.9 -48.13 83.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.854 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -69.58 -54.96 11.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.947 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 360' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 355' ' ' GLN . . . -68.61 -47.75 65.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.115 -172.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.594 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.5 tm? -65.46 -44.63 86.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.964 -174.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.45 -53.12 53.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.986 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -67.5 -45.89 74.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.54 85.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.565 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 78.4 mm-40 -76.02 -25.73 55.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.001 -176.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 53.5 m -62.39 -35.08 78.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.086 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -59.94 -30.23 68.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.893 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 71.4 mt -60.46 -37.6 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.088 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 60.9 p -94.56 -15.0 24.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.168 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 179.252 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.726 0.298 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.421 HG21 ' HD2' ' A' ' 271' ' ' PRO . 49.4 mt -100.47 141.26 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.144 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -139.13 144.86 38.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.8 133.74 37.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.79 10.6 64.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.46 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.2 tttt -163.78 130.79 3.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.91 176.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.615 ' CD2' HD11 ' A' ' 33' ' ' ILE . 1.4 pt? -141.58 151.89 43.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.974 -169.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.515 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 80.4 t -110.48 135.97 47.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.091 -176.327 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.656 HD11 HG13 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -120.03 134.08 64.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.159 176.626 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.784 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 72.4 m95 -103.75 128.05 51.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 163.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.441 HD12 ' HG ' ' A' ' 20' ' ' LEU . 13.8 tt -108.52 149.95 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.193 -165.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.67 153.16 13.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.795 -173.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.17 -22.45 29.22 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.509 -177.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -72.42 -17.11 61.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.359 . . . . 0.0 110.924 -169.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -140.07 131.87 27.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 168.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.93 -71.96 1.23 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.544 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -109.08 -40.15 5.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -66.9 -52.44 43.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.866 -149.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.411 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -52.96 -51.61 44.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.425 -176.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.468 ' HB3' HG22 ' A' ' 37' ' ' VAL . 3.9 mt -54.98 -57.35 12.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.775 0.321 . . . . 0.0 110.919 173.139 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.85 -37.4 13.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 -176.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.56 -55.69 9.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.3 m -73.79 -35.27 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.187 -173.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.566 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -66.66 -46.67 73.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.482 176.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -53.42 -36.64 61.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 110.898 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -56.22 -42.8 77.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.904 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -64.0 -43.49 95.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.833 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 98.8 mt-10 -61.23 -37.64 83.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.944 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.77 -41.49 68.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.886 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -94.46 -46.96 6.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.944 -164.441 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.7 p -108.57 -7.87 15.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.111 -172.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.81 8.3 87.84 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.436 168.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.035 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.64 134.69 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.807 0.337 . . . . 0.0 111.168 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.1 mttt -73.34 135.69 44.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.959 -170.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.656 HG13 HD11 ' A' ' 9' ' ' ILE . 96.6 t -115.74 126.34 73.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.989 0.423 . . . . 0.0 111.075 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.555 ' O ' HD12 ' A' ' 9' ' ' ILE . 96.7 m -108.47 127.9 54.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.126 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 20' ' ' LEU . 94.2 t -103.1 130.07 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -119.38 152.01 37.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.835 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 64.9 t-80 -90.72 141.66 27.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.612 0.72 . . . . 0.0 110.902 -167.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.462 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 86.2 Cg_exo -55.11 -26.66 51.72 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.676 2.25 . . . . 0.0 112.386 -175.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -49.72 -55.72 12.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.96 -1.74 58.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.853 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 8.8 tt -46.9 -53.33 12.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.901 -175.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -67.81 -38.31 83.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.869 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.21 -42.21 89.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.843 -171.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -83.63 -21.56 32.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.523 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 62.1 t80 -47.11 -50.27 47.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.669 0.747 . . . . 0.0 110.832 -169.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 69.7 Cg_endo -79.89 -28.82 3.05 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.25 . . . . 0.0 112.347 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -73.86 -40.01 63.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -172.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.435 HG11 ' HD3' ' A' ' 57' ' ' PRO . 33.7 m -67.91 -28.12 40.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.197 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.664 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -70.38 -38.06 74.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.055 175.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.57 -33.86 75.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.164 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 p -90.11 -15.97 30.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.224 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.44 9.15 77.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.395 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -139.96 132.25 28.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 110.815 177.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.02 -114.95 0.52 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.51 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.784 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 61.2 Cg_endo -74.75 149.06 37.39 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.677 2.251 . . . . 0.0 112.282 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -86.97 -32.89 19.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 158.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.595 ' HB ' HG23 ' A' ' 9' ' ' ILE . 40.7 mt -128.19 137.77 56.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.116 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 tp -131.78 126.1 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -89.79 139.65 30.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 169.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.514 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 35.6 p90 -142.61 165.04 28.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.966 171.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.9 -88.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.034 -163.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.484 ' NE2' ' HA3' ' A' ' 260' ' ' GLY . 27.4 m170 -111.65 -75.72 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.861 -174.671 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -103.69 -3.89 24.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 -161.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -56.52 -16.89 6.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 -169.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.502 ' HB2' HD13 ' A' ' 104' ' ' ILE . 37.6 p90 -57.42 -28.52 63.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -177.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.41 -50.6 63.55 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.493 -173.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.12 -38.06 94.86 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.56 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 1.6 t80 -57.22 -48.22 79.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 0.0 110.93 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.37 -43.79 31.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.053 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -56.58 -38.85 72.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.9 -175.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.412 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 60.3 m -83.72 -6.75 59.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.878 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.46 30.52 60.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.452 173.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.664 HD22 ' HB1' ' A' ' 51' ' ' ALA . 52.8 mt -88.01 -9.74 52.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.905 0.384 . . . . 0.0 110.914 -167.472 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.486 ' HA ' ' H ' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -130.15 153.16 48.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -172.891 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.83 144.93 31.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.081 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.28 139.22 54.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 175.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.6 pt -105.05 153.92 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.067 -173.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.5 m -108.66 125.15 32.39 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.577 0.704 . . . . 0.0 111.104 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.65 156.0 53.89 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.631 2.22 . . . . 0.0 112.328 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -105.96 122.51 46.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 175.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.23 -35.02 48.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.807 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.05 -37.92 89.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.098 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -88.29 -25.47 22.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.4 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 66.5 tt0 -54.9 -45.27 74.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -68.11 -23.81 64.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.831 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.55 -19.63 22.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.976 -167.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.597 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -99.67 -32.44 11.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.956 -168.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.597 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 11.7 m-30 92.42 144.45 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.638 0.733 . . . . 0.0 110.947 175.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.32 -40.0 87.58 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 0.0 112.406 -174.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -71.34 -23.17 61.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.949 -171.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.4 p -80.17 -37.67 32.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.231 173.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.525 ' HA ' HG22 ' A' ' 97' ' ' VAL . 55.7 m95 -65.03 -29.21 70.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.996 171.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -71.13 -34.62 71.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 177.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.14 -24.77 63.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.566 HG23 HD22 ' A' ' 103' ' ' LEU . 18.4 m -106.96 15.64 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.164 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -101.34 131.62 47.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -130.94 116.03 17.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 174.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 t30 58.65 35.95 24.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.77 0.26 89.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.511 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -118.17 148.07 42.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 110.818 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.566 HD22 HG23 ' A' ' 97' ' ' VAL . 32.6 mt -88.74 134.42 33.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.502 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -125.81 3.42 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.033 -169.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.514 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -163.7 162.71 24.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.184 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.497 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 94.0 m-85 -111.12 138.13 21.14 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.563 0.697 . . . . 0.0 110.941 173.176 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 15.1 Cg_exo -68.09 121.35 8.34 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.654 2.236 . . . . 0.0 112.362 170.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.044 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp -104.72 -40.02 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 173.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -145.72 154.86 42.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.064 -167.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.7 t -114.95 125.57 72.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.177 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -104.02 124.48 49.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.949 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.541 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -149.07 141.41 24.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.147 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.8 mp -90.91 168.65 11.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.7 p -156.67 154.74 30.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.864 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -93.68 124.45 37.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 168.441 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.549 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.1 mp -110.15 131.46 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.067 -175.726 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -131.31 145.28 51.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -94.49 114.37 26.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.825 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.426 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.7 mttt -66.03 -19.42 65.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.847 -173.354 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -84.67 -25.35 28.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.831 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.0 mp -82.17 -52.55 6.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.549 ' H ' HD23 ' A' ' 122' ' ' LEU . 2.0 pt? -140.03 128.55 13.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.621 0.724 . . . . 0.0 110.878 173.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -77.8 -11.97 16.59 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.709 2.272 . . . . 0.0 112.349 -173.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -144.46 102.84 4.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.6 0.714 . . . . 0.0 110.895 -175.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -71.27 153.84 61.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.618 2.212 . . . . 0.0 112.364 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.07 143.02 70.31 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.654 2.236 . . . . 0.0 112.314 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.0 -18.73 42.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.8 p -135.05 159.66 40.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.178 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.419 ' HA ' HD13 ' A' ' 132' ' ' ILE . 79.9 m95 -69.77 -28.14 65.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.994 177.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.68 -22.32 66.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.817 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -82.26 -24.63 34.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.869 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.475 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -57.15 -46.95 99.8 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.564 0.697 . . . . 0.0 111.243 -171.073 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 84.0 Cg_exo -51.92 -49.25 17.91 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.613 2.209 . . . . 0.0 112.457 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.76 -59.08 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 -174.269 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.131 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -70.09 -16.15 63.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -172.02 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.528 ' N ' HD13 ' A' ' 135' ' ' LEU . 32.2 t70 -61.32 -38.61 87.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.879 168.504 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.76 -30.5 71.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.05 -48.01 47.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -177.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.645 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.4 pp -84.96 -13.24 51.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.645 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.2 tttt -57.99 -34.46 70.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 170.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.48 -24.83 67.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.078 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -94.97 3.67 54.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.912 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.27 30.74 56.52 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.439 177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -109.68 171.19 7.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.914 0.387 . . . . 0.0 110.824 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.6 t -124.49 140.13 53.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 168.366 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -68.09 -43.47 78.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.09 -170.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -143.21 127.36 17.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 57.5 ttm -110.49 132.75 53.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -152.9 158.27 41.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.896 -173.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -84.87 -59.15 2.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.972 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.143 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.1 tm? 48.27 30.49 2.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 -163.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -103.06 -6.8 21.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.99 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.7 152.36 79.64 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.656 0.741 . . . . 0.0 110.921 -175.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.446 ' HB3' ' HB3' ' A' ' 340' ' ' TRP . 53.9 Cg_exo -56.48 -32.21 88.61 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.694 2.262 . . . . 0.0 112.317 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -70.6 -27.47 64.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -79.67 -41.18 27.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.823 171.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.455 HG23 HG11 ' A' ' 347' ' ' VAL . 15.7 m -61.64 -49.58 75.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.121 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.567 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 17.4 t-105 -59.56 -48.65 95.1 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.471 0.653 . . . . 0.0 110.903 -161.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.567 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 94.5 Cg_exo -51.26 -44.78 40.96 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.812 2.341 . . . . 0.0 112.329 -176.6 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.709 HD23 ' O ' ' A' ' 160' ' ' LEU . 6.7 tt -72.16 -39.33 68.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -171.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.43 -41.59 73.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.149 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.15 -23.91 59.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.068 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.47 -35.24 71.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.188 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -103.58 10.05 37.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.973 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.88 4.7 22.62 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 169.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.38 67.87 3.02 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.46 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -89.86 133.15 34.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.858 0.361 . . . . 0.0 110.978 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.45 10.18 7.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.08 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -152.21 154.48 35.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -99.75 123.37 43.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 157.042 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -112.42 121.76 45.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.959 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -152.64 130.07 11.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -174.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 54.89 43.67 29.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 174.373 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.14 16.77 78.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.572 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.86 138.73 49.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.773 0.321 . . . . 0.0 110.862 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.87 144.25 27.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 170.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -125.51 112.42 16.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.562 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.2 pp -79.53 -12.02 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -177.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.96 -12.08 22.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -119.43 87.85 2.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.866 169.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.7 m -115.88 161.08 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -171.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.02 25.47 25.17 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.464 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.482 HG21 HD12 ' A' ' 368' ' ' ILE . 3.4 m -109.44 -19.01 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.838 0.351 . . . . 0.0 111.032 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -87.29 19.88 3.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -177.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -122.19 -170.06 2.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.019 -178.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.36 -29.55 70.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 -172.541 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.64 -42.99 95.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.529 -167.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.6 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.99 -37.23 86.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.988 0.423 . . . . 0.0 111.107 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.555 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -62.3 -38.25 88.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.825 175.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.9 -37.99 89.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.138 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.09 -46.3 81.44 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.521 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.701 HD11 ' HA ' ' A' ' 347' ' ' VAL . 19.7 tp -68.63 -34.23 75.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.87 0.367 . . . . 0.0 110.826 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.482 ' OG1' HG21 ' A' ' 357' ' ' VAL . 90.7 m -64.3 -42.77 96.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.197 176.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 74.8 t80 -68.43 -47.0 68.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.841 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.616 HD11 HD21 ' A' ' 151' ' ' LEU . 7.3 tt -50.45 -51.47 46.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 -174.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.95 -23.06 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.126 -174.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.3 m-20 -62.14 -33.39 74.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.946 -177.496 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.442 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.8 OUTLIER -81.49 -39.99 23.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.847 -173.883 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.414 ' H ' HG13 ' A' ' 199' ' ' ILE . 1.8 pp -73.53 -28.81 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.175 171.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.54 -37.61 80.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -79.22 -0.32 31.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 65.3 40.72 4.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 169.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -76.06 -16.11 59.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.782 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -144.71 157.99 43.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.873 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -95.44 152.01 18.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.871 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.02 -26.26 68.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -94.96 1.79 55.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.7 m -66.31 128.34 35.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -121.57 171.38 8.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -66.05 -36.85 84.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.029 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 97.2 p -68.76 -37.33 79.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.852 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.03 -41.0 90.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.052 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.99 -38.29 90.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.004 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -65.26 -43.52 91.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.927 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.37 95.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.132 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.66 -41.59 98.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.203 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -64.07 -39.56 94.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.939 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -63.97 -33.63 76.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.895 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -85.08 -17.38 37.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.969 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.66 24.44 46.13 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.545 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.39 -22.45 28.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 110.895 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.8 t -128.3 137.42 51.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.187 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.478 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -64.07 -52.14 60.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.128 -175.39 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.557 ' HB3' HD21 ' A' ' 115' ' ' LEU . 61.8 mtm -135.82 155.1 50.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.765 -172.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 65.3 p -139.64 162.21 35.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.239 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.7 mm -110.41 126.92 67.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.136 174.494 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -153.0 174.68 13.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.913 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -87.14 -156.27 29.25 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.471 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.3 -21.94 26.02 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.645 2.23 . . . . 0.0 112.341 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' TRP . . . . . 0.643 ' HD1' ' O ' ' A' ' 230' ' ' TRP . 4.9 t90 -67.37 -30.01 69.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 48.74 44.96 21.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -65.07 -20.82 66.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -173.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 67.6 m -47.75 -41.1 22.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.913 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 49.8 p30 -85.02 -178.86 6.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.881 -171.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 237' ' ' THR . 77.7 mt -117.7 120.27 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.228 -168.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 55.9 p30 -89.52 -2.62 58.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 -175.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' THR . . . . . 0.452 ' H ' HG22 ' A' ' 235' ' ' ILE . 24.1 m -136.83 74.95 1.51 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.205 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 35.9 t -174.72 162.67 3.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -96.33 -0.43 49.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.3 m -59.91 159.99 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.102 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -104.28 128.73 52.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 -176.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.426 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 37.8 p90 -148.13 154.25 39.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.27 160.73 24.79 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.444 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' A' ' 316' ' ' ARG . 2.8 p -134.52 135.13 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.967 0.413 . . . . 0.0 111.099 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.3 t -154.13 149.88 27.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.136 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.5 m -60.54 165.57 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.09 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 1.4 mp -66.16 152.29 94.23 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.521 0.676 . . . . 0.0 111.047 -164.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -75.78 -176.41 2.99 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.747 2.298 . . . . 0.0 112.358 -173.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 94.9 m -86.9 145.43 26.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.07 -171.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -130.99 111.4 12.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 54.85 35.3 23.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.927 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.94 2.62 80.86 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -126.59 126.2 24.52 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.566 0.698 . . . . 0.0 110.844 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.01 134.98 66.74 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.654 2.236 . . . . 0.0 112.306 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 256' ' ' LYS . 73.1 m -82.52 -1.48 50.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.046 0.451 . . . . 0.0 110.844 174.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 255' ' ' SER . 90.9 mttt -37.28 130.0 0.8 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.605 0.717 . . . . 0.0 110.881 -178.113 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -78.16 163.17 28.13 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.632 2.221 . . . . 0.0 112.333 -163.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -74.52 163.97 27.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.842 -175.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 47.7 t -111.45 127.49 68.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.181 -168.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.484 ' HA3' ' NE2' ' A' ' 64' ' ' HIS . . . -112.85 141.49 16.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.426 174.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 89.2 t -124.7 116.98 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.746 0.308 . . . . 0.0 111.183 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.33 119.97 11.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.881 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.7 m -126.18 131.1 52.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.785 -167.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.58 139.07 51.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.093 -175.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.67 170.13 21.21 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.432 -169.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.696 HG13 ' HG2' ' A' ' 277' ' ' LYS . 24.7 mm -111.23 125.03 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 -174.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -63.14 130.79 46.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.486 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -58.17 -28.56 64.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.123 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.17 -7.0 58.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.019 -173.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 22.3 t -67.31 119.04 62.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.649 0.738 . . . . 0.0 110.915 -172.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.421 ' HD2' HG21 ' A' ' 2' ' ' ILE . 83.8 Cg_endo -71.26 -10.47 27.23 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.587 2.192 . . . . 0.0 112.327 168.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -103.4 12.88 34.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.824 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -49.33 -35.89 19.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -167.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -68.49 -47.52 66.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.969 -171.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.3 pp -81.47 -27.47 34.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.24 -46.89 75.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.054 173.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.696 ' HG2' HG13 ' A' ' 266' ' ' ILE . 50.3 mtmt -58.08 -41.73 84.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.902 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 95.6 mt-10 -69.87 -40.66 75.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.898 -177.238 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 15.9 m-30 -67.63 -39.5 84.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.529 ' HA ' HD22 ' A' ' 284' ' ' LEU . 4.0 tt -65.29 -53.26 46.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.977 -172.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.431 ' HA ' HD21 ' A' ' 285' ' ' LEU . 40.3 tt0 -75.19 -35.6 61.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -175.646 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 82.8 m-20 -103.57 -12.77 16.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.846 -160.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.644 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 62.3 m-85 -128.55 -48.6 1.28 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -177.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.529 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.7 OUTLIER -64.39 -36.56 84.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.98 -174.061 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 1.044 ' HB3' HG13 ' A' ' 108' ' ' ILE . 2.4 pp -124.71 38.27 4.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -175.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.455 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 6.6 t -114.25 163.65 14.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 286' ' ' THR . 16.4 p-10 -40.15 -43.88 1.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -175.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -74.85 -41.42 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.893 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.644 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.75 -53.9 7.84 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.516 -169.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.553 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -72.63 -20.1 61.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.725 0.298 . . . . 0.0 110.9 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.503 ' N ' HD12 ' A' ' 290' ' ' LEU . 86.5 tt0 -67.16 -45.56 76.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.813 169.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.93 -38.77 92.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.071 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.411 HG13 ' HA3' ' A' ' 19' ' ' GLY . 59.9 t -75.18 -46.8 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.116 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -64.97 -28.89 69.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.62 -25.95 68.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.826 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -82.23 -48.14 11.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.935 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.404 ' O ' HD13 ' A' ' 299' ' ' LEU . 85.7 tttt -151.03 138.94 12.49 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.511 0.672 . . . . 0.0 110.942 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -50.66 116.76 2.76 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.769 2.312 . . . . 0.0 112.363 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 299' ' ' LEU . 0.2 OUTLIER -85.98 -19.99 29.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.005 174.275 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 98.49 -57.7 0.99 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.442 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.608 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -168.19 155.33 7.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.787 0.327 . . . . 0.0 111.165 175.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.805 HG21 ' HB3' ' A' ' 307' ' ' TYR . 18.4 m -115.89 154.58 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.03 -15.62 61.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.103 173.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.553 ' CD2' HD21 ' A' ' 290' ' ' LEU . 39.9 tp -80.92 121.93 26.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.936 -174.116 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -53.91 -41.88 68.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.935 -177.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 48.3 t -62.99 -49.98 72.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -169.169 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.805 ' HB3' HG21 ' A' ' 302' ' ' VAL . 10.9 t80 -76.5 -30.71 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.987 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -60.73 -40.67 93.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 176.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.33 -36.94 76.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.65 -39.33 57.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 176.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.608 HD13 ' HA ' ' A' ' 301' ' ' ALA . 76.7 mt -61.19 -34.57 75.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.11 -19.12 61.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 -176.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -64.89 -21.12 66.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.005 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -93.17 121.86 64.57 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.663 0.744 . . . . 0.0 110.916 167.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.29 -25.41 9.84 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.776 2.318 . . . . 0.0 112.35 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' ARG . . . . . 0.405 ' HA ' HG11 ' A' ' 244' ' ' VAL . 82.7 mtt85 -60.91 -33.38 73.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -176.188 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.586 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.1 mp -81.19 -26.98 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.088 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.83 -40.41 79.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.07 -172.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.9 81.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.088 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 58.1 p -64.18 -29.55 70.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 -173.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.6 mtp -67.92 -34.87 77.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -65.64 -47.07 76.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.842 -172.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.404 ' O ' ' N ' ' A' ' 327' ' ' GLY . 8.7 p-10 -80.0 -25.69 40.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.797 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.44 -49.18 74.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.103 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -70.72 -37.18 73.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.89 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -105.44 -7.55 18.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 -168.107 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -90.94 -159.92 36.09 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.481 -172.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -139.9 147.78 41.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.776 0.322 . . . . 0.0 111.03 -175.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 40.7 mm -64.74 123.2 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.136 -171.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 50.2 tpp -46.58 132.3 8.12 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.565 0.697 . . . . 0.0 110.898 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.551 ' HG3' ' CZ2' ' A' ' 158' ' ' TRP . 79.6 Cg_endo -72.01 68.6 3.17 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.763 2.309 . . . . 0.0 112.359 173.048 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -97.55 25.05 6.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -172.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 47.7 pt -77.1 160.7 75.46 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.719 . . . . 0.0 111.203 -175.947 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -55.59 -38.22 94.39 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.718 2.279 . . . . 0.0 112.234 -173.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -68.66 -28.14 66.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.889 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.435 ' HG3' ' HB2' ' A' ' 331' ' ' PRO . 73.9 mmm -80.07 -17.5 52.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -172.299 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.6 m -61.94 -40.97 97.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.825 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.62 -37.05 60.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.549 ' O ' HG13 ' A' ' 343' ' ' VAL . 3.6 m-30 -65.12 -41.27 95.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.812 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 154' ' ' PRO . 12.2 m0 -60.03 -35.66 75.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 176.06 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -68.06 -41.85 81.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.25 -44.1 84.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.004 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 339' ' ' PHE . 16.9 m -74.07 -31.03 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 -176.094 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 347' ' ' VAL . 4.9 tmt_? -65.6 -39.65 91.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 175.027 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 87.4 m -58.72 -35.39 72.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 174.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.78 -43.63 95.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 -175.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.701 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.0 m -74.17 -34.13 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.169 -174.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.439 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -63.34 -47.1 93.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 174.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -64.85 -39.51 93.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.26 -44.42 62.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.114 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.33 -39.9 77.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.086 -175.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.2 p -75.69 -11.09 59.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.838 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.21 16.56 74.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.463 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.21 -32.45 44.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.318 . . . . 0.0 110.883 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -138.78 155.35 48.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.1 p -76.74 171.43 14.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 170.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.482 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.1 t -57.51 -43.22 82.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.124 171.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -61.44 -45.71 93.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.863 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -69.64 -52.41 26.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -72.3 -48.25 43.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.121 -173.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.6 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.4 tm? -65.59 -45.02 84.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -173.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.82 -53.57 48.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.965 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -68.09 -46.03 72.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -173.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.71 -42.31 91.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 -174.981 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 79.0 mm-40 -76.81 -27.93 55.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.97 -176.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 53.3 m -61.73 -34.99 76.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.225 171.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -58.77 -30.09 67.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.482 HD12 HG21 ' A' ' 183' ' ' VAL . 70.3 mt -60.85 -38.14 78.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.151 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.0 p -94.64 -14.98 24.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.154 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.831 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.773 0.32 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.431 HG21 ' HD2' ' A' ' 271' ' ' PRO . 74.8 mt -100.46 131.81 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 177.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -148.15 139.81 23.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -51.93 136.47 28.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.792 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.74 2.69 62.88 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.529 -173.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 64.3 pttt -165.03 146.96 7.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 0.0 110.954 171.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.543 HD22 HD11 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -147.68 160.01 43.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -177.231 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.409 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 71.2 t -111.98 134.05 55.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.081 -177.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.729 HG23 ' HB ' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -120.02 131.56 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.082 179.094 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.716 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 65.2 m95 -107.51 128.25 54.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.952 168.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.452 ' HB ' HD22 ' A' ' 20' ' ' LEU . 7.2 tt -109.59 149.86 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.076 -166.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -58.1 155.35 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -173.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.35 -22.76 24.06 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.378 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -73.78 -14.12 61.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.877 0.37 . . . . 0.0 110.906 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HD2' ' HD3' ' A' ' 297' ' ' LYS . 24.0 mmmt -134.3 137.25 44.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.924 171.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.02 -85.08 0.98 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.466 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -110.04 -44.91 3.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.904 0.383 . . . . 0.0 110.92 -176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -68.16 -51.87 40.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 -148.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 1.008 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -57.74 -49.82 70.83 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.516 -176.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.596 HD21 ' HB ' ' A' ' 9' ' ' ILE . 55.1 tp -57.24 -41.94 80.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.827 0.346 . . . . 0.0 110.914 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.82 -38.61 67.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.071 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 67.2 mm-40 -70.57 -50.4 37.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.807 -176.381 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 20' ' ' LEU . 17.7 m -72.53 -36.54 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.185 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.407 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -64.34 -49.34 66.33 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.494 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 57.7 pttt -59.47 -24.71 63.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.924 0.392 . . . . 0.0 110.956 -175.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -59.88 -37.11 78.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 1.2 m-30 -56.75 -47.73 79.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.472 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 88.7 mt-10 -66.6 -35.96 81.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.981 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.53 -35.49 73.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.85 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -94.8 -50.04 5.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.811 -170.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.2 p -115.86 -1.08 12.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 -169.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.41 9.92 84.48 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.421 167.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.858 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -99.36 132.93 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 111.159 -177.783 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.8 mttt -74.21 140.36 45.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 -171.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.542 ' HB ' HD11 ' A' ' 9' ' ' ILE . 2.9 m -116.72 134.34 60.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.113 177.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.514 ' O ' HD12 ' A' ' 9' ' ' ILE . 99.6 m -103.94 127.8 51.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 176.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.59 HG13 HD23 ' A' ' 20' ' ' LEU . 54.8 t -93.07 126.66 45.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.201 175.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -119.93 145.74 46.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.974 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -88.95 141.14 29.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.528 0.68 . . . . 0.0 110.929 -168.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.439 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 85.2 Cg_exo -56.62 -26.29 64.0 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.736 2.291 . . . . 0.0 112.251 -174.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -47.34 -51.28 19.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 -171.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.84 -8.92 55.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 9.8 tt -47.85 -55.26 10.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 -170.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -64.76 -35.83 82.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.36 -39.52 92.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 50' ' ' VAL . 75.1 mmtt -80.44 -23.84 39.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.57 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 83.9 t80 -50.87 -50.26 75.25 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.665 0.745 . . . . 0.0 110.807 -160.637 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 44.4 Cg_endo -82.72 -32.32 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.685 2.256 . . . . 0.0 112.306 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -75.89 -46.41 30.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 -165.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.508 HG21 ' HG3' ' A' ' 57' ' ' PRO . 21.0 m -72.36 -27.16 25.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.04 -171.702 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.714 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -70.28 -35.78 73.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.098 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.11 -33.2 74.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.124 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.9 p -90.58 -20.25 22.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.2 8.35 69.73 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.542 172.788 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -118.35 116.84 27.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.35 . . . . 0.0 110.87 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.94 -92.75 0.13 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.502 171.075 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.716 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 71.2 Cg_endo -79.42 146.79 19.7 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.68 2.254 . . . . 0.0 112.362 -177.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -97.53 -35.06 10.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.777 163.27 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.729 ' HB ' HG23 ' A' ' 9' ' ' ILE . 35.4 mt -124.79 137.37 57.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.106 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.3 tp -132.77 125.22 52.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -88.34 140.11 29.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.731 168.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.463 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 21.9 p90 -142.85 163.39 32.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.979 171.145 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.83 -90.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 -164.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.669 ' CE1' ' HA3' ' A' ' 260' ' ' GLY . 23.2 m170 -130.56 -64.63 0.83 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 -173.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -95.13 -13.92 24.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -167.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.78 -14.49 14.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.997 -165.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.556 ' HB2' HD13 ' A' ' 104' ' ' ILE . 30.5 p90 -57.42 -32.43 66.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.875 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.77 -51.21 60.05 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.492 -170.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.59 -36.96 92.15 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.576 175.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.689 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 13.6 t80 -66.56 -41.94 87.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 -176.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.85 -40.98 68.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.169 174.419 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -57.58 -37.54 73.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.9 m -85.47 -4.98 59.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.982 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.32 30.07 59.21 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.492 174.292 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.714 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 58.9 mt -87.17 -10.07 53.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.919 0.39 . . . . 0.0 110.929 -167.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.689 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -130.95 153.77 48.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.924 -176.808 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -81.4 142.12 33.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 174.462 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.81 142.3 49.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.433 HD12 ' CZ ' ' A' ' 106' ' ' TYR . 36.9 pt -106.52 155.41 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 -177.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.6 m -96.1 130.57 30.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.666 0.746 . . . . 0.0 111.064 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.36 142.31 65.6 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.673 2.248 . . . . 0.0 112.326 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -113.92 114.78 26.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.21 -36.02 60.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.78 -43.47 98.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.021 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -74.54 -32.98 62.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.875 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.478 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 85.6 mt-30 -54.94 -51.49 65.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -57.6 -34.71 69.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.781 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.27 -24.53 57.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 -175.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.97 -104.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 -170.573 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 33.9 t80 172.66 128.84 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.739 0.781 . . . . 0.0 110.903 -169.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -52.31 -36.26 67.5 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.345 -173.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -65.14 -35.19 80.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 -173.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.3 p -73.47 -29.7 62.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.169 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.625 ' HA ' HG22 ' A' ' 97' ' ' VAL . 92.5 m95 -67.88 -30.55 69.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.972 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -69.25 -30.17 68.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.943 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.14 -26.04 62.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.038 175.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.625 HG22 ' HA ' ' A' ' 94' ' ' TRP . 16.3 m -109.96 20.7 5.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.14 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -113.8 132.52 55.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -132.1 119.45 20.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.5 t30 58.4 35.29 24.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.918 176.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.21 -0.41 89.74 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.449 175.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.25 149.42 42.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 0.0 110.861 175.589 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.596 HD22 HG23 ' A' ' 97' ' ' VAL . 18.4 mt -84.03 136.0 34.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.556 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -123.11 -2.3 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.051 -175.053 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.463 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -161.15 164.45 30.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.12 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.433 ' CZ ' HD12 ' A' ' 79' ' ' ILE . 89.9 m-85 -112.27 143.26 28.49 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.626 0.727 . . . . 0.0 110.948 170.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.33 121.42 5.24 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.669 2.246 . . . . 0.0 112.336 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.926 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -104.25 -36.72 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.177 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -146.0 153.12 40.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 -170.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.3 t -117.96 130.42 72.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.5 mp0 -110.64 131.98 54.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.806 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -153.09 144.66 23.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.119 177.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.6 mp -89.0 160.25 17.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.972 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.9 p -151.49 152.44 33.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.86 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.869 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -93.76 128.88 40.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 171.043 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.626 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.7 mp -111.39 132.04 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.236 -174.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -131.81 146.97 52.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.988 0.423 . . . . 0.0 110.86 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -91.88 117.4 29.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.893 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.91 -25.92 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.964 -172.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -84.68 -20.82 30.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 -172.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.9 mp -80.08 -54.03 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 169.63 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.747 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.3 pt? -140.32 127.23 12.23 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.564 0.697 . . . . 0.0 110.921 173.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.42 -7.06 14.87 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.665 2.244 . . . . 0.0 112.348 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.426 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 56.3 t-20 -147.22 95.27 4.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.725 0.774 . . . . 0.0 110.839 -176.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 58.6 Cg_endo -68.23 155.68 68.48 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.64 2.227 . . . . 0.0 112.376 177.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.52 143.67 76.4 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.64 2.226 . . . . 0.0 112.423 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -86.72 -15.76 38.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 80.6 p -133.68 156.75 47.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.409 ' HA ' HD13 ' A' ' 132' ' ' ILE . 74.1 m95 -70.77 -27.98 64.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.982 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.21 -19.58 65.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.843 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -80.3 -25.53 39.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.488 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -57.56 -46.27 99.79 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.567 0.698 . . . . 0.0 111.184 -169.249 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 86.4 Cg_exo -52.93 -50.74 13.02 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.712 2.274 . . . . 0.0 112.385 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.95 -59.49 4.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.158 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.41 -16.24 63.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -172.711 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.576 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.7 t70 -61.88 -41.69 98.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 167.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.66 -30.59 69.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.923 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.1 -46.86 60.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.84 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.1 pp -85.08 -14.32 47.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.965 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.612 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.6 tttt -60.98 -33.99 74.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.95 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.32 -24.03 67.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.993 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -94.98 4.3 53.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.942 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.03 31.98 57.11 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.572 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -110.24 170.14 8.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 0.0 110.885 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.7 t -121.04 140.94 51.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.827 168.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -67.67 -40.6 84.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.144 -174.647 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.406 HD22 ' H ' ' A' ' 148' ' ' MET . 2.1 tm? -140.78 133.48 28.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.958 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.406 ' H ' HD22 ' A' ' 147' ' ' LEU . 53.2 ttm -119.22 131.35 55.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.844 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -153.99 155.64 35.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 -174.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -86.27 -53.37 5.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -177.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.987 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.3 tm? 48.01 32.81 3.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.909 -169.085 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -100.24 -7.15 24.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.887 175.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.65 154.92 80.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.68 0.753 . . . . 0.0 110.922 -172.29 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -59.94 -25.07 78.48 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.673 2.248 . . . . 0.0 112.38 173.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -71.62 -29.41 64.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.84 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -81.43 -39.79 24.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 171.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.411 HG23 HG11 ' A' ' 347' ' ' VAL . 22.1 m -60.35 -48.34 82.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.585 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 40.5 t-105 -57.07 -54.42 54.78 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.444 0.64 . . . . 0.0 110.81 -168.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 24.3 Cg_endo -63.99 -20.04 67.31 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.544 2.163 . . . . 0.0 112.388 -174.113 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.774 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.7 tm? -81.6 -44.92 16.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.507 HG22 ' HA3' ' A' ' 166' ' ' GLY . 79.2 mt -74.98 -43.78 45.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.84 -24.7 66.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.972 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -58.26 -30.87 66.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.56 3.59 42.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 104.63 8.32 37.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.547 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.507 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -75.7 67.41 2.3 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.435 177.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -80.5 132.2 35.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.772 0.32 . . . . 0.0 110.939 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.86 6.36 11.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.127 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.549 ' CE1' ' HB3' ' A' ' 331' ' ' PRO . 51.2 p90 -154.0 155.81 36.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.906 -175.601 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -99.99 127.4 46.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.915 156.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -114.19 120.6 41.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -153.26 130.03 10.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -171.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 54.97 42.2 31.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.19 16.09 78.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.526 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.97 139.95 50.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.698 0.285 . . . . 0.0 110.93 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -96.47 144.94 26.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.923 170.72 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -128.06 111.97 14.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.885 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.562 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.2 pp -80.06 -11.38 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -96.9 -10.16 27.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -125.51 85.97 2.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 169' ' ' PHE . 31.1 m -113.97 164.79 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.056 -170.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.8 25.55 22.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.562 -173.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.439 HG21 HD12 ' A' ' 368' ' ' ILE . 2.1 m -106.53 -19.99 6.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.904 0.383 . . . . 0.0 111.156 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -87.39 21.79 2.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.799 -176.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -109.31 -176.32 2.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.927 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.52 -28.34 66.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.071 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.53 -40.08 78.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.492 -169.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.514 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -59.88 -40.08 87.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 111.11 175.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.574 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.2 mttt -62.23 -39.04 91.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.979 175.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.0 86.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.196 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.438 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -67.15 -46.02 76.02 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.516 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.736 HD11 ' HA ' ' A' ' 347' ' ' VAL . 22.8 tp -66.62 -35.5 80.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 110.821 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.55 ' OG1' HG21 ' A' ' 357' ' ' VAL . 94.3 m -65.07 -41.48 95.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 176.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 51.8 t80 -66.03 -49.68 66.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 177.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.701 HD23 ' C ' ' A' ' 195' ' ' LEU . 5.4 tt -50.72 -51.11 52.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.884 -174.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 199' ' ' ILE . 31.2 m -64.25 -22.47 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.177 -174.131 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.2 m-20 -62.27 -33.53 74.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 0.43 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.9 OUTLIER -80.69 -40.09 26.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -174.556 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.548 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.8 pp -73.7 -28.67 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.234 172.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -68.57 -37.63 80.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -80.63 2.79 24.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 68.0 38.51 2.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 169.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -78.28 -17.04 57.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.548 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.2 ppp? -145.3 157.18 44.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.934 174.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -94.63 150.65 20.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.4 -26.22 67.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -96.59 1.52 51.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.936 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 94.1 m -64.0 125.05 23.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.07 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.425 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 17.3 t0 -120.45 174.98 6.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.905 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -62.82 -40.41 97.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.999 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 98.6 p -67.58 -38.05 83.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.823 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.425 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 76.6 mt -65.05 -42.32 94.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.14 174.348 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.47 -35.6 80.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.107 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.27 -48.1 82.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.49 -42.36 95.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.111 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.05 -49.03 71.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.2 -43.39 98.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.911 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -63.18 -29.61 70.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.861 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -85.92 -16.74 37.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.24 25.04 29.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.431 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -83.28 -21.28 33.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 110.916 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.8 t -126.16 136.37 52.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.25 178.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.594 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -62.18 -48.8 78.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.024 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.586 ' HB3' HD21 ' A' ' 115' ' ' LEU . 66.9 mtm -135.0 160.06 39.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 -173.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.0 t -150.44 157.34 42.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.183 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 mm -111.58 129.42 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 -176.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -155.42 173.71 16.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -83.73 -153.37 15.64 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.395 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.11 -26.4 36.69 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.736 2.29 . . . . 0.0 112.328 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -76.01 -29.18 58.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 43.79 44.96 5.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.169 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 32.1 m0 -66.11 -20.63 66.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 63.6 m -71.22 -18.1 62.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -81.2 -175.37 5.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -174.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 87.9 mt -93.82 125.78 46.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -80.09 -57.85 3.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.81 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 88.4 m -145.17 122.79 11.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.149 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 27.5 t -174.77 163.08 3.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.887 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.4 -20.96 66.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.963 171.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 97.9 t -69.18 125.59 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.07 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -77.77 140.98 39.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.33 149.93 38.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.3 161.73 26.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.503 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.08 139.4 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.932 0.396 . . . . 0.0 111.1 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.3 t -153.4 149.08 27.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.161 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 22.4 m -59.95 163.51 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.153 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 3.8 mp -67.7 153.3 95.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.625 0.726 . . . . 0.0 111.029 -159.232 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 47.5 Cg_exo -63.75 178.92 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.699 2.266 . . . . 0.0 112.393 -175.036 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.0 m -92.52 145.71 24.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.21 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -131.26 112.2 12.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.952 -172.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 54.65 34.97 22.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.943 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.1 1.59 81.74 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.565 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -128.38 127.03 23.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.582 0.706 . . . . 0.0 110.896 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -55.28 136.9 75.56 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.673 2.249 . . . . 0.0 112.337 -176.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 256' ' ' LYS . 67.7 m -80.06 -5.05 55.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.798 170.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 255' ' ' SER . 97.3 mttt -38.31 129.05 1.05 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.514 0.673 . . . . 0.0 110.912 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -83.09 163.11 15.52 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.666 2.244 . . . . 0.0 112.384 -163.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -72.99 164.95 25.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.4 t -110.89 132.29 59.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.173 -168.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.669 ' HA3' ' CE1' ' A' ' 64' ' ' HIS . . . -114.85 138.92 15.19 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.443 176.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 74.0 t -126.13 116.54 46.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 111.24 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -66.28 122.52 17.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.984 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 51.0 m -124.11 131.11 53.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 -166.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.99 133.88 50.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.02 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.55 172.5 20.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.455 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 34.9 mm -113.99 130.48 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.785 0.326 . . . . 0.0 111.178 -173.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -61.86 128.99 38.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.984 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.469 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -58.85 -30.93 68.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.165 -178.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.28 -5.21 59.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.033 -172.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 15.6 t -71.51 120.23 78.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.68 0.752 . . . . 0.0 110.951 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' PRO . . . . . 0.431 ' HD2' HG21 ' A' ' 2' ' ' ILE . 97.8 Cg_endo -67.49 -9.89 26.85 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.623 2.215 . . . . 0.0 112.342 167.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -109.06 16.89 22.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -55.79 -32.93 63.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -170.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.67 -47.48 63.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.958 0.409 . . . . 0.0 110.896 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.0 pp -78.69 -31.03 46.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.9 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.77 -48.74 68.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.064 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -65.97 -34.98 79.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.51 -40.98 73.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 19.0 m-30 -66.97 -38.73 86.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 176.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.427 ' HA ' HD22 ' A' ' 284' ' ' LEU . 5.3 tt -57.62 -51.5 69.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 -176.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -75.31 -27.98 59.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -98.68 -13.5 20.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -167.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.754 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 69.0 m-85 -121.19 -60.13 1.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 280' ' ' LEU . 1.4 mp -61.44 -33.68 74.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.937 -161.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.926 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.2 pp -123.78 37.88 4.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.994 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.462 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 67.9 p -121.25 162.36 20.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 177.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.432 ' HA ' HD11 ' A' ' 290' ' ' LEU . 38.7 t70 -45.66 -36.29 4.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 -167.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -78.73 -42.02 29.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.984 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.754 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.9 -52.9 8.57 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.505 -170.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.604 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -72.62 -20.08 61.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.754 0.312 . . . . 0.0 110.965 -178.457 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.563 ' N ' HD12 ' A' ' 290' ' ' LEU . 35.3 tt0 -70.62 -47.93 57.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.774 172.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.65 97.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.098 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 1.008 HG23 ' HA3' ' A' ' 19' ' ' GLY . 2.8 p -78.71 -32.17 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 -176.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -68.78 -27.72 66.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.785 171.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.62 -25.05 67.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -88.39 -40.12 13.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.404 ' HD3' ' HD2' ' A' ' 15' ' ' LYS . 85.2 tttt -146.06 135.17 11.26 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.475 0.655 . . . . 0.0 110.951 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -58.28 109.03 0.44 Allowed 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.744 2.296 . . . . 0.0 112.289 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 61.6 mt -89.89 -18.59 25.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.978 -171.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 109.49 -59.49 0.35 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.525 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.6 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -169.37 165.24 10.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.359 . . . . 0.0 111.095 175.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.681 HG21 ' HB3' ' A' ' 307' ' ' TYR . 29.8 m -124.9 153.92 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.02 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.91 -8.41 56.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.115 172.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.604 ' CD2' HD21 ' A' ' 290' ' ' LEU . 44.7 tp -85.9 119.06 25.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.953 -177.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.01 -40.99 67.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -174.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.8 m -65.12 -50.13 67.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.829 -168.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.681 ' HB3' HG21 ' A' ' 302' ' ' VAL . 17.5 t80 -77.11 -28.62 54.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.953 -177.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -64.77 -38.98 92.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.915 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.31 -35.01 78.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.935 175.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -73.38 -41.33 63.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.952 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.6 HD13 ' HA ' ' A' ' 301' ' ' ALA . 77.2 mt -60.05 -31.87 70.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.884 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.54 -17.86 56.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.06 -19.64 66.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -90.9 121.73 67.67 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.624 0.726 . . . . 0.0 110.895 164.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -47.37 -28.05 7.88 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.737 2.291 . . . . 0.0 112.304 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -61.32 -30.96 70.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -172.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.467 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.1 mp -79.98 -30.23 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 -173.079 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.53 96.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.032 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.06 -44.1 77.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.023 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 82.6 p -65.43 -31.13 72.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 -171.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.9 mtp -65.49 -33.3 75.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -64.75 -47.19 79.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 -174.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.477 HD21 ' HB1' ' A' ' 112' ' ' ALA . 8.5 p-10 -82.97 -28.87 29.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.766 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.39 -52.31 62.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.033 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -65.86 -28.3 68.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.016 0.436 . . . . 0.0 110.984 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -109.63 -8.32 14.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.8 -168.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -89.88 -153.57 28.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.461 -166.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -146.1 140.81 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 0.0 110.919 -170.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 42.2 mm -60.31 121.37 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 -166.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 93.0 mtp -49.34 143.89 9.25 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.522 0.677 . . . . 0.0 110.902 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.549 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 70.7 Cg_endo -77.85 84.89 1.9 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.688 2.259 . . . . 0.0 112.274 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -111.8 21.77 15.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 -173.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 48.4 pt -75.44 159.39 81.99 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 0.0 111.114 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -55.74 -38.1 94.76 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.706 2.271 . . . . 0.0 112.317 -174.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -67.68 -27.46 66.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.908 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.452 ' HG3' ' HB2' ' A' ' 331' ' ' PRO . 54.7 mmm -80.13 -17.37 52.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.811 -170.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.5 m -60.82 -41.44 95.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.846 176.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.83 -35.64 59.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 6.4 m-30 -66.21 -42.37 88.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.964 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -56.51 -37.85 70.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.02 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -68.47 -41.22 80.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.17 -43.4 87.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.097 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 339' ' ' PHE . 20.4 m -73.4 -32.04 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.137 -177.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.451 ' O ' HG22 ' A' ' 347' ' ' VAL . 5.0 tmt_? -64.93 -38.94 92.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.873 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.3 m -58.68 -36.68 74.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.173 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.05 -43.75 91.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.108 -174.225 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.736 ' HA ' HD11 ' A' ' 192' ' ' LEU . 8.2 m -73.17 -34.92 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.153 -175.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.455 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -63.62 -47.27 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 173.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -63.59 -39.7 95.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.16 -45.51 60.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.025 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.29 -40.38 81.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.116 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 92.0 p -76.31 -10.91 59.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.09 16.61 74.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.46 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.03 -32.39 50.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 0.0 110.95 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -139.37 155.15 47.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.984 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 48.7 p -77.7 167.44 21.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 170.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.55 HG21 ' OG1' ' A' ' 193' ' ' THR . 54.8 t -55.89 -42.03 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.16 173.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -60.65 -46.88 88.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -69.11 -52.2 30.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -71.87 -49.39 38.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 -173.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.608 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 1.4 tm? -65.14 -46.87 79.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.968 -173.259 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.02 -53.44 53.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.847 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -67.14 -46.61 73.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -174.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.09 -41.8 94.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.091 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 68.0 mm-40 -77.74 -26.75 50.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.95 -177.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.2 m -64.44 -35.99 82.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.226 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.18 -30.4 68.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.971 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.439 HD12 HG21 ' A' ' 183' ' ' VAL . 70.0 mt -60.35 -38.49 77.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 173.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 60.8 p -93.45 -14.46 26.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.886 179.209 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.713 0.292 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 76.4 mt -95.96 133.93 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.191 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -146.51 139.15 25.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -52.43 137.77 28.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.16 1.62 62.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.442 -173.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 64.4 pttt -164.53 149.85 10.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.74 0.305 . . . . 0.0 110.966 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.628 HD23 ' H ' ' A' ' 7' ' ' LEU . 1.2 pt? -147.67 158.07 43.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.947 -176.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 70.4 t -110.79 131.83 60.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.743 HG23 ' HB ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -119.94 132.08 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.149 -179.269 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.673 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 70.8 m95 -106.08 128.8 54.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.943 169.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 20' ' ' LEU . 5.9 tt -109.41 149.96 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.157 -168.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -60.89 154.69 21.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -172.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.19 -21.3 31.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.495 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -72.93 -12.34 60.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.358 . . . . 0.0 110.812 -171.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.588 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -146.98 135.64 22.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 167.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.07 -79.91 1.06 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.599 -171.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -105.57 -44.93 4.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.958 0.409 . . . . 0.0 110.917 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -67.91 -52.92 30.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.864 -148.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 1.117 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -57.11 -51.95 54.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.498 -175.675 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.603 HD21 ' HB ' ' A' ' 9' ' ' ILE . 59.6 tp -57.87 -43.76 86.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 0.0 110.968 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.76 -40.05 59.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.991 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -69.71 -55.29 10.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 20' ' ' LEU . 22.0 m -69.83 -35.95 67.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.164 -175.387 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -62.83 -45.65 95.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.407 172.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -56.76 -30.2 63.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 110.996 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -57.55 -38.2 74.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 176.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 1.8 m-30 -56.22 -49.61 73.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.888 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 93.2 mt-10 -66.28 -35.41 80.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -69.3 -37.33 77.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -96.55 -47.99 5.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.918 0.39 . . . . 0.0 110.925 -169.792 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.8 p -114.73 -1.97 13.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.161 -169.344 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.88 8.73 82.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.417 166.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -99.46 133.0 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 111.121 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.6 mttt -75.17 139.75 42.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.852 -169.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.486 ' HB ' HD11 ' A' ' 9' ' ' ILE . 2.7 m -116.44 134.46 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.498 ' O ' HD12 ' A' ' 9' ' ' ILE . 98.3 m -105.12 127.54 52.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.136 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.578 HG13 HD23 ' A' ' 20' ' ' LEU . 54.5 t -91.53 127.05 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.155 175.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -119.14 147.01 44.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.828 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 63.6 t-80 -88.82 142.18 30.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.593 0.711 . . . . 0.0 110.887 -166.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 86.8 Cg_exo -54.9 -25.21 42.62 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.569 2.179 . . . . 0.0 112.379 -175.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -48.43 -56.79 7.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 -173.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -86.6 -4.07 59.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 8.1 tt -45.94 -53.81 9.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.896 -172.046 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.02 -35.48 80.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.846 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -67.37 -43.48 81.3 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.884 -173.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -80.47 -21.36 42.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 50.6 t80 -49.99 -51.51 60.98 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.564 0.697 . . . . 0.0 110.806 -165.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 61.6 Cg_endo -80.94 -29.68 2.0 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.615 2.21 . . . . 0.0 112.403 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -74.6 -40.33 61.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 -168.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 m -66.58 -27.68 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.121 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.782 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -67.61 -36.09 80.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.09 -31.38 70.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.024 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.8 p -93.0 -17.77 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.128 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.22 11.22 75.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.522 173.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -140.05 140.06 36.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.881 0.372 . . . . 0.0 110.827 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.96 -96.61 0.16 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.435 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.673 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 78.9 Cg_endo -80.08 148.79 19.54 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.728 2.286 . . . . 0.0 112.238 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -96.94 -35.99 10.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 165.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.743 ' HB ' HG23 ' A' ' 9' ' ' ILE . 46.6 mt -125.87 138.26 55.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.105 -176.14 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 tp -131.2 125.91 58.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.153 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -91.31 137.57 32.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 167.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.489 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 31.2 p90 -140.5 162.62 34.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.017 172.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.46 -87.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.039 -167.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.504 ' NE2' ' HA3' ' A' ' 260' ' ' GLY . 10.8 m170 -128.17 -68.69 0.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -173.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -96.81 -10.92 25.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.811 -162.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -57.27 -14.28 4.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 -169.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.564 ' HB2' HD13 ' A' ' 104' ' ' ILE . 33.5 p90 -59.29 -29.41 67.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.9 -51.75 57.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.468 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.76 -36.55 92.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.522 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -55.45 -51.75 65.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 110.931 179.053 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.2 -43.11 58.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.16 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -56.86 -38.83 73.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 -175.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.404 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 61.8 m -84.8 -7.44 59.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.003 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.95 30.26 59.58 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.469 173.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.782 HD22 ' HB1' ' A' ' 51' ' ' ALA . 42.1 mt -89.35 -8.78 52.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.827 0.346 . . . . 0.0 110.886 -168.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -129.06 152.2 48.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -176.458 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.03 139.65 35.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.025 172.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.69 142.95 51.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.0 pt -104.15 154.53 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.9 m -90.67 123.85 64.0 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.672 0.749 . . . . 0.0 111.115 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.83 136.6 75.33 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.772 2.315 . . . . 0.0 112.395 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -105.05 111.79 24.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.16 -40.0 92.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.84 -176.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.39 97.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -71.97 -36.87 69.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.454 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 66.3 tt0 -51.73 -51.8 53.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.96 174.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -57.99 -37.07 73.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.802 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.38 -21.66 52.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.863 -174.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -105.06 -105.02 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.907 -172.04 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 27.7 t80 172.19 126.7 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.682 0.753 . . . . 0.0 110.963 -167.557 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 93.7 Cg_exo -54.66 -36.38 89.6 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.796 2.33 . . . . 0.0 112.407 -172.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -65.03 -35.1 80.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -172.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.1 p -76.72 -32.21 57.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.215 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.545 ' CE3' HD13 ' A' ' 103' ' ' LEU . 92.7 m95 -70.32 -29.09 65.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.002 173.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.07 -31.44 71.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 177.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.03 -24.04 64.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.092 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' A' ' 94' ' ' TRP . 17.9 m -106.35 15.95 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -99.98 131.5 45.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -129.37 117.45 20.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.7 t30 57.8 35.57 25.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.857 175.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.79 0.19 89.72 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.536 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -124.69 146.37 49.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 110.835 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.545 HD13 ' CE3' ' A' ' 94' ' ' TRP . 26.8 mt -88.56 135.35 33.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.799 -171.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.564 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.8 pp -121.87 -1.68 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.489 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -158.8 161.43 36.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.086 -176.288 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.491 ' HB3' ' CD2' ' A' ' 285' ' ' LEU . 93.9 m-85 -110.27 138.25 20.82 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.662 0.744 . . . . 0.0 110.878 172.434 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.05 118.15 5.15 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.636 2.224 . . . . 0.0 112.303 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.898 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -103.24 -36.4 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -148.81 152.7 36.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 -172.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.54 130.71 73.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.112 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.469 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 92.0 mt-10 -129.74 128.57 42.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.801 ' HB1' HD21 ' A' ' 323' ' ' ASN . . . -150.8 152.26 33.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.126 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.522 ' HB2' ' CB ' ' A' ' 257' ' ' PRO . 5.1 mp -84.29 171.34 12.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.976 -161.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.1 p -156.02 154.7 31.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 -172.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.876 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -99.14 127.66 45.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.812 168.639 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.594 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.3 mp -111.45 130.04 65.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.21 -175.22 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -131.34 148.46 52.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.928 -173.371 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -92.06 120.01 32.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.823 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.416 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.5 mttt -70.13 -25.74 63.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -174.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -86.59 -23.07 25.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.8 mp -75.02 -56.71 4.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.979 167.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.765 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.1 pt? -140.02 127.89 12.87 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.589 0.709 . . . . 0.0 110.969 173.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.57 -7.84 16.9 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.592 2.194 . . . . 0.0 112.315 -175.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -147.27 96.71 4.18 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.648 0.737 . . . . 0.0 110.912 -176.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.64 155.04 71.7 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.636 2.224 . . . . 0.0 112.375 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.43 143.3 69.04 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.678 2.252 . . . . 0.0 112.274 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -84.86 -16.33 41.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.996 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.9 p -132.03 157.91 42.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.195 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.488 ' HA ' HG12 ' A' ' 132' ' ' ILE . 82.4 m95 -70.08 -20.79 63.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.88 -28.82 67.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -82.27 -8.14 59.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.881 -176.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.627 ' O ' HD13 ' A' ' 135' ' ' LEU . 46.8 mm -60.82 -53.14 67.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.576 0.703 . . . . 0.0 111.17 -173.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 21.6 Cg_endo -60.48 -39.88 61.92 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.566 2.177 . . . . 0.0 112.377 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.52 -61.14 2.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.147 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -70.88 -16.93 62.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.01 -175.628 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.52 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.9 t70 -63.54 -42.39 98.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.874 168.458 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.67 -30.43 68.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.963 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -69.98 -47.48 62.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.623 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.6 pp -87.22 -15.19 38.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.923 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.623 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.5 tttt -61.93 -33.86 75.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.012 175.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.41 -24.19 67.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.076 176.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -95.04 6.14 49.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.848 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.86 32.04 57.41 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.528 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -110.4 166.5 10.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 110.878 174.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.4 t -118.5 143.04 47.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 169.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.62 -44.13 71.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.132 -173.73 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -139.05 124.02 18.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.842 -174.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 62.1 tpp -113.4 132.57 55.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.81 -175.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -157.39 160.0 37.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.987 -175.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' ASN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 209' ' ' ASP . 40.3 p-10 -99.21 -43.44 6.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -175.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.108 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.4 tm? 52.13 34.58 14.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -175.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -103.28 -11.61 17.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 -176.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 96.6 mt-10 -123.4 144.11 43.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.655 0.74 . . . . 0.0 110.924 -170.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 153' ' ' GLU . 73.1 Cg_exo -54.64 -32.75 76.64 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.634 2.222 . . . . 0.0 112.339 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -65.21 -29.96 70.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -79.89 -40.19 28.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 39.3 p -62.79 -39.59 94.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.066 -175.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.596 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 32.0 t-105 -65.91 -50.14 54.56 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.63 0.728 . . . . 0.0 110.936 -164.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 78.4 Cg_exo -48.33 -46.55 22.73 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.702 2.268 . . . . 0.0 112.312 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.716 HD23 ' O ' ' A' ' 160' ' ' LEU . 6.4 tt -74.91 -40.35 60.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.957 -174.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.8 mt -69.13 -43.05 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.213 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.63 -24.71 61.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.91 -33.49 71.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.076 -178.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -93.57 3.35 55.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.99 7.32 35.96 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.428 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.38 65.7 3.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -85.67 134.8 33.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.794 0.331 . . . . 0.0 110.989 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.53 1.57 16.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.091 -177.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -153.69 155.41 35.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.996 0.427 . . . . 0.0 110.853 -175.087 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -99.47 121.95 41.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 157.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -112.95 123.26 49.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -152.84 131.03 11.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.4 t30 55.07 44.89 27.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.985 173.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.29 15.69 78.84 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.485 173.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.01 139.84 50.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.794 0.331 . . . . 0.0 110.951 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -95.82 144.38 26.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.943 169.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -119.32 111.7 18.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 37.1 pt -78.18 -18.24 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -94.54 -8.99 36.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.817 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -123.45 92.8 3.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 24.9 m -118.72 164.26 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.081 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -108.46 22.38 26.7 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.541 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 365' ' ' GLN . 1.5 m -108.8 -23.3 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 111.165 -173.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -91.79 24.03 3.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.793 174.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -118.88 176.25 5.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.877 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.09 -25.49 67.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.133 -177.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.09 -39.75 94.79 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.445 -172.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.693 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.48 -35.57 81.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.958 0.408 . . . . 0.0 111.124 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.566 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.7 mttt -59.69 -36.17 75.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 176.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.44 91.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.11 -48.16 67.32 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.496 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.526 HD11 ' HA ' ' A' ' 347' ' ' VAL . 19.0 tp -65.96 -33.2 75.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.927 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 357' ' ' VAL . 88.3 m -65.98 -44.02 86.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.172 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 32.6 t80 -67.31 -46.52 73.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.864 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.579 HD23 ' C ' ' A' ' 195' ' ' LEU . 7.9 tt -51.12 -52.21 46.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -175.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 199' ' ' ILE . 27.6 m -64.03 -21.95 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 -173.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.9 m-20 -61.51 -33.06 73.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -80.33 -40.07 27.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -175.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.658 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.8 pp -74.94 -28.31 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.214 173.05 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -70.49 -39.08 74.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 174.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -78.29 2.15 19.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.876 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 66.55 40.9 3.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 166.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -78.11 -17.63 56.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.779 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.658 ' SD ' HG22 ' A' ' 199' ' ' ILE . 4.3 ppp? -143.33 158.09 43.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.899 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -92.21 153.6 19.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.817 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.7 -26.99 67.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.102 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -94.77 2.33 55.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 98.4 m -69.17 129.99 41.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.105 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.514 ' HA ' ' HB3' ' A' ' 150' ' ' ASN . 18.7 t0 -126.69 175.67 7.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.961 173.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -59.18 -35.78 74.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.01 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.7 p -68.4 -38.79 81.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 76.2 mt -67.46 -40.04 83.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.125 175.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.08 -35.52 80.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.001 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -61.4 -47.25 86.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.862 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.06 -41.23 99.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.11 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.9 -47.62 77.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.071 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -62.38 -41.86 98.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.5 m-20 -63.96 -31.4 72.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.913 -177.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.47 -19.3 28.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.836 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.37 22.43 31.94 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.453 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -80.96 -19.66 43.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.996 0.427 . . . . 0.0 110.9 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.7 t -128.76 137.47 51.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.153 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.444 ' HB1' HD21 ' A' ' 122' ' ' LEU . . . -66.34 -46.91 75.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.022 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.645 ' HB3' HD21 ' A' ' 115' ' ' LEU . 75.3 mtm -133.71 151.02 51.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.962 -168.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 66.1 p -138.69 156.9 47.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.161 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.4 mm -110.37 125.06 67.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -155.01 175.31 13.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -169.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.409 ' HA2' ' HG ' ' A' ' 113' ' ' LEU . . . -84.34 -164.17 37.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.419 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.469 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 36.5 Cg_endo -65.34 -23.78 58.48 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.685 2.257 . . . . 0.0 112.361 177.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -72.26 -30.79 65.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 45.37 45.09 9.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.104 174.535 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 29.7 m0 -63.68 -19.61 65.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.868 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -69.75 -14.88 63.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.855 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -78.45 -171.32 2.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.483 HG21 ' HB3' ' A' ' 238' ' ' SER . 92.9 mt -96.28 140.06 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.152 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -92.03 -49.49 6.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 86.3 m -144.85 119.9 10.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.185 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' SER . . . . . 0.483 ' HB3' HG21 ' A' ' 235' ' ' ILE . 29.2 t -178.75 164.37 1.54 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -79.14 -10.44 59.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 172.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.09 130.96 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.056 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -82.99 139.13 33.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.416 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 39.0 p90 -150.02 156.6 41.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.927 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.7 163.86 26.46 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.431 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.0 p -135.53 135.93 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 111.127 -176.235 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 13.2 t -159.71 152.45 21.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 175.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 322' ' ' GLU . 28.2 m -59.2 163.26 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.288 -175.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.526 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 2.4 mp -67.02 153.66 94.07 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 110.985 -165.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.51 -178.17 2.12 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.777 2.318 . . . . 0.0 112.358 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 68.2 p -100.85 160.09 14.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.078 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -138.8 119.75 14.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.911 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 54.89 33.99 21.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 -173.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.78 9.92 73.66 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.558 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -126.17 139.94 35.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.619 0.723 . . . . 0.0 110.842 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -73.29 139.58 29.33 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.736 2.291 . . . . 0.0 112.298 -172.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 256' ' ' LYS . 73.8 m -85.33 1.5 48.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.845 168.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 255' ' ' SER . 99.0 mttt -38.4 118.06 0.99 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.569 0.7 . . . . 0.0 110.879 -175.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.522 ' CB ' ' HB2' ' A' ' 113' ' ' LEU . 53.0 Cg_exo -65.66 162.13 35.75 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.699 2.266 . . . . 0.0 112.33 -170.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -74.48 167.2 22.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.901 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.7 t -117.56 134.5 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.082 -165.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.504 ' HA3' ' NE2' ' A' ' 64' ' ' HIS . . . -116.7 135.52 12.07 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.469 176.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.2 t -124.96 118.24 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 111.197 174.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -66.28 123.06 18.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.3 m -126.49 133.45 51.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.789 -168.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.26 138.88 52.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.066 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.39 172.07 21.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.419 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.479 HG13 ' HB2' ' A' ' 277' ' ' LYS . 29.1 mm -113.64 129.96 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 0.0 111.106 -173.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -61.85 128.74 37.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.455 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -59.83 -29.19 68.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.099 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.82 -5.76 59.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.065 -173.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.5 t -73.14 121.0 83.99 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.654 0.74 . . . . 0.0 110.936 -173.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -68.04 -9.38 25.52 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.635 2.224 . . . . 0.0 112.353 168.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -108.66 19.72 19.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -53.97 -33.97 58.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.856 -171.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -67.55 -50.65 57.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -172.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.99 -32.08 39.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.45 -47.51 75.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.071 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' LYS . . . . . 0.479 ' HB2' HG13 ' A' ' 266' ' ' ILE . 37.3 ttpt -66.24 -42.41 88.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 176.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.46 -46.57 82.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -66.29 -43.2 87.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 284' ' ' LEU . 8.2 tt -55.83 -50.57 70.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 -176.427 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -72.4 -25.21 61.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -100.27 -11.15 20.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 -171.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.756 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 73.9 m-85 -122.91 -60.55 1.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 280' ' ' LEU . 1.4 mp -62.66 -32.49 73.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.908 -159.56 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.898 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.4 pp -123.22 38.07 4.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.96 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.474 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 64.0 p -124.68 163.47 21.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.438 ' HA ' HD11 ' A' ' 290' ' ' LEU . 38.7 t70 -45.63 -37.51 5.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -166.044 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -78.3 -41.63 33.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.756 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.52 -55.96 5.8 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.593 -170.685 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 291' ' ' GLU . 0.6 OUTLIER -67.2 -21.36 65.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 110.852 -178.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.592 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.9 tt0 -68.44 -47.6 66.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 172.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.63 -45.15 91.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -174.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 1.117 HG23 ' HA3' ' A' ' 19' ' ' GLY . 2.6 p -75.83 -34.56 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.176 -175.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 294' ' ' ASN . . . . . 0.434 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 46.2 t30 -67.4 -28.24 67.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 173.352 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.09 -26.47 68.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -85.46 -41.76 15.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.992 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -145.36 131.78 9.78 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.572 0.701 . . . . 0.0 110.853 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.32 109.01 0.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.727 2.285 . . . . 0.0 112.358 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.434 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 59.4 mt -90.06 -19.6 24.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.97 -171.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 113.36 -59.46 0.38 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.461 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.658 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -171.37 169.63 6.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.807 0.337 . . . . 0.0 111.114 174.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.635 HG21 ' HB3' ' A' ' 307' ' ' TYR . 32.9 m -125.24 154.67 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.07 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.46 -10.71 60.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.077 171.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.574 ' CD2' HD21 ' A' ' 290' ' ' LEU . 54.1 tp -85.9 120.01 26.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -175.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -55.85 -40.45 72.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.883 -174.065 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.7 m -65.72 -50.02 66.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.849 -168.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.635 ' HB3' HG21 ' A' ' 302' ' ' VAL . 17.4 t80 -76.42 -28.63 56.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.979 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -64.8 -38.87 92.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.9 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.53 -34.76 77.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.909 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -75.02 -40.44 60.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.924 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.658 HD13 ' HA ' ' A' ' 301' ' ' ALA . 80.1 mt -61.23 -32.0 71.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.901 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.64 -18.64 60.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.06 -176.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.79 -19.37 65.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 173.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -91.4 122.7 65.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.608 0.718 . . . . 0.0 110.88 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -48.61 -28.69 12.73 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.668 2.245 . . . . 0.0 112.375 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -62.75 -27.25 69.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.888 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.405 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.4 mp -75.06 -32.88 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 -174.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.2 -46.03 91.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.046 -171.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.35 -39.3 89.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.169 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.619 HG23 ' HB3' ' A' ' 112' ' ' ALA . 21.6 m -59.32 -36.39 75.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.182 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.8 mmm -73.86 -34.24 64.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 322' ' ' GLU . . . . . 0.408 ' HB2' HG13 ' A' ' 246' ' ' VAL . 86.1 mt-10 -59.46 -44.14 93.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.942 -172.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.801 HD21 ' HB1' ' A' ' 112' ' ' ALA . 16.4 p-10 -87.83 -26.28 22.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -178.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.64 -45.31 92.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.133 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -62.46 -33.7 75.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.88 -177.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -107.62 -2.29 20.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.857 -173.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -90.17 -166.57 41.44 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.452 -164.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -144.94 143.0 30.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 110.962 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 47.0 mm -60.44 118.7 3.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 -171.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 47.6 tpp -54.28 130.22 60.69 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.561 0.696 . . . . 0.0 110.87 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.528 ' HB2' ' HG3' ' A' ' 336' ' ' MET . 43.0 Cg_endo -70.95 99.9 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.692 2.261 . . . . 0.0 112.321 -175.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 13.3 m120 -120.58 23.29 10.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -174.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 51.0 pt -75.8 160.13 79.55 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.626 0.727 . . . . 0.0 111.129 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -54.81 -38.25 92.14 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.775 2.317 . . . . 0.0 112.301 -173.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -67.68 -29.18 68.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.528 ' HG3' ' HB2' ' A' ' 331' ' ' PRO . 66.1 mmm -80.03 -18.06 51.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 -168.902 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 95.0 p -63.8 -37.71 88.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.782 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -76.85 -35.13 57.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.14 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.547 ' O ' HG13 ' A' ' 343' ' ' VAL . 5.0 m-30 -67.61 -41.0 84.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.451 ' HA ' HG22 ' A' ' 343' ' ' VAL . 7.7 m0 -59.89 -34.64 73.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 174.367 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -69.43 -39.77 77.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.889 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.51 -43.22 85.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.109 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 339' ' ' PHE . 15.4 m -75.15 -28.58 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.098 -176.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.445 ' O ' HG22 ' A' ' 347' ' ' VAL . 49.3 ttt180 -58.62 -45.56 88.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.845 172.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 93.2 m -56.11 -36.25 67.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.148 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.64 -44.05 91.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.188 -174.347 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.526 ' HA ' HD11 ' A' ' 192' ' ' LEU . 3.0 m -74.88 -34.86 34.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.175 -174.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 347' ' ' VAL . 1.4 mp -62.95 -52.18 62.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.196 173.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -62.5 -39.21 92.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.59 -45.71 61.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.111 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.72 -39.67 76.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.049 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 89.4 p -75.39 -10.56 59.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.921 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 82.02 17.13 70.5 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.414 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.72 -33.4 46.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 110.863 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -140.02 155.1 47.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.5 p -77.38 169.45 18.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.217 170.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.435 ' O ' ' CB ' ' A' ' 361' ' ' LEU . 53.8 t -56.17 -42.37 72.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.198 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -61.13 -46.58 89.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.828 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -70.09 -53.19 18.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -70.96 -48.04 55.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.146 -172.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.3 tm? -65.08 -41.76 94.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -174.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.73 -54.08 26.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -70.39 -48.35 56.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -171.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.34 85.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.175 -174.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.493 ' HB3' ' HB ' ' A' ' 183' ' ' VAL . 79.4 mm-40 -73.55 -34.79 65.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -175.868 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 26.9 m -60.17 -27.93 67.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.175 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -56.99 -30.11 63.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.804 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 365' ' ' GLN . 77.3 mt -60.6 -40.18 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.076 174.657 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 45.7 p -98.22 -11.38 22.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.019 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.955 175.938 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.835 0.35 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.6 mt -93.68 130.73 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.177 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -145.52 146.59 31.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.918 -176.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.22 137.15 35.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.27 6.13 63.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.458 -174.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.2 tttt -165.32 135.85 3.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.741 0.305 . . . . 0.0 110.961 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.406 HD23 ' HB3' ' A' ' 275' ' ' LEU . 0.5 OUTLIER -142.34 149.57 39.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 -178.804 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 78.3 t -107.62 133.76 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.712 HG23 ' HB ' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -119.92 133.87 65.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.12 -179.397 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.803 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 68.5 m95 -108.25 126.2 52.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.014 166.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.485 HD12 ' HG ' ' A' ' 20' ' ' LEU . 14.9 tt -110.55 150.06 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 -165.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.58 149.21 39.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -172.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.86 -17.84 23.3 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.459 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -73.5 -12.32 60.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.785 0.326 . . . . 0.0 110.826 -176.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -147.83 128.17 13.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 164.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.87 -77.25 1.0 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.443 -167.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -108.47 -44.91 3.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.923 0.392 . . . . 0.0 110.979 -175.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -67.47 -50.34 59.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.887 -152.601 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.653 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -54.95 -49.54 62.04 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.42 -173.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 9' ' ' ILE . 3.2 mt -52.21 -54.43 31.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 0.0 110.913 170.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.96 -35.84 25.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -70.63 -59.22 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.971 0.415 . . . . 0.0 110.88 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.0 m -71.19 -37.77 67.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.127 -173.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.69 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -66.4 -45.88 82.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.426 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -57.43 -32.99 67.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 0.0 110.984 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -57.81 -37.83 74.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 176.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 6.0 m-30 -59.66 -44.61 93.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -64.81 -37.9 89.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.96 -40.62 75.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.867 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -97.54 -47.06 5.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.835 -166.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.6 p -108.13 -6.1 16.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.152 -173.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.91 3.83 90.53 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.432 169.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.829 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -100.13 133.17 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 0.0 111.177 -176.444 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.2 mttt -79.36 142.71 35.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.841 -172.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.69 HG21 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -120.01 133.79 65.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 178.359 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.471 ' O ' HD12 ' A' ' 9' ' ' ILE . 97.5 m -104.68 128.68 52.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.049 177.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 20' ' ' LEU . 93.5 t -98.26 125.18 51.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.199 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -117.97 148.25 42.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' HIS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 96.8 m-70 -86.75 148.3 45.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.597 0.713 . . . . 0.0 110.895 -165.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.452 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 50.7 Cg_exo -59.81 -24.96 77.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.69 2.26 . . . . 0.0 112.3 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -53.24 -50.09 65.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.937 -171.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.08 -3.83 56.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.836 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 7.7 tt -46.39 -52.63 12.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 -172.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -66.63 -36.45 82.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.767 176.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.38 -43.65 85.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.816 -172.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.4 -21.31 39.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 56.6 t80 -48.83 -51.17 56.51 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.614 0.721 . . . . 0.0 110.821 -167.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 63.1 Cg_endo -80.75 -29.46 2.2 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.731 2.287 . . . . 0.0 112.375 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -74.66 -39.65 61.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.929 -169.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.439 HG11 ' HD3' ' A' ' 57' ' ' PRO . 34.2 m -65.09 -27.83 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.031 -177.354 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.826 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -68.87 -37.01 78.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 177.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.11 -30.62 68.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.148 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.3 p -92.39 -15.37 27.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 176.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.48 10.22 78.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 175.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -141.05 133.28 28.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.38 -115.07 0.53 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.486 176.752 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.803 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 61.1 Cg_endo -75.28 152.57 39.64 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.723 2.282 . . . . 0.0 112.415 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.39 -34.99 17.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 159.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.712 ' HB ' HG23 ' A' ' 9' ' ' ILE . 30.5 mt -128.59 139.31 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 -175.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 tp -131.87 127.87 59.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -93.65 137.2 33.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 172.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.422 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 30.0 p90 -144.66 165.03 29.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.932 171.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.81 -89.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.048 -169.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.414 ' CD2' ' HA2' ' A' ' 260' ' ' GLY . 18.0 m80 -105.47 -81.58 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.828 -171.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.579 ' H ' ' HB3' ' A' ' 332' ' ' ASN . 70.0 m-20 -103.88 -6.71 21.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.77 -154.227 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -52.15 -21.5 3.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -173.916 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.483 ' HB2' HD13 ' A' ' 104' ' ' ILE . 30.7 p90 -59.27 -28.96 67.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.815 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.62 -51.47 57.7 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.73 91.89 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.442 171.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.408 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -54.96 -51.68 65.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.981 0.42 . . . . 0.0 110.999 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.24 -42.6 45.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.113 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.5 tp60 -56.88 -38.62 73.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.87 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.415 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 62.8 m -85.94 -6.9 58.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.847 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.73 30.78 59.26 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.561 174.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.826 HD22 ' HB1' ' A' ' 51' ' ' ALA . 39.0 mt -89.87 -10.07 46.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 0.0 110.972 -169.218 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.483 ' C ' ' HB2' ' A' ' 268' ' ' ALA . 0.2 OUTLIER -127.97 149.41 50.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 -176.38 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -77.36 141.11 40.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.124 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.8 136.48 45.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.957 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -105.1 156.86 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.8 m -100.7 130.32 25.69 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.606 0.717 . . . . 0.0 111.096 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.44 134.57 62.15 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.738 2.292 . . . . 0.0 112.329 176.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -104.04 118.62 37.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.817 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.21 -41.96 98.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.897 -176.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.89 -45.05 87.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -74.88 -32.4 61.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.951 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLN . . . . . 0.483 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 66.9 tt0 -55.04 -50.87 68.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.901 175.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.03 -32.68 71.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 174.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -76.22 -21.32 56.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.7 -105.21 0.3 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.949 -172.461 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 30.3 t80 171.75 128.92 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.655 0.74 . . . . 0.0 110.92 -167.752 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -53.48 -37.03 81.98 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.746 2.297 . . . . 0.0 112.352 -173.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -64.97 -35.72 82.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.785 -174.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.8 p -73.12 -30.97 64.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.186 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.527 ' HA ' HG22 ' A' ' 97' ' ' VAL . 86.3 m95 -67.47 -30.85 70.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 174.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.4 -30.75 70.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.852 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.96 -25.76 62.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.034 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.528 HG23 HD22 ' A' ' 103' ' ' LEU . 15.6 m -106.02 13.04 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 -174.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -100.04 129.74 46.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -123.68 115.03 20.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 172.592 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.8 t30 56.82 38.88 29.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 173.017 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.39 0.39 89.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.56 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -116.71 151.29 36.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.833 0.349 . . . . 0.0 110.805 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.528 HD22 HG23 ' A' ' 97' ' ' VAL . 15.1 mt -90.82 135.11 33.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.873 177.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.483 HD13 ' HB2' ' A' ' 67' ' ' PHE . 2.0 pp -125.68 3.9 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.037 -172.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.422 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -163.03 165.47 24.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.162 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 92.4 m-85 -116.04 140.46 26.34 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.609 0.718 . . . . 0.0 110.993 172.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 11.4 Cg_exo -72.13 126.38 11.73 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.733 2.289 . . . . 0.0 112.391 172.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 1.076 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.5 mp -107.61 -39.98 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.213 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -144.02 152.09 40.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.162 -164.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.3 t -125.06 131.19 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.109 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLU . . . . . 0.508 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 92.5 mt-10 -133.89 132.31 40.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 175.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.563 ' HB3' HG23 ' A' ' 320' ' ' THR . . . -154.18 152.73 30.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.119 176.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.36 169.65 16.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.941 -168.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 98.9 p -157.59 159.14 36.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.897 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.2 OUTLIER -92.33 126.09 37.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 169.581 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.587 ' N ' HD22 ' A' ' 115' ' ' LEU . 65.7 mt -113.71 132.14 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -172.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -132.13 145.03 51.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.418 ' O ' HD23 ' A' ' 122' ' ' LEU . 54.8 t-20 -93.36 114.43 26.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.831 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.484 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.8 mttt -64.78 -18.43 65.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 -173.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -77.33 -29.98 53.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.865 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 mp -83.69 -49.51 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.653 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.5 pt? -140.0 126.53 12.18 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.567 0.699 . . . . 0.0 110.89 176.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -79.16 -14.59 13.3 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.693 2.262 . . . . 0.0 112.377 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -142.23 97.16 6.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.564 0.697 . . . . 0.0 110.825 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.67 154.98 54.66 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.725 2.283 . . . . 0.0 112.282 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.39 146.23 74.21 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.624 2.216 . . . . 0.0 112.347 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -88.53 -18.16 28.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.988 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 69.6 p -132.27 158.72 41.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.166 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.541 ' HA ' HD13 ' A' ' 132' ' ' ILE . 58.7 m95 -69.66 -27.21 64.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.978 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.96 -24.6 67.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.14 -24.62 40.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.823 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.624 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -57.15 -49.68 92.53 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.586 0.708 . . . . 0.0 111.151 -172.034 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 40.0 Cg_endo -68.67 -38.02 11.32 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.67 2.247 . . . . 0.0 112.398 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.14 -60.73 3.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 176.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.205 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.96 -16.8 63.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 -175.708 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.504 ' N ' HD13 ' A' ' 135' ' ' LEU . 37.0 t70 -58.39 -39.63 80.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.821 168.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.52 -30.22 68.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.79 -47.6 52.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.032 0.444 . . . . 0.0 110.864 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.9 pp -85.62 -15.27 43.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.6 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.7 tttt -59.74 -33.45 71.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 173.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.03 -24.63 67.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 176.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -95.03 3.35 54.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.927 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.79 33.16 52.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.471 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -110.5 169.97 8.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.749 0.309 . . . . 0.0 110.909 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.0 t -118.93 142.13 48.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.996 0.427 . . . . 0.0 110.745 169.033 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -68.62 -39.87 80.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 -175.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -142.17 130.68 22.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 62.3 tpp -118.22 131.9 56.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.823 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -154.59 157.49 38.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.53 -51.56 5.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.104 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.4 tm? 48.04 33.37 3.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.891 -169.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -102.16 -2.76 28.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.936 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -127.97 153.68 78.32 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.683 0.754 . . . . 0.0 110.864 -174.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.44 ' HA ' ' HB ' ' A' ' 157' ' ' THR . 37.5 Cg_endo -61.81 -24.78 77.73 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.626 2.217 . . . . 0.0 112.362 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -66.68 -30.06 70.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -87.49 -39.39 15.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' THR . . . . . 0.44 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 20.5 m -61.18 -46.87 88.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.135 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.571 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 37.3 t-105 -58.81 -53.84 62.37 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.499 0.666 . . . . 0.0 110.833 -169.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 34.4 Cg_endo -66.12 -18.01 55.73 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.694 2.263 . . . . 0.0 112.255 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.775 ' C ' HD13 ' A' ' 160' ' ' LEU . 1.6 tm? -81.61 -45.34 15.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.837 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.569 HG22 ' HA3' ' A' ' 166' ' ' GLY . 77.9 mt -74.24 -44.46 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.98 -20.95 63.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -60.66 -31.15 70.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.093 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.98 3.1 55.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.891 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 104.11 7.91 39.92 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.485 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.569 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -77.06 67.05 2.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.541 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -86.05 131.11 34.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.361 . . . . 0.0 110.89 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.54 13.48 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -174.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.409 ' HA ' HG12 ' A' ' 181' ' ' VAL . 52.9 p90 -153.43 154.4 34.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 86.8 tttt -101.48 127.5 48.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 158.273 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -116.22 125.81 52.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.983 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -153.55 130.39 10.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.0 t30 54.31 42.76 31.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.946 172.573 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.95 18.47 80.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -132.27 138.51 47.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.965 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -97.72 145.11 26.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.811 170.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -126.24 112.14 15.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.914 174.183 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 178' ' ' ILE . 1.1 pp -79.43 -12.82 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -95.23 -10.1 31.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 -176.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 67.2 t0 -126.42 90.13 3.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 169.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 169' ' ' PHE . 29.3 m -113.55 164.07 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -173.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.11 22.59 32.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.519 -172.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 368' ' ' ILE . 3.5 m -106.64 -17.91 7.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 111.046 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -87.68 21.23 2.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.829 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -120.05 -171.41 2.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.863 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.72 -30.38 71.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.128 -173.227 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.37 -40.51 94.57 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.434 -167.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.618 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.04 -38.36 90.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 111.107 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.531 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -61.92 -38.66 89.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.906 174.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.98 -38.79 92.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.05 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.506 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -65.75 -47.76 73.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.51 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.738 HD11 ' HA ' ' A' ' 347' ' ' VAL . 18.8 tp -67.33 -34.51 77.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.802 0.334 . . . . 0.0 110.845 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.471 ' OG1' HG21 ' A' ' 357' ' ' VAL . 89.2 m -64.98 -43.84 91.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.18 177.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 79.9 t80 -65.95 -48.58 70.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.881 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.705 HD23 ' C ' ' A' ' 195' ' ' LEU . 5.2 tt -50.98 -51.28 54.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.974 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 199' ' ' ILE . 27.5 m -64.5 -21.48 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.101 -173.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.3 m-20 -61.03 -33.13 72.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.808 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -80.86 -40.05 25.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.551 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.7 pp -74.37 -28.4 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 172.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.84 -37.66 79.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 173.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -80.04 2.17 24.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 66.41 40.18 3.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.802 166.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -78.98 -15.72 57.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.843 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.551 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.1 ppp? -141.33 155.53 45.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 178.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -94.63 150.04 20.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.26 68.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.044 -175.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -94.96 0.55 54.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.931 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 89.6 m -62.24 125.04 22.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.441 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 13.6 t0 -120.0 -179.65 3.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.844 177.288 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -64.1 -46.05 85.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.99 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.1 p -67.0 -37.09 83.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.82 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.441 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 80.9 mt -65.01 -43.9 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.088 174.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.41 84.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -63.49 -46.4 86.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 176.142 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.91 93.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.01 88.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.115 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -64.02 -42.08 97.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.963 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -66.28 -34.3 77.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -81.96 -23.34 36.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.884 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.43 27.03 26.2 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.448 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -83.46 -20.02 34.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.985 0.421 . . . . 0.0 110.9 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.7 t -131.22 137.54 48.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.133 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.571 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -67.37 -41.98 84.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.012 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 61.6 mtm -137.63 160.84 38.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -177.612 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.3 t -150.26 159.55 44.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.264 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.489 HD12 HD11 ' A' ' 247' ' ' LEU . 49.2 mm -109.24 126.23 66.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -154.97 174.4 15.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.861 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -81.64 -163.71 31.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.41 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.508 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 39.7 Cg_endo -68.61 -22.05 38.54 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.697 2.265 . . . . 0.0 112.281 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 54.1 m0 -70.09 -30.0 67.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.868 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 47.56 45.04 17.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.062 174.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 34.1 m0 -66.26 -16.12 63.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.88 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 74.3 m -53.01 -40.07 63.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.966 0.412 . . . . 0.0 110.875 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -86.36 -177.29 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -173.692 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 77.1 mt -120.08 125.76 74.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.154 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -70.12 -38.73 75.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.773 -175.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 86.7 m -124.96 106.2 9.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 27.9 t -174.06 162.98 3.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 177.319 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -77.8 -19.23 55.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.851 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 23.3 m -60.19 150.67 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.158 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -104.51 140.01 38.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.86 175.171 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.484 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 42.8 p90 -150.01 154.78 38.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.31 160.7 25.13 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.538 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.2 p -138.6 137.34 43.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 0.0 111.154 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.1 t -154.09 146.19 23.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.14 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.6 m -61.33 167.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.929 HD23 ' HD3' ' A' ' 257' ' ' PRO . 3.1 mm? -64.65 144.88 98.8 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.546 0.689 . . . . 0.0 111.077 -163.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.11 -172.12 1.27 Allowed 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.753 2.302 . . . . 0.0 112.487 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 94.7 m -108.82 146.04 34.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.179 -173.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' PHE . . . . . 0.412 ' HB3' ' CD1' ' A' ' 129' ' ' TRP . 43.6 p90 -137.39 126.43 24.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 54.05 35.06 21.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.97 6.97 84.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.48 173.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -133.66 131.34 21.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.634 0.73 . . . . 0.0 110.859 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.47 137.42 25.41 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.674 2.249 . . . . 0.0 112.296 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.76 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 82.3 p -87.04 -1.07 57.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 173.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -39.31 132.99 1.23 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.567 0.699 . . . . 0.0 110.915 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.929 ' HD3' HD23 ' A' ' 247' ' ' LEU . 58.8 Cg_endo -83.22 157.94 15.03 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.607 2.205 . . . . 0.0 112.419 -169.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -75.77 167.24 22.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.865 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 45.5 t -111.24 136.37 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.203 -165.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLY . . . . . 0.414 ' HA2' ' CD2' ' A' ' 64' ' ' HIS . . . -114.41 131.98 10.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.38 172.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 83.7 t -125.08 115.38 43.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.774 0.321 . . . . 0.0 111.196 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -64.92 122.03 16.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.944 -177.749 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 42.6 m -127.53 133.25 49.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.839 -170.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -127.35 140.3 52.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.081 -172.221 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.41 170.77 22.17 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.479 -171.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.7 mm -112.36 128.22 69.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.745 0.307 . . . . 0.0 111.2 -172.134 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -63.31 128.24 34.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.973 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.483 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -60.56 -28.65 68.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.121 -178.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.57 -6.74 59.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.104 -173.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.2 t -79.75 123.16 84.05 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.596 0.712 . . . . 0.0 110.903 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -69.53 -7.16 20.26 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.733 2.289 . . . . 0.0 112.396 169.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -102.1 21.97 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 -167.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -50.12 -36.28 29.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -173.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.3 -39.7 89.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.406 ' HB3' HD23 ' A' ' 7' ' ' LEU . 33.9 mt -66.79 -56.87 8.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 173.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.91 -50.99 36.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.991 -167.583 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -61.21 -40.64 94.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.955 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.9 tt0 -69.34 -47.75 63.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.944 -177.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -66.53 -36.21 82.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.491 ' HA ' HD22 ' A' ' 284' ' ' LEU . 5.4 tt -59.17 -52.39 65.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -177.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 281' ' ' GLU . . . . . 0.4 ' HA ' HD21 ' A' ' 285' ' ' LEU . 24.4 pt-20 -78.66 -30.68 46.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.784 -174.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 63.7 m-80 -100.85 -13.96 18.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 -164.759 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.702 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 52.4 m-85 -126.7 -53.52 1.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.813 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.517 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.3 OUTLIER -61.66 -35.43 77.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.963 -167.363 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 1.076 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.9 pp -124.43 38.23 4.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -175.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.444 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 68.2 p -122.51 164.32 18.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.188 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.458 ' HA ' HD11 ' A' ' 290' ' ' LEU . 38.8 t70 -45.77 -38.0 6.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 -165.275 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -77.15 -42.57 37.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.954 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -71.98 -51.54 14.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 -170.316 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.56 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -74.07 -20.49 60.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.67 0.271 . . . . 0.0 110.892 -178.349 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.544 ' N ' HD12 ' A' ' 290' ' ' LEU . 35.8 tt0 -70.27 -46.45 64.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 171.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.97 -43.99 97.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.011 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.653 HG23 ' HA3' ' A' ' 19' ' ' GLY . 1.8 p -79.95 -30.55 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.236 -176.04 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -68.09 -28.97 67.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.777 170.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.03 -24.81 68.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.944 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -77.02 -43.24 35.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -162.87 135.79 4.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.545 0.688 . . . . 0.0 110.976 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -45.43 114.66 0.76 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.745 2.297 . . . . 0.0 112.42 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 51.2 mt -89.98 -14.85 33.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.894 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 114.92 -59.48 0.41 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.488 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.687 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -173.72 170.15 4.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 111.095 171.678 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.693 HG21 ' HB3' ' A' ' 307' ' ' TYR . 30.8 m -122.68 154.84 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.136 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.23 -10.49 59.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.023 171.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.56 ' CD2' HD21 ' A' ' 290' ' ' LEU . 40.1 tp -83.15 120.35 25.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.843 -177.107 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.16 -40.1 73.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.4 m -65.25 -50.14 66.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.882 -169.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.693 ' HB3' HG21 ' A' ' 302' ' ' VAL . 15.7 t80 -76.9 -29.13 55.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.973 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.09 -40.1 96.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.88 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.53 -35.29 78.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -74.47 -40.25 61.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.687 HD13 ' HA ' ' A' ' 301' ' ' ALA . 77.8 mt -60.91 -32.25 71.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 175.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.93 -19.8 61.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.022 0.439 . . . . 0.0 111.202 -177.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.57 -20.62 66.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.977 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -90.26 121.12 68.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.606 0.717 . . . . 0.0 110.88 166.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.81 -28.29 9.56 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.753 2.302 . . . . 0.0 112.355 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -60.24 -30.44 69.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.2 mp -79.99 -29.99 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.074 -176.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.71 85.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.047 -168.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.75 -47.64 62.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.067 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.563 HG23 ' HB3' ' A' ' 112' ' ' ALA . 26.9 m -61.09 -37.11 81.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.156 -174.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.6 ttp -65.22 -35.49 81.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -64.64 -47.76 77.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.835 -170.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.495 ' H ' HD21 ' A' ' 323' ' ' ASN . 0.1 OUTLIER -83.43 -26.23 30.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 -178.35 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.64 -49.74 72.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.192 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -66.98 -29.86 69.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -109.74 -9.23 14.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -168.24 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.13 -148.87 23.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.458 -166.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -143.32 139.94 30.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.872 0.368 . . . . 0.0 110.824 -171.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 40.6 mm -65.52 122.4 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 59.0 ttm -64.57 137.27 97.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.575 0.702 . . . . 0.0 110.911 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.423 ' HB2' ' HG3' ' A' ' 336' ' ' MET . 34.3 Cg_endo -67.38 128.52 18.46 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.641 2.227 . . . . 0.0 112.3 -176.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.579 ' HB3' ' H ' ' A' ' 65' ' ' ASP . 63.8 t30 -135.91 24.28 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 40.7 pt -78.67 157.0 77.52 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.627 0.727 . . . . 0.0 111.171 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -55.18 -36.18 92.6 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.747 2.298 . . . . 0.0 112.309 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -71.31 -30.56 66.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.904 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.423 ' HG3' ' HB2' ' A' ' 331' ' ' PRO . 74.1 mmm -79.9 -19.05 49.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 -171.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.9 m -61.84 -41.73 98.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.773 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.32 -35.14 61.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.112 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.544 ' O ' HG13 ' A' ' 343' ' ' VAL . 8.2 m-30 -66.41 -40.42 89.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.458 ' HA ' HG22 ' A' ' 343' ' ' VAL . 18.6 m0 -59.01 -35.87 73.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.978 174.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -67.82 -41.88 82.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.95 -44.18 81.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.061 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 339' ' ' PHE . 16.7 m -74.38 -30.87 26.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 -176.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.474 ' O ' HG22 ' A' ' 347' ' ' VAL . 4.9 tmt_? -65.0 -39.38 93.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 175.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.7 m -58.36 -35.74 72.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.89 -43.62 95.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.189 -174.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.738 ' HA ' HD11 ' A' ' 192' ' ' LEU . 3.8 m -73.56 -33.7 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.237 -175.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 348' ' ' ILE . . . . . 0.434 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -63.8 -46.51 94.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.151 173.018 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -65.05 -39.85 93.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.53 62.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.079 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.61 -40.19 80.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.033 -175.627 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.8 p -75.43 -10.71 59.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.11 16.93 73.28 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.54 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.95 -32.82 45.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 0.0 110.854 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -139.59 154.87 47.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.0 p -77.63 168.91 19.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.096 169.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.471 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.7 t -56.04 -42.09 70.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.205 172.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -61.29 -46.53 89.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.857 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -69.71 -53.23 19.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -70.75 -48.3 55.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.06 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.618 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.3 tm? -66.02 -45.63 80.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -173.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.67 -53.07 57.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.972 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -67.23 -47.11 71.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.1 -41.54 94.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.119 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 72.5 mm-40 -78.17 -26.79 47.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.014 -176.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.2 m -64.48 -36.03 82.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.161 171.167 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.01 -30.41 67.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.464 HD12 HG21 ' A' ' 183' ' ' VAL . 67.7 mt -60.4 -38.11 76.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.165 174.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 59.8 p -93.83 -14.85 25.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 178.728 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.73 0.3 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.7 mt -82.55 134.61 26.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.099 175.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -135.83 142.21 44.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.006 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -56.56 135.96 54.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.554 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 98.94 -0.17 57.54 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.518 -174.518 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -162.59 150.87 14.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.831 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.691 HD23 ' H ' ' A' ' 7' ' ' LEU . 0.6 OUTLIER -147.23 156.72 43.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -176.559 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 91.2 t -113.92 131.12 66.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.095 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.901 ' HB ' HD21 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -119.97 126.82 75.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.12 -177.694 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.548 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 47.5 m0 -107.72 131.46 54.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.959 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.47 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 65.9 mt -117.75 142.41 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.078 173.053 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.403 ' O ' HG22 ' A' ' 11' ' ' ILE . 33.2 t30 -47.68 141.08 5.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 172.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.16 -13.03 13.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.569 -172.385 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -78.49 -15.22 58.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 0.0 110.844 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -130.99 112.07 12.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 167.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.75 -96.58 0.84 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.548 -153.035 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -102.97 -43.3 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.886 0.374 . . . . 0.0 110.931 -167.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.752 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 95.7 m-20 -62.49 -50.36 71.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 -157.144 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.7 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -57.8 -47.71 86.88 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 -175.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.901 HD21 ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -57.09 -61.02 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.76 0.314 . . . . 0.0 110.997 175.682 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.39 -40.94 37.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.14 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -65.03 -53.53 44.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.1 m -75.55 -36.06 33.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.179 -175.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.747 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -65.08 -47.22 84.16 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.98 -39.57 72.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.813 0.34 . . . . 0.0 110.861 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.67 -36.9 79.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -64.68 -41.56 95.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.57 -39.39 94.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.888 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -67.33 -33.84 76.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.879 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -89.32 -44.1 10.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.845 -170.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.559 ' OG1' HG13 ' A' ' 33' ' ' ILE . 66.6 p -110.73 -12.69 14.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.195 -171.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.53 7.23 87.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.589 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.849 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.4 pp -99.01 133.51 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.078 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -82.62 140.28 33.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.96 -173.027 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.747 HG21 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -118.09 134.61 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.14 -177.411 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.2 m -102.52 127.15 49.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.162 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.521 HG22 ' HG ' ' A' ' 20' ' ' LEU . 61.9 t -95.24 120.98 45.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.159 177.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.548 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 66.4 mm-40 -129.98 133.77 47.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.816 170.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -142.19 57.43 6.57 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.622 0.725 . . . . 0.0 110.873 174.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.01 -23.59 7.67 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.74 2.294 . . . . 0.0 112.369 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t0 62.63 20.77 12.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -170.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 45' ' ' GLU . 98.9 mttt -85.22 2.85 42.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.958 169.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.3 mt -43.45 -47.86 7.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -171.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.86 -36.87 77.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 42' ' ' LYS . 89.0 tt0 -74.54 -36.38 63.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -78.95 -29.98 44.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.506 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 9.8 m-30 -45.16 -55.58 11.06 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.664 0.745 . . . . 0.0 110.851 -175.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.4 Cg_endo -68.68 -27.2 32.33 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.795 2.33 . . . . 0.0 112.317 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -79.4 -44.02 22.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.881 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.8 m -68.02 -30.52 48.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.154 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.37 79.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 172.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.42 -30.92 67.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.062 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.5 p -92.66 -12.33 31.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.169 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.45 15.27 81.31 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.462 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -161.08 154.21 21.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.862 0.363 . . . . 0.0 110.877 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.436 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . -162.76 -138.14 2.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.409 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.518 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 72.6 Cg_endo -68.62 155.88 67.4 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.621 2.214 . . . . 0.0 112.395 169.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.48 -38.03 26.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.729 ' HB ' HG23 ' A' ' 9' ' ' ILE . 4.1 mp -128.4 138.01 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.079 176.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.5 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 1.9 tp -130.36 129.06 64.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.169 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.567 ' CE2' HG13 ' A' ' 108' ' ' ILE . 2.5 m-85 -98.62 141.25 31.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.819 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.5 ' CZ2' HG23 ' A' ' 60' ' ' ILE . 8.6 m-90 -118.12 139.96 50.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.54 -83.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.198 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.414 ' HB3' ' SD ' ' A' ' 330' ' ' MET . 98.2 m-70 -128.0 -57.22 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.835 170.088 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -85.36 -26.61 26.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.778 -170.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.492 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 98.7 mtt180 -59.94 -29.97 68.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 -158.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -67.99 -28.31 67.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -169.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.12 -51.48 52.65 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.433 -172.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.85 -36.99 92.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.482 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.536 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 17.4 t80 -66.53 -37.74 85.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.879 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.54 -44.43 62.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -62.66 -33.31 74.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.5 p -80.33 -10.76 59.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.932 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.22 32.44 68.85 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.454 174.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 1.7 mp -86.34 1.24 51.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 0.0 110.905 -172.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.536 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.7 OUTLIER -131.93 159.86 37.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.949 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -68.36 130.63 43.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.034 174.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -69.99 123.35 21.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.937 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.6 pt -108.78 159.97 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.053 -172.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.1 p -103.49 146.64 32.86 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.604 0.716 . . . . 0.0 111.169 -171.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.73 146.87 30.61 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.747 2.298 . . . . 0.0 112.354 -177.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -108.08 116.09 31.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.55 -35.86 61.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.18 95.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -70.03 -38.23 75.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.855 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -54.92 -48.03 73.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.02 -36.39 83.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.85 -20.09 58.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -104.02 -103.36 0.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -173.137 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 46.2 t80 -166.82 134.56 2.1 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.649 0.738 . . . . 0.0 110.883 -172.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 68.0 Cg_exo -52.29 -39.71 71.79 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.738 2.292 . . . . 0.0 112.393 -170.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -77.76 -30.62 51.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.96 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.3 m -69.63 -48.94 58.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 -165.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.46 ' HA ' HG22 ' A' ' 97' ' ' VAL . 53.8 p-90 -66.23 -28.74 68.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.888 178.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -71.33 -37.48 71.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.813 175.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.86 -25.1 64.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.119 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.523 HG23 HD22 ' A' ' 103' ' ' LEU . 21.5 m -101.16 16.36 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.135 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 67.9 ttt180 -101.52 132.58 47.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -148.15 130.56 15.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.1 t30 68.61 36.43 2.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.16 -4.6 66.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.464 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -140.04 164.34 30.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.853 0.359 . . . . 0.0 110.885 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.523 HD22 HG23 ' A' ' 97' ' ' VAL . 12.9 mt -73.83 146.49 44.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 -175.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.424 HD12 ' C ' ' A' ' 104' ' ' ILE . 2.0 pp -122.48 8.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.138 174.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.753 ' HB1' ' HB3' ' A' ' 263' ' ' SER . . . -168.45 158.54 9.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.02 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -125.15 151.24 69.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.722 0.773 . . . . 0.0 110.96 164.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.408 ' HB3' HG11 ' A' ' 261' ' ' VAL . 59.3 Cg_endo -72.39 121.1 7.18 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.648 2.232 . . . . 0.0 112.384 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.567 HG13 ' CE2' ' A' ' 61' ' ' PHE . 24.6 mm -98.1 -32.84 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.089 176.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.02 153.35 27.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 -177.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.1 t -117.51 133.76 63.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.14 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -119.5 129.24 54.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.934 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -149.84 158.82 44.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.732 HD23 ' HA3' ' A' ' 228' ' ' GLY . 59.3 mt -99.61 158.37 15.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.042 -173.227 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.0 p -153.53 160.01 42.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.865 HD13 ' O ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.8 124.16 44.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.955 175.578 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.614 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.3 mp -106.28 133.71 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.163 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -133.15 147.77 52.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.957 -176.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -97.6 115.6 28.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.63 -16.37 63.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 21.5 t70 -80.16 -33.78 38.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.6 mp -88.67 -45.34 9.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.942 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.529 HD22 ' HB1' ' A' ' 223' ' ' ALA . 3.0 mp -108.47 130.88 22.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.537 0.684 . . . . 0.0 110.894 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.44 -30.5 15.2 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.677 2.251 . . . . 0.0 112.345 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -153.87 89.93 3.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.56 0.695 . . . . 0.0 110.973 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.479 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 51.1 Cg_exo -58.21 139.56 90.95 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.678 2.252 . . . . 0.0 112.383 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 125' ' ' PRO . 62.6 Cg_exo -54.98 146.53 57.24 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.245 . . . . 0.0 112.327 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -100.65 -0.82 36.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 176.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.9 p -132.95 157.06 46.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.04 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -71.36 -25.32 62.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.967 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -66.36 -35.54 80.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -172.218 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -83.42 -9.98 58.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.612 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 47.0 mm -58.99 -52.64 73.42 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.628 0.728 . . . . 0.0 111.219 -172.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 28.6 Cg_endo -61.03 -38.85 64.98 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.737 2.291 . . . . 0.0 112.31 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.88 -60.51 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.177 ' O ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.53 -17.03 64.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -175.364 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.626 ' HA ' HD22 ' A' ' 139' ' ' LEU . 38.7 t70 -60.9 -38.47 85.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 168.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.81 -37.18 85.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.945 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.91 -49.72 23.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -75.14 -16.98 60.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -176.592 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.667 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.6 tttt -57.46 -34.97 69.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.961 171.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.0 -24.53 67.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.121 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.8 7.89 44.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.87 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.01 28.62 62.11 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.509 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.427 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 46.9 mtmt -117.79 168.61 10.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.391 . . . . 0.0 110.821 174.301 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.9 t -129.46 137.38 50.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.82 176.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.441 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -70.06 -57.67 4.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.087 -165.181 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -137.53 126.82 24.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.954 -167.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 92.7 mmm -103.25 126.16 50.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.809 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -155.65 165.04 37.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -126.22 144.21 50.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.905 171.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.473 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 48.3 tp -113.44 -2.59 13.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 -175.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -69.39 -10.06 56.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.26 151.74 51.45 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 121.704 0.764 . . . . 0.0 110.811 -175.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.526 ' HD3' ' HD2' ' A' ' 344' ' ' ARG . 30.4 Cg_endo -66.05 -18.5 56.86 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.634 2.223 . . . . 0.0 112.389 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -59.63 -39.49 84.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.957 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -83.76 -38.38 21.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.864 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.4 p -64.19 -38.89 92.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.121 -173.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.561 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 11.0 t-105 -63.6 -54.23 44.65 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.556 0.694 . . . . 0.0 110.943 -170.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 33.3 Cg_endo -68.48 -32.07 25.98 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.729 2.286 . . . . 0.0 112.385 -172.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 160' ' ' LEU . 7.1 tt -74.51 -40.78 61.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.619 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 75.9 mt -68.28 -40.16 82.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.141 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.54 -27.09 63.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.069 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.35 -33.02 70.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.024 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASP . . . . . 0.518 ' HA ' ' HD3' ' A' ' 251' ' ' LYS . 66.0 m-20 -91.3 -9.0 46.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.837 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.52 3.37 9.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.511 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.63 66.53 3.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.406 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -90.0 151.26 21.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 110.968 -174.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . 0.485 ' HB3' ' SD ' ' A' ' 336' ' ' MET . . . -76.42 -6.89 53.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.003 -176.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -155.0 155.04 33.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.974 0.416 . . . . 0.0 110.873 -173.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -98.91 129.3 45.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 156.536 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -95.69 124.06 39.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -149.97 129.81 13.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.3 t30 57.1 44.98 21.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.908 171.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.41 7.82 73.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.408 172.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -132.91 140.92 48.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.831 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.415 ' N ' ' HD1' ' A' ' 176' ' ' TYR . 3.4 m-30 -79.29 132.94 36.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.991 166.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -94.12 105.01 17.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.6 tp -67.0 -19.23 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -95.13 -7.35 39.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -135.15 96.01 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.805 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.468 HG23 HG22 ' A' ' 183' ' ' VAL . 32.6 m -116.91 172.38 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -102.52 14.69 56.45 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.516 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.542 HG21 ' CD1' ' A' ' 368' ' ' ILE . 17.6 m -100.1 -17.05 6.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.83 0.347 . . . . 0.0 111.126 -175.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.487 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 57.9 p-10 -96.62 19.74 11.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.015 175.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -116.04 173.68 6.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.898 -174.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.39 -27.6 69.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.102 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.67 -40.27 90.31 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.551 -170.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.587 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.46 -41.19 93.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 111.041 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.496 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 91.9 mttt -60.8 -36.4 78.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.889 173.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.3 -37.05 86.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.01 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.619 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.51 -47.18 86.75 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.42 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.592 HD11 ' HA ' ' A' ' 347' ' ' VAL . 15.9 tp -68.19 -31.24 70.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.913 0.387 . . . . 0.0 110.99 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.426 ' O ' HG12 ' A' ' 196' ' ' VAL . 84.8 m -64.53 -42.87 95.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.04 176.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -67.05 -57.52 6.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.876 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.61 ' C ' HD12 ' A' ' 195' ' ' LEU . 3.6 pp -63.19 -27.8 69.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.926 -167.523 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.568 ' N ' HD12 ' A' ' 195' ' ' LEU . 1.3 p -74.27 -22.21 17.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.135 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -65.57 -58.34 6.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 1.034 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.66 -22.37 56.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -167.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.798 ' N ' HD22 ' A' ' 198' ' ' LEU . 2.2 pp -80.92 -33.53 13.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 172.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.38 -33.02 74.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 169.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -84.48 4.81 30.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.862 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 66.4 39.98 3.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -82.3 -11.17 58.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 172.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.489 ' CG ' HG22 ' A' ' 199' ' ' ILE . 5.1 ppp? -140.14 153.18 46.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 175.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -97.05 157.5 15.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 -177.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.21 -24.28 67.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.147 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -94.85 -1.81 52.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.1 m -64.02 131.7 48.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.204 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -149.25 174.22 12.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -177.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -79.76 -31.43 40.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.833 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 94.8 p -71.72 -39.46 70.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.871 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 36.6 pt -66.37 -22.28 29.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.135 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.65 -30.01 71.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.069 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -57.46 -44.02 84.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.847 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.02 -36.36 84.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.106 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.95 -36.44 81.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.097 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -64.09 -42.42 96.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -64.89 -33.79 76.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -89.18 -22.31 22.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.42 29.92 23.36 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.508 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.19 -30.12 16.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.383 . . . . 0.0 110.945 -171.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 52.8 m -110.08 125.35 52.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.093 -170.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.529 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -71.16 -48.97 48.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.149 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' A' ' 116' ' ' ILE . 68.5 mtm -133.55 146.65 51.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -172.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 226' ' ' ILE . 80.7 m -145.01 152.37 40.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.126 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' ILE . . . . . 0.406 ' N ' HG22 ' A' ' 225' ' ' THR . 40.6 mm -111.52 120.33 61.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -161.87 170.52 19.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.798 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.732 ' HA3' HD23 ' A' ' 113' ' ' LEU . . . -130.26 -107.54 1.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.488 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.51 -16.48 42.96 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.728 2.285 . . . . 0.0 112.288 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -66.94 -30.03 70.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 54.02 49.59 18.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -66.1 -27.75 68.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.8 m -65.08 142.8 58.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 -175.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -100.0 -175.27 2.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 174.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.2 mt 59.96 74.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.163 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -54.72 -46.85 74.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 52.8 p -85.59 175.82 8.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.154 -174.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 96.3 p -75.66 -6.09 48.75 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.88 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -59.68 167.6 2.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.888 177.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 240' ' ' VAL . 12.6 t 55.0 38.63 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 -173.906 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.508 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 70.1 m-20 45.03 69.8 0.4 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -127.57 132.68 49.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.927 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.37 157.86 23.74 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.474 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.429 HG23 HG13 ' A' ' 116' ' ' ILE . 2.5 p -143.15 140.01 26.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.959 0.409 . . . . 0.0 111.067 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.3 t -153.93 150.11 27.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.544 HG11 ' HB2' ' A' ' 323' ' ' ASN . 31.3 m -61.92 168.87 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.617 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.9 mm? -61.15 145.4 89.91 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.742 0.782 . . . . 0.0 110.837 -160.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.37 -177.01 2.75 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.76 2.306 . . . . 0.0 112.392 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 63.6 p -109.14 160.05 16.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.03 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -145.26 128.24 16.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.865 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' LYS . . . . . 0.67 ' HG2' ' O ' ' A' ' 251' ' ' LYS . 81.0 tttt 55.49 36.04 26.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 -177.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.06 8.36 82.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.536 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -134.68 139.37 32.23 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.58 0.705 . . . . 0.0 110.98 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.6 142.61 29.43 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.693 2.262 . . . . 0.0 112.343 -175.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.617 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 89.5 p -83.51 -5.02 59.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 169.502 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -41.95 125.69 2.6 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.522 0.677 . . . . 0.0 111.025 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.673 ' HG3' ' HB2' ' A' ' 113' ' ' LEU . 84.4 Cg_endo -86.94 164.91 8.78 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.704 2.269 . . . . 0.0 112.319 -174.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -75.01 170.03 16.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 175.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.412 HG21 ' HA ' ' A' ' 324' ' ' ALA . 99.0 t -103.87 134.98 43.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.106 -170.072 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.54 140.69 15.47 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.536 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.408 HG11 ' HB3' ' A' ' 107' ' ' PRO . 90.4 t -126.64 126.94 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.868 0.366 . . . . 0.0 111.133 -176.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.424 HD23 ' N ' ' A' ' 263' ' ' SER . 2.0 tt -70.07 130.6 42.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.923 166.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.753 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 67.7 m -119.04 149.21 42.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.811 -175.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -133.81 139.62 46.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.087 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.485 ' HA3' ' HH2' ' A' ' 62' ' ' TRP . . . -142.31 171.52 24.61 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.508 -175.737 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 30.8 mm -113.33 130.39 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 111.089 -171.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -69.29 132.63 46.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -65.61 -24.99 67.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.048 -176.24 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.73 -11.96 58.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 -171.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.7 t -70.45 120.04 76.14 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.67 0.748 . . . . 0.0 110.929 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.72 -15.72 21.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.721 2.28 . . . . 0.0 112.305 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -114.74 30.93 7.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -61.67 -24.36 66.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -168.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -64.07 -40.55 96.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.798 -169.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.6 pp -78.81 -32.17 46.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 59' ' ' ILE . . . -65.13 -45.9 83.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.018 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -69.53 -33.3 72.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.919 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.88 -50.06 73.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -172.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.482 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 1.9 p90 -68.64 -33.59 74.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 -176.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 280' ' ' LEU . 8.4 tt -62.66 -47.62 82.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.901 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.4 -39.52 67.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -99.93 -12.73 19.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -161.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.509 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 69.5 t80 -123.73 -51.33 1.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 2.1 mp -67.3 -46.01 74.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.849 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.34 48.75 1.32 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 169.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.439 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 80.5 m -146.47 145.27 30.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.194 176.233 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.435 ' HA ' HD11 ' A' ' 290' ' ' LEU . 49.5 t0 -42.57 -35.03 0.97 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.842 -175.788 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -74.69 -43.64 54.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.847 -174.221 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.97 -52.04 9.63 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.453 -171.015 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.685 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.7 OUTLIER -72.05 -22.54 61.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.336 . . . . 0.0 110.943 -177.869 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.512 ' N ' HD12 ' A' ' 290' ' ' LEU . 86.5 tt0 -67.13 -41.37 86.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 169.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.59 84.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.069 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.7 HG13 ' HA3' ' A' ' 19' ' ' GLY . 46.4 t -75.66 -45.54 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 -178.403 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -65.31 -35.09 79.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.98 -32.15 73.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 -173.424 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.752 ' HB3' ' HB3' ' A' ' 18' ' ' ASN . 63.8 m-20 -99.77 -35.19 9.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 -174.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.435 ' O ' HD13 ' A' ' 299' ' ' LEU . 46.9 tptt -129.11 124.45 22.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.563 0.697 . . . . 0.0 110.947 170.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -52.3 108.02 0.22 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.743 2.295 . . . . 0.0 112.281 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 297' ' ' LYS . 2.2 mp -92.26 -28.67 16.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 175.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.1 -55.9 1.81 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.466 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -174.27 168.53 3.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.0 111.094 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.586 ' CG2' ' HB3' ' A' ' 307' ' ' TYR . 32.2 m -135.0 161.84 39.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.126 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.44 -10.19 59.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.027 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.685 ' CD2' HD21 ' A' ' 290' ' ' LEU . 61.2 tp -79.75 129.43 34.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.866 -174.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -42.99 -31.93 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.899 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.443 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 70.6 m -47.83 -38.77 16.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.846 175.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.586 ' HB3' ' CG2' ' A' ' 302' ' ' VAL . 0.1 OUTLIER -58.99 -45.62 90.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.918 173.303 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.48 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 88.1 tt0 -56.96 -37.71 71.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.855 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -79.91 -64.1 1.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.833 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -85.01 -58.89 2.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -171.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 307' ' ' TYR . 56.0 mt -62.66 -32.62 73.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -168.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.1 -12.78 54.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.057 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.95 -18.31 64.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.838 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.498 ' HB3' HD12 ' A' ' 317' ' ' ILE . 58.2 t0 -78.88 121.23 83.18 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.616 0.722 . . . . 0.0 110.819 167.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.85 -36.4 15.19 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.647 2.231 . . . . 0.0 112.327 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 94.7 mtm-85 -73.12 -36.5 66.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.498 HD12 ' HB3' ' A' ' 314' ' ' ASP . 74.3 mt -77.07 -29.98 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.41 91.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.085 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.98 -48.56 73.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.076 175.373 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 68.9 p -67.58 -26.55 66.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.082 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 63.8 ttp -58.31 -37.28 74.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.866 173.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -67.36 -45.07 77.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.806 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.544 ' HB2' HG11 ' A' ' 246' ' ' VAL . 29.8 t30 -63.49 -36.53 84.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 176.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' A' ' 259' ' ' VAL . . . -65.03 -47.56 76.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.032 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -71.48 -34.17 69.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.7 -3.7 42.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.938 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -106.17 -162.25 22.74 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.465 -174.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.67 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 94.9 mt-10 -143.64 139.93 29.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.838 0.351 . . . . 0.0 110.779 -171.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.587 ' O ' ' C ' ' A' ' 330' ' ' MET . 41.2 mm -81.32 112.78 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.148 -172.287 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.587 ' C ' ' O ' ' A' ' 329' ' ' ILE . 71.6 mtm 23.89 56.68 0.31 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.583 0.706 . . . . 0.0 110.823 174.369 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.67 ' HG3' ' HB3' ' A' ' 328' ' ' GLU . 42.8 Cg_endo -96.59 -7.3 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.658 2.239 . . . . 0.0 112.339 -169.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.602 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 90.2 m-20 -95.0 2.05 55.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.941 -155.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.631 HG22 ' H ' ' A' ' 335' ' ' GLN . 45.7 mm 87.56 133.23 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.62 0.724 . . . . 0.0 111.128 173.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.07 -22.48 73.4 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.686 2.257 . . . . 0.0 112.396 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.631 ' H ' HG22 ' A' ' 333' ' ' ILE . 99.2 mm-40 -60.65 -17.72 49.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.485 ' SD ' ' HB3' ' A' ' 168' ' ' ALA . 37.6 mmt -62.2 -26.04 68.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 -174.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.5 m -57.92 -36.86 73.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.814 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.59 -36.68 73.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.542 ' O ' HG13 ' A' ' 343' ' ' VAL . 45.5 m-85 -65.25 -44.23 88.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.814 174.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -64.96 -39.25 93.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.925 -176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -67.6 -47.39 69.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.72 -42.42 97.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 339' ' ' PHE . 7.7 m -80.98 -23.08 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.526 ' HD2' ' HD3' ' A' ' 154' ' ' PRO . 57.6 ttt180 -57.41 -56.56 20.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 81.5 p -60.68 -25.69 66.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.066 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.511 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -60.08 -41.13 91.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.592 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.5 m -73.11 -32.95 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.061 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.05 -45.24 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -64.35 -36.17 83.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.61 -46.15 60.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.113 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.38 88.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 -175.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 92.8 p -74.98 -10.79 59.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.904 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.4 15.02 81.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.549 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.85 -31.79 45.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.71 0.29 . . . . 0.0 110.761 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -138.25 154.78 49.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.895 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.7 p -79.73 167.53 20.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.184 169.087 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.421 ' HA ' HD23 ' A' ' 192' ' ' LEU . 55.6 t -54.98 -42.04 61.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -59.11 -46.43 88.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 177.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -71.7 -53.22 14.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.81 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -67.99 -43.75 78.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -171.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -67.54 -40.71 84.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 -178.58 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.82 -39.69 93.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 173.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.2 -38.9 90.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.865 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.511 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -63.44 -42.24 98.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 173.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.487 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 23.3 tm0? -64.47 -36.83 85.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.052 0.453 . . . . 0.0 110.885 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 370' ' ' LYS . 93.2 m -67.01 -40.44 87.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 177.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -67.51 -35.02 78.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.847 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.542 ' CD1' HG21 ' A' ' 183' ' ' VAL . 62.2 mt -63.38 -40.13 87.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.079 0.466 . . . . 0.0 111.229 176.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.8 p -93.81 -10.92 32.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.174 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 366' ' ' THR . 99.6 mttt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.9 mt -85.9 132.19 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -135.4 143.97 46.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.934 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -55.67 134.13 51.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.431 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 94.94 2.01 62.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.519 -176.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.5 tttt -164.97 138.2 4.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.947 0.403 . . . . 0.0 110.851 174.308 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.55 HD23 ' H ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -146.68 157.4 43.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.823 -173.821 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 86.6 t -114.5 133.47 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 -177.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.825 HD13 HD11 ' A' ' 20' ' ' LEU . 1.3 mp -119.28 125.81 74.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.596 ' CE3' ' HG3' ' A' ' 57' ' ' PRO . 45.1 m0 -106.02 128.97 54.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 178.202 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 12' ' ' ASN . 68.0 mt -122.1 141.45 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.168 172.223 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.417 ' O ' HG22 ' A' ' 11' ' ' ILE . 65.0 t30 -49.19 141.77 7.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 172.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.51 ' HA3' ' OD2' ' A' ' 41' ' ' ASP . . . -57.72 -11.14 7.32 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 -172.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -71.93 -17.07 62.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 110.868 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -129.92 111.2 12.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 161.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.98 -90.47 0.83 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.504 -159.472 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -101.71 -41.65 6.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.833 -172.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.78 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 85.2 m-20 -63.56 -53.58 49.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.804 -156.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.717 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -59.86 -48.07 87.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.503 -175.326 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.825 HD11 HD13 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -55.35 -60.97 2.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.0 110.914 175.66 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.21 -41.37 60.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -176.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -65.17 -54.24 32.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.65 -35.7 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.429 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -65.04 -41.88 96.98 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 176.458 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.01 -41.26 82.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 110.892 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -64.39 -39.62 94.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.26 -45.81 89.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.953 178.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -68.44 -38.97 81.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.806 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.38 -37.05 82.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -82.1 -39.27 23.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -169.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.539 ' OG1' HG13 ' A' ' 33' ' ' ILE . 71.2 p -109.94 -11.17 14.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.178 -174.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.44 14.04 82.59 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.462 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.127 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 pp -104.82 125.09 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.926 0.393 . . . . 0.0 111.029 -177.014 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.3 mttt -71.61 135.93 47.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 -168.31 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.539 HG12 HD21 ' A' ' 7' ' ' LEU . 8.4 m -110.7 135.45 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.046 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.405 ' O ' HD12 ' A' ' 9' ' ' ILE . 97.7 m -107.62 128.54 54.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.186 176.802 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.535 HG22 ' HG ' ' A' ' 20' ' ' LEU . 71.0 t -96.76 120.79 46.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.577 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 68.3 mm-40 -130.53 144.62 51.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.841 172.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -156.71 58.61 1.66 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.543 0.687 . . . . 0.0 110.79 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.462 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 77.6 Cg_endo -81.84 -13.23 10.6 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.719 2.28 . . . . 0.0 112.382 -171.01 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.51 ' OD2' ' HA3' ' A' ' 13' ' ' GLY . 20.8 m-20 63.06 20.05 12.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -171.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 45' ' ' GLU . 98.0 mttt -91.06 0.96 57.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 174.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.2 mt -43.69 -50.15 7.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -170.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.16 -36.56 82.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 42' ' ' LYS . 99.1 mt-10 -74.96 -33.17 61.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 69.8 mmtt -82.57 -29.98 29.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.936 -175.204 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.511 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 11.6 m-30 -40.18 -56.01 3.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.626 0.727 . . . . 0.0 110.783 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 57.3 Cg_endo -69.13 -28.09 28.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.313 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -79.08 -43.62 23.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 -172.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.8 m -65.69 -30.6 50.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.75 -36.04 79.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 172.398 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.13 -31.25 68.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.966 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 p -93.02 -11.45 33.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.112 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.47 15.27 81.32 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.469 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -164.86 159.05 17.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.953 0.406 . . . . 0.0 110.812 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.7 -140.33 2.85 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.321 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.596 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 72.6 Cg_endo -67.8 148.57 77.33 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.664 2.243 . . . . 0.0 112.354 168.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -74.32 -39.07 63.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.63 ' HB ' HG23 ' A' ' 9' ' ' ILE . 3.7 mp -126.13 138.71 53.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 176.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.47 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 1.8 tp -131.39 130.06 62.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.09 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.515 ' CE2' HG13 ' A' ' 108' ' ' ILE . 4.3 m-85 -98.63 140.31 33.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.785 176.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.529 ' CH2' ' HA3' ' A' ' 265' ' ' GLY . 9.1 m-90 -116.99 140.09 49.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 262' ' ' LEU . . . -57.99 -82.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.129 -176.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -126.41 -58.21 1.35 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.989 166.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -86.11 -24.35 26.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.807 -167.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 97.0 mtt180 -59.87 -29.72 68.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.981 -160.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -68.08 -27.68 66.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.923 -170.65 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.32 -51.36 53.22 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.434 -172.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.7 -35.91 91.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.537 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 15.2 t80 -65.68 -38.12 88.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.866 0.365 . . . . 0.0 110.887 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.51 -44.03 58.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.085 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -62.39 -31.78 72.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -80.87 -11.95 59.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.99 176.055 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.8 32.08 64.24 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.515 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 1.8 mp -86.3 -3.04 58.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.829 0.347 . . . . 0.0 110.862 -172.63 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.541 ' C ' ' HB2' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -127.85 154.38 45.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 -177.381 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.627 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -73.94 136.86 43.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.127 175.131 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -71.02 131.37 43.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.903 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.468 HD12 ' CE2' ' A' ' 106' ' ' TYR . 33.6 pt -110.19 159.76 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 70.1 p -105.87 147.6 35.03 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.663 0.744 . . . . 0.0 111.087 -172.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.76 145.78 29.3 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.689 2.259 . . . . 0.0 112.301 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -112.96 112.03 23.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 170.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.58 -37.4 62.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.947 -178.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.95 94.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.549 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 18.6 m-30 -68.8 -49.51 57.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.822 178.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -53.74 -40.08 65.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.913 -176.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -57.69 -32.29 67.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.07 -15.28 54.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 61.8 mt -105.0 -104.95 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -167.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 40.6 t80 -165.23 133.94 2.61 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.675 0.75 . . . . 0.0 110.953 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 71.3 Cg_exo -52.89 -39.91 76.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.748 2.299 . . . . 0.0 112.372 -171.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -80.08 -28.13 39.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.0 m -69.92 -48.31 59.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.086 -167.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.479 ' HA ' HG22 ' A' ' 97' ' ' VAL . 53.8 p-90 -66.96 -28.96 68.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.898 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -70.69 -35.97 73.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.74 -25.9 65.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.506 HG23 HD22 ' A' ' 103' ' ' LEU . 19.8 m -101.27 17.71 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.177 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 67.5 ttt180 -102.56 133.67 47.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.972 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -147.89 130.11 15.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.827 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.6 t30 67.16 35.68 4.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.928 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.78 -4.25 66.09 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.539 174.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -133.96 159.99 39.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.33 . . . . 0.0 110.943 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.506 HD22 HG23 ' A' ' 97' ' ' VAL . 13.8 mt -73.51 144.82 46.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pp -122.17 6.81 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.19 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.678 ' HB1' ' HB3' ' A' ' 263' ' ' SER . . . -167.83 159.3 11.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.051 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.468 ' CE2' HD12 ' A' ' 79' ' ' ILE . 62.1 m-85 -117.25 147.44 40.45 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.689 0.757 . . . . 0.0 110.928 164.064 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.516 ' HB3' HG11 ' A' ' 261' ' ' VAL . 59.6 Cg_endo -72.36 118.09 5.44 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.666 2.244 . . . . 0.0 112.358 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.515 HG13 ' CE2' ' A' ' 61' ' ' PHE . 30.8 mm -96.29 -36.88 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -151.93 154.67 36.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.083 -176.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.44 134.95 63.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.018 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -118.07 129.76 55.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -150.92 157.12 42.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.113 177.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.635 ' HB2' ' HG3' ' A' ' 257' ' ' PRO . 7.4 mp -108.49 156.92 18.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 -172.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.1 p -150.39 161.19 42.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.929 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.899 HD13 ' O ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.22 124.3 44.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 175.922 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.71 HG13 HG23 ' A' ' 244' ' ' VAL . 4.6 mp -109.0 132.76 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.072 -174.605 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -133.08 148.28 52.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 -173.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -97.4 115.91 28.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.806 174.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -66.55 -15.84 63.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.781 172.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.537 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 22.8 t70 -80.87 -33.99 34.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.885 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 mp -87.9 -45.0 10.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.041 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.439 HD22 ' HB1' ' A' ' 223' ' ' ALA . 2.1 mp -106.08 127.62 27.97 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.545 0.688 . . . . 0.0 110.897 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.31 -30.09 16.14 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.732 2.288 . . . . 0.0 112.343 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -148.9 90.0 4.85 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.61 0.719 . . . . 0.0 110.944 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.51 144.97 90.84 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.668 2.245 . . . . 0.0 112.351 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.58 153.31 73.82 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.689 2.26 . . . . 0.0 112.336 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -107.72 -3.96 18.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.847 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.6 p -133.94 159.02 42.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.148 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.428 ' HA ' HG12 ' A' ' 132' ' ' ILE . 64.4 m95 -72.2 -24.65 61.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.4 -30.02 70.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.05 -19.31 60.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.85 -177.471 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.604 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 49.8 mm -61.49 -53.52 61.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.716 0.769 . . . . 0.0 111.138 -165.346 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 22.6 Cg_endo -61.7 -40.03 48.91 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.635 2.223 . . . . 0.0 112.276 -176.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.24 -60.67 2.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.065 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.178 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.52 -16.5 63.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.862 -174.462 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.629 ' HA ' HD22 ' A' ' 139' ' ' LEU . 38.7 t70 -61.74 -38.9 89.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.848 168.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.87 -36.44 82.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -73.6 -49.79 24.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.726 -174.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.662 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -74.97 -15.94 60.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -176.654 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.662 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.8 tttt -56.43 -34.92 67.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.928 171.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.99 -23.75 67.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -94.32 7.99 43.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.95 27.41 64.6 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.415 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.417 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 45.5 mtmt -119.94 169.5 10.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.4 . . . . 0.0 110.863 173.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.52 ' HA ' HD21 ' A' ' 139' ' ' LEU . 33.5 t -133.1 143.95 49.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 172.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 224' ' ' MET . . . -71.98 -54.12 10.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.101 -162.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -139.65 125.47 19.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.948 -165.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.422 ' SD ' ' HB2' ' A' ' 213' ' ' ALA . 57.6 ttm -106.28 129.22 54.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.891 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -154.71 164.24 39.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -122.81 142.92 50.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.942 171.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.495 ' O ' ' HG ' ' A' ' 151' ' ' LEU . 50.8 tp -111.4 -0.13 16.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 -176.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -74.17 -6.04 45.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.936 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -119.73 150.18 49.85 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 121.679 0.752 . . . . 0.0 110.905 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.54 -18.82 64.13 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.632 2.221 . . . . 0.0 112.417 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -61.75 -37.21 83.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.927 -173.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -82.89 -40.17 20.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 23.6 p -63.77 -38.66 91.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.101 -175.269 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.581 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 22.2 t-105 -62.98 -54.44 46.56 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.567 0.699 . . . . 0.0 110.911 -168.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 28.5 Cg_endo -66.87 -32.19 36.75 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.696 2.264 . . . . 0.0 112.37 -172.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 160' ' ' LEU . 6.4 tt -74.69 -41.04 60.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.53 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 74.4 mt -70.48 -40.89 77.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.109 177.909 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.96 -26.14 63.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.45 -29.46 70.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.126 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -91.29 2.75 56.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 104.99 7.05 39.05 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.56 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -79.02 65.06 3.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.359 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -90.22 146.2 24.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.863 0.363 . . . . 0.0 110.911 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.42 -15.35 63.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.063 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -164.42 150.07 10.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.841 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -81.74 128.18 33.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.937 163.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -100.79 120.5 40.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.921 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -149.72 133.2 16.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.881 -173.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 61.9 t30 57.51 43.42 22.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.04 7.25 70.47 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.499 173.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -134.9 145.29 48.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.785 0.326 . . . . 0.0 110.888 -177.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -78.66 143.24 36.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 168.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -107.18 105.98 16.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.8 tp -71.28 -18.03 20.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.14 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -94.61 -8.99 36.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -177.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -129.56 93.05 3.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 172.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.9 m -114.01 167.62 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.128 -175.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.58 13.35 54.09 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.486 -171.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.512 HG11 ' CD1' ' A' ' 368' ' ' ILE . 33.7 m -104.85 -16.91 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.318 . . . . 0.0 111.096 -173.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.42 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 57.9 p-10 -95.09 18.07 12.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.934 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -115.91 172.86 6.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.88 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.21 -26.71 68.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.209 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.11 -41.28 92.68 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.526 -170.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.625 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.08 -40.6 94.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 111.02 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.49 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.1 mttt -60.83 -37.1 80.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 173.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.5 87.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.121 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.72 -46.02 91.06 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.421 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.591 HD11 ' HA ' ' A' ' 347' ' ' VAL . 22.6 tp -68.64 -34.8 76.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.922 0.391 . . . . 0.0 110.993 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.406 ' O ' HG12 ' A' ' 196' ' ' VAL . 85.4 m -61.83 -42.26 98.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -68.07 -56.99 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.676 ' C ' HD12 ' A' ' 195' ' ' LEU . 2.6 pp -63.64 -27.5 69.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 -165.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.553 ' N ' HD12 ' A' ' 195' ' ' LEU . 4.5 p -72.65 -22.85 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.182 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -66.03 -58.22 5.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -174.096 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 1.057 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.5 -24.25 56.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -167.474 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.801 ' N ' HD22 ' A' ' 198' ' ' LEU . 2.0 pp -77.46 -35.64 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.15 172.432 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.02 -30.36 70.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.8 168.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -84.65 5.37 28.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.878 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 66.07 40.06 4.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.94 170.209 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -82.12 -10.54 59.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.5 ' CG ' HG22 ' A' ' 199' ' ' ILE . 5.4 ppp? -141.08 154.26 45.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.848 175.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -99.0 156.13 17.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.89 -24.88 68.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.132 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.83 -2.59 50.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 88.7 m -64.38 131.49 47.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.227 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -147.23 173.39 12.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.926 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -78.66 -32.09 47.03 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.899 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 99.1 p -74.13 -38.84 63.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -172.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 39.5 pt -65.04 -20.11 26.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.105 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.422 ' HB2' ' SD ' ' A' ' 148' ' ' MET . . . -58.42 -32.45 68.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.19 -43.53 87.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.834 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.04 -36.82 85.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.147 174.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.1 79.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.065 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -65.08 -42.46 94.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.895 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -64.95 -33.94 77.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.896 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -92.51 -24.36 18.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.05 30.99 21.5 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.568 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -91.83 -31.61 15.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.85 0.357 . . . . 0.0 110.914 -168.96 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 96.9 m -115.89 127.58 55.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.089 -171.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.439 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -70.71 -44.97 65.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 -175.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.415 ' N ' ' O ' ' A' ' 146' ' ' ALA . 68.1 mtm -134.05 146.98 50.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 -172.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' THR . . . . . 0.421 HG21 ' HB1' ' A' ' 213' ' ' ALA . 43.3 p -140.01 161.64 37.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 177.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.2 mm -112.4 114.85 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.07 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ASN . . . . . 0.451 ' HB2' HD13 ' A' ' 116' ' ' ILE . 31.3 m120 -145.41 153.32 41.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -171.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.456 ' HA3' ' HG ' ' A' ' 113' ' ' LEU . . . -133.56 -123.3 2.38 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.5 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' PRO . . . . . 0.404 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 30.2 Cg_endo -61.97 -19.95 67.78 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.766 2.311 . . . . 0.0 112.269 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -65.19 -30.08 70.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.925 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 51.12 38.3 20.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.078 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -70.02 -27.87 65.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.046 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 72.7 m -53.22 117.95 3.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.86 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -74.86 -169.05 0.82 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 20.4 mt 57.07 75.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -56.53 -47.6 79.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 -171.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 46.1 p -90.18 178.01 6.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.071 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 95.8 p -76.34 -5.06 45.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.919 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.11 167.9 2.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.876 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 240' ' ' VAL . 15.8 t 54.95 41.82 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.046 -172.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.537 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 74.6 m-20 42.12 70.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -126.0 132.8 51.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 -172.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.97 158.33 24.17 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.508 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.71 HG23 HG13 ' A' ' 116' ' ' ILE . 3.2 p -145.46 139.94 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 0.0 111.156 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.0 t -155.37 151.82 28.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.075 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' VAL . . . . . 0.485 HG11 ' HB2' ' A' ' 323' ' ' ASN . 28.2 m -62.3 168.4 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.096 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.753 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.7 mm? -61.81 143.37 94.28 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.644 0.735 . . . . 0.0 110.921 -162.198 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.56 -176.52 3.17 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.649 2.233 . . . . 0.0 112.457 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 95.2 m -100.41 146.33 27.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.14 -171.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -139.02 119.12 13.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 54.97 37.13 28.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.96 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.09 -0.46 83.96 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -130.96 140.09 37.62 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.588 0.709 . . . . 0.0 110.914 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -70.93 141.23 39.98 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.669 2.246 . . . . 0.0 112.412 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.753 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 82.7 p -82.39 -3.47 55.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 172.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -40.48 129.69 1.77 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.555 0.693 . . . . 0.0 110.894 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.635 ' HG3' ' HB2' ' A' ' 113' ' ' LEU . 85.8 Cg_endo -86.32 164.82 9.67 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.731 2.287 . . . . 0.0 112.446 -171.462 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -75.0 169.96 16.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.863 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.14 132.29 57.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.114 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.52 143.9 16.23 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.458 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' A' ' 107' ' ' PRO . 97.9 t -128.66 126.51 65.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.986 0.422 . . . . 0.0 111.081 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 2.0 tt -71.86 136.34 46.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 171.185 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.678 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 74.7 m -118.9 148.97 42.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -174.232 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.471 ' HB1' HD11 ' A' ' 280' ' ' LEU . . . -133.78 137.53 45.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 174.151 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.529 ' HA3' ' CH2' ' A' ' 62' ' ' TRP . . . -140.76 170.14 24.61 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.549 -173.493 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 22.7 mm -114.22 132.37 63.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 111.136 -171.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -65.04 133.8 52.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -172.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.627 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -63.0 -29.79 71.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.115 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.38 -8.11 59.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.038 -172.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 24.2 t -69.98 120.14 75.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.698 0.761 . . . . 0.0 110.848 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.42 -16.23 19.41 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.733 2.289 . . . . 0.0 112.362 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.405 ' HB2' HD21 ' A' ' 275' ' ' LEU . 53.2 p-10 -114.16 29.97 7.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -177.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -61.48 -24.55 66.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 -169.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -63.65 -45.58 89.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.851 -169.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 272' ' ' ASN . 2.2 pp -75.8 -33.28 60.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -178.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.413 ' HB1' HD11 ' A' ' 59' ' ' ILE . . . -65.8 -50.24 65.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.056 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -65.95 -36.48 83.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.868 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -68.98 -45.36 70.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -59.08 -47.12 86.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.93 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.471 HD11 ' HB1' ' A' ' 264' ' ' ALA . 8.0 tt -59.54 -52.24 66.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.889 -175.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -73.99 -25.72 60.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.953 -174.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -99.74 -14.18 18.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.942 -170.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.484 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 44.6 t80 -122.2 -56.54 1.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.404 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.4 OUTLIER -68.58 -39.69 80.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.854 -176.264 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.84 23.03 0.57 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 174.071 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 89.1 m -128.51 147.61 50.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.206 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.493 ' HA ' HD11 ' A' ' 290' ' ' LEU . 37.4 t70 -40.78 -38.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.774 -176.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.27 -42.57 68.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.856 -173.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.51 -52.03 8.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.445 -171.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.669 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -73.41 -21.97 60.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.815 0.34 . . . . 0.0 110.952 -177.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.478 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.4 tt0 -66.71 -42.69 85.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 169.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.93 -35.94 81.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.003 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.717 HG13 ' HA3' ' A' ' 19' ' ' GLY . 42.3 t -75.78 -44.27 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.166 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -65.05 -31.81 73.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.787 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.97 -32.2 72.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.932 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.78 ' HB3' ' HB3' ' A' ' 18' ' ' ASN . 63.7 m-20 -95.02 -29.64 14.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.834 -173.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.431 ' O ' HD13 ' A' ' 299' ' ' LEU . 77.3 tttt -146.1 135.47 11.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.626 0.727 . . . . 0.0 110.854 164.952 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.27 116.78 3.18 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.667 2.245 . . . . 0.0 112.33 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.431 HD13 ' O ' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -90.08 -22.57 21.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 174.829 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.95 -55.79 1.85 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.531 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.427 ' HA ' HD23 ' A' ' 311' ' ' LEU . . . -177.71 161.87 1.7 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.868 0.366 . . . . 0.0 111.191 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.594 ' CG2' ' HB3' ' A' ' 307' ' ' TYR . 33.8 m -128.57 159.93 39.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.153 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.46 -2.07 30.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.669 ' CD2' HD21 ' A' ' 290' ' ' LEU . 60.3 tp -87.94 130.38 34.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 -175.736 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -44.55 -32.42 1.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.484 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 74.4 m -48.16 -39.2 20.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.594 ' HB3' ' CG2' ' A' ' 302' ' ' VAL . 0.1 OUTLIER -58.93 -45.41 90.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 173.477 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.463 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 84.4 tt0 -54.63 -34.34 61.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.808 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -79.85 -63.3 1.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.8 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -82.71 -58.27 2.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -170.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 311' ' ' LEU . 0.0 OUTLIER -60.14 -36.63 77.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -170.562 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.98 -14.42 53.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.41 -20.46 65.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.491 ' HB3' HD12 ' A' ' 317' ' ' ILE . 60.3 t0 -79.61 120.7 81.05 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.609 0.719 . . . . 0.0 110.921 167.234 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.68 -35.42 13.02 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.656 2.237 . . . . 0.0 112.351 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -70.81 -36.99 73.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.875 -176.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.491 HD12 ' HB3' ' A' ' 314' ' ' ASP . 70.7 mt -78.46 -30.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.182 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.48 -39.59 91.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.102 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.98 -47.24 78.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.118 174.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 320' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 74.1 p -67.55 -25.17 65.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.188 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -62.05 -38.03 87.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 174.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -65.02 -47.05 78.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.821 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.485 ' HB2' HG11 ' A' ' 246' ' ' VAL . 36.9 t30 -63.47 -38.17 90.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.73 -46.94 85.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.095 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -72.82 -30.98 64.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.37 -4.38 42.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.924 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -101.74 -161.78 26.88 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.465 -172.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.717 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 95.4 mt-10 -143.37 140.58 30.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.361 . . . . 0.0 110.825 -172.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.584 ' O ' ' C ' ' A' ' 330' ' ' MET . 44.9 mm -82.51 106.63 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.17 -169.657 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.584 ' C ' ' O ' ' A' ' 329' ' ' ILE . 63.3 tpp 22.88 57.5 0.28 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.636 0.731 . . . . 0.0 110.874 175.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.717 ' HG3' ' HB3' ' A' ' 328' ' ' GLU . 46.2 Cg_endo -94.3 -5.79 2.33 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.67 2.247 . . . . 0.0 112.346 -172.164 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.551 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 74.5 m-20 -100.02 12.55 36.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.917 -158.421 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 47.9 mm 86.35 132.13 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.634 0.73 . . . . 0.0 111.124 162.081 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.23 -27.67 28.72 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.663 2.242 . . . . 0.0 112.392 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.45 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.7 mt-30 -72.35 -26.23 61.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.926 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' MET . . . . . 0.455 ' CG ' ' HB ' ' A' ' 333' ' ' ILE . 22.8 mmt -77.9 -26.05 48.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 -175.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 62.1 p -65.27 -27.31 68.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.876 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -76.21 -36.06 58.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.168 173.258 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.408 ' N ' ' CD1' ' A' ' 339' ' ' PHE . 7.8 m-30 -61.16 -37.82 84.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.827 170.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -62.62 -32.7 73.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.021 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -72.87 -40.52 65.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.92 -40.08 91.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.106 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 346' ' ' ALA . 13.2 m -80.33 -24.01 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.142 177.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.555 ' O ' HG22 ' A' ' 347' ' ' VAL . 1.1 tmt_? -59.92 -50.24 74.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 171.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 56.1 m -57.88 -29.94 65.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.084 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 343' ' ' VAL . . . -56.33 -39.3 72.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.591 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.0 OUTLIER -72.6 -32.66 42.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 -176.402 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.35 -46.78 92.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.077 172.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -63.2 -34.66 78.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.98 -45.72 59.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.58 -40.51 88.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.155 -175.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.1 p -75.05 -12.08 60.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 110.891 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.16 14.95 82.06 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.579 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.27 -32.43 49.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.815 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -136.77 153.88 50.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.959 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.6 p -79.47 167.82 20.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.192 169.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.441 ' HA ' HD23 ' A' ' 192' ' ' LEU . 54.4 t -55.12 -41.99 62.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 172.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.35 -45.95 89.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.828 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -72.25 -53.18 13.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.831 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.11 -44.65 75.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.031 -171.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.625 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -66.98 -40.53 87.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.969 -178.142 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.98 -40.45 94.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.954 174.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.38 -39.72 94.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.75 98.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.42 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 1.1 tm0? -63.26 -38.44 91.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.958 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.9 m -65.01 -38.56 91.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.102 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 79.4 mtt-85 -67.25 -35.67 80.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.84 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.512 ' CD1' HG11 ' A' ' 183' ' ' VAL . 73.8 mt -66.47 -45.05 90.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.127 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 71.1 p -99.02 -8.63 25.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.158 -174.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.956 176.27 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.0 mt -82.82 129.93 36.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.159 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.44 143.48 43.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -56.35 134.98 53.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.575 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 97.61 -1.62 60.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.465 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 65.0 pttt -165.3 144.09 6.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.783 0.325 . . . . 0.0 110.902 172.794 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.533 HD22 HD13 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -148.49 159.97 43.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.792 -175.019 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 90.3 t -113.78 132.94 61.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.161 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.814 HD13 HD11 ' A' ' 20' ' ' LEU . 1.2 mp -119.32 124.97 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.081 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.574 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 44.2 m0 -104.62 127.1 52.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.894 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -119.4 141.75 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.146 172.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -51.36 147.52 5.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.47 -12.8 9.69 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.501 -172.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -75.17 -17.05 60.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.856 0.36 . . . . 0.0 110.813 -174.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.1 mtmm -129.94 110.09 11.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 163.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.09 -91.53 0.81 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.443 -160.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -101.81 -42.37 6.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 110.856 -171.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASN . . . . . 0.76 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 86.0 m-20 -61.86 -52.08 65.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.843 -157.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.746 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -61.99 -48.55 82.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.516 -175.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.814 HD11 HD13 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -56.52 -61.2 2.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.879 0.371 . . . . 0.0 110.922 177.824 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.66 -41.38 70.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 -174.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -65.05 -53.11 50.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -176.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 19' ' ' GLY . 18.7 m -74.89 -38.06 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.162 -175.768 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.617 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -65.12 -42.47 96.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.527 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.34 -41.33 88.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 110.927 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -63.21 -39.6 95.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.853 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -66.18 -36.95 84.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.839 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -62.12 -39.91 94.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 172.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -67.82 -33.98 75.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.911 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -86.76 -41.78 13.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -170.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.625 ' OG1' HG13 ' A' ' 33' ' ' ILE . 77.0 p -106.8 -14.86 14.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.212 -174.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.75 8.93 83.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.503 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.96 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.2 pp -106.35 130.41 58.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 111.093 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.9 mttt -75.95 139.78 41.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -171.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.617 HG21 ' HA3' ' A' ' 24' ' ' GLY . 5.8 m -112.36 135.81 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.402 ' O ' HD12 ' A' ' 9' ' ' ILE . 99.3 m -105.93 128.31 53.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.083 176.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.539 HG22 ' HG ' ' A' ' 20' ' ' LEU . 80.9 t -96.57 120.0 45.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.105 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.574 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 68.3 mm-40 -130.31 145.2 51.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.891 171.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -156.1 58.3 1.71 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.599 0.714 . . . . 0.0 110.87 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.95 -27.43 5.8 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.762 2.308 . . . . 0.0 112.343 -172.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.0 t0 68.87 13.19 8.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.863 -167.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 45' ' ' GLU . 99.1 mttt -87.84 1.56 53.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.988 171.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.3 mt -44.37 -50.14 9.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.948 -168.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.9 -27.56 67.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 42' ' ' LYS . 98.3 mt-10 -79.01 -32.45 45.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.882 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -81.84 -29.27 32.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.868 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.544 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 14.4 m-30 -45.26 -54.4 14.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.635 0.731 . . . . 0.0 110.852 -175.248 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 53.1 Cg_endo -66.4 -27.3 47.3 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.656 2.237 . . . . 0.0 112.336 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -79.4 -42.98 24.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.915 -175.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.3 m -71.62 -28.03 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.106 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.23 -35.2 79.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.109 171.101 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.35 -31.99 71.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.132 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.9 p -92.47 -12.11 32.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.96 14.97 81.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.609 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -161.9 157.14 23.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.891 0.377 . . . . 0.0 110.842 176.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.431 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . -165.04 -141.08 3.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.437 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.55 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 69.9 Cg_endo -66.97 149.78 82.87 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.622 2.214 . . . . 0.0 112.376 169.8 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -75.49 -38.45 59.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.56 ' HB ' HG23 ' A' ' 9' ' ' ILE . 4.1 mp -126.61 138.82 53.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 177.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.534 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 2.2 tp -133.35 131.56 57.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.117 -178.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.503 ' CE2' HG13 ' A' ' 108' ' ' ILE . 3.1 m-85 -99.36 139.69 34.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.769 177.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.627 ' HH2' ' HA3' ' A' ' 265' ' ' GLY . 3.4 m-90 -120.06 140.09 51.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.829 174.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.49 -85.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.06 -178.298 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -116.26 -62.99 1.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.834 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -85.41 -30.46 23.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -167.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -62.1 -31.58 72.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.935 -158.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -67.77 -29.29 68.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -172.562 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.22 -52.33 41.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.439 -174.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.14 -39.93 98.55 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.507 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.552 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 28.8 t80 -66.08 -41.38 90.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 110.891 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.08 -44.29 63.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.096 176.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -55.02 -39.9 69.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.893 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.2 m -82.53 -8.12 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.65 35.06 59.31 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.519 174.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 mp -84.99 -2.16 57.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 0.0 110.907 -173.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.552 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -128.67 154.55 46.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -178.178 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.623 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -70.93 134.38 47.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 175.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -71.18 131.09 43.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.445 HD12 ' CE2' ' A' ' 106' ' ' TYR . 29.3 pt -110.12 160.0 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.99 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.2 p -105.17 148.34 36.04 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.565 0.697 . . . . 0.0 111.127 -172.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.15 142.66 31.07 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.774 2.316 . . . . 0.0 112.362 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -103.44 120.3 40.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 172.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.67 -38.67 69.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.47 91.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -72.87 -35.29 67.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.853 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -54.58 -46.72 73.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.84 176.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -65.83 -34.59 78.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.819 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -78.63 -24.01 45.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 -174.663 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -95.01 -96.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.957 -171.392 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.439 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 36.9 t80 -176.31 137.75 0.48 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.718 0.771 . . . . 0.0 110.833 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -53.42 -39.28 82.35 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.331 -172.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -79.3 -30.27 42.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.439 ' OG1' ' HB3' ' A' ' 90' ' ' TYR . 55.7 m -70.0 -49.35 52.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.204 -165.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.434 ' HA ' HG22 ' A' ' 97' ' ' VAL . 51.7 p-90 -64.32 -29.98 71.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.46 -35.35 68.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.886 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.32 -25.01 64.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.741 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 19.6 m -101.8 17.92 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.172 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 63.7 ttt180 -101.13 133.3 45.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.957 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -144.25 129.45 18.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.4 t30 65.01 35.27 8.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.88 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.94 -4.77 73.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.476 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -132.55 158.59 41.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.816 0.341 . . . . 0.0 110.897 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.523 HD22 HG23 ' A' ' 97' ' ' VAL . 13.9 mt -72.98 147.52 45.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.1 pp -125.21 10.34 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.147 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.761 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -163.26 151.32 13.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.041 -176.672 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 45.1 m-85 -115.02 136.28 22.58 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.659 0.742 . . . . 0.0 110.919 163.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 40.0 Cg_exo -60.23 118.17 5.01 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.664 2.243 . . . . 0.0 112.393 177.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.503 HG13 ' CE2' ' A' ' 61' ' ' PHE . 30.6 mm -99.38 -41.63 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.184 177.063 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -152.95 152.56 31.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.133 -175.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.7 p -123.91 134.18 67.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.082 -175.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.06 128.73 54.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.802 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.09 153.96 37.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.092 172.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.482 HD22 ' HG3' ' A' ' 257' ' ' PRO . 8.0 mp -104.72 158.87 16.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.86 -169.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.2 p -150.45 156.49 41.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.937 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.859 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.3 OUTLIER -100.06 125.9 46.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 176.193 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.584 ' N ' HD22 ' A' ' 115' ' ' LEU . 3.7 mp -106.03 135.33 44.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 -175.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -136.7 149.89 48.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -92.95 119.83 32.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.793 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -67.47 -18.65 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 167.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.484 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 20.3 t70 -75.28 -32.42 61.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.908 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.2 mp -93.25 -44.98 8.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.965 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 21.6 mt -104.42 113.63 64.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.599 0.714 . . . . 0.0 110.872 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.84 -26.64 31.98 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.702 2.268 . . . . 0.0 112.378 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.424 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 56.5 t-20 -149.57 94.99 3.8 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.56 0.695 . . . . 0.0 110.871 172.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 37.8 Cg_endo -69.14 151.03 72.64 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 0.0 112.237 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.86 151.62 62.94 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.691 2.26 . . . . 0.0 112.33 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -108.54 -8.6 15.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.937 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 72.3 p -132.21 159.01 40.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -65.25 -31.35 72.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.03 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.85 -27.83 67.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.81 -12.7 59.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.625 ' O ' HD13 ' A' ' 135' ' ' LEU . 49.4 mm -64.98 -53.07 44.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.679 0.752 . . . . 0.0 111.19 -172.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 30.1 Cg_endo -61.74 -37.21 69.56 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.635 2.223 . . . . 0.0 112.347 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.65 -61.31 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.018 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.181 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -71.16 -18.34 62.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 -177.258 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.577 ' HA ' HD22 ' A' ' 139' ' ' LEU . 38.9 t70 -63.6 -40.94 98.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 169.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.85 -38.16 89.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.93 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.6 -50.66 23.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -75.73 -16.53 60.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.937 -175.893 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.623 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.2 tttt -56.96 -34.41 68.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.97 172.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.78 -23.68 67.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -95.19 10.22 36.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.769 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.97 30.1 59.8 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.515 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.453 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 90.7 mttt -120.06 169.57 10.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 110.796 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.0 t -132.39 138.52 47.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.518 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -71.75 -53.87 12.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 -165.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -137.36 131.72 32.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 -164.132 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' MET . . . . . 0.658 ' HG2' ' HB2' ' A' ' 213' ' ' ALA . 60.3 tpp -105.04 120.1 40.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -153.28 164.97 37.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -174.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -131.66 167.19 19.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 168.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.8 tp -116.26 -23.2 8.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -70.37 -4.07 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.851 -168.11 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -110.39 152.12 43.09 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.681 0.753 . . . . 0.0 110.819 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' PRO . . . . . 0.533 ' HD3' ' NE ' ' A' ' 344' ' ' ARG . 29.9 Cg_endo -67.55 -20.89 46.92 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.633 2.222 . . . . 0.0 112.304 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -59.19 -39.07 81.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.907 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -83.24 -42.97 16.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.786 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 41.9 p -65.37 -39.86 92.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.096 -170.081 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.574 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 17.5 t-105 -64.31 -53.86 43.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.589 0.709 . . . . 0.0 110.959 -169.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 36.2 Cg_endo -68.91 -32.24 22.77 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.596 2.198 . . . . 0.0 112.394 -172.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.717 HD23 ' O ' ' A' ' 160' ' ' LEU . 6.4 tt -72.74 -40.75 65.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.561 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 72.1 mt -69.77 -41.44 79.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.78 -27.67 63.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.034 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.56 -31.41 71.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -92.38 3.79 54.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 107.89 3.95 34.03 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.507 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.404 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -79.6 66.22 3.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.427 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' TYR . . . . . 0.432 ' O ' HG13 ' A' ' 183' ' ' VAL . 80.8 m-85 -90.02 145.41 25.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.853 0.359 . . . . 0.0 110.911 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.96 0.41 15.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.987 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -154.67 151.74 29.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.86 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -100.38 129.99 46.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.822 159.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -92.42 123.75 35.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -151.3 131.29 13.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.908 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.0 t30 57.57 43.6 22.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 171.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.65 77.41 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.54 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.88 144.26 47.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.877 -176.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -80.79 133.68 35.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 167.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -99.57 114.33 27.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.1 tp -72.91 -20.05 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.12 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.0 -10.25 36.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.908 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -127.57 95.02 4.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 169.282 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.4 m -112.01 163.11 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.1 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -97.64 13.29 64.17 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.486 -171.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.719 HG21 HD12 ' A' ' 368' ' ' ILE . 35.4 m -106.97 -13.43 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 111.058 -176.202 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -89.17 15.34 9.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -127.26 -171.27 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.26 -25.98 64.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.2 -173.657 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.93 -43.6 95.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.552 -167.41 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.718 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -67.57 -38.48 84.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 0.0 111.049 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.487 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.3 mttt -60.23 -35.29 75.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 174.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.29 -38.04 89.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.207 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -65.02 -45.75 91.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.365 177.466 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.604 HD11 ' HA ' ' A' ' 347' ' ' VAL . 17.8 tp -69.9 -32.99 71.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 0.0 110.964 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.45 ' O ' HG12 ' A' ' 196' ' ' VAL . 79.1 m -64.69 -42.11 95.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.169 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -70.55 -54.69 11.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.648 ' C ' HD12 ' A' ' 195' ' ' LEU . 3.6 pp -63.67 -23.91 67.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.989 -167.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.582 ' N ' HD12 ' A' ' 195' ' ' LEU . 1.2 p -74.54 -24.08 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.157 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.78 -55.41 19.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.837 -172.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 1.03 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.74 -24.6 56.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.943 -168.044 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.764 ' N ' HD22 ' A' ' 198' ' ' LEU . 2.0 pp -81.73 -33.88 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.077 173.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -65.26 -31.08 72.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -84.15 4.33 30.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.897 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 64.94 39.73 5.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.923 172.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -80.15 -11.71 59.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 174.406 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' MET . . . . . 0.428 ' CG ' HG22 ' A' ' 199' ' ' ILE . 5.3 ppp? -142.95 154.54 44.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.81 174.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -101.25 157.12 17.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.96 -28.37 70.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -97.44 -0.01 46.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.7 m -59.25 131.78 52.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.435 ' H ' HD11 ' A' ' 212' ' ' ILE . 23.1 t0 -144.17 171.55 14.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -82.42 -29.67 30.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.8 p -70.66 -38.54 73.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.925 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.435 HD11 ' H ' ' A' ' 209' ' ' ASP . 40.7 pt -67.48 -24.52 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.148 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ALA . . . . . 0.658 ' HB2' ' HG2' ' A' ' 148' ' ' MET . . . -59.68 -37.44 78.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 -177.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -57.74 -40.66 80.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.0 93.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.52 91.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.153 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -65.55 -33.9 77.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.78 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.43 -31.97 70.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.01 -18.44 22.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.914 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.63 29.04 22.56 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.477 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -92.03 -27.02 18.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 110.889 -171.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 98.3 m -111.02 125.03 53.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.167 -176.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.28 -49.43 23.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.173 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.414 ' N ' ' O ' ' A' ' 146' ' ' ALA . 66.3 mtm -134.98 155.45 50.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -171.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.7 t -153.02 166.26 32.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.111 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 40.3 mm -113.49 124.03 69.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -142.29 153.16 43.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.824 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -135.0 -95.03 0.49 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.446 175.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.97 -24.02 24.62 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.759 2.306 . . . . 0.0 112.239 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -74.75 -37.79 62.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.872 -173.546 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 49.72 40.3 19.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 -175.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -70.76 -22.99 62.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.4 t -51.37 130.8 27.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.907 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -87.7 -167.78 2.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.95 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.7 mt 55.11 75.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 -174.704 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -52.73 -45.67 67.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.916 -174.01 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 49.3 p -89.8 -178.97 5.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.11 -174.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 93.3 p -79.26 -5.02 53.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.944 176.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.81 171.8 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 240' ' ' VAL . 14.9 t 54.88 41.09 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.164 -174.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 74.4 m-20 42.31 69.97 0.33 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -127.09 133.07 50.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -174.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -133.69 155.09 21.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.446 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.4 p -145.61 138.97 21.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.907 0.384 . . . . 0.0 111.113 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -155.64 152.61 28.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.116 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.8 m -60.81 168.45 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.681 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.5 mm? -61.12 150.74 77.97 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.658 0.742 . . . . 0.0 110.907 -162.249 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.48 -178.23 4.44 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.631 2.221 . . . . 0.0 112.293 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.5 m -98.37 142.24 30.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.12 -174.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -132.84 114.87 14.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.825 -176.447 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 54.91 36.52 26.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.99 2.74 88.24 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.613 174.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -130.71 138.1 32.26 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.618 0.723 . . . . 0.0 110.954 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -68.5 137.45 39.45 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.706 2.271 . . . . 0.0 112.389 -174.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.681 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 98.8 p -79.19 -8.12 58.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.823 174.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -49.99 116.6 6.53 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.475 0.655 . . . . 0.0 110.888 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' PRO . . . . . 0.482 ' HG3' HD22 ' A' ' 113' ' ' LEU . 72.5 Cg_endo -80.44 167.75 18.88 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.689 2.259 . . . . 0.0 112.264 -176.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -66.89 169.89 7.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 80.5 t -106.86 133.16 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.089 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.5 139.6 15.22 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.551 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 97.5 t -125.6 120.07 56.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.916 0.388 . . . . 0.0 111.1 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.407 HD23 ' C ' ' A' ' 262' ' ' LEU . 7.3 tt -78.98 129.13 34.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.989 168.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.761 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 96.5 p -132.39 160.76 35.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -170.622 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.62 143.04 50.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -175.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.627 ' HA3' ' HH2' ' A' ' 62' ' ' TRP . . . -139.64 172.53 23.27 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.47 -175.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 23.3 mm -113.53 131.0 66.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.847 0.356 . . . . 0.0 111.191 -171.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -65.28 133.59 51.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 -173.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.623 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -64.94 -27.2 68.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 -177.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.46 -8.58 59.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.996 -173.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.5 t -69.14 121.66 82.63 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.648 0.737 . . . . 0.0 110.948 -175.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.19 -17.79 18.86 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.311 172.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -112.05 29.29 8.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.963 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.02 -25.38 65.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -170.129 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -64.99 -43.38 92.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.822 -169.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.0 pp -76.93 -33.4 57.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.989 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.31 77.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.989 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -66.64 -35.01 79.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.921 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -69.4 -48.94 59.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.903 -173.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 0.6 OUTLIER -67.5 -31.24 71.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.922 -175.16 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 6.2 tt -64.61 -46.39 82.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.945 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -79.3 -24.88 42.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.887 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -97.61 -20.01 17.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.949 -168.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -119.97 -56.49 2.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.952 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 0.1 OUTLIER -65.68 -41.28 92.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.911 -176.085 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.66 48.21 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.922 169.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.432 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 74.2 m -145.52 146.69 31.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.112 173.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.431 ' HA ' HD11 ' A' ' 290' ' ' LEU . 35.8 t70 -40.0 -39.77 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.907 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.0 -41.69 64.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -172.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.83 -51.18 16.02 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.534 -172.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.69 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -75.49 -22.99 56.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.717 0.294 . . . . 0.0 110.89 -177.562 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.433 ' N ' HD12 ' A' ' 290' ' ' LEU . 86.6 tt0 -67.11 -40.6 86.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 169.747 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.95 -35.06 79.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.015 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.746 HG13 ' HA3' ' A' ' 19' ' ' GLY . 47.3 t -74.86 -43.68 46.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.14 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -63.28 -31.14 72.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.24 -32.34 73.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.807 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' ASP . . . . . 0.76 ' HB3' ' HB3' ' A' ' 18' ' ' ASN . 67.0 m-20 -94.99 -27.32 15.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 -173.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.401 ' O ' HD13 ' A' ' 299' ' ' LEU . 78.5 tttt -148.1 136.7 11.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.556 0.694 . . . . 0.0 110.857 168.136 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.33 111.87 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.687 2.258 . . . . 0.0 112.35 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 297' ' ' LYS . 0.4 OUTLIER -90.08 -28.58 18.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 174.697 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.06 -55.08 1.84 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.49 -176.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.436 ' HA ' HD23 ' A' ' 311' ' ' LEU . . . -179.37 159.27 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.79 0.329 . . . . 0.0 111.067 -176.164 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.584 HG23 ' HB3' ' A' ' 307' ' ' TYR . 32.6 m -127.02 164.67 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.135 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -79.1 -4.22 49.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.066 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.69 ' CD2' HD21 ' A' ' 290' ' ' LEU . 58.9 tp -86.12 135.64 33.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.751 -172.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -47.3 -31.79 4.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.521 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 70.8 m -47.85 -39.99 20.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.843 173.635 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.584 ' HB3' HG23 ' A' ' 302' ' ' VAL . 0.0 OUTLIER -63.37 -46.1 88.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 173.556 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 32.9 tt0 -54.54 -36.78 64.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.736 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -80.76 -61.77 1.87 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.804 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -83.02 -58.3 2.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.938 -168.375 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.509 HD12 ' HA ' ' A' ' 311' ' ' LEU . 0.0 OUTLIER -60.38 -36.44 78.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 -171.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.06 -14.97 58.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.077 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.26 -22.0 66.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.892 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.446 ' HB3' HD12 ' A' ' 317' ' ' ILE . 62.9 t0 -78.25 119.59 77.91 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.584 0.707 . . . . 0.0 110.938 167.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -45.65 -35.24 12.65 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.638 2.225 . . . . 0.0 112.323 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 -69.65 -37.54 76.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -176.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 314' ' ' ASP . 66.0 mt -79.9 -29.91 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.087 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.63 -39.9 85.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.091 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.18 -47.27 74.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 174.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 78.9 p -65.07 -24.98 67.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.057 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 65.6 ttp -63.51 -40.57 97.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.937 174.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -65.01 -42.54 94.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.774 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -58.77 -44.64 90.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.928 173.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.91 90.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.052 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.84 -34.98 77.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.929 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -101.07 -3.73 28.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.939 -174.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -95.11 -163.59 34.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.43 -173.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.616 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 95.7 mt-10 -140.9 137.24 33.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.841 0.353 . . . . 0.0 110.835 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.59 ' O ' ' C ' ' A' ' 330' ' ' MET . 35.6 mm -81.06 109.83 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.191 -170.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.59 ' C ' ' O ' ' A' ' 329' ' ' ILE . 6.9 tpt 23.03 57.71 0.29 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.565 0.698 . . . . 0.0 110.899 174.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.616 ' HG3' ' HB3' ' A' ' 328' ' ' GLU . 44.5 Cg_endo -90.87 -4.6 4.54 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.639 2.226 . . . . 0.0 112.287 -176.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.57 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 94.6 m-20 -101.51 4.96 41.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.869 -161.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.57 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 45.7 mm 86.06 132.93 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.654 0.74 . . . . 0.0 111.086 162.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -68.07 -28.72 34.52 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.692 2.261 . . . . 0.0 112.398 -175.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.465 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.7 mt-30 -69.98 -27.27 64.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 176.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 17.4 mmt -74.6 -24.58 58.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.789 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.9 m -61.89 -33.71 74.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.879 177.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.65 -35.72 67.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.167 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -64.25 -35.22 80.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 172.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 340' ' ' TRP . . . . . 0.407 ' HA ' HG22 ' A' ' 343' ' ' VAL . 52.5 m0 -63.86 -31.12 72.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 174.25 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -73.64 -37.07 65.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.08 96.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.133 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 340' ' ' TRP . 10.1 m -80.88 -23.44 10.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.137 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.533 ' NE ' ' HD3' ' A' ' 154' ' ' PRO . 64.9 ttt180 -57.43 -53.17 61.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 172.099 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 67.4 p -62.52 -25.96 68.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.141 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -58.21 -39.0 77.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.085 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.604 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.2 m -73.1 -31.86 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.194 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.39 -44.85 97.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.152 173.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -64.95 -34.96 79.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.86 -45.12 62.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.82 -39.56 87.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.129 -175.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.2 p -75.88 -12.81 60.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.799 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.2 14.86 82.13 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.588 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.52 -32.2 47.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.741 0.305 . . . . 0.0 110.873 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -136.4 153.68 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 46.0 p -79.85 167.65 20.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.133 170.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.424 ' HA ' HD23 ' A' ' 192' ' ' LEU . 53.8 t -55.4 -41.58 63.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.12 172.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -59.56 -45.03 93.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.929 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -72.84 -53.91 10.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.2 76.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.091 -171.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -67.08 -40.36 86.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.905 -178.105 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.09 -40.19 94.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.88 -39.91 93.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -63.39 -42.87 98.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 175.028 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -62.8 -39.05 93.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.821 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.4 m -64.38 -38.62 91.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.121 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -68.69 -35.11 76.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.719 HD12 HG21 ' A' ' 183' ' ' VAL . 75.2 mt -67.32 -45.32 86.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.099 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.6 p -101.71 -14.01 17.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.97 -179.558 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.71 0.291 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.55 131.81 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.095 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -135.59 144.27 46.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.937 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -56.14 135.14 53.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . 0.483 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 98.32 -1.85 59.06 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.492 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.3 tttt -166.29 137.34 3.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 174.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.62 HD23 ' H ' ' A' ' 7' ' ' LEU . 0.7 OUTLIER -143.48 157.54 44.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 -172.745 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 86.4 t -113.45 132.34 62.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.116 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.836 ' HB ' HD21 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -119.95 127.41 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.062 -178.928 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' TRP . . . . . 0.573 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 44.8 m0 -106.16 129.47 54.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 12' ' ' ASN . 60.7 mt -122.21 140.54 45.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.137 170.6 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.426 ' O ' HG22 ' A' ' 11' ' ' ILE . 64.2 t30 -50.15 141.74 10.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.906 172.023 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' HA3' ' OD2' ' A' ' 41' ' ' ASP . . . -58.06 -11.34 8.63 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.43 -172.582 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -73.32 -14.39 61.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.873 0.368 . . . . 0.0 110.923 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -136.94 109.99 7.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.957 158.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.36 -91.09 0.84 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.413 -154.562 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -104.7 -47.49 4.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.857 0.361 . . . . 0.0 110.849 -167.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -66.53 -46.86 74.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 -156.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.672 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -58.13 -47.06 91.6 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.512 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.836 HD21 ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -55.65 -60.97 2.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.792 0.329 . . . . 0.0 110.898 173.834 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.04 -39.28 55.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 -177.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -64.58 -52.83 55.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.3 m -75.69 -35.4 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.183 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.702 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -65.38 -44.57 93.13 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.481 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.67 -36.46 78.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.802 0.334 . . . . 0.0 110.832 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -61.6 -39.84 92.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.868 173.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PHE . . . . . 0.448 ' CD2' HD11 ' A' ' 33' ' ' ILE . 1.3 t80 -61.32 -44.82 96.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.0 -38.99 93.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.848 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.27 -31.85 73.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.13 -43.77 15.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -172.368 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . 0.53 ' OG1' HG13 ' A' ' 33' ' ' ILE . 53.8 p -113.85 -11.63 12.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.183 -171.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.87 14.0 81.46 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.142 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.8 pp -104.55 126.83 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 0.0 111.137 -176.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.6 mttt -75.77 141.53 42.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -171.005 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.702 HG21 ' HA3' ' A' ' 24' ' ' GLY . 2.9 m -114.99 135.97 53.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.081 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.432 ' O ' HD12 ' A' ' 9' ' ' ILE . 99.0 m -105.29 128.1 53.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.045 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . 0.523 HG22 ' HG ' ' A' ' 20' ' ' LEU . 58.4 t -96.24 121.38 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.145 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.573 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 69.2 mm-40 -130.09 144.61 51.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.837 172.159 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -156.82 58.78 1.68 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.585 0.707 . . . . 0.0 110.867 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 73.5 Cg_endo -80.71 -12.91 12.12 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.686 2.257 . . . . 0.0 112.296 -170.752 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 26.2 m-20 63.59 19.96 11.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -171.192 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 45' ' ' GLU . 98.6 mttt -93.67 0.25 56.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.966 174.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 43' ' ' LEU . 14.1 mt -45.77 -51.77 12.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.951 -166.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.67 -26.53 66.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.95 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 42' ' ' LYS . 98.4 mt-10 -78.68 -33.1 47.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.993 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 69.0 mmtt -82.72 -30.22 29.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.9 -174.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' PHE . . . . . 0.51 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 14.1 m-30 -40.72 -56.07 4.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.637 0.732 . . . . 0.0 110.826 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 51.6 Cg_endo -67.34 -27.44 40.47 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.717 2.278 . . . . 0.0 112.307 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -79.65 -44.41 20.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.2 m -69.75 -27.49 33.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.152 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.91 78.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.101 170.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.28 -30.48 67.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.08 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.3 p -92.58 -12.1 32.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.217 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.69 15.12 81.48 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.42 175.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -163.78 157.31 18.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.91 0.386 . . . . 0.0 110.859 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.5 -138.81 2.49 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 -178.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PRO . . . . . 0.491 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 73.6 Cg_endo -67.69 150.41 79.37 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.655 2.236 . . . . 0.0 112.401 168.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -76.32 -38.57 55.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.716 ' HB ' HG23 ' A' ' 9' ' ' ILE . 3.7 mp -126.4 138.66 53.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.207 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.514 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 2.2 tp -128.48 129.8 68.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.131 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.549 ' CE2' HG13 ' A' ' 108' ' ' ILE . 2.0 m-85 -98.53 142.68 29.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.831 175.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TRP . . . . . 0.535 ' HH2' ' HA3' ' A' ' 265' ' ' GLY . 6.1 m-90 -119.68 139.81 51.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.922 176.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 262' ' ' LEU . . . -59.65 -85.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.092 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -122.52 -61.46 1.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -84.56 -27.92 26.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.773 -167.046 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.452 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 89.4 mtt180 -60.07 -30.5 69.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.891 -158.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -67.8 -27.92 67.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -170.284 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.85 -51.84 47.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.515 -173.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.16 -36.27 92.74 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' TYR . . . . . 0.574 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 18.4 t80 -65.98 -38.31 88.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.932 0.396 . . . . 0.0 110.891 -178.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.14 -43.94 60.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -62.61 -32.06 73.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.2 m -80.48 -12.57 59.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 175.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.1 31.95 66.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.503 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.49 -1.26 56.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.79 0.329 . . . . 0.0 110.879 -172.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.574 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -130.99 156.94 44.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.975 -179.287 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -66.9 130.46 43.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.132 175.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -69.52 122.97 20.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -109.3 159.97 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.05 -171.82 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.6 p -103.23 146.5 32.56 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.629 0.728 . . . . 0.0 111.065 -171.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.84 146.25 29.56 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.682 2.255 . . . . 0.0 112.326 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -107.94 114.68 28.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -52.68 -35.92 56.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.828 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.08 -40.97 95.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -69.97 -38.25 76.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.862 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -54.95 -48.61 72.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.76 -36.39 83.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.845 175.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -75.78 -19.99 58.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -103.34 -103.52 0.29 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 -173.304 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 43.0 t80 -165.92 134.28 2.41 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.688 0.756 . . . . 0.0 110.933 -172.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 70.9 Cg_exo -52.51 -39.94 73.33 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.375 -170.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -78.44 -30.51 47.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.96 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.2 m -69.48 -48.7 59.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.196 -166.382 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TRP . . . . . 0.454 ' HA ' HG22 ' A' ' 97' ' ' VAL . 51.9 p-90 -66.57 -28.4 68.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.87 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -71.44 -37.59 71.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.855 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.98 -25.07 65.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 21.7 m -101.55 16.54 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.189 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 68.1 ttt180 -101.8 133.11 47.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.905 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -149.06 130.31 14.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.3 t30 68.69 36.26 2.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.12 -5.01 64.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.52 174.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -139.73 163.85 31.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LEU . . . . . 0.553 HD22 HG23 ' A' ' 97' ' ' VAL . 13.1 mt -73.07 146.09 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.002 -175.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.431 HD12 ' C ' ' A' ' 104' ' ' ILE . 1.9 pp -122.33 9.91 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.179 173.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.876 ' HB1' ' HB3' ' A' ' 263' ' ' SER . . . -168.09 156.68 9.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.045 -177.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' TYR . . . . . 0.436 ' HB3' HD21 ' A' ' 285' ' ' LEU . 21.4 m-85 -124.99 146.34 53.21 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.766 0.793 . . . . 0.0 110.905 163.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.65 ' HB3' HG11 ' A' ' 261' ' ' VAL . 42.9 Cg_endo -71.4 121.09 7.43 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.616 2.211 . . . . 0.0 112.359 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ILE . . . . . 0.549 HG13 ' CE2' ' A' ' 61' ' ' PHE . 25.1 mm -98.31 -32.28 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.137 177.372 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.04 151.34 26.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.6 t -115.02 132.99 62.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.079 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -112.88 131.72 55.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.83 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.08 154.49 40.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.966 176.5 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.425 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 11.0 mp -94.29 152.05 18.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.946 -174.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -148.22 157.59 43.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.813 ' C ' HD13 ' A' ' 115' ' ' LEU . 0.4 OUTLIER -99.23 125.2 44.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.85 174.524 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ILE . . . . . 0.58 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.7 mp -107.54 132.1 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 -176.14 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -131.71 145.15 51.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.944 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -100.2 113.08 25.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.749 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 241' ' ' ASN . 99.5 mttt -64.78 -15.01 61.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.812 -176.52 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 15.1 t70 -80.47 -29.87 37.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 mp -88.83 -46.49 8.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.533 HD22 ' HB1' ' A' ' 223' ' ' ALA . 2.2 mp -111.24 124.94 31.53 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.587 0.708 . . . . 0.0 110.81 175.331 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -71.71 -26.71 19.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.652 2.234 . . . . 0.0 112.302 173.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -152.47 96.28 3.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.628 0.728 . . . . 0.0 110.921 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.78 153.99 68.2 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.687 2.258 . . . . 0.0 112.331 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.58 151.53 64.46 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.651 2.234 . . . . 0.0 112.38 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -113.62 -5.07 13.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.864 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 130' ' ' GLU . 11.8 m -127.9 146.08 50.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.106 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TRP . . . . . 0.458 ' HA ' HG12 ' A' ' 132' ' ' ILE . 63.1 m95 -66.39 -25.63 66.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.955 -177.314 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . 0.495 ' H ' HG22 ' A' ' 128' ' ' THR . 98.3 mt-10 -62.11 -30.32 70.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.15 -19.67 56.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 -175.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.587 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 49.5 mm -62.0 -53.46 59.38 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.656 0.741 . . . . 0.0 111.133 -166.206 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 31.9 Cg_endo -62.75 -40.06 38.81 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.7 2.266 . . . . 0.0 112.339 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.0 -59.44 4.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LEU . . . . . 1.17 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.71 -17.67 63.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -175.257 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.637 ' HA ' HD22 ' A' ' 139' ' ' LEU . 39.0 t70 -63.49 -39.08 93.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 169.027 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.01 -36.72 82.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -73.16 -50.3 23.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -174.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -75.18 -15.2 60.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.892 -176.524 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.675 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.8 tttt -56.28 -35.06 67.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 170.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.18 -23.84 67.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.129 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -94.9 8.64 42.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.816 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.22 27.51 63.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.425 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.434 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 46.0 mtmt -120.87 165.41 15.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.859 0.361 . . . . 0.0 110.862 173.174 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . 0.52 ' HA ' HD21 ' A' ' 139' ' ' LEU . 37.1 t -128.56 146.69 50.77 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 170.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -72.04 -58.31 3.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.084 -164.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -138.64 128.87 25.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -161.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.1 mmm -105.91 128.64 53.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -153.77 162.38 41.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -123.89 142.95 50.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.421 ' HG ' HG21 ' A' ' 347' ' ' VAL . 54.4 tp -113.35 -9.73 13.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.975 -175.586 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -73.71 0.14 13.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -118.0 148.39 43.37 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 121.738 0.78 . . . . 0.0 110.828 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.77 -20.01 64.66 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.595 2.197 . . . . 0.0 112.327 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -62.37 -36.69 83.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -84.32 -37.69 21.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.4 p -64.09 -37.77 88.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' TRP . . . . . 0.561 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 12.4 t-105 -62.21 -55.13 43.27 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.621 0.724 . . . . 0.0 110.935 -172.033 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 26.4 Cg_endo -67.37 -32.48 32.4 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.68 2.253 . . . . 0.0 112.326 -171.375 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.702 HD23 ' O ' ' A' ' 160' ' ' LEU . 6.5 tt -74.48 -40.31 61.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.981 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.481 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 76.0 mt -69.74 -40.44 79.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.128 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.78 -26.72 64.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.142 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.59 -30.25 70.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -94.56 0.56 55.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 112.19 5.41 24.96 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.55 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.473 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -79.21 66.68 3.41 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.383 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -90.28 152.58 20.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.883 -174.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.68 -17.95 60.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.112 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -147.56 154.04 40.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.087 0.47 . . . . 0.0 110.813 -173.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -97.24 128.93 44.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.885 159.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -96.19 122.64 39.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.918 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -149.73 130.71 14.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.954 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.4 t30 56.9 44.28 23.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 172.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.14 6.43 74.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -132.71 142.39 49.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.858 0.361 . . . . 0.0 110.942 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -77.77 134.85 37.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.917 165.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -95.12 104.97 16.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.3 tp -65.76 -19.95 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.106 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -94.74 -8.43 37.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -132.63 95.58 3.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 174.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' VAL . . . . . 0.501 HG23 HG22 ' A' ' 183' ' ' VAL . 33.1 m -115.82 173.05 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.107 -177.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -99.95 12.13 60.7 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.442 -167.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' VAL . . . . . 0.563 HG21 ' CD1' ' A' ' 368' ' ' ILE . 17.9 m -101.62 -17.92 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 0.0 111.156 -172.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ASP . . . . . 0.449 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 57.5 p-10 -95.57 19.85 10.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.868 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 34.8 m120 -118.11 171.55 8.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.08 -24.46 67.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.069 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.05 -39.78 94.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.524 -172.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.637 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.5 -39.4 91.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 111.068 177.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' LYS . . . . . 0.505 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.2 mttt -59.73 -37.37 78.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 173.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.58 -38.11 89.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.121 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.0 -45.41 94.03 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.374 177.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' LEU . . . . . 0.593 HD11 ' HA ' ' A' ' 347' ' ' VAL . 18.7 tp -68.33 -33.31 74.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.928 0.394 . . . . 0.0 110.971 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' THR . . . . . 0.415 ' O ' HG12 ' A' ' 196' ' ' VAL . 89.5 m -63.06 -42.28 99.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.159 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -67.29 -58.03 5.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' LEU . . . . . 0.626 ' C ' HD12 ' A' ' 195' ' ' LEU . 3.4 pp -63.49 -27.78 69.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 -165.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' VAL . . . . . 0.563 ' N ' HD12 ' A' ' 195' ' ' LEU . 3.7 p -72.77 -22.55 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.11 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -66.06 -58.79 4.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.886 -174.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' LEU . . . . . 1.055 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.42 -24.54 57.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -167.404 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ILE . . . . . 0.804 ' N ' HD22 ' A' ' 198' ' ' LEU . 2.1 pp -77.35 -35.8 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.173 172.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.89 -30.71 71.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.919 169.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -85.55 5.79 29.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.843 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 67.26 40.02 2.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.904 170.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -82.8 -14.36 54.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 170.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 60.5 ttp -133.14 146.31 51.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -94.94 155.91 16.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.9 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.2 -25.03 68.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -95.09 -3.5 47.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 95.3 m -63.53 130.88 46.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.17 -175.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ASP . . . . . 0.514 ' H ' HD11 ' A' ' 212' ' ' ILE . 21.5 t0 -146.78 172.24 13.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 176.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -75.49 -34.38 60.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 -172.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 47.7 t -68.81 -48.3 63.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 -174.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ILE . . . . . 0.514 HD11 ' H ' ' A' ' 209' ' ' ASP . 29.8 pt -65.94 -24.85 34.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.123 176.201 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.97 -35.6 81.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.18 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -67.84 -35.96 79.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.809 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.16 -40.16 95.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.164 173.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.0 -40.49 95.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.136 174.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -65.09 -39.4 93.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.868 -177.134 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -63.64 -32.09 73.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.842 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.17 -10.87 48.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.979 -176.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.9 25.75 36.9 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.533 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -86.54 -26.23 24.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.898 0.38 . . . . 0.0 110.805 -175.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -125.45 134.51 52.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' ALA . . . . . 0.533 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -72.55 -35.74 68.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.085 -175.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 72.5 mtm -131.99 155.51 47.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 110.879 -176.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.6 t -149.01 160.12 43.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.7 mm -115.09 125.02 72.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.114 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -145.02 151.06 37.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -135.07 -97.51 0.55 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.457 174.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.93 -17.39 36.83 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.741 2.294 . . . . 0.0 112.329 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -67.38 -33.33 74.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.999 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 53.57 32.9 15.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.032 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 35.2 m0 -72.65 -34.58 67.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.035 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 19.2 t -55.52 112.77 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.868 -171.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ASN . . . . . 0.413 ' O ' ' HB ' ' A' ' 235' ' ' ILE . 44.7 p30 -95.47 -162.85 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.955 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 235' ' ' ILE . 47.6 mt 69.86 54.54 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.157 -175.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -60.03 -29.99 68.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.913 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 72.3 p -82.14 169.23 16.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.032 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 97.2 p -76.16 -6.11 49.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.973 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -61.03 160.56 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.923 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 240' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 240' ' ' VAL . 11.6 t 55.99 35.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.174 -178.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ASN . . . . . 0.46 ' C ' ' O ' ' A' ' 240' ' ' VAL . 77.4 m-20 37.27 70.0 0.2 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 169.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 242' ' ' TYR . 4.4 t80 -119.48 135.39 54.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.908 -171.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.07 158.47 24.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.428 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' VAL . . . . . 0.526 HG22 ' HB2' ' A' ' 319' ' ' ALA . 7.4 p -141.48 139.95 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.871 0.367 . . . . 0.0 111.11 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.3 t -153.02 148.92 27.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.162 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 18.9 m -61.76 168.94 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.096 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' LEU . . . . . 0.578 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.8 mm? -62.06 146.92 91.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.659 0.742 . . . . 0.0 110.895 -162.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -72.69 -177.42 2.81 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.65 2.233 . . . . 0.0 112.35 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.8 p -108.71 160.02 16.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.15 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -143.59 122.38 12.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 110.89 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 55.02 35.83 25.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.09 7.35 77.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.546 169.93 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -132.83 139.86 35.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.613 0.72 . . . . 0.0 110.905 176.285 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.87 140.9 36.03 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.741 2.294 . . . . 0.0 112.376 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 255' ' ' SER . . . . . 0.578 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 97.3 p -82.42 -5.87 58.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.865 170.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -49.93 113.33 3.31 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.545 0.688 . . . . 0.0 110.934 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.91 168.89 20.21 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.563 2.175 . . . . 0.0 112.426 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -72.9 171.75 12.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.883 -177.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.478 HG21 ' HA ' ' A' ' 324' ' ' ALA . 76.4 t -104.33 134.83 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.163 -170.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -109.77 137.91 14.51 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.502 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' A' ' 107' ' ' PRO . 93.8 t -121.84 124.04 70.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.938 0.399 . . . . 0.0 111.168 -176.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 5.2 tt -72.09 128.82 36.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 168.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' SER . . . . . 0.876 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 58.5 m -121.31 153.89 37.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 -171.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ALA . . . . . 0.461 ' CB ' HD11 ' A' ' 280' ' ' LEU . . . -134.62 139.79 45.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 177.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' GLY . . . . . 0.535 ' HA3' ' HH2' ' A' ' 62' ' ' TRP . . . -142.41 172.22 24.37 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.518 -176.392 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 24.4 mm -112.87 134.31 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.333 . . . . 0.0 111.177 -169.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -64.55 132.07 48.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.936 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' ALA . . . . . 0.62 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -64.49 -30.21 71.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.1 -8.76 59.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.069 -172.065 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.3 t -68.21 121.66 81.11 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.639 0.733 . . . . 0.0 110.937 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.27 -16.95 19.35 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.71 2.273 . . . . 0.0 112.352 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ASN . . . . . 0.439 ' HB2' HD21 ' A' ' 275' ' ' LEU . 53.1 p-10 -113.24 29.93 7.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.814 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -61.87 -25.29 67.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -169.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -65.65 -43.53 89.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 110.805 -168.331 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 272' ' ' ASN . 2.5 pp -74.75 -33.73 62.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' ALA . . . . . 0.444 ' HB1' HD11 ' A' ' 59' ' ' ILE . . . -65.81 -49.17 69.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -65.22 -35.13 80.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 94.0 mt-10 -68.62 -43.39 76.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.874 -177.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -60.12 -46.58 89.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' LEU . . . . . 0.461 HD11 ' CB ' ' A' ' 264' ' ' ALA . 7.6 tt -62.43 -46.56 87.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 -177.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.99 -38.81 72.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 -177.894 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 94.8 m-20 -102.28 -10.9 19.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -161.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' TYR . . . . . 0.426 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 53.5 t80 -122.46 -51.57 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 284' ' ' LEU . . . . . 0.429 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.5 OUTLIER -70.58 -43.22 69.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -176.724 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 285' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 106' ' ' TYR . 4.5 mm? -81.69 44.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 169.183 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 286' ' ' THR . . . . . 0.431 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 89.6 m -145.77 145.37 30.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.168 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 287' ' ' ASP . . . . . 0.556 ' HA ' HD11 ' A' ' 290' ' ' LEU . 48.5 p-10 -50.11 -25.93 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -171.203 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -75.78 -45.89 33.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 289' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.71 -49.71 13.42 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 -169.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 290' ' ' LEU . . . . . 0.646 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.7 OUTLIER -73.06 -23.64 60.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.715 0.293 . . . . 0.0 110.877 -177.841 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 291' ' ' GLU . . . . . 0.516 ' N ' HD12 ' A' ' 290' ' ' LEU . 87.7 tt0 -68.71 -40.08 80.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 171.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.95 78.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.15 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 293' ' ' VAL . . . . . 0.672 HG13 ' HA3' ' A' ' 19' ' ' GLY . 39.9 t -77.89 -44.57 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.103 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -62.92 -29.66 70.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 177.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.01 -27.77 69.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -89.16 -36.77 15.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.819 -177.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' LYS . . . . . 0.423 ' O ' HD13 ' A' ' 299' ' ' LEU . 85.9 tttt -152.84 138.35 11.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.638 0.732 . . . . 0.0 110.864 175.191 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.78 112.72 0.9 Allowed 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.694 2.263 . . . . 0.0 112.329 175.279 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 297' ' ' LYS . 0.1 OUTLIER -88.98 -20.36 24.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 178.059 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 300' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 301' ' ' ALA . . . 102.18 -41.2 2.19 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.573 177.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 301' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 300' ' ' GLY . . . -179.86 175.92 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.884 0.373 . . . . 0.0 111.069 171.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 302' ' ' VAL . . . . . 0.621 ' CG2' ' HB3' ' A' ' 307' ' ' TYR . 22.3 m -135.85 160.06 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.136 162.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.27 -14.2 61.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.07 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 304' ' ' LEU . . . . . 0.646 ' CD2' HD21 ' A' ' 290' ' ' LEU . 60.4 tp -77.07 128.69 34.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -173.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -41.88 -33.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 -177.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' SER . . . . . 0.432 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 48.0 t -46.86 -38.66 10.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.866 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' TYR . . . . . 0.621 ' HB3' ' CG2' ' A' ' 302' ' ' VAL . 0.2 OUTLIER -57.36 -44.18 84.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 175.313 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 308' ' ' GLU . . . . . 0.472 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 88.7 tt0 -56.92 -39.99 75.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.786 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -80.01 -64.55 1.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.829 -174.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -85.81 -57.84 2.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.88 -171.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' LEU . . . . . 0.609 ' HB3' HD13 ' A' ' 317' ' ' ILE . 34.3 mt -59.34 -34.77 72.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 -169.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 312' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 318' ' ' ALA . . . -59.66 -18.19 39.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 -176.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -65.02 -23.01 67.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.767 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 314' ' ' ASP . . . . . 0.585 ' HB3' HD12 ' A' ' 317' ' ' ILE . 59.9 t0 -86.44 125.7 66.75 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.442 0.639 . . . . 0.0 110.876 173.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -49.23 -30.85 20.48 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.564 2.176 . . . . 0.0 112.334 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -65.11 -32.16 73.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 317' ' ' ILE . . . . . 0.609 HD13 ' HB3' ' A' ' 311' ' ' LEU . 6.9 mt -94.88 -36.07 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.082 -178.278 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 318' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 312' ' ' ALA . . . -53.82 -43.43 69.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.085 -174.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' ALA . . . . . 0.526 ' HB2' HG22 ' A' ' 244' ' ' VAL . . . -66.96 -44.62 80.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.091 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 64.2 p -64.7 -25.58 68.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.097 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 65.8 ttp -62.61 -38.6 90.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.911 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -66.82 -36.86 83.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.789 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 323' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 327' ' ' GLY . 63.7 t30 -78.88 -38.66 37.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.906 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 324' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 259' ' ' VAL . . . -64.92 -46.89 79.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.057 -175.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -70.36 -33.44 71.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 -177.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.66 -4.17 34.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -103.36 -160.2 25.13 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.443 -174.2 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 328' ' ' GLU . . . . . 0.648 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 94.8 mt-10 -143.41 139.32 29.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.841 0.353 . . . . 0.0 110.837 -173.118 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 329' ' ' ILE . . . . . 0.582 ' O ' ' C ' ' A' ' 330' ' ' MET . 43.8 mm -82.35 112.33 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.189 -171.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 330' ' ' MET . . . . . 0.582 ' C ' ' O ' ' A' ' 329' ' ' ILE . 74.1 mtm 23.69 56.96 0.31 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.653 0.739 . . . . 0.0 110.892 175.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 331' ' ' PRO . . . . . 0.648 ' HG3' ' HB3' ' A' ' 328' ' ' GLU . 45.0 Cg_endo -93.14 -8.75 2.23 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.596 2.197 . . . . 0.0 112.287 -173.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 332' ' ' ASN . . . . . 0.552 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 27.5 t30 -98.0 11.42 37.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.84 -160.019 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 333' ' ' ILE . . . . . 0.616 HG22 ' H ' ' A' ' 335' ' ' GLN . 50.1 mm 86.38 132.34 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.69 0.757 . . . . 0.0 111.055 164.785 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.41 -24.83 76.31 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.662 2.241 . . . . 0.0 112.371 -176.06 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 335' ' ' GLN . . . . . 0.616 ' H ' HG22 ' A' ' 333' ' ' ILE . 99.2 mm-40 -61.93 -17.54 57.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.96 174.74 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -57.57 -27.23 62.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.939 -173.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -35.97 79.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.34 -37.25 66.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.111 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 339' ' ' PHE . . . . . 0.437 ' HA ' HG12 ' A' ' 368' ' ' ILE . 35.4 m-85 -63.9 -49.02 74.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.8 174.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -64.89 -36.8 85.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.988 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -68.72 -47.23 66.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.71 89.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 343' ' ' VAL . . . . . 0.444 ' O ' ' HB3' ' A' ' 346' ' ' ALA . 13.9 m -80.6 -23.48 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 344' ' ' ARG . . . . . 0.52 ' O ' HG22 ' A' ' 347' ' ' VAL . 3.0 tmt_? -62.37 -47.39 84.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 81.4 p -60.85 -26.69 67.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.148 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 346' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -62.06 -41.91 98.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.044 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 347' ' ' VAL . . . . . 0.593 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.2 m -72.68 -32.83 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.072 -175.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.94 -45.97 95.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.194 172.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -63.8 -35.45 80.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.819 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.65 -45.76 61.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.096 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.0 89.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.185 -175.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 98.5 p -75.7 -9.99 59.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.947 -177.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.72 16.6 79.91 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.558 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.84 -32.77 40.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.719 0.295 . . . . 0.0 110.848 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -138.11 154.76 49.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.861 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.8 p -79.66 167.42 20.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.217 168.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 357' ' ' VAL . . . . . 0.463 ' HA ' HD23 ' A' ' 192' ' ' LEU . 55.1 t -54.72 -41.94 58.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.061 173.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -59.66 -45.76 91.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.858 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -72.55 -52.84 13.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.2 -43.64 77.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.053 -171.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 361' ' ' LEU . . . . . 0.637 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -67.52 -40.91 85.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 -178.471 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.9 -39.83 94.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.936 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -63.09 -38.53 91.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.841 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 364' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -63.58 -42.5 98.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.083 174.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 365' ' ' GLN . . . . . 0.449 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 23.1 tm0? -64.27 -36.79 85.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 177.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 366' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 370' ' ' LYS . 92.2 m -66.06 -40.22 90.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 176.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -67.59 -35.06 78.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 368' ' ' ILE . . . . . 0.563 ' CD1' HG21 ' A' ' 183' ' ' VAL . 68.3 mt -62.71 -40.88 90.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.061 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.3 p -94.68 -10.53 31.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 370' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 366' ' ' THR . 99.5 mttt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.778 0.323 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.7 mt -104.37 134.42 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -145.0 143.12 30.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -54.66 136.17 45.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.794 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.424 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 99.27 3.14 56.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.488 -173.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -166.34 149.83 7.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.797 0.332 . . . . 0.0 110.962 173.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.68 HD22 HD13 ' A' ' 33' ' ' ILE . 1.5 pt? -149.53 154.05 38.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.978 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 75.8 t -109.41 135.05 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.118 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.739 HG22 ' CG1' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -123.07 133.02 70.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.104 179.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.476 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 45.9 m0 -109.46 133.32 53.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.945 173.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.509 HD12 ' HB2' ' A' ' 20' ' ' LEU . 4.4 tt -109.99 149.79 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.136 -169.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -57.54 155.31 9.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.93 -14.47 16.94 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.531 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -76.46 -13.52 60.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.855 0.359 . . . . 0.0 110.843 -172.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -138.91 144.27 39.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.06 -84.11 1.01 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.452 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -112.99 -37.66 4.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.925 0.393 . . . . 0.0 110.895 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -66.33 -52.26 48.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.969 -144.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.68 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -62.92 -48.07 83.7 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.556 -176.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.67 HD21 HG13 ' A' ' 9' ' ' ILE . 10.9 tp -67.02 -35.87 80.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.947 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.74 84.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 173.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -65.07 -52.78 53.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.831 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 20' ' ' LEU . 14.1 m -73.9 -35.58 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 -176.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.517 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -66.67 -44.39 89.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.519 176.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -64.95 -40.02 94.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -65.39 -38.88 91.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.415 ' CE2' HD11 ' A' ' 33' ' ' ILE . 73.6 t80 -66.14 -39.81 90.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.857 174.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -57.49 -39.98 77.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.2 -30.18 68.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -83.51 -38.96 21.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 -170.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.609 ' OG1' HG13 ' A' ' 33' ' ' ILE . 61.1 p -105.73 -12.93 15.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.41 5.91 89.09 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.519 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.828 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.6 pp -99.29 133.96 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 0.0 111.159 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -70.47 129.25 38.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 -168.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.517 HG11 ' HA3' ' A' ' 24' ' ' GLY . 90.2 t -110.81 119.79 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.135 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.8 m -115.44 116.99 29.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.127 -173.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.446 HG22 ' HG ' ' A' ' 20' ' ' LEU . 79.0 t -98.77 139.29 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.476 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 73.9 mm-40 -121.25 161.83 21.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.888 176.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -84.78 141.04 37.98 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.612 0.72 . . . . 0.0 110.898 -171.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 85.6 Cg_exo -52.33 -30.72 43.96 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.724 2.282 . . . . 0.0 112.339 -177.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -49.34 -48.97 46.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.937 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.92 -19.31 48.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.875 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.612 ' C ' HD23 ' A' ' 43' ' ' LEU . 7.3 tt -52.4 -59.29 4.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.918 -171.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.06 -39.22 83.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.67 -42.7 57.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.845 -170.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -85.25 -29.27 24.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -171.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.549 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 91.2 t80 -47.72 -51.85 42.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.744 . . . . 0.0 110.885 -165.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 62.9 Cg_endo -69.04 -29.26 27.59 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 0.0 112.313 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -76.99 -43.4 35.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.6 m -72.29 -26.69 25.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.186 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.437 ' HB1' ' HG ' ' A' ' 75' ' ' LEU . . . -65.65 -34.23 77.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 173.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.33 -29.64 70.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.077 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.2 p -92.38 -14.01 29.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.155 175.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.56 14.79 81.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.497 173.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -140.01 129.91 24.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.797 0.332 . . . . 0.0 110.916 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.85 -115.01 0.54 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.523 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.473 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 98.3 Cg_endo -72.84 151.41 51.1 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.658 2.239 . . . . 0.0 112.367 173.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.86 -35.49 15.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 168.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.739 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -138.51 150.03 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.054 177.073 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.573 HD11 HD21 ' A' ' 43' ' ' LEU . 4.1 tp -125.95 126.42 69.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.051 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.439 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 7.9 m-85 -108.07 123.35 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 177.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 16.7 t-105 -143.94 -172.81 3.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.3 -88.72 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.195 172.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -106.5 -54.64 2.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.82 -39.55 77.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 -159.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.58 -29.99 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 -174.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.801 ' HD1' ' O ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -49.99 -52.95 29.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.934 -175.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.96 -41.33 97.4 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.495 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.97 -61.34 7.47 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.557 ' HD1' HD22 ' A' ' 76' ' ' LEU . 4.8 p90 -81.63 -25.52 35.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 110.929 -168.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.449 ' N ' ' CD1' ' A' ' 70' ' ' TYR . . . -70.22 -54.44 12.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.165 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -67.27 -34.14 76.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.845 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.6 m -84.77 -8.0 58.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 -173.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.39 31.75 63.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.481 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.437 ' HG ' ' HB1' ' A' ' 51' ' ' ALA . 2.5 mp -86.81 -4.63 59.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.929 0.395 . . . . 0.0 110.947 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.557 HD22 ' HD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -124.36 149.41 46.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.994 -175.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.01 140.53 37.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 169.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -71.63 135.35 46.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.909 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.854 HG13 ' HB3' ' A' ' 103' ' ' LEU . 42.5 pt -116.89 165.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 176.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 p -115.3 150.06 43.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.607 0.718 . . . . 0.0 111.122 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.32 144.99 47.3 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -103.14 119.96 39.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.61 -41.99 98.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.66 -46.46 82.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.16 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.43 ' HB3' ' HZ2' ' A' ' 94' ' ' TRP . 18.1 m-85 -73.55 -31.24 63.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.473 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.7 tt0 -53.5 -45.07 69.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.911 174.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -67.6 -33.9 75.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 175.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -77.84 -24.85 48.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.478 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 1.9 mp -104.98 -105.06 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 -174.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -169.26 128.1 0.9 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.637 0.732 . . . . 0.0 110.967 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -53.33 -36.51 78.85 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.586 2.19 . . . . 0.0 112.365 -171.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.62 -30.01 67.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.976 -173.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.4 p -76.66 -31.12 57.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.158 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.601 ' HA ' HG22 ' A' ' 97' ' ' VAL . 92.0 m95 -72.37 -27.51 62.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.932 171.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -72.78 -31.45 64.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 169.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . 0.42 ' CB ' HG21 ' A' ' 329' ' ' ILE . . . -65.03 -28.1 69.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.065 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.601 HG22 ' HA ' ' A' ' 94' ' ' TRP . 29.9 m -110.9 17.2 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.16 -171.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 72.3 ttt180 -112.46 138.06 49.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -143.05 125.24 15.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.4 t30 60.83 34.93 19.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.852 174.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.82 -6.44 74.29 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.499 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -122.53 145.31 48.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 0.0 110.915 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.854 ' HB3' HG13 ' A' ' 79' ' ' ILE . 3.6 tp -73.62 139.68 45.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -178.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.475 ' C ' HD12 ' A' ' 104' ' ' ILE . 2.5 pp -127.17 10.01 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 -173.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -173.26 169.63 4.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.093 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.483 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 89.4 m-85 -116.13 144.52 33.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.729 0.776 . . . . 0.0 110.88 166.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 15.0 Cg_exo -69.66 117.12 4.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.693 2.262 . . . . 0.0 112.316 172.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 29.7 mm -97.81 -47.01 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.14 154.98 38.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.108 -170.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.9 t -120.45 133.35 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 -178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -120.83 134.19 55.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.63 161.78 41.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.06 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.589 ' HG ' ' HA3' ' A' ' 228' ' ' GLY . 6.0 mp -112.58 159.07 19.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.899 -173.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.9 p -154.37 162.92 40.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.848 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -93.64 123.72 37.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.953 176.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.545 ' N ' HD22 ' A' ' 115' ' ' LEU . 47.0 mt -108.44 132.06 57.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 -174.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -135.09 151.4 50.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 -175.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -96.33 117.86 31.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -66.91 -17.51 64.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -73.09 -29.61 63.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.837 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.537 HD21 ' O ' ' A' ' 220' ' ' GLY . 7.2 mp -99.94 -49.62 4.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 18.0 mt -102.25 125.55 36.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.608 0.718 . . . . 0.0 110.899 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.36 -23.5 23.87 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.643 2.229 . . . . 0.0 112.331 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -153.07 130.0 5.69 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.637 0.732 . . . . 0.0 110.873 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.1 153.6 77.11 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.71 2.273 . . . . 0.0 112.363 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.34 144.83 41.97 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.717 2.278 . . . . 0.0 112.324 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -94.01 -28.74 15.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.929 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 79.8 p -130.13 156.11 45.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.426 ' HA ' HD13 ' A' ' 132' ' ' ILE . 26.9 t-105 -68.76 -24.47 64.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.9 -23.95 63.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.899 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.55 -23.2 53.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.585 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.5 mp -62.32 -51.87 70.57 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.685 0.755 . . . . 0.0 111.173 -170.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 39.7 Cg_endo -71.57 -39.09 3.84 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.66 2.24 . . . . 0.0 112.378 -171.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.37 -39.69 85.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.195 173.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.8 tp -60.89 -44.53 96.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.531 ' OD1' ' HB3' ' A' ' 146' ' ' ALA . 40.5 m-20 -49.72 -35.01 20.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.821 178.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.14 -34.55 68.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 -178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -74.61 -53.36 9.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -171.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.541 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.9 OUTLIER -80.08 -10.96 59.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -175.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.541 ' N ' HD23 ' A' ' 139' ' ' LEU . 86.3 tttt -55.39 -31.22 61.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 168.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.74 -25.02 67.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.141 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -95.0 7.66 45.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.45 26.89 66.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.462 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.463 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 42.1 mmtm -116.83 162.7 17.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.839 0.352 . . . . 0.0 110.911 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.0 t -127.14 132.37 50.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.884 175.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.687 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -80.57 -38.3 29.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.084 -162.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -139.78 130.21 25.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.915 -174.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.777 ' SD ' ' HB2' ' A' ' 213' ' ' ALA . 56.8 ttm -117.04 130.15 56.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -177.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -151.04 157.2 42.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.8 -171.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -101.21 98.13 8.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.787 HD21 HD11 ' A' ' 195' ' ' LEU . 0.8 OUTLIER -69.24 -36.98 77.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -76.23 -3.77 38.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.891 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -99.87 148.92 35.45 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.624 0.726 . . . . 0.0 110.908 174.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.469 ' HD3' ' HD3' ' A' ' 344' ' ' ARG . 24.9 Cg_endo -63.0 -18.69 66.52 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.723 2.282 . . . . 0.0 112.379 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -64.33 -40.87 96.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.514 ' CD2' HD23 ' A' ' 151' ' ' LEU . 90.4 t80 -86.22 -37.8 18.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.875 -176.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 60.7 p -61.13 -36.95 81.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.226 -170.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.551 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 78.8 t90 -69.22 -53.65 13.12 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.504 0.669 . . . . 0.0 110.84 -174.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 44.0 Cg_endo -67.86 -17.17 46.82 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.647 2.231 . . . . 0.0 112.446 -176.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.836 HD13 ' O ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER -82.5 -48.49 10.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 172.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 68.0 mt -74.84 -40.03 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.97 65.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.136 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -63.34 -34.86 78.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.059 -168.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -91.87 2.6 56.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 120.08 3.41 11.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.503 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.54 60.6 4.8 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.488 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -79.84 134.45 36.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 110.969 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.42 5.29 18.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 -174.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -147.04 149.99 34.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.907 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 79.2 tttt -103.87 122.45 45.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 158.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -118.81 122.1 41.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.968 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -152.36 130.83 12.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 55.42 39.08 31.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.81 16.54 80.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.03 138.14 50.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 110.888 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -96.45 144.89 26.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -129.31 104.94 7.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.894 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.496 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.4 pp -74.71 -11.21 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.204 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -97.56 -12.26 22.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 -174.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 51.4 t0 -124.3 62.54 1.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.11 174.9 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.167 -166.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -104.82 17.96 44.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.501 -164.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.5 m -100.2 -19.91 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 111.148 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -86.7 19.08 3.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -113.77 175.14 5.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.94 -25.28 67.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.89 -39.85 96.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.471 -172.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.656 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -68.77 -36.88 78.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 111.113 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.516 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 93.5 mttt -59.54 -33.25 71.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 174.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.0 69.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.152 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.19 -51.1 59.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.413 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.5 mt -64.51 -34.92 79.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.87 0.367 . . . . 0.0 110.916 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 94.9 m -56.81 -46.77 81.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.582 ' HD2' HD21 ' A' ' 160' ' ' LEU . 71.8 t80 -75.66 -44.89 40.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.787 HD11 HD21 ' A' ' 151' ' ' LEU . 7.7 tt -52.84 -44.41 66.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -171.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 34.9 m -70.45 -21.21 23.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.101 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.636 ' HB3' HD13 ' A' ' 198' ' ' LEU . 38.8 t70 -56.96 -49.87 74.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 -166.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.758 ' N ' HD13 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -87.09 -30.47 21.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 -170.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.541 ' H ' HD22 ' A' ' 198' ' ' LEU . 2.3 pp -78.33 -34.28 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.01 -27.6 68.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 168.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -83.94 4.68 28.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 174.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 65.11 39.31 5.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.901 172.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -77.43 -8.63 58.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 27.9 ptm -144.17 159.59 42.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.871 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -98.78 159.27 15.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.36 -26.3 68.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.049 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -93.76 -2.13 54.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.3 m -64.26 135.0 55.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -144.66 169.3 18.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -68.43 -34.59 76.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.854 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 91.6 p -67.47 -33.18 74.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.795 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 82.6 mt -63.48 -39.3 84.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.125 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.777 ' HB2' ' SD ' ' A' ' 148' ' ' MET . . . -62.43 -40.06 95.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 234' ' ' ASN . 92.9 mt-10 -63.1 -40.74 98.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -70.0 -38.95 76.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.089 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.45 -33.17 74.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.185 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -60.05 -30.69 69.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -62.01 -36.31 81.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.77 -19.01 19.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.537 ' O ' HD21 ' A' ' 121' ' ' LEU . . . 87.78 28.03 25.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.459 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -81.92 -28.61 32.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 0.0 110.901 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 93.1 m -119.24 131.36 55.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.687 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -75.82 -47.14 26.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.065 -174.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 61.0 mtm -134.97 158.95 43.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.853 -174.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 9.6 t -149.15 166.33 29.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 mm -109.46 124.23 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 172.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -155.33 171.8 19.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.835 -170.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.589 ' HA3' ' HG ' ' A' ' 113' ' ' LEU . . . -155.56 -115.71 0.53 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.504 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.3 -22.84 74.71 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.681 2.254 . . . . 0.0 112.317 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -78.26 -10.8 59.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.998 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.93 -16.57 61.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.092 -170.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 36.1 p-90 -54.94 -30.0 57.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.981 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.5 t -50.16 -56.34 11.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 214' ' ' GLU . 49.3 t30 -163.79 64.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 32.1 mm . . . . . 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 167.918 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 29.0 m . . . . . 0 N--CA 1.458 -0.065 0 CA-C-O 120.898 0.38 . . . . 0.0 111.138 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -112.8 82.09 1.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -117.99 148.59 42.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.82 162.17 25.52 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.552 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.79 HG11 ' O ' ' A' ' 315' ' ' PRO . 10.1 p -144.04 138.49 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.942 0.401 . . . . 0.0 111.169 -175.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.6 t -150.68 149.2 29.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.106 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 30.4 m -63.62 168.44 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.135 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.809 ' HB3' ' HB2' ' A' ' 255' ' ' SER . 3.9 mm? -63.27 137.01 96.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.569 0.7 . . . . 0.0 110.903 -162.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -72.04 -172.68 0.89 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.359 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 82.5 p -105.67 151.79 23.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.134 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.402 ' HD2' ' HB3' ' A' ' 163' ' ' ALA . 33.5 t80 -136.48 120.48 17.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 176.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 56.55 35.5 26.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.81 9.3 74.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.486 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -129.97 140.88 39.98 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.722 . . . . 0.0 110.877 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.2 142.17 33.57 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.672 2.248 . . . . 0.0 112.35 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.809 ' HB2' ' HB3' ' A' ' 247' ' ' LEU . 64.3 m -85.3 0.83 50.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.823 173.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -45.01 112.49 1.53 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.61 0.719 . . . . 0.0 110.935 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.11 162.0 32.03 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.724 2.282 . . . . 0.0 112.325 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -72.98 152.5 41.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 -172.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.13 134.99 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.112 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -112.48 135.19 12.51 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.44 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.3 t -125.88 128.4 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.884 0.373 . . . . 0.0 111.147 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 108' ' ' ILE . 1.7 tt -69.99 130.13 41.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 77.3 p -122.23 135.92 54.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.825 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.458 ' HB1' HD11 ' A' ' 280' ' ' LEU . . . -124.8 127.53 47.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.12 -178.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.2 160.9 14.69 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.474 -170.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.41 ' HA ' HG22 ' A' ' 59' ' ' ILE . 20.6 mm -99.98 121.62 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.819 0.342 . . . . 0.0 111.129 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -66.68 129.5 40.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -175.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.42 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -60.67 -27.72 68.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.083 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.83 -11.77 57.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.041 -173.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.8 t -75.48 121.25 84.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.719 . . . . 0.0 110.934 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -68.76 -10.42 29.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.658 2.239 . . . . 0.0 112.286 167.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -102.44 17.65 23.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.937 -171.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -48.78 -34.84 13.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.884 -172.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -70.37 -48.26 57.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 -170.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.0 pp -81.76 -30.38 32.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.51 -46.28 73.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.09 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -67.53 -34.47 77.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 89.2 tt0 -63.92 -52.28 60.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 -173.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.491 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.2 p90 -69.99 -34.18 73.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.458 HD11 ' HB1' ' A' ' 264' ' ' ALA . 4.3 tt -58.38 -50.99 71.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -80.11 -31.26 39.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 61.9 m-80 -101.4 -28.94 12.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.921 -165.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.555 ' O ' HG22 ' A' ' 286' ' ' THR . 85.4 t80 -110.25 -43.4 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 -169.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.2 mp -72.54 -47.07 51.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.2 mp -83.33 61.29 6.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 283' ' ' TYR . 14.5 t -153.1 155.72 37.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.16 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.492 ' HA ' HD11 ' A' ' 290' ' ' LEU . 39.1 p-10 -52.41 -27.25 15.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.857 -168.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -78.23 -46.02 21.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.92 -49.39 17.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.449 -168.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.595 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.4 OUTLIER -74.96 -21.56 59.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 0.0 110.908 -178.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.427 ' N ' HD12 ' A' ' 290' ' ' LEU . 83.1 tt0 -67.22 -40.91 86.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.95 170.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.31 76.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.129 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.68 HG13 ' HA3' ' A' ' 19' ' ' GLY . 19.7 t -80.22 -43.67 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.134 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.405 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 41.7 t30 -65.77 -28.78 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.926 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.55 -26.01 67.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -82.33 -45.21 15.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.838 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -153.51 135.52 9.09 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.583 0.706 . . . . 0.0 110.947 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -49.3 114.66 1.39 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.632 2.221 . . . . 0.0 112.414 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 40.1 mt -92.74 -19.04 22.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 -177.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 114.94 -60.48 0.39 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -176.4 168.43 2.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.815 0.34 . . . . 0.0 111.064 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 30.3 m -124.62 157.7 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.157 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.96 -17.28 61.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.595 ' CD2' HD21 ' A' ' 290' ' ' LEU . 58.4 tp -81.0 123.5 28.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.977 -174.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -61.44 -33.25 73.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.89 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.2 m -61.84 -47.67 84.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.815 -170.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.454 ' CD2' HD23 ' A' ' 311' ' ' LEU . 20.8 t80 -89.11 -28.66 19.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -57.78 -42.63 84.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.909 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.68 -34.96 79.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -73.02 -45.55 57.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.692 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.4 pp -73.43 -27.04 61.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.874 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.41 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.58 -11.23 57.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.34 -15.98 61.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -86.24 128.76 56.25 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.539 0.685 . . . . 0.0 110.882 169.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.79 ' O ' HG11 ' A' ' 244' ' ' VAL . 83.6 Cg_exo -52.6 -31.69 50.8 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.518 ' HG3' HG13 ' A' ' 317' ' ' ILE . 27.6 ptt-85 -66.3 -31.05 71.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -171.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.692 HG21 ' CD1' ' A' ' 311' ' ' LEU . 63.3 mt -95.12 -37.38 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 -176.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.53 -44.5 62.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 -168.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.97 -42.4 80.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.053 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 71.9 p -63.85 -28.22 69.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . 0.411 ' HE2' ' HA ' ' A' ' 321' ' ' MET . 33.5 mmt -66.75 -31.91 72.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -66.06 -44.18 85.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 327' ' ' GLY . 40.9 t30 -64.46 -37.21 86.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 174.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.7 -45.05 95.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.1 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -73.78 -34.37 64.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.9 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -100.49 -0.0 38.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -96.57 -155.63 30.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.408 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.56 139.19 42.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 0.0 110.922 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.587 ' O ' ' C ' ' A' ' 330' ' ' MET . 42.6 mm -76.69 110.01 11.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.1 -173.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.587 ' C ' ' O ' ' A' ' 329' ' ' ILE . 99.3 mmm . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 170.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.765 0.317 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 87.4 mmm -72.81 -26.12 61.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.953 -172.061 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.0 m -60.88 -41.43 95.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.4 -36.44 71.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -65.22 -37.73 88.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -61.04 -37.84 84.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -75.91 -35.26 59.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.92 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 367' ' ' ARG . . . -62.68 -41.27 99.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.134 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.6 m -79.86 -25.17 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.469 ' HD3' ' HD3' ' A' ' 154' ' ' PRO . 54.5 ttp85 -61.3 -45.31 94.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.821 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 84.6 m -57.23 -36.63 71.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.131 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.735 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -60.58 -43.93 96.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.116 -175.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 344' ' ' ARG . 2.0 m -73.75 -32.69 35.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.171 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.74 -46.21 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.196 173.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.489 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 89.5 m-20 -69.13 -34.97 75.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.47 -45.35 65.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.01 -41.18 87.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 89.3 p -77.19 -11.96 59.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.836 -175.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.31 14.06 82.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.576 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.75 -29.85 56.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.755 0.312 . . . . 0.0 110.85 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 86.9 mt-30 -135.63 157.26 47.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 175.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.4 p -77.64 169.77 17.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.197 168.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 69.5 t -55.55 -42.83 70.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 170.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -59.87 -45.28 92.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -71.25 -52.78 17.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.838 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.24 -45.04 74.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 -173.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -66.75 -39.95 88.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.907 -176.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.537 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 87.9 tttt -64.68 -39.62 93.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 177.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.82 -37.91 89.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.735 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -64.75 -45.83 84.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.074 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.537 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 1.2 pp0? -73.82 -30.09 62.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 56.8 m -64.04 -41.54 97.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.404 ' HB2' ' HB1' ' A' ' 342' ' ' ALA . 99.6 mtt180 -66.08 -39.07 89.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 70.4 mt -65.4 -37.86 81.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.209 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.3 p -92.37 -10.12 39.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.158 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.874 176.07 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.8 0.333 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 98.9 mt -91.44 125.03 44.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.132 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.31 146.07 36.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.855 -176.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.47 136.83 43.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.775 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.27 4.79 58.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.484 -174.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -169.89 153.22 4.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.869 0.366 . . . . 0.0 110.899 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.551 ' H ' HD23 ' A' ' 7' ' ' LEU . 1.0 OUTLIER -151.68 157.0 41.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.495 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 89.8 t -110.65 135.63 49.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.738 HG22 ' CG1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -122.98 132.01 72.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.075 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.445 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 41.9 m0 -108.77 125.75 52.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.936 171.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 14.8 tt -106.3 150.02 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.094 -170.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -59.21 151.46 22.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.91 -15.73 21.69 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.511 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -75.06 -11.14 60.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.845 -172.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -147.84 137.75 22.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.943 160.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.15 -83.26 1.04 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.443 -167.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -110.52 -45.67 3.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.013 0.435 . . . . 0.0 110.942 -172.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -68.22 -51.93 39.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.944 -151.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.518 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -60.09 -48.05 88.0 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.582 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.686 ' CD2' HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -58.13 -45.61 87.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.369 . . . . 0.0 110.884 176.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.99 76.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -64.86 -48.25 74.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 -177.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.0 m -74.38 -36.05 41.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.442 ' CA ' HG11 ' A' ' 35' ' ' VAL . . . -66.68 -48.34 62.55 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.576 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -65.45 -39.26 91.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.999 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -64.47 -41.58 96.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.457 ' CD2' HD11 ' A' ' 33' ' ' ILE . 63.1 t80 -65.42 -38.0 88.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.55 -41.76 99.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.89 -31.92 69.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.822 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -82.43 -40.48 21.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -171.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.636 ' OG1' HG13 ' A' ' 33' ' ' ILE . 60.8 p -102.61 -9.46 20.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.11 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.44 9.73 84.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.56 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.036 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 pp -103.91 132.15 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.011 0.434 . . . . 0.0 111.07 -175.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -71.11 127.78 33.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.957 -168.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.474 HG22 HD21 ' A' ' 7' ' ' LEU . 99.2 t -110.67 122.06 64.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.086 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.457 ' HB ' HG22 ' A' ' 8' ' ' VAL . 99.7 m -111.57 117.94 34.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.146 -175.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.522 HG22 HD13 ' A' ' 20' ' ' LEU . 84.7 t -93.78 134.98 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.061 176.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.445 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 74.5 mm-40 -121.58 162.95 19.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.861 173.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.4 t-80 -84.9 139.73 37.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.615 0.722 . . . . 0.0 110.897 -167.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 70.9 Cg_exo -60.49 -16.85 44.71 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.754 2.303 . . . . 0.0 112.307 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -49.21 -56.37 9.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.936 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -86.69 1.31 52.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -175.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.53 HD11 ' O ' ' A' ' 61' ' ' PHE . 9.4 tt -43.65 -53.34 5.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 -175.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -71.28 -43.8 66.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.21 -48.05 16.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.879 -161.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HG2' HG13 ' A' ' 50' ' ' VAL . 84.3 tttt -84.58 -33.09 23.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -170.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 90.3 t80 -47.8 -53.54 30.61 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.69 0.757 . . . . 0.0 110.9 -172.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 31.5 Cg_endo -61.99 -29.31 81.62 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.612 2.208 . . . . 0.0 112.375 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -74.78 -43.47 54.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.456 HG13 ' HG2' ' A' ' 46' ' ' LYS . 35.7 m -74.97 -25.12 18.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.219 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.43 -33.9 74.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.13 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.18 -27.14 66.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.02 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.3 p -91.83 -13.6 31.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.164 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.26 14.27 82.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.478 170.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -145.89 137.29 24.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 0.0 110.876 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.446 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . 165.01 -131.2 2.34 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.466 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.495 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 54.1 Cg_endo -62.83 139.06 72.38 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.666 2.244 . . . . 0.0 112.372 171.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.449 ' HB2' HD13 ' A' ' 59' ' ' ILE . 2.6 m-20 -86.57 -35.03 19.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 171.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.738 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -132.51 148.12 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.134 177.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.7 tp -127.98 127.16 67.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.154 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.53 ' O ' HD11 ' A' ' 43' ' ' LEU . 9.1 m-85 -99.86 125.52 45.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.428 ' CG ' ' N ' ' A' ' 63' ' ' ALA . 41.6 t-105 -145.02 -175.81 4.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.928 169.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.428 ' N ' ' CG ' ' A' ' 62' ' ' TRP . . . -90.52 -87.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.136 173.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -126.23 -58.14 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.93 -44.4 96.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 -151.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -66.57 -28.52 68.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.836 -170.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -51.86 -42.9 62.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.868 -175.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.63 -49.66 74.26 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.531 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.84 -43.35 99.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.568 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -66.52 -46.97 74.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 110.874 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.91 -43.91 91.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.154 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.93 -34.96 79.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.016 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.5 m -84.91 -7.03 59.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.91 29.54 60.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.491 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.1 mp -84.13 -12.1 55.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.819 0.342 . . . . 0.0 110.837 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.598 HD11 HG22 ' A' ' 104' ' ' ILE . 4.4 pp -131.2 143.17 50.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.956 -177.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -79.65 144.94 33.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.45 134.2 48.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.864 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.802 HG13 ' HB3' ' A' ' 103' ' ' LEU . 36.4 pt -110.39 160.72 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.18 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.6 p -103.68 141.62 22.88 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.621 0.724 . . . . 0.0 111.065 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.79 145.19 31.99 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.728 2.285 . . . . 0.0 112.386 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -111.53 119.52 39.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.66 -41.63 98.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.897 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.45 89.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -73.43 -33.75 65.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.495 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.3 tt0 -53.6 -49.0 68.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.901 174.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -60.6 -34.98 75.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.01 -22.9 52.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.822 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -103.22 -109.43 0.25 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.813 -173.316 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -169.9 133.13 1.1 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.599 0.714 . . . . 0.0 110.992 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.8 -40.12 81.38 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.685 2.257 . . . . 0.0 112.303 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -69.13 -29.95 68.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -171.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 107' ' ' PRO . 54.3 p -73.38 -31.36 63.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.112 -174.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.598 ' HA ' HG22 ' A' ' 97' ' ' VAL . 81.0 m95 -71.89 -25.47 61.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.042 174.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.53 -38.33 71.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.779 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.33 -26.98 63.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 94' ' ' TRP . 19.7 m -100.01 15.44 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.132 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 34.8 ttp-105 -110.2 141.85 42.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.788 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -138.83 122.76 17.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.864 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 59.82 34.94 21.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.945 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.24 -2.64 84.08 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.451 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.56 144.52 48.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 0.0 110.912 174.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.802 ' HB3' HG13 ' A' ' 79' ' ' ILE . 4.9 tp -79.5 138.51 37.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.803 -173.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.598 HG22 HD11 ' A' ' 76' ' ' LEU . 2.5 pp -126.93 1.53 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 -171.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -167.14 168.41 13.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.448 ' CZ ' HD12 ' A' ' 79' ' ' ILE . 93.6 m-85 -114.52 139.91 24.56 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.676 0.751 . . . . 0.0 110.962 170.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.476 ' HB3' ' HB ' ' A' ' 93' ' ' THR . 74.1 Cg_endo -73.74 120.16 6.28 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.75 2.3 . . . . 0.0 112.368 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.6 mm -100.13 -56.13 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.587 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -142.16 154.87 45.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.162 -166.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.0 t -120.7 136.85 56.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.111 -169.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -126.34 131.1 51.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -148.8 157.91 43.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.122 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.519 ' CD2' ' HA3' ' A' ' 228' ' ' GLY . 72.5 mt -102.02 168.76 9.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.89 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.8 p -155.93 158.15 37.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.931 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -96.26 127.74 42.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.889 172.594 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.554 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.9 mp -110.95 133.05 57.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.066 -175.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -132.57 149.98 52.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.913 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -88.05 111.77 21.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.854 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.427 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 88.6 tttt -62.69 -22.9 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -76.54 -22.5 54.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.866 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.459 HD21 ' O ' ' A' ' 220' ' ' GLY . 7.0 mp -97.46 -49.23 4.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.823 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.509 HD11 ' HB1' ' A' ' 223' ' ' ALA . 22.8 mt -107.17 132.49 20.89 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 110.898 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.04 -20.68 28.57 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.632 2.221 . . . . 0.0 112.384 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.573 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 20.3 p30 -154.26 161.72 28.63 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.685 0.755 . . . . 0.0 110.805 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.573 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 58.8 Cg_endo -70.23 158.5 56.16 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 0.0 112.388 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.48 148.33 66.65 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.679 2.253 . . . . 0.0 112.306 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -103.54 -44.99 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.8 p -133.24 157.88 44.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.14 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -70.02 -24.89 63.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.92 -19.81 66.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -73.99 -30.13 62.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.483 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 1.4 mp -63.34 -47.76 83.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.63 0.728 . . . . 0.0 111.138 -167.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.483 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 85.3 Cg_exo -53.93 -51.62 10.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.569 2.179 . . . . 0.0 112.293 -176.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.6 -40.45 73.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.6 tp -54.55 -43.46 72.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.904 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.422 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . 1.8 m-20 -50.09 -44.29 51.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.816 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.77 -33.48 75.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 -176.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.8 -46.93 27.95 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 -173.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.422 ' CD2' ' HA ' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -90.53 -19.95 23.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.872 -173.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 85.8 tttt -61.81 -26.39 68.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.901 170.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.89 -24.94 67.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.111 171.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -95.37 8.88 41.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.81 28.08 65.68 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.501 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 89.3 mttt -117.26 170.03 9.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 110.908 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.4 t -131.53 142.23 49.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.803 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -73.14 -51.3 18.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.049 -170.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -139.24 130.78 27.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.91 -169.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.415 ' SD ' ' OG1' ' A' ' 222' ' ' THR . 94.9 mtp -117.9 129.76 55.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.853 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -153.47 162.94 40.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.884 -169.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -95.81 104.37 16.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.027 169.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.752 HD21 HD11 ' A' ' 195' ' ' LEU . 0.7 OUTLIER -75.05 -35.96 61.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 177.271 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . 0.484 ' HA ' HD11 ' A' ' 348' ' ' ILE . 88.2 mt-30 -78.69 0.13 27.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.826 -175.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -106.82 150.44 39.72 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.635 0.731 . . . . 0.0 110.962 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.11 -20.31 69.39 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.691 2.26 . . . . 0.0 112.321 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -59.86 -44.07 94.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.011 -172.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -84.89 -39.99 17.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.863 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.0 p -64.02 -37.88 89.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.198 -169.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.569 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 19.9 t-105 -64.36 -55.47 30.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.583 0.706 . . . . 0.0 110.872 -173.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 23.6 Cg_endo -65.96 -30.74 48.03 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.616 2.211 . . . . 0.0 112.513 -171.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.692 ' O ' HD23 ' A' ' 160' ' ' LEU . 6.4 tt -72.89 -41.77 64.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.978 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 69.1 mt -73.81 -39.75 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.026 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.37 -33.17 67.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.17 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.468 ' HB3' ' HD2' ' A' ' 250' ' ' PHE . . . -61.7 -36.41 80.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.99 -168.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -89.12 1.03 56.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 121.84 1.22 10.73 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.49 169.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.36 64.99 3.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.446 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -86.71 132.88 33.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.868 0.366 . . . . 0.0 110.926 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.35 10.2 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.445 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.1 p90 -147.27 153.88 40.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -105.87 126.61 52.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 158.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -116.27 126.72 53.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.931 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -151.78 129.78 11.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.885 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.5 t30 55.07 44.55 27.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.04 14.0 82.19 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.484 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -129.92 139.62 51.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 110.887 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -99.98 145.96 27.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 170.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -121.26 110.1 15.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.839 171.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.512 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.3 pp -80.0 -11.92 12.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.189 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.77 -12.71 19.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -123.33 88.17 2.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 169.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 169' ' ' PHE . 33.5 m -116.58 170.96 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.177 -168.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.04 26.11 23.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.484 -168.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.511 HG21 HD12 ' A' ' 368' ' ' ILE . 12.6 m -109.9 -13.66 10.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.81 0.338 . . . . 0.0 111.145 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -85.07 20.04 2.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -112.81 -176.8 2.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.878 -175.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.51 -25.09 63.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 190' ' ' ALA . . . -72.01 -42.43 51.94 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.492 -169.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.624 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -63.26 -36.75 84.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.353 . . . . 0.0 111.038 176.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.511 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.2 mttt -59.97 -34.09 72.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 173.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 187' ' ' GLY . . . -65.15 -31.85 73.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.091 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.64 -45.48 95.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.439 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 192' ' ' LEU . 21.7 mt -64.98 -38.34 90.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.857 0.36 . . . . 0.0 110.902 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.9 m -57.56 -46.32 84.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.275 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -73.49 -47.75 38.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.752 HD11 HD21 ' A' ' 151' ' ' LEU . 6.8 tt -53.72 -47.14 70.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 -170.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 30.3 m -67.96 -18.82 24.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 -176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -59.99 -58.08 10.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -171.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 1.049 HD13 ' H ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.67 -23.73 56.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.908 -166.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.603 ' H ' HD22 ' A' ' 198' ' ' LEU . 2.0 pp -83.77 -36.41 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 174.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.36 -32.6 73.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 168.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -82.25 4.1 24.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 65.06 39.79 5.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 168.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -85.88 -14.94 43.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.784 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -146.64 161.85 39.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.926 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -99.88 150.5 22.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.849 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.59 -25.83 68.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.5 p-10 -93.78 5.34 51.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 59.7 m -62.55 129.99 43.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.086 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -137.45 169.83 17.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.957 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -63.91 -42.68 97.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.3 m -64.77 -39.45 93.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.11 -40.03 86.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.154 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.81 -37.34 87.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.086 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -63.17 -40.47 97.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.925 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.91 94.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 175.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.92 -38.25 90.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -61.58 -42.04 98.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -57.94 -32.31 67.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.799 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -89.39 -23.8 22.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.459 ' O ' HD21 ' A' ' 121' ' ' LEU . . . 90.51 25.78 24.81 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.504 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.59 -23.98 21.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.922 0.391 . . . . 0.0 110.877 -173.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.415 ' OG1' ' SD ' ' A' ' 148' ' ' MET . 99.8 m -119.11 128.76 54.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 -176.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.509 ' HB1' HD11 ' A' ' 122' ' ' LEU . . . -65.58 -52.07 54.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.052 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.455 ' HB3' HD21 ' A' ' 115' ' ' LEU . 71.2 mtm -135.65 156.26 49.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.859 -169.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.3 t -150.82 161.56 42.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 44.6 mm -110.05 124.25 66.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.158 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -154.34 170.63 20.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.804 -166.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.519 ' HA3' ' CD2' ' A' ' 113' ' ' LEU . . . -157.16 -113.69 0.41 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.522 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.411 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 40.4 Cg_endo -61.29 -22.34 74.32 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.618 2.212 . . . . 0.0 112.366 173.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -78.89 -16.51 56.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.05 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.29 -23.7 67.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.057 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -60.04 -23.13 63.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.928 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 42.9 t -57.65 -59.64 4.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -152.03 45.56 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -173.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.0 mm . . . . . 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.164 168.646 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.7 m . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.909 0.385 . . . . 0.0 111.13 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -100.0 70.0 1.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.427 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 87.0 m-85 -130.91 146.67 52.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.019 174.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -130.95 155.66 21.36 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.487 HG22 ' CB ' ' A' ' 319' ' ' ALA . 3.3 p -134.79 134.88 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.961 0.41 . . . . 0.0 111.167 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.9 t -154.41 149.76 27.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.071 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 27.9 m -59.93 162.03 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.116 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.57 HD12 ' N ' ' A' ' 247' ' ' LEU . 5.5 mp -70.48 150.11 95.63 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.577 0.703 . . . . 0.0 110.906 -159.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.48 -179.24 2.66 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.706 2.271 . . . . 0.0 112.347 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 52.1 p -101.02 161.19 13.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.131 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.468 ' HD2' ' HB3' ' A' ' 163' ' ' ALA . 55.0 t80 -138.6 119.56 14.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 55.53 33.69 21.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.97 -169.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.15 9.77 72.77 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.529 171.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.478 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 86.1 mm-40 -132.66 129.46 21.33 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.651 0.738 . . . . 0.0 110.879 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 60.2 Cg_exo -59.59 144.8 99.34 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.577 2.185 . . . . 0.0 112.327 -175.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 65.2 p -88.65 16.69 6.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.809 171.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -43.05 112.34 1.17 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.634 0.731 . . . . 0.0 110.903 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.18 160.38 32.98 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.754 2.302 . . . . 0.0 112.326 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -72.51 161.55 30.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.801 -171.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 56.2 t -109.06 136.17 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.057 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -113.43 131.09 9.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.511 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.9 t -121.13 119.11 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 111.166 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.401 ' C ' ' CD2' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -67.91 117.94 10.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 175.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 19.4 m -130.6 151.29 51.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 -170.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.06 129.79 44.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.15 -171.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -118.07 168.45 13.09 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.45 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.553 HD13 HG22 ' A' ' 59' ' ' ILE . 23.9 mm -99.68 126.84 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.0 111.183 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -68.36 129.3 39.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.853 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.429 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -66.2 -24.21 66.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.096 -176.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.91 -11.08 58.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.041 -171.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.6 t -75.97 120.28 80.98 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.642 0.734 . . . . 0.0 110.898 -176.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -69.0 -11.78 32.7 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.294 168.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -111.76 36.1 3.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.878 -171.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.85 -25.07 66.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 -167.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -71.32 -38.51 71.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' A' ' 7' ' ' LEU . 37.8 tp -63.13 -48.65 77.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 173.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.615 ' HB1' HG23 ' A' ' 59' ' ' ILE . . . -69.05 -48.8 61.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.093 -173.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -63.82 -41.58 97.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -66.27 -54.57 23.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 -173.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.411 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -68.31 -34.0 75.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 -173.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.578 ' O ' HD23 ' A' ' 280' ' ' LEU . 4.8 tt -56.0 -45.54 79.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.875 176.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -72.93 -42.68 63.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -102.35 -9.3 20.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.889 -159.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 67.9 t80 -123.33 -48.65 1.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.0 OUTLIER -68.56 -46.59 69.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 285' ' ' LEU . 0.8 OUTLIER -82.92 63.24 6.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 174.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.491 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 30.1 p -143.51 150.18 38.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.172 170.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.561 ' HA ' HD11 ' A' ' 290' ' ' LEU . 41.4 p-10 -53.19 -25.24 13.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -79.5 -44.08 21.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.49 -50.57 25.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.432 -170.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.561 HD11 ' HA ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -73.97 -21.27 60.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.43 ' N ' HD12 ' A' ' 290' ' ' LEU . 82.8 tt0 -66.07 -42.31 89.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 169.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.32 -34.77 75.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.518 HG13 ' HA3' ' A' ' 19' ' ' GLY . 21.6 t -76.83 -41.91 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.173 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.49 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 52.6 t30 -64.96 -25.42 67.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.981 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -66.83 -30.95 71.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.9 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -88.79 -40.87 12.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -141.97 130.05 11.79 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.514 0.673 . . . . 0.0 110.911 172.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.09 111.59 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.642 2.228 . . . . 0.0 112.376 174.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.49 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 43.0 mt -93.32 -13.1 28.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.016 -171.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.44 -53.71 1.0 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.433 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -173.77 166.15 4.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.795 0.331 . . . . 0.0 111.02 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.587 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 31.3 m -123.76 156.49 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.166 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 89' ' ' LEU . . . -69.96 -17.16 63.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.018 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' A' ' 89' ' ' LEU . 57.6 tp -85.87 120.69 27.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.049 -171.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.2 -40.02 70.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.926 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.8 m -64.55 -50.33 67.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -167.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.477 ' HB3' HG21 ' A' ' 302' ' ' VAL . 38.2 t80 -81.13 -26.73 35.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.11 -42.28 94.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.4 -34.46 76.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.831 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -70.62 -48.53 54.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.652 HD13 HD13 ' A' ' 317' ' ' ILE . 4.6 pp -66.72 -28.81 68.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.856 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.461 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.95 -11.12 58.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.053 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.94 -15.57 62.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -79.78 128.66 73.61 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.633 0.73 . . . . 0.0 110.805 170.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -49.21 -38.37 41.17 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.678 2.252 . . . . 0.0 112.305 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.482 ' HA ' HG11 ' A' ' 244' ' ' VAL . 8.5 ptp85 -71.26 -24.83 62.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.918 -169.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.652 HD13 HD13 ' A' ' 311' ' ' LEU . 78.9 mt -92.26 -32.45 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.09 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.91 -34.95 63.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.059 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.487 ' CB ' HG22 ' A' ' 244' ' ' VAL . . . -65.01 -45.58 84.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.058 174.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 68.7 p -69.01 -24.38 64.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.162 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 87.6 mmm -58.84 -36.39 74.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -69.47 -46.92 65.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 327' ' ' GLY . 34.7 t30 -66.04 -36.01 82.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.995 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.28 84.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -72.62 -35.07 67.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -94.97 -1.83 51.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -100.01 -161.62 28.61 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.458 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -140.8 141.5 34.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 110.812 -176.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.605 ' O ' ' C ' ' A' ' 330' ' ' MET . 18.8 mm -81.74 100.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.094 -169.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.605 ' C ' ' O ' ' A' ' 329' ' ' ILE . 95.3 mtp . . . . . 0 C--N 1.329 -0.315 0 CA-C-O 121.55 0.691 . . . . 0.0 110.88 176.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 . . . . . 0 C--O 1.23 0.058 0 CA-C-O 120.751 0.31 . . . . 0.0 110.966 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 79.4 mmm -72.38 -24.0 61.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.8 m -63.59 -39.2 93.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -77.35 -35.4 54.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.136 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -62.66 -39.24 93.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.855 174.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -58.38 -36.28 73.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.809 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -75.9 -37.1 59.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.933 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.05 94.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.135 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.2 m -80.2 -25.46 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.177 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 347' ' ' VAL . 7.3 tmm_? -64.39 -43.33 94.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 173.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.5 m -58.67 -34.62 71.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.166 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -58.93 -42.22 89.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 -177.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 344' ' ' ARG . 1.3 m -74.08 -32.85 33.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -174.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 152' ' ' GLN . 1.6 mp -62.01 -48.74 87.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.184 173.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 86.5 m-20 -65.6 -38.12 88.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.85 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.71 -46.22 63.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.188 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.15 -42.03 85.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.025 -176.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.6 p -76.5 -11.24 59.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.11 13.57 82.81 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.547 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.18 -31.36 58.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 110.883 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.498 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 90.9 mt-30 -136.33 159.53 41.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.4 p -78.45 169.75 17.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.131 168.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 72.9 t -55.52 -43.83 73.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.125 170.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -59.64 -44.79 93.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -70.44 -52.39 22.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.79 -45.93 70.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.079 -173.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.624 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -65.21 -40.01 93.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -177.404 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.0 tttt -65.3 -38.35 89.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 176.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -65.04 -38.91 92.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.795 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -64.79 -46.47 81.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.085 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 5.0 pp0? -70.55 -31.39 68.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.979 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 81.8 m -65.69 -42.63 91.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.199 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.29 -36.56 81.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.799 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.511 HD12 HG21 ' A' ' 183' ' ' VAL . 64.0 mt -64.96 -39.82 86.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.189 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.3 p -91.51 -11.05 38.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.195 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.917 176.71 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.806 0.336 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 83.6 mt -95.67 135.1 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.102 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -149.43 142.1 24.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -55.12 137.4 46.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.463 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 97.77 1.85 58.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.544 -172.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -166.1 149.16 7.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.837 0.351 . . . . 0.0 110.968 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.703 HD22 HD13 ' A' ' 33' ' ' ILE . 1.6 pt? -148.73 153.51 38.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 69.9 t -108.84 138.67 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.104 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.813 HG13 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -122.21 132.55 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.001 177.018 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.479 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 45.2 m0 -108.82 127.81 54.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.887 172.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.551 ' HB ' HD22 ' A' ' 20' ' ' LEU . 7.2 tt -109.76 148.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.22 -168.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -57.28 146.86 27.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.888 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.89 -12.93 16.69 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.459 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -75.15 -10.29 59.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 110.842 -173.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -150.12 135.39 18.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 162.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.14 -84.71 1.0 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 -166.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -113.19 -45.65 3.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.923 0.392 . . . . 0.0 110.922 -170.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -68.05 -52.83 30.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.908 -149.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.63 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -63.17 -46.85 92.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.513 -176.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.813 HD21 HG13 ' A' ' 9' ' ' ILE . 17.7 tp -65.69 -39.94 91.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.839 0.352 . . . . 0.0 110.879 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.74 72.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.082 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -65.75 -48.23 72.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 m -75.36 -36.07 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.065 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.455 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -66.94 -46.41 73.95 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.444 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -65.58 -40.37 92.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.961 -176.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.94 -40.45 95.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.404 ' CE2' HD11 ' A' ' 33' ' ' ILE . 78.0 t80 -64.81 -39.34 93.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.05 -40.04 79.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.913 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -69.1 -30.02 68.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -84.42 -40.13 18.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.803 -170.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.604 ' OG1' HG13 ' A' ' 33' ' ' ILE . 62.3 p -103.79 -12.32 17.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.48 7.93 87.79 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.496 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.849 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.6 pp -102.7 132.54 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 111.105 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -71.17 130.16 40.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 -168.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.517 HG22 HD21 ' A' ' 7' ' ' LEU . 90.0 t -110.57 120.17 60.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.5 m -113.62 118.03 33.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.159 -173.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.497 HG22 ' HG ' ' A' ' 20' ' ' LEU . 92.3 t -94.41 134.11 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.479 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 73.5 mm-40 -119.8 161.63 20.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.9 t-80 -83.41 139.38 41.51 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.626 0.727 . . . . 0.0 110.771 -168.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 75.6 Cg_exo -56.59 -25.09 57.39 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.768 2.312 . . . . 0.0 112.303 -176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -47.64 -50.18 25.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -173.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -86.61 -8.56 57.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.487 HD11 ' O ' ' A' ' 61' ' ' PHE . 9.4 tt -46.73 -54.28 10.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.896 -167.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -75.03 -34.69 61.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -71.69 -48.87 44.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -168.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -87.2 -28.63 22.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 -170.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.559 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 91.5 t80 -47.49 -51.66 42.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.769 0.795 . . . . 0.0 110.922 -166.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 59.7 Cg_endo -68.3 -28.98 32.75 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.725 2.283 . . . . 0.0 112.296 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -76.56 -43.66 37.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.67 -24.96 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.127 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.86 -32.71 74.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.049 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.5 -27.65 67.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.03 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.2 p -94.61 -13.85 25.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.114 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.74 15.6 81.19 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.405 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -142.55 130.42 21.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.831 0.348 . . . . 0.0 110.998 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.69 -115.09 0.57 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.58 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.437 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 84.4 Cg_endo -70.32 146.48 56.83 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.306 168.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -90.72 -36.34 14.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 169.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.691 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -138.46 150.04 24.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.175 176.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.0 tp -126.44 125.25 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 -169.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.523 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 4.8 m-85 -110.06 126.38 53.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 20.7 t-105 -143.1 -171.51 3.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 169.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.16 -89.53 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.119 171.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -106.55 -54.79 2.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.835 -172.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.49 -38.59 63.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.902 -158.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -74.46 -18.76 60.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 -169.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -39.99 -55.32 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.47 -38.43 44.72 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.493 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.32 -57.78 11.06 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 -171.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.579 ' HD1' HD22 ' A' ' 76' ' ' LEU . 8.8 p90 -85.79 -27.06 25.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.935 0.398 . . . . 0.0 110.93 -172.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.421 ' N ' ' CD1' ' A' ' 70' ' ' TYR . . . -71.62 -57.25 4.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.091 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -65.55 -32.02 73.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 -176.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.3 m -82.21 -7.88 59.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.58 30.42 68.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.503 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.447 ' HA ' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -87.45 -4.23 59.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.842 0.353 . . . . 0.0 110.835 -174.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.579 HD22 ' HD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -125.68 147.94 49.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -177.117 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.96 143.7 37.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.033 171.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -71.79 135.1 46.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.866 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.894 HG13 ' HB3' ' A' ' 103' ' ' LEU . 37.9 pt -117.31 164.97 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.087 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.2 p -115.81 150.03 44.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.543 0.687 . . . . 0.0 111.181 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.45 146.42 44.55 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.683 2.255 . . . . 0.0 112.32 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -105.65 119.92 40.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.828 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.03 -41.93 99.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.41 -45.02 89.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.53 ' HB3' ' HZ2' ' A' ' 94' ' ' TRP . 7.4 m-85 -72.4 -33.32 67.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.494 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.5 tt0 -52.1 -46.64 65.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.27 -36.14 82.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 174.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -78.86 -24.42 44.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.815 -173.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.3 OUTLIER -104.96 -105.04 0.31 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -172.164 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.467 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 39.7 t80 -164.6 129.63 1.97 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.671 0.748 . . . . 0.0 110.983 -174.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 96.9 Cg_exo -57.15 -43.03 56.98 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.62 2.213 . . . . 0.0 112.421 -169.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -72.44 -26.35 61.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.964 -173.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.645 ' CG2' ' HB3' ' A' ' 107' ' ' PRO . 96.7 m -69.75 -40.01 76.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.151 -174.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.587 ' HA ' HG22 ' A' ' 97' ' ' VAL . 92.2 m95 -65.68 -27.6 68.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.985 174.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -71.76 -35.24 70.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.54 -27.39 63.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.081 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.587 HG22 ' HA ' ' A' ' 94' ' ' TRP . 19.4 m -101.2 16.36 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.129 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.455 ' HB2' HD12 ' A' ' 103' ' ' LEU . 75.2 ttt180 -113.48 137.42 51.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -144.29 127.7 16.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.1 t30 62.19 34.78 15.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.899 174.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.82 -6.24 71.26 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.44 172.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -124.05 147.25 47.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.965 173.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.894 ' HB3' HG13 ' A' ' 79' ' ' ILE . 4.2 tp -73.28 139.99 46.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.924 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.46 ' C ' HD12 ' A' ' 104' ' ' ILE . 2.5 pp -126.28 10.01 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.012 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -170.72 162.12 7.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -112.75 145.67 33.48 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.738 0.78 . . . . 0.0 110.914 164.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.645 ' HB3' ' CG2' ' A' ' 93' ' ' THR . 90.9 Cg_endo -75.63 118.52 5.13 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.668 2.246 . . . . 0.0 112.386 173.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 27.3 mm -94.75 -49.35 12.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.097 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.74 157.57 43.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.129 -170.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.7 t -121.46 134.64 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 -173.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -115.85 138.01 51.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.847 169.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -151.48 160.04 43.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.023 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.424 ' HG ' ' HA3' ' A' ' 228' ' ' GLY . 7.0 mp -109.72 158.09 18.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 -170.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.5 p -154.82 161.9 41.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.925 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.93 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.98 128.19 46.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.996 176.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.569 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.3 mp -109.64 130.97 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.099 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -133.17 153.42 51.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -93.02 116.69 29.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.877 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.04 -20.22 66.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.854 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 11.8 t70 -77.33 -29.89 53.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.841 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.664 HD21 ' O ' ' A' ' 220' ' ' GLY . 8.8 mp -95.17 -47.91 6.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.6 mt -102.28 115.02 65.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.535 0.683 . . . . 0.0 111.032 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.79 -27.09 21.99 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.646 2.231 . . . . 0.0 112.333 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 60.5 t-20 -145.95 102.47 4.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.587 0.708 . . . . 0.0 110.88 173.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.0 Cg_endo -71.02 146.17 51.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.677 2.251 . . . . 0.0 112.324 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 150.83 62.89 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.384 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -110.47 -6.34 14.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.971 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 79.1 p -131.15 157.4 43.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.226 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -66.74 -30.63 70.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.998 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.06 -26.14 68.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.928 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -78.96 -23.32 44.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.61 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.5 mp -60.94 -51.21 81.0 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.645 0.736 . . . . 0.0 111.153 -169.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.5 Cg_endo -71.18 -40.63 3.1 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.62 2.213 . . . . 0.0 112.439 -170.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.31 -41.93 80.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.954 ' O ' HD23 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -56.8 -42.8 80.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.973 172.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.427 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . 24.7 t70 -54.39 -35.34 62.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.772 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.0 -34.31 75.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.819 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -76.29 -51.75 11.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.864 -172.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.575 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.8 OUTLIER -80.04 -10.06 59.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.839 -176.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.575 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.1 tttt -55.41 -31.99 62.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 167.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.66 -24.34 67.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.97 5.53 51.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.5 25.56 67.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.482 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.481 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 41.4 mmtm -118.35 165.81 13.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.886 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.6 t -126.67 142.03 51.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.831 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.17 -58.38 4.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.094 -166.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.415 HD13 ' C ' ' A' ' 147' ' ' LEU . 3.0 tm? -139.96 124.58 18.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.937 -168.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 58.0 ttm -109.93 128.82 55.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -155.83 157.18 36.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.832 -171.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -99.98 81.82 2.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.868 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.902 HD21 HD11 ' A' ' 195' ' ' LEU . 1.2 tm? -56.17 -32.52 64.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.876 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.37 9.53 3.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -108.73 145.01 30.76 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.597 0.713 . . . . 0.0 110.933 170.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.7 -24.91 68.88 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.706 2.271 . . . . 0.0 112.349 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -69.4 -32.11 70.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -87.98 -30.82 19.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.87 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 57.2 p -66.4 -32.46 73.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.233 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.587 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 29.8 t-105 -61.94 -55.57 40.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.903 -171.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 13.4 Cg_endo -61.13 -36.79 79.5 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.703 2.269 . . . . 0.0 112.481 -171.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.677 ' O ' HD23 ' A' ' 160' ' ' LEU . 6.3 tt -72.59 -43.0 63.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 73.3 mt -70.64 -40.04 76.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.66 -30.48 62.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.11 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.514 ' HB3' ' HD2' ' A' ' 250' ' ' PHE . . . -63.29 -34.48 77.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 -169.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -92.57 3.03 56.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.968 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.21 1.96 13.87 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.462 169.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.17 65.55 3.96 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.472 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -86.31 134.12 33.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.821 0.343 . . . . 0.0 110.964 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.61 7.14 10.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.106 -170.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.44 ' HA ' HG12 ' A' ' 181' ' ' VAL . 50.3 p90 -150.06 154.37 38.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.951 0.405 . . . . 0.0 110.931 -175.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -102.61 127.71 49.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.92 155.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -118.19 124.42 47.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.017 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -153.05 132.21 12.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.05 42.03 31.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.912 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.94 16.06 80.69 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.507 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -130.03 138.62 50.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.764 0.316 . . . . 0.0 110.923 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -95.78 143.42 27.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.863 169.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -121.39 109.83 15.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.932 172.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.626 ' O ' HD12 ' A' ' 178' ' ' ILE . 1.0 OUTLIER -79.24 -12.3 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.164 -178.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.7 -12.06 24.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.896 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -123.83 89.28 3.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.833 169.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 169' ' ' PHE . 32.9 m -117.17 166.48 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.087 -171.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.01 24.0 29.3 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.514 -170.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.492 HG21 HD12 ' A' ' 368' ' ' ILE . 13.8 m -108.9 -15.4 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 111.112 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -85.26 19.92 2.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -112.14 -178.25 3.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.95 -24.86 63.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.999 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.98 -40.5 73.45 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.438 -171.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.633 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.68 -37.32 87.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.872 0.367 . . . . 0.0 111.124 176.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.504 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.0 mttt -59.98 -34.21 72.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.953 173.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.09 -30.9 71.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.42 93.9 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.458 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 347' ' ' VAL . 24.9 mt -66.03 -37.52 86.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.952 0.406 . . . . 0.0 110.916 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.2 m -56.67 -45.27 81.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.226 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -75.26 -44.57 45.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.902 HD11 HD21 ' A' ' 151' ' ' LEU . 8.7 tt -56.99 -53.66 55.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.936 -172.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.526 ' HA ' HD13 ' A' ' 199' ' ' ILE . 13.6 m -64.96 -21.2 29.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.185 -176.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.33 -29.9 66.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.813 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -71.4 -48.88 47.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 177.053 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.823 ' H ' HD12 ' A' ' 199' ' ' ILE . 2.6 mp -64.23 -36.66 77.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.151 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.95 -39.84 94.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -90.47 -1.32 57.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.971 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.66 39.99 6.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -77.6 -14.31 59.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.834 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -139.31 154.34 47.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -100.22 151.32 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 -176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.89 -27.65 69.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.119 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -95.0 2.97 55.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.795 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.8 m -58.64 133.26 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.125 -177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -144.07 170.08 16.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 175.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -65.96 -35.78 81.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.906 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 97.4 p -65.65 -36.01 82.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.839 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 75.2 mt -65.06 -40.27 88.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.27 93.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.984 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.24 -39.5 86.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.868 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.01 -36.73 85.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.129 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.71 -32.71 71.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.131 -176.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -61.39 -32.08 72.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -61.32 -35.63 77.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -101.69 -21.61 14.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.664 ' O ' HD21 ' A' ' 121' ' ' LEU . . . 88.96 31.71 11.83 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.538 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -82.54 -30.67 29.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.881 0.372 . . . . 0.0 110.915 -171.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 93.0 m -116.62 127.28 54.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -69.86 -45.79 66.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.401 ' HB3' HD21 ' A' ' 115' ' ' LEU . 76.3 mtp -134.19 145.75 49.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 -175.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 30.6 p -142.35 161.87 36.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.203 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 31.0 mm -111.64 125.42 68.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.148 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -154.33 158.08 39.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.424 ' HA3' ' HG ' ' A' ' 113' ' ' LEU . . . -137.53 -108.58 0.87 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.529 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.76 -17.28 47.35 Favored 'Trans proline' 0 C--O 1.23 0.096 0 C-N-CA 122.645 2.23 . . . . 0.0 112.359 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -80.25 -12.43 59.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.897 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -50.46 -39.0 46.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.017 -168.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -57.12 -24.38 53.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 27.8 t -50.08 -59.28 4.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.826 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -155.1 54.64 0.64 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.4 ' O ' ' HD3' ' A' ' 316' ' ' ARG . 29.2 mm . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 170.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.2 m . . . . . 0 N--CA 1.457 -0.097 0 CA-C-O 120.827 0.346 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 74.4 m-80 -110.68 71.64 0.76 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.802 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -117.68 147.45 42.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -135.54 160.09 24.36 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.593 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.705 HG11 ' O ' ' A' ' 315' ' ' PRO . 5.8 p -140.82 138.23 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.928 0.394 . . . . 0.0 111.112 -176.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.1 t -152.86 152.19 31.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.118 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 24.4 m -60.02 167.4 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.085 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.465 ' N ' HD22 ' A' ' 247' ' ' LEU . 3.5 mm? -63.2 141.09 97.76 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.608 0.718 . . . . 0.0 110.919 -159.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.97 167.68 19.18 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.641 2.228 . . . . 0.0 112.335 174.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 71.1 p -103.51 161.44 13.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.15 -170.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.514 ' HD2' ' HB3' ' A' ' 163' ' ' ALA . 30.7 t80 -143.18 121.06 11.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.864 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 57.25 34.98 25.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.89 10.32 79.09 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.462 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -126.44 145.06 51.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.651 0.739 . . . . 0.0 110.877 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -71.95 139.23 32.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.66 2.24 . . . . 0.0 112.309 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 70.2 m -84.95 0.14 52.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 171.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -46.18 110.16 1.14 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.658 0.742 . . . . 0.0 110.916 -176.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -76.7 161.09 34.11 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.783 2.322 . . . . 0.0 112.359 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -75.17 153.18 38.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -174.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.408 HG21 ' HA ' ' A' ' 324' ' ' ALA . 63.4 t -99.88 134.0 40.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.159 -170.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.21 133.62 11.75 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.438 -178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 86.0 t -124.91 131.44 72.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.936 0.398 . . . . 0.0 111.155 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.407 ' HB3' ' HB ' ' A' ' 108' ' ' ILE . 2.5 tt -67.98 131.1 44.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 171.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.569 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 70.8 p -118.84 140.62 49.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.85 -176.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.545 ' HB1' HD11 ' A' ' 280' ' ' LEU . . . -127.87 130.17 48.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.089 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -122.52 163.19 16.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.495 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.466 ' HA ' HG22 ' A' ' 59' ' ' ILE . 15.7 mm -100.96 125.06 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 111.159 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -66.01 127.8 33.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.428 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -60.92 -28.42 68.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.121 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.9 -10.9 56.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.061 -172.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.3 t -75.88 121.11 84.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.674 0.75 . . . . 0.0 110.865 -174.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -67.23 -8.77 22.95 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 167.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -103.05 17.86 23.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 -173.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -52.72 -34.41 52.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 -168.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -71.38 -47.85 53.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.841 -170.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.3 pp -80.04 -31.02 39.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.966 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.464 ' HB1' HD12 ' A' ' 59' ' ' ILE . . . -67.84 -45.92 73.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -69.41 -34.05 73.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 89.2 tt0 -62.9 -52.93 61.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.477 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.2 p90 -69.9 -33.61 72.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.82 -176.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.545 HD11 ' HB1' ' A' ' 264' ' ' ALA . 5.6 tt -56.93 -47.55 80.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -85.15 -32.11 22.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 69.4 m-20 -101.95 -14.01 17.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 -164.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 73.2 t80 -121.92 -49.49 2.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -175.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.506 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -64.39 -46.99 80.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 177.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 64.2 mt -85.98 59.98 5.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.984 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.484 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 47.5 p -139.18 150.42 45.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.065 172.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.531 ' HA ' HD11 ' A' ' 290' ' ' LEU . 42.4 p-10 -51.01 -26.4 6.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 -175.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -81.0 -43.9 18.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.834 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.05 -50.82 21.24 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.478 -169.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.555 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.4 OUTLIER -74.37 -20.85 59.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.894 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.426 ' N ' HD12 ' A' ' 290' ' ' LEU . 82.4 tt0 -67.12 -41.86 85.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.937 170.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.08 -34.37 74.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.145 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.63 HG13 ' HA3' ' A' ' 19' ' ' GLY . 21.1 t -79.4 -42.23 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.453 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 47.0 t30 -64.96 -27.4 68.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.944 177.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.82 -29.67 70.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -85.97 -39.99 16.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -150.87 133.77 8.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.584 0.707 . . . . 0.0 110.888 173.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.52 112.33 0.73 Allowed 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.662 2.242 . . . . 0.0 112.375 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.453 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 36.9 mt -91.05 -12.48 35.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.15 -58.98 0.49 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.43 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -175.01 167.28 3.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.846 0.355 . . . . 0.0 111.097 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 27.8 m -124.04 156.8 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.119 176.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -71.77 -17.73 62.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.983 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.555 ' CD2' HD21 ' A' ' 290' ' ' LEU . 58.6 tp -80.13 122.34 26.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.991 -173.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -56.09 -39.74 72.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -173.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.2 m -63.18 -48.47 78.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.825 -167.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.447 ' CD2' HD23 ' A' ' 311' ' ' LEU . 24.0 t80 -84.86 -28.31 26.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.74 -43.07 90.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.937 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.56 -37.9 89.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -72.32 -47.88 46.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.865 -176.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.709 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.5 pp -69.42 -27.76 65.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.959 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.433 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.0 -11.52 57.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.201 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.13 -15.02 61.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -81.2 130.09 64.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.503 0.668 . . . . 0.0 110.92 170.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.705 ' O ' HG11 ' A' ' 244' ' ' VAL . 87.1 Cg_exo -51.69 -35.21 56.9 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.272 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.522 ' HG3' HG13 ' A' ' 317' ' ' ILE . 23.3 ptt-85 -66.91 -32.61 73.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.838 -173.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.709 HG21 ' CD1' ' A' ' 311' ' ' LEU . 64.9 mt -93.35 -33.78 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.094 -175.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -52.47 -43.08 64.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -172.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.457 ' CB ' HG22 ' A' ' 244' ' ' VAL . . . -66.47 -43.1 86.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 72.4 p -65.3 -28.81 69.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.086 -174.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 34.6 mmt -68.72 -30.15 68.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -64.95 -44.41 89.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 327' ' ' GLY . 39.1 t30 -64.61 -36.88 85.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 174.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.408 ' HA ' HG21 ' A' ' 259' ' ' VAL . . . -62.14 -45.3 94.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -73.54 -34.5 65.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.54 -1.15 51.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -175.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -103.45 -157.3 24.76 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.431 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -141.17 142.09 34.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 0.0 110.952 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.577 ' O ' ' C ' ' A' ' 330' ' ' MET . 37.9 mm -81.69 110.6 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 -171.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.577 ' C ' ' O ' ' A' ' 329' ' ' ILE . 96.1 mmm . . . . . 0 C--N 1.329 -0.312 0 CA-C-O 121.553 0.692 . . . . 0.0 110.782 174.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 . . . . . 0 N--CA 1.458 -0.064 0 CA-C-O 120.812 0.339 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 89.4 mmm -74.35 -24.59 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -172.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.7 m -64.13 -39.88 94.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.46 -36.7 65.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.045 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.401 ' O ' HG13 ' A' ' 343' ' ' VAL . 11.1 m-30 -65.04 -41.22 95.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -61.97 -35.42 78.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.764 177.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -69.3 -43.83 72.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.958 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 367' ' ' ARG . . . -61.45 -40.5 94.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.221 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 339' ' ' PHE . 16.1 m -79.47 -24.86 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.121 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -62.29 -45.44 93.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 87.2 m -57.28 -35.08 69.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.042 173.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.636 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -60.25 -44.42 95.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.057 -175.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.414 ' HA ' HD22 ' A' ' 192' ' ' LEU . 1.5 m -74.06 -33.63 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.124 -174.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -63.5 -47.92 89.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.242 173.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 84.9 m-20 -67.02 -37.72 84.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.83 -47.9 49.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.154 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.21 -37.1 80.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.177 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.5 p -74.81 -13.92 60.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.823 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.53 12.2 84.5 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.436 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -81.74 -26.46 34.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.777 0.322 . . . . 0.0 110.91 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 93.3 mt-30 -133.43 159.4 40.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 170.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.2 p -80.42 169.54 17.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.249 170.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 69.7 t -56.48 -43.09 77.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.175 170.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -59.13 -45.09 91.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -70.1 -52.66 21.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.919 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.15 74.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.093 -173.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.633 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -67.05 -40.01 87.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.002 -176.185 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.547 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.0 tttt -65.1 -39.12 92.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.935 176.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -64.71 -37.08 86.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.636 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -63.95 -45.56 88.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.091 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -73.5 -30.04 62.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.073 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 67.9 m -64.6 -41.16 96.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.118 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.413 ' HB2' ' HB1' ' A' ' 342' ' ' ALA . 99.7 mtt180 -66.75 -39.98 88.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.848 175.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.492 HD12 HG21 ' A' ' 183' ' ' VAL . 67.1 mt -65.93 -38.42 82.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.099 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 70.7 p -93.9 -8.95 38.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.168 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 173.713 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.74 0.305 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.8 mt -97.71 128.5 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.215 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -158.01 145.8 18.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -51.86 138.39 24.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.501 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 98.1 2.52 58.08 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.405 -173.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -170.35 152.38 4.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.597 HD22 HD13 ' A' ' 33' ' ' ILE . 1.3 pt? -153.51 155.37 36.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.984 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 71.4 t -109.92 135.8 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.159 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.681 HG22 ' CG1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -122.78 132.27 71.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.449 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 40.0 m0 -107.05 125.8 51.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.939 169.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.485 ' HB ' HD12 ' A' ' 20' ' ' LEU . 15.8 tt -107.74 149.71 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.194 -171.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -58.97 148.11 31.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.796 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.75 -14.64 37.66 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.476 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -73.84 -9.94 59.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.0 110.856 -174.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -150.23 133.76 16.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 159.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.91 -84.97 0.98 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.534 -163.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -106.69 -45.02 4.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.905 0.383 . . . . 0.0 110.921 -173.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -68.22 -52.46 33.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 -151.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.596 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -59.2 -48.04 87.89 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.556 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.602 ' CD1' HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -58.69 -46.38 87.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.933 176.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.65 -38.14 77.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -65.51 -49.4 69.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.8 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.6 m -73.36 -34.66 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -67.31 -43.22 88.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.87 -44.87 96.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.817 0.341 . . . . 0.0 110.932 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -67.33 -40.11 85.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 33' ' ' ILE . 42.6 t80 -64.58 -38.85 92.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 176.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.93 -41.86 97.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.966 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.68 -36.4 82.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.842 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -81.49 -39.7 24.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.793 -170.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.631 ' OG1' HG13 ' A' ' 33' ' ' ILE . 63.9 p -103.62 -8.54 19.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.95 11.07 83.99 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.557 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.038 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 pp -105.14 131.11 55.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.889 0.376 . . . . 0.0 111.168 -174.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -68.68 128.21 35.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.94 -168.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.463 HG22 HD21 ' A' ' 7' ' ' LEU . 95.8 t -110.42 119.97 60.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.458 ' HB ' HG22 ' A' ' 8' ' ' VAL . 99.8 m -111.12 116.71 31.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.501 HG22 HD13 ' A' ' 20' ' ' LEU . 87.9 t -92.82 133.51 33.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.12 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.449 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 74.0 mm-40 -120.02 160.88 21.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 174.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 64.7 t-80 -84.03 138.13 40.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 110.775 -167.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 58.8 Cg_exo -61.45 -17.42 53.52 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.717 2.278 . . . . 0.0 112.304 -174.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -47.39 -49.69 24.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 75.4 mmtt -90.88 -0.1 57.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.714 HD11 ' O ' ' A' ' 61' ' ' PHE . 9.8 tt -45.29 -56.93 4.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.954 -170.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -76.63 -38.42 54.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.879 -175.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -79.86 -44.84 19.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.896 -166.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 85.3 tttt -85.13 -36.02 21.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -171.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.597 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 84.0 t80 -49.23 -53.82 35.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.666 0.746 . . . . 0.0 110.989 -171.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 22.7 Cg_endo -59.17 -30.63 93.6 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.654 2.236 . . . . 0.0 112.325 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -74.46 -44.67 50.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.942 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.7 m -75.01 -24.71 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.168 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.65 -34.39 78.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.22 -31.0 71.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.071 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.5 p -89.99 -13.42 36.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.189 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.2 16.35 80.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.513 168.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -137.81 130.0 29.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.823 0.344 . . . . 0.0 110.821 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.3 -118.56 0.76 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.493 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.48 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 68.1 Cg_endo -70.54 153.22 65.51 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.711 2.274 . . . . 0.0 112.349 176.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.432 ' HB2' HD13 ' A' ' 59' ' ' ILE . 1.8 m-20 -86.4 -38.88 16.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.901 169.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.752 HG23 ' HB1' ' A' ' 276' ' ' ALA . 0.0 OUTLIER -133.81 149.69 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 178.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 tp -128.97 125.07 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.107 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.714 ' O ' HD11 ' A' ' 43' ' ' LEU . 2.3 m-85 -101.5 134.51 44.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.409 ' CH2' ' HB2' ' A' ' 105' ' ' ALA . 32.0 p90 -144.94 -178.74 6.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.948 175.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.96 -98.71 0.32 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -107.3 -55.1 2.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.822 -176.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.12 -34.35 73.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.872 -162.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.57 -20.01 54.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 -171.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -45.55 -53.14 9.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.928 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.42 -52.28 44.89 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.556 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.23 -49.93 73.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.576 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -70.93 -47.52 58.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.96 -172.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.3 -47.7 63.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.162 -173.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -64.45 -35.35 80.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.1 m -83.76 -7.48 59.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.814 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.26 33.48 61.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mp -84.0 -4.82 59.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 110.975 -176.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.746 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.8 pp -132.34 145.66 51.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.974 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.23 142.19 43.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.126 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -66.73 134.26 51.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.883 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.835 HG13 ' HB3' ' A' ' 103' ' ' LEU . 39.8 pt -111.58 160.71 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.137 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.9 m -101.46 130.06 25.53 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.627 0.727 . . . . 0.0 111.173 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.27 147.91 54.32 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.655 2.236 . . . . 0.0 112.33 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -114.46 120.06 38.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.15 -38.73 91.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.07 -44.77 83.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -71.44 -35.19 70.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.501 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 43.6 tt0 -53.32 -46.53 69.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.929 173.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.63 -34.55 75.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.905 174.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.26 -23.3 54.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.4 OUTLIER -108.09 -93.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.879 -171.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -169.98 129.18 0.87 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.631 0.729 . . . . 0.0 111.067 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -56.2 -43.68 53.85 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.6 2.2 . . . . 0.0 112.291 -171.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 1.8 t80 -72.04 -32.78 67.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.994 -173.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.551 ' CG2' ' HB3' ' A' ' 107' ' ' PRO . 96.2 m -64.39 -34.77 78.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.011 -171.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.69 ' HA ' HG22 ' A' ' 97' ' ' VAL . 61.0 m95 -70.37 -21.61 62.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.986 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 92' ' ' PHE . 97.5 m-20 -72.99 -33.73 65.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.83 171.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.92 -27.7 64.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.69 HG22 ' HA ' ' A' ' 94' ' ' TRP . 15.7 m -100.38 15.51 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.09 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 70.8 ttt180 -110.4 136.48 49.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -140.12 126.59 20.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.975 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.4 t30 59.87 34.7 21.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.95 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.41 -3.0 83.77 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.528 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.14 147.41 49.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.707 0.289 . . . . 0.0 110.961 174.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.835 ' HB3' HG13 ' A' ' 79' ' ' ILE . 3.3 tp -76.87 140.1 40.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.857 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 76' ' ' LEU . 2.0 pp -122.14 -6.16 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 -171.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.409 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . . . -164.97 166.67 19.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.085 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.433 ' HB3' HD11 ' A' ' 285' ' ' LEU . 87.1 m-85 -112.93 146.42 35.09 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.696 0.76 . . . . 0.0 110.939 169.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.551 ' HB3' ' CG2' ' A' ' 93' ' ' THR . 72.0 Cg_endo -76.16 118.93 5.13 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.631 2.22 . . . . 0.0 112.426 176.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.431 HD13 HD21 ' A' ' 285' ' ' LEU . 27.2 mm -92.5 -55.26 6.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.43 160.48 43.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.08 -168.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.0 t -119.41 136.67 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.101 -172.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -121.33 140.14 52.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.907 171.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.481 ' HB1' HD22 ' A' ' 323' ' ' ASN . . . -150.45 159.27 44.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.419 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 8.8 mp -92.31 169.23 10.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.903 -173.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.5 p -157.05 157.86 35.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.899 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -100.03 126.06 46.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.021 171.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.569 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.8 mp -110.2 133.3 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.177 -174.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -133.25 150.37 51.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -91.12 118.75 30.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.58 -20.71 66.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.939 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -77.76 -27.94 50.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.497 HD21 ' O ' ' A' ' 220' ' ' GLY . 6.7 mp -95.5 -44.76 7.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.946 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 24.6 mt -108.74 103.32 51.24 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.631 0.729 . . . . 0.0 110.89 177.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 122' ' ' LEU . 72.6 Cg_endo -67.7 -23.61 42.09 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.686 2.257 . . . . 0.0 112.358 171.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -147.16 94.02 4.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.621 0.724 . . . . 0.0 110.894 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.94 152.7 79.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.684 2.256 . . . . 0.0 112.364 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.37 144.9 63.57 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.65 2.234 . . . . 0.0 112.389 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.53 -13.62 27.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.0 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.4 p -130.22 155.88 45.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.079 -174.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.558 ' HA ' HD13 ' A' ' 132' ' ' ILE . 64.2 m95 -68.44 -29.27 67.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.958 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.53 -25.02 67.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 -176.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -78.74 -21.22 48.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.894 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.598 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.6 mp -60.43 -52.88 69.78 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.661 0.743 . . . . 0.0 111.065 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 27.7 Cg_endo -66.89 -40.04 13.16 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.623 2.215 . . . . 0.0 112.441 -171.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.18 -41.61 76.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.118 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.7 tp -55.14 -43.45 74.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.437 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . 1.5 m-20 -49.87 -42.37 47.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.95 -35.13 79.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.898 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -75.5 -46.17 33.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 -171.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.46 ' HG ' ' HB2' ' A' ' 144' ' ' LYS . 0.8 OUTLIER -89.94 -18.74 25.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.96 -174.218 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -53.67 -30.33 42.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.83 167.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.18 -25.08 67.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.12 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -95.0 7.01 47.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.865 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.16 24.91 72.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.464 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.46 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 26.5 mmtp -110.04 167.55 10.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.37 . . . . 0.0 110.904 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.0 t -130.64 137.95 49.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.899 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 224' ' ' MET . . . -72.94 -53.48 11.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.068 -166.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.461 HD22 ' H ' ' A' ' 148' ' ' MET . 1.9 tm? -138.24 138.12 38.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 -167.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.461 ' H ' HD22 ' A' ' 147' ' ' LEU . 98.7 mtp -125.14 133.27 52.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.852 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -159.98 161.69 34.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.823 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -95.47 90.05 5.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.829 HD21 HD11 ' A' ' 195' ' ' LEU . 1.2 tm? -66.44 -32.75 74.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.951 -173.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.29 0.07 23.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -100.4 142.87 25.44 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.586 0.707 . . . . 0.0 110.914 176.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.604 ' HG3' ' CE1' ' A' ' 341' ' ' TYR . 29.9 Cg_endo -64.32 -22.47 66.36 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.672 2.248 . . . . 0.0 112.429 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -69.26 -35.47 76.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.964 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -92.09 -29.97 16.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.836 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.2 p -65.68 -45.67 81.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.271 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.598 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 90.6 t90 -66.21 -46.83 61.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.521 0.677 . . . . 0.0 110.82 -166.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 96.9 Cg_exo -48.81 -45.39 28.5 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.685 2.257 . . . . 0.0 112.422 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.761 ' O ' HD23 ' A' ' 160' ' ' LEU . 6.2 tt -69.15 -39.11 79.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 67.2 mt -71.55 -40.5 71.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.73 -26.47 44.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -60.41 -33.68 72.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.046 -171.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -95.02 3.3 55.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.846 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.88 -1.06 13.52 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.45 171.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.3 67.14 3.11 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.422 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -87.76 132.38 34.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 0.0 110.928 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.07 13.98 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.409 ' HA ' HG12 ' A' ' 181' ' ' VAL . 49.1 p90 -147.47 151.45 36.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.868 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -103.21 129.62 50.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.836 158.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -120.88 125.03 46.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -151.99 129.81 11.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.994 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.09 41.78 31.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 172.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.02 15.35 81.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.525 173.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -129.97 139.03 51.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.739 0.304 . . . . 0.0 110.842 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -99.74 144.6 28.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 171.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -122.06 108.05 12.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.865 172.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.528 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.4 pp -77.77 -11.99 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.134 -178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.14 -11.44 22.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -176.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -130.01 85.08 2.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 172.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 169' ' ' PHE . 30.6 m -113.84 173.08 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 -169.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -101.97 23.76 33.57 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.455 -166.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.534 HG21 HD12 ' A' ' 368' ' ' ILE . 31.3 m -114.41 -7.59 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 0.0 111.131 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.5 p-10 -85.5 18.07 2.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -125.74 -170.02 2.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.84 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.07 -27.64 68.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.111 -173.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.2 -44.76 74.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.479 -164.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.747 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -67.01 -36.01 81.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.81 0.338 . . . . 0.0 111.07 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.476 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.5 mttt -59.04 -33.7 71.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.898 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.13 -31.68 73.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.105 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.83 -45.22 96.16 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.481 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.463 HD11 ' HB1' ' A' ' 346' ' ' ALA . 22.7 mt -64.98 -38.63 91.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.9 0.381 . . . . 0.0 110.98 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.1 m -58.2 -44.99 88.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.244 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -75.88 -45.49 35.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.829 HD11 HD21 ' A' ' 151' ' ' LEU . 6.5 tt -54.39 -48.57 71.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.961 -170.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.418 ' HA ' HD11 ' A' ' 199' ' ' ILE . 23.0 m -70.1 -19.93 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 -174.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.443 ' HB3' HD13 ' A' ' 198' ' ' LEU . 38.6 t70 -56.52 -56.74 17.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 -168.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.985 HD13 ' H ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.5 -26.6 58.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.928 -167.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.581 ' H ' HD22 ' A' ' 198' ' ' LEU . 1.8 pp -86.99 -34.52 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.176 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.74 -32.6 69.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.914 166.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -84.88 5.0 30.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 65.19 36.84 6.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -86.24 -14.44 43.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 57.9 ttp -138.08 153.27 49.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.962 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -97.7 150.16 21.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.81 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.97 -26.65 68.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.103 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -93.78 4.9 53.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.809 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 91.5 m -61.03 129.97 44.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -139.81 169.65 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.837 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -66.63 -36.19 81.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 99.5 p -66.08 -36.57 83.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.745 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 73.4 mt -64.94 -39.36 85.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.31 83.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.172 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.41 -45.73 93.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.949 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.03 -38.64 91.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.15 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.93 97.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.176 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -65.22 -36.91 85.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -61.35 -34.01 74.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -89.59 -22.59 22.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.497 ' O ' HD21 ' A' ' 121' ' ' LEU . . . 88.19 24.92 32.81 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.505 -178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -87.91 -26.84 22.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.38 . . . . 0.0 110.861 -173.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . 0.443 HG21 ' SD ' ' A' ' 148' ' ' MET . 75.6 m -116.87 129.92 56.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 -173.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.92 -49.8 55.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.428 ' N ' ' O ' ' A' ' 146' ' ' ALA . 71.1 mtm -136.43 157.06 47.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -170.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.9 t -149.15 157.68 43.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.2 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.3 mm -112.81 121.26 64.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.119 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.545 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 9.4 t-20 -156.05 170.0 23.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -172.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -132.42 -100.32 0.77 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.571 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.26 -22.94 39.45 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.703 2.269 . . . . 0.0 112.306 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -83.56 -20.11 34.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.002 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -55.6 -45.1 77.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.073 -166.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -63.14 -19.1 64.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 -171.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.1 p -54.05 -25.41 21.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.879 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -136.17 39.94 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.442 ' HB ' ' HG2' ' A' ' 316' ' ' ARG . 95.6 mt . . . . . 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 170.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 30.8 m . . . . . 0 CA--C 1.524 -0.026 0 CA-C-O 120.907 0.384 . . . . 0.0 111.089 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -123.41 82.49 2.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.836 176.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.03 147.88 47.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.868 171.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -127.67 153.09 19.12 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.542 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.532 HG22 ' CB ' ' A' ' 319' ' ' ALA . 5.0 p -137.8 134.07 45.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 111.166 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.8 t -155.78 147.86 23.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.105 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.4 m -60.66 168.87 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.068 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.656 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.8 mm? -64.09 149.13 94.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.615 0.721 . . . . 0.0 110.855 -159.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 32.1 Cg_exo -65.12 179.08 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.705 2.27 . . . . 0.0 112.254 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 97.3 m -101.04 146.41 27.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.189 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -136.79 119.42 16.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 56.14 35.05 24.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.51 3.33 86.64 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.478 171.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -133.7 142.73 44.85 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.683 0.754 . . . . 0.0 110.886 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.78 144.94 44.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.727 2.284 . . . . 0.0 112.315 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.656 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 70.0 p -87.03 10.28 16.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 173.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -43.07 112.21 1.16 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.648 0.737 . . . . 0.0 110.887 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.408 ' CD ' HD23 ' A' ' 247' ' ' LEU . 80.7 Cg_endo -78.5 164.63 26.0 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.654 2.236 . . . . 0.0 112.355 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -71.27 163.26 28.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -174.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 60.5 t -107.88 135.22 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 -172.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.12 135.98 13.17 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.455 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 89.6 t -122.8 132.13 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 111.114 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.4 tt -66.61 128.89 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 171.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 59.7 p -123.11 132.17 53.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 280' ' ' LEU . . . -124.92 127.75 47.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.163 -173.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.78 167.01 14.46 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.416 -171.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.406 HD13 HG22 ' A' ' 59' ' ' ILE . 12.6 mm -99.98 126.81 53.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 111.148 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -62.86 126.39 27.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.889 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.85 -25.11 68.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.083 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.59 -10.52 55.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.112 -173.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.3 t -75.61 120.37 81.33 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.581 0.705 . . . . 0.0 110.928 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -70.91 -12.24 30.45 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.631 2.221 . . . . 0.0 112.289 171.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -112.07 35.75 3.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.984 -170.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.05 -25.11 65.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -169.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.94 -39.07 76.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.802 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 43.1 tp -66.26 -48.21 71.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 173.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.752 ' HB1' HG23 ' A' ' 59' ' ' ILE . . . -68.0 -50.0 58.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.053 -172.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -62.97 -41.34 99.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -63.86 -53.46 50.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.954 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -70.05 -36.88 75.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -173.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.509 ' O ' HD23 ' A' ' 280' ' ' LEU . 6.4 tt -58.53 -46.56 86.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -77.23 -40.31 45.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.832 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -102.8 -9.68 19.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 -160.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 75.7 t80 -122.48 -49.07 2.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.502 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.1 OUTLIER -64.43 -47.1 80.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 178.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 106' ' ' TYR . 64.6 mt -85.0 59.2 5.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.483 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 37.4 p -140.23 151.16 44.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.149 172.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.524 ' HA ' HD11 ' A' ' 290' ' ' LEU . 43.1 p-10 -51.12 -26.06 6.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.916 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -79.6 -44.93 20.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.801 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.88 -50.1 20.12 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.532 -168.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -74.79 -20.9 59.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.737 0.303 . . . . 0.0 110.903 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.421 ' N ' HD12 ' A' ' 290' ' ' LEU . 82.4 tt0 -66.13 -40.43 90.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.931 169.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.68 -34.74 76.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.193 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.596 HG13 ' HA3' ' A' ' 19' ' ' GLY . 24.7 t -78.45 -45.23 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.182 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.4 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 48.3 t30 -65.53 -27.79 68.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.04 -27.31 69.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -85.99 -41.33 14.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.928 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -150.96 129.82 6.27 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.576 0.703 . . . . 0.0 110.906 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.8 110.35 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.396 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.4 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 55.8 mt -88.19 -17.81 30.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.98 -171.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.626 ' O ' HG23 ' A' ' 317' ' ' ILE . . . 105.13 -42.78 1.81 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.445 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 300' ' ' GLY . . . -176.04 173.17 2.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.861 0.362 . . . . 0.0 111.059 164.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.523 HG22 HD21 ' A' ' 311' ' ' LEU . 23.2 m -122.7 153.69 27.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.149 170.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -68.19 -18.8 64.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.041 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.453 ' HA ' HD12 ' A' ' 89' ' ' LEU . 52.6 tp -83.03 121.95 27.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.967 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -60.37 -34.99 74.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 -174.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.7 m -64.06 -50.21 69.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.844 -169.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.597 ' CD2' HD23 ' A' ' 311' ' ' LEU . 36.0 t80 -82.8 -26.93 31.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.954 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -55.71 -43.85 76.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.903 177.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.22 -36.89 85.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -77.62 -48.49 16.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.787 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.825 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.5 pp -65.68 -24.78 67.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.988 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.506 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -62.72 -18.74 63.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.094 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.36 -19.93 64.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -79.15 122.12 83.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.575 0.703 . . . . 0.0 110.903 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.504 ' O ' HG11 ' A' ' 244' ' ' VAL . 84.0 Cg_exo -48.58 -31.97 19.97 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.721 2.28 . . . . 0.0 112.241 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.442 ' HG2' ' HB ' ' A' ' 235' ' ' ILE . 99.1 mtt180 -59.01 -36.73 75.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.846 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.825 HG21 ' CD1' ' A' ' 311' ' ' LEU . 38.7 mt -99.97 -34.25 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -171.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.39 -41.52 20.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 -164.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.532 ' CB ' HG22 ' A' ' 244' ' ' VAL . . . -65.69 -44.49 86.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.013 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 317' ' ' ILE . 73.1 p -68.09 -29.7 68.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.074 -176.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -68.24 -38.17 81.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.894 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.1 -46.67 80.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.481 HD22 ' HB1' ' A' ' 112' ' ' ALA . 27.6 t30 -65.43 -35.49 81.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 176.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.79 -46.27 89.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -77.18 -32.96 56.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.05 -2.52 50.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -100.26 -156.63 27.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.449 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -137.36 143.08 41.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.585 ' O ' ' C ' ' A' ' 330' ' ' MET . 45.2 mm -78.79 104.79 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 -170.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.585 ' C ' ' O ' ' A' ' 329' ' ' ILE . 22.1 ptp . . . . . 0 C--N 1.329 -0.318 0 CA-C-O 121.57 0.7 . . . . 0.0 110.846 174.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 . . . . . 0 CA--C 1.527 0.084 0 CA-C-O 120.846 0.355 . . . . 0.0 110.891 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 88.2 mmm -75.17 -23.18 57.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 -171.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.6 m -62.25 -42.25 99.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.08 -33.0 63.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.989 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -64.85 -38.78 92.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.869 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 154' ' ' PRO . 38.3 m0 -60.59 -35.33 75.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 175.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . 0.604 ' CE1' ' HG3' ' A' ' 154' ' ' PRO . 32.3 m-85 -73.61 -38.62 65.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.33 94.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.148 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.1 m -80.4 -25.12 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.453 ' O ' HG22 ' A' ' 347' ' ' VAL . 7.9 tmm_? -62.12 -45.58 92.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 173.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 98.1 m -55.61 -34.74 65.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.206 173.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -61.34 -42.99 99.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 -176.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 344' ' ' ARG . 1.4 m -74.35 -33.72 34.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.138 -174.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.44 -47.04 94.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.204 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 95.1 m-20 -64.98 -39.67 93.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.29 -46.74 60.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.2 -42.66 88.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.6 p -76.04 -10.61 59.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.82 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.18 14.97 81.68 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.581 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.65 -31.29 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.684 0.278 . . . . 0.0 110.848 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 84.9 mm-40 -139.56 158.3 44.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 51.2 p -78.39 166.55 22.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.194 170.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 62.7 t -55.72 -42.46 69.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 172.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -60.16 -46.09 90.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -69.89 -52.5 24.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.848 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -67.66 -45.5 75.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.041 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.747 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -67.42 -39.78 85.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.001 -177.068 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 87.9 tttt -64.78 -38.42 90.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -63.96 -38.02 89.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 175.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -64.61 -45.97 84.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.016 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 1.1 pp0? -73.03 -30.91 64.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -177.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 73.9 m -65.62 -42.73 91.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.153 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -66.26 -37.11 84.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.534 HD12 HG21 ' A' ' 183' ' ' VAL . 62.9 mt -66.0 -39.9 85.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.186 177.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 72.0 p -90.36 -11.15 41.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.153 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.927 175.487 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.784 0.326 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.9 mt -102.11 127.77 55.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -152.4 144.08 23.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.6 137.65 30.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.784 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 97.66 3.15 58.44 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.505 -172.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -170.1 153.31 4.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.76 0.315 . . . . 0.0 110.983 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.549 HD22 HD13 ' A' ' 33' ' ' ILE . 1.3 pt? -153.17 155.97 37.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 78.1 t -110.62 137.87 41.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.128 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.927 HG13 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -122.09 132.76 70.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.095 -179.32 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.453 ' HB3' HD12 ' A' ' 43' ' ' LEU . 45.6 m0 -109.89 127.44 54.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 168.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.542 ' HB ' HD22 ' A' ' 20' ' ' LEU . 6.9 tt -108.18 145.6 15.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.137 -170.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -53.01 143.96 16.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.28 -13.53 21.99 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.418 -174.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -74.76 -10.29 59.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.861 0.363 . . . . 0.0 110.854 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -145.29 136.92 25.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 158.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.93 -83.86 1.01 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.537 -164.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -114.5 -45.0 3.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.951 0.405 . . . . 0.0 110.908 -173.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -68.6 -52.94 26.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.886 -149.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.592 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -60.27 -48.99 83.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 -175.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.927 HD21 HG13 ' A' ' 9' ' ' ILE . 18.0 tp -65.09 -41.41 95.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 110.978 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.23 67.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 173.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -67.17 -48.77 66.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.941 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.402 HG22 ' HA ' ' A' ' 20' ' ' LEU . 14.3 m -74.7 -34.47 34.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.491 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -65.53 -45.11 91.44 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.536 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -64.2 -38.93 92.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.84 0.352 . . . . 0.0 110.905 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -63.31 -42.65 99.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.974 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.466 ' CD2' HD11 ' A' ' 33' ' ' ILE . 56.3 t80 -65.06 -37.74 88.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.822 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.98 -41.55 98.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.974 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.96 -31.99 69.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.875 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -80.61 -41.53 23.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.83 -172.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.603 ' OG1' HG13 ' A' ' 33' ' ' ILE . 51.1 p -105.11 -8.44 18.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.031 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.71 10.0 84.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.555 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.997 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 pp -103.29 132.51 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.943 0.401 . . . . 0.0 111.119 -174.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -70.61 126.94 31.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.911 -168.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.506 HG22 HD21 ' A' ' 7' ' ' LEU . 93.2 t -110.27 120.52 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.099 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.6 m -112.83 113.83 26.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.064 -174.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.482 HG22 ' HG ' ' A' ' 20' ' ' LEU . 96.1 t -93.22 132.62 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.149 176.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -126.06 155.15 42.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.3 t-80 -77.04 140.03 66.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.604 0.716 . . . . 0.0 110.841 -161.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 72.7 Cg_exo -56.76 -22.22 43.77 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.72 2.28 . . . . 0.0 112.332 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -47.1 -50.16 20.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 -173.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -86.98 -9.85 54.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 10' ' ' TRP . 7.7 tt -46.93 -54.24 10.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 -167.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.05 -35.23 66.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.868 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -74.96 -47.2 30.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.906 -168.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -84.75 -33.66 23.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -170.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.589 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 94.4 t80 -48.22 -53.12 36.5 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.587 0.708 . . . . 0.0 110.966 -165.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 39.1 Cg_endo -62.8 -30.51 77.92 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.65 2.233 . . . . 0.0 112.443 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -76.7 -43.72 36.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.1 m -74.78 -25.05 18.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.208 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.83 -33.67 76.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.119 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.97 69.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.3 p -91.4 -13.85 31.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.17 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.14 15.27 81.76 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.499 170.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -138.92 130.04 26.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.884 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.09 -118.84 0.73 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.454 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 84.4 Cg_endo -72.8 154.11 53.75 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.756 2.304 . . . . 0.0 112.432 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.431 ' CB ' HD13 ' A' ' 59' ' ' ILE . 1.7 m-20 -87.15 -38.42 16.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 170.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.732 HG23 ' HB1' ' A' ' 276' ' ' ALA . 0.0 OUTLIER -134.05 150.05 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.077 179.155 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 tp -129.33 124.73 60.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.1 -174.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.448 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 2.4 m-85 -100.15 134.75 42.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.457 ' CH2' ' HB2' ' A' ' 105' ' ' ALA . 32.2 p90 -145.01 -177.82 5.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.842 174.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.75 -97.14 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.144 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -110.44 -55.43 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -58.83 -35.75 73.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -162.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.523 ' HD3' ' CZ ' ' A' ' 70' ' ' TYR . 4.4 mmp_? -74.56 -21.24 59.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 -172.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -45.95 -54.59 8.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.95 -53.58 36.42 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.45 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.69 -52.44 53.07 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.523 ' CZ ' ' HD3' ' A' ' 66' ' ' ARG . 15.8 m-30 -75.78 -41.98 51.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.919 0.39 . . . . 0.0 110.893 -168.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.34 -47.18 71.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.096 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -65.07 -34.93 79.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.8 m -81.7 -7.97 59.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.45 32.08 62.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.472 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mp -84.75 -4.5 59.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 110.978 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.737 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.2 pp -128.28 145.02 51.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.18 141.43 47.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.4 mp0 -69.27 132.33 46.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.89 HG13 ' HB3' ' A' ' 103' ' ' LEU . 37.7 pt -118.82 167.11 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.154 175.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.5 p -113.76 149.55 41.95 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.599 0.714 . . . . 0.0 111.118 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.08 146.82 41.93 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.691 2.261 . . . . 0.0 112.39 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -108.11 119.25 38.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.999 0.428 . . . . 0.0 110.789 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.14 -42.23 99.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.852 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.12 -46.52 80.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.142 -177.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.524 ' HB3' ' HZ2' ' A' ' 94' ' ' TRP . 9.1 m-85 -72.07 -33.86 68.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -177.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.449 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.6 tt0 -53.95 -48.07 70.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.933 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.6 -35.02 79.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.95 -23.26 55.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.978 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.566 HD23 ' HG2' ' A' ' 107' ' ' PRO . 1.4 mp -108.75 -92.3 0.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 -173.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 33.6 t80 -169.68 127.84 0.84 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.597 0.713 . . . . 0.0 110.996 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 87.3 Cg_exo -57.07 -42.66 61.47 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.646 2.23 . . . . 0.0 112.341 -170.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.589 ' HD1' ' O ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -70.18 -33.27 71.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -174.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.634 ' CG2' ' HB3' ' A' ' 107' ' ' PRO . 88.3 m -67.56 -36.26 80.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 -173.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.598 ' HA ' HG22 ' A' ' 97' ' ' VAL . 68.5 m95 -67.83 -26.45 66.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.933 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -73.76 -32.17 63.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.82 171.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.11 -25.8 62.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.085 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 94' ' ' TRP . 19.8 m -101.39 17.81 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.099 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 75.7 ttt180 -112.91 132.1 55.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.933 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -138.41 127.75 24.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 62.05 34.87 16.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.919 175.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.31 -4.17 78.34 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.578 173.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.42 150.05 48.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.353 . . . . 0.0 110.959 173.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.89 ' HB3' HG13 ' A' ' 79' ' ' ILE . 2.9 tp -74.42 140.4 44.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.548 HG22 HD11 ' A' ' 76' ' ' LEU . 2.0 pp -118.56 -7.35 11.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.091 -174.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.457 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . . . -164.78 168.83 17.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.117 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.433 ' HB3' HD11 ' A' ' 285' ' ' LEU . 94.5 m-85 -112.22 146.41 34.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.714 0.769 . . . . 0.0 110.903 168.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.634 ' HB3' ' CG2' ' A' ' 93' ' ' THR . 73.9 Cg_endo -74.11 118.23 5.31 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.629 2.219 . . . . 0.0 112.381 172.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.409 HD11 HD21 ' A' ' 280' ' ' LEU . 29.7 mm -92.09 -54.97 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.147 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.89 158.63 44.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.059 -167.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.65 137.47 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.076 -172.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -122.01 139.07 54.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.551 ' HB1' HD22 ' A' ' 323' ' ' ASN . . . -152.1 160.16 43.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.063 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -94.56 168.68 10.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.852 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 100.0 p -154.87 152.92 30.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.819 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.961 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -100.03 128.38 46.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 169.316 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.511 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.3 mp -111.07 137.01 45.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -133.75 149.58 51.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -86.45 110.98 20.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.471 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 88.9 tttt -62.1 -23.12 66.34 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -76.01 -24.19 55.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.893 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.528 HD21 ' O ' ' A' ' 220' ' ' GLY . 7.0 mp -94.76 -53.37 3.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.862 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.477 HD22 ' HB1' ' A' ' 223' ' ' ALA . 1.7 mp -105.07 132.31 20.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.678 0.751 . . . . 0.0 110.863 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.44 -16.99 24.21 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.686 2.257 . . . . 0.0 112.331 -175.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.571 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 20.8 p30 -154.33 161.62 28.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.614 0.721 . . . . 0.0 110.915 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.571 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 57.8 Cg_endo -69.59 155.12 67.38 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.646 2.231 . . . . 0.0 112.392 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.14 146.38 70.02 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.669 2.246 . . . . 0.0 112.299 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -100.12 -48.6 4.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 72.7 p -133.17 158.56 42.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 48.9 t-105 -64.2 -30.23 71.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 175.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.06 -23.67 65.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -174.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -72.75 -32.17 65.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.494 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 1.6 mp -66.03 -47.17 63.55 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.644 0.735 . . . . 0.0 111.085 -163.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 97.9 Cg_exo -53.31 -50.89 12.37 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.653 2.235 . . . . 0.0 112.267 -175.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.94 -39.21 69.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.134 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 30.3 tp -56.02 -45.32 79.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -53.74 -34.97 60.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.837 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.47 -36.76 79.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -73.44 -53.21 11.23 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -172.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.8 OUTLIER -80.01 -10.64 59.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -175.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.566 ' N ' HD23 ' A' ' 139' ' ' LEU . 86.5 tttt -55.99 -31.61 63.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.943 166.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.87 -25.1 68.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -95.14 5.59 51.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.47 28.85 60.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.528 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -120.09 170.09 9.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.758 0.313 . . . . 0.0 110.904 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.3 t -131.25 141.25 49.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -70.42 -55.13 9.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.048 -166.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -141.97 131.05 23.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 -170.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.726 ' SD ' ' HB2' ' A' ' 213' ' ' ALA . 52.7 ttm -110.54 123.76 50.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -150.46 157.15 42.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -167.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -101.81 96.24 6.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.965 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.844 HD21 HD11 ' A' ' 195' ' ' LEU . 1.8 tm? -76.12 -18.29 59.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.973 172.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -80.36 -2.49 45.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.425 ' O ' HG23 ' A' ' 157' ' ' THR . 38.4 mt-10 -113.53 152.21 45.17 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.574 0.702 . . . . 0.0 110.909 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.532 ' HD3' ' CD ' ' A' ' 344' ' ' ARG . 30.5 Cg_endo -66.91 -19.82 51.97 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.68 2.254 . . . . 0.0 112.367 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -65.02 -40.66 95.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -172.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . 0.411 ' HD2' HD23 ' A' ' 151' ' ' LEU . 74.7 t80 -82.97 -36.04 25.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.807 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 153' ' ' GLU . 81.9 p -60.51 -46.7 89.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.189 -170.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.645 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 89.0 t90 -67.84 -48.17 41.53 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.502 0.667 . . . . 0.0 110.897 -167.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 78.5 Cg_exo -47.57 -46.37 20.86 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.666 2.244 . . . . 0.0 112.512 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.674 ' O ' HD23 ' A' ' 160' ' ' LEU . 6.5 tt -70.07 -39.87 75.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.965 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 71.0 mt -70.39 -41.02 78.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.014 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.63 -28.6 61.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.116 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.504 ' HB3' ' HD2' ' A' ' 250' ' ' PHE . . . -63.12 -34.96 78.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 -170.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -91.48 1.99 56.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.884 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.01 1.31 14.48 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.467 170.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.33 65.02 4.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.55 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -84.86 133.55 34.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.912 0.387 . . . . 0.0 110.893 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.25 5.43 10.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.076 -170.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.421 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.0 p90 -146.85 152.9 39.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.944 0.402 . . . . 0.0 110.956 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -103.78 126.15 50.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.98 156.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -115.69 126.28 53.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.857 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -151.58 130.07 12.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.913 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.1 t30 55.02 43.87 29.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 171.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.98 14.85 81.41 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.48 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.23 138.71 50.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 0.0 110.845 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -99.37 144.61 28.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 170.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -121.48 110.59 16.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.876 172.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.572 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.2 pp -80.0 -12.64 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.082 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.96 -13.13 20.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -122.94 85.23 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.874 170.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 169' ' ' PHE . 34.1 m -116.9 170.48 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.115 -169.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.63 24.42 29.84 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.45 -167.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.516 HG21 HD12 ' A' ' 368' ' ' ILE . 11.3 m -110.01 -15.45 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.0 111.112 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -85.92 19.61 2.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.786 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -110.32 -179.91 3.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.1 -24.6 64.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.097 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 190' ' ' ALA . . . -70.87 -40.63 63.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.456 -171.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.631 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.38 -35.35 80.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 111.115 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.534 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.1 mttt -59.05 -31.22 68.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 175.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 187' ' ' GLY . . . -65.51 -30.69 71.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.115 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.16 -47.46 84.9 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.379 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.495 HD11 ' HB1' ' A' ' 346' ' ' ALA . 19.7 mt -64.89 -38.91 92.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.883 0.373 . . . . 0.0 110.936 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.3 m -58.71 -45.12 90.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.21 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -77.28 -43.06 34.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.843 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.844 HD11 HD21 ' A' ' 151' ' ' LEU . 6.0 tt -55.57 -48.6 74.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 -171.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 24.8 m -68.58 -19.22 24.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -57.5 -54.87 41.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 -169.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 1.045 HD13 ' H ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -76.1 -26.48 56.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.925 -168.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.613 ' H ' HD22 ' A' ' 198' ' ' LEU . 1.8 pp -86.65 -34.42 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.172 177.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.86 -31.81 68.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.856 165.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -85.86 6.06 29.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.861 177.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 65.0 39.94 5.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 170.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -84.54 -9.76 58.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 58.7 ttp -134.54 151.38 51.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -97.69 155.56 16.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.921 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.95 -27.76 69.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -95.25 4.25 53.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.903 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.402 ' CG2' ' HG3' ' A' ' 148' ' ' MET . 90.0 m -63.08 132.14 50.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.15 -176.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.432 ' H ' HD12 ' A' ' 212' ' ' ILE . 23.6 t0 -149.75 167.39 26.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.858 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -68.58 -34.01 75.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.0 p -63.57 -32.58 74.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.432 HD12 ' H ' ' A' ' 209' ' ' ASP . 79.7 mt -62.42 -36.56 75.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.08 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.726 ' HB2' ' SD ' ' A' ' 148' ' ' MET . . . -66.07 -42.22 89.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.081 -173.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -64.82 -39.24 93.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.986 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.32 -40.3 85.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.102 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.89 -34.59 78.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.121 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -59.95 -33.66 72.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.825 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -59.91 -34.98 73.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.954 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -96.45 -21.13 17.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.98 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . 0.528 ' O ' HD21 ' A' ' 121' ' ' LEU . . . 91.05 30.51 11.0 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.439 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -84.73 -27.75 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.876 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 94.9 m -116.96 131.1 57.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.216 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.477 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -66.26 -54.57 23.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.098 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.441 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 67.0 mtm -137.82 160.0 40.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.797 -168.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 10.4 t -149.76 164.17 36.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.7 mm -111.29 125.58 68.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.07 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -144.65 167.82 21.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.893 -169.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -118.52 -155.13 9.85 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.471 -174.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -59.99 -22.53 69.49 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.725 2.283 . . . . 0.0 112.289 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.9 p90 -81.54 4.33 21.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.949 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -51.57 -29.24 16.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.0 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -53.54 -20.59 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 26.3 t -42.03 -57.81 2.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.808 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -150.65 40.36 0.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.465 HD12 HG21 ' A' ' 116' ' ' ILE . 46.5 mm . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.124 174.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.6 m . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.828 0.347 . . . . 0.0 111.135 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -99.14 70.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -174.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.471 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 82.4 m-85 -130.03 145.58 51.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.004 172.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -128.26 153.13 19.36 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.509 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.628 HG22 ' HB2' ' A' ' 319' ' ' ALA . 6.7 p -138.53 135.96 43.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.381 . . . . 0.0 111.193 -177.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.2 t -153.44 149.89 28.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.408 ' CG1' ' HB2' ' A' ' 323' ' ' ASN . 25.1 m -60.76 167.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.666 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.3 mm? -64.77 146.19 98.62 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.586 0.708 . . . . 0.0 110.899 -160.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.85 -177.01 2.61 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.727 2.284 . . . . 0.0 112.285 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.2 p -106.76 162.63 13.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.143 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.504 ' HD2' ' HB3' ' A' ' 163' ' ' ALA . 44.7 t80 -146.03 123.43 11.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 176.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 55.33 35.25 24.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.84 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.53 12.12 70.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.531 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -137.05 140.37 31.19 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.56 0.695 . . . . 0.0 110.947 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.36 140.82 30.94 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.677 2.251 . . . . 0.0 112.407 -174.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.666 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 89.8 p -83.33 -5.1 59.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.798 169.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -48.33 110.07 1.33 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.546 0.689 . . . . 0.0 110.901 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.0 163.53 30.83 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.623 2.216 . . . . 0.0 112.32 -177.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -73.66 174.82 7.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.828 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.5 t -108.39 132.32 56.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.048 -170.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -112.12 126.85 7.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.436 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 96.9 t -116.0 134.41 59.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.854 0.359 . . . . 0.0 111.098 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 263' ' ' SER . 2.6 tt -67.32 129.75 40.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.945 171.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.406 ' N ' HD23 ' A' ' 262' ' ' LEU . 64.3 p -124.63 131.82 53.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.899 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -125.25 125.87 44.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.137 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -119.75 170.34 14.08 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.424 -171.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 59' ' ' ILE . 13.1 mm -99.96 127.93 52.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.768 0.318 . . . . 0.0 111.107 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -64.91 127.25 30.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.9 -24.29 67.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.122 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.65 -11.57 55.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.037 -172.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.6 t -77.67 122.38 85.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.632 0.73 . . . . 0.0 110.87 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.34 -11.57 30.31 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.591 2.194 . . . . 0.0 112.349 171.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -111.73 35.19 3.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.917 -169.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -59.31 -26.68 65.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.834 -170.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -69.03 -39.86 78.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.864 -172.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.38 -48.45 72.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.732 ' HB1' HG23 ' A' ' 59' ' ' ILE . . . -67.38 -48.17 68.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.153 -172.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -65.25 -37.46 87.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.5 tt0 -68.21 -53.7 22.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 -172.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.1 p90 -67.54 -35.13 78.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.837 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 4.8 tt -58.58 -50.04 75.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -79.95 -33.51 39.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 65.6 m-80 -100.01 -17.71 17.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 -164.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.407 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 40.0 t80 -121.33 -48.64 2.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.954 -172.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 0.3 OUTLIER -65.04 -46.39 81.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.82 176.228 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 106' ' ' TYR . 64.8 mt -84.97 59.39 5.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.486 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 52.5 p -138.47 150.2 46.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.187 172.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.57 ' HA ' HD11 ' A' ' 290' ' ' LEU . 42.9 p-10 -51.56 -26.0 7.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.84 -174.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -78.65 -44.8 22.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.791 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.4 -51.07 13.68 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 -169.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.57 HD11 ' HA ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -73.31 -20.78 60.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 110.91 -179.251 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.426 ' N ' HD12 ' A' ' 290' ' ' LEU . 81.8 tt0 -66.06 -40.75 91.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.933 168.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.79 76.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.075 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.592 HG13 ' HA3' ' A' ' 19' ' ' GLY . 24.9 t -77.4 -44.62 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.143 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.42 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 49.8 t30 -65.03 -25.86 68.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.968 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.4 -28.96 70.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -87.01 -41.65 13.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.822 -176.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -147.69 132.8 9.08 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 121.515 0.674 . . . . 0.0 111.027 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -51.99 111.92 0.72 Allowed 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.628 2.219 . . . . 0.0 112.408 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.42 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 55.3 mt -90.98 -17.17 26.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -172.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.528 ' O ' HG23 ' A' ' 317' ' ' ILE . . . 102.96 -43.04 1.75 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.394 175.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -176.27 168.72 2.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.823 0.344 . . . . 0.0 110.974 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.51 HG22 HD21 ' A' ' 311' ' ' LEU . 23.9 m -122.6 154.29 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.199 170.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -69.44 -18.39 63.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.09 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.477 ' CD2' HD21 ' A' ' 290' ' ' LEU . 63.3 tp -83.63 122.62 28.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.014 -173.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -59.55 -36.33 75.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.787 -173.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.8 m -63.11 -49.87 72.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 -168.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.591 ' CD2' HD23 ' A' ' 311' ' ' LEU . 33.1 t80 -83.79 -26.97 29.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -56.43 -44.38 80.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.918 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.01 -36.23 83.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.875 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -76.01 -48.89 19.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.815 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.6 pp -66.72 -25.43 66.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -64.2 -17.37 63.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.061 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -67.3 -17.86 64.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.872 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -80.02 123.28 83.61 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.557 0.694 . . . . 0.0 110.904 173.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.554 ' O ' HG11 ' A' ' 244' ' ' VAL . 83.7 Cg_exo -52.85 -35.59 70.68 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.582 2.188 . . . . 0.0 112.319 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -64.79 -26.83 68.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.92 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.815 HG21 ' CD1' ' A' ' 311' ' ' LEU . 56.3 mt -96.75 -34.54 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.115 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.21 -39.41 13.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.012 -167.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.628 ' HB2' HG22 ' A' ' 244' ' ' VAL . . . -65.15 -44.32 88.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.05 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 317' ' ' ILE . 69.2 p -68.27 -29.9 68.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.128 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 18.0 tmm? -69.99 -40.13 75.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -65.69 -45.6 82.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.551 HD22 ' HB1' ' A' ' 112' ' ' ALA . 25.4 t30 -63.42 -36.3 83.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.967 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.79 -48.28 79.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.032 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -75.4 -32.69 60.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -94.75 -5.6 44.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.931 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -95.28 -157.73 32.43 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.496 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -140.02 142.73 36.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 110.925 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.581 ' O ' ' C ' ' A' ' 330' ' ' MET . 31.4 mm -79.91 108.47 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.215 -170.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.643 ' HG3' ' O ' ' A' ' 330' ' ' MET . 20.4 ptp . . . . . 0 C--N 1.327 -0.384 0 CA-C-O 121.503 0.668 . . . . 0.0 110.848 174.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 . . . . . 0 N--CA 1.457 -0.124 0 CA-C-O 120.804 0.335 . . . . 0.0 110.946 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 79.7 mmm -71.33 -25.02 62.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.91 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.0 m -61.76 -40.06 93.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 176.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.88 -34.3 60.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.995 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -63.39 -37.97 89.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.891 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 154' ' ' PRO . 21.0 m0 -61.07 -34.5 75.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -76.79 -35.27 57.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 367' ' ' ARG . . . -63.2 -39.98 96.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.057 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.8 m -81.82 -24.2 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.091 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.532 ' CD ' ' HD3' ' A' ' 154' ' ' PRO . 52.9 ttt180 -55.63 -55.45 31.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.824 173.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 96.6 m -56.87 -33.0 66.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.131 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.637 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -56.94 -44.51 82.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.136 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.432 ' HA ' HD22 ' A' ' 192' ' ' LEU . 1.3 m -74.96 -33.1 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.179 -174.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.3 -47.21 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.22 173.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . 0.561 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 84.5 m-20 -66.73 -37.01 83.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.52 -47.26 61.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.091 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.45 -39.87 92.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.094 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.5 p -74.86 -14.17 60.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.007 0.432 . . . . 0.0 110.85 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 76.67 10.61 85.83 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.505 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -79.77 -25.09 41.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.765 0.317 . . . . 0.0 110.844 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 87.5 mt-30 -133.15 158.26 43.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 169.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.5 p -79.37 171.01 15.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.154 168.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 67.1 t -55.88 -44.5 78.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.07 169.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -58.21 -44.93 88.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -70.84 -52.02 22.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -69.19 -44.66 71.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.132 -173.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -65.49 -39.99 92.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 -177.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.0 tttt -64.91 -38.4 90.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.894 176.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -65.83 -36.89 84.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.637 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -63.92 -44.77 91.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.077 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -73.26 -30.38 63.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.942 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 68.5 m -64.34 -41.17 96.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.422 ' HB2' ' HB1' ' A' ' 342' ' ' ALA . 99.6 mtt180 -67.74 -39.62 84.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.748 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.516 HD12 HG21 ' A' ' 183' ' ' VAL . 67.9 mt -65.6 -39.27 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.164 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.8 p -92.59 -9.04 42.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.064 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.99 173.966 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.733 0.301 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.458 HG21 ' HD2' ' A' ' 271' ' ' PRO . 87.1 mt -79.75 126.35 39.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -148.49 147.38 29.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.801 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.3 129.77 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.817 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.458 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 96.33 5.85 59.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.448 -174.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.0 tttt -164.71 139.86 5.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.779 0.324 . . . . 0.0 110.945 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.669 HD22 HD13 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -146.39 157.45 43.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 75.3 t -108.94 133.43 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.114 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.762 HG13 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -123.11 135.36 63.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 -178.493 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -109.07 160.87 15.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.553 HG21 ' HB2' ' A' ' 15' ' ' LYS . 87.9 mt -132.93 149.26 31.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.154 166.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.501 ' O ' HG22 ' A' ' 11' ' ' ILE . 62.0 t30 -58.26 159.81 5.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 174.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.51 -15.36 8.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.555 -174.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.91 -24.05 65.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 110.872 -172.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.553 ' HB2' HG21 ' A' ' 11' ' ' ILE . 35.4 mtmt -134.25 132.04 39.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.944 169.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.07 -94.07 0.76 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.459 -168.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -115.24 -46.67 2.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 110.943 -172.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -64.03 -47.85 78.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.963 -155.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.916 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -57.91 -45.66 93.39 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.431 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.762 HD11 HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -51.51 -50.73 59.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.872 0.368 . . . . 0.0 110.865 177.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.18 -39.37 63.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.167 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -70.1 -52.33 24.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.0 m -69.2 -36.33 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.56 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -66.72 -41.14 93.93 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.513 173.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -54.07 -46.06 71.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.889 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.9 -44.06 90.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.945 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.663 ' CE2' HD11 ' A' ' 33' ' ' ILE . 44.0 t80 -65.71 -38.09 88.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.812 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 34.7 tt0 -64.5 -42.94 95.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.841 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.6 -32.46 68.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -81.14 -39.35 25.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.872 -171.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.715 ' OG1' HG13 ' A' ' 33' ' ' ILE . 67.8 p -103.78 -10.21 18.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.42 7.39 85.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.453 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.076 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.8 pp -104.08 132.51 50.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.882 0.372 . . . . 0.0 111.064 -175.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.8 mttt -70.41 136.74 49.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -171.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.56 HG21 ' HA3' ' A' ' 24' ' ' GLY . 3.0 m -111.99 133.07 58.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 174.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.6 m -110.1 125.66 53.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.102 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.584 HG22 ' HG ' ' A' ' 20' ' ' LEU . 60.9 t -89.66 126.29 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 178.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -112.91 148.88 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 175.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 64.8 t-80 -86.27 136.19 35.95 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.658 0.742 . . . . 0.0 110.883 -169.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 83.2 Cg_exo -56.04 -21.36 34.17 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.721 2.28 . . . . 0.0 112.322 -175.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -48.07 -53.99 14.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 43' ' ' LEU . 99.1 mttt -88.78 0.92 56.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -172.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 42' ' ' LYS . 16.4 tp -39.88 -54.73 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.975 -173.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.48 -35.27 68.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.844 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.19 -47.93 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 -166.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -78.6 -43.81 25.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 -171.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.557 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 83.6 t80 -50.87 -53.88 42.76 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.574 0.702 . . . . 0.0 110.851 -167.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 38.9 Cg_endo -65.98 -30.11 48.44 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.629 2.22 . . . . 0.0 112.351 -177.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -74.8 -41.99 58.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.428 HG21 ' HD3' ' A' ' 57' ' ' PRO . 24.9 m -75.48 -21.5 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.201 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 -31.69 72.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.057 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.15 -29.76 70.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.11 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.9 p -92.62 -15.19 27.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.199 170.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.98 18.38 79.64 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.432 171.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -140.2 143.85 36.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.863 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.48 -78.31 0.33 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.477 168.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 89.0 Cg_endo -78.52 140.99 17.35 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.727 2.284 . . . . 0.0 112.329 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.413 ' HB2' HD13 ' A' ' 59' ' ' ILE . 1.5 m-20 -101.41 -41.13 6.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.97 173.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.64 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -132.92 143.68 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.195 176.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.0 tp -136.08 128.06 44.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.174 -169.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.486 ' N ' ' HD1' ' A' ' 61' ' ' PHE . 2.0 m-30 -97.89 142.28 29.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.926 -175.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 80.3 m95 -140.72 159.74 41.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 174.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.17 -88.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.059 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -125.48 -62.54 1.19 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.874 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -75.39 -35.42 61.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 -161.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.467 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 9.4 mpt_? -54.66 -33.75 61.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.895 -168.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.563 ' HB3' HD13 ' A' ' 104' ' ' ILE . 51.0 m-85 -56.79 -38.71 72.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -172.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.06 -50.49 57.31 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.485 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.13 -42.35 99.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.515 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -74.66 -33.21 62.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.945 0.403 . . . . 0.0 110.985 -176.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' A' ' 76' ' ' LEU . . . -65.11 -38.71 91.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.074 170.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -63.97 -34.63 78.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 98.9 p -86.7 -10.14 54.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.886 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.54 28.97 62.41 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.554 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 mp -90.39 -17.2 27.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 -173.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 1.328 HD13 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.09 121.17 37.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.807 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -64.73 137.83 58.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.084 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.21 137.05 56.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.446 HD12 ' CE2' ' A' ' 106' ' ' TYR . 37.2 pt -109.98 160.42 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.8 p -96.97 149.87 36.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.547 0.689 . . . . 0.0 111.214 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.13 137.93 29.8 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.74 2.294 . . . . 0.0 112.397 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -104.06 108.8 20.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.888 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.77 -41.78 91.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.969 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.38 -41.88 98.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.218 -176.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.565 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 13.0 m-30 -74.35 -47.6 33.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -49.44 -42.53 43.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -57.35 -30.58 64.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.889 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 305' ' ' LYS . 84.9 mttt -87.45 -13.81 42.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.931 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 46.8 mt -104.93 -145.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.973 -170.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.97 140.69 37.11 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.743 0.782 . . . . 0.0 110.888 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.48 -28.78 38.31 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.628 2.218 . . . . 0.0 112.405 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -65.58 -42.81 91.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.506 HG22 HG21 ' A' ' 261' ' ' VAL . 81.2 p -78.25 -38.37 42.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.161 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -49.37 -46.97 47.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.931 169.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.42 -35.6 80.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.76 -24.94 65.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.024 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.479 HG23 HD11 ' A' ' 103' ' ' LEU . 31.7 m -112.46 20.77 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.206 -171.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.464 ' HB3' HD12 ' A' ' 103' ' ' LEU . 54.7 ptt85 -120.01 146.7 45.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.919 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -136.93 125.58 23.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.014 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.3 t30 60.01 37.05 21.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.73 1.07 90.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.517 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -117.46 150.15 39.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.758 0.314 . . . . 0.0 110.905 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.479 HD11 HG23 ' A' ' 97' ' ' VAL . 6.3 tp -81.68 136.79 35.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.563 HD13 ' HB3' ' A' ' 67' ' ' PHE . 2.1 pp -128.04 2.72 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.153 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.486 ' HB2' ' CE1' ' A' ' 67' ' ' PHE . . . -168.32 169.22 10.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.064 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 263' ' ' SER . 99.4 m-85 -120.1 139.67 28.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.682 0.753 . . . . 0.0 110.887 166.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.52 122.99 5.75 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.586 2.19 . . . . 0.0 112.362 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.2 mp -109.66 -42.92 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.039 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -137.36 144.46 42.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 -165.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.27 131.49 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.17 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -117.6 125.37 50.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.511 ' HB3' ' CG2' ' A' ' 320' ' ' THR . . . -163.57 163.74 24.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.145 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.421 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 6.6 mp -101.03 170.93 7.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.917 -167.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 86.7 p -158.84 154.4 26.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 171.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.872 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -100.06 129.62 46.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.898 174.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.623 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.2 mp -114.34 135.99 52.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 -177.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -135.8 154.93 51.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 -172.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -96.78 119.31 35.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.471 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 98.4 mttt -65.6 -18.98 65.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -83.38 -28.16 29.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.811 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 223' ' ' ALA . 10.4 mp -88.09 -44.6 10.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.744 HD22 ' HB1' ' A' ' 223' ' ' ALA . 2.2 pt? -139.94 127.29 12.67 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.607 0.718 . . . . 0.0 110.907 168.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.73 -10.37 17.03 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.592 2.195 . . . . 0.0 112.412 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -143.48 108.32 5.2 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.643 0.735 . . . . 0.0 110.881 -175.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.03 148.61 76.04 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.728 2.286 . . . . 0.0 112.222 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.17 142.7 56.57 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.721 2.281 . . . . 0.0 112.341 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -83.38 -27.93 29.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.4 p -127.15 154.54 44.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.106 -177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.667 ' HA ' HD13 ' A' ' 132' ' ' ILE . 54.4 m95 -69.89 -23.96 63.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.29 -23.1 63.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -78.52 -22.59 47.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.667 HD13 ' HA ' ' A' ' 129' ' ' TRP . 1.4 mp -56.16 -51.13 83.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.677 0.751 . . . . 0.0 111.15 -170.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.6 Cg_endo -69.36 -41.25 4.97 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.621 2.214 . . . . 0.0 112.299 -172.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.0 -40.54 71.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.994 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 0.832 ' CD2' ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -58.35 -42.67 87.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.963 174.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.512 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 32.7 t70 -52.65 -37.24 58.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.09 -31.01 69.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.9 -56.39 5.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.842 -174.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 140' ' ' LYS . 1.0 OUTLIER -80.89 -10.06 59.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -175.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.52 ' N ' HD23 ' A' ' 139' ' ' LEU . 86.0 tttt -54.36 -30.77 52.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.804 165.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.82 -24.92 68.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.086 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -95.01 4.05 54.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.36 27.37 59.72 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.478 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.447 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 38.4 mmtm -116.48 155.52 28.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 0.0 110.891 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.9 t -100.73 147.53 25.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.834 173.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.512 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -67.25 -43.32 82.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.171 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.459 HD11 HG12 ' A' ' 226' ' ' ILE . 48.9 tp -141.4 152.6 44.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.843 -177.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 61.5 tpp -128.0 125.17 38.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.793 170.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -161.07 165.05 30.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -110.0 165.63 11.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 172.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.486 HD11 HD11 ' A' ' 195' ' ' LEU . 36.6 tp -130.15 -16.81 3.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.856 171.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -71.92 0.71 8.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.847 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 70.3 mm-40 -121.82 144.9 41.99 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.672 0.749 . . . . 0.0 110.882 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' A' ' 340' ' ' TRP . 53.9 Cg_exo -55.22 -28.74 63.33 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.789 2.326 . . . . 0.0 112.313 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -59.49 -42.29 91.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -86.47 -32.24 20.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.452 HG22 HG21 ' A' ' 347' ' ' VAL . 65.0 p -64.84 -37.47 87.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.225 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.567 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 42.7 t-105 -61.93 -54.52 49.92 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 121.597 0.713 . . . . 0.0 111.016 -173.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 33.2 Cg_endo -67.14 -27.6 41.56 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.699 2.266 . . . . 0.0 112.38 -174.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.668 HD13 ' C ' ' A' ' 160' ' ' LEU . 2.9 tm? -64.77 -41.85 95.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.572 HG22 ' HA3' ' A' ' 166' ' ' GLY . 2.9 mp -78.08 -41.91 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.23 176.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.32 -20.21 65.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.072 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -57.87 -34.17 69.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.985 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -101.51 5.37 41.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.864 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.33 9.21 24.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.379 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.572 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -75.09 65.79 2.25 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.344 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -95.69 134.81 38.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.885 0.374 . . . . 0.0 110.96 173.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.533 ' HB1' HG21 ' A' ' 368' ' ' ILE . . . -47.77 -31.0 4.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 -175.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.411 ' CD1' HG12 ' A' ' 181' ' ' VAL . 98.5 m-85 -138.48 148.03 43.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.911 174.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -69.11 127.66 33.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -102.04 119.95 39.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.933 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -150.83 130.61 13.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.809 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.3 t30 55.38 42.43 30.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.934 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.38 9.39 81.39 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.416 173.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.03 141.55 49.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.7 0.286 . . . . 0.0 110.892 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -94.11 135.33 35.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 172.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -95.92 105.41 17.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.907 -170.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.454 ' C ' HD12 ' A' ' 178' ' ' ILE . 2.4 pp -71.31 -6.52 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -100.89 -16.7 17.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -134.95 100.75 4.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 168' ' ' ALA . 32.4 m -101.45 162.14 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.132 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -101.75 -0.1 52.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.527 -168.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.5 m -100.72 -20.03 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 0.0 111.128 -171.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -96.28 20.11 10.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -106.62 -175.08 2.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 -174.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.49 71.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.061 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -71.4 -41.25 58.96 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.461 -170.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.71 -34.68 76.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.775 0.321 . . . . 0.0 111.036 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -61.75 -40.87 96.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.969 174.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.06 76.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.025 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.504 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -58.68 -48.88 82.5 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.458 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.475 HD11 ' HB1' ' A' ' 346' ' ' ALA . 25.8 mt -66.41 -39.11 88.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.943 0.402 . . . . 0.0 110.967 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.9 m -58.55 -45.39 89.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.197 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.433 ' O ' HD22 ' A' ' 198' ' ' LEU . 82.3 t80 -68.91 -48.53 63.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 174.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.835 HD23 ' C ' ' A' ' 195' ' ' LEU . 3.2 tt -50.76 -51.79 46.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -174.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.504 ' HA ' HG23 ' A' ' 199' ' ' ILE . 34.7 m -63.52 -23.47 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.071 -175.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.54 -34.01 73.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.961 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.6 OUTLIER -82.15 -40.02 22.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -174.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 199' ' ' ILE . 0.0 OUTLIER -75.23 -29.56 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 175.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . 0.428 ' N ' HD13 ' A' ' 199' ' ' ILE . 87.6 tttt -72.36 -46.54 54.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.901 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -90.16 5.75 45.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 67.27 37.72 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 170.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -83.04 -13.78 55.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.918 173.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -138.22 155.15 48.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.917 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -103.78 139.83 38.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.824 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.96 -22.24 64.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.071 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.72 -5.84 58.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.895 -172.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 86.7 m -60.03 137.98 57.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.469 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 20.9 t0 -139.25 175.41 9.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -60.82 -45.8 93.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.917 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 96.3 p -67.57 -35.97 80.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.469 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 85.8 mt -64.17 -41.61 92.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.145 175.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.76 -38.89 84.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.091 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -63.17 -45.86 89.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.803 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.14 95.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.159 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.67 97.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.02 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -66.78 -47.38 72.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.873 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -66.0 -30.52 71.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -86.02 -13.6 46.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.924 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.03 26.23 53.56 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.47 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -86.42 -28.62 23.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 0.0 110.911 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 15.3 t -119.79 134.38 55.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.109 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.744 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -78.45 -34.14 47.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.107 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.46 ' HB3' HD21 ' A' ' 115' ' ' LEU . 77.7 mtm -128.94 150.33 50.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.847 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.8 t -145.34 150.97 37.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.459 HG12 HD11 ' A' ' 147' ' ' LEU . 39.2 mm -107.04 122.22 60.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.11 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -140.98 149.39 41.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -127.24 -150.58 7.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.482 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.05 -20.36 71.22 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.658 2.239 . . . . 0.0 112.282 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -71.6 -24.47 61.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.905 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 55.09 54.92 8.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.079 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -60.27 -38.17 82.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.953 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 35.7 t -105.0 118.79 37.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 168.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -75.45 72.83 2.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 116' ' ' ILE . 78.7 mt . . . . . 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.155 -178.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 25.5 m . . . . . 0 C--O 1.23 0.047 0 CA-C-O 120.846 0.355 . . . . 0.0 111.134 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -92.71 121.06 33.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.897 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.471 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 31.3 p90 -143.53 152.56 41.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.937 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -143.01 167.8 26.23 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.606 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 315' ' ' PRO . 7.7 p -132.27 139.5 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.966 0.412 . . . . 0.0 111.061 -172.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.0 t -144.92 147.16 32.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 168.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 16.6 m -56.92 156.45 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.133 168.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 247' ' ' LEU . 7.4 mp -66.76 148.99 98.61 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.514 0.673 . . . . 0.0 110.897 -157.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 48.1 Cg_exo -60.69 178.34 0.49 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.781 2.321 . . . . 0.0 112.369 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 82.1 p -99.96 153.98 18.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -135.31 117.05 15.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 54.77 35.17 23.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 89.11 5.7 72.73 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.472 171.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -124.36 140.54 35.35 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.606 0.717 . . . . 0.0 110.854 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.02 129.5 17.43 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.688 2.258 . . . . 0.0 112.326 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 68.0 m -78.81 -26.76 44.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.87 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -47.63 109.92 1.22 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.557 0.694 . . . . 0.0 110.91 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -58.72 161.31 15.33 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.731 2.287 . . . . 0.0 112.307 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -62.4 162.1 10.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.456 HG23 ' HB2' ' A' ' 112' ' ' ALA . 3.5 p -108.3 134.03 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.11 -175.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.25 142.94 16.06 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.451 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.506 HG21 HG22 ' A' ' 93' ' ' THR . 73.3 t -127.65 122.54 59.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 111.194 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 263' ' ' SER . 1.6 tt -82.05 130.77 35.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 172.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.637 ' N ' HD23 ' A' ' 262' ' ' LEU . 62.2 m -132.32 158.16 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.902 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.18 138.98 50.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.063 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.76 178.27 18.23 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.46 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 77' ' ' ALA . 27.0 mm -103.6 137.06 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.908 0.385 . . . . 0.0 111.092 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -72.29 127.4 32.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.807 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -65.43 -23.06 66.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.1 -176.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.75 -11.72 55.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.054 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.7 t -77.16 120.84 83.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.66 0.743 . . . . 0.0 110.917 -173.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.458 ' HD2' HG21 ' A' ' 2' ' ' ILE . 77.7 Cg_endo -69.12 -10.57 29.42 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.707 2.271 . . . . 0.0 112.32 170.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -103.01 21.41 15.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 -170.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -52.97 -31.63 41.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 -170.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -66.18 -47.3 74.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.83 -170.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.04 -26.94 20.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.948 -177.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.567 ' HB1' HG23 ' A' ' 59' ' ' ILE . . . -63.14 -45.11 93.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.16 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -69.73 -33.95 73.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.987 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 92.4 mt-10 -66.43 -35.52 80.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.827 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.498 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 0.8 OUTLIER -56.27 -53.56 55.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.795 175.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.495 ' HB2' HD12 ' A' ' 284' ' ' LEU . 2.1 pp -79.06 -34.78 43.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.906 -170.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.22 -42.4 72.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 95.4 m-20 -97.56 -4.38 37.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 -164.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.621 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 47.3 m-85 -118.36 -54.4 2.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.033 173.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.558 ' O ' ' HB3' ' A' ' 290' ' ' LEU . 25.3 mt -81.17 -42.49 20.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.942 -169.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.469 HD23 HD12 ' A' ' 280' ' ' LEU . 4.0 mm? -81.58 19.94 0.97 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 169.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.63 ' O ' HD22 ' A' ' 290' ' ' LEU . 94.0 m -132.61 142.67 49.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.101 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 47.9 p-10 -51.44 -26.19 7.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -168.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -74.46 -46.8 37.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -175.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -80.62 -48.04 6.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 -165.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 291' ' ' GLU . 0.7 OUTLIER -70.21 -16.06 63.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 110.936 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.713 ' N ' HD23 ' A' ' 290' ' ' LEU . 83.2 tt0 -71.99 -47.33 52.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 167.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.81 -40.75 98.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.087 -172.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.916 HG23 ' HA3' ' A' ' 19' ' ' GLY . 3.3 p -70.75 -36.83 66.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -67.43 -25.21 65.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.784 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.84 -29.36 70.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -90.67 -43.11 10.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.409 ' O ' HD13 ' A' ' 299' ' ' LEU . 65.8 mttm -127.92 145.78 56.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.531 0.681 . . . . 0.0 110.902 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.7 107.14 1.59 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.748 2.298 . . . . 0.0 112.329 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.455 ' HG ' ' HD3' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -91.89 -19.21 22.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.944 -179.021 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.488 ' O ' HD11 ' A' ' 317' ' ' ILE . . . 88.58 -62.02 3.78 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.573 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -160.25 167.49 27.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 111.17 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.73 HG21 ' HB3' ' A' ' 307' ' ' TYR . 33.2 m -131.14 156.15 42.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.213 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.06 -14.82 60.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.077 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' A' ' 89' ' ' LEU . 50.4 tp -81.21 126.83 31.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -173.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 87.2 tttt -55.41 -44.99 76.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 63.7 m -61.59 -52.18 65.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.802 -168.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.73 ' HB3' HG21 ' A' ' 302' ' ' VAL . 12.6 t80 -78.02 -32.67 51.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -62.91 -42.03 99.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.921 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -62.09 -38.99 90.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.894 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.69 -48.76 29.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.601 HD21 HG22 ' A' ' 302' ' ' VAL . 4.6 pp -69.13 -23.48 63.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.854 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.422 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.41 -14.96 63.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.14 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.45 -16.4 62.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.965 176.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.48 133.48 44.43 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.575 0.702 . . . . 0.0 110.864 169.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . 0.423 ' O ' HG11 ' A' ' 244' ' ' VAL . 90.5 Cg_exo -47.74 -35.74 24.3 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.673 2.249 . . . . 0.0 112.342 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -61.96 -27.64 68.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -167.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.488 HD11 ' O ' ' A' ' 300' ' ' GLY . 2.1 mp -100.03 -40.85 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.162 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.11 -47.24 61.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -162.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.25 -34.77 75.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.19 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.511 ' CG2' ' HB3' ' A' ' 112' ' ' ALA . 62.9 m -61.42 -37.01 81.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.058 -176.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.6 mtp -60.16 -30.46 69.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.896 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -65.45 -43.95 88.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -77.06 -39.75 48.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.36 -39.79 73.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.156 -168.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.3 -28.32 69.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -108.6 -1.68 19.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -86.16 -160.21 33.68 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.414 -168.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -140.93 154.75 46.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.987 0.422 . . . . 0.0 110.825 -173.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 40.6 mm -68.07 116.28 7.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.114 -171.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 63.3 ttp . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 121.515 0.674 . . . . 0.0 110.904 174.784 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 CA--C 1.527 0.093 0 CA-C-O 120.8 0.333 . . . . 0.0 110.885 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.465 ' HA ' ' CD2' ' A' ' 339' ' ' PHE . 68.0 ttp -54.84 -34.88 63.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 95.9 p -65.14 -31.12 72.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.29 -35.54 63.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.163 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.55 ' HB3' ' CZ3' ' A' ' 158' ' ' TRP . 3.2 m-30 -56.34 -55.65 30.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 176.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.429 ' HB3' ' HB3' ' A' ' 154' ' ' PRO . 52.5 m0 -62.79 -37.82 88.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.92 -172.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -69.71 -48.04 61.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.826 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.14 -42.36 93.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.168 -173.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.449 HG21 ' HA ' ' A' ' 158' ' ' TRP . 19.6 m -73.0 -28.0 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.065 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -62.71 -40.95 98.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.938 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 93.0 m -57.33 -36.07 70.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.157 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.475 ' HB1' HD11 ' A' ' 192' ' ' LEU . . . -65.41 -45.76 82.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.017 -175.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.452 HG21 HG22 ' A' ' 157' ' ' THR . 2.4 m -72.18 -34.42 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.132 -174.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.433 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -63.18 -46.36 96.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.187 173.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -67.81 -39.49 83.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.924 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.59 -47.61 39.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.105 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.32 -37.43 80.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.12 -173.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.2 p -74.99 -9.1 58.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 75.51 11.66 84.2 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -78.77 -27.14 44.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.791 0.329 . . . . 0.0 110.893 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -139.67 156.23 46.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.939 173.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.6 p -77.15 164.96 25.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.194 170.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.7 t -51.91 -41.01 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 175.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.78 -48.94 76.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.994 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -76.82 -44.23 33.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.937 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.56 -47.35 81.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.102 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 13.5 tp -67.07 -52.86 36.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.957 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -54.03 -46.8 71.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.939 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -72.23 -43.68 64.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.08 -47.07 54.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.168 -175.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -67.66 -30.77 70.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 24.9 m -55.14 -31.87 61.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.111 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -58.98 -29.84 67.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.533 HG21 ' HB1' ' A' ' 168' ' ' ALA . 77.9 mt -56.15 -40.11 62.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.113 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.6 p -100.99 -10.43 20.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.115 -174.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.882 179.643 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.718 0.294 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.2 mt -94.08 125.11 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -150.07 147.96 28.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -50.79 133.85 25.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.799 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.96 4.92 64.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.508 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.9 tttt -163.11 141.71 8.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 110.959 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.581 ' CD2' HD11 ' A' ' 33' ' ' ILE . 2.3 pt? -146.51 154.49 41.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.93 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.501 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 88.6 t -110.91 134.7 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.09 -177.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.654 HD11 ' HB ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -119.96 133.56 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 -178.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.72 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 65.2 m95 -106.59 124.19 49.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.942 164.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.501 HD12 ' HG ' ' A' ' 20' ' ' LEU . 12.1 tt -110.01 150.0 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.114 -165.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -62.74 148.18 47.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 -173.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.61 -17.69 21.02 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.454 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.88 -27.34 68.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -173.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 15' ' ' LYS . 35.7 mmtm -140.06 133.67 30.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 166.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.63 -80.77 0.95 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.497 -169.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -99.97 -38.7 8.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.839 0.352 . . . . 0.0 110.914 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -68.15 -51.91 40.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -151.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.11 -55.47 23.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.461 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.501 ' HG ' HD12 ' A' ' 11' ' ' ILE . 5.7 mt -53.82 -53.04 57.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.44 -40.21 7.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.082 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -72.12 -59.51 2.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.854 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 20' ' ' LEU . 20.7 m -70.33 -38.16 73.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 -172.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.767 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -66.98 -48.39 60.62 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.525 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -56.75 -35.0 68.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.846 0.355 . . . . 0.0 110.957 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -55.36 -39.62 70.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.987 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 5.6 m-30 -59.17 -46.32 88.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -65.0 -39.61 93.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -69.44 -38.23 77.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.853 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -94.95 -48.2 6.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -169.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.8 p -110.62 -1.47 16.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 -171.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.87 3.71 90.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.45 168.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.07 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -99.99 134.02 40.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.928 0.394 . . . . 0.0 111.124 -176.046 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.5 mttt -83.08 144.09 30.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.924 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.767 HG21 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -120.01 134.62 62.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 175.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.488 ' O ' HD12 ' A' ' 9' ' ' ILE . 97.0 m -102.21 129.09 48.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.145 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 20' ' ' LEU . 87.2 t -99.57 125.86 53.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -115.06 149.9 36.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.4 t-80 -86.13 138.92 34.45 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.573 0.702 . . . . 0.0 110.928 -165.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 77.1 Cg_exo -56.49 -27.57 69.41 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.695 2.263 . . . . 0.0 112.291 -175.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -47.97 -50.55 26.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -172.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -88.79 -5.04 58.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.6 tt -46.11 -54.85 7.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.897 -169.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.32 -38.32 90.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.953 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.95 -40.82 95.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.899 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HB3' HG13 ' A' ' 50' ' ' VAL . 75.3 mmtt -82.91 -20.01 36.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.57 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 84.4 t80 -49.29 -50.73 62.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.635 0.731 . . . . 0.0 110.799 -165.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 43.3 Cg_endo -82.85 -30.16 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.673 2.248 . . . . 0.0 112.385 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -74.86 -41.45 59.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 -167.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.479 HG21 ' HG3' ' A' ' 57' ' ' PRO . 32.1 m -67.58 -27.11 37.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 -175.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.496 ' CB ' ' HB3' ' A' ' 75' ' ' LEU . . . -69.33 -36.52 77.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.12 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.36 -33.49 75.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.147 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.8 p -94.46 -21.9 18.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.111 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.83 9.16 65.4 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.44 174.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -123.01 120.04 32.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.88 -95.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.427 172.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.72 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 64.5 Cg_endo -79.79 147.3 19.26 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.734 2.29 . . . . 0.0 112.394 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.04 -35.17 12.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.781 161.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.603 ' HB ' HG23 ' A' ' 9' ' ' ILE . 45.8 mt -125.24 136.87 59.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.141 -175.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.0 tp -132.88 126.41 53.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.187 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -92.22 138.98 31.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.857 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.484 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 24.9 p90 -145.07 163.35 34.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.042 170.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.25 -90.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.039 -168.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.3 m170 -123.34 -68.04 0.9 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.868 -171.572 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -103.29 -12.36 17.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.844 -159.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 55.8 ttm-85 -51.05 -20.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 -174.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.475 ' HB2' HD13 ' A' ' 104' ' ' ILE . 32.6 p90 -59.21 -33.48 71.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.06 -50.45 65.97 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.46 -168.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.16 -37.65 94.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.5 174.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.633 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 9.3 t80 -69.01 -42.1 76.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.849 0.357 . . . . 0.0 110.89 -175.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.61 -42.95 70.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.095 175.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -58.24 -37.59 75.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.957 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.407 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 58.1 m -84.55 -5.01 59.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.795 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.01 30.27 59.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.464 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.496 ' HB3' ' CB ' ' A' ' 51' ' ' ALA . 46.1 mt -89.39 -10.04 48.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.867 0.365 . . . . 0.0 110.905 -168.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.633 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -131.03 153.27 49.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.877 -179.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -80.0 139.73 36.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.128 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.4 mp0 -65.68 137.34 57.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.3 pt -100.57 152.09 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.107 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.7 m -96.91 119.0 64.39 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.591 0.71 . . . . 0.0 111.085 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.616 ' HB3' HD12 ' A' ' 103' ' ' LEU . 73.1 Cg_endo -73.97 155.55 47.95 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.745 2.297 . . . . 0.0 112.324 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -105.52 117.86 35.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.842 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -52.87 -35.06 57.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.02 90.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.5 m-30 -75.87 -33.28 59.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.896 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.511 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 86.4 mt-30 -54.9 -51.93 64.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.71 -33.84 70.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -81.96 -18.43 43.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.841 -172.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -104.7 -105.02 0.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 -172.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.509 ' CG ' ' HD2' ' A' ' 91' ' ' PRO . 5.0 t80 -178.72 142.74 0.42 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.705 0.764 . . . . 0.0 110.956 -166.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.509 ' HD2' ' CG ' ' A' ' 90' ' ' TYR . 31.3 Cg_endo -68.25 -37.6 13.72 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.731 2.287 . . . . 0.0 112.337 -175.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -75.08 -29.28 60.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.9 p -72.68 -37.05 68.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.266 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.745 ' CE3' HD13 ' A' ' 103' ' ' LEU . 86.4 m95 -73.61 -26.43 60.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.893 173.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -73.02 -31.31 64.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.853 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.23 -23.88 63.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.07 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.59 HG22 ' HA ' ' A' ' 94' ' ' TRP . 17.9 m -106.16 16.4 6.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.075 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.3 ttp85 -100.97 126.31 47.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.974 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -125.82 115.8 20.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.7 t30 57.17 35.11 25.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.897 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.65 -0.97 89.18 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.558 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -120.97 143.55 48.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 110.862 174.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.745 HD13 ' CE3' ' A' ' 94' ' ' TRP . 41.5 mt -89.59 135.58 33.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 -172.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.475 HD13 ' HB2' ' A' ' 67' ' ' PHE . 2.1 pp -127.21 3.36 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 -166.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.484 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -160.97 160.21 30.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.166 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.429 ' HB3' ' CD2' ' A' ' 285' ' ' LEU . 97.0 m-85 -108.53 139.57 20.94 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.582 0.706 . . . . 0.0 110.871 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -78.91 121.63 5.06 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.708 2.272 . . . . 0.0 112.327 170.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.072 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -105.59 -40.92 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.225 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -141.74 150.84 42.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.103 -164.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.6 t -115.65 123.91 71.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -112.92 122.34 47.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.656 ' HB1' HD21 ' A' ' 323' ' ' ASN . . . -150.18 144.8 25.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.065 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 257' ' ' PRO . 7.1 mp -87.56 170.03 11.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -174.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.2 p -158.33 154.92 27.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.845 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.817 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -91.92 129.1 37.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 169.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.611 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.9 mp -116.37 130.89 70.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.116 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -133.19 154.26 50.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 -171.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.451 ' O ' HD23 ' A' ' 122' ' ' LEU . 69.8 m-80 -88.0 119.57 28.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.862 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.44 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.6 mttt -64.82 -27.35 68.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -82.84 -24.13 33.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.819 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.0 mp -80.49 -54.43 5.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 172.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.706 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.6 pt? -140.36 127.9 12.51 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.617 0.722 . . . . 0.0 110.952 176.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.44 -9.43 14.91 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.659 2.239 . . . . 0.0 112.436 -176.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -149.28 98.0 3.53 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.554 0.693 . . . . 0.0 110.871 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.27 157.08 63.36 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.623 2.215 . . . . 0.0 112.293 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -66.4 143.07 68.34 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.633 2.222 . . . . 0.0 112.36 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.1 -17.48 37.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.5 p -134.5 157.53 46.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.185 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.497 ' HA ' HD13 ' A' ' 132' ' ' ILE . 71.4 m95 -70.15 -23.15 62.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.967 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.02 -24.59 67.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -85.59 -18.38 33.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.901 -177.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.576 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -59.54 -42.87 94.32 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.686 0.755 . . . . 0.0 111.163 -170.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 92.9 Cg_endo -80.01 -37.83 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.664 2.243 . . . . 0.0 112.35 -173.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.88 -58.92 6.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.12 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.236 HD22 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.49 -17.08 64.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -176.038 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.549 ' N ' HD13 ' A' ' 135' ' ' LEU . 37.8 t70 -60.04 -41.39 92.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 168.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.72 -30.8 70.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.29 -47.29 61.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.88 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.1 pp -85.16 -14.61 46.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.888 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.627 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.8 tttt -60.36 -34.47 73.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.955 174.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.06 -23.4 67.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -95.03 4.23 54.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.935 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.06 32.6 56.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.369 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -111.09 169.96 8.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 0.0 110.836 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.8 t -120.82 139.4 53.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 167.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -67.64 -44.02 78.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 -171.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -138.88 131.46 28.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 52.2 ttm -117.11 130.85 56.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -153.62 155.13 35.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -174.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -86.17 -51.98 5.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.78 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.038 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.5 tm? 48.34 31.71 2.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.919 -169.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -102.11 -9.02 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 176.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -129.71 152.39 79.7 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 121.726 0.774 . . . . 0.0 110.818 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.409 ' HB3' ' HB3' ' A' ' 340' ' ' TRP . 51.8 Cg_exo -55.01 -29.62 65.75 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.675 2.25 . . . . 0.0 112.343 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -68.45 -30.0 68.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -79.91 -41.05 26.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 172.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.435 HG23 HG11 ' A' ' 347' ' ' VAL . 19.4 m -60.8 -52.45 65.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.132 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.568 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 15.1 t-105 -59.23 -48.75 95.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.488 0.661 . . . . 0.0 110.907 -161.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 90.8 Cg_exo -52.25 -44.71 44.36 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.694 2.262 . . . . 0.0 112.355 -177.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.604 HD23 ' C ' ' A' ' 160' ' ' LEU . 7.7 tt -71.26 -40.09 71.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.826 -171.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 83.0 mt -71.08 -43.44 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.71 -22.0 60.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.158 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.49 -28.57 68.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.107 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -99.11 1.77 45.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.856 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 108.5 5.65 31.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.478 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.59 67.97 2.52 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.541 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -83.83 132.68 34.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.895 0.379 . . . . 0.0 110.999 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.38 6.77 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.134 -174.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.427 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.3 p90 -149.73 155.01 39.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.912 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 87.3 tttt -104.97 124.69 49.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 157.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -116.26 124.42 50.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -153.91 130.63 10.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.02 43.04 30.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.75 17.29 80.06 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.518 173.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.63 138.58 48.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.71 0.29 . . . . 0.0 110.866 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -96.99 144.69 26.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 169.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -123.51 111.66 16.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.583 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.1 pp -79.98 -12.74 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.55 -11.05 25.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.899 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 66.0 t0 -127.28 88.24 2.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 171.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 169' ' ' PHE . 32.7 m -116.13 166.92 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.063 -170.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.16 22.3 31.54 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.517 -170.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.479 HG21 HD12 ' A' ' 368' ' ' ILE . 1.5 m -105.47 -20.0 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.753 0.311 . . . . 0.0 111.083 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -86.48 21.16 2.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -104.96 -174.97 2.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 -175.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.9 -29.37 67.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.05 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.64 -40.18 77.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.437 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.499 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -62.57 -37.64 86.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.934 0.397 . . . . 0.0 111.162 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.593 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 88.6 mttt -62.92 -37.97 89.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 174.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.13 -36.99 85.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.079 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.42 -47.57 62.39 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.507 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.775 HD11 ' HA ' ' A' ' 347' ' ' VAL . 20.6 tp -66.41 -34.25 77.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 0.0 110.841 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.512 ' OG1' HG21 ' A' ' 357' ' ' VAL . 91.5 m -63.69 -40.68 97.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.227 174.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 61.8 t80 -67.15 -49.27 65.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 195' ' ' LEU . 7.2 tt -50.43 -51.69 44.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.884 -175.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 199' ' ' ILE . 35.2 m -63.9 -22.48 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.145 -174.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.5 m-20 -61.8 -34.58 76.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.412 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.9 OUTLIER -80.95 -40.15 24.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -173.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.6 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.7 pp -72.98 -29.76 30.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 172.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.91 -37.59 79.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.917 173.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -80.09 2.31 24.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 68.16 38.57 2.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.773 168.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -78.99 -17.33 55.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.823 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.6 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.2 ppp? -145.2 158.14 43.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.864 176.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -94.94 148.87 21.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.87 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.89 -25.75 67.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.169 -175.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -95.9 1.72 53.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 94.7 m -62.48 124.97 22.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.196 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.439 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 14.5 t0 -119.93 177.68 4.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -64.89 -37.38 87.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.035 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 96.1 p -70.32 -38.37 74.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.439 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 77.7 mt -65.09 -42.66 95.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.105 174.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.16 -36.18 83.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.046 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -61.5 -47.26 86.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.836 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.48 89.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.004 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.0 -44.87 87.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.141 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -62.75 -44.48 96.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.992 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -64.77 -31.86 73.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.885 -177.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -83.72 -15.82 47.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.55 26.43 30.1 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.551 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -84.83 -21.79 29.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 110.84 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.1 t -123.91 137.47 54.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.598 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -62.74 -48.57 78.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.009 177.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.752 ' HB3' HD21 ' A' ' 115' ' ' LEU . 71.7 mtm -134.19 160.01 39.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 -172.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.4 t -151.33 157.16 42.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.199 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 48.4 mm -111.55 129.14 67.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.164 -175.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -155.05 175.02 14.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -81.74 -159.15 23.6 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.449 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.82 -24.92 24.28 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.584 2.189 . . . . 0.0 112.348 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 51.5 m0 -75.0 -29.44 60.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.961 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 47.4 45.52 17.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 174.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -65.62 -17.63 64.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.964 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 91.1 p -74.93 -9.41 58.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.961 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -76.8 -171.31 1.88 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.4 mt . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 -173.821 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 88.9 t . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 120.858 0.361 . . . . 0.0 111.144 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -79.95 139.92 36.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.44 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 45.1 p90 -144.95 158.65 43.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.881 176.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.65 166.67 26.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.496 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.1 p -135.02 135.16 53.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.888 0.375 . . . . 0.0 111.125 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.63 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 9.5 t -159.37 142.53 14.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.082 175.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.0 m -63.89 168.31 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.065 -169.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 2.1 mp -68.71 155.55 92.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.562 0.696 . . . . 0.0 110.942 -161.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -77.93 -176.22 3.12 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.739 2.293 . . . . 0.0 112.353 -173.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 93.9 m -85.93 145.13 27.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.225 -173.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -130.56 113.33 14.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.799 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 54.94 34.63 22.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.81 -0.54 86.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.471 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -127.54 127.54 24.08 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.598 0.713 . . . . 0.0 110.863 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 249' ' ' THR . 81.2 Cg_exo -54.73 131.05 43.68 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.662 2.242 . . . . 0.0 112.351 -176.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 256' ' ' LYS . 96.0 p -83.77 1.36 43.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 172.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 97.8 mttt -37.09 130.2 0.76 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.512 0.672 . . . . 0.0 110.832 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.486 ' HB3' ' HB2' ' A' ' 113' ' ' LEU . 74.0 Cg_exo -61.56 155.91 50.38 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.66 2.24 . . . . 0.0 112.378 -169.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -74.98 165.15 25.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.845 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.88 126.76 69.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.192 -168.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -112.28 137.35 14.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.454 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 62.5 t -125.04 116.03 45.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 111.13 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.17 123.42 19.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.941 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 47.4 m -127.59 130.39 48.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.803 -168.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.01 136.17 52.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 -171.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.88 169.35 16.85 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.403 -171.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.908 HG13 ' HG2' ' A' ' 277' ' ' LYS . 31.2 mm -112.69 130.16 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 111.082 -174.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -63.37 126.02 26.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -60.6 -28.24 68.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.144 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.0 -6.52 59.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.074 -170.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.4 t -75.08 122.91 88.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.644 0.735 . . . . 0.0 110.868 -173.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -68.59 -12.59 35.14 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.727 2.285 . . . . 0.0 112.373 166.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.46 HD21 HD22 ' A' ' 275' ' ' LEU . 55.5 t30 -111.12 31.27 6.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.919 -168.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -60.84 -29.78 69.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -57.52 -40.11 78.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.692 HD23 HG13 ' A' ' 33' ' ' ILE . 8.6 mp -75.16 -45.67 39.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.963 174.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -62.7 -56.22 19.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.058 -171.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.908 ' HG2' HG13 ' A' ' 266' ' ' ILE . 91.7 mttt -60.92 -40.26 92.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.922 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.7 tt0 -71.0 -49.26 47.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.834 -173.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -67.16 -34.11 76.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.483 ' HA ' HD22 ' A' ' 284' ' ' LEU . 4.6 tt -62.46 -51.39 67.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.965 -175.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -77.88 -33.33 52.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 67.7 m-80 -98.72 -11.19 22.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -163.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.856 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 77.5 m-85 -129.67 -52.32 1.16 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.873 177.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.5 OUTLIER -62.81 -35.69 80.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -168.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 1.072 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.5 pp -123.96 37.76 4.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.885 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.435 ' CG2' ' N ' ' A' ' 287' ' ' ASP . 8.2 m -117.97 153.7 33.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.109 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.454 ' HA ' HD11 ' A' ' 290' ' ' LEU . 31.0 t70 -43.45 -36.38 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.85 -166.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -79.36 -40.62 29.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.856 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.14 -56.73 5.56 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.446 -171.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.647 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.1 -21.08 66.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 0.0 110.98 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.593 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.0 tt0 -66.74 -45.87 77.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.788 171.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.2 -46.64 88.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.102 -174.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -46.06 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.172 -175.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.511 ' HB2' HD22 ' A' ' 299' ' ' LEU . 43.2 t30 -63.38 -27.89 69.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.21 -27.59 68.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -91.14 -47.64 7.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.943 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -136.31 145.46 51.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.545 0.688 . . . . 0.0 110.93 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.6 110.08 1.78 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.729 2.286 . . . . 0.0 112.402 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.511 HD22 ' HB2' ' A' ' 294' ' ' ASN . 0.8 OUTLIER -82.02 -27.67 32.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 176.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 103.69 -58.55 0.52 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.419 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.598 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -169.25 165.02 10.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.915 0.388 . . . . 0.0 111.129 174.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 26.1 m -125.92 153.93 34.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.02 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.39 -10.88 60.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.143 173.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.647 ' CD2' HD21 ' A' ' 290' ' ' LEU . 51.4 tp -85.23 120.27 26.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.31 -39.96 76.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.948 -172.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 41.3 t -64.75 -51.36 62.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 -168.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.489 ' HB3' HG21 ' A' ' 302' ' ' VAL . 19.0 t80 -76.73 -29.04 56.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -64.34 -38.46 91.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.16 -37.24 82.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.91 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -74.25 -39.93 62.71 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.93 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.598 HD13 ' HA ' ' A' ' 301' ' ' ALA . 77.4 mt -60.05 -33.01 71.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 175.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.31 -19.58 61.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.08 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.73 -20.32 66.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -90.12 123.59 65.49 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.664 0.745 . . . . 0.0 110.807 167.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -47.93 -28.86 10.78 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.649 2.232 . . . . 0.0 112.377 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -61.75 -32.58 72.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.95 -173.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.585 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.4 mp -80.07 -35.53 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.082 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.1 -39.63 72.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.085 -174.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.16 75.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.051 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 82.6 p -59.82 -28.38 67.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.147 -174.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.3 mmm -66.36 -33.11 74.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.86 174.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -62.52 -47.43 83.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 -175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.656 HD21 ' HB1' ' A' ' 112' ' ' ALA . 14.4 p-10 -83.42 -25.92 30.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.06 -43.96 97.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -67.4 -35.03 78.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.84 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -106.03 -4.48 20.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.829 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.94 -170.02 39.89 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.534 -167.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -139.91 149.39 43.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.881 0.372 . . . . 0.0 110.805 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 42.9 mm -63.85 117.7 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.082 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 59.6 ttm . . . . . 0 C--N 1.33 -0.268 0 CA-C-O 121.463 0.649 . . . . 0.0 110.982 -176.033 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.806 0.336 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 40.4 tpp -73.6 -26.89 61.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.854 -170.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.0 m -57.37 -37.95 73.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.846 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.96 -36.12 59.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.011 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.524 ' O ' HG13 ' A' ' 343' ' ' VAL . 4.7 m-30 -66.87 -46.98 73.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.446 ' HA ' HG22 ' A' ' 343' ' ' VAL . 28.1 m0 -61.07 -32.5 72.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -66.92 -47.09 72.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.03 -40.36 94.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.163 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 339' ' ' PHE . 17.9 m -74.1 -30.83 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.128 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.491 ' O ' HG22 ' A' ' 347' ' ' VAL . 4.9 tmt_? -65.0 -38.98 92.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.2 m -58.22 -36.19 72.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.194 173.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.57 95.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.189 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.775 ' HA ' HD11 ' A' ' 192' ' ' LEU . 5.8 m -73.99 -35.01 40.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.191 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.458 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -62.44 -47.94 90.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.191 174.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -63.91 -39.18 93.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.05 -45.55 60.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.098 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.37 -39.86 77.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.0 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.8 p -75.58 -10.7 59.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.911 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.96 17.25 72.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.449 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.25 -33.29 43.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 0.0 110.907 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -138.63 154.4 48.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.4 p -77.19 169.89 17.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.18 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.512 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.5 t -56.53 -42.34 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 173.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -62.09 -45.62 92.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -69.94 -51.59 31.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -75.4 -51.79 12.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.188 -173.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.593 ' HG ' ' HA ' ' A' ' 189' ' ' LYS . 1.9 tm? -65.04 -48.97 71.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 -171.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.51 -52.83 61.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 -173.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -67.94 -48.65 65.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.808 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.25 85.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.156 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 66.3 mm-40 -78.04 -29.03 49.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.907 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 89.5 m -65.92 -33.96 77.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.178 170.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -56.39 -31.95 64.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.854 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.479 HD12 HG21 ' A' ' 183' ' ' VAL . 62.0 mt -59.02 -34.93 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.951 0.405 . . . . 0.0 111.191 173.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 69.9 p -95.07 -14.34 24.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 89.7 mttt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 177.096 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.729 0.3 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.455 HG21 ' HD2' ' A' ' 271' ' ' PRO . 60.1 mt -97.81 139.96 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.181 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -140.13 145.03 37.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.822 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.29 133.5 39.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.83 11.58 61.63 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.494 -175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.2 tttt -165.07 134.77 3.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.834 0.349 . . . . 0.0 110.944 177.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.585 ' CD2' HD11 ' A' ' 33' ' ' ILE . 1.6 pt? -144.0 152.71 41.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.94 -173.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 87.2 t -110.76 137.67 42.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.02 -177.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.716 HD11 HG13 ' A' ' 35' ' ' VAL . 1.1 mp -119.79 134.47 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.094 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.61 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 76.6 m95 -103.69 124.66 49.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 164.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.494 HD12 ' HG ' ' A' ' 20' ' ' LEU . 11.5 tt -108.83 150.04 11.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.052 -163.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -58.43 153.2 16.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 -174.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.38 -15.97 40.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.416 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -79.2 -13.28 59.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.866 0.365 . . . . 0.0 110.897 -172.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -139.96 129.2 23.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 163.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.52 -70.72 1.29 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.469 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -109.92 -39.19 5.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.958 0.409 . . . . 0.0 110.98 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -67.37 -52.28 41.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.871 -150.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.436 ' CA ' HG23 ' A' ' 293' ' ' VAL . . . -54.1 -50.35 55.78 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.565 -175.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.502 ' HB3' HG22 ' A' ' 37' ' ' VAL . 6.0 mt -55.08 -52.57 62.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.699 0.285 . . . . 0.0 110.933 171.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.48 -35.92 21.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.125 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -72.45 -59.99 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.413 HG22 ' HA ' ' A' ' 20' ' ' LEU . 21.5 m -71.64 -38.15 65.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.158 -172.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.55 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -65.64 -47.84 73.25 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.422 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -54.73 -35.65 63.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -57.93 -39.12 77.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.039 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 4.8 m-30 -62.9 -45.42 92.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 99.8 mt-10 -60.7 -36.96 80.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -71.24 -41.17 70.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.898 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -94.52 -47.81 6.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.889 -164.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.3 p -109.1 -7.83 15.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.18 -172.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.65 8.12 87.97 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.514 167.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.994 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.52 133.86 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 111.085 -179.074 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.2 mttt -72.02 136.0 46.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 -169.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.716 HG13 HD11 ' A' ' 9' ' ' ILE . 99.2 t -115.87 125.01 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.061 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.56 ' O ' HD12 ' A' ' 9' ' ' ILE . 95.5 m -109.93 130.02 55.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.067 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 20' ' ' LEU . 87.4 t -103.58 131.17 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.159 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -119.36 154.09 34.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 66.3 t-80 -88.25 139.93 30.41 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.694 0.759 . . . . 0.0 110.863 -167.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -55.02 -29.86 66.99 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.758 2.305 . . . . 0.0 112.335 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -49.03 -52.62 24.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.873 -172.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -90.07 0.68 57.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.832 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 43' ' ' LEU . 10.5 tt -45.86 -51.09 13.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.937 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -74.44 -40.37 61.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.862 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -80.44 -51.88 8.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.956 -164.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -83.33 -38.39 22.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.919 -170.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.606 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 83.9 t80 -49.83 -53.39 42.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.684 0.754 . . . . 0.0 110.872 -169.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 29.4 Cg_endo -61.19 -30.83 89.3 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.668 2.245 . . . . 0.0 112.331 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -73.08 -44.18 60.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.414 HG21 ' HD3' ' A' ' 57' ' ' PRO . 21.2 m -75.56 -24.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.112 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.13 78.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.054 174.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.11 -29.74 70.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.099 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.0 p -88.36 -14.54 37.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.11 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.44 14.72 81.72 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.477 168.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -135.39 129.39 33.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 110.816 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.47 -92.34 0.14 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.497 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.61 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 67.6 Cg_endo -79.36 148.0 20.71 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.68 2.253 . . . . 0.0 112.375 -177.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -107.52 -32.09 7.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.798 165.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.55 ' HB ' HG23 ' A' ' 9' ' ' ILE . 57.6 mt -128.11 137.53 57.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.169 -176.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 10' ' ' TRP . 6.3 tp -132.64 127.13 55.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -92.55 128.21 38.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.771 170.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -114.38 145.15 42.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.994 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.58 -83.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.036 -168.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.0 m170 -120.81 -65.85 1.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.835 174.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -99.98 -16.54 17.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.84 -167.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -61.36 -6.31 2.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -165.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.461 ' O ' ' HB3' ' A' ' 70' ' ' TYR . 31.5 p90 -59.08 -25.58 63.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 173.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.47 -48.36 86.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.46 -174.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.04 -32.16 83.25 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.515 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.716 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 2.3 t80 -54.96 -51.71 65.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.857 0.36 . . . . 0.0 110.931 175.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.92 -42.98 56.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.164 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -56.1 -38.94 71.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.967 -175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.0 m -83.68 -7.65 59.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.93 31.1 58.39 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.582 172.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 63.4 mt -88.86 -5.01 58.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.859 0.362 . . . . 0.0 110.972 -165.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.716 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -128.01 154.3 45.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.912 -171.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.19 144.58 29.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.086 167.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -65.1 136.18 56.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.884 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.405 HD12 ' CZ ' ' A' ' 106' ' ' TYR . 42.3 pt -100.12 151.54 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.09 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.5 m -96.15 126.5 44.06 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.585 0.707 . . . . 0.0 111.09 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.07 134.06 61.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.637 2.225 . . . . 0.0 112.349 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -103.22 119.71 39.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.99 -41.66 99.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.794 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.73 -44.75 89.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.1 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -75.0 -32.3 61.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.486 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 67.0 tt0 -53.48 -49.71 66.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.936 174.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.35 -32.63 72.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.894 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.39 -20.3 54.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.828 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.86 -106.54 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -172.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 29.2 t80 171.52 129.51 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.687 0.756 . . . . 0.0 110.973 -168.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -52.82 -36.01 72.16 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.762 2.308 . . . . 0.0 112.39 -173.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -64.91 -36.5 84.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -173.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.2 p -73.83 -30.35 62.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.17 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.588 ' HA ' HG22 ' A' ' 97' ' ' VAL . 80.7 m95 -67.27 -30.03 69.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 173.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.62 -31.31 68.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.827 174.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.07 -24.27 61.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.106 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.588 HG22 ' HA ' ' A' ' 94' ' ' TRP . 20.0 m -107.8 16.01 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.143 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -101.56 136.25 41.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -136.43 117.35 14.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 173.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 60.56 36.05 19.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.868 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.49 2.19 89.03 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.51 172.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -127.97 149.87 50.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.825 0.345 . . . . 0.0 110.875 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.51 HD22 HG23 ' A' ' 97' ' ' VAL . 15.3 mt -86.01 135.49 33.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.838 -175.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -122.15 -1.52 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.026 -170.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.89 165.86 20.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.405 ' CZ ' HD12 ' A' ' 79' ' ' ILE . 97.1 m-85 -114.35 145.05 32.92 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.604 0.716 . . . . 0.0 110.926 170.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.21 125.23 7.0 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.686 2.257 . . . . 0.0 112.304 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.092 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp -106.29 -39.91 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.194 177.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -143.19 150.9 40.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.11 -167.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.3 t -114.69 130.89 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.164 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -120.53 119.89 34.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -150.06 144.95 26.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.068 -173.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.6 mp -89.88 170.04 10.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.973 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.0 p -158.81 157.98 32.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.91 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.88 127.03 46.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.924 170.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.566 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.2 mp -110.3 130.32 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.14 -175.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -128.39 146.52 50.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -92.75 115.0 27.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.806 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.435 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.9 mttt -65.66 -23.26 66.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.917 -175.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -78.68 -25.23 44.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.811 -175.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.7 mp -84.26 -49.24 8.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.871 174.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.643 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -143.67 128.5 9.61 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.743 0.782 . . . . 0.0 110.832 174.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.72 -9.03 15.89 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.634 2.223 . . . . 0.0 112.366 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -143.19 97.01 5.75 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.64 0.733 . . . . 0.0 110.812 -174.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.26 156.04 62.92 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.746 2.297 . . . . 0.0 112.365 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.43 144.95 63.34 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.748 2.299 . . . . 0.0 112.314 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.18 -17.16 28.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.89 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 71.5 p -130.71 157.68 42.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.192 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.498 ' HA ' HD13 ' A' ' 132' ' ' ILE . 57.0 m95 -68.83 -28.94 67.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.951 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.04 -22.13 66.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.85 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.84 -24.25 41.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.624 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -55.88 -50.05 89.44 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.676 0.751 . . . . 0.0 111.197 -172.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.8 Cg_endo -68.24 -39.11 10.74 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.622 2.215 . . . . 0.0 112.376 -173.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.02 -60.15 3.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.263 HD22 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.28 -17.01 63.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.989 -175.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.513 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.8 t70 -58.47 -40.42 82.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.848 168.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.07 -30.75 69.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.49 -46.42 54.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.773 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.638 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.0 pp -84.86 -14.35 48.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.964 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.638 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.7 tttt -61.15 -34.41 74.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.955 174.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.95 -23.44 67.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -94.96 3.62 54.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.921 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.48 33.16 53.45 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.56 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -111.75 169.95 8.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 0.0 110.867 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.0 t -121.12 140.22 52.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.917 168.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.429 ' HA ' HD21 ' A' ' 139' ' ' LEU . . . -66.69 -40.37 88.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.112 -172.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -144.53 130.59 19.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 55.2 ttm -118.18 132.92 56.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -153.53 157.35 39.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -173.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -84.93 -54.64 4.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.94 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.819 HD13 ' O ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER 49.28 30.72 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.022 -168.362 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -103.45 -4.35 24.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -129.91 156.53 78.88 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.59 0.71 . . . . 0.0 110.952 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.406 ' HD3' ' HD2' ' A' ' 344' ' ' ARG . 40.3 Cg_endo -60.76 -24.37 78.7 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.684 2.256 . . . . 0.0 112.321 174.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -68.23 -30.02 68.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.822 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -84.27 -38.31 20.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.844 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.433 HG23 HG11 ' A' ' 347' ' ' VAL . 23.0 m -61.11 -47.23 87.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.979 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.579 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 39.2 t-105 -56.96 -54.58 52.96 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.534 0.683 . . . . 0.0 110.949 -169.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 31.2 Cg_endo -65.83 -19.63 58.78 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.731 2.287 . . . . 0.0 112.41 -174.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.718 HD13 ' C ' ' A' ' 160' ' ' LEU . 1.3 tm? -81.63 -45.29 16.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.505 HG22 ' HA3' ' A' ' 166' ' ' GLY . 80.1 mt -74.23 -43.3 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.116 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.9 -22.57 64.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.099 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -58.87 -32.28 69.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.172 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -100.87 1.13 39.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 112.29 5.48 24.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.492 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.505 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -77.2 69.6 2.48 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.509 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -87.36 132.64 33.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.86 0.362 . . . . 0.0 110.98 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.75 10.34 9.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.154 -171.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.433 ' HA ' HG12 ' A' ' 181' ' ' VAL . 52.8 p90 -158.13 152.34 24.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -93.28 128.38 39.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.816 159.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -118.08 121.57 40.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.827 172.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.02 130.05 11.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.901 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.02 41.83 31.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.842 174.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.37 17.52 79.75 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.533 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.01 139.35 51.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.768 0.318 . . . . 0.0 110.86 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -98.88 145.01 27.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -128.32 108.95 11.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.874 174.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.572 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.3 pp -79.1 -8.52 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.131 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -100.27 -12.31 19.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 -177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -119.49 85.81 2.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 170.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 169' ' ' PHE . 27.4 m -114.28 161.3 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 -170.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.02 22.66 32.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.495 -172.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.515 HG21 HD12 ' A' ' 368' ' ' ILE . 6.8 m -107.37 -17.05 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.772 0.32 . . . . 0.0 111.112 -178.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -87.04 20.47 2.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -119.97 -171.51 2.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.91 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.29 -29.71 69.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.106 -173.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.7 -41.41 95.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.484 -167.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.611 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.24 -38.06 89.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.972 0.415 . . . . 0.0 111.093 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.577 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 96.8 mttt -62.04 -37.82 86.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.943 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.07 -37.91 89.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.074 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.415 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -66.2 -46.47 79.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.576 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.664 HD11 ' HA ' ' A' ' 347' ' ' VAL . 27.3 tp -65.08 -35.92 82.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 110.855 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.408 ' OG1' HG21 ' A' ' 357' ' ' VAL . 90.0 m -64.52 -41.17 96.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.151 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 65.0 t80 -66.32 -47.94 71.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.861 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.673 HD23 ' C ' ' A' ' 195' ' ' LEU . 5.2 tt -50.32 -51.56 44.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.963 -175.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.431 ' HA ' ' CG1' ' A' ' 199' ' ' ILE . 27.9 m -65.04 -21.61 29.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.075 -173.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.0 m-20 -62.59 -33.92 75.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.802 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.9 OUTLIER -81.21 -39.9 24.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.959 -174.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.576 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.6 pp -73.95 -26.99 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.07 172.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.25 -38.23 84.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 170.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -80.95 2.92 24.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 176.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 66.53 37.68 4.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 56.0 m170 -77.58 -18.94 56.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.819 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.576 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.1 ppp? -144.14 156.95 44.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -95.02 152.0 18.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.14 -26.93 68.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -95.5 1.73 54.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.813 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.1 m -63.84 126.08 26.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.101 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.438 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 16.9 t0 -120.05 174.28 6.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.843 177.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -64.98 -37.0 86.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.969 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.8 p -70.45 -37.52 74.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.438 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 80.3 mt -65.01 -42.48 94.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.077 173.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.68 81.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.06 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.0 -45.04 94.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.865 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.8 -41.44 95.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.096 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.86 -42.86 97.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.058 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -63.8 -39.67 94.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.936 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -64.33 -35.73 81.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -83.59 -20.02 34.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.982 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.84 25.83 33.71 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.418 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -84.79 -21.65 29.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.976 0.417 . . . . 0.0 110.902 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.2 t -124.45 136.81 54.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.076 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.588 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -65.03 -47.68 76.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.061 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.522 ' HB3' HD21 ' A' ' 115' ' ' LEU . 71.8 mtm -134.49 158.32 44.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -174.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 60.8 p -139.73 161.29 37.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.171 172.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.2 mm -110.75 127.18 67.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.03 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -154.95 175.04 14.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.957 -172.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -88.64 -156.87 31.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.523 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -22.26 32.28 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.66 2.24 . . . . 0.0 112.384 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -78.36 -24.93 46.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 48.76 51.95 14.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.175 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -60.04 -23.94 64.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 61.3 m -50.05 -43.95 51.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -87.0 176.7 7.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 -172.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.7 mp . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.211 -171.698 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.9 m . . . . . 0 C--O 1.232 0.144 0 CA-C-O 120.834 0.35 . . . . 0.0 111.129 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -108.29 128.28 54.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.435 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 50.2 p90 -145.21 158.21 43.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.92 162.35 25.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.387 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.1 p -135.72 135.32 51.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 111.142 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.7 t -154.39 148.75 26.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.9 167.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.173 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 1.022 HD23 ' HD3' ' A' ' 257' ' ' PRO . 2.6 mm? -63.1 149.53 90.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.575 0.702 . . . . 0.0 110.961 -164.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.84 -176.33 3.11 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.691 2.261 . . . . 0.0 112.382 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 96.8 m -92.47 145.17 24.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.057 -172.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -130.91 113.26 13.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.933 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 55.0 36.59 27.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.815 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.43 2.79 84.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.494 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -131.36 130.62 22.61 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.539 0.685 . . . . 0.0 110.843 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 249' ' ' THR . 22.9 Cg_endo -65.42 133.93 36.7 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.715 2.277 . . . . 0.0 112.324 -173.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.604 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 97.0 p -84.52 0.19 50.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.766 173.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -37.4 135.02 0.73 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.522 0.677 . . . . 0.0 110.9 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 1.022 ' HD3' HD23 ' A' ' 247' ' ' LEU . 38.0 Cg_endo -80.05 157.85 23.66 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.729 2.286 . . . . 0.0 112.336 -166.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -75.09 169.67 17.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.53 129.67 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 -166.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.96 137.7 14.48 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.369 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 76.9 t -125.36 117.11 48.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.806 0.336 . . . . 0.0 111.207 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -65.27 119.73 11.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 178.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.9 m -126.4 126.61 44.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.79 -167.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -125.67 137.07 53.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.041 -171.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -131.42 171.44 21.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.486 -170.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.846 HG13 ' HG2' ' A' ' 277' ' ' LYS . 25.0 mm -113.41 126.17 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.81 0.338 . . . . 0.0 111.297 -171.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -61.27 131.12 49.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.464 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -59.81 -26.17 65.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.125 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.21 -8.49 57.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 -173.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.8 t -70.81 127.16 92.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.674 0.75 . . . . 0.0 110.913 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.455 ' HD2' HG21 ' A' ' 2' ' ' ILE . 74.1 Cg_endo -72.87 -10.46 24.83 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.658 2.239 . . . . 0.0 112.401 165.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -104.04 19.09 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -169.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -54.09 -34.91 61.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.925 -171.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.14 -52.43 63.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.6 pp -84.36 -27.97 27.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.924 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.81 -50.51 56.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.06 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.846 ' HG2' HG13 ' A' ' 266' ' ' ILE . 96.1 mttt -59.74 -38.49 81.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.839 173.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.7 tt0 -68.45 -48.25 65.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -175.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -67.59 -35.37 78.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.497 ' HA ' HD22 ' A' ' 284' ' ' LEU . 7.3 tt -61.8 -51.96 66.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.892 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -78.15 -31.5 49.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.836 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 63.8 m-80 -99.46 -11.61 20.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.848 -165.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.918 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 66.6 m-85 -129.95 -52.82 1.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.497 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.6 OUTLIER -62.73 -36.74 83.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.912 -169.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 1.092 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.6 pp -124.27 37.63 4.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.979 176.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.457 ' CG2' ' N ' ' A' ' 287' ' ' ASP . 4.1 m -116.08 154.91 29.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.099 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.501 ' HA ' HD11 ' A' ' 290' ' ' LEU . 33.0 t70 -42.93 -37.42 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.796 -167.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -78.03 -40.81 37.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.971 -176.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.918 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.06 -57.16 5.37 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 -172.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.584 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.1 -21.17 66.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.34 . . . . 0.0 110.974 -178.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.581 ' N ' HD12 ' A' ' 290' ' ' LEU . 84.6 tt0 -67.44 -45.1 77.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 170.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.81 95.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.131 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.436 HG23 ' CA ' ' A' ' 19' ' ' GLY . 1.4 p -80.03 -30.0 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.11 -174.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -70.12 -27.17 64.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 172.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.32 -25.79 67.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.927 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.95 -51.28 8.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -143.2 152.7 58.47 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 121.615 0.722 . . . . 0.0 110.847 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -62.17 116.4 3.46 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.771 2.314 . . . . 0.0 112.298 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 299' ' ' LEU . 0.2 OUTLIER -87.55 -18.58 29.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 176.194 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 103.64 -58.55 0.52 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.525 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.639 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -170.73 164.76 8.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 111.138 175.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 21.7 m -124.23 156.08 31.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.101 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.22 -11.02 59.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.109 172.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.584 ' CD2' HD21 ' A' ' 290' ' ' LEU . 47.3 tp -83.2 122.06 27.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -175.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.32 -39.15 75.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 46.5 t -64.73 -49.95 68.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.881 -168.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.468 ' HB3' HG21 ' A' ' 302' ' ' VAL . 18.4 t80 -81.62 -29.07 33.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -61.95 -39.73 93.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.831 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -59.39 -38.21 79.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -73.7 -38.49 64.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.639 HD13 ' HA ' ' A' ' 301' ' ' ALA . 78.5 mt -62.82 -32.91 74.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.26 -18.83 62.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.113 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.06 -20.07 66.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 174.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -91.34 121.07 68.11 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.636 0.731 . . . . 0.0 110.87 166.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.98 -26.76 7.91 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.756 2.304 . . . . 0.0 112.313 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -61.76 -35.63 78.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.873 -175.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.545 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.1 mp -80.12 -32.6 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.076 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.4 -40.09 85.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 -172.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.17 -46.25 74.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.108 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 81.2 p -64.97 -29.21 70.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.066 -174.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.5 mtp -63.7 -34.38 77.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.6 tp10 -64.75 -47.7 77.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -173.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.522 HD21 ' HB1' ' A' ' 112' ' ' ALA . 8.9 p-10 -82.14 -28.01 32.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.864 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.01 -50.24 67.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.011 -175.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -69.25 -29.92 67.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.922 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -108.2 -8.55 15.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 -169.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.13 -153.55 29.99 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.43 -166.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -147.33 143.69 28.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.796 0.332 . . . . 0.0 110.902 -170.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 44.4 mm -61.76 124.01 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.092 -167.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 95.5 mtp . . . . . 0 C--N 1.33 -0.262 0 CA-C-O 121.49 0.662 . . . . 0.0 110.969 -177.838 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.804 0.335 . . . . 0.0 110.85 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 69.1 mmm -80.01 -17.83 51.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.826 -172.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 47.6 t -62.18 -41.99 98.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.831 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.49 -37.04 63.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.156 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.429 ' O ' HG13 ' A' ' 343' ' ' VAL . 7.4 m-30 -66.28 -36.29 82.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -54.93 -37.9 66.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.982 172.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -71.79 -38.05 70.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.939 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.92 -42.81 80.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.105 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 339' ' ' PHE . 21.4 m -72.72 -31.36 36.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.184 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.425 ' O ' HG22 ' A' ' 347' ' ' VAL . 74.0 ttt-85 -61.67 -40.93 96.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 175.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.0 m -55.76 -36.14 66.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.186 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.13 -46.19 81.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.084 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.664 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.4 m -75.55 -34.78 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.199 -172.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.448 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -62.42 -48.01 90.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.21 -37.94 88.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.32 -46.61 60.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.66 81.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.053 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.2 p -75.74 -11.88 60.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.981 0.419 . . . . 0.0 110.927 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.57 18.02 69.46 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.424 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.83 -32.95 46.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.757 0.313 . . . . 0.0 110.848 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -140.08 157.01 46.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 50.0 p -77.27 165.76 24.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.159 169.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.408 HG21 ' OG1' ' A' ' 193' ' ' THR . 55.4 t -54.94 -42.7 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.167 174.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.04 -44.13 96.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.832 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -69.38 -54.0 16.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -69.37 -47.78 63.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.5 tm? -64.95 -45.03 87.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.96 -174.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -65.41 -53.04 48.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.945 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -69.64 -45.68 67.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -173.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.23 -42.87 83.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.075 -174.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 85.6 mm-40 -72.49 -30.96 64.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.979 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 55.5 m -59.01 -32.59 69.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.093 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -57.11 -29.94 63.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.515 HD12 HG21 ' A' ' 183' ' ' VAL . 69.8 mt -59.72 -39.6 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 175.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.3 p -94.78 -14.98 24.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.808 179.074 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.745 0.307 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.459 HG21 ' HD2' ' A' ' 271' ' ' PRO . 83.2 mt -97.54 133.05 40.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.179 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -144.97 146.8 32.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.97 132.99 48.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.1 7.74 63.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.406 -176.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.1 tttt -164.44 134.67 4.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.744 0.306 . . . . 0.0 110.959 176.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.663 HD22 HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -141.72 154.81 45.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.956 -172.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.424 HG22 ' HB ' ' A' ' 36' ' ' THR . 77.3 t -113.59 135.74 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.133 -177.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.635 HG23 ' HB ' ' A' ' 59' ' ' ILE . 1.4 mp -119.65 133.97 64.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.735 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 74.9 m95 -105.18 124.24 49.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.943 166.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.484 HD12 ' HG ' ' A' ' 20' ' ' LEU . 13.6 tt -110.35 149.97 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.146 -167.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -64.52 158.63 23.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.756 -171.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.36 -16.07 26.43 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.511 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -68.25 -29.9 68.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.883 0.373 . . . . 0.0 110.853 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -139.18 130.02 26.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.845 166.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.16 -80.14 1.01 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.468 -172.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -96.72 -42.36 8.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.941 0.401 . . . . 0.0 110.97 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -67.59 -49.93 60.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.837 -153.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.12 -56.97 20.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.407 -176.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.545 ' HB3' HG22 ' A' ' 37' ' ' VAL . 5.5 mt -51.72 -46.48 63.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.797 0.332 . . . . 0.0 110.923 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.04 -37.48 45.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.061 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -75.68 -60.04 2.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.972 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 m -71.94 -36.61 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.171 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.46 -40.84 99.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.477 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -61.04 -31.24 70.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.928 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -50.0 -39.94 42.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.919 172.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 0.9 OUTLIER -54.97 -49.24 71.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 176.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -71.75 -34.92 69.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.899 -174.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.23 -37.99 84.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.958 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -95.2 -47.29 6.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 -168.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.8 p -115.1 -5.96 12.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.197 -169.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.53 4.9 85.44 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.377 169.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.989 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -89.73 132.36 34.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.826 0.346 . . . . 0.0 111.078 -179.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.4 mttt -70.03 136.73 50.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 -170.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.494 HG23 HD11 ' A' ' 9' ' ' ILE . 9.8 p -112.76 134.32 55.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.067 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.501 ' O ' HD12 ' A' ' 9' ' ' ILE . 99.3 m -113.19 129.24 56.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.124 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 20' ' ' LEU . 84.8 t -102.41 128.43 55.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.204 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -120.12 152.0 38.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.919 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -91.64 150.62 41.32 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.566 0.698 . . . . 0.0 110.823 -166.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.544 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 37.1 Cg_endo -68.92 -19.62 39.97 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.611 2.207 . . . . 0.0 112.39 -175.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -54.13 -49.02 70.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -174.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -89.58 -9.1 51.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.586 ' C ' HD23 ' A' ' 43' ' ' LEU . 8.3 tt -48.64 -53.86 16.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 -168.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.77 -35.37 80.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.852 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -70.13 -36.4 74.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.857 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.403 ' O ' HG22 ' A' ' 50' ' ' VAL . 74.7 mmtt -80.64 -24.54 38.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.579 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 86.3 t80 -49.45 -50.6 64.53 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 0.0 110.877 -163.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 46.2 Cg_endo -82.58 -32.08 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.648 2.232 . . . . 0.0 112.391 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -77.22 -44.17 30.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.867 -165.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.517 HG21 ' HG3' ' A' ' 57' ' ' PRO . 24.8 m -70.31 -27.72 32.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.075 -173.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.624 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -71.85 -35.19 69.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.042 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.48 -32.56 73.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.106 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.7 p -89.13 -18.87 26.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.11 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.94 8.77 78.79 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.49 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -128.18 130.01 47.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 110.827 174.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.97 -91.57 0.13 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.554 169.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.735 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 77.4 Cg_endo -80.07 146.92 18.41 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.349 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -94.25 -35.03 12.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.777 161.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.635 ' HB ' HG23 ' A' ' 9' ' ' ILE . 29.4 mt -127.03 138.48 54.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.173 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 tp -133.23 127.39 54.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.101 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -87.94 140.7 29.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.508 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 24.2 p90 -145.11 160.83 40.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.001 170.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.73 -87.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.113 -166.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -127.19 -68.41 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -171.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -99.33 -10.65 22.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.839 -162.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -56.11 -19.07 11.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -169.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.522 ' HB2' HD13 ' A' ' 104' ' ' ILE . 36.0 p90 -57.67 -31.45 66.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.851 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.76 -52.32 53.13 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.572 -171.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.92 -35.99 85.64 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.528 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.617 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 11.1 t80 -66.87 -41.73 86.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.726 0.298 . . . . 0.0 110.902 -176.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -39.87 67.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 174.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -58.51 -35.9 72.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.928 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.415 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 64.5 m -87.67 -5.01 58.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.01 31.25 58.05 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.526 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.624 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 53.6 mt -87.73 -12.06 46.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -169.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.617 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -129.08 151.66 49.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.934 -178.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.415 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -78.95 140.83 37.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.021 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -74.16 141.43 45.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.836 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.402 HD12 ' CZ ' ' A' ' 106' ' ' TYR . 42.7 pt -110.45 162.84 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.125 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 p -107.25 149.91 39.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 111.119 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.14 141.22 35.7 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.624 2.216 . . . . 0.0 112.417 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -105.26 120.02 40.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.928 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.22 -42.0 98.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.841 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.9 91.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.154 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -74.3 -32.89 63.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.471 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 65.1 tt0 -54.88 -50.09 69.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.043 176.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.36 -30.33 70.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.751 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -78.86 -20.03 50.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.18 -104.92 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -172.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 22.4 t80 172.12 129.47 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.704 0.764 . . . . 0.0 110.885 -169.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.63 -37.59 83.58 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.647 2.231 . . . . 0.0 112.356 -174.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -65.22 -34.06 77.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -173.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.9 p -75.5 -31.01 60.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.079 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.575 ' HA ' HG22 ' A' ' 97' ' ' VAL . 88.6 m95 -65.54 -30.01 70.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.935 173.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -69.56 -32.07 70.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.55 -26.24 62.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.626 HG23 HD22 ' A' ' 103' ' ' LEU . 18.5 m -108.28 16.88 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 -175.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -104.71 135.76 45.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -132.45 117.47 18.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.7 t30 58.68 35.07 24.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.818 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.62 -0.85 89.19 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.588 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.11 145.11 50.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.356 . . . . 0.0 110.843 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.626 HD22 HG23 ' A' ' 97' ' ' VAL . 28.8 mt -80.86 139.14 36.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -172.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.522 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.8 pp -123.46 -2.7 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.096 -174.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.508 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -161.74 165.29 28.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.152 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.402 ' CZ ' HD12 ' A' ' 79' ' ' ILE . 90.2 m-85 -114.31 144.47 31.77 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.646 0.736 . . . . 0.0 110.93 170.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.57 122.26 5.45 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.606 2.204 . . . . 0.0 112.326 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.009 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -106.49 -36.64 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.205 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -144.44 150.86 38.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.183 -169.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.6 t -120.33 134.91 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.134 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -124.97 136.78 54.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.845 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.628 ' HB1' HD21 ' A' ' 323' ' ' ASN . . . -151.89 145.78 25.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 176.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -85.57 164.16 17.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.7 p -157.22 154.86 29.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.913 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -95.92 127.04 41.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.96 169.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.605 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.2 mp -110.02 133.17 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -133.63 148.85 51.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -90.92 115.14 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.861 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.508 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.3 mttt -63.06 -22.75 67.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.979 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.34 -25.42 51.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -88.33 -52.9 4.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.674 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -141.74 126.13 10.26 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.725 0.774 . . . . 0.0 110.844 174.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -81.92 -2.32 11.27 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.671 2.247 . . . . 0.0 112.293 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -150.78 102.6 3.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.61 0.719 . . . . 0.0 110.812 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.64 156.74 60.46 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.667 2.245 . . . . 0.0 112.375 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -66.45 145.08 75.91 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.663 2.242 . . . . 0.0 112.251 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -81.27 -18.28 46.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.8 p -133.92 159.0 42.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.2 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.442 ' HE1' ' HG ' ' A' ' 255' ' ' SER . 69.6 m95 -72.08 -29.95 64.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.85 -20.35 66.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.864 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -77.69 -27.24 50.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.547 ' HA ' HD12 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -55.24 -47.22 99.07 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.57 0.7 . . . . 0.0 111.152 -169.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.466 ' N ' HG22 ' A' ' 132' ' ' ILE . 81.9 Cg_exo -51.15 -49.31 17.5 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.695 2.263 . . . . 0.0 112.377 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.67 -58.39 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.149 -176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.247 HD22 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.34 -17.64 64.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 -173.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.575 ' N ' HD13 ' A' ' 135' ' ' LEU . 34.3 t70 -60.28 -41.83 94.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.869 168.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.38 -30.83 69.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -70.4 -47.39 61.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.65 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.9 pp -85.0 -14.38 47.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.65 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.9 tttt -61.75 -34.7 76.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 174.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.96 -23.2 67.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.06 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -95.03 5.0 53.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.918 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 31.89 57.32 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.463 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -110.36 170.14 8.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.857 0.361 . . . . 0.0 110.832 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.6 t -123.29 140.41 53.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 166.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -65.62 -41.24 92.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.144 -172.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -144.45 128.4 17.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 98.3 mmm -106.73 134.43 49.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -157.82 161.92 38.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 -175.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -96.64 -47.61 5.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.154 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.1 tm? 46.17 33.47 1.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 -168.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -99.43 -7.75 25.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -118.86 153.82 52.71 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.7 0.762 . . . . 0.0 110.917 -174.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.26 -24.46 50.88 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.669 2.246 . . . . 0.0 112.354 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -75.53 -29.88 59.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.832 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -83.04 -31.53 27.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.843 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.6 m -58.48 -43.29 88.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.046 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.568 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 43.9 t-105 -58.14 -55.63 43.37 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.532 0.682 . . . . 0.0 110.85 -171.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.598 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 23.7 Cg_endo -64.23 -18.64 64.08 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.682 2.255 . . . . 0.0 112.416 -174.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.713 HD13 ' C ' ' A' ' 160' ' ' LEU . 1.7 tm? -82.3 -45.55 14.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.897 177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.579 HG22 ' HA3' ' A' ' 166' ' ' GLY . 85.4 mt -75.48 -44.65 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.052 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.17 -23.35 60.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.05 -173.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -58.98 -35.27 72.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -171.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.7 p30 -103.06 8.42 38.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 118.52 3.76 14.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.442 171.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.579 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -76.78 65.87 2.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.507 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -89.32 135.01 33.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.855 0.36 . . . . 0.0 110.945 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.23 0.45 36.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.223 -174.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -152.13 141.65 21.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -176.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 37.9 tptt -72.68 135.69 45.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.998 156.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -124.69 116.38 22.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.922 164.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -147.77 118.47 7.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 53.51 38.17 27.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.35 23.96 74.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.519 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -127.26 139.22 53.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.854 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -97.47 120.61 38.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 171.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -110.86 105.13 13.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.845 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.4 tp -63.51 -17.34 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.063 -174.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.95 -7.54 48.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.941 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 48.8 t0 -130.87 60.35 1.65 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 29.0 m -107.93 167.56 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.115 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -102.61 5.22 51.15 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.562 -166.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' A' ' 365' ' ' GLN . 0.8 OUTLIER -101.25 -25.49 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 111.096 -168.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -93.65 24.96 3.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 173.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -116.71 176.12 5.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.15 -27.25 68.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.047 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.87 -40.69 97.44 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.521 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.59 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.05 -37.85 88.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.997 0.427 . . . . 0.0 111.19 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.586 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 90.5 mttt -62.38 -37.62 86.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.813 175.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.07 89.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.099 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.484 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -66.99 -47.99 62.66 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.535 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.518 HD11 ' HA ' ' A' ' 347' ' ' VAL . 27.4 tp -65.95 -35.25 80.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.904 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.528 ' OG1' HG21 ' A' ' 357' ' ' VAL . 93.4 m -64.97 -43.29 93.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.186 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 91.4 t80 -67.81 -47.12 69.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.723 HD23 ' C ' ' A' ' 195' ' ' LEU . 4.7 tt -50.39 -50.38 51.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 199' ' ' ILE . 35.7 m -65.04 -22.45 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.15 -174.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.9 m-20 -61.86 -33.14 73.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.431 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.8 OUTLIER -81.16 -40.07 24.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.876 -173.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 196' ' ' VAL . 1.6 pp -72.65 -29.76 31.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 171.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -68.22 -38.14 81.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -82.67 3.67 28.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.847 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 66.36 40.22 3.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.832 170.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -76.73 -14.93 59.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.767 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -142.0 154.58 45.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.865 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -94.6 155.0 17.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.902 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.86 -27.71 68.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.044 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -96.04 0.14 51.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.817 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.2 m -63.26 135.06 56.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.061 -176.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -142.62 174.41 10.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.991 176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -61.94 -41.58 98.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.975 0.416 . . . . 0.0 111.014 -175.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.0 m -62.25 -40.45 96.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.883 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 66.3 mt -64.94 -43.66 96.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.122 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.86 -34.24 77.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -61.83 -47.79 83.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.928 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.59 95.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.088 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.67 -44.27 90.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -64.81 -39.9 94.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -64.83 -34.2 77.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -86.29 -16.77 36.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.828 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.85 28.31 29.3 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.502 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -84.07 -22.77 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.923 0.392 . . . . 0.0 110.861 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 67.4 p -130.91 144.02 51.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.503 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -66.55 -60.99 2.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.058 -173.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.516 ' HB3' HD21 ' A' ' 115' ' ' LEU . 59.4 mtm -134.62 158.5 43.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 -166.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.4 t -150.43 157.29 42.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.26 126.98 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.182 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -154.62 174.26 15.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -172.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -85.11 -158.29 29.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.52 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.87 -23.66 40.98 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.677 2.251 . . . . 0.0 112.404 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -78.04 -30.38 49.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.914 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 45.69 49.91 11.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -59.98 -24.0 64.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.6 p -79.01 -5.22 53.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -81.03 -174.95 5.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 89.5 mt . . . . . 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.172 -177.897 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 99.6 t . . . . . 0 N--CA 1.456 -0.133 0 CA-C-O 120.822 0.344 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -88.09 147.91 24.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.508 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 49.3 p90 -145.9 163.23 35.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.967 178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -128.78 158.0 21.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.446 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.39 135.28 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 111.111 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.4 t -153.73 149.86 27.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.132 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.2 m -61.23 163.4 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.157 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.484 HD12 ' N ' ' A' ' 247' ' ' LEU . 3.9 mp -69.1 150.01 97.55 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.59 0.71 . . . . 0.0 111.049 -164.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.56 -176.4 2.95 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.809 2.339 . . . . 0.0 112.366 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.4 m -84.25 143.15 29.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.161 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -130.08 112.79 13.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 55.16 35.78 25.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.41 0.97 84.17 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.534 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.414 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 91.4 mm-40 -125.73 125.82 24.93 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.496 0.665 . . . . 0.0 110.914 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 73.0 Cg_exo -54.54 132.82 53.4 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.736 2.291 . . . . 0.0 112.312 -178.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.442 ' HG ' ' HE1' ' A' ' 129' ' ' TRP . 66.7 m -81.14 -4.97 57.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.862 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -39.69 129.45 1.47 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.547 0.689 . . . . 0.0 110.874 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -82.19 164.16 17.33 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.758 2.305 . . . . 0.0 112.287 -164.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -74.96 170.04 16.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 29.2 t -114.46 134.4 57.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.207 -168.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -115.18 135.09 12.02 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.416 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.8 t -125.64 117.43 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.773 0.321 . . . . 0.0 111.19 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -66.13 122.92 18.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.914 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 45.2 m -125.43 132.26 52.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 -168.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.92 137.5 53.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.118 -174.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.9 173.99 21.31 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.377 -171.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.2 mm -113.3 130.68 66.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.702 0.287 . . . . 0.0 111.166 -172.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -62.36 129.48 40.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.456 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -59.58 -29.33 67.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.9 -6.07 59.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.081 -174.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.8 t -75.33 122.14 86.66 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.579 0.704 . . . . 0.0 110.88 -175.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.459 ' HD2' HG21 ' A' ' 2' ' ' ILE . 89.5 Cg_endo -68.88 -6.99 19.45 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.695 2.263 . . . . 0.0 112.437 167.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -102.92 14.38 32.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -51.73 -35.0 41.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.798 -168.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -72.15 -47.68 49.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.989 -171.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.0 pp -79.97 -33.68 39.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.906 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.73 -48.77 70.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.071 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -66.81 -34.42 77.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.14 -45.39 88.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.955 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -70.28 -36.12 74.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.786 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.684 ' O ' HD23 ' A' ' 280' ' ' LEU . 4.5 tt -59.4 -47.1 86.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -177.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -78.75 -28.53 44.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.03 -17.71 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -161.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.86 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 14.7 m-30 -121.18 -46.42 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.842 -178.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 1.0 OUTLIER -63.94 -44.11 93.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -171.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 1.009 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.7 pp -124.42 37.95 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -166.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 82.0 p -121.46 162.25 20.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.16 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.408 ' HA ' HD11 ' A' ' 290' ' ' LEU . 36.1 p-10 -47.84 -35.06 9.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.806 -167.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -80.18 -40.32 27.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.86 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -71.6 -58.64 5.28 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 -171.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.65 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.11 -22.23 66.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.719 0.295 . . . . 0.0 110.907 -178.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.576 ' N ' HD12 ' A' ' 290' ' ' LEU . 87.9 tt0 -68.19 -46.25 71.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.819 172.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.94 -46.32 89.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.052 -174.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 289' ' ' GLY . 0.2 OUTLIER -70.04 -44.82 78.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 178.297 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.53 ' HB2' HD22 ' A' ' 299' ' ' LEU . 29.0 t30 -55.54 -31.46 62.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.853 175.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.76 -26.82 68.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.974 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -83.75 -40.76 18.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -161.41 139.89 7.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.576 0.703 . . . . 0.0 110.861 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -48.86 126.52 15.01 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.68 2.253 . . . . 0.0 112.295 -174.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.53 HD22 ' HB2' ' A' ' 294' ' ' ASN . 0.1 OUTLIER -87.67 -19.11 28.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 173.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.37 -67.18 1.43 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.663 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.583 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -157.9 144.98 18.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.933 0.397 . . . . 0.0 111.082 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 24.8 m -125.55 159.93 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.041 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.59 -13.24 60.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.021 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.65 ' CD2' HD21 ' A' ' 290' ' ' LEU . 43.2 tp -81.3 125.21 30.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.887 -174.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -61.58 -36.04 79.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.876 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.3 m -60.7 -50.07 74.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -170.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.558 ' CE2' HD21 ' A' ' 311' ' ' LEU . 23.0 t80 -77.1 -35.25 56.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.987 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.665 ' HA ' HD12 ' A' ' 311' ' ' LEU . 87.3 tt0 -53.37 -39.88 64.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.885 175.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -52.11 -38.69 58.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.905 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -79.85 -34.37 39.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 308' ' ' GLU . 54.2 mt -64.1 -30.66 71.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 -175.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.84 -22.36 47.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.216 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.67 -20.57 65.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.003 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -89.3 122.64 68.38 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.695 0.76 . . . . 0.0 110.88 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -48.44 -30.2 15.19 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.754 2.303 . . . . 0.0 112.317 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -62.62 -30.72 71.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 -172.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.531 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.3 mp -74.9 -30.09 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.037 -173.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.14 -41.63 93.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 -170.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.66 -43.63 68.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 76.5 p -63.86 -31.27 72.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.093 -171.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 38.4 mmt -70.35 -31.43 68.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -64.38 -49.17 72.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 -175.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.628 HD21 ' HB1' ' A' ' 112' ' ' ALA . 10.2 p-10 -80.35 -25.6 39.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.807 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.37 -50.58 69.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.143 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.72 -34.7 77.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.952 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -104.13 -5.03 22.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -170.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -96.53 -156.35 30.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.448 -168.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -151.12 148.08 27.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.832 0.349 . . . . 0.0 110.843 -171.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 44.3 mm -60.85 124.94 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.132 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 96.9 mtp . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 121.5 0.667 . . . . 0.0 110.962 -178.405 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.671 0.272 . . . . 0.0 110.782 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 87.2 mmm -69.62 -28.27 65.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.837 -168.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.9 m -52.13 -42.76 63.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.821 -171.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.65 -36.28 73.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.99 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 2.5 m-30 -64.91 -42.7 94.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.851 -175.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -54.67 -42.69 71.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -70.72 -43.24 69.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.3 95.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.122 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 339' ' ' PHE . 17.7 m -73.8 -31.56 31.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.426 ' O ' HG22 ' A' ' 347' ' ' VAL . 55.2 ttt180 -62.9 -41.82 99.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 90.8 m -57.19 -38.05 73.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.145 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.71 91.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 -173.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.518 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.5 m -74.53 -34.9 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.16 -174.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.447 HD12 HG23 ' A' ' 347' ' ' VAL . 1.4 mp -63.52 -49.14 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.209 174.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -65.36 -39.1 91.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.926 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.17 -45.55 59.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.109 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.83 -39.57 79.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.138 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.6 p -76.38 -10.44 59.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.881 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.8 17.2 70.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.39 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.12 -33.46 44.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.934 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -140.06 155.45 47.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.7 p -77.82 169.16 18.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 170.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.528 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.3 t -56.82 -41.34 75.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -62.06 -45.96 91.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -70.0 -52.92 20.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -72.64 -49.73 29.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.048 -172.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.6 tm? -65.1 -47.7 76.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.75 -50.79 63.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.49 -49.97 55.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.47 -43.64 84.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.134 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.518 ' HB3' ' HB ' ' A' ' 183' ' ' VAL . 78.8 mm-40 -71.7 -35.01 70.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.974 -175.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 31.1 m -60.31 -28.08 67.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.243 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -56.83 -30.78 64.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 78.3 mt -59.09 -40.57 81.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.162 173.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 63.5 p -97.99 -13.54 21.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.227 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.9 tttt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.817 177.313 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.729 0.299 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.7 mt -94.48 139.83 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.155 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.92 138.95 53.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.856 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.97 134.57 43.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.35 8.02 71.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.492 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -160.37 140.61 11.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.757 0.313 . . . . 0.0 110.901 171.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.66 ' H ' HD23 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -143.02 156.39 44.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 -167.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 69.7 t -112.33 136.43 48.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.693 HD11 HG13 ' A' ' 35' ' ' VAL . 1.1 mp -118.4 131.46 71.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.182 175.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.779 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 73.0 m95 -104.37 126.04 51.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 165.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.507 HD12 ' HG ' ' A' ' 20' ' ' LEU . 13.3 tt -109.49 150.32 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.06 -166.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -58.14 155.05 11.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.808 -170.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.04 -17.51 23.2 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.472 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -78.16 -15.08 59.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.318 . . . . 0.0 110.843 -173.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' A' ' 15' ' ' LYS . 28.8 mmmt -135.0 136.04 41.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 171.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.0 -84.25 1.0 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.495 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -110.25 -38.08 5.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 110.891 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -65.56 -50.97 63.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -150.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.07 -59.98 9.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.443 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.507 ' HG ' HD12 ' A' ' 11' ' ' ILE . 2.0 mt -45.53 -49.95 13.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.952 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.68 -38.01 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.044 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -70.61 -54.42 12.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.853 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.0 m -74.44 -37.74 45.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.186 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.485 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -63.03 -46.76 92.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.443 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -56.88 -30.04 63.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.938 0.399 . . . . 0.0 110.898 -177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -58.35 -37.41 75.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.955 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 1.5 m-30 -60.71 -48.82 80.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.929 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.12 -34.91 78.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -72.18 -37.26 69.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -94.78 -50.0 5.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 -167.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.2 p -116.42 -3.25 11.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.155 -171.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.48 14.2 82.21 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.427 166.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.818 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -98.25 133.27 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.352 . . . . 0.0 111.107 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -74.54 134.18 42.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -166.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.693 HG13 HD11 ' A' ' 9' ' ' ILE . 94.5 t -113.45 127.12 70.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.138 -172.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.578 ' O ' HD12 ' A' ' 9' ' ' ILE . 97.2 m -110.85 128.01 55.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.096 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 81.6 t -102.24 132.16 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.195 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -118.67 155.17 31.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.936 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.1 t-80 -89.09 140.11 28.92 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.543 0.687 . . . . 0.0 110.945 -170.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 85.6 Cg_exo -55.02 -27.97 57.52 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.603 2.202 . . . . 0.0 112.406 -174.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -48.39 -51.11 28.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 -171.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.23 -1.19 57.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.984 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 tt -46.64 -53.03 12.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.048 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -67.39 -39.41 85.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.963 175.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -63.8 -40.54 96.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.914 -171.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -80.85 -22.93 39.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.547 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 75.9 t80 -48.32 -50.47 56.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 0.0 110.883 -166.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 60.0 Cg_endo -80.59 -28.68 2.66 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.721 2.281 . . . . 0.0 112.343 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -74.5 -37.6 63.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 -170.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.592 HG11 ' HD3' ' A' ' 57' ' ' PRO . 33.6 m -65.9 -26.86 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.03 78.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 173.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.06 68.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.0 p -87.3 -12.23 47.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.135 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.98 11.11 84.07 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.525 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -164.46 156.97 16.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.753 0.311 . . . . 0.0 110.934 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.91 -114.99 0.53 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.505 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.779 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 89.6 Cg_endo -77.6 150.67 28.07 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.739 2.293 . . . . 0.0 112.318 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.25 -35.3 21.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.805 163.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.521 ' HB ' HG23 ' A' ' 9' ' ' ILE . 40.5 mt -126.5 136.33 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.108 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 tp -132.12 125.84 55.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.119 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -89.81 139.56 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.805 166.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.438 ' CH2' ' HB2' ' A' ' 105' ' ' ALA . 35.2 p90 -141.12 163.0 34.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.936 171.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.53 -85.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.09 -168.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.537 ' NE2' ' HA3' ' A' ' 260' ' ' GLY . 11.3 m170 -126.89 -68.2 0.81 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -100.65 -10.01 21.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 -158.029 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -51.83 -20.0 2.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.85 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.482 ' HB2' HD13 ' A' ' 104' ' ' ILE . 34.3 p90 -55.92 -28.88 58.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.53 -51.08 59.95 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.24 -36.7 90.21 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.425 172.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 1.4 t80 -55.83 -51.73 66.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.811 0.338 . . . . 0.0 110.913 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.32 -42.26 59.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.131 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -56.9 -37.98 72.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.938 -175.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.404 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 62.3 m -84.9 -6.42 59.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.949 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.96 30.47 59.24 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.591 173.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.404 ' HG ' ' HB2' ' A' ' 73' ' ' SER . 52.6 mt -89.04 -12.18 42.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.829 -167.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.461 ' HA ' ' H ' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -128.94 151.39 49.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 -173.246 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -77.07 142.21 39.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.118 175.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.94 135.89 48.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.903 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -104.22 153.7 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.255 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.2 m -96.39 126.74 42.65 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 111.112 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.98 134.79 65.56 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.653 2.236 . . . . 0.0 112.347 176.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -104.93 120.1 40.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.85 -39.84 94.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.88 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.13 -45.27 85.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.059 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -75.31 -31.75 60.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.501 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 65.4 tt0 -53.94 -51.18 64.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.52 -32.18 70.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 174.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -76.66 -22.01 54.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.51 -105.36 0.3 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.952 -171.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 25.0 t80 171.94 130.02 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.624 0.726 . . . . 0.0 110.966 -168.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -52.79 -37.68 76.73 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.727 2.285 . . . . 0.0 112.359 -175.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -66.57 -34.78 78.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.852 -172.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.5 p -73.93 -30.01 62.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.17 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.501 ' HE1' ' HA ' ' A' ' 86' ' ' GLN . 75.8 m95 -65.82 -31.99 73.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.931 173.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.66 -32.33 72.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.812 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.72 -23.9 62.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.501 HG22 ' HA ' ' A' ' 94' ' ' TRP . 19.5 m -107.27 14.06 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 -177.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -100.02 130.12 46.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.823 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -126.07 113.71 17.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.2 t30 58.99 38.31 24.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.839 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.36 0.64 89.46 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.502 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -118.9 151.62 37.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.878 0.37 . . . . 0.0 110.843 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.499 HD22 HG23 ' A' ' 97' ' ' VAL . 14.6 mt -89.93 133.53 34.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -124.0 4.15 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 -172.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.438 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . . . -163.47 164.58 24.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.106 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -114.11 142.21 27.59 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.575 0.702 . . . . 0.0 110.923 171.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.93 122.16 5.25 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.625 2.216 . . . . 0.0 112.296 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.062 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp -104.22 -37.69 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -146.48 154.09 41.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.034 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.4 t -115.49 129.86 71.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.089 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -109.96 129.28 55.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -154.93 143.67 20.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.06 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.97 169.0 11.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.95 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.7 p -157.31 156.37 32.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.893 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -100.06 128.58 46.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.902 169.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.614 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.9 mp -110.07 133.14 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.102 -175.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -131.01 145.28 52.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -93.5 113.9 26.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.856 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.33 -20.79 66.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -175.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -79.5 -28.46 41.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.895 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.19 -49.61 11.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 175.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -141.71 133.76 13.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.564 0.697 . . . . 0.0 110.831 175.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.44 -14.38 14.55 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.625 2.217 . . . . 0.0 112.352 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -143.72 98.35 5.32 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.564 0.697 . . . . 0.0 110.879 -173.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.45 156.5 61.41 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.684 2.256 . . . . 0.0 112.357 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.44 143.83 59.15 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.664 2.243 . . . . 0.0 112.321 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -89.89 -13.84 35.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.6 p -132.44 158.38 42.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.132 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -68.64 -30.04 68.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.56 -19.97 65.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.953 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -79.99 -26.97 39.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.851 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.478 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -56.7 -46.94 99.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.613 0.721 . . . . 0.0 111.303 -169.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 86.7 Cg_exo -52.58 -50.78 12.87 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.657 2.238 . . . . 0.0 112.374 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.71 -57.68 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 -174.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.156 HD22 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.37 -17.26 63.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 -173.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.572 ' N ' HD13 ' A' ' 135' ' ' LEU . 36.2 t70 -61.17 -40.16 92.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 168.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.16 -30.89 71.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.879 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.8 -46.24 58.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.842 -177.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.0 pp -84.11 -13.9 51.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.631 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.7 tttt -58.77 -34.92 71.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.93 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.72 -24.14 67.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.057 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -95.0 3.4 54.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.888 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.75 32.32 54.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.445 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -110.65 171.76 7.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 110.911 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.6 t -124.63 140.17 53.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.753 168.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -67.28 -42.95 82.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.168 -170.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -138.54 128.79 25.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 63.2 tpp -110.81 129.32 55.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -153.22 155.18 36.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -88.57 -50.94 5.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.845 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.076 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.8 tm? 48.47 31.12 2.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -170.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -103.06 -7.36 21.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.977 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -129.99 152.52 80.12 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-O 121.652 0.739 . . . . 0.0 110.882 -174.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.49 -32.51 53.36 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.752 2.301 . . . . 0.0 112.315 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -69.7 -30.05 67.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -80.01 -39.64 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.835 172.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.8 m -60.1 -52.3 65.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.124 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.578 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 22.7 t-105 -60.7 -48.65 92.56 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.598 0.713 . . . . 0.0 110.889 -160.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 84.3 Cg_exo -50.82 -44.43 41.33 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.62 2.213 . . . . 0.0 112.276 -176.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 160' ' ' LEU . 7.0 tt -72.92 -39.99 65.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 -171.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.17 -42.07 66.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.136 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.14 -23.32 60.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.126 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.26 -35.02 71.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.111 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.6 p30 -104.29 9.44 35.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.877 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.44 4.75 23.32 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.472 169.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.37 68.89 2.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.531 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -92.62 133.53 35.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.771 0.32 . . . . 0.0 110.944 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.44 ' HB1' HD13 ' A' ' 368' ' ' ILE . . . -83.94 12.61 5.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 -173.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 53.1 p90 -151.52 153.32 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.911 -179.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -99.79 122.29 42.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 156.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -112.72 122.31 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.872 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -152.2 130.58 12.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.2 t30 54.99 43.96 29.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.77 15.46 79.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.602 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.38 139.75 50.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.867 -176.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -96.99 145.0 26.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 170.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -126.03 110.15 13.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.87 172.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.554 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.6 pp -80.04 -9.02 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -98.2 -11.93 22.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -121.93 89.14 3.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 169.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 26.0 m -116.61 164.55 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.082 -172.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -107.45 24.78 23.4 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.574 -173.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.423 HG21 HD12 ' A' ' 368' ' ' ILE . 2.5 m -109.24 -21.05 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.811 0.338 . . . . 0.0 111.055 -176.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -90.96 28.9 1.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.794 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -125.12 -170.04 2.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.893 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.85 -29.09 68.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.88 -41.71 95.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.477 -168.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.644 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.03 -37.04 85.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.942 0.401 . . . . 0.0 111.156 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.582 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -61.83 -38.13 87.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.868 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.14 -38.07 89.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.136 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.09 -47.73 63.38 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.505 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 347' ' ' VAL . 22.6 tp -67.39 -34.8 78.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.912 0.387 . . . . 0.0 110.901 -177.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.49 ' OG1' HG21 ' A' ' 357' ' ' VAL . 93.1 m -65.09 -41.43 94.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.148 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.461 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 59.8 t80 -67.33 -47.02 71.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.903 177.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 195' ' ' LEU . 7.4 tt -51.6 -51.42 55.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 -175.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 199' ' ' ILE . 31.2 m -64.01 -22.67 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.0 m-20 -61.59 -34.43 75.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.946 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.43 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.8 OUTLIER -81.28 -39.91 24.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.922 -173.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.516 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.8 pp -73.46 -29.3 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.135 172.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.6 -37.29 79.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -80.82 2.6 25.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.885 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 67.1 39.74 3.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.799 170.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -77.32 -17.94 57.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.91 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.516 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.2 ppp? -146.11 157.12 43.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.885 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -94.09 150.09 20.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.844 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.97 -25.88 67.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.075 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -95.4 0.99 54.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 94.0 m -63.55 127.18 30.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.095 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.429 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 14.7 t0 -120.02 177.36 5.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.853 177.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -65.01 -36.96 86.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.94 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.3 p -70.48 -38.03 74.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.911 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.429 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 78.7 mt -65.83 -43.12 93.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.072 175.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.31 87.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.209 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -61.6 -46.8 88.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.88 -40.77 97.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.056 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.91 -49.11 76.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.124 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -64.7 -41.1 96.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.966 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -63.51 -31.58 72.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.903 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.24 -13.17 44.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.962 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.14 25.01 35.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.556 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -85.87 -21.18 28.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 110.907 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.8 t -125.63 138.48 53.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.576 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -63.08 -48.84 76.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.012 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.489 ' HB3' HD21 ' A' ' 115' ' ' LEU . 69.9 mtm -133.3 159.89 38.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.949 -173.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.4 t -149.07 155.66 41.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.237 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.0 mm -111.47 130.05 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.178 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -155.77 174.63 15.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.5 -151.48 9.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.441 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.69 -26.18 28.16 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.621 2.214 . . . . 0.0 112.337 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -74.32 -32.06 62.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.942 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 43.19 45.04 4.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.151 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 35.6 m0 -69.45 -16.77 63.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 66.6 m -65.03 -26.42 68.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.514 ' HB3' HG21 ' A' ' 116' ' ' ILE . 39.1 p30 -82.62 -179.1 7.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 -172.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.8 mt . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.125 -177.254 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 87.9 t . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.781 0.324 . . . . 0.0 111.081 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -79.05 140.11 37.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.29 151.52 38.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.72 161.93 26.23 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 173.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.1 p -137.03 138.47 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.418 . . . . 0.0 111.025 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.4 t -155.72 150.97 26.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.176 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 30.7 m -59.97 167.08 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.119 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.946 HD23 ' HD3' ' A' ' 257' ' ' PRO . 2.8 mm? -59.24 149.82 66.25 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.519 0.676 . . . . 0.0 110.946 -168.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.23 -176.58 2.76 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.786 2.324 . . . . 0.0 112.406 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 99.3 m -88.92 144.03 26.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.108 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -131.34 110.96 11.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 54.92 36.16 26.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.988 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 89.81 -0.16 79.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.449 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -128.78 139.16 34.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.543 0.687 . . . . 0.0 110.843 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -67.38 138.28 45.9 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.734 2.289 . . . . 0.0 112.375 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 247' ' ' LEU . 75.6 m -81.48 -4.81 56.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 173.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 255' ' ' SER . 91.3 mttt -37.41 130.93 0.82 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.494 0.664 . . . . 0.0 110.878 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.946 ' HD3' HD23 ' A' ' 247' ' ' LEU . 37.8 Cg_endo -84.24 168.07 11.94 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.7 2.266 . . . . 0.0 112.278 -159.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -60.36 166.83 2.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.4 t -117.88 130.23 73.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.152 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.537 ' HA3' ' NE2' ' A' ' 64' ' ' HIS . . . -117.93 139.72 14.98 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.438 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 83.8 t -124.77 116.95 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.756 0.312 . . . . 0.0 111.189 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -65.14 119.97 11.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.961 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.3 m -123.8 130.88 53.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.809 -167.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.93 138.69 52.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.049 -174.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.6 170.82 22.21 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.43 -171.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.576 HG13 ' HB3' ' A' ' 277' ' ' LYS . 23.1 mm -114.96 127.64 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 0.0 111.198 -173.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -63.24 129.56 40.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 -175.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.461 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -58.68 -29.94 67.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.16 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.92 -6.34 59.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 -172.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 18.2 t -70.66 123.47 89.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.557 0.694 . . . . 0.0 110.981 -173.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -68.47 -8.34 22.84 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.669 2.246 . . . . 0.0 112.388 167.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -106.35 11.12 31.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.907 -176.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -47.58 -37.52 12.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 -168.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.54 -47.18 61.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.875 -171.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.1 pp -81.02 -30.7 34.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.945 -176.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.35 -49.55 68.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.071 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.576 ' HB3' HG13 ' A' ' 266' ' ' ILE . 57.9 pttt -69.33 -34.1 74.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.56 -45.82 81.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.822 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -67.75 -38.88 84.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.797 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 7.5 tt -58.55 -50.73 72.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 -175.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -72.2 -26.7 62.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -100.02 -11.06 20.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.967 -169.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.868 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 79.1 m-85 -128.33 -55.27 1.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 3.5 mp -66.13 -34.88 79.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 -165.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 1.062 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.2 pp -123.82 37.45 4.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.97 175.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 287' ' ' ASP . 9.3 m -115.53 153.86 30.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.108 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.566 ' HA ' HD11 ' A' ' 290' ' ' LEU . 28.7 t70 -45.7 -34.82 3.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -166.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -78.49 -41.09 33.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.868 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.04 -56.53 5.72 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.472 -171.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.573 HD12 ' N ' ' A' ' 291' ' ' GLU . 0.5 OUTLIER -66.42 -21.26 66.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.908 -179.157 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.573 ' N ' HD12 ' A' ' 290' ' ' LEU . 84.4 tt0 -68.29 -46.94 68.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.798 171.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.91 -42.87 99.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.071 -174.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 4.0 m -79.59 -36.31 17.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.182 -174.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -64.97 -28.73 69.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.934 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.79 -26.72 68.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -87.95 -41.96 12.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -146.13 135.53 11.47 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.541 0.686 . . . . 0.0 110.902 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -53.12 113.9 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.655 2.236 . . . . 0.0 112.394 175.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.411 ' HA ' HD12 ' A' ' 299' ' ' LEU . 0.7 OUTLIER -86.45 -24.94 25.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.949 177.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 103.63 -57.01 0.56 Allowed Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.506 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.577 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -168.18 161.83 12.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.384 . . . . 0.0 111.036 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.606 HG21 ' HB3' ' A' ' 307' ' ' TYR . 32.6 m -124.33 155.55 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.099 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.02 -9.99 59.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.034 173.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.557 ' CD2' HD21 ' A' ' 290' ' ' LEU . 45.0 tp -86.5 119.95 27.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.858 -176.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.61 -38.64 72.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.945 -174.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 42.7 t -64.56 -50.32 67.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.916 -169.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.606 ' HB3' HG21 ' A' ' 302' ' ' VAL . 16.9 t80 -78.52 -29.13 46.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -64.74 -37.76 88.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.37 -37.9 85.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.939 173.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -72.81 -39.8 66.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.963 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.577 HD13 ' HA ' ' A' ' 301' ' ' ALA . 79.2 mt -61.93 -32.64 73.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.928 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.26 -17.52 58.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.8 -19.12 65.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.978 173.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -91.63 121.74 66.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.746 0.784 . . . . 0.0 110.852 164.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -48.2 -26.93 8.73 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.679 2.252 . . . . 0.0 112.344 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -61.26 -29.64 69.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -172.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 1.2 mp -76.84 -29.86 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.188 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.51 85.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.046 -170.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.21 -43.74 77.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 80.8 p -63.78 -30.99 72.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -171.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.5 mmm -70.91 -32.86 69.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.85 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -64.46 -46.68 82.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.869 -173.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.447 ' OD1' ' HB1' ' A' ' 112' ' ' ALA . 7.5 p-10 -80.08 -27.07 39.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.728 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.13 -49.21 73.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.116 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -68.0 -34.98 77.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -105.51 -6.54 19.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.823 -169.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -93.18 -159.6 34.94 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.435 -170.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -142.22 148.53 38.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 0.0 110.92 -172.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 41.7 mm -65.13 122.3 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.083 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 36.2 ttp . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 121.574 0.702 . . . . 0.0 110.913 -179.639 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 . . . . . 0 C--O 1.23 0.04 0 CA-C-O 120.704 0.287 . . . . 0.0 110.858 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 85.1 mmm -79.99 -22.76 42.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 -173.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.5 m -55.52 -39.95 71.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.806 -171.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -68.71 -33.48 74.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.031 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 1.5 m-30 -67.51 -37.33 82.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -54.98 -42.04 71.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -78.28 -36.18 47.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.774 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.12 -38.44 90.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.043 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 339' ' ' PHE . 19.3 m -74.72 -31.32 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.071 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 347' ' ' VAL . 4.9 tmt_? -64.16 -37.33 87.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.863 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.9 m -57.27 -36.73 71.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.212 174.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.89 -42.54 94.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.183 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.541 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.9 m -74.26 -34.57 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.202 -174.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.452 HD12 HG23 ' A' ' 347' ' ' VAL . 1.4 mp -63.37 -47.91 89.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.119 173.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.97 -40.29 97.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.26 -46.39 41.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.105 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.33 78.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.039 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.2 p -75.26 -10.73 59.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.3 18.31 69.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.484 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.87 -33.32 45.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.764 0.316 . . . . 0.0 110.938 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.494 ' HB2' ' HB2' ' A' ' 360' ' ' ALA . 90.3 mm-40 -140.58 156.44 46.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 52.3 p -77.48 166.59 22.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.183 171.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.49 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.2 t -56.19 -41.92 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.226 173.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.52 -46.85 88.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.951 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -70.49 -56.42 6.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' A' ' 355' ' ' GLN . . . -68.45 -48.42 64.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.11 -172.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.644 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.8 tm? -65.0 -45.85 83.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -175.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.34 -53.76 50.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 -176.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . 0.409 ' O ' ' HG3' ' A' ' 367' ' ' ARG . 32.1 t70 -68.07 -50.08 57.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 -174.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -64.06 -38.29 90.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 -172.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 75.5 mm-40 -78.08 -32.34 50.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 40.9 m -66.21 -29.13 69.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.172 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 363' ' ' ASP . 79.6 mtt180 -56.9 -32.16 65.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 174.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 365' ' ' GLN . 71.4 mt -59.89 -40.72 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 41.6 p -97.1 -11.07 24.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.189 -175.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.812 175.363 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.755 0.312 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.425 HG21 ' HD2' ' A' ' 271' ' ' PRO . 62.3 mt -99.45 140.06 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.154 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -143.9 145.0 31.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -54.34 138.24 39.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 176.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.15 8.35 68.88 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.538 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.2 tttt -166.09 131.09 2.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.827 0.346 . . . . 0.0 110.91 176.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.611 HD22 HD11 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -141.76 155.97 45.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.963 -172.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 69.3 t -114.45 135.43 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.18 -175.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.712 HD11 HG13 ' A' ' 35' ' ' VAL . 0.9 OUTLIER -120.0 134.88 62.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.047 176.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.859 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 60.5 m95 -108.62 124.46 50.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 163.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.513 HD12 ' HG ' ' A' ' 20' ' ' LEU . 12.1 tt -109.75 151.77 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.074 -163.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -54.75 148.28 13.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.807 -172.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.99 -16.85 41.87 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.504 -175.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -80.61 -14.12 58.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.854 0.359 . . . . 0.0 110.888 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 15' ' ' LYS . 33.0 mmtm -140.0 128.09 22.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 166.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.1 -78.13 1.07 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.49 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -104.88 -35.92 7.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -67.33 -52.47 39.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.862 -150.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.32 -52.62 43.16 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.508 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.526 HD22 HD13 ' A' ' 9' ' ' ILE . 5.8 mt -55.09 -53.44 55.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.359 . . . . 0.0 110.907 174.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.29 -39.02 6.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.133 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -71.47 -57.99 3.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 178.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 20' ' ' LEU . 20.9 m -74.29 -36.19 42.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.199 -170.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.55 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -63.6 -45.62 94.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.489 174.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -54.33 -36.49 63.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.878 0.37 . . . . 0.0 110.831 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -58.92 -41.12 86.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.967 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 4.7 m-30 -62.34 -47.03 86.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 98.1 mt-10 -61.27 -36.05 78.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -75.42 -40.18 58.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.924 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -91.24 -49.84 6.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 -166.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.6 p -108.66 -7.55 15.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.174 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.13 8.83 87.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.369 167.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.927 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.8 133.66 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 111.219 -178.39 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.7 mttt -69.97 136.18 50.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.853 -172.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.712 HG13 HD11 ' A' ' 9' ' ' ILE . 92.1 t -114.7 125.02 71.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.007 -175.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.565 ' O ' HD12 ' A' ' 9' ' ' ILE . 98.6 m -108.91 125.66 52.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.098 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.422 HG22 ' HB3' ' A' ' 20' ' ' LEU . 84.8 t -102.43 130.91 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.138 177.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -118.13 154.27 32.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.958 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 65.8 t-80 -87.13 138.61 32.48 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.558 0.694 . . . . 0.0 110.884 -169.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 81.4 Cg_exo -57.34 -25.51 65.88 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.652 2.235 . . . . 0.0 112.303 -173.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -48.36 -51.1 27.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.838 -173.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.94 -0.82 57.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 -175.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 8.1 tt -46.56 -52.71 12.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -174.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -65.01 -40.81 95.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.81 -40.89 97.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.865 -172.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -81.55 -21.14 38.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.526 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 53.2 t80 -50.06 -51.16 64.45 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.696 0.76 . . . . 0.0 110.816 -165.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 55.5 Cg_endo -81.69 -30.06 1.55 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.656 2.238 . . . . 0.0 112.405 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -75.12 -40.05 60.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -167.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.51 -27.69 41.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.032 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.706 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -68.08 -36.21 79.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.096 177.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.81 -32.08 71.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.051 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.2 p -92.18 -15.7 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.135 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.76 10.89 80.64 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.403 173.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -140.2 132.62 28.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 0.0 110.811 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.434 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . 170.69 -127.76 1.51 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.474 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.859 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 35.0 Cg_endo -64.18 149.01 91.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.713 2.275 . . . . 0.0 112.399 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -92.1 -33.2 14.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.826 161.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.68 ' HB ' HG23 ' A' ' 9' ' ' ILE . 38.7 mt -124.16 136.09 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.114 -177.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 tp -131.44 127.56 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.157 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -93.77 136.7 33.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.802 170.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.479 ' CH2' ' HB2' ' A' ' 105' ' ' ALA . 33.0 p90 -140.89 167.17 22.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.969 171.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.59 -82.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.016 -167.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -127.32 -73.42 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.881 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 70.1 m-20 -99.96 -10.73 21.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -159.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -51.25 -22.34 2.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.516 ' HB2' HD13 ' A' ' 104' ' ' ILE . 32.9 p90 -56.8 -31.77 65.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.807 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.89 -50.99 60.91 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.447 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.73 -35.98 90.56 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.533 171.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -55.1 -51.63 65.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 0.0 110.946 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.73 -44.07 51.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.072 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -57.04 -38.86 73.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.982 -174.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.4 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 63.4 m -85.02 -7.15 59.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.77 30.3 59.9 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.545 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.706 HD22 ' HB1' ' A' ' 51' ' ' ALA . 35.5 mt -88.83 -9.35 52.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.808 0.337 . . . . 0.0 110.904 -170.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.467 ' HA ' ' H ' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -128.61 152.11 48.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 -178.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.413 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -80.37 142.82 34.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.069 175.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -73.12 135.38 44.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.836 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 pt -105.06 155.87 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.109 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.9 m -97.65 130.04 30.08 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.536 0.684 . . . . 0.0 111.08 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.42 135.55 66.2 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.669 2.246 . . . . 0.0 112.335 176.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -103.39 117.85 35.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 175.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.31 -41.34 98.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.849 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.25 87.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.002 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.42 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 16.5 m-85 -75.84 -31.75 59.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.857 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.45 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 66.8 tt0 -53.4 -50.84 64.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.949 173.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.76 -32.99 72.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 85' ' ' PHE . 93.7 mttt -75.87 -21.04 57.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -174.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -104.76 -105.08 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -171.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 26.9 t80 171.66 128.33 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.68 0.752 . . . . 0.0 110.956 -167.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -52.77 -36.78 74.69 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . 0.4 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 62.9 t80 -65.19 -35.11 80.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.4 p -73.79 -31.08 63.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.168 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.65 ' HA ' HG22 ' A' ' 97' ' ' VAL . 79.6 m95 -67.95 -29.72 68.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 173.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.04 -31.48 72.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.95 -23.84 58.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.65 HG22 ' HA ' ' A' ' 94' ' ' TRP . 17.7 m -111.51 19.28 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 -173.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.1 ttp-105 -111.95 136.5 51.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.842 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -135.39 121.89 20.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.952 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.2 t30 58.91 35.39 24.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.96 0.76 89.78 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.57 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -118.29 151.0 38.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 110.853 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.606 HD22 HG23 ' A' ' 97' ' ' VAL . 22.2 mt -86.58 135.27 33.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.951 177.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.516 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -124.79 3.6 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.065 -173.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.479 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . . . -163.46 165.83 23.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.196 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.463 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 90.2 m-85 -114.87 140.57 25.64 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.618 0.723 . . . . 0.0 110.976 170.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 12.0 Cg_exo -70.07 123.63 10.19 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.603 2.202 . . . . 0.0 112.294 170.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.014 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -106.98 -39.83 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 175.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -144.51 153.78 42.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 -166.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.8 t -118.68 129.86 74.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.135 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -119.89 127.78 53.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.621 ' HB1' HD21 ' A' ' 323' ' ' ASN . . . -155.02 146.42 23.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.036 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.6 mp -85.71 170.01 12.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.996 -175.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.4 p -154.75 153.63 31.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.988 0.423 . . . . 0.0 110.853 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.878 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -94.89 126.79 40.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 169.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.592 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.1 mp -111.63 131.73 62.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 -175.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -132.47 147.93 52.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 -175.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -92.37 115.49 28.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.872 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.483 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.2 mttt -66.56 -22.12 66.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -77.94 -23.35 48.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 -176.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.8 mp -85.29 -57.5 3.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 168.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.726 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -144.32 125.89 8.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.696 0.76 . . . . 0.0 110.785 177.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.46 -0.76 10.66 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.594 2.196 . . . . 0.0 112.41 -176.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -147.93 101.87 3.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.654 0.74 . . . . 0.0 110.761 -174.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.52 155.06 50.39 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.755 2.303 . . . . 0.0 112.401 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.444 ' HD2' ' SD ' ' A' ' 224' ' ' MET . 52.4 Cg_exo -55.28 143.06 77.56 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.699 2.266 . . . . 0.0 112.294 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -78.87 -22.03 46.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 52.9 p -135.62 159.95 40.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.202 -177.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.428 ' HA ' HD13 ' A' ' 132' ' ' ILE . 77.8 m95 -70.82 -28.13 64.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.09 -19.41 65.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -84.07 -20.63 32.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.554 ' O ' HD13 ' A' ' 135' ' ' LEU . 0.7 OUTLIER -57.36 -45.35 99.9 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.635 0.731 . . . . 0.0 111.133 -171.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 82.0 Cg_exo -51.27 -47.67 24.81 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.612 2.208 . . . . 0.0 112.335 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.84 -59.84 3.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.054 -174.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.113 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.99 -16.8 63.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.866 -173.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.542 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.4 t70 -61.3 -40.1 92.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 168.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.36 -30.07 69.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.7 -47.95 57.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.832 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.1 pp -87.42 -16.69 34.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.924 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.602 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.4 tttt -59.45 -32.86 70.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.41 -25.13 68.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.983 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -95.36 7.04 47.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.919 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.9 30.96 58.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.531 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -109.7 169.99 8.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 0.0 110.887 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.5 t -125.63 142.22 51.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 174.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.63 -42.48 74.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.124 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -139.3 127.78 22.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.945 -175.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 63.3 tpp -105.25 129.14 53.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 -174.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.18 158.33 38.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.929 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -98.63 -42.87 7.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.82 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.026 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.5 tm? 48.46 31.2 2.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 -170.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -103.73 -6.76 21.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.887 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -137.67 156.5 74.63 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.645 0.736 . . . . 0.0 110.901 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.476 ' HA ' ' HB ' ' A' ' 157' ' ' THR . 67.7 Cg_exo -52.37 -26.39 27.6 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.671 2.247 . . . . 0.0 112.339 176.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -63.22 -38.49 91.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -85.85 -37.19 19.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 20.0 m -58.87 -52.13 67.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.116 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.574 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 23.6 t-105 -62.54 -49.23 84.21 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.561 0.696 . . . . 0.0 110.893 -163.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 81.6 Cg_exo -50.07 -48.26 20.42 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.724 2.283 . . . . 0.0 112.392 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.691 ' O ' HD23 ' A' ' 160' ' ' LEU . 6.8 tt -72.0 -39.91 68.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 -170.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.3 mt -71.12 -42.41 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.119 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.38 -25.86 59.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -60.66 -35.03 75.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -169.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.4 ' HB3' ' CD2' ' A' ' 250' ' ' PHE . 59.6 p30 -97.53 3.48 50.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.76 2.15 13.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.415 173.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.89 64.78 3.0 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.563 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -87.08 136.02 33.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.916 0.388 . . . . 0.0 110.987 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.49 -0.33 22.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.466 ' HA ' HG12 ' A' ' 181' ' ' VAL . 49.6 p90 -154.05 154.82 34.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.909 -175.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -97.22 121.96 39.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.952 157.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -109.76 123.14 49.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.882 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -152.69 131.52 12.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.3 t30 55.74 44.97 25.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 172.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.92 15.29 78.34 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.463 173.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.89 139.11 50.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.0 110.864 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -98.75 140.43 32.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 172.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -122.33 109.94 15.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.528 ' C ' HD12 ' A' ' 178' ' ' ILE . 2.1 pp -83.4 -6.2 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.071 -177.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -99.67 -16.92 18.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -117.01 88.74 2.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.834 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 169' ' ' PHE . 22.9 m -117.82 165.03 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.094 -169.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -109.96 25.71 15.86 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.509 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 365' ' ' GLN . 1.2 m -106.6 -23.06 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.821 0.344 . . . . 0.0 111.06 -176.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -92.09 24.15 3.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -107.72 -174.97 2.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.8 -28.31 63.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.11 -40.43 92.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.524 -171.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.583 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -60.45 -38.39 84.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 111.099 177.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.589 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.6 mttt -61.67 -37.3 83.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.9 176.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.77 88.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.042 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.0 -46.62 71.39 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.564 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.549 HD11 ' HA ' ' A' ' 347' ' ' VAL . 20.2 tp -67.56 -33.63 75.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.958 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.516 ' OG1' HG21 ' A' ' 357' ' ' VAL . 91.8 m -65.57 -42.02 92.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.24 176.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 92.3 t80 -69.4 -44.68 70.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 195' ' ' LEU . 6.9 tt -51.13 -51.6 51.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.932 -175.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 35.1 m -63.89 -22.48 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.0 m-20 -62.25 -34.18 76.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.843 -177.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.457 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.7 OUTLIER -82.02 -39.96 22.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.959 -173.444 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.8 pp -72.02 -29.96 34.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.151 172.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -67.47 -37.73 83.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 171.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -82.72 2.54 33.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.925 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 66.86 39.94 3.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.829 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -75.96 -15.66 60.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.811 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -144.1 156.1 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.842 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -94.19 152.61 18.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.58 -27.11 68.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -94.1 2.67 55.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -177.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.9 m -65.62 134.92 54.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -138.36 171.73 13.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.918 176.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.07 -46.04 82.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 -176.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.8 m -60.37 -40.61 91.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.95 -42.25 94.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.178 173.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.98 -36.91 85.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.136 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . 0.402 ' HG2' ' HA ' ' A' ' 233' ' ' SER . 93.8 mt-10 -65.04 -44.24 89.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.874 177.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.96 -39.56 93.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.087 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.18 -45.02 95.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.099 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -64.25 -38.67 91.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.22 -34.7 76.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.0 -19.26 27.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.39 26.1 26.48 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -82.07 -19.96 39.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.928 0.395 . . . . 0.0 110.915 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.9 t -123.89 134.76 53.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 174.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.514 ' HB1' HD21 ' A' ' 122' ' ' LEU . . . -66.8 -47.38 72.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.996 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.626 ' HB3' HD21 ' A' ' 115' ' ' LEU . 72.9 mtm -133.86 153.78 51.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -171.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 10.1 t -151.04 155.81 39.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.213 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.2 mm -109.69 124.76 66.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.185 -175.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -153.51 174.64 14.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 -170.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.41 -164.13 34.17 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.435 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.2 -20.9 49.1 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.662 2.241 . . . . 0.0 112.341 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -78.16 -25.52 47.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 49.4 53.52 12.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.115 178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -60.0 -23.61 63.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 -177.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.402 ' HA ' ' HG2' ' A' ' 214' ' ' GLU . 65.2 m -57.09 -40.69 77.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.89 -176.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -85.91 179.19 7.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 69.8 mt . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 -167.543 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 34.9 m . . . . . 0 N--CA 1.457 -0.1 0 CA-C-O 120.809 0.338 . . . . 0.0 111.122 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -106.15 124.25 49.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.483 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 52.5 p90 -143.82 155.97 44.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.89 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -135.84 160.16 24.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.512 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.38 135.12 54.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.938 0.399 . . . . 0.0 111.061 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.8 t -153.8 149.14 27.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.36 162.07 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 3.1 mp -68.05 151.58 97.09 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.539 0.685 . . . . 0.0 110.919 -162.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.09 -173.6 1.85 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.663 2.242 . . . . 0.0 112.327 -174.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 99.5 m -89.03 143.01 27.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 -171.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 164' ' ' ASP . 11.1 t80 -132.17 113.13 12.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -176.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 56.22 35.46 25.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.37 1.89 83.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.583 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 90.0 mm-40 -126.86 127.94 24.32 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 121.555 0.693 . . . . 0.0 110.887 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 78.1 Cg_exo -55.12 133.24 57.0 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.631 2.221 . . . . 0.0 112.375 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 256' ' ' LYS . 69.4 m -78.81 -9.61 59.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.855 173.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 85.7 mttt -39.8 128.61 1.53 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.539 0.685 . . . . 0.0 110.861 -173.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 71.2 Cg_exo -63.51 156.25 57.77 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.648 2.232 . . . . 0.0 112.377 -167.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -70.75 166.6 20.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 173.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.83 131.68 61.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.146 -167.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.95 135.13 12.09 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.436 173.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 96.4 t -123.53 115.91 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 0.0 111.159 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -64.17 120.71 12.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.992 -178.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 48.4 m -124.74 131.63 53.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.835 -169.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.84 138.89 52.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.105 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -135.04 172.85 21.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.463 -170.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 23.4 mm -111.39 127.91 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.759 0.314 . . . . 0.0 111.244 -173.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -62.48 132.03 51.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.988 -176.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.467 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -60.13 -28.48 67.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.113 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.7 -5.15 59.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.8 t -74.79 120.06 79.75 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.675 0.75 . . . . 0.0 110.917 -174.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.425 ' HD2' HG21 ' A' ' 2' ' ' ILE . 92.0 Cg_endo -70.4 -7.1 20.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.637 2.225 . . . . 0.0 112.389 164.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -101.11 14.93 30.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 -171.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -51.87 -40.18 60.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.898 -169.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.3 -52.4 58.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 -172.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.4 pp -80.51 -33.65 36.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.004 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.62 -47.43 69.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.018 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -61.48 -41.75 97.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.854 173.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.8 tt0 -61.38 -47.32 86.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 17.9 m-30 -68.4 -36.56 79.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.813 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.52 ' HA ' HD22 ' A' ' 284' ' ' LEU . 5.8 tt -59.37 -52.4 65.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.873 -177.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -77.91 -33.5 51.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 -176.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.584 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 61.7 m-80 -99.97 -13.19 19.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.845 -163.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.762 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 59.2 m-85 -127.36 -50.49 1.41 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.52 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.5 OUTLIER -63.85 -39.36 94.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -170.523 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 1.014 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.7 pp -124.38 38.2 4.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 -175.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.477 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 5.9 t -115.66 162.73 16.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.088 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.423 ' HA ' HD11 ' A' ' 290' ' ' LEU . 28.4 t70 -48.51 -34.12 10.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -169.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -80.24 -41.09 25.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.859 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.762 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.77 -57.24 5.48 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.452 -170.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.549 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -66.42 -21.47 66.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.0 110.973 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.537 ' N ' HD12 ' A' ' 290' ' ' LEU . 83.9 tt0 -67.06 -46.49 74.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.825 171.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.67 -37.66 88.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.61 -46.33 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.086 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -65.81 -30.09 70.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.797 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.05 -27.8 67.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.95 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -87.41 -49.92 6.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.83 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 74.1 mmtt -138.6 139.15 23.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.57 0.7 . . . . 0.0 110.865 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 297' ' ' LYS . 80.1 Cg_exo -55.03 115.83 2.71 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.66 2.24 . . . . 0.0 112.381 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 299' ' ' LEU . 0.3 OUTLIER -84.41 -22.54 30.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 173.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 96.8 -59.71 1.22 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.516 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.659 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -167.53 160.23 12.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.814 0.34 . . . . 0.0 111.231 174.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.691 HG21 ' HB3' ' A' ' 307' ' ' TYR . 22.1 m -120.84 153.3 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.87 -9.58 58.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.061 173.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.549 ' CD2' HD21 ' A' ' 290' ' ' LEU . 44.0 tp -83.48 121.1 26.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.886 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.58 -38.61 75.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.86 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.7 t -64.46 -50.0 69.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.847 -169.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.691 ' HB3' HG21 ' A' ' 302' ' ' VAL . 13.6 t80 -77.26 -31.32 54.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.91 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.93 -39.15 93.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -58.67 -38.01 77.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -75.05 -38.78 61.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.979 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.659 HD13 ' HA ' ' A' ' 301' ' ' ALA . 80.3 mt -61.84 -34.25 75.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.98 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.38 -18.05 63.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.055 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.12 -19.56 66.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.934 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -93.14 121.43 65.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.6 0.715 . . . . 0.0 110.865 166.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -47.9 -26.65 7.56 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.66 2.24 . . . . 0.0 112.396 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -62.91 -34.88 78.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 -175.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.531 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.0 OUTLIER -81.5 -35.95 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.2 90.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.118 -170.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.92 -47.96 73.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.035 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 75.6 p -67.84 -27.16 66.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.086 -176.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.5 ttp -62.48 -34.96 77.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -62.31 -51.37 67.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.84 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.621 HD21 ' HB1' ' A' ' 112' ' ' ALA . 12.3 p-10 -80.06 -26.48 39.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.77 -177.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.41 -51.62 62.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.095 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -69.33 -29.77 67.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.88 -8.13 16.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.824 -168.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -91.39 -153.24 29.33 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.436 -168.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.0 144.83 37.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.856 0.36 . . . . 0.0 110.895 -172.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 36.0 mm -63.78 119.54 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.089 -172.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 60.2 ttm . . . . . 0 C--N 1.329 -0.295 0 CA-C-O 121.517 0.675 . . . . 0.0 110.89 178.058 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 339' ' ' PHE . 99.4 mm-40 . . . . . 0 N--CA 1.456 -0.127 0 CA-C-O 120.73 0.3 . . . . 0.0 110.83 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 88.4 mmm -64.96 -28.64 69.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.871 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.1 m -58.07 -39.91 79.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.767 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.07 -39.39 63.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 3.8 m-30 -63.17 -46.74 85.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -60.14 -37.71 80.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.901 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -69.63 -39.67 77.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.2 -43.01 83.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.104 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 339' ' ' PHE . 19.7 m -73.91 -33.17 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.133 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.454 ' O ' HG22 ' A' ' 347' ' ' VAL . 5.0 tmt_? -65.2 -38.68 91.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 86.1 m -58.53 -38.6 78.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.76 94.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.549 ' HA ' HD11 ' A' ' 192' ' ' LEU . 12.4 m -73.97 -35.51 42.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.084 -174.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 347' ' ' VAL . 1.4 mp -63.68 -47.01 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.221 173.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.02 -40.98 99.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.891 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.96 -45.94 47.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.11 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.01 -40.17 78.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.7 p -75.67 -10.11 59.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.32 18.67 68.43 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.375 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.13 -32.85 44.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 0.0 110.911 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -140.88 157.72 44.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.6 p -77.21 169.11 18.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.288 170.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.516 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.0 t -57.56 -43.07 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.14 172.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.65 -47.04 88.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -69.52 -55.3 10.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.5 -47.7 66.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.084 -172.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.589 ' HG ' ' HA ' ' A' ' 189' ' ' LYS . 1.6 tm? -65.08 -44.96 87.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -174.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.46 -53.71 38.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.949 -177.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.01 -47.07 66.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 -172.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.07 -43.92 81.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 -174.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.502 ' HB3' ' HB ' ' A' ' 183' ' ' VAL . 86.9 mm-40 -73.36 -32.98 64.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.933 -175.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 35.9 m -61.76 -28.23 69.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.172 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.88 -30.11 65.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 365' ' ' GLN . 74.5 mt -60.9 -37.7 77.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.233 174.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 43.4 p -98.01 -12.01 22.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.174 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 176.539 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.752 0.31 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.6 mt -108.96 138.16 37.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -121.37 136.13 55.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.83 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -54.32 134.92 45.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.843 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.24 9.4 67.32 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.475 -174.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 39.2 ttpt -160.07 129.97 5.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.363 . . . . 0.0 110.936 173.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.675 ' H ' HD23 ' A' ' 7' ' ' LEU . 1.1 pt? -136.24 152.77 51.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.93 -169.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 74.5 t -112.64 135.22 52.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.189 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.631 HD11 HG23 ' A' ' 35' ' ' VAL . 1.1 mp -118.64 132.69 67.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 177.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.799 ' HD1' ' HB3' ' A' ' 57' ' ' PRO . 78.7 m95 -104.45 125.77 50.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.929 164.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.518 HD12 ' HG ' ' A' ' 20' ' ' LEU . 10.4 tt -110.88 150.03 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.096 -166.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -58.99 150.09 25.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -173.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.83 -16.62 12.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.417 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -72.68 -15.21 61.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.917 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -139.98 137.85 35.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.899 167.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.97 -81.56 1.07 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.504 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -109.99 -37.13 5.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.932 0.396 . . . . 0.0 110.946 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -66.9 -50.01 63.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.92 -151.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.754 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -54.67 -53.6 38.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.537 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.518 ' HG ' HD12 ' A' ' 11' ' ' ILE . 8.1 mt -55.01 -48.07 73.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.783 0.325 . . . . 0.0 110.926 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.73 -34.77 12.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.11 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -78.66 -60.13 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.848 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 24' ' ' GLY . 26.4 m -74.55 -42.1 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 -169.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.465 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -64.99 -40.61 97.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -59.04 -29.95 67.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.908 0.385 . . . . 0.0 110.88 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -56.99 -33.08 66.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.026 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 2.5 m-30 -56.6 -47.76 78.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.895 177.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -70.36 -41.42 73.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.07 -34.85 79.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.846 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -92.63 -48.94 6.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.908 0.385 . . . . 0.0 110.853 -170.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.1 p -116.56 -0.72 12.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.213 -169.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.04 11.72 85.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.429 167.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.959 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.02 133.86 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.868 0.366 . . . . 0.0 111.11 -179.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 73.4 mmtt -74.13 140.62 45.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.844 -171.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.631 HG23 HD11 ' A' ' 9' ' ' ILE . 13.1 p -122.72 128.1 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.065 -174.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.621 ' O ' HD12 ' A' ' 9' ' ' ILE . 96.9 m -111.94 129.08 56.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.093 -174.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 20' ' ' LEU . 91.6 t -104.48 131.51 53.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.125 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -117.18 155.02 30.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.0 t-80 -85.07 138.96 36.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.683 0.754 . . . . 0.0 110.837 -170.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 86.6 Cg_exo -54.98 -29.39 64.34 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.627 2.218 . . . . 0.0 112.303 -175.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -48.28 -51.34 26.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 -172.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.03 -0.85 57.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.885 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.2 tt -47.06 -53.12 13.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -68.69 -38.45 80.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.7 -41.35 96.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 -171.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -81.66 -21.43 38.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.528 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 65.9 t80 -48.6 -50.71 57.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.624 0.726 . . . . 0.0 110.84 -167.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 66.3 Cg_endo -80.06 -28.48 3.13 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.596 2.198 . . . . 0.0 112.352 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -74.43 -39.16 62.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 -171.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.428 HG11 ' HD3' ' A' ' 57' ' ' PRO . 33.5 m -67.88 -27.97 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.13 -177.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.575 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -68.29 -37.77 80.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.057 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.19 -32.11 72.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.076 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.8 p -92.89 -14.92 27.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.56 10.79 79.95 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.407 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -142.79 136.2 28.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.776 0.322 . . . . 0.0 110.766 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.95 -114.95 0.52 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.514 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.799 ' HB3' ' HD1' ' A' ' 10' ' ' TRP . 61.2 Cg_endo -73.97 154.54 47.89 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.709 2.273 . . . . 0.0 112.285 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.67 -32.77 13.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 160.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.608 ' HB ' HG23 ' A' ' 9' ' ' ILE . 39.0 mt -127.63 137.77 56.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.229 -177.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 tp -131.38 126.84 59.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.193 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -88.97 141.6 28.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 167.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.579 ' CZ2' ' HB3' ' A' ' 67' ' ' PHE . 1.8 p90 -138.41 160.9 38.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.968 172.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.43 -82.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.164 -169.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.537 ' CD2' ' HA3' ' A' ' 260' ' ' GLY . 40.5 m170 -121.88 -71.07 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -170.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.95 -11.78 16.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.815 -164.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -56.78 -17.07 7.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -158.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.579 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . 27.9 p90 -61.77 -23.23 66.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.826 -173.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.55 -48.81 63.53 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.404 -174.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.43 -36.77 92.03 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.474 171.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 1.5 t80 -55.17 -51.23 67.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.897 0.38 . . . . 0.0 110.874 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.99 -41.91 40.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.119 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -59.19 -36.18 74.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.0 m -85.06 -7.69 59.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.28 31.73 58.95 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.575 HD22 ' HB1' ' A' ' 51' ' ' ALA . 52.1 mt -88.12 -9.62 52.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.812 0.339 . . . . 0.0 110.884 -167.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.538 HD11 ' HB ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -128.42 152.95 47.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -172.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -79.18 141.25 37.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.091 175.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -70.74 137.85 50.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 173.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.427 HD12 ' CZ ' ' A' ' 106' ' ' TYR . 39.3 pt -103.88 156.64 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.143 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.9 m -92.08 130.04 39.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.536 0.684 . . . . 0.0 111.088 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . 0.412 ' HB3' HD12 ' A' ' 103' ' ' LEU . 50.0 Cg_endo -67.41 141.14 55.03 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.687 2.258 . . . . 0.0 112.328 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -110.14 118.75 37.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.94 -36.78 73.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.25 -45.17 92.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.178 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -75.64 -32.44 60.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.483 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.5 tt0 -51.51 -49.1 62.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -66.35 -32.89 74.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.799 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.02 -23.26 52.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 -172.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.96 -104.64 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.993 -169.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 t80 174.94 107.98 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.668 0.747 . . . . 0.0 111.036 -160.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.0 -32.17 30.0 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.725 2.283 . . . . 0.0 112.329 -177.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.99 -36.93 85.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.2 p -78.3 -31.52 48.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.579 ' HA ' HG22 ' A' ' 97' ' ' VAL . 86.2 m95 -63.16 -29.99 71.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 171.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -69.46 -32.15 70.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.792 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.73 -23.01 61.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.08 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 94' ' ' TRP . 19.8 m -110.7 17.98 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.134 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -107.57 132.93 52.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.817 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -126.2 119.22 26.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 174.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.2 t30 57.57 37.04 27.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.868 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.64 1.12 90.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.482 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -121.83 148.75 44.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.843 0.354 . . . . 0.0 110.852 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.564 HD22 HG23 ' A' ' 97' ' ' VAL . 16.8 mt -86.03 133.79 33.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -176.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.538 ' HB ' HD11 ' A' ' 76' ' ' LEU . 1.2 pp -114.84 -9.29 12.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.095 -172.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.55 ' HB3' ' HH2' ' A' ' 62' ' ' TRP . . . -169.44 173.4 6.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.183 -173.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 99.2 m-85 -115.88 140.17 25.86 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.671 0.748 . . . . 0.0 110.925 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 12.2 Cg_exo -70.82 127.85 14.29 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.705 2.27 . . . . 0.0 112.323 172.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.898 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -108.9 -39.93 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.117 177.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 262' ' ' LEU . . . -143.29 154.17 43.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.149 -171.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.2 t -116.15 127.28 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.204 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -110.62 125.23 53.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.452 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -146.36 141.05 26.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.9 mp -89.66 167.12 13.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.004 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.5 p -156.27 154.99 31.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.845 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.874 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -92.27 123.48 35.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 168.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.555 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.0 mp -109.94 131.56 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.177 -175.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -132.35 148.41 52.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 -173.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -91.06 113.97 26.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.909 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.11 -25.41 68.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -173.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -83.47 -22.15 32.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 -173.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 mp -81.23 -55.51 4.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.857 169.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.696 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -141.05 127.34 11.5 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.554 0.693 . . . . 0.0 110.888 173.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.18 -5.54 13.64 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.663 2.242 . . . . 0.0 112.365 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -149.27 102.43 3.32 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.621 0.725 . . . . 0.0 110.793 -175.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -72.01 156.92 55.49 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.769 2.312 . . . . 0.0 112.321 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.14 144.84 82.98 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.737 2.291 . . . . 0.0 112.247 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.02 -17.97 44.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.977 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 56.8 p -135.06 159.51 41.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.21 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.519 ' HA ' HD13 ' A' ' 132' ' ' ILE . 64.7 m95 -70.76 -28.35 64.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.039 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.99 -22.78 67.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.807 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -82.34 -21.96 35.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.791 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.638 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -56.76 -48.73 96.76 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.67 0.747 . . . . 0.0 111.2 -173.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 41.8 Cg_endo -69.07 -37.41 10.87 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.669 2.246 . . . . 0.0 112.332 -174.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.89 -60.74 2.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.081 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.272 HD22 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.23 -16.95 64.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -175.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.504 ' N ' HD13 ' A' ' 135' ' ' LEU . 34.5 t70 -57.79 -40.4 79.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.039 0.447 . . . . 0.0 110.866 168.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.25 -30.66 69.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -70.97 -47.69 57.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.812 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.9 pp -84.91 -14.47 47.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.618 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.8 tttt -60.87 -34.01 73.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.968 174.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.73 -24.05 67.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.085 175.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -95.12 4.35 53.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.877 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.02 32.13 56.96 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -110.22 170.72 7.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.932 173.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.9 t -124.14 138.73 54.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 168.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -65.4 -43.69 89.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 -170.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -143.11 127.87 18.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 63.5 tpp -107.55 132.58 53.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -153.57 158.44 41.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -172.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -90.11 -51.08 5.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.851 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.064 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.6 tm? 48.04 32.36 2.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.03 -167.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -101.2 -6.16 24.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.866 175.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.36 155.02 80.72 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.638 0.732 . . . . 0.0 110.939 -174.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.06 -25.95 77.9 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.743 2.295 . . . . 0.0 112.391 177.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -72.26 -27.48 62.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -80.01 -38.88 31.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.848 170.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.405 HG23 HG11 ' A' ' 347' ' ' VAL . 22.5 m -63.15 -45.66 90.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.07 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.591 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 46.2 t-105 -54.95 -54.55 48.66 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.609 0.719 . . . . 0.0 110.931 -169.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 22.1 Cg_endo -63.99 -19.92 67.15 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.634 2.222 . . . . 0.0 112.38 -173.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.706 HD13 ' C ' ' A' ' 160' ' ' LEU . 1.7 tm? -82.77 -45.87 13.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.858 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.532 HG22 ' HA3' ' A' ' 166' ' ' GLY . 85.3 mt -75.3 -44.77 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.143 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.11 -23.65 61.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 -173.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -59.59 -35.95 75.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.104 -170.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 58.9 p30 -102.51 8.39 39.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.94 2.01 12.81 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.501 170.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.532 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -77.34 65.49 3.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.498 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -88.23 134.57 33.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.865 0.364 . . . . 0.0 111.035 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.6 2.1 17.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.135 -174.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.442 ' HA ' HG12 ' A' ' 181' ' ' VAL . 44.3 p90 -159.45 154.74 25.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 -175.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -93.67 123.13 36.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.847 160.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -114.95 120.58 40.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.987 175.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -151.93 130.13 11.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -173.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.04 41.41 31.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.955 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.21 17.81 79.67 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.536 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.32 138.5 50.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.853 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -99.24 144.98 27.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -126.39 110.0 12.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.832 174.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.7 pt -77.48 -15.73 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.105 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.95 -9.52 33.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -121.78 84.17 2.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.833 172.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 169' ' ' PHE . 27.6 m -112.75 160.44 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 -172.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -104.53 19.06 43.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.516 -174.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.3 m -102.6 -20.65 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 0.0 111.098 -175.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -87.61 21.71 2.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.788 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -117.13 175.01 5.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.81 -24.95 67.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.076 -175.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.99 -40.61 97.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.491 -173.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.594 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.86 -37.77 88.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 111.055 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.562 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -61.14 -38.5 86.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 174.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.08 89.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.078 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.491 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -66.52 -47.74 67.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.5 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.717 HD11 ' HA ' ' A' ' 347' ' ' VAL . 20.3 tp -66.67 -34.72 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.954 0.406 . . . . 0.0 110.926 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.545 ' OG1' HG21 ' A' ' 357' ' ' VAL . 91.7 m -64.84 -42.64 94.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.11 177.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 91.5 t80 -68.06 -47.75 67.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.699 HD23 ' C ' ' A' ' 195' ' ' LEU . 5.3 tt -50.83 -50.66 56.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.91 -174.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 35.0 m -64.38 -22.7 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.111 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.3 m-20 -62.45 -33.95 75.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.918 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.462 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.6 OUTLIER -81.66 -39.86 23.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.966 -173.368 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.424 ' H ' HG13 ' A' ' 199' ' ' ILE . 1.7 pp -72.05 -29.77 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.15 171.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.93 -36.82 83.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 171.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -83.65 4.03 30.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.952 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 66.23 39.9 4.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.835 170.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -75.73 -17.87 59.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -143.01 154.93 44.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.892 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -94.39 154.56 17.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.01 -26.85 68.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.151 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -95.03 0.42 54.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 97.1 m -66.17 128.82 37.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.153 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.401 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 19.7 t0 -122.0 173.6 7.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 173.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -62.77 -40.96 98.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.6 p -68.28 -37.37 80.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.862 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.401 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 79.9 mt -65.03 -42.22 94.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.081 174.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.1 93.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.078 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.26 -41.92 89.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.04 90.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.076 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.85 -39.11 93.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.129 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -63.68 -39.64 94.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.914 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -61.27 -33.19 73.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.3 -13.93 48.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.867 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.16 25.15 41.32 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.483 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -85.45 -22.16 28.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.952 0.406 . . . . 0.0 110.893 -175.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.9 t -129.57 139.95 51.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.566 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -65.05 -54.23 33.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.05 -174.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.656 ' HB3' HD21 ' A' ' 115' ' ' LEU . 67.8 mtm -134.42 153.2 52.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 -170.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 68.8 p -139.37 161.64 36.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.185 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 44.9 mm -108.94 126.21 65.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -154.75 175.05 14.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 -171.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -85.93 -159.98 33.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.411 -174.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.26 -23.52 33.0 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.679 2.253 . . . . 0.0 112.391 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -75.92 -24.88 55.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 48.05 50.08 16.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.153 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -59.98 -20.49 57.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 70.0 m -48.78 -50.1 35.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.865 174.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -85.02 179.33 7.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -172.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.2 mt . . . . . 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.158 -176.607 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 87.5 t . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.85 0.357 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -90.95 132.02 36.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -127.29 147.65 50.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.846 176.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -129.6 156.81 21.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.489 170.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 316' ' ' ARG . 3.1 p -135.72 135.17 51.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.962 0.411 . . . . 0.0 111.086 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.6 t -154.62 150.95 28.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.2 m -61.04 164.75 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.17 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 2.5 mp -71.26 152.75 94.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.583 0.706 . . . . 0.0 110.95 -163.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.62 -176.44 3.22 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.28 . . . . 0.0 112.479 -171.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.2 m -86.02 143.84 27.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.196 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -129.85 111.78 12.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.957 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 54.99 36.84 27.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.53 0.78 84.05 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.462 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 91.2 mm-40 -126.5 125.89 24.53 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 121.576 0.703 . . . . 0.0 110.862 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 77.3 Cg_exo -54.43 128.58 30.71 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.736 2.29 . . . . 0.0 112.338 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 82.4 p -84.32 0.41 49.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.024 0.44 . . . . 0.0 110.9 174.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -37.71 134.95 0.79 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.54 0.686 . . . . 0.0 110.825 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.452 ' HD3' HD13 ' A' ' 247' ' ' LEU . 30.3 Cg_endo -79.05 156.66 26.57 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.657 2.238 . . . . 0.0 112.385 -163.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . 0.552 ' HB2' ' SD ' ' A' ' 330' ' ' MET . 10.4 m-85 -75.46 167.19 22.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.885 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 42.6 t -114.49 132.77 62.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.181 -167.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.537 ' HA3' ' CD2' ' A' ' 64' ' ' HIS . . . -115.2 141.78 17.21 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.41 173.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 81.4 t -121.42 112.08 33.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.767 0.318 . . . . 0.0 111.122 -176.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -75.82 114.51 14.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -176.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.417 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . 19.1 m -131.62 154.11 49.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.777 -164.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.421 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -132.61 133.56 43.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.123 -176.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.01 171.24 16.3 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.459 -174.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.636 HG13 ' HB3' ' A' ' 277' ' ' LYS . 37.5 mm -113.31 124.99 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.246 -170.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -62.97 130.68 45.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 -176.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.479 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -59.26 -29.36 67.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.2 -177.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.03 -8.19 58.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.001 -172.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.4 t -67.39 123.56 86.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.58 0.705 . . . . 0.0 110.866 -172.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -69.71 -11.49 31.02 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.576 2.184 . . . . 0.0 112.408 168.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -103.92 14.1 31.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -51.82 -35.25 43.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 -167.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . 0.405 ' HA ' ' HE3' ' A' ' 277' ' ' LYS . 72.0 mm-40 -70.08 -49.4 51.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.006 -174.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.94 -30.33 39.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.901 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.83 -50.53 66.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.636 ' HB3' HG13 ' A' ' 266' ' ' ILE . 13.7 pttp -71.96 -34.07 68.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.915 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -63.39 -46.62 85.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 177.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -69.7 -36.33 75.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.884 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.437 ' HA ' HD22 ' A' ' 284' ' ' LEU . 5.9 tt -55.73 -51.32 67.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.922 -178.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -75.79 -26.35 57.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.816 -177.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -100.28 -13.25 18.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.78 -166.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.846 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 63.0 m-85 -120.15 -59.77 1.75 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.813 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 280' ' ' LEU . 1.6 mp -62.37 -34.23 76.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.951 -161.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.898 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.3 pp -124.77 37.52 4.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.475 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 66.7 p -118.59 160.6 21.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.176 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.569 ' HA ' HD11 ' A' ' 290' ' ' LEU . 42.2 p-10 -51.12 -28.51 10.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.778 -167.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -78.93 -45.0 21.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 175.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.846 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.27 -56.8 6.0 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.497 -169.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.59 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.5 -21.63 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.766 0.317 . . . . 0.0 110.976 -178.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.581 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.1 tt0 -69.34 -49.31 56.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 172.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.65 96.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.077 -172.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.754 HG23 ' HA3' ' A' ' 19' ' ' GLY . 1.5 p -79.78 -29.89 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.417 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 27.7 t30 -63.9 -29.79 70.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 174.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.58 -20.76 66.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.935 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -82.17 -39.96 22.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.917 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -161.89 138.37 6.09 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.424 0.631 . . . . 0.0 110.935 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -45.82 115.94 1.23 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.685 2.256 . . . . 0.0 112.448 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.417 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 49.4 mt -93.49 -12.15 30.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 98.33 -61.7 0.89 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.528 171.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.607 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -167.1 159.55 13.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.844 0.354 . . . . 0.0 111.141 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 19.3 m -124.95 159.85 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.212 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.81 -14.44 61.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 172.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.59 ' CD2' HD21 ' A' ' 290' ' ' LEU . 49.9 tp -83.74 121.01 26.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -172.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -59.4 -33.79 71.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.944 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.9 m -61.34 -47.53 85.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.775 -172.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.512 ' HB3' HG21 ' A' ' 302' ' ' VAL . 4.5 t80 -78.78 -32.69 46.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.933 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.27 -40.89 62.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.849 173.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -55.14 -40.19 70.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.877 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -78.12 -37.83 45.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 177.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.607 HD13 ' HA ' ' A' ' 301' ' ' ALA . 83.4 mt -63.68 -33.03 74.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.58 -20.26 59.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.05 -20.22 66.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -93.09 121.28 65.94 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.65 0.738 . . . . 0.0 110.899 168.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.97 -25.13 11.81 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 0.0 112.373 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.451 ' HA ' HG11 ' A' ' 244' ' ' VAL . 78.3 mtt85 -62.25 -29.87 70.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.935 -175.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.565 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.2 mp -75.3 -28.67 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.81 87.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.031 -171.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.26 -45.32 73.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.145 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 67.0 p -64.47 -29.61 70.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.151 -173.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 61.9 tpp -68.63 -35.66 77.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.791 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -65.03 -47.75 76.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -173.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 327' ' ' GLY . 8.2 p-10 -79.94 -24.78 40.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.39 -42.79 92.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.93 -38.84 86.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.925 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.47 -4.14 15.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.818 -166.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.87 -162.7 36.99 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.526 -166.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -150.31 147.11 27.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 -171.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 36.8 mm -59.85 123.14 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.115 -170.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 258' ' ' PHE . 74.4 mmm . . . . . 0 C--N 1.331 -0.222 0 CA-C-O 121.554 0.692 . . . . 0.0 110.917 178.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 . . . . . 0 N--CA 1.458 -0.055 0 CA-C-O 120.949 0.404 . . . . 0.0 110.989 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 80.8 mmm -75.43 -18.36 59.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.812 -171.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.4 m -58.4 -42.17 86.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.774 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.0 -39.45 63.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.519 ' O ' HG13 ' A' ' 343' ' ' VAL . 4.2 m-30 -67.3 -45.42 76.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -174.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.461 ' HA ' HG22 ' A' ' 343' ' ' VAL . 6.9 m0 -59.7 -37.32 78.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.955 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -63.6 -45.18 91.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.23 79.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.106 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 339' ' ' PHE . 18.4 m -73.49 -32.46 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -175.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.442 ' O ' HG22 ' A' ' 347' ' ' VAL . 5.1 tmt_? -66.05 -39.04 89.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 175.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.2 m -58.74 -36.96 75.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 173.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.85 91.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -174.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.717 ' HA ' HD11 ' A' ' 192' ' ' LEU . 8.5 m -73.01 -34.79 46.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.211 -175.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.457 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -64.22 -46.78 92.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.09 174.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -67.9 -37.18 81.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.815 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.86 -44.93 65.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.18 85.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.062 -176.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.6 p -77.7 -10.16 59.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.09 17.07 73.01 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.45 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.02 -31.12 50.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.74 0.305 . . . . 0.0 110.881 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 360' ' ' ALA . 77.8 mt-30 -139.98 155.07 47.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.901 176.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 57.2 p -78.81 166.04 22.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 169.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.545 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.8 t -56.12 -41.95 70.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.116 174.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -60.9 -48.13 83.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.854 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -69.58 -54.96 11.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.947 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 355' ' ' GLN . . . -68.61 -47.75 65.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.115 -172.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.594 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.5 tm? -65.46 -44.63 86.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.964 -174.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.45 -53.12 53.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.986 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -67.5 -45.89 74.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.54 85.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.565 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 78.4 mm-40 -76.02 -25.73 55.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.001 -176.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 53.5 m -62.39 -35.08 78.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.086 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -59.94 -30.23 68.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.893 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 71.4 mt -60.46 -37.6 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.088 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 60.9 p -94.56 -15.0 24.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.168 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 179.252 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.726 0.298 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.421 HG21 ' HD2' ' A' ' 271' ' ' PRO . 49.4 mt -100.47 141.26 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.144 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -139.13 144.86 38.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.8 133.74 37.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.79 10.6 64.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.46 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.2 tttt -163.78 130.79 3.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.91 176.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.615 ' CD2' HD11 ' A' ' 33' ' ' ILE . 1.4 pt? -141.58 151.89 43.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.974 -169.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.515 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 80.4 t -110.48 135.97 47.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.091 -176.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.656 HD11 HG13 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -120.03 134.08 64.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.159 176.626 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.784 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 72.4 m95 -103.75 128.05 51.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 163.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.441 HD12 ' HG ' ' A' ' 20' ' ' LEU . 13.8 tt -108.52 149.95 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.193 -165.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.67 153.16 13.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.795 -173.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.17 -22.45 29.22 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.509 -177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -72.42 -17.11 61.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.359 . . . . 0.0 110.924 -169.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -140.07 131.87 27.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 168.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.93 -71.96 1.23 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.544 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -109.08 -40.15 5.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -66.9 -52.44 43.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.866 -149.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.411 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -52.96 -51.61 44.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.425 -176.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.468 ' HB3' HG22 ' A' ' 37' ' ' VAL . 3.9 mt -54.98 -57.35 12.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.775 0.321 . . . . 0.0 110.919 173.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.85 -37.4 13.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 -176.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.56 -55.69 9.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.3 m -73.79 -35.27 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.187 -173.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.566 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -66.66 -46.67 73.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.482 176.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -53.42 -36.64 61.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 110.898 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -56.22 -42.8 77.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.904 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -64.0 -43.49 95.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.833 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 98.8 mt-10 -61.23 -37.64 83.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.944 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.77 -41.49 68.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.886 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -94.46 -46.96 6.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.944 -164.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.7 p -108.57 -7.87 15.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.111 -172.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.81 8.3 87.84 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.436 168.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.035 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.64 134.69 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.807 0.337 . . . . 0.0 111.168 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.1 mttt -73.34 135.69 44.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.959 -170.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.656 HG13 HD11 ' A' ' 9' ' ' ILE . 96.6 t -115.74 126.34 73.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.989 0.423 . . . . 0.0 111.075 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.555 ' O ' HD12 ' A' ' 9' ' ' ILE . 96.7 m -108.47 127.9 54.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.126 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 20' ' ' LEU . 94.2 t -103.1 130.07 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -119.38 152.01 37.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.835 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 64.9 t-80 -90.72 141.66 27.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.612 0.72 . . . . 0.0 110.902 -167.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.462 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 86.2 Cg_exo -55.11 -26.66 51.72 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.676 2.25 . . . . 0.0 112.386 -175.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -49.72 -55.72 12.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.96 -1.74 58.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.853 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 8.8 tt -46.9 -53.33 12.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.901 -175.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -67.81 -38.31 83.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.869 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.21 -42.21 89.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.843 -171.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -83.63 -21.56 32.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.523 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 62.1 t80 -47.11 -50.27 47.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.669 0.747 . . . . 0.0 110.832 -169.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 69.7 Cg_endo -79.89 -28.82 3.05 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.25 . . . . 0.0 112.347 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -73.86 -40.01 63.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -172.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.435 HG11 ' HD3' ' A' ' 57' ' ' PRO . 33.7 m -67.91 -28.12 40.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.197 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.664 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -70.38 -38.06 74.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.055 175.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.57 -33.86 75.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.164 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 p -90.11 -15.97 30.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.224 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.44 9.15 77.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.395 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -139.96 132.25 28.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 110.815 177.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.02 -114.95 0.52 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.51 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.784 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 61.2 Cg_endo -74.75 149.06 37.39 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.677 2.251 . . . . 0.0 112.282 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -86.97 -32.89 19.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 158.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.595 ' HB ' HG23 ' A' ' 9' ' ' ILE . 40.7 mt -128.19 137.77 56.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.116 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 tp -131.78 126.1 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -89.79 139.65 30.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 169.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.514 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 35.6 p90 -142.61 165.04 28.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.966 171.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.9 -88.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.034 -163.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.484 ' NE2' ' HA3' ' A' ' 260' ' ' GLY . 27.4 m170 -111.65 -75.72 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.861 -174.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -103.69 -3.89 24.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 -161.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -56.52 -16.89 6.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 -169.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.502 ' HB2' HD13 ' A' ' 104' ' ' ILE . 37.6 p90 -57.42 -28.52 63.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -177.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.41 -50.6 63.55 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.493 -173.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.12 -38.06 94.86 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.56 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 1.6 t80 -57.22 -48.22 79.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 0.0 110.93 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.37 -43.79 31.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.053 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -56.58 -38.85 72.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.9 -175.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.412 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 60.3 m -83.72 -6.75 59.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.878 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.46 30.52 60.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.452 173.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.664 HD22 ' HB1' ' A' ' 51' ' ' ALA . 52.8 mt -88.01 -9.74 52.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.905 0.384 . . . . 0.0 110.914 -167.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.486 ' HA ' ' H ' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -130.15 153.16 48.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -172.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.83 144.93 31.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.081 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.28 139.22 54.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 175.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.6 pt -105.05 153.92 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.067 -173.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.5 m -108.66 125.15 32.39 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.577 0.704 . . . . 0.0 111.104 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.65 156.0 53.89 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.631 2.22 . . . . 0.0 112.328 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -105.96 122.51 46.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 175.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.23 -35.02 48.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.807 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.05 -37.92 89.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.098 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -88.29 -25.47 22.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.4 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 66.5 tt0 -54.9 -45.27 74.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -68.11 -23.81 64.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.831 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.55 -19.63 22.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.976 -167.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.597 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -99.67 -32.44 11.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.956 -168.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.597 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 11.7 m-30 92.42 144.45 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.638 0.733 . . . . 0.0 110.947 175.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.32 -40.0 87.58 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 0.0 112.406 -174.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -71.34 -23.17 61.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.949 -171.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.4 p -80.17 -37.67 32.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.231 173.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.525 ' HA ' HG22 ' A' ' 97' ' ' VAL . 55.7 m95 -65.03 -29.21 70.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.996 171.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -71.13 -34.62 71.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 177.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.14 -24.77 63.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.566 HG23 HD22 ' A' ' 103' ' ' LEU . 18.4 m -106.96 15.64 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.164 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -101.34 131.62 47.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -130.94 116.03 17.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 174.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 t30 58.65 35.95 24.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.77 0.26 89.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.511 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -118.17 148.07 42.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 110.818 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.566 HD22 HG23 ' A' ' 97' ' ' VAL . 32.6 mt -88.74 134.42 33.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.502 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -125.81 3.42 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.033 -169.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.514 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -163.7 162.71 24.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.184 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.497 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 94.0 m-85 -111.12 138.13 21.14 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.563 0.697 . . . . 0.0 110.941 173.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 15.1 Cg_exo -68.09 121.35 8.34 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.654 2.236 . . . . 0.0 112.362 170.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.044 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp -104.72 -40.02 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 173.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -145.72 154.86 42.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.064 -167.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.7 t -114.95 125.57 72.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.177 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -104.02 124.48 49.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.949 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.541 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -149.07 141.41 24.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.147 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.8 mp -90.91 168.65 11.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.7 p -156.67 154.74 30.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.864 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -93.68 124.45 37.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 168.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.549 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.1 mp -110.15 131.46 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.067 -175.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -131.31 145.28 51.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -94.49 114.37 26.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.825 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.426 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.7 mttt -66.03 -19.42 65.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.847 -173.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -84.67 -25.35 28.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.831 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.0 mp -82.17 -52.55 6.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.549 ' H ' HD23 ' A' ' 122' ' ' LEU . 2.0 pt? -140.03 128.55 13.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.621 0.724 . . . . 0.0 110.878 173.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -77.8 -11.97 16.59 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.709 2.272 . . . . 0.0 112.349 -173.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -144.46 102.84 4.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.6 0.714 . . . . 0.0 110.895 -175.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -71.27 153.84 61.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.618 2.212 . . . . 0.0 112.364 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.07 143.02 70.31 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.654 2.236 . . . . 0.0 112.314 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.0 -18.73 42.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.8 p -135.05 159.66 40.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.178 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.419 ' HA ' HD13 ' A' ' 132' ' ' ILE . 79.9 m95 -69.77 -28.14 65.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.994 177.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.68 -22.32 66.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.817 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -82.26 -24.63 34.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.869 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.475 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -57.15 -46.95 99.8 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.564 0.697 . . . . 0.0 111.243 -171.073 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 84.0 Cg_exo -51.92 -49.25 17.91 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.613 2.209 . . . . 0.0 112.457 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.76 -59.08 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 -174.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.131 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -70.09 -16.15 63.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -172.02 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.528 ' N ' HD13 ' A' ' 135' ' ' LEU . 32.2 t70 -61.32 -38.61 87.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.879 168.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.76 -30.5 71.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.05 -48.01 47.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -177.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.645 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.4 pp -84.96 -13.24 51.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.645 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.2 tttt -57.99 -34.46 70.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 170.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.48 -24.83 67.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.078 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -94.97 3.67 54.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.912 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.27 30.74 56.52 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.439 177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -109.68 171.19 7.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.914 0.387 . . . . 0.0 110.824 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.6 t -124.49 140.13 53.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 168.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -68.09 -43.47 78.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.09 -170.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -143.21 127.36 17.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 57.5 ttm -110.49 132.75 53.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -152.9 158.27 41.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.896 -173.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -84.87 -59.15 2.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.972 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.143 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.1 tm? 48.27 30.49 2.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 -163.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -103.06 -6.8 21.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.99 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.7 152.36 79.64 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.656 0.741 . . . . 0.0 110.921 -175.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.446 ' HB3' ' HB3' ' A' ' 340' ' ' TRP . 53.9 Cg_exo -56.48 -32.21 88.61 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.694 2.262 . . . . 0.0 112.317 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -70.6 -27.47 64.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -79.67 -41.18 27.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.823 171.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.455 HG23 HG11 ' A' ' 347' ' ' VAL . 15.7 m -61.64 -49.58 75.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.121 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.567 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 17.4 t-105 -59.56 -48.65 95.1 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.471 0.653 . . . . 0.0 110.903 -161.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.567 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 94.5 Cg_exo -51.26 -44.78 40.96 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.812 2.341 . . . . 0.0 112.329 -176.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.709 ' O ' HD23 ' A' ' 160' ' ' LEU . 6.7 tt -72.16 -39.33 68.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -171.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.43 -41.59 73.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.149 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.15 -23.91 59.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.068 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.47 -35.24 71.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.188 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -103.58 10.05 37.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.973 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.88 4.7 22.62 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 169.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.38 67.87 3.02 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.46 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -89.86 133.15 34.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.858 0.361 . . . . 0.0 110.978 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.45 10.18 7.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.08 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -152.21 154.48 35.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -99.75 123.37 43.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 157.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -112.42 121.76 45.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.959 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -152.64 130.07 11.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -174.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 54.89 43.67 29.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 174.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.14 16.77 78.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.572 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.86 138.73 49.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.773 0.321 . . . . 0.0 110.862 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.87 144.25 27.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 170.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -125.51 112.42 16.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.562 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.2 pp -79.53 -12.02 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -177.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.96 -12.08 22.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -119.43 87.85 2.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.866 169.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.7 m -115.88 161.08 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -171.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.02 25.47 25.17 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.464 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.482 HG21 HD12 ' A' ' 368' ' ' ILE . 3.4 m -109.44 -19.01 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.838 0.351 . . . . 0.0 111.032 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -87.29 19.88 3.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -177.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -122.19 -170.06 2.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.019 -178.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.36 -29.55 70.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 -172.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.64 -42.99 95.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.529 -167.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.6 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.99 -37.23 86.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.988 0.423 . . . . 0.0 111.107 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.555 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -62.3 -38.25 88.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.825 175.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.9 -37.99 89.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.138 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.09 -46.3 81.44 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.521 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.701 HD11 ' HA ' ' A' ' 347' ' ' VAL . 19.7 tp -68.63 -34.23 75.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.87 0.367 . . . . 0.0 110.826 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.482 ' OG1' HG21 ' A' ' 357' ' ' VAL . 90.7 m -64.3 -42.77 96.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.197 176.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 74.8 t80 -68.43 -47.0 68.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.841 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.616 HD11 HD21 ' A' ' 151' ' ' LEU . 7.3 tt -50.45 -51.47 46.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 -174.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.95 -23.06 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.126 -174.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.3 m-20 -62.14 -33.39 74.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.946 -177.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.442 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.8 OUTLIER -81.49 -39.99 23.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.847 -173.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.414 ' H ' HG13 ' A' ' 199' ' ' ILE . 1.8 pp -73.53 -28.81 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.175 171.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.54 -37.61 80.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -79.22 -0.32 31.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 65.3 40.72 4.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 169.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -76.06 -16.11 59.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.782 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -144.71 157.99 43.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.873 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -95.44 152.01 18.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.871 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.02 -26.26 68.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -94.96 1.79 55.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.7 m -66.31 128.34 35.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -121.57 171.38 8.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -66.05 -36.85 84.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.029 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 97.2 p -68.76 -37.33 79.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.852 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.03 -41.0 90.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.052 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.99 -38.29 90.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.004 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -65.26 -43.52 91.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.927 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.37 95.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.132 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.66 -41.59 98.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.203 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -64.07 -39.56 94.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.939 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -63.97 -33.63 76.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.895 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -85.08 -17.38 37.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.969 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.66 24.44 46.13 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.545 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.39 -22.45 28.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 110.895 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.8 t -128.3 137.42 51.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.187 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.478 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -64.07 -52.14 60.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.128 -175.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.557 ' HB3' HD21 ' A' ' 115' ' ' LEU . 61.8 mtm -135.82 155.1 50.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.765 -172.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 65.3 p -139.64 162.21 35.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.239 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.7 mm -110.41 126.92 67.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.136 174.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -153.0 174.68 13.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.913 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -87.14 -156.27 29.25 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.471 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.3 -21.94 26.02 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.645 2.23 . . . . 0.0 112.341 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . 0.643 ' HD1' ' O ' ' A' ' 230' ' ' TRP . 4.9 t90 -67.37 -30.01 69.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 48.74 44.96 21.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -65.07 -20.82 66.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -173.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 67.6 m -47.75 -41.1 22.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.913 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 49.8 p30 -85.02 -178.86 6.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.881 -171.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 77.7 mt . . . . . 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.228 -168.364 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 N--CA 1.456 -0.14 0 CA-C-O 120.84 0.353 . . . . 0.0 111.102 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -104.28 128.73 52.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 -176.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.426 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 37.8 p90 -148.13 154.25 39.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.27 160.73 24.79 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.444 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' A' ' 316' ' ' ARG . 2.8 p -134.52 135.13 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.967 0.413 . . . . 0.0 111.099 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.3 t -154.13 149.88 27.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.136 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.5 m -60.54 165.57 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.09 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 1.4 mp -66.16 152.29 94.23 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.521 0.676 . . . . 0.0 111.047 -164.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -75.78 -176.41 2.99 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.747 2.298 . . . . 0.0 112.358 -173.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 94.9 m -86.9 145.43 26.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.07 -171.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -130.99 111.4 12.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 54.85 35.3 23.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.927 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.94 2.62 80.86 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -126.59 126.2 24.52 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.566 0.698 . . . . 0.0 110.844 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.01 134.98 66.74 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.654 2.236 . . . . 0.0 112.306 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 256' ' ' LYS . 73.1 m -82.52 -1.48 50.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.046 0.451 . . . . 0.0 110.844 174.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 255' ' ' SER . 90.9 mttt -37.28 130.0 0.8 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.605 0.717 . . . . 0.0 110.881 -178.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -78.16 163.17 28.13 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.632 2.221 . . . . 0.0 112.333 -163.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -74.52 163.97 27.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.842 -175.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 47.7 t -111.45 127.49 68.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.181 -168.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.484 ' HA3' ' NE2' ' A' ' 64' ' ' HIS . . . -112.85 141.49 16.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.426 174.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 89.2 t -124.7 116.98 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.746 0.308 . . . . 0.0 111.183 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.33 119.97 11.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.881 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.7 m -126.18 131.1 52.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.785 -167.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.58 139.07 51.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.093 -175.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.67 170.13 21.21 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.432 -169.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.696 HG13 ' HG2' ' A' ' 277' ' ' LYS . 24.7 mm -111.23 125.03 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 -174.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -63.14 130.79 46.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.486 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -58.17 -28.56 64.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.123 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.17 -7.0 58.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.019 -173.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 22.3 t -67.31 119.04 62.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.649 0.738 . . . . 0.0 110.915 -172.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.421 ' HD2' HG21 ' A' ' 2' ' ' ILE . 83.8 Cg_endo -71.26 -10.47 27.23 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.587 2.192 . . . . 0.0 112.327 168.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -103.4 12.88 34.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.824 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -49.33 -35.89 19.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -167.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -68.49 -47.52 66.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.969 -171.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.3 pp -81.47 -27.47 34.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.24 -46.89 75.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.054 173.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.696 ' HG2' HG13 ' A' ' 266' ' ' ILE . 50.3 mtmt -58.08 -41.73 84.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.902 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 95.6 mt-10 -69.87 -40.66 75.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.898 -177.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 15.9 m-30 -67.63 -39.5 84.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.529 ' HA ' HD22 ' A' ' 284' ' ' LEU . 4.0 tt -65.29 -53.26 46.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.977 -172.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.431 ' HA ' HD21 ' A' ' 285' ' ' LEU . 40.3 tt0 -75.19 -35.6 61.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -175.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 82.8 m-20 -103.57 -12.77 16.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.846 -160.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.644 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 62.3 m-85 -128.55 -48.6 1.28 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -177.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.529 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.7 OUTLIER -64.39 -36.56 84.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.98 -174.061 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 1.044 ' HB3' HG13 ' A' ' 108' ' ' ILE . 2.4 pp -124.71 38.27 4.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -175.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.455 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 6.6 t -114.25 163.65 14.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 286' ' ' THR . 16.4 p-10 -40.15 -43.88 1.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -175.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -74.85 -41.42 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.893 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.644 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.75 -53.9 7.84 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.516 -169.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.553 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -72.63 -20.1 61.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.725 0.298 . . . . 0.0 110.9 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.503 ' N ' HD12 ' A' ' 290' ' ' LEU . 86.5 tt0 -67.16 -45.56 76.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.813 169.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.93 -38.77 92.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.071 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.411 HG13 ' HA3' ' A' ' 19' ' ' GLY . 59.9 t -75.18 -46.8 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.116 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -64.97 -28.89 69.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.62 -25.95 68.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.826 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -82.23 -48.14 11.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.935 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.404 ' O ' HD13 ' A' ' 299' ' ' LEU . 85.7 tttt -151.03 138.94 12.49 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.511 0.672 . . . . 0.0 110.942 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -50.66 116.76 2.76 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.769 2.312 . . . . 0.0 112.363 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 299' ' ' LEU . 0.2 OUTLIER -85.98 -19.99 29.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.005 174.275 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 98.49 -57.7 0.99 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.442 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.608 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -168.19 155.33 7.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.787 0.327 . . . . 0.0 111.165 175.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.805 HG21 ' HB3' ' A' ' 307' ' ' TYR . 18.4 m -115.89 154.58 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.03 -15.62 61.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.103 173.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.553 ' CD2' HD21 ' A' ' 290' ' ' LEU . 39.9 tp -80.92 121.93 26.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.936 -174.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -53.91 -41.88 68.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.935 -177.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 48.3 t -62.99 -49.98 72.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -169.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.805 ' HB3' HG21 ' A' ' 302' ' ' VAL . 10.9 t80 -76.5 -30.71 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.987 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -60.73 -40.67 93.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 176.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.33 -36.94 76.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.65 -39.33 57.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 176.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.608 HD13 ' HA ' ' A' ' 301' ' ' ALA . 76.7 mt -61.19 -34.57 75.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.11 -19.12 61.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 -176.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -64.89 -21.12 66.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.005 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -93.17 121.86 64.57 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.663 0.744 . . . . 0.0 110.916 167.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.29 -25.41 9.84 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.776 2.318 . . . . 0.0 112.35 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . 0.405 ' HA ' HG11 ' A' ' 244' ' ' VAL . 82.7 mtt85 -60.91 -33.38 73.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -176.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.586 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.1 mp -81.19 -26.98 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.088 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.83 -40.41 79.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.07 -172.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.9 81.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.088 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 58.1 p -64.18 -29.55 70.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 -173.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.6 mtp -67.92 -34.87 77.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -65.64 -47.07 76.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.842 -172.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.404 ' O ' ' N ' ' A' ' 327' ' ' GLY . 8.7 p-10 -80.0 -25.69 40.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.797 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.44 -49.18 74.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.103 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -70.72 -37.18 73.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.89 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -105.44 -7.55 18.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 -168.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -90.94 -159.92 36.09 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.481 -172.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -139.9 147.78 41.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.776 0.322 . . . . 0.0 111.03 -175.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 40.7 mm -64.74 123.2 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.136 -171.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 50.2 tpp . . . . . 0 C--N 1.329 -0.286 0 CA-C-O 121.565 0.697 . . . . 0.0 110.898 -178.786 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 C--O 1.23 0.044 0 CA-C-O 120.741 0.305 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 73.9 mmm -80.07 -17.5 52.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -172.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.6 m -61.94 -40.97 97.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.825 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.62 -37.05 60.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.549 ' O ' HG13 ' A' ' 343' ' ' VAL . 3.6 m-30 -65.12 -41.27 95.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.812 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 154' ' ' PRO . 12.2 m0 -60.03 -35.66 75.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 176.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -68.06 -41.85 81.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.25 -44.1 84.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.004 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 339' ' ' PHE . 16.9 m -74.07 -31.03 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 -176.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 347' ' ' VAL . 4.9 tmt_? -65.6 -39.65 91.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 175.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 87.4 m -58.72 -35.39 72.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 174.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.78 -43.63 95.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 -175.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.701 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.0 m -74.17 -34.13 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.169 -174.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.439 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -63.34 -47.1 93.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 174.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -64.85 -39.51 93.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.26 -44.42 62.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.114 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.33 -39.9 77.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.086 -175.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.2 p -75.69 -11.09 59.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.838 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.21 16.56 74.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.463 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.21 -32.45 44.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.318 . . . . 0.0 110.883 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -138.78 155.35 48.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.1 p -76.74 171.43 14.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 170.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.482 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.1 t -57.51 -43.22 82.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.124 171.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -61.44 -45.71 93.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.863 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -69.64 -52.41 26.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -72.3 -48.25 43.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.121 -173.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.6 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.4 tm? -65.59 -45.02 84.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -173.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.82 -53.57 48.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.965 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -68.09 -46.03 72.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -173.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.71 -42.31 91.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 -174.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 79.0 mm-40 -76.81 -27.93 55.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.97 -176.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 53.3 m -61.73 -34.99 76.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.225 171.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -58.77 -30.09 67.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.482 HD12 HG21 ' A' ' 183' ' ' VAL . 70.3 mt -60.85 -38.14 78.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.151 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.0 p -94.64 -14.98 24.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.154 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.831 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.773 0.32 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . 0.431 HG21 ' HD2' ' A' ' 271' ' ' PRO . 74.8 mt -100.46 131.81 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 177.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -148.15 139.81 23.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -51.93 136.47 28.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.792 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.74 2.69 62.88 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.529 -173.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 64.3 pttt -165.03 146.96 7.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 0.0 110.954 171.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.543 HD22 HD11 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -147.68 160.01 43.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -177.231 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.409 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 71.2 t -111.98 134.05 55.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.081 -177.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.729 HG23 ' HB ' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -120.02 131.56 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.082 179.094 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.716 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 65.2 m95 -107.51 128.25 54.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.952 168.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.452 ' HB ' HD22 ' A' ' 20' ' ' LEU . 7.2 tt -109.59 149.86 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.076 -166.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -58.1 155.35 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -173.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.35 -22.76 24.06 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.378 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -73.78 -14.12 61.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.877 0.37 . . . . 0.0 110.906 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HD2' ' HD3' ' A' ' 297' ' ' LYS . 24.0 mmmt -134.3 137.25 44.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.924 171.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.02 -85.08 0.98 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.466 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -110.04 -44.91 3.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.904 0.383 . . . . 0.0 110.92 -176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -68.16 -51.87 40.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 -148.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 1.008 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -57.74 -49.82 70.83 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.516 -176.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.596 HD21 ' HB ' ' A' ' 9' ' ' ILE . 55.1 tp -57.24 -41.94 80.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.827 0.346 . . . . 0.0 110.914 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.82 -38.61 67.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.071 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 67.2 mm-40 -70.57 -50.4 37.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.807 -176.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 20' ' ' LEU . 17.7 m -72.53 -36.54 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.185 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.407 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -64.34 -49.34 66.33 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.494 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 57.7 pttt -59.47 -24.71 63.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.924 0.392 . . . . 0.0 110.956 -175.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -59.88 -37.11 78.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 1.2 m-30 -56.75 -47.73 79.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.472 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 88.7 mt-10 -66.6 -35.96 81.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.981 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.53 -35.49 73.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.85 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -94.8 -50.04 5.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.811 -170.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.2 p -115.86 -1.08 12.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 -169.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.41 9.92 84.48 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.421 167.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.858 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -99.36 132.93 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 111.159 -177.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.8 mttt -74.21 140.36 45.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 -171.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.542 ' HB ' HD11 ' A' ' 9' ' ' ILE . 2.9 m -116.72 134.34 60.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.113 177.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.514 ' O ' HD12 ' A' ' 9' ' ' ILE . 99.6 m -103.94 127.8 51.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 176.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.59 HG13 HD23 ' A' ' 20' ' ' LEU . 54.8 t -93.07 126.66 45.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.201 175.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -119.93 145.74 46.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.974 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -88.95 141.14 29.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.528 0.68 . . . . 0.0 110.929 -168.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.439 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 85.2 Cg_exo -56.62 -26.29 64.0 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.736 2.291 . . . . 0.0 112.251 -174.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -47.34 -51.28 19.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 -171.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.84 -8.92 55.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 9.8 tt -47.85 -55.26 10.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 -170.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -64.76 -35.83 82.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.36 -39.52 92.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 50' ' ' VAL . 75.1 mmtt -80.44 -23.84 39.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.57 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 83.9 t80 -50.87 -50.26 75.25 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.665 0.745 . . . . 0.0 110.807 -160.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 44.4 Cg_endo -82.72 -32.32 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.685 2.256 . . . . 0.0 112.306 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -75.89 -46.41 30.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 -165.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.508 HG21 ' HG3' ' A' ' 57' ' ' PRO . 21.0 m -72.36 -27.16 25.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.04 -171.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.714 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -70.28 -35.78 73.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.098 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.11 -33.2 74.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.124 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.9 p -90.58 -20.25 22.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.2 8.35 69.73 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.542 172.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -118.35 116.84 27.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.35 . . . . 0.0 110.87 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.94 -92.75 0.13 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.502 171.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.716 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 71.2 Cg_endo -79.42 146.79 19.7 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.68 2.254 . . . . 0.0 112.362 -177.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -97.53 -35.06 10.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.777 163.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.729 ' HB ' HG23 ' A' ' 9' ' ' ILE . 35.4 mt -124.79 137.37 57.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.106 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.3 tp -132.77 125.22 52.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -88.34 140.11 29.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.731 168.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.463 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 21.9 p90 -142.85 163.39 32.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.979 171.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.83 -90.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 -164.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.669 ' CE1' ' HA3' ' A' ' 260' ' ' GLY . 23.2 m170 -130.56 -64.63 0.83 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 -173.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -95.13 -13.92 24.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -167.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.78 -14.49 14.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.997 -165.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.556 ' HB2' HD13 ' A' ' 104' ' ' ILE . 30.5 p90 -57.42 -32.43 66.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.875 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.77 -51.21 60.05 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.492 -170.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.59 -36.96 92.15 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.576 175.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.689 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 13.6 t80 -66.56 -41.94 87.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 -176.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.85 -40.98 68.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.169 174.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -57.58 -37.54 73.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.9 m -85.47 -4.98 59.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.982 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.32 30.07 59.21 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.492 174.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.714 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 58.9 mt -87.17 -10.07 53.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.919 0.39 . . . . 0.0 110.929 -167.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.689 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -130.95 153.77 48.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.924 -176.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -81.4 142.12 33.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 174.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.81 142.3 49.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.433 HD12 ' CZ ' ' A' ' 106' ' ' TYR . 36.9 pt -106.52 155.41 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 -177.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.6 m -96.1 130.57 30.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.666 0.746 . . . . 0.0 111.064 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.36 142.31 65.6 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.673 2.248 . . . . 0.0 112.326 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -113.92 114.78 26.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.21 -36.02 60.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.78 -43.47 98.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.021 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -74.54 -32.98 62.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.875 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.478 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 85.6 mt-30 -54.94 -51.49 65.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -57.6 -34.71 69.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.781 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.27 -24.53 57.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 -175.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.97 -104.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 -170.573 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 33.9 t80 172.66 128.84 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.739 0.781 . . . . 0.0 110.903 -169.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -52.31 -36.26 67.5 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.345 -173.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -65.14 -35.19 80.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 -173.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.3 p -73.47 -29.7 62.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.169 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.625 ' HA ' HG22 ' A' ' 97' ' ' VAL . 92.5 m95 -67.88 -30.55 69.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.972 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -69.25 -30.17 68.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.943 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.14 -26.04 62.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.038 175.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.625 HG22 ' HA ' ' A' ' 94' ' ' TRP . 16.3 m -109.96 20.7 5.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.14 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -113.8 132.52 55.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -132.1 119.45 20.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.5 t30 58.4 35.29 24.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.918 176.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.21 -0.41 89.74 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.449 175.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.25 149.42 42.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 0.0 110.861 175.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.596 HD22 HG23 ' A' ' 97' ' ' VAL . 18.4 mt -84.03 136.0 34.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.556 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -123.11 -2.3 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.051 -175.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.463 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -161.15 164.45 30.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.12 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.433 ' CZ ' HD12 ' A' ' 79' ' ' ILE . 89.9 m-85 -112.27 143.26 28.49 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.626 0.727 . . . . 0.0 110.948 170.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.33 121.42 5.24 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.669 2.246 . . . . 0.0 112.336 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.926 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -104.25 -36.72 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.177 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -146.0 153.12 40.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 -170.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.3 t -117.96 130.42 72.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.5 mp0 -110.64 131.98 54.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.806 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -153.09 144.66 23.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.119 177.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.6 mp -89.0 160.25 17.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.972 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.9 p -151.49 152.44 33.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.86 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.869 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -93.76 128.88 40.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 171.043 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.626 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.7 mp -111.39 132.04 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.236 -174.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -131.81 146.97 52.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.988 0.423 . . . . 0.0 110.86 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -91.88 117.4 29.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.893 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.91 -25.92 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.964 -172.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -84.68 -20.82 30.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 -172.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.9 mp -80.08 -54.03 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 169.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.747 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.3 pt? -140.32 127.23 12.23 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.564 0.697 . . . . 0.0 110.921 173.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.42 -7.06 14.87 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.665 2.244 . . . . 0.0 112.348 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.426 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 56.3 t-20 -147.22 95.27 4.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.725 0.774 . . . . 0.0 110.839 -176.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 58.6 Cg_endo -68.23 155.68 68.48 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.64 2.227 . . . . 0.0 112.376 177.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.52 143.67 76.4 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.64 2.226 . . . . 0.0 112.423 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -86.72 -15.76 38.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 80.6 p -133.68 156.75 47.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.409 ' HA ' HD13 ' A' ' 132' ' ' ILE . 74.1 m95 -70.77 -27.98 64.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.982 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.21 -19.58 65.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.843 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -80.3 -25.53 39.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.488 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -57.56 -46.27 99.79 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.567 0.698 . . . . 0.0 111.184 -169.249 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 86.4 Cg_exo -52.93 -50.74 13.02 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.712 2.274 . . . . 0.0 112.385 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.95 -59.49 4.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.158 HD22 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.41 -16.24 63.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -172.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.576 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.7 t70 -61.88 -41.69 98.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 167.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.66 -30.59 69.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.923 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.1 -46.86 60.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.84 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.1 pp -85.08 -14.32 47.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.965 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.612 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.6 tttt -60.98 -33.99 74.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.95 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.32 -24.03 67.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.993 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -94.98 4.3 53.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.942 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.03 31.98 57.11 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.572 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -110.24 170.14 8.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 0.0 110.885 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.7 t -121.04 140.94 51.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.827 168.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -67.67 -40.6 84.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.144 -174.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.406 HD22 ' H ' ' A' ' 148' ' ' MET . 2.1 tm? -140.78 133.48 28.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.958 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.406 ' H ' HD22 ' A' ' 147' ' ' LEU . 53.2 ttm -119.22 131.35 55.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.844 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -153.99 155.64 35.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 -174.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -86.27 -53.37 5.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -177.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.987 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.3 tm? 48.01 32.81 3.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.909 -169.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -100.24 -7.15 24.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.887 175.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.65 154.92 80.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.68 0.753 . . . . 0.0 110.922 -172.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -59.94 -25.07 78.48 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.673 2.248 . . . . 0.0 112.38 173.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -71.62 -29.41 64.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.84 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -81.43 -39.79 24.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 171.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.411 HG23 HG11 ' A' ' 347' ' ' VAL . 22.1 m -60.35 -48.34 82.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.585 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 40.5 t-105 -57.07 -54.42 54.78 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.444 0.64 . . . . 0.0 110.81 -168.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 24.3 Cg_endo -63.99 -20.04 67.31 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.544 2.163 . . . . 0.0 112.388 -174.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.774 HD13 ' C ' ' A' ' 160' ' ' LEU . 1.7 tm? -81.6 -44.92 16.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.507 HG22 ' HA3' ' A' ' 166' ' ' GLY . 79.2 mt -74.98 -43.78 45.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.84 -24.7 66.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.972 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -58.26 -30.87 66.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.56 3.59 42.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 104.63 8.32 37.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.547 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.507 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -75.7 67.41 2.3 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.435 177.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -80.5 132.2 35.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.772 0.32 . . . . 0.0 110.939 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.86 6.36 11.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.127 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.452 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.2 p90 -154.0 155.81 36.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.906 -175.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -99.99 127.4 46.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.915 156.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -114.19 120.6 41.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -153.26 130.03 10.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -171.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 54.97 42.2 31.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.19 16.09 78.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.526 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.97 139.95 50.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.698 0.285 . . . . 0.0 110.93 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -96.47 144.94 26.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.923 170.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -128.06 111.97 14.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.885 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.562 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.2 pp -80.06 -11.38 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -96.9 -10.16 27.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -125.51 85.97 2.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 169' ' ' PHE . 31.1 m -113.97 164.79 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.056 -170.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.8 25.55 22.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.562 -173.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.439 HG21 HD12 ' A' ' 368' ' ' ILE . 2.1 m -106.53 -19.99 6.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.904 0.383 . . . . 0.0 111.156 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -87.39 21.79 2.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.799 -176.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -109.31 -176.32 2.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.927 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.52 -28.34 66.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.071 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.53 -40.08 78.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.492 -169.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.514 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -59.88 -40.08 87.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 111.11 175.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.574 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.2 mttt -62.23 -39.04 91.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.979 175.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.0 86.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.196 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.438 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -67.15 -46.02 76.02 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.516 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.736 HD11 ' HA ' ' A' ' 347' ' ' VAL . 22.8 tp -66.62 -35.5 80.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 110.821 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.55 ' OG1' HG21 ' A' ' 357' ' ' VAL . 94.3 m -65.07 -41.48 95.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 176.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 51.8 t80 -66.03 -49.68 66.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 177.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.701 HD23 ' C ' ' A' ' 195' ' ' LEU . 5.4 tt -50.72 -51.11 52.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.884 -174.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 199' ' ' ILE . 31.2 m -64.25 -22.47 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.177 -174.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.2 m-20 -62.27 -33.53 74.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 0.43 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.9 OUTLIER -80.69 -40.09 26.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -174.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.548 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.8 pp -73.7 -28.67 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.234 172.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -68.57 -37.63 80.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -80.63 2.79 24.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 68.0 38.51 2.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 169.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -78.28 -17.04 57.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.548 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.2 ppp? -145.3 157.18 44.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.934 174.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -94.63 150.65 20.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.4 -26.22 67.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -96.59 1.52 51.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.936 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 94.1 m -64.0 125.05 23.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.07 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.425 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 17.3 t0 -120.45 174.98 6.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.905 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -62.82 -40.41 97.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.999 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 98.6 p -67.58 -38.05 83.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.823 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.425 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 76.6 mt -65.05 -42.32 94.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.14 174.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.47 -35.6 80.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.107 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.27 -48.1 82.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.49 -42.36 95.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.111 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.05 -49.03 71.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.2 -43.39 98.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.911 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -63.18 -29.61 70.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.861 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -85.92 -16.74 37.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.24 25.04 29.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.431 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -83.28 -21.28 33.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 110.916 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.8 t -126.16 136.37 52.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.25 178.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.594 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -62.18 -48.8 78.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.024 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.586 ' HB3' HD21 ' A' ' 115' ' ' LEU . 66.9 mtm -135.0 160.06 39.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 -173.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.0 t -150.44 157.34 42.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.183 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 mm -111.58 129.42 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 -176.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -155.42 173.71 16.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -83.73 -153.37 15.64 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.395 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.11 -26.4 36.69 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.736 2.29 . . . . 0.0 112.328 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -76.01 -29.18 58.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 43.79 44.96 5.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.169 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 32.1 m0 -66.11 -20.63 66.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 63.6 m -71.22 -18.1 62.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -81.2 -175.37 5.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -174.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 87.9 mt . . . . . 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 176.561 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 97.9 t . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.892 0.377 . . . . 0.0 111.07 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -77.77 140.98 39.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.33 149.93 38.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.3 161.73 26.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.503 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.08 139.4 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.932 0.396 . . . . 0.0 111.1 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.3 t -153.4 149.08 27.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.161 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 22.4 m -59.95 163.51 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.153 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 3.8 mp -67.7 153.3 95.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.625 0.726 . . . . 0.0 111.029 -159.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 47.5 Cg_exo -63.75 178.92 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.699 2.266 . . . . 0.0 112.393 -175.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.0 m -92.52 145.71 24.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.21 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -131.26 112.2 12.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.952 -172.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 54.65 34.97 22.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.943 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.1 1.59 81.74 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.565 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -128.38 127.03 23.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.582 0.706 . . . . 0.0 110.896 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -55.28 136.9 75.56 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.673 2.249 . . . . 0.0 112.337 -176.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 256' ' ' LYS . 67.7 m -80.06 -5.05 55.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.798 170.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 255' ' ' SER . 97.3 mttt -38.31 129.05 1.05 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.514 0.673 . . . . 0.0 110.912 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -83.09 163.11 15.52 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.666 2.244 . . . . 0.0 112.384 -163.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -72.99 164.95 25.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.4 t -110.89 132.29 59.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.173 -168.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.669 ' HA3' ' CE1' ' A' ' 64' ' ' HIS . . . -114.85 138.92 15.19 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.443 176.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 74.0 t -126.13 116.54 46.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 111.24 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -66.28 122.52 17.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.984 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 51.0 m -124.11 131.11 53.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 -166.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.99 133.88 50.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.02 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.55 172.5 20.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.455 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 34.9 mm -113.99 130.48 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.785 0.326 . . . . 0.0 111.178 -173.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -61.86 128.99 38.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.984 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.469 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -58.85 -30.93 68.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.165 -178.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.28 -5.21 59.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.033 -172.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 15.6 t -71.51 120.23 78.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.68 0.752 . . . . 0.0 110.951 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . 0.431 ' HD2' HG21 ' A' ' 2' ' ' ILE . 97.8 Cg_endo -67.49 -9.89 26.85 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.623 2.215 . . . . 0.0 112.342 167.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -109.06 16.89 22.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -55.79 -32.93 63.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -170.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.67 -47.48 63.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.958 0.409 . . . . 0.0 110.896 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.0 pp -78.69 -31.03 46.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.9 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.77 -48.74 68.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.064 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -65.97 -34.98 79.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.51 -40.98 73.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 19.0 m-30 -66.97 -38.73 86.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 176.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.427 ' HA ' HD22 ' A' ' 284' ' ' LEU . 5.3 tt -57.62 -51.5 69.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 -176.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -75.31 -27.98 59.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -98.68 -13.5 20.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -167.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.754 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 69.0 m-85 -121.19 -60.13 1.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 280' ' ' LEU . 1.4 mp -61.44 -33.68 74.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.937 -161.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.926 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.2 pp -123.78 37.88 4.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.994 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.462 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 67.9 p -121.25 162.36 20.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 177.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.432 ' HA ' HD11 ' A' ' 290' ' ' LEU . 38.7 t70 -45.66 -36.29 4.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 -167.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -78.73 -42.02 29.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.984 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.754 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.9 -52.9 8.57 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.505 -170.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.604 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -72.62 -20.08 61.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.754 0.312 . . . . 0.0 110.965 -178.457 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.563 ' N ' HD12 ' A' ' 290' ' ' LEU . 35.3 tt0 -70.62 -47.93 57.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.774 172.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.65 97.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.098 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 1.008 HG23 ' HA3' ' A' ' 19' ' ' GLY . 2.8 p -78.71 -32.17 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 -176.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -68.78 -27.72 66.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.785 171.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.62 -25.05 67.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -88.39 -40.12 13.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.404 ' HD3' ' HD2' ' A' ' 15' ' ' LYS . 85.2 tttt -146.06 135.17 11.26 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.475 0.655 . . . . 0.0 110.951 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -58.28 109.03 0.44 Allowed 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.744 2.296 . . . . 0.0 112.289 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 61.6 mt -89.89 -18.59 25.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.978 -171.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 109.49 -59.49 0.35 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.525 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.6 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -169.37 165.24 10.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.359 . . . . 0.0 111.095 175.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.681 HG21 ' HB3' ' A' ' 307' ' ' TYR . 29.8 m -124.9 153.92 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.02 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.91 -8.41 56.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.115 172.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.604 ' CD2' HD21 ' A' ' 290' ' ' LEU . 44.7 tp -85.9 119.06 25.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.953 -177.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.01 -40.99 67.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -174.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.8 m -65.12 -50.13 67.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.829 -168.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.681 ' HB3' HG21 ' A' ' 302' ' ' VAL . 17.5 t80 -77.11 -28.62 54.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.953 -177.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -64.77 -38.98 92.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.915 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.31 -35.01 78.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.935 175.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -73.38 -41.33 63.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.952 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.6 HD13 ' HA ' ' A' ' 301' ' ' ALA . 77.2 mt -60.05 -31.87 70.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.884 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.54 -17.86 56.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.06 -19.64 66.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -90.9 121.73 67.67 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.624 0.726 . . . . 0.0 110.895 164.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -47.37 -28.05 7.88 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.737 2.291 . . . . 0.0 112.304 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -61.32 -30.96 70.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -172.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.467 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.1 mp -79.98 -30.23 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 -173.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.53 96.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.032 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.06 -44.1 77.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.023 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 82.6 p -65.43 -31.13 72.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 -171.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.9 mtp -65.49 -33.3 75.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -64.75 -47.19 79.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 -174.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.477 HD21 ' HB1' ' A' ' 112' ' ' ALA . 8.5 p-10 -82.97 -28.87 29.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.766 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.39 -52.31 62.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.033 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -65.86 -28.3 68.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.016 0.436 . . . . 0.0 110.984 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -109.63 -8.32 14.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.8 -168.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -89.88 -153.57 28.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.461 -166.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -146.1 140.81 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 0.0 110.919 -170.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 42.2 mm -60.31 121.37 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 -166.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 93.0 mtp . . . . . 0 C--N 1.33 -0.254 0 CA-C-O 121.522 0.677 . . . . 0.0 110.902 179.34 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.8 0.333 . . . . 0.0 110.908 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 54.7 mmm -80.13 -17.37 52.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.811 -170.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.5 m -60.82 -41.44 95.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.846 176.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.83 -35.64 59.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 6.4 m-30 -66.21 -42.37 88.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.964 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -56.51 -37.85 70.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.02 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -68.47 -41.22 80.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.17 -43.4 87.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.097 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 339' ' ' PHE . 20.4 m -73.4 -32.04 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.137 -177.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.451 ' O ' HG22 ' A' ' 347' ' ' VAL . 5.0 tmt_? -64.93 -38.94 92.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.873 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.3 m -58.68 -36.68 74.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.173 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.05 -43.75 91.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.108 -174.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.736 ' HA ' HD11 ' A' ' 192' ' ' LEU . 8.2 m -73.17 -34.92 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.153 -175.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.455 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -63.62 -47.27 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 173.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -63.59 -39.7 95.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.16 -45.51 60.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.025 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.29 -40.38 81.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.116 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 92.0 p -76.31 -10.91 59.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.09 16.61 74.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.46 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.03 -32.39 50.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 0.0 110.95 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -139.37 155.15 47.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.984 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 48.7 p -77.7 167.44 21.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 170.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.55 HG21 ' OG1' ' A' ' 193' ' ' THR . 54.8 t -55.89 -42.03 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.16 173.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -60.65 -46.88 88.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -69.11 -52.2 30.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -71.87 -49.39 38.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 -173.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.608 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 1.4 tm? -65.14 -46.87 79.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.968 -173.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.02 -53.44 53.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.847 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -67.14 -46.61 73.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -174.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.09 -41.8 94.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.091 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 68.0 mm-40 -77.74 -26.75 50.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.95 -177.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.2 m -64.44 -35.99 82.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.226 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.18 -30.4 68.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.971 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.439 HD12 HG21 ' A' ' 183' ' ' VAL . 70.0 mt -60.35 -38.49 77.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 173.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 60.8 p -93.45 -14.46 26.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.886 179.209 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.713 0.292 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 76.4 mt -95.96 133.93 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.191 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -146.51 139.15 25.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -52.43 137.77 28.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.16 1.62 62.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.442 -173.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 64.4 pttt -164.53 149.85 10.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.74 0.305 . . . . 0.0 110.966 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.628 ' H ' HD23 ' A' ' 7' ' ' LEU . 1.2 pt? -147.67 158.07 43.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.947 -176.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 70.4 t -110.79 131.83 60.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.743 HG23 ' HB ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -119.94 132.08 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.149 -179.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.673 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 70.8 m95 -106.08 128.8 54.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.943 169.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 20' ' ' LEU . 5.9 tt -109.41 149.96 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.157 -168.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -60.89 154.69 21.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -172.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.19 -21.3 31.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.495 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -72.93 -12.34 60.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.358 . . . . 0.0 110.812 -171.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.588 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -146.98 135.64 22.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 167.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.07 -79.91 1.06 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.599 -171.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -105.57 -44.93 4.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.958 0.409 . . . . 0.0 110.917 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -67.91 -52.92 30.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.864 -148.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 1.117 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -57.11 -51.95 54.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.498 -175.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.603 HD21 ' HB ' ' A' ' 9' ' ' ILE . 59.6 tp -57.87 -43.76 86.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 0.0 110.968 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.76 -40.05 59.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.991 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -69.71 -55.29 10.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 20' ' ' LEU . 22.0 m -69.83 -35.95 67.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.164 -175.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.406 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -62.83 -45.65 95.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.407 172.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -56.76 -30.2 63.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 110.996 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -57.55 -38.2 74.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 176.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 1.8 m-30 -56.22 -49.61 73.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.888 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 93.2 mt-10 -66.28 -35.41 80.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -69.3 -37.33 77.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -96.55 -47.99 5.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.918 0.39 . . . . 0.0 110.925 -169.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.8 p -114.73 -1.97 13.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.161 -169.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.88 8.73 82.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.417 166.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -99.46 133.0 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 111.121 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.6 mttt -75.17 139.75 42.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.852 -169.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.486 ' HB ' HD11 ' A' ' 9' ' ' ILE . 2.7 m -116.44 134.46 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.498 ' O ' HD12 ' A' ' 9' ' ' ILE . 98.3 m -105.12 127.54 52.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.136 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.578 HG13 HD23 ' A' ' 20' ' ' LEU . 54.5 t -91.53 127.05 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.155 175.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -119.14 147.01 44.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.828 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 63.6 t-80 -88.82 142.18 30.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.593 0.711 . . . . 0.0 110.887 -166.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 86.8 Cg_exo -54.9 -25.21 42.62 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.569 2.179 . . . . 0.0 112.379 -175.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -48.43 -56.79 7.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 -173.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -86.6 -4.07 59.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 8.1 tt -45.94 -53.81 9.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.896 -172.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.02 -35.48 80.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.846 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -67.37 -43.48 81.3 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.884 -173.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -80.47 -21.36 42.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 50.6 t80 -49.99 -51.51 60.98 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.564 0.697 . . . . 0.0 110.806 -165.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 61.6 Cg_endo -80.94 -29.68 2.0 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.615 2.21 . . . . 0.0 112.403 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -74.6 -40.33 61.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 -168.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 m -66.58 -27.68 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.121 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.782 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -67.61 -36.09 80.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.09 -31.38 70.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.024 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.8 p -93.0 -17.77 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.128 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.22 11.22 75.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.522 173.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -140.05 140.06 36.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.881 0.372 . . . . 0.0 110.827 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.96 -96.61 0.16 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.435 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.673 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 78.9 Cg_endo -80.08 148.79 19.54 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.728 2.286 . . . . 0.0 112.238 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -96.94 -35.99 10.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 165.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.743 ' HB ' HG23 ' A' ' 9' ' ' ILE . 46.6 mt -125.87 138.26 55.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.105 -176.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 tp -131.2 125.91 58.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.153 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -91.31 137.57 32.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 167.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.489 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 31.2 p90 -140.5 162.62 34.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.017 172.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.46 -87.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.039 -167.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.504 ' NE2' ' HA3' ' A' ' 260' ' ' GLY . 10.8 m170 -128.17 -68.69 0.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -173.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -96.81 -10.92 25.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.811 -162.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -57.27 -14.28 4.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 -169.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.564 ' HB2' HD13 ' A' ' 104' ' ' ILE . 33.5 p90 -59.29 -29.41 67.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.9 -51.75 57.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.468 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.76 -36.55 92.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.522 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -55.45 -51.75 65.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 110.931 179.053 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.2 -43.11 58.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.16 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -56.86 -38.83 73.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 -175.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.404 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 61.8 m -84.8 -7.44 59.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.003 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.95 30.26 59.58 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.469 173.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.782 HD22 ' HB1' ' A' ' 51' ' ' ALA . 42.1 mt -89.35 -8.78 52.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.827 0.346 . . . . 0.0 110.886 -168.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -129.06 152.2 48.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -176.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.03 139.65 35.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.025 172.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.69 142.95 51.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.0 pt -104.15 154.53 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.9 m -90.67 123.85 64.0 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.672 0.749 . . . . 0.0 111.115 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.83 136.6 75.33 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.772 2.315 . . . . 0.0 112.395 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -105.05 111.79 24.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.16 -40.0 92.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.84 -176.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.39 97.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -71.97 -36.87 69.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.454 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 66.3 tt0 -51.73 -51.8 53.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.96 174.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -57.99 -37.07 73.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.802 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.38 -21.66 52.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.863 -174.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -105.06 -105.02 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.907 -172.04 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 27.7 t80 172.19 126.7 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.682 0.753 . . . . 0.0 110.963 -167.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 93.7 Cg_exo -54.66 -36.38 89.6 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.796 2.33 . . . . 0.0 112.407 -172.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -65.03 -35.1 80.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -172.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.1 p -76.72 -32.21 57.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.215 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.545 ' CE3' HD13 ' A' ' 103' ' ' LEU . 92.7 m95 -70.32 -29.09 65.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.002 173.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.07 -31.44 71.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 177.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.03 -24.04 64.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.092 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' A' ' 94' ' ' TRP . 17.9 m -106.35 15.95 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -99.98 131.5 45.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -129.37 117.45 20.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.7 t30 57.8 35.57 25.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.857 175.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.79 0.19 89.72 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.536 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -124.69 146.37 49.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 110.835 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.545 HD13 ' CE3' ' A' ' 94' ' ' TRP . 26.8 mt -88.56 135.35 33.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.799 -171.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.564 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.8 pp -121.87 -1.68 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.489 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -158.8 161.43 36.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.086 -176.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.491 ' HB3' ' CD2' ' A' ' 285' ' ' LEU . 93.9 m-85 -110.27 138.25 20.82 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.662 0.744 . . . . 0.0 110.878 172.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.05 118.15 5.15 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.636 2.224 . . . . 0.0 112.303 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.898 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -103.24 -36.4 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -148.81 152.7 36.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 -172.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.54 130.71 73.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.112 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.469 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 92.0 mt-10 -129.74 128.57 42.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.801 ' HB1' HD21 ' A' ' 323' ' ' ASN . . . -150.8 152.26 33.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.126 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.522 ' HB2' ' CB ' ' A' ' 257' ' ' PRO . 5.1 mp -84.29 171.34 12.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.976 -161.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.1 p -156.02 154.7 31.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 -172.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.876 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -99.14 127.66 45.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.812 168.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.594 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.3 mp -111.45 130.04 65.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.21 -175.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -131.34 148.46 52.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.928 -173.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -92.06 120.01 32.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.823 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.416 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.5 mttt -70.13 -25.74 63.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -174.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -86.59 -23.07 25.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.8 mp -75.02 -56.71 4.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.979 167.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.765 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.1 pt? -140.02 127.89 12.87 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.589 0.709 . . . . 0.0 110.969 173.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.57 -7.84 16.9 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.592 2.194 . . . . 0.0 112.315 -175.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -147.27 96.71 4.18 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.648 0.737 . . . . 0.0 110.912 -176.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.64 155.04 71.7 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.636 2.224 . . . . 0.0 112.375 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.43 143.3 69.04 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.678 2.252 . . . . 0.0 112.274 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -84.86 -16.33 41.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.996 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.9 p -132.03 157.91 42.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.195 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.488 ' HA ' HG12 ' A' ' 132' ' ' ILE . 82.4 m95 -70.08 -20.79 63.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.88 -28.82 67.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -82.27 -8.14 59.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.881 -176.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.627 ' O ' HD13 ' A' ' 135' ' ' LEU . 46.8 mm -60.82 -53.14 67.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.576 0.703 . . . . 0.0 111.17 -173.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 21.6 Cg_endo -60.48 -39.88 61.92 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.566 2.177 . . . . 0.0 112.377 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.52 -61.14 2.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.147 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -70.88 -16.93 62.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.01 -175.628 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.52 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.9 t70 -63.54 -42.39 98.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.874 168.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.67 -30.43 68.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.963 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -69.98 -47.48 62.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.623 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.6 pp -87.22 -15.19 38.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.923 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.623 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.5 tttt -61.93 -33.86 75.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.012 175.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.41 -24.19 67.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.076 176.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -95.04 6.14 49.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.848 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.86 32.04 57.41 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.528 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -110.4 166.5 10.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 110.878 174.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.4 t -118.5 143.04 47.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 169.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.62 -44.13 71.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.132 -173.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -139.05 124.02 18.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.842 -174.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 62.1 tpp -113.4 132.57 55.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.81 -175.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -157.39 160.0 37.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.987 -175.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 209' ' ' ASP . 40.3 p-10 -99.21 -43.44 6.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -175.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.108 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.4 tm? 52.13 34.58 14.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -175.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -103.28 -11.61 17.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 -176.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 96.6 mt-10 -123.4 144.11 43.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.655 0.74 . . . . 0.0 110.924 -170.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 153' ' ' GLU . 73.1 Cg_exo -54.64 -32.75 76.64 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.634 2.222 . . . . 0.0 112.339 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -65.21 -29.96 70.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -79.89 -40.19 28.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 39.3 p -62.79 -39.59 94.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.066 -175.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.596 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 32.0 t-105 -65.91 -50.14 54.56 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.63 0.728 . . . . 0.0 110.936 -164.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 78.4 Cg_exo -48.33 -46.55 22.73 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.702 2.268 . . . . 0.0 112.312 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.716 ' O ' HD23 ' A' ' 160' ' ' LEU . 6.4 tt -74.91 -40.35 60.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.957 -174.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.8 mt -69.13 -43.05 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.213 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.63 -24.71 61.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.91 -33.49 71.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.076 -178.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -93.57 3.35 55.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.99 7.32 35.96 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.428 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.38 65.7 3.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -85.67 134.8 33.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.794 0.331 . . . . 0.0 110.989 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.53 1.57 16.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.091 -177.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -153.69 155.41 35.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.996 0.427 . . . . 0.0 110.853 -175.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -99.47 121.95 41.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 157.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -112.95 123.26 49.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -152.84 131.03 11.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.4 t30 55.07 44.89 27.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.985 173.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.29 15.69 78.84 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.485 173.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.01 139.84 50.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.794 0.331 . . . . 0.0 110.951 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -95.82 144.38 26.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.943 169.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -119.32 111.7 18.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 37.1 pt -78.18 -18.24 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -94.54 -8.99 36.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.817 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -123.45 92.8 3.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 24.9 m -118.72 164.26 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.081 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -108.46 22.38 26.7 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.541 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 365' ' ' GLN . 1.5 m -108.8 -23.3 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 111.165 -173.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -91.79 24.03 3.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.793 174.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -118.88 176.25 5.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.877 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.09 -25.49 67.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.133 -177.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.09 -39.75 94.79 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.445 -172.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.693 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.48 -35.57 81.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.958 0.408 . . . . 0.0 111.124 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.566 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.7 mttt -59.69 -36.17 75.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 176.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.44 91.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.11 -48.16 67.32 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.496 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.526 HD11 ' HA ' ' A' ' 347' ' ' VAL . 19.0 tp -65.96 -33.2 75.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.927 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 357' ' ' VAL . 88.3 m -65.98 -44.02 86.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.172 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 32.6 t80 -67.31 -46.52 73.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.864 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.579 HD23 ' C ' ' A' ' 195' ' ' LEU . 7.9 tt -51.12 -52.21 46.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -175.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 199' ' ' ILE . 27.6 m -64.03 -21.95 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 -173.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.9 m-20 -61.51 -33.06 73.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -80.33 -40.07 27.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -175.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.658 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.8 pp -74.94 -28.31 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.214 173.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -70.49 -39.08 74.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 174.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -78.29 2.15 19.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.876 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 66.55 40.9 3.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 166.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -78.11 -17.63 56.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.779 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.658 ' SD ' HG22 ' A' ' 199' ' ' ILE . 4.3 ppp? -143.33 158.09 43.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.899 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -92.21 153.6 19.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.817 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.7 -26.99 67.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.102 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -94.77 2.33 55.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 98.4 m -69.17 129.99 41.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.105 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.514 ' HA ' ' HB3' ' A' ' 150' ' ' ASN . 18.7 t0 -126.69 175.67 7.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.961 173.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -59.18 -35.78 74.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.01 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.7 p -68.4 -38.79 81.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 76.2 mt -67.46 -40.04 83.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.125 175.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.08 -35.52 80.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.001 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -61.4 -47.25 86.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.862 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.06 -41.23 99.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.11 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.9 -47.62 77.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.071 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -62.38 -41.86 98.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -63.96 -31.4 72.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.913 -177.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.47 -19.3 28.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.836 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.37 22.43 31.94 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.453 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -80.96 -19.66 43.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.996 0.427 . . . . 0.0 110.9 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.7 t -128.76 137.47 51.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.153 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.444 ' HB1' HD21 ' A' ' 122' ' ' LEU . . . -66.34 -46.91 75.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.022 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.645 ' HB3' HD21 ' A' ' 115' ' ' LEU . 75.3 mtm -133.71 151.02 51.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.962 -168.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 66.1 p -138.69 156.9 47.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.161 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.4 mm -110.37 125.06 67.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -155.01 175.31 13.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -169.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.409 ' HA2' ' HG ' ' A' ' 113' ' ' LEU . . . -84.34 -164.17 37.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.419 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.469 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 36.5 Cg_endo -65.34 -23.78 58.48 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.685 2.257 . . . . 0.0 112.361 177.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -72.26 -30.79 65.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 45.37 45.09 9.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.104 174.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 29.7 m0 -63.68 -19.61 65.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.868 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -69.75 -14.88 63.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.855 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -78.45 -171.32 2.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 92.9 mt . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.152 -178.933 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 71.7 t . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.826 0.346 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -82.99 139.13 33.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.416 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 39.0 p90 -150.02 156.6 41.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.927 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.7 163.86 26.46 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.431 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.0 p -135.53 135.93 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 111.127 -176.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 13.2 t -159.71 152.45 21.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 175.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 322' ' ' GLU . 28.2 m -59.2 163.26 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.288 -175.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.526 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 2.4 mp -67.02 153.66 94.07 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 110.985 -165.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.51 -178.17 2.12 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.777 2.318 . . . . 0.0 112.358 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 68.2 p -100.85 160.09 14.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.078 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -138.8 119.75 14.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.911 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 54.89 33.99 21.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 -173.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.78 9.92 73.66 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.558 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -126.17 139.94 35.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.619 0.723 . . . . 0.0 110.842 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -73.29 139.58 29.33 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.736 2.291 . . . . 0.0 112.298 -172.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 256' ' ' LYS . 73.8 m -85.33 1.5 48.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.845 168.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 255' ' ' SER . 99.0 mttt -38.4 118.06 0.99 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.569 0.7 . . . . 0.0 110.879 -175.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.522 ' CB ' ' HB2' ' A' ' 113' ' ' LEU . 53.0 Cg_exo -65.66 162.13 35.75 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.699 2.266 . . . . 0.0 112.33 -170.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -74.48 167.2 22.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.901 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.7 t -117.56 134.5 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.082 -165.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.504 ' HA3' ' NE2' ' A' ' 64' ' ' HIS . . . -116.7 135.52 12.07 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.469 176.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.2 t -124.96 118.24 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 111.197 174.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -66.28 123.06 18.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.3 m -126.49 133.45 51.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.789 -168.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.26 138.88 52.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.066 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.39 172.07 21.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.419 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.479 HG13 ' HB2' ' A' ' 277' ' ' LYS . 29.1 mm -113.64 129.96 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 0.0 111.106 -173.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -61.85 128.74 37.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.455 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -59.83 -29.19 68.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.099 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.82 -5.76 59.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.065 -173.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.5 t -73.14 121.0 83.99 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.654 0.74 . . . . 0.0 110.936 -173.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -68.04 -9.38 25.52 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.635 2.224 . . . . 0.0 112.353 168.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -108.66 19.72 19.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -53.97 -33.97 58.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.856 -171.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -67.55 -50.65 57.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -172.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.99 -32.08 39.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.45 -47.51 75.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.071 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . 0.479 ' HB2' HG13 ' A' ' 266' ' ' ILE . 37.3 ttpt -66.24 -42.41 88.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 176.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.46 -46.57 82.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -66.29 -43.2 87.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 284' ' ' LEU . 8.2 tt -55.83 -50.57 70.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 -176.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -72.4 -25.21 61.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -100.27 -11.15 20.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 -171.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.756 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 73.9 m-85 -122.91 -60.55 1.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 280' ' ' LEU . 1.4 mp -62.66 -32.49 73.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.908 -159.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.898 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.4 pp -123.22 38.07 4.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.96 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.474 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 64.0 p -124.68 163.47 21.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.438 ' HA ' HD11 ' A' ' 290' ' ' LEU . 38.7 t70 -45.63 -37.51 5.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -166.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -78.3 -41.63 33.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.756 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.52 -55.96 5.8 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.593 -170.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 291' ' ' GLU . 0.6 OUTLIER -67.2 -21.36 65.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 110.852 -178.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.592 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.9 tt0 -68.44 -47.6 66.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 172.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.63 -45.15 91.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -174.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 1.117 HG23 ' HA3' ' A' ' 19' ' ' GLY . 2.6 p -75.83 -34.56 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.176 -175.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . 0.434 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 46.2 t30 -67.4 -28.24 67.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 173.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.09 -26.47 68.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -85.46 -41.76 15.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.992 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -145.36 131.78 9.78 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.572 0.701 . . . . 0.0 110.853 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.32 109.01 0.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.727 2.285 . . . . 0.0 112.358 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.434 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 59.4 mt -90.06 -19.6 24.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.97 -171.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 113.36 -59.46 0.38 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.461 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.658 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -171.37 169.63 6.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.807 0.337 . . . . 0.0 111.114 174.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.635 HG21 ' HB3' ' A' ' 307' ' ' TYR . 32.9 m -125.24 154.67 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.07 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.46 -10.71 60.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.077 171.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.574 ' CD2' HD21 ' A' ' 290' ' ' LEU . 54.1 tp -85.9 120.01 26.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -175.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -55.85 -40.45 72.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.883 -174.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.7 m -65.72 -50.02 66.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.849 -168.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.635 ' HB3' HG21 ' A' ' 302' ' ' VAL . 17.4 t80 -76.42 -28.63 56.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.979 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -64.8 -38.87 92.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.9 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.53 -34.76 77.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.909 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -75.02 -40.44 60.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.924 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.658 HD13 ' HA ' ' A' ' 301' ' ' ALA . 80.1 mt -61.23 -32.0 71.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.901 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.64 -18.64 60.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.06 -176.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.79 -19.37 65.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 173.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -91.4 122.7 65.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.608 0.718 . . . . 0.0 110.88 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -48.61 -28.69 12.73 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.668 2.245 . . . . 0.0 112.375 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -62.75 -27.25 69.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.888 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.405 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.4 mp -75.06 -32.88 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 -174.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.2 -46.03 91.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.046 -171.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.35 -39.3 89.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.169 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.619 HG23 ' HB3' ' A' ' 112' ' ' ALA . 21.6 m -59.32 -36.39 75.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.182 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.8 mmm -73.86 -34.24 64.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . 0.408 ' HB2' HG13 ' A' ' 246' ' ' VAL . 86.1 mt-10 -59.46 -44.14 93.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.942 -172.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.801 HD21 ' HB1' ' A' ' 112' ' ' ALA . 16.4 p-10 -87.83 -26.28 22.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.64 -45.31 92.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.133 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -62.46 -33.7 75.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.88 -177.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -107.62 -2.29 20.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.857 -173.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -90.17 -166.57 41.44 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.452 -164.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -144.94 143.0 30.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 110.962 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 47.0 mm -60.44 118.7 3.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 -171.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 47.6 tpp . . . . . 0 C--N 1.33 -0.248 0 CA-C-O 121.561 0.696 . . . . 0.0 110.87 -178.537 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.79 0.328 . . . . 0.0 110.864 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 66.1 mmm -80.03 -18.06 51.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 -168.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 95.0 p -63.8 -37.71 88.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.782 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -76.85 -35.13 57.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.14 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.547 ' O ' HG13 ' A' ' 343' ' ' VAL . 5.0 m-30 -67.61 -41.0 84.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.451 ' HA ' HG22 ' A' ' 343' ' ' VAL . 7.7 m0 -59.89 -34.64 73.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 174.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -69.43 -39.77 77.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.889 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.51 -43.22 85.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.109 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 339' ' ' PHE . 15.4 m -75.15 -28.58 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.098 -176.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.445 ' O ' HG22 ' A' ' 347' ' ' VAL . 49.3 ttt180 -58.62 -45.56 88.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.845 172.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 93.2 m -56.11 -36.25 67.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.148 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.64 -44.05 91.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.188 -174.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.526 ' HA ' HD11 ' A' ' 192' ' ' LEU . 3.0 m -74.88 -34.86 34.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.175 -174.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 347' ' ' VAL . 1.4 mp -62.95 -52.18 62.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.196 173.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -62.5 -39.21 92.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.59 -45.71 61.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.111 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.72 -39.67 76.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.049 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 89.4 p -75.39 -10.56 59.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.921 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 82.02 17.13 70.5 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.414 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.72 -33.4 46.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 110.863 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -140.02 155.1 47.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.5 p -77.38 169.45 18.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.217 170.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.435 ' O ' ' CB ' ' A' ' 361' ' ' LEU . 53.8 t -56.17 -42.37 72.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.198 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -61.13 -46.58 89.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.828 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -70.09 -53.19 18.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -70.96 -48.04 55.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.146 -172.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.3 tm? -65.08 -41.76 94.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -174.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.73 -54.08 26.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -70.39 -48.35 56.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -171.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.34 85.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.175 -174.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.493 ' HB3' ' HB ' ' A' ' 183' ' ' VAL . 79.4 mm-40 -73.55 -34.79 65.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -175.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 26.9 m -60.17 -27.93 67.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.175 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -56.99 -30.11 63.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.804 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 365' ' ' GLN . 77.3 mt -60.6 -40.18 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.076 174.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 45.7 p -98.22 -11.38 22.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.019 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.955 175.938 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.835 0.35 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.6 mt -93.68 130.73 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.177 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -145.52 146.59 31.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.918 -176.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.22 137.15 35.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.27 6.13 63.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.458 -174.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.2 tttt -165.32 135.85 3.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.741 0.305 . . . . 0.0 110.961 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.406 HD23 ' HB3' ' A' ' 275' ' ' LEU . 0.5 OUTLIER -142.34 149.57 39.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 -178.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 78.3 t -107.62 133.76 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.712 HG23 ' HB ' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -119.92 133.87 65.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.12 -179.397 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.803 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 68.5 m95 -108.25 126.2 52.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.014 166.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.485 HD12 ' HG ' ' A' ' 20' ' ' LEU . 14.9 tt -110.55 150.06 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 -165.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.58 149.21 39.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -172.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.86 -17.84 23.3 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.459 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -73.5 -12.32 60.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.785 0.326 . . . . 0.0 110.826 -176.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -147.83 128.17 13.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 164.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.87 -77.25 1.0 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.443 -167.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -108.47 -44.91 3.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.923 0.392 . . . . 0.0 110.979 -175.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -67.47 -50.34 59.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.887 -152.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.653 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -54.95 -49.54 62.04 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.42 -173.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 9' ' ' ILE . 3.2 mt -52.21 -54.43 31.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 0.0 110.913 170.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.96 -35.84 25.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -70.63 -59.22 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.971 0.415 . . . . 0.0 110.88 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.0 m -71.19 -37.77 67.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.127 -173.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.69 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -66.4 -45.88 82.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.426 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -57.43 -32.99 67.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 0.0 110.984 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -57.81 -37.83 74.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 176.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 6.0 m-30 -59.66 -44.61 93.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -64.81 -37.9 89.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.96 -40.62 75.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.867 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -97.54 -47.06 5.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.835 -166.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.6 p -108.13 -6.1 16.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.152 -173.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.91 3.83 90.53 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.432 169.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.829 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -100.13 133.17 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 0.0 111.177 -176.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.2 mttt -79.36 142.71 35.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.841 -172.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.69 HG21 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -120.01 133.79 65.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 178.359 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.471 ' O ' HD12 ' A' ' 9' ' ' ILE . 97.5 m -104.68 128.68 52.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.049 177.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 20' ' ' LEU . 93.5 t -98.26 125.18 51.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.199 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -117.97 148.25 42.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 96.8 m-70 -86.75 148.3 45.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.597 0.713 . . . . 0.0 110.895 -165.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.452 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 50.7 Cg_exo -59.81 -24.96 77.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.69 2.26 . . . . 0.0 112.3 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -53.24 -50.09 65.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.937 -171.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.08 -3.83 56.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.836 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 7.7 tt -46.39 -52.63 12.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 -172.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -66.63 -36.45 82.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.767 176.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.38 -43.65 85.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.816 -172.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.4 -21.31 39.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 56.6 t80 -48.83 -51.17 56.51 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.614 0.721 . . . . 0.0 110.821 -167.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 63.1 Cg_endo -80.75 -29.46 2.2 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.731 2.287 . . . . 0.0 112.375 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -74.66 -39.65 61.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.929 -169.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.439 HG11 ' HD3' ' A' ' 57' ' ' PRO . 34.2 m -65.09 -27.83 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.031 -177.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.826 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -68.87 -37.01 78.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 177.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.11 -30.62 68.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.148 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.3 p -92.39 -15.37 27.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 176.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.48 10.22 78.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 175.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -141.05 133.28 28.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.38 -115.07 0.53 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.486 176.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.803 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 61.1 Cg_endo -75.28 152.57 39.64 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.723 2.282 . . . . 0.0 112.415 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.39 -34.99 17.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 159.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.712 ' HB ' HG23 ' A' ' 9' ' ' ILE . 30.5 mt -128.59 139.31 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 -175.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 tp -131.87 127.87 59.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -93.65 137.2 33.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 172.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.422 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 30.0 p90 -144.66 165.03 29.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.932 171.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.81 -89.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.048 -169.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.414 ' CD2' ' HA2' ' A' ' 260' ' ' GLY . 18.0 m80 -105.47 -81.58 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.828 -171.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 70.0 m-20 -103.88 -6.71 21.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.77 -154.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -52.15 -21.5 3.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -173.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.483 ' HB2' HD13 ' A' ' 104' ' ' ILE . 30.7 p90 -59.27 -28.96 67.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.815 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.62 -51.47 57.7 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.73 91.89 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.442 171.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.408 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -54.96 -51.68 65.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.981 0.42 . . . . 0.0 110.999 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.24 -42.6 45.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.113 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.5 tp60 -56.88 -38.62 73.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.87 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.415 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 62.8 m -85.94 -6.9 58.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.847 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.73 30.78 59.26 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.561 174.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.826 HD22 ' HB1' ' A' ' 51' ' ' ALA . 39.0 mt -89.87 -10.07 46.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 0.0 110.972 -169.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.483 ' C ' ' HB2' ' A' ' 268' ' ' ALA . 0.2 OUTLIER -127.97 149.41 50.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 -176.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -77.36 141.11 40.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.124 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.8 136.48 45.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.957 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -105.1 156.86 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.8 m -100.7 130.32 25.69 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.606 0.717 . . . . 0.0 111.096 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.44 134.57 62.15 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.738 2.292 . . . . 0.0 112.329 176.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -104.04 118.62 37.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.817 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.21 -41.96 98.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.897 -176.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.89 -45.05 87.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -74.88 -32.4 61.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.951 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . 0.483 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 66.9 tt0 -55.04 -50.87 68.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.901 175.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.03 -32.68 71.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 174.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -76.22 -21.32 56.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.7 -105.21 0.3 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.949 -172.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 30.3 t80 171.75 128.92 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.655 0.74 . . . . 0.0 110.92 -167.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -53.48 -37.03 81.98 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.746 2.297 . . . . 0.0 112.352 -173.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -64.97 -35.72 82.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.785 -174.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.8 p -73.12 -30.97 64.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.186 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.527 ' HA ' HG22 ' A' ' 97' ' ' VAL . 86.3 m95 -67.47 -30.85 70.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 174.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.4 -30.75 70.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.852 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.96 -25.76 62.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.034 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.528 HG23 HD22 ' A' ' 103' ' ' LEU . 15.6 m -106.02 13.04 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 -174.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -100.04 129.74 46.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -123.68 115.03 20.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 172.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.8 t30 56.82 38.88 29.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 173.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.39 0.39 89.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.56 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -116.71 151.29 36.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.833 0.349 . . . . 0.0 110.805 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.528 HD22 HG23 ' A' ' 97' ' ' VAL . 15.1 mt -90.82 135.11 33.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.873 177.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.483 HD13 ' HB2' ' A' ' 67' ' ' PHE . 2.0 pp -125.68 3.9 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.037 -172.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.422 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -163.03 165.47 24.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.162 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 92.4 m-85 -116.04 140.46 26.34 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.609 0.718 . . . . 0.0 110.993 172.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 11.4 Cg_exo -72.13 126.38 11.73 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.733 2.289 . . . . 0.0 112.391 172.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 1.076 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.5 mp -107.61 -39.98 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.213 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -144.02 152.09 40.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.162 -164.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.3 t -125.06 131.19 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.109 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . 0.508 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 92.5 mt-10 -133.89 132.31 40.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 175.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.783 ' HB1' HD21 ' A' ' 323' ' ' ASN . . . -154.18 152.73 30.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.119 176.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.36 169.65 16.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.941 -168.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 98.9 p -157.59 159.14 36.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.897 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -92.33 126.09 37.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 169.581 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.587 ' N ' HD22 ' A' ' 115' ' ' LEU . 65.7 mt -113.71 132.14 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -172.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -132.13 145.03 51.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.418 ' O ' HD23 ' A' ' 122' ' ' LEU . 54.8 t-20 -93.36 114.43 26.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.831 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.484 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.8 mttt -64.78 -18.43 65.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 -173.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -77.33 -29.98 53.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.865 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 mp -83.69 -49.51 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.653 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.5 pt? -140.0 126.53 12.18 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.567 0.699 . . . . 0.0 110.89 176.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -79.16 -14.59 13.3 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.693 2.262 . . . . 0.0 112.377 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -142.23 97.16 6.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.564 0.697 . . . . 0.0 110.825 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.67 154.98 54.66 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.725 2.283 . . . . 0.0 112.282 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.39 146.23 74.21 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.624 2.216 . . . . 0.0 112.347 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -88.53 -18.16 28.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.988 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 69.6 p -132.27 158.72 41.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.166 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.541 ' HA ' HD13 ' A' ' 132' ' ' ILE . 58.7 m95 -69.66 -27.21 64.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.978 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.96 -24.6 67.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.14 -24.62 40.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.823 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.624 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -57.15 -49.68 92.53 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.586 0.708 . . . . 0.0 111.151 -172.034 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 40.0 Cg_endo -68.67 -38.02 11.32 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.67 2.247 . . . . 0.0 112.398 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.14 -60.73 3.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 176.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.205 HD22 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.96 -16.8 63.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 -175.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.504 ' N ' HD13 ' A' ' 135' ' ' LEU . 37.0 t70 -58.39 -39.63 80.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.821 168.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.52 -30.22 68.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.79 -47.6 52.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.032 0.444 . . . . 0.0 110.864 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.9 pp -85.62 -15.27 43.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.6 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.7 tttt -59.74 -33.45 71.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 173.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.03 -24.63 67.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 176.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -95.03 3.35 54.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.927 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.79 33.16 52.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.471 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -110.5 169.97 8.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.749 0.309 . . . . 0.0 110.909 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.0 t -118.93 142.13 48.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.996 0.427 . . . . 0.0 110.745 169.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -68.62 -39.87 80.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 -175.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -142.17 130.68 22.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 62.3 tpp -118.22 131.9 56.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.823 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -154.59 157.49 38.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.53 -51.56 5.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.104 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.4 tm? 48.04 33.37 3.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.891 -169.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -102.16 -2.76 28.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.936 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -127.97 153.68 78.32 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.683 0.754 . . . . 0.0 110.864 -174.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.44 ' HA ' ' HB ' ' A' ' 157' ' ' THR . 37.5 Cg_endo -61.81 -24.78 77.73 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.626 2.217 . . . . 0.0 112.362 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -66.68 -30.06 70.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -87.49 -39.39 15.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . 0.44 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 20.5 m -61.18 -46.87 88.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.135 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.571 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 37.3 t-105 -58.81 -53.84 62.37 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.499 0.666 . . . . 0.0 110.833 -169.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 34.4 Cg_endo -66.12 -18.01 55.73 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.694 2.263 . . . . 0.0 112.255 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.775 HD13 ' C ' ' A' ' 160' ' ' LEU . 1.6 tm? -81.61 -45.34 15.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.837 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.569 HG22 ' HA3' ' A' ' 166' ' ' GLY . 77.9 mt -74.24 -44.46 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.98 -20.95 63.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -60.66 -31.15 70.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.093 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.98 3.1 55.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.891 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 104.11 7.91 39.92 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.485 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.569 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -77.06 67.05 2.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.541 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -86.05 131.11 34.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.361 . . . . 0.0 110.89 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.54 13.48 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -174.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.409 ' HA ' HG12 ' A' ' 181' ' ' VAL . 52.9 p90 -153.43 154.4 34.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 86.8 tttt -101.48 127.5 48.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 158.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -116.22 125.81 52.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.983 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -153.55 130.39 10.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.0 t30 54.31 42.76 31.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.946 172.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.95 18.47 80.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -132.27 138.51 47.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.965 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -97.72 145.11 26.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.811 170.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -126.24 112.14 15.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.914 174.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . 0.6 ' O ' HD12 ' A' ' 178' ' ' ILE . 1.1 pp -79.43 -12.82 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -95.23 -10.1 31.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 -176.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 67.2 t0 -126.42 90.13 3.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 169.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 169' ' ' PHE . 29.3 m -113.55 164.07 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -173.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.11 22.59 32.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.519 -172.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 368' ' ' ILE . 3.5 m -106.64 -17.91 7.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 111.046 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -87.68 21.23 2.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.829 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -120.05 -171.41 2.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.863 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.72 -30.38 71.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.128 -173.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.37 -40.51 94.57 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.434 -167.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.618 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.04 -38.36 90.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 111.107 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.531 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -61.92 -38.66 89.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.906 174.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.98 -38.79 92.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.05 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.506 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -65.75 -47.76 73.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.51 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.738 HD11 ' HA ' ' A' ' 347' ' ' VAL . 18.8 tp -67.33 -34.51 77.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.802 0.334 . . . . 0.0 110.845 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.471 ' OG1' HG21 ' A' ' 357' ' ' VAL . 89.2 m -64.98 -43.84 91.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.18 177.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 79.9 t80 -65.95 -48.58 70.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.881 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.705 HD23 ' C ' ' A' ' 195' ' ' LEU . 5.2 tt -50.98 -51.28 54.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.974 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 199' ' ' ILE . 27.5 m -64.5 -21.48 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.101 -173.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.3 m-20 -61.03 -33.13 72.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.808 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -80.86 -40.05 25.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.551 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.7 pp -74.37 -28.4 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 172.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.84 -37.66 79.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 173.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -80.04 2.17 24.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 66.41 40.18 3.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.802 166.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -78.98 -15.72 57.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.843 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.551 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.1 ppp? -141.33 155.53 45.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 178.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -94.63 150.04 20.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.26 68.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.044 -175.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -94.96 0.55 54.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.931 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 89.6 m -62.24 125.04 22.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.441 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 13.6 t0 -120.0 -179.65 3.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.844 177.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -64.1 -46.05 85.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.99 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.1 p -67.0 -37.09 83.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.82 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.441 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 80.9 mt -65.01 -43.9 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.088 174.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.41 84.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -63.49 -46.4 86.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 176.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.91 93.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.01 88.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.115 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -64.02 -42.08 97.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.963 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -66.28 -34.3 77.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -81.96 -23.34 36.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.884 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.43 27.03 26.2 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.448 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -83.46 -20.02 34.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.985 0.421 . . . . 0.0 110.9 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.7 t -131.22 137.54 48.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.133 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.571 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -67.37 -41.98 84.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.012 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 61.6 mtm -137.63 160.84 38.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -177.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.3 t -150.26 159.55 44.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.264 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.489 HD12 HD11 ' A' ' 247' ' ' LEU . 49.2 mm -109.24 126.23 66.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -154.97 174.4 15.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.861 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -81.64 -163.71 31.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.41 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.508 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 39.7 Cg_endo -68.61 -22.05 38.54 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.697 2.265 . . . . 0.0 112.281 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 54.1 m0 -70.09 -30.0 67.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.868 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 47.56 45.04 17.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.062 174.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 34.1 m0 -66.26 -16.12 63.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.88 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 74.3 m -53.01 -40.07 63.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.966 0.412 . . . . 0.0 110.875 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -86.36 -177.29 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -173.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 77.1 mt . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.154 -174.876 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 23.3 m . . . . . 0 C--O 1.232 0.175 0 CA-C-O 120.763 0.316 . . . . 0.0 111.158 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -104.51 140.01 38.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.86 175.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.484 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 42.8 p90 -150.01 154.78 38.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.31 160.7 25.13 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.538 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.2 p -138.6 137.34 43.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 0.0 111.154 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.1 t -154.09 146.19 23.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.14 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.6 m -61.33 167.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.929 HD23 ' HD3' ' A' ' 257' ' ' PRO . 3.1 mm? -64.65 144.88 98.8 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.546 0.689 . . . . 0.0 111.077 -163.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.11 -172.12 1.27 Allowed 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.753 2.302 . . . . 0.0 112.487 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 94.7 m -108.82 146.04 34.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.179 -173.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . 0.412 ' HB3' ' CD1' ' A' ' 129' ' ' TRP . 43.6 p90 -137.39 126.43 24.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 54.05 35.06 21.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.97 6.97 84.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.48 173.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -133.66 131.34 21.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.634 0.73 . . . . 0.0 110.859 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.47 137.42 25.41 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.674 2.249 . . . . 0.0 112.296 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.76 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 82.3 p -87.04 -1.07 57.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 173.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -39.31 132.99 1.23 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.567 0.699 . . . . 0.0 110.915 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.929 ' HD3' HD23 ' A' ' 247' ' ' LEU . 58.8 Cg_endo -83.22 157.94 15.03 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.607 2.205 . . . . 0.0 112.419 -169.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -75.77 167.24 22.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.865 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 45.5 t -111.24 136.37 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.203 -165.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . 0.414 ' HA2' ' CD2' ' A' ' 64' ' ' HIS . . . -114.41 131.98 10.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.38 172.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 83.7 t -125.08 115.38 43.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.774 0.321 . . . . 0.0 111.196 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -64.92 122.03 16.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.944 -177.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 42.6 m -127.53 133.25 49.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.839 -170.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -127.35 140.3 52.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.081 -172.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.41 170.77 22.17 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.479 -171.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.7 mm -112.36 128.22 69.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.745 0.307 . . . . 0.0 111.2 -172.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -63.31 128.24 34.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.973 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.483 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -60.56 -28.65 68.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.121 -178.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.57 -6.74 59.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.104 -173.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.2 t -79.75 123.16 84.05 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.596 0.712 . . . . 0.0 110.903 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -69.53 -7.16 20.26 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.733 2.289 . . . . 0.0 112.396 169.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -102.1 21.97 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 -167.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -50.12 -36.28 29.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -173.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.3 -39.7 89.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.406 ' HB3' HD23 ' A' ' 7' ' ' LEU . 33.9 mt -66.79 -56.87 8.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 173.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.91 -50.99 36.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.991 -167.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -61.21 -40.64 94.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.955 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.9 tt0 -69.34 -47.75 63.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.944 -177.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -66.53 -36.21 82.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.491 ' HA ' HD22 ' A' ' 284' ' ' LEU . 5.4 tt -59.17 -52.39 65.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -177.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . 0.4 ' HA ' HD21 ' A' ' 285' ' ' LEU . 24.4 pt-20 -78.66 -30.68 46.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.784 -174.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 63.7 m-80 -100.85 -13.96 18.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 -164.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.702 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 52.4 m-85 -126.7 -53.52 1.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.813 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.517 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.3 OUTLIER -61.66 -35.43 77.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.963 -167.363 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 1.076 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.9 pp -124.43 38.23 4.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -175.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.444 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 68.2 p -122.51 164.32 18.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.188 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.458 ' HA ' HD11 ' A' ' 290' ' ' LEU . 38.8 t70 -45.77 -38.0 6.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 -165.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -77.15 -42.57 37.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.954 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -71.98 -51.54 14.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 -170.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.56 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -74.07 -20.49 60.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.67 0.271 . . . . 0.0 110.892 -178.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.544 ' N ' HD12 ' A' ' 290' ' ' LEU . 35.8 tt0 -70.27 -46.45 64.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 171.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.97 -43.99 97.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.011 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.653 HG23 ' HA3' ' A' ' 19' ' ' GLY . 1.8 p -79.95 -30.55 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.236 -176.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -68.09 -28.97 67.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.777 170.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.03 -24.81 68.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.944 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -77.02 -43.24 35.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -162.87 135.79 4.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.545 0.688 . . . . 0.0 110.976 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -45.43 114.66 0.76 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.745 2.297 . . . . 0.0 112.42 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 51.2 mt -89.98 -14.85 33.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.894 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 114.92 -59.48 0.41 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.488 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.687 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -173.72 170.15 4.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 111.095 171.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.693 HG21 ' HB3' ' A' ' 307' ' ' TYR . 30.8 m -122.68 154.84 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.136 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.23 -10.49 59.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.023 171.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.56 ' CD2' HD21 ' A' ' 290' ' ' LEU . 40.1 tp -83.15 120.35 25.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.843 -177.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.16 -40.1 73.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.4 m -65.25 -50.14 66.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.882 -169.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.693 ' HB3' HG21 ' A' ' 302' ' ' VAL . 15.7 t80 -76.9 -29.13 55.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.973 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.09 -40.1 96.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.88 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.53 -35.29 78.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -74.47 -40.25 61.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.687 HD13 ' HA ' ' A' ' 301' ' ' ALA . 77.8 mt -60.91 -32.25 71.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 175.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.93 -19.8 61.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.022 0.439 . . . . 0.0 111.202 -177.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.57 -20.62 66.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.977 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -90.26 121.12 68.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.606 0.717 . . . . 0.0 110.88 166.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.81 -28.29 9.56 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.753 2.302 . . . . 0.0 112.355 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -60.24 -30.44 69.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.2 mp -79.99 -29.99 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.074 -176.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.71 85.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.047 -168.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.75 -47.64 62.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.067 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.563 HG23 ' HB3' ' A' ' 112' ' ' ALA . 26.9 m -61.09 -37.11 81.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.156 -174.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.6 ttp -65.22 -35.49 81.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -64.64 -47.76 77.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.835 -170.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.783 HD21 ' HB1' ' A' ' 112' ' ' ALA . 9.6 p-10 -83.43 -26.23 30.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 -178.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.64 -49.74 72.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.192 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -66.98 -29.86 69.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -109.74 -9.23 14.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -168.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.13 -148.87 23.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.458 -166.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -143.32 139.94 30.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.872 0.368 . . . . 0.0 110.824 -171.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 40.6 mm -65.52 122.4 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 59.0 ttm . . . . . 0 C--N 1.329 -0.305 0 CA-C-O 121.575 0.702 . . . . 0.0 110.911 -179.701 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 . . . . . 0 N--CA 1.458 -0.054 0 CA-C-O 120.813 0.339 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 74.1 mmm -79.9 -19.05 49.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 -171.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.9 m -61.84 -41.73 98.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.773 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.32 -35.14 61.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.112 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.544 ' O ' HG13 ' A' ' 343' ' ' VAL . 8.2 m-30 -66.41 -40.42 89.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.458 ' HA ' HG22 ' A' ' 343' ' ' VAL . 18.6 m0 -59.01 -35.87 73.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.978 174.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -67.82 -41.88 82.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.95 -44.18 81.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.061 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 339' ' ' PHE . 16.7 m -74.38 -30.87 26.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 -176.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.474 ' O ' HG22 ' A' ' 347' ' ' VAL . 4.9 tmt_? -65.0 -39.38 93.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 175.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.7 m -58.36 -35.74 72.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.89 -43.62 95.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.189 -174.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.738 ' HA ' HD11 ' A' ' 192' ' ' LEU . 3.8 m -73.56 -33.7 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.237 -175.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . 0.434 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -63.8 -46.51 94.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.151 173.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -65.05 -39.85 93.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.53 62.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.079 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.61 -40.19 80.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.033 -175.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.8 p -75.43 -10.71 59.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.11 16.93 73.28 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.54 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.95 -32.82 45.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 0.0 110.854 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -139.59 154.87 47.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.0 p -77.63 168.91 19.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.096 169.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.471 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.7 t -56.04 -42.09 70.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.205 172.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -61.29 -46.53 89.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.857 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -69.71 -53.23 19.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -70.75 -48.3 55.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.06 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.618 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.3 tm? -66.02 -45.63 80.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -173.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.67 -53.07 57.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.972 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -67.23 -47.11 71.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.1 -41.54 94.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.119 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 72.5 mm-40 -78.17 -26.79 47.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.014 -176.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.2 m -64.48 -36.03 82.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.161 171.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.01 -30.41 67.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.464 HD12 HG21 ' A' ' 183' ' ' VAL . 67.7 mt -60.4 -38.11 76.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.165 174.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 59.8 p -93.83 -14.85 25.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 178.728 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.73 0.3 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.7 mt -82.55 134.61 26.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.099 175.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -135.83 142.21 44.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.006 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -56.56 135.96 54.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.554 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 98.94 -0.17 57.54 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.518 -174.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -162.59 150.87 14.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.831 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.691 ' H ' HD23 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -147.23 156.72 43.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -176.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 91.2 t -113.92 131.12 66.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.095 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.901 ' HB ' HD21 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -119.97 126.82 75.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.12 -177.694 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.548 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 47.5 m0 -107.72 131.46 54.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.959 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.47 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 65.9 mt -117.75 142.41 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.078 173.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.403 ' O ' HG22 ' A' ' 11' ' ' ILE . 33.2 t30 -47.68 141.08 5.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 172.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.16 -13.03 13.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.569 -172.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -78.49 -15.22 58.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 0.0 110.844 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -130.99 112.07 12.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 167.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.75 -96.58 0.84 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.548 -153.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -102.97 -43.3 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.886 0.374 . . . . 0.0 110.931 -167.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.752 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 95.7 m-20 -62.49 -50.36 71.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 -157.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.7 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -57.8 -47.71 86.88 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 -175.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.901 HD21 ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -57.09 -61.02 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.76 0.314 . . . . 0.0 110.997 175.682 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.39 -40.94 37.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.14 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -65.03 -53.53 44.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.1 m -75.55 -36.06 33.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.179 -175.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.747 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -65.08 -47.22 84.16 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.98 -39.57 72.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.813 0.34 . . . . 0.0 110.861 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.67 -36.9 79.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -64.68 -41.56 95.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.57 -39.39 94.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.888 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -67.33 -33.84 76.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.879 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -89.32 -44.1 10.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.845 -170.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.559 ' OG1' HG13 ' A' ' 33' ' ' ILE . 66.6 p -110.73 -12.69 14.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.195 -171.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.53 7.23 87.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.589 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.849 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.4 pp -99.01 133.51 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.078 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -82.62 140.28 33.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.96 -173.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.747 HG21 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -118.09 134.61 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.14 -177.411 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.2 m -102.52 127.15 49.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.162 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.521 HG22 ' HG ' ' A' ' 20' ' ' LEU . 61.9 t -95.24 120.98 45.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.159 177.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.548 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 66.4 mm-40 -129.98 133.77 47.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.816 170.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -142.19 57.43 6.57 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.622 0.725 . . . . 0.0 110.873 174.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.01 -23.59 7.67 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.74 2.294 . . . . 0.0 112.369 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t0 62.63 20.77 12.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -170.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 45' ' ' GLU . 98.9 mttt -85.22 2.85 42.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.958 169.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.3 mt -43.45 -47.86 7.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -171.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.86 -36.87 77.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 42' ' ' LYS . 89.0 tt0 -74.54 -36.38 63.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -78.95 -29.98 44.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.506 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 9.8 m-30 -45.16 -55.58 11.06 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.664 0.745 . . . . 0.0 110.851 -175.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.4 Cg_endo -68.68 -27.2 32.33 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.795 2.33 . . . . 0.0 112.317 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -79.4 -44.02 22.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.881 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.8 m -68.02 -30.52 48.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.154 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.37 79.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 172.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.42 -30.92 67.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.062 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.5 p -92.66 -12.33 31.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.169 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.45 15.27 81.31 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.462 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -161.08 154.21 21.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.862 0.363 . . . . 0.0 110.877 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.436 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . -162.76 -138.14 2.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.409 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.518 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 72.6 Cg_endo -68.62 155.88 67.4 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.621 2.214 . . . . 0.0 112.395 169.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.48 -38.03 26.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.729 ' HB ' HG23 ' A' ' 9' ' ' ILE . 4.1 mp -128.4 138.01 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.079 176.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.5 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 1.9 tp -130.36 129.06 64.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.169 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.567 ' CE2' HG13 ' A' ' 108' ' ' ILE . 2.5 m-85 -98.62 141.25 31.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.819 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.5 ' CZ2' HG23 ' A' ' 60' ' ' ILE . 8.6 m-90 -118.12 139.96 50.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.54 -83.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.198 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.414 ' HB3' ' SD ' ' A' ' 330' ' ' MET . 98.2 m-70 -128.0 -57.22 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.835 170.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -85.36 -26.61 26.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.778 -170.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.492 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 98.7 mtt180 -59.94 -29.97 68.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 -158.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -67.99 -28.31 67.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -169.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.12 -51.48 52.65 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.433 -172.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.85 -36.99 92.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.482 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.536 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 17.4 t80 -66.53 -37.74 85.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.879 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.54 -44.43 62.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -62.66 -33.31 74.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.5 p -80.33 -10.76 59.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.932 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.22 32.44 68.85 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.454 174.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 1.7 mp -86.34 1.24 51.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 0.0 110.905 -172.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.536 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.7 OUTLIER -131.93 159.86 37.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.949 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -68.36 130.63 43.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.034 174.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -69.99 123.35 21.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.937 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.6 pt -108.78 159.97 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.053 -172.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.1 p -103.49 146.64 32.86 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.604 0.716 . . . . 0.0 111.169 -171.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.73 146.87 30.61 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.747 2.298 . . . . 0.0 112.354 -177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -108.08 116.09 31.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.55 -35.86 61.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.18 95.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -70.03 -38.23 75.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.855 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -54.92 -48.03 73.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.02 -36.39 83.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.85 -20.09 58.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -104.02 -103.36 0.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -173.137 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 46.2 t80 -166.82 134.56 2.1 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.649 0.738 . . . . 0.0 110.883 -172.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 68.0 Cg_exo -52.29 -39.71 71.79 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.738 2.292 . . . . 0.0 112.393 -170.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -77.76 -30.62 51.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.96 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.3 m -69.63 -48.94 58.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 -165.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.46 ' HA ' HG22 ' A' ' 97' ' ' VAL . 53.8 p-90 -66.23 -28.74 68.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.888 178.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -71.33 -37.48 71.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.813 175.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.86 -25.1 64.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.119 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.523 HG23 HD22 ' A' ' 103' ' ' LEU . 21.5 m -101.16 16.36 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.135 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 67.9 ttt180 -101.52 132.58 47.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -148.15 130.56 15.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.1 t30 68.61 36.43 2.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.16 -4.6 66.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.464 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -140.04 164.34 30.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.853 0.359 . . . . 0.0 110.885 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.523 HD22 HG23 ' A' ' 97' ' ' VAL . 12.9 mt -73.83 146.49 44.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 -175.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.424 ' C ' HD12 ' A' ' 104' ' ' ILE . 2.0 pp -122.48 8.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.138 174.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.753 ' HB1' ' HB3' ' A' ' 263' ' ' SER . . . -168.45 158.54 9.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.02 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -125.15 151.24 69.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.722 0.773 . . . . 0.0 110.96 164.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.408 ' HB3' HG11 ' A' ' 261' ' ' VAL . 59.3 Cg_endo -72.39 121.1 7.18 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.648 2.232 . . . . 0.0 112.384 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.567 HG13 ' CE2' ' A' ' 61' ' ' PHE . 24.6 mm -98.1 -32.84 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.089 176.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.02 153.35 27.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 -177.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.1 t -117.51 133.76 63.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.14 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -119.5 129.24 54.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.934 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -149.84 158.82 44.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.732 HD23 ' HA3' ' A' ' 228' ' ' GLY . 59.3 mt -99.61 158.37 15.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.042 -173.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.0 p -153.53 160.01 42.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.865 HD13 ' O ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.8 124.16 44.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.955 175.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.614 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.3 mp -106.28 133.71 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.163 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -133.15 147.77 52.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.957 -176.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -97.6 115.6 28.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.63 -16.37 63.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 21.5 t70 -80.16 -33.78 38.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.6 mp -88.67 -45.34 9.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.942 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.529 HD22 ' HB1' ' A' ' 223' ' ' ALA . 3.0 mp -108.47 130.88 22.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.537 0.684 . . . . 0.0 110.894 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.44 -30.5 15.2 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.677 2.251 . . . . 0.0 112.345 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -153.87 89.93 3.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.56 0.695 . . . . 0.0 110.973 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.479 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 51.1 Cg_exo -58.21 139.56 90.95 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.678 2.252 . . . . 0.0 112.383 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 125' ' ' PRO . 62.6 Cg_exo -54.98 146.53 57.24 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.245 . . . . 0.0 112.327 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -100.65 -0.82 36.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 176.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.9 p -132.95 157.06 46.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.04 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -71.36 -25.32 62.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.967 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -66.36 -35.54 80.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -172.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -83.42 -9.98 58.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.612 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 47.0 mm -58.99 -52.64 73.42 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.628 0.728 . . . . 0.0 111.219 -172.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 28.6 Cg_endo -61.03 -38.85 64.98 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.737 2.291 . . . . 0.0 112.31 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.88 -60.51 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.177 HD22 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.53 -17.03 64.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -175.364 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.626 ' HA ' HD22 ' A' ' 139' ' ' LEU . 38.7 t70 -60.9 -38.47 85.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 168.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.81 -37.18 85.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.945 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.91 -49.72 23.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -75.14 -16.98 60.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -176.592 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.667 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.6 tttt -57.46 -34.97 69.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.961 171.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.0 -24.53 67.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.121 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.8 7.89 44.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.87 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.01 28.62 62.11 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.509 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.427 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 46.9 mtmt -117.79 168.61 10.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.391 . . . . 0.0 110.821 174.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.9 t -129.46 137.38 50.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.82 176.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.441 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -70.06 -57.67 4.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.087 -165.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -137.53 126.82 24.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.954 -167.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 92.7 mmm -103.25 126.16 50.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.809 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -155.65 165.04 37.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -126.22 144.21 50.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.905 171.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 151' ' ' LEU . 48.3 tp -113.44 -2.59 13.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 -175.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -69.39 -10.06 56.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.26 151.74 51.45 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 121.704 0.764 . . . . 0.0 110.811 -175.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.526 ' HD3' ' HD2' ' A' ' 344' ' ' ARG . 30.4 Cg_endo -66.05 -18.5 56.86 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.634 2.223 . . . . 0.0 112.389 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -59.63 -39.49 84.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.957 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -83.76 -38.38 21.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.864 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.4 p -64.19 -38.89 92.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.121 -173.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.561 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 11.0 t-105 -63.6 -54.23 44.65 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.556 0.694 . . . . 0.0 110.943 -170.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 33.3 Cg_endo -68.48 -32.07 25.98 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.729 2.286 . . . . 0.0 112.385 -172.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 160' ' ' LEU . 7.1 tt -74.51 -40.78 61.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.619 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 75.9 mt -68.28 -40.16 82.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.141 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.54 -27.09 63.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.069 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.35 -33.02 70.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.024 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . 0.518 ' HA ' ' HD3' ' A' ' 251' ' ' LYS . 66.0 m-20 -91.3 -9.0 46.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.837 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.52 3.37 9.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.511 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.63 66.53 3.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.406 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -90.0 151.26 21.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 110.968 -174.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . 0.485 ' HB3' ' SD ' ' A' ' 336' ' ' MET . . . -76.42 -6.89 53.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.003 -176.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -155.0 155.04 33.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.974 0.416 . . . . 0.0 110.873 -173.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -98.91 129.3 45.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 156.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -95.69 124.06 39.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -149.97 129.81 13.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.3 t30 57.1 44.98 21.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.908 171.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.41 7.82 73.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.408 172.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -132.91 140.92 48.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.831 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.415 ' N ' ' HD1' ' A' ' 176' ' ' TYR . 3.4 m-30 -79.29 132.94 36.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.991 166.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -94.12 105.01 17.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.6 tp -67.0 -19.23 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -95.13 -7.35 39.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -135.15 96.01 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.805 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.468 HG23 HG22 ' A' ' 183' ' ' VAL . 32.6 m -116.91 172.38 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -102.52 14.69 56.45 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.516 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.542 HG21 ' CD1' ' A' ' 368' ' ' ILE . 17.6 m -100.1 -17.05 6.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.83 0.347 . . . . 0.0 111.126 -175.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.487 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 57.9 p-10 -96.62 19.74 11.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.015 175.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -116.04 173.68 6.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.898 -174.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.39 -27.6 69.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.102 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.67 -40.27 90.31 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.551 -170.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.587 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.46 -41.19 93.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 111.041 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.496 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 91.9 mttt -60.8 -36.4 78.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.889 173.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.3 -37.05 86.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.01 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.619 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.51 -47.18 86.75 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.42 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.592 HD11 ' HA ' ' A' ' 347' ' ' VAL . 15.9 tp -68.19 -31.24 70.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.913 0.387 . . . . 0.0 110.99 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.426 ' O ' HG12 ' A' ' 196' ' ' VAL . 84.8 m -64.53 -42.87 95.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.04 176.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -67.05 -57.52 6.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.876 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.61 HD12 ' C ' ' A' ' 195' ' ' LEU . 3.6 pp -63.19 -27.8 69.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.926 -167.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.568 ' N ' HD12 ' A' ' 195' ' ' LEU . 1.3 p -74.27 -22.21 17.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.135 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -65.57 -58.34 6.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 1.034 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.66 -22.37 56.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -167.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.798 ' N ' HD22 ' A' ' 198' ' ' LEU . 2.2 pp -80.92 -33.53 13.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 172.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.38 -33.02 74.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 169.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -84.48 4.81 30.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.862 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 66.4 39.98 3.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -82.3 -11.17 58.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 172.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.489 ' CG ' HG22 ' A' ' 199' ' ' ILE . 5.1 ppp? -140.14 153.18 46.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 175.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -97.05 157.5 15.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 -177.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.21 -24.28 67.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.147 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -94.85 -1.81 52.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.1 m -64.02 131.7 48.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.204 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -149.25 174.22 12.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -177.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -79.76 -31.43 40.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.833 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 94.8 p -71.72 -39.46 70.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.871 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 36.6 pt -66.37 -22.28 29.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.135 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.65 -30.01 71.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.069 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -57.46 -44.02 84.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.847 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.02 -36.36 84.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.106 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.95 -36.44 81.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.097 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -64.09 -42.42 96.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -64.89 -33.79 76.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -89.18 -22.31 22.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.42 29.92 23.36 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.508 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.19 -30.12 16.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.383 . . . . 0.0 110.945 -171.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 52.8 m -110.08 125.35 52.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.093 -170.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.529 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -71.16 -48.97 48.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.149 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' A' ' 116' ' ' ILE . 68.5 mtm -133.55 146.65 51.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -172.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 226' ' ' ILE . 80.7 m -145.01 152.37 40.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.126 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . 0.406 ' N ' HG22 ' A' ' 225' ' ' THR . 40.6 mm -111.52 120.33 61.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -161.87 170.52 19.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.798 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.732 ' HA3' HD23 ' A' ' 113' ' ' LEU . . . -130.26 -107.54 1.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.488 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.51 -16.48 42.96 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.728 2.285 . . . . 0.0 112.288 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -66.94 -30.03 70.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 54.02 49.59 18.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -66.1 -27.75 68.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.8 m -65.08 142.8 58.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 -175.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -100.0 -175.27 2.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 174.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.2 mt . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.163 -178.3 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 240' ' ' VAL . 12.6 t . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.956 0.408 . . . . 0.0 111.081 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.508 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 70.1 m-20 45.03 69.8 0.4 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -127.57 132.68 49.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.927 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.37 157.86 23.74 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.474 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.429 HG23 HG13 ' A' ' 116' ' ' ILE . 2.5 p -143.15 140.01 26.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.959 0.409 . . . . 0.0 111.067 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.3 t -153.93 150.11 27.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.544 HG11 ' HB2' ' A' ' 323' ' ' ASN . 31.3 m -61.92 168.87 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.617 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.9 mm? -61.15 145.4 89.91 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.742 0.782 . . . . 0.0 110.837 -160.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.37 -177.01 2.75 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.76 2.306 . . . . 0.0 112.392 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 63.6 p -109.14 160.05 16.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.03 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -145.26 128.24 16.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.865 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . 0.67 ' HG2' ' O ' ' A' ' 251' ' ' LYS . 81.0 tttt 55.49 36.04 26.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 -177.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.06 8.36 82.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.536 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -134.68 139.37 32.23 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.58 0.705 . . . . 0.0 110.98 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.6 142.61 29.43 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.693 2.262 . . . . 0.0 112.343 -175.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.617 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 89.5 p -83.51 -5.02 59.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 169.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -41.95 125.69 2.6 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.522 0.677 . . . . 0.0 111.025 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.673 ' HG3' ' HB2' ' A' ' 113' ' ' LEU . 84.4 Cg_endo -86.94 164.91 8.78 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.704 2.269 . . . . 0.0 112.319 -174.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -75.01 170.03 16.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 175.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.412 HG21 ' HA ' ' A' ' 324' ' ' ALA . 99.0 t -103.87 134.98 43.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.106 -170.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.54 140.69 15.47 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.536 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.408 HG11 ' HB3' ' A' ' 107' ' ' PRO . 90.4 t -126.64 126.94 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.868 0.366 . . . . 0.0 111.133 -176.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.424 HD23 ' N ' ' A' ' 263' ' ' SER . 2.0 tt -70.07 130.6 42.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.923 166.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.753 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 67.7 m -119.04 149.21 42.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.811 -175.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -133.81 139.62 46.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.087 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.485 ' HA3' ' HH2' ' A' ' 62' ' ' TRP . . . -142.31 171.52 24.61 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.508 -175.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 30.8 mm -113.33 130.39 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 111.089 -171.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -69.29 132.63 46.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -65.61 -24.99 67.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.048 -176.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.73 -11.96 58.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 -171.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.7 t -70.45 120.04 76.14 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.67 0.748 . . . . 0.0 110.929 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.72 -15.72 21.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.721 2.28 . . . . 0.0 112.305 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -114.74 30.93 7.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -61.67 -24.36 66.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -168.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -64.07 -40.55 96.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.798 -169.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.6 pp -78.81 -32.17 46.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 59' ' ' ILE . . . -65.13 -45.9 83.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.018 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -69.53 -33.3 72.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.919 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.88 -50.06 73.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -172.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.482 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 1.9 p90 -68.64 -33.59 74.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 -176.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 280' ' ' LEU . 8.4 tt -62.66 -47.62 82.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.901 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.4 -39.52 67.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -99.93 -12.73 19.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -161.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.509 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 69.5 t80 -123.73 -51.33 1.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 2.1 mp -67.3 -46.01 74.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.849 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.34 48.75 1.32 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 169.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.439 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 80.5 m -146.47 145.27 30.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.194 176.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.435 ' HA ' HD11 ' A' ' 290' ' ' LEU . 49.5 t0 -42.57 -35.03 0.97 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.842 -175.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -74.69 -43.64 54.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.847 -174.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.97 -52.04 9.63 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.453 -171.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.685 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.7 OUTLIER -72.05 -22.54 61.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.336 . . . . 0.0 110.943 -177.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.512 ' N ' HD12 ' A' ' 290' ' ' LEU . 86.5 tt0 -67.13 -41.37 86.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 169.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.59 84.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.069 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.7 HG13 ' HA3' ' A' ' 19' ' ' GLY . 46.4 t -75.66 -45.54 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 -178.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -65.31 -35.09 79.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.98 -32.15 73.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 -173.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.752 ' HB3' ' HB3' ' A' ' 18' ' ' ASN . 63.8 m-20 -99.77 -35.19 9.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 -174.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.435 ' O ' HD13 ' A' ' 299' ' ' LEU . 46.9 tptt -129.11 124.45 22.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.563 0.697 . . . . 0.0 110.947 170.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -52.3 108.02 0.22 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.743 2.295 . . . . 0.0 112.281 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 297' ' ' LYS . 2.2 mp -92.26 -28.67 16.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 175.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.1 -55.9 1.81 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.466 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -174.27 168.53 3.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.0 111.094 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.586 ' CG2' ' HB3' ' A' ' 307' ' ' TYR . 32.2 m -135.0 161.84 39.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.126 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.44 -10.19 59.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.027 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.685 ' CD2' HD21 ' A' ' 290' ' ' LEU . 61.2 tp -79.75 129.43 34.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.866 -174.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -42.99 -31.93 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.899 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.443 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 70.6 m -47.83 -38.77 16.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.846 175.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.586 ' HB3' ' CG2' ' A' ' 302' ' ' VAL . 0.1 OUTLIER -58.99 -45.62 90.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.918 173.303 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.48 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 88.1 tt0 -56.96 -37.71 71.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.855 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -79.91 -64.1 1.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.833 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -85.01 -58.89 2.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -171.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 307' ' ' TYR . 56.0 mt -62.66 -32.62 73.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -168.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.1 -12.78 54.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.057 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.95 -18.31 64.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.838 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.498 ' HB3' HD12 ' A' ' 317' ' ' ILE . 58.2 t0 -78.88 121.23 83.18 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.616 0.722 . . . . 0.0 110.819 167.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.85 -36.4 15.19 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.647 2.231 . . . . 0.0 112.327 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 94.7 mtm-85 -73.12 -36.5 66.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.498 HD12 ' HB3' ' A' ' 314' ' ' ASP . 74.3 mt -77.07 -29.98 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.41 91.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.085 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.98 -48.56 73.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.076 175.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 68.9 p -67.58 -26.55 66.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.082 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 63.8 ttp -58.31 -37.28 74.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.866 173.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -67.36 -45.07 77.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.806 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.544 ' HB2' HG11 ' A' ' 246' ' ' VAL . 29.8 t30 -63.49 -36.53 84.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 176.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' A' ' 259' ' ' VAL . . . -65.03 -47.56 76.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.032 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -71.48 -34.17 69.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.7 -3.7 42.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.938 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -106.17 -162.25 22.74 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.465 -174.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -143.64 139.93 29.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.838 0.351 . . . . 0.0 110.779 -171.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.587 ' O ' ' C ' ' A' ' 330' ' ' MET . 41.2 mm -81.32 112.78 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.148 -172.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.587 ' C ' ' O ' ' A' ' 329' ' ' ILE . 71.6 mtm . . . . . 0 C--N 1.329 -0.29 0 CA-C-O 121.583 0.706 . . . . 0.0 110.823 174.369 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 N--CA 1.457 -0.104 0 CA-C-O 120.87 0.367 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . 0.485 ' SD ' ' HB3' ' A' ' 168' ' ' ALA . 37.6 mmt -62.2 -26.04 68.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 -174.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.5 m -57.92 -36.86 73.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.814 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.59 -36.68 73.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.542 ' O ' HG13 ' A' ' 343' ' ' VAL . 45.5 m-85 -65.25 -44.23 88.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.814 174.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -64.96 -39.25 93.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.925 -176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -67.6 -47.39 69.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.72 -42.42 97.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 339' ' ' PHE . 7.7 m -80.98 -23.08 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.526 ' HD2' ' HD3' ' A' ' 154' ' ' PRO . 57.6 ttt180 -57.41 -56.56 20.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 81.5 p -60.68 -25.69 66.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.066 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.511 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -60.08 -41.13 91.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.592 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.5 m -73.11 -32.95 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.061 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.05 -45.24 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -64.35 -36.17 83.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.61 -46.15 60.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.113 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.38 88.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 -175.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 92.8 p -74.98 -10.79 59.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.904 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.4 15.02 81.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.549 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.85 -31.79 45.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.71 0.29 . . . . 0.0 110.761 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -138.25 154.78 49.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.895 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.7 p -79.73 167.53 20.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.184 169.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.421 ' HA ' HD23 ' A' ' 192' ' ' LEU . 55.6 t -54.98 -42.04 61.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -59.11 -46.43 88.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 177.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -71.7 -53.22 14.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.81 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -67.99 -43.75 78.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -171.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -67.54 -40.71 84.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 -178.58 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.82 -39.69 93.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 173.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.2 -38.9 90.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.865 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.511 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -63.44 -42.24 98.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 173.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.487 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 23.3 tm0? -64.47 -36.83 85.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.052 0.453 . . . . 0.0 110.885 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 370' ' ' LYS . 93.2 m -67.01 -40.44 87.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 177.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -67.51 -35.02 78.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.847 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.542 ' CD1' HG21 ' A' ' 183' ' ' VAL . 62.2 mt -63.38 -40.13 87.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.079 0.466 . . . . 0.0 111.229 176.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.8 p -93.81 -10.92 32.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.174 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 366' ' ' THR . 99.6 mttt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.9 mt -85.9 132.19 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -135.4 143.97 46.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.934 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -55.67 134.13 51.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.431 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 94.94 2.01 62.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.519 -176.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.5 tttt -164.97 138.2 4.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.947 0.403 . . . . 0.0 110.851 174.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.55 ' H ' HD23 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -146.68 157.4 43.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.823 -173.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 86.6 t -114.5 133.47 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 -177.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.825 HD13 HD11 ' A' ' 20' ' ' LEU . 1.3 mp -119.28 125.81 74.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.596 ' CE3' ' HG3' ' A' ' 57' ' ' PRO . 45.1 m0 -106.02 128.97 54.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 178.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 12' ' ' ASN . 68.0 mt -122.1 141.45 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.168 172.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.417 ' O ' HG22 ' A' ' 11' ' ' ILE . 65.0 t30 -49.19 141.77 7.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 172.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.51 ' HA3' ' OD2' ' A' ' 41' ' ' ASP . . . -57.72 -11.14 7.32 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 -172.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -71.93 -17.07 62.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 110.868 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -129.92 111.2 12.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 161.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.98 -90.47 0.83 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.504 -159.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -101.71 -41.65 6.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.833 -172.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.78 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 85.2 m-20 -63.56 -53.58 49.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.804 -156.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.717 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -59.86 -48.07 87.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.503 -175.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.825 HD11 HD13 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -55.35 -60.97 2.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.0 110.914 175.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.21 -41.37 60.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -176.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -65.17 -54.24 32.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.65 -35.7 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.429 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -65.04 -41.88 96.98 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 176.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.01 -41.26 82.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 110.892 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -64.39 -39.62 94.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.26 -45.81 89.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.953 178.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -68.44 -38.97 81.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.806 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.38 -37.05 82.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -82.1 -39.27 23.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -169.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.539 ' OG1' HG13 ' A' ' 33' ' ' ILE . 71.2 p -109.94 -11.17 14.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.178 -174.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.44 14.04 82.59 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.462 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.127 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 pp -104.82 125.09 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.926 0.393 . . . . 0.0 111.029 -177.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.3 mttt -71.61 135.93 47.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 -168.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.539 HG12 HD21 ' A' ' 7' ' ' LEU . 8.4 m -110.7 135.45 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.046 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.405 ' O ' HD12 ' A' ' 9' ' ' ILE . 97.7 m -107.62 128.54 54.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.186 176.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.535 HG22 ' HG ' ' A' ' 20' ' ' LEU . 71.0 t -96.76 120.79 46.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.577 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 68.3 mm-40 -130.53 144.62 51.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.841 172.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -156.71 58.61 1.66 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.543 0.687 . . . . 0.0 110.79 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.462 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 77.6 Cg_endo -81.84 -13.23 10.6 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.719 2.28 . . . . 0.0 112.382 -171.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.51 ' OD2' ' HA3' ' A' ' 13' ' ' GLY . 20.8 m-20 63.06 20.05 12.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -171.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 45' ' ' GLU . 98.0 mttt -91.06 0.96 57.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 174.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.2 mt -43.69 -50.15 7.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -170.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.16 -36.56 82.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 42' ' ' LYS . 99.1 mt-10 -74.96 -33.17 61.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 69.8 mmtt -82.57 -29.98 29.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.936 -175.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.511 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 11.6 m-30 -40.18 -56.01 3.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.626 0.727 . . . . 0.0 110.783 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 57.3 Cg_endo -69.13 -28.09 28.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.313 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -79.08 -43.62 23.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 -172.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.8 m -65.69 -30.6 50.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.75 -36.04 79.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 172.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.13 -31.25 68.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.966 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 p -93.02 -11.45 33.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.112 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.47 15.27 81.32 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.469 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -164.86 159.05 17.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.953 0.406 . . . . 0.0 110.812 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.7 -140.33 2.85 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.321 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.596 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 72.6 Cg_endo -67.8 148.57 77.33 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.664 2.243 . . . . 0.0 112.354 168.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -74.32 -39.07 63.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.63 ' HB ' HG23 ' A' ' 9' ' ' ILE . 3.7 mp -126.13 138.71 53.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 176.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.47 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 1.8 tp -131.39 130.06 62.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.09 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.515 ' CE2' HG13 ' A' ' 108' ' ' ILE . 4.3 m-85 -98.63 140.31 33.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.785 176.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.529 ' CH2' ' HA3' ' A' ' 265' ' ' GLY . 9.1 m-90 -116.99 140.09 49.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 262' ' ' LEU . . . -57.99 -82.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.129 -176.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -126.41 -58.21 1.35 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.989 166.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -86.11 -24.35 26.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.807 -167.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 97.0 mtt180 -59.87 -29.72 68.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.981 -160.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -68.08 -27.68 66.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.923 -170.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.32 -51.36 53.22 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.434 -172.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.7 -35.91 91.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.537 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 15.2 t80 -65.68 -38.12 88.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.866 0.365 . . . . 0.0 110.887 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.51 -44.03 58.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.085 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -62.39 -31.78 72.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -80.87 -11.95 59.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.99 176.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.8 32.08 64.24 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.515 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 1.8 mp -86.3 -3.04 58.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.829 0.347 . . . . 0.0 110.862 -172.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.541 ' C ' ' HB2' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -127.85 154.38 45.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 -177.381 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.627 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -73.94 136.86 43.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.127 175.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -71.02 131.37 43.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.903 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.468 HD12 ' CE2' ' A' ' 106' ' ' TYR . 33.6 pt -110.19 159.76 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 70.1 p -105.87 147.6 35.03 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.663 0.744 . . . . 0.0 111.087 -172.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.76 145.78 29.3 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.689 2.259 . . . . 0.0 112.301 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -112.96 112.03 23.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 170.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.58 -37.4 62.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.947 -178.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.95 94.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . 0.549 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 18.6 m-30 -68.8 -49.51 57.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.822 178.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -53.74 -40.08 65.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.913 -176.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -57.69 -32.29 67.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.07 -15.28 54.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 61.8 mt -105.0 -104.95 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -167.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 40.6 t80 -165.23 133.94 2.61 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.675 0.75 . . . . 0.0 110.953 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 71.3 Cg_exo -52.89 -39.91 76.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.748 2.299 . . . . 0.0 112.372 -171.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -80.08 -28.13 39.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.0 m -69.92 -48.31 59.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.086 -167.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.479 ' HA ' HG22 ' A' ' 97' ' ' VAL . 53.8 p-90 -66.96 -28.96 68.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.898 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -70.69 -35.97 73.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.74 -25.9 65.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.506 HG23 HD22 ' A' ' 103' ' ' LEU . 19.8 m -101.27 17.71 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.177 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 67.5 ttt180 -102.56 133.67 47.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.972 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -147.89 130.11 15.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.827 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.6 t30 67.16 35.68 4.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.928 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.78 -4.25 66.09 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.539 174.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -133.96 159.99 39.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.33 . . . . 0.0 110.943 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.506 HD22 HG23 ' A' ' 97' ' ' VAL . 13.8 mt -73.51 144.82 46.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pp -122.17 6.81 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.19 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.678 ' HB1' ' HB3' ' A' ' 263' ' ' SER . . . -167.83 159.3 11.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.051 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.468 ' CE2' HD12 ' A' ' 79' ' ' ILE . 62.1 m-85 -117.25 147.44 40.45 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.689 0.757 . . . . 0.0 110.928 164.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.516 ' HB3' HG11 ' A' ' 261' ' ' VAL . 59.6 Cg_endo -72.36 118.09 5.44 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.666 2.244 . . . . 0.0 112.358 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.515 HG13 ' CE2' ' A' ' 61' ' ' PHE . 30.8 mm -96.29 -36.88 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -151.93 154.67 36.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.083 -176.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.44 134.95 63.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.018 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -118.07 129.76 55.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -150.92 157.12 42.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.113 177.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.635 ' HB2' ' HG3' ' A' ' 257' ' ' PRO . 7.4 mp -108.49 156.92 18.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 -172.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.1 p -150.39 161.19 42.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.929 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.899 HD13 ' O ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.22 124.3 44.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 175.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.71 HG13 HG23 ' A' ' 244' ' ' VAL . 4.6 mp -109.0 132.76 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.072 -174.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -133.08 148.28 52.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 -173.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -97.4 115.91 28.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.806 174.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -66.55 -15.84 63.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.781 172.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.537 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 22.8 t70 -80.87 -33.99 34.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.885 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 mp -87.9 -45.0 10.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.041 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.439 HD22 ' HB1' ' A' ' 223' ' ' ALA . 2.1 mp -106.08 127.62 27.97 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.545 0.688 . . . . 0.0 110.897 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.31 -30.09 16.14 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.732 2.288 . . . . 0.0 112.343 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -148.9 90.0 4.85 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.61 0.719 . . . . 0.0 110.944 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.51 144.97 90.84 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.668 2.245 . . . . 0.0 112.351 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.58 153.31 73.82 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.689 2.26 . . . . 0.0 112.336 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -107.72 -3.96 18.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.847 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.6 p -133.94 159.02 42.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.148 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.428 ' HA ' HG12 ' A' ' 132' ' ' ILE . 64.4 m95 -72.2 -24.65 61.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.4 -30.02 70.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.05 -19.31 60.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.85 -177.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.604 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 49.8 mm -61.49 -53.52 61.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.716 0.769 . . . . 0.0 111.138 -165.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 22.6 Cg_endo -61.7 -40.03 48.91 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.635 2.223 . . . . 0.0 112.276 -176.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.24 -60.67 2.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.065 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.178 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.52 -16.5 63.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.862 -174.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.629 ' HA ' HD22 ' A' ' 139' ' ' LEU . 38.7 t70 -61.74 -38.9 89.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.848 168.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.87 -36.44 82.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -73.6 -49.79 24.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.726 -174.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.662 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -74.97 -15.94 60.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -176.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.662 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.8 tttt -56.43 -34.92 67.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.928 171.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.99 -23.75 67.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -94.32 7.99 43.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.95 27.41 64.6 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.415 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.417 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 45.5 mtmt -119.94 169.5 10.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.4 . . . . 0.0 110.863 173.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.52 ' HA ' HD21 ' A' ' 139' ' ' LEU . 33.5 t -133.1 143.95 49.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 172.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 224' ' ' MET . . . -71.98 -54.12 10.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.101 -162.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -139.65 125.47 19.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.948 -165.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.422 ' SD ' ' HB2' ' A' ' 213' ' ' ALA . 57.6 ttm -106.28 129.22 54.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.891 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -154.71 164.24 39.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -122.81 142.92 50.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.942 171.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 151' ' ' LEU . 50.8 tp -111.4 -0.13 16.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 -176.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -74.17 -6.04 45.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.936 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -119.73 150.18 49.85 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 121.679 0.752 . . . . 0.0 110.905 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.54 -18.82 64.13 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.632 2.221 . . . . 0.0 112.417 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -61.75 -37.21 83.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.927 -173.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -82.89 -40.17 20.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 23.6 p -63.77 -38.66 91.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.101 -175.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.581 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 22.2 t-105 -62.98 -54.44 46.56 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.567 0.699 . . . . 0.0 110.911 -168.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 28.5 Cg_endo -66.87 -32.19 36.75 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.696 2.264 . . . . 0.0 112.37 -172.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.702 ' O ' HD23 ' A' ' 160' ' ' LEU . 6.4 tt -74.69 -41.04 60.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.53 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 74.4 mt -70.48 -40.89 77.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.109 177.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.96 -26.14 63.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.45 -29.46 70.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.126 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -91.29 2.75 56.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 104.99 7.05 39.05 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.56 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -79.02 65.06 3.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.359 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -90.22 146.2 24.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.863 0.363 . . . . 0.0 110.911 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.42 -15.35 63.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.063 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -164.42 150.07 10.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.841 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -81.74 128.18 33.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.937 163.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -100.79 120.5 40.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.921 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -149.72 133.2 16.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.881 -173.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 61.9 t30 57.51 43.42 22.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.04 7.25 70.47 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.499 173.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -134.9 145.29 48.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.785 0.326 . . . . 0.0 110.888 -177.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -78.66 143.24 36.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 168.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -107.18 105.98 16.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.8 tp -71.28 -18.03 20.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.14 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -94.61 -8.99 36.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -177.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -129.56 93.05 3.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 172.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.9 m -114.01 167.62 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.128 -175.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.58 13.35 54.09 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.486 -171.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.512 HG11 ' CD1' ' A' ' 368' ' ' ILE . 33.7 m -104.85 -16.91 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.318 . . . . 0.0 111.096 -173.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.42 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 57.9 p-10 -95.09 18.07 12.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.934 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -115.91 172.86 6.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.88 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.21 -26.71 68.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.209 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.11 -41.28 92.68 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.526 -170.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.625 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.08 -40.6 94.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 111.02 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.49 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.1 mttt -60.83 -37.1 80.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 173.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.5 87.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.121 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.72 -46.02 91.06 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.421 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.591 HD11 ' HA ' ' A' ' 347' ' ' VAL . 22.6 tp -68.64 -34.8 76.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.922 0.391 . . . . 0.0 110.993 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.406 ' O ' HG12 ' A' ' 196' ' ' VAL . 85.4 m -61.83 -42.26 98.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -68.07 -56.99 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.676 HD12 ' C ' ' A' ' 195' ' ' LEU . 2.6 pp -63.64 -27.5 69.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 -165.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.553 ' N ' HD12 ' A' ' 195' ' ' LEU . 4.5 p -72.65 -22.85 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.182 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -66.03 -58.22 5.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -174.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 1.057 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.5 -24.25 56.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -167.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.801 ' N ' HD22 ' A' ' 198' ' ' LEU . 2.0 pp -77.46 -35.64 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.15 172.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.02 -30.36 70.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.8 168.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -84.65 5.37 28.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.878 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 66.07 40.06 4.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.94 170.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -82.12 -10.54 59.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.5 ' CG ' HG22 ' A' ' 199' ' ' ILE . 5.4 ppp? -141.08 154.26 45.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.848 175.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -99.0 156.13 17.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.89 -24.88 68.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.132 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.83 -2.59 50.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 88.7 m -64.38 131.49 47.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.227 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -147.23 173.39 12.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.926 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -78.66 -32.09 47.03 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.899 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 99.1 p -74.13 -38.84 63.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -172.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 39.5 pt -65.04 -20.11 26.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.105 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.422 ' HB2' ' SD ' ' A' ' 148' ' ' MET . . . -58.42 -32.45 68.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.19 -43.53 87.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.834 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.04 -36.82 85.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.147 174.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.1 79.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.065 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -65.08 -42.46 94.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.895 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -64.95 -33.94 77.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.896 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -92.51 -24.36 18.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.05 30.99 21.5 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.568 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -91.83 -31.61 15.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.85 0.357 . . . . 0.0 110.914 -168.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 96.9 m -115.89 127.58 55.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.089 -171.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.439 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -70.71 -44.97 65.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 -175.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.415 ' N ' ' O ' ' A' ' 146' ' ' ALA . 68.1 mtm -134.05 146.98 50.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 -172.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . 0.421 HG21 ' HB1' ' A' ' 213' ' ' ALA . 43.3 p -140.01 161.64 37.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 177.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.2 mm -112.4 114.85 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.07 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . 0.451 ' HB2' HD13 ' A' ' 116' ' ' ILE . 63.8 m-80 -145.41 153.32 41.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -171.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.456 ' HA3' ' HG ' ' A' ' 113' ' ' LEU . . . -133.56 -123.3 2.38 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.5 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . 0.404 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 30.2 Cg_endo -61.97 -19.95 67.78 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.766 2.311 . . . . 0.0 112.269 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -65.19 -30.08 70.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.925 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 51.12 38.3 20.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.078 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -70.02 -27.87 65.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.046 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 72.7 m -53.22 117.95 3.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.86 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -74.86 -169.05 0.82 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 20.4 mt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 -178.442 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 240' ' ' VAL . 15.8 t . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.877 0.37 . . . . 0.0 111.046 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.537 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 74.6 m-20 42.12 70.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -126.0 132.8 51.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 -172.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.97 158.33 24.17 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.508 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.71 HG23 HG13 ' A' ' 116' ' ' ILE . 3.2 p -145.46 139.94 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 0.0 111.156 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.0 t -155.37 151.82 28.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.075 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . 0.485 HG11 ' HB2' ' A' ' 323' ' ' ASN . 28.2 m -62.3 168.4 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.096 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.753 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.7 mm? -61.81 143.37 94.28 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.644 0.735 . . . . 0.0 110.921 -162.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.56 -176.52 3.17 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.649 2.233 . . . . 0.0 112.457 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 95.2 m -100.41 146.33 27.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.14 -171.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -139.02 119.12 13.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 54.97 37.13 28.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.96 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.09 -0.46 83.96 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -130.96 140.09 37.62 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.588 0.709 . . . . 0.0 110.914 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -70.93 141.23 39.98 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.669 2.246 . . . . 0.0 112.412 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.753 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 82.7 p -82.39 -3.47 55.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 172.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -40.48 129.69 1.77 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.555 0.693 . . . . 0.0 110.894 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.635 ' HG3' ' HB2' ' A' ' 113' ' ' LEU . 85.8 Cg_endo -86.32 164.82 9.67 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.731 2.287 . . . . 0.0 112.446 -171.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -75.0 169.96 16.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.863 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.14 132.29 57.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.114 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.52 143.9 16.23 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.458 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' A' ' 107' ' ' PRO . 97.9 t -128.66 126.51 65.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.986 0.422 . . . . 0.0 111.081 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 2.0 tt -71.86 136.34 46.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 171.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.678 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 74.7 m -118.9 148.97 42.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -174.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.471 ' HB1' HD11 ' A' ' 280' ' ' LEU . . . -133.78 137.53 45.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 174.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.529 ' HA3' ' CH2' ' A' ' 62' ' ' TRP . . . -140.76 170.14 24.61 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.549 -173.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 22.7 mm -114.22 132.37 63.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 111.136 -171.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -65.04 133.8 52.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -172.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.627 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -63.0 -29.79 71.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.115 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.38 -8.11 59.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.038 -172.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 24.2 t -69.98 120.14 75.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.698 0.761 . . . . 0.0 110.848 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.42 -16.23 19.41 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.733 2.289 . . . . 0.0 112.362 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.405 ' HB2' HD21 ' A' ' 275' ' ' LEU . 53.2 p-10 -114.16 29.97 7.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -177.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -61.48 -24.55 66.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 -169.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -63.65 -45.58 89.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.851 -169.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 272' ' ' ASN . 2.2 pp -75.8 -33.28 60.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -178.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.413 ' HB1' HD11 ' A' ' 59' ' ' ILE . . . -65.8 -50.24 65.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.056 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -65.95 -36.48 83.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.868 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -68.98 -45.36 70.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -59.08 -47.12 86.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.93 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.471 HD11 ' HB1' ' A' ' 264' ' ' ALA . 8.0 tt -59.54 -52.24 66.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.889 -175.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -73.99 -25.72 60.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.953 -174.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -99.74 -14.18 18.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.942 -170.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.484 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 44.6 t80 -122.2 -56.54 1.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.404 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.4 OUTLIER -68.58 -39.69 80.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.854 -176.264 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.84 23.03 0.57 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 174.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 89.1 m -128.51 147.61 50.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.206 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.493 ' HA ' HD11 ' A' ' 290' ' ' LEU . 37.4 t70 -40.78 -38.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.774 -176.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.27 -42.57 68.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.856 -173.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.51 -52.03 8.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.445 -171.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.669 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -73.41 -21.97 60.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.815 0.34 . . . . 0.0 110.952 -177.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.478 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.4 tt0 -66.71 -42.69 85.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 169.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.93 -35.94 81.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.003 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.717 HG13 ' HA3' ' A' ' 19' ' ' GLY . 42.3 t -75.78 -44.27 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.166 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -65.05 -31.81 73.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.787 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.97 -32.2 72.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.932 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.78 ' HB3' ' HB3' ' A' ' 18' ' ' ASN . 63.7 m-20 -95.02 -29.64 14.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.834 -173.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.431 ' O ' HD13 ' A' ' 299' ' ' LEU . 77.3 tttt -146.1 135.47 11.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.626 0.727 . . . . 0.0 110.854 164.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.27 116.78 3.18 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.667 2.245 . . . . 0.0 112.33 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.431 HD13 ' O ' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -90.08 -22.57 21.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 174.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.95 -55.79 1.85 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.531 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.427 ' HA ' HD23 ' A' ' 311' ' ' LEU . . . -177.71 161.87 1.7 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.868 0.366 . . . . 0.0 111.191 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.594 ' CG2' ' HB3' ' A' ' 307' ' ' TYR . 33.8 m -128.57 159.93 39.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.153 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.46 -2.07 30.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.669 ' CD2' HD21 ' A' ' 290' ' ' LEU . 60.3 tp -87.94 130.38 34.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 -175.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -44.55 -32.42 1.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.484 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 74.4 m -48.16 -39.2 20.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.594 ' HB3' ' CG2' ' A' ' 302' ' ' VAL . 0.1 OUTLIER -58.93 -45.41 90.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 173.477 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.463 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 84.4 tt0 -54.63 -34.34 61.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.808 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -79.85 -63.3 1.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.8 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -82.71 -58.27 2.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -170.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 311' ' ' LEU . 0.0 OUTLIER -60.14 -36.63 77.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -170.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.98 -14.42 53.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.41 -20.46 65.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.491 ' HB3' HD12 ' A' ' 317' ' ' ILE . 60.3 t0 -79.61 120.7 81.05 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.609 0.719 . . . . 0.0 110.921 167.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.68 -35.42 13.02 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.656 2.237 . . . . 0.0 112.351 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -70.81 -36.99 73.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.875 -176.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.491 HD12 ' HB3' ' A' ' 314' ' ' ASP . 70.7 mt -78.46 -30.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.182 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.48 -39.59 91.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.102 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.98 -47.24 78.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.118 174.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 74.1 p -67.55 -25.17 65.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.188 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -62.05 -38.03 87.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 174.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -65.02 -47.05 78.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.821 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.485 ' HB2' HG11 ' A' ' 246' ' ' VAL . 36.9 t30 -63.47 -38.17 90.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.73 -46.94 85.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.095 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -72.82 -30.98 64.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.37 -4.38 42.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.924 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -101.74 -161.78 26.88 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.465 -172.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -143.37 140.58 30.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.361 . . . . 0.0 110.825 -172.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.584 ' O ' ' C ' ' A' ' 330' ' ' MET . 44.9 mm -82.51 106.63 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.17 -169.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.584 ' C ' ' O ' ' A' ' 329' ' ' ILE . 63.3 tpp . . . . . 0 C--N 1.33 -0.244 0 CA-C-O 121.636 0.731 . . . . 0.0 110.874 175.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 . . . . . 0 N--CA 1.457 -0.106 0 CA-C-O 120.8 0.333 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 22.8 mmt -77.9 -26.05 48.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 -175.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 62.1 p -65.27 -27.31 68.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.876 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -76.21 -36.06 58.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.168 173.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.408 ' N ' ' CD1' ' A' ' 339' ' ' PHE . 7.8 m-30 -61.16 -37.82 84.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.827 170.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -62.62 -32.7 73.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.021 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -72.87 -40.52 65.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.92 -40.08 91.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.106 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 346' ' ' ALA . 13.2 m -80.33 -24.01 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.142 177.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.555 ' O ' HG22 ' A' ' 347' ' ' VAL . 1.1 tmt_? -59.92 -50.24 74.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 171.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 56.1 m -57.88 -29.94 65.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.084 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 343' ' ' VAL . . . -56.33 -39.3 72.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.591 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.0 OUTLIER -72.6 -32.66 42.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 -176.402 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.35 -46.78 92.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.077 172.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -63.2 -34.66 78.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.98 -45.72 59.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.58 -40.51 88.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.155 -175.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.1 p -75.05 -12.08 60.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 110.891 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.16 14.95 82.06 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.579 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.27 -32.43 49.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.815 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -136.77 153.88 50.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.959 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.6 p -79.47 167.82 20.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.192 169.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.441 ' HA ' HD23 ' A' ' 192' ' ' LEU . 54.4 t -55.12 -41.99 62.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 172.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.35 -45.95 89.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.828 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -72.25 -53.18 13.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.831 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.11 -44.65 75.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.031 -171.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.625 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -66.98 -40.53 87.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.969 -178.142 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.98 -40.45 94.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.954 174.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.38 -39.72 94.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.75 98.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.42 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 16.8 tm0? -63.26 -38.44 91.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.958 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.9 m -65.01 -38.56 91.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.102 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 79.4 mtt-85 -67.25 -35.67 80.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.84 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.512 ' CD1' HG11 ' A' ' 183' ' ' VAL . 73.8 mt -66.47 -45.05 90.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.127 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 71.1 p -99.02 -8.63 25.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.158 -174.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.956 176.27 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.0 mt -82.82 129.93 36.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.159 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.44 143.48 43.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -56.35 134.98 53.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.575 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 97.61 -1.62 60.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.465 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 65.0 pttt -165.3 144.09 6.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.783 0.325 . . . . 0.0 110.902 172.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.533 HD22 HD13 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -148.49 159.97 43.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.792 -175.019 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 90.3 t -113.78 132.94 61.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.161 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.814 HD13 HD11 ' A' ' 20' ' ' LEU . 1.2 mp -119.32 124.97 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.081 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.574 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 44.2 m0 -104.62 127.1 52.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.894 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -119.4 141.75 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.146 172.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -51.36 147.52 5.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.47 -12.8 9.69 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.501 -172.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -75.17 -17.05 60.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.856 0.36 . . . . 0.0 110.813 -174.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.1 mtmm -129.94 110.09 11.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 163.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.09 -91.53 0.81 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.443 -160.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -101.81 -42.37 6.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 110.856 -171.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . 0.76 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 86.0 m-20 -61.86 -52.08 65.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.843 -157.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.746 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -61.99 -48.55 82.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.516 -175.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.814 HD11 HD13 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -56.52 -61.2 2.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.879 0.371 . . . . 0.0 110.922 177.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.66 -41.38 70.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 -174.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -65.05 -53.11 50.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -176.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 19' ' ' GLY . 18.7 m -74.89 -38.06 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.162 -175.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.617 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -65.12 -42.47 96.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.527 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.34 -41.33 88.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 110.927 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -63.21 -39.6 95.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.853 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -66.18 -36.95 84.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.839 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -62.12 -39.91 94.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 172.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -67.82 -33.98 75.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.911 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -86.76 -41.78 13.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -170.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.625 ' OG1' HG13 ' A' ' 33' ' ' ILE . 77.0 p -106.8 -14.86 14.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.212 -174.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.75 8.93 83.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.503 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.96 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.2 pp -106.35 130.41 58.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 111.093 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.9 mttt -75.95 139.78 41.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -171.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.617 HG21 ' HA3' ' A' ' 24' ' ' GLY . 5.8 m -112.36 135.81 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.402 ' O ' HD12 ' A' ' 9' ' ' ILE . 99.3 m -105.93 128.31 53.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.083 176.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.539 HG22 ' HG ' ' A' ' 20' ' ' LEU . 80.9 t -96.57 120.0 45.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.105 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.574 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 68.3 mm-40 -130.31 145.2 51.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.891 171.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -156.1 58.3 1.71 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.599 0.714 . . . . 0.0 110.87 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.95 -27.43 5.8 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.762 2.308 . . . . 0.0 112.343 -172.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.0 t0 68.87 13.19 8.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.863 -167.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 45' ' ' GLU . 99.1 mttt -87.84 1.56 53.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.988 171.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.3 mt -44.37 -50.14 9.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.948 -168.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.9 -27.56 67.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 42' ' ' LYS . 98.3 mt-10 -79.01 -32.45 45.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.882 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -81.84 -29.27 32.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.868 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.544 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 14.4 m-30 -45.26 -54.4 14.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.635 0.731 . . . . 0.0 110.852 -175.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 53.1 Cg_endo -66.4 -27.3 47.3 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.656 2.237 . . . . 0.0 112.336 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -79.4 -42.98 24.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.915 -175.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.3 m -71.62 -28.03 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.106 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.23 -35.2 79.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.109 171.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.35 -31.99 71.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.132 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.9 p -92.47 -12.11 32.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.96 14.97 81.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.609 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -161.9 157.14 23.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.891 0.377 . . . . 0.0 110.842 176.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.431 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . -165.04 -141.08 3.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.437 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.55 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 69.9 Cg_endo -66.97 149.78 82.87 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.622 2.214 . . . . 0.0 112.376 169.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -75.49 -38.45 59.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.56 ' HB ' HG23 ' A' ' 9' ' ' ILE . 4.1 mp -126.61 138.82 53.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 177.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.534 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 2.2 tp -133.35 131.56 57.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.117 -178.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.503 ' CE2' HG13 ' A' ' 108' ' ' ILE . 3.1 m-85 -99.36 139.69 34.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.769 177.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.627 ' HH2' ' HA3' ' A' ' 265' ' ' GLY . 3.4 m-90 -120.06 140.09 51.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.829 174.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.49 -85.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.06 -178.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -116.26 -62.99 1.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.834 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -85.41 -30.46 23.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -167.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -62.1 -31.58 72.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.935 -158.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -67.77 -29.29 68.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -172.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.22 -52.33 41.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.439 -174.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.14 -39.93 98.55 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.507 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.552 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 28.8 t80 -66.08 -41.38 90.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 110.891 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.08 -44.29 63.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.096 176.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -55.02 -39.9 69.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.893 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.2 m -82.53 -8.12 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.65 35.06 59.31 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.519 174.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 mp -84.99 -2.16 57.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 0.0 110.907 -173.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.552 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -128.67 154.55 46.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -178.178 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.623 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -70.93 134.38 47.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 175.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -71.18 131.09 43.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.445 HD12 ' CE2' ' A' ' 106' ' ' TYR . 29.3 pt -110.12 160.0 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.99 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.2 p -105.17 148.34 36.04 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.565 0.697 . . . . 0.0 111.127 -172.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.15 142.66 31.07 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.774 2.316 . . . . 0.0 112.362 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -103.44 120.3 40.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 172.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.67 -38.67 69.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.47 91.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -72.87 -35.29 67.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.853 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -54.58 -46.72 73.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.84 176.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -65.83 -34.59 78.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.819 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -78.63 -24.01 45.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 -174.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -95.01 -96.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.957 -171.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.439 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 36.9 t80 -176.31 137.75 0.48 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.718 0.771 . . . . 0.0 110.833 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -53.42 -39.28 82.35 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.331 -172.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -79.3 -30.27 42.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.439 ' OG1' ' HB3' ' A' ' 90' ' ' TYR . 55.7 m -70.0 -49.35 52.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.204 -165.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.434 ' HA ' HG22 ' A' ' 97' ' ' VAL . 51.7 p-90 -64.32 -29.98 71.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.46 -35.35 68.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.886 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.32 -25.01 64.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.741 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 19.6 m -101.8 17.92 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.172 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 63.7 ttt180 -101.13 133.3 45.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.957 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -144.25 129.45 18.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.4 t30 65.01 35.27 8.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.88 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.94 -4.77 73.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.476 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -132.55 158.59 41.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.816 0.341 . . . . 0.0 110.897 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.523 HD22 HG23 ' A' ' 97' ' ' VAL . 13.9 mt -72.98 147.52 45.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.1 pp -125.21 10.34 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.147 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.761 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -163.26 151.32 13.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.041 -176.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 45.1 m-85 -115.02 136.28 22.58 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.659 0.742 . . . . 0.0 110.919 163.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 40.0 Cg_exo -60.23 118.17 5.01 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.664 2.243 . . . . 0.0 112.393 177.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.503 HG13 ' CE2' ' A' ' 61' ' ' PHE . 30.6 mm -99.38 -41.63 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.184 177.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -152.95 152.56 31.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.133 -175.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.7 p -123.91 134.18 67.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.082 -175.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.06 128.73 54.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.802 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.09 153.96 37.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.092 172.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.482 HD22 ' HG3' ' A' ' 257' ' ' PRO . 8.0 mp -104.72 158.87 16.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.86 -169.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.2 p -150.45 156.49 41.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.937 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.859 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -100.06 125.9 46.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 176.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.584 ' N ' HD22 ' A' ' 115' ' ' LEU . 3.7 mp -106.03 135.33 44.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 -175.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -136.7 149.89 48.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -92.95 119.83 32.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.793 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -67.47 -18.65 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 167.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.484 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 20.3 t70 -75.28 -32.42 61.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.908 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.2 mp -93.25 -44.98 8.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.965 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 21.6 mt -104.42 113.63 64.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.599 0.714 . . . . 0.0 110.872 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.84 -26.64 31.98 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.702 2.268 . . . . 0.0 112.378 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.424 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 56.5 t-20 -149.57 94.99 3.8 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.56 0.695 . . . . 0.0 110.871 172.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 37.8 Cg_endo -69.14 151.03 72.64 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 0.0 112.237 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.86 151.62 62.94 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.691 2.26 . . . . 0.0 112.33 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -108.54 -8.6 15.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.937 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 72.3 p -132.21 159.01 40.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -65.25 -31.35 72.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.03 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.85 -27.83 67.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.81 -12.7 59.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.625 ' O ' HD13 ' A' ' 135' ' ' LEU . 49.4 mm -64.98 -53.07 44.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.679 0.752 . . . . 0.0 111.19 -172.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 30.1 Cg_endo -61.74 -37.21 69.56 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.635 2.223 . . . . 0.0 112.347 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.65 -61.31 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.018 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.181 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -71.16 -18.34 62.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 -177.258 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.577 ' HA ' HD22 ' A' ' 139' ' ' LEU . 38.9 t70 -63.6 -40.94 98.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 169.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.85 -38.16 89.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.93 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.6 -50.66 23.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -75.73 -16.53 60.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.937 -175.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.623 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.2 tttt -56.96 -34.41 68.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.97 172.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.78 -23.68 67.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -95.19 10.22 36.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.769 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.97 30.1 59.8 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.515 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.453 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 90.7 mttt -120.06 169.57 10.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 110.796 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.0 t -132.39 138.52 47.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.518 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -71.75 -53.87 12.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 -165.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -137.36 131.72 32.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 -164.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . 0.658 ' HG2' ' HB2' ' A' ' 213' ' ' ALA . 60.3 tpp -105.04 120.1 40.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -153.28 164.97 37.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -174.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -131.66 167.19 19.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 168.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.8 tp -116.26 -23.2 8.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -70.37 -4.07 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.851 -168.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -110.39 152.12 43.09 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.681 0.753 . . . . 0.0 110.819 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . 0.533 ' HD3' ' NE ' ' A' ' 344' ' ' ARG . 29.9 Cg_endo -67.55 -20.89 46.92 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.633 2.222 . . . . 0.0 112.304 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -59.19 -39.07 81.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.907 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -83.24 -42.97 16.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.786 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 41.9 p -65.37 -39.86 92.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.096 -170.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.574 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 17.5 t-105 -64.31 -53.86 43.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.589 0.709 . . . . 0.0 110.959 -169.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 36.2 Cg_endo -68.91 -32.24 22.77 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.596 2.198 . . . . 0.0 112.394 -172.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.717 ' O ' HD23 ' A' ' 160' ' ' LEU . 6.4 tt -72.74 -40.75 65.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.561 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 72.1 mt -69.77 -41.44 79.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.78 -27.67 63.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.034 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.56 -31.41 71.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -92.38 3.79 54.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 107.89 3.95 34.03 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.507 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.404 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -79.6 66.22 3.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.427 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . 0.432 ' O ' HG13 ' A' ' 183' ' ' VAL . 80.8 m-85 -90.02 145.41 25.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.853 0.359 . . . . 0.0 110.911 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.96 0.41 15.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.987 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -154.67 151.74 29.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.86 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -100.38 129.99 46.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.822 159.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -92.42 123.75 35.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -151.3 131.29 13.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.908 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.0 t30 57.57 43.6 22.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 171.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.65 77.41 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.54 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.88 144.26 47.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.877 -176.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -80.79 133.68 35.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 167.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -99.57 114.33 27.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.1 tp -72.91 -20.05 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.12 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.0 -10.25 36.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.908 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -127.57 95.02 4.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 169.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.4 m -112.01 163.11 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.1 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -97.64 13.29 64.17 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.486 -171.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.719 HG21 HD12 ' A' ' 368' ' ' ILE . 35.4 m -106.97 -13.43 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 111.058 -176.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -89.17 15.34 9.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -127.26 -171.27 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.26 -25.98 64.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.2 -173.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.93 -43.6 95.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.552 -167.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.718 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -67.57 -38.48 84.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 0.0 111.049 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.487 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.3 mttt -60.23 -35.29 75.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 174.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.29 -38.04 89.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.207 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -65.02 -45.75 91.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.365 177.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.604 HD11 ' HA ' ' A' ' 347' ' ' VAL . 17.8 tp -69.9 -32.99 71.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 0.0 110.964 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.45 ' O ' HG12 ' A' ' 196' ' ' VAL . 79.1 m -64.69 -42.11 95.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.169 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -70.55 -54.69 11.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.648 HD12 ' C ' ' A' ' 195' ' ' LEU . 3.6 pp -63.67 -23.91 67.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.989 -167.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.582 ' N ' HD12 ' A' ' 195' ' ' LEU . 1.2 p -74.54 -24.08 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.157 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.78 -55.41 19.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.837 -172.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 1.03 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.74 -24.6 56.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.943 -168.044 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.764 ' N ' HD22 ' A' ' 198' ' ' LEU . 2.0 pp -81.73 -33.88 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.077 173.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -65.26 -31.08 72.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -84.15 4.33 30.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.897 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 64.94 39.73 5.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.923 172.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -80.15 -11.71 59.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 174.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . 0.428 ' CG ' HG22 ' A' ' 199' ' ' ILE . 5.3 ppp? -142.95 154.54 44.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.81 174.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -101.25 157.12 17.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.96 -28.37 70.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -97.44 -0.01 46.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.7 m -59.25 131.78 52.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.435 ' H ' HD11 ' A' ' 212' ' ' ILE . 23.1 t0 -144.17 171.55 14.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -82.42 -29.67 30.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.8 p -70.66 -38.54 73.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.925 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.435 HD11 ' H ' ' A' ' 209' ' ' ASP . 40.7 pt -67.48 -24.52 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.148 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . 0.658 ' HB2' ' HG2' ' A' ' 148' ' ' MET . . . -59.68 -37.44 78.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 -177.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -57.74 -40.66 80.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.0 93.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.52 91.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.153 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -65.55 -33.9 77.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.78 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.43 -31.97 70.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.01 -18.44 22.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.914 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.63 29.04 22.56 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.477 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -92.03 -27.02 18.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 110.889 -171.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 98.3 m -111.02 125.03 53.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.167 -176.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.28 -49.43 23.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.173 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.414 ' N ' ' O ' ' A' ' 146' ' ' ALA . 66.3 mtm -134.98 155.45 50.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -171.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.7 t -153.02 166.26 32.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.111 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 40.3 mm -113.49 124.03 69.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -142.29 153.16 43.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.824 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -135.0 -95.03 0.49 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.446 175.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.97 -24.02 24.62 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.759 2.306 . . . . 0.0 112.239 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -74.75 -37.79 62.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.872 -173.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 49.72 40.3 19.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 -175.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -70.76 -22.99 62.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.4 t -51.37 130.8 27.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.907 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -87.7 -167.78 2.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.95 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.7 mt . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 -174.704 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 240' ' ' VAL . 14.9 t . . . . . 0 N--CA 1.457 -0.099 0 CA-C-O 120.911 0.386 . . . . 0.0 111.164 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 74.4 m-20 42.31 69.97 0.33 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -127.09 133.07 50.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -174.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -133.69 155.09 21.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.446 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.4 p -145.61 138.97 21.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.907 0.384 . . . . 0.0 111.113 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -155.64 152.61 28.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.116 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.8 m -60.81 168.45 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.681 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.5 mm? -61.12 150.74 77.97 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.658 0.742 . . . . 0.0 110.907 -162.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.48 -178.23 4.44 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.631 2.221 . . . . 0.0 112.293 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.5 m -98.37 142.24 30.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.12 -174.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -132.84 114.87 14.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.825 -176.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 54.91 36.52 26.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.99 2.74 88.24 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.613 174.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -130.71 138.1 32.26 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.618 0.723 . . . . 0.0 110.954 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -68.5 137.45 39.45 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.706 2.271 . . . . 0.0 112.389 -174.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.681 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 98.8 p -79.19 -8.12 58.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.823 174.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -49.99 116.6 6.53 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.475 0.655 . . . . 0.0 110.888 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . 0.482 ' HG3' HD22 ' A' ' 113' ' ' LEU . 72.5 Cg_endo -80.44 167.75 18.88 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.689 2.259 . . . . 0.0 112.264 -176.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -66.89 169.89 7.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 80.5 t -106.86 133.16 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.089 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.5 139.6 15.22 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.551 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 97.5 t -125.6 120.07 56.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.916 0.388 . . . . 0.0 111.1 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.407 HD23 ' C ' ' A' ' 262' ' ' LEU . 7.3 tt -78.98 129.13 34.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.989 168.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.761 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 96.5 p -132.39 160.76 35.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -170.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.62 143.04 50.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -175.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.627 ' HA3' ' HH2' ' A' ' 62' ' ' TRP . . . -139.64 172.53 23.27 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.47 -175.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 23.3 mm -113.53 131.0 66.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.847 0.356 . . . . 0.0 111.191 -171.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -65.28 133.59 51.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 -173.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.623 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -64.94 -27.2 68.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 -177.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.46 -8.58 59.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.996 -173.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.5 t -69.14 121.66 82.63 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.648 0.737 . . . . 0.0 110.948 -175.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.19 -17.79 18.86 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.311 172.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -112.05 29.29 8.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.963 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.02 -25.38 65.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -170.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -64.99 -43.38 92.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.822 -169.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.0 pp -76.93 -33.4 57.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.989 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.31 77.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.989 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -66.64 -35.01 79.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.921 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -69.4 -48.94 59.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.903 -173.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 0.6 OUTLIER -67.5 -31.24 71.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.922 -175.16 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 6.2 tt -64.61 -46.39 82.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.945 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -79.3 -24.88 42.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.887 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -97.61 -20.01 17.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.949 -168.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -119.97 -56.49 2.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.952 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 0.1 OUTLIER -65.68 -41.28 92.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.911 -176.085 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.66 48.21 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.922 169.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.432 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 74.2 m -145.52 146.69 31.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.112 173.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.431 ' HA ' HD11 ' A' ' 290' ' ' LEU . 35.8 t70 -40.0 -39.77 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.907 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.0 -41.69 64.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -172.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.83 -51.18 16.02 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.534 -172.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.69 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -75.49 -22.99 56.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.717 0.294 . . . . 0.0 110.89 -177.562 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.433 ' N ' HD12 ' A' ' 290' ' ' LEU . 86.6 tt0 -67.11 -40.6 86.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 169.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.95 -35.06 79.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.015 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.746 HG13 ' HA3' ' A' ' 19' ' ' GLY . 47.3 t -74.86 -43.68 46.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.14 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -63.28 -31.14 72.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.24 -32.34 73.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.807 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . 0.76 ' HB3' ' HB3' ' A' ' 18' ' ' ASN . 67.0 m-20 -94.99 -27.32 15.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 -173.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.401 ' O ' HD13 ' A' ' 299' ' ' LEU . 78.5 tttt -148.1 136.7 11.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.556 0.694 . . . . 0.0 110.857 168.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.33 111.87 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.687 2.258 . . . . 0.0 112.35 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 297' ' ' LYS . 0.4 OUTLIER -90.08 -28.58 18.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 174.697 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.06 -55.08 1.84 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.49 -176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.436 ' HA ' HD23 ' A' ' 311' ' ' LEU . . . -179.37 159.27 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.79 0.329 . . . . 0.0 111.067 -176.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.584 HG23 ' HB3' ' A' ' 307' ' ' TYR . 32.6 m -127.02 164.67 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.135 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -79.1 -4.22 49.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.066 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.69 ' CD2' HD21 ' A' ' 290' ' ' LEU . 58.9 tp -86.12 135.64 33.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.751 -172.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -47.3 -31.79 4.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.521 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 70.8 m -47.85 -39.99 20.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.843 173.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.584 ' HB3' HG23 ' A' ' 302' ' ' VAL . 0.0 OUTLIER -63.37 -46.1 88.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 173.556 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 32.9 tt0 -54.54 -36.78 64.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.736 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -80.76 -61.77 1.87 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.804 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -83.02 -58.3 2.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.938 -168.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.509 ' HA ' HD12 ' A' ' 311' ' ' LEU . 0.0 OUTLIER -60.38 -36.44 78.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 -171.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.06 -14.97 58.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.077 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.26 -22.0 66.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.892 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.446 ' HB3' HD12 ' A' ' 317' ' ' ILE . 62.9 t0 -78.25 119.59 77.91 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.584 0.707 . . . . 0.0 110.938 167.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -45.65 -35.24 12.65 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.638 2.225 . . . . 0.0 112.323 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 -69.65 -37.54 76.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -176.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 314' ' ' ASP . 66.0 mt -79.9 -29.91 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.087 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.63 -39.9 85.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.091 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.18 -47.27 74.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 174.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 78.9 p -65.07 -24.98 67.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.057 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 65.6 ttp -63.51 -40.57 97.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.937 174.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -65.01 -42.54 94.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.774 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -58.77 -44.64 90.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.928 173.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.91 90.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.052 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.84 -34.98 77.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.929 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -101.07 -3.73 28.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.939 -174.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -95.11 -163.59 34.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.43 -173.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -140.9 137.24 33.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.841 0.353 . . . . 0.0 110.835 -178.021 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.59 ' O ' ' C ' ' A' ' 330' ' ' MET . 35.6 mm -81.06 109.83 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.191 -170.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.59 ' C ' ' O ' ' A' ' 329' ' ' ILE . 6.9 tpt . . . . . 0 C--N 1.33 -0.269 0 CA-C-O 121.565 0.698 . . . . 0.0 110.899 174.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.775 0.322 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 17.4 mmt -74.6 -24.58 58.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.789 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.9 m -61.89 -33.71 74.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.879 177.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.65 -35.72 67.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.167 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -64.25 -35.22 80.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 172.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . 0.407 ' HA ' HG22 ' A' ' 343' ' ' VAL . 52.5 m0 -63.86 -31.12 72.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 174.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -73.64 -37.07 65.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.08 96.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.133 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 340' ' ' TRP . 10.1 m -80.88 -23.44 10.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.137 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.533 ' NE ' ' HD3' ' A' ' 154' ' ' PRO . 64.9 ttt180 -57.43 -53.17 61.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 172.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 67.4 p -62.52 -25.96 68.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.141 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -58.21 -39.0 77.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.085 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.604 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.2 m -73.1 -31.86 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.194 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.39 -44.85 97.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.152 173.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -64.95 -34.96 79.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.86 -45.12 62.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.82 -39.56 87.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.129 -175.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.2 p -75.88 -12.81 60.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.799 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.2 14.86 82.13 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.588 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.52 -32.2 47.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.741 0.305 . . . . 0.0 110.873 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -136.4 153.68 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 46.0 p -79.85 167.65 20.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.133 170.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.424 ' HA ' HD23 ' A' ' 192' ' ' LEU . 53.8 t -55.4 -41.58 63.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.12 172.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -59.56 -45.03 93.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.929 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -72.84 -53.91 10.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.2 76.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.091 -171.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -67.08 -40.36 86.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.905 -178.105 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.09 -40.19 94.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.88 -39.91 93.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -63.39 -42.87 98.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 175.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -62.8 -39.05 93.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.821 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.4 m -64.38 -38.62 91.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.121 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -68.69 -35.11 76.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.719 HD12 HG21 ' A' ' 183' ' ' VAL . 75.2 mt -67.32 -45.32 86.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.099 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.6 p -101.71 -14.01 17.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.97 -179.558 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.71 0.291 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.55 131.81 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.095 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -135.59 144.27 46.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.937 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -56.14 135.14 53.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLY . . . . . 0.483 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 98.32 -1.85 59.06 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.492 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.3 tttt -166.29 137.34 3.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 174.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LEU . . . . . 0.62 ' H ' HD23 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -143.48 157.54 44.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 -172.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 86.4 t -113.45 132.34 62.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.116 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.836 ' HB ' HD21 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -119.95 127.41 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.062 -178.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' TRP . . . . . 0.573 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 44.8 m0 -106.16 129.47 54.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 12' ' ' ASN . 60.7 mt -122.21 140.54 45.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.137 170.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.426 ' O ' HG22 ' A' ' 11' ' ' ILE . 64.2 t30 -50.15 141.74 10.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.906 172.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.403 ' HA3' ' OD2' ' A' ' 41' ' ' ASP . . . -58.06 -11.34 8.63 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.43 -172.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -73.32 -14.39 61.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.873 0.368 . . . . 0.0 110.923 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -136.94 109.99 7.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.957 158.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.36 -91.09 0.84 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.413 -154.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -104.7 -47.49 4.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.857 0.361 . . . . 0.0 110.849 -167.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -66.53 -46.86 74.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 -156.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.672 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -58.13 -47.06 91.6 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.512 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.836 HD21 ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -55.65 -60.97 2.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.792 0.329 . . . . 0.0 110.898 173.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.04 -39.28 55.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 -177.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -64.58 -52.83 55.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.3 m -75.69 -35.4 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.183 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.702 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -65.38 -44.57 93.13 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.481 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.67 -36.46 78.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.802 0.334 . . . . 0.0 110.832 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -61.6 -39.84 92.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.868 173.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PHE . . . . . 0.448 ' CD2' HD11 ' A' ' 33' ' ' ILE . 1.3 t80 -61.32 -44.82 96.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.0 -38.99 93.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.848 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.27 -31.85 73.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.13 -43.77 15.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -172.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . 0.53 ' OG1' HG13 ' A' ' 33' ' ' ILE . 53.8 p -113.85 -11.63 12.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.183 -171.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.87 14.0 81.46 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.142 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.8 pp -104.55 126.83 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 0.0 111.137 -176.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.6 mttt -75.77 141.53 42.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -171.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.702 HG21 ' HA3' ' A' ' 24' ' ' GLY . 2.9 m -114.99 135.97 53.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.081 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.432 ' O ' HD12 ' A' ' 9' ' ' ILE . 99.0 m -105.29 128.1 53.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.045 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . 0.523 HG22 ' HG ' ' A' ' 20' ' ' LEU . 58.4 t -96.24 121.38 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.145 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.573 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 69.2 mm-40 -130.09 144.61 51.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.837 172.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -156.82 58.78 1.68 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.585 0.707 . . . . 0.0 110.867 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 73.5 Cg_endo -80.71 -12.91 12.12 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.686 2.257 . . . . 0.0 112.296 -170.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 26.2 m-20 63.59 19.96 11.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -171.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 45' ' ' GLU . 98.6 mttt -93.67 0.25 56.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.966 174.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 43' ' ' LEU . 14.1 mt -45.77 -51.77 12.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.951 -166.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.67 -26.53 66.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.95 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 42' ' ' LYS . 98.4 mt-10 -78.68 -33.1 47.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.993 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 69.0 mmtt -82.72 -30.22 29.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.9 -174.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' PHE . . . . . 0.51 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 14.1 m-30 -40.72 -56.07 4.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.637 0.732 . . . . 0.0 110.826 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 51.6 Cg_endo -67.34 -27.44 40.47 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.717 2.278 . . . . 0.0 112.307 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -79.65 -44.41 20.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.2 m -69.75 -27.49 33.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.152 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.91 78.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.101 170.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.28 -30.48 67.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.08 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.3 p -92.58 -12.1 32.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.217 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.69 15.12 81.48 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.42 175.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -163.78 157.31 18.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.91 0.386 . . . . 0.0 110.859 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.5 -138.81 2.49 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 -178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PRO . . . . . 0.491 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 73.6 Cg_endo -67.69 150.41 79.37 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.655 2.236 . . . . 0.0 112.401 168.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -76.32 -38.57 55.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.716 ' HB ' HG23 ' A' ' 9' ' ' ILE . 3.7 mp -126.4 138.66 53.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.207 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.514 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 2.2 tp -128.48 129.8 68.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.131 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.549 ' CE2' HG13 ' A' ' 108' ' ' ILE . 2.0 m-85 -98.53 142.68 29.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.831 175.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TRP . . . . . 0.535 ' HH2' ' HA3' ' A' ' 265' ' ' GLY . 6.1 m-90 -119.68 139.81 51.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.922 176.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 262' ' ' LEU . . . -59.65 -85.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.092 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -122.52 -61.46 1.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -84.56 -27.92 26.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.773 -167.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.452 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 89.4 mtt180 -60.07 -30.5 69.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.891 -158.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -67.8 -27.92 67.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -170.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.85 -51.84 47.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.515 -173.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.16 -36.27 92.74 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' TYR . . . . . 0.574 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 18.4 t80 -65.98 -38.31 88.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.932 0.396 . . . . 0.0 110.891 -178.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.14 -43.94 60.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -62.61 -32.06 73.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.2 m -80.48 -12.57 59.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 175.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.1 31.95 66.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.503 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.49 -1.26 56.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.79 0.329 . . . . 0.0 110.879 -172.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.574 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -130.99 156.94 44.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.975 -179.287 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -66.9 130.46 43.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.132 175.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -69.52 122.97 20.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -109.3 159.97 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.05 -171.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.6 p -103.23 146.5 32.56 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.629 0.728 . . . . 0.0 111.065 -171.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.84 146.25 29.56 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.682 2.255 . . . . 0.0 112.326 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -107.94 114.68 28.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -52.68 -35.92 56.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.828 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.08 -40.97 95.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -69.97 -38.25 76.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.862 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -54.95 -48.61 72.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.76 -36.39 83.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.845 175.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -75.78 -19.99 58.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -103.34 -103.52 0.29 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 -173.304 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 43.0 t80 -165.92 134.28 2.41 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.688 0.756 . . . . 0.0 110.933 -172.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 70.9 Cg_exo -52.51 -39.94 73.33 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.375 -170.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -78.44 -30.51 47.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.96 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.2 m -69.48 -48.7 59.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.196 -166.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TRP . . . . . 0.454 ' HA ' HG22 ' A' ' 97' ' ' VAL . 51.9 p-90 -66.57 -28.4 68.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.87 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -71.44 -37.59 71.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.855 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.98 -25.07 65.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 21.7 m -101.55 16.54 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.189 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 68.1 ttt180 -101.8 133.11 47.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.905 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -149.06 130.31 14.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.3 t30 68.69 36.26 2.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.12 -5.01 64.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.52 174.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -139.73 163.85 31.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LEU . . . . . 0.553 HD22 HG23 ' A' ' 97' ' ' VAL . 13.1 mt -73.07 146.09 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.002 -175.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.431 ' C ' HD12 ' A' ' 104' ' ' ILE . 1.9 pp -122.33 9.91 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.179 173.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.876 ' HB1' ' HB3' ' A' ' 263' ' ' SER . . . -168.09 156.68 9.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.045 -177.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' TYR . . . . . 0.436 ' HB3' HD21 ' A' ' 285' ' ' LEU . 21.4 m-85 -124.99 146.34 53.21 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.766 0.793 . . . . 0.0 110.905 163.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PRO . . . . . 0.65 ' HB3' HG11 ' A' ' 261' ' ' VAL . 42.9 Cg_endo -71.4 121.09 7.43 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.616 2.211 . . . . 0.0 112.359 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ILE . . . . . 0.549 HG13 ' CE2' ' A' ' 61' ' ' PHE . 25.1 mm -98.31 -32.28 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.137 177.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.04 151.34 26.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.6 t -115.02 132.99 62.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.079 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -112.88 131.72 55.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.83 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.08 154.49 40.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.966 176.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.425 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 11.0 mp -94.29 152.05 18.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.946 -174.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -148.22 157.59 43.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.813 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -99.23 125.2 44.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.85 174.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ILE . . . . . 0.58 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.7 mp -107.54 132.1 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 -176.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -131.71 145.15 51.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.944 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -100.2 113.08 25.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.749 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 241' ' ' ASN . 99.5 mttt -64.78 -15.01 61.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.812 -176.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 15.1 t70 -80.47 -29.87 37.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 mp -88.83 -46.49 8.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.533 HD22 ' HB1' ' A' ' 223' ' ' ALA . 2.2 mp -111.24 124.94 31.53 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.587 0.708 . . . . 0.0 110.81 175.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -71.71 -26.71 19.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.652 2.234 . . . . 0.0 112.302 173.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -152.47 96.28 3.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.628 0.728 . . . . 0.0 110.921 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.78 153.99 68.2 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.687 2.258 . . . . 0.0 112.331 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.58 151.53 64.46 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.651 2.234 . . . . 0.0 112.38 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -113.62 -5.07 13.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.864 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 130' ' ' GLU . 11.8 m -127.9 146.08 50.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.106 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TRP . . . . . 0.458 ' HA ' HG12 ' A' ' 132' ' ' ILE . 63.1 m95 -66.39 -25.63 66.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.955 -177.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' GLU . . . . . 0.495 ' H ' HG22 ' A' ' 128' ' ' THR . 98.3 mt-10 -62.11 -30.32 70.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.15 -19.67 56.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 -175.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.587 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 49.5 mm -62.0 -53.46 59.38 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.656 0.741 . . . . 0.0 111.133 -166.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 31.9 Cg_endo -62.75 -40.06 38.81 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.7 2.266 . . . . 0.0 112.339 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.0 -59.44 4.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LEU . . . . . 1.17 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.71 -17.67 63.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -175.257 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.637 ' HA ' HD22 ' A' ' 139' ' ' LEU . 39.0 t70 -63.49 -39.08 93.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 169.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.01 -36.72 82.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -73.16 -50.3 23.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -174.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -75.18 -15.2 60.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.892 -176.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.675 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.8 tttt -56.28 -35.06 67.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 170.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.18 -23.84 67.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.129 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -94.9 8.64 42.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.816 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.22 27.51 63.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.425 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.434 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 46.0 mtmt -120.87 165.41 15.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.859 0.361 . . . . 0.0 110.862 173.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' SER . . . . . 0.52 ' HA ' HD21 ' A' ' 139' ' ' LEU . 37.1 t -128.56 146.69 50.77 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 170.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -72.04 -58.31 3.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.084 -164.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -138.64 128.87 25.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -161.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.1 mmm -105.91 128.64 53.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -153.77 162.38 41.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -123.89 142.95 50.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.421 ' HG ' HG21 ' A' ' 347' ' ' VAL . 54.4 tp -113.35 -9.73 13.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.975 -175.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -73.71 0.14 13.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -118.0 148.39 43.37 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 121.738 0.78 . . . . 0.0 110.828 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.77 -20.01 64.66 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.595 2.197 . . . . 0.0 112.327 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -62.37 -36.69 83.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -84.32 -37.69 21.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.4 p -64.09 -37.77 88.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' TRP . . . . . 0.561 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 12.4 t-105 -62.21 -55.13 43.27 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.621 0.724 . . . . 0.0 110.935 -172.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 26.4 Cg_endo -67.37 -32.48 32.4 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.68 2.253 . . . . 0.0 112.326 -171.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.702 ' O ' HD23 ' A' ' 160' ' ' LEU . 6.5 tt -74.48 -40.31 61.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.981 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ILE . . . . . 0.481 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 76.0 mt -69.74 -40.44 79.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.128 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.78 -26.72 64.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.142 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.59 -30.25 70.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -94.56 0.56 55.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 112.19 5.41 24.96 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.55 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.473 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -79.21 66.68 3.41 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.383 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -90.28 152.58 20.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.883 -174.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.68 -17.95 60.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.112 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -147.56 154.04 40.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.087 0.47 . . . . 0.0 110.813 -173.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -97.24 128.93 44.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.885 159.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -96.19 122.64 39.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.918 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -149.73 130.71 14.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.954 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.4 t30 56.9 44.28 23.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 172.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.14 6.43 74.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -132.71 142.39 49.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.858 0.361 . . . . 0.0 110.942 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -77.77 134.85 37.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.917 165.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -95.12 104.97 16.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.3 tp -65.76 -19.95 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.106 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -94.74 -8.43 37.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -132.63 95.58 3.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 174.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' VAL . . . . . 0.501 HG23 HG22 ' A' ' 183' ' ' VAL . 33.1 m -115.82 173.05 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.107 -177.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -99.95 12.13 60.7 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.442 -167.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' VAL . . . . . 0.563 HG21 ' CD1' ' A' ' 368' ' ' ILE . 17.9 m -101.62 -17.92 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 0.0 111.156 -172.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ASP . . . . . 0.449 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 57.5 p-10 -95.57 19.85 10.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.868 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -118.11 171.55 8.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.08 -24.46 67.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.069 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.05 -39.78 94.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.524 -172.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.637 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.5 -39.4 91.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 111.068 177.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' LYS . . . . . 0.505 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.2 mttt -59.73 -37.37 78.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 173.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.58 -38.11 89.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.121 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.0 -45.41 94.03 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.374 177.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' LEU . . . . . 0.593 HD11 ' HA ' ' A' ' 347' ' ' VAL . 18.7 tp -68.33 -33.31 74.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.928 0.394 . . . . 0.0 110.971 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' THR . . . . . 0.415 ' O ' HG12 ' A' ' 196' ' ' VAL . 89.5 m -63.06 -42.28 99.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.159 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -67.29 -58.03 5.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' LEU . . . . . 0.626 HD12 ' C ' ' A' ' 195' ' ' LEU . 3.4 pp -63.49 -27.78 69.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 -165.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' VAL . . . . . 0.563 ' N ' HD12 ' A' ' 195' ' ' LEU . 3.7 p -72.77 -22.55 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.11 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -66.06 -58.79 4.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.886 -174.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' LEU . . . . . 1.055 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.42 -24.54 57.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -167.404 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ILE . . . . . 0.804 ' N ' HD22 ' A' ' 198' ' ' LEU . 2.1 pp -77.35 -35.8 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.173 172.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.89 -30.71 71.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.919 169.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -85.55 5.79 29.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.843 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 67.26 40.02 2.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.904 170.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -82.8 -14.36 54.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 170.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 60.5 ttp -133.14 146.31 51.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -94.94 155.91 16.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.9 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.2 -25.03 68.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -95.09 -3.5 47.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 95.3 m -63.53 130.88 46.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.17 -175.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ASP . . . . . 0.514 ' H ' HD11 ' A' ' 212' ' ' ILE . 21.5 t0 -146.78 172.24 13.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 176.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -75.49 -34.38 60.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 -172.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 47.7 t -68.81 -48.3 63.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 -174.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ILE . . . . . 0.514 HD11 ' H ' ' A' ' 209' ' ' ASP . 29.8 pt -65.94 -24.85 34.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.123 176.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.97 -35.6 81.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.18 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -67.84 -35.96 79.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.809 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.16 -40.16 95.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.164 173.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.0 -40.49 95.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.136 174.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -65.09 -39.4 93.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.868 -177.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -63.64 -32.09 73.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.842 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.17 -10.87 48.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.979 -176.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.9 25.75 36.9 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.533 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -86.54 -26.23 24.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.898 0.38 . . . . 0.0 110.805 -175.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -125.45 134.51 52.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' ALA . . . . . 0.533 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -72.55 -35.74 68.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.085 -175.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 72.5 mtm -131.99 155.51 47.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 110.879 -176.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.6 t -149.01 160.12 43.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.7 mm -115.09 125.02 72.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.114 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -145.02 151.06 37.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -135.07 -97.51 0.55 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.457 174.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.93 -17.39 36.83 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.741 2.294 . . . . 0.0 112.329 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -67.38 -33.33 74.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.999 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 53.57 32.9 15.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.032 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 35.2 m0 -72.65 -34.58 67.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.035 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 19.2 t -55.52 112.77 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.868 -171.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ASN . . . . . 0.413 ' O ' ' HB ' ' A' ' 235' ' ' ILE . 44.7 p30 -95.47 -162.85 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.955 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 235' ' ' ILE . 47.6 mt . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.157 -175.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 240' ' ' VAL . 11.6 t . . . . . 0 CA--C 1.523 -0.08 0 CA-C-O 120.904 0.383 . . . . 0.0 111.174 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ASN . . . . . 0.46 ' C ' ' O ' ' A' ' 240' ' ' VAL . 77.4 m-20 37.27 70.0 0.2 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 169.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 242' ' ' TYR . 4.4 t80 -119.48 135.39 54.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.908 -171.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.07 158.47 24.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.428 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' VAL . . . . . 0.526 HG22 ' HB2' ' A' ' 319' ' ' ALA . 7.4 p -141.48 139.95 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.871 0.367 . . . . 0.0 111.11 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.3 t -153.02 148.92 27.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.162 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 18.9 m -61.76 168.94 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.096 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' LEU . . . . . 0.578 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.8 mm? -62.06 146.92 91.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.659 0.742 . . . . 0.0 110.895 -162.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -72.69 -177.42 2.81 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.65 2.233 . . . . 0.0 112.35 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.8 p -108.71 160.02 16.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.15 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -143.59 122.38 12.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 110.89 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 55.02 35.83 25.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.09 7.35 77.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.546 169.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -132.83 139.86 35.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.613 0.72 . . . . 0.0 110.905 176.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.87 140.9 36.03 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.741 2.294 . . . . 0.0 112.376 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' SER . . . . . 0.578 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 97.3 p -82.42 -5.87 58.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.865 170.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -49.93 113.33 3.31 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.545 0.688 . . . . 0.0 110.934 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.91 168.89 20.21 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.563 2.175 . . . . 0.0 112.426 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -72.9 171.75 12.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.883 -177.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.478 HG21 ' HA ' ' A' ' 324' ' ' ALA . 76.4 t -104.33 134.83 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.163 -170.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -109.77 137.91 14.51 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.502 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' A' ' 107' ' ' PRO . 93.8 t -121.84 124.04 70.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.938 0.399 . . . . 0.0 111.168 -176.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 5.2 tt -72.09 128.82 36.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 168.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' SER . . . . . 0.876 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 58.5 m -121.31 153.89 37.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 -171.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ALA . . . . . 0.461 ' CB ' HD11 ' A' ' 280' ' ' LEU . . . -134.62 139.79 45.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 177.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' GLY . . . . . 0.535 ' HA3' ' HH2' ' A' ' 62' ' ' TRP . . . -142.41 172.22 24.37 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.518 -176.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 24.4 mm -112.87 134.31 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.333 . . . . 0.0 111.177 -169.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -64.55 132.07 48.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.936 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' ALA . . . . . 0.62 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -64.49 -30.21 71.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.1 -8.76 59.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.069 -172.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.3 t -68.21 121.66 81.11 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.639 0.733 . . . . 0.0 110.937 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.27 -16.95 19.35 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.71 2.273 . . . . 0.0 112.352 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 272' ' ' ASN . . . . . 0.439 ' HB2' HD21 ' A' ' 275' ' ' LEU . 53.1 p-10 -113.24 29.93 7.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.814 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -61.87 -25.29 67.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -169.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -65.65 -43.53 89.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 110.805 -168.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 275' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 272' ' ' ASN . 2.5 pp -74.75 -33.73 62.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 276' ' ' ALA . . . . . 0.444 ' HB1' HD11 ' A' ' 59' ' ' ILE . . . -65.81 -49.17 69.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -65.22 -35.13 80.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 94.0 mt-10 -68.62 -43.39 76.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.874 -177.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -60.12 -46.58 89.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' LEU . . . . . 0.461 HD11 ' CB ' ' A' ' 264' ' ' ALA . 7.6 tt -62.43 -46.56 87.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 -177.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.99 -38.81 72.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 -177.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 94.8 m-20 -102.28 -10.9 19.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -161.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' TYR . . . . . 0.426 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 53.5 t80 -122.46 -51.57 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' LEU . . . . . 0.429 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.5 OUTLIER -70.58 -43.22 69.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -176.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 106' ' ' TYR . 4.5 mm? -81.69 44.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 169.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' THR . . . . . 0.431 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 89.6 m -145.77 145.37 30.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.168 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' ASP . . . . . 0.556 ' HA ' HD11 ' A' ' 290' ' ' LEU . 48.5 p-10 -50.11 -25.93 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -171.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -75.78 -45.89 33.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.71 -49.71 13.42 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 -169.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' LEU . . . . . 0.646 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.7 OUTLIER -73.06 -23.64 60.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.715 0.293 . . . . 0.0 110.877 -177.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' GLU . . . . . 0.516 ' N ' HD12 ' A' ' 290' ' ' LEU . 87.7 tt0 -68.71 -40.08 80.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 171.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.95 78.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.15 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' VAL . . . . . 0.672 HG13 ' HA3' ' A' ' 19' ' ' GLY . 39.9 t -77.89 -44.57 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.103 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -62.92 -29.66 70.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 177.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.01 -27.77 69.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -89.16 -36.77 15.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.819 -177.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' LYS . . . . . 0.423 ' O ' HD13 ' A' ' 299' ' ' LEU . 85.9 tttt -152.84 138.35 11.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.638 0.732 . . . . 0.0 110.864 175.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.78 112.72 0.9 Allowed 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.694 2.263 . . . . 0.0 112.329 175.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 297' ' ' LYS . 0.1 OUTLIER -88.98 -20.36 24.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 178.059 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 301' ' ' ALA . . . 102.18 -41.2 2.19 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.573 177.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 300' ' ' GLY . . . -179.86 175.92 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.884 0.373 . . . . 0.0 111.069 171.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' VAL . . . . . 0.621 ' CG2' ' HB3' ' A' ' 307' ' ' TYR . 22.3 m -135.85 160.06 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.136 162.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.27 -14.2 61.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.07 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' LEU . . . . . 0.646 ' CD2' HD21 ' A' ' 290' ' ' LEU . 60.4 tp -77.07 128.69 34.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -173.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -41.88 -33.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 -177.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' SER . . . . . 0.432 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 48.0 t -46.86 -38.66 10.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.866 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' TYR . . . . . 0.621 ' HB3' ' CG2' ' A' ' 302' ' ' VAL . 0.2 OUTLIER -57.36 -44.18 84.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 175.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' GLU . . . . . 0.472 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 88.7 tt0 -56.92 -39.99 75.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.786 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -80.01 -64.55 1.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.829 -174.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -85.81 -57.84 2.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.88 -171.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' LEU . . . . . 0.609 ' HB3' HD13 ' A' ' 317' ' ' ILE . 34.3 mt -59.34 -34.77 72.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 -169.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 318' ' ' ALA . . . -59.66 -18.19 39.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 -176.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -65.02 -23.01 67.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.767 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' ASP . . . . . 0.585 ' HB3' HD12 ' A' ' 317' ' ' ILE . 59.9 t0 -86.44 125.7 66.75 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.442 0.639 . . . . 0.0 110.876 173.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -49.23 -30.85 20.48 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.564 2.176 . . . . 0.0 112.334 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -65.11 -32.16 73.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' ILE . . . . . 0.609 HD13 ' HB3' ' A' ' 311' ' ' LEU . 6.9 mt -94.88 -36.07 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.082 -178.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 312' ' ' ALA . . . -53.82 -43.43 69.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.085 -174.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' ALA . . . . . 0.526 ' HB2' HG22 ' A' ' 244' ' ' VAL . . . -66.96 -44.62 80.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.091 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 64.2 p -64.7 -25.58 68.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.097 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 65.8 ttp -62.61 -38.6 90.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.911 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -66.82 -36.86 83.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.789 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 327' ' ' GLY . 63.7 t30 -78.88 -38.66 37.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.906 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 259' ' ' VAL . . . -64.92 -46.89 79.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.057 -175.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -70.36 -33.44 71.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 -177.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.66 -4.17 34.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -103.36 -160.2 25.13 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.443 -174.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -143.41 139.32 29.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.841 0.353 . . . . 0.0 110.837 -173.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' ILE . . . . . 0.582 ' O ' ' C ' ' A' ' 330' ' ' MET . 43.8 mm -82.35 112.33 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.189 -171.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' MET . . . . . 0.582 ' C ' ' O ' ' A' ' 329' ' ' ILE . 74.1 mtm . . . . . 0 C--N 1.33 -0.27 0 CA-C-O 121.653 0.739 . . . . 0.0 110.892 175.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 . . . . . 0 N--CA 1.456 -0.128 0 CA-C-O 120.817 0.342 . . . . 0.0 110.96 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -57.57 -27.23 62.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.939 -173.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -35.97 79.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.34 -37.25 66.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.111 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 339' ' ' PHE . . . . . 0.437 ' HA ' HG12 ' A' ' 368' ' ' ILE . 35.4 m-85 -63.9 -49.02 74.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.8 174.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -64.89 -36.8 85.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.988 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -68.72 -47.23 66.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.71 89.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 343' ' ' VAL . . . . . 0.444 ' O ' ' HB3' ' A' ' 346' ' ' ALA . 13.9 m -80.6 -23.48 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 344' ' ' ARG . . . . . 0.52 ' O ' HG22 ' A' ' 347' ' ' VAL . 3.0 tmt_? -62.37 -47.39 84.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 81.4 p -60.85 -26.69 67.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.148 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 346' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -62.06 -41.91 98.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.044 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 347' ' ' VAL . . . . . 0.593 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.2 m -72.68 -32.83 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.072 -175.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.94 -45.97 95.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.194 172.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -63.8 -35.45 80.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.819 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.65 -45.76 61.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.096 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.0 89.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.185 -175.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 98.5 p -75.7 -9.99 59.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.947 -177.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.72 16.6 79.91 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.558 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.84 -32.77 40.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.719 0.295 . . . . 0.0 110.848 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -138.11 154.76 49.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.861 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.8 p -79.66 167.42 20.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.217 168.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 357' ' ' VAL . . . . . 0.463 ' HA ' HD23 ' A' ' 192' ' ' LEU . 55.1 t -54.72 -41.94 58.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.061 173.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -59.66 -45.76 91.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.858 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -72.55 -52.84 13.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.2 -43.64 77.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.053 -171.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 361' ' ' LEU . . . . . 0.637 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -67.52 -40.91 85.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 -178.471 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.9 -39.83 94.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.936 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -63.09 -38.53 91.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.841 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 364' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -63.58 -42.5 98.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.083 174.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 365' ' ' GLN . . . . . 0.449 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 23.1 tm0? -64.27 -36.79 85.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 177.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 366' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 370' ' ' LYS . 92.2 m -66.06 -40.22 90.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 176.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -67.59 -35.06 78.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 368' ' ' ILE . . . . . 0.563 ' CD1' HG21 ' A' ' 183' ' ' VAL . 68.3 mt -62.71 -40.88 90.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.061 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.3 p -94.68 -10.53 31.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 370' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 366' ' ' THR . 99.5 mttt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.778 0.323 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 71.7 mt -104.37 134.42 45.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.145 177.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -145.0 143.12 30.34 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.918 -173.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -54.66 136.17 45.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.794 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.424 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 99.27 3.14 56.68 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.741 -0.743 . . . . 0.0 112.488 -173.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -166.34 149.83 7.33 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.797 0.332 . . . . 0.0 110.962 173.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.68 HD22 HD13 ' A' ' 33' ' ' ILE . 1.5 pt? -149.53 154.05 38.14 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.978 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 75.8 t -109.41 135.05 49.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.118 -179.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.739 HG22 ' CG1' ' A' ' 59' ' ' ILE . 0.2 OUTLIER -123.07 133.02 70.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.104 179.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.476 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 45.9 m0 -109.46 133.32 53.21 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.945 173.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.509 HD12 ' HB2' ' A' ' 20' ' ' LEU . 4.4 tt -109.99 149.79 12.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.136 -169.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 60.0 t30 -57.54 155.31 9.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.876 -178.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.93 -14.47 16.94 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.531 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -76.46 -13.52 60.1 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.855 0.359 . . . . 0.0 110.843 -172.241 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -138.91 144.27 39.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.925 166.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.06 -84.11 1.01 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.452 -177.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 58.5 m-85 -112.99 -37.66 4.74 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.925 0.393 . . . . 0.0 110.895 178.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -66.33 -52.26 48.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.969 -144.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.68 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -62.92 -48.07 83.7 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.556 -176.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.67 HD21 HG13 ' A' ' 9' ' ' ILE . 10.9 tp -67.02 -35.87 80.87 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.866 0.365 . . . . 0.0 110.947 -179.412 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.4 -37.74 84.52 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.124 173.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.7 tp10 -65.07 -52.78 53.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.831 179.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.404 HG22 ' HA ' ' A' ' 20' ' ' LEU . 14.1 m -73.9 -35.58 42.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.109 -176.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.517 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -66.67 -44.39 89.73 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.671 -0.776 . . . . 0.0 112.519 176.723 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.3 tptt -64.95 -40.02 94.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.853 0.359 . . . . 0.0 110.931 -178.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 25.0 mmtp -65.39 -38.88 91.34 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.415 ' CE2' HD11 ' A' ' 33' ' ' ILE . 73.6 t80 -66.14 -39.81 90.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.857 174.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -57.49 -39.98 77.63 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.904 177.065 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -69.2 -30.18 68.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.854 -179.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -83.51 -38.96 21.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.88 -170.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.609 ' OG1' HG13 ' A' ' 33' ' ' ILE . 61.1 p -105.73 -12.93 15.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.108 -178.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.41 5.91 89.09 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.519 178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.828 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.6 pp -99.29 133.96 40.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 0.0 111.159 -178.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -70.47 129.25 38.76 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.915 -168.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.517 HG11 ' HA3' ' A' ' 24' ' ' GLY . 90.2 t -110.81 119.79 60.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.135 -179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.8 m -115.44 116.99 29.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.127 -173.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.446 HG22 ' HG ' ' A' ' 20' ' ' LEU . 79.0 t -98.77 139.29 20.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.158 -178.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.476 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 73.9 mm-40 -121.25 161.83 21.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.888 176.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 62.4 t-80 -84.78 141.04 37.98 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.612 0.72 . . . . 0.0 110.898 -171.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 85.6 Cg_exo -52.33 -30.72 43.96 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.724 2.282 . . . . 0.0 112.339 -177.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 79.2 m-20 -49.34 -48.97 46.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.937 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -79.92 -19.31 48.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.875 179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.612 ' C ' HD23 ' A' ' 43' ' ' LEU . 7.3 tt -52.4 -59.29 4.6 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.918 -171.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -68.06 -39.22 83.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.836 -176.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -74.67 -42.7 57.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.845 -170.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -85.25 -29.27 24.77 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.876 -171.565 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.549 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 91.2 t80 -47.72 -51.85 42.77 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.663 0.744 . . . . 0.0 110.885 -165.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 62.9 Cg_endo -69.04 -29.26 27.59 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.689 2.259 . . . . 0.0 112.313 178.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -76.99 -43.4 35.03 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.911 -177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.6 m -72.29 -26.69 25.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.186 -179.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.437 ' HB1' ' HG ' ' A' ' 75' ' ' LEU . . . -65.65 -34.23 77.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.128 173.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.33 -29.64 70.39 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.077 177.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.2 p -92.38 -14.01 29.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.155 175.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.56 14.79 81.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.497 173.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.4 m-20 -140.01 129.91 24.72 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.797 0.332 . . . . 0.0 110.916 176.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.85 -115.01 0.54 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.523 178.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.473 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 98.3 Cg_endo -72.84 151.41 51.1 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.658 2.239 . . . . 0.0 112.367 173.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -89.86 -35.49 15.61 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.903 168.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.739 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -138.51 150.03 24.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.054 177.073 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.573 HD11 HD21 ' A' ' 43' ' ' LEU . 4.1 tp -125.95 126.42 69.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.051 -175.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.439 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 7.9 m-85 -108.07 123.35 48.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.905 177.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 16.7 t-105 -143.94 -172.81 3.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.893 171.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -96.3 -88.72 0.27 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.195 172.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.0 t60 -106.5 -54.64 2.44 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.894 -173.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -57.82 -39.55 77.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.83 -159.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -67.58 -29.99 69.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.82 -174.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.801 ' HD1' ' O ' ' A' ' 67' ' ' PHE . 0.2 OUTLIER -49.99 -52.95 29.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.934 -175.384 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.96 -41.33 97.4 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.495 174.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -54.97 -61.34 7.47 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.486 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.557 ' HD1' HD22 ' A' ' 76' ' ' LEU . 4.8 p90 -81.63 -25.52 35.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.871 0.367 . . . . 0.0 110.929 -168.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.449 ' N ' ' CD1' ' A' ' 70' ' ' TYR . . . -70.22 -54.44 12.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.165 179.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -67.27 -34.14 76.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.845 -177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 71.6 m -84.77 -8.0 58.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 -173.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.39 31.75 63.07 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.481 177.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.437 ' HG ' ' HB1' ' A' ' 51' ' ' ALA . 2.5 mp -86.81 -4.63 59.2 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.929 0.395 . . . . 0.0 110.947 -174.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.557 HD22 ' HD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -124.36 149.41 46.68 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.994 -175.002 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -79.01 140.53 37.94 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.157 169.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.8 mt-10 -71.63 135.35 46.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.909 -175.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.854 HG13 ' HB3' ' A' ' 103' ' ' LEU . 42.5 pt -116.89 165.08 12.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 176.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 p -115.3 150.06 43.81 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.607 0.718 . . . . 0.0 111.122 -178.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.32 144.99 47.3 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.69 2.26 . . . . 0.0 112.361 -178.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -103.14 119.96 39.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.891 179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -61.61 -41.99 98.24 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.844 -176.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.66 -46.46 82.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.16 -177.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.43 ' HB3' ' HZ2' ' A' ' 94' ' ' TRP . 18.1 m-85 -73.55 -31.24 63.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.853 -178.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.473 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.7 tt0 -53.5 -45.07 69.54 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.911 174.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -67.6 -33.9 75.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.842 175.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -77.84 -24.85 48.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -173.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.478 ' HB2' ' HE1' ' A' ' 94' ' ' TRP . 1.9 mp -104.98 -105.06 0.31 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.91 -174.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 38.6 t80 -169.26 128.1 0.9 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.637 0.732 . . . . 0.0 110.967 -179.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -53.33 -36.51 78.85 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.586 2.19 . . . . 0.0 112.365 -171.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -69.62 -30.01 67.64 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.976 -173.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 72.4 p -76.66 -31.12 57.12 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.158 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.601 ' HA ' HG22 ' A' ' 97' ' ' VAL . 92.0 m95 -72.37 -27.51 62.44 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.932 171.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -72.78 -31.45 64.89 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.848 169.094 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . 0.42 ' CB ' HG21 ' A' ' 329' ' ' ILE . . . -65.03 -28.1 69.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.065 176.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.601 HG22 ' HA ' ' A' ' 94' ' ' TRP . 29.9 m -110.9 17.2 7.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.16 -171.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.425 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 72.3 ttt180 -112.46 138.06 49.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.872 -179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -143.05 125.24 15.42 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.876 -177.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 55.4 t30 60.83 34.93 19.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.852 174.341 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.82 -6.44 74.29 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.499 173.256 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -122.53 145.31 48.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 0.0 110.915 174.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.854 ' HB3' HG13 ' A' ' 79' ' ' ILE . 3.6 tp -73.62 139.68 45.65 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.9 -178.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.475 ' C ' HD12 ' A' ' 104' ' ' ILE . 2.5 pp -127.17 10.01 3.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.13 -173.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -173.26 169.63 4.46 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.093 176.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.483 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 89.4 m-85 -116.13 144.52 33.05 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.729 0.776 . . . . 0.0 110.88 166.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.483 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 15.0 Cg_exo -69.66 117.12 4.89 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.693 2.262 . . . . 0.0 112.316 172.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.473 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 29.7 mm -97.81 -47.01 12.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 -179.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.14 154.98 38.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.108 -170.185 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 97.9 t -120.45 133.35 67.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.136 -178.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -120.83 134.19 55.3 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 172.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -154.63 161.78 41.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.06 178.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.589 ' HG ' ' HA3' ' A' ' 228' ' ' GLY . 6.0 mp -112.58 159.07 19.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.899 -173.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.9 p -154.37 162.92 40.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.848 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -93.64 123.72 37.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.953 176.836 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.545 ' N ' HD22 ' A' ' 115' ' ' LEU . 47.0 mt -108.44 132.06 57.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.166 -174.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.4 p90 -135.09 151.4 50.71 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.901 -175.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -96.33 117.86 31.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.891 177.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -66.91 -17.51 64.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 174.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -73.09 -29.61 63.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.837 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.537 HD21 ' O ' ' A' ' 220' ' ' GLY . 7.2 mp -99.94 -49.62 4.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.859 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 18.0 mt -102.25 125.55 36.08 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.608 0.718 . . . . 0.0 110.899 -177.458 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -71.36 -23.5 23.87 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.643 2.229 . . . . 0.0 112.331 178.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 40.0 t30 -153.07 130.0 5.69 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.637 0.732 . . . . 0.0 110.873 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -67.1 153.6 77.11 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.71 2.273 . . . . 0.0 112.363 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.34 144.83 41.97 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.717 2.278 . . . . 0.0 112.324 -177.154 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -94.01 -28.74 15.6 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.929 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 79.8 p -130.13 156.11 45.1 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.137 178.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.426 ' HA ' HD13 ' A' ' 132' ' ' ILE . 26.9 t-105 -68.76 -24.47 64.44 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.94 -179.407 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -59.9 -23.95 63.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.899 -178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -76.55 -23.2 53.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.918 -177.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.585 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.5 mp -62.32 -51.87 70.57 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.685 0.755 . . . . 0.0 111.173 -170.513 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 39.7 Cg_endo -71.57 -39.09 3.84 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.66 2.24 . . . . 0.0 112.378 -171.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -67.37 -39.69 85.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.195 173.263 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 49.8 tp -60.89 -44.53 96.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.972 174.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.531 ' OD1' ' HB3' ' A' ' 146' ' ' ALA . 40.5 m-20 -49.72 -35.01 20.51 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.821 178.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -72.14 -34.55 68.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.883 -178.398 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -74.61 -53.36 9.53 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.872 -171.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.541 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.9 OUTLIER -80.08 -10.96 59.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -175.79 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.541 ' N ' HD23 ' A' ' 139' ' ' LEU . 86.3 tttt -55.39 -31.22 61.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.873 168.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.74 -25.02 67.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.141 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -95.0 7.66 45.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.914 177.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.45 26.89 66.74 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.462 -178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.463 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 42.1 mmtm -116.83 162.7 17.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.839 0.352 . . . . 0.0 110.911 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 48.0 t -127.14 132.37 50.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.884 175.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.687 ' HA ' ' HB3' ' A' ' 223' ' ' ALA . . . -80.57 -38.3 29.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.084 -162.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -139.78 130.21 25.51 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.915 -174.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.777 ' SD ' ' HB2' ' A' ' 213' ' ' ALA . 56.8 ttm -117.04 130.15 56.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -177.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.0 p90 -151.04 157.2 42.53 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.8 -171.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 98.4 m-20 -101.21 98.13 8.57 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 175.564 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.787 HD21 HD11 ' A' ' 195' ' ' LEU . 0.8 OUTLIER -69.24 -36.98 77.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 -179.562 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -76.23 -3.77 38.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.891 -175.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 72.1 mm-40 -99.87 148.92 35.45 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.624 0.726 . . . . 0.0 110.908 174.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.469 ' HD3' ' HD3' ' A' ' 344' ' ' ARG . 24.9 Cg_endo -63.0 -18.69 66.52 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.723 2.282 . . . . 0.0 112.379 -179.421 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 61.8 m-85 -64.33 -40.87 96.74 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.919 -174.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.514 ' CD2' HD23 ' A' ' 151' ' ' LEU . 90.4 t80 -86.22 -37.8 18.26 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.875 -176.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 60.7 p -61.13 -36.95 81.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.226 -170.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.551 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 78.8 t90 -69.22 -53.65 13.12 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.504 0.669 . . . . 0.0 110.84 -174.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 44.0 Cg_endo -67.86 -17.17 46.82 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.647 2.231 . . . . 0.0 112.446 -176.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.836 HD13 ' O ' ' A' ' 160' ' ' LEU . 0.7 OUTLIER -82.5 -48.49 10.98 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.915 172.962 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 68.0 mt -74.84 -40.03 45.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.098 -175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.42 -30.97 65.11 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.136 -176.4 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.473 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -63.34 -34.86 78.63 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.059 -168.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 55.6 p30 -91.87 2.6 56.42 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.868 178.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 120.08 3.41 11.95 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.503 169.41 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -84.54 60.6 4.8 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.694 -0.765 . . . . 0.0 112.488 -179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 48.8 m-85 -79.84 134.45 36.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.843 0.354 . . . . 0.0 110.969 -175.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.42 5.29 18.04 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.139 -174.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.8 p90 -147.04 149.99 34.19 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.907 -174.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 79.2 tttt -103.87 122.45 45.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.907 158.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 82.6 t80 -118.81 122.1 41.6 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.968 177.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -152.36 130.83 12.17 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 -177.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 55.42 39.08 31.09 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.871 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.81 16.54 80.59 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.489 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.03 138.14 50.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.79 0.329 . . . . 0.0 110.888 -177.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -96.45 144.89 26.15 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.927 171.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -129.31 104.94 7.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.894 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.496 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.4 pp -74.71 -11.21 14.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.204 -175.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -97.56 -12.26 22.75 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 -174.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.533 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 51.4 t0 -124.3 62.54 1.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.937 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.9 m -111.11 174.9 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.167 -166.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -104.82 17.96 44.45 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.501 -164.143 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.5 m -100.2 -19.91 5.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.804 0.335 . . . . 0.0 111.148 179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.7 p-10 -86.7 19.08 3.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.829 179.441 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -113.77 175.14 5.59 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.839 -179.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.94 -25.28 67.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.89 -39.85 96.83 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.471 -172.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.656 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -68.77 -36.88 78.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.88 0.371 . . . . 0.0 111.113 178.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.516 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 93.5 mttt -59.54 -33.25 71.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.906 174.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.2 -29.0 69.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.152 173.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.19 -51.1 59.07 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.85 -0.691 . . . . 0.0 112.413 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . . . . . . . . . 23.5 mt -64.51 -34.92 79.35 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.87 0.367 . . . . 0.0 110.916 179.474 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 94.9 m -56.81 -46.77 81.4 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.168 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.582 ' HD2' HD21 ' A' ' 160' ' ' LEU . 71.8 t80 -75.66 -44.89 40.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.897 177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.787 HD11 HD21 ' A' ' 151' ' ' LEU . 7.7 tt -52.84 -44.41 66.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.88 -171.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 34.9 m -70.45 -21.21 23.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.101 -177.382 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.636 ' HB3' HD13 ' A' ' 198' ' ' LEU . 38.8 t70 -56.96 -49.87 74.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.879 -166.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.758 ' N ' HD13 ' A' ' 198' ' ' LEU . 0.0 OUTLIER -87.09 -30.47 21.1 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.925 -170.587 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.541 ' H ' HD22 ' A' ' 198' ' ' LEU . 2.3 pp -78.33 -34.28 18.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.099 177.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.01 -27.6 68.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.91 168.314 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 92.9 m-20 -83.94 4.68 28.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.856 174.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 65.11 39.31 5.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.901 172.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 62.0 m170 -77.43 -8.63 58.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.849 175.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 27.9 ptm -144.17 159.59 42.4 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.871 173.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -98.78 159.27 15.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.852 174.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.36 -26.3 68.41 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.049 -179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -93.76 -2.13 54.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.841 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.3 m -64.26 135.0 55.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.104 -176.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -144.66 169.3 18.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 -175.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 21.2 p90 -68.43 -34.59 76.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.854 -176.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 91.6 p -67.47 -33.18 74.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.795 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 82.6 mt -63.48 -39.3 84.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.125 173.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.777 ' HB2' ' SD ' ' A' ' 148' ' ' MET . . . -62.43 -40.06 95.35 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.081 175.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.409 ' HB3' ' HB3' ' A' ' 234' ' ' ASN . 92.9 mt-10 -63.1 -40.74 98.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.931 178.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -70.0 -38.95 76.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.089 175.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.45 -33.17 74.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.185 -175.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 11.9 m-30 -60.05 -30.69 69.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.921 179.3 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -62.01 -36.31 81.14 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.904 -178.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.77 -19.01 19.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.901 177.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.537 ' O ' HD21 ' A' ' 121' ' ' LEU . . . 87.78 28.03 25.02 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.459 -178.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -81.92 -28.61 32.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.857 0.361 . . . . 0.0 110.901 -173.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 93.1 m -119.24 131.36 55.78 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.176 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.687 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -75.82 -47.14 26.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.065 -174.047 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.451 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 61.0 mtm -134.97 158.95 43.0 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.853 -174.516 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 9.6 t -149.15 166.33 29.12 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.149 174.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 mm -109.46 124.23 65.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.113 172.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -155.33 171.8 19.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.835 -170.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.589 ' HA3' ' HG ' ' A' ' 113' ' ' LEU . . . -155.56 -115.71 0.53 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.504 -178.145 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -62.3 -22.84 74.71 Favored 'Trans proline' 0 C--O 1.231 0.138 0 C-N-CA 122.681 2.254 . . . . 0.0 112.317 176.339 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.8 m0 -78.26 -10.8 59.81 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.998 -178.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.93 -16.57 61.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.092 -170.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 36.1 p-90 -54.94 -30.0 57.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.981 177.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 13.5 t -50.16 -56.34 11.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.822 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.409 ' HB3' ' HB3' ' A' ' 214' ' ' GLU . 49.3 t30 -163.79 64.92 0.16 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.908 179.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 32.1 mm -131.79 112.78 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 167.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -171.32 160.05 5.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.883 -177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 96.7 m -120.44 108.67 14.39 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.156 -176.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 44.1 t -147.18 118.02 7.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.974 0.416 . . . . 0.0 110.923 172.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.2 mttt 60.35 35.45 20.62 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 -176.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 29.0 m -149.3 171.11 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.138 -178.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -112.8 82.09 1.6 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 175.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 23.2 m-30 -117.99 148.59 42.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.931 175.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.82 162.17 25.52 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.552 176.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.79 HG11 ' O ' ' A' ' 315' ' ' PRO . 10.1 p -144.04 138.49 24.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.942 0.401 . . . . 0.0 111.169 -175.053 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.6 t -150.68 149.2 29.52 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.106 174.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 30.4 m -63.62 168.44 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.135 -179.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.809 ' HB3' ' HB2' ' A' ' 255' ' ' SER . 3.9 mm? -63.27 137.01 96.95 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.569 0.7 . . . . 0.0 110.903 -162.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_endo -72.04 -172.68 0.89 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.683 2.255 . . . . 0.0 112.359 176.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 82.5 p -105.67 151.79 23.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.134 -178.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.402 ' HD2' ' HB3' ' A' ' 163' ' ' ALA . 33.5 t80 -136.48 120.48 17.62 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.873 176.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 56.55 35.5 26.14 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.893 -177.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.81 9.3 74.78 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.486 169.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -129.97 140.88 39.98 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.617 0.722 . . . . 0.0 110.877 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.2 142.17 33.57 Favored 'Trans proline' 0 C--N 1.342 0.212 0 C-N-CA 122.672 2.248 . . . . 0.0 112.35 -175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.809 ' HB2' ' HB3' ' A' ' 247' ' ' LEU . 64.3 m -85.3 0.83 50.77 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.823 173.133 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.2 mtmt -45.01 112.49 1.53 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.61 0.719 . . . . 0.0 110.935 -177.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.11 162.0 32.03 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.724 2.282 . . . . 0.0 112.325 -177.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 55.5 m-85 -72.98 152.5 41.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.829 -172.554 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.1 t -103.13 134.99 42.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.112 -172.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -112.48 135.19 12.51 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.44 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.3 t -125.88 128.4 71.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 120.884 0.373 . . . . 0.0 111.147 177.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.473 ' HB3' ' HB ' ' A' ' 108' ' ' ILE . 1.7 tt -69.99 130.13 41.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.9 174.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 77.3 p -122.23 135.92 54.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.825 -176.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.458 ' HB1' HD11 ' A' ' 280' ' ' LEU . . . -124.8 127.53 47.32 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.12 -178.519 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -120.2 160.9 14.69 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.474 -170.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.41 ' HA ' HG22 ' A' ' 59' ' ' ILE . 20.6 mm -99.98 121.62 50.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.819 0.342 . . . . 0.0 111.129 -179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -66.68 129.5 40.07 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.851 -175.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.42 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -60.67 -27.72 68.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.083 -177.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.83 -11.77 57.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.041 -173.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.8 t -75.48 121.25 84.77 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.719 . . . . 0.0 110.934 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -68.76 -10.42 29.06 Favored 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.658 2.239 . . . . 0.0 112.286 167.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 78.0 m-20 -102.44 17.65 23.06 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.937 -171.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -48.78 -34.84 13.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.884 -172.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 69.4 mm-40 -70.37 -48.26 57.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.858 -170.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.0 pp -81.76 -30.38 32.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.879 -179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.51 -46.28 73.32 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.09 178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -67.53 -34.47 77.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.939 177.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.446 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 89.2 tt0 -63.92 -52.28 60.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.917 -173.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.491 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.2 p90 -69.99 -34.18 73.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.855 -175.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.458 HD11 ' HB1' ' A' ' 264' ' ' ALA . 4.3 tt -58.38 -50.99 71.68 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.89 179.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 22.2 pt-20 -80.11 -31.26 39.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.86 -174.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.446 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 61.9 m-80 -101.4 -28.94 12.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.921 -165.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.555 ' O ' HG22 ' A' ' 286' ' ' THR . 85.4 t80 -110.25 -43.4 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 -169.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . . . . . . . . . 1.2 mp -72.54 -47.07 51.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.931 173.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 1.2 mp -83.33 61.29 6.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.929 176.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.555 HG22 ' O ' ' A' ' 283' ' ' TYR . 14.5 t -153.1 155.72 37.34 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.16 170.785 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.492 ' HA ' HD11 ' A' ' 290' ' ' LEU . 39.1 p-10 -52.41 -27.25 15.1 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.857 -168.437 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -78.23 -46.02 21.44 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.845 -179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.92 -49.39 17.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.449 -168.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.595 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.4 OUTLIER -74.96 -21.56 59.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.834 0.35 . . . . 0.0 110.908 -178.986 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.427 ' N ' HD12 ' A' ' 290' ' ' LEU . 83.1 tt0 -67.22 -40.91 86.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.95 170.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.07 -35.31 76.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.129 -176.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.68 HG13 ' HA3' ' A' ' 19' ' ' GLY . 19.7 t -80.22 -43.67 22.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.134 -178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.405 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 41.7 t30 -65.77 -28.78 69.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.926 179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -65.55 -26.01 67.69 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.876 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -82.33 -45.21 15.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.838 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -153.51 135.52 9.09 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.583 0.706 . . . . 0.0 110.947 175.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 81.6 Cg_exo -49.3 114.66 1.39 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.632 2.221 . . . . 0.0 112.414 178.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.405 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 40.1 mt -92.74 -19.04 22.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.934 -177.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 114.94 -60.48 0.39 Allowed Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.484 178.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -176.4 168.43 2.75 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.815 0.34 . . . . 0.0 111.064 174.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.494 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 30.3 m -124.62 157.7 32.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.157 175.865 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.96 -17.28 61.49 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.095 174.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.595 ' CD2' HD21 ' A' ' 290' ' ' LEU . 58.4 tp -81.0 123.5 28.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.977 -174.208 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -61.44 -33.25 73.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.89 -173.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.2 m -61.84 -47.67 84.0 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.815 -170.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.454 ' CD2' HD23 ' A' ' 311' ' ' LEU . 20.8 t80 -89.11 -28.66 19.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.916 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 86.6 tt0 -57.78 -42.63 84.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.909 -179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.68 -34.96 79.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.872 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.7 mm-40 -73.02 -45.55 57.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.894 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.692 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.4 pp -73.43 -27.04 61.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.874 178.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.41 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.58 -11.23 57.63 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.108 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.34 -15.98 61.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.864 175.861 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 71.6 m-20 -86.24 128.76 56.25 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.539 0.685 . . . . 0.0 110.882 169.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.79 ' O ' HG11 ' A' ' 244' ' ' VAL . 83.6 Cg_exo -52.6 -31.69 50.8 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.68 2.253 . . . . 0.0 112.37 -178.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.518 ' HG3' HG13 ' A' ' 317' ' ' ILE . 27.6 ptt-85 -66.3 -31.05 71.61 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.883 -171.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.692 HG21 ' CD1' ' A' ' 311' ' ' LEU . 63.3 mt -95.12 -37.38 7.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.149 -176.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.53 -44.5 62.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.073 -168.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.97 -42.4 80.91 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.053 179.5 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 71.9 p -63.85 -28.22 69.7 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 -174.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . 0.411 ' HE2' ' HA ' ' A' ' 321' ' ' MET . 33.5 mmt -66.75 -31.91 72.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.876 176.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.3 tt0 -66.06 -44.18 85.27 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.876 176.101 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.456 ' O ' ' N ' ' A' ' 327' ' ' GLY . 40.9 t30 -64.46 -37.21 86.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.911 174.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -61.7 -45.05 95.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.1 -179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -73.78 -34.37 64.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.9 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -100.49 -0.0 38.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.908 -172.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -96.57 -155.63 30.72 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.408 -177.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.56 139.19 42.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.846 0.355 . . . . 0.0 110.922 -178.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.587 ' O ' ' C ' ' A' ' 330' ' ' MET . 42.6 mm -76.69 110.01 11.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.1 -173.59 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.587 ' C ' ' O ' ' A' ' 329' ' ' ILE . 99.3 mmm 22.88 60.03 0.33 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.583 0.706 . . . . 0.0 110.862 170.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.413 ' N ' ' O ' ' A' ' 329' ' ' ILE . 36.4 Cg_endo -91.1 -10.02 2.92 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.716 2.277 . . . . 0.0 112.375 -170.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.556 ' O ' ' CG1' ' A' ' 333' ' ' ILE . 51.9 p-10 -94.86 9.87 37.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.854 -157.335 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.556 ' CG1' ' O ' ' A' ' 332' ' ' ASN . 31.6 pt 57.16 162.28 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.694 0.759 . . . . 0.0 111.099 162.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -57.6 -31.47 91.82 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.677 2.252 . . . . 0.0 112.342 -175.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -65.16 -32.07 73.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.911 -169.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.527 ' HG3' ' HB2' ' A' ' 332' ' ' ASN . 87.4 mmm -72.81 -26.12 61.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.953 -172.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.0 m -60.88 -41.43 95.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.859 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -71.4 -36.44 71.37 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.103 176.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 10.2 m-30 -65.22 -37.73 88.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.866 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 26.3 m0 -61.04 -37.84 84.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.899 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 34.3 m-85 -75.91 -35.26 59.86 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.92 179.628 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.404 ' HB1' ' HB2' ' A' ' 367' ' ' ARG . . . -62.68 -41.27 99.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.134 177.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.6 m -79.86 -25.17 12.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.084 177.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.469 ' HD3' ' HD3' ' A' ' 154' ' ' PRO . 54.5 ttp85 -61.3 -45.31 94.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.821 176.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 84.6 m -57.23 -36.63 71.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.131 173.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.735 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -60.58 -43.93 96.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.116 -175.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 344' ' ' ARG . 2.0 m -73.75 -32.69 35.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.171 -175.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.5 mp -62.74 -46.21 96.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.196 173.087 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.489 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 89.5 m-20 -69.13 -34.97 75.87 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.842 -177.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.47 -45.35 65.92 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.128 176.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.01 -41.18 87.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.084 -176.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 89.3 p -77.19 -11.96 59.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.836 -175.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.31 14.06 82.94 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.576 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.75 -29.85 56.32 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.755 0.312 . . . . 0.0 110.85 179.824 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.489 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 86.9 mt-30 -135.63 157.26 47.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.91 175.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.4 p -77.64 169.77 17.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.197 168.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.445 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 69.5 t -55.55 -42.83 70.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.139 170.462 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -59.87 -45.28 92.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.902 178.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -71.25 -52.78 17.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.838 -178.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.24 -45.04 74.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.114 -173.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.656 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -66.75 -39.95 88.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.907 -176.85 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.537 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 87.9 tttt -64.68 -39.62 93.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.876 177.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -64.82 -37.91 89.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.84 177.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.735 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -64.75 -45.83 84.75 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.074 -179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.537 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 1.2 pp0? -73.82 -30.09 62.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 56.8 m -64.04 -41.54 97.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.179 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.404 ' HB2' ' HB1' ' A' ' 342' ' ' ALA . 99.6 mtt180 -66.08 -39.07 89.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 176.165 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 70.4 mt -65.4 -37.86 81.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.209 178.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.3 p -92.37 -10.12 39.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.158 -177.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--N 1.328 -0.333 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.874 176.07 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.8 0.333 . . . . 0.0 110.852 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 98.9 mt -91.44 125.03 44.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.132 177.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -141.31 146.07 36.27 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.855 -176.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.47 136.83 43.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.775 175.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 97.27 4.79 58.34 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.484 -174.299 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 62.1 pttt -169.89 153.22 4.71 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.869 0.366 . . . . 0.0 110.899 175.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.551 ' H ' HD23 ' A' ' 7' ' ' LEU . 1.0 OUTLIER -151.68 157.0 41.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.871 179.308 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.495 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 89.8 t -110.65 135.63 49.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.142 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.738 HG22 ' CG1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -122.98 132.01 72.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.075 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.445 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 41.9 m0 -108.77 125.75 52.28 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.936 171.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.459 ' HB ' ' CD1' ' A' ' 20' ' ' LEU . 14.8 tt -106.3 150.02 9.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.094 -170.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 59.3 t30 -59.21 151.46 22.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.828 -175.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.91 -15.73 21.69 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.511 -176.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -75.06 -11.14 60.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.825 0.345 . . . . 0.0 110.845 -172.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 45.4 tptt -147.84 137.75 22.69 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.943 160.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.15 -83.26 1.04 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.443 -167.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 86.4 t80 -110.52 -45.67 3.5 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.013 0.435 . . . . 0.0 110.942 -172.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -68.22 -51.93 39.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.944 -151.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.518 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -60.09 -48.05 88.0 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.582 -179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.686 ' CD2' HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -58.13 -45.61 87.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.876 0.369 . . . . 0.0 110.884 176.452 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.3 -36.99 76.62 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.142 177.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.3 tp10 -64.86 -48.25 74.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.941 -177.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 19.0 m -74.38 -36.05 41.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.129 179.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.442 ' CA ' HG11 ' A' ' 35' ' ' VAL . . . -66.68 -48.34 62.55 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.576 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.8 tptt -65.45 -39.26 91.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.854 0.359 . . . . 0.0 110.999 -176.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 70.7 mmtt -64.47 -41.58 96.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.897 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.457 ' CD2' HD11 ' A' ' 33' ' ' ILE . 63.1 t80 -65.42 -38.0 88.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.87 175.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -62.55 -41.76 99.11 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.9 178.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.89 -31.92 69.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.822 -177.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -82.43 -40.48 21.15 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.885 -171.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.636 ' OG1' HG13 ' A' ' 33' ' ' ILE . 60.8 p -102.61 -9.46 20.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.11 -177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.44 9.73 84.51 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.56 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.036 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 pp -103.91 132.15 51.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.011 0.434 . . . . 0.0 111.07 -175.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -71.11 127.78 33.73 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.957 -168.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.474 HG22 HD21 ' A' ' 7' ' ' LEU . 99.2 t -110.67 122.06 64.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.086 179.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.457 ' HB ' HG22 ' A' ' 8' ' ' VAL . 99.7 m -111.57 117.94 34.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.146 -175.173 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.522 HG22 HD13 ' A' ' 20' ' ' LEU . 84.7 t -93.78 134.98 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.061 176.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.445 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 74.5 mm-40 -121.58 162.95 19.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.861 173.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.4 t-80 -84.9 139.73 37.29 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.615 0.722 . . . . 0.0 110.897 -167.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 70.9 Cg_exo -60.49 -16.85 44.71 Favored 'Trans proline' 0 C--O 1.231 0.158 0 C-N-CA 122.754 2.303 . . . . 0.0 112.307 -174.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 63.5 t0 -49.21 -56.37 9.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.936 -176.113 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 73.1 mmtt -86.69 1.31 52.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.88 -175.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.53 HD11 ' O ' ' A' ' 61' ' ' PHE . 9.4 tt -43.65 -53.34 5.8 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.858 -175.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -71.28 -43.8 66.45 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.876 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -78.21 -48.05 16.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.879 -161.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.456 ' HG2' HG13 ' A' ' 50' ' ' VAL . 84.3 tttt -84.58 -33.09 23.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.887 -170.178 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.594 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 90.3 t80 -47.8 -53.54 30.61 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.69 0.757 . . . . 0.0 110.9 -172.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.594 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 31.5 Cg_endo -61.99 -29.31 81.62 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.612 2.208 . . . . 0.0 112.375 -179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -74.78 -43.47 54.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.948 -179.318 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.456 HG13 ' HG2' ' A' ' 46' ' ' LYS . 35.7 m -74.97 -25.12 18.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.219 -176.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -61.43 -33.9 74.5 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.13 174.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.18 -27.14 66.15 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.02 178.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 71.3 p -91.83 -13.6 31.14 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.164 -179.837 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 78.26 14.27 82.4 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.478 170.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -145.89 137.29 24.86 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.833 0.349 . . . . 0.0 110.876 174.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.446 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . 165.01 -131.2 2.34 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.466 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.495 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 54.1 Cg_endo -62.83 139.06 72.38 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.666 2.244 . . . . 0.0 112.372 171.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.449 ' HB2' HD13 ' A' ' 59' ' ' ILE . 2.6 m-20 -86.57 -35.03 19.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.822 171.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.738 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -132.51 148.12 31.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.134 177.622 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.7 tp -127.98 127.16 67.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.154 -175.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.53 ' O ' HD11 ' A' ' 43' ' ' LEU . 9.1 m-85 -99.86 125.52 45.83 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.915 179.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.428 ' CG ' ' N ' ' A' ' 63' ' ' ALA . 41.6 t-105 -145.02 -175.81 4.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.928 169.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.428 ' N ' ' CG ' ' A' ' 62' ' ' TRP . . . -90.52 -87.38 0.19 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.136 173.73 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 38.9 t-80 -126.23 -58.14 1.37 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.869 -175.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.1 m-20 -62.93 -44.4 96.18 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 -151.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 41.1 mmt180 -66.57 -28.52 68.59 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.836 -170.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -51.86 -42.9 62.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.868 -175.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -61.63 -49.66 74.26 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.531 -177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.84 -43.35 99.35 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.568 175.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -66.52 -46.97 74.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.892 0.377 . . . . 0.0 110.874 -177.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -64.91 -43.91 91.28 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.154 -179.213 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -64.93 -34.96 79.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.016 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 74.5 m -84.91 -7.03 59.33 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.844 -176.183 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.91 29.54 60.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.709 -0.757 . . . . 0.0 112.491 178.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.1 mp -84.13 -12.1 55.53 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.819 0.342 . . . . 0.0 110.837 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.598 HD11 HG22 ' A' ' 104' ' ' ILE . 4.4 pp -131.2 143.17 50.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.956 -177.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.429 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -79.65 144.94 33.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.11 177.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -69.45 134.2 48.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.864 -179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.802 HG13 ' HB3' ' A' ' 103' ' ' LEU . 36.4 pt -110.39 160.72 9.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.18 -178.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 62.6 p -103.68 141.62 22.88 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.621 0.724 . . . . 0.0 111.065 -178.305 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -74.79 145.19 31.99 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.728 2.285 . . . . 0.0 112.386 -178.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -111.53 119.52 39.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.834 178.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.66 -41.63 98.18 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.897 -177.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.45 89.39 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.158 -176.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 10.0 m-85 -73.43 -33.75 65.1 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.861 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.495 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.3 tt0 -53.6 -49.0 68.72 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.901 174.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -60.6 -34.98 75.02 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.914 174.27 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -77.01 -22.9 52.36 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.822 -175.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.441 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -103.22 -109.43 0.25 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.813 -173.316 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 32.5 t80 -169.9 133.13 1.1 Allowed Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.599 0.714 . . . . 0.0 110.992 -177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -53.8 -40.12 81.38 Favored 'Trans proline' 0 N--CA 1.465 -0.201 0 C-N-CA 122.685 2.257 . . . . 0.0 112.303 -170.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 9.1 m-30 -69.13 -29.95 68.11 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -171.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 107' ' ' PRO . 54.3 p -73.38 -31.36 63.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.112 -174.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.598 ' HA ' HG22 ' A' ' 97' ' ' VAL . 81.0 m95 -71.89 -25.47 61.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.042 174.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.2 m-20 -71.53 -38.33 71.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.779 176.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.33 -26.98 63.06 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.097 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 94' ' ' TRP . 19.7 m -100.01 15.44 4.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.132 -178.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.401 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 34.8 ttp-105 -110.2 141.85 42.56 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.788 177.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 91.1 t80 -138.83 122.76 17.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.864 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 59.82 34.94 21.94 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.945 177.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.24 -2.64 84.08 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.451 174.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.56 144.52 48.04 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.819 0.342 . . . . 0.0 110.912 174.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.802 ' HB3' HG13 ' A' ' 79' ' ' ILE . 4.9 tp -79.5 138.51 37.56 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.803 -173.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.598 HG22 HD11 ' A' ' 76' ' ' LEU . 2.5 pp -126.93 1.53 3.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.118 -171.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -167.14 168.41 13.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.138 174.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.448 ' CZ ' HD12 ' A' ' 79' ' ' ILE . 93.6 m-85 -114.52 139.91 24.56 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-O 121.676 0.751 . . . . 0.0 110.962 170.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.476 ' HB3' ' HB ' ' A' ' 93' ' ' THR . 74.1 Cg_endo -73.74 120.16 6.28 Favored 'Trans proline' 0 N--CA 1.465 -0.182 0 C-N-CA 122.75 2.3 . . . . 0.0 112.368 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 25.6 mm -100.13 -56.13 5.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.106 -178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.587 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -142.16 154.87 45.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.162 -166.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.0 t -120.7 136.85 56.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.111 -169.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -126.34 131.1 51.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 174.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -148.8 157.91 43.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.122 -179.047 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.519 ' CD2' ' HA3' ' A' ' 228' ' ' GLY . 72.5 mt -102.02 168.76 9.19 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.89 -173.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 87.8 p -155.93 158.15 37.46 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -178.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.931 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -96.26 127.74 42.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.889 172.594 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.554 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.9 mp -110.95 133.05 57.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.066 -175.007 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.6 p90 -132.57 149.98 52.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.913 -177.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -88.05 111.77 21.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.854 178.579 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.427 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 88.6 tttt -62.69 -22.9 66.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.84 -177.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -76.54 -22.5 54.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.866 -179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.459 HD21 ' O ' ' A' ' 220' ' ' GLY . 7.0 mp -97.46 -49.23 4.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.823 179.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.509 HD11 ' HB1' ' A' ' 223' ' ' ALA . 22.8 mt -107.17 132.49 20.89 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.652 0.739 . . . . 0.0 110.898 -179.311 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -71.04 -20.68 28.57 Favored 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.632 2.221 . . . . 0.0 112.384 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.573 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 20.3 p30 -154.26 161.72 28.63 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.685 0.755 . . . . 0.0 110.805 -179.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.573 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 58.8 Cg_endo -70.23 158.5 56.16 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.66 2.24 . . . . 0.0 112.388 178.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -69.48 148.33 66.65 Favored 'Trans proline' 0 C--O 1.231 0.159 0 C-N-CA 122.679 2.253 . . . . 0.0 112.306 179.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -103.54 -44.99 4.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.934 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.8 p -133.24 157.88 44.29 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.14 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 75.9 m95 -70.02 -24.89 63.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.873 177.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -64.92 -19.81 66.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.929 -178.433 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 58.5 mt-10 -73.99 -30.13 62.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.912 -178.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.483 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 1.4 mp -63.34 -47.76 83.68 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.63 0.728 . . . . 0.0 111.138 -167.236 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.483 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 85.3 Cg_exo -53.93 -51.62 10.31 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.569 2.179 . . . . 0.0 112.293 -176.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -70.6 -40.45 73.21 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.066 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 22.6 tp -54.55 -43.46 72.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.904 174.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.422 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . 1.8 m-20 -50.09 -44.29 51.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.816 178.435 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.77 -33.48 75.25 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.864 -176.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -75.8 -46.93 27.95 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.875 -173.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.422 ' CD2' ' HA ' ' A' ' 136' ' ' ASP . 0.6 OUTLIER -90.53 -19.95 23.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.872 -173.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 144' ' ' LYS . 85.8 tttt -61.81 -26.39 68.08 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.901 170.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -61.89 -24.94 67.25 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.111 171.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -95.37 8.88 41.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 175.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 73.81 28.08 65.68 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.501 -178.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 140' ' ' LYS . 89.3 mttt -117.26 170.03 9.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.793 0.33 . . . . 0.0 110.908 177.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 41.4 t -131.53 142.23 49.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.803 177.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -73.14 -51.3 18.43 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.049 -170.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -139.24 130.78 27.17 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.91 -169.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.415 ' SD ' ' OG1' ' A' ' 222' ' ' THR . 94.9 mtp -117.9 129.76 55.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.853 -179.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -153.47 162.94 40.77 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.884 -169.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 71.6 m-80 -95.81 104.37 16.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.027 169.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.752 HD21 HD11 ' A' ' 195' ' ' LEU . 0.7 OUTLIER -75.05 -35.96 61.86 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.882 177.271 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . 0.484 ' HA ' HD11 ' A' ' 348' ' ' ILE . 88.2 mt-30 -78.69 0.13 27.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.826 -175.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -106.82 150.44 39.72 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.635 0.731 . . . . 0.0 110.962 173.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 29.6 Cg_endo -62.11 -20.31 69.39 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.691 2.26 . . . . 0.0 112.321 -179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 68.3 m-85 -59.86 -44.07 94.33 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.011 -172.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 84.3 t80 -84.89 -39.99 17.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.863 -177.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 72.0 p -64.02 -37.88 89.03 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.198 -169.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.569 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 19.9 t-105 -64.36 -55.47 30.36 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.583 0.706 . . . . 0.0 110.872 -173.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 23.6 Cg_endo -65.96 -30.74 48.03 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.616 2.211 . . . . 0.0 112.513 -171.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.692 ' O ' HD23 ' A' ' 160' ' ' LEU . 6.4 tt -72.89 -41.77 64.29 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.978 176.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 69.1 mt -73.81 -39.75 52.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.026 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.37 -33.17 67.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.17 -176.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.468 ' HB3' ' HD2' ' A' ' 250' ' ' PHE . . . -61.7 -36.41 80.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.99 -168.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 53.3 p30 -89.12 1.03 56.22 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 179.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 121.84 1.22 10.73 Favored Glycine 0 N--CA 1.449 -0.445 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.49 169.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -80.36 64.99 3.91 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.446 -179.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 67.6 m-85 -86.71 132.88 33.75 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.868 0.366 . . . . 0.0 110.926 -179.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.35 10.2 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 -173.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.445 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.1 p90 -147.27 153.88 40.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.91 -179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -105.87 126.61 52.38 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.904 158.076 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 70.9 t80 -116.27 126.72 53.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.931 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -151.78 129.78 11.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.885 -179.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.5 t30 55.07 44.55 27.84 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.866 170.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 75.04 14.0 82.19 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.484 173.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -129.92 139.62 51.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.818 0.342 . . . . 0.0 110.887 -178.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -99.98 145.96 27.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.9 170.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.3 t0 -121.26 110.1 15.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.839 171.128 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.512 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.3 pp -80.0 -11.92 12.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.189 -177.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -99.77 -12.71 19.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.888 -177.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -123.33 88.17 2.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.886 169.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.445 HG12 ' HA ' ' A' ' 169' ' ' PHE . 33.5 m -116.58 170.96 5.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.177 -168.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.04 26.11 23.19 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.484 -168.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.511 HG21 HD12 ' A' ' 368' ' ' ILE . 12.6 m -109.9 -13.66 10.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.81 0.338 . . . . 0.0 111.145 178.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -85.07 20.04 2.01 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.855 -178.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.4 p30 -112.81 -176.8 2.99 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.878 -175.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.51 -25.09 63.87 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.417 ' O ' ' HB3' ' A' ' 190' ' ' ALA . . . -72.01 -42.43 51.94 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.492 -169.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.624 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -63.26 -36.75 84.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.84 0.353 . . . . 0.0 111.038 176.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.511 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.2 mttt -59.97 -34.09 72.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.906 173.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.417 ' HB3' ' O ' ' A' ' 187' ' ' GLY . . . -65.15 -31.85 73.24 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.091 175.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.64 -45.48 95.71 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.439 -179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 192' ' ' LEU . 21.7 mt -64.98 -38.34 90.64 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.857 0.36 . . . . 0.0 110.902 176.764 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.9 m -57.56 -46.32 84.09 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.275 -178.575 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 92.9 t80 -73.49 -47.75 38.74 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.844 177.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.752 HD11 HD21 ' A' ' 151' ' ' LEU . 6.8 tt -53.72 -47.14 70.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.916 -170.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 30.3 m -67.96 -18.82 24.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.112 -176.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -59.99 -58.08 10.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.873 -171.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 1.049 HD13 ' H ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.67 -23.73 56.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.908 -166.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.603 ' H ' HD22 ' A' ' 198' ' ' LEU . 2.0 pp -83.77 -36.41 12.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.112 174.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -62.36 -32.6 73.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.935 168.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -82.25 4.1 24.91 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 65.06 39.79 5.45 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 168.78 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 28.5 m-70 -85.88 -14.94 43.34 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.784 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -146.64 161.85 39.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.926 -177.106 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -99.88 150.5 22.31 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.849 -174.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.59 -25.83 68.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.099 -179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.5 p-10 -93.78 5.34 51.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -178.649 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 59.7 m -62.55 129.99 43.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.086 -177.341 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -137.45 169.83 17.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.957 178.531 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 15.4 m-30 -63.91 -42.68 97.33 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.907 -177.118 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.3 m -64.77 -39.45 93.63 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.874 -179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.11 -40.03 86.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.154 174.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.81 -37.34 87.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.086 179.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -63.17 -40.47 97.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.925 177.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.92 -39.91 94.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 175.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.92 -38.25 90.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.154 177.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -61.58 -42.04 98.28 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.87 177.098 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -57.94 -32.31 67.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.799 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -89.39 -23.8 22.09 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.832 178.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.459 ' O ' HD21 ' A' ' 121' ' ' LEU . . . 90.51 25.78 24.81 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.504 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -89.59 -23.98 21.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.922 0.391 . . . . 0.0 110.877 -173.03 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.415 ' OG1' ' SD ' ' A' ' 148' ' ' MET . 99.8 m -119.11 128.76 54.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.165 -176.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.509 ' HB1' HD11 ' A' ' 122' ' ' LEU . . . -65.58 -52.07 54.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.052 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.455 ' HB3' HD21 ' A' ' 115' ' ' LEU . 71.2 mtm -135.65 156.26 49.12 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.859 -169.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 15.3 t -150.82 161.56 42.43 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.197 177.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 44.6 mm -110.05 124.25 66.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.158 177.241 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -154.34 170.63 20.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.804 -166.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.519 ' HA3' ' CD2' ' A' ' 113' ' ' LEU . . . -157.16 -113.69 0.41 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.522 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.411 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 40.4 Cg_endo -61.29 -22.34 74.32 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.618 2.212 . . . . 0.0 112.366 173.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 6.7 m-90 -78.89 -16.51 56.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.05 179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -63.29 -23.7 67.53 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.057 -175.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 90.0 m95 -60.04 -23.13 63.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.928 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 42.9 t -57.65 -59.64 4.9 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 -179.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -152.03 45.56 0.75 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -173.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 33.0 mm -126.19 129.58 72.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.164 168.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 21.6 t0 -166.37 161.62 16.61 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 53.8 m -133.2 82.18 1.98 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.158 171.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 42.0 t -134.22 109.06 8.62 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.001 0.429 . . . . 0.0 110.808 175.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 60.1 30.96 20.36 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.939 -176.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 21.7 m -142.09 165.03 17.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.13 178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -100.0 70.0 1.56 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.88 -174.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.427 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 87.0 m-85 -130.91 146.67 52.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.019 174.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -130.95 155.66 21.36 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.507 177.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.487 HG22 ' CB ' ' A' ' 319' ' ' ALA . 3.3 p -134.79 134.88 53.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.961 0.41 . . . . 0.0 111.167 -177.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.9 t -154.41 149.76 27.16 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.071 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 27.9 m -59.93 162.03 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.116 178.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.57 HD12 ' N ' ' A' ' 247' ' ' LEU . 5.5 mp -70.48 150.11 95.63 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.577 0.703 . . . . 0.0 110.906 -159.382 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -69.48 -179.24 2.66 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.706 2.271 . . . . 0.0 112.347 -179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 52.1 p -101.02 161.19 13.77 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.131 -176.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.468 ' HD2' ' HB3' ' A' ' 163' ' ' ALA . 55.0 t80 -138.6 119.56 14.37 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.969 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 55.53 33.69 21.59 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.97 -169.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.15 9.77 72.77 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.529 171.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.478 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 86.1 mm-40 -132.66 129.46 21.33 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.651 0.738 . . . . 0.0 110.879 -177.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.478 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 60.2 Cg_exo -59.59 144.8 99.34 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 122.577 2.185 . . . . 0.0 112.327 -175.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 65.2 p -88.65 16.69 6.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.809 171.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 49.8 mtmt -43.05 112.34 1.17 Allowed Pre-proline 0 C--N 1.327 -0.403 0 CA-C-O 121.634 0.731 . . . . 0.0 110.903 -178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.18 160.38 32.98 Favored 'Trans proline' 0 C--N 1.343 0.256 0 C-N-CA 122.754 2.302 . . . . 0.0 112.326 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 51.6 m-85 -72.51 161.55 30.65 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.801 -171.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 56.2 t -109.06 136.17 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.057 -175.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -113.43 131.09 9.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.511 178.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 90.9 t -121.13 119.11 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.891 0.377 . . . . 0.0 111.166 -175.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.401 ' C ' ' CD2' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -67.91 117.94 10.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.913 175.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 106' ' ' TYR . 19.4 m -130.6 151.29 51.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.87 -170.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.06 129.79 44.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.15 -171.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -118.07 168.45 13.09 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.45 -178.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.553 HD13 HG22 ' A' ' 59' ' ' ILE . 23.9 mm -99.68 126.84 53.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.771 0.319 . . . . 0.0 111.183 -178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -68.36 129.3 39.51 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.853 -179.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.429 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -66.2 -24.21 66.58 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.096 -176.228 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.91 -11.08 58.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.041 -171.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.6 t -75.97 120.28 80.98 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.642 0.734 . . . . 0.0 110.898 -176.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 95.5 Cg_endo -69.0 -11.78 32.7 Favored 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.674 2.249 . . . . 0.0 112.294 168.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -111.76 36.1 3.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.878 -171.012 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -60.85 -25.07 66.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.896 -167.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 74.3 mm-40 -71.32 -38.51 71.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -173.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.428 HD23 ' HB3' ' A' ' 7' ' ' LEU . 37.8 tp -63.13 -48.65 77.61 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 173.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.615 ' HB1' HG23 ' A' ' 59' ' ' ILE . . . -69.05 -48.8 61.91 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.093 -173.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 63.3 tttm -63.82 -41.58 97.83 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -66.27 -54.57 23.31 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.956 -173.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.411 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -68.31 -34.0 75.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.922 -173.578 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.578 ' O ' HD23 ' A' ' 280' ' ' LEU . 4.8 tt -56.0 -45.54 79.01 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.875 176.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 -72.93 -42.68 63.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.875 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -102.35 -9.3 20.46 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.889 -159.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.411 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 67.9 t80 -123.33 -48.65 1.95 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.919 -178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.461 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.0 OUTLIER -68.56 -46.59 69.05 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.88 179.906 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.487 HD13 ' HA ' ' A' ' 285' ' ' LEU . 0.8 OUTLIER -82.92 63.24 6.91 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.886 174.546 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.491 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 30.1 p -143.51 150.18 38.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.172 170.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.561 ' HA ' HD11 ' A' ' 290' ' ' LEU . 41.4 p-10 -53.19 -25.24 13.15 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.898 -177.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -79.5 -44.08 21.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.846 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -70.49 -50.57 25.45 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.432 -170.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.561 HD11 ' HA ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -73.97 -21.27 60.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.855 0.36 . . . . 0.0 110.889 -179.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.43 ' N ' HD12 ' A' ' 290' ' ' LEU . 82.8 tt0 -66.07 -42.31 89.58 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.92 169.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.32 -34.77 75.81 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.096 -178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.518 HG13 ' HA3' ' A' ' 19' ' ' GLY . 21.6 t -76.83 -41.91 32.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.173 178.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.49 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 52.6 t30 -64.96 -25.42 67.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.981 176.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -66.83 -30.95 71.27 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.9 -179.563 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 61.4 m-20 -88.79 -40.87 12.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.872 -176.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -141.97 130.05 11.79 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.514 0.673 . . . . 0.0 110.911 172.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -53.09 111.59 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.642 2.228 . . . . 0.0 112.376 174.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.49 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 43.0 mt -93.32 -13.1 28.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.016 -171.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 99.44 -53.71 1.0 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.433 179.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -173.77 166.15 4.44 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.795 0.331 . . . . 0.0 111.02 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.587 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 31.3 m -123.76 156.49 30.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.166 178.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . 0.426 ' O ' ' HA ' ' A' ' 89' ' ' LEU . . . -69.96 -17.16 63.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.018 175.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.441 ' HA ' HD12 ' A' ' 89' ' ' LEU . 57.6 tp -85.87 120.69 27.55 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.049 -171.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.2 -40.02 70.3 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.926 -171.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.8 m -64.55 -50.33 67.71 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.877 -167.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.477 ' HB3' HG21 ' A' ' 302' ' ' VAL . 38.2 t80 -81.13 -26.73 35.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.884 178.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -65.11 -42.28 94.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.888 -176.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -68.4 -34.46 76.05 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.831 177.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -70.62 -48.53 54.59 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.874 -177.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.652 HD13 HD13 ' A' ' 317' ' ' ILE . 4.6 pp -66.72 -28.81 68.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.856 176.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.461 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.95 -11.12 58.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.053 -178.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -64.94 -15.57 62.28 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.856 177.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -79.78 128.66 73.61 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.633 0.73 . . . . 0.0 110.805 170.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -49.21 -38.37 41.17 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.678 2.252 . . . . 0.0 112.305 -176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.482 ' HA ' HG11 ' A' ' 244' ' ' VAL . 8.5 ptp85 -71.26 -24.83 62.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.918 -169.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.652 HD13 HD13 ' A' ' 311' ' ' LEU . 78.9 mt -92.26 -32.45 5.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.09 -179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -54.91 -34.95 63.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.059 -175.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.487 ' CB ' HG22 ' A' ' 244' ' ' VAL . . . -65.01 -45.58 84.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.058 174.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 68.7 p -69.01 -24.38 64.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.162 -176.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 87.6 mmm -58.84 -36.39 74.46 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.859 172.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -69.47 -46.92 65.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -178.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.469 ' O ' ' N ' ' A' ' 327' ' ' GLY . 34.7 t30 -66.04 -36.01 82.09 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.995 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.68 -47.28 84.34 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.121 -178.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -72.62 -35.07 67.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.897 178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -94.97 -1.83 51.66 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.936 -174.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -100.01 -161.62 28.61 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.458 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.494 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 83.4 mt-10 -140.8 141.5 34.75 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.821 0.343 . . . . 0.0 110.812 -176.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.605 ' O ' ' C ' ' A' ' 330' ' ' MET . 18.8 mm -81.74 100.17 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.094 -169.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.605 ' C ' ' O ' ' A' ' 329' ' ' ILE . 95.3 mtp 20.52 60.43 0.25 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.55 0.691 . . . . 0.0 110.88 176.219 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.494 ' HG3' ' HB3' ' A' ' 328' ' ' GLU . 16.6 Cg_endo -95.1 -6.37 1.85 Allowed 'Trans proline' 0 N--CA 1.465 -0.159 0 C-N-CA 122.766 2.311 . . . . 0.0 112.333 -170.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.522 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 52.7 p-10 -97.08 9.11 43.01 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.881 -147.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.587 HG22 ' H ' ' A' ' 335' ' ' GLN . 45.5 mm 78.81 130.42 0.04 OUTLIER Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.689 0.757 . . . . 0.0 111.07 176.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 85.3 Cg_exo -53.14 -25.46 29.49 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.623 2.215 . . . . 0.0 112.391 -176.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.587 ' H ' HG22 ' A' ' 333' ' ' ILE . 99.3 mm-40 -62.63 -18.39 62.17 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.966 -178.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 79.4 mmm -72.38 -24.0 61.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 -176.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.8 m -63.59 -39.2 93.78 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 176.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -77.35 -35.4 54.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.136 177.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -62.66 -39.24 93.29 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.855 174.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 42.1 m0 -58.38 -36.28 73.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.809 175.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 24.1 m-85 -75.9 -37.1 59.15 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.933 -178.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.98 -40.05 94.39 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.135 177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.2 m -80.2 -25.46 11.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.177 178.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 347' ' ' VAL . 7.3 tmm_? -64.39 -43.33 94.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.858 173.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.5 m -58.67 -34.62 71.46 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.166 173.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -58.93 -42.22 89.2 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.08 -177.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.486 HG22 ' O ' ' A' ' 344' ' ' ARG . 1.3 m -74.08 -32.85 33.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.096 -174.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.484 HD11 ' HA ' ' A' ' 152' ' ' GLN . 1.6 mp -62.01 -48.74 87.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.184 173.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.498 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 86.5 m-20 -65.6 -38.12 88.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.85 -177.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.71 -46.22 63.49 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.188 178.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.15 -42.03 85.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.025 -176.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.6 p -76.5 -11.24 59.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.845 -175.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 79.11 13.57 82.81 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.663 -0.779 . . . . 0.0 112.547 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.18 -31.36 58.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.774 0.321 . . . . 0.0 110.883 178.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.498 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 90.9 mt-30 -136.33 159.53 41.47 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.93 175.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.4 p -78.45 169.75 17.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.131 168.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 72.9 t -55.52 -43.83 73.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.125 170.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.3 m-20 -59.64 -44.79 93.38 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.86 179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.0 mt-10 -70.44 -52.39 22.51 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.902 -179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.79 -45.93 70.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.079 -173.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.624 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -65.21 -40.01 93.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.925 -177.404 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.0 tttt -65.3 -38.35 89.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 176.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 89.8 m-20 -65.04 -38.91 92.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.795 177.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.589 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -64.79 -46.47 81.94 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.085 -179.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 5.0 pp0? -70.55 -31.39 68.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.979 -178.108 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 81.8 m -65.69 -42.63 91.01 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.199 177.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -67.29 -36.56 81.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.799 178.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.511 HD12 HG21 ' A' ' 183' ' ' VAL . 64.0 mt -64.96 -39.82 86.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.189 177.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 68.3 p -91.51 -11.05 38.57 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.195 -176.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.917 176.71 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.5 mttt . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.806 0.336 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 83.6 mt -95.67 135.1 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.102 178.043 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -149.43 142.1 24.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.876 -176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -55.12 137.4 46.81 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.876 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.463 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 97.77 1.85 58.62 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.808 -0.71 . . . . 0.0 112.544 -172.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.2 pttt -166.1 149.16 7.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.837 0.351 . . . . 0.0 110.968 173.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.703 HD22 HD13 ' A' ' 33' ' ' ILE . 1.6 pt? -148.73 153.51 38.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 -178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.437 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 69.9 t -108.84 138.67 34.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.104 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.813 HG13 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -122.21 132.55 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.001 177.018 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.479 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 45.2 m0 -108.82 127.81 54.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.887 172.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.551 ' HB ' HD22 ' A' ' 20' ' ' LEU . 7.2 tt -109.76 148.44 13.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.22 -168.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -57.28 146.86 27.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.888 177.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.89 -12.93 16.69 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.459 -175.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -75.15 -10.29 59.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.812 0.339 . . . . 0.0 110.842 -173.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.0 tptt -150.12 135.39 18.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.897 162.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.14 -84.71 1.0 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.496 -166.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.4 t80 -113.19 -45.65 3.14 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.923 0.392 . . . . 0.0 110.922 -170.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -68.05 -52.83 30.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.908 -149.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.63 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -63.17 -46.85 92.27 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.709 -0.758 . . . . 0.0 112.513 -176.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.813 HD21 HG13 ' A' ' 9' ' ' ILE . 17.7 tp -65.69 -39.94 91.79 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.839 0.352 . . . . 0.0 110.879 179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.74 72.42 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.082 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.7 tp10 -65.75 -48.23 72.58 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.867 -178.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 15.9 m -75.36 -36.07 34.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.065 -177.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.455 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -66.94 -46.41 73.95 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.639 -0.791 . . . . 0.0 112.444 178.181 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 58.0 tptt -65.58 -40.37 92.66 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.844 0.354 . . . . 0.0 110.961 -176.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -64.94 -40.45 95.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.906 177.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.404 ' CE2' HD11 ' A' ' 33' ' ' ILE . 78.0 t80 -64.81 -39.34 93.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.939 174.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -58.05 -40.04 79.97 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.913 176.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -69.1 -30.02 68.23 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.834 -179.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -84.42 -40.13 18.16 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.803 -170.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.604 ' OG1' HG13 ' A' ' 33' ' ' ILE . 62.3 p -103.79 -12.32 17.02 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.139 -178.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.48 7.93 87.79 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.654 -0.784 . . . . 0.0 112.496 177.583 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.849 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.6 pp -102.7 132.54 48.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.972 0.415 . . . . 0.0 111.105 -178.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 89.0 tttt -71.17 130.16 40.77 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.855 -168.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.517 HG22 HD21 ' A' ' 7' ' ' LEU . 90.0 t -110.57 120.17 60.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 -179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.5 m -113.62 118.03 33.24 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.159 -173.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.497 HG22 ' HG ' ' A' ' 20' ' ' LEU . 92.3 t -94.41 134.11 33.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.094 178.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.479 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 73.5 mm-40 -119.8 161.63 20.46 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 176.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.9 t-80 -83.41 139.38 41.51 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.626 0.727 . . . . 0.0 110.771 -168.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 75.6 Cg_exo -56.59 -25.09 57.39 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.768 2.312 . . . . 0.0 112.303 -176.216 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -47.64 -50.18 25.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.894 -173.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -86.61 -8.56 57.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.879 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.487 HD11 ' O ' ' A' ' 61' ' ' PHE . 9.4 tt -46.73 -54.28 10.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.896 -167.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 59.8 mt-10 -75.03 -34.69 61.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.843 -179.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -71.69 -48.87 44.45 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.892 -168.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt -87.2 -28.63 22.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.818 -170.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.559 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 91.5 t80 -47.49 -51.66 42.46 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.769 0.795 . . . . 0.0 110.922 -166.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 59.7 Cg_endo -68.3 -28.98 32.75 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.725 2.283 . . . . 0.0 112.296 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.6 mt-30 -76.56 -43.66 37.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.846 -178.415 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 27.2 m -73.67 -24.96 20.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.127 -179.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -62.86 -32.71 74.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.049 174.355 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.5 -27.65 67.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.03 178.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 67.2 p -94.61 -13.85 25.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.114 177.127 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.74 15.6 81.19 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.405 172.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -142.55 130.42 21.69 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.831 0.348 . . . . 0.0 110.998 176.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.69 -115.09 0.57 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.58 179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.437 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 84.4 Cg_endo -70.32 146.48 56.83 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.678 2.252 . . . . 0.0 112.306 168.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -90.72 -36.34 14.38 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.883 169.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.691 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -138.46 150.04 24.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.175 176.989 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.0 tp -126.44 125.25 67.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.103 -169.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.523 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 4.8 m-85 -110.06 126.38 53.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 20.7 t-105 -143.1 -171.51 3.49 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.901 169.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -97.16 -89.53 0.28 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.119 171.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -106.55 -54.79 2.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.835 -172.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -53.49 -38.59 63.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.902 -158.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -74.46 -18.76 60.59 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.857 -169.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -39.99 -55.32 2.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.912 -179.491 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -74.47 -38.43 44.72 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.493 175.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -51.32 -57.78 11.06 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.488 -171.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.579 ' HD1' HD22 ' A' ' 76' ' ' LEU . 8.8 p90 -85.79 -27.06 25.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.935 0.398 . . . . 0.0 110.93 -172.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.421 ' N ' ' CD1' ' A' ' 70' ' ' TYR . . . -71.62 -57.25 4.55 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.091 -177.048 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -65.55 -32.02 73.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.837 -176.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.3 m -82.21 -7.88 59.63 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 -175.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.58 30.42 68.76 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.503 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.447 ' HA ' HD12 ' A' ' 75' ' ' LEU . 1.0 OUTLIER -87.45 -4.23 59.01 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.842 0.353 . . . . 0.0 110.835 -174.894 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.579 HD22 ' HD1' ' A' ' 70' ' ' TYR . 0.1 OUTLIER -125.68 147.94 49.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -177.117 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -77.96 143.7 37.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.033 171.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -71.79 135.1 46.57 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.866 -175.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.894 HG13 ' HB3' ' A' ' 103' ' ' LEU . 37.9 pt -117.31 164.97 13.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.087 176.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.2 p -115.81 150.03 44.2 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.543 0.687 . . . . 0.0 111.181 -176.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -72.45 146.42 44.55 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.683 2.255 . . . . 0.0 112.32 -178.343 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.8 t0 -105.65 119.92 40.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.828 179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -63.03 -41.93 99.65 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.853 -175.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.41 -45.02 89.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.111 -177.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.53 ' HB3' ' HZ2' ' A' ' 94' ' ' TRP . 7.4 m-85 -72.4 -33.32 67.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.802 -179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.494 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.5 tt0 -52.1 -46.64 65.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.872 174.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.6 m-20 -63.27 -36.14 82.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.913 174.411 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -78.86 -24.42 44.33 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.815 -173.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.457 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.3 OUTLIER -104.96 -105.04 0.31 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.92 -172.164 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.467 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 39.7 t80 -164.6 129.63 1.97 Allowed Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.671 0.748 . . . . 0.0 110.983 -174.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 96.9 Cg_exo -57.15 -43.03 56.98 Favored 'Trans proline' 0 C--N 1.342 0.226 0 C-N-CA 122.62 2.213 . . . . 0.0 112.421 -169.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -72.44 -26.35 61.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.964 -173.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.645 ' CG2' ' HB3' ' A' ' 107' ' ' PRO . 96.7 m -69.75 -40.01 76.41 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.151 -174.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.587 ' HA ' HG22 ' A' ' 97' ' ' VAL . 92.2 m95 -65.68 -27.6 68.48 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.985 174.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -71.76 -35.24 70.02 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.883 174.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.54 -27.39 63.15 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.081 -0.508 . . . . 0.0 111.081 179.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.587 HG22 ' HA ' ' A' ' 94' ' ' TRP . 19.4 m -101.2 16.36 4.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.129 -179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.455 ' HB2' HD12 ' A' ' 103' ' ' LEU . 75.2 ttt180 -113.48 137.42 51.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 178.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 83.6 t80 -144.29 127.7 16.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 -178.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.1 t30 62.19 34.78 15.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.899 174.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.82 -6.24 71.26 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.89 -0.671 . . . . 0.0 112.44 172.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -124.05 147.25 47.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.798 0.332 . . . . 0.0 110.965 173.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.894 ' HB3' HG13 ' A' ' 79' ' ' ILE . 4.2 tp -73.28 139.99 46.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.924 -178.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.46 ' C ' HD12 ' A' ' 104' ' ' ILE . 2.5 pp -126.28 10.01 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.012 -173.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -170.72 162.12 7.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.138 175.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -112.75 145.67 33.48 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.738 0.78 . . . . 0.0 110.914 164.455 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.645 ' HB3' ' CG2' ' A' ' 93' ' ' THR . 90.9 Cg_endo -75.63 118.52 5.13 Favored 'Trans proline' 0 C--O 1.233 0.244 0 C-N-CA 122.668 2.246 . . . . 0.0 112.386 173.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.407 ' HB ' ' HB3' ' A' ' 262' ' ' LEU . 27.3 mm -94.75 -49.35 12.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.097 179.636 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.497 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.74 157.57 43.1 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.129 -170.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.7 t -121.46 134.64 64.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 -173.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -115.85 138.01 51.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.847 169.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.476 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -151.48 160.04 43.89 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.023 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.424 ' HG ' ' HA3' ' A' ' 228' ' ' GLY . 7.0 mp -109.72 158.09 18.46 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.89 -170.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.5 p -154.82 161.9 41.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.925 -179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.93 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.98 128.19 46.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.996 176.157 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.569 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.3 mp -109.64 130.97 61.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.099 -177.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -133.17 153.42 51.55 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.941 -177.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 78.2 m-20 -93.02 116.69 29.29 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.877 176.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.04 -20.22 66.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.854 169.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 11.8 t70 -77.33 -29.89 53.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.841 -177.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.664 HD21 ' O ' ' A' ' 220' ' ' GLY . 8.8 mp -95.17 -47.91 6.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.81 178.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 22.6 mt -102.28 115.02 65.17 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.535 0.683 . . . . 0.0 111.032 -177.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -70.79 -27.09 21.99 Favored 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.646 2.231 . . . . 0.0 112.333 174.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.413 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 60.5 t-20 -145.95 102.47 4.17 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.587 0.708 . . . . 0.0 110.88 173.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.413 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 43.0 Cg_endo -71.02 146.17 51.73 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.677 2.251 . . . . 0.0 112.324 -174.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.74 150.83 62.89 Favored 'Trans proline' 0 N--CA 1.465 -0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.384 -179.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -110.47 -6.34 14.95 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.971 -179.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 79.1 p -131.15 157.4 43.26 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.226 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 11.5 m0 -66.74 -30.63 70.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.998 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -62.06 -26.14 68.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.928 -175.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -78.96 -23.32 44.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 -176.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.61 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.5 mp -60.94 -51.21 81.0 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.645 0.736 . . . . 0.0 111.153 -169.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.61 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.5 Cg_endo -71.18 -40.63 3.1 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.62 2.213 . . . . 0.0 112.439 -170.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -68.31 -41.93 80.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.081 173.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.954 ' O ' HD23 ' A' ' 135' ' ' LEU . 0.2 OUTLIER -56.8 -42.8 80.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.973 172.299 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.427 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . 24.7 t70 -54.39 -35.34 62.74 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.772 -179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.0 -34.31 75.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.819 -178.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -76.29 -51.75 11.36 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.864 -172.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.575 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.8 OUTLIER -80.04 -10.06 59.74 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.839 -176.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.575 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.1 tttt -55.41 -31.99 62.3 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.941 167.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.66 -24.34 67.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.113 177.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.97 5.53 51.66 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.923 177.175 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.5 25.56 67.64 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.482 -179.516 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.481 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 41.4 mmtm -118.35 165.81 13.4 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.805 0.336 . . . . 0.0 110.886 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.6 t -126.67 142.03 51.67 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.831 178.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.4 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.17 -58.38 4.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.094 -166.367 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.415 HD13 ' C ' ' A' ' 147' ' ' LEU . 3.0 tm? -139.96 124.58 18.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.937 -168.125 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 58.0 ttm -109.93 128.82 55.61 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.887 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 18.1 p90 -155.83 157.18 36.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.832 -171.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.3 m-20 -99.98 81.82 2.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.868 -178.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.902 HD21 HD11 ' A' ' 195' ' ' LEU . 1.2 tm? -56.17 -32.52 64.39 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.876 177.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -78.37 9.53 3.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -174.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 85.9 mt-10 -108.73 145.01 30.76 Favored Pre-proline 0 C--N 1.33 -0.246 0 CA-C-O 121.597 0.713 . . . . 0.0 110.933 170.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -63.7 -24.91 68.88 Favored 'Trans proline' 0 C--N 1.341 0.133 0 C-N-CA 122.706 2.271 . . . . 0.0 112.349 -177.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -69.4 -32.11 70.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.953 -177.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -87.98 -30.82 19.72 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.87 -174.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 57.2 p -66.4 -32.46 73.85 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.233 177.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.587 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 29.8 t-105 -61.94 -55.57 40.04 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.643 0.735 . . . . 0.0 110.903 -171.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 13.4 Cg_endo -61.13 -36.79 79.5 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.703 2.269 . . . . 0.0 112.481 -171.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.677 ' O ' HD23 ' A' ' 160' ' ' LEU . 6.3 tt -72.59 -43.0 63.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -178.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 73.3 mt -70.64 -40.04 76.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.167 -179.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.66 -30.48 62.95 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.11 -177.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.514 ' HB3' ' HD2' ' A' ' 250' ' ' PHE . . . -63.29 -34.48 77.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.112 -169.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 56.0 p30 -92.57 3.03 56.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.968 178.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.21 1.96 13.87 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.462 169.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.17 65.55 3.96 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.472 -179.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 72.4 m-85 -86.31 134.12 33.76 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.821 0.343 . . . . 0.0 110.964 -179.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.61 7.14 10.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.106 -170.789 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.44 ' HA ' HG12 ' A' ' 181' ' ' VAL . 50.3 p90 -150.06 154.37 38.02 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.951 0.405 . . . . 0.0 110.931 -175.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -102.61 127.71 49.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.92 155.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -118.19 124.42 47.89 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.017 179.265 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -153.05 132.21 12.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.896 -176.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.05 42.03 31.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.912 173.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.94 16.06 80.69 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.507 174.152 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -130.03 138.62 50.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.764 0.316 . . . . 0.0 110.923 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 88.9 m-85 -95.78 143.42 27.03 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.863 169.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -121.39 109.83 15.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.932 172.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.626 ' O ' HD12 ' A' ' 178' ' ' ILE . 1.0 OUTLIER -79.24 -12.3 13.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.164 -178.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.7 -12.06 24.31 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.896 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -123.83 89.28 3.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.833 169.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.44 HG12 ' HA ' ' A' ' 169' ' ' PHE . 32.9 m -117.17 166.48 11.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.087 -171.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.01 24.0 29.3 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.514 -170.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.492 HG21 HD12 ' A' ' 368' ' ' ILE . 13.8 m -108.9 -15.4 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.818 0.342 . . . . 0.0 111.112 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -85.26 19.92 2.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.834 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -112.14 -178.25 3.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.852 -178.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.95 -24.86 63.41 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.999 179.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.98 -40.5 73.45 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.438 -171.003 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.633 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.68 -37.32 87.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.872 0.367 . . . . 0.0 111.124 176.667 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.504 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.0 mttt -59.98 -34.21 72.99 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.953 173.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.09 -30.9 71.88 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.112 174.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.38 -46.42 93.9 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.87 -0.681 . . . . 0.0 112.458 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.414 HD22 ' HA ' ' A' ' 347' ' ' VAL . 24.9 mt -66.03 -37.52 86.07 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.952 0.406 . . . . 0.0 110.916 176.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.2 m -56.67 -45.27 81.8 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.226 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -75.26 -44.57 45.2 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.836 177.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.902 HD11 HD21 ' A' ' 151' ' ' LEU . 8.7 tt -56.99 -53.66 55.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.936 -172.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.526 ' HA ' HD13 ' A' ' 199' ' ' ILE . 13.6 m -64.96 -21.2 29.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.185 -176.111 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -58.33 -29.9 66.28 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.813 175.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.58 ' CD1' ' N ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -71.4 -48.88 47.03 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.845 177.053 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.823 ' H ' HD12 ' A' ' 199' ' ' ILE . 2.6 mp -64.23 -36.66 77.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.151 173.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -64.95 -39.84 94.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.879 176.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -90.47 -1.32 57.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.971 179.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 64.66 39.99 6.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 172.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 67.5 m-70 -77.6 -14.31 59.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.834 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.4 ppp? -139.31 154.34 47.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.865 177.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -100.22 151.32 21.58 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.877 -176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.89 -27.65 69.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.119 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -95.0 2.97 55.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.795 -177.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 70.8 m -58.64 133.26 55.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.125 -177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 23.3 t0 -144.07 170.08 16.62 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.907 175.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -65.96 -35.78 81.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.906 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 97.4 p -65.65 -36.01 82.43 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.839 179.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 75.2 mt -65.06 -40.27 88.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.151 173.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.96 -39.27 93.77 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.984 178.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -67.24 -39.5 86.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.868 177.12 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.01 -36.73 85.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.129 178.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -60.71 -32.71 71.94 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.131 -176.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -61.39 -32.08 72.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.909 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -61.32 -35.63 77.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.95 -174.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -101.69 -21.61 14.62 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.871 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.664 ' O ' HD21 ' A' ' 121' ' ' LEU . . . 88.96 31.71 11.83 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.538 -177.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -82.54 -30.67 29.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.881 0.372 . . . . 0.0 110.915 -171.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 93.0 m -116.62 127.28 54.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.106 -176.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -69.86 -45.79 66.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.135 -174.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.401 ' HB3' HD21 ' A' ' 115' ' ' LEU . 76.3 mtp -134.19 145.75 49.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.898 -175.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 30.6 p -142.35 161.87 36.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.203 178.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 31.0 mm -111.64 125.42 68.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.148 177.145 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -154.33 158.08 39.58 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.869 -174.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.424 ' HA3' ' HG ' ' A' ' 113' ' ' LEU . . . -137.53 -108.58 0.87 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.529 -176.532 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -67.76 -17.28 47.35 Favored 'Trans proline' 0 C--O 1.23 0.096 0 C-N-CA 122.645 2.23 . . . . 0.0 112.359 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 97.5 m95 -80.25 -12.43 59.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.897 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -50.46 -39.0 46.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.017 -168.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 61.1 p-90 -57.12 -24.38 53.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.941 -174.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 27.8 t -50.08 -59.28 4.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.826 177.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 61.5 t30 -155.1 54.64 0.64 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.899 -179.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.4 ' O ' ' HD3' ' A' ' 316' ' ' ARG . 29.2 mm -129.42 115.72 36.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.136 170.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -171.55 160.0 5.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.867 178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 91.1 m -125.02 106.18 9.75 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.049 -179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 44.8 t -149.44 118.71 6.82 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.02 0.438 . . . . 0.0 110.879 174.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.1 mttt 60.15 35.02 21.14 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.873 -176.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 28.2 m -145.69 173.88 3.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.144 -178.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.438 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 74.4 m-80 -110.68 71.64 0.76 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.802 176.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 21.9 m-30 -117.68 147.45 42.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.928 176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -135.54 160.09 24.36 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.593 173.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.705 HG11 ' O ' ' A' ' 315' ' ' PRO . 5.8 p -140.82 138.23 34.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.928 0.394 . . . . 0.0 111.112 -176.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.1 t -152.86 152.19 31.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.118 174.039 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 24.4 m -60.02 167.4 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.085 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.465 ' N ' HD22 ' A' ' 247' ' ' LEU . 3.5 mm? -63.2 141.09 97.76 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.608 0.718 . . . . 0.0 110.919 -159.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -66.97 167.68 19.18 Favored 'Trans proline' 0 C--N 1.343 0.258 0 C-N-CA 122.641 2.228 . . . . 0.0 112.335 174.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 71.1 p -103.51 161.44 13.87 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.15 -170.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.514 ' HD2' ' HB3' ' A' ' 163' ' ' ALA . 30.7 t80 -143.18 121.06 11.98 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.864 -177.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.0 mmtt 57.25 34.98 25.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.904 179.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.89 10.32 79.09 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.462 169.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 78.8 mm-40 -126.44 145.06 51.54 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.651 0.739 . . . . 0.0 110.877 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -71.95 139.23 32.71 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.66 2.24 . . . . 0.0 112.309 -176.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 70.2 m -84.95 0.14 52.29 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.874 171.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 54.2 mtmt -46.18 110.16 1.14 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.658 0.742 . . . . 0.0 110.916 -176.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -76.7 161.09 34.11 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.783 2.322 . . . . 0.0 112.359 -178.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -75.17 153.18 38.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.9 -174.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.408 HG21 ' HA ' ' A' ' 324' ' ' ALA . 63.4 t -99.88 134.0 40.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.159 -170.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.21 133.62 11.75 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.438 -178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 86.0 t -124.91 131.44 72.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 120.936 0.398 . . . . 0.0 111.155 179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.407 ' HB3' ' HB ' ' A' ' 108' ' ' ILE . 2.5 tt -67.98 131.1 44.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 171.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.569 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 70.8 p -118.84 140.62 49.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.85 -176.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.545 ' HB1' HD11 ' A' ' 280' ' ' LEU . . . -127.87 130.17 48.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.089 179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -122.52 163.19 16.02 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.495 -174.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.466 ' HA ' HG22 ' A' ' 59' ' ' ILE . 15.7 mm -100.96 125.06 54.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 120.795 0.331 . . . . 0.0 111.159 179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -66.01 127.8 33.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.879 -176.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.428 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -60.92 -28.42 68.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.121 -177.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.9 -10.9 56.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.061 -172.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.3 t -75.88 121.11 84.41 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.674 0.75 . . . . 0.0 110.865 -174.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 80.4 Cg_endo -67.23 -8.77 22.95 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.672 2.248 . . . . 0.0 112.352 167.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -103.05 17.86 23.06 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.962 -173.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -52.72 -34.41 52.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.874 -168.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -71.38 -47.85 53.63 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.841 -170.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.3 pp -80.04 -31.02 39.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.966 -179.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.464 ' HB1' HD12 ' A' ' 59' ' ' ILE . . . -67.84 -45.92 73.25 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.086 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 43.2 pttt -69.41 -34.05 73.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.931 178.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.506 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 89.2 tt0 -62.9 -52.93 61.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -175.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.477 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.2 p90 -69.9 -33.61 72.42 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.82 -176.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.545 HD11 ' HB1' ' A' ' 264' ' ' ALA . 5.6 tt -56.93 -47.55 80.36 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.897 -178.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -85.15 -32.11 22.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.861 -177.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 69.4 m-20 -101.95 -14.01 17.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 -164.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.477 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 73.2 t80 -121.92 -49.49 2.09 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -175.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.506 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.2 OUTLIER -64.39 -46.99 80.91 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.851 177.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 64.2 mt -85.98 59.98 5.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.984 -179.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.484 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 47.5 p -139.18 150.42 45.57 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.065 172.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.531 ' HA ' HD11 ' A' ' 290' ' ' LEU . 42.4 p-10 -51.01 -26.4 6.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.814 -175.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -81.0 -43.9 18.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.834 177.758 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.05 -50.82 21.24 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.862 -0.685 . . . . 0.0 112.478 -169.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.555 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.4 OUTLIER -74.37 -20.85 59.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.862 0.363 . . . . 0.0 110.894 -179.924 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.426 ' N ' HD12 ' A' ' 290' ' ' LEU . 82.4 tt0 -67.12 -41.86 85.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.937 170.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.08 -34.37 74.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.145 -177.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.63 HG13 ' HA3' ' A' ' 19' ' ' GLY . 21.1 t -79.4 -42.23 23.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.453 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 47.0 t30 -64.96 -27.4 68.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.944 177.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.82 -29.67 70.64 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.948 -179.333 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -85.97 -39.99 16.32 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.899 -176.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -150.87 133.77 8.6 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.584 0.707 . . . . 0.0 110.888 173.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -50.52 112.33 0.73 Allowed 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.662 2.242 . . . . 0.0 112.375 176.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.453 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 36.9 mt -91.05 -12.48 35.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.986 -176.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 104.15 -58.98 0.49 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.43 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -175.01 167.28 3.54 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.846 0.355 . . . . 0.0 111.097 175.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 27.8 m -124.04 156.8 31.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.119 176.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -71.77 -17.73 62.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.983 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.555 ' CD2' HD21 ' A' ' 290' ' ' LEU . 58.6 tp -80.13 122.34 26.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.991 -173.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -56.09 -39.74 72.59 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.882 -173.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.2 m -63.18 -48.47 78.26 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.825 -167.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.447 ' CD2' HD23 ' A' ' 311' ' ' LEU . 24.0 t80 -84.86 -28.31 26.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.866 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -58.74 -43.07 90.13 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.937 179.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -63.56 -37.9 89.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.881 178.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -72.32 -47.88 46.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.865 -176.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.709 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.5 pp -69.42 -27.76 65.56 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.959 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.433 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.0 -11.52 57.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.201 -179.526 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -65.13 -15.02 61.94 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 177.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 71.3 m-20 -81.2 130.09 64.14 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.503 0.668 . . . . 0.0 110.92 170.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.705 ' O ' HG11 ' A' ' 244' ' ' VAL . 87.1 Cg_exo -51.69 -35.21 56.9 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.653 2.235 . . . . 0.0 112.272 -177.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.522 ' HG3' HG13 ' A' ' 317' ' ' ILE . 23.3 ptt-85 -66.91 -32.61 73.98 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.838 -173.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.709 HG21 ' CD1' ' A' ' 311' ' ' LEU . 64.9 mt -93.35 -33.78 5.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.094 -175.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -52.47 -43.08 64.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.077 -172.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.457 ' CB ' HG22 ' A' ' 244' ' ' VAL . . . -66.47 -43.1 86.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.084 178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.476 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 72.4 p -65.3 -28.81 69.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.086 -174.702 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 34.6 mmt -68.72 -30.15 68.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.887 177.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -64.95 -44.41 89.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.885 175.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.467 ' O ' ' N ' ' A' ' 327' ' ' GLY . 39.1 t30 -64.61 -36.88 85.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.941 174.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.408 ' HA ' HG21 ' A' ' 259' ' ' VAL . . . -62.14 -45.3 94.06 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.141 -179.146 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -73.54 -34.5 65.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.921 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -95.54 -1.15 51.13 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.846 -175.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -103.45 -157.3 24.76 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.431 -178.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -141.17 142.09 34.06 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.827 0.346 . . . . 0.0 110.952 -176.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.577 ' O ' ' C ' ' A' ' 330' ' ' MET . 37.9 mm -81.69 110.6 17.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.104 -171.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.577 ' C ' ' O ' ' A' ' 329' ' ' ILE . 96.1 mmm 23.44 60.02 0.35 Allowed Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.553 0.692 . . . . 0.0 110.782 174.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -88.48 -11.73 4.06 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.753 2.302 . . . . 0.0 112.302 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.547 ' HB2' ' HG3' ' A' ' 336' ' ' MET . 52.4 p-10 -99.28 15.15 27.11 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.964 -155.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.539 ' O ' ' O ' ' A' ' 332' ' ' ASN . 28.4 pt 58.41 161.68 0.09 OUTLIER Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.747 0.784 . . . . 0.0 111.098 159.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_exo -59.64 -30.54 92.51 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.706 2.271 . . . . 0.0 112.362 -174.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -65.01 -29.84 70.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.903 -169.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.547 ' HG3' ' HB2' ' A' ' 332' ' ' ASN . 89.4 mmm -74.35 -24.59 59.19 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.898 -172.013 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.7 m -64.13 -39.88 94.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.884 175.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.46 -36.7 65.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.045 176.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.401 ' O ' HG13 ' A' ' 343' ' ' VAL . 11.1 m-30 -65.04 -41.22 95.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.919 178.268 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.2 m0 -61.97 -35.42 78.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.764 177.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 93.3 t80 -69.3 -43.83 72.99 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.958 176.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.413 ' HB1' ' HB2' ' A' ' 367' ' ' ARG . . . -61.45 -40.5 94.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.221 -179.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.401 HG13 ' O ' ' A' ' 339' ' ' PHE . 16.1 m -79.47 -24.86 12.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.121 179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 4.4 tmt_? -62.29 -45.44 93.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.864 175.057 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 87.2 m -57.28 -35.08 69.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.042 173.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.636 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -60.25 -44.42 95.28 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.057 -175.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.414 ' HA ' HD22 ' A' ' 192' ' ' LEU . 1.5 m -74.06 -33.63 36.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.124 -174.638 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.407 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -63.5 -47.92 89.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.242 173.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.509 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 84.9 m-20 -67.02 -37.72 84.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.909 -177.425 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.83 -47.9 49.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.154 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.21 -37.1 80.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.177 -174.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.5 p -74.81 -13.92 60.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.823 -177.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.53 12.2 84.5 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.436 178.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -81.74 -26.46 34.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.777 0.322 . . . . 0.0 110.91 178.43 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.509 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 93.3 mt-30 -133.43 159.4 40.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.925 170.078 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.2 p -80.42 169.54 17.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.249 170.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.426 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 69.7 t -56.48 -43.09 77.12 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.175 170.342 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -59.13 -45.09 91.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.838 178.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 57.7 mt-10 -70.1 -52.66 21.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.919 -179.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.15 -45.15 74.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.093 -173.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.633 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -67.05 -40.01 87.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.002 -176.185 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.547 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.0 tttt -65.1 -39.12 92.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.935 176.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 92.9 m-20 -64.71 -37.08 86.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.856 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.636 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -63.95 -45.56 88.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.091 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.547 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -73.5 -30.04 62.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.863 -179.073 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 67.9 m -64.6 -41.16 96.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.118 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.413 ' HB2' ' HB1' ' A' ' 342' ' ' ALA . 99.7 mtt180 -66.75 -39.98 88.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.848 175.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.492 HD12 HG21 ' A' ' 183' ' ' VAL . 67.1 mt -65.93 -38.42 82.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.099 178.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 70.7 p -93.9 -8.95 38.74 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.168 -176.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.906 173.713 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.74 0.305 . . . . 0.0 110.924 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.8 mt -97.71 128.5 48.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.215 178.387 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -158.01 145.8 18.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.905 -177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -51.86 138.39 24.23 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.864 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.501 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 98.1 2.52 58.08 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.405 -173.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 59.9 pttt -170.35 152.38 4.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.852 0.358 . . . . 0.0 110.928 176.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.597 HD22 HD13 ' A' ' 33' ' ' ILE . 1.3 pt? -153.51 155.37 36.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.984 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 71.4 t -109.92 135.8 47.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.159 178.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.681 HG22 ' CG1' ' A' ' 59' ' ' ILE . 0.1 OUTLIER -122.78 132.27 71.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.115 -179.703 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.449 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 40.0 m0 -107.05 125.8 51.51 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.939 169.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.485 ' HB ' HD12 ' A' ' 20' ' ' LEU . 15.8 tt -107.74 149.71 10.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.194 -171.203 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.7 t30 -58.97 148.11 31.84 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.796 -177.01 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.75 -14.64 37.66 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.476 -175.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.0 m-20 -73.84 -9.94 59.16 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.856 0.36 . . . . 0.0 110.856 -174.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 43.8 tptt -150.23 133.76 16.56 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.909 159.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.91 -84.97 0.98 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.534 -163.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 85.0 t80 -106.69 -45.02 4.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.905 0.383 . . . . 0.0 110.921 -173.221 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -68.22 -52.46 33.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.932 -151.44 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.596 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -59.2 -48.04 87.89 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.556 -178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.602 ' CD1' HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -58.69 -46.38 87.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.804 0.335 . . . . 0.0 110.933 176.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -58.65 -38.14 77.48 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.117 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 54.2 tp10 -65.51 -49.4 69.12 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.8 -177.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.6 m -73.36 -34.66 44.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.124 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -67.31 -43.22 88.98 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.496 177.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -60.87 -44.87 96.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.817 0.341 . . . . 0.0 110.932 -178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -67.33 -40.11 85.87 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.869 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.539 ' CE2' HD11 ' A' ' 33' ' ' ILE . 42.6 t80 -64.58 -38.85 92.42 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.909 176.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -63.93 -41.86 97.52 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.966 175.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -66.68 -36.4 82.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.842 -178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.4 m-20 -81.49 -39.7 24.37 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.793 -170.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.631 ' OG1' HG13 ' A' ' 33' ' ' ILE . 63.9 p -103.62 -8.54 19.9 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.136 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.95 11.07 83.99 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.557 178.171 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.038 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 pp -105.14 131.11 55.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.889 0.376 . . . . 0.0 111.168 -174.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -68.68 128.21 35.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.94 -168.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.463 HG22 HD21 ' A' ' 7' ' ' LEU . 95.8 t -110.42 119.97 60.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 179.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.458 ' HB ' HG22 ' A' ' 8' ' ' VAL . 99.8 m -111.12 116.71 31.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.175 -174.618 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.501 HG22 HD13 ' A' ' 20' ' ' LEU . 87.9 t -92.82 133.51 33.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.12 178.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.449 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 74.0 mm-40 -120.02 160.88 21.91 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.909 174.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 64.7 t-80 -84.03 138.13 40.05 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 110.775 -167.948 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 58.8 Cg_exo -61.45 -17.42 53.52 Favored 'Trans proline' 0 C--O 1.232 0.211 0 C-N-CA 122.717 2.278 . . . . 0.0 112.304 -174.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -47.39 -49.69 24.13 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.923 -175.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.449 ' HB3' ' HB2' ' A' ' 46' ' ' LYS . 75.4 mmtt -90.88 -0.1 57.63 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.929 -174.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.714 HD11 ' O ' ' A' ' 61' ' ' PHE . 9.8 tt -45.29 -56.93 4.38 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.954 -170.054 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.3 tt0 -76.63 -38.42 54.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.879 -175.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -79.86 -44.84 19.74 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.896 -166.372 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.449 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 85.3 tttt -85.13 -36.02 21.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -171.18 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.597 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 84.0 t80 -49.23 -53.82 35.55 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.666 0.746 . . . . 0.0 110.989 -171.596 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 22.7 Cg_endo -59.17 -30.63 93.6 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.654 2.236 . . . . 0.0 112.325 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -74.46 -44.67 50.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.942 -179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 21.7 m -75.01 -24.71 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.168 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.65 -34.39 78.11 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.076 174.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.22 -31.0 71.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.071 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.5 p -89.99 -13.42 36.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.189 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.2 16.35 80.67 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.513 168.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -137.81 130.0 29.05 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.823 0.344 . . . . 0.0 110.821 175.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 170.3 -118.56 0.76 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.493 174.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.48 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 68.1 Cg_endo -70.54 153.22 65.51 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.711 2.274 . . . . 0.0 112.349 176.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.432 ' HB2' HD13 ' A' ' 59' ' ' ILE . 1.8 m-20 -86.4 -38.88 16.93 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.901 169.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.752 HG23 ' HB1' ' A' ' 276' ' ' ALA . 0.0 OUTLIER -133.81 149.69 30.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.072 178.803 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.5 tp -128.97 125.07 62.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.107 -176.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.714 ' O ' HD11 ' A' ' 43' ' ' LEU . 2.3 m-85 -101.5 134.51 44.49 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.859 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.409 ' CH2' ' HB2' ' A' ' 105' ' ' ALA . 32.0 p90 -144.94 -178.74 6.19 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.948 175.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.96 -98.71 0.32 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.105 178.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -107.3 -55.1 2.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.822 -176.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -60.12 -34.35 73.39 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.872 -162.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -77.57 -20.01 54.74 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.775 -171.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -45.55 -53.14 9.44 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.928 177.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.42 -52.28 44.89 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.556 -178.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -59.23 -49.93 73.26 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.641 -0.79 . . . . 0.0 112.576 -175.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -70.93 -47.52 58.61 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.878 0.37 . . . . 0.0 110.96 -172.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.3 -47.7 63.75 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.162 -173.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.4 tt0 -64.45 -35.35 80.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.833 -178.211 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.1 m -83.76 -7.48 59.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.814 -175.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.26 33.48 61.76 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.461 176.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.2 mp -84.0 -4.82 59.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.899 0.38 . . . . 0.0 110.975 -176.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.746 ' O ' HD12 ' A' ' 76' ' ' LEU . 2.8 pp -132.34 145.66 51.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.974 -177.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.23 142.19 43.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.126 176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 58.9 mp0 -66.73 134.26 51.85 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.883 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.835 HG13 ' HB3' ' A' ' 103' ' ' LEU . 39.8 pt -111.58 160.71 10.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.137 -179.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.9 m -101.46 130.06 25.53 Favored Pre-proline 0 C--N 1.33 -0.275 0 CA-C-O 121.627 0.727 . . . . 0.0 111.173 -178.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.27 147.91 54.32 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.655 2.236 . . . . 0.0 112.33 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -114.46 120.06 38.97 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.847 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.15 -38.73 91.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.861 -177.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -66.07 -44.77 83.52 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.168 -177.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -71.44 -35.19 70.83 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.898 -179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.501 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 43.6 tt0 -53.32 -46.53 69.46 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.929 173.288 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -61.63 -34.55 75.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.905 174.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.26 -23.3 54.45 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.911 -177.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.453 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.4 OUTLIER -108.09 -93.5 0.4 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.879 -171.676 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -169.98 129.18 0.87 Allowed Pre-proline 0 C--N 1.327 -0.412 0 CA-C-O 121.631 0.729 . . . . 0.0 111.067 -179.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 94.8 Cg_exo -56.2 -43.68 53.85 Favored 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.6 2.2 . . . . 0.0 112.291 -171.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 95' ' ' ASP . 1.8 t80 -72.04 -32.78 67.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.994 -173.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.551 ' CG2' ' HB3' ' A' ' 107' ' ' PRO . 96.2 m -64.39 -34.77 78.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.011 -171.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.69 ' HA ' HG22 ' A' ' 97' ' ' VAL . 61.0 m95 -70.37 -21.61 62.86 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.986 178.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 92' ' ' PHE . 97.5 m-20 -72.99 -33.73 65.99 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.83 171.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.92 -27.7 64.99 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 177.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.69 HG22 ' HA ' ' A' ' 94' ' ' TRP . 15.7 m -100.38 15.51 4.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.09 178.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.406 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 70.8 ttt180 -110.4 136.48 49.49 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.905 178.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.9 t80 -140.12 126.59 20.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.975 -178.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.4 t30 59.87 34.7 21.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.95 174.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.41 -3.0 83.77 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.528 174.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -125.14 147.41 49.04 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.707 0.289 . . . . 0.0 110.961 174.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.835 ' HB3' HG13 ' A' ' 79' ' ' ILE . 3.3 tp -76.87 140.1 40.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.857 -178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.43 HG22 HD11 ' A' ' 76' ' ' LEU . 2.0 pp -122.14 -6.16 8.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 -171.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.409 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . . . -164.97 166.67 19.2 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.085 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.433 ' HB3' HD11 ' A' ' 285' ' ' LEU . 87.1 m-85 -112.93 146.42 35.09 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.696 0.76 . . . . 0.0 110.939 169.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.551 ' HB3' ' CG2' ' A' ' 93' ' ' THR . 72.0 Cg_endo -76.16 118.93 5.13 Favored 'Trans proline' 0 C--O 1.233 0.242 0 C-N-CA 122.631 2.22 . . . . 0.0 112.426 176.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.431 HD13 HD21 ' A' ' 285' ' ' LEU . 27.2 mm -92.5 -55.26 6.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.124 -178.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.504 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.43 160.48 43.72 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.08 -168.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 89.0 t -119.41 136.67 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.101 -172.866 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -121.33 140.14 52.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.907 171.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.481 ' HB1' HD22 ' A' ' 323' ' ' ASN . . . -150.45 159.27 44.59 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.086 176.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.419 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 8.8 mp -92.31 169.23 10.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.903 -173.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.5 p -157.05 157.86 35.4 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.845 -177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.899 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -100.03 126.06 46.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.021 171.162 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.569 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.8 mp -110.2 133.3 56.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.177 -174.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 52.5 p90 -133.25 150.37 51.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.942 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -91.12 118.75 30.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.8 176.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -64.58 -20.71 66.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.939 -178.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 60.2 m-20 -77.76 -27.94 50.49 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.899 -177.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.497 HD21 ' O ' ' A' ' 220' ' ' GLY . 6.7 mp -95.5 -44.76 7.37 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.946 -178.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.406 ' HA ' ' HD2' ' A' ' 123' ' ' PRO . 24.6 mt -108.74 103.32 51.24 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.631 0.729 . . . . 0.0 110.89 177.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 122' ' ' LEU . 72.6 Cg_endo -67.7 -23.61 42.09 Favored 'Trans proline' 0 C--O 1.231 0.129 0 C-N-CA 122.686 2.257 . . . . 0.0 112.358 171.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -147.16 94.02 4.62 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.621 0.724 . . . . 0.0 110.894 171.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -66.94 152.7 79.89 Favored 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.684 2.256 . . . . 0.0 112.364 -176.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_endo -68.37 144.9 63.57 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.65 2.234 . . . . 0.0 112.389 -177.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -93.53 -13.62 27.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.0 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.4 p -130.22 155.88 45.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.079 -174.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.558 ' HA ' HD13 ' A' ' 132' ' ' ILE . 64.2 m95 -68.44 -29.27 67.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.958 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -61.53 -25.02 67.02 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.917 -176.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -78.74 -21.22 48.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.894 -175.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.598 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.6 mp -60.43 -52.88 69.78 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.661 0.743 . . . . 0.0 111.065 -171.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.598 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 27.7 Cg_endo -66.89 -40.04 13.16 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.623 2.215 . . . . 0.0 112.441 -171.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -69.18 -41.61 76.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.118 173.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 33.7 tp -55.14 -43.45 74.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.978 173.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.437 ' HA ' ' CD2' ' A' ' 139' ' ' LEU . 1.5 m-20 -49.87 -42.37 47.59 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.878 -179.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -63.95 -35.13 79.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.898 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -75.5 -46.17 33.91 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.907 -171.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.46 ' HG ' ' HB2' ' A' ' 144' ' ' LYS . 0.8 OUTLIER -89.94 -18.74 25.52 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.96 -174.218 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -53.67 -30.33 42.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.83 167.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.18 -25.08 67.57 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.12 177.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -95.0 7.01 47.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.865 176.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.16 24.91 72.38 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.464 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.46 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 26.5 mmtp -110.04 167.55 10.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.878 0.37 . . . . 0.0 110.904 178.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.0 t -130.64 137.95 49.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.899 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.428 ' O ' ' N ' ' A' ' 224' ' ' MET . . . -72.94 -53.48 11.16 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.068 -166.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.461 HD22 ' H ' ' A' ' 148' ' ' MET . 1.9 tm? -138.24 138.12 38.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.872 -167.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.461 ' H ' HD22 ' A' ' 147' ' ' LEU . 98.7 mtp -125.14 133.27 52.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.852 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 22.0 p90 -159.98 161.69 34.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.823 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 49.8 m-20 -95.47 90.05 5.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.901 -178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.829 HD21 HD11 ' A' ' 195' ' ' LEU . 1.2 tm? -66.44 -32.75 74.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.951 -173.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.0 mt-30 -77.29 0.07 23.52 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -100.4 142.87 25.44 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.586 0.707 . . . . 0.0 110.914 176.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.604 ' HG3' ' CE1' ' A' ' 341' ' ' TYR . 29.9 Cg_endo -64.32 -22.47 66.36 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.672 2.248 . . . . 0.0 112.429 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 95.8 m-85 -69.26 -35.47 76.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.964 -176.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -92.09 -29.97 16.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.836 -172.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 65.2 p -65.68 -45.67 81.98 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.271 -177.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.598 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 90.6 t90 -66.21 -46.83 61.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.521 0.677 . . . . 0.0 110.82 -166.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.598 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 96.9 Cg_exo -48.81 -45.39 28.5 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.685 2.257 . . . . 0.0 112.422 178.47 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.761 ' O ' HD23 ' A' ' 160' ' ' LEU . 6.2 tt -69.15 -39.11 79.01 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.885 179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 67.2 mt -71.55 -40.5 71.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 -179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -78.73 -26.47 44.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 -177.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.47 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -60.41 -33.68 72.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.046 -171.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 57.1 p30 -95.02 3.3 55.05 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.846 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.88 -1.06 13.52 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.45 171.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.3 67.14 3.11 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.422 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -87.76 132.38 34.17 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.891 0.377 . . . . 0.0 110.928 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -80.07 13.98 2.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.137 -174.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.409 ' HA ' HG12 ' A' ' 181' ' ' VAL . 49.1 p90 -147.47 151.45 36.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.868 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -103.21 129.62 50.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.836 158.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 73.5 t80 -120.88 125.03 46.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.913 179.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -151.99 129.81 11.67 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.994 -177.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.09 41.78 31.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.851 172.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 76.02 15.35 81.45 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.525 173.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -129.97 139.03 51.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.739 0.304 . . . . 0.0 110.842 -177.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -99.74 144.6 28.62 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.898 171.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -122.06 108.05 12.92 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.865 172.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.528 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.4 pp -77.77 -11.99 13.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.134 -178.264 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.14 -11.44 22.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 -176.296 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -130.01 85.08 2.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.897 172.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 169' ' ' PHE . 30.6 m -113.84 173.08 3.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.145 -169.134 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -101.97 23.76 33.57 Favored Glycine 0 C--N 1.332 0.317 0 C-N-CA 120.585 -0.817 . . . . 0.0 112.455 -166.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.534 HG21 HD12 ' A' ' 368' ' ' ILE . 31.3 m -114.41 -7.59 12.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.846 0.355 . . . . 0.0 111.131 176.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 53.5 p-10 -85.5 18.07 2.93 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.82 178.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -125.74 -170.02 2.11 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.84 -178.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -66.07 -27.64 68.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.111 -173.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -68.2 -44.76 74.52 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.768 -0.729 . . . . 0.0 112.479 -164.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.747 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -67.01 -36.01 81.19 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.81 0.338 . . . . 0.0 111.07 -178.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.476 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.5 mttt -59.04 -33.7 71.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.898 174.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.13 -31.68 73.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.105 174.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -62.83 -45.22 96.16 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.481 -179.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.463 HD11 ' HB1' ' A' ' 346' ' ' ALA . 22.7 mt -64.98 -38.63 91.61 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.9 0.381 . . . . 0.0 110.98 177.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 93.1 m -58.2 -44.99 88.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.244 -177.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 94.6 t80 -75.88 -45.49 35.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.886 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.829 HD11 HD21 ' A' ' 151' ' ' LEU . 6.5 tt -54.39 -48.57 71.41 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.961 -170.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.418 ' HA ' HD11 ' A' ' 199' ' ' ILE . 23.0 m -70.1 -19.93 22.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.138 -174.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.443 ' HB3' HD13 ' A' ' 198' ' ' LEU . 38.6 t70 -56.52 -56.74 17.46 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.92 -168.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.985 HD13 ' H ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.5 -26.6 58.26 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.928 -167.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.581 ' H ' HD22 ' A' ' 198' ' ' LEU . 1.8 pp -86.99 -34.52 7.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.176 177.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -58.74 -32.6 69.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.914 166.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -84.88 5.0 30.65 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 176.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 65.19 36.84 6.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.86 169.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 64.4 m-70 -86.24 -14.44 43.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.86 176.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 57.9 ttp -138.08 153.27 49.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.962 179.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -97.7 150.16 21.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.81 -175.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.97 -26.65 68.39 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.103 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -93.78 4.9 53.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.809 -176.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 91.5 m -61.03 129.97 44.04 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.143 -178.077 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 23.2 t0 -139.81 169.65 17.33 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.837 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.6 p90 -66.63 -36.19 81.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.847 -175.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 99.5 p -66.08 -36.57 83.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.745 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 73.4 mt -64.94 -39.36 85.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 172.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.05 -36.31 83.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.172 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -61.41 -45.73 93.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.949 176.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.03 -38.64 91.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.15 176.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.98 -42.93 97.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.176 -178.617 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 5.0 m-85 -65.22 -36.91 85.62 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.871 177.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -61.35 -34.01 74.58 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.923 176.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -89.59 -22.59 22.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.898 179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.497 ' O ' HD21 ' A' ' 121' ' ' LEU . . . 88.19 24.92 32.81 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.505 -178.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -87.91 -26.84 22.52 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.897 0.38 . . . . 0.0 110.861 -173.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . 0.443 HG21 ' SD ' ' A' ' 148' ' ' MET . 75.6 m -116.87 129.92 56.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.164 -173.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -68.92 -49.8 55.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.103 -179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.428 ' N ' ' O ' ' A' ' 146' ' ' ALA . 71.1 mtm -136.43 157.06 47.68 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.906 -170.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.9 t -149.15 157.68 43.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.2 176.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.3 mm -112.81 121.26 64.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.119 178.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.545 ' HB3' ' HB2' ' A' ' 231' ' ' ALA . 9.4 t-20 -156.05 170.0 23.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 -172.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.419 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -132.42 -100.32 0.77 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.571 -178.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -68.26 -22.94 39.45 Favored 'Trans proline' 0 C--O 1.231 0.136 0 C-N-CA 122.703 2.269 . . . . 0.0 112.306 -177.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -83.56 -20.11 34.4 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.002 177.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' A' ' 227' ' ' ASN . . . -55.6 -45.1 77.49 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.073 -166.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 64.3 p-90 -63.14 -19.1 64.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 -171.734 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 84.1 p -54.05 -25.41 21.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.879 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -136.17 39.94 2.7 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.964 -178.24 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.442 ' HB ' ' HG2' ' A' ' 316' ' ' ARG . 95.6 mt -119.43 128.46 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.133 170.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -165.06 162.55 20.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.968 178.526 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 73.6 p -135.07 54.64 1.93 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.083 176.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 43.4 t -138.4 110.55 7.33 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.02 0.438 . . . . 0.0 110.827 178.357 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 97.3 mttt 62.34 21.33 12.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.858 -174.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 30.8 m -145.25 163.1 12.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.089 179.07 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -123.41 82.49 2.01 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.836 176.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 97.7 m-85 -124.03 147.88 47.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.868 171.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -127.67 153.09 19.12 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.542 177.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.532 HG22 ' CB ' ' A' ' 319' ' ' ALA . 5.0 p -137.8 134.07 45.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.958 0.409 . . . . 0.0 111.166 -178.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.8 t -155.78 147.86 23.42 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.105 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.4 m -60.66 168.87 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.068 -175.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.656 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.8 mm? -64.09 149.13 94.46 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.615 0.721 . . . . 0.0 110.855 -159.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.401 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 32.1 Cg_exo -65.12 179.08 1.62 Allowed 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.705 2.27 . . . . 0.0 112.254 -177.101 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 97.3 m -101.04 146.41 27.47 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.189 178.398 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 42.0 t80 -136.79 119.42 16.04 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.911 -175.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.4 mmtt 56.14 35.05 24.99 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.917 -178.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.51 3.33 86.64 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.478 171.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 87.6 mm-40 -133.7 142.73 44.85 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.683 0.754 . . . . 0.0 110.886 178.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -71.78 144.94 44.91 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.727 2.284 . . . . 0.0 112.315 -171.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.656 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 70.0 p -87.03 10.28 16.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.861 173.717 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 47.1 mtmt -43.07 112.21 1.16 Allowed Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.648 0.737 . . . . 0.0 110.887 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.408 ' CD ' HD23 ' A' ' 247' ' ' LEU . 80.7 Cg_endo -78.5 164.63 26.0 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.654 2.236 . . . . 0.0 112.355 178.756 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -71.27 163.26 28.0 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.869 -174.15 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 60.5 t -107.88 135.22 47.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.065 -172.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.12 135.98 13.17 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.455 -179.169 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 89.6 t -122.8 132.13 71.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 120.953 0.406 . . . . 0.0 111.114 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 2.4 tt -66.61 128.89 37.97 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.899 171.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 59.7 p -123.11 132.17 53.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.863 -177.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.47 ' HB1' HD11 ' A' ' 280' ' ' LEU . . . -124.92 127.75 47.56 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.163 -173.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -121.78 167.01 14.46 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.416 -171.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.406 HD13 HG22 ' A' ' 59' ' ' ILE . 12.6 mm -99.98 126.81 53.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.762 0.315 . . . . 0.0 111.148 -179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -62.86 126.39 27.17 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.889 -176.671 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -62.85 -25.11 68.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.083 -176.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.59 -10.52 55.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.112 -173.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.3 t -75.61 120.37 81.33 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.581 0.705 . . . . 0.0 110.928 -174.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -70.91 -12.24 30.45 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.631 2.221 . . . . 0.0 112.289 171.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.7 t30 -112.07 35.75 3.62 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.984 -170.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.05 -25.11 65.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.876 -169.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.94 -39.07 76.29 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.802 -173.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 43.1 tp -66.26 -48.21 71.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.946 173.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.752 ' HB1' HG23 ' A' ' 59' ' ' ILE . . . -68.0 -50.0 58.21 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.053 -172.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 57.4 tttm -62.97 -41.34 99.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.913 -177.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -63.86 -53.46 50.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.954 -172.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.467 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 0.4 OUTLIER -70.05 -36.88 75.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.89 -173.369 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.509 ' O ' HD23 ' A' ' 280' ' ' LEU . 6.4 tt -58.53 -46.56 86.53 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.88 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -77.23 -40.31 45.38 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.832 179.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -102.8 -9.68 19.76 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.85 -160.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.467 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 75.7 t80 -122.48 -49.07 2.04 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.929 -178.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.502 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.1 OUTLIER -64.43 -47.1 80.38 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.978 178.082 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 106' ' ' TYR . 64.6 mt -85.0 59.2 5.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.853 -179.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.483 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 37.4 p -140.23 151.16 44.95 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.149 172.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.524 ' HA ' HD11 ' A' ' 290' ' ' LEU . 43.1 p-10 -51.12 -26.06 6.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.916 -174.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -79.6 -44.93 20.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.801 178.738 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.88 -50.1 20.12 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.532 -168.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.524 HD11 ' HA ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -74.79 -20.9 59.6 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.737 0.303 . . . . 0.0 110.903 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.421 ' N ' HD12 ' A' ' 290' ' ' LEU . 82.4 tt0 -66.13 -40.43 90.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.931 169.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.68 -34.74 76.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.193 -179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.596 HG13 ' HA3' ' A' ' 19' ' ' GLY . 24.7 t -78.45 -45.23 26.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.182 -179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.4 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 48.3 t30 -65.53 -27.79 68.71 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.908 179.426 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.04 -27.31 69.02 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.86 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 96.5 m-20 -85.99 -41.33 14.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.928 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -150.96 129.82 6.27 Favored Pre-proline 0 C--N 1.328 -0.369 0 CA-C-O 121.576 0.703 . . . . 0.0 110.906 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_exo -51.8 110.35 0.42 Allowed 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.714 2.276 . . . . 0.0 112.396 176.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.4 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 55.8 mt -88.19 -17.81 30.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.98 -171.299 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.626 ' O ' HG23 ' A' ' 317' ' ' ILE . . . 105.13 -42.78 1.81 Allowed Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.445 176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 300' ' ' GLY . . . -176.04 173.17 2.28 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.861 0.362 . . . . 0.0 111.059 164.372 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.523 HG22 HD21 ' A' ' 311' ' ' LEU . 23.2 m -122.7 153.69 27.6 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.149 170.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -68.19 -18.8 64.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.041 174.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.453 ' HA ' HD12 ' A' ' 89' ' ' LEU . 52.6 tp -83.03 121.95 27.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.967 -174.098 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -60.37 -34.99 74.68 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.922 -174.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.7 m -64.06 -50.21 69.29 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.844 -169.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.597 ' CD2' HD23 ' A' ' 311' ' ' LEU . 36.0 t80 -82.8 -26.93 31.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.954 179.363 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 -55.71 -43.85 76.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.903 177.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -64.22 -36.89 85.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.901 -178.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -77.62 -48.49 16.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.787 -176.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.825 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.5 pp -65.68 -24.78 67.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.988 179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.506 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -62.72 -18.74 63.04 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.094 179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.36 -19.93 64.67 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.818 -179.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -79.15 122.12 83.95 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.575 0.703 . . . . 0.0 110.903 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.504 ' O ' HG11 ' A' ' 244' ' ' VAL . 84.0 Cg_exo -48.58 -31.97 19.97 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.721 2.28 . . . . 0.0 112.241 177.632 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.442 ' HG2' ' HB ' ' A' ' 235' ' ' ILE . 99.1 mtt180 -59.01 -36.73 75.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.846 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.825 HG21 ' CD1' ' A' ' 311' ' ' LEU . 38.7 mt -99.97 -34.25 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 -171.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.39 -41.52 20.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.073 -164.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.532 ' CB ' HG22 ' A' ' 244' ' ' VAL . . . -65.69 -44.49 86.02 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.013 176.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.45 ' N ' ' O ' ' A' ' 317' ' ' ILE . 73.1 p -68.09 -29.7 68.7 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.074 -176.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 18.1 tmm? -68.24 -38.17 81.56 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.894 176.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -65.1 -46.67 80.12 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 -177.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.481 HD22 ' HB1' ' A' ' 112' ' ' ALA . 27.6 t30 -65.43 -35.49 81.07 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.944 176.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.79 -46.27 89.71 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.052 -179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 86.2 mt-30 -77.18 -32.96 56.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.923 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -95.05 -2.52 50.03 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.894 -174.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.44 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -100.26 -156.63 27.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.449 178.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -137.36 143.08 41.81 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.89 0.376 . . . . 0.0 110.868 -179.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.585 ' O ' ' C ' ' A' ' 330' ' ' MET . 45.2 mm -78.79 104.79 7.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.153 -170.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.585 ' C ' ' O ' ' A' ' 329' ' ' ILE . 22.1 ptp 22.21 59.78 0.3 Allowed Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.57 0.7 . . . . 0.0 110.846 174.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -84.41 -15.61 6.27 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.744 2.296 . . . . 0.0 112.388 -176.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.555 ' O ' ' O ' ' A' ' 333' ' ' ILE . 52.5 p-10 -98.09 20.52 12.21 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.888 -151.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.555 ' O ' ' O ' ' A' ' 332' ' ' ASN . 30.4 pt 60.17 160.05 0.11 Allowed Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.647 0.737 . . . . 0.0 111.098 154.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -61.0 -32.46 92.35 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.73 2.287 . . . . 0.0 112.316 -175.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.62 -25.45 67.97 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.891 -169.173 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.539 ' HG3' ' HB2' ' A' ' 332' ' ' ASN . 88.2 mmm -75.17 -23.18 57.71 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.889 -171.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.6 m -62.25 -42.25 99.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.889 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.08 -33.0 63.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.989 177.8 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.5 m-30 -64.85 -38.78 92.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.869 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.405 ' HB3' ' HB2' ' A' ' 154' ' ' PRO . 38.3 m0 -60.59 -35.33 75.84 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 175.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . 0.604 ' CE1' ' HG3' ' A' ' 154' ' ' PRO . 32.3 m-85 -73.61 -38.62 65.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.916 178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -63.71 -39.33 94.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.148 178.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 17.1 m -80.4 -25.12 11.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.054 178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.453 ' O ' HG22 ' A' ' 347' ' ' VAL . 7.9 tmm_? -62.12 -45.58 92.82 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 173.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 98.1 m -55.61 -34.74 65.15 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.206 173.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -61.34 -42.99 99.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.114 -176.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 344' ' ' ARG . 1.4 m -74.35 -33.72 34.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.138 -174.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -62.44 -47.04 94.87 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.204 172.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.427 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 95.1 m-20 -64.98 -39.67 93.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.858 -178.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.29 -46.74 60.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 -179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.2 -42.66 88.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.13 -176.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.6 p -76.04 -10.61 59.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.82 -175.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 78.18 14.97 81.68 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.581 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -76.65 -31.29 57.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.684 0.278 . . . . 0.0 110.848 179.176 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.427 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 84.9 mm-40 -139.56 158.3 44.36 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.921 176.881 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 51.2 p -78.39 166.55 22.52 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.194 170.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 62.7 t -55.72 -42.46 69.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.12 172.431 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -60.16 -46.09 90.88 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.907 178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -69.89 -52.5 24.17 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.848 -179.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -67.66 -45.5 75.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.041 -173.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.747 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.6 OUTLIER -67.42 -39.78 85.51 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.001 -177.068 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.56 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 87.9 tttt -64.78 -38.42 90.93 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.909 175.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -63.96 -38.02 89.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.914 175.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.512 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -64.61 -45.97 84.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.016 -179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.56 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 1.1 pp0? -73.03 -30.91 64.1 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.852 -177.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 73.9 m -65.62 -42.73 91.2 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.153 176.539 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 82.4 mtp180 -66.26 -37.11 84.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.834 177.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.534 HD12 HG21 ' A' ' 183' ' ' VAL . 62.9 mt -66.0 -39.9 85.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.186 177.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 72.0 p -90.36 -11.15 41.46 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.153 -177.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.5 tttt . . . . . 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.927 175.487 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.3 mttt . . . . . 0 C--O 1.231 0.087 0 CA-C-O 120.784 0.326 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 94.9 mt -102.11 127.77 55.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.159 178.173 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -152.4 144.08 23.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.912 -177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.6 137.65 30.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.784 178.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.401 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 97.66 3.15 58.44 Favored Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.505 -172.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 61.5 pttt -170.1 153.31 4.57 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.76 0.315 . . . . 0.0 110.983 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.549 HD22 HD13 ' A' ' 33' ' ' ILE . 1.3 pt? -153.17 155.97 37.7 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.949 178.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.454 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 78.1 t -110.62 137.87 41.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.128 179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.927 HG13 HD21 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -122.09 132.76 70.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.095 -179.32 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.453 ' HB3' HD12 ' A' ' 43' ' ' LEU . 45.6 m0 -109.89 127.44 54.73 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.979 168.127 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.542 ' HB ' HD22 ' A' ' 20' ' ' LEU . 6.9 tt -108.18 145.6 15.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.137 -170.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -53.01 143.96 16.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 176.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.28 -13.53 21.99 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.418 -174.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -74.76 -10.29 59.37 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.861 0.363 . . . . 0.0 110.854 -173.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 40.4 tptt -145.29 136.92 25.34 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.954 158.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.93 -83.86 1.01 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.537 -164.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -114.5 -45.0 3.04 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.951 0.405 . . . . 0.0 110.908 -173.219 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -68.6 -52.94 26.06 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.886 -149.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.592 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -60.27 -48.99 83.44 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.494 -175.67 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.927 HD21 HG13 ' A' ' 9' ' ' ILE . 18.0 tp -65.09 -41.41 95.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.863 0.363 . . . . 0.0 110.978 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.94 -38.23 67.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.105 173.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -67.17 -48.77 66.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.941 -177.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.402 HG22 ' HA ' ' A' ' 20' ' ' LEU . 14.3 m -74.7 -34.47 34.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.115 -178.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.491 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -65.53 -45.11 91.44 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.536 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 55.9 tptt -64.2 -38.93 92.82 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.84 0.352 . . . . 0.0 110.905 -179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.4 mmtt -63.31 -42.65 99.03 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.974 176.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.466 ' CD2' HD11 ' A' ' 33' ' ' ILE . 56.3 t80 -65.06 -37.74 88.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.822 176.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -61.98 -41.55 98.15 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.974 177.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -69.96 -31.99 69.99 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.875 -179.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -80.61 -41.53 23.79 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.83 -172.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.603 ' OG1' HG13 ' A' ' 33' ' ' ILE . 51.1 p -105.11 -8.44 18.44 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.031 -176.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.71 10.0 84.86 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.555 178.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.997 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 pp -103.29 132.51 49.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.943 0.401 . . . . 0.0 111.119 -174.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -70.61 126.94 31.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.911 -168.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.506 HG22 HD21 ' A' ' 7' ' ' LEU . 93.2 t -110.27 120.52 61.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.099 179.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 99.6 m -112.83 113.83 26.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.064 -174.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.482 HG22 ' HG ' ' A' ' 20' ' ' LEU . 96.1 t -93.22 132.62 36.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.149 176.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 94.9 mt-10 -126.06 155.15 42.01 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 177.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.446 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.3 t-80 -77.04 140.03 66.06 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.604 0.716 . . . . 0.0 110.841 -161.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 72.7 Cg_exo -56.76 -22.22 43.77 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.72 2.28 . . . . 0.0 112.332 -177.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -47.1 -50.16 20.55 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.932 -173.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -86.98 -9.85 54.6 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.908 -176.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.453 HD12 ' HB3' ' A' ' 10' ' ' TRP . 7.7 tt -46.93 -54.24 10.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.897 -167.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.05 -35.23 66.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.868 -178.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -74.96 -47.2 30.67 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.906 -168.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -84.75 -33.66 23.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.884 -170.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.589 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 94.4 t80 -48.22 -53.12 36.5 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.587 0.708 . . . . 0.0 110.966 -165.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.589 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 39.1 Cg_endo -62.8 -30.51 77.92 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.65 2.233 . . . . 0.0 112.443 178.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 60.0 mt-30 -76.7 -43.72 36.47 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.885 -179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 20.1 m -74.78 -25.05 18.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.208 -177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.83 -33.67 76.39 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.119 172.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.52 -29.97 69.51 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.1 177.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.3 p -91.4 -13.85 31.67 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.17 174.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 77.14 15.27 81.76 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.499 170.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -138.92 130.04 26.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 0.0 110.884 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 173.09 -118.84 0.73 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.504 174.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.454 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 84.4 Cg_endo -72.8 154.11 53.75 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.756 2.304 . . . . 0.0 112.432 175.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.431 ' CB ' HD13 ' A' ' 59' ' ' ILE . 1.7 m-20 -87.15 -38.42 16.45 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.933 170.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.732 HG23 ' HB1' ' A' ' 276' ' ' ALA . 0.0 OUTLIER -134.05 150.05 30.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.077 179.155 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.2 tp -129.33 124.73 60.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.1 -174.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.448 ' HB2' ' HA ' ' A' ' 11' ' ' ILE . 2.4 m-85 -100.15 134.75 42.62 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.457 ' CH2' ' HB2' ' A' ' 105' ' ' ALA . 32.2 p90 -145.01 -177.82 5.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.842 174.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -104.75 -97.14 0.32 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.144 177.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -110.44 -55.43 2.47 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.905 -177.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -58.83 -35.75 73.42 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.863 -162.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.523 ' HD3' ' CZ ' ' A' ' 70' ' ' TYR . 4.4 mmp_? -74.56 -21.24 59.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.896 -172.613 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 31.7 t80 -45.95 -54.59 8.03 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.937 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -63.95 -53.58 36.42 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.45 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -58.69 -52.44 53.07 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.494 -174.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.523 ' CZ ' ' HD3' ' A' ' 66' ' ' ARG . 15.8 m-30 -75.78 -41.98 51.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.919 0.39 . . . . 0.0 110.893 -168.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -67.34 -47.18 71.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.096 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -65.07 -34.93 79.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.894 -179.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 72.8 m -81.7 -7.97 59.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.847 -176.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.45 32.08 62.55 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.472 176.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.6 mp -84.75 -4.5 59.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.888 0.375 . . . . 0.0 110.978 -177.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.737 ' O ' HD12 ' A' ' 76' ' ' LEU . 3.2 pp -128.28 145.02 51.18 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.887 -178.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.18 141.43 47.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.175 177.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.4 mp0 -69.27 132.33 46.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.925 -177.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.89 HG13 ' HB3' ' A' ' 103' ' ' LEU . 37.7 pt -118.82 167.11 12.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.154 175.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.5 p -113.76 149.55 41.95 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.599 0.714 . . . . 0.0 111.118 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.08 146.82 41.93 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.691 2.261 . . . . 0.0 112.39 -179.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -108.11 119.25 38.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.999 0.428 . . . . 0.0 110.789 178.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.14 -42.23 99.04 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.852 -176.558 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.12 -46.52 80.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.142 -177.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.524 ' HB3' ' HZ2' ' A' ' 94' ' ' TRP . 9.1 m-85 -72.07 -33.86 68.25 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 -177.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.449 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.6 tt0 -53.95 -48.07 70.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.933 174.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -63.6 -35.02 79.12 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.922 175.125 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -75.95 -23.26 55.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.978 -175.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.566 HD23 ' HG2' ' A' ' 107' ' ' PRO . 1.4 mp -108.75 -92.3 0.43 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.906 -173.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 33.6 t80 -169.68 127.84 0.84 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.597 0.713 . . . . 0.0 110.996 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 87.3 Cg_exo -57.07 -42.66 61.47 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.646 2.23 . . . . 0.0 112.341 -170.645 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.589 ' HD1' ' O ' ' A' ' 92' ' ' PHE . 1.0 OUTLIER -70.18 -33.27 71.53 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -174.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.634 ' CG2' ' HB3' ' A' ' 107' ' ' PRO . 88.3 m -67.56 -36.26 80.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.138 -173.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.598 ' HA ' HG22 ' A' ' 97' ' ' VAL . 68.5 m95 -67.83 -26.45 66.06 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.933 175.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -73.76 -32.17 63.68 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.82 171.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.11 -25.8 62.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.085 178.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.598 HG22 ' HA ' ' A' ' 94' ' ' TRP . 19.8 m -101.39 17.81 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.099 177.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.407 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 75.7 ttt180 -112.91 132.1 55.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.933 179.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 88.1 t80 -138.41 127.75 24.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.936 -177.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 54.4 t30 62.05 34.87 16.24 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.919 175.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 82.31 -4.17 78.34 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.578 173.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -126.42 150.05 48.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.84 0.353 . . . . 0.0 110.959 173.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.89 ' HB3' HG13 ' A' ' 79' ' ' ILE . 2.9 tp -74.42 140.4 44.66 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.918 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.548 HG22 HD11 ' A' ' 76' ' ' LEU . 2.0 pp -118.56 -7.35 11.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.091 -174.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.457 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . . . -164.78 168.83 17.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.117 179.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.433 ' HB3' HD11 ' A' ' 285' ' ' LEU . 94.5 m-85 -112.22 146.41 34.83 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.714 0.769 . . . . 0.0 110.903 168.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.634 ' HB3' ' CG2' ' A' ' 93' ' ' THR . 73.9 Cg_endo -74.11 118.23 5.31 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.629 2.219 . . . . 0.0 112.381 172.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.409 HD11 HD21 ' A' ' 280' ' ' LEU . 29.7 mm -92.09 -54.97 6.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.147 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -150.89 158.63 44.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.059 -167.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 79.7 t -116.65 137.47 50.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.076 -172.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -122.01 139.07 54.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.905 172.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.551 ' HB1' HD22 ' A' ' 323' ' ' ASN . . . -152.1 160.16 43.49 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.063 178.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 10.6 mp -94.56 168.68 10.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.852 -175.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 100.0 p -154.87 152.92 30.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.819 -175.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.961 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -100.03 128.38 46.12 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.918 169.316 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.511 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.3 mp -111.07 137.01 45.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.149 -176.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 45.3 p90 -133.75 149.58 51.46 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.899 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 57.4 t-20 -86.45 110.98 20.11 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.933 175.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.471 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 88.9 tttt -62.1 -23.12 66.34 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.854 -175.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -76.01 -24.19 55.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.893 -179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.528 HD21 ' O ' ' A' ' 220' ' ' GLY . 7.0 mp -94.76 -53.37 3.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.862 177.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.477 HD22 ' HB1' ' A' ' 223' ' ' ALA . 1.7 mp -105.07 132.31 20.99 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.678 0.751 . . . . 0.0 110.863 178.615 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -73.44 -16.99 24.21 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.686 2.257 . . . . 0.0 112.331 -175.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.571 ' HB2' ' HD2' ' A' ' 125' ' ' PRO . 20.8 p30 -154.33 161.62 28.88 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.614 0.721 . . . . 0.0 110.915 -178.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.571 ' HD2' ' HB2' ' A' ' 124' ' ' ASN . 57.8 Cg_endo -69.59 155.12 67.38 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.646 2.231 . . . . 0.0 112.392 178.346 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -68.14 146.38 70.02 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.669 2.246 . . . . 0.0 112.299 176.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -100.12 -48.6 4.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.815 178.189 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 72.7 p -133.17 158.56 42.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.104 -177.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 48.9 t-105 -64.2 -30.23 71.29 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 175.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -61.06 -23.67 65.62 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.91 -174.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -72.75 -32.17 65.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.904 -176.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.494 ' HB ' ' HD3' ' A' ' 133' ' ' PRO . 1.6 mp -66.03 -47.17 63.55 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.644 0.735 . . . . 0.0 111.085 -163.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.494 ' HD3' ' HB ' ' A' ' 132' ' ' ILE . 97.9 Cg_exo -53.31 -50.89 12.37 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.653 2.235 . . . . 0.0 112.267 -175.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.94 -39.21 69.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.134 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . . . . . . . . . 30.3 tp -56.02 -45.32 79.14 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.893 176.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.5 t70 -53.74 -34.97 60.64 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.837 -177.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -68.47 -36.76 79.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.962 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -73.44 -53.21 11.23 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.849 -172.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.566 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.8 OUTLIER -80.01 -10.64 59.79 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.915 -175.804 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.566 ' N ' HD23 ' A' ' 139' ' ' LEU . 86.5 tttt -55.99 -31.61 63.19 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.943 166.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.87 -25.1 68.13 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.144 177.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -95.14 5.59 51.4 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.823 176.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.47 28.85 60.81 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.528 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -120.09 170.09 9.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.758 0.313 . . . . 0.0 110.904 178.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.3 t -131.25 141.25 49.97 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.825 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.441 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -70.42 -55.13 9.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.048 -166.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -141.97 131.05 23.24 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.881 -170.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.726 ' SD ' ' HB2' ' A' ' 213' ' ' ALA . 52.7 ttm -110.54 123.76 50.54 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.902 -179.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 28.4 p90 -150.46 157.15 42.7 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.829 -167.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -101.81 96.24 6.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.965 173.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.844 HD21 HD11 ' A' ' 195' ' ' LEU . 1.8 tm? -76.12 -18.29 59.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.973 172.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 68.2 mt-30 -80.36 -2.49 45.67 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.905 178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.425 ' O ' HG23 ' A' ' 157' ' ' THR . 38.4 mt-10 -113.53 152.21 45.17 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.574 0.702 . . . . 0.0 110.909 176.396 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.532 ' HD3' ' CD ' ' A' ' 344' ' ' ARG . 30.5 Cg_endo -66.91 -19.82 51.97 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.68 2.254 . . . . 0.0 112.367 -176.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -65.02 -40.66 95.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.886 -172.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . 0.411 ' HD2' HD23 ' A' ' 151' ' ' LEU . 74.7 t80 -82.97 -36.04 25.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.807 -177.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.425 HG23 ' O ' ' A' ' 153' ' ' GLU . 81.9 p -60.51 -46.7 89.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.189 -170.579 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.645 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 89.0 t90 -67.84 -48.17 41.53 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-O 121.502 0.667 . . . . 0.0 110.897 -167.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.645 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 78.5 Cg_exo -47.57 -46.37 20.86 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.666 2.244 . . . . 0.0 112.512 178.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.674 ' O ' HD23 ' A' ' 160' ' ' LEU . 6.5 tt -70.07 -39.87 75.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.965 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 71.0 mt -70.39 -41.02 78.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.014 -179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.63 -28.6 61.88 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.116 179.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.504 ' HB3' ' HD2' ' A' ' 250' ' ' PHE . . . -63.12 -34.96 78.73 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 -170.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -91.48 1.99 56.74 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.884 178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.01 1.31 14.48 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.599 -0.81 . . . . 0.0 112.467 170.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -81.33 65.02 4.08 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.55 -179.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -84.86 133.55 34.31 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.912 0.387 . . . . 0.0 110.893 -176.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.25 5.43 10.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.076 -170.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.421 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.0 p90 -146.85 152.9 39.48 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.944 0.402 . . . . 0.0 110.956 -177.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -103.78 126.15 50.71 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.98 156.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -115.69 126.28 53.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.857 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -151.58 130.07 12.17 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.913 -179.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.1 t30 55.02 43.87 29.08 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.922 171.388 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.98 14.85 81.41 Favored Glycine 0 N--CA 1.453 -0.193 0 C-N-CA 120.686 -0.768 . . . . 0.0 112.48 173.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.23 138.71 50.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.841 0.353 . . . . 0.0 110.845 -178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -99.37 144.61 28.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.926 170.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -121.48 110.59 16.23 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.876 172.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.572 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.2 pp -80.0 -12.64 13.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.082 -177.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -98.96 -13.13 20.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.877 -177.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -122.94 85.23 2.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.874 170.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.421 HG12 ' HA ' ' A' ' 169' ' ' PHE . 34.1 m -116.9 170.48 6.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.115 -169.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.63 24.42 29.84 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.45 -167.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.516 HG21 HD12 ' A' ' 368' ' ' ILE . 11.3 m -110.01 -15.45 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.787 0.327 . . . . 0.0 111.112 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.3 p-10 -85.92 19.61 2.51 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.786 -178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.8 p30 -110.32 -179.91 3.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 -177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.1 -24.6 64.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.097 178.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 190' ' ' ALA . . . -70.87 -40.63 63.6 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.456 -171.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.631 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.38 -35.35 80.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.812 0.339 . . . . 0.0 111.115 178.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.534 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 94.1 mttt -59.05 -31.22 68.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.842 175.545 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.406 ' HB3' ' O ' ' A' ' 187' ' ' GLY . . . -65.51 -30.69 71.49 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.115 175.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -64.16 -47.46 84.9 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.957 -0.64 . . . . 0.0 112.379 -177.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.495 HD11 ' HB1' ' A' ' 346' ' ' ALA . 19.7 mt -64.89 -38.91 92.53 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.883 0.373 . . . . 0.0 110.936 177.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 92.3 m -58.71 -45.12 90.28 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.21 -178.165 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 32.3 t80 -77.28 -43.06 34.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.843 178.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.844 HD11 HD21 ' A' ' 151' ' ' LEU . 6.0 tt -55.57 -48.6 74.51 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.913 -171.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 24.8 m -68.58 -19.22 24.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.197 -175.905 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 38.7 t70 -57.5 -54.87 41.92 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.91 -169.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 1.045 HD13 ' H ' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -76.1 -26.48 56.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.925 -168.021 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.613 ' H ' HD22 ' A' ' 198' ' ' LEU . 1.8 pp -86.65 -34.42 7.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.172 177.018 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -58.86 -31.81 68.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.856 165.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -85.86 6.06 29.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.861 177.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 65.0 39.94 5.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.903 170.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -84.54 -9.76 58.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.876 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 58.7 ttp -134.54 151.38 51.07 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.868 176.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -97.69 155.56 16.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.921 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -64.95 -27.76 69.06 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.065 -177.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -95.25 4.25 53.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.903 -177.534 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.402 ' CG2' ' HG3' ' A' ' 148' ' ' MET . 90.0 m -63.08 132.14 50.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.15 -176.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.432 ' H ' HD12 ' A' ' 212' ' ' ILE . 23.6 t0 -149.75 167.39 26.63 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.858 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -68.58 -34.01 75.05 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.88 -173.246 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.0 p -63.57 -32.58 74.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.909 -177.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.432 HD12 ' H ' ' A' ' 209' ' ' ASP . 79.7 mt -62.42 -36.56 75.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.08 174.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.726 ' HB2' ' SD ' ' A' ' 148' ' ' MET . . . -66.07 -42.22 89.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.081 -173.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 95.7 mt-10 -64.82 -39.24 93.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.986 179.697 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -67.32 -40.3 85.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.102 173.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.89 -34.59 78.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.449 . . . . 0.0 111.121 -178.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 12.9 m-30 -59.95 -33.66 72.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.825 179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -59.91 -34.98 73.92 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.954 -177.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -96.45 -21.13 17.93 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.98 177.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . 0.528 ' O ' HD21 ' A' ' 121' ' ' LEU . . . 91.05 30.51 11.0 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.648 -0.787 . . . . 0.0 112.439 -179.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -84.73 -27.75 26.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.872 0.368 . . . . 0.0 110.876 -172.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 94.9 m -116.96 131.1 57.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.216 -175.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.477 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -66.26 -54.57 23.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.098 179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.441 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 67.0 mtm -137.82 160.0 40.46 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.797 -168.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 10.4 t -149.76 164.17 36.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.158 176.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.7 mm -111.29 125.58 68.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.07 173.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -144.65 167.82 21.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.893 -169.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -118.52 -155.13 9.85 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.471 -174.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -59.99 -22.53 69.49 Favored 'Trans proline' 0 N--CA 1.465 -0.184 0 C-N-CA 122.725 2.283 . . . . 0.0 112.289 176.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.9 p90 -81.54 4.33 21.73 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.949 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . -51.57 -29.24 16.49 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.0 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 63.3 p-90 -53.54 -20.59 5.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.931 -176.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 26.3 t -42.03 -57.81 2.32 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.808 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 64.9 t30 -150.65 40.36 0.75 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.91 177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.465 HD12 HG21 ' A' ' 116' ' ' ILE . 46.5 mm -125.01 108.8 20.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.124 174.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.8 t0 -168.95 162.71 11.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.901 170.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 82.8 m -125.05 102.25 7.42 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.204 -178.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 43.4 t -134.67 104.26 5.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.838 172.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 95.5 mttt 59.04 34.12 23.32 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.868 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.6 m -138.94 165.68 23.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.135 178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 98.0 m-20 -99.14 70.09 1.76 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.832 -174.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.471 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 82.4 m-85 -130.03 145.58 51.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.004 172.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -128.26 153.13 19.36 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.509 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.628 HG22 ' HB2' ' A' ' 319' ' ' ALA . 6.7 p -138.53 135.96 43.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-O 120.899 0.381 . . . . 0.0 111.193 -177.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.2 t -153.44 149.89 28.23 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.127 177.455 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.408 ' CG1' ' HB2' ' A' ' 323' ' ' ASN . 25.1 m -60.76 167.33 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.124 179.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.666 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.3 mm? -64.77 146.19 98.62 Favored Pre-proline 0 C--N 1.327 -0.396 0 CA-C-O 121.586 0.708 . . . . 0.0 110.899 -160.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -72.85 -177.01 2.61 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.727 2.284 . . . . 0.0 112.285 178.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 73.2 p -106.76 162.63 13.62 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.143 -176.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.504 ' HD2' ' HB3' ' A' ' 163' ' ' ALA . 44.7 t80 -146.03 123.43 11.66 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.89 176.2 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt 55.33 35.25 24.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.84 -177.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.53 12.12 70.22 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.531 169.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 63.1 mm-40 -137.05 140.37 31.19 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.56 0.695 . . . . 0.0 110.947 178.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -73.36 140.82 30.94 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.677 2.251 . . . . 0.0 112.407 -174.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.666 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 89.8 p -83.33 -5.1 59.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.798 169.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 50.9 mtmt -48.33 110.07 1.33 Allowed Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.546 0.689 . . . . 0.0 110.901 -176.743 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -66.0 163.53 30.83 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.623 2.216 . . . . 0.0 112.32 -177.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 82.5 m-85 -73.66 174.82 7.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.828 -179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 61.5 t -108.39 132.32 56.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.048 -170.704 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -112.12 126.85 7.8 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.436 -179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 96.9 t -116.0 134.41 59.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.854 0.359 . . . . 0.0 111.098 -175.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.406 HD23 ' N ' ' A' ' 263' ' ' SER . 2.6 tt -67.32 129.75 40.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.945 171.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.406 ' N ' HD23 ' A' ' 262' ' ' LEU . 64.3 p -124.63 131.82 53.45 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.899 -177.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -125.25 125.87 44.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.137 -173.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -119.75 170.34 14.08 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.424 -171.142 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.414 HD13 HG22 ' A' ' 59' ' ' ILE . 13.1 mm -99.96 127.93 52.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.768 0.318 . . . . 0.0 111.107 -179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.3 t-20 -64.91 127.25 30.8 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.9 -178.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . . . . . . . . . . . -64.9 -24.29 67.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.122 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.65 -11.57 55.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.037 -172.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.6 t -77.67 122.38 85.67 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.632 0.73 . . . . 0.0 110.87 -176.108 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -70.34 -11.57 30.31 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.591 2.194 . . . . 0.0 112.349 171.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.2 t30 -111.73 35.19 3.77 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.917 -169.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -59.31 -26.68 65.2 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.834 -170.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 75.2 mm-40 -69.03 -39.86 78.97 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.864 -172.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 42.7 tp -65.38 -48.45 72.87 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.887 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.732 ' HB1' HG23 ' A' ' 59' ' ' ILE . . . -67.38 -48.17 68.22 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.153 -172.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 41.1 pttt -65.25 -37.46 87.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.907 -176.448 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.5 tt0 -68.21 -53.7 22.97 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.935 -172.022 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.407 ' O ' ' HB3' ' A' ' 283' ' ' TYR . 1.1 p90 -67.54 -35.13 78.47 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.837 -174.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.468 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 4.8 tt -58.58 -50.04 75.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.904 -177.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -79.95 -33.51 39.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.891 -177.192 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.419 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 65.6 m-80 -100.01 -17.71 17.38 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.919 -164.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.407 ' HB3' ' O ' ' A' ' 279' ' ' PHE . 40.0 t80 -121.33 -48.64 2.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.954 -172.059 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.468 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 0.3 OUTLIER -65.04 -46.39 81.47 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.82 176.228 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.433 HD11 ' HB3' ' A' ' 106' ' ' TYR . 64.8 mt -84.97 59.39 5.58 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.954 -179.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.486 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 52.5 p -138.47 150.2 46.21 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.187 172.228 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.57 ' HA ' HD11 ' A' ' 290' ' ' LEU . 42.9 p-10 -51.56 -26.0 7.83 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.84 -174.057 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -78.65 -44.8 22.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.791 179.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -72.4 -51.07 13.68 Favored Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.466 -169.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.57 HD11 ' HA ' ' A' ' 287' ' ' ASP . 0.5 OUTLIER -73.31 -20.78 60.72 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.846 0.355 . . . . 0.0 110.91 -179.251 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.426 ' N ' HD12 ' A' ' 290' ' ' LEU . 81.8 tt0 -66.06 -40.75 91.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.933 168.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.74 -33.79 76.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.075 -178.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.592 HG13 ' HA3' ' A' ' 19' ' ' GLY . 24.9 t -77.4 -44.62 30.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.143 179.486 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.42 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 49.8 t30 -65.03 -25.86 68.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.968 177.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -64.4 -28.96 70.04 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.923 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 91.7 m-20 -87.01 -41.65 13.72 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.822 -176.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 36.4 ttpt -147.69 132.8 9.08 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 121.515 0.674 . . . . 0.0 111.027 174.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -51.99 111.92 0.72 Allowed 'Trans proline' 0 C--O 1.234 0.277 0 C-N-CA 122.628 2.219 . . . . 0.0 112.408 175.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.42 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 55.3 mt -90.98 -17.17 26.77 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.877 -172.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.528 ' O ' HG23 ' A' ' 317' ' ' ILE . . . 102.96 -43.04 1.75 Allowed Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.394 175.793 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -176.27 168.72 2.8 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.823 0.344 . . . . 0.0 110.974 168.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.51 HG22 HD21 ' A' ' 311' ' ' LEU . 23.9 m -122.6 154.29 27.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.199 170.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -69.44 -18.39 63.73 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.09 175.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.477 ' CD2' HD21 ' A' ' 290' ' ' LEU . 63.3 tp -83.63 122.62 28.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.014 -173.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 55.9 mttp -59.55 -36.33 75.96 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.787 -173.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.8 m -63.11 -49.87 72.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.908 -168.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.591 ' CD2' HD23 ' A' ' 311' ' ' LEU . 33.1 t80 -83.79 -26.97 29.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.88 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -56.43 -44.38 80.37 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.918 178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -65.01 -36.23 83.73 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.875 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.7 mm-40 -76.01 -48.89 19.27 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.921 -176.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.815 ' CD1' HG21 ' A' ' 317' ' ' ILE . 4.6 pp -66.72 -25.43 66.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.873 178.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -64.2 -17.37 63.48 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.061 178.641 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -67.3 -17.86 64.95 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.872 178.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 71.2 m-20 -80.02 123.28 83.61 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.557 0.694 . . . . 0.0 110.904 173.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.554 ' O ' HG11 ' A' ' 244' ' ' VAL . 83.7 Cg_exo -52.85 -35.59 70.68 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.582 2.188 . . . . 0.0 112.319 -178.546 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 35.6 ptt-85 -64.79 -26.83 68.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.92 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.815 HG21 ' CD1' ' A' ' 311' ' ' LEU . 56.3 mt -96.75 -34.54 5.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.115 -177.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -47.21 -39.41 13.97 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.012 -167.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.628 ' HB2' HG22 ' A' ' 244' ' ' VAL . . . -65.15 -44.32 88.98 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.05 176.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 317' ' ' ILE . 69.2 p -68.27 -29.9 68.8 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.128 -178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 18.0 tmm? -69.99 -40.13 75.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.88 176.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 85.4 tt0 -65.69 -45.6 82.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.863 -178.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.551 HD22 ' HB1' ' A' ' 112' ' ' ALA . 25.4 t30 -63.42 -36.3 83.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.967 175.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.79 -48.28 79.83 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.032 -178.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 84.5 mt-30 -75.4 -32.69 60.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -94.75 -5.6 44.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.931 -176.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -95.28 -157.73 32.43 Favored Glycine 0 C--N 1.33 0.219 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.496 -178.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -140.02 142.73 36.22 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.851 0.358 . . . . 0.0 110.925 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.581 ' O ' ' C ' ' A' ' 330' ' ' MET . 31.4 mm -79.91 108.47 13.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.215 -170.331 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.643 ' HG3' ' O ' ' A' ' 330' ' ' MET . 20.4 ptp 23.13 60.47 0.34 Allowed Pre-proline 0 C--N 1.327 -0.384 0 CA-C-O 121.503 0.668 . . . . 0.0 110.848 174.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -90.05 -19.45 1.24 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.76 2.307 . . . . 0.0 112.264 -169.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.474 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 52.0 p-10 -97.17 6.88 47.71 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.93 -148.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.605 HG22 ' H ' ' A' ' 335' ' ' GLN . 39.0 mm 77.97 135.69 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.681 0.753 . . . . 0.0 111.111 174.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_exo -53.89 -24.68 32.43 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.694 2.263 . . . . 0.0 112.303 -178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.605 ' H ' HG22 ' A' ' 333' ' ' ILE . 99.6 mm-40 -63.43 -21.26 66.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.946 -177.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 79.7 mmm -71.33 -25.02 62.23 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.91 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.0 m -61.76 -40.06 93.83 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.885 176.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.88 -34.3 60.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.995 178.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 11.6 m-30 -63.39 -37.97 89.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.891 176.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.404 ' HB3' ' HB2' ' A' ' 154' ' ' PRO . 21.0 m0 -61.07 -34.5 75.01 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.87 175.147 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -76.79 -35.27 57.76 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.893 178.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 367' ' ' ARG . . . -63.2 -39.98 96.18 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.057 176.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . . . . . . . . . 14.8 m -81.82 -24.2 9.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.091 177.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.532 ' CD ' ' HD3' ' A' ' 154' ' ' PRO . 52.9 ttt180 -55.63 -55.45 31.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.824 173.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 96.6 m -56.87 -33.0 66.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.131 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.637 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -56.94 -44.51 82.59 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.136 -177.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.432 ' HA ' HD22 ' A' ' 192' ' ' LEU . 1.3 m -74.96 -33.1 28.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.179 -174.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.3 -47.21 93.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.22 173.163 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . 0.561 ' HB3' ' HB2' ' A' ' 355' ' ' GLN . 84.5 m-20 -66.73 -37.01 83.79 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.865 -178.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.52 -47.26 61.29 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.091 178.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -65.45 -39.87 92.54 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.094 -177.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.5 p -74.86 -14.17 60.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.007 0.432 . . . . 0.0 110.85 -175.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 76.67 10.61 85.83 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.735 -0.745 . . . . 0.0 112.505 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 40.4 mmt180 -79.77 -25.09 41.09 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.765 0.317 . . . . 0.0 110.844 178.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.561 ' HB2' ' HB3' ' A' ' 349' ' ' ASN . 87.5 mt-30 -133.15 158.26 43.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.906 169.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.5 p -79.37 171.01 15.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.154 168.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.431 ' O ' ' HB2' ' A' ' 361' ' ' LEU . 67.1 t -55.88 -44.5 78.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.07 169.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -58.21 -44.93 88.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.916 179.225 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 57.5 mt-10 -70.84 -52.02 22.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.883 -179.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -69.19 -44.66 71.73 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.132 -173.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.631 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -65.49 -39.99 92.54 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.95 -177.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . 0.563 ' O ' ' HG3' ' A' ' 365' ' ' GLN . 88.0 tttt -64.91 -38.4 90.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.894 176.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -65.83 -36.89 84.75 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.898 177.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.637 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -63.92 -44.77 91.91 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.077 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.563 ' HG3' ' O ' ' A' ' 362' ' ' LYS . 0.7 OUTLIER -73.26 -30.38 63.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.942 -179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 68.5 m -64.34 -41.17 96.9 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.2 177.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.422 ' HB2' ' HB1' ' A' ' 342' ' ' ALA . 99.6 mtt180 -67.74 -39.62 84.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.748 176.451 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.516 HD12 HG21 ' A' ' 183' ' ' VAL . 67.9 mt -65.6 -39.27 84.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.164 178.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 73.8 p -92.59 -9.04 42.55 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.064 -176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.4 tttt . . . . . 0 C--N 1.327 -0.371 0 CA-C-O 119.308 -0.377 . . . . 0.0 110.99 173.966 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.6 tttt . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.733 0.301 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.458 HG21 ' HD2' ' A' ' 271' ' ' PRO . 87.1 mt -79.75 126.35 39.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.064 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.3 pt-20 -148.49 147.38 29.03 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.801 179.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.3 129.77 29.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.817 178.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.458 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 96.33 5.85 59.03 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.448 -174.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.436 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.0 tttt -164.71 139.86 5.53 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.779 0.324 . . . . 0.0 110.945 177.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.669 HD22 HD13 ' A' ' 33' ' ' ILE . 0.8 OUTLIER -146.39 157.45 43.77 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.933 -179.614 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.471 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 75.3 t -108.94 133.43 54.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.114 179.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.762 HG13 HD11 ' A' ' 20' ' ' LEU . 0.1 OUTLIER -123.11 135.36 63.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 -178.493 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . . . . . . . . . 42.3 m95 -109.07 160.87 15.7 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.932 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.553 HG21 ' HB2' ' A' ' 15' ' ' LYS . 87.9 mt -132.93 149.26 31.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.154 166.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.501 ' O ' HG22 ' A' ' 11' ' ' ILE . 62.0 t30 -58.26 159.81 5.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.943 174.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.51 -15.36 8.29 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.555 -174.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.91 -24.05 65.16 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.94 0.4 . . . . 0.0 110.872 -172.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.553 ' HB2' HG21 ' A' ' 11' ' ' ILE . 35.4 mtmt -134.25 132.04 39.19 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.944 169.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.07 -94.07 0.76 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.459 -168.451 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -115.24 -46.67 2.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.916 0.389 . . . . 0.0 110.943 -172.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -64.03 -47.85 78.6 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.963 -155.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.916 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -57.91 -45.66 93.39 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.431 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.762 HD11 HG13 ' A' ' 9' ' ' ILE . 0.1 OUTLIER -51.51 -50.73 59.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.872 0.368 . . . . 0.0 110.865 177.024 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.18 -39.37 63.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.167 -178.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.4 tp10 -70.1 -52.33 24.57 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.861 -176.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.0 m -69.2 -36.33 72.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.102 -178.399 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.56 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -66.72 -41.14 93.93 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.513 173.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -54.07 -46.06 71.88 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.801 0.334 . . . . 0.0 110.889 177.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -64.9 -44.06 90.86 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.945 -179.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.663 ' CE2' HD11 ' A' ' 33' ' ' ILE . 44.0 t80 -65.71 -38.09 88.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.812 179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 33' ' ' ILE . 34.7 tt0 -64.5 -42.94 95.52 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.841 178.691 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -71.6 -32.46 68.05 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.861 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -81.14 -39.35 25.69 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.872 -171.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.715 ' OG1' HG13 ' A' ' 33' ' ' ILE . 67.8 p -103.78 -10.21 18.46 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.139 -178.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.42 7.39 85.17 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.453 178.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.076 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.8 pp -104.08 132.51 50.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.882 0.372 . . . . 0.0 111.064 -175.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.436 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.8 mttt -70.41 136.74 49.85 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.912 -171.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.56 HG21 ' HA3' ' A' ' 24' ' ' GLY . 3.0 m -111.99 133.07 58.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.104 174.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 94.6 m -110.1 125.66 53.22 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.102 179.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.584 HG22 ' HG ' ' A' ' 20' ' ' LEU . 60.9 t -89.66 126.29 42.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.095 178.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 39.8 mm-40 -112.91 148.88 34.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.912 175.018 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.413 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 64.8 t-80 -86.27 136.19 35.95 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-O 121.658 0.742 . . . . 0.0 110.883 -169.387 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 83.2 Cg_exo -56.04 -21.36 34.17 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.721 2.28 . . . . 0.0 112.322 -175.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 39.0 t70 -48.07 -53.99 14.64 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.885 -176.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.416 ' O ' ' C ' ' A' ' 43' ' ' LEU . 99.1 mttt -88.78 0.92 56.05 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.88 -172.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.416 ' C ' ' O ' ' A' ' 42' ' ' LYS . 16.4 tp -39.88 -54.73 2.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.975 -173.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -72.48 -35.27 68.16 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.844 179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -81.19 -47.93 12.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.892 -166.475 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 79.1 tttt -78.6 -43.81 25.52 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.913 -171.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.557 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 83.6 t80 -50.87 -53.88 42.76 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.574 0.702 . . . . 0.0 110.851 -167.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.557 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 38.9 Cg_endo -65.98 -30.11 48.44 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.629 2.22 . . . . 0.0 112.351 -177.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -74.8 -41.99 58.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.901 179.688 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.428 HG21 ' HD3' ' A' ' 57' ' ' PRO . 24.9 m -75.48 -21.5 16.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.201 178.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -65.87 -31.69 72.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.092 -0.503 . . . . 0.0 111.057 172.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -64.15 -29.76 70.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.11 175.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 70.9 p -92.62 -15.19 27.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.199 170.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.98 18.38 79.64 Favored Glycine 0 N--CA 1.452 -0.233 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.432 171.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 35.8 t0 -140.2 143.85 36.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.805 0.336 . . . . 0.0 110.863 -175.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 136.48 -78.31 0.33 Allowed Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.477 168.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.471 ' HA ' ' HB ' ' A' ' 8' ' ' VAL . 89.0 Cg_endo -78.52 140.99 17.35 Favored 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.727 2.284 . . . . 0.0 112.329 177.47 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.413 ' HB2' HD13 ' A' ' 59' ' ' ILE . 1.5 m-20 -101.41 -41.13 6.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.97 173.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.64 ' CG1' HG22 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -132.92 143.68 38.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.195 176.91 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 6.0 tp -136.08 128.06 44.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.174 -169.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.486 ' N ' ' HD1' ' A' ' 61' ' ' PHE . 2.0 m-30 -97.89 142.28 29.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.926 -175.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 66' ' ' ARG . 80.3 m95 -140.72 159.74 41.55 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.921 174.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.17 -88.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.059 179.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 86.1 t60 -125.48 -62.54 1.19 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.874 -179.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 49.0 m-20 -75.39 -35.42 61.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.894 -161.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.467 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 9.4 mpt_? -54.66 -33.75 61.22 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.895 -168.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.563 ' HB3' HD13 ' A' ' 104' ' ' ILE . 51.0 m-85 -56.79 -38.71 72.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 -172.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.06 -50.49 57.31 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.485 -174.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.13 -42.35 99.76 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.515 177.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . . . . . . . . . 43.5 m-85 -74.66 -33.21 62.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.945 0.403 . . . . 0.0 110.985 -176.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.402 ' HA ' HD12 ' A' ' 76' ' ' LEU . . . -65.11 -38.71 91.57 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.074 170.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 tt0 -63.97 -34.63 78.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.894 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 98.9 p -86.7 -10.14 54.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.886 -178.902 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.54 28.97 62.41 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.554 176.183 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 mp -90.39 -17.2 27.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.876 0.37 . . . . 0.0 110.923 -173.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 1.328 HD13 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -121.09 121.17 37.3 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.941 -179.105 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.807 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -64.73 137.83 58.03 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.084 -173.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.4 mt-10 -66.21 137.05 56.72 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.446 HD12 ' CE2' ' A' ' 106' ' ' TYR . 37.2 pt -109.98 160.42 9.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.182 -177.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 77.8 p -96.97 149.87 36.19 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.547 0.689 . . . . 0.0 111.214 176.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -72.13 137.93 29.8 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.74 2.294 . . . . 0.0 112.397 -177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -104.06 108.8 20.32 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.888 172.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -59.77 -41.78 91.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.969 -177.37 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.38 -41.88 98.81 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.218 -176.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.565 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 13.0 m-30 -74.35 -47.6 33.32 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.891 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 65.0 tt0 -49.44 -42.53 43.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.882 -179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -57.35 -30.58 64.95 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.889 176.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.419 ' O ' ' HB2' ' A' ' 305' ' ' LYS . 84.9 mttt -87.45 -13.81 42.21 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.931 -176.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.565 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 46.8 mt -104.93 -145.0 0.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.973 -170.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 98.0 m-85 -133.97 140.69 37.11 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.743 0.782 . . . . 0.0 110.888 -178.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -67.48 -28.78 38.31 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.628 2.218 . . . . 0.0 112.405 175.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -65.58 -42.81 91.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.85 175.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.506 HG22 HG21 ' A' ' 261' ' ' VAL . 81.2 p -78.25 -38.37 42.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.161 179.668 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . . . . . . . . . 19.7 t-105 -49.37 -46.97 47.85 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.931 169.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -63.42 -35.6 80.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.887 176.357 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.76 -24.94 65.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.024 -179.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.479 HG23 HD11 ' A' ' 103' ' ' LEU . 31.7 m -112.46 20.77 6.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.206 -171.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.464 ' HB3' HD12 ' A' ' 103' ' ' LEU . 54.7 ptt85 -120.01 146.7 45.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.919 174.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 87.4 t80 -136.93 125.58 23.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.014 177.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.3 t30 60.01 37.05 21.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.825 177.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.73 1.07 90.08 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.517 175.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -117.46 150.15 39.39 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.758 0.314 . . . . 0.0 110.905 175.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.479 HD11 HG23 ' A' ' 97' ' ' VAL . 6.3 tp -81.68 136.79 35.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.954 178.262 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.563 HD13 ' HB3' ' A' ' 67' ' ' PHE . 2.1 pp -128.04 2.72 3.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.153 -173.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.486 ' HB2' ' CE1' ' A' ' 67' ' ' PHE . . . -168.32 169.22 10.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.064 179.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.45 ' O ' ' HA ' ' A' ' 263' ' ' SER . 99.4 m-85 -120.1 139.67 28.74 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.682 0.753 . . . . 0.0 110.887 166.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -78.52 122.99 5.75 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.586 2.19 . . . . 0.0 112.362 172.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . . . . . . . . . 2.2 mp -109.66 -42.92 5.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.039 -174.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -137.36 144.46 42.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.09 -165.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 83.9 t -127.27 131.49 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.17 -175.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -117.6 125.37 50.66 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.832 176.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.511 ' HB3' ' CG2' ' A' ' 320' ' ' THR . . . -163.57 163.74 24.45 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.145 177.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.421 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 6.6 mp -101.03 170.93 7.94 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.917 -167.03 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 86.7 p -158.84 154.4 26.03 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.882 171.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.872 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -100.06 129.62 46.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.898 174.722 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.623 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.2 mp -114.34 135.99 52.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.173 -177.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -135.8 154.93 51.05 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.002 -172.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -96.78 119.31 35.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.471 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 98.4 mttt -65.6 -18.98 65.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.874 179.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -83.38 -28.16 29.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.811 -175.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.453 HD22 ' HA ' ' A' ' 223' ' ' ALA . 10.4 mp -88.09 -44.6 10.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.927 178.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.744 HD22 ' HB1' ' A' ' 223' ' ' ALA . 2.2 pt? -139.94 127.29 12.67 Favored Pre-proline 0 C--N 1.327 -0.399 0 CA-C-O 121.607 0.718 . . . . 0.0 110.907 168.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -77.73 -10.37 17.03 Favored 'Trans proline' 0 C--N 1.343 0.24 0 C-N-CA 122.592 2.195 . . . . 0.0 112.412 -175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.0 t-20 -143.48 108.32 5.2 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.643 0.735 . . . . 0.0 110.881 -175.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -68.03 148.61 76.04 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.728 2.286 . . . . 0.0 112.222 -178.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -68.17 142.7 56.57 Favored 'Trans proline' 0 C--O 1.232 0.181 0 C-N-CA 122.721 2.281 . . . . 0.0 112.341 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -83.38 -27.93 29.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.908 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 81.4 p -127.15 154.54 44.64 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.106 -177.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.667 ' HA ' HD13 ' A' ' 132' ' ' ILE . 54.4 m95 -69.89 -23.96 63.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.92 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -60.29 -23.1 63.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.919 178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -78.52 -22.59 47.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.821 -176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.667 HD13 ' HA ' ' A' ' 129' ' ' TRP . 1.4 mp -56.16 -51.13 83.19 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.677 0.751 . . . . 0.0 111.15 -170.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.6 Cg_endo -69.36 -41.25 4.97 Favored 'Trans proline' 0 C--N 1.343 0.242 0 C-N-CA 122.621 2.214 . . . . 0.0 112.299 -172.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -71.0 -40.54 71.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.994 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 0.832 ' CD2' ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -58.35 -42.67 87.42 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.963 174.443 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.512 ' HA ' ' HB2' ' A' ' 146' ' ' ALA . 32.7 t70 -52.65 -37.24 58.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.881 178.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -69.09 -31.01 69.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.942 -177.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -73.9 -56.39 5.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.842 -174.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.52 HD23 ' N ' ' A' ' 140' ' ' LYS . 1.0 OUTLIER -80.89 -10.06 59.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.885 -175.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.52 ' N ' HD23 ' A' ' 139' ' ' LEU . 86.0 tttt -54.36 -30.77 52.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.804 165.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -62.82 -24.92 68.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.086 178.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -95.01 4.05 54.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.892 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 77.36 27.37 59.72 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.478 -178.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.447 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 38.4 mmtm -116.48 155.52 28.45 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.78 0.324 . . . . 0.0 110.891 -179.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.9 t -100.73 147.53 25.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.834 173.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.512 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -67.25 -43.32 82.17 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.171 178.176 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.459 HD11 HG12 ' A' ' 226' ' ' ILE . 48.9 tp -141.4 152.6 44.46 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.843 -177.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 61.5 tpp -128.0 125.17 38.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.793 170.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -161.07 165.05 30.32 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.84 -174.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -110.0 165.63 11.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.882 172.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.486 HD11 HD11 ' A' ' 195' ' ' LEU . 36.6 tp -130.15 -16.81 3.54 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.856 171.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -71.92 0.71 8.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.847 -175.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.414 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 70.3 mm-40 -121.82 144.9 41.99 Favored Pre-proline 0 C--N 1.33 -0.263 0 CA-C-O 121.672 0.749 . . . . 0.0 110.882 -179.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.429 ' HB3' ' HB3' ' A' ' 340' ' ' TRP . 53.9 Cg_exo -55.22 -28.74 63.33 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.789 2.326 . . . . 0.0 112.313 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 79.6 t80 -59.49 -42.29 91.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.877 -173.118 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 80.4 m-85 -86.47 -32.24 20.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.926 -173.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.452 HG22 HG21 ' A' ' 347' ' ' VAL . 65.0 p -64.84 -37.47 87.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.225 -176.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.567 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 42.7 t-105 -61.93 -54.52 49.92 Favored Pre-proline 0 C--N 1.331 -0.204 0 CA-C-O 121.597 0.713 . . . . 0.0 111.016 -173.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 33.2 Cg_endo -67.14 -27.6 41.56 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.699 2.266 . . . . 0.0 112.38 -174.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.668 HD13 ' C ' ' A' ' 160' ' ' LEU . 2.9 tm? -64.77 -41.85 95.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.93 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.572 HG22 ' HA3' ' A' ' 166' ' ' GLY . 2.9 mp -78.08 -41.91 27.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.23 176.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -67.32 -20.21 65.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.072 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.471 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -57.87 -34.17 69.47 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.985 -175.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -101.51 5.37 41.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.864 -178.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 110.33 9.21 24.08 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.379 -179.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.572 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -75.09 65.79 2.25 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.344 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 41.0 m-85 -95.69 134.81 38.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.885 0.374 . . . . 0.0 110.96 173.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.533 ' HB1' HG21 ' A' ' 368' ' ' ILE . . . -47.77 -31.0 4.38 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.104 -175.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.411 ' CD1' HG12 ' A' ' 181' ' ' VAL . 98.5 m-85 -138.48 148.03 43.88 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.911 174.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 35.8 ttpt -69.11 127.66 33.88 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.889 171.524 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 59.1 t80 -102.04 119.95 39.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.933 -177.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -150.83 130.61 13.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.809 -177.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.3 t30 55.38 42.43 30.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.934 173.57 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.38 9.39 81.39 Favored Glycine 0 C--N 1.331 0.255 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.416 173.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -132.03 141.55 49.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.7 0.286 . . . . 0.0 110.892 -178.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -94.11 135.33 35.6 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 172.338 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -95.92 105.41 17.43 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.907 -170.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.454 ' C ' HD12 ' A' ' 178' ' ' ILE . 2.4 pp -71.31 -6.52 7.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.134 -178.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -100.89 -16.7 17.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.001 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -134.95 100.75 4.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.856 175.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.449 ' HB ' ' O ' ' A' ' 168' ' ' ALA . 32.4 m -101.45 162.14 3.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.132 -179.438 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -101.75 -0.1 52.43 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.527 -168.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 18.5 m -100.72 -20.03 5.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.794 0.331 . . . . 0.0 111.128 -171.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -96.28 20.11 10.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.864 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 45.6 p30 -106.62 -175.08 2.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.904 -174.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.15 -31.49 71.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.061 -178.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -71.4 -41.25 58.96 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.461 -170.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . . . . . . . . . . . -61.71 -34.68 76.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.775 0.321 . . . . 0.0 111.036 177.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -61.75 -40.87 96.64 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.969 174.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.52 -34.06 76.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.025 177.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.504 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -58.68 -48.88 82.5 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.458 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.475 HD11 ' HB1' ' A' ' 346' ' ' ALA . 25.8 mt -66.41 -39.11 88.78 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.943 0.402 . . . . 0.0 110.967 177.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . . . . . . . . . 91.9 m -58.55 -45.39 89.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.197 -179.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.433 ' O ' HD22 ' A' ' 198' ' ' LEU . 82.3 t80 -68.91 -48.53 63.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.828 174.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.835 HD23 ' C ' ' A' ' 195' ' ' LEU . 3.2 tt -50.76 -51.79 46.9 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.86 -174.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.504 ' HA ' HG23 ' A' ' 199' ' ' ILE . 34.7 m -63.52 -23.47 33.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.071 -175.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.54 -34.01 73.51 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.961 -177.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.433 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.6 OUTLIER -82.15 -40.02 22.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -174.952 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.543 HG12 ' O ' ' A' ' 199' ' ' ILE . 0.0 OUTLIER -75.23 -29.56 21.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.135 175.829 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . 0.428 ' N ' HD13 ' A' ' 199' ' ' ILE . 87.6 tttt -72.36 -46.54 54.97 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.901 178.053 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -90.16 5.75 45.57 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.904 -176.193 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.8 mttt 67.27 37.72 3.53 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 170.474 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 95.0 m-70 -83.04 -13.78 55.16 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.918 173.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -138.22 155.15 48.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.917 -178.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.7 m-20 -103.78 139.83 38.46 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.824 -178.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -68.96 -22.24 64.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.071 178.047 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -87.72 -5.84 58.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.895 -172.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 86.7 m -60.03 137.98 57.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.081 -177.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.469 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 20.9 t0 -139.25 175.41 9.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.893 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 65.8 m-85 -60.82 -45.8 93.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.917 -175.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 96.3 p -67.57 -35.97 80.04 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.873 -179.175 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.469 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 85.8 mt -64.17 -41.61 92.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.145 175.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -67.76 -38.89 84.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.091 -178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -63.17 -45.86 89.85 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.803 177.082 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.02 -41.14 95.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.159 177.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.49 -41.67 97.62 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.02 -177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 78.4 t80 -66.78 -47.38 72.33 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.873 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -66.0 -30.52 71.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.888 -176.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -86.02 -13.6 46.97 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.924 -177.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 81.03 26.23 53.56 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.682 -0.77 . . . . 0.0 112.47 -179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -86.42 -28.62 23.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.814 0.34 . . . . 0.0 110.911 -178.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 15.3 t -119.79 134.38 55.26 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.109 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.744 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -78.45 -34.14 47.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.107 -174.55 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.46 ' HB3' HD21 ' A' ' 115' ' ' LEU . 77.7 mtm -128.94 150.33 50.42 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.847 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 8.8 t -145.34 150.97 37.55 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.129 175.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.459 HG12 HD11 ' A' ' 147' ' ' LEU . 39.2 mm -107.04 122.22 60.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.11 -178.16 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -140.98 149.39 41.72 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.916 179.659 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -127.24 -150.58 7.49 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.844 -0.693 . . . . 0.0 112.482 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -63.05 -20.36 71.22 Favored 'Trans proline' 0 C--O 1.233 0.236 0 C-N-CA 122.658 2.239 . . . . 0.0 112.282 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 89.8 m95 -71.6 -24.47 61.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.905 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 55.09 54.92 8.22 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.079 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -60.27 -38.17 82.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.953 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 35.7 t -105.0 118.79 37.42 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.892 168.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 57.4 t30 -75.45 72.83 2.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.969 -177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.409 HD13 HG21 ' A' ' 116' ' ' ILE . 78.7 mt -85.56 111.24 20.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.155 -178.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -125.05 -85.01 0.64 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.879 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 96.8 m -128.21 130.11 47.48 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.193 -175.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 45.2 t -147.16 155.42 42.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.791 175.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -69.51 -24.09 63.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.891 -177.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 25.5 m -72.33 165.01 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.134 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -92.71 121.06 33.73 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.897 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.471 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 31.3 p90 -143.53 152.56 41.6 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.937 -178.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -143.01 167.8 26.23 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.804 -0.712 . . . . 0.0 112.606 176.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.423 HG11 ' O ' ' A' ' 315' ' ' PRO . 7.7 p -132.27 139.5 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 120.966 0.412 . . . . 0.0 111.061 -172.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 5.0 t -144.92 147.16 32.41 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.138 168.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 16.6 m -56.92 156.45 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.133 168.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 247' ' ' LEU . 7.4 mp -66.76 148.99 98.61 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.514 0.673 . . . . 0.0 110.897 -157.109 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 48.1 Cg_exo -60.69 178.34 0.49 Allowed 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.781 2.321 . . . . 0.0 112.369 -178.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 82.1 p -99.96 153.98 18.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.135 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 62.6 t80 -135.31 117.05 15.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.841 -177.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 54.77 35.17 23.45 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.859 -173.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 89.11 5.7 72.73 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.472 171.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -124.36 140.54 35.35 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.606 0.717 . . . . 0.0 110.854 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -70.02 129.5 17.43 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.688 2.258 . . . . 0.0 112.326 -177.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 68.0 m -78.81 -26.76 44.33 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.87 -179.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 20.9 tptp -47.63 109.92 1.22 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.557 0.694 . . . . 0.0 110.91 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -58.72 161.31 15.33 Favored 'Trans proline' 0 C--O 1.231 0.13 0 C-N-CA 122.731 2.287 . . . . 0.0 112.307 -175.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -62.4 162.1 10.61 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.843 179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.456 HG23 ' HB2' ' A' ' 112' ' ' ALA . 3.5 p -108.3 134.03 51.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.11 -175.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.25 142.94 16.06 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.451 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.506 HG21 HG22 ' A' ' 93' ' ' THR . 73.3 t -127.65 122.54 59.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 CA-C-O 120.865 0.364 . . . . 0.0 111.194 -177.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.637 HD23 ' N ' ' A' ' 263' ' ' SER . 1.6 tt -82.05 130.77 35.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.926 172.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.637 ' N ' HD23 ' A' ' 262' ' ' LEU . 62.2 m -132.32 158.16 42.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.902 178.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.18 138.98 50.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.063 -174.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -132.76 178.27 18.23 Favored Glycine 0 C--N 1.33 0.216 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.46 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.515 ' O ' ' N ' ' A' ' 77' ' ' ALA . 27.0 mm -103.6 137.06 33.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.908 0.385 . . . . 0.0 111.092 -176.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 48.4 t-20 -72.29 127.4 32.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.92 174.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.807 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -65.43 -23.06 66.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.1 -176.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.75 -11.72 55.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.054 -175.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 27.7 t -77.16 120.84 83.27 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.66 0.743 . . . . 0.0 110.917 -173.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.458 ' HD2' HG21 ' A' ' 2' ' ' ILE . 77.7 Cg_endo -69.12 -10.57 29.42 Favored 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.707 2.271 . . . . 0.0 112.32 170.177 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -103.01 21.41 15.76 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.904 -170.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.8 pttt -52.97 -31.63 41.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.932 -170.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 74.7 mm-40 -66.18 -47.3 74.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.83 -170.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.04 -26.94 20.03 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.948 -177.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.567 ' HB1' HG23 ' A' ' 59' ' ' ILE . . . -63.14 -45.11 93.48 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.16 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 60.3 pttt -69.73 -33.95 73.18 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.987 177.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 92.4 mt-10 -66.43 -35.52 80.52 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.827 178.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.498 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 0.8 OUTLIER -56.27 -53.56 55.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.795 175.769 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.495 ' HB2' HD12 ' A' ' 284' ' ' LEU . 2.1 pp -79.06 -34.78 43.44 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.906 -170.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -70.22 -42.4 72.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 178.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.471 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 95.4 m-20 -97.56 -4.38 37.87 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.832 -164.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.621 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 47.3 m-85 -118.36 -54.4 2.29 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.033 173.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.558 ' O ' ' HB3' ' A' ' 290' ' ' LEU . 25.3 mt -81.17 -42.49 20.76 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.942 -169.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.469 HD23 HD12 ' A' ' 280' ' ' LEU . 4.0 mm? -81.58 19.94 0.97 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 169.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.63 ' O ' HD22 ' A' ' 290' ' ' LEU . 94.0 m -132.61 142.67 49.24 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.101 -178.452 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . . . . . . . . . 47.9 p-10 -51.44 -26.19 7.64 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -168.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 49.6 tp10 -74.46 -46.8 37.39 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.881 -175.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.621 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -80.62 -48.04 6.46 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.506 -165.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.713 HD23 ' N ' ' A' ' 291' ' ' GLU . 0.7 OUTLIER -70.21 -16.06 63.01 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.86 0.362 . . . . 0.0 110.936 179.991 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.713 ' N ' HD23 ' A' ' 290' ' ' LEU . 83.2 tt0 -71.99 -47.33 52.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.854 167.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.81 -40.75 98.33 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.087 -172.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.916 HG23 ' HA3' ' A' ' 19' ' ' GLY . 3.3 p -70.75 -36.83 66.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.098 -179.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 52.7 t30 -67.43 -25.21 65.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.784 176.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -64.84 -29.36 70.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.892 178.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 57.5 m-20 -90.67 -43.11 10.35 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.881 -177.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.409 ' O ' HD13 ' A' ' 299' ' ' LEU . 65.8 mttm -127.92 145.78 56.51 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.531 0.681 . . . . 0.0 110.902 179.315 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -68.7 107.14 1.59 Allowed 'Trans proline' 0 C--O 1.231 0.162 0 C-N-CA 122.748 2.298 . . . . 0.0 112.329 174.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.455 ' HG ' ' HD3' ' A' ' 15' ' ' LYS . 0.8 OUTLIER -91.89 -19.21 22.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.944 -179.021 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.488 ' O ' HD11 ' A' ' 317' ' ' ILE . . . 88.58 -62.02 3.78 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.573 -179.466 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -160.25 167.49 27.43 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.814 0.34 . . . . 0.0 111.17 -177.182 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.73 HG21 ' HB3' ' A' ' 307' ' ' TYR . 33.2 m -131.14 156.15 42.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.213 177.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.06 -14.82 60.63 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.077 175.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.447 ' HA ' HD23 ' A' ' 89' ' ' LEU . 50.4 tp -81.21 126.83 31.99 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.862 -173.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 88' ' ' LYS . 87.2 tttt -55.41 -44.99 76.71 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.862 -174.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 63.7 m -61.59 -52.18 65.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.802 -168.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.73 ' HB3' HG21 ' A' ' 302' ' ' VAL . 12.6 t80 -78.02 -32.67 51.18 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -179.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 43.6 tp10 -62.91 -42.03 99.65 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.921 -177.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -62.09 -38.99 90.97 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.894 179.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.2 mm-40 -73.69 -48.76 29.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -176.466 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.601 HD21 HG22 ' A' ' 302' ' ' VAL . 4.6 pp -69.13 -23.48 63.98 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.854 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.422 ' N ' HD12 ' A' ' 311' ' ' LEU . . . -67.41 -14.96 63.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.14 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -64.45 -16.4 62.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.965 176.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -84.48 133.48 44.43 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.575 0.702 . . . . 0.0 110.864 169.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . 0.423 ' O ' HG11 ' A' ' 244' ' ' VAL . 90.5 Cg_exo -47.74 -35.74 24.3 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.673 2.249 . . . . 0.0 112.342 -178.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 17.7 ptp180 -61.96 -27.64 68.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -167.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.488 HD11 ' O ' ' A' ' 300' ' ' GLY . 2.1 mp -100.03 -40.85 8.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.162 -176.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -51.11 -47.24 61.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.124 -162.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.25 -34.77 75.3 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.19 177.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.511 ' CG2' ' HB3' ' A' ' 112' ' ' ALA . 62.9 m -61.42 -37.01 81.94 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.058 -176.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.6 mtp -60.16 -30.46 69.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.896 178.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.7 tp10 -65.45 -43.95 88.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.913 -176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 -77.06 -39.75 48.72 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.87 175.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -56.36 -39.79 73.47 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.156 -168.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.1 mt-30 -63.3 -28.32 69.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.881 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -108.6 -1.68 19.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.892 -175.527 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -86.16 -160.21 33.68 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.414 -168.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -140.93 154.75 46.23 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.987 0.422 . . . . 0.0 110.825 -173.174 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 40.6 mm -68.07 116.28 7.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.114 -171.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 63.3 ttp -60.09 140.18 90.85 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.515 0.674 . . . . 0.0 110.904 174.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -58.89 109.34 0.51 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.635 2.223 . . . . 0.0 112.383 172.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 71.9 m-80 -107.02 10.17 30.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.848 -177.727 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 42.0 pt -72.52 162.02 76.15 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.73 0.776 . . . . 0.0 111.138 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 75.2 Cg_exo -53.07 -31.49 54.39 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.679 2.253 . . . . 0.0 112.347 -179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -66.58 -16.46 64.19 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.885 -178.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.465 ' HA ' ' CD2' ' A' ' 339' ' ' PHE . 68.0 ttp -54.84 -34.88 63.37 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.892 -176.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 95.9 p -65.14 -31.12 72.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.881 176.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.29 -35.54 63.72 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.163 178.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.55 ' HB3' ' CZ3' ' A' ' 158' ' ' TRP . 3.2 m-30 -56.34 -55.65 30.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.909 176.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.429 ' HB3' ' HB3' ' A' ' 154' ' ' PRO . 52.5 m0 -62.79 -37.82 88.2 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.92 -172.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 79.8 t80 -69.71 -48.04 61.0 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.826 179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.14 -42.36 93.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.168 -173.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.449 HG21 ' HA ' ' A' ' 158' ' ' TRP . 19.6 m -73.0 -28.0 25.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.065 -177.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . . . . . . . . . 78.6 ttt-85 -62.71 -40.95 98.76 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.938 173.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 93.0 m -57.33 -36.07 70.69 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.157 175.075 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.475 ' HB1' HD11 ' A' ' 192' ' ' LEU . . . -65.41 -45.76 82.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.017 -175.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.452 HG21 HG22 ' A' ' 157' ' ' THR . 2.4 m -72.18 -34.42 49.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.132 -174.586 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.433 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -63.18 -46.36 96.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.187 173.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -67.81 -39.49 83.95 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.924 -176.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.59 -47.61 39.1 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.105 -179.401 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.32 -37.43 80.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.12 -173.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 95.2 p -74.99 -9.1 58.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.882 -177.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 75.51 11.66 84.2 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.491 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 41.3 mmt180 -78.77 -27.14 44.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.791 0.329 . . . . 0.0 110.893 -179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -139.67 156.23 46.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.939 173.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.6 p -77.15 164.96 25.18 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.194 170.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . . . . . . . . . 53.7 t -51.91 -41.01 29.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.171 175.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -62.78 -48.94 76.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.994 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -76.82 -44.23 33.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.937 -177.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -63.56 -47.35 81.93 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.102 -177.612 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . . . . . . . . . 13.5 tp -67.07 -52.86 36.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.957 -178.478 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -54.03 -46.8 71.97 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.939 -176.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -72.23 -43.68 64.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.866 -176.036 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -72.08 -47.07 54.12 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.168 -175.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 87.9 mm-40 -67.66 -30.77 70.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.878 -175.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 24.9 m -55.14 -31.87 61.65 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.111 174.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -58.98 -29.84 67.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.897 -178.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.533 HG21 ' HB1' ' A' ' 168' ' ' ALA . 77.9 mt -56.15 -40.11 62.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.113 174.517 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 77.6 p -100.99 -10.43 20.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.163 -0.472 . . . . 0.0 111.115 -174.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.6 tttt . . . . . 0 C--N 1.327 -0.376 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.882 179.643 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.718 0.294 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.2 mt -94.08 125.11 46.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.09 -179.183 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 24.4 pt-20 -150.07 147.96 28.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.836 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -50.79 133.85 25.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.799 177.808 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.96 4.92 64.62 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.508 -175.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.464 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.9 tttt -163.11 141.71 8.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.77 0.319 . . . . 0.0 110.959 178.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.581 ' CD2' HD11 ' A' ' 33' ' ' ILE . 2.3 pt? -146.51 154.49 41.61 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.93 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.501 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 88.6 t -110.91 134.7 52.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.09 -177.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.654 HD11 ' HB ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -119.96 133.56 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 -178.994 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.72 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 65.2 m95 -106.59 124.19 49.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.942 164.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.501 HD12 ' HG ' ' A' ' 20' ' ' LEU . 12.1 tt -110.01 150.0 12.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.114 -165.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.6 t-20 -62.74 148.18 47.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.85 -173.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.61 -17.69 21.02 Favored Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.454 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 92.2 m-20 -64.88 -27.34 68.79 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.781 0.324 . . . . 0.0 110.921 -173.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 15' ' ' LYS . 35.7 mmtm -140.06 133.67 30.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.939 166.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.63 -80.77 0.95 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.497 -169.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 68.7 m-85 -99.97 -38.7 8.49 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.839 0.352 . . . . 0.0 110.914 -176.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.3 m-20 -68.15 -51.91 40.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.908 -151.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -53.11 -55.47 23.92 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.461 -178.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.501 ' HG ' HD12 ' A' ' 11' ' ' ILE . 5.7 mt -53.82 -53.04 57.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.843 0.354 . . . . 0.0 110.903 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.44 -40.21 7.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.082 179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 63.8 mm-40 -72.12 -59.51 2.7 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.854 179.322 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.456 HG22 ' HA ' ' A' ' 20' ' ' LEU . 20.7 m -70.33 -38.16 73.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.111 -172.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.767 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -66.98 -48.39 60.62 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.525 178.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -56.75 -35.0 68.12 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.846 0.355 . . . . 0.0 110.957 -177.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 61.9 tttp -55.36 -39.62 70.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.987 176.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.453 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 5.6 m-30 -59.17 -46.32 88.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 178.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -65.0 -39.61 93.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -69.44 -38.23 77.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.853 -177.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -94.95 -48.2 6.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.882 -169.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 33.8 p -110.62 -1.47 16.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.159 -171.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.87 3.71 90.49 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.45 168.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.07 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -99.99 134.02 40.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.928 0.394 . . . . 0.0 111.124 -176.046 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.464 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.5 mttt -83.08 144.09 30.13 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.924 -174.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.767 HG21 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -120.01 134.62 62.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 175.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.488 ' O ' HD12 ' A' ' 9' ' ' ILE . 97.0 m -102.21 129.09 48.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.145 176.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.456 HG22 ' HB3' ' A' ' 20' ' ' LEU . 87.2 t -99.57 125.86 53.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.172 179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.5 mm-40 -115.06 149.9 36.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 177.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.417 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.4 t-80 -86.13 138.92 34.45 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.573 0.702 . . . . 0.0 110.928 -165.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 77.1 Cg_exo -56.49 -27.57 69.41 Favored 'Trans proline' 0 N--CA 1.465 -0.185 0 C-N-CA 122.695 2.263 . . . . 0.0 112.291 -175.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -47.97 -50.55 26.91 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.832 -172.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -88.79 -5.04 58.33 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.911 -174.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.6 tt -46.11 -54.85 7.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.897 -169.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -63.32 -38.32 90.72 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.953 177.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.95 -40.82 95.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.899 -176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.427 ' HB3' HG13 ' A' ' 50' ' ' VAL . 75.3 mmtt -82.91 -20.01 36.22 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.962 178.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.57 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 84.4 t80 -49.29 -50.73 62.79 Favored Pre-proline 0 C--N 1.329 -0.287 0 CA-C-O 121.635 0.731 . . . . 0.0 110.799 -165.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 43.3 Cg_endo -82.85 -30.16 1.07 Allowed 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.673 2.248 . . . . 0.0 112.385 179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.2 mt-30 -74.86 -41.45 59.8 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.918 -167.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.479 HG21 ' HG3' ' A' ' 57' ' ' PRO . 32.1 m -67.58 -27.11 37.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.115 -175.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.496 ' CB ' ' HB3' ' A' ' 75' ' ' LEU . . . -69.33 -36.52 77.03 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.12 177.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.36 -33.49 75.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.147 -178.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.8 p -94.46 -21.9 18.61 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.111 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 70.83 9.16 65.4 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.44 174.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -123.01 120.04 32.16 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 0.0 110.868 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.88 -95.14 0.15 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.427 172.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.72 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 64.5 Cg_endo -79.79 147.3 19.26 Favored 'Trans proline' 0 N--CA 1.465 -0.199 0 C-N-CA 122.734 2.29 . . . . 0.0 112.394 -175.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.04 -35.17 12.71 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.781 161.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.603 ' HB ' HG23 ' A' ' 9' ' ' ILE . 45.8 mt -125.24 136.87 59.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.141 -175.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.0 tp -132.88 126.41 53.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.187 177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -92.22 138.98 31.08 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.857 173.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.484 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 24.9 p90 -145.07 163.35 34.52 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.042 170.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -62.25 -90.36 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.039 -168.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.6 ' HB2' ' HB3' ' A' ' 332' ' ' ASN . 6.3 m170 -123.34 -68.04 0.9 Allowed 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.868 -171.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 97.3 m-20 -103.29 -12.36 17.32 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.844 -159.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 55.8 ttm-85 -51.05 -20.45 1.42 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 -174.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.475 ' HB2' HD13 ' A' ' 104' ' ' ILE . 32.6 p90 -59.21 -33.48 71.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.834 -175.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.06 -50.45 65.97 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.46 -168.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.16 -37.65 94.32 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.5 174.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.633 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 9.3 t80 -69.01 -42.1 76.87 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 120.849 0.357 . . . . 0.0 110.89 -175.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -70.61 -42.95 70.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.095 175.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.4 tt0 -58.24 -37.59 75.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.957 -177.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.407 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 58.1 m -84.55 -5.01 59.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.795 -179.216 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.01 30.27 59.46 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.464 174.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.496 ' HB3' ' CB ' ' A' ' 51' ' ' ALA . 46.1 mt -89.39 -10.04 48.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.867 0.365 . . . . 0.0 110.905 -168.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.633 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -131.03 153.27 49.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.877 -179.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -80.0 139.73 36.87 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.128 176.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 59.4 mp0 -65.68 137.34 57.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.832 173.541 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.3 pt -100.57 152.09 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.107 -173.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.7 m -96.91 119.0 64.39 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.591 0.71 . . . . 0.0 111.085 172.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.616 ' HB3' HD12 ' A' ' 103' ' ' LEU . 73.1 Cg_endo -73.97 155.55 47.95 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.745 2.297 . . . . 0.0 112.324 -179.427 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -105.52 117.86 35.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.842 178.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -52.87 -35.06 57.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.87 -179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.73 -39.02 90.72 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.101 178.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 14.5 m-30 -75.87 -33.28 59.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.896 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.511 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 86.4 mt-30 -54.9 -51.93 64.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 177.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -58.71 -33.84 70.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.875 174.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 95.9 mttt -81.96 -18.43 43.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.841 -172.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -104.7 -105.02 0.31 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.91 -172.812 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.509 ' CG ' ' HD2' ' A' ' 91' ' ' PRO . 5.0 t80 -178.72 142.74 0.42 Allowed Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.705 0.764 . . . . 0.0 110.956 -166.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.509 ' HD2' ' CG ' ' A' ' 90' ' ' TYR . 31.3 Cg_endo -68.25 -37.6 13.72 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.731 2.287 . . . . 0.0 112.337 -175.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 48.4 m-85 -75.08 -29.28 60.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.877 -175.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 81.9 p -72.68 -37.05 68.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.266 -178.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.745 ' CE3' HD13 ' A' ' 103' ' ' LEU . 86.4 m95 -73.61 -26.43 60.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.893 173.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -73.02 -31.31 64.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.853 173.489 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.23 -23.88 63.0 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.07 176.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.59 HG22 ' HA ' ' A' ' 94' ' ' TRP . 17.9 m -106.16 16.4 6.65 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.075 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 55.3 ttp85 -100.97 126.31 47.61 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.974 -175.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 79.3 t80 -125.82 115.8 20.58 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.909 177.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.7 t30 57.17 35.11 25.83 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.897 175.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.65 -0.97 89.18 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.558 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -120.97 143.55 48.95 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.818 0.342 . . . . 0.0 110.862 174.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.745 HD13 ' CE3' ' A' ' 94' ' ' TRP . 41.5 mt -89.59 135.58 33.52 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.907 -172.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.475 HD13 ' HB2' ' A' ' 67' ' ' PHE . 2.1 pp -127.21 3.36 3.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.054 -166.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.484 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -160.97 160.21 30.46 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.166 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.429 ' HB3' ' CD2' ' A' ' 285' ' ' LEU . 97.0 m-85 -108.53 139.57 20.94 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.582 0.706 . . . . 0.0 110.871 172.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -78.91 121.63 5.06 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.708 2.272 . . . . 0.0 112.327 170.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.072 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -105.59 -40.92 5.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.225 177.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.567 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -141.74 150.84 42.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.103 -164.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 95.6 t -115.65 123.91 71.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.155 176.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -112.92 122.34 47.36 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.93 176.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.656 ' HB1' HD21 ' A' ' 323' ' ' ASN . . . -150.18 144.8 25.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.065 -177.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.486 ' HB2' ' HB3' ' A' ' 257' ' ' PRO . 7.1 mp -87.56 170.03 11.67 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.939 -174.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 94.2 p -158.33 154.92 27.84 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.845 -176.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.817 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.5 OUTLIER -91.92 129.1 37.95 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.903 169.102 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.611 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.9 mp -116.37 130.89 70.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.116 -177.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -133.19 154.26 50.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.893 -171.815 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.451 ' O ' HD23 ' A' ' 122' ' ' LEU . 69.8 m-80 -88.0 119.57 28.49 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.862 175.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.44 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.6 mttt -64.82 -27.35 68.82 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.946 178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -82.84 -24.13 33.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.819 -173.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.0 mp -80.49 -54.43 5.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.942 172.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.706 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.6 pt? -140.36 127.9 12.51 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.617 0.722 . . . . 0.0 110.952 176.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.44 -9.43 14.91 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.659 2.239 . . . . 0.0 112.436 -176.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 -149.28 98.0 3.53 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.554 0.693 . . . . 0.0 110.871 -174.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -68.27 157.08 63.36 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.623 2.215 . . . . 0.0 112.293 176.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -66.4 143.07 68.34 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.633 2.222 . . . . 0.0 112.36 -177.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -85.1 -17.48 37.21 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.897 -177.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.5 p -134.5 157.53 46.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.185 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.497 ' HA ' HD13 ' A' ' 132' ' ' ILE . 71.4 m95 -70.15 -23.15 62.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.967 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -65.02 -24.59 67.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.847 175.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -85.59 -18.38 33.5 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.901 -177.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.576 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -59.54 -42.87 94.32 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.686 0.755 . . . . 0.0 111.163 -170.382 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.576 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 92.9 Cg_endo -80.01 -37.83 0.4 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.664 2.243 . . . . 0.0 112.35 -173.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.88 -58.92 6.07 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.12 175.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.236 HD22 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.49 -17.08 64.1 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.916 -176.038 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.549 ' N ' HD13 ' A' ' 135' ' ' LEU . 37.8 t70 -60.04 -41.39 92.18 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 168.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.72 -30.8 70.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.899 -177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -70.29 -47.29 61.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.88 -178.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.1 pp -85.16 -14.61 46.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.888 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.627 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.8 tttt -60.36 -34.47 73.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.955 174.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.06 -23.4 67.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.083 175.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -95.03 4.23 54.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.935 179.43 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.06 32.6 56.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.369 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -111.09 169.96 8.43 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.891 0.377 . . . . 0.0 110.836 174.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.8 t -120.82 139.4 53.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.779 167.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -67.64 -44.02 78.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.113 -171.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -138.88 131.46 28.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.87 -177.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 52.2 ttm -117.11 130.85 56.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.783 -177.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -153.62 155.13 35.5 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.89 -174.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -86.17 -51.98 5.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.78 -177.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.038 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.5 tm? 48.34 31.71 2.85 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.919 -169.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.4 mm-40 -102.11 -9.02 20.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.924 176.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -129.71 152.39 79.7 Favored Pre-proline 0 C--N 1.331 -0.202 0 CA-C-O 121.726 0.774 . . . . 0.0 110.818 -173.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.409 ' HB3' ' HB3' ' A' ' 340' ' ' TRP . 51.8 Cg_exo -55.01 -29.62 65.75 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.675 2.25 . . . . 0.0 112.343 177.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 25.8 m-85 -68.45 -30.0 68.77 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -178.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -79.91 -41.05 26.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.875 172.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.435 HG23 HG11 ' A' ' 347' ' ' VAL . 19.4 m -60.8 -52.45 65.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.132 -179.029 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.568 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 15.1 t-105 -59.23 -48.75 95.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.488 0.661 . . . . 0.0 110.907 -161.338 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.568 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 90.8 Cg_exo -52.25 -44.71 44.36 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.694 2.262 . . . . 0.0 112.355 -177.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.604 HD23 ' C ' ' A' ' 160' ' ' LEU . 7.7 tt -71.26 -40.09 71.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.826 -171.237 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 83.0 mt -71.08 -43.44 75.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.095 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.71 -22.0 60.96 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.158 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -60.49 -28.57 68.46 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.107 -178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -99.11 1.77 45.41 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.856 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 108.5 5.65 31.75 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.478 178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.59 67.97 2.52 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.541 178.215 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -83.83 132.68 34.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.895 0.379 . . . . 0.0 110.999 179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -78.38 6.77 7.68 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.134 -174.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.427 ' HA ' HG12 ' A' ' 181' ' ' VAL . 51.3 p90 -149.73 155.01 39.45 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.912 -175.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 87.3 tttt -104.97 124.69 49.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.881 157.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 77.8 t80 -116.26 124.42 50.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -153.91 130.63 10.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.877 -175.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.02 43.04 30.45 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 173.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.75 17.29 80.06 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.518 173.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -131.63 138.58 48.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.71 0.29 . . . . 0.0 110.866 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 95.2 m-85 -96.99 144.69 26.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.881 169.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -123.51 111.66 16.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.896 172.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.583 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.1 pp -79.98 -12.74 13.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.111 -177.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -96.55 -11.05 25.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.899 -175.653 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.401 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 66.0 t0 -127.28 88.24 2.77 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.888 171.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.427 HG12 ' HA ' ' A' ' 169' ' ' PHE . 32.7 m -116.13 166.92 9.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.063 -170.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.16 22.3 31.54 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.517 -170.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.479 HG21 HD12 ' A' ' 368' ' ' ILE . 1.5 m -105.47 -20.0 6.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.753 0.311 . . . . 0.0 111.083 -176.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -86.48 21.16 2.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.854 -178.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 53.6 p30 -104.96 -174.97 2.66 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.95 -175.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.9 -29.37 67.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.05 179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.64 -40.18 77.42 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.437 -169.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.499 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -62.57 -37.64 86.99 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.934 0.397 . . . . 0.0 111.162 177.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.593 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 88.6 mttt -62.92 -37.97 89.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.904 174.073 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.13 -36.99 85.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.079 175.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.42 -47.57 62.39 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.507 -179.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.775 HD11 ' HA ' ' A' ' 347' ' ' VAL . 20.6 tp -66.41 -34.25 77.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.85 0.357 . . . . 0.0 110.841 -178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.512 ' OG1' HG21 ' A' ' 357' ' ' VAL . 91.5 m -63.69 -40.68 97.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.227 174.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.474 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 61.8 t80 -67.15 -49.27 65.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.874 177.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 195' ' ' LEU . 7.2 tt -50.43 -51.69 44.41 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.884 -175.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 199' ' ' ILE . 35.2 m -63.9 -22.48 31.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.145 -174.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.5 m-20 -61.8 -34.58 76.17 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.871 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.412 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.9 OUTLIER -80.95 -40.15 24.96 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.847 -173.996 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.6 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.7 pp -72.98 -29.76 30.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.15 172.545 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.91 -37.59 79.03 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.917 173.31 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -80.09 2.31 24.46 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 176.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 68.16 38.57 2.59 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.773 168.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 54.1 m170 -78.99 -17.33 55.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.823 177.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.6 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.2 ppp? -145.2 158.14 43.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.864 176.57 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -94.94 148.87 21.86 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.87 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.89 -25.75 67.74 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.169 -175.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -95.9 1.72 53.14 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.862 -177.156 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 94.7 m -62.48 124.97 22.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.196 -176.332 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.439 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 14.5 t0 -119.93 177.68 4.89 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.941 178.182 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 20.9 p90 -64.89 -37.38 87.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.035 -179.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 96.1 p -70.32 -38.37 74.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.908 178.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.439 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 77.7 mt -65.09 -42.66 95.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.105 174.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.16 -36.18 83.22 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.046 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 86.1 tt0 -61.5 -47.26 86.43 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.836 175.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.95 -44.48 89.3 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.004 -179.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.0 -44.87 87.85 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.141 -178.317 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 66.7 t80 -62.75 -44.48 96.09 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.992 179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -64.77 -31.86 73.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.885 -177.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -83.72 -15.82 47.19 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.947 179.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.55 26.43 30.1 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.551 177.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -84.83 -21.79 29.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.955 0.407 . . . . 0.0 110.84 -176.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.1 t -123.91 137.47 54.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.123 -179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.598 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -62.74 -48.57 78.63 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.009 177.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.752 ' HB3' HD21 ' A' ' 115' ' ' LEU . 71.7 mtm -134.19 160.01 39.15 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.915 -172.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.4 t -151.33 157.16 42.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.199 174.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 48.4 mm -111.55 129.14 67.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.164 -175.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.9 t-20 -155.05 175.02 14.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.894 -174.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -81.74 -159.15 23.6 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.449 179.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -70.82 -24.92 24.28 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.584 2.189 . . . . 0.0 112.348 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 51.5 m0 -75.0 -29.44 60.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.961 -178.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 47.4 45.52 17.04 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.185 174.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 32.5 m0 -65.62 -17.63 64.73 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.964 -179.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 91.1 p -74.93 -9.41 58.51 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.961 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 31.6 p30 -76.8 -171.31 1.88 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 -179.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.4 mt -104.98 125.45 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.155 -173.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 64.6 m-20 -101.11 -40.11 7.35 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.915 -175.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 39.5 m -134.66 89.98 2.6 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.221 -174.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 14.7 t -176.48 165.59 2.67 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.879 175.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -87.3 -1.77 58.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.912 178.065 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 88.9 t -71.22 125.46 29.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.144 179.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.2 m-80 -79.95 139.92 36.85 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.872 -177.398 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.44 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 45.1 p90 -144.95 158.65 43.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.881 176.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -142.65 166.67 26.46 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.496 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 5.1 p -135.02 135.16 53.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.888 0.375 . . . . 0.0 111.125 -175.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.63 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 9.5 t -159.37 142.53 14.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.082 175.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.0 m -63.89 168.31 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.065 -169.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.498 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 2.1 mp -68.71 155.55 92.84 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.562 0.696 . . . . 0.0 110.942 -161.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -77.93 -176.22 3.12 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.739 2.293 . . . . 0.0 112.353 -173.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.424 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 93.9 m -85.93 145.13 27.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.225 -173.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 33.1 t80 -130.56 113.33 14.11 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.799 -173.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt 54.94 34.63 22.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.889 -179.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.81 -0.54 86.53 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.667 -0.777 . . . . 0.0 112.471 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -127.54 127.54 24.08 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.598 0.713 . . . . 0.0 110.863 177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.424 ' HA ' ' HA ' ' A' ' 249' ' ' THR . 81.2 Cg_exo -54.73 131.05 43.68 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.662 2.242 . . . . 0.0 112.351 -176.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.404 ' O ' ' C ' ' A' ' 256' ' ' LYS . 96.0 p -83.77 1.36 43.21 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.865 172.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.449 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 97.8 mttt -37.09 130.2 0.76 Allowed Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.512 0.672 . . . . 0.0 110.832 179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.486 ' HB3' ' HB2' ' A' ' 113' ' ' LEU . 74.0 Cg_exo -61.56 155.91 50.38 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.66 2.24 . . . . 0.0 112.378 -169.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -74.98 165.15 25.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.845 176.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 47.5 t -111.88 126.76 69.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.192 -168.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -112.28 137.35 14.2 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.454 175.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 62.5 t -125.04 116.03 45.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.839 0.352 . . . . 0.0 111.13 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -65.17 123.42 19.48 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.941 -178.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 47.4 m -127.59 130.39 48.95 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.803 -168.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.01 136.17 52.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.074 -171.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.88 169.35 16.85 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.403 -171.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.908 HG13 ' HG2' ' A' ' 277' ' ' LYS . 31.2 mm -112.69 130.16 66.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.843 0.354 . . . . 0.0 111.082 -174.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 -63.37 126.02 26.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.922 -176.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -60.6 -28.24 68.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.144 -179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.0 -6.52 59.03 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.074 -170.097 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.4 t -75.08 122.91 88.45 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.644 0.735 . . . . 0.0 110.868 -173.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -68.59 -12.59 35.14 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.727 2.285 . . . . 0.0 112.373 166.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.46 HD21 HD22 ' A' ' 275' ' ' LEU . 55.5 t30 -111.12 31.27 6.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.919 -168.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 88.6 mttt -60.84 -29.78 69.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.847 -174.375 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -57.52 -40.11 78.03 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.896 -176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.692 HD23 HG13 ' A' ' 33' ' ' ILE . 8.6 mp -75.16 -45.67 39.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.963 174.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -62.7 -56.22 19.61 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.058 -171.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.908 ' HG2' HG13 ' A' ' 266' ' ' ILE . 91.7 mttt -60.92 -40.26 92.49 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.922 -179.397 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.454 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.7 tt0 -71.0 -49.26 47.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.834 -173.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -67.16 -34.11 76.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.868 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.483 ' HA ' HD22 ' A' ' 284' ' ' LEU . 4.6 tt -62.46 -51.39 67.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.965 -175.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -77.88 -33.33 52.06 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.881 -176.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.454 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 67.7 m-80 -98.72 -11.19 22.17 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.891 -163.516 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.856 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 77.5 m-85 -129.67 -52.32 1.16 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.873 177.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.5 OUTLIER -62.81 -35.69 80.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.878 -168.852 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 1.072 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.5 pp -123.96 37.76 4.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.885 177.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.435 ' CG2' ' N ' ' A' ' 287' ' ' ASP . 8.2 m -117.97 153.7 33.19 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.109 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.454 ' HA ' HD11 ' A' ' 290' ' ' LEU . 31.0 t70 -43.45 -36.38 1.95 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.85 -166.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -79.36 -40.62 29.76 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.838 -177.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.856 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.14 -56.73 5.56 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.446 -171.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.647 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.1 -21.08 66.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.827 0.346 . . . . 0.0 110.98 -178.944 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.593 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.0 tt0 -66.74 -45.87 77.21 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.788 171.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.2 -46.64 88.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.102 -174.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -71.14 -46.06 68.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.172 -175.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.511 ' HB2' HD22 ' A' ' 299' ' ' LEU . 43.2 t30 -63.38 -27.89 69.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.828 179.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -61.21 -27.59 68.54 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.875 179.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -91.14 -47.64 7.41 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.943 -179.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -136.31 145.46 51.98 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.545 0.688 . . . . 0.0 110.93 -175.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -66.6 110.08 1.78 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.729 2.286 . . . . 0.0 112.402 -177.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.511 HD22 ' HB2' ' A' ' 294' ' ' ASN . 0.8 OUTLIER -82.02 -27.67 32.95 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.931 176.309 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 103.69 -58.55 0.52 Allowed Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.419 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.598 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -169.25 165.02 10.99 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.915 0.388 . . . . 0.0 111.129 174.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.567 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 26.1 m -125.92 153.93 34.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.02 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.39 -10.88 60.2 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.143 173.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.647 ' CD2' HD21 ' A' ' 290' ' ' LEU . 51.4 tp -85.23 120.27 26.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.888 -176.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -57.31 -39.96 76.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.948 -172.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 41.3 t -64.75 -51.36 62.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.934 -168.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.489 ' HB3' HG21 ' A' ' 302' ' ' VAL . 19.0 t80 -76.73 -29.04 56.03 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.949 -179.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 48.5 tp10 -64.34 -38.46 91.13 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.852 176.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.16 -37.24 82.19 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.91 175.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -74.25 -39.93 62.71 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.93 175.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.598 HD13 ' HA ' ' A' ' 301' ' ' ALA . 77.4 mt -60.05 -33.01 71.46 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.909 175.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.31 -19.58 61.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.08 -176.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -65.73 -20.32 66.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.915 174.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -90.12 123.59 65.49 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-O 121.664 0.745 . . . . 0.0 110.807 167.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -47.93 -28.86 10.78 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.649 2.232 . . . . 0.0 112.377 -178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 89.2 mtm180 -61.75 -32.58 72.84 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.95 -173.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.585 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.4 mp -80.07 -35.53 15.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.082 -178.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -56.1 -39.63 72.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.085 -174.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.91 -46.16 75.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.051 178.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 82.6 p -59.82 -28.38 67.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.147 -174.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.3 mmm -66.36 -33.11 74.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.86 174.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -62.52 -47.43 83.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.892 -175.437 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.656 HD21 ' HB1' ' A' ' 112' ' ' ALA . 14.4 p-10 -83.42 -25.92 30.84 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.769 -177.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.06 -43.96 97.71 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.106 -178.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -67.4 -35.03 78.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.84 -177.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -106.03 -4.48 20.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.829 -172.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.94 -170.02 39.89 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.665 -0.779 . . . . 0.0 112.534 -167.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -139.91 149.39 43.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.881 0.372 . . . . 0.0 110.805 -176.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 42.9 mm -63.85 117.7 4.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.082 -173.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 59.6 ttm -64.21 134.79 96.08 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.463 0.649 . . . . 0.0 110.982 -176.033 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -67.54 128.02 17.44 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.713 2.275 . . . . 0.0 112.382 -176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.607 ' CG ' ' O ' ' A' ' 332' ' ' ASN . 1.8 t-20 -133.56 20.17 3.93 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.949 -176.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 49.5 pt -70.58 153.66 94.85 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.584 0.707 . . . . 0.0 111.151 179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -54.69 -35.99 88.79 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.615 2.21 . . . . 0.0 112.408 -176.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -69.06 -24.99 64.23 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.924 -179.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 40.4 tpp -73.6 -26.89 61.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.854 -170.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.0 m -57.37 -37.95 73.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.846 176.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.96 -36.12 59.41 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.011 177.729 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.524 ' O ' HG13 ' A' ' 343' ' ' VAL . 4.7 m-30 -66.87 -46.98 73.3 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.859 179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.446 ' HA ' HG22 ' A' ' 343' ' ' VAL . 28.1 m0 -61.07 -32.5 72.14 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 177.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -66.92 -47.09 72.8 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.914 173.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.03 -40.36 94.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.163 -176.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.524 HG13 ' O ' ' A' ' 339' ' ' PHE . 17.9 m -74.1 -30.83 28.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.128 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.491 ' O ' HG22 ' A' ' 347' ' ' VAL . 4.9 tmt_? -65.0 -38.98 92.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.922 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 94.2 m -58.22 -36.19 72.79 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.194 173.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.97 -43.57 95.38 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.189 -174.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.775 ' HA ' HD11 ' A' ' 192' ' ' LEU . 5.8 m -73.99 -35.01 40.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.191 -174.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.458 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -62.44 -47.94 90.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.191 174.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -63.91 -39.18 93.58 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -178.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.05 -45.55 60.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.098 -179.688 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.37 -39.86 77.78 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.0 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.8 p -75.58 -10.7 59.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.911 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 80.96 17.25 72.84 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.449 179.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.25 -33.29 43.7 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.853 0.359 . . . . 0.0 110.907 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -138.63 154.4 48.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.93 177.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.4 p -77.19 169.89 17.51 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.18 170.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.512 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.5 t -56.53 -42.34 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.088 173.383 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -62.09 -45.62 92.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.916 177.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 91.6 mt-10 -69.94 -51.59 31.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.881 -179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -75.4 -51.79 12.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.188 -173.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.593 ' HG ' ' HA ' ' A' ' 189' ' ' LYS . 1.9 tm? -65.04 -48.97 71.94 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 -171.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.51 -52.83 61.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.914 -173.286 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -67.94 -48.65 65.33 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.808 -175.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -62.59 -37.25 85.48 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.156 -174.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.587 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 66.3 mm-40 -78.04 -29.03 49.13 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.907 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 89.5 m -65.92 -33.96 77.03 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.178 170.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 84.8 mtt180 -56.39 -31.95 64.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.854 178.011 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.479 HD12 HG21 ' A' ' 183' ' ' VAL . 62.0 mt -59.02 -34.93 54.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.951 0.405 . . . . 0.0 111.191 173.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 69.9 p -95.07 -14.34 24.36 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.129 -176.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 89.7 mttt . . . . . 0 C--N 1.33 -0.246 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 177.096 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.0 mttt . . . . . 0 C--O 1.232 0.176 0 CA-C-O 120.729 0.3 . . . . 0.0 110.93 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.455 HG21 ' HD2' ' A' ' 271' ' ' PRO . 60.1 mt -97.81 139.96 18.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.181 -177.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -140.13 145.03 37.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.822 178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.29 133.5 39.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.872 177.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 90.83 11.58 61.63 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.494 -175.061 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.404 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.2 tttt -165.07 134.77 3.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.834 0.349 . . . . 0.0 110.944 177.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.585 ' CD2' HD11 ' A' ' 33' ' ' ILE . 1.6 pt? -144.0 152.71 41.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.94 -173.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 87.2 t -110.76 137.67 42.17 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.02 -177.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.716 HD11 HG13 ' A' ' 35' ' ' VAL . 1.1 mp -119.79 134.47 63.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.094 177.508 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.61 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 76.6 m95 -103.69 124.66 49.26 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.901 164.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.494 HD12 ' HG ' ' A' ' 20' ' ' LEU . 11.5 tt -108.83 150.04 11.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.052 -163.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 55.5 t30 -58.43 153.2 16.28 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.798 -174.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -60.38 -15.97 40.97 Favored Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.416 -176.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -79.2 -13.28 59.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.866 0.365 . . . . 0.0 110.897 -172.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -139.96 129.2 23.84 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.911 163.027 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.52 -70.72 1.29 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.469 -175.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -109.92 -39.19 5.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.958 0.409 . . . . 0.0 110.98 179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 89.4 m-20 -67.37 -52.28 41.98 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.871 -150.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.436 ' CA ' HG23 ' A' ' 293' ' ' VAL . . . -54.1 -50.35 55.78 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.707 -0.758 . . . . 0.0 112.565 -175.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.502 ' HB3' HG22 ' A' ' 37' ' ' VAL . 6.0 mt -55.08 -52.57 62.8 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.699 0.285 . . . . 0.0 110.933 171.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.48 -35.92 21.23 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.125 -179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -72.45 -59.99 2.46 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.833 177.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.413 HG22 ' HA ' ' A' ' 20' ' ' LEU . 21.5 m -71.64 -38.15 65.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.158 -172.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.55 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -65.64 -47.84 73.25 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.422 178.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -54.73 -35.65 63.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.887 0.375 . . . . 0.0 110.889 -178.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.3 tttp -57.93 -39.12 77.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.039 177.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.45 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 4.8 m-30 -62.9 -45.42 92.59 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.922 179.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 99.8 mt-10 -60.7 -36.96 80.09 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.897 178.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -71.24 -41.17 70.47 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.898 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 93.4 m-20 -94.52 -47.81 6.38 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.889 -164.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.3 p -109.1 -7.83 15.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.18 -172.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.65 8.12 87.97 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.514 167.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.994 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.52 133.86 39.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 111.085 -179.074 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.41 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.2 mttt -72.02 136.0 46.56 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.888 -169.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.716 HG13 HD11 ' A' ' 9' ' ' ILE . 99.2 t -115.87 125.01 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.061 -175.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.56 ' O ' HD12 ' A' ' 9' ' ' ILE . 95.5 m -109.93 130.02 55.58 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.067 -176.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.502 HG22 ' HB3' ' A' ' 20' ' ' LEU . 87.4 t -103.58 131.17 52.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.159 -179.11 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.7 mm-40 -119.36 154.09 34.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.877 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 66.3 t-80 -88.25 139.93 30.41 Favored Pre-proline 0 C--N 1.327 -0.393 0 CA-C-O 121.694 0.759 . . . . 0.0 110.863 -167.453 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -55.02 -29.86 66.99 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.758 2.305 . . . . 0.0 112.335 -175.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -49.03 -52.62 24.23 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.873 -172.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -90.07 0.68 57.01 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.832 -176.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.427 ' C ' HD23 ' A' ' 43' ' ' LEU . 10.5 tt -45.86 -51.09 13.58 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.937 -177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 99.6 mt-10 -74.44 -40.37 61.99 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.862 177.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -80.44 -51.88 8.3 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.956 -164.335 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -83.33 -38.39 22.14 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.919 -170.283 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.606 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 83.9 t80 -49.83 -53.39 42.78 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.684 0.754 . . . . 0.0 110.872 -169.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.606 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 29.4 Cg_endo -61.19 -30.83 89.3 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.668 2.245 . . . . 0.0 112.331 -179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 64.9 mt-30 -73.08 -44.18 60.86 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.917 179.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.414 HG21 ' HD3' ' A' ' 57' ' ' PRO . 21.2 m -75.56 -24.61 17.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.112 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.37 -35.13 78.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.054 174.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.11 -29.74 70.62 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.099 176.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.0 p -88.36 -14.54 37.9 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.11 174.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.44 14.72 81.72 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.477 168.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -135.39 129.39 33.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.868 0.366 . . . . 0.0 110.816 175.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 150.47 -92.34 0.14 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.497 175.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.61 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 67.6 Cg_endo -79.36 148.0 20.71 Favored 'Trans proline' 0 N--CA 1.464 -0.242 0 C-N-CA 122.68 2.253 . . . . 0.0 112.375 -177.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -107.52 -32.09 7.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.798 165.721 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.55 ' HB ' HG23 ' A' ' 9' ' ' ILE . 57.6 mt -128.11 137.53 57.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.169 -176.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.489 HD12 ' HB2' ' A' ' 10' ' ' TRP . 6.3 tp -132.64 127.13 55.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.138 -179.285 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 29.7 m-85 -92.55 128.21 38.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.771 170.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . . . . . . . . . 99.1 m95 -114.38 145.15 42.19 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.994 174.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -55.58 -83.74 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.036 -168.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 332' ' ' ASN . 16.0 m170 -120.81 -65.85 1.11 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.835 174.547 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -99.98 -16.54 17.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.84 -167.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.5 mmt85 -61.36 -6.31 2.16 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 -165.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.461 ' O ' ' HB3' ' A' ' 70' ' ' TYR . 31.5 p90 -59.08 -25.58 63.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 173.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.47 -48.36 86.59 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.46 -174.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.04 -32.16 83.25 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.515 171.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.716 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 2.3 t80 -54.96 -51.71 65.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.857 0.36 . . . . 0.0 110.931 175.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.92 -42.98 56.69 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.164 -179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -56.1 -38.94 71.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.967 -175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 63.0 m -83.68 -7.65 59.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.933 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.93 31.1 58.39 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.582 172.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 63.4 mt -88.86 -5.01 58.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.859 0.362 . . . . 0.0 110.972 -165.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.716 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -128.01 154.3 45.79 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.912 -171.779 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.19 144.58 29.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.086 167.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 88.1 tt0 -65.1 136.18 56.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.884 176.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.405 HD12 ' CZ ' ' A' ' 106' ' ' TYR . 42.3 pt -100.12 151.54 5.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.09 179.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.5 m -96.15 126.5 44.06 Favored Pre-proline 0 C--N 1.331 -0.225 0 CA-C-O 121.585 0.707 . . . . 0.0 111.09 -179.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -55.07 134.06 61.63 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.637 2.225 . . . . 0.0 112.349 177.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -103.22 119.71 39.37 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.9 177.678 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.99 -41.66 99.64 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.794 -177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.73 -44.75 89.16 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.1 -177.024 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -75.0 -32.3 61.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.887 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.486 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 67.0 tt0 -53.48 -49.71 66.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.936 174.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -61.35 -32.63 72.53 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.894 174.786 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.39 -20.3 54.88 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.828 -175.009 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.86 -106.54 0.3 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.932 -172.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.478 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 29.2 t80 171.52 129.51 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.687 0.756 . . . . 0.0 110.973 -168.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -52.82 -36.01 72.16 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.762 2.308 . . . . 0.0 112.39 -173.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 72.8 t80 -64.91 -36.5 84.58 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.893 -173.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.2 p -73.83 -30.35 62.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.17 -179.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.588 ' HA ' HG22 ' A' ' 97' ' ' VAL . 80.7 m95 -67.27 -30.03 69.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.875 173.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -70.62 -31.31 68.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.827 174.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -72.07 -24.27 61.49 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.106 177.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.588 HG22 ' HA ' ' A' ' 94' ' ' TRP . 20.0 m -107.8 16.01 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.143 -178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.0 ttp180 -101.56 136.25 41.71 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.881 178.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 67.2 t80 -136.43 117.35 14.21 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.944 173.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 56.2 t30 60.56 36.05 19.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.868 175.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.49 2.19 89.03 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.51 172.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -127.97 149.87 50.15 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.825 0.345 . . . . 0.0 110.875 174.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.51 HD22 HG23 ' A' ' 97' ' ' VAL . 15.3 mt -86.01 135.49 33.63 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.838 -175.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 1.8 pp -122.15 -1.52 7.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.026 -170.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -164.89 165.86 20.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.139 -176.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.405 ' CZ ' HD12 ' A' ' 79' ' ' ILE . 97.1 m-85 -114.35 145.05 32.92 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.604 0.716 . . . . 0.0 110.926 170.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -78.21 125.23 7.0 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.686 2.257 . . . . 0.0 112.304 175.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.092 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp -106.29 -39.91 5.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.194 177.08 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.577 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -143.19 150.9 40.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.11 -167.002 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 77.3 t -114.69 130.89 68.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.164 177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 86.5 tt0 -120.53 119.89 34.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.538 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -150.06 144.95 26.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.068 -173.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.6 mp -89.88 170.04 10.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.973 -175.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.0 p -158.81 157.98 32.63 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.873 -176.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.91 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.88 127.03 46.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.924 170.822 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.566 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.2 mp -110.3 130.32 63.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.14 -175.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.3 p90 -128.39 146.52 50.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.835 -176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.0 t-20 -92.75 115.0 27.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.806 179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.435 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.9 mttt -65.66 -23.26 66.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.917 -175.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -78.68 -25.23 44.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.811 -175.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.7 mp -84.26 -49.24 8.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.871 174.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.643 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -143.67 128.5 9.61 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.743 0.782 . . . . 0.0 110.832 174.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -78.72 -9.03 15.89 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.634 2.223 . . . . 0.0 112.366 -176.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -143.19 97.01 5.75 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.64 0.733 . . . . 0.0 110.812 -174.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_endo -70.26 156.04 62.92 Favored 'Trans proline' 0 C--O 1.232 0.209 0 C-N-CA 122.746 2.297 . . . . 0.0 112.365 177.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -68.43 144.95 63.34 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.748 2.299 . . . . 0.0 112.314 -179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.18 -17.16 28.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.89 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 71.5 p -130.71 157.68 42.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.192 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.498 ' HA ' HD13 ' A' ' 132' ' ' ILE . 57.0 m95 -68.83 -28.94 67.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.951 -179.385 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -65.04 -22.13 66.93 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.85 -179.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.84 -24.25 41.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.858 -177.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.624 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -55.88 -50.05 89.44 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.676 0.751 . . . . 0.0 111.197 -172.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 37.8 Cg_endo -68.24 -39.11 10.74 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.622 2.215 . . . . 0.0 112.376 -173.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.02 -60.15 3.6 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.101 177.143 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.263 HD22 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.28 -17.01 63.69 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.989 -175.732 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.513 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.8 t70 -58.47 -40.42 82.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.848 168.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.07 -30.75 69.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.862 -178.486 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -72.49 -46.42 54.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.773 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.638 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.0 pp -84.86 -14.35 48.17 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.964 179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.638 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.7 tttt -61.15 -34.41 74.96 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.955 174.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.95 -23.44 67.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.099 176.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -94.96 3.62 54.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.921 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.48 33.16 53.45 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.56 178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.8 mptt -111.75 169.95 8.47 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.838 0.351 . . . . 0.0 110.867 174.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 29.0 t -121.12 140.22 52.27 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.917 168.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.429 ' HA ' HD21 ' A' ' 139' ' ' LEU . . . -66.69 -40.37 88.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.112 -172.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -144.53 130.59 19.45 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.93 -177.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 55.2 ttm -118.18 132.92 56.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.848 -177.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 35.6 p90 -153.53 157.35 39.65 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.878 -173.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 92.1 m-20 -84.93 -54.64 4.53 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.94 -177.108 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.819 HD13 ' O ' ' A' ' 151' ' ' LEU . 0.7 OUTLIER 49.28 30.72 3.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.022 -168.362 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 91.0 mm-40 -103.45 -4.35 24.17 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.938 174.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -129.91 156.53 78.88 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.59 0.71 . . . . 0.0 110.952 -176.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.406 ' HD3' ' HD2' ' A' ' 344' ' ' ARG . 40.3 Cg_endo -60.76 -24.37 78.7 Favored 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.684 2.256 . . . . 0.0 112.321 174.282 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 77.4 m-85 -68.23 -30.02 68.98 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.822 179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.4 m-85 -84.27 -38.31 20.62 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.844 173.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.433 HG23 HG11 ' A' ' 347' ' ' VAL . 23.0 m -61.11 -47.23 87.22 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.979 -179.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.579 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 39.2 t-105 -56.96 -54.58 52.96 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.534 0.683 . . . . 0.0 110.949 -169.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.579 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 31.2 Cg_endo -65.83 -19.63 58.78 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.731 2.287 . . . . 0.0 112.41 -174.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.718 HD13 ' C ' ' A' ' 160' ' ' LEU . 1.3 tm? -81.63 -45.29 16.0 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.864 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.505 HG22 ' HA3' ' A' ' 166' ' ' GLY . 80.1 mt -74.23 -43.3 50.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.116 179.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -68.9 -22.57 64.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.099 -178.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.541 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -58.87 -32.28 69.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.172 -176.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -100.87 1.13 39.69 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.879 -178.585 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 112.29 5.48 24.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.492 177.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.505 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -77.2 69.6 2.48 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.509 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -87.36 132.64 33.89 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.86 0.362 . . . . 0.0 110.98 179.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -83.75 10.34 9.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.154 -171.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.433 ' HA ' HG12 ' A' ' 181' ' ' VAL . 52.8 p90 -158.13 152.34 24.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.881 -178.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -93.28 128.38 39.26 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.816 159.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -118.08 121.57 40.93 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.827 172.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -152.02 130.05 11.83 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.901 -174.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.02 41.83 31.5 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.842 174.545 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.37 17.52 79.75 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.533 174.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.01 139.35 51.04 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.768 0.318 . . . . 0.0 110.86 -176.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -98.88 145.01 27.43 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.832 171.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -128.32 108.95 11.01 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.874 174.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.572 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.3 pp -79.1 -8.52 11.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.131 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -100.27 -12.31 19.62 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.907 -177.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -119.49 85.81 2.44 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.854 170.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.433 HG12 ' HA ' ' A' ' 169' ' ' PHE . 27.4 m -114.28 161.3 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.135 -170.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.02 22.66 32.83 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.495 -172.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.515 HG21 HD12 ' A' ' 368' ' ' ILE . 6.8 m -107.37 -17.05 8.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.772 0.32 . . . . 0.0 111.112 -178.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -87.04 20.47 2.66 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.841 -177.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.6 p30 -119.97 -171.51 2.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.91 -178.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.29 -29.71 69.38 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.106 -173.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.7 -41.41 95.87 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.69 -0.766 . . . . 0.0 112.484 -167.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.611 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.24 -38.06 89.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.972 0.415 . . . . 0.0 111.093 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.577 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 96.8 mttt -62.04 -37.82 86.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.943 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.07 -37.91 89.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.074 176.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.415 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -66.2 -46.47 79.36 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.753 -0.736 . . . . 0.0 112.576 178.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.664 HD11 ' HA ' ' A' ' 347' ' ' VAL . 27.3 tp -65.08 -35.92 82.66 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.831 0.348 . . . . 0.0 110.855 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.408 ' OG1' HG21 ' A' ' 357' ' ' VAL . 90.0 m -64.52 -41.17 96.56 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.151 177.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.455 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 65.0 t80 -66.32 -47.94 71.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.861 177.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.673 HD23 ' C ' ' A' ' 195' ' ' LEU . 5.2 tt -50.32 -51.56 44.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.963 -175.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.431 ' HA ' ' CG1' ' A' ' 199' ' ' ILE . 27.9 m -65.04 -21.61 29.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.075 -173.583 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.0 m-20 -62.59 -33.92 75.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.802 -178.752 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.9 OUTLIER -81.21 -39.9 24.69 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.959 -174.635 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.576 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.6 pp -73.95 -26.99 21.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.07 172.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.25 -38.23 84.83 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.97 170.273 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -80.95 2.92 24.73 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.895 176.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.2 mttt 66.53 37.68 4.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.922 170.775 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 56.0 m170 -77.58 -18.94 56.38 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.819 179.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.576 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.1 ppp? -144.14 156.95 44.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.865 175.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -95.02 152.0 18.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.815 178.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.14 -26.93 68.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.075 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -95.5 1.73 54.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.813 -177.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.1 m -63.84 126.08 26.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.101 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.438 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 16.9 t0 -120.05 174.28 6.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.843 177.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 12.4 p90 -64.98 -37.0 86.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.969 -178.642 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.8 p -70.45 -37.52 74.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.912 177.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.438 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 80.3 mt -65.01 -42.48 94.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.077 173.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.12 -35.68 81.57 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.06 177.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 85.8 tt0 -63.0 -45.04 94.27 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.865 175.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.8 -41.44 95.81 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.096 178.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.86 -42.86 97.45 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.058 178.553 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -63.8 -39.67 94.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.936 178.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -64.33 -35.73 81.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.869 178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -83.59 -20.02 34.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.982 -178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.84 25.83 33.71 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.418 -178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -84.79 -21.65 29.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.976 0.417 . . . . 0.0 110.902 -177.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.2 t -124.45 136.81 54.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.076 178.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.588 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -65.03 -47.68 76.54 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.061 179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.522 ' HB3' HD21 ' A' ' 115' ' ' LEU . 71.8 mtm -134.49 158.32 44.24 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.88 -174.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 60.8 p -139.73 161.29 37.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.171 172.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.2 mm -110.75 127.18 67.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.03 175.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 -154.95 175.04 14.31 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.957 -172.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -88.64 -156.87 31.77 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.523 -176.357 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 -22.26 32.28 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.66 2.24 . . . . 0.0 112.384 -178.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 28.8 m-90 -78.36 -24.93 46.19 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.945 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 48.76 51.95 14.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.175 175.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 88.7 m95 -60.04 -23.94 64.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.973 -177.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 61.3 m -50.05 -43.95 51.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.853 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 53.2 p30 -87.0 176.7 7.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.922 -172.48 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 4.7 mp -122.13 123.39 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.211 -171.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -69.51 -35.11 75.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.847 -174.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 87.3 m -125.03 101.82 7.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.166 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 29.2 t -174.35 159.75 3.13 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.871 177.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -80.53 -14.83 57.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.876 -178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 27.9 m -59.98 153.53 4.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.129 -178.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -108.29 128.28 54.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.831 179.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.435 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 50.2 p90 -145.21 158.21 43.88 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.884 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.92 162.35 25.92 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.387 174.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.1 p -135.72 135.32 51.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.974 0.416 . . . . 0.0 111.142 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.7 t -154.39 148.75 26.1 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.144 177.524 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.5 m -62.9 167.43 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.173 -176.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 1.022 HD23 ' HD3' ' A' ' 257' ' ' PRO . 2.6 mm? -63.1 149.53 90.62 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.575 0.702 . . . . 0.0 110.961 -164.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -76.84 -176.33 3.11 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.691 2.261 . . . . 0.0 112.382 -177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . 0.405 ' HA ' ' HA ' ' A' ' 254' ' ' PRO . 96.8 m -92.47 145.17 24.66 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.057 -172.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 40.9 t80 -130.91 113.26 13.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.933 -176.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt 55.0 36.59 27.28 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.815 178.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.43 2.79 84.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.494 175.124 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -131.36 130.62 22.61 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-O 121.539 0.685 . . . . 0.0 110.843 177.66 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 249' ' ' THR . 22.9 Cg_endo -65.42 133.93 36.7 Favored 'Trans proline' 0 N--CA 1.465 -0.179 0 C-N-CA 122.715 2.277 . . . . 0.0 112.324 -173.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.604 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 97.0 p -84.52 0.19 50.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.766 173.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -37.4 135.02 0.73 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.522 0.677 . . . . 0.0 110.9 177.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 1.022 ' HD3' HD23 ' A' ' 247' ' ' LEU . 38.0 Cg_endo -80.05 157.85 23.66 Favored 'Trans proline' 0 C--O 1.231 0.151 0 C-N-CA 122.729 2.286 . . . . 0.0 112.336 -166.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -75.09 169.67 17.56 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.871 -178.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 39.0 t -114.53 129.67 70.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.146 -166.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -110.96 137.7 14.48 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.369 173.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 76.9 t -125.36 117.11 48.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.806 0.336 . . . . 0.0 111.207 179.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.425 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -65.27 119.73 11.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.908 178.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.9 m -126.4 126.61 44.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.79 -167.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -125.67 137.07 53.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.041 -171.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -131.42 171.44 21.14 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.486 -170.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.846 HG13 ' HG2' ' A' ' 277' ' ' LYS . 25.0 mm -113.41 126.17 70.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.81 0.338 . . . . 0.0 111.297 -171.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -61.27 131.12 49.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.873 -174.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.464 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -59.81 -26.17 65.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.125 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.21 -8.49 57.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.072 -173.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 29.8 t -70.81 127.16 92.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.674 0.75 . . . . 0.0 110.913 -171.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.455 ' HD2' HG21 ' A' ' 2' ' ' ILE . 74.1 Cg_endo -72.87 -10.46 24.83 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.658 2.239 . . . . 0.0 112.401 165.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 72.4 m-80 -104.04 19.09 20.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.88 -169.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 94.4 mttt -54.09 -34.91 61.4 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.925 -171.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.14 -52.43 63.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.962 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.6 pp -84.36 -27.97 27.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.924 -176.56 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.81 -50.51 56.43 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.06 178.626 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.846 ' HG2' HG13 ' A' ' 266' ' ' ILE . 96.1 mttt -59.74 -38.49 81.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.839 173.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.541 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.7 tt0 -68.45 -48.25 65.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.901 -175.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 20.9 m-30 -67.59 -35.37 78.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.89 -177.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.497 ' HA ' HD22 ' A' ' 284' ' ' LEU . 7.3 tt -61.8 -51.96 66.12 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.892 -175.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.7 pt-20 -78.15 -31.5 49.8 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.836 -176.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.541 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 63.8 m-80 -99.46 -11.61 20.95 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.848 -165.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.918 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 66.6 m-85 -129.95 -52.82 1.13 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.863 177.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.497 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.6 OUTLIER -62.73 -36.74 83.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.912 -169.425 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 1.092 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.6 pp -124.27 37.63 4.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.979 176.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.457 ' CG2' ' N ' ' A' ' 287' ' ' ASP . 4.1 m -116.08 154.91 29.09 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.099 177.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.501 ' HA ' HD11 ' A' ' 290' ' ' LEU . 33.0 t70 -42.93 -37.42 1.86 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.796 -167.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -78.03 -40.81 37.71 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.971 -176.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.918 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.06 -57.16 5.37 Favored Glycine 0 N--CA 1.453 -0.18 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.497 -172.007 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.584 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.1 -21.17 66.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.815 0.34 . . . . 0.0 110.974 -178.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.581 ' N ' HD12 ' A' ' 290' ' ' LEU . 84.6 tt0 -67.44 -45.1 77.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 170.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.84 -44.81 95.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.131 -173.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.436 HG23 ' CA ' ' A' ' 19' ' ' GLY . 1.4 p -80.03 -30.0 12.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.11 -174.498 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 43.2 t30 -70.12 -27.17 64.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.827 172.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -65.32 -25.79 67.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.927 179.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -81.95 -51.28 8.22 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 74.3 mmtt -143.2 152.7 58.47 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-O 121.615 0.722 . . . . 0.0 110.847 178.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -62.17 116.4 3.46 Favored 'Trans proline' 0 C--O 1.231 0.139 0 C-N-CA 122.771 2.314 . . . . 0.0 112.298 177.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.446 HD12 ' HA ' ' A' ' 299' ' ' LEU . 0.2 OUTLIER -87.55 -18.58 29.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.898 176.194 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 103.64 -58.55 0.52 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.525 177.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.639 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -170.73 164.76 8.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.842 0.353 . . . . 0.0 111.138 175.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.577 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 21.7 m -124.23 156.08 31.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.101 178.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.22 -11.02 59.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.109 172.574 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.584 ' CD2' HD21 ' A' ' 290' ' ' LEU . 47.3 tp -83.2 122.06 27.9 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.88 -175.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.32 -39.15 75.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.858 -174.222 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 46.5 t -64.73 -49.95 68.82 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.881 -168.314 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.468 ' HB3' HG21 ' A' ' 302' ' ' VAL . 18.4 t80 -81.62 -29.07 33.39 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 -179.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -61.95 -39.73 93.13 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.831 175.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -59.39 -38.21 79.97 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 175.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -73.7 -38.49 64.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.956 176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.639 HD13 ' HA ' ' A' ' 301' ' ' ALA . 78.5 mt -62.82 -32.91 74.21 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.935 176.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.26 -18.83 62.29 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.113 -177.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.06 -20.07 66.3 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.901 174.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -91.34 121.07 68.11 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.636 0.731 . . . . 0.0 110.87 166.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -47.98 -26.76 7.91 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.756 2.304 . . . . 0.0 112.313 178.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.9 mtt85 -61.76 -35.63 78.68 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.873 -175.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.545 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.1 mp -80.12 -32.6 13.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.076 -177.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.4 -40.09 85.49 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.14 -172.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -67.17 -46.25 74.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.108 176.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.538 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 81.2 p -64.97 -29.21 70.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.066 -174.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.5 mtp -63.7 -34.38 77.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.873 176.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.6 tp10 -64.75 -47.7 77.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.895 -173.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.522 HD21 ' HB1' ' A' ' 112' ' ' ALA . 8.9 p-10 -82.14 -28.01 32.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.864 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.01 -50.24 67.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.011 -175.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -69.25 -29.92 67.94 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.922 -176.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -108.2 -8.55 15.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 -169.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.13 -153.55 29.99 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.43 -166.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -147.33 143.69 28.22 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.796 0.332 . . . . 0.0 110.902 -170.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 44.4 mm -61.76 124.01 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.092 -167.482 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 95.5 mtp -50.3 156.91 1.3 Allowed Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.49 0.662 . . . . 0.0 110.969 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.464 ' HG3' ' CE2' ' A' ' 158' ' ' TRP . 89.6 Cg_endo -77.63 72.26 6.13 Favored 'Trans proline' 0 C--O 1.23 0.124 0 C-N-CA 122.693 2.262 . . . . 0.0 112.379 174.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.428 ' HB3' ' HB2' ' A' ' 64' ' ' HIS . 12.7 t-20 -101.49 13.37 35.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.918 -172.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 45.7 pt -77.81 157.51 79.19 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.539 0.685 . . . . 0.0 111.207 -177.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -56.48 -37.04 98.03 Favored 'Trans proline' 0 C--O 1.23 0.111 0 C-N-CA 122.757 2.305 . . . . 0.0 112.254 -173.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -67.62 -29.7 69.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.85 -177.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.416 ' HE2' ' HB3' ' A' ' 336' ' ' MET . 69.1 mmm -80.01 -17.83 51.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.826 -172.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 47.6 t -62.18 -41.99 98.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.831 176.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.49 -37.04 63.26 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.156 176.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.429 ' O ' HG13 ' A' ' 343' ' ' VAL . 7.4 m-30 -66.28 -36.29 82.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.882 178.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 17.7 m0 -54.93 -37.9 66.99 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.982 172.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 19.3 m-30 -71.79 -38.05 70.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.939 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.92 -42.81 80.5 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.105 -179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.429 HG13 ' O ' ' A' ' 339' ' ' PHE . 21.4 m -72.72 -31.36 36.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.184 -178.085 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.425 ' O ' HG22 ' A' ' 347' ' ' VAL . 74.0 ttt-85 -61.67 -40.93 96.7 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.876 175.604 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.0 m -55.76 -36.14 66.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.186 178.334 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.13 -46.19 81.97 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.084 -176.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.664 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.4 m -75.55 -34.78 30.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.199 -172.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.448 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -62.42 -48.01 90.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.114 173.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 82.9 m-20 -65.21 -37.94 88.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.858 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.32 -46.61 60.27 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.128 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.42 -40.66 81.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.053 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.2 p -75.74 -11.88 60.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.981 0.419 . . . . 0.0 110.927 -177.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.57 18.02 69.46 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.424 179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.83 -32.95 46.4 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.757 0.313 . . . . 0.0 110.848 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.0 mt-30 -140.08 157.01 46.31 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.91 177.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 50.0 p -77.27 165.76 24.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.159 169.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.408 HG21 ' OG1' ' A' ' 193' ' ' THR . 55.4 t -54.94 -42.7 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.167 174.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -63.04 -44.13 96.75 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.832 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 86.8 mt-10 -69.38 -54.0 16.64 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.896 178.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -69.37 -47.78 63.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.132 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.5 tm? -64.95 -45.03 87.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.96 -174.449 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -65.41 -53.04 48.83 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.945 -177.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -69.64 -45.68 67.92 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.892 -173.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.23 -42.87 83.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.075 -174.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 85.6 mm-40 -72.49 -30.96 64.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.979 -177.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 55.5 m -59.01 -32.59 69.85 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.093 175.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.8 mtt180 -57.11 -29.94 63.95 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.937 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.515 HD12 HG21 ' A' ' 183' ' ' VAL . 69.8 mt -59.72 -39.6 80.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.147 175.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.3 p -94.78 -14.98 24.18 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.149 -177.601 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.808 179.074 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.745 0.307 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.459 HG21 ' HD2' ' A' ' 271' ' ' PRO . 83.2 mt -97.54 133.05 40.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.179 179.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.1 pt-20 -144.97 146.8 32.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.844 -178.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -54.97 132.99 48.16 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 92.1 7.74 63.78 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.406 -176.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.519 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.1 tttt -164.44 134.67 4.04 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.744 0.306 . . . . 0.0 110.959 176.355 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.663 HD22 HD11 ' A' ' 33' ' ' ILE . 1.0 OUTLIER -141.72 154.81 45.54 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.956 -172.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.424 HG22 ' HB ' ' A' ' 36' ' ' THR . 77.3 t -113.59 135.74 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.133 -177.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.635 HG23 ' HB ' ' A' ' 59' ' ' ILE . 1.4 mp -119.65 133.97 64.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.116 176.237 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.735 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 74.9 m95 -105.18 124.24 49.2 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.943 166.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.484 HD12 ' HG ' ' A' ' 20' ' ' LEU . 13.6 tt -110.35 149.97 13.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.146 -167.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -64.52 158.63 23.59 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.756 -171.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.36 -16.07 26.43 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.699 -0.763 . . . . 0.0 112.511 -177.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 98.4 m-20 -68.25 -29.9 68.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.883 0.373 . . . . 0.0 110.853 -172.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 37.2 mmtm -139.18 130.02 26.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.845 166.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.16 -80.14 1.01 Allowed Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.468 -172.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.2 t80 -96.72 -42.36 8.04 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.941 0.401 . . . . 0.0 110.97 -178.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -67.59 -49.93 60.76 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.837 -153.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.12 -56.97 20.54 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.407 -176.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.545 ' HB3' HG22 ' A' ' 37' ' ' VAL . 5.5 mt -51.72 -46.48 63.97 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.797 0.332 . . . . 0.0 110.923 176.512 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.04 -37.48 45.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.061 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -75.68 -60.04 2.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.972 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 20.3 m -71.94 -36.61 58.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.171 -172.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -62.46 -40.84 99.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.477 175.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 54.4 tptt -61.04 -31.24 70.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.824 0.345 . . . . 0.0 110.928 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 28.2 tptt -50.0 -39.94 42.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.919 172.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.604 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 0.9 OUTLIER -54.97 -49.24 71.91 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.9 176.818 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -71.75 -34.92 69.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.899 -174.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -67.23 -37.99 84.49 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.958 -177.704 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.6 m-20 -95.2 -47.29 6.41 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 -168.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.8 p -115.1 -5.96 12.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.197 -169.48 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 77.53 4.9 85.44 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.377 169.108 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.989 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -89.73 132.36 34.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-O 120.826 0.346 . . . . 0.0 111.078 -179.202 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.4 mttt -70.03 136.73 50.68 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.931 -170.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.494 HG23 HD11 ' A' ' 9' ' ' ILE . 9.8 p -112.76 134.32 55.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.067 -177.206 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.501 ' O ' HD12 ' A' ' 9' ' ' ILE . 99.3 m -113.19 129.24 56.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.124 -178.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 20' ' ' LEU . 84.8 t -102.41 128.43 55.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.204 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.3 mm-40 -120.12 152.0 38.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.919 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 96.8 m-70 -91.64 150.62 41.32 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.566 0.698 . . . . 0.0 110.823 -166.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.544 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 37.1 Cg_endo -68.92 -19.62 39.97 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.611 2.207 . . . . 0.0 112.39 -175.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -54.13 -49.02 70.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.904 -174.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -89.58 -9.1 51.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.881 -178.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.586 ' C ' HD23 ' A' ' 43' ' ' LEU . 8.3 tt -48.64 -53.86 16.94 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.891 -168.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -63.77 -35.37 80.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.852 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -70.13 -36.4 74.77 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.857 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.403 ' O ' HG22 ' A' ' 50' ' ' VAL . 74.7 mmtt -80.64 -24.54 38.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.899 178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.579 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 86.3 t80 -49.45 -50.6 64.53 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-O 121.607 0.718 . . . . 0.0 110.877 -163.031 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 46.2 Cg_endo -82.58 -32.08 0.7 Allowed 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.648 2.232 . . . . 0.0 112.391 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -77.22 -44.17 30.94 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.867 -165.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.517 HG21 ' HG3' ' A' ' 57' ' ' PRO . 24.8 m -70.31 -27.72 32.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.075 -173.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.624 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -71.85 -35.19 69.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.042 177.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.48 -32.56 73.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.106 179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.7 p -89.13 -18.87 26.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.11 174.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.94 8.77 78.79 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.49 169.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 56.2 m-20 -128.18 130.01 47.37 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.829 0.347 . . . . 0.0 110.827 174.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.97 -91.57 0.13 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.554 169.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.735 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 77.4 Cg_endo -80.07 146.92 18.41 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.688 2.259 . . . . 0.0 112.349 179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -94.25 -35.03 12.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.777 161.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.635 ' HB ' HG23 ' A' ' 9' ' ' ILE . 29.4 mt -127.03 138.48 54.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.173 -178.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 tp -133.23 127.39 54.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.101 -179.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.1 m-85 -87.94 140.7 29.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.816 169.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.508 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 24.2 p90 -145.11 160.83 40.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.001 170.316 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -60.73 -87.56 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.113 -166.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -127.19 -68.41 0.8 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.927 -171.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.442 ' HB2' ' HB2' ' A' ' 332' ' ' ASN . 69.2 m-20 -99.33 -10.65 22.04 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.839 -162.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -56.11 -19.07 11.7 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.921 -169.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.522 ' HB2' HD13 ' A' ' 104' ' ' ILE . 36.0 p90 -57.67 -31.45 66.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.851 -179.37 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.76 -52.32 53.13 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.572 -171.416 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.92 -35.99 85.64 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.528 174.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.617 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 11.1 t80 -66.87 -41.73 86.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.726 0.298 . . . . 0.0 110.902 -176.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.4 -39.87 67.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.112 174.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.1 tp60 -58.51 -35.9 72.98 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.928 -177.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.415 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 64.5 m -87.67 -5.01 58.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.93 179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.01 31.25 58.05 Favored Glycine 0 N--CA 1.449 -0.433 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.526 175.014 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.624 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 53.6 mt -87.73 -12.06 46.38 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.864 0.364 . . . . 0.0 110.889 -169.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.617 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -129.08 151.66 49.52 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.934 -178.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.415 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -78.95 140.83 37.96 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.021 175.131 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -74.16 141.43 45.53 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.836 179.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.402 HD12 ' CZ ' ' A' ' 106' ' ' TYR . 42.7 pt -110.45 162.84 7.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.125 -179.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 82.1 p -107.25 149.91 39.3 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.639 0.733 . . . . 0.0 111.119 177.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -72.14 141.22 35.7 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.624 2.216 . . . . 0.0 112.417 -179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -105.26 120.02 40.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.928 173.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -62.22 -42.0 98.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.841 -177.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.98 -43.9 91.09 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.154 -177.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.6 m-85 -74.3 -32.89 63.04 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.875 179.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.471 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 65.1 tt0 -54.88 -50.09 69.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.043 176.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -61.36 -30.33 70.46 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.751 175.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -78.86 -20.03 50.55 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.821 -176.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.18 -104.92 0.3 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.94 -172.925 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 22.4 t80 172.12 129.47 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.704 0.764 . . . . 0.0 110.885 -169.679 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -53.63 -37.59 83.58 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.647 2.231 . . . . 0.0 112.356 -174.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -65.22 -34.06 77.48 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.917 -173.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.9 p -75.5 -31.01 60.02 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.079 -178.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.575 ' HA ' HG22 ' A' ' 97' ' ' VAL . 88.6 m95 -65.54 -30.01 70.7 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.935 173.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -69.56 -32.07 70.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.862 177.559 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.55 -26.24 62.56 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.137 177.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.626 HG23 HD22 ' A' ' 103' ' ' LEU . 18.5 m -108.28 16.88 7.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.14 -175.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 58.1 ttp180 -104.71 135.76 45.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.907 -179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -132.45 117.47 18.1 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 175.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.7 t30 58.68 35.07 24.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.818 177.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.62 -0.85 89.19 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.588 175.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -125.11 145.11 50.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.849 0.356 . . . . 0.0 110.843 176.232 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.626 HD22 HG23 ' A' ' 97' ' ' VAL . 28.8 mt -80.86 139.14 36.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.892 -172.545 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.522 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.8 pp -123.46 -2.7 6.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.096 -174.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.508 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -161.74 165.29 28.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.152 -176.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.402 ' CZ ' HD12 ' A' ' 79' ' ' ILE . 90.2 m-85 -114.31 144.47 31.77 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.646 0.736 . . . . 0.0 110.93 170.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.57 122.26 5.45 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.606 2.204 . . . . 0.0 112.326 175.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.009 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -106.49 -36.64 3.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.205 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -144.44 150.86 38.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.183 -169.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 90.6 t -120.33 134.91 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.134 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 82.9 mt-10 -124.97 136.78 54.06 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.845 172.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.628 ' HB1' HD21 ' A' ' 323' ' ' ASN . . . -151.89 145.78 25.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.083 176.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.7 mp -85.57 164.16 17.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.887 -173.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.7 p -157.22 154.86 29.88 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.916 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.913 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -95.92 127.04 41.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.96 169.545 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.605 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.2 mp -110.02 133.17 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.153 -175.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.2 p90 -133.63 148.85 51.57 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 -176.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 56.4 t-20 -90.92 115.14 27.72 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.861 179.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.508 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.3 mttt -63.06 -22.75 67.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.979 -177.46 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 30.7 t70 -77.34 -25.42 51.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.863 -174.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.4 mp -88.33 -52.9 4.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 173.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.674 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -141.74 126.13 10.26 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.725 0.774 . . . . 0.0 110.844 174.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -81.92 -2.32 11.27 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.671 2.247 . . . . 0.0 112.293 -175.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -150.78 102.6 3.04 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.61 0.719 . . . . 0.0 110.812 -174.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -70.64 156.74 60.46 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.667 2.245 . . . . 0.0 112.375 179.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -66.45 145.08 75.91 Favored 'Trans proline' 0 C--N 1.34 0.128 0 C-N-CA 122.663 2.242 . . . . 0.0 112.251 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -81.27 -18.28 46.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.87 -175.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.8 p -133.92 159.0 42.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.2 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.442 ' HE1' ' HG ' ' A' ' 255' ' ' SER . 69.6 m95 -72.08 -29.95 64.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.873 178.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -65.85 -20.35 66.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.864 -179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 82.8 mt-10 -77.69 -27.24 50.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.866 -179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.547 ' HA ' HD12 ' A' ' 135' ' ' LEU . 0.6 OUTLIER -55.24 -47.22 99.07 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.57 0.7 . . . . 0.0 111.152 -169.455 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.466 ' N ' HG22 ' A' ' 132' ' ' ILE . 81.9 Cg_exo -51.15 -49.31 17.5 Favored 'Trans proline' 0 N--CA 1.465 -0.164 0 C-N-CA 122.695 2.263 . . . . 0.0 112.377 178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.67 -58.39 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.149 -176.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.247 HD22 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.34 -17.64 64.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.955 -173.955 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.575 ' N ' HD13 ' A' ' 135' ' ' LEU . 34.3 t70 -60.28 -41.83 94.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.869 168.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.38 -30.83 69.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 -178.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -70.4 -47.39 61.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.891 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.65 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.9 pp -85.0 -14.38 47.62 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.829 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.65 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.9 tttt -61.75 -34.7 76.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 174.633 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.96 -23.2 67.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.06 175.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -95.03 5.0 53.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.918 179.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.99 31.89 57.32 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.463 178.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.2 mptt -110.36 170.14 8.28 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.857 0.361 . . . . 0.0 110.832 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.6 t -123.29 140.41 53.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.881 166.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.465 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -65.62 -41.24 92.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.144 -172.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -144.45 128.4 17.45 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 -176.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 98.3 mmm -106.73 134.43 49.89 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.6 p90 -157.82 161.92 38.39 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.861 -175.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 93.0 m-20 -96.64 -47.61 5.84 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.929 174.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.154 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.1 tm? 46.17 33.47 1.77 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 -168.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 89.3 mm-40 -99.43 -7.75 25.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.879 171.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -118.86 153.82 52.71 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-O 121.7 0.762 . . . . 0.0 110.917 -174.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_endo -66.26 -24.46 50.88 Favored 'Trans proline' 0 C--N 1.343 0.277 0 C-N-CA 122.669 2.246 . . . . 0.0 112.354 178.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -75.53 -29.88 59.57 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.832 -173.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 61.0 t80 -83.04 -31.53 27.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.843 171.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 18.6 m -58.48 -43.29 88.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.046 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.568 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 43.9 t-105 -58.14 -55.63 43.37 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.532 0.682 . . . . 0.0 110.85 -171.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.598 ' O ' ' HB2' ' A' ' 163' ' ' ALA . 23.7 Cg_endo -64.23 -18.64 64.08 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.682 2.255 . . . . 0.0 112.416 -174.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.713 HD13 ' C ' ' A' ' 160' ' ' LEU . 1.7 tm? -82.3 -45.55 14.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.897 177.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.579 HG22 ' HA3' ' A' ' 166' ' ' GLY . 85.4 mt -75.48 -44.65 41.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.052 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.17 -23.35 60.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.05 -173.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -58.98 -35.27 72.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.166 -171.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.7 p30 -103.06 8.42 38.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.881 -178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 118.52 3.76 14.1 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.442 171.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.579 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -76.78 65.87 2.83 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.507 178.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 82.0 m-85 -89.32 135.01 33.82 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.855 0.36 . . . . 0.0 110.945 -177.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.23 0.45 36.64 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.223 -174.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.6 p90 -152.13 141.65 21.69 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.875 -176.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 37.9 tptt -72.68 135.69 45.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.998 156.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -124.69 116.38 22.26 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.922 164.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -147.77 118.47 7.54 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.895 -176.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 53.51 38.17 27.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.893 178.628 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.35 23.96 74.34 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.519 178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -127.26 139.22 53.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 110.854 -175.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -97.47 120.61 38.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.961 171.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -110.86 105.13 13.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.845 178.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 5.4 tp -63.51 -17.34 19.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.063 -174.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.95 -7.54 48.75 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.941 -169.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 48.8 t0 -130.87 60.35 1.65 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.859 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 29.0 m -107.93 167.56 3.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.115 -174.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -102.61 5.22 51.15 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.562 -166.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.518 ' HB ' ' HB3' ' A' ' 365' ' ' GLN . 0.8 OUTLIER -101.25 -25.49 3.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.886 0.374 . . . . 0.0 111.096 -168.728 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 63.1 m-20 -93.65 24.96 3.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.871 173.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -116.71 176.12 5.26 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.903 -178.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.15 -27.25 68.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.047 -176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.87 -40.69 97.44 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.521 -172.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.59 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.05 -37.85 88.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.997 0.427 . . . . 0.0 111.19 178.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.586 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 90.5 mttt -62.38 -37.62 86.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.813 175.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.05 -38.07 89.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.099 177.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.484 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -66.99 -47.99 62.66 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.535 178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.518 HD11 ' HA ' ' A' ' 347' ' ' VAL . 27.4 tp -65.95 -35.25 80.09 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.879 0.371 . . . . 0.0 110.904 -177.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.528 ' OG1' HG21 ' A' ' 357' ' ' VAL . 93.4 m -64.97 -43.29 93.13 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.186 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 91.4 t80 -67.81 -47.12 69.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.871 178.057 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.723 HD23 ' C ' ' A' ' 195' ' ' LEU . 4.7 tt -50.39 -50.38 51.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.918 -174.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.425 ' O ' HG13 ' A' ' 199' ' ' ILE . 35.7 m -65.04 -22.45 31.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.15 -174.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.9 m-20 -61.86 -33.14 73.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.898 -178.682 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.431 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.8 OUTLIER -81.16 -40.07 24.55 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.876 -173.829 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.425 HG13 ' O ' ' A' ' 196' ' ' VAL . 1.6 pp -72.65 -29.76 31.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.134 171.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -68.22 -38.14 81.59 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.863 173.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.7 m-20 -82.67 3.67 28.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.847 177.414 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 66.36 40.22 3.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.832 170.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 58.0 m170 -76.73 -14.93 59.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.767 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -142.0 154.58 45.12 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.865 174.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -94.6 155.0 17.09 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.902 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.86 -27.71 68.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.044 -176.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 58.0 p-10 -96.04 0.14 51.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.817 -177.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 90.2 m -63.26 135.06 56.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.061 -176.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -142.62 174.41 10.66 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.991 176.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -61.94 -41.58 98.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.975 0.416 . . . . 0.0 111.014 -175.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 74.0 m -62.25 -40.45 96.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.883 178.295 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 66.3 mt -64.94 -43.66 96.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.122 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.86 -34.24 77.9 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.097 -179.338 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -61.83 -47.79 83.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.928 176.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.91 -41.59 95.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.088 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.67 -44.27 90.91 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.137 -179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 63.3 t80 -64.81 -39.9 94.33 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.9 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -64.83 -34.2 77.8 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.915 -178.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -86.29 -16.77 36.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.828 179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.85 28.31 29.3 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.502 178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -84.07 -22.77 31.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.923 0.392 . . . . 0.0 110.861 -176.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 67.4 p -130.91 144.02 51.16 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.185 -178.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.503 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -66.55 -60.99 2.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.058 -173.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.516 ' HB3' HD21 ' A' ' 115' ' ' LEU . 59.4 mtm -134.62 158.5 43.88 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 -166.409 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 12.4 t -150.43 157.29 42.87 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.128 179.227 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 47.5 mm -109.26 126.98 66.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.182 -176.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -154.62 174.26 15.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.917 -172.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -85.11 -158.29 29.33 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.52 -179.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -67.87 -23.66 40.98 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.677 2.251 . . . . 0.0 112.404 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -78.04 -30.38 49.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.914 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 45.69 49.91 11.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.127 175.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 71.6 m95 -59.98 -24.0 64.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.959 179.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 83.6 p -79.01 -5.22 53.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.804 -175.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 27.5 p30 -81.03 -174.95 5.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.931 -178.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.414 HG21 ' HB3' ' A' ' 238' ' ' SER . 89.5 mt -98.01 130.89 46.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.172 -177.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -92.01 -53.68 4.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.86 -177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 85.7 m -132.95 112.98 12.31 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.188 -177.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . 0.414 ' HB3' HG21 ' A' ' 235' ' ' ILE . 33.8 t -175.11 164.58 3.33 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.838 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -83.83 -4.65 58.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.895 171.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 99.6 t -81.3 124.42 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.341 -0.39 . . . . 0.0 111.12 178.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -88.09 147.91 24.72 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.831 -179.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.508 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 49.3 p90 -145.9 163.23 35.77 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.967 178.41 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -128.78 158.0 21.7 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.446 -176.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.7 p -136.39 135.28 49.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.953 0.406 . . . . 0.0 111.111 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.4 t -153.73 149.86 27.92 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.132 177.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 28.2 m -61.23 163.4 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.157 -179.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.484 HD12 ' N ' ' A' ' 247' ' ' LEU . 3.9 mp -69.1 150.01 97.55 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.59 0.71 . . . . 0.0 111.049 -164.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.56 -176.4 2.95 Favored 'Trans proline' 0 N--CA 1.465 -0.196 0 C-N-CA 122.809 2.339 . . . . 0.0 112.366 -174.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.4 m -84.25 143.15 29.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.161 -173.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -130.08 112.79 13.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.874 -176.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt 55.16 35.78 25.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.887 -179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.41 0.97 84.17 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.534 175.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.414 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 91.4 mm-40 -125.73 125.82 24.93 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.496 0.665 . . . . 0.0 110.914 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 73.0 Cg_exo -54.54 132.82 53.4 Favored 'Trans proline' 0 N--CA 1.465 -0.151 0 C-N-CA 122.736 2.291 . . . . 0.0 112.312 -178.566 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.442 ' HG ' ' HE1' ' A' ' 129' ' ' TRP . 66.7 m -81.14 -4.97 57.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.862 175.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -39.69 129.45 1.47 Allowed Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.547 0.689 . . . . 0.0 110.874 -178.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -82.19 164.16 17.33 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.758 2.305 . . . . 0.0 112.287 -164.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 21.9 m-85 -74.96 170.04 16.77 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.911 -178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 29.2 t -114.46 134.4 57.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.207 -168.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -115.18 135.09 12.02 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.416 176.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 95.8 t -125.64 117.43 49.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.773 0.321 . . . . 0.0 111.19 176.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.416 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -66.13 122.92 18.52 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.914 179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 45.2 m -125.43 132.26 52.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.91 -168.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.92 137.5 53.14 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.118 -174.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -134.9 173.99 21.31 Favored Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.377 -171.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.2 mm -113.3 130.68 66.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 120.702 0.287 . . . . 0.0 111.166 -172.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.2 t-20 -62.36 129.48 40.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.881 -176.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.456 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -59.58 -29.33 67.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.135 -179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.9 -6.07 59.34 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.081 -174.012 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 17.8 t -75.33 122.14 86.66 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.579 0.704 . . . . 0.0 110.88 -175.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.459 ' HD2' HG21 ' A' ' 2' ' ' ILE . 89.5 Cg_endo -68.88 -6.99 19.45 Favored 'Trans proline' 0 N--CA 1.465 -0.169 0 C-N-CA 122.695 2.263 . . . . 0.0 112.437 167.154 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 73.8 m-80 -102.92 14.38 32.09 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.875 -173.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.9 pttt -51.73 -35.0 41.61 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.798 -168.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 71.2 mm-40 -72.15 -47.68 49.14 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.989 -171.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.0 pp -79.97 -33.68 39.27 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.906 -177.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.73 -48.77 70.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.071 178.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 41.2 pttt -66.81 -34.42 77.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.871 178.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.14 -45.39 88.73 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.955 177.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 14.1 m-30 -70.28 -36.12 74.18 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.786 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.684 ' O ' HD23 ' A' ' 280' ' ' LEU . 4.5 tt -59.4 -47.1 86.72 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.905 -177.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.8 pt-20 -78.75 -28.53 44.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.891 -177.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -106.03 -17.71 14.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.916 -161.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.86 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 14.7 m-30 -121.18 -46.42 2.31 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.842 -178.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 1.0 OUTLIER -63.94 -44.11 93.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.874 -171.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 1.009 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.7 pp -124.42 37.95 4.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.943 -166.716 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.478 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 82.0 p -121.46 162.25 20.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.16 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.408 ' HA ' HD11 ' A' ' 290' ' ' LEU . 36.1 p-10 -47.84 -35.06 9.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.806 -167.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -80.18 -40.32 27.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.913 179.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.86 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -71.6 -58.64 5.28 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.485 -171.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.65 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.11 -22.23 66.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.719 0.295 . . . . 0.0 110.907 -178.488 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.576 ' N ' HD12 ' A' ' 290' ' ' LEU . 87.9 tt0 -68.19 -46.25 71.15 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.819 172.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.94 -46.32 89.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.052 -174.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.484 HG12 ' O ' ' A' ' 289' ' ' GLY . 0.2 OUTLIER -70.04 -44.82 78.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 178.297 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.53 ' HB2' HD22 ' A' ' 299' ' ' LEU . 29.0 t30 -55.54 -31.46 62.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.853 175.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.76 -26.82 68.89 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.974 -178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -83.75 -40.76 18.4 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.887 178.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -161.41 139.89 7.23 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.576 0.703 . . . . 0.0 110.861 178.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_exo -48.86 126.52 15.01 Favored 'Trans proline' 0 C--O 1.231 0.135 0 C-N-CA 122.68 2.253 . . . . 0.0 112.295 -174.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.53 HD22 ' HB2' ' A' ' 294' ' ' ASN . 0.1 OUTLIER -87.67 -19.11 28.14 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 173.764 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.37 -67.18 1.43 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.663 174.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.583 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -157.9 144.98 18.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.933 0.397 . . . . 0.0 111.082 178.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 24.8 m -125.55 159.93 32.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.041 -179.102 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.59 -13.24 60.98 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.021 174.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.65 ' CD2' HD21 ' A' ' 290' ' ' LEU . 43.2 tp -81.3 125.21 30.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.887 -174.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 95.1 mttt -61.58 -36.04 79.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.876 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.3 m -60.7 -50.07 74.95 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.926 -170.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.558 ' CE2' HD21 ' A' ' 311' ' ' LEU . 23.0 t80 -77.1 -35.25 56.61 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.987 178.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.665 ' HA ' HD12 ' A' ' 311' ' ' LEU . 87.3 tt0 -53.37 -39.88 64.55 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.885 175.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -52.11 -38.69 58.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.905 176.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.3 mm-40 -79.85 -34.37 39.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.908 177.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 308' ' ' GLU . 54.2 mt -64.1 -30.66 71.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.903 -175.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -57.84 -22.36 47.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.216 -178.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -67.67 -20.57 65.31 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.003 177.141 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 62.2 t0 -89.3 122.64 68.38 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.695 0.76 . . . . 0.0 110.88 173.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -48.44 -30.2 15.19 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.754 2.303 . . . . 0.0 112.317 -179.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -62.62 -30.72 71.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.908 -172.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.531 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.3 mp -74.9 -30.09 23.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.037 -173.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.14 -41.63 93.11 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.145 -170.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -70.66 -43.63 68.73 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.104 178.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.436 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 76.5 p -63.86 -31.27 72.4 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.093 -171.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 38.4 mmt -70.35 -31.43 68.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 40.1 tp10 -64.38 -49.17 72.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.9 -175.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.628 HD21 ' HB1' ' A' ' 112' ' ' ALA . 10.2 p-10 -80.35 -25.6 39.14 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.807 -179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.37 -50.58 69.33 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.143 -179.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -67.72 -34.7 77.38 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.952 -177.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -104.13 -5.03 22.42 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 -170.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.445 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -96.53 -156.35 30.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.448 -168.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -151.12 148.08 27.85 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.832 0.349 . . . . 0.0 110.843 -171.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 44.3 mm -60.85 124.94 16.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.132 -172.386 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 96.9 mtp -51.6 142.28 23.07 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-O 121.5 0.667 . . . . 0.0 110.962 -178.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -75.07 100.8 1.4 Allowed 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.685 2.257 . . . . 0.0 112.307 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.442 ' HB2' ' HB2' ' A' ' 65' ' ' ASP . 25.9 m-80 -120.64 18.69 11.96 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.892 -175.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 48.7 pt -77.15 159.44 78.1 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.636 0.731 . . . . 0.0 111.131 -176.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -54.97 -33.42 82.82 Favored 'Trans proline' 0 C--O 1.231 0.152 0 C-N-CA 122.72 2.28 . . . . 0.0 112.292 -174.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -64.23 -27.74 69.26 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.782 -176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 87.2 mmm -69.62 -28.27 65.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.837 -168.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.9 m -52.13 -42.76 63.6 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.821 -171.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.65 -36.28 73.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.99 175.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.521 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 2.5 m-30 -64.91 -42.7 94.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.851 -175.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 97.0 m95 -54.67 -42.69 71.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.915 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.6 t80 -70.72 -43.24 69.35 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.885 -178.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.3 95.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.122 -174.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 339' ' ' PHE . 17.7 m -73.8 -31.56 31.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.124 -179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.426 ' O ' HG22 ' A' ' 347' ' ' VAL . 55.2 ttt180 -62.9 -41.82 99.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.934 175.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 90.8 m -57.19 -38.05 73.08 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.145 178.624 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.11 -43.71 91.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.105 -173.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.518 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.5 m -74.53 -34.9 36.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.16 -174.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.447 HD12 HG23 ' A' ' 347' ' ' VAL . 1.4 mp -63.52 -49.14 83.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.209 174.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -65.36 -39.1 91.91 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.926 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.17 -45.55 59.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.109 -179.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.83 -39.57 79.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.138 -175.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.6 p -76.38 -10.44 59.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.881 -178.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.8 17.2 70.9 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.827 -0.702 . . . . 0.0 112.39 179.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.12 -33.46 44.25 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 110.934 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -140.06 155.45 47.04 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.885 179.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.7 p -77.82 169.16 18.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.12 170.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.528 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.3 t -56.82 -41.34 75.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.16 173.086 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -62.06 -45.96 91.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.838 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -70.0 -52.92 20.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -72.64 -49.73 29.92 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.048 -172.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.59 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.6 tm? -65.1 -47.7 76.28 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.903 -173.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 88.8 tttt -65.75 -50.79 63.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.947 -176.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -68.49 -49.97 55.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.851 -174.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.47 -43.64 84.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.134 -173.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.518 ' HB3' ' HB ' ' A' ' 183' ' ' VAL . 78.8 mm-40 -71.7 -35.01 70.09 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.974 -175.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 31.1 m -60.31 -28.08 67.84 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.243 177.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 85.6 mtt180 -56.83 -30.78 64.09 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 175.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 78.3 mt -59.09 -40.57 81.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.162 173.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 63.5 p -97.99 -13.54 21.06 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.227 -175.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.9 tttt . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.817 177.313 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.6 mttt . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.729 0.299 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 86.7 mt -94.48 139.83 17.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.155 178.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -125.92 138.95 53.81 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.856 177.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.97 134.57 43.32 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 177.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 88.35 8.02 71.86 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.492 -177.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 10.5 ptpp? -160.37 140.61 11.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.757 0.313 . . . . 0.0 110.901 171.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.66 ' H ' HD23 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -143.02 156.39 44.83 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.961 -167.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.48 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 69.7 t -112.33 136.43 48.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.096 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.693 HD11 HG13 ' A' ' 35' ' ' VAL . 1.1 mp -118.4 131.46 71.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.182 175.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.779 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 73.0 m95 -104.37 126.04 51.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.903 165.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.507 HD12 ' HG ' ' A' ' 20' ' ' LEU . 13.3 tt -109.49 150.32 12.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.06 -166.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -58.14 155.05 11.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.808 -170.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.04 -17.51 23.2 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.472 -177.262 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -78.16 -15.08 59.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.769 0.318 . . . . 0.0 110.843 -173.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.42 ' HE3' ' HB3' ' A' ' 15' ' ' LYS . 28.8 mmmt -135.0 136.04 41.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.889 171.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.0 -84.25 1.0 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.699 -0.762 . . . . 0.0 112.495 -179.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -110.25 -38.08 5.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.9 0.381 . . . . 0.0 110.891 -177.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.2 m-20 -65.56 -50.97 63.17 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.86 -150.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -55.07 -59.98 9.52 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.443 -178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.507 ' HG ' HD12 ' A' ' 11' ' ' ILE . 2.0 mt -45.53 -49.95 13.34 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.865 0.364 . . . . 0.0 110.952 177.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -50.68 -38.01 44.36 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.044 -178.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.5 mm-40 -70.61 -54.42 12.08 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.853 -179.23 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.0 m -74.44 -37.74 45.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.186 -174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.485 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -63.03 -46.76 92.8 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.642 -0.789 . . . . 0.0 112.443 177.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 50.6 tptt -56.88 -30.04 63.52 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.938 0.399 . . . . 0.0 110.898 -177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.0 mmtt -58.35 -37.41 75.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.955 176.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.575 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 1.5 m-30 -60.71 -48.82 80.07 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.929 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.12 -34.91 78.62 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.825 178.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.3 mttt -72.18 -37.26 69.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.909 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.5 m-20 -94.78 -50.0 5.34 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.87 -167.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 36.2 p -116.42 -3.25 11.91 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.155 -171.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.48 14.2 82.21 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.427 166.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.818 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -98.25 133.27 41.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.838 0.352 . . . . 0.0 111.107 -179.747 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -74.54 134.18 42.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.892 -166.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.693 HG13 HD11 ' A' ' 9' ' ' ILE . 94.5 t -113.45 127.12 70.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.138 -172.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.578 ' O ' HD12 ' A' ' 9' ' ' ILE . 97.2 m -110.85 128.01 55.62 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.096 179.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 81.6 t -102.24 132.16 48.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.195 177.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -118.67 155.17 31.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.936 177.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.1 t-80 -89.09 140.11 28.92 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.543 0.687 . . . . 0.0 110.945 -170.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 85.6 Cg_exo -55.02 -27.97 57.52 Favored 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.603 2.202 . . . . 0.0 112.406 -174.629 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -48.39 -51.11 28.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.941 -171.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.23 -1.19 57.74 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.984 -175.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.8 tt -46.64 -53.03 12.41 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.048 -175.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -67.39 -39.41 85.6 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.963 175.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -63.8 -40.54 96.88 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.914 -171.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -80.85 -22.93 39.47 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.855 -178.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.547 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 75.9 t80 -48.32 -50.47 56.73 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.624 0.726 . . . . 0.0 110.883 -166.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.547 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 60.0 Cg_endo -80.59 -28.68 2.66 Favored 'Trans proline' 0 N--CA 1.465 -0.154 0 C-N-CA 122.721 2.281 . . . . 0.0 112.343 178.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -74.5 -37.6 63.09 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 -170.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.592 HG11 ' HD3' ' A' ' 57' ' ' PRO . 33.6 m -65.9 -26.86 39.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.113 -178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -68.54 -36.03 78.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.128 173.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.41 -31.06 68.1 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.024 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 79.0 p -87.3 -12.23 47.17 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.135 176.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.98 11.11 84.07 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.525 176.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -164.46 156.97 16.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.753 0.311 . . . . 0.0 110.934 175.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.91 -114.99 0.53 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.505 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.779 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 89.6 Cg_endo -77.6 150.67 28.07 Favored 'Trans proline' 0 N--CA 1.464 -0.208 0 C-N-CA 122.739 2.293 . . . . 0.0 112.318 176.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -85.25 -35.3 21.66 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.805 163.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.521 ' HB ' HG23 ' A' ' 9' ' ' ILE . 40.5 mt -126.5 136.33 61.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.108 -176.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 tp -132.12 125.84 55.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.119 177.527 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -89.81 139.56 30.46 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.805 166.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.438 ' CH2' ' HB2' ' A' ' 105' ' ' ALA . 35.2 p90 -141.12 163.0 34.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.936 171.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -58.53 -85.88 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.09 -168.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.537 ' NE2' ' HA3' ' A' ' 260' ' ' GLY . 11.3 m170 -126.89 -68.2 0.81 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.84 -178.023 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.456 ' HB3' HG22 ' A' ' 333' ' ' ILE . 99.7 m-20 -100.65 -10.01 21.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.883 -158.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 59.9 ttm-85 -51.83 -20.0 2.0 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.85 -173.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.482 ' HB2' HD13 ' A' ' 104' ' ' ILE . 34.3 p90 -55.92 -28.88 58.84 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.894 -177.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.53 -51.08 59.95 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.48 -175.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -67.24 -36.7 90.21 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.425 172.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 1.4 t80 -55.83 -51.73 66.49 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.811 0.338 . . . . 0.0 110.913 -179.647 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.32 -42.26 59.76 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.131 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.7 tt0 -56.9 -37.98 72.18 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.938 -175.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.404 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 62.3 m -84.9 -6.42 59.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.949 179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.96 30.47 59.24 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.591 173.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.404 ' HG ' ' HB2' ' A' ' 73' ' ' SER . 52.6 mt -89.04 -12.18 42.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.749 0.309 . . . . 0.0 110.829 -167.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.461 ' HA ' ' H ' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -128.94 151.39 49.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.907 -173.246 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.449 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -77.07 142.21 39.92 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.118 175.05 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -70.94 135.89 48.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.903 175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.0 pt -104.22 153.7 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.255 -176.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 99.2 m -96.39 126.74 42.65 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.587 0.708 . . . . 0.0 111.112 -179.472 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.98 134.79 65.56 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.653 2.236 . . . . 0.0 112.347 176.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -104.93 120.1 40.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.89 178.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -64.85 -39.84 94.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.88 -176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.13 -45.27 85.75 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.059 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 -75.31 -31.75 60.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.875 -179.246 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.501 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 65.4 tt0 -53.94 -51.18 64.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.907 174.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -59.52 -32.18 70.07 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.842 174.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -76.66 -22.01 54.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.852 -176.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.481 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.51 -105.36 0.3 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.952 -171.413 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 25.0 t80 171.94 130.02 0.08 OUTLIER Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.624 0.726 . . . . 0.0 110.966 -168.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -52.79 -37.68 76.73 Favored 'Trans proline' 0 C--N 1.34 0.124 0 C-N-CA 122.727 2.285 . . . . 0.0 112.359 -175.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.1 t80 -66.57 -34.78 78.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.852 -172.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.5 p -73.93 -30.01 62.33 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.17 -178.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.501 ' HE1' ' HA ' ' A' ' 86' ' ' GLN . 75.8 m95 -65.82 -31.99 73.27 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.931 173.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -67.66 -32.33 72.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.812 -179.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.72 -23.9 62.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.075 177.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.501 HG22 ' HA ' ' A' ' 94' ' ' TRP . 19.5 m -107.27 14.06 8.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.155 -177.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.3 ttp180 -100.02 130.12 46.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.823 -179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 67.9 t80 -126.07 113.71 17.46 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.874 174.041 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 59.2 t30 58.99 38.31 24.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.839 174.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.36 0.64 89.46 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.502 174.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -118.9 151.62 37.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.878 0.37 . . . . 0.0 110.843 172.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.499 HD22 HG23 ' A' ' 97' ' ' VAL . 14.6 mt -89.93 133.53 34.73 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.482 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -124.0 4.15 5.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.109 -172.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.438 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . . . -163.47 164.58 24.4 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.106 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 90.2 m-85 -114.11 142.21 27.59 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.575 0.702 . . . . 0.0 110.923 171.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -78.93 122.16 5.25 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.625 2.216 . . . . 0.0 112.296 176.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.062 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp -104.22 -37.69 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.172 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.593 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -146.48 154.09 41.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.034 -170.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.4 t -115.49 129.86 71.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.089 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 81.5 tt0 -109.96 129.28 55.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.863 174.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.504 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -154.93 143.67 20.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.06 179.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.2 mp -89.97 169.0 11.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.95 -177.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.7 p -157.31 156.37 32.28 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.836 -176.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.893 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -100.06 128.58 46.12 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.902 169.451 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.614 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.9 mp -110.07 133.14 56.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.102 -175.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.2 p90 -131.01 145.28 52.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 -178.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 52.8 t-20 -93.5 113.9 26.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.856 -179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -66.33 -20.79 66.19 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.939 -175.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -79.5 -28.46 41.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.895 -175.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.19 -49.61 11.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.894 175.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -141.71 133.76 13.68 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.564 0.697 . . . . 0.0 110.831 175.641 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -78.44 -14.38 14.55 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.625 2.217 . . . . 0.0 112.352 -174.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -143.72 98.35 5.32 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.564 0.697 . . . . 0.0 110.879 -173.013 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.45 156.5 61.41 Favored 'Trans proline' 0 C--O 1.232 0.187 0 C-N-CA 122.684 2.256 . . . . 0.0 112.357 176.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -68.44 143.83 59.15 Favored 'Trans proline' 0 C--O 1.231 0.142 0 C-N-CA 122.664 2.243 . . . . 0.0 112.321 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -89.89 -13.84 35.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.906 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 63.6 p -132.44 158.38 42.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.132 -179.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 65.5 m95 -68.64 -30.04 68.66 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.97 177.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -66.56 -19.97 65.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.953 -177.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -79.99 -26.97 39.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.851 -179.274 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.478 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -56.7 -46.94 99.79 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-O 121.613 0.721 . . . . 0.0 111.303 -169.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.478 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 86.7 Cg_exo -52.58 -50.78 12.87 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.657 2.238 . . . . 0.0 112.374 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.71 -57.68 6.63 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.146 -174.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.156 HD22 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.37 -17.26 63.66 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.876 -173.18 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.572 ' N ' HD13 ' A' ' 135' ' ' LEU . 36.2 t70 -61.17 -40.16 92.83 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.814 168.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -62.16 -30.89 71.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.879 -178.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -71.8 -46.24 58.89 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.842 -177.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.631 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.0 pp -84.11 -13.9 51.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.953 179.768 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.631 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.7 tttt -58.77 -34.92 71.97 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.93 172.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.72 -24.14 67.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.057 177.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -95.0 3.4 54.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.888 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.75 32.32 54.15 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.445 178.171 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 8.5 mptt -110.65 171.76 7.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.814 0.34 . . . . 0.0 110.911 175.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 38.6 t -124.63 140.17 53.19 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.753 168.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -67.28 -42.95 82.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.168 -170.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -138.54 128.79 25.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.933 -178.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 63.2 tpp -110.81 129.32 55.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.885 -178.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -153.22 155.18 36.14 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.896 -174.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 97.1 m-20 -88.57 -50.94 5.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.845 -178.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.076 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.8 tm? 48.47 31.12 2.67 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.874 -170.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -103.06 -7.36 21.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.977 176.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -129.99 152.52 80.12 Favored Pre-proline 0 C--N 1.332 -0.189 0 CA-C-O 121.652 0.739 . . . . 0.0 110.882 -174.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_exo -52.49 -32.51 53.36 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.752 2.301 . . . . 0.0 112.315 177.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 41.4 m-85 -69.7 -30.05 67.59 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.938 -176.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 55.2 m-85 -80.01 -39.64 29.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.835 172.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 17.8 m -60.1 -52.3 65.93 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.124 -179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.578 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 22.7 t-105 -60.7 -48.65 92.56 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.598 0.713 . . . . 0.0 110.889 -160.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.578 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 84.3 Cg_exo -50.82 -44.43 41.33 Favored 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.62 2.213 . . . . 0.0 112.276 -176.34 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 160' ' ' LEU . 7.0 tt -72.92 -39.99 65.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.94 -171.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.17 -42.07 66.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.136 -179.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -73.14 -23.32 60.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.126 -179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.26 -35.02 71.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.111 -173.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 59.6 p30 -104.29 9.44 35.95 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.877 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.44 4.75 23.32 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.472 169.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -77.37 68.89 2.62 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.531 177.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 73.1 m-85 -92.62 133.53 35.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.771 0.32 . . . . 0.0 110.944 179.339 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.44 ' HB1' HD13 ' A' ' 368' ' ' ILE . . . -83.94 12.61 5.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 -173.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.449 ' HD1' ' HE1' ' A' ' 336' ' ' MET . 53.1 p90 -151.52 153.32 34.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.911 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.2 tptt -99.79 122.29 42.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 156.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 75.1 t80 -112.72 122.31 47.28 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.872 175.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -152.2 130.58 12.1 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.932 -174.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.2 t30 54.99 43.96 29.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.905 173.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.77 15.46 79.48 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.675 -0.774 . . . . 0.0 112.602 174.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -130.38 139.75 50.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.808 0.337 . . . . 0.0 110.867 -176.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -96.99 145.0 26.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 170.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.8 t0 -126.03 110.15 13.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.87 172.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.554 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.6 pp -80.04 -9.02 11.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.113 -177.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -98.2 -11.93 22.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.916 -177.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -121.93 89.14 3.06 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.858 169.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 26.0 m -116.61 164.55 12.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.082 -172.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -107.45 24.78 23.4 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.574 -173.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.423 HG21 HD12 ' A' ' 368' ' ' ILE . 2.5 m -109.24 -21.05 5.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.811 0.338 . . . . 0.0 111.055 -176.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -90.96 28.9 1.46 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.794 178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -125.12 -170.04 2.1 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.893 177.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -67.85 -29.09 68.13 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.148 -172.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.88 -41.71 95.34 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.477 -168.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.644 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.03 -37.04 85.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.942 0.401 . . . . 0.0 111.156 179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.582 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -61.83 -38.13 87.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.868 175.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.14 -38.07 89.72 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.136 176.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.09 -47.73 63.38 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.505 179.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.541 HD11 ' HA ' ' A' ' 347' ' ' VAL . 22.6 tp -67.39 -34.8 78.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.912 0.387 . . . . 0.0 110.901 -177.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.49 ' OG1' HG21 ' A' ' 357' ' ' VAL . 93.1 m -65.09 -41.43 94.99 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.148 175.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.461 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 59.8 t80 -67.33 -47.02 71.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.903 177.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.613 HD23 ' C ' ' A' ' 195' ' ' LEU . 7.4 tt -51.6 -51.42 55.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.95 -175.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 199' ' ' ILE . 31.2 m -64.01 -22.67 31.58 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.104 -174.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.0 m-20 -61.59 -34.43 75.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.946 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.43 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.8 OUTLIER -81.28 -39.91 24.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.922 -173.92 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.516 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.8 pp -73.46 -29.3 27.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.135 172.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -68.6 -37.29 79.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.891 173.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -80.82 2.6 25.7 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.885 176.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 67.1 39.74 3.07 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.799 170.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 66.1 m170 -77.32 -17.94 57.89 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.91 176.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.516 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.2 ppp? -146.11 157.12 43.83 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.885 175.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -94.09 150.09 20.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.844 -179.347 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.97 -25.88 67.88 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.075 -176.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -95.4 0.99 54.04 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.948 -177.632 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 94.0 m -63.55 127.18 30.17 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.095 -177.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.429 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 14.7 t0 -120.02 177.36 5.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.853 177.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 21.8 p90 -65.01 -36.96 86.08 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.94 -178.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.3 p -70.48 -38.03 74.33 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.911 178.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.429 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 78.7 mt -65.83 -43.12 93.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.072 175.652 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.22 -37.31 87.01 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.209 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -61.6 -46.8 88.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.862 174.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.88 -40.77 97.31 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.056 179.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.91 -49.11 76.08 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.124 -178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 51.9 t80 -64.7 -41.1 96.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.966 -178.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -63.51 -31.58 72.79 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.903 -178.235 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.24 -13.17 44.59 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.962 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.14 25.01 35.24 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.556 179.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -85.87 -21.18 28.15 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.924 0.392 . . . . 0.0 110.907 -175.374 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.8 t -125.63 138.48 53.92 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.125 178.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.576 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -63.08 -48.84 76.9 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.012 178.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.489 ' HB3' HD21 ' A' ' 115' ' ' LEU . 69.9 mtm -133.3 159.89 38.91 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.949 -173.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.4 t -149.07 155.66 41.07 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.237 176.309 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 50.0 mm -111.47 130.05 65.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.178 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -155.77 174.63 15.03 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.841 179.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.5 -151.48 9.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.441 -178.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -69.69 -26.18 28.16 Favored 'Trans proline' 0 C--N 1.342 0.223 0 C-N-CA 122.621 2.214 . . . . 0.0 112.337 -177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.5 m0 -74.32 -32.06 62.7 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.942 -178.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 43.19 45.04 4.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.151 176.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 35.6 m0 -69.45 -16.77 63.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.941 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 66.6 m -65.03 -26.42 68.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.924 -179.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.514 ' HB3' HG21 ' A' ' 116' ' ' ILE . 39.1 p30 -82.62 -179.1 7.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 -172.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.8 mt -97.57 122.51 49.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.125 -177.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 30.9 t70 -79.95 -60.0 2.51 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.821 -173.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 86.2 m -129.28 118.38 22.21 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.227 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 29.8 t -175.01 162.2 3.04 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.9 -179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -68.71 -19.69 64.37 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.93 170.382 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 87.9 t -65.16 124.97 21.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.081 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -79.05 140.11 37.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.879 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 50.2 p90 -145.29 151.52 38.47 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.871 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -139.72 161.93 26.23 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.499 173.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.1 p -137.03 138.47 45.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.979 0.418 . . . . 0.0 111.025 -178.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.4 t -155.72 150.97 26.78 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.176 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 30.7 m -59.97 167.08 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.119 -178.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.946 HD23 ' HD3' ' A' ' 257' ' ' PRO . 2.8 mm? -59.24 149.82 66.25 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.519 0.676 . . . . 0.0 110.946 -168.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -74.23 -176.58 2.76 Favored 'Trans proline' 0 C--O 1.232 0.195 0 C-N-CA 122.786 2.324 . . . . 0.0 112.406 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 99.3 m -88.92 144.03 26.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.108 -173.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 25.5 t80 -131.34 110.96 11.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.857 -175.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 54.92 36.16 26.12 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.988 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 89.81 -0.16 79.22 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.449 173.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 89.0 mm-40 -128.78 139.16 34.82 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.543 0.687 . . . . 0.0 110.843 175.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 30.2 Cg_endo -67.38 138.28 45.9 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.734 2.289 . . . . 0.0 112.375 -174.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.442 ' HB2' ' HB3' ' A' ' 247' ' ' LEU . 75.6 m -81.48 -4.81 56.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.92 173.5 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 255' ' ' SER . 91.3 mttt -37.41 130.93 0.82 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.494 0.664 . . . . 0.0 110.878 -178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.946 ' HD3' HD23 ' A' ' 247' ' ' LEU . 37.8 Cg_endo -84.24 168.07 11.94 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.7 2.266 . . . . 0.0 112.278 -159.97 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 20.0 p90 -60.36 166.83 2.8 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.877 -177.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.4 t -117.88 130.23 73.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.152 179.336 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.537 ' HA3' ' NE2' ' A' ' 64' ' ' HIS . . . -117.93 139.72 14.98 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.438 175.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 83.8 t -124.77 116.95 48.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.756 0.312 . . . . 0.0 111.189 176.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -65.14 119.97 11.83 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.961 179.263 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.3 m -123.8 130.88 53.32 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.809 -167.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.93 138.69 52.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.077 -0.511 . . . . 0.0 111.049 -174.421 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.6 170.82 22.21 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.43 -171.548 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.576 HG13 ' HB3' ' A' ' 277' ' ' LYS . 23.1 mm -114.96 127.64 72.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.763 0.316 . . . . 0.0 111.198 -173.201 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.9 t-20 -63.24 129.56 40.82 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.877 -175.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.461 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -58.68 -29.94 67.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.16 -177.152 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.92 -6.34 59.34 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.08 -172.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 18.2 t -70.66 123.47 89.19 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.557 0.694 . . . . 0.0 110.981 -173.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.0 Cg_endo -68.47 -8.34 22.84 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.669 2.246 . . . . 0.0 112.388 167.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 74.2 m-80 -106.35 11.12 31.32 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.907 -176.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 64.6 pttt -47.58 -37.52 12.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.865 -168.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -70.54 -47.18 61.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.875 -171.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.1 pp -81.02 -30.7 34.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.945 -176.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.35 -49.55 68.94 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.071 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.576 ' HB3' HG13 ' A' ' 266' ' ' ILE . 57.9 pttt -69.33 -34.1 74.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.874 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.56 -45.82 81.86 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.822 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 19.6 m-30 -67.75 -38.88 84.06 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.797 179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 7.5 tt -58.55 -50.73 72.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.916 -175.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -72.2 -26.7 62.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 -178.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 -100.02 -11.06 20.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.967 -169.166 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.868 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 79.1 m-85 -128.33 -55.27 1.26 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 178.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 3.5 mp -66.13 -34.88 79.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.938 -165.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 1.062 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.2 pp -123.82 37.45 4.41 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.97 175.501 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.427 ' CG2' ' N ' ' A' ' 287' ' ' ASP . 9.3 m -115.53 153.86 30.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.108 177.209 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.566 ' HA ' HD11 ' A' ' 290' ' ' LEU . 28.7 t70 -45.7 -34.82 3.78 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.858 -166.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -78.49 -41.09 33.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 -178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.868 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.04 -56.53 5.72 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.472 -171.686 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.573 HD12 ' N ' ' A' ' 291' ' ' GLU . 0.5 OUTLIER -66.42 -21.26 66.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.743 0.306 . . . . 0.0 110.908 -179.157 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.573 ' N ' HD12 ' A' ' 290' ' ' LEU . 84.4 tt0 -68.29 -46.94 68.96 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.798 171.254 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -61.91 -42.87 99.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.071 -174.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 4.0 m -79.59 -36.31 17.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.182 -174.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 44.9 t30 -64.97 -28.73 69.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.934 175.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -62.79 -26.72 68.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.865 176.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -87.95 -41.96 12.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.931 -178.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -146.13 135.53 11.47 Favored Pre-proline 0 C--N 1.33 -0.268 0 CA-C-O 121.541 0.686 . . . . 0.0 110.902 178.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_exo -53.12 113.9 1.49 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.655 2.236 . . . . 0.0 112.394 175.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.411 ' HA ' HD12 ' A' ' 299' ' ' LEU . 0.7 OUTLIER -86.45 -24.94 25.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.949 177.77 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 103.63 -57.01 0.56 Allowed Glycine 0 C--N 1.33 0.247 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.506 178.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.577 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -168.18 161.83 12.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.905 0.384 . . . . 0.0 111.036 176.085 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.606 HG21 ' HB3' ' A' ' 307' ' ' TYR . 32.6 m -124.33 155.55 31.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.099 -179.498 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.02 -9.99 59.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.09 -0.504 . . . . 0.0 111.034 173.405 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.557 ' CD2' HD21 ' A' ' 290' ' ' LEU . 45.0 tp -86.5 119.95 27.31 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.858 -176.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -56.61 -38.64 72.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.945 -174.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 42.7 t -64.56 -50.32 67.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.916 -169.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.606 ' HB3' HG21 ' A' ' 302' ' ' VAL . 16.9 t80 -78.52 -29.13 46.35 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.911 -178.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 50.0 tp10 -64.74 -37.76 88.71 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.949 177.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -61.37 -37.9 85.06 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.939 173.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 76.5 mm-40 -72.81 -39.8 66.36 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.963 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.577 HD13 ' HA ' ' A' ' 301' ' ' ALA . 79.2 mt -61.93 -32.64 73.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.928 175.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -62.26 -17.52 58.7 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.117 -177.397 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -64.8 -19.12 65.66 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.978 173.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 64.0 t0 -91.63 121.74 66.78 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.746 0.784 . . . . 0.0 110.852 164.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -48.2 -26.93 8.73 Favored 'Trans proline' 0 C--N 1.343 0.241 0 C-N-CA 122.679 2.252 . . . . 0.0 112.344 -179.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 77.6 mtt85 -61.26 -29.64 69.97 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.906 -172.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . . . . . . . . . 1.2 mp -76.84 -29.86 18.01 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.188 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.03 -40.51 85.25 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.046 -170.314 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.21 -43.74 77.33 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.164 177.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.504 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 80.8 p -63.78 -30.99 72.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.177 -171.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 97.5 mmm -70.91 -32.86 69.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.85 177.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 42.9 tp10 -64.46 -46.68 82.08 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.869 -173.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.447 ' OD1' ' HB1' ' A' ' 112' ' ' ALA . 7.5 p-10 -80.08 -27.07 39.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.728 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.13 -49.21 73.06 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.116 -177.701 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -68.0 -34.98 77.55 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.871 -177.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -105.51 -6.54 19.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.823 -169.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -93.18 -159.6 34.94 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.435 -170.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -142.22 148.53 38.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.855 0.359 . . . . 0.0 110.92 -172.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 41.7 mm -65.13 122.3 15.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.083 -172.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 36.2 ttp -52.46 139.64 37.7 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.574 0.702 . . . . 0.0 110.913 -179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.457 ' HB2' ' HE2' ' A' ' 336' ' ' MET . 58.5 Cg_endo -67.7 84.33 0.4 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.728 2.285 . . . . 0.0 112.348 176.53 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.433 ' CG ' ' O ' ' A' ' 332' ' ' ASN . 10.6 t-20 -106.51 16.52 24.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.85 -170.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.456 HG22 ' HB3' ' A' ' 65' ' ' ASP . 48.2 pt -83.22 159.98 60.96 Favored Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.614 0.721 . . . . 0.0 111.217 -177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -57.17 -36.32 99.09 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.736 2.291 . . . . 0.0 112.315 -172.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.3 mm-40 -71.16 -28.1 64.02 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.858 -175.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.457 ' HE2' ' HB2' ' A' ' 331' ' ' PRO . 85.1 mmm -79.99 -22.76 42.15 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.829 -173.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.5 m -55.52 -39.95 71.17 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.806 -171.792 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -68.71 -33.48 74.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.031 177.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 1.5 m-30 -67.51 -37.33 82.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.905 -178.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 75.6 m95 -54.98 -42.04 71.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 174.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -78.28 -36.18 47.0 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.774 -178.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -65.12 -38.44 90.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.043 -176.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.42 HG13 ' O ' ' A' ' 339' ' ' PHE . 19.3 m -74.72 -31.32 26.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.071 177.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 347' ' ' VAL . 4.9 tmt_? -64.16 -37.33 87.07 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.863 176.202 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.9 m -57.27 -36.73 71.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.212 174.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.89 -42.54 94.69 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.183 -174.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.541 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.9 m -74.26 -34.57 37.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.202 -174.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.452 HD12 HG23 ' A' ' 347' ' ' VAL . 1.4 mp -63.37 -47.91 89.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.119 173.856 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -62.97 -40.29 97.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.844 -178.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -74.26 -46.39 41.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.105 -177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.12 -39.33 78.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.039 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 96.2 p -75.26 -10.73 59.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.3 18.31 69.36 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.484 178.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.87 -33.32 45.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.764 0.316 . . . . 0.0 110.938 -178.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.494 ' HB2' ' HB2' ' A' ' 360' ' ' ALA . 90.3 mm-40 -140.58 156.44 46.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.919 178.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 52.3 p -77.48 166.59 22.9 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.183 171.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.49 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.2 t -56.19 -41.92 71.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.226 173.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -60.52 -46.85 88.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.951 178.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -70.49 -56.42 6.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.934 179.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.494 ' HB2' ' HB2' ' A' ' 355' ' ' GLN . . . -68.45 -48.42 64.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.11 -172.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.644 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.8 tm? -65.0 -45.85 83.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.906 -175.035 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -62.34 -53.76 50.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.894 -176.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . 0.409 ' O ' ' HG3' ' A' ' 367' ' ' ARG . 32.1 t70 -68.07 -50.08 57.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.854 -174.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -64.06 -38.29 90.53 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.106 -172.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.469 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 75.5 mm-40 -78.08 -32.34 50.62 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.089 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 40.9 m -66.21 -29.13 69.33 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.172 174.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . 0.409 ' HG3' ' O ' ' A' ' 363' ' ' ASP . 79.6 mtt180 -56.9 -32.16 65.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.926 174.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.451 ' HB ' ' O ' ' A' ' 365' ' ' GLN . 71.4 mt -59.89 -40.72 83.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.087 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 41.6 p -97.1 -11.07 24.83 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.189 -175.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.812 175.363 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.755 0.312 . . . . 0.0 110.84 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.425 HG21 ' HD2' ' A' ' 271' ' ' PRO . 62.3 mt -99.45 140.06 19.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.154 -178.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.2 pt-20 -143.9 145.0 31.98 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.836 -179.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -54.34 138.24 39.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.871 176.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.15 8.35 68.88 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.538 -174.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.2 tttt -166.09 131.09 2.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.827 0.346 . . . . 0.0 110.91 176.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.611 HD22 HD11 ' A' ' 33' ' ' ILE . 0.9 OUTLIER -141.76 155.97 45.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.963 -172.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.44 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 69.3 t -114.45 135.43 54.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.18 -175.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.712 HD11 HG13 ' A' ' 35' ' ' VAL . 0.9 OUTLIER -120.0 134.88 62.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.047 176.603 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.859 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 60.5 m95 -108.62 124.46 50.54 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.878 163.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.513 HD12 ' HG ' ' A' ' 20' ' ' LEU . 12.1 tt -109.75 151.77 11.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.074 -163.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -54.75 148.28 13.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.807 -172.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -59.99 -16.85 41.87 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.504 -175.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -80.61 -14.12 58.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.854 0.359 . . . . 0.0 110.888 -172.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.424 ' HA ' ' HD3' ' A' ' 15' ' ' LYS . 33.0 mmtm -140.0 128.09 22.3 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.911 166.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.1 -78.13 1.07 Allowed Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.665 -0.778 . . . . 0.0 112.49 -169.241 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 70.6 m-85 -104.88 -35.92 7.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.851 0.358 . . . . 0.0 110.937 -178.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -67.33 -52.47 39.94 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.862 -150.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -54.32 -52.62 43.16 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.508 -177.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.526 HD22 HD13 ' A' ' 9' ' ' ILE . 5.8 mt -55.09 -53.44 55.89 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.853 0.359 . . . . 0.0 110.907 174.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -45.29 -39.02 6.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.133 -179.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -71.47 -57.99 3.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.969 178.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.464 HG22 ' HA ' ' A' ' 20' ' ' LEU . 20.9 m -74.29 -36.19 42.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.199 -170.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.55 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -63.6 -45.62 94.19 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.489 174.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -54.33 -36.49 63.84 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.878 0.37 . . . . 0.0 110.831 179.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.1 tptt -58.92 -41.12 86.57 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.967 177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.472 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 4.7 m-30 -62.34 -47.03 86.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.867 -179.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 98.1 mt-10 -61.27 -36.05 78.97 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.838 179.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -75.42 -40.18 58.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.924 178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -91.24 -49.84 6.15 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.921 -166.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.6 p -108.66 -7.55 15.61 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.174 -173.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.13 8.83 87.27 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.369 167.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.927 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.8 133.66 40.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.779 0.323 . . . . 0.0 111.219 -178.39 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.7 mttt -69.97 136.18 50.22 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.853 -172.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.712 HG13 HD11 ' A' ' 9' ' ' ILE . 92.1 t -114.7 125.02 71.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.007 -175.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.565 ' O ' HD12 ' A' ' 9' ' ' ILE . 98.6 m -108.91 125.66 52.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.098 -179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.422 HG22 ' HB3' ' A' ' 20' ' ' LEU . 84.8 t -102.43 130.91 51.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.138 177.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -118.13 154.27 32.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.958 177.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.456 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 65.8 t-80 -87.13 138.61 32.48 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-O 121.558 0.694 . . . . 0.0 110.884 -169.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 81.4 Cg_exo -57.34 -25.51 65.88 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.652 2.235 . . . . 0.0 112.303 -173.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -48.36 -51.1 27.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.838 -173.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -90.94 -0.82 57.83 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.878 -175.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 8.1 tt -46.56 -52.71 12.87 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.911 -174.642 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.9 tt0 -65.01 -40.81 95.45 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.902 175.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.81 -40.89 97.71 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.865 -172.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -81.55 -21.14 38.69 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.927 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.526 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 53.2 t80 -50.06 -51.16 64.45 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.696 0.76 . . . . 0.0 110.816 -165.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.526 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 55.5 Cg_endo -81.69 -30.06 1.55 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.656 2.238 . . . . 0.0 112.405 179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -75.12 -40.05 60.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.85 -167.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.4 m -66.51 -27.69 41.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.032 -176.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.706 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -68.08 -36.21 79.46 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.096 177.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.81 -32.08 71.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.051 -178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.2 p -92.18 -15.7 27.26 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.135 177.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.76 10.89 80.64 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.403 173.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -140.2 132.62 28.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.838 0.351 . . . . 0.0 110.811 176.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.434 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . 170.69 -127.76 1.51 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.474 178.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.859 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 35.0 Cg_endo -64.18 149.01 91.17 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.713 2.275 . . . . 0.0 112.399 176.238 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.1 m-20 -92.1 -33.2 14.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.826 161.251 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.68 ' HB ' HG23 ' A' ' 9' ' ' ILE . 38.7 mt -124.16 136.09 61.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.114 -177.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 tp -131.44 127.56 59.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.157 178.199 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 35.8 m-85 -93.77 136.7 33.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.802 170.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.479 ' CH2' ' HB2' ' A' ' 105' ' ' ALA . 33.0 p90 -140.89 167.17 22.82 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.969 171.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.59 -82.02 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.016 -167.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -127.32 -73.42 0.61 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.881 -171.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.467 ' H ' ' HB3' ' A' ' 332' ' ' ASN . 70.1 m-20 -99.96 -10.73 21.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.853 -159.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.1 ttm-85 -51.25 -22.34 2.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.842 -174.16 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.516 ' HB2' HD13 ' A' ' 104' ' ' ILE . 32.9 p90 -56.8 -31.77 65.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.807 -177.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.89 -50.99 60.91 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.447 -173.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.73 -35.98 90.56 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.533 171.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -55.1 -51.63 65.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.808 0.337 . . . . 0.0 110.946 179.501 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.73 -44.07 51.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.072 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -57.04 -38.86 73.8 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.982 -174.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.4 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 63.4 m -85.02 -7.15 59.25 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.91 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.77 30.3 59.9 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.545 174.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.706 HD22 ' HB1' ' A' ' 51' ' ' ALA . 35.5 mt -88.83 -9.35 52.04 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.808 0.337 . . . . 0.0 110.904 -170.012 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.467 ' HA ' ' H ' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -128.61 152.11 48.71 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 -178.161 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -80.37 142.82 34.04 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.069 175.695 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -73.12 135.38 44.72 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.836 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.6 pt -105.06 155.87 6.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.109 -177.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.9 m -97.65 130.04 30.08 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.536 0.684 . . . . 0.0 111.08 -178.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.42 135.55 66.2 Favored 'Trans proline' 0 C--N 1.34 0.125 0 C-N-CA 122.669 2.246 . . . . 0.0 112.335 176.428 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -103.39 117.85 35.42 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.893 175.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.31 -41.34 98.44 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.849 -177.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.25 87.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.002 -176.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.42 ' HA ' ' HB2' ' A' ' 88' ' ' LYS . 16.5 m-85 -75.84 -31.75 59.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.857 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.45 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 66.8 tt0 -53.4 -50.84 64.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.949 173.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.76 -32.99 72.27 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.906 174.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.42 ' HB2' ' HA ' ' A' ' 85' ' ' PHE . 93.7 mttt -75.87 -21.04 57.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.873 -174.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.461 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -104.76 -105.08 0.31 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.885 -171.528 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.461 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 26.9 t80 171.66 128.33 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.354 0 CA-C-O 121.68 0.752 . . . . 0.0 110.956 -167.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -52.77 -36.78 74.69 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.684 2.256 . . . . 0.0 112.33 -174.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . 0.4 ' HB3' ' CD2' ' A' ' 90' ' ' TYR . 62.9 t80 -65.19 -35.11 80.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.857 -174.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 68.4 p -73.79 -31.08 63.11 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.168 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.65 ' HA ' HG22 ' A' ' 97' ' ' VAL . 79.6 m95 -67.95 -29.72 68.84 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 173.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -65.04 -31.48 72.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.907 177.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -74.95 -23.84 58.37 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.091 179.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.65 HG22 ' HA ' ' A' ' 94' ' ' TRP . 17.7 m -111.51 19.28 6.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.132 -173.146 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 35.1 ttp-105 -111.95 136.5 51.2 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.842 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 74.9 t80 -135.39 121.89 20.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.952 174.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.2 t30 58.91 35.39 24.14 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.864 175.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.96 0.76 89.78 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.57 175.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -118.29 151.0 38.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.851 0.358 . . . . 0.0 110.853 175.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.606 HD22 HG23 ' A' ' 97' ' ' VAL . 22.2 mt -86.58 135.27 33.5 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.951 177.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.516 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -124.79 3.6 4.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.065 -173.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.479 ' HB2' ' CH2' ' A' ' 62' ' ' TRP . . . -163.46 165.83 23.38 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.196 -179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.463 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 90.2 m-85 -114.87 140.57 25.64 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.618 0.723 . . . . 0.0 110.976 170.653 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 12.0 Cg_exo -70.07 123.63 10.19 Favored 'Trans proline' 0 C--O 1.232 0.194 0 C-N-CA 122.603 2.202 . . . . 0.0 112.294 170.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.014 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -106.98 -39.83 4.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.176 175.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.581 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -144.51 153.78 42.21 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 -166.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.8 t -118.68 129.86 74.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.135 175.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -119.89 127.78 53.03 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.91 177.224 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.621 ' HB1' HD21 ' A' ' 323' ' ' ASN . . . -155.02 146.42 23.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.036 178.712 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.6 mp -85.71 170.01 12.89 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.996 -175.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 92.4 p -154.75 153.63 31.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.988 0.423 . . . . 0.0 110.853 -176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.878 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -94.89 126.79 40.45 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.867 169.411 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.592 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.1 mp -111.63 131.73 62.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.163 -175.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 51.9 p90 -132.47 147.93 52.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.898 -175.091 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.3 t-20 -92.37 115.49 28.14 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.872 -178.343 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.483 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.2 mttt -66.56 -22.12 66.15 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.921 -175.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -77.94 -23.35 48.57 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.888 -176.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.8 mp -85.29 -57.5 3.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.905 168.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.726 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.0 OUTLIER -144.32 125.89 8.03 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-O 121.696 0.76 . . . . 0.0 110.785 177.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 91.9 Cg_endo -81.46 -0.76 10.66 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.594 2.196 . . . . 0.0 112.41 -176.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.8 t-20 -147.93 101.87 3.64 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.654 0.74 . . . . 0.0 110.761 -174.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -73.52 155.06 50.39 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.755 2.303 . . . . 0.0 112.401 -178.126 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.444 ' HD2' ' SD ' ' A' ' 224' ' ' MET . 52.4 Cg_exo -55.28 143.06 77.56 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.699 2.266 . . . . 0.0 112.294 178.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -78.87 -22.03 46.63 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.909 178.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 52.9 p -135.62 159.95 40.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.202 -177.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.428 ' HA ' HD13 ' A' ' 132' ' ' ILE . 77.8 m95 -70.82 -28.13 64.39 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 178.449 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -66.09 -19.41 65.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.845 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -84.07 -20.63 32.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.854 -177.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.554 ' O ' HD13 ' A' ' 135' ' ' LEU . 0.7 OUTLIER -57.36 -45.35 99.9 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-O 121.635 0.731 . . . . 0.0 111.133 -171.865 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.499 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 82.0 Cg_exo -51.27 -47.67 24.81 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.612 2.208 . . . . 0.0 112.335 178.622 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.84 -59.84 3.76 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.054 -174.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.113 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.99 -16.8 63.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.866 -173.328 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.542 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.4 t70 -61.3 -40.1 92.92 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.857 168.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.36 -30.07 69.32 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.873 -177.611 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -70.7 -47.95 57.19 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.832 -176.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.602 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.1 pp -87.42 -16.69 34.15 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.924 -178.81 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.602 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.4 tttt -59.45 -32.86 70.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.923 174.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.41 -25.13 68.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.983 178.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -95.36 7.04 47.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.919 178.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.9 30.96 58.61 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.531 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -109.7 169.99 8.35 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.887 0.375 . . . . 0.0 110.887 174.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.5 t -125.63 142.22 51.62 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.874 174.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.421 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.63 -42.48 74.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.124 -173.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -139.3 127.78 22.97 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.945 -175.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 63.3 tpp -105.25 129.14 53.68 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.832 -174.342 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 37.9 p90 -155.18 158.33 38.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.929 -175.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -98.63 -42.87 7.06 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.82 179.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.026 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.5 tm? 48.46 31.2 2.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.924 -170.205 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.3 mm-40 -103.73 -6.76 21.2 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.887 175.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -137.67 156.5 74.63 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-O 121.645 0.736 . . . . 0.0 110.901 -175.151 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.476 ' HA ' ' HB ' ' A' ' 157' ' ' THR . 67.7 Cg_exo -52.37 -26.39 27.6 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.671 2.247 . . . . 0.0 112.339 176.176 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 87.5 m-85 -63.22 -38.49 91.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.829 -177.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -85.85 -37.19 19.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.899 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 20.0 m -58.87 -52.13 67.03 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.116 -177.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.574 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 23.6 t-105 -62.54 -49.23 84.21 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.561 0.696 . . . . 0.0 110.893 -163.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.574 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 81.6 Cg_exo -50.07 -48.26 20.42 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.724 2.283 . . . . 0.0 112.392 -177.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.691 ' O ' HD23 ' A' ' 160' ' ' LEU . 6.8 tt -72.0 -39.91 68.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.884 -170.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.3 mt -71.12 -42.41 75.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.119 -179.476 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.38 -25.86 59.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.137 -177.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.416 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -60.66 -35.03 75.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.064 -169.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.4 ' HB3' ' CD2' ' A' ' 250' ' ' PHE . 59.6 p30 -97.53 3.48 50.63 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.848 -179.223 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.76 2.15 13.0 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.829 -0.701 . . . . 0.0 112.415 173.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -76.89 64.78 3.0 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.563 178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 70.9 m-85 -87.08 136.02 33.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.916 0.388 . . . . 0.0 110.987 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.49 -0.33 22.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.107 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.781 ' CE1' ' HG3' ' A' ' 331' ' ' PRO . 49.6 p90 -154.05 154.82 34.36 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.909 -175.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -97.22 121.96 39.7 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.952 157.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 66.0 t80 -109.76 123.14 49.01 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.882 176.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -152.69 131.52 12.45 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.869 -176.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.3 t30 55.74 44.97 25.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.923 172.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 72.92 15.29 78.34 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.463 173.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.89 139.11 50.07 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.818 0.342 . . . . 0.0 110.864 -177.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -98.75 140.43 32.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.921 172.711 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -122.33 109.94 15.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 177.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.528 ' C ' HD12 ' A' ' 178' ' ' ILE . 2.1 pp -83.4 -6.2 9.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.071 -177.581 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -99.67 -16.92 18.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.931 -177.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -117.01 88.74 2.96 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.834 169.396 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 169' ' ' PHE . 22.9 m -117.82 165.03 13.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.094 -169.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -109.96 25.71 15.86 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.509 -176.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.502 ' HB ' ' HB3' ' A' ' 365' ' ' GLN . 1.2 m -106.6 -23.06 4.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 120.821 0.344 . . . . 0.0 111.06 -176.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.3 m-20 -92.09 24.15 3.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 175.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 52.1 p30 -107.72 -174.97 2.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.927 -178.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -71.8 -28.31 63.51 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.098 176.312 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.11 -40.43 92.87 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.524 -171.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.583 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -60.45 -38.39 84.01 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.864 0.364 . . . . 0.0 111.099 177.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.589 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.6 mttt -61.67 -37.3 83.57 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.9 176.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.93 -37.77 88.63 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.042 177.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -67.0 -46.62 71.39 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.628 -0.796 . . . . 0.0 112.564 179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.549 HD11 ' HA ' ' A' ' 347' ' ' VAL . 20.2 tp -67.56 -33.63 75.43 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.858 0.361 . . . . 0.0 110.958 -178.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.516 ' OG1' HG21 ' A' ' 357' ' ' VAL . 91.8 m -65.57 -42.02 92.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.24 176.511 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.465 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 92.3 t80 -69.4 -44.68 70.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.901 178.369 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.632 HD23 ' C ' ' A' ' 195' ' ' LEU . 6.9 tt -51.13 -51.6 51.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.932 -175.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 35.1 m -63.89 -22.48 31.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.137 -174.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.465 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.0 m-20 -62.25 -34.18 76.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.843 -177.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.457 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.7 OUTLIER -82.02 -39.96 22.79 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.959 -173.444 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . . . . . . . . . 1.8 pp -72.02 -29.96 34.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.151 172.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -67.47 -37.73 83.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.83 171.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -82.72 2.54 33.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.925 178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 66.86 39.94 3.25 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.829 170.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 52.5 m170 -75.96 -15.66 60.13 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.811 179.446 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -144.1 156.1 44.22 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.842 177.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -94.19 152.61 18.59 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.833 -179.258 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.58 -27.11 68.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.116 -177.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -94.1 2.67 55.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.893 -177.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.9 m -65.62 134.92 54.3 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.163 -176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 22.7 t0 -138.36 171.73 13.94 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.918 176.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -57.07 -46.04 82.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.95 -176.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 73.8 m -60.37 -40.61 91.42 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.877 179.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 64.3 mt -64.95 -42.25 94.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.178 173.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.98 -36.91 85.91 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.136 -178.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . 0.402 ' HG2' ' HA ' ' A' ' 233' ' ' SER . 93.8 mt-10 -65.04 -44.24 89.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.874 177.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.96 -39.56 93.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.087 176.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.18 -45.02 95.24 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.099 179.45 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 60.2 t80 -64.25 -38.67 91.89 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.877 177.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.3 m-20 -62.22 -34.7 76.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.819 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.0 -19.26 27.42 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.865 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.39 26.1 26.48 Favored Glycine 0 N--CA 1.453 -0.202 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.494 -179.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 59.7 mm-40 -82.07 -19.96 39.21 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.928 0.395 . . . . 0.0 110.915 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.9 t -123.89 134.76 53.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.146 174.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.514 ' HB1' HD21 ' A' ' 122' ' ' LEU . . . -66.8 -47.38 72.26 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.996 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.626 ' HB3' HD21 ' A' ' 115' ' ' LEU . 72.9 mtm -133.86 153.78 51.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.881 -171.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 10.1 t -151.04 155.81 39.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.213 178.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.2 mm -109.69 124.76 66.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.185 -175.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -153.51 174.64 14.16 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.835 -170.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -82.41 -164.13 34.17 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.435 -177.341 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.2 -20.9 49.1 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.662 2.241 . . . . 0.0 112.341 -179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 28.5 m-90 -78.16 -25.52 47.29 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.908 -178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 49.4 53.52 12.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.115 178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 88.6 m95 -60.0 -23.61 63.79 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.872 -177.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.402 ' HA ' ' HG2' ' A' ' 214' ' ' GLU . 65.2 m -57.09 -40.69 77.46 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.89 -176.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 51.7 p30 -85.91 179.19 7.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.922 -173.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 69.8 mt -120.47 127.32 75.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.096 -167.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 16.6 t70 -95.38 -9.91 31.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.835 -176.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 65.2 p -130.59 71.41 1.46 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.19 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 31.5 t -168.26 163.94 13.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.926 177.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -94.24 -3.03 51.44 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -177.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 34.9 m -57.85 156.47 1.81 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.122 177.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.0 m-80 -106.15 124.25 49.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.866 -176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.483 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 52.5 p90 -143.82 155.97 44.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.89 179.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -135.84 160.16 24.48 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.512 175.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.7 p -134.38 135.12 54.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 120.938 0.399 . . . . 0.0 111.061 -177.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.8 t -153.8 149.14 27.1 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.139 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 22.5 m -60.36 162.07 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.135 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.466 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 3.1 mp -68.05 151.58 97.09 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.539 0.685 . . . . 0.0 110.919 -162.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -77.09 -173.6 1.85 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.663 2.242 . . . . 0.0 112.327 -174.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 99.5 m -89.03 143.01 27.15 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.166 -171.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.4 ' CD2' ' HB3' ' A' ' 164' ' ' ASP . 11.1 t80 -132.17 113.13 12.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 -176.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 56.22 35.46 25.79 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.892 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.37 1.89 83.35 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.651 -0.785 . . . . 0.0 112.583 174.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 90.0 mm-40 -126.86 127.94 24.32 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-O 121.555 0.693 . . . . 0.0 110.887 177.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 78.1 Cg_exo -55.12 133.24 57.0 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 122.631 2.221 . . . . 0.0 112.375 -179.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.414 ' O ' ' C ' ' A' ' 256' ' ' LYS . 69.4 m -78.81 -9.61 59.51 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.855 173.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.435 ' HA ' ' HD3' ' A' ' 257' ' ' PRO . 85.7 mttt -39.8 128.61 1.53 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.539 0.685 . . . . 0.0 110.861 -173.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 256' ' ' LYS . 71.2 Cg_exo -63.51 156.25 57.77 Favored 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.648 2.232 . . . . 0.0 112.377 -167.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 47.5 m-85 -70.75 166.6 20.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.845 173.048 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 41.0 t -110.83 131.68 61.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.146 -167.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -114.95 135.13 12.09 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.436 173.111 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 96.4 t -123.53 115.91 46.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.832 0.349 . . . . 0.0 111.159 177.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -64.17 120.71 12.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.992 -178.525 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 48.4 m -124.74 131.63 53.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.835 -169.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.84 138.89 52.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.105 -174.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -135.04 172.85 21.86 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.463 -170.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 23.4 mm -111.39 127.91 68.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.759 0.314 . . . . 0.0 111.244 -173.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 -62.48 132.03 51.15 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.988 -176.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.467 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -60.13 -28.48 67.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.113 -178.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.7 -5.15 59.3 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.996 -175.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 23.8 t -74.79 120.06 79.75 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.675 0.75 . . . . 0.0 110.917 -174.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.425 ' HD2' HG21 ' A' ' 2' ' ' ILE . 92.0 Cg_endo -70.4 -7.1 20.45 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.637 2.225 . . . . 0.0 112.389 164.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -101.11 14.93 30.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.939 -171.022 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -51.87 -40.18 60.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.898 -169.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -64.3 -52.4 58.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.948 -172.018 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.4 pp -80.51 -33.65 36.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.004 -175.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -67.62 -47.43 69.65 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.018 178.797 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -61.48 -41.75 97.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.854 173.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.584 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.8 tt0 -61.38 -47.32 86.35 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.926 -179.664 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.413 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 17.9 m-30 -68.4 -36.56 79.3 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.813 -178.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.52 ' HA ' HD22 ' A' ' 284' ' ' LEU . 5.8 tt -59.37 -52.4 65.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.873 -177.005 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -77.91 -33.5 51.82 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.931 -176.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.584 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 61.7 m-80 -99.97 -13.19 19.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.845 -163.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.762 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 59.2 m-85 -127.36 -50.49 1.41 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.52 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.5 OUTLIER -63.85 -39.36 94.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.912 -170.523 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 1.014 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.7 pp -124.38 38.2 4.24 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.976 -175.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.477 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 5.9 t -115.66 162.73 16.83 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.088 178.293 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.423 ' HA ' HD11 ' A' ' 290' ' ' LEU . 28.4 t70 -48.51 -34.12 10.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.874 -169.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -80.24 -41.09 25.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.859 -178.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.762 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.77 -57.24 5.48 Favored Glycine 0 N--CA 1.453 -0.205 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.452 -170.224 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.549 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -66.42 -21.47 66.21 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.836 0.351 . . . . 0.0 110.973 179.666 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.537 ' N ' HD12 ' A' ' 290' ' ' LEU . 83.9 tt0 -67.06 -46.49 74.2 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.825 171.135 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.67 -37.66 88.33 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.125 -179.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . . . . . . . . . 61.0 t -74.61 -46.33 42.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.086 -177.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 45.3 t30 -65.81 -30.09 70.67 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.797 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -67.05 -27.8 67.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.95 -177.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -87.41 -49.92 6.9 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.83 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 298' ' ' PRO . 74.1 mmtt -138.6 139.15 23.62 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.57 0.7 . . . . 0.0 110.865 177.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 297' ' ' LYS . 80.1 Cg_exo -55.03 115.83 2.71 Favored 'Trans proline' 0 C--N 1.341 0.163 0 C-N-CA 122.66 2.24 . . . . 0.0 112.381 -176.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 299' ' ' LEU . 0.3 OUTLIER -84.41 -22.54 30.38 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.887 173.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 96.8 -59.71 1.22 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.516 -179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.659 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -167.53 160.23 12.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.814 0.34 . . . . 0.0 111.231 174.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.691 HG21 ' HB3' ' A' ' 307' ' ' TYR . 22.1 m -120.84 153.3 24.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.178 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.87 -9.58 58.68 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.061 173.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.549 ' CD2' HD21 ' A' ' 290' ' ' LEU . 44.0 tp -83.48 121.1 26.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.886 -177.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -57.58 -38.61 75.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.86 -174.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 39.7 t -64.46 -50.0 69.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.847 -169.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.691 ' HB3' HG21 ' A' ' 302' ' ' VAL . 13.6 t80 -77.26 -31.32 54.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.91 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 89.1 tt0 -62.93 -39.15 93.7 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.9 177.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -58.67 -38.01 77.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.832 175.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 79.2 mm-40 -75.05 -38.78 61.3 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.979 176.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.659 HD13 ' HA ' ' A' ' 301' ' ' ALA . 80.3 mt -61.84 -34.25 75.64 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.98 176.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.38 -18.05 63.27 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.055 -175.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -65.12 -19.56 66.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.934 174.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.2 t0 -93.14 121.43 65.53 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.6 0.715 . . . . 0.0 110.865 166.024 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -47.9 -26.65 7.56 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.66 2.24 . . . . 0.0 112.396 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 77.4 mtt85 -62.91 -34.88 78.36 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.967 -175.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.531 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.0 OUTLIER -81.5 -35.95 14.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.06 -179.964 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.67 -39.2 90.57 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.118 -170.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -65.92 -47.96 73.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.035 176.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.526 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 75.6 p -67.84 -27.16 66.46 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.086 -176.09 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.5 ttp -62.48 -34.96 77.88 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.78 176.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 82.9 tt0 -62.31 -51.37 67.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.84 -175.489 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.621 HD21 ' HB1' ' A' ' 112' ' ' ALA . 12.3 p-10 -80.06 -26.48 39.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.77 -177.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -64.41 -51.62 62.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.095 -179.06 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -69.33 -29.77 67.67 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.984 -177.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -107.88 -8.13 16.06 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.824 -168.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -91.39 -153.24 29.33 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.686 -0.769 . . . . 0.0 112.436 -168.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -140.0 144.83 37.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.856 0.36 . . . . 0.0 110.895 -172.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 36.0 mm -63.78 119.54 8.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.089 -172.426 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 60.2 ttm -62.54 135.93 95.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.517 0.675 . . . . 0.0 110.89 178.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.781 ' HG3' ' CE1' ' A' ' 169' ' ' PHE . 32.0 Cg_endo -67.89 126.21 14.26 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.678 2.252 . . . . 0.0 112.312 -177.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.467 ' HB3' ' H ' ' A' ' 65' ' ' ASP . 61.0 t30 -117.58 21.84 12.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.895 -179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 50.4 pt -79.78 153.53 75.51 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.677 0.751 . . . . 0.0 111.128 -176.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -54.11 -30.97 62.94 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.717 2.278 . . . . 0.0 112.315 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.409 ' HB3' ' CZ ' ' A' ' 339' ' ' PHE . 99.4 mm-40 -67.03 -24.55 66.01 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.83 -173.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 88.4 mmm -64.96 -28.64 69.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.871 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.1 m -58.07 -39.91 79.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.767 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.07 -39.39 63.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.107 177.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.485 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 3.8 m-30 -63.17 -46.74 85.7 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.936 -178.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -60.14 -37.71 80.9 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.901 -179.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 18.3 m-30 -69.63 -39.67 77.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.898 177.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.2 -43.01 83.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.104 -178.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.4 HG13 ' O ' ' A' ' 339' ' ' PHE . 19.7 m -73.91 -33.17 36.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.133 -178.124 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.454 ' O ' HG22 ' A' ' 347' ' ' VAL . 5.0 tmt_? -65.2 -38.68 91.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.874 174.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 86.1 m -58.53 -38.6 78.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.148 173.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.02 -42.76 94.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.136 -174.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.549 ' HA ' HD11 ' A' ' 192' ' ' LEU . 12.4 m -73.97 -35.51 42.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.084 -174.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 347' ' ' VAL . 1.4 mp -63.68 -47.01 93.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.221 173.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -63.02 -40.98 99.37 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.891 -177.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -73.96 -45.94 47.14 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.11 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.01 -40.17 78.83 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.032 -173.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.7 p -75.67 -10.11 59.16 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.906 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.32 18.67 68.43 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.375 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.13 -32.85 44.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.854 0.359 . . . . 0.0 110.911 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 90.5 mm-40 -140.88 157.72 44.97 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.878 178.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.6 p -77.21 169.11 18.92 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.288 170.713 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.516 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.0 t -57.56 -43.07 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.14 172.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.9 m-20 -60.65 -47.04 88.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.85 -179.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.2 mm-40 -69.52 -55.3 10.58 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.93 179.891 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.5 -47.7 66.34 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.084 -172.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.589 ' HG ' ' HA ' ' A' ' 189' ' ' LYS . 1.6 tm? -65.08 -44.96 87.21 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.919 -174.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -65.46 -53.71 38.81 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.949 -177.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -69.01 -47.07 66.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.842 -172.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -67.07 -43.92 81.41 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.144 -174.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.502 ' HB3' ' HB ' ' A' ' 183' ' ' VAL . 86.9 mm-40 -73.36 -32.98 64.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.933 -175.032 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 35.9 m -61.76 -28.23 69.29 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.172 177.233 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -57.88 -30.11 65.58 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.921 175.323 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.429 ' HB ' ' O ' ' A' ' 365' ' ' GLN . 74.5 mt -60.9 -37.7 77.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.233 174.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 43.4 p -98.01 -12.01 22.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.174 -178.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.882 176.539 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.752 0.31 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 54.6 mt -108.96 138.16 37.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.11 -178.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -121.37 136.13 55.0 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.83 -179.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -54.32 134.92 45.31 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.843 176.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.24 9.4 67.32 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.475 -174.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.495 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 39.2 ttpt -160.07 129.97 5.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.861 0.363 . . . . 0.0 110.936 173.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.675 ' H ' HD23 ' A' ' 7' ' ' LEU . 1.1 pt? -136.24 152.77 51.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.93 -169.326 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.455 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 74.5 t -112.64 135.22 52.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.189 -177.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.631 HD11 HG23 ' A' ' 35' ' ' VAL . 1.1 mp -118.64 132.69 67.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.065 177.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.799 ' HD1' ' HB3' ' A' ' 57' ' ' PRO . 78.7 m95 -104.45 125.77 50.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.929 164.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.518 HD12 ' HG ' ' A' ' 20' ' ' LEU . 10.4 tt -110.88 150.03 13.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.096 -166.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -58.99 150.09 25.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.842 -173.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.83 -16.62 12.75 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.417 -179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -72.68 -15.21 61.7 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.874 0.368 . . . . 0.0 110.917 -177.111 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 14.6 mmmt -139.98 137.85 35.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.899 167.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.97 -81.56 1.07 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.504 -179.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 79.1 m-85 -109.99 -37.13 5.69 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.932 0.396 . . . . 0.0 110.946 -178.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.5 m-20 -66.9 -50.01 63.77 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.92 -151.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.754 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -54.67 -53.6 38.13 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.537 -177.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.518 ' HG ' HD12 ' A' ' 11' ' ' ILE . 8.1 mt -55.01 -48.07 73.85 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 120.783 0.325 . . . . 0.0 110.926 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.73 -34.77 12.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.11 178.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -78.66 -60.13 2.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.848 177.138 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.465 HG23 ' N ' ' A' ' 24' ' ' GLY . 26.4 m -74.55 -42.1 48.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 -169.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.465 ' N ' HG23 ' A' ' 23' ' ' VAL . . . -64.99 -40.61 97.26 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.524 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 57.8 tptt -59.04 -29.95 67.67 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.908 0.385 . . . . 0.0 110.88 -177.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -56.99 -33.08 66.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.026 176.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.549 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 2.5 m-30 -56.6 -47.76 78.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.895 177.278 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -70.36 -41.42 73.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.937 -178.541 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -65.07 -34.85 79.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.846 -175.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.7 m-20 -92.63 -48.94 6.35 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.908 0.385 . . . . 0.0 110.853 -170.476 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 35.1 p -116.56 -0.72 12.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.213 -169.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.04 11.72 85.1 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.705 -0.759 . . . . 0.0 112.429 167.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.959 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.02 133.86 38.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.868 0.366 . . . . 0.0 111.11 -179.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 73.4 mmtt -74.13 140.62 45.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.097 -0.502 . . . . 0.0 110.844 -171.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.631 HG23 HD11 ' A' ' 9' ' ' ILE . 13.1 p -122.72 128.1 75.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.065 -174.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.621 ' O ' HD12 ' A' ' 9' ' ' ILE . 96.9 m -111.94 129.08 56.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.093 -174.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.467 HG22 ' HB3' ' A' ' 20' ' ' LEU . 91.6 t -104.48 131.51 53.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.125 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 71.0 mm-40 -117.18 155.02 30.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.936 177.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.431 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 66.0 t-80 -85.07 138.96 36.71 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.683 0.754 . . . . 0.0 110.837 -170.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 39' ' ' HIS . 86.6 Cg_exo -54.98 -29.39 64.34 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.627 2.218 . . . . 0.0 112.303 -175.361 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -48.28 -51.34 26.23 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.951 -172.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -91.03 -0.85 57.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.885 -174.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 8.2 tt -47.06 -53.12 13.37 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.949 -176.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -68.69 -38.45 80.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.873 175.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -64.7 -41.35 96.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 -171.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -81.66 -21.43 38.16 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.889 -178.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.528 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 65.9 t80 -48.6 -50.71 57.8 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.624 0.726 . . . . 0.0 110.84 -167.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.528 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 66.3 Cg_endo -80.06 -28.48 3.13 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.596 2.198 . . . . 0.0 112.352 179.045 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -74.43 -39.16 62.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.875 -171.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.428 HG11 ' HD3' ' A' ' 57' ' ' PRO . 33.5 m -67.88 -27.97 39.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.13 -177.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.575 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -68.29 -37.77 80.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.057 177.02 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.19 -32.11 72.96 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.076 -179.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.8 p -92.89 -14.92 27.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.103 177.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.56 10.79 79.95 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.407 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.9 m-20 -142.79 136.2 28.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.776 0.322 . . . . 0.0 110.766 178.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.95 -114.95 0.52 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.514 177.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.799 ' HB3' ' HD1' ' A' ' 10' ' ' TRP . 61.2 Cg_endo -73.97 154.54 47.89 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.709 2.273 . . . . 0.0 112.285 177.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -93.67 -32.77 13.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.842 160.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.608 ' HB ' HG23 ' A' ' 9' ' ' ILE . 39.0 mt -127.63 137.77 56.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.229 -177.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.4 tp -131.38 126.84 59.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.193 178.074 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -88.97 141.6 28.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.855 167.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.579 ' CZ2' ' HB3' ' A' ' 67' ' ' PHE . 1.8 p90 -138.41 160.9 38.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.968 172.002 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -69.43 -82.37 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.164 -169.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.537 ' CD2' ' HA3' ' A' ' 260' ' ' GLY . 40.5 m170 -121.88 -71.07 0.75 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.878 -170.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -104.95 -11.78 16.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.815 -164.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -56.78 -17.07 7.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.915 -158.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.579 ' HB3' ' CZ2' ' A' ' 62' ' ' TRP . 27.9 p90 -61.77 -23.23 66.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.826 -173.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -54.55 -48.81 63.53 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.404 -174.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.43 -36.77 92.03 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.474 171.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.499 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 1.5 t80 -55.17 -51.23 67.17 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.897 0.38 . . . . 0.0 110.874 -179.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.99 -41.91 40.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.119 -178.02 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.2 tp60 -59.19 -36.18 74.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -175.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 67.0 m -85.06 -7.69 59.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.882 178.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.28 31.73 58.95 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.513 173.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.575 HD22 ' HB1' ' A' ' 51' ' ' ALA . 52.1 mt -88.12 -9.62 52.64 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.812 0.339 . . . . 0.0 110.884 -167.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.538 HD11 ' HB ' ' A' ' 104' ' ' ILE . 0.3 OUTLIER -128.42 152.95 47.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.925 -172.254 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.428 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -79.18 141.25 37.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.091 175.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -70.74 137.85 50.02 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.882 173.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.427 HD12 ' CZ ' ' A' ' 106' ' ' TYR . 39.3 pt -103.88 156.64 5.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.143 -176.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.9 m -92.08 130.04 39.54 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.536 0.684 . . . . 0.0 111.088 177.603 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . 0.412 ' HB3' HD12 ' A' ' 103' ' ' LEU . 50.0 Cg_endo -67.41 141.14 55.03 Favored 'Trans proline' 0 N--CA 1.466 -0.135 0 C-N-CA 122.687 2.258 . . . . 0.0 112.328 178.653 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -110.14 118.75 37.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.894 174.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -57.94 -36.78 73.01 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.852 178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.25 -45.17 92.79 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.178 -177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 23.5 m-85 -75.64 -32.44 60.23 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.945 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.483 ' HA ' ' NE1' ' A' ' 94' ' ' TRP . 66.5 tt0 -51.51 -49.1 62.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.897 175.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -66.35 -32.89 74.56 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.799 177.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.02 -23.26 52.18 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.84 -172.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.96 -104.64 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.993 -169.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 t80 174.94 107.98 0.08 OUTLIER Pre-proline 0 C--N 1.327 -0.373 0 CA-C-O 121.668 0.747 . . . . 0.0 111.036 -160.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_exo -50.0 -32.17 30.0 Favored 'Trans proline' 0 C--O 1.232 0.21 0 C-N-CA 122.725 2.283 . . . . 0.0 112.329 -177.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -63.99 -36.93 85.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.854 -179.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.2 p -78.3 -31.52 48.91 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.154 178.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.579 ' HA ' HG22 ' A' ' 97' ' ' VAL . 86.2 m95 -63.16 -29.99 71.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.937 171.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -69.46 -32.15 70.9 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.792 175.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.73 -23.01 61.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.08 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.579 HG22 ' HA ' ' A' ' 94' ' ' TRP . 19.8 m -110.7 17.98 7.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.134 -178.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.4 ttp180 -107.57 132.93 52.74 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.817 179.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 80.7 t80 -126.2 119.22 26.91 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.889 174.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.2 t30 57.57 37.04 27.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.868 175.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.64 1.12 90.1 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.482 175.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -121.83 148.75 44.29 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 120.843 0.354 . . . . 0.0 110.852 176.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.564 HD22 HG23 ' A' ' 97' ' ' VAL . 16.8 mt -86.03 133.79 33.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.853 -176.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.538 ' HB ' HD11 ' A' ' 76' ' ' LEU . 1.2 pp -114.84 -9.29 12.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.095 -172.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.55 ' HB3' ' HH2' ' A' ' 62' ' ' TRP . . . -169.44 173.4 6.54 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.183 -173.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 99.2 m-85 -115.88 140.17 25.86 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.671 0.748 . . . . 0.0 110.925 179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 12.2 Cg_exo -70.82 127.85 14.29 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.705 2.27 . . . . 0.0 112.323 172.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.898 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -108.9 -39.93 4.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.117 177.074 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.597 ' HB3' ' HB3' ' A' ' 262' ' ' LEU . . . -143.29 154.17 43.52 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.149 -171.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.2 t -116.15 127.28 73.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.204 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -110.62 125.23 53.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.904 176.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.452 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -146.36 141.05 26.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.093 -178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 7.9 mp -89.66 167.12 13.17 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.004 -174.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.5 p -156.27 154.99 31.56 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.845 -176.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.874 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -92.27 123.48 35.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 168.335 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.555 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.0 mp -109.94 131.56 60.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.177 -175.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -132.35 148.41 52.42 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.904 -173.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.0 t-20 -91.06 113.97 26.38 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.909 -179.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 96.7 mttt -63.11 -25.41 68.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.874 -173.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -83.47 -22.15 32.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.823 -173.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.5 mp -81.23 -55.51 4.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.857 169.11 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.696 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.7 pt? -141.05 127.34 11.5 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.554 0.693 . . . . 0.0 110.888 173.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -80.18 -5.54 13.64 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.663 2.242 . . . . 0.0 112.365 -175.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 59.7 t-20 -149.27 102.43 3.32 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.621 0.725 . . . . 0.0 110.793 -175.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -72.01 156.92 55.49 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.769 2.312 . . . . 0.0 112.321 179.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_endo -65.14 144.84 82.98 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.737 2.291 . . . . 0.0 112.247 -179.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.02 -17.97 44.93 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.977 -177.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 56.8 p -135.06 159.51 41.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.21 -177.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.519 ' HA ' HD13 ' A' ' 132' ' ' ILE . 64.7 m95 -70.76 -28.35 64.62 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.039 179.16 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -64.99 -22.78 67.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.807 179.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -82.34 -21.96 35.77 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.791 -177.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.638 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 0.8 OUTLIER -56.76 -48.73 96.76 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.67 0.747 . . . . 0.0 111.2 -173.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 41.8 Cg_endo -69.07 -37.41 10.87 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.669 2.246 . . . . 0.0 112.332 -174.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.89 -60.74 2.73 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.081 176.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.272 HD22 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.23 -16.95 64.17 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.88 -175.99 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.504 ' N ' HD13 ' A' ' 135' ' ' LEU . 34.5 t70 -57.79 -40.4 79.77 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.039 0.447 . . . . 0.0 110.866 168.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -60.25 -30.66 69.57 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.844 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.3 mt-10 -70.97 -47.69 57.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.812 -178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.618 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.9 pp -84.91 -14.47 47.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.867 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.618 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.8 tttt -60.87 -34.01 73.97 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.968 174.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.73 -24.05 67.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.085 175.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -95.12 4.35 53.76 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.877 179.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.02 32.13 56.96 Favored Glycine 0 N--CA 1.453 -0.219 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.489 178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -110.22 170.72 7.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.862 0.363 . . . . 0.0 110.932 173.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 40.9 t -124.14 138.73 54.39 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.866 168.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -65.4 -43.69 89.81 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.088 -170.236 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -143.11 127.87 18.21 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.915 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 63.5 tpp -107.55 132.58 53.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.833 -176.853 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 45.4 p90 -153.57 158.44 41.22 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.871 -172.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -90.11 -51.08 5.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.851 177.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.064 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.6 tm? 48.04 32.36 2.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.03 -167.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.7 mm-40 -101.2 -6.16 24.62 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.866 175.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.36 155.02 80.72 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.638 0.732 . . . . 0.0 110.939 -174.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -62.06 -25.95 77.9 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.743 2.295 . . . . 0.0 112.391 177.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 29.8 m-85 -72.26 -27.48 62.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.905 178.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -80.01 -38.88 31.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.848 170.507 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.405 HG23 HG11 ' A' ' 347' ' ' VAL . 22.5 m -63.15 -45.66 90.82 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.07 -179.363 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.591 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 46.2 t-105 -54.95 -54.55 48.66 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-O 121.609 0.719 . . . . 0.0 110.931 -169.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.591 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 22.1 Cg_endo -63.99 -19.92 67.15 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.634 2.222 . . . . 0.0 112.38 -173.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.706 HD13 ' C ' ' A' ' 160' ' ' LEU . 1.7 tm? -82.77 -45.87 13.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.858 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.532 HG22 ' HA3' ' A' ' 166' ' ' GLY . 85.3 mt -75.3 -44.77 42.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.143 -178.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.11 -23.65 61.36 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.092 -173.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.586 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -59.59 -35.95 75.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.104 -170.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 58.9 p30 -102.51 8.39 39.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.862 -178.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 119.94 2.01 12.81 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.745 -0.741 . . . . 0.0 112.501 170.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.532 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -77.34 65.49 3.06 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.498 179.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 84.6 m-85 -88.23 134.57 33.76 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.865 0.364 . . . . 0.0 111.035 -178.602 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -77.6 2.1 17.61 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.135 -174.271 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.442 ' HA ' HG12 ' A' ' 181' ' ' VAL . 44.3 p90 -159.45 154.74 25.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.893 -175.632 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 54.1 tptt -93.67 123.13 36.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.847 160.367 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 63.7 t80 -114.95 120.58 40.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.987 175.116 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.4 tt0 -151.93 130.13 11.96 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 -173.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 55.04 41.41 31.83 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.955 174.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.21 17.81 79.67 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.536 175.253 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -130.32 138.5 50.48 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.837 0.351 . . . . 0.0 110.853 -176.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -99.24 144.98 27.74 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.885 172.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.6 t0 -126.39 110.0 12.85 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.832 174.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 39.7 pt -77.48 -15.73 14.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.105 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -94.95 -9.52 33.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.914 -177.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -121.78 84.17 2.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.833 172.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.442 HG12 ' HA ' ' A' ' 169' ' ' PHE . 27.6 m -112.75 160.44 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.109 -172.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -104.53 19.06 43.16 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.516 -174.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . . . . . . . . . 2.3 m -102.6 -20.65 5.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.872 0.368 . . . . 0.0 111.098 -175.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.8 p-10 -87.61 21.71 2.47 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.788 -179.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -117.13 175.01 5.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.941 -177.219 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.81 -24.95 67.96 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.076 -175.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.99 -40.61 97.25 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.752 -0.737 . . . . 0.0 112.491 -173.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.594 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.86 -37.77 88.75 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.856 0.36 . . . . 0.0 111.055 178.099 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.562 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -61.14 -38.5 86.64 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.845 174.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.3 -38.08 89.78 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.078 178.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.491 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -66.52 -47.74 67.47 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.5 179.285 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.717 HD11 ' HA ' ' A' ' 347' ' ' VAL . 20.3 tp -66.67 -34.72 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.954 0.406 . . . . 0.0 110.926 -177.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.545 ' OG1' HG21 ' A' ' 357' ' ' VAL . 91.7 m -64.84 -42.64 94.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.11 177.516 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 91.5 t80 -68.06 -47.75 67.48 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.883 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.699 HD23 ' C ' ' A' ' 195' ' ' LEU . 5.3 tt -50.83 -50.66 56.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.91 -174.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 35.0 m -64.38 -22.7 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.111 -174.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.3 m-20 -62.45 -33.95 75.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.918 -178.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.462 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.6 OUTLIER -81.66 -39.86 23.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.966 -173.368 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.424 ' H ' HG13 ' A' ' 199' ' ' ILE . 1.7 pp -72.05 -29.77 34.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.15 171.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -66.93 -36.82 83.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 171.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.9 m-20 -83.65 4.03 30.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.952 177.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 66.23 39.9 4.0 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.835 170.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 61.4 m170 -75.73 -17.87 59.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.824 178.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.3 ppp? -143.01 154.93 44.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.892 175.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -94.39 154.56 17.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.964 -178.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.01 -26.85 68.48 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.151 -177.032 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.7 p-10 -95.03 0.42 54.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.846 -177.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 97.1 m -66.17 128.82 37.62 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.153 -176.949 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.401 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 19.7 t0 -122.0 173.6 7.43 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 173.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 17.1 p90 -62.77 -40.96 98.92 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.97 -178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.6 p -68.28 -37.37 80.61 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.862 179.338 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.401 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 79.9 mt -65.03 -42.22 94.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.081 174.428 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.44 -39.1 93.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.078 178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -66.26 -41.92 89.26 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.859 177.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.05 -44.04 90.34 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.076 179.018 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.85 -39.11 93.03 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.129 177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 65.5 t80 -63.68 -39.64 94.83 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.914 177.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -61.27 -33.19 73.13 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.877 177.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -85.3 -13.93 48.13 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.867 -178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.16 25.15 41.32 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.483 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -85.45 -22.16 28.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.952 0.406 . . . . 0.0 110.893 -175.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.9 t -129.57 139.95 51.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.103 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.566 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -65.05 -54.23 33.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.05 -174.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.656 ' HB3' HD21 ' A' ' 115' ' ' LEU . 67.8 mtm -134.42 153.2 52.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.813 -170.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 68.8 p -139.37 161.64 36.96 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.185 175.036 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 44.9 mm -108.94 126.21 65.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.174 175.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -154.75 175.05 14.19 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.927 -171.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -85.93 -159.98 33.06 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.411 -174.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -69.26 -23.52 33.0 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.679 2.253 . . . . 0.0 112.391 -177.321 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 29.7 m-90 -75.92 -24.88 55.59 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.905 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 48.05 50.08 16.42 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.153 178.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 68.2 m95 -59.98 -20.49 57.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.881 -178.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 70.0 m -48.78 -50.1 35.62 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.865 174.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 48.9 p30 -85.02 179.33 7.3 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -172.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 83.2 mt -124.25 131.7 72.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.158 -176.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -69.97 -39.62 75.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.893 -174.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 91.4 m -124.69 109.97 13.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.055 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 27.3 t -172.1 150.13 2.44 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.98 -26.83 67.74 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.907 173.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 87.5 t -68.22 134.31 30.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.128 178.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 -90.95 132.02 36.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.858 -175.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -127.29 147.65 50.23 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.846 176.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -129.6 156.81 21.54 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.489 170.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.451 HG11 ' HA ' ' A' ' 316' ' ' ARG . 3.1 p -135.72 135.17 51.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.962 0.411 . . . . 0.0 111.086 -177.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 11.6 t -154.62 150.95 28.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.152 174.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 29.2 m -61.04 164.75 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.17 179.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.524 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 2.5 mp -71.26 152.75 94.38 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.583 0.706 . . . . 0.0 110.95 -163.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.62 -176.44 3.22 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.719 2.28 . . . . 0.0 112.479 -171.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.2 m -86.02 143.84 27.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.196 -174.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 16.4 t80 -129.85 111.78 12.92 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.957 -176.123 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 54.99 36.84 27.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.887 -179.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.53 0.78 84.05 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.462 174.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . 0.412 ' HA ' ' HD3' ' A' ' 254' ' ' PRO . 91.2 mm-40 -126.5 125.89 24.53 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 121.576 0.703 . . . . 0.0 110.862 177.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 253' ' ' GLN . 77.3 Cg_exo -54.43 128.58 30.71 Favored 'Trans proline' 0 C--O 1.231 0.153 0 C-N-CA 122.736 2.29 . . . . 0.0 112.338 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . . . . . . . . . 82.4 p -84.32 0.41 49.25 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.024 0.44 . . . . 0.0 110.9 174.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -37.71 134.95 0.79 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.54 0.686 . . . . 0.0 110.825 179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.452 ' HD3' HD13 ' A' ' 247' ' ' LEU . 30.3 Cg_endo -79.05 156.66 26.57 Favored 'Trans proline' 0 C--O 1.231 0.175 0 C-N-CA 122.657 2.238 . . . . 0.0 112.385 -163.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . 0.552 ' HB2' ' SD ' ' A' ' 330' ' ' MET . 10.4 m-85 -75.46 167.19 22.36 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.885 -179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 42.6 t -114.49 132.77 62.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.181 -167.167 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.537 ' HA3' ' CD2' ' A' ' 64' ' ' HIS . . . -115.2 141.78 17.21 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.41 173.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 81.4 t -121.42 112.08 33.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.767 0.318 . . . . 0.0 111.122 -176.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.597 ' HB3' ' HB3' ' A' ' 109' ' ' ALA . 0.0 OUTLIER -75.82 114.51 14.51 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.016 -176.57 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.417 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . 19.1 m -131.62 154.11 49.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.777 -164.133 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.421 ' O ' ' HB1' ' A' ' 105' ' ' ALA . . . -132.61 133.56 43.79 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.123 -176.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -124.01 171.24 16.3 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.459 -174.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.636 HG13 ' HB3' ' A' ' 277' ' ' LYS . 37.5 mm -113.31 124.99 70.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.246 -170.698 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -62.97 130.68 45.8 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 -176.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.479 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -59.26 -29.36 67.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.2 -177.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.03 -8.19 58.81 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.001 -172.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.4 t -67.39 123.56 86.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.58 0.705 . . . . 0.0 110.866 -172.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -69.71 -11.49 31.02 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.576 2.184 . . . . 0.0 112.408 168.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 71.8 m-80 -103.92 14.1 31.43 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.888 -176.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 19.8 pttp -51.82 -35.25 43.72 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.904 -167.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . 0.405 ' HA ' ' HE3' ' A' ' 277' ' ' LYS . 72.0 mm-40 -70.08 -49.4 51.41 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.006 -174.024 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.5 pp -79.94 -30.33 39.89 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.901 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -64.83 -50.53 66.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.051 179.416 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.636 ' HB3' HG13 ' A' ' 266' ' ' ILE . 13.7 pttp -71.96 -34.07 68.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.915 -179.403 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -63.39 -46.62 85.62 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.933 177.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 16.3 m-30 -69.7 -36.33 75.85 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.884 178.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.437 ' HA ' HD22 ' A' ' 284' ' ' LEU . 5.9 tt -55.73 -51.32 67.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.922 -178.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -75.79 -26.35 57.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.816 -177.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -100.28 -13.25 18.93 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.78 -166.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.846 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 63.0 m-85 -120.15 -59.77 1.75 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.813 177.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.437 HD22 ' HA ' ' A' ' 280' ' ' LEU . 1.6 mp -62.37 -34.23 76.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.951 -161.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.898 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.3 pp -124.77 37.52 4.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.929 -175.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.475 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 66.7 p -118.59 160.6 21.5 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.176 175.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.569 ' HA ' HD11 ' A' ' 290' ' ' LEU . 42.2 p-10 -51.12 -28.51 10.96 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.778 -167.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -78.93 -45.0 21.4 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.909 175.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.846 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.27 -56.8 6.0 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.497 -169.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.59 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -66.5 -21.63 66.18 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.766 0.317 . . . . 0.0 110.976 -178.884 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.581 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.1 tt0 -69.34 -49.31 56.79 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.89 172.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.91 -40.65 96.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.077 -172.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.754 HG23 ' HA3' ' A' ' 19' ' ' GLY . 1.5 p -79.78 -29.89 13.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -176.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.417 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 27.7 t30 -63.9 -29.79 70.93 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.854 174.262 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -66.58 -20.76 66.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.935 179.159 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 68.8 m-20 -82.17 -39.96 22.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.917 178.086 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -161.89 138.37 6.09 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.424 0.631 . . . . 0.0 110.935 174.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_exo -45.82 115.94 1.23 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.685 2.256 . . . . 0.0 112.448 176.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.417 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 49.4 mt -93.49 -12.15 30.35 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.897 -178.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 98.33 -61.7 0.89 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.528 171.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.607 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -167.1 159.55 13.15 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.844 0.354 . . . . 0.0 111.141 177.581 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.581 ' HA ' ' HA ' ' A' ' 109' ' ' ALA . 19.3 m -124.95 159.85 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.212 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.81 -14.44 61.1 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.12 172.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.59 ' CD2' HD21 ' A' ' 290' ' ' LEU . 49.9 tp -83.74 121.01 26.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.9 -172.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -59.4 -33.79 71.65 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.944 -175.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 72.9 m -61.34 -47.53 85.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.775 -172.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.512 ' HB3' HG21 ' A' ' 302' ' ' VAL . 4.5 t80 -78.78 -32.69 46.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.933 -179.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 90.8 mt-10 -52.27 -40.89 62.35 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.849 173.618 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -55.14 -40.19 70.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.877 177.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 79.0 mm-40 -78.12 -37.83 45.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.92 177.257 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.607 HD13 ' HA ' ' A' ' 301' ' ' ALA . 83.4 mt -63.68 -33.03 74.74 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.967 -177.102 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.58 -20.26 59.98 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.099 -176.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -65.05 -20.22 66.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.837 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -93.09 121.28 65.94 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.65 0.738 . . . . 0.0 110.899 168.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -49.97 -25.13 11.81 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.669 2.246 . . . . 0.0 112.373 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.451 ' HA ' HG11 ' A' ' 244' ' ' VAL . 78.3 mtt85 -62.25 -29.87 70.71 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.935 -175.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.565 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.2 mp -75.3 -28.67 20.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.41 -40.81 87.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.031 -171.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.26 -45.32 73.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.145 176.096 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.452 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 67.0 p -64.47 -29.61 70.65 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.151 -173.43 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 61.9 tpp -68.63 -35.66 77.6 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.791 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 41.4 tp10 -65.03 -47.75 76.31 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 -173.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.479 ' O ' ' N ' ' A' ' 327' ' ' GLY . 8.2 p-10 -79.94 -24.78 40.79 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.851 -177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.39 -42.79 92.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.085 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.4 mt-30 -66.93 -38.84 86.9 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.925 178.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -110.47 -4.14 15.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.818 -166.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.87 -162.7 36.99 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.526 -166.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -150.31 147.11 27.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.862 0.363 . . . . 0.0 110.885 -171.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 36.8 mm -59.85 123.14 11.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.115 -170.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.552 ' SD ' ' HB2' ' A' ' 258' ' ' PHE . 74.4 mmm -42.0 134.42 2.38 Favored Pre-proline 0 C--N 1.331 -0.222 0 CA-C-O 121.554 0.692 . . . . 0.0 110.917 178.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.444 ' HG3' ' CE2' ' A' ' 158' ' ' TRP . 74.5 Cg_endo -75.22 80.64 2.43 Favored 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.666 2.244 . . . . 0.0 112.294 178.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -111.07 22.59 15.1 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.83 -177.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 46.3 pt -74.77 159.71 82.52 Favored Pre-proline 0 C--N 1.327 -0.4 0 CA-C-O 121.642 0.734 . . . . 0.0 111.114 -177.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_exo -54.44 -35.11 84.0 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.64 2.226 . . . . 0.0 112.292 -174.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -67.21 -28.05 67.75 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.989 -177.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 80.8 mmm -75.43 -18.36 59.92 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.812 -171.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.4 m -58.4 -42.17 86.55 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.774 177.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -74.0 -39.45 63.61 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.159 175.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.519 ' O ' HG13 ' A' ' 343' ' ' VAL . 4.2 m-30 -67.3 -45.42 76.6 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.869 -174.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.461 ' HA ' HG22 ' A' ' 343' ' ' VAL . 6.9 m0 -59.7 -37.32 78.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.955 177.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.1 t80 -63.6 -45.18 91.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.875 176.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -67.41 -44.23 79.31 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.106 -177.693 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.519 HG13 ' O ' ' A' ' 339' ' ' PHE . 18.4 m -73.49 -32.46 36.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 -175.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.442 ' O ' HG22 ' A' ' 347' ' ' VAL . 5.1 tmt_? -66.05 -39.04 89.81 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 175.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 89.2 m -58.74 -36.96 75.18 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.145 173.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.01 -43.85 91.17 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.145 -174.043 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.717 ' HA ' HD11 ' A' ' 192' ' ' LEU . 8.5 m -73.01 -34.79 46.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.211 -175.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.457 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -64.22 -46.78 92.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.09 174.025 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -67.9 -37.18 81.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.815 -176.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -70.86 -44.93 65.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.126 177.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.18 85.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.062 -176.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 90.6 p -77.7 -10.16 59.38 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.914 -177.572 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.09 17.07 73.01 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.45 179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -78.02 -31.12 50.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.74 0.305 . . . . 0.0 110.881 -179.06 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . 0.554 ' HB2' ' HB2' ' A' ' 360' ' ' ALA . 77.8 mt-30 -139.98 155.07 47.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.901 176.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 57.2 p -78.81 166.04 22.89 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.216 169.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.545 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.8 t -56.12 -41.95 70.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.116 174.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -60.9 -48.13 83.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.854 178.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -69.58 -54.96 11.54 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.947 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . 0.554 ' HB2' ' HB2' ' A' ' 355' ' ' GLN . . . -68.61 -47.75 65.87 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.115 -172.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.594 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.5 tm? -65.46 -44.63 86.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.964 -174.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.45 -53.12 53.31 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.986 -178.745 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -67.5 -45.89 74.5 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.896 -173.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.34 -43.54 85.83 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.095 -175.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.565 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 78.4 mm-40 -76.02 -25.73 55.97 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.001 -176.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 53.5 m -62.39 -35.08 78.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.086 171.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -59.94 -30.23 68.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.893 179.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . . . . . . . . . 71.4 mt -60.46 -37.6 75.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.088 174.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 60.9 p -94.56 -15.0 24.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.168 -178.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.328 -0.334 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.856 179.252 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.0 mttt . . . . . 0 C--O 1.232 0.153 0 CA-C-O 120.726 0.298 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.421 HG21 ' HD2' ' A' ' 271' ' ' PRO . 49.4 mt -100.47 141.26 17.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.144 -179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -139.13 144.86 38.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.903 -178.272 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -52.8 133.74 37.09 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.823 177.372 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 89.79 10.6 64.77 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.46 -178.311 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.2 tttt -163.78 130.79 3.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.698 0.285 . . . . 0.0 110.91 176.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.615 ' CD2' HD11 ' A' ' 33' ' ' ILE . 1.4 pt? -141.58 151.89 43.56 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.974 -169.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.515 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 80.4 t -110.48 135.97 47.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.091 -176.327 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.656 HD11 HG13 ' A' ' 35' ' ' VAL . 1.0 OUTLIER -120.03 134.08 64.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.159 176.626 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.784 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 72.4 m95 -103.75 128.05 51.17 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.938 163.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.441 HD12 ' HG ' ' A' ' 20' ' ' LEU . 13.8 tt -108.52 149.95 11.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.193 -165.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -57.67 153.16 13.9 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.795 -173.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -55.17 -22.45 29.22 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.509 -177.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 94.4 m-20 -72.42 -17.11 61.82 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.855 0.359 . . . . 0.0 110.924 -169.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 11.5 mmmm -140.07 131.87 27.5 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.879 168.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -79.93 -71.96 1.23 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.544 -174.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 75.1 m-85 -109.08 -40.15 5.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.863 0.363 . . . . 0.0 110.906 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -66.9 -52.44 43.28 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.866 -149.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.411 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -52.96 -51.61 44.72 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.425 -176.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.468 ' HB3' HG22 ' A' ' 37' ' ' VAL . 3.9 mt -54.98 -57.35 12.04 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.775 0.321 . . . . 0.0 110.919 173.139 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -47.85 -37.4 13.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.11 -176.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 73.2 mm-40 -69.56 -55.69 9.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.909 179.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.3 m -73.79 -35.27 42.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.02 -0.537 . . . . 0.0 111.187 -173.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.566 ' HA3' HG11 ' A' ' 35' ' ' VAL . . . -66.66 -46.67 73.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.749 -0.738 . . . . 0.0 112.482 176.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -53.42 -36.64 61.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.862 0.363 . . . . 0.0 110.898 -179.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 59.3 tttp -56.22 -42.8 77.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.904 176.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 10.3 m-30 -64.0 -43.49 95.52 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.833 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.424 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 98.8 mt-10 -61.23 -37.64 83.77 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.944 176.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -71.77 -41.49 68.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.886 179.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -94.46 -46.96 6.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.944 -164.441 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 39.7 p -108.57 -7.87 15.62 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.111 -172.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.81 8.3 87.84 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.436 168.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.035 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -98.64 134.69 36.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.807 0.337 . . . . 0.0 111.168 -179.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.424 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.1 mttt -73.34 135.69 44.36 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.959 -170.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.656 HG13 HD11 ' A' ' 9' ' ' ILE . 96.6 t -115.74 126.34 73.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.989 0.423 . . . . 0.0 111.075 -175.08 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.555 ' O ' HD12 ' A' ' 9' ' ' ILE . 96.7 m -108.47 127.9 54.32 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.126 -179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 20' ' ' LEU . 94.2 t -103.1 130.07 53.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.137 179.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.2 mm-40 -119.38 152.01 37.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.835 177.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 64.9 t-80 -90.72 141.66 27.13 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.612 0.72 . . . . 0.0 110.902 -167.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.462 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 86.2 Cg_exo -55.11 -26.66 51.72 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.676 2.25 . . . . 0.0 112.386 -175.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.1 t0 -49.72 -55.72 12.86 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.851 -173.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.96 -1.74 58.18 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.853 -176.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.462 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 8.8 tt -46.9 -53.33 12.42 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.901 -175.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -67.81 -38.31 83.12 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.869 175.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -66.21 -42.21 89.05 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.843 -171.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.2 mmtt -83.63 -21.56 32.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.865 -178.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.523 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 62.1 t80 -47.11 -50.27 47.36 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.669 0.747 . . . . 0.0 110.832 -169.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.523 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 69.7 Cg_endo -79.89 -28.82 3.05 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.676 2.25 . . . . 0.0 112.347 179.222 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 83.0 mt-30 -73.86 -40.01 63.56 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.87 -172.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.435 HG11 ' HD3' ' A' ' 57' ' ' PRO . 33.7 m -67.91 -28.12 40.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.197 -177.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.664 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -70.38 -38.06 74.64 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.055 175.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.57 -33.86 75.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.164 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 61.9 p -90.11 -15.97 30.57 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.224 176.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.44 9.15 77.37 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.395 175.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.7 m-20 -139.96 132.25 28.29 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.808 0.337 . . . . 0.0 110.815 177.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 175.02 -114.95 0.52 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.51 177.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.784 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 61.2 Cg_endo -74.75 149.06 37.39 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.677 2.251 . . . . 0.0 112.282 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -86.97 -32.89 19.84 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.804 158.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.595 ' HB ' HG23 ' A' ' 9' ' ' ILE . 40.7 mt -128.19 137.77 56.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.116 -177.707 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 tp -131.78 126.1 56.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.104 176.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 25.0 m-85 -89.79 139.65 30.36 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.836 169.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.514 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 35.6 p90 -142.61 165.04 28.49 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.966 171.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -71.9 -88.62 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.034 -163.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.484 ' NE2' ' HA3' ' A' ' 260' ' ' GLY . 27.4 m170 -111.65 -75.72 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.861 -174.671 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 -103.69 -3.89 24.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.842 -161.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 88.0 mtt-85 -56.52 -16.89 6.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.877 -169.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.502 ' HB2' HD13 ' A' ' 104' ' ' ILE . 37.6 p90 -57.42 -28.52 63.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.849 -177.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.41 -50.6 63.55 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.703 -0.761 . . . . 0.0 112.493 -173.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.12 -38.06 94.86 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.56 173.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.454 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 1.6 t80 -57.22 -48.22 79.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.813 0.34 . . . . 0.0 110.93 -179.044 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -77.37 -43.79 31.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.053 -178.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.6 tt0 -56.58 -38.85 72.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.9 -175.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.412 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 60.3 m -83.72 -6.75 59.51 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.878 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.46 30.52 60.2 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.452 173.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.664 HD22 ' HB1' ' A' ' 51' ' ' ALA . 52.8 mt -88.01 -9.74 52.51 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.905 0.384 . . . . 0.0 110.914 -167.472 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.486 ' HA ' ' H ' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -130.15 153.16 48.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.87 -172.891 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -80.83 144.93 31.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.081 173.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -69.28 139.22 54.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.935 175.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 37.6 pt -105.05 153.92 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.067 -173.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 97.5 m -108.66 125.15 32.39 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.577 0.704 . . . . 0.0 111.104 173.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -72.65 156.0 53.89 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.631 2.22 . . . . 0.0 112.328 -176.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 64.7 t0 -105.96 122.51 46.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.909 175.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -52.23 -35.02 48.4 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.807 -177.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -63.05 -37.92 89.14 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.098 -178.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 73.6 m-85 -88.29 -25.47 22.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.913 177.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.4 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 66.5 tt0 -54.9 -45.27 74.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.886 -176.55 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -68.11 -23.81 64.96 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.831 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -91.55 -19.63 22.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.976 -167.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.597 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.4 OUTLIER -99.67 -32.44 11.07 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.956 -168.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.597 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 11.7 m-30 92.42 144.45 0.04 OUTLIER Pre-proline 0 C--N 1.326 -0.413 0 CA-C-O 121.638 0.733 . . . . 0.0 110.947 175.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -56.32 -40.0 87.58 Favored 'Trans proline' 0 C--N 1.342 0.19 0 C-N-CA 122.667 2.245 . . . . 0.0 112.406 -174.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 19.5 p90 -71.34 -23.17 61.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.949 -171.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 63.4 p -80.17 -37.67 32.86 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.231 173.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.525 ' HA ' HG22 ' A' ' 97' ' ' VAL . 55.7 m95 -65.03 -29.21 70.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.996 171.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -71.13 -34.62 71.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.831 177.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.14 -24.77 63.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.107 178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.566 HG23 HD22 ' A' ' 103' ' ' LEU . 18.4 m -106.96 15.64 7.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.164 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.1 ttp180 -101.34 131.62 47.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.866 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -130.94 116.03 17.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 174.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.0 t30 58.65 35.95 24.74 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.885 176.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.77 0.26 89.16 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.511 174.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -118.17 148.07 42.72 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.837 0.351 . . . . 0.0 110.818 173.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.566 HD22 HG23 ' A' ' 97' ' ' VAL . 32.6 mt -88.74 134.42 33.92 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 -179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.502 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -125.81 3.42 4.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.033 -169.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.514 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -163.7 162.71 24.19 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.184 -178.385 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.497 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 94.0 m-85 -111.12 138.13 21.14 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.563 0.697 . . . . 0.0 110.941 173.176 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 15.1 Cg_exo -68.09 121.35 8.34 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.654 2.236 . . . . 0.0 112.362 170.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.044 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.3 mp -104.72 -40.02 5.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.081 173.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.601 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -145.72 154.86 42.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.064 -167.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.7 t -114.95 125.57 72.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.177 176.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -104.02 124.48 49.09 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.949 175.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.541 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -149.07 141.41 24.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.147 -178.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.8 mp -90.91 168.65 11.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.852 -178.385 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 88.7 p -156.67 154.74 30.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.935 -177.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.864 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -93.68 124.45 37.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.898 168.441 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.549 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.1 mp -110.15 131.46 61.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.067 -175.726 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.6 p90 -131.31 145.28 51.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.83 -174.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 -94.49 114.37 26.37 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.825 -179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.426 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.7 mttt -66.03 -19.42 65.85 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.847 -173.354 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 87.3 m-20 -84.67 -25.35 28.53 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.831 -175.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.0 mp -82.17 -52.55 6.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.891 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.549 ' H ' HD23 ' A' ' 122' ' ' LEU . 2.0 pt? -140.03 128.55 13.19 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-O 121.621 0.724 . . . . 0.0 110.878 173.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -77.8 -11.97 16.59 Favored 'Trans proline' 0 C--N 1.341 0.172 0 C-N-CA 122.709 2.272 . . . . 0.0 112.349 -173.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 61.1 t-20 -144.46 102.84 4.65 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.6 0.714 . . . . 0.0 110.895 -175.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 70.6 Cg_endo -71.27 153.84 61.64 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.618 2.212 . . . . 0.0 112.364 177.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -66.07 143.02 70.31 Favored 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.654 2.236 . . . . 0.0 112.314 -178.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.0 -18.73 42.31 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.888 -177.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.8 p -135.05 159.66 40.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.178 -176.341 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.419 ' HA ' HD13 ' A' ' 132' ' ' ILE . 79.9 m95 -69.77 -28.14 65.51 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.994 177.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -65.68 -22.32 66.62 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.817 -179.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -82.26 -24.63 34.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.869 -177.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.475 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -57.15 -46.95 99.8 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.564 0.697 . . . . 0.0 111.243 -171.073 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.475 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 84.0 Cg_exo -51.92 -49.25 17.91 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.613 2.209 . . . . 0.0 112.457 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -66.76 -59.08 3.87 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.165 -174.269 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.131 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -70.09 -16.15 63.08 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.878 -172.02 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.528 ' N ' HD13 ' A' ' 135' ' ' LEU . 32.2 t70 -61.32 -38.61 87.49 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.879 168.504 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -62.76 -30.5 71.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.848 -179.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -72.05 -48.01 47.5 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.899 -177.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.645 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.4 pp -84.96 -13.24 51.3 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.913 -179.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.645 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.2 tttt -57.99 -34.46 70.01 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.909 170.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.48 -24.83 67.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.078 176.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -94.97 3.67 54.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.912 177.81 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 76.27 30.74 56.52 Favored Glycine 0 N--CA 1.453 -0.21 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.439 177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -109.68 171.19 7.59 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.914 0.387 . . . . 0.0 110.824 174.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.6 t -124.49 140.13 53.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 168.366 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.455 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -68.09 -43.47 78.43 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.09 -170.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -143.21 127.36 17.54 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.921 178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 57.5 ttm -110.49 132.75 53.91 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.846 -179.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -152.9 158.27 41.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.896 -173.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 69.1 m-20 -84.87 -59.15 2.43 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.972 -179.179 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.143 HD13 ' O ' ' A' ' 151' ' ' LEU . 2.1 tm? 48.27 30.49 2.26 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.863 -163.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -103.06 -6.8 21.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.99 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.7 152.36 79.64 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-O 121.656 0.741 . . . . 0.0 110.921 -175.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.446 ' HB3' ' HB3' ' A' ' 340' ' ' TRP . 53.9 Cg_exo -56.48 -32.21 88.61 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.694 2.262 . . . . 0.0 112.317 -179.107 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 26.2 m-85 -70.6 -27.47 64.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.515 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 35.3 m-85 -79.67 -41.18 27.41 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.823 171.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.455 HG23 HG11 ' A' ' 347' ' ' VAL . 15.7 m -61.64 -49.58 75.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.121 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.567 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 17.4 t-105 -59.56 -48.65 95.1 Favored Pre-proline 0 C--N 1.326 -0.429 0 CA-C-O 121.471 0.653 . . . . 0.0 110.903 -161.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.567 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 94.5 Cg_exo -51.26 -44.78 40.96 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.812 2.341 . . . . 0.0 112.329 -176.6 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.709 ' O ' HD23 ' A' ' 160' ' ' LEU . 6.7 tt -72.16 -39.33 68.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 -171.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 86.8 mt -71.43 -41.59 73.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.149 179.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -74.15 -23.91 59.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.068 -179.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -58.47 -35.24 71.87 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.188 -173.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 58.8 p30 -103.58 10.05 37.16 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.973 -179.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 113.88 4.7 22.62 Favored Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.497 169.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.38 67.87 3.02 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.602 -0.809 . . . . 0.0 112.46 178.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 68.5 m-85 -89.86 133.15 34.9 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.858 0.361 . . . . 0.0 110.978 179.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -82.45 10.18 7.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.08 -172.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.4 p90 -152.21 154.48 35.87 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.852 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 53.4 tptt -99.75 123.37 43.94 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.887 157.042 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -112.42 121.76 45.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.959 175.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -152.64 130.07 11.39 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.866 -174.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 54.89 43.67 29.58 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.87 174.373 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.14 16.77 78.53 Favored Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.572 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.86 138.73 49.96 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.773 0.321 . . . . 0.0 110.862 -176.03 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 94.6 m-85 -97.87 144.25 27.64 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.888 170.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.7 t0 -125.51 112.42 16.2 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.895 174.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.562 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.2 pp -79.53 -12.02 13.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.161 -177.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -97.96 -12.08 22.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.858 -177.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -119.43 87.85 2.82 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.866 169.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.7 m -115.88 161.08 14.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.084 -171.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.02 25.47 25.17 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.464 -174.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.482 HG21 HD12 ' A' ' 368' ' ' ILE . 3.4 m -109.44 -19.01 7.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.838 0.351 . . . . 0.0 111.032 -178.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -87.29 19.88 3.03 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.873 -177.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -122.19 -170.06 2.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.019 -178.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.36 -29.55 70.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.13 -172.541 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -65.64 -42.99 95.16 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.529 -167.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.6 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -64.99 -37.23 86.98 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.988 0.423 . . . . 0.0 111.107 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.555 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -62.3 -38.25 88.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.825 175.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.9 -37.99 89.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.138 176.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.09 -46.3 81.44 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.521 179.298 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.701 HD11 ' HA ' ' A' ' 347' ' ' VAL . 19.7 tp -68.63 -34.23 75.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.87 0.367 . . . . 0.0 110.826 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.482 ' OG1' HG21 ' A' ' 357' ' ' VAL . 90.7 m -64.3 -42.77 96.21 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.197 176.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.479 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 74.8 t80 -68.43 -47.0 68.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.841 177.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.616 HD11 HD21 ' A' ' 151' ' ' LEU . 7.3 tt -50.45 -51.47 46.52 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.953 -174.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . . . . . . . . . 30.9 m -63.95 -23.06 32.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.126 -174.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.479 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.3 m-20 -62.14 -33.39 74.39 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.946 -177.496 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.442 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.8 OUTLIER -81.49 -39.99 23.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.847 -173.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.414 ' H ' HG13 ' A' ' 199' ' ' ILE . 1.8 pp -73.53 -28.81 25.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.175 171.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -68.54 -37.61 80.12 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.92 172.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -79.22 -0.32 31.59 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 176.371 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 65.3 40.72 4.69 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.887 169.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 64.7 m-70 -76.06 -16.11 59.99 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.782 175.204 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 5.2 ppp? -144.71 157.99 43.96 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.873 178.413 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -95.44 152.01 18.79 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.871 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.02 -26.26 68.13 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.107 -175.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.9 p-10 -94.96 1.79 55.28 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.907 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 96.7 m -66.31 128.34 35.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.129 -177.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -121.57 171.38 8.86 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.932 175.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 16.7 p90 -66.05 -36.85 84.33 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.029 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 97.2 p -68.76 -37.33 79.29 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.852 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 80.2 mt -65.03 -41.0 90.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.052 173.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.99 -38.29 90.47 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.004 178.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 93.2 mt-10 -65.26 -43.52 91.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.927 177.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.04 -41.37 95.3 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.132 177.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.66 -41.59 98.19 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.203 178.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 43.1 t80 -64.07 -39.56 94.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.939 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 97.4 m-20 -63.97 -33.63 76.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.895 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -85.08 -17.38 37.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.969 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 84.66 24.44 46.13 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.545 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -85.39 -22.45 28.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.957 0.408 . . . . 0.0 110.895 -176.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.8 t -128.3 137.42 51.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.187 -178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.478 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -64.07 -52.14 60.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.128 -175.39 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.557 ' HB3' HD21 ' A' ' 115' ' ' LEU . 61.8 mtm -135.82 155.1 50.86 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.765 -172.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 65.3 p -139.64 162.21 35.66 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.239 176.878 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.7 mm -110.41 126.92 67.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.136 174.494 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -153.0 174.68 13.84 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.913 -171.018 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -87.14 -156.27 29.25 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.471 -174.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 37.4 Cg_endo -71.3 -21.94 26.02 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.645 2.23 . . . . 0.0 112.341 -176.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . 0.643 ' HD1' ' O ' ' A' ' 230' ' ' TRP . 4.9 t90 -67.37 -30.01 69.7 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.948 178.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 48.74 44.96 21.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.15 -173.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 3.7 t90 -65.07 -20.82 66.66 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.906 -173.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 67.6 m -47.75 -41.1 22.33 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.913 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 49.8 p30 -85.02 -178.86 6.93 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.881 -171.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.452 HG22 ' H ' ' A' ' 237' ' ' THR . 77.7 mt -117.7 120.27 64.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.228 -168.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 55.9 p30 -89.52 -2.62 58.41 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.791 -175.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . 0.452 ' H ' HG22 ' A' ' 235' ' ' ILE . 24.1 m -136.83 74.95 1.51 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.205 179.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 35.9 t -174.72 162.67 3.33 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.854 178.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -96.33 -0.43 49.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 35.3 m -59.91 159.99 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.102 178.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 68.8 m-80 -104.28 128.73 52.1 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.939 -176.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.426 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 37.8 p90 -148.13 154.25 39.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.909 177.493 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.27 160.73 24.79 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.444 175.481 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.405 HG11 ' HA ' ' A' ' 316' ' ' ARG . 2.8 p -134.52 135.13 54.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.967 0.413 . . . . 0.0 111.099 -178.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.3 t -154.13 149.88 27.56 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.136 176.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.5 m -60.54 165.57 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.09 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.483 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 1.4 mp -66.16 152.29 94.23 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.521 0.676 . . . . 0.0 111.047 -164.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -75.78 -176.41 2.99 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.747 2.298 . . . . 0.0 112.358 -173.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 94.9 m -86.9 145.43 26.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.07 -171.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 33.6 t80 -130.99 111.4 12.0 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.881 -178.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt 54.85 35.3 23.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.927 -179.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.94 2.62 80.86 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.495 175.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -126.59 126.2 24.52 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-O 121.566 0.698 . . . . 0.0 110.844 177.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -55.01 134.98 66.74 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.654 2.236 . . . . 0.0 112.306 -178.137 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.424 ' O ' ' C ' ' A' ' 256' ' ' LYS . 73.1 m -82.52 -1.48 50.64 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.046 0.451 . . . . 0.0 110.844 174.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 255' ' ' SER . 90.9 mttt -37.28 130.0 0.8 Allowed Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.605 0.717 . . . . 0.0 110.881 -178.113 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -78.16 163.17 28.13 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.632 2.221 . . . . 0.0 112.333 -163.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 73.3 m-85 -74.52 163.97 27.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.842 -175.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 47.7 t -111.45 127.49 68.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.181 -168.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.484 ' HA3' ' NE2' ' A' ' 64' ' ' HIS . . . -112.85 141.49 16.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.783 -0.722 . . . . 0.0 112.426 174.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 89.2 t -124.7 116.98 49.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.746 0.308 . . . . 0.0 111.183 -179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.33 119.97 11.33 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.881 -179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 49.7 m -126.18 131.1 52.07 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.785 -167.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -129.58 139.07 51.58 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.093 -175.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.67 170.13 21.21 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.432 -169.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.696 HG13 ' HG2' ' A' ' 277' ' ' LYS . 24.7 mm -111.23 125.03 68.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 120.83 0.348 . . . . 0.0 111.157 -174.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.6 t-20 -63.14 130.79 46.12 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.888 -175.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.486 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -58.17 -28.56 64.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.123 -177.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.17 -7.0 58.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.019 -173.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 22.3 t -67.31 119.04 62.09 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.649 0.738 . . . . 0.0 110.915 -172.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.421 ' HD2' HG21 ' A' ' 2' ' ' ILE . 83.8 Cg_endo -71.26 -10.47 27.23 Favored 'Trans proline' 0 C--N 1.341 0.184 0 C-N-CA 122.587 2.192 . . . . 0.0 112.327 168.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 70.5 m-80 -103.4 12.88 34.76 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.824 -178.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -49.33 -35.89 19.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.828 -167.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -68.49 -47.52 66.8 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.969 -171.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 1.3 pp -81.47 -27.47 34.58 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.949 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.24 -46.89 75.56 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.054 173.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.696 ' HG2' HG13 ' A' ' 266' ' ' ILE . 50.3 mtmt -58.08 -41.73 84.07 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.902 174.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.538 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 95.6 mt-10 -69.87 -40.66 75.6 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.898 -177.238 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.436 ' O ' ' HB2' ' A' ' 283' ' ' TYR . 15.9 m-30 -67.63 -39.5 84.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.852 178.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.529 ' HA ' HD22 ' A' ' 284' ' ' LEU . 4.0 tt -65.29 -53.26 46.56 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.977 -172.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.431 ' HA ' HD21 ' A' ' 285' ' ' LEU . 40.3 tt0 -75.19 -35.6 61.51 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -175.646 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.538 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 82.8 m-20 -103.57 -12.77 16.87 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.846 -160.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.644 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 62.3 m-85 -128.55 -48.6 1.28 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.857 -177.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.529 HD22 ' HA ' ' A' ' 280' ' ' LEU . 0.7 OUTLIER -64.39 -36.56 84.54 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.98 -174.061 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 1.044 ' HB3' HG13 ' A' ' 108' ' ' ILE . 2.4 pp -124.71 38.27 4.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.939 -175.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.455 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 6.6 t -114.25 163.65 14.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.161 179.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.403 ' C ' ' O ' ' A' ' 286' ' ' THR . 16.4 p-10 -40.15 -43.88 1.72 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.851 -175.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 87.8 tt0 -74.85 -41.42 59.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.893 -176.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.644 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.75 -53.9 7.84 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.516 -169.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.553 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -72.63 -20.1 61.33 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.725 0.298 . . . . 0.0 110.9 -178.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.503 ' N ' HD12 ' A' ' 290' ' ' LEU . 86.5 tt0 -67.16 -45.56 76.68 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.813 169.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.93 -38.77 92.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.071 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.411 HG13 ' HA3' ' A' ' 19' ' ' GLY . 59.9 t -75.18 -46.8 38.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.116 -177.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 48.5 t30 -64.97 -28.89 69.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.849 179.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -64.62 -25.95 68.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.826 -179.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 38.0 t70 -82.23 -48.14 11.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.935 178.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.404 ' O ' HD13 ' A' ' 299' ' ' LEU . 85.7 tttt -151.03 138.94 12.49 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.511 0.672 . . . . 0.0 110.942 -179.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_exo -50.66 116.76 2.76 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.769 2.312 . . . . 0.0 112.363 -177.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.473 HD12 ' HA ' ' A' ' 299' ' ' LEU . 0.2 OUTLIER -85.98 -19.99 29.58 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.005 174.275 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 98.49 -57.7 0.99 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.442 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.608 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -168.19 155.33 7.91 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.787 0.327 . . . . 0.0 111.165 175.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.805 HG21 ' HB3' ' A' ' 307' ' ' TYR . 18.4 m -115.89 154.58 17.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.134 -179.324 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.03 -15.62 61.51 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.103 173.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.553 ' CD2' HD21 ' A' ' 290' ' ' LEU . 39.9 tp -80.92 121.93 26.62 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.936 -174.116 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -53.91 -41.88 68.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.935 -177.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 48.3 t -62.99 -49.98 72.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 -169.169 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.805 ' HB3' HG21 ' A' ' 302' ' ' VAL . 10.9 t80 -76.5 -30.71 57.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.987 -178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -60.73 -40.67 93.2 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.857 176.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -59.33 -36.94 76.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.872 176.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.6 mm-40 -75.65 -39.33 57.85 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.879 176.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.608 HD13 ' HA ' ' A' ' 301' ' ' ALA . 76.7 mt -61.19 -34.57 75.28 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.902 178.77 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.11 -19.12 61.11 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.109 -176.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -64.89 -21.12 66.75 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.005 175.979 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.0 t0 -93.17 121.86 64.57 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.663 0.744 . . . . 0.0 110.916 167.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -49.29 -25.41 9.84 Favored 'Trans proline' 0 C--N 1.341 0.137 0 C-N-CA 122.776 2.318 . . . . 0.0 112.35 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . 0.405 ' HA ' HG11 ' A' ' 244' ' ' VAL . 82.7 mtt85 -60.91 -33.38 73.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.868 -176.188 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.586 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.1 mp -81.19 -26.98 10.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.088 -179.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.83 -40.41 79.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.07 -172.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.52 -44.9 81.23 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.088 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 58.1 p -64.18 -29.55 70.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.156 -173.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.6 mtp -67.92 -34.87 77.44 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.9 176.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 47.6 tp10 -65.64 -47.07 76.82 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.842 -172.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.404 ' O ' ' N ' ' A' ' 327' ' ' GLY . 8.7 p-10 -80.0 -25.69 40.19 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.797 -178.439 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.44 -49.18 74.68 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.103 -179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -70.72 -37.18 73.49 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.89 -177.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -105.44 -7.55 18.67 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.837 -168.107 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -90.94 -159.92 36.09 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.481 -172.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -139.9 147.78 41.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.776 0.322 . . . . 0.0 111.03 -175.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 40.7 mm -64.74 123.2 17.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.136 -171.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 50.2 tpp -46.58 132.3 8.12 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.565 0.697 . . . . 0.0 110.898 -178.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.551 ' HG3' ' CZ2' ' A' ' 158' ' ' TRP . 79.6 Cg_endo -72.01 68.6 3.17 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.763 2.309 . . . . 0.0 112.359 173.048 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -97.55 25.05 6.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.91 -172.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 47.7 pt -77.1 160.7 75.46 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.611 0.719 . . . . 0.0 111.203 -175.947 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -55.59 -38.22 94.39 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.718 2.279 . . . . 0.0 112.234 -173.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -68.66 -28.14 66.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.889 -178.355 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.435 ' HG3' ' HB2' ' A' ' 331' ' ' PRO . 73.9 mmm -80.07 -17.5 52.52 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 -172.299 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.6 m -61.94 -40.97 97.36 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.825 176.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.62 -37.05 60.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.098 177.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.549 ' O ' HG13 ' A' ' 343' ' ' VAL . 3.6 m-30 -65.12 -41.27 95.01 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.812 176.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.446 ' HB3' ' HB3' ' A' ' 154' ' ' PRO . 12.2 m0 -60.03 -35.66 75.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.916 176.06 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.9 m-30 -68.06 -41.85 81.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.952 176.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.25 -44.1 84.68 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.004 -179.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.549 HG13 ' O ' ' A' ' 339' ' ' PHE . 16.9 m -74.07 -31.03 28.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 -176.094 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.486 ' O ' HG22 ' A' ' 347' ' ' VAL . 4.9 tmt_? -65.6 -39.65 91.79 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.866 175.027 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 87.4 m -58.72 -35.39 72.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.168 174.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.78 -43.63 95.79 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.125 -175.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.701 ' HA ' HD11 ' A' ' 192' ' ' LEU . 4.0 m -74.17 -34.13 37.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.169 -174.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.439 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -63.34 -47.1 93.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.098 174.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -64.85 -39.51 93.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.887 -178.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.26 -44.42 62.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.114 -179.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.33 -39.9 77.9 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.086 -175.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 93.2 p -75.69 -11.09 59.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.838 -178.143 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.21 16.56 74.0 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.799 -0.715 . . . . 0.0 112.463 179.493 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -79.21 -32.45 44.01 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.767 0.318 . . . . 0.0 110.883 -179.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -138.78 155.35 48.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.863 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.1 p -76.74 171.43 14.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.115 170.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.482 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.1 t -57.51 -43.22 82.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.124 171.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 92.6 m-20 -61.44 -45.71 93.16 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.863 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 87.5 mt-10 -69.64 -52.41 26.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -179.116 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -72.3 -48.25 43.71 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.121 -173.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.6 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.4 tm? -65.59 -45.02 84.81 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.935 -173.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.82 -53.57 48.69 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.965 -177.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.9 m-20 -68.09 -46.03 72.13 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 -173.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.71 -42.31 91.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.158 -174.981 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.573 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 79.0 mm-40 -76.81 -27.93 55.38 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.97 -176.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 53.3 m -61.73 -34.99 76.79 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.225 171.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -58.77 -30.09 67.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.917 179.101 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.482 HD12 HG21 ' A' ' 183' ' ' VAL . 70.3 mt -60.85 -38.14 78.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.151 175.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 58.0 p -94.64 -14.98 24.38 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.154 -178.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.895 179.831 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 98.9 mttt . . . . . 0 C--O 1.232 0.168 0 CA-C-O 120.773 0.32 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.431 HG21 ' HD2' ' A' ' 271' ' ' PRO . 74.8 mt -100.46 131.81 47.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.14 177.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -148.15 139.81 23.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.895 -178.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -51.93 136.47 28.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.792 -178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 94.74 2.69 62.88 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.529 -173.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.451 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 64.3 pttt -165.03 146.96 7.89 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.788 0.328 . . . . 0.0 110.954 171.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.543 HD22 HD11 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -147.68 160.01 43.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.919 -177.231 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.409 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 71.2 t -111.98 134.05 55.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.081 -177.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.729 HG23 ' HB ' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -120.02 131.56 72.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.082 179.094 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.716 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 65.2 m95 -107.51 128.25 54.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.952 168.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.452 ' HB ' HD22 ' A' ' 20' ' ' LEU . 7.2 tt -109.59 149.86 12.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.076 -166.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -58.1 155.35 11.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.889 -173.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -54.35 -22.76 24.06 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.378 -179.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -73.78 -14.12 61.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.877 0.37 . . . . 0.0 110.906 -171.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.404 ' HD2' ' HD3' ' A' ' 297' ' ' LYS . 24.0 mmmt -134.3 137.25 44.09 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.924 171.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.02 -85.08 0.98 Allowed Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.466 -179.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 81.1 m-85 -110.04 -44.91 3.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.904 0.383 . . . . 0.0 110.92 -176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -68.16 -51.87 40.98 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.844 -148.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 1.008 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -57.74 -49.82 70.83 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.688 -0.767 . . . . 0.0 112.516 -176.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.596 HD21 ' HB ' ' A' ' 9' ' ' ILE . 55.1 tp -57.24 -41.94 80.51 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.827 0.346 . . . . 0.0 110.914 179.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.82 -38.61 67.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.071 175.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.446 ' O ' ' HG2' ' A' ' 25' ' ' LYS . 67.2 mm-40 -70.57 -50.4 37.73 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.807 -176.381 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 20' ' ' LEU . 17.7 m -72.53 -36.54 54.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.185 179.69 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.407 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -64.34 -49.34 66.33 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.494 178.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.446 ' HG2' ' O ' ' A' ' 22' ' ' GLU . 57.7 pttt -59.47 -24.71 63.8 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.924 0.392 . . . . 0.0 110.956 -175.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -59.88 -37.11 78.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.905 174.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 1.2 m-30 -56.75 -47.73 79.42 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.917 174.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.472 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 88.7 mt-10 -66.6 -35.96 81.45 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.981 -178.103 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -70.53 -35.49 73.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.85 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 95.0 m-20 -94.8 -50.04 5.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.811 -170.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 34.2 p -115.86 -1.08 12.67 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.164 -169.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 75.41 9.92 84.48 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.421 167.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.858 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -99.36 132.93 43.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.843 0.354 . . . . 0.0 111.159 -177.783 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.472 ' HA ' ' HG2' ' A' ' 28' ' ' GLU . 98.8 mttt -74.21 140.36 45.03 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.927 -171.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.542 ' HB ' HD11 ' A' ' 9' ' ' ILE . 2.9 m -116.72 134.34 60.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.113 177.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.514 ' O ' HD12 ' A' ' 9' ' ' ILE . 99.6 m -103.94 127.8 51.47 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.114 176.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.59 HG13 HD23 ' A' ' 20' ' ' LEU . 54.8 t -93.07 126.66 45.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.201 175.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.3 mm-40 -119.93 145.74 46.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.974 177.779 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 63.2 t-80 -88.95 141.14 29.37 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.528 0.68 . . . . 0.0 110.929 -168.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.439 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 85.2 Cg_exo -56.62 -26.29 64.0 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.736 2.291 . . . . 0.0 112.251 -174.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 38.6 t70 -47.34 -51.28 19.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.847 -171.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -87.84 -8.92 55.23 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.87 -176.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.439 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 9.8 tt -47.85 -55.26 10.17 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.932 -170.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 95.2 mt-10 -64.76 -35.83 82.34 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.873 179.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -65.36 -39.52 92.42 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.869 178.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.407 ' O ' HG22 ' A' ' 50' ' ' VAL . 75.1 mmtt -80.44 -23.84 39.99 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.9 177.625 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.57 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 83.9 t80 -50.87 -50.26 75.25 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.665 0.745 . . . . 0.0 110.807 -160.637 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.57 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 44.4 Cg_endo -82.72 -32.32 0.62 Allowed 'Trans proline' 0 C--N 1.341 0.162 0 C-N-CA 122.685 2.256 . . . . 0.0 112.306 179.238 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -75.89 -46.41 30.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.903 -165.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.508 HG21 ' HG3' ' A' ' 57' ' ' PRO . 21.0 m -72.36 -27.16 25.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.04 -171.702 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.714 ' HB1' ' HB3' ' A' ' 75' ' ' LEU . . . -70.28 -35.78 73.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.098 178.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.11 -33.2 74.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.124 179.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 66.9 p -90.58 -20.25 22.81 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.15 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.2 8.35 69.73 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.801 -0.714 . . . . 0.0 112.542 172.788 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -118.35 116.84 27.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.836 0.35 . . . . 0.0 110.87 178.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.94 -92.75 0.13 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.502 171.075 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.716 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 71.2 Cg_endo -79.42 146.79 19.7 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.68 2.254 . . . . 0.0 112.362 -177.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.7 m-20 -97.53 -35.06 10.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.777 163.27 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.729 ' HB ' HG23 ' A' ' 9' ' ' ILE . 35.4 mt -124.79 137.37 57.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.106 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.3 tp -132.77 125.22 52.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.112 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 34.4 m-85 -88.34 140.11 29.81 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.731 168.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.463 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 21.9 p90 -142.85 163.39 32.92 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.979 171.145 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.83 -90.59 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.15 -164.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.669 ' CE1' ' HA3' ' A' ' 260' ' ' GLY . 23.2 m170 -130.56 -64.63 0.83 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.926 -173.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -95.13 -13.92 24.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.892 -167.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -59.78 -14.49 14.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.997 -165.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.556 ' HB2' HD13 ' A' ' 104' ' ' ILE . 30.5 p90 -57.42 -32.43 66.86 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.875 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -60.77 -51.21 60.05 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.492 -170.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.59 -36.96 92.15 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.576 175.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.689 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 13.6 t80 -66.56 -41.94 87.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.832 0.349 . . . . 0.0 110.931 -176.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -71.85 -40.98 68.65 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.169 174.419 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 72.9 tp60 -57.58 -37.54 73.35 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.016 -177.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 59.9 m -85.47 -4.98 59.33 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.982 -179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 75.32 30.07 59.21 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.674 -0.774 . . . . 0.0 112.492 174.292 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.714 ' HB3' ' HB1' ' A' ' 51' ' ' ALA . 58.9 mt -87.17 -10.07 53.6 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.919 0.39 . . . . 0.0 110.929 -167.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.689 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -130.95 153.77 48.84 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.924 -176.808 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.445 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -81.4 142.12 33.3 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 174.462 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -71.81 142.3 49.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.872 178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.433 HD12 ' CZ ' ' A' ' 106' ' ' TYR . 36.9 pt -106.52 155.41 7.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.129 -177.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.6 m -96.1 130.57 30.87 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.666 0.746 . . . . 0.0 111.064 179.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -66.36 142.31 65.6 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.673 2.248 . . . . 0.0 112.326 178.159 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.5 t0 -113.92 114.78 26.69 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.867 174.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.21 -36.02 60.53 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.894 -178.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -62.78 -43.47 98.71 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.021 -178.445 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -74.54 -32.98 62.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.875 -179.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.478 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 85.6 mt-30 -54.94 -51.49 65.96 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 175.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.7 m-20 -57.6 -34.71 69.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.781 174.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.27 -24.53 57.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.835 -175.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.97 -104.96 0.31 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.93 -170.573 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 33.9 t80 172.66 128.84 0.09 OUTLIER Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.739 0.781 . . . . 0.0 110.903 -169.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_exo -52.31 -36.26 67.5 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.702 2.268 . . . . 0.0 112.345 -173.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -65.14 -35.19 80.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.811 -173.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.3 p -73.47 -29.7 62.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.169 -175.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.625 ' HA ' HG22 ' A' ' 97' ' ' VAL . 92.5 m95 -67.88 -30.55 69.93 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.972 177.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 -69.25 -30.17 68.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.943 177.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -71.14 -26.04 62.83 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.038 175.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.625 HG22 ' HA ' ' A' ' 94' ' ' TRP . 16.3 m -109.96 20.7 5.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.14 -178.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 67.1 ttp85 -113.8 132.52 55.83 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.921 -175.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 68.7 t80 -132.1 119.45 20.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.849 178.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.5 t30 58.4 35.29 24.67 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.918 176.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.21 -0.41 89.74 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.449 175.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -120.25 149.42 42.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.864 0.364 . . . . 0.0 110.861 175.589 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.596 HD22 HG23 ' A' ' 97' ' ' VAL . 18.4 mt -84.03 136.0 34.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.869 -177.446 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.556 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.9 pp -123.11 -2.3 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.051 -175.053 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.463 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -161.15 164.45 30.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.12 -178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.433 ' CZ ' HD12 ' A' ' 79' ' ' ILE . 89.9 m-85 -112.27 143.26 28.49 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.626 0.727 . . . . 0.0 110.948 170.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -78.33 121.42 5.24 Favored 'Trans proline' 0 C--O 1.232 0.203 0 C-N-CA 122.669 2.246 . . . . 0.0 112.336 174.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.926 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -104.25 -36.72 4.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.177 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -146.0 153.12 40.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.125 -170.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 74.3 t -117.96 130.42 72.86 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 177.347 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 42.5 mp0 -110.64 131.98 54.59 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.806 174.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.606 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -153.09 144.66 23.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.119 177.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 8.6 mp -89.0 160.25 17.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.972 -176.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.9 p -151.49 152.44 33.0 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.86 -177.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.869 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -93.76 128.88 40.21 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.868 171.043 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.626 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.7 mp -111.39 132.04 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.236 -174.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -131.81 146.97 52.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.988 0.423 . . . . 0.0 110.86 -176.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 -91.88 117.4 29.76 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.893 178.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -65.91 -25.92 67.37 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.964 -172.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -84.68 -20.82 30.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.918 -172.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.9 mp -80.08 -54.03 6.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.889 169.63 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.747 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.3 pt? -140.32 127.23 12.23 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-O 121.564 0.697 . . . . 0.0 110.921 173.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -79.42 -7.06 14.87 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.665 2.244 . . . . 0.0 112.348 -175.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.426 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 56.3 t-20 -147.22 95.27 4.41 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-O 121.725 0.774 . . . . 0.0 110.839 -176.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.426 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 58.6 Cg_endo -68.23 155.68 68.48 Favored 'Trans proline' 0 C--N 1.343 0.249 0 C-N-CA 122.64 2.227 . . . . 0.0 112.376 177.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.52 143.67 76.4 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.64 2.226 . . . . 0.0 112.423 -179.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -86.72 -15.76 38.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.906 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 80.6 p -133.68 156.75 47.35 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.097 -178.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.409 ' HA ' HD13 ' A' ' 132' ' ' ILE . 74.1 m95 -70.77 -27.98 64.33 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.982 -179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -66.21 -19.58 65.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.843 -179.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -80.3 -25.53 39.33 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.867 -178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.488 ' N ' ' CD ' ' A' ' 133' ' ' PRO . 0.7 OUTLIER -57.56 -46.27 99.79 Favored Pre-proline 0 C--N 1.33 -0.274 0 CA-C-O 121.567 0.698 . . . . 0.0 111.184 -169.249 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.488 ' CD ' ' N ' ' A' ' 132' ' ' ILE . 86.4 Cg_exo -52.93 -50.74 13.02 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.712 2.274 . . . . 0.0 112.385 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.95 -59.49 4.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 -175.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.158 HD22 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.41 -16.24 63.46 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.925 -172.711 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.576 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.7 t70 -61.88 -41.69 98.16 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.875 167.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -60.66 -30.59 69.99 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.923 -177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.1 -46.86 60.91 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.84 -178.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.612 HD12 ' N ' ' A' ' 140' ' ' LYS . 3.1 pp -85.08 -14.32 47.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.965 179.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.612 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.6 tttt -60.98 -33.99 74.09 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.95 173.804 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.32 -24.03 67.51 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.993 175.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -94.98 4.3 53.96 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.942 178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.03 31.98 57.11 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.692 -0.765 . . . . 0.0 112.572 178.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -110.24 170.14 8.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.785 0.326 . . . . 0.0 110.885 174.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.7 t -121.04 140.94 51.24 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.827 168.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.479 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -67.67 -40.6 84.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.144 -174.647 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.406 HD22 ' H ' ' A' ' 148' ' ' MET . 2.1 tm? -140.78 133.48 28.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.958 -178.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.406 ' H ' HD22 ' A' ' 147' ' ' LEU . 53.2 ttm -119.22 131.35 55.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.844 -178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.7 p90 -153.99 155.64 35.95 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.927 -174.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -86.27 -53.37 5.07 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.87 -177.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.987 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.3 tm? 48.01 32.81 3.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.909 -169.085 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 93.2 mm-40 -100.24 -7.15 24.98 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.887 175.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -129.65 154.92 80.99 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.68 0.753 . . . . 0.0 110.922 -172.29 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -59.94 -25.07 78.48 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.673 2.248 . . . . 0.0 112.38 173.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -71.62 -29.41 64.63 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.84 178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 40.8 m-85 -81.43 -39.79 24.36 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.868 171.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.411 HG23 HG11 ' A' ' 347' ' ' VAL . 22.1 m -60.35 -48.34 82.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.098 -178.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.585 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 40.5 t-105 -57.07 -54.42 54.78 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.444 0.64 . . . . 0.0 110.81 -168.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.585 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 24.3 Cg_endo -63.99 -20.04 67.31 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.544 2.163 . . . . 0.0 112.388 -174.113 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.774 HD13 ' C ' ' A' ' 160' ' ' LEU . 1.7 tm? -81.6 -44.92 16.57 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.901 178.646 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.507 HG22 ' HA3' ' A' ' 166' ' ' GLY . 79.2 mt -74.98 -43.78 45.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.148 179.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -65.84 -24.7 66.95 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.972 179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.528 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -58.26 -30.87 66.91 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.159 -177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -100.56 3.59 42.84 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.928 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 104.63 8.32 37.68 Favored Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.809 -0.71 . . . . 0.0 112.547 177.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.507 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -75.7 67.41 2.3 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.435 177.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 13.4 m-30 -80.5 132.2 35.66 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.772 0.32 . . . . 0.0 110.939 178.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -79.86 6.36 11.31 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.127 -177.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.549 ' CE1' ' HB3' ' A' ' 331' ' ' PRO . 51.2 p90 -154.0 155.81 36.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.906 -175.601 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 38.0 ttpt -99.99 127.4 46.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.915 156.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 64.7 t80 -114.19 120.6 41.02 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.879 172.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -153.26 130.03 10.87 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.905 -171.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 54.97 42.2 31.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.925 176.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.19 16.09 78.66 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.526 175.236 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -130.97 139.95 50.09 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.698 0.285 . . . . 0.0 110.93 -175.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.1 m-85 -96.47 144.94 26.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.923 170.72 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.4 t0 -128.06 111.97 14.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.885 174.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.562 ' C ' HD12 ' A' ' 178' ' ' ILE . 1.2 pp -80.06 -11.38 12.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.105 -178.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -96.9 -10.16 27.0 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.884 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -125.51 85.97 2.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.887 170.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 169' ' ' PHE . 31.1 m -113.97 164.79 9.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.056 -170.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -106.8 25.55 22.27 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.562 -173.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.439 HG21 HD12 ' A' ' 368' ' ' ILE . 2.1 m -106.53 -19.99 6.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.904 0.383 . . . . 0.0 111.156 -178.474 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 54.4 p-10 -87.39 21.79 2.36 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.799 -176.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.6 p30 -109.31 -176.32 2.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.927 -176.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -68.52 -28.34 66.9 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.071 -179.815 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -69.53 -40.08 78.7 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.492 -169.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.514 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -59.88 -40.08 87.47 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.91 0.386 . . . . 0.0 111.11 175.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.574 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.2 mttt -62.23 -39.04 91.5 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.979 175.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -65.0 -37.0 86.21 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.196 177.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.438 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -67.15 -46.02 76.02 Favored Glycine 0 N--CA 1.452 -0.245 0 C-N-CA 120.703 -0.76 . . . . 0.0 112.516 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.736 HD11 ' HA ' ' A' ' 347' ' ' VAL . 22.8 tp -66.62 -35.5 80.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.855 0.36 . . . . 0.0 110.821 -179.483 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.55 ' OG1' HG21 ' A' ' 357' ' ' VAL . 94.3 m -65.07 -41.48 95.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.127 176.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 51.8 t80 -66.03 -49.68 66.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.843 177.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.701 HD23 ' C ' ' A' ' 195' ' ' LEU . 5.4 tt -50.72 -51.11 52.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.884 -174.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.404 ' O ' HG13 ' A' ' 199' ' ' ILE . 31.2 m -64.25 -22.47 31.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.177 -174.131 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.469 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.2 m-20 -62.27 -33.53 74.8 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.93 -179.204 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 0.43 HD22 ' O ' ' A' ' 194' ' ' PHE . 0.9 OUTLIER -80.69 -40.09 26.04 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.882 -174.556 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.548 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.8 pp -73.7 -28.67 24.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.234 172.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -68.57 -37.63 80.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.876 172.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.0 m-20 -80.63 2.79 24.28 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.895 176.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.3 mttt 68.0 38.51 2.74 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 169.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 54.5 m170 -78.28 -17.04 57.16 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.872 178.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.548 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.2 ppp? -145.3 157.18 44.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.934 174.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -94.63 150.65 20.01 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.827 -179.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -61.4 -26.22 67.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.121 -175.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -96.59 1.52 51.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.936 -176.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 94.1 m -64.0 125.05 23.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.07 -176.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.425 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 17.3 t0 -120.45 174.98 6.21 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.905 177.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 18.2 p90 -62.82 -40.41 97.33 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.999 -178.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 98.6 p -67.58 -38.05 83.5 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.823 178.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.425 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 76.6 mt -65.05 -42.32 94.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.14 174.348 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.47 -35.6 80.98 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.107 178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -61.27 -48.1 82.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.883 176.517 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -64.49 -42.36 95.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.111 179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.05 -49.03 71.7 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.109 -177.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -63.2 -43.39 98.29 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.911 -179.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -63.18 -29.61 70.92 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.861 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -85.92 -16.74 37.53 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.864 177.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 89.24 25.04 29.78 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.431 178.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -83.28 -21.28 33.32 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 110.916 -177.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 8.8 t -126.16 136.37 52.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.25 178.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.594 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -62.18 -48.8 78.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.024 179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.586 ' HB3' HD21 ' A' ' 115' ' ' LEU . 66.9 mtm -135.0 160.06 39.53 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 -173.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 13.0 t -150.44 157.34 42.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.183 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 45.3 mm -111.58 129.42 66.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.18 -176.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 -155.42 173.71 16.28 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.859 -179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -83.73 -153.37 15.64 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.842 -0.694 . . . . 0.0 112.395 -177.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -68.11 -26.4 36.69 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.736 2.29 . . . . 0.0 112.328 -178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 50.9 m0 -76.01 -29.18 58.05 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.922 -178.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 43.79 44.96 5.95 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.169 173.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 32.1 m0 -66.11 -20.63 66.22 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.903 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 63.6 m -71.22 -18.1 62.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.872 -175.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 33.9 p-10 -81.2 -175.37 5.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -174.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 87.9 mt -93.82 125.78 46.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.112 176.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -80.09 -57.85 3.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.81 -175.139 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 88.4 m -145.17 122.79 11.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.149 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 27.5 t -174.77 163.08 3.36 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.887 -178.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -66.4 -20.96 66.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.963 171.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 97.9 t -69.18 125.59 27.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.07 176.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -77.77 140.98 39.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.885 -178.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 50.9 p90 -143.33 149.93 38.47 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.875 178.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.3 161.73 26.47 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.503 175.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 2.8 p -138.08 139.4 42.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.932 0.396 . . . . 0.0 111.1 -177.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 12.3 t -153.4 149.08 27.43 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.161 176.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 22.4 m -59.95 163.51 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.153 -179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.443 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 3.8 mp -67.7 153.3 95.31 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.625 0.726 . . . . 0.0 111.029 -159.232 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 247' ' ' LEU . 47.5 Cg_exo -63.75 178.92 1.16 Allowed 'Trans proline' 0 C--N 1.341 0.136 0 C-N-CA 122.699 2.266 . . . . 0.0 112.393 -175.036 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.0 m -92.52 145.71 24.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.21 178.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 43.9 t80 -131.26 112.2 12.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.952 -172.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt 54.65 34.97 22.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.943 179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.1 1.59 81.74 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.565 175.053 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -128.38 127.03 23.69 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.582 0.706 . . . . 0.0 110.896 176.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 78.9 Cg_exo -55.28 136.9 75.56 Favored 'Trans proline' 0 C--N 1.34 0.113 0 C-N-CA 122.673 2.249 . . . . 0.0 112.337 -176.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.4 ' O ' ' C ' ' A' ' 256' ' ' LYS . 67.7 m -80.06 -5.05 55.15 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.798 170.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.4 ' C ' ' O ' ' A' ' 255' ' ' SER . 97.3 mttt -38.31 129.05 1.05 Allowed Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.514 0.673 . . . . 0.0 110.912 -178.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -83.09 163.11 15.52 Favored 'Trans proline' 0 C--O 1.232 0.206 0 C-N-CA 122.666 2.244 . . . . 0.0 112.384 -163.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 17.9 m-85 -72.99 164.95 25.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.845 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.4 t -110.89 132.29 59.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.173 -168.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.669 ' HA3' ' CE1' ' A' ' 64' ' ' HIS . . . -114.85 138.92 15.19 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.443 176.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 74.0 t -126.13 116.54 46.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.822 0.344 . . . . 0.0 111.24 176.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.414 ' HA ' HD23 ' A' ' 262' ' ' LEU . 0.0 OUTLIER -66.28 122.52 17.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.984 -179.608 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 51.0 m -124.11 131.11 53.51 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.805 -166.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -126.99 133.88 50.48 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.02 -173.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -130.55 172.5 20.4 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.674 -0.775 . . . . 0.0 112.455 -171.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 34.9 mm -113.99 130.48 68.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.785 0.326 . . . . 0.0 111.178 -173.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 58.7 t-20 -61.86 128.99 38.83 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.984 -175.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.469 ' H ' ' HA ' ' A' ' 76' ' ' LEU . . . -58.85 -30.93 68.08 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.165 -178.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -86.28 -5.21 59.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.033 -172.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 15.6 t -71.51 120.23 78.62 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.68 0.752 . . . . 0.0 110.951 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . 0.431 ' HD2' HG21 ' A' ' 2' ' ' ILE . 97.8 Cg_endo -67.49 -9.89 26.85 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.623 2.215 . . . . 0.0 112.342 167.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -109.06 16.89 22.22 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.876 -175.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -55.79 -32.93 63.94 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.836 -170.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -69.67 -47.48 63.11 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.958 0.409 . . . . 0.0 110.896 -171.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.0 pp -78.69 -31.03 46.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.9 -178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -66.77 -48.74 68.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.064 178.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 46.8 pttt -65.97 -34.98 79.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.846 -179.115 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -70.51 -40.98 73.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.951 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 19.0 m-30 -66.97 -38.73 86.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.886 176.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.427 ' HA ' HD22 ' A' ' 284' ' ' LEU . 5.3 tt -57.62 -51.5 69.25 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.896 -176.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 24.2 pt-20 -75.31 -27.98 59.52 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.837 -175.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 90.0 m-20 -98.68 -13.5 20.25 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.873 -167.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.754 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 69.0 m-85 -121.19 -60.13 1.66 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 178.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.427 HD22 ' HA ' ' A' ' 280' ' ' LEU . 1.4 mp -61.44 -33.68 74.14 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.937 -161.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.926 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.2 pp -123.78 37.88 4.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.994 -176.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.462 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 67.9 p -121.25 162.36 20.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.053 177.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.432 ' HA ' HD11 ' A' ' 290' ' ' LEU . 38.7 t70 -45.66 -36.29 4.76 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.833 -167.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -78.73 -42.02 29.33 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.984 -179.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.754 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.9 -52.9 8.57 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.505 -170.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.604 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -72.62 -20.08 61.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.754 0.312 . . . . 0.0 110.965 -178.457 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.563 ' N ' HD12 ' A' ' 290' ' ' LEU . 35.3 tt0 -70.62 -47.93 57.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.774 172.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.79 -42.65 97.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.098 -174.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 1.008 HG23 ' HA3' ' A' ' 19' ' ' GLY . 2.8 p -78.71 -32.17 15.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.12 -176.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -68.78 -27.72 66.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.785 171.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -61.62 -25.05 67.11 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -88.39 -40.12 13.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.95 -179.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.404 ' HD3' ' HD2' ' A' ' 15' ' ' LYS . 85.2 tttt -146.06 135.17 11.26 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-O 121.475 0.655 . . . . 0.0 110.951 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -58.28 109.03 0.44 Allowed 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.744 2.296 . . . . 0.0 112.289 175.6 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 61.6 mt -89.89 -18.59 25.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.978 -171.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 109.49 -59.49 0.35 Allowed Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.525 173.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.6 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -169.37 165.24 10.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.855 0.359 . . . . 0.0 111.095 175.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.681 HG21 ' HB3' ' A' ' 307' ' ' TYR . 29.8 m -124.9 153.92 32.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.02 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.91 -8.41 56.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.115 172.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.604 ' CD2' HD21 ' A' ' 290' ' ' LEU . 44.7 tp -85.9 119.06 25.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.953 -177.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -54.01 -40.99 67.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.905 -174.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.8 m -65.12 -50.13 67.23 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.829 -168.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.681 ' HB3' HG21 ' A' ' 302' ' ' VAL . 17.5 t80 -77.11 -28.62 54.51 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.953 -177.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 47.9 tp10 -64.77 -38.98 92.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.915 178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.31 -35.01 78.96 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.935 175.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -73.38 -41.33 63.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.952 174.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.6 HD13 ' HA ' ' A' ' 301' ' ' ALA . 77.2 mt -60.05 -31.87 70.38 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.884 175.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.54 -17.86 56.69 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.118 -177.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -65.06 -19.64 66.09 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.909 173.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -90.9 121.73 67.67 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.624 0.726 . . . . 0.0 110.895 164.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_exo -47.37 -28.05 7.88 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.737 2.291 . . . . 0.0 112.304 -179.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 76.7 mtt85 -61.32 -30.96 70.83 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -172.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.467 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.1 mp -79.98 -30.23 12.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.16 -173.079 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.91 -41.53 96.3 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.032 -168.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -68.06 -44.1 77.14 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.023 177.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.606 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 82.6 p -65.43 -31.13 72.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.114 -171.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 96.9 mtp -65.49 -33.3 75.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 177.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 54.4 tp10 -64.75 -47.19 79.12 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.833 -174.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.477 HD21 ' HB1' ' A' ' 112' ' ' ALA . 8.5 p-10 -82.97 -28.87 29.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.766 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.39 -52.31 62.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.033 -176.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.9 mt-30 -65.86 -28.3 68.86 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.016 0.436 . . . . 0.0 110.984 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -109.63 -8.32 14.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.8 -168.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -89.88 -153.57 28.43 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.698 -0.763 . . . . 0.0 112.461 -166.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -146.1 140.81 26.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.818 0.342 . . . . 0.0 110.919 -170.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 42.2 mm -60.31 121.37 7.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.131 -166.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 93.0 mtp -49.34 143.89 9.25 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-O 121.522 0.677 . . . . 0.0 110.902 179.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.549 ' HB3' ' CE1' ' A' ' 169' ' ' PHE . 70.7 Cg_endo -77.85 84.89 1.9 Allowed 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.688 2.259 . . . . 0.0 112.274 -179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.535 ' ND2' ' ND1' ' A' ' 64' ' ' HIS . 44.7 m-80 -111.8 21.77 15.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.921 -173.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 48.4 pt -75.44 159.39 81.99 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.648 0.737 . . . . 0.0 111.114 178.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_exo -55.74 -38.1 94.76 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.706 2.271 . . . . 0.0 112.317 -174.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -67.68 -27.46 66.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.908 -177.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.452 ' HG3' ' HB2' ' A' ' 331' ' ' PRO . 54.7 mmm -80.13 -17.37 52.7 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.811 -170.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.5 m -60.82 -41.44 95.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.846 176.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.83 -35.64 59.92 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.111 176.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.432 ' CD1' ' N ' ' A' ' 339' ' ' PHE . 6.4 m-30 -66.21 -42.37 88.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.964 -179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 10.2 m0 -56.51 -37.85 70.99 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.02 174.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.5 m-30 -68.47 -41.22 80.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 179.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.17 -43.4 87.04 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.097 -179.08 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.424 HG13 ' O ' ' A' ' 339' ' ' PHE . 20.4 m -73.4 -32.04 35.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.137 -177.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.451 ' O ' HG22 ' A' ' 347' ' ' VAL . 5.0 tmt_? -64.93 -38.94 92.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.873 175.767 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.3 m -58.68 -36.68 74.58 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.173 173.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -65.05 -43.75 91.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.108 -174.225 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.736 ' HA ' HD11 ' A' ' 192' ' ' LEU . 8.2 m -73.17 -34.92 46.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.153 -175.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.455 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -63.62 -47.27 92.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.116 173.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 -63.59 -39.7 95.06 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.916 -178.188 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -72.16 -45.51 60.13 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.025 -179.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.29 -40.38 81.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.116 -175.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 92.0 p -76.31 -10.91 59.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.825 -178.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.09 16.61 74.14 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.46 179.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.03 -32.39 50.95 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.818 0.342 . . . . 0.0 110.95 -179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -139.37 155.15 47.85 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.984 176.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 48.7 p -77.7 167.44 21.57 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.169 170.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.55 HG21 ' OG1' ' A' ' 193' ' ' THR . 54.8 t -55.89 -42.03 69.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.16 173.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 93.6 m-20 -60.65 -46.88 88.67 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.874 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 89.1 mt-10 -69.11 -52.2 30.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.851 -179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -71.87 -49.39 38.46 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.127 -173.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.608 ' O ' ' HG2' ' A' ' 365' ' ' GLN . 1.4 tm? -65.14 -46.87 79.16 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.968 -173.259 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.02 -53.44 53.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.847 -176.295 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -67.14 -46.61 73.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.904 -174.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.09 -41.8 94.64 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.091 -174.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.608 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 68.0 mm-40 -77.74 -26.75 50.16 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.95 -177.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.2 m -64.44 -35.99 82.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.226 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.18 -30.4 68.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.971 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.439 HD12 HG21 ' A' ' 183' ' ' VAL . 70.0 mt -60.35 -38.49 77.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.172 173.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 60.8 p -93.45 -14.46 26.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.134 -177.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.886 179.209 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.2 mttt . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.713 0.292 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 76.4 mt -95.96 133.93 35.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.191 -178.248 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 88.7 tt0 -146.51 139.15 25.24 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.82 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -52.43 137.77 28.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.897 -179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 95.16 1.62 62.71 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.442 -173.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 64.4 pttt -164.53 149.85 10.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.74 0.305 . . . . 0.0 110.966 171.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.628 ' H ' HD23 ' A' ' 7' ' ' LEU . 1.2 pt? -147.67 158.07 43.84 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.947 -176.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.461 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 70.4 t -110.79 131.83 60.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.08 -178.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.743 HG23 ' HB ' ' A' ' 59' ' ' ILE . 0.9 OUTLIER -119.94 132.08 70.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.149 -179.269 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.673 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 70.8 m95 -106.08 128.8 54.12 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.943 169.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.503 HD12 ' HB2' ' A' ' 20' ' ' LEU . 5.9 tt -109.41 149.96 12.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.157 -168.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -60.89 154.69 21.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.844 -172.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.19 -21.3 31.95 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.495 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -72.93 -12.34 60.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.853 0.358 . . . . 0.0 110.812 -171.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.588 ' HA ' ' HE2' ' A' ' 15' ' ' LYS . 0.2 OUTLIER -146.98 135.64 22.07 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.907 167.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.07 -79.91 1.06 Allowed Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.829 -0.7 . . . . 0.0 112.599 -171.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -105.57 -44.93 4.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.958 0.409 . . . . 0.0 110.917 -177.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.6 m-20 -67.91 -52.92 30.75 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.864 -148.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 1.117 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -57.11 -51.95 54.32 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.695 -0.764 . . . . 0.0 112.498 -175.675 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.603 HD21 ' HB ' ' A' ' 9' ' ' ILE . 59.6 tp -57.87 -43.76 86.21 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.846 0.355 . . . . 0.0 110.968 179.886 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.76 -40.05 59.63 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.991 176.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 62.4 mm-40 -69.71 -55.29 10.36 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.894 -178.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.457 HG22 ' HA ' ' A' ' 20' ' ' LEU . 22.0 m -69.83 -35.95 67.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.164 -175.387 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -62.83 -45.65 95.27 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.407 172.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.4 tptt -56.76 -30.2 63.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.886 0.374 . . . . 0.0 110.996 -177.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 69.3 mmtt -57.55 -38.2 74.37 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.936 176.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.548 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 1.8 m-30 -56.22 -49.61 73.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.888 174.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.466 ' HG2' ' HA ' ' A' ' 34' ' ' LYS . 93.2 mt-10 -66.28 -35.41 80.31 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.925 -176.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -69.3 -37.33 77.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.907 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.0 m-20 -96.55 -47.99 5.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.918 0.39 . . . . 0.0 110.925 -169.792 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.8 p -114.73 -1.97 13.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.161 -169.344 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 74.88 8.73 82.85 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.417 166.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.871 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.1 OUTLIER -99.46 133.0 43.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.835 0.35 . . . . 0.0 111.121 -177.23 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.6 mttt -75.17 139.75 42.88 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.852 -169.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.486 ' HB ' HD11 ' A' ' 9' ' ' ILE . 2.7 m -116.44 134.46 59.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.132 177.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.498 ' O ' HD12 ' A' ' 9' ' ' ILE . 98.3 m -105.12 127.54 52.95 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.136 177.459 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.578 HG13 HD23 ' A' ' 20' ' ' LEU . 54.5 t -91.53 127.05 44.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.155 175.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 69.1 mm-40 -119.14 147.01 44.66 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.828 175.565 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.42 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 63.6 t-80 -88.82 142.18 30.39 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-O 121.593 0.711 . . . . 0.0 110.887 -166.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 86.8 Cg_exo -54.9 -25.21 42.62 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.569 2.179 . . . . 0.0 112.379 -175.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -48.43 -56.79 7.26 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.965 -173.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -86.6 -4.07 59.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.836 -175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.443 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 8.1 tt -45.94 -53.81 9.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.896 -172.046 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -66.02 -35.48 80.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.846 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -67.37 -43.48 81.3 Favored 'General case' 0 C--O 1.233 0.223 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.884 -173.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -80.47 -21.36 42.12 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.89 179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.518 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 50.6 t80 -49.99 -51.51 60.98 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.564 0.697 . . . . 0.0 110.806 -165.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 61.6 Cg_endo -80.94 -29.68 2.0 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.615 2.21 . . . . 0.0 112.403 179.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 89.5 mt-30 -74.6 -40.33 61.64 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.897 -168.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 33.2 m -66.58 -27.68 40.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.121 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.782 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -67.61 -36.09 80.18 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.121 177.291 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.09 -31.38 70.96 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.024 -179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 63.8 p -93.0 -17.77 23.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.128 177.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 72.22 11.22 75.23 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.522 173.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 -140.05 140.06 36.08 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.881 0.372 . . . . 0.0 110.827 177.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 154.96 -96.61 0.16 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.435 170.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.673 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 78.9 Cg_endo -80.08 148.79 19.54 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.728 2.286 . . . . 0.0 112.238 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -96.94 -35.99 10.7 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.9 165.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.743 ' HB ' HG23 ' A' ' 9' ' ' ILE . 46.6 mt -125.87 138.26 55.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.105 -176.14 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.1 tp -131.2 125.91 58.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.153 177.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -91.31 137.57 32.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.872 167.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.489 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 31.2 p90 -140.5 162.62 34.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.017 172.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -59.46 -87.76 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.039 -167.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.515 ' ND1' ' ND2' ' A' ' 332' ' ' ASN . 10.8 m170 -128.17 -68.69 0.76 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.915 -173.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.6 m-20 -96.81 -10.92 25.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.811 -162.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 28.1 mmt85 -57.27 -14.28 4.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.871 -169.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.564 ' HB2' HD13 ' A' ' 104' ' ' ILE . 33.5 p90 -59.29 -29.41 67.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -58.9 -51.75 57.33 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.468 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -65.76 -36.55 92.41 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.522 172.684 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.483 ' CZ ' ' HB3' ' A' ' 76' ' ' LEU . 1.0 OUTLIER -55.45 -51.75 65.88 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.836 0.351 . . . . 0.0 110.931 179.053 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.2 -43.11 58.5 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.16 -179.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.0 tp60 -56.86 -38.83 73.26 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.924 -175.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.404 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 61.8 m -84.8 -7.44 59.19 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.003 179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.95 30.26 59.58 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.604 -0.808 . . . . 0.0 112.469 173.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.782 HD22 ' HB1' ' A' ' 51' ' ' ALA . 42.1 mt -89.35 -8.78 52.49 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.827 0.346 . . . . 0.0 110.886 -168.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.483 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -129.06 152.2 48.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.912 -176.458 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -81.03 139.65 35.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.025 172.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -70.69 142.95 51.49 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 178.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 41.0 pt -104.15 154.53 6.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.12 -175.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.9 m -90.67 123.85 64.0 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.672 0.749 . . . . 0.0 111.115 177.062 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -55.83 136.6 75.33 Favored 'Trans proline' 0 N--CA 1.465 -0.181 0 C-N-CA 122.772 2.315 . . . . 0.0 112.395 175.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 t0 -105.05 111.79 24.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.945 176.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -61.16 -40.0 92.21 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.84 -176.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.07 -41.39 97.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.117 -179.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.4 m-30 -71.97 -36.87 69.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.807 179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.454 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 66.3 tt0 -51.73 -51.8 53.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.96 174.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -57.99 -37.07 73.57 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.802 174.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.4 mttt -77.38 -21.66 52.88 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.863 -174.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.499 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -105.06 -105.02 0.31 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.907 -172.04 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.457 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 27.7 t80 172.19 126.7 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.317 0 CA-C-O 121.682 0.753 . . . . 0.0 110.963 -167.557 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 93.7 Cg_exo -54.66 -36.38 89.6 Favored 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.796 2.33 . . . . 0.0 112.407 -172.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 51.1 t80 -65.03 -35.1 80.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.921 -172.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 70.1 p -76.72 -32.21 57.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.215 -179.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.545 ' CE3' HD13 ' A' ' 103' ' ' LEU . 92.7 m95 -70.32 -29.09 65.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.002 173.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 96.1 m-20 -68.07 -31.44 71.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.929 177.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -69.03 -24.04 64.15 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.092 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' A' ' 94' ' ' TRP . 17.9 m -106.35 15.95 6.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.11 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 58.6 ttp180 -99.98 131.5 45.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.892 -179.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -129.37 117.45 20.63 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.9 174.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.7 t30 57.8 35.57 25.61 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.857 175.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 83.79 0.19 89.72 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.681 -0.771 . . . . 0.0 112.536 174.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -124.69 146.37 49.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.854 0.359 . . . . 0.0 110.835 174.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.545 HD13 ' CE3' ' A' ' 94' ' ' TRP . 26.8 mt -88.56 135.35 33.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.799 -171.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.564 HD13 ' HB2' ' A' ' 67' ' ' PHE . 1.8 pp -121.87 -1.68 7.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -170.069 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.489 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -158.8 161.43 36.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.086 -176.288 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.491 ' HB3' ' CD2' ' A' ' 285' ' ' LEU . 93.9 m-85 -110.27 138.25 20.82 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-O 121.662 0.744 . . . . 0.0 110.878 172.434 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -75.05 118.15 5.15 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.636 2.224 . . . . 0.0 112.303 173.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.898 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.4 mp -103.24 -36.4 4.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.149 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.512 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -148.81 152.7 36.97 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.096 -172.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.7 t -123.54 130.71 73.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.112 177.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.469 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 92.0 mt-10 -129.74 128.57 42.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.875 177.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.801 ' HB1' HD21 ' A' ' 323' ' ' ASN . . . -150.8 152.26 33.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.126 177.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.522 ' HB2' ' CB ' ' A' ' 257' ' ' PRO . 5.1 mp -84.29 171.34 12.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.976 -161.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 95.1 p -156.02 154.7 31.45 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.923 -172.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.876 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -99.14 127.66 45.13 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.812 168.639 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.594 ' N ' HD22 ' A' ' 115' ' ' LEU . 5.3 mp -111.45 130.04 65.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.21 -175.22 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.8 p90 -131.34 148.46 52.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.928 -173.371 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -92.06 120.01 32.29 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.823 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.416 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.5 mttt -70.13 -25.74 63.62 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.859 -174.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 78.6 m-20 -86.59 -23.07 25.89 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.903 -172.674 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.8 mp -75.02 -56.71 4.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.979 167.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.765 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.1 pt? -140.02 127.89 12.87 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.589 0.709 . . . . 0.0 110.969 173.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.57 -7.84 16.9 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.592 2.194 . . . . 0.0 112.315 -175.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -147.27 96.71 4.18 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-O 121.648 0.737 . . . . 0.0 110.912 -176.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -67.64 155.04 71.7 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.636 2.224 . . . . 0.0 112.375 178.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -66.43 143.3 69.04 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.678 2.252 . . . . 0.0 112.274 -178.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -84.86 -16.33 41.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.996 -176.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 44.9 p -132.03 157.91 42.9 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.195 -176.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.488 ' HA ' HG12 ' A' ' 132' ' ' ILE . 82.4 m95 -70.08 -20.79 63.2 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.97 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.88 -28.82 67.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.837 178.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -82.27 -8.14 59.64 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.881 -176.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.627 ' O ' HD13 ' A' ' 135' ' ' LEU . 46.8 mm -60.82 -53.14 67.12 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.576 0.703 . . . . 0.0 111.17 -173.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.597 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 21.6 Cg_endo -60.48 -39.88 61.92 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.566 2.177 . . . . 0.0 112.377 -178.502 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -61.52 -61.14 2.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.123 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.147 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -70.88 -16.93 62.72 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.01 -175.628 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.52 ' N ' HD13 ' A' ' 135' ' ' LEU . 35.9 t70 -63.54 -42.39 98.39 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.874 168.458 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.67 -30.43 68.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.963 -177.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.1 mt-10 -69.98 -47.48 62.05 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.88 -177.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.623 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.6 pp -87.22 -15.19 38.93 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.923 -179.251 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.623 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.5 tttt -61.93 -33.86 75.02 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.012 175.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -63.41 -24.19 67.73 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.076 176.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -95.04 6.14 49.91 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.848 178.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.86 32.04 57.41 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.633 -0.794 . . . . 0.0 112.528 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.5 mptp? -110.4 166.5 10.93 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.78 0.324 . . . . 0.0 110.878 174.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 28.4 t -118.5 143.04 47.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.851 169.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -69.62 -44.13 71.28 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.132 -173.73 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -139.05 124.02 18.84 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.842 -174.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 62.1 tpp -113.4 132.57 55.57 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.81 -175.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 34.8 p90 -157.39 160.0 37.98 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.987 -175.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . 0.514 ' HB3' ' HA ' ' A' ' 209' ' ' ASP . 40.3 p-10 -99.21 -43.44 6.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.831 -175.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.108 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.4 tm? 52.13 34.58 14.56 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.903 -175.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -103.28 -11.61 17.84 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.869 -176.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . 0.422 ' HA ' ' HD3' ' A' ' 154' ' ' PRO . 96.6 mt-10 -123.4 144.11 43.08 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.655 0.74 . . . . 0.0 110.924 -170.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 153' ' ' GLU . 73.1 Cg_exo -54.64 -32.75 76.64 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.634 2.222 . . . . 0.0 112.339 -179.2 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 11.9 m-85 -65.21 -29.96 70.82 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.831 -178.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -79.89 -40.19 28.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.866 175.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 39.3 p -62.79 -39.59 94.71 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.066 -175.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.596 ' HB3' ' HD3' ' A' ' 159' ' ' PRO . 32.0 t-105 -65.91 -50.14 54.56 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-O 121.63 0.728 . . . . 0.0 110.936 -164.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.596 ' HD3' ' HB3' ' A' ' 158' ' ' TRP . 78.4 Cg_exo -48.33 -46.55 22.73 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.702 2.268 . . . . 0.0 112.312 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.716 ' O ' HD23 ' A' ' 160' ' ' LEU . 6.4 tt -74.91 -40.35 60.91 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.957 -174.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . . . . . . . . . 82.8 mt -69.13 -43.05 81.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.213 -179.487 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -72.63 -24.71 61.09 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.087 179.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.91 -33.49 71.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.076 -178.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -93.57 3.35 55.67 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 178.205 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 105.99 7.32 35.96 Favored Glycine 0 N--CA 1.453 -0.212 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.428 176.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -78.38 65.7 3.34 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.484 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -85.67 134.8 33.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.794 0.331 . . . . 0.0 110.989 178.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -76.53 1.57 16.3 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.091 -177.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.7 p90 -153.69 155.41 35.94 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.996 0.427 . . . . 0.0 110.853 -175.087 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 55.5 tptt -99.47 121.95 41.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.856 157.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 76.9 t80 -112.95 123.26 49.91 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.902 179.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -152.84 131.03 11.95 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.92 -174.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.4 t30 55.07 44.89 27.32 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.985 173.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.29 15.69 78.84 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.724 -0.75 . . . . 0.0 112.485 173.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -131.01 139.84 50.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.794 0.331 . . . . 0.0 110.951 -176.886 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -95.82 144.38 26.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.943 169.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 64.6 t0 -119.32 111.7 18.51 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.827 176.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 37.1 pt -78.18 -18.24 13.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.043 -177.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -94.54 -8.99 36.68 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.817 -177.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -123.45 92.8 3.77 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.89 171.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 24.9 m -118.72 164.26 15.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.081 -176.513 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -108.46 22.38 26.7 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.541 -177.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.493 ' HB ' ' HB3' ' A' ' 365' ' ' GLN . 1.5 m -108.8 -23.3 4.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-O 120.912 0.387 . . . . 0.0 111.165 -173.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -91.79 24.03 3.34 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.793 174.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.9 m-20 -118.88 176.25 5.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.877 -178.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.09 -25.49 67.81 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.133 -177.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.09 -39.75 94.79 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.445 -172.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.693 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.48 -35.57 81.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.958 0.408 . . . . 0.0 111.124 178.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.566 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.7 mttt -59.69 -36.17 75.94 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.928 176.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -61.53 -39.44 91.06 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.092 177.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . -66.11 -48.16 67.32 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.496 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.526 HD11 ' HA ' ' A' ' 347' ' ' VAL . 19.0 tp -65.96 -33.2 75.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.868 0.366 . . . . 0.0 110.927 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.405 ' OG1' HG21 ' A' ' 357' ' ' VAL . 88.3 m -65.98 -44.02 86.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.172 177.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.472 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 32.6 t80 -67.31 -46.52 73.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.864 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.579 HD23 ' C ' ' A' ' 195' ' ' LEU . 7.9 tt -51.12 -52.21 46.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.862 -175.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.426 ' O ' HG13 ' A' ' 199' ' ' ILE . 27.6 m -64.03 -21.95 29.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.096 -173.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.472 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 98.9 m-20 -61.51 -33.06 73.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -178.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -80.33 -40.07 27.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.847 -175.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.658 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.8 pp -74.94 -28.31 21.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.214 173.05 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -70.49 -39.08 74.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.898 174.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 98.1 m-20 -78.29 2.15 19.41 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.876 175.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.3 mttt 66.55 40.9 3.29 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.852 166.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -78.11 -17.63 56.7 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.779 173.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.658 ' SD ' HG22 ' A' ' 199' ' ' ILE . 4.3 ppp? -143.33 158.09 43.93 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.899 178.248 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -92.21 153.6 19.19 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.817 176.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -60.7 -26.99 67.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.102 -175.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -94.77 2.33 55.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.888 -177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 98.4 m -69.17 129.99 41.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.105 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.514 ' HA ' ' HB3' ' A' ' 150' ' ' ASN . 18.7 t0 -126.69 175.67 7.8 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.961 173.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 33.0 p90 -59.18 -35.78 74.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.01 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.7 p -68.4 -38.79 81.62 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.833 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 76.2 mt -67.46 -40.04 83.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.125 175.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.08 -35.52 80.54 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.001 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -61.4 -47.25 86.67 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.862 174.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.06 -41.23 99.41 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.11 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.9 -47.62 77.11 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.071 -179.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 60.8 t80 -62.38 -41.86 98.96 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.949 -177.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -63.96 -31.4 72.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.913 -177.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -87.47 -19.3 28.18 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.836 177.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 91.37 22.43 31.94 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.453 179.491 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -80.96 -19.66 43.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.996 0.427 . . . . 0.0 110.9 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.7 t -128.76 137.47 51.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.153 175.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.444 ' HB1' HD21 ' A' ' 122' ' ' LEU . . . -66.34 -46.91 75.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.022 178.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.645 ' HB3' HD21 ' A' ' 115' ' ' LEU . 75.3 mtm -133.71 151.02 51.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.962 -168.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 66.1 p -138.69 156.9 47.02 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.161 175.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 43.4 mm -110.37 125.06 67.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.037 177.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -155.01 175.31 13.98 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.907 -169.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.409 ' HA2' ' HG ' ' A' ' 113' ' ' LEU . . . -84.34 -164.17 37.23 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.925 -0.655 . . . . 0.0 112.419 179.464 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.469 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 36.5 Cg_endo -65.34 -23.78 58.48 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 122.685 2.257 . . . . 0.0 112.361 177.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 47.2 m0 -72.26 -30.79 65.19 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.904 178.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 45.37 45.09 9.87 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.104 174.535 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 29.7 m0 -63.68 -19.61 65.04 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.868 -179.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 78.1 p -69.75 -14.88 63.0 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.855 -179.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 32.5 p30 -78.45 -171.32 2.4 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.859 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.483 HG21 ' HB3' ' A' ' 238' ' ' SER . 92.9 mt -96.28 140.06 18.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.152 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -92.03 -49.49 6.19 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.849 -177.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 86.3 m -144.85 119.9 10.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.185 178.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . 0.483 ' HB3' HG21 ' A' ' 235' ' ' ILE . 29.2 t -178.75 164.37 1.54 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.822 177.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -79.14 -10.44 59.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.905 172.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 71.7 t -67.09 130.96 32.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.056 179.81 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 69.7 m-80 -82.99 139.13 33.48 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.917 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.416 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 39.0 p90 -150.02 156.6 41.99 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.927 175.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -140.7 163.86 26.46 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.431 179.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.0 p -135.53 135.93 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.917 0.389 . . . . 0.0 111.127 -176.235 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 115' ' ' LEU . 13.2 t -159.71 152.45 21.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.161 175.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.408 HG13 ' HB2' ' A' ' 322' ' ' GLU . 28.2 m -59.2 163.26 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.288 -175.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.526 ' CD1' ' N ' ' A' ' 247' ' ' LEU . 2.4 mp -67.02 153.66 94.07 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.566 0.698 . . . . 0.0 110.985 -165.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.51 -178.17 2.12 Favored 'Trans proline' 0 C--O 1.232 0.175 0 C-N-CA 122.777 2.318 . . . . 0.0 112.358 -179.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 68.2 p -100.85 160.09 14.66 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.078 -177.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 58.5 t80 -138.8 119.75 14.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.911 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 54.89 33.99 21.17 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.913 -173.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 86.78 9.92 73.66 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.66 -0.781 . . . . 0.0 112.558 172.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -126.17 139.94 35.73 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.619 0.723 . . . . 0.0 110.842 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -73.29 139.58 29.33 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.736 2.291 . . . . 0.0 112.298 -172.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.425 ' O ' ' C ' ' A' ' 256' ' ' LYS . 73.8 m -85.33 1.5 48.19 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.845 168.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . 0.425 ' C ' ' O ' ' A' ' 255' ' ' SER . 99.0 mttt -38.4 118.06 0.99 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.569 0.7 . . . . 0.0 110.879 -175.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.522 ' CB ' ' HB2' ' A' ' 113' ' ' LEU . 53.0 Cg_exo -65.66 162.13 35.75 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.699 2.266 . . . . 0.0 112.33 -170.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -74.48 167.2 22.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.901 177.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 38.7 t -117.56 134.5 60.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.082 -165.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.504 ' HA3' ' NE2' ' A' ' 64' ' ' HIS . . . -116.7 135.52 12.07 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.732 -0.747 . . . . 0.0 112.469 176.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 92.2 t -124.96 118.24 52.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.82 0.343 . . . . 0.0 111.197 174.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.403 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -66.28 123.06 18.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.873 -179.32 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 46.3 m -126.49 133.45 51.17 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.789 -168.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -128.26 138.88 52.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.066 -173.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.39 172.07 21.66 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.419 -172.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.479 HG13 ' HB2' ' A' ' 277' ' ' LYS . 29.1 mm -113.64 129.96 68.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.811 0.339 . . . . 0.0 111.106 -173.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.5 t-20 -61.85 128.74 37.65 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.892 -175.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.455 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -59.83 -29.19 68.09 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.099 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -85.82 -5.76 59.2 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.065 -173.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.5 t -73.14 121.0 83.99 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.654 0.74 . . . . 0.0 110.936 -173.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -68.04 -9.38 25.52 Favored 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.635 2.224 . . . . 0.0 112.353 168.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 -108.66 19.72 19.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.864 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 20.3 pttp -53.97 -33.97 58.46 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.856 -171.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -67.55 -50.65 57.59 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 -172.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.6 pp -79.99 -32.08 39.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.923 -175.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.45 -47.51 75.93 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.071 176.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . 0.479 ' HB2' HG13 ' A' ' 266' ' ' ILE . 37.3 ttpt -66.24 -42.41 88.66 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.909 176.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -64.46 -46.57 82.54 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.947 -175.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -66.29 -43.2 87.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.871 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.434 ' HA ' HD22 ' A' ' 284' ' ' LEU . 8.2 tt -55.83 -50.57 70.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.89 -176.427 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.1 pt-20 -72.4 -25.21 61.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.865 -176.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -100.27 -11.15 20.6 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.912 -171.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.756 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 73.9 m-85 -122.91 -60.55 1.51 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.961 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.434 HD22 ' HA ' ' A' ' 280' ' ' LEU . 1.4 mp -62.66 -32.49 73.55 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.908 -159.56 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.898 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.4 pp -123.22 38.07 4.27 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.96 -178.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.474 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 64.0 p -124.68 163.47 21.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.113 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.438 ' HA ' HD11 ' A' ' 290' ' ' LEU . 38.7 t70 -45.63 -37.51 5.72 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.885 -166.044 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -78.3 -41.63 33.23 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.98 -177.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.756 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.52 -55.96 5.8 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.632 -0.794 . . . . 0.0 112.593 -170.685 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.592 HD12 ' N ' ' A' ' 291' ' ' GLU . 0.6 OUTLIER -67.2 -21.36 65.78 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 0.0 110.852 -178.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.592 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.9 tt0 -68.44 -47.6 66.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.887 172.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.63 -45.15 91.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.045 -174.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 1.117 HG23 ' HA3' ' A' ' 19' ' ' GLY . 2.6 p -75.83 -34.56 28.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.176 -175.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . 0.434 ' HA ' ' HG ' ' A' ' 299' ' ' LEU . 46.2 t30 -67.4 -28.24 67.76 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.891 173.352 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -63.09 -26.47 68.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.891 179.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 99.8 m-20 -85.46 -41.76 15.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.992 -179.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -145.36 131.78 9.78 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.572 0.701 . . . . 0.0 110.853 177.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -53.32 109.01 0.31 Allowed 'Trans proline' 0 N--CA 1.465 -0.195 0 C-N-CA 122.727 2.285 . . . . 0.0 112.358 173.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.434 ' HG ' ' HA ' ' A' ' 294' ' ' ASN . 59.4 mt -90.06 -19.6 24.17 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.97 -171.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 113.36 -59.46 0.38 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.461 176.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.658 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -171.37 169.63 6.2 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.807 0.337 . . . . 0.0 111.114 174.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.635 HG21 ' HB3' ' A' ' 307' ' ' TYR . 32.9 m -125.24 154.67 33.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.07 179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -72.46 -10.71 60.12 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.077 171.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.574 ' CD2' HD21 ' A' ' 290' ' ' LEU . 54.1 tp -85.9 120.01 26.83 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.863 -175.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -55.85 -40.45 72.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.883 -174.065 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 71.7 m -65.72 -50.02 66.37 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.849 -168.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.635 ' HB3' HG21 ' A' ' 302' ' ' VAL . 17.4 t80 -76.42 -28.63 56.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.979 -179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 49.4 tp10 -64.8 -38.87 92.44 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.9 178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -62.53 -34.76 77.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.909 176.036 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -75.02 -40.44 60.55 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.924 174.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.658 HD13 ' HA ' ' A' ' 301' ' ' ALA . 80.1 mt -61.23 -32.0 71.79 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.901 175.344 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -61.64 -18.64 60.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.06 -176.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -64.79 -19.37 65.79 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.918 173.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 59.5 t0 -91.4 122.7 65.65 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.608 0.718 . . . . 0.0 110.88 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_exo -48.61 -28.69 12.73 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.668 2.245 . . . . 0.0 112.375 -177.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 89.3 mtm180 -62.75 -27.25 69.15 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.888 -171.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.405 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.4 mp -75.06 -32.88 27.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.109 -174.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -60.2 -46.03 91.15 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.046 -171.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.35 -39.3 89.11 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.169 179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.619 HG23 ' HB3' ' A' ' 112' ' ' ALA . 21.6 m -59.32 -36.39 75.56 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.182 179.211 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 98.8 mmm -73.86 -34.24 64.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 177.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . 0.408 ' HB2' HG13 ' A' ' 246' ' ' VAL . 86.1 mt-10 -59.46 -44.14 93.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.942 -172.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.801 HD21 ' HB1' ' A' ' 112' ' ' ALA . 16.4 p-10 -87.83 -26.28 22.89 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.857 -178.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -59.64 -45.31 92.36 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.133 -177.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -62.46 -33.7 75.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.88 -177.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -107.62 -2.29 20.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.857 -173.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.453 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -90.17 -166.57 41.44 Favored Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.452 -164.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 87.4 tt0 -144.94 143.0 30.32 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 110.962 -174.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 47.0 mm -60.44 118.7 3.59 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.122 -171.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 47.6 tpp -54.28 130.22 60.69 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 121.561 0.696 . . . . 0.0 110.87 -178.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.528 ' HB2' ' HG3' ' A' ' 336' ' ' MET . 43.0 Cg_endo -70.95 99.9 0.92 Allowed 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.692 2.261 . . . . 0.0 112.321 -175.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.515 ' ND2' ' ND1' ' A' ' 64' ' ' HIS . 23.3 m-80 -120.58 23.29 10.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.894 -174.263 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 51.0 pt -75.8 160.13 79.55 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.626 0.727 . . . . 0.0 111.129 178.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 80.9 Cg_exo -54.81 -38.25 92.14 Favored 'Trans proline' 0 C--O 1.232 0.182 0 C-N-CA 122.775 2.317 . . . . 0.0 112.301 -173.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.7 mm-40 -67.68 -29.18 68.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 -178.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.528 ' HG3' ' HB2' ' A' ' 331' ' ' PRO . 66.1 mmm -80.03 -18.06 51.15 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.797 -168.902 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 95.0 p -63.8 -37.71 88.39 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.782 178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -76.85 -35.13 57.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.14 175.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.547 ' O ' HG13 ' A' ' 343' ' ' VAL . 5.0 m-30 -67.61 -41.0 84.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.912 179.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.451 ' HA ' HG22 ' A' ' 343' ' ' VAL . 7.7 m0 -59.89 -34.64 73.45 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.89 174.367 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.6 m-30 -69.43 -39.77 77.63 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.889 175.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.51 -43.22 85.86 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.109 179.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.547 HG13 ' O ' ' A' ' 339' ' ' PHE . 15.4 m -75.15 -28.58 20.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.098 -176.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.445 ' O ' HG22 ' A' ' 347' ' ' VAL . 49.3 ttt180 -58.62 -45.56 88.95 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.845 172.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 93.2 m -56.11 -36.25 67.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.148 178.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -64.64 -44.05 91.72 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.188 -174.347 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.526 ' HA ' HD11 ' A' ' 192' ' ' LEU . 3.0 m -74.88 -34.86 34.33 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.175 -174.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.438 HD12 HG23 ' A' ' 347' ' ' VAL . 1.4 mp -62.95 -52.18 62.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.196 173.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -62.5 -39.21 92.77 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.881 -175.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.59 -45.71 61.42 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.111 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -69.72 -39.67 76.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.049 -174.606 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 89.4 p -75.39 -10.56 59.56 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.921 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 82.02 17.13 70.5 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.414 178.935 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.72 -33.4 46.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.8 0.333 . . . . 0.0 110.863 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 94.2 mt-30 -140.02 155.1 47.24 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.852 178.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 43.5 p -77.38 169.45 18.29 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.217 170.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.435 ' O ' ' CB ' ' A' ' 361' ' ' LEU . 53.8 t -56.17 -42.37 72.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.198 172.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -61.13 -46.58 89.98 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.828 177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -70.09 -53.19 18.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.903 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -70.96 -48.04 55.62 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.146 -172.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.693 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.3 tm? -65.08 -41.76 94.74 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.906 -174.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -66.73 -54.08 26.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.885 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 98.8 m-20 -70.39 -48.35 56.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.863 -171.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -66.89 -42.34 85.71 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.175 -174.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.493 ' HB3' ' HB ' ' A' ' 183' ' ' VAL . 79.4 mm-40 -73.55 -34.79 65.35 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.919 -175.868 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 26.9 m -60.17 -27.93 67.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.175 177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -56.99 -30.11 63.85 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.804 175.292 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.421 ' HB ' ' O ' ' A' ' 365' ' ' GLN . 77.3 mt -60.6 -40.18 83.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.076 174.657 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 45.7 p -98.22 -11.38 22.76 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.019 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.329 -0.297 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.955 175.938 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 99.4 mttt . . . . . 0 C--O 1.23 0.078 0 CA-C-O 120.835 0.35 . . . . 0.0 110.879 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 78.6 mt -93.68 130.73 42.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.177 -177.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 25.0 pt-20 -145.52 146.59 31.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.918 -176.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -53.22 137.15 35.07 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.874 177.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 93.27 6.13 63.17 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.458 -174.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.2 tttt -165.32 135.85 3.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.741 0.305 . . . . 0.0 110.961 -178.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.406 HD23 ' HB3' ' A' ' 275' ' ' LEU . 0.5 OUTLIER -142.34 149.57 39.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.022 -178.804 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.452 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 78.3 t -107.62 133.76 51.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.149 179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.712 HG23 ' HB ' ' A' ' 59' ' ' ILE . 0.8 OUTLIER -119.92 133.87 65.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.12 -179.397 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.803 ' CD1' ' HB3' ' A' ' 57' ' ' PRO . 68.5 m95 -108.25 126.2 52.54 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.014 166.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.485 HD12 ' HG ' ' A' ' 20' ' ' LEU . 14.9 tt -110.55 150.06 13.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.102 -165.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -61.58 149.21 39.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.875 -172.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -56.86 -17.84 23.3 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.459 -179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 97.9 m-20 -73.5 -12.32 60.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.785 0.326 . . . . 0.0 110.826 -176.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.1 tppt? -147.83 128.17 13.93 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.861 164.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -80.87 -77.25 1.0 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.443 -167.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 88.5 t80 -108.47 -44.91 3.98 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.923 0.392 . . . . 0.0 110.979 -175.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 99.4 m-20 -67.47 -50.34 59.55 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.075 -0.512 . . . . 0.0 110.887 -152.601 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.653 ' HA3' HG23 ' A' ' 293' ' ' VAL . . . -54.95 -49.54 62.04 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.791 -0.719 . . . . 0.0 112.42 -173.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.507 HD21 HG21 ' A' ' 9' ' ' ILE . 3.2 mt -52.21 -54.43 31.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.838 0.351 . . . . 0.0 110.913 170.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.96 -35.84 25.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.082 -178.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 70.3 mm-40 -70.63 -59.22 2.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.971 0.415 . . . . 0.0 110.88 178.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.0 m -71.19 -37.77 67.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.127 -173.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.69 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -66.4 -45.88 82.34 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.426 179.454 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -57.43 -32.99 67.44 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.919 0.39 . . . . 0.0 110.984 -177.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 63.8 mttm -57.81 -37.83 74.46 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.881 176.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.448 ' CD1' ' N ' ' A' ' 27' ' ' PHE . 6.0 m-30 -59.66 -44.61 93.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 83.1 tt0 -64.81 -37.9 89.16 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.935 178.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.1 mttt -69.96 -40.62 75.32 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.867 -179.267 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 69.2 m-20 -97.54 -47.06 5.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.835 -166.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 38.6 p -108.13 -6.1 16.62 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.152 -173.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 80.91 3.83 90.53 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.432 169.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.829 HD13 ' O ' ' A' ' 33' ' ' ILE . 0.0 OUTLIER -100.13 133.17 44.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.833 0.349 . . . . 0.0 111.177 -176.444 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.467 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.2 mttt -79.36 142.71 35.78 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.841 -172.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.69 HG21 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -120.01 133.79 65.63 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.113 178.359 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.471 ' O ' HD12 ' A' ' 9' ' ' ILE . 97.5 m -104.68 128.68 52.83 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.049 177.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.468 HG22 ' HB3' ' A' ' 20' ' ' LEU . 93.5 t -98.26 125.18 51.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.199 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 70.0 mm-40 -117.97 148.25 42.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.951 178.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 40' ' ' PRO . 96.8 m-70 -86.75 148.3 45.63 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.597 0.713 . . . . 0.0 110.895 -165.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.452 ' HA ' ' HB2' ' A' ' 43' ' ' LEU . 50.7 Cg_exo -59.81 -24.96 77.84 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.69 2.26 . . . . 0.0 112.3 -176.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 99.5 m-20 -53.24 -50.09 65.48 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.937 -171.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -91.08 -3.83 56.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.836 -177.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.452 ' HB2' ' HA ' ' A' ' 40' ' ' PRO . 7.7 tt -46.39 -52.63 12.57 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.936 -172.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -66.63 -36.45 82.59 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.767 176.081 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.8 tt0 -66.38 -43.65 85.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.816 -172.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -81.4 -21.31 39.07 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.836 -179.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.522 ' HB3' ' HD3' ' A' ' 48' ' ' PRO . 56.6 t80 -48.83 -51.17 56.51 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.614 0.721 . . . . 0.0 110.821 -167.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.522 ' HD3' ' HB3' ' A' ' 47' ' ' PHE . 63.1 Cg_endo -80.75 -29.46 2.2 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.731 2.287 . . . . 0.0 112.375 179.014 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -74.66 -39.65 61.92 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.929 -169.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.439 HG11 ' HD3' ' A' ' 57' ' ' PRO . 34.2 m -65.09 -27.83 43.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.031 -177.354 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.826 ' HB1' HD22 ' A' ' 75' ' ' LEU . . . -68.87 -37.01 78.78 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.057 177.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -69.11 -30.62 68.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.148 -178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 64.3 p -92.39 -15.37 27.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.101 176.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 73.48 10.22 78.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.507 175.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.2 m-20 -141.05 133.28 28.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.887 0.375 . . . . 0.0 110.845 177.506 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 174.38 -115.07 0.53 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.486 176.752 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.803 ' HB3' ' CD1' ' A' ' 10' ' ' TRP . 61.1 Cg_endo -75.28 152.57 39.64 Favored 'Trans proline' 0 N--CA 1.463 -0.265 0 C-N-CA 122.723 2.282 . . . . 0.0 112.415 179.514 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -88.39 -34.99 17.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.869 159.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.712 ' HB ' HG23 ' A' ' 9' ' ' ILE . 30.5 mt -128.59 139.31 52.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.15 -175.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 tp -131.87 127.87 59.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.219 176.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -93.65 137.2 33.16 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.834 172.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.422 ' CZ2' ' HB2' ' A' ' 105' ' ' ALA . 30.0 p90 -144.66 165.03 29.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.932 171.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -76.81 -89.4 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.048 -169.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.414 ' CD2' ' HA2' ' A' ' 260' ' ' GLY . 18.0 m80 -105.47 -81.58 0.54 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.828 -171.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.579 ' H ' ' HB3' ' A' ' 332' ' ' ASN . 70.0 m-20 -103.88 -6.71 21.08 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.77 -154.227 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 60.2 ttm-85 -52.15 -21.5 3.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.891 -173.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.483 ' HB2' HD13 ' A' ' 104' ' ' ILE . 30.7 p90 -59.27 -28.96 67.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.815 -178.557 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -57.62 -51.47 57.7 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.479 -175.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -66.52 -36.73 91.89 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.442 171.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.408 ' CD1' ' HB2' ' A' ' 75' ' ' LEU . 0.8 OUTLIER -54.96 -51.68 65.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.981 0.42 . . . . 0.0 110.999 179.579 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.24 -42.6 45.35 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.113 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 73.5 tp60 -56.88 -38.62 73.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.87 -176.025 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.415 ' HB2' ' HG ' ' A' ' 75' ' ' LEU . 62.8 m -85.94 -6.9 58.98 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.847 -179.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 74.73 30.78 59.26 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.658 -0.782 . . . . 0.0 112.561 174.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.826 HD22 ' HB1' ' A' ' 51' ' ' ALA . 39.0 mt -89.87 -10.07 46.65 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.888 0.375 . . . . 0.0 110.972 -169.218 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.483 ' C ' ' HB2' ' A' ' 268' ' ' ALA . 0.2 OUTLIER -127.97 149.41 50.35 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.969 -176.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -77.36 141.11 40.0 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.124 175.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.8 136.48 45.42 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.957 179.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -105.1 156.86 6.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.088 -178.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 98.8 m -100.7 130.32 25.69 Favored Pre-proline 0 C--N 1.331 -0.237 0 CA-C-O 121.606 0.717 . . . . 0.0 111.096 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -54.44 134.57 62.15 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.738 2.292 . . . . 0.0 112.329 176.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -104.04 118.62 37.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.817 177.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.21 -41.96 98.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.897 -176.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.89 -45.05 87.57 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.078 -177.547 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 16.3 m-85 -74.88 -32.4 61.84 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.951 -178.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . 0.483 ' HA ' ' HE1' ' A' ' 94' ' ' TRP . 66.9 tt0 -55.04 -50.87 68.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.901 175.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -60.03 -32.68 71.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.87 174.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -76.22 -21.32 56.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 -175.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.462 ' O ' ' HB2' ' A' ' 90' ' ' TYR . 0.3 OUTLIER -104.7 -105.21 0.3 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.949 -172.461 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 30.3 t80 171.75 128.92 0.07 OUTLIER Pre-proline 0 C--N 1.328 -0.367 0 CA-C-O 121.655 0.74 . . . . 0.0 110.92 -167.752 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -53.48 -37.03 81.98 Favored 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.746 2.297 . . . . 0.0 112.352 -173.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.2 t80 -64.97 -35.72 82.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.785 -174.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 69.8 p -73.12 -30.97 64.02 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.186 -179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.527 ' HA ' HG22 ' A' ' 97' ' ' VAL . 86.3 m95 -67.47 -30.85 70.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 174.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -67.4 -30.75 70.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.852 179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -70.96 -25.76 62.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.034 177.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.528 HG23 HD22 ' A' ' 103' ' ' LEU . 15.6 m -106.02 13.04 8.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.189 -174.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . . . . . . . . . 59.5 ttp180 -100.04 129.74 46.12 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 -178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 59.6 t80 -123.68 115.03 20.77 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.897 172.592 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.8 t30 56.82 38.88 29.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.856 173.017 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 84.39 0.39 89.4 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.765 -0.731 . . . . 0.0 112.56 175.411 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -116.71 151.29 36.68 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.833 0.349 . . . . 0.0 110.805 172.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.528 HD22 HG23 ' A' ' 97' ' ' VAL . 15.1 mt -90.82 135.11 33.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.873 177.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.483 HD13 ' HB2' ' A' ' 67' ' ' PHE . 2.0 pp -125.68 3.9 4.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.037 -172.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.422 ' HB2' ' CZ2' ' A' ' 62' ' ' TRP . . . -163.03 165.47 24.78 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.162 -178.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.451 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 92.4 m-85 -116.04 140.46 26.34 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.609 0.718 . . . . 0.0 110.993 172.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 11.4 Cg_exo -72.13 126.38 11.73 Favored 'Trans proline' 0 C--O 1.233 0.257 0 C-N-CA 122.733 2.289 . . . . 0.0 112.391 172.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 1.076 HG13 ' HB3' ' A' ' 285' ' ' LEU . 1.5 mp -107.61 -39.98 4.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.213 174.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.571 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -144.02 152.09 40.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.162 -164.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 96.3 t -125.06 131.19 72.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.109 175.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . 0.508 ' HB3' ' HG3' ' A' ' 229' ' ' PRO . 92.5 mt-10 -133.89 132.31 40.15 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.851 175.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.783 ' HB1' HD21 ' A' ' 323' ' ' ASN . . . -154.18 152.73 30.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.119 176.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.3 mp -81.36 169.65 16.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.941 -168.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 98.9 p -157.59 159.14 36.78 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.957 -177.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.897 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -92.33 126.09 37.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.832 169.581 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.587 ' N ' HD22 ' A' ' 115' ' ' LEU . 65.7 mt -113.71 132.14 63.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.14 -172.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -132.13 145.03 51.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.9 -175.315 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.418 ' O ' HD23 ' A' ' 122' ' ' LEU . 54.8 t-20 -93.36 114.43 26.86 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.831 179.341 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.484 ' H ' ' HA ' ' A' ' 242' ' ' TYR . 97.8 mttt -64.78 -18.43 65.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.93 -173.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . . . . . . . . . 88.4 m-20 -77.33 -29.98 53.76 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.865 -177.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.2 mp -83.69 -49.51 9.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.935 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.653 ' H ' HD23 ' A' ' 122' ' ' LEU . 1.5 pt? -140.0 126.53 12.18 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-O 121.567 0.699 . . . . 0.0 110.89 176.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -79.16 -14.59 13.3 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.693 2.262 . . . . 0.0 112.377 -176.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 60.5 t-20 -142.23 97.16 6.31 Favored Pre-proline 0 C--N 1.328 -0.368 0 CA-C-O 121.564 0.697 . . . . 0.0 110.825 -174.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -72.67 154.98 54.66 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.725 2.283 . . . . 0.0 112.282 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -67.39 146.23 74.21 Favored 'Trans proline' 0 C--O 1.233 0.226 0 C-N-CA 122.624 2.216 . . . . 0.0 112.347 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -88.53 -18.16 28.73 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.988 -179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 69.6 p -132.27 158.72 41.11 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.166 -177.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.541 ' HA ' HD13 ' A' ' 132' ' ' ILE . 58.7 m95 -69.66 -27.21 64.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.978 -179.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -64.96 -24.6 67.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.85 179.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -80.14 -24.62 40.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.823 -177.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.624 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 1.0 OUTLIER -57.15 -49.68 92.53 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.586 0.708 . . . . 0.0 111.151 -172.034 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.624 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 40.0 Cg_endo -68.67 -38.02 11.32 Favored 'Trans proline' 0 C--N 1.342 0.2 0 C-N-CA 122.67 2.247 . . . . 0.0 112.398 -173.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.14 -60.73 3.04 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.116 176.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.205 HD22 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.96 -16.8 63.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.933 -175.708 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.504 ' N ' HD13 ' A' ' 135' ' ' LEU . 37.0 t70 -58.39 -39.63 80.2 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.821 168.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -59.52 -30.22 68.43 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -71.79 -47.6 52.27 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.032 0.444 . . . . 0.0 110.864 -177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.6 HD12 ' N ' ' A' ' 140' ' ' LYS . 2.9 pp -85.62 -15.27 43.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.859 -179.649 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.6 ' N ' HD12 ' A' ' 139' ' ' LEU . 87.7 tttt -59.74 -33.45 71.67 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.971 173.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.03 -24.63 67.78 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.099 176.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -95.03 3.35 54.98 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.927 177.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.79 33.16 52.03 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.72 -0.752 . . . . 0.0 112.471 178.012 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 9.3 mptt -110.5 169.97 8.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.749 0.309 . . . . 0.0 110.909 174.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 27.0 t -118.93 142.13 48.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.996 0.427 . . . . 0.0 110.745 169.033 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -68.62 -39.87 80.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.076 -175.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -142.17 130.68 22.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.868 -178.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 62.3 tpp -118.22 131.9 56.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.823 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -154.59 157.49 38.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.852 -176.194 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 -91.53 -51.56 5.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.898 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.104 HD13 ' O ' ' A' ' 151' ' ' LEU . 1.4 tm? 48.04 33.37 3.44 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.891 -169.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 97.1 mm-40 -102.16 -2.76 28.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.936 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -127.97 153.68 78.32 Favored Pre-proline 0 C--N 1.33 -0.255 0 CA-C-O 121.683 0.754 . . . . 0.0 110.864 -174.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.44 ' HA ' ' HB ' ' A' ' 157' ' ' THR . 37.5 Cg_endo -61.81 -24.78 77.73 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.626 2.217 . . . . 0.0 112.362 176.188 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 44.4 m-85 -66.68 -30.06 70.22 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.874 177.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 8.6 m-30 -87.49 -39.39 15.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.879 174.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . 0.44 ' HB ' ' HA ' ' A' ' 154' ' ' PRO . 20.5 m -61.18 -46.87 88.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.135 -178.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.571 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 37.3 t-105 -58.81 -53.84 62.37 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-O 121.499 0.666 . . . . 0.0 110.833 -169.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.571 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 34.4 Cg_endo -66.12 -18.01 55.73 Favored 'Trans proline' 0 C--O 1.233 0.268 0 C-N-CA 122.694 2.263 . . . . 0.0 112.255 -175.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.775 HD13 ' C ' ' A' ' 160' ' ' LEU . 1.6 tm? -81.61 -45.34 15.97 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.837 177.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.569 HG22 ' HA3' ' A' ' 166' ' ' GLY . 77.9 mt -74.24 -44.46 49.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.12 -179.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.98 -20.95 63.28 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.054 -176.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 159' ' ' PRO . . . -60.66 -31.15 70.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.093 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 93.0 m-20 -94.98 3.1 55.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.891 177.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 104.11 7.91 39.92 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.485 179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.569 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -77.06 67.05 2.77 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.541 178.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -86.05 131.11 34.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.857 0.361 . . . . 0.0 110.89 176.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -81.54 13.48 3.04 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.202 -174.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.409 ' HA ' HG12 ' A' ' 181' ' ' VAL . 52.9 p90 -153.43 154.4 34.37 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.841 -179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.412 ' HB2' ' O ' ' A' ' 180' ' ' ASP . 86.8 tttt -101.48 127.5 48.13 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.897 158.273 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 81.6 t80 -116.22 125.81 52.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.983 177.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -153.55 130.39 10.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.919 -176.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.0 t30 54.31 42.76 31.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.946 172.573 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.95 18.47 80.18 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.458 174.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -132.27 138.51 47.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.778 0.323 . . . . 0.0 110.965 -176.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -97.72 145.11 26.67 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.811 170.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -126.24 112.14 15.39 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.914 174.183 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . 0.6 ' O ' HD12 ' A' ' 178' ' ' ILE . 1.1 pp -79.43 -12.82 13.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.151 -178.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -95.23 -10.1 31.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.918 -176.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . 0.412 ' O ' ' HB2' ' A' ' 170' ' ' LYS . 67.2 t0 -126.42 90.13 3.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.83 169.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.409 HG12 ' HA ' ' A' ' 169' ' ' PHE . 29.3 m -113.55 164.07 10.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.104 -173.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -105.11 22.59 32.81 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.519 -172.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.464 HG21 HD12 ' A' ' 368' ' ' ILE . 3.5 m -106.64 -17.91 7.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.827 0.346 . . . . 0.0 111.046 -178.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 56.4 p-10 -87.68 21.23 2.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.829 -176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 26.5 p30 -120.05 -171.41 2.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.863 -177.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -65.72 -30.38 71.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.128 -173.227 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.37 -40.51 94.57 Favored Glycine 0 N--CA 1.451 -0.367 0 C-N-CA 120.771 -0.728 . . . . 0.0 112.434 -167.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.618 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.04 -38.36 90.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.909 0.385 . . . . 0.0 111.107 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.531 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 89.3 mttt -61.92 -38.66 89.24 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.906 174.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -62.98 -38.79 92.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.05 176.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.506 ' O ' HD11 ' A' ' 160' ' ' LEU . . . -65.75 -47.76 73.17 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.51 179.359 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.738 HD11 ' HA ' ' A' ' 347' ' ' VAL . 18.8 tp -67.33 -34.51 77.48 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.802 0.334 . . . . 0.0 110.845 -177.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.471 ' OG1' HG21 ' A' ' 357' ' ' VAL . 89.2 m -64.98 -43.84 91.31 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.18 177.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . 0.457 ' O ' ' HB2' ' A' ' 197' ' ' ASP . 79.9 t80 -65.95 -48.58 70.85 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.881 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.705 HD23 ' C ' ' A' ' 195' ' ' LEU . 5.2 tt -50.98 -51.28 54.28 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.974 -175.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.416 ' O ' HG13 ' A' ' 199' ' ' ILE . 27.5 m -64.5 -21.48 29.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.101 -173.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 194' ' ' PHE . 99.3 m-20 -61.03 -33.13 72.8 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.808 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -80.86 -40.05 25.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.883 -174.494 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.551 HG22 ' SD ' ' A' ' 204' ' ' MET . 1.7 pp -74.37 -28.4 22.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.164 172.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -68.84 -37.66 79.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.932 173.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 97.8 m-20 -80.04 2.17 24.84 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.918 174.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 95.0 mttt 66.41 40.18 3.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.802 166.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 79.7 m-70 -78.98 -15.72 57.9 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.843 177.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.551 ' SD ' HG22 ' A' ' 199' ' ' ILE . 5.1 ppp? -141.33 155.53 45.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.841 178.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 96.1 m-20 -94.63 150.04 20.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.981 178.307 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.32 -26.26 68.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.044 -175.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.6 p-10 -94.96 0.55 54.77 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.931 -176.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 89.6 m -62.24 125.04 22.52 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.172 -176.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.441 ' H ' ' HB ' ' A' ' 212' ' ' ILE . 13.6 t0 -120.0 -179.65 3.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.844 177.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -64.1 -46.05 85.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.99 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 95.1 p -67.0 -37.09 83.57 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.82 -178.89 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.441 ' HB ' ' H ' ' A' ' 209' ' ' ASP . 80.9 mt -65.01 -43.9 96.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.079 -0.509 . . . . 0.0 111.088 174.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -65.09 -36.41 84.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.078 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -63.49 -46.4 86.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.858 176.142 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.08 -39.91 93.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.014 178.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.72 -45.01 88.36 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.115 -179.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 56.0 t80 -64.02 -42.08 97.24 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.963 178.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 99.7 m-20 -66.28 -34.3 77.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.894 179.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -81.96 -23.34 36.15 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.884 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 88.43 27.03 26.2 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.669 -0.776 . . . . 0.0 112.448 -178.125 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -83.46 -20.02 34.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.985 0.421 . . . . 0.0 110.9 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.7 t -131.22 137.54 48.96 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.133 178.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.571 ' HB2' HD22 ' A' ' 139' ' ' LEU . . . -67.37 -41.98 84.17 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.012 -178.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.469 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 61.6 mtm -137.63 160.84 38.07 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.905 -177.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.3 t -150.26 159.55 44.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.264 178.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.489 HD12 HD11 ' A' ' 247' ' ' LEU . 49.2 mm -109.24 126.23 66.32 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.135 -179.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -154.97 174.4 15.2 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.861 -176.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -81.64 -163.71 31.96 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.789 -0.719 . . . . 0.0 112.41 -177.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.508 ' HG3' ' HB3' ' A' ' 111' ' ' GLU . 39.7 Cg_endo -68.61 -22.05 38.54 Favored 'Trans proline' 0 C--O 1.232 0.22 0 C-N-CA 122.697 2.265 . . . . 0.0 112.281 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 54.1 m0 -70.09 -30.0 67.11 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.868 -179.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 47.56 45.04 17.55 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.062 174.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 34.1 m0 -66.26 -16.12 63.76 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.88 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 74.3 m -53.01 -40.07 63.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.966 0.412 . . . . 0.0 110.875 177.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 54.4 p30 -86.36 -177.29 6.18 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.923 -173.692 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 77.1 mt -120.08 125.76 74.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.154 -174.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -70.12 -38.73 75.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.773 -175.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 86.7 m -124.96 106.2 9.79 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.193 -179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 27.9 t -174.06 162.98 3.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.917 177.319 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -77.8 -19.23 55.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.851 179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . . . . . . . . . 23.3 m -60.19 150.67 6.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.158 -178.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . . . . . . . . . 95.6 m-20 -104.51 140.01 38.59 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.86 175.171 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.484 ' HA ' ' H ' ' A' ' 119' ' ' LYS . 42.8 p90 -150.01 154.78 38.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.964 179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -137.31 160.7 25.13 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.538 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 4.2 p -138.6 137.34 43.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.913 0.387 . . . . 0.0 111.154 -178.177 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 10.1 t -154.09 146.19 23.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.14 177.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 31.6 m -61.33 167.55 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.164 -175.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.929 HD23 ' HD3' ' A' ' 257' ' ' PRO . 3.1 mm? -64.65 144.88 98.8 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.546 0.689 . . . . 0.0 111.077 -163.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.11 -172.12 1.27 Allowed 'Trans proline' 0 N--CA 1.464 -0.213 0 C-N-CA 122.753 2.302 . . . . 0.0 112.487 -178.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 94.7 m -108.82 146.04 34.28 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.179 -173.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . 0.412 ' HB3' ' CD1' ' A' ' 129' ' ' TRP . 43.6 p90 -137.39 126.43 24.35 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.896 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.7 mmtt 54.05 35.06 21.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.908 174.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.97 6.97 84.48 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.702 -0.761 . . . . 0.0 112.48 173.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 85.7 mm-40 -133.66 131.34 21.19 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-O 121.634 0.73 . . . . 0.0 110.859 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -73.47 137.42 25.41 Favored 'Trans proline' 0 C--N 1.342 0.232 0 C-N-CA 122.674 2.249 . . . . 0.0 112.296 -175.765 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.76 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 82.3 p -87.04 -1.07 57.6 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.841 173.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -39.31 132.99 1.23 Allowed Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.567 0.699 . . . . 0.0 110.915 -179.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.929 ' HD3' HD23 ' A' ' 247' ' ' LEU . 58.8 Cg_endo -83.22 157.94 15.03 Favored 'Trans proline' 0 C--O 1.232 0.196 0 C-N-CA 122.607 2.205 . . . . 0.0 112.419 -169.037 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -75.77 167.24 22.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.865 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 45.5 t -111.24 136.37 47.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.203 -165.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . 0.414 ' HA2' ' CD2' ' A' ' 64' ' ' HIS . . . -114.41 131.98 10.19 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.38 172.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 83.7 t -125.08 115.38 43.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.774 0.321 . . . . 0.0 111.196 174.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -64.92 122.03 16.03 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.944 -177.749 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . . . . . . . . . 42.6 m -127.53 133.25 49.81 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.839 -170.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -127.35 140.3 52.28 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.081 -172.221 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . . . . . . . . . . . -133.41 170.77 22.17 Favored Glycine 0 N--CA 1.45 -0.427 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.479 -171.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 32.7 mm -112.36 128.22 69.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 120.745 0.307 . . . . 0.0 111.2 -172.134 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.2 t-20 -63.31 128.24 34.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.973 -177.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.483 ' HB2' ' C ' ' A' ' 76' ' ' LEU . . . -60.56 -28.65 68.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.121 -178.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -83.57 -6.74 59.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.104 -173.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.2 t -79.75 123.16 84.05 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.596 0.712 . . . . 0.0 110.903 -175.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -69.53 -7.16 20.26 Favored 'Trans proline' 0 N--CA 1.465 -0.203 0 C-N-CA 122.733 2.289 . . . . 0.0 112.396 169.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 95.9 m-20 -102.1 21.97 13.94 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.935 -167.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -50.12 -36.28 29.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.869 -173.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -66.3 -39.7 89.52 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.924 -179.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.406 ' HB3' HD23 ' A' ' 7' ' ' LEU . 33.9 mt -66.79 -56.87 8.52 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.866 173.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -69.91 -50.99 36.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.991 -167.583 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 57.5 tttm -61.21 -40.64 94.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.955 -178.291 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 88.9 tt0 -69.34 -47.75 63.46 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.944 -177.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 20.4 m-30 -66.53 -36.21 82.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.916 -178.243 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.491 ' HA ' HD22 ' A' ' 284' ' ' LEU . 5.4 tt -59.17 -52.39 65.91 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.961 -177.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . 0.4 ' HA ' HD21 ' A' ' 285' ' ' LEU . 24.4 pt-20 -78.66 -30.68 46.4 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.784 -174.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.476 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 63.7 m-80 -100.85 -13.96 18.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.849 -164.759 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.702 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 52.4 m-85 -126.7 -53.52 1.44 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.813 179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.517 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.3 OUTLIER -61.66 -35.43 77.92 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.963 -167.363 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 1.076 ' HB3' HG13 ' A' ' 108' ' ' ILE . 1.9 pp -124.43 38.23 4.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.947 -175.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.444 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 68.2 p -122.51 164.32 18.32 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.188 177.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.458 ' HA ' HD11 ' A' ' 290' ' ' LEU . 38.8 t70 -45.77 -38.0 6.59 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.804 -165.275 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -77.15 -42.57 37.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.954 -178.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.702 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -71.98 -51.54 14.27 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.474 -170.316 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.56 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -74.07 -20.49 60.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.67 0.271 . . . . 0.0 110.892 -178.349 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.544 ' N ' HD12 ' A' ' 290' ' ' LEU . 35.8 tt0 -70.27 -46.45 64.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.885 171.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -60.97 -43.99 97.98 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.011 -174.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.653 HG23 ' HA3' ' A' ' 19' ' ' GLY . 1.8 p -79.95 -30.55 13.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.236 -176.04 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -68.09 -28.97 67.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.777 170.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.9 tttt -63.03 -24.81 68.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.944 -179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -77.02 -43.24 35.36 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.882 177.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -162.87 135.79 4.33 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.545 0.688 . . . . 0.0 110.976 177.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_exo -45.43 114.66 0.76 Allowed 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.745 2.297 . . . . 0.0 112.42 177.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . . . . . . . . . 51.2 mt -89.98 -14.85 33.15 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.894 -175.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 114.92 -59.48 0.41 Allowed Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.488 176.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.687 ' HA ' HD13 ' A' ' 311' ' ' LEU . . . -173.72 170.15 4.06 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.867 0.365 . . . . 0.0 111.095 171.678 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.693 HG21 ' HB3' ' A' ' 307' ' ' TYR . 30.8 m -122.68 154.84 27.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.136 177.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -74.23 -10.49 59.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.023 171.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.56 ' CD2' HD21 ' A' ' 290' ' ' LEU . 40.1 tp -83.15 120.35 25.67 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.843 -177.107 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -56.16 -40.1 73.37 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.881 -174.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . . . . . . . . . 70.4 m -65.25 -50.14 66.94 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.882 -169.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.693 ' HB3' HG21 ' A' ' 302' ' ' VAL . 15.7 t80 -76.9 -29.13 55.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.973 -179.421 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.09 -40.1 96.67 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.88 178.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -62.53 -35.29 78.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.944 176.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 78.2 mm-40 -74.47 -40.25 61.99 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.895 175.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.687 HD13 ' HA ' ' A' ' 301' ' ' ALA . 77.8 mt -60.91 -32.25 71.73 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.886 175.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -60.93 -19.8 61.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.022 0.439 . . . . 0.0 111.202 -177.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -65.57 -20.62 66.4 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.977 174.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . . . . . . . . . 67.4 t0 -90.26 121.12 68.95 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.606 0.717 . . . . 0.0 110.88 166.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -47.81 -28.29 9.56 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.753 2.302 . . . . 0.0 112.355 179.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 75.2 mtt85 -60.24 -30.44 69.42 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 -174.029 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.495 HG12 ' HB3' ' A' ' 311' ' ' LEU . 1.2 mp -79.99 -29.99 12.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.074 -176.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -58.42 -41.71 85.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.047 -168.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -69.75 -47.64 62.27 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.067 176.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.563 HG23 ' HB3' ' A' ' 112' ' ' ALA . 26.9 m -61.09 -37.11 81.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.156 -174.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 66.6 ttp -65.22 -35.49 81.21 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.818 -179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 53.0 tp10 -64.64 -47.76 77.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.835 -170.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.783 HD21 ' HB1' ' A' ' 112' ' ' ALA . 9.6 p-10 -83.43 -26.23 30.55 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.852 -178.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -63.64 -49.74 72.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.192 -178.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -66.98 -29.86 69.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.868 -177.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -109.74 -9.23 14.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.915 -168.24 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.448 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -92.13 -148.87 23.34 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.67 -0.776 . . . . 0.0 112.458 -166.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . . . . . . . . . 89.2 tt0 -143.32 139.94 30.33 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.872 0.368 . . . . 0.0 110.824 -171.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . . . . . . . . . 40.6 mm -65.52 122.4 16.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.091 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . . . . . . . . . 59.0 ttm -64.57 137.27 97.08 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 121.575 0.702 . . . . 0.0 110.911 -179.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.423 ' HB2' ' HG3' ' A' ' 336' ' ' MET . 34.3 Cg_endo -67.38 128.52 18.46 Favored 'Trans proline' 0 C--N 1.341 0.153 0 C-N-CA 122.641 2.227 . . . . 0.0 112.3 -176.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.579 ' HB3' ' H ' ' A' ' 65' ' ' ASP . 63.8 t30 -135.91 24.28 3.33 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.884 179.177 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . . . . . . . . . 40.7 pt -78.67 157.0 77.52 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.627 0.727 . . . . 0.0 111.171 178.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_exo -55.18 -36.18 92.6 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 122.747 2.298 . . . . 0.0 112.309 -173.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . . . . . . . . . 99.6 mm-40 -71.31 -30.56 66.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.904 -176.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.423 ' HG3' ' HB2' ' A' ' 331' ' ' PRO . 74.1 mmm -79.9 -19.05 49.05 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.891 -171.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.9 m -61.84 -41.73 98.17 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.773 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -75.32 -35.14 61.27 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.112 176.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.544 ' O ' HG13 ' A' ' 343' ' ' VAL . 8.2 m-30 -66.41 -40.42 89.56 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 179.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.458 ' HA ' HG22 ' A' ' 343' ' ' VAL . 18.6 m0 -59.01 -35.87 73.99 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.978 174.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 20.4 m-30 -67.82 -41.88 82.35 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.974 177.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -66.95 -44.18 81.25 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.068 -0.514 . . . . 0.0 111.061 -179.649 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 339' ' ' PHE . 16.7 m -74.38 -30.87 26.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.131 -176.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.474 ' O ' HG22 ' A' ' 347' ' ' VAL . 4.9 tmt_? -65.0 -39.38 93.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 175.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 91.7 m -58.36 -35.74 72.41 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.161 173.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . . . . . . . . . . . -63.89 -43.62 95.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.189 -174.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.738 ' HA ' HD11 ' A' ' 192' ' ' LEU . 3.8 m -73.56 -33.7 39.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.237 -175.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . 0.434 HD12 HG23 ' A' ' 347' ' ' VAL . 1.5 mp -63.8 -46.51 94.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.151 173.018 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 79.5 m-20 -65.05 -39.85 93.92 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.82 -178.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.56 -45.53 62.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.079 -179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -68.61 -40.19 80.51 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.033 -175.627 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 97.8 p -75.43 -10.71 59.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.913 -178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 81.11 16.93 73.28 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.54 179.553 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.95 -32.82 45.59 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.776 0.322 . . . . 0.0 110.854 -179.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 94.5 mt-30 -139.59 154.87 47.69 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.882 177.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.0 p -77.63 168.91 19.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.096 169.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.471 HG21 ' OG1' ' A' ' 193' ' ' THR . 53.7 t -56.04 -42.09 70.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.205 172.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 94.0 m-20 -61.29 -46.53 89.93 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.857 177.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -69.71 -53.23 19.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.856 -179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -70.75 -48.3 55.14 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.06 -173.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.618 HD11 ' HB3' ' A' ' 188' ' ' ALA . 1.3 tm? -66.02 -45.63 80.81 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.948 -173.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -63.67 -53.07 57.14 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.972 -177.359 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 99.0 m-20 -67.23 -47.11 71.77 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.855 -174.051 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -65.1 -41.54 94.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.119 -174.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 361' ' ' LEU . 72.5 mm-40 -78.17 -26.79 47.81 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.014 -176.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 52.2 m -64.48 -36.03 82.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.161 171.167 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -59.01 -30.41 67.98 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.891 178.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.464 HD12 HG21 ' A' ' 183' ' ' VAL . 67.7 mt -60.4 -38.11 76.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.165 174.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 59.8 p -93.83 -14.85 25.68 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.129 -178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 88.7 tttt . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.905 178.728 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.5 tttt . . . . . 0 C--O 1.233 0.185 0 CA-C-O 120.73 0.3 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 97.7 mt -82.55 134.61 26.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.099 175.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -135.83 142.21 44.79 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.006 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -56.56 135.96 54.5 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.938 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.554 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 98.94 -0.17 57.54 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.518 -174.518 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -162.59 150.87 14.33 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.877 0.37 . . . . 0.0 110.831 172.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.691 ' H ' HD23 ' A' ' 7' ' ' LEU . 0.6 OUTLIER -147.23 156.72 43.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.927 -176.559 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.42 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 91.2 t -113.92 131.12 66.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.095 -179.47 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.901 ' HB ' HD21 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -119.97 126.82 75.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.12 -177.694 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.548 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 47.5 m0 -107.72 131.46 54.4 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.959 178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.47 ' HA ' ' HB2' ' A' ' 61' ' ' PHE . 65.9 mt -117.75 142.41 32.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.078 173.053 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.403 ' O ' HG22 ' A' ' 11' ' ' ILE . 33.2 t30 -47.68 141.08 5.67 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.865 172.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -58.16 -13.03 13.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.598 -0.81 . . . . 0.0 112.569 -172.385 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 94.7 m-20 -78.49 -15.22 58.85 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.848 0.356 . . . . 0.0 110.844 -173.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.3 mptt -130.99 112.07 12.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.911 167.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.75 -96.58 0.84 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.548 -153.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 84.5 t80 -102.97 -43.3 5.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.886 0.374 . . . . 0.0 110.931 -167.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.752 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 95.7 m-20 -62.49 -50.36 71.73 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.849 -157.144 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.7 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -57.8 -47.71 86.88 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.566 -175.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.901 HD21 ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -57.09 -61.02 2.75 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.76 0.314 . . . . 0.0 110.997 175.682 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -49.39 -40.94 37.92 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.14 -175.795 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 51.6 tp10 -65.03 -53.53 44.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.924 -177.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 18.1 m -75.55 -36.06 33.68 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.179 -175.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.747 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -65.08 -47.22 84.16 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.485 178.588 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -55.98 -39.57 72.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.813 0.34 . . . . 0.0 110.861 -176.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 64.2 tttm -60.67 -36.9 79.87 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.86 178.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -64.68 -41.56 95.98 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.934 -177.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.9 tt0 -63.57 -39.39 94.27 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.888 176.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -67.33 -33.84 76.1 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.879 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -89.32 -44.1 10.46 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.845 -170.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.559 ' OG1' HG13 ' A' ' 33' ' ' ILE . 66.6 p -110.73 -12.69 14.28 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.195 -171.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 82.53 7.23 87.78 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.589 178.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.849 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.4 pp -99.01 133.51 41.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.887 0.375 . . . . 0.0 111.078 -177.27 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -82.62 140.28 33.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.96 -173.027 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.747 HG21 ' HA3' ' A' ' 24' ' ' GLY . 1.0 OUTLIER -118.09 134.61 61.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.14 -177.411 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 98.2 m -102.52 127.15 49.7 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.162 179.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.521 HG22 ' HG ' ' A' ' 20' ' ' LEU . 61.9 t -95.24 120.98 45.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.159 177.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.548 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 66.4 mm-40 -129.98 133.77 47.0 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.816 170.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 50.2 p-80 -142.19 57.43 6.57 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.622 0.725 . . . . 0.0 110.873 174.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -79.01 -23.59 7.67 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.74 2.294 . . . . 0.0 112.369 -177.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 7.0 t0 62.63 20.77 12.26 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.897 -170.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.441 ' O ' ' N ' ' A' ' 45' ' ' GLU . 98.9 mttt -85.22 2.85 42.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.958 169.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 11.3 mt -43.45 -47.86 7.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.902 -171.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.86 -36.87 77.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.939 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.441 ' N ' ' O ' ' A' ' 42' ' ' LYS . 89.0 tt0 -74.54 -36.38 63.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.919 -179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -78.95 -29.98 44.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.92 -175.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.506 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 9.8 m-30 -45.16 -55.58 11.06 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.664 0.745 . . . . 0.0 110.851 -175.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 57.4 Cg_endo -68.68 -27.2 32.33 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.795 2.33 . . . . 0.0 112.317 179.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 99.2 mm-40 -79.4 -44.02 22.25 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.881 -173.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 30.8 m -68.02 -30.52 48.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.154 -178.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.01 -35.37 79.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.103 172.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.42 -30.92 67.91 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.062 179.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.5 p -92.66 -12.33 31.84 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.169 177.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.45 15.27 81.31 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.462 175.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -161.08 154.21 21.35 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.862 0.363 . . . . 0.0 110.877 175.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.436 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . -162.76 -138.14 2.34 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.409 -178.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.518 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 72.6 Cg_endo -68.62 155.88 67.4 Favored 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.621 2.214 . . . . 0.0 112.395 169.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -81.48 -38.03 26.99 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.907 172.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.729 ' HB ' HG23 ' A' ' 9' ' ' ILE . 4.1 mp -128.4 138.01 55.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.079 176.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.5 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 1.9 tp -130.36 129.06 64.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.169 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.567 ' CE2' HG13 ' A' ' 108' ' ' ILE . 2.5 m-85 -98.62 141.25 31.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.819 176.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.5 ' CZ2' HG23 ' A' ' 60' ' ' ILE . 8.6 m-90 -118.12 139.96 50.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.855 178.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.54 -83.14 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.198 -176.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.414 ' HB3' ' SD ' ' A' ' 330' ' ' MET . 98.2 m-70 -128.0 -57.22 1.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.835 170.088 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.5 m-20 -85.36 -26.61 26.39 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.778 -170.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.492 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 98.7 mtt180 -59.94 -29.97 68.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.938 -158.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 16.4 p90 -67.99 -28.31 67.31 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.92 -169.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.12 -51.48 52.65 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.433 -172.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -60.85 -36.99 92.95 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.482 176.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.536 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 17.4 t80 -66.53 -37.74 85.68 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.889 0.376 . . . . 0.0 110.879 -178.117 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.54 -44.43 62.15 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.15 177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.6 mt-30 -62.66 -33.31 74.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.881 -177.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 97.5 p -80.33 -10.76 59.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.932 176.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 70.22 32.44 68.85 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.789 -0.72 . . . . 0.0 112.454 174.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 1.7 mp -86.34 1.24 51.82 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.872 0.368 . . . . 0.0 110.905 -172.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.536 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.7 OUTLIER -131.93 159.86 37.45 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.949 -179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.692 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -68.36 130.63 43.46 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.034 174.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 20.5 tt0 -69.99 123.35 21.33 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.937 174.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 43.6 pt -108.78 159.97 7.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.053 -172.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.1 p -103.49 146.64 32.86 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.604 0.716 . . . . 0.0 111.169 -171.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -75.73 146.87 30.61 Favored 'Trans proline' 0 C--N 1.341 0.179 0 C-N-CA 122.747 2.298 . . . . 0.0 112.354 -177.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.0 t0 -108.08 116.09 31.33 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.835 169.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.55 -35.86 61.22 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.886 -179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.11 -41.18 95.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.147 179.454 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.5 m-30 -70.03 -38.23 75.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.855 -178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -54.92 -48.03 73.63 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.933 176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -64.02 -36.39 83.85 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.884 175.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -75.85 -20.09 58.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.842 -176.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.439 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -104.02 -103.36 0.3 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -173.137 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 46.2 t80 -166.82 134.56 2.1 Favored Pre-proline 0 C--N 1.327 -0.375 0 CA-C-O 121.649 0.738 . . . . 0.0 110.883 -172.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 68.0 Cg_exo -52.29 -39.71 71.79 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.738 2.292 . . . . 0.0 112.393 -170.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -77.76 -30.62 51.56 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.96 -177.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 64.3 m -69.63 -48.94 58.25 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.14 -165.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.46 ' HA ' HG22 ' A' ' 97' ' ' VAL . 53.8 p-90 -66.23 -28.74 68.97 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.888 178.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -71.33 -37.48 71.73 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.813 175.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.86 -25.1 64.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.119 -179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.523 HG23 HD22 ' A' ' 103' ' ' LEU . 21.5 m -101.16 16.36 4.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.135 179.596 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.45 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 67.9 ttt180 -101.52 132.58 47.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.889 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.6 t80 -148.15 130.56 15.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.869 177.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.1 t30 68.61 36.43 2.83 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.87 177.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.16 -4.6 66.25 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.464 174.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -140.04 164.34 30.28 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.853 0.359 . . . . 0.0 110.885 177.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.523 HD22 HG23 ' A' ' 97' ' ' VAL . 12.9 mt -73.83 146.49 44.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.918 -175.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.424 ' C ' HD12 ' A' ' 104' ' ' ILE . 2.0 pp -122.48 8.41 5.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.138 174.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.753 ' HB1' ' HB3' ' A' ' 263' ' ' SER . . . -168.45 158.54 9.72 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.02 -178.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -125.15 151.24 69.02 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.722 0.773 . . . . 0.0 110.96 164.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.408 ' HB3' HG11 ' A' ' 261' ' ' VAL . 59.3 Cg_endo -72.39 121.1 7.18 Favored 'Trans proline' 0 C--N 1.341 0.171 0 C-N-CA 122.648 2.232 . . . . 0.0 112.384 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.567 HG13 ' CE2' ' A' ' 61' ' ' PHE . 24.6 mm -98.1 -32.84 4.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.089 176.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -157.02 153.35 27.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.139 -177.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 73.1 t -117.51 133.76 63.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.14 178.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -119.5 129.24 54.62 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.934 175.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -149.84 158.82 44.54 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.133 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.732 HD23 ' HA3' ' A' ' 228' ' ' GLY . 59.3 mt -99.61 158.37 15.8 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.235 -0.438 . . . . 0.0 111.042 -173.227 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 90.0 p -153.53 160.01 42.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.87 177.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.865 HD13 ' O ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.8 124.16 44.79 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.955 175.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.614 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.3 mp -106.28 133.71 49.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.163 -175.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -133.15 147.77 52.08 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.957 -176.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 -97.6 115.6 28.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.889 174.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -65.63 -16.37 63.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 173.229 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.508 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 21.5 t70 -80.16 -33.78 38.13 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.912 -178.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.6 mp -88.67 -45.34 9.91 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.942 -177.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.529 HD22 ' HB1' ' A' ' 223' ' ' ALA . 3.0 mp -108.47 130.88 22.2 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.537 0.684 . . . . 0.0 110.894 178.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -71.44 -30.5 15.2 Favored 'Trans proline' 0 N--CA 1.465 -0.2 0 C-N-CA 122.677 2.251 . . . . 0.0 112.345 176.37 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.0 t-20 -153.87 89.93 3.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.56 0.695 . . . . 0.0 110.973 174.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.479 ' HA ' ' HD3' ' A' ' 126' ' ' PRO . 51.1 Cg_exo -58.21 139.56 90.95 Favored 'Trans proline' 0 N--CA 1.465 -0.198 0 C-N-CA 122.678 2.252 . . . . 0.0 112.383 -178.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 125' ' ' PRO . 62.6 Cg_exo -54.98 146.53 57.24 Favored 'Trans proline' 0 C--N 1.342 0.194 0 C-N-CA 122.667 2.245 . . . . 0.0 112.327 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -100.65 -0.82 36.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.861 176.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 57.9 p -132.95 157.06 46.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.04 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 83.0 m95 -71.36 -25.32 62.34 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.967 178.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -66.36 -35.54 80.61 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.91 -172.218 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 73.8 mm-40 -83.42 -9.98 58.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.871 -174.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.612 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 47.0 mm -58.99 -52.64 73.42 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.628 0.728 . . . . 0.0 111.219 -172.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.612 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 28.6 Cg_endo -61.03 -38.85 64.98 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 122.737 2.291 . . . . 0.0 112.31 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -63.88 -60.51 3.18 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.061 -178.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.177 HD22 ' O ' ' A' ' 135' ' ' LEU . 0.0 OUTLIER -68.53 -17.03 64.07 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.885 -175.364 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.626 ' HA ' HD22 ' A' ' 139' ' ' LEU . 38.7 t70 -60.9 -38.47 85.81 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 168.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -65.81 -37.18 85.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.945 178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -73.91 -49.72 23.48 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.852 -174.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.667 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -75.14 -16.98 60.5 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.893 -176.592 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.667 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.6 tttt -57.46 -34.97 69.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.961 171.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.0 -24.53 67.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.121 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -94.8 7.89 44.41 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.87 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.01 28.62 62.11 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.509 176.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.427 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 46.9 mtmt -117.79 168.61 10.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.922 0.391 . . . . 0.0 110.821 174.301 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 44.9 t -129.46 137.38 50.82 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.82 176.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.441 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -70.06 -57.67 4.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.087 -165.181 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -137.53 126.82 24.71 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.954 -167.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 92.7 mmm -103.25 126.16 50.27 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.809 177.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -155.65 165.04 37.74 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.838 -177.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 31.8 t-20 -126.22 144.21 50.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.905 171.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.473 ' HG ' ' O ' ' A' ' 151' ' ' LEU . 48.3 tp -113.44 -2.59 13.89 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.875 -175.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -69.39 -10.06 56.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.88 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -119.26 151.74 51.45 Favored Pre-proline 0 C--N 1.331 -0.207 0 CA-C-O 121.704 0.764 . . . . 0.0 110.811 -175.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.526 ' HD3' ' HD2' ' A' ' 344' ' ' ARG . 30.4 Cg_endo -66.05 -18.5 56.86 Favored 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.634 2.223 . . . . 0.0 112.389 -178.475 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.3 m-85 -59.63 -39.49 84.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.957 -175.417 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -83.76 -38.38 21.41 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.864 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 29.4 p -64.19 -38.89 92.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.121 -173.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.561 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 11.0 t-105 -63.6 -54.23 44.65 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-O 121.556 0.694 . . . . 0.0 110.943 -170.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 33.3 Cg_endo -68.48 -32.07 25.98 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.729 2.286 . . . . 0.0 112.385 -172.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.633 HD23 ' C ' ' A' ' 160' ' ' LEU . 7.1 tt -74.51 -40.78 61.56 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.883 179.511 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.619 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 75.9 mt -68.28 -40.16 82.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.141 176.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.54 -27.09 63.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.069 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -59.35 -33.02 70.65 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.024 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . 0.518 ' HA ' ' HD3' ' A' ' 251' ' ' LYS . 66.0 m-20 -91.3 -9.0 46.63 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.837 -178.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 122.52 3.37 9.42 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.511 179.409 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.63 66.53 3.51 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.406 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -90.0 151.26 21.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.919 0.39 . . . . 0.0 110.968 -174.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . 0.485 ' HB3' ' SD ' ' A' ' 336' ' ' MET . . . -76.42 -6.89 53.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.003 -176.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 52.2 p90 -155.0 155.04 33.47 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.974 0.416 . . . . 0.0 110.873 -173.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -98.91 129.3 45.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.856 156.536 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 61.7 t80 -95.69 124.06 39.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -149.97 129.81 13.33 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.889 178.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.3 t30 57.1 44.98 21.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.908 171.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.41 7.82 73.97 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.655 -0.783 . . . . 0.0 112.408 172.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -132.91 140.92 48.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.789 0.328 . . . . 0.0 110.831 -176.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.415 ' N ' ' HD1' ' A' ' 176' ' ' TYR . 3.4 m-30 -79.29 132.94 36.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.991 166.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -94.12 105.01 17.01 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.852 -178.386 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.6 tp -67.0 -19.23 25.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.112 -178.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -95.13 -7.35 39.58 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.937 -177.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -135.15 96.01 3.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.805 175.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.468 HG23 HG22 ' A' ' 183' ' ' VAL . 32.6 m -116.91 172.38 4.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.151 -177.601 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -102.52 14.69 56.45 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.516 -169.799 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.542 HG21 ' CD1' ' A' ' 368' ' ' ILE . 17.6 m -100.1 -17.05 6.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.83 0.347 . . . . 0.0 111.126 -175.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.487 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 57.9 p-10 -96.62 19.74 11.87 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.015 175.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 94.0 m-20 -116.04 173.68 6.44 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.898 -174.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -63.39 -27.6 69.41 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.102 -177.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.67 -40.27 90.31 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.551 -170.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.587 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.46 -41.19 93.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.79 0.329 . . . . 0.0 111.041 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.496 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 91.9 mttt -60.8 -36.4 78.91 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.889 173.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.3 -37.05 86.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.01 177.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.619 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.51 -47.18 86.75 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.42 177.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.592 HD11 ' HA ' ' A' ' 347' ' ' VAL . 15.9 tp -68.19 -31.24 70.63 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.913 0.387 . . . . 0.0 110.99 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.426 ' O ' HG12 ' A' ' 196' ' ' VAL . 84.8 m -64.53 -42.87 95.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.233 -0.439 . . . . 0.0 111.04 176.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 42.7 t80 -67.05 -57.52 6.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.876 -179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.61 HD12 ' C ' ' A' ' 195' ' ' LEU . 3.6 pp -63.19 -27.8 69.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.926 -167.523 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.568 ' N ' HD12 ' A' ' 195' ' ' LEU . 1.3 p -74.27 -22.21 17.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.135 178.766 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 55.0 t0 -65.57 -58.34 6.01 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.816 -174.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 1.034 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.66 -22.37 56.81 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.978 -167.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.798 ' N ' HD22 ' A' ' 198' ' ' LEU . 2.2 pp -80.92 -33.53 13.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.101 172.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -67.38 -33.02 74.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.957 169.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 95.0 m-20 -84.48 4.81 30.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.862 179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.6 mttt 66.4 39.98 3.77 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 85.6 m-70 -82.3 -11.17 58.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 172.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.489 ' CG ' HG22 ' A' ' 199' ' ' ILE . 5.1 ppp? -140.14 153.18 46.6 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.864 175.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -97.05 157.5 15.88 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.896 -177.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.21 -24.28 67.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.147 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -94.85 -1.81 52.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.1 m -64.02 131.7 48.39 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.204 -177.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -149.25 174.22 12.63 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -177.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -79.76 -31.43 40.94 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.833 -175.732 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 94.8 p -71.72 -39.46 70.11 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.871 -173.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 36.6 pt -66.37 -22.28 29.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.135 179.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -63.65 -30.01 71.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.069 -177.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.4 tt0 -57.46 -44.02 84.46 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.847 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.02 -36.36 84.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.106 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.95 -36.44 81.44 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.097 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 15.6 m-85 -64.09 -42.42 96.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.893 177.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -64.89 -33.79 76.86 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.912 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -89.18 -22.31 22.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.905 -177.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.42 29.92 23.36 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.65 -0.786 . . . . 0.0 112.508 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -91.19 -30.12 16.85 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.903 0.383 . . . . 0.0 110.945 -171.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 52.8 m -110.08 125.35 52.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.093 -170.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.529 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -71.16 -48.97 48.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.149 179.039 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.417 ' HA ' ' O ' ' A' ' 116' ' ' ILE . 68.5 mtm -133.55 146.65 51.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.854 -172.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.406 HG22 ' N ' ' A' ' 226' ' ' ILE . 80.7 m -145.01 152.37 40.03 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.126 -178.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . 0.406 ' N ' HG22 ' A' ' 225' ' ' THR . 40.6 mm -111.52 120.33 61.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.111 -179.222 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 23.4 p30 -161.87 170.52 19.31 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.798 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.732 ' HA3' HD23 ' A' ' 113' ' ' LEU . . . -130.26 -107.54 1.22 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.488 176.555 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -68.51 -16.48 42.96 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 122.728 2.285 . . . . 0.0 112.288 178.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 99.7 m95 -66.94 -30.03 70.06 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.879 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 54.02 49.59 18.56 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.113 176.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 64.0 m95 -66.1 -27.75 68.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.836 175.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 75.8 m -65.08 142.8 58.27 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.897 -175.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -100.0 -175.27 2.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.939 174.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.2 mt 59.96 74.93 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.163 -178.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 97.2 m-20 -54.72 -46.85 74.28 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.882 -171.628 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 52.8 p -85.59 175.82 8.56 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.154 -174.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 96.3 p -75.66 -6.09 48.75 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.88 178.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -59.68 167.6 2.01 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.888 177.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.517 ' O ' HG12 ' A' ' 240' ' ' VAL . 12.6 t 55.0 38.63 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 -173.906 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.508 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 70.1 m-20 45.03 69.8 0.4 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.948 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 32.8 t80 -127.57 132.68 49.81 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.927 -175.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.37 157.86 23.74 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.474 178.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.429 HG23 HG13 ' A' ' 116' ' ' ILE . 2.5 p -143.15 140.01 26.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.959 0.409 . . . . 0.0 111.067 178.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.3 t -153.93 150.11 27.99 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.12 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.544 HG11 ' HB2' ' A' ' 323' ' ' ASN . 31.3 m -61.92 168.87 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.05 -178.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.617 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.9 mm? -61.15 145.4 89.91 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.742 0.782 . . . . 0.0 110.837 -160.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -73.37 -177.01 2.75 Favored 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.76 2.306 . . . . 0.0 112.392 -179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 63.6 p -109.14 160.05 16.39 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.03 -175.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 64.7 t80 -145.26 128.24 16.49 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.865 174.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . 0.67 ' HG2' ' O ' ' A' ' 251' ' ' LYS . 81.0 tttt 55.49 36.04 26.33 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.92 -177.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 85.06 8.36 82.25 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.536 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -134.68 139.37 32.23 Favored Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.58 0.705 . . . . 0.0 110.98 -179.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.6 142.61 29.43 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.693 2.262 . . . . 0.0 112.343 -175.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.617 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 89.5 p -83.51 -5.02 59.04 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.845 169.502 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 93.5 mttt -41.95 125.69 2.6 Favored Pre-proline 0 C--N 1.327 -0.39 0 CA-C-O 121.522 0.677 . . . . 0.0 111.025 -178.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.673 ' HG3' ' HB2' ' A' ' 113' ' ' LEU . 84.4 Cg_endo -86.94 164.91 8.78 Favored 'Trans proline' 0 C--N 1.342 0.228 0 C-N-CA 122.704 2.269 . . . . 0.0 112.319 -174.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -75.01 170.03 16.82 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.848 175.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.412 HG21 ' HA ' ' A' ' 324' ' ' ALA . 99.0 t -103.87 134.98 43.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.106 -170.072 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -107.54 140.69 15.47 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.536 177.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.408 HG11 ' HB3' ' A' ' 107' ' ' PRO . 90.4 t -126.64 126.94 69.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.868 0.366 . . . . 0.0 111.133 -176.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.424 HD23 ' N ' ' A' ' 263' ' ' SER . 2.0 tt -70.07 130.6 42.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.923 166.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.753 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 67.7 m -119.04 149.21 42.04 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.811 -175.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -133.81 139.62 46.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.087 175.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.485 ' HA3' ' HH2' ' A' ' 62' ' ' TRP . . . -142.31 171.52 24.61 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.508 -175.737 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 30.8 mm -113.33 130.39 67.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.791 0.329 . . . . 0.0 111.089 -171.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 60.4 t-20 -69.29 132.63 46.75 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.951 -174.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.692 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -65.61 -24.99 67.19 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.048 -176.24 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.73 -11.96 58.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.124 -171.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 28.7 t -70.45 120.04 76.14 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.67 0.748 . . . . 0.0 110.929 -176.127 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -74.72 -15.72 21.34 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.721 2.28 . . . . 0.0 112.305 176.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 49.8 p-10 -114.74 30.93 7.0 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.842 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.6 pttp -61.67 -24.36 66.69 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.891 -168.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -64.07 -40.55 96.5 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.798 -169.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 2.6 pp -78.81 -32.17 46.19 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.929 177.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.48 ' HB1' HD11 ' A' ' 59' ' ' ILE . . . -65.13 -45.9 83.15 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.018 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 50.4 pttt -69.53 -33.3 72.6 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.919 179.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -61.88 -50.06 73.73 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.93 -172.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.482 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 1.9 p90 -68.64 -33.59 74.28 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.888 -176.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.421 HD23 ' C ' ' A' ' 280' ' ' LEU . 8.4 tt -62.66 -47.62 82.88 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.901 179.385 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -72.4 -39.52 67.9 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.877 179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -99.93 -12.73 19.55 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.884 -161.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.509 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 69.5 t80 -123.73 -51.33 1.82 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.864 -179.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 2.1 mp -67.3 -46.01 74.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.849 -177.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -82.34 48.75 1.32 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.917 169.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.439 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 80.5 m -146.47 145.27 30.14 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.194 176.233 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.435 ' HA ' HD11 ' A' ' 290' ' ' LEU . 49.5 t0 -42.57 -35.03 0.97 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.842 -175.788 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 99.0 mt-10 -74.69 -43.64 54.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.847 -174.221 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -72.97 -52.04 9.63 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.453 -171.015 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.685 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.7 OUTLIER -72.05 -22.54 61.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.805 0.336 . . . . 0.0 110.943 -177.869 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.512 ' N ' HD12 ' A' ' 290' ' ' LEU . 86.5 tt0 -67.13 -41.37 86.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.837 169.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -64.37 -36.59 84.65 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.069 179.662 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.7 HG13 ' HA3' ' A' ' 19' ' ' GLY . 46.4 t -75.66 -45.54 38.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.073 -178.403 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 40.7 t30 -65.31 -35.09 79.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.875 -178.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -66.98 -32.15 73.19 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.937 -173.424 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.752 ' HB3' ' HB3' ' A' ' 18' ' ' ASN . 63.8 m-20 -99.77 -35.19 9.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.893 -174.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.435 ' O ' HD13 ' A' ' 299' ' ' LEU . 46.9 tptt -129.11 124.45 22.3 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.563 0.697 . . . . 0.0 110.947 170.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_exo -52.3 108.02 0.22 Allowed 'Trans proline' 0 C--O 1.232 0.218 0 C-N-CA 122.743 2.295 . . . . 0.0 112.281 -177.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.435 HD13 ' O ' ' A' ' 297' ' ' LYS . 2.2 mp -92.26 -28.67 16.84 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.919 175.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.1 -55.9 1.81 Allowed Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.683 -0.77 . . . . 0.0 112.466 -179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . . . . . . . . . . . -174.27 168.53 3.97 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.875 0.369 . . . . 0.0 111.094 -177.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.586 ' CG2' ' HB3' ' A' ' 307' ' ' TYR . 32.2 m -135.0 161.84 39.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.126 178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -75.44 -10.19 59.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.027 177.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.685 ' CD2' HD21 ' A' ' 290' ' ' LEU . 61.2 tp -79.75 129.43 34.47 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.866 -174.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -42.99 -31.93 0.58 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.899 -176.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.443 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 70.6 m -47.83 -38.77 16.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.846 175.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.586 ' HB3' ' CG2' ' A' ' 302' ' ' VAL . 0.1 OUTLIER -58.99 -45.62 90.19 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.918 173.303 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.48 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 88.1 tt0 -56.96 -37.71 71.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.855 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -79.91 -64.1 1.26 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.833 -177.196 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -85.01 -58.89 2.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.879 -171.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.435 ' HB2' ' HA ' ' A' ' 307' ' ' TYR . 56.0 mt -62.66 -32.62 73.71 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.877 -168.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -65.1 -12.78 54.6 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.057 -178.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -63.95 -18.31 64.13 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.838 178.516 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.498 ' HB3' HD12 ' A' ' 317' ' ' ILE . 58.2 t0 -78.88 121.23 83.18 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.616 0.722 . . . . 0.0 110.819 167.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_exo -45.85 -36.4 15.19 Favored 'Trans proline' 0 C--N 1.341 0.167 0 C-N-CA 122.647 2.231 . . . . 0.0 112.327 -179.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 94.7 mtm-85 -73.12 -36.5 66.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.85 -175.444 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.498 HD12 ' HB3' ' A' ' 314' ' ' ASP . 74.3 mt -77.07 -29.98 17.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.12 177.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -63.71 -38.41 91.0 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.085 -179.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.98 -48.56 73.57 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.076 175.373 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 68.9 p -67.58 -26.55 66.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.082 -178.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 63.8 ttp -58.31 -37.28 74.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.866 173.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.5 tt0 -67.36 -45.07 77.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.806 179.236 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.544 ' HB2' HG11 ' A' ' 246' ' ' VAL . 29.8 t30 -63.49 -36.53 84.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.891 176.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.412 ' HA ' HG21 ' A' ' 259' ' ' VAL . . . -65.03 -47.56 76.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.032 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 89.1 mt-30 -71.48 -34.17 69.93 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.898 -178.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -96.7 -3.7 42.13 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.938 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -106.17 -162.25 22.74 Favored Glycine 0 C--N 1.33 0.233 0 C-N-CA 120.636 -0.792 . . . . 0.0 112.465 -174.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.67 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 94.9 mt-10 -143.64 139.93 29.85 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.838 0.351 . . . . 0.0 110.779 -171.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.587 ' O ' ' C ' ' A' ' 330' ' ' MET . 41.2 mm -81.32 112.78 19.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.101 -0.5 . . . . 0.0 111.148 -172.287 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.587 ' C ' ' O ' ' A' ' 329' ' ' ILE . 71.6 mtm 23.89 56.68 0.31 Allowed Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.583 0.706 . . . . 0.0 110.823 174.369 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.67 ' HG3' ' HB3' ' A' ' 328' ' ' GLU . 42.8 Cg_endo -96.59 -7.3 1.15 Allowed 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.658 2.239 . . . . 0.0 112.339 -169.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.602 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 90.2 m-20 -95.0 2.05 55.27 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.941 -155.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.631 HG22 ' H ' ' A' ' 335' ' ' GLN . 45.7 mm 87.56 133.23 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.62 0.724 . . . . 0.0 111.128 173.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -63.07 -22.48 73.4 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.686 2.257 . . . . 0.0 112.396 -176.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.631 ' H ' HG22 ' A' ' 333' ' ' ILE . 99.2 mm-40 -60.65 -17.72 49.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.915 177.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.485 ' SD ' ' HB3' ' A' ' 168' ' ' ALA . 37.6 mmt -62.2 -26.04 68.13 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.802 -174.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 75.5 m -57.92 -36.86 73.07 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.814 179.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -70.59 -36.68 73.69 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.078 178.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.542 ' O ' HG13 ' A' ' 343' ' ' VAL . 45.5 m-85 -65.25 -44.23 88.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.814 174.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 44.5 m0 -64.96 -39.25 93.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.925 -176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 94.1 t80 -67.6 -47.39 69.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.947 178.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.72 -42.42 97.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.13 -178.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.542 HG13 ' O ' ' A' ' 339' ' ' PHE . 7.7 m -80.98 -23.08 10.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.152 -179.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.526 ' HD2' ' HD3' ' A' ' 154' ' ' PRO . 57.6 ttt180 -57.41 -56.56 20.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.939 172.7 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 81.5 p -60.68 -25.69 66.56 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.066 -179.111 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.511 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -60.08 -41.13 91.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.134 -178.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.592 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.5 m -73.11 -32.95 40.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.061 -176.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.05 -45.24 97.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.093 173.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -64.35 -36.17 83.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.851 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.61 -46.15 60.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.113 178.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.82 -40.38 88.02 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.142 -175.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 92.8 p -74.98 -10.79 59.82 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.904 -176.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.4 15.02 81.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.549 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.85 -31.79 45.79 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.71 0.29 . . . . 0.0 110.761 -178.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.2 mm-40 -138.25 154.78 49.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.895 178.888 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.7 p -79.73 167.53 20.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.184 169.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.421 ' HA ' HD23 ' A' ' 192' ' ' LEU . 55.6 t -54.98 -42.04 61.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.119 173.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -59.11 -46.43 88.33 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.89 177.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 75.4 mm-40 -71.7 -53.22 14.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.81 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -67.99 -43.75 78.19 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -171.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -67.54 -40.71 84.99 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.938 -178.58 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.82 -39.69 93.99 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.895 173.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -62.2 -38.9 90.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.865 178.398 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.511 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -63.44 -42.24 98.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 173.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.487 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 23.3 tm0? -64.47 -36.83 85.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.052 0.453 . . . . 0.0 110.885 177.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.405 ' O ' ' N ' ' A' ' 370' ' ' LYS . 93.2 m -67.01 -40.44 87.31 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.149 177.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 79.0 mtt-85 -67.51 -35.02 78.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.847 178.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.542 ' CD1' HG21 ' A' ' 183' ' ' VAL . 62.2 mt -63.38 -40.13 87.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.079 0.466 . . . . 0.0 111.229 176.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 81.8 p -93.81 -10.92 32.48 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.174 -178.281 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.405 ' N ' ' O ' ' A' ' 366' ' ' THR . 99.6 mttt . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.907 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 C--O 1.233 0.19 0 CA-C-O 120.791 0.329 . . . . 0.0 110.899 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.9 mt -85.9 132.19 32.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.972 176.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -135.4 143.97 46.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.934 -178.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -55.67 134.13 51.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.857 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.431 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 94.94 2.01 62.87 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.519 -176.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.406 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 87.5 tttt -164.97 138.2 4.69 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.947 0.403 . . . . 0.0 110.851 174.308 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.55 ' H ' HD23 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -146.68 157.4 43.69 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.823 -173.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 86.6 t -114.5 133.47 60.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.17 -177.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.825 HD13 HD11 ' A' ' 20' ' ' LEU . 1.3 mp -119.28 125.81 74.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.129 -179.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.596 ' CE3' ' HG3' ' A' ' 57' ' ' PRO . 45.1 m0 -106.02 128.97 54.2 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.85 178.202 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.417 HG22 ' O ' ' A' ' 12' ' ' ASN . 68.0 mt -122.1 141.45 42.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.168 172.223 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.417 ' O ' HG22 ' A' ' 11' ' ' ILE . 65.0 t30 -49.19 141.77 7.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.914 172.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.51 ' HA3' ' OD2' ' A' ' 41' ' ' ASP . . . -57.72 -11.14 7.32 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.504 -172.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -71.93 -17.07 62.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.854 0.359 . . . . 0.0 110.868 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.9 mtmm -129.92 111.2 12.32 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.943 161.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -84.98 -90.47 0.83 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.504 -159.472 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 79.2 t80 -101.71 -41.65 6.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.82 0.343 . . . . 0.0 110.833 -172.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.78 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 85.2 m-20 -63.56 -53.58 49.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.804 -156.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.717 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -59.86 -48.07 87.86 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.696 -0.764 . . . . 0.0 112.503 -175.326 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.825 HD11 HD13 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -55.35 -60.97 2.66 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.828 0.347 . . . . 0.0 110.914 175.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.21 -41.37 60.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.097 -176.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.2 tp10 -65.17 -54.24 32.64 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.9 -175.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.3 m -74.65 -35.7 38.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.129 -176.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.429 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -65.04 -41.88 96.98 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.484 176.458 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.2 tttt -58.01 -41.26 82.72 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 0.0 110.892 179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 75.0 mmtt -64.39 -39.62 94.21 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.828 175.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 1.2 t80 -63.26 -45.81 89.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.953 178.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.0 tt0 -68.44 -38.97 81.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.806 -177.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 88.4 tttt -67.38 -37.05 82.55 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.896 -178.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 94.8 m-20 -82.1 -39.27 23.6 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.938 -169.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.539 ' OG1' HG13 ' A' ' 33' ' ' ILE . 71.2 p -109.94 -11.17 14.69 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.178 -174.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 78.44 14.04 82.59 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.462 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.127 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.0 pp -104.82 125.09 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.926 0.393 . . . . 0.0 111.029 -177.014 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.3 mttt -71.61 135.93 47.17 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.867 -168.31 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.539 HG12 HD21 ' A' ' 7' ' ' LEU . 8.4 m -110.7 135.45 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.046 179.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.405 ' O ' HD12 ' A' ' 9' ' ' ILE . 97.7 m -107.62 128.54 54.63 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.186 176.802 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.535 HG22 ' HG ' ' A' ' 20' ' ' LEU . 71.0 t -96.76 120.79 46.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.15 178.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.577 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 68.3 mm-40 -130.53 144.62 51.53 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.841 172.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 53.3 p-80 -156.71 58.61 1.66 Allowed Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.543 0.687 . . . . 0.0 110.79 176.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.462 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 77.6 Cg_endo -81.84 -13.23 10.6 Favored 'Trans proline' 0 C--O 1.232 0.189 0 C-N-CA 122.719 2.28 . . . . 0.0 112.382 -171.01 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.51 ' OD2' ' HA3' ' A' ' 13' ' ' GLY . 20.8 m-20 63.06 20.05 12.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.884 -171.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.413 ' O ' ' N ' ' A' ' 45' ' ' GLU . 98.0 mttt -91.06 0.96 57.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.901 174.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 14.2 mt -43.69 -50.15 7.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.918 -170.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.16 -36.56 82.21 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.871 -179.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' A' ' 42' ' ' LYS . 99.1 mt-10 -74.96 -33.17 61.88 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.887 -177.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.412 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 69.8 mmtt -82.57 -29.98 29.94 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.936 -175.204 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.511 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 11.6 m-30 -40.18 -56.01 3.65 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.626 0.727 . . . . 0.0 110.783 -178.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.511 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 57.3 Cg_endo -69.13 -28.09 28.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.666 2.244 . . . . 0.0 112.313 -179.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -79.08 -43.62 23.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.883 -172.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 28.8 m -65.69 -30.6 50.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.151 179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.75 -36.04 79.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.148 172.398 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.13 -31.25 68.68 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.966 179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 80.7 p -93.02 -11.45 33.11 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.112 177.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.47 15.27 81.32 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.469 176.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 28.9 t0 -164.86 159.05 17.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.953 0.406 . . . . 0.0 110.812 175.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -164.7 -140.33 2.85 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.646 -0.787 . . . . 0.0 112.321 -178.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.596 ' HG3' ' CE3' ' A' ' 10' ' ' TRP . 72.6 Cg_endo -67.8 148.57 77.33 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.664 2.243 . . . . 0.0 112.354 168.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -74.32 -39.07 63.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.88 176.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.63 ' HB ' HG23 ' A' ' 9' ' ' ILE . 3.7 mp -126.13 138.71 53.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.141 176.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.47 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 1.8 tp -131.39 130.06 62.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.09 179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.515 ' CE2' HG13 ' A' ' 108' ' ' ILE . 4.3 m-85 -98.63 140.31 33.04 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.785 176.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.529 ' CH2' ' HA3' ' A' ' 265' ' ' GLY . 9.1 m-90 -116.99 140.09 49.89 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.877 178.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 262' ' ' LEU . . . -57.99 -82.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.129 -176.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -126.41 -58.21 1.35 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.989 166.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -86.11 -24.35 26.28 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.807 -167.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.481 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 97.0 mtt180 -59.87 -29.72 68.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.981 -160.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -68.08 -27.68 66.7 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.923 -170.65 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.32 -51.36 53.22 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.434 -172.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -61.7 -35.91 91.91 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.648 -0.786 . . . . 0.0 112.537 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 15.2 t80 -65.68 -38.12 88.39 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.866 0.365 . . . . 0.0 110.887 -179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.51 -44.03 58.68 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.085 178.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 -62.39 -31.78 72.51 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.883 -178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -80.87 -11.95 59.5 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.99 176.055 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.8 32.08 64.24 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.515 175.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.406 ' HB3' ' CZ ' ' A' ' 70' ' ' TYR . 1.8 mp -86.3 -3.04 58.91 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.829 0.347 . . . . 0.0 110.862 -172.63 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.541 ' C ' ' HB2' ' A' ' 268' ' ' ALA . 0.3 OUTLIER -127.85 154.38 45.54 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.846 -177.381 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.627 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -73.94 136.86 43.31 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.127 175.131 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.4 mt-10 -71.02 131.37 43.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.903 178.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.468 HD12 ' CE2' ' A' ' 106' ' ' TYR . 33.6 pt -110.19 159.76 9.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.003 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 70.1 p -105.87 147.6 35.03 Favored Pre-proline 0 C--N 1.331 -0.224 0 CA-C-O 121.663 0.744 . . . . 0.0 111.087 -172.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.76 145.78 29.3 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.689 2.259 . . . . 0.0 112.301 -177.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -112.96 112.03 23.2 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.957 170.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -53.58 -37.4 62.91 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.947 -178.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -64.4 -39.95 94.85 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.142 -178.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.549 ' O ' ' HG ' ' A' ' 89' ' ' LEU . 18.6 m-30 -68.8 -49.51 57.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.822 178.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 89.6 mt-30 -53.74 -40.08 65.85 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.913 -176.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 98.5 m-20 -57.69 -32.29 67.21 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.869 175.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -82.07 -15.28 54.04 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.95 -176.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 85' ' ' PHE . 61.8 mt -105.0 -104.95 0.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.898 -167.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 40.6 t80 -165.23 133.94 2.61 Favored Pre-proline 0 C--N 1.327 -0.405 0 CA-C-O 121.675 0.75 . . . . 0.0 110.953 -175.874 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 71.3 Cg_exo -52.89 -39.91 76.97 Favored 'Trans proline' 0 C--N 1.342 0.188 0 C-N-CA 122.748 2.299 . . . . 0.0 112.372 -171.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -80.08 -28.13 39.16 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -176.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 54.0 m -69.92 -48.31 59.03 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.086 -167.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.479 ' HA ' HG22 ' A' ' 97' ' ' VAL . 53.8 p-90 -66.96 -28.96 68.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.898 177.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -70.69 -35.97 73.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.848 174.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.74 -25.9 65.87 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.101 179.566 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.506 HG23 HD22 ' A' ' 103' ' ' LEU . 19.8 m -101.27 17.71 3.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.177 179.725 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.438 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 67.5 ttt180 -102.56 133.67 47.16 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.972 178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 90.4 t80 -147.89 130.11 15.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.827 177.547 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 57.6 t30 67.16 35.68 4.41 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.928 177.387 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 79.78 -4.25 66.09 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.539 174.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -133.96 159.99 39.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.794 0.33 . . . . 0.0 110.943 176.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.506 HD22 HG23 ' A' ' 97' ' ' VAL . 13.8 mt -73.51 144.82 46.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.914 -179.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.0 pp -122.17 6.81 5.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.19 178.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.678 ' HB1' ' HB3' ' A' ' 263' ' ' SER . . . -167.83 159.3 11.49 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.051 -178.13 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.468 ' CE2' HD12 ' A' ' 79' ' ' ILE . 62.1 m-85 -117.25 147.44 40.45 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.689 0.757 . . . . 0.0 110.928 164.064 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.516 ' HB3' HG11 ' A' ' 261' ' ' VAL . 59.6 Cg_endo -72.36 118.09 5.44 Favored 'Trans proline' 0 C--N 1.342 0.195 0 C-N-CA 122.666 2.244 . . . . 0.0 112.358 176.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.515 HG13 ' CE2' ' A' ' 61' ' ' PHE . 30.8 mm -96.29 -36.88 6.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.088 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.533 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -151.93 154.67 36.54 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.083 -176.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 14.4 p -121.44 134.95 63.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.018 -178.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -118.07 129.76 55.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.837 179.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.414 ' HB3' ' HB ' ' A' ' 320' ' ' THR . . . -150.92 157.12 42.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.113 177.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.635 ' HB2' ' HG3' ' A' ' 257' ' ' PRO . 7.4 mp -108.49 156.92 18.93 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.925 -172.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 89.1 p -150.39 161.19 42.96 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.929 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.899 HD13 ' O ' ' A' ' 115' ' ' LEU . 0.2 OUTLIER -99.22 124.3 44.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.953 175.922 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.71 HG13 HG23 ' A' ' 244' ' ' VAL . 4.6 mp -109.0 132.76 56.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.072 -174.605 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 54.5 p90 -133.08 148.28 52.17 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.911 -173.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 73.1 m-80 -97.4 115.91 28.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.806 174.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -66.55 -15.84 63.7 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.781 172.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.537 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 22.8 t70 -80.87 -33.99 34.02 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.885 -178.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 mp -87.9 -45.0 10.64 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.041 -178.175 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.439 HD22 ' HB1' ' A' ' 223' ' ' ALA . 2.1 mp -106.08 127.62 27.97 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-O 121.545 0.688 . . . . 0.0 110.897 176.089 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.31 -30.09 16.14 Favored 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.732 2.288 . . . . 0.0 112.343 175.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 53.9 t-20 -148.9 90.0 4.85 Favored Pre-proline 0 C--N 1.33 -0.262 0 CA-C-O 121.61 0.719 . . . . 0.0 110.944 174.482 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -57.51 144.97 90.84 Favored 'Trans proline' 0 N--CA 1.464 -0.207 0 C-N-CA 122.668 2.245 . . . . 0.0 112.351 -178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -68.58 153.31 73.82 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.689 2.26 . . . . 0.0 112.336 -179.04 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -107.72 -3.96 18.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.847 -177.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 64.6 p -133.94 159.02 42.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.148 -179.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.428 ' HA ' HG12 ' A' ' 132' ' ' ILE . 64.4 m95 -72.2 -24.65 61.44 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 179.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -66.4 -30.02 70.31 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.844 -178.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.5 mt-10 -75.05 -19.31 60.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.85 -177.471 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.604 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 49.8 mm -61.49 -53.52 61.09 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.716 0.769 . . . . 0.0 111.138 -165.346 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.604 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 22.6 Cg_endo -61.7 -40.03 48.91 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.635 2.223 . . . . 0.0 112.276 -176.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.24 -60.67 2.92 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.065 -178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.178 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.52 -16.5 63.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.862 -174.462 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.629 ' HA ' HD22 ' A' ' 139' ' ' LEU . 38.7 t70 -61.74 -38.9 89.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.088 -0.506 . . . . 0.0 110.848 168.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -66.87 -36.44 82.32 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.879 178.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.5 mt-10 -73.6 -49.79 24.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.726 -174.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.662 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -74.97 -15.94 60.65 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.913 -176.654 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.662 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.8 tttt -56.43 -34.92 67.28 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.928 171.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.99 -23.75 67.31 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.139 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -94.32 7.99 43.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.879 178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.95 27.41 64.6 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.415 178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.417 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 45.5 mtmt -119.94 169.5 10.12 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.939 0.4 . . . . 0.0 110.863 173.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.52 ' HA ' HD21 ' A' ' 139' ' ' LEU . 33.5 t -133.1 143.95 49.64 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.881 172.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 224' ' ' MET . . . -71.98 -54.12 10.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.101 -162.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -139.65 125.47 19.57 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.948 -165.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.422 ' SD ' ' HB2' ' A' ' 213' ' ' ALA . 57.6 ttm -106.28 129.22 54.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.891 179.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -154.71 164.24 39.07 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.83 -174.521 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -122.81 142.92 50.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.942 171.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.495 ' HG ' ' O ' ' A' ' 151' ' ' LEU . 50.8 tp -111.4 -0.13 16.4 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.932 -176.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 69.9 mt-30 -74.17 -6.04 45.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.936 -178.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -119.73 150.18 49.85 Favored Pre-proline 0 C--N 1.332 -0.195 0 CA-C-O 121.679 0.752 . . . . 0.0 110.905 -179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -64.54 -18.82 64.13 Favored 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.632 2.221 . . . . 0.0 112.417 -178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.7 m-85 -61.75 -37.21 83.42 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.927 -173.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -82.89 -40.17 20.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.882 178.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 23.6 p -63.77 -38.66 91.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.101 -175.269 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.581 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 22.2 t-105 -62.98 -54.44 46.56 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 121.567 0.699 . . . . 0.0 110.911 -168.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.581 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 28.5 Cg_endo -66.87 -32.19 36.75 Favored 'Trans proline' 0 C--O 1.232 0.219 0 C-N-CA 122.696 2.264 . . . . 0.0 112.37 -172.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.702 ' O ' HD23 ' A' ' 160' ' ' LEU . 6.4 tt -74.69 -41.04 60.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.924 179.772 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.53 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 74.4 mt -70.48 -40.89 77.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.109 177.909 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -70.96 -26.14 63.04 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.126 -177.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -63.45 -29.46 70.74 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.126 -177.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 62.1 m-20 -91.29 2.75 56.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.933 175.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 104.99 7.05 39.05 Favored Glycine 0 C--N 1.331 0.288 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.56 178.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.525 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -79.02 65.06 3.62 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.359 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 72.8 m-85 -90.22 146.2 24.43 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.863 0.363 . . . . 0.0 110.911 -178.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -66.42 -15.35 63.25 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.063 177.272 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 46.0 p90 -164.42 150.07 10.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.841 -175.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -81.74 128.18 33.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.937 163.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.2 t80 -100.79 120.5 40.2 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.921 178.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -149.72 133.2 16.62 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.881 -173.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 61.9 t30 57.51 43.42 22.83 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.842 174.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.04 7.25 70.47 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.499 173.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -134.9 145.29 48.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.785 0.326 . . . . 0.0 110.888 -177.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 35.1 p90 -78.66 143.24 36.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 168.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.1 t0 -107.18 105.98 16.23 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.935 177.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.8 tp -71.28 -18.03 20.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.14 -177.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -94.61 -8.99 36.46 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.894 -177.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.9 t0 -129.56 93.05 3.45 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.903 172.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 31.9 m -114.01 167.62 6.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.128 -175.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -103.58 13.35 54.09 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.486 -171.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.512 HG11 ' CD1' ' A' ' 368' ' ' ILE . 33.7 m -104.85 -16.91 7.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.769 0.318 . . . . 0.0 111.096 -173.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.42 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 57.9 p-10 -95.09 18.07 12.86 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.934 173.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 93.8 m-20 -115.91 172.86 6.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.88 -174.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.21 -26.71 68.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.209 -178.158 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -67.11 -41.28 92.68 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.796 -0.716 . . . . 0.0 112.526 -170.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.625 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.08 -40.6 94.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.848 0.356 . . . . 0.0 111.02 179.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.49 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.1 mttt -60.83 -37.1 80.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.854 173.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.68 -37.5 87.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.121 177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.72 -46.02 91.06 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.787 -0.72 . . . . 0.0 112.421 177.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.591 HD11 ' HA ' ' A' ' 347' ' ' VAL . 22.6 tp -68.64 -34.8 76.35 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.922 0.391 . . . . 0.0 110.993 -179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.406 ' O ' HG12 ' A' ' 196' ' ' VAL . 85.4 m -61.83 -42.26 98.81 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.133 -179.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -68.07 -56.99 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.964 178.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.676 HD12 ' C ' ' A' ' 195' ' ' LEU . 2.6 pp -63.64 -27.5 69.28 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.956 -165.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.553 ' N ' HD12 ' A' ' 195' ' ' LEU . 4.5 p -72.65 -22.85 20.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.182 176.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 56.5 t0 -66.03 -58.22 5.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.879 -174.096 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 1.057 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.5 -24.25 56.85 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.883 -167.474 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.801 ' N ' HD22 ' A' ' 198' ' ' LEU . 2.0 pp -77.46 -35.64 22.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.15 172.432 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -66.02 -30.36 70.89 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.8 168.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 94.8 m-20 -84.65 5.37 28.32 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.878 177.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.5 mttt 66.07 40.06 4.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.94 170.209 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 80.2 m-70 -82.12 -10.54 59.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.762 171.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.5 ' CG ' HG22 ' A' ' 199' ' ' ILE . 5.4 ppp? -141.08 154.26 45.85 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.848 175.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -99.0 156.13 17.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.912 -177.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.89 -24.88 68.04 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.132 179.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -94.83 -2.59 50.54 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.922 -178.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 88.7 m -64.38 131.49 47.37 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.227 -177.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -147.23 173.39 12.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.926 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -78.66 -32.09 47.03 Favored 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.899 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 99.1 p -74.13 -38.84 63.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.889 -172.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . . . . . . . . . 39.5 pt -65.04 -20.11 26.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.105 -179.468 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.422 ' HB2' ' SD ' ' A' ' 148' ' ' MET . . . -58.42 -32.45 68.68 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.127 -179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -58.19 -43.53 87.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.834 178.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -65.04 -36.82 85.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.147 174.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.6 -36.1 79.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.065 177.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 27.7 m-85 -65.08 -42.46 94.08 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.895 175.202 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 49.3 m-80 -64.95 -33.94 77.23 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.896 -177.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.3 mttt -92.51 -24.36 18.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.91 -177.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 86.05 30.99 21.5 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.568 179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -91.83 -31.61 15.65 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.85 0.357 . . . . 0.0 110.914 -168.96 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 96.9 m -115.89 127.58 55.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.089 -171.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.439 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -70.71 -44.97 65.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.11 -175.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.415 ' N ' ' O ' ' A' ' 146' ' ' ALA . 68.1 mtm -134.05 146.98 50.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.78 -172.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . 0.421 HG21 ' HB1' ' A' ' 213' ' ' ALA . 43.3 p -140.01 161.64 37.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.171 177.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 39.2 mm -112.4 114.85 48.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.07 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . 0.451 ' HB2' HD13 ' A' ' 116' ' ' ILE . 63.8 m-80 -145.41 153.32 41.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.838 -171.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.456 ' HA3' ' HG ' ' A' ' 113' ' ' LEU . . . -133.56 -123.3 2.38 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.5 -179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . 0.404 ' HD2' ' HA3' ' A' ' 228' ' ' GLY . 30.2 Cg_endo -61.97 -19.95 67.78 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.766 2.311 . . . . 0.0 112.269 -179.817 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 97.4 m95 -65.19 -30.08 70.95 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.925 178.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 51.12 38.3 20.48 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.078 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 12.2 m0 -70.02 -27.87 65.03 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.046 178.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 72.7 m -53.22 117.95 3.42 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.86 177.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 32.3 t30 -74.86 -169.05 0.82 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.911 -179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 20.4 mt 57.07 75.0 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.166 -178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 97.5 m-20 -56.53 -47.6 79.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.917 -171.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 46.1 p -90.18 178.01 6.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.071 -173.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 95.8 p -76.34 -5.06 45.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.919 178.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -60.11 167.9 2.15 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.876 177.9 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.53 ' O ' HG12 ' A' ' 240' ' ' VAL . 15.8 t 54.95 41.82 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.046 -172.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.537 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 74.6 m-20 42.12 70.18 0.3 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.883 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 34.6 t80 -126.0 132.8 51.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.847 -172.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -136.97 158.33 24.17 Favored Glycine 0 C--N 1.331 0.271 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.508 177.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.71 HG23 HG13 ' A' ' 116' ' ' ILE . 3.2 p -145.46 139.94 22.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.91 0.386 . . . . 0.0 111.156 179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 15.0 t -155.37 151.82 28.35 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.075 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . 0.485 HG11 ' HB2' ' A' ' 323' ' ' ASN . 28.2 m -62.3 168.4 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.096 -178.041 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.753 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.7 mm? -61.81 143.37 94.28 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.644 0.735 . . . . 0.0 110.921 -162.198 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.56 -176.52 3.17 Favored 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.649 2.233 . . . . 0.0 112.457 -178.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 95.2 m -100.41 146.33 27.14 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.14 -171.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -139.02 119.12 13.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.869 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt 54.97 37.13 28.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.96 177.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 88.09 -0.46 83.96 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.513 169.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 38.7 mt-30 -130.96 140.09 37.62 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.588 0.709 . . . . 0.0 110.914 175.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -70.93 141.23 39.98 Favored 'Trans proline' 0 C--O 1.231 0.149 0 C-N-CA 122.669 2.246 . . . . 0.0 112.412 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.753 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 82.7 p -82.39 -3.47 55.61 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 172.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 95.4 mttt -40.48 129.69 1.77 Allowed Pre-proline 0 C--N 1.328 -0.356 0 CA-C-O 121.555 0.693 . . . . 0.0 110.894 179.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.635 ' HG3' ' HB2' ' A' ' 113' ' ' LEU . 85.8 Cg_endo -86.32 164.82 9.67 Favored 'Trans proline' 0 C--O 1.232 0.207 0 C-N-CA 122.731 2.287 . . . . 0.0 112.446 -171.462 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 52.9 p90 -75.0 169.96 16.96 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.863 175.378 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 60.8 t -109.14 132.29 57.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.114 -175.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.52 143.9 16.23 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.458 176.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.516 HG11 ' HB3' ' A' ' 107' ' ' PRO . 97.9 t -128.66 126.51 65.31 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 120.986 0.422 . . . . 0.0 111.081 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.45 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 2.0 tt -71.86 136.34 46.94 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.907 171.185 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.678 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 74.7 m -118.9 148.97 42.34 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.903 -174.232 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.471 ' HB1' HD11 ' A' ' 280' ' ' LEU . . . -133.78 137.53 45.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.109 174.151 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.529 ' HA3' ' CH2' ' A' ' 62' ' ' TRP . . . -140.76 170.14 24.61 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.701 -0.762 . . . . 0.0 112.549 -173.493 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 22.7 mm -114.22 132.37 63.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.884 0.373 . . . . 0.0 111.136 -171.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 56.2 t-20 -65.04 133.8 52.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.853 -172.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.627 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -63.0 -29.79 71.1 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.115 -179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -82.38 -8.11 59.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.038 -172.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 24.2 t -69.98 120.14 75.99 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.698 0.761 . . . . 0.0 110.848 -174.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -75.42 -16.23 19.41 Favored 'Trans proline' 0 C--N 1.342 0.202 0 C-N-CA 122.733 2.289 . . . . 0.0 112.362 174.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.405 ' HB2' HD21 ' A' ' 275' ' ' LEU . 53.2 p-10 -114.16 29.97 7.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.865 -177.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -61.48 -24.55 66.66 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.838 -169.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -63.65 -45.58 89.5 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.851 -169.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.405 HD21 ' HB2' ' A' ' 272' ' ' ASN . 2.2 pp -75.8 -33.28 60.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.866 -178.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.413 ' HB1' HD11 ' A' ' 59' ' ' ILE . . . -65.8 -50.24 65.39 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.056 -179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 17.1 pttp -65.95 -36.48 83.46 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.868 -176.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 64.4 mm-40 -68.98 -45.36 70.83 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.903 -174.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -59.08 -47.12 86.42 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.93 178.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.471 HD11 ' HB1' ' A' ' 264' ' ' ALA . 8.0 tt -59.54 -52.24 66.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.889 -175.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 15.8 pt-20 -73.99 -25.72 60.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.953 -174.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 93.6 m-20 -99.74 -14.18 18.98 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.942 -170.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.484 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 44.6 t80 -122.2 -56.54 1.82 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.894 -176.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.404 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.4 OUTLIER -68.58 -39.69 80.83 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.854 -176.264 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -80.84 23.03 0.57 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.874 174.071 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . . . . . . . . . 89.1 m -128.51 147.61 50.7 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.206 -179.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.493 ' HA ' HD11 ' A' ' 290' ' ' LEU . 37.4 t70 -40.78 -38.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.774 -176.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -71.27 -42.57 68.59 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.856 -173.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.51 -52.03 8.95 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.445 -171.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.669 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.6 OUTLIER -73.41 -21.97 60.35 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.815 0.34 . . . . 0.0 110.952 -177.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.478 ' N ' HD12 ' A' ' 290' ' ' LEU . 85.4 tt0 -66.71 -42.69 85.97 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.865 169.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.93 -35.94 81.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.003 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.717 HG13 ' HA3' ' A' ' 19' ' ' GLY . 42.3 t -75.78 -44.27 39.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.166 179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 41.5 t30 -65.05 -31.81 73.21 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.787 -179.807 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 87.0 tttt -67.97 -32.2 72.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.932 -174.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.78 ' HB3' ' HB3' ' A' ' 18' ' ' ASN . 63.7 m-20 -95.02 -29.64 14.51 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.834 -173.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.431 ' O ' HD13 ' A' ' 299' ' ' LEU . 77.3 tttt -146.1 135.47 11.44 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.626 0.727 . . . . 0.0 110.854 164.952 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -53.27 116.78 3.18 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.667 2.245 . . . . 0.0 112.33 179.747 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.431 HD13 ' O ' ' A' ' 297' ' ' LYS . 0.3 OUTLIER -90.08 -22.57 21.75 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.884 174.829 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 94.95 -55.79 1.85 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.531 -175.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.427 ' HA ' HD23 ' A' ' 311' ' ' LEU . . . -177.71 161.87 1.7 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.868 0.366 . . . . 0.0 111.191 -179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.594 ' CG2' ' HB3' ' A' ' 307' ' ' TYR . 33.8 m -128.57 159.93 39.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.153 177.627 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -76.46 -2.07 30.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.157 -179.741 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.669 ' CD2' HD21 ' A' ' 290' ' ' LEU . 60.3 tp -87.94 130.38 34.95 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.931 -175.736 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -44.55 -32.42 1.42 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.949 -176.354 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.484 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 74.4 m -48.16 -39.2 20.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.8 176.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.594 ' HB3' ' CG2' ' A' ' 302' ' ' VAL . 0.1 OUTLIER -58.93 -45.41 90.47 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.869 173.477 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.463 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 84.4 tt0 -54.63 -34.34 61.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.808 179.693 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -79.85 -63.3 1.44 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.8 178.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 73.3 mm-40 -82.71 -58.27 2.97 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.916 -170.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 311' ' ' LEU . 0.0 OUTLIER -60.14 -36.63 77.96 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.836 -170.562 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -63.98 -14.42 53.86 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.069 -176.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -63.41 -20.46 65.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.869 179.607 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.491 ' HB3' HD12 ' A' ' 317' ' ' ILE . 60.3 t0 -79.61 120.7 81.05 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.609 0.719 . . . . 0.0 110.921 167.234 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_exo -45.68 -35.42 13.02 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.656 2.237 . . . . 0.0 112.351 -179.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.9 mtm-85 -70.81 -36.99 73.23 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.875 -176.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.491 HD12 ' HB3' ' A' ' 314' ' ' ASP . 70.7 mt -78.46 -30.12 15.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.182 179.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -61.48 -39.59 91.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.102 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -64.98 -47.24 78.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.118 174.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . 0.414 ' HB ' ' HB3' ' A' ' 112' ' ' ALA . 74.1 p -67.55 -25.17 65.68 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.188 -177.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 17.6 tmm? -62.05 -38.03 87.23 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.933 174.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 87.9 tt0 -65.02 -47.05 78.81 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.821 178.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.485 ' HB2' HG11 ' A' ' 246' ' ' VAL . 36.9 t30 -63.47 -38.17 90.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 177.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -62.73 -46.94 85.76 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.095 -177.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -72.82 -30.98 64.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.926 -179.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -96.37 -4.38 42.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.924 -177.178 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.459 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -101.74 -161.78 26.88 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.644 -0.789 . . . . 0.0 112.465 -172.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.717 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 95.4 mt-10 -143.37 140.58 30.56 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.857 0.361 . . . . 0.0 110.825 -172.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.584 ' O ' ' C ' ' A' ' 330' ' ' MET . 44.9 mm -82.51 106.63 13.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.17 -169.657 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.584 ' C ' ' O ' ' A' ' 329' ' ' ILE . 63.3 tpp 22.88 57.5 0.28 Allowed Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 121.636 0.731 . . . . 0.0 110.874 175.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.717 ' HG3' ' HB3' ' A' ' 328' ' ' GLU . 46.2 Cg_endo -94.3 -5.79 2.33 Favored 'Trans proline' 0 C--N 1.342 0.216 0 C-N-CA 122.67 2.247 . . . . 0.0 112.346 -172.164 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.551 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 74.5 m-20 -100.02 12.55 36.59 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.917 -158.421 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.551 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 47.9 mm 86.35 132.13 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.634 0.73 . . . . 0.0 111.124 162.081 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.23 -27.67 28.72 Favored 'Trans proline' 0 C--O 1.232 0.184 0 C-N-CA 122.663 2.242 . . . . 0.0 112.392 -175.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.45 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.7 mt-30 -72.35 -26.23 61.84 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.926 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . 0.455 ' CG ' ' HB ' ' A' ' 333' ' ' ILE . 22.8 mmt -77.9 -26.05 48.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.891 -175.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 62.1 p -65.27 -27.31 68.55 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.876 177.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -76.21 -36.06 58.77 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.168 173.258 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.408 ' N ' ' CD1' ' A' ' 339' ' ' PHE . 7.8 m-30 -61.16 -37.82 84.23 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.827 170.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 50.8 m0 -62.62 -32.7 73.77 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.021 175.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 86.2 t80 -72.87 -40.52 65.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.928 176.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.92 -40.08 91.82 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.106 178.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.452 ' O ' ' HB3' ' A' ' 346' ' ' ALA . 13.2 m -80.33 -24.01 11.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.142 177.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.555 ' O ' HG22 ' A' ' 347' ' ' VAL . 1.1 tmt_? -59.92 -50.24 74.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.834 171.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 56.1 m -57.88 -29.94 65.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.084 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.452 ' HB3' ' O ' ' A' ' 343' ' ' VAL . . . -56.33 -39.3 72.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.091 177.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.591 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.0 OUTLIER -72.6 -32.66 42.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.146 -176.402 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.7 mp -64.35 -46.78 92.12 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.077 172.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -63.2 -34.66 78.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.861 -179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.98 -45.72 59.97 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.58 -40.51 88.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.155 -175.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 94.1 p -75.05 -12.08 60.24 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 121.038 0.447 . . . . 0.0 110.891 -177.38 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.16 14.95 82.06 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.579 -178.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.27 -32.43 49.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.765 0.317 . . . . 0.0 110.815 -177.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.5 mm-40 -136.77 153.88 50.71 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.959 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.6 p -79.47 167.82 20.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.192 169.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.441 ' HA ' HD23 ' A' ' 192' ' ' LEU . 54.4 t -55.12 -41.99 62.83 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.083 172.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -59.35 -45.95 89.97 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.828 177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.8 mm-40 -72.25 -53.18 13.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.831 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.11 -44.65 75.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.031 -171.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.625 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -66.98 -40.53 87.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.969 -178.142 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -64.98 -40.45 94.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.954 174.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -62.38 -39.72 94.12 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.846 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.75 98.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 175.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.42 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 16.8 tm0? -63.26 -38.44 91.18 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.958 176.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 88.9 m -65.01 -38.56 91.33 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.102 178.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 79.4 mtt-85 -67.25 -35.67 80.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.84 176.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.512 ' CD1' HG11 ' A' ' 183' ' ' VAL . 73.8 mt -66.47 -45.05 90.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.127 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 71.1 p -99.02 -8.63 25.06 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.158 -174.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.7 mttt . . . . . 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.956 176.27 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.7 tttt . . . . . 0 C--O 1.232 0.181 0 CA-C-O 120.805 0.336 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 90.0 mt -82.82 129.93 36.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.159 176.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -136.44 143.48 43.93 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.951 -177.62 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -56.35 134.98 53.97 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.934 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.575 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 97.61 -1.62 60.13 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.661 -0.78 . . . . 0.0 112.465 -176.351 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.401 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 65.0 pttt -165.3 144.09 6.41 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.783 0.325 . . . . 0.0 110.902 172.794 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.533 HD22 HD13 ' A' ' 33' ' ' ILE . 0.3 OUTLIER -148.49 159.97 43.53 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.792 -175.019 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.4 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 90.3 t -113.78 132.94 61.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.161 -176.862 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.814 HD13 HD11 ' A' ' 20' ' ' LEU . 1.2 mp -119.32 124.97 73.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.081 -178.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.574 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 44.2 m0 -104.62 127.1 52.28 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.894 176.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 66.0 mt -119.4 141.75 37.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.146 172.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -51.36 147.52 5.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.916 176.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -57.47 -12.8 9.69 Favored Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.501 -172.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -75.17 -17.05 60.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.856 0.36 . . . . 0.0 110.813 -174.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 17.1 mtmm -129.94 110.09 11.4 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.913 163.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.09 -91.53 0.81 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.443 -160.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 82.0 t80 -101.81 -42.37 6.18 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.866 0.365 . . . . 0.0 110.856 -171.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . 0.76 ' HB3' ' HB3' ' A' ' 296' ' ' ASP . 86.0 m-20 -61.86 -52.08 65.58 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.843 -157.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.746 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -61.99 -48.55 82.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.516 -175.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.814 HD11 HD13 ' A' ' 9' ' ' ILE . 0.0 OUTLIER -56.52 -61.2 2.58 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.879 0.371 . . . . 0.0 110.922 177.824 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -54.66 -41.38 70.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.145 -174.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.4 tp10 -65.05 -53.11 50.81 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.907 -176.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.468 HG22 ' O ' ' A' ' 19' ' ' GLY . 18.7 m -74.89 -38.06 42.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.162 -175.768 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.617 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -65.12 -42.47 96.51 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.527 178.608 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -59.34 -41.33 88.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.797 0.332 . . . . 0.0 110.927 -178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 66.6 tttm -63.21 -39.6 95.09 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.853 175.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . . . . . . . . . 14.8 m-30 -66.18 -36.95 84.43 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.839 -179.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -62.12 -39.91 94.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.912 172.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -67.82 -33.98 75.85 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.911 178.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 96.6 m-20 -86.76 -41.78 13.85 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.881 -170.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.625 ' OG1' HG13 ' A' ' 33' ' ' ILE . 77.0 p -106.8 -14.86 14.88 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.212 -174.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.75 8.93 83.77 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.685 -0.769 . . . . 0.0 112.503 178.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.96 ' O ' HD12 ' A' ' 33' ' ' ILE . 2.2 pp -106.35 130.41 58.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.898 0.38 . . . . 0.0 111.093 -175.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.9 mttt -75.95 139.78 41.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 -171.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.617 HG21 ' HA3' ' A' ' 24' ' ' GLY . 5.8 m -112.36 135.81 50.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.157 -179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.402 ' O ' HD12 ' A' ' 9' ' ' ILE . 99.3 m -105.93 128.31 53.71 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.083 176.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.539 HG22 ' HG ' ' A' ' 20' ' ' LEU . 80.9 t -96.57 120.0 45.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.105 -178.256 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.574 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 68.3 mm-40 -130.31 145.2 51.75 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.891 171.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 48.3 p-80 -156.1 58.3 1.71 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-O 121.599 0.714 . . . . 0.0 110.87 -179.805 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -77.95 -27.43 5.8 Favored 'Trans proline' 0 C--O 1.232 0.204 0 C-N-CA 122.762 2.308 . . . . 0.0 112.343 -172.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . . . . . . . . . 26.0 t0 68.87 13.19 8.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.863 -167.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.429 ' O ' ' N ' ' A' ' 45' ' ' GLU . 99.1 mttt -87.84 1.56 53.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.988 171.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . . . . . . . . . 12.3 mt -44.37 -50.14 9.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.948 -168.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -66.9 -27.56 67.6 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.955 -177.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 42' ' ' LYS . 98.3 mt-10 -79.01 -32.45 45.08 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.882 177.79 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -81.84 -29.27 32.63 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.868 -174.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.544 ' N ' ' HD2' ' A' ' 48' ' ' PRO . 14.4 m-30 -45.26 -54.4 14.49 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 121.635 0.731 . . . . 0.0 110.852 -175.248 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 47' ' ' PHE . 53.1 Cg_endo -66.4 -27.3 47.3 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.656 2.237 . . . . 0.0 112.336 178.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -79.4 -42.98 24.28 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.915 -175.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 26.3 m -71.62 -28.03 30.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.106 -179.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -67.23 -35.2 79.08 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.109 171.101 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.35 -31.99 71.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.132 178.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.9 p -92.47 -12.11 32.9 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.127 177.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 74.96 14.97 81.27 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.609 175.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.4 t0 -161.9 157.14 23.44 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.891 0.377 . . . . 0.0 110.842 176.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.431 ' HA3' ' HD2' ' A' ' 57' ' ' PRO . . . -165.04 -141.08 3.03 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.437 -178.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.55 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 69.9 Cg_endo -66.97 149.78 82.87 Favored 'Trans proline' 0 C--O 1.231 0.163 0 C-N-CA 122.622 2.214 . . . . 0.0 112.376 169.8 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 52.5 t0 -75.49 -38.45 59.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.924 177.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.56 ' HB ' HG23 ' A' ' 9' ' ' ILE . 4.1 mp -126.61 138.82 53.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.149 177.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.534 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 2.2 tp -133.35 131.56 57.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.117 -178.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.503 ' CE2' HG13 ' A' ' 108' ' ' ILE . 3.1 m-85 -99.36 139.69 34.64 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.769 177.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.627 ' HH2' ' HA3' ' A' ' 265' ' ' GLY . 3.4 m-90 -120.06 140.09 51.55 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.829 174.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -73.49 -85.25 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.06 -178.298 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 65.8 m170 -116.26 -62.99 1.51 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.834 177.431 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.6 m-20 -85.41 -30.46 23.57 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.894 -167.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 94.7 mtt180 -62.1 -31.58 72.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.935 -158.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 8.8 p90 -67.77 -29.29 68.45 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 -172.562 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -65.22 -52.33 41.73 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.439 -174.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -63.14 -39.93 98.55 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.507 176.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.552 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 28.8 t80 -66.08 -41.38 90.79 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.927 0.394 . . . . 0.0 110.891 -177.314 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -72.08 -44.29 63.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.096 176.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 66.5 tt0 -55.02 -39.9 69.59 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.893 -178.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 73.2 m -82.53 -8.12 59.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.851 -179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 72.65 35.06 59.31 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.634 -0.793 . . . . 0.0 112.519 174.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 mp -84.99 -2.16 57.64 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.869 0.366 . . . . 0.0 110.907 -173.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.552 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.3 OUTLIER -128.67 154.55 46.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.909 -178.178 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.623 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -70.93 134.38 47.19 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.116 175.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 99.7 mt-10 -71.18 131.09 43.03 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.93 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.445 HD12 ' CE2' ' A' ' 106' ' ' TYR . 29.3 pt -110.12 160.0 9.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.99 -179.443 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 68.2 p -105.17 148.34 36.04 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-O 121.565 0.697 . . . . 0.0 111.127 -172.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -74.15 142.66 31.07 Favored 'Trans proline' 0 N--CA 1.465 -0.205 0 C-N-CA 122.774 2.316 . . . . 0.0 112.362 -175.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.8 t0 -103.44 120.3 40.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.84 172.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -55.67 -38.67 69.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.848 179.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.16 -43.47 91.64 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.112 -178.378 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.0 m-30 -72.87 -35.29 67.14 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.853 -178.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 62.8 tt0 -54.58 -46.72 73.78 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.84 176.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.1 m-20 -65.83 -34.59 78.51 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.819 176.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -78.63 -24.01 45.52 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.879 -174.663 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.455 ' HA ' HD12 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -95.01 -96.16 0.17 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.957 -171.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.439 ' HB3' ' OG1' ' A' ' 93' ' ' THR . 36.9 t80 -176.31 137.75 0.48 Allowed Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.718 0.771 . . . . 0.0 110.833 -174.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -53.42 -39.28 82.35 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.671 2.247 . . . . 0.0 112.331 -172.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 53.7 m-85 -79.3 -30.27 42.84 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.91 -178.019 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.439 ' OG1' ' HB3' ' A' ' 90' ' ' TYR . 55.7 m -70.0 -49.35 52.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.204 -165.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.434 ' HA ' HG22 ' A' ' 97' ' ' VAL . 51.7 p-90 -64.32 -29.98 71.04 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.923 177.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -72.46 -35.35 68.24 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.886 175.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -68.32 -25.01 64.91 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.144 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.741 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 19.6 m -101.8 17.92 3.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.172 179.583 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.433 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 63.7 ttt180 -101.13 133.3 45.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.957 179.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -144.25 129.45 18.71 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.835 175.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 58.4 t30 65.01 35.27 8.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.88 176.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 81.94 -4.77 73.77 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.476 173.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -132.55 158.59 41.78 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.816 0.341 . . . . 0.0 110.897 175.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.523 HD22 HG23 ' A' ' 97' ' ' VAL . 13.9 mt -72.98 147.52 45.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.865 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . . . . . . . . . 2.1 pp -125.21 10.34 4.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.147 178.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.761 ' HB1' ' HB2' ' A' ' 263' ' ' SER . . . -163.26 151.32 13.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.041 -176.672 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.465 ' HA ' ' HD3' ' A' ' 107' ' ' PRO . 45.1 m-85 -115.02 136.28 22.58 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.659 0.742 . . . . 0.0 110.919 163.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 106' ' ' TYR . 40.0 Cg_exo -60.23 118.17 5.01 Favored 'Trans proline' 0 C--N 1.342 0.192 0 C-N-CA 122.664 2.243 . . . . 0.0 112.393 177.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.503 HG13 ' CE2' ' A' ' 61' ' ' PHE . 30.6 mm -99.38 -41.63 9.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.184 177.063 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.546 ' HA ' ' HA ' ' A' ' 302' ' ' VAL . . . -152.95 152.56 31.58 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.133 -175.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.7 p -123.91 134.18 67.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.082 -175.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -107.06 128.73 54.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.802 173.219 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -150.09 153.96 37.3 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.092 172.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.482 HD22 ' HG3' ' A' ' 257' ' ' PRO . 8.0 mp -104.72 158.87 16.21 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.86 -169.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.2 p -150.45 156.49 41.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.937 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.859 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.3 OUTLIER -100.06 125.9 46.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.86 176.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.584 ' N ' HD22 ' A' ' 115' ' ' LEU . 3.7 mp -106.03 135.33 44.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.113 -175.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -136.7 149.89 48.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.891 179.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 -92.95 119.83 32.63 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.793 171.228 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -67.47 -18.65 65.16 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.919 167.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.484 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 20.3 t70 -75.28 -32.42 61.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.908 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.2 mp -93.25 -44.98 8.06 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.965 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . . . . . . . . . 21.6 mt -104.42 113.63 64.92 Favored Pre-proline 0 C--N 1.328 -0.349 0 CA-C-O 121.599 0.714 . . . . 0.0 110.872 -178.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -68.84 -26.64 31.98 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 122.702 2.268 . . . . 0.0 112.378 173.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.424 ' HA ' ' HD2' ' A' ' 125' ' ' PRO . 56.5 t-20 -149.57 94.99 3.8 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-O 121.56 0.695 . . . . 0.0 110.871 172.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 124' ' ' ASN . 37.8 Cg_endo -69.14 151.03 72.64 Favored 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.707 2.271 . . . . 0.0 112.237 -174.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -70.86 151.62 62.94 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.691 2.26 . . . . 0.0 112.33 -177.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -108.54 -8.6 15.48 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.937 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . . . . . . . . . 72.3 p -132.21 159.01 40.26 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.136 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . . . . . . . . . 72.4 t-105 -65.25 -31.35 72.46 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.03 179.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -67.85 -27.83 67.03 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.89 -175.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -79.81 -12.7 59.75 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.825 -178.568 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.625 ' O ' HD13 ' A' ' 135' ' ' LEU . 49.4 mm -64.98 -53.07 44.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-O 121.679 0.752 . . . . 0.0 111.19 -172.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.607 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 30.1 Cg_endo -61.74 -37.21 69.56 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.635 2.223 . . . . 0.0 112.347 -178.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -60.65 -61.31 2.68 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.018 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.181 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -71.16 -18.34 62.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.864 -177.258 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.577 ' HA ' HD22 ' A' ' 139' ' ' LEU . 38.9 t70 -63.6 -40.94 98.23 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 169.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -62.85 -38.16 89.7 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.93 179.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -72.6 -50.66 23.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.827 -174.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.623 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -75.73 -16.53 60.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.937 -175.893 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.623 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.2 tttt -56.96 -34.41 68.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.97 172.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -64.78 -23.68 67.32 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.081 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -95.19 10.22 36.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.769 178.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 74.97 30.1 59.8 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.515 178.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.453 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 90.7 mttt -120.06 169.57 10.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.899 0.381 . . . . 0.0 110.796 177.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 47.0 t -132.39 138.52 47.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.911 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.518 ' HB2' ' HA ' ' A' ' 136' ' ' ASP . . . -71.75 -53.87 12.06 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.107 -165.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -137.36 131.72 32.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.932 -164.132 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . 0.658 ' HG2' ' HB2' ' A' ' 213' ' ' ALA . 60.3 tpp -105.04 120.1 40.66 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.902 -179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -153.28 164.97 37.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.896 -174.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 51.0 p30 -131.66 167.19 19.89 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.922 168.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 41.8 tp -116.26 -23.2 8.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.886 179.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 88.6 mt-30 -70.37 -4.07 20.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.851 -168.11 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -110.39 152.12 43.09 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-O 121.681 0.753 . . . . 0.0 110.819 177.112 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . 0.533 ' HD3' ' NE ' ' A' ' 344' ' ' ARG . 29.9 Cg_endo -67.55 -20.89 46.92 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.633 2.222 . . . . 0.0 112.304 -176.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -59.19 -39.07 81.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.907 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -83.24 -42.97 16.6 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.786 -178.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 41.9 p -65.37 -39.86 92.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.096 -170.081 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.574 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 17.5 t-105 -64.31 -53.86 43.13 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-O 121.589 0.709 . . . . 0.0 110.959 -169.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.574 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 36.2 Cg_endo -68.91 -32.24 22.77 Favored 'Trans proline' 0 C--O 1.233 0.227 0 C-N-CA 122.596 2.198 . . . . 0.0 112.394 -172.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.717 ' O ' HD23 ' A' ' 160' ' ' LEU . 6.4 tt -72.74 -40.75 65.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.852 178.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.561 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 72.1 mt -69.77 -41.44 79.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.111 176.803 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -71.78 -27.67 63.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.034 -177.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.56 -31.41 71.45 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.135 -177.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -92.38 3.79 54.72 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.883 177.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 107.89 3.95 34.03 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.507 176.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.404 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -79.6 66.22 3.55 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.427 -178.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . 0.432 ' O ' HG13 ' A' ' 183' ' ' VAL . 80.8 m-85 -90.02 145.41 25.11 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.853 0.359 . . . . 0.0 110.911 179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.96 0.41 15.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.987 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 51.2 p90 -154.67 151.74 29.12 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.86 -175.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -100.38 129.99 46.42 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.822 159.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 58.4 t80 -92.42 123.75 35.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.912 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.2 tt0 -151.3 131.29 13.39 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.908 178.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.0 t30 57.57 43.6 22.34 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.921 171.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 73.7 8.65 77.41 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.54 173.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -134.88 144.26 47.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.877 -176.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.3 m-30 -80.79 133.68 35.67 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.949 167.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 65.0 t0 -99.57 114.33 27.29 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.849 -178.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.1 tp -72.91 -20.05 18.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.12 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.0 -10.25 36.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.908 -179.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 67.5 t0 -127.57 95.02 4.12 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.864 169.282 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . . . . . . . . . 34.4 m -112.01 163.11 9.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.1 -179.51 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -97.64 13.29 64.17 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.781 -0.724 . . . . 0.0 112.486 -171.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.719 HG21 HD12 ' A' ' 368' ' ' ILE . 35.4 m -106.97 -13.43 9.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.843 0.354 . . . . 0.0 111.058 -176.202 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . . . . . . . . . 55.2 p-10 -89.17 15.34 9.0 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.897 -179.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 27.2 p30 -127.26 -171.27 2.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.863 -178.688 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -69.26 -25.98 64.54 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.2 -173.657 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -64.93 -43.6 95.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.552 -167.41 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.718 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -67.57 -38.48 84.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.854 0.359 . . . . 0.0 111.049 178.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.487 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.3 mttt -60.23 -35.29 75.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.862 174.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -64.29 -38.04 89.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.207 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -65.02 -45.75 91.25 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.365 177.466 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.604 HD11 ' HA ' ' A' ' 347' ' ' VAL . 17.8 tp -69.9 -32.99 71.6 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.932 0.396 . . . . 0.0 110.964 -179.371 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.45 ' O ' HG12 ' A' ' 196' ' ' VAL . 79.1 m -64.69 -42.11 95.56 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.169 178.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 62.9 t80 -70.55 -54.69 11.11 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.883 -179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.648 HD12 ' C ' ' A' ' 195' ' ' LEU . 3.6 pp -63.67 -23.91 67.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.989 -167.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.582 ' N ' HD12 ' A' ' 195' ' ' LEU . 1.2 p -74.54 -24.08 18.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.157 178.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 99.7 m-20 -64.78 -55.41 19.92 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.837 -172.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 1.03 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.74 -24.6 56.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.943 -168.044 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.764 ' N ' HD22 ' A' ' 198' ' ' LEU . 2.0 pp -81.73 -33.88 12.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.077 173.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -65.26 -31.08 72.05 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.842 168.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 96.3 m-20 -84.15 4.33 30.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.897 177.698 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.9 mttt 64.94 39.73 5.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.923 172.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 56.5 m170 -80.15 -11.71 59.72 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.895 174.406 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . 0.428 ' CG ' HG22 ' A' ' 199' ' ' ILE . 5.3 ppp? -142.95 154.54 44.16 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.81 174.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 94.2 m-20 -101.25 157.12 17.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.894 -176.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -62.96 -28.37 70.04 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.079 -177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 57.8 p-10 -97.44 -0.01 46.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.915 -177.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 99.7 m -59.25 131.78 52.03 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.127 -179.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.435 ' H ' HD11 ' A' ' 212' ' ' ILE . 23.1 t0 -144.17 171.55 14.13 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.882 -178.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -82.42 -29.67 30.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.9 -179.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 93.8 p -70.66 -38.54 73.81 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.925 -174.588 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.435 HD11 ' H ' ' A' ' 209' ' ' ASP . 40.7 pt -67.48 -24.52 31.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.148 178.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . 0.658 ' HB2' ' HG2' ' A' ' 148' ' ' MET . . . -59.68 -37.44 78.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.112 -177.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 89.0 tt0 -57.74 -40.66 80.21 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.896 -176.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -63.82 -39.0 93.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.118 176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -64.98 -38.52 91.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.153 176.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -65.55 -33.9 77.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.78 179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -60.43 -31.97 70.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.867 176.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -93.01 -18.44 22.69 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.914 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 87.63 29.04 22.56 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.477 -177.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -92.03 -27.02 18.07 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.889 0.376 . . . . 0.0 110.889 -171.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 98.3 m -111.02 125.03 53.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.167 -176.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . . . . . . . . . . . -74.28 -49.43 23.14 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.173 -177.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.414 ' N ' ' O ' ' A' ' 146' ' ' ALA . 66.3 mtm -134.98 155.45 50.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 -171.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 14.7 t -153.02 166.26 32.99 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.111 177.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 40.3 mm -113.49 124.03 69.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.114 176.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 59.9 m-80 -142.29 153.16 43.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.824 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . -135.0 -95.03 0.49 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.446 175.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -70.97 -24.02 24.62 Favored 'Trans proline' 0 C--O 1.231 0.156 0 C-N-CA 122.759 2.306 . . . . 0.0 112.239 -179.716 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 90.3 m95 -74.75 -37.79 62.4 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.872 -173.546 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 49.72 40.3 19.72 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.133 -175.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 16.2 m0 -70.76 -22.99 62.34 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.927 -179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 29.4 t -51.37 130.8 27.9 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.907 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . . . . . . . . . 51.2 p30 -87.7 -167.78 2.0 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.95 -178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . . . . . . . . . 35.7 mt 55.11 75.07 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.125 -174.704 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 95.6 m-20 -52.73 -45.67 67.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.916 -174.01 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 49.3 p -89.8 -178.97 5.64 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.11 -174.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 93.3 p -79.26 -5.02 53.42 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.944 176.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.81 171.8 1.96 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.525 ' O ' HG12 ' A' ' 240' ' ' VAL . 14.9 t 54.88 41.09 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.164 -174.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.484 ' HB2' ' HB2' ' A' ' 120' ' ' ASP . 74.4 m-20 42.31 69.97 0.33 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.923 179.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 56.3 t80 -127.09 133.07 50.5 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.95 -174.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -133.69 155.09 21.59 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.446 178.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . . . . . . . . . 3.4 p -145.61 138.97 21.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.907 0.384 . . . . 0.0 111.113 178.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.5 t -155.64 152.61 28.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.116 -178.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 21.8 m -60.81 168.45 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.151 -176.534 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.681 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.5 mm? -61.12 150.74 77.97 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.658 0.742 . . . . 0.0 110.907 -162.249 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -79.48 -178.23 4.44 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.631 2.221 . . . . 0.0 112.293 -176.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 98.5 m -98.37 142.24 30.25 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.12 -174.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -132.84 114.87 14.58 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.825 -176.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt 54.91 36.52 26.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.881 -178.459 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 84.99 2.74 88.24 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.661 -0.781 . . . . 0.0 112.613 174.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 -130.71 138.1 32.26 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-O 121.618 0.723 . . . . 0.0 110.954 178.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -68.5 137.45 39.45 Favored 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.706 2.271 . . . . 0.0 112.389 -174.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.681 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 98.8 p -79.19 -8.12 58.76 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.823 174.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 51.7 mtmt -49.99 116.6 6.53 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-O 121.475 0.655 . . . . 0.0 110.888 -179.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . 0.482 ' HG3' HD22 ' A' ' 113' ' ' LEU . 72.5 Cg_endo -80.44 167.75 18.88 Favored 'Trans proline' 0 N--CA 1.464 -0.21 0 C-N-CA 122.689 2.259 . . . . 0.0 112.264 -176.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 24.5 p90 -66.89 169.89 7.46 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.885 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . . . . . . . . . 80.5 t -106.86 133.16 52.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.089 -176.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -108.5 139.6 15.22 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.551 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . . . . . . . . . 97.5 t -125.6 120.07 56.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.916 0.388 . . . . 0.0 111.1 178.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.407 HD23 ' C ' ' A' ' 262' ' ' LEU . 7.3 tt -78.98 129.13 34.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.989 168.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.761 ' HB2' ' HB1' ' A' ' 105' ' ' ALA . 96.5 p -132.39 160.76 35.43 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.915 -170.622 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . . . . . . . . . . . -130.62 143.04 50.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.147 -175.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.627 ' HA3' ' HH2' ' A' ' 62' ' ' TRP . . . -139.64 172.53 23.27 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.635 -0.793 . . . . 0.0 112.47 -175.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 23.3 mm -113.53 131.0 66.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 120.847 0.356 . . . . 0.0 111.191 -171.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 57.0 t-20 -65.28 133.59 51.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.861 -173.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.623 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -64.94 -27.2 68.68 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.155 -177.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -81.46 -8.58 59.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.996 -173.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.5 t -69.14 121.66 82.63 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-O 121.648 0.737 . . . . 0.0 110.948 -175.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.19 -17.79 18.86 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.717 2.278 . . . . 0.0 112.311 172.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . . . . . . . . . 52.3 p-10 -112.05 29.29 8.01 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.963 -178.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.5 pttp -60.02 -25.38 65.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.861 -170.129 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 65.9 mm-40 -64.99 -43.38 92.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.822 -169.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . . . . . . . . . 3.0 pp -76.93 -33.4 57.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.989 179.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . . . . . . . . . . . -65.02 -47.31 77.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.989 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 53.0 pttt -66.64 -35.01 79.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.921 -177.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . . . . . . . . . 88.9 mt-10 -69.4 -48.94 59.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.903 -173.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . 0.496 ' CD1' ' C ' ' A' ' 279' ' ' PHE . 0.6 OUTLIER -67.5 -31.24 71.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.922 -175.16 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.44 ' O ' ' HB2' ' A' ' 284' ' ' LEU . 6.2 tt -64.61 -46.39 82.83 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.945 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 23.6 pt-20 -79.3 -24.88 42.57 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.887 -177.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 -97.61 -20.01 17.93 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.949 -168.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -119.97 -56.49 2.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.952 -179.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 280' ' ' LEU . 0.1 OUTLIER -65.68 -41.28 92.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.911 -176.085 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -84.66 48.21 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.922 169.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.432 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 74.2 m -145.52 146.69 31.54 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.112 173.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.431 ' HA ' HD11 ' A' ' 290' ' ' LEU . 35.8 t70 -40.0 -39.77 0.92 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.907 -178.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.9 mt-10 -73.0 -41.69 64.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.884 -172.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . . . . . . . . . . . -71.83 -51.18 16.02 Favored Glycine 0 N--CA 1.453 -0.225 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.534 -172.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.69 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.5 OUTLIER -75.49 -22.99 56.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.717 0.294 . . . . 0.0 110.89 -177.562 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.433 ' N ' HD12 ' A' ' 290' ' ' LEU . 86.6 tt0 -67.11 -40.6 86.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.888 169.747 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -63.95 -35.06 79.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.015 -179.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.746 HG13 ' HA3' ' A' ' 19' ' ' GLY . 47.3 t -74.86 -43.68 46.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.14 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 42.2 t30 -63.28 -31.14 72.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.897 179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -67.24 -32.34 73.31 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.807 -176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . 0.76 ' HB3' ' HB3' ' A' ' 18' ' ' ASN . 67.0 m-20 -94.99 -27.32 15.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.856 -173.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.401 ' O ' HD13 ' A' ' 299' ' ' LEU . 78.5 tttt -148.1 136.7 11.51 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-O 121.556 0.694 . . . . 0.0 110.857 168.136 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 77.2 Cg_exo -52.33 111.87 0.73 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.687 2.258 . . . . 0.0 112.35 178.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.401 HD13 ' O ' ' A' ' 297' ' ' LYS . 0.4 OUTLIER -90.08 -28.58 18.91 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.894 174.697 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . . . . . . . . . . . 95.06 -55.08 1.84 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.817 -0.706 . . . . 0.0 112.49 -176.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.436 ' HA ' HD23 ' A' ' 311' ' ' LEU . . . -179.37 159.27 0.91 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.79 0.329 . . . . 0.0 111.067 -176.164 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.584 HG23 ' HB3' ' A' ' 307' ' ' TYR . 32.6 m -127.02 164.67 27.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.135 177.566 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -79.1 -4.22 49.22 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.066 -179.762 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.69 ' CD2' HD21 ' A' ' 290' ' ' LEU . 58.9 tp -86.12 135.64 33.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.751 -172.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -47.3 -31.79 4.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.928 -178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.521 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 70.8 m -47.85 -39.99 20.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.843 173.635 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.584 ' HB3' HG23 ' A' ' 302' ' ' VAL . 0.0 OUTLIER -63.37 -46.1 88.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.935 173.556 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.432 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 32.9 tt0 -54.54 -36.78 64.65 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.736 -179.178 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -80.76 -61.77 1.87 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.804 178.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 72.9 mm-40 -83.02 -58.3 2.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.938 -168.375 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.509 ' HA ' HD12 ' A' ' 311' ' ' LEU . 0.0 OUTLIER -60.38 -36.44 78.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.913 -171.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . . . . . . . . . . . -64.06 -14.97 58.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.077 -176.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -63.26 -22.0 66.6 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.892 178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.446 ' HB3' HD12 ' A' ' 317' ' ' ILE . 62.9 t0 -78.25 119.59 77.91 Favored Pre-proline 0 C--N 1.327 -0.387 0 CA-C-O 121.584 0.707 . . . . 0.0 110.938 167.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_exo -45.65 -35.24 12.65 Favored 'Trans proline' 0 C--N 1.343 0.26 0 C-N-CA 122.638 2.225 . . . . 0.0 112.323 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 94.2 mtm-85 -69.65 -37.54 76.79 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -176.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.446 HD12 ' HB3' ' A' ' 314' ' ' ASP . 66.0 mt -79.9 -29.91 13.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.087 178.446 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . . . . . . . . . . . -59.63 -39.9 85.84 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.091 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . . . . . . . . . . . -66.18 -47.27 74.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.078 174.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 78.9 p -65.07 -24.98 67.61 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.057 -179.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 65.6 ttp -63.51 -40.57 97.39 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.937 174.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 88.0 tt0 -65.01 -42.54 94.37 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.774 176.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -58.77 -44.64 90.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.928 173.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . . . . . . . . . . . -65.03 -43.91 90.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.052 -178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.5 mt-30 -67.84 -34.98 77.77 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.929 -178.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -101.07 -3.73 28.74 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.939 -174.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . . . . . . . . . . . -95.11 -163.59 34.83 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.43 -173.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.616 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 95.7 mt-10 -140.9 137.24 33.01 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.841 0.353 . . . . 0.0 110.835 -178.021 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.59 ' O ' ' C ' ' A' ' 330' ' ' MET . 35.6 mm -81.06 109.83 15.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.191 -170.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.59 ' C ' ' O ' ' A' ' 329' ' ' ILE . 6.9 tpt 23.03 57.71 0.29 Allowed Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.565 0.698 . . . . 0.0 110.899 174.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.616 ' HG3' ' HB3' ' A' ' 328' ' ' GLU . 44.5 Cg_endo -90.87 -4.6 4.54 Favored 'Trans proline' 0 C--N 1.341 0.151 0 C-N-CA 122.639 2.226 . . . . 0.0 112.287 -176.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.57 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 94.6 m-20 -101.51 4.96 41.63 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.869 -161.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.57 ' HB ' ' O ' ' A' ' 332' ' ' ASN . 45.7 mm 86.06 132.93 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.654 0.74 . . . . 0.0 111.086 162.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -68.07 -28.72 34.52 Favored 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.692 2.261 . . . . 0.0 112.398 -175.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.465 ' H ' HG22 ' A' ' 333' ' ' ILE . 89.7 mt-30 -69.98 -27.27 64.58 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.923 176.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 17.4 mmt -74.6 -24.58 58.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.789 -179.738 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 73.9 m -61.89 -33.71 74.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.879 177.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -72.65 -35.72 67.8 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.167 175.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . . . . . . . . . 10.6 m-30 -64.25 -35.22 80.12 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.871 172.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . 0.407 ' HA ' HG22 ' A' ' 343' ' ' VAL . 52.5 m0 -63.86 -31.12 72.19 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.962 174.25 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 21.8 m-30 -73.64 -37.07 65.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.966 176.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -61.41 -41.08 96.59 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.133 176.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.407 HG22 ' HA ' ' A' ' 340' ' ' TRP . 10.1 m -80.88 -23.44 10.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.137 177.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.533 ' NE ' ' HD3' ' A' ' 154' ' ' PRO . 64.9 ttt180 -57.43 -53.17 61.19 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.897 172.099 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 67.4 p -62.52 -25.96 68.31 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.141 -179.241 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -58.21 -39.0 77.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.085 178.801 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.604 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.2 m -73.1 -31.86 36.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.194 -177.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.39 -44.85 97.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.152 173.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 96.2 m-20 -64.95 -34.96 79.67 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.873 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.86 -45.12 62.43 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.068 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.82 -39.56 87.72 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.129 -175.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 91.2 p -75.88 -12.81 60.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.799 -177.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.2 14.86 82.13 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.588 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -78.52 -32.2 47.96 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.741 0.305 . . . . 0.0 110.873 -178.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 79.4 mm-40 -136.4 153.68 51.03 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.879 179.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 46.0 p -79.85 167.65 20.27 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.133 170.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.424 ' HA ' HD23 ' A' ' 192' ' ' LEU . 53.8 t -55.4 -41.58 63.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.12 172.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -59.56 -45.03 93.02 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.929 177.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 74.5 mm-40 -72.84 -53.91 10.19 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.842 179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.29 -44.2 76.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.091 -171.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.718 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -67.08 -40.36 86.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.905 -178.105 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -65.09 -40.19 94.26 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.928 174.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -61.88 -39.91 93.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.834 178.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -63.39 -42.87 98.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.128 175.028 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . . . . . . . . . 19.7 tm0? -62.8 -39.05 93.07 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.821 177.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . . . . . . . . . 90.4 m -64.38 -38.62 91.67 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.121 178.633 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 77.9 mtt-85 -68.69 -35.11 76.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.89 177.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.719 HD12 HG21 ' A' ' 183' ' ' VAL . 75.2 mt -67.32 -45.32 86.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.099 -178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.6 p -101.71 -14.01 17.53 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.149 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . . . . . . . . . 99.1 mttt . . . . . 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.97 -179.558 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 87.8 tttt . . . . . 0 C--O 1.232 0.165 0 CA-C-O 120.71 0.291 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 96.0 mt -81.55 131.81 32.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.095 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -135.59 144.27 46.08 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.937 -177.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 88.6 tt0 -56.14 135.14 53.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.917 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . 0.483 ' HA2' HG22 ' A' ' 33' ' ' ILE . . . 98.32 -1.85 59.06 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.492 -178.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 88.3 tttt -166.29 137.34 3.53 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.862 0.363 . . . . 0.0 110.874 174.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.62 ' H ' HD23 ' A' ' 7' ' ' LEU . 0.7 OUTLIER -143.48 157.54 44.36 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.935 -172.745 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.425 ' HB ' ' HA ' ' A' ' 57' ' ' PRO . 86.4 t -113.45 132.34 62.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.116 -176.696 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.836 ' HB ' HD21 ' A' ' 20' ' ' LEU . 1.0 OUTLIER -119.95 127.41 75.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.062 -178.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' TRP . . . . . 0.573 ' CD1' ' HB2' ' A' ' 38' ' ' GLU . 44.8 m0 -106.16 129.47 54.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.887 178.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.426 HG22 ' O ' ' A' ' 12' ' ' ASN . 60.7 mt -122.21 140.54 45.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.137 170.6 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.426 ' O ' HG22 ' A' ' 11' ' ' ILE . 64.2 t30 -50.15 141.74 10.76 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.906 172.023 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.403 ' HA3' ' OD2' ' A' ' 41' ' ' ASP . . . -58.06 -11.34 8.63 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.814 -0.707 . . . . 0.0 112.43 -172.582 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 99.9 m-20 -73.32 -14.39 61.29 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.873 0.368 . . . . 0.0 110.923 -176.502 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -136.94 109.99 7.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.957 158.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.36 -91.09 0.84 Allowed Glycine 0 N--CA 1.453 -0.228 0 C-N-CA 120.755 -0.735 . . . . 0.0 112.413 -154.562 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 90.6 t80 -104.7 -47.49 4.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.857 0.361 . . . . 0.0 110.849 -167.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASN . . . . . . . . . . . . . 97.7 m-20 -66.53 -46.86 74.76 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.922 -156.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.672 ' HA3' HG13 ' A' ' 293' ' ' VAL . . . -58.13 -47.06 91.6 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.512 -179.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.836 HD21 ' HB ' ' A' ' 9' ' ' ILE . 0.1 OUTLIER -55.65 -60.97 2.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.792 0.329 . . . . 0.0 110.898 173.834 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -51.04 -39.28 55.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.118 -177.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 53.5 tp10 -64.58 -52.83 55.56 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.895 -177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 17.3 m -75.69 -35.4 31.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.183 -177.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.702 ' HA3' HG21 ' A' ' 35' ' ' VAL . . . -65.38 -44.57 93.13 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.481 -179.829 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.67 -36.46 78.78 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.802 0.334 . . . . 0.0 110.832 -178.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 58.9 tptt -61.6 -39.84 92.67 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.868 173.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PHE . . . . . 0.448 ' CD2' HD11 ' A' ' 33' ' ' ILE . 1.3 t80 -61.32 -44.82 96.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.892 178.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 88.5 tt0 -63.0 -38.99 93.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.848 178.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -65.27 -31.85 73.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.891 -179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 97.7 m-20 -83.13 -43.77 15.84 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.895 -172.368 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . 0.53 ' OG1' HG13 ' A' ' 33' ' ' ILE . 53.8 p -113.85 -11.63 12.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.183 -171.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.87 14.0 81.46 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.524 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.142 ' O ' HD12 ' A' ' 33' ' ' ILE . 1.8 pp -104.55 126.83 59.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.761 0.315 . . . . 0.0 111.137 -176.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.42 ' O ' ' HA ' ' A' ' 6' ' ' LYS . 98.6 mttt -75.77 141.53 42.55 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.947 -171.005 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.702 HG21 ' HA3' ' A' ' 24' ' ' GLY . 2.9 m -114.99 135.97 53.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.081 -178.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.432 ' O ' HD12 ' A' ' 9' ' ' ILE . 99.0 m -105.29 128.1 53.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.045 178.479 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . 0.523 HG22 ' HG ' ' A' ' 20' ' ' LEU . 58.4 t -96.24 121.38 46.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.145 179.424 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.573 ' HB2' ' CD1' ' A' ' 10' ' ' TRP . 69.2 mm-40 -130.09 144.61 51.44 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.273 -0.422 . . . . 0.0 110.837 172.159 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' HIS . . . . . . . . . . . . . 55.6 p-80 -156.82 58.78 1.68 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 121.585 0.707 . . . . 0.0 110.867 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . 0.474 ' O ' ' HB2' ' A' ' 41' ' ' ASP . 73.5 Cg_endo -80.71 -12.91 12.12 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.686 2.257 . . . . 0.0 112.296 -170.752 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ASP . . . . . 0.474 ' HB2' ' O ' ' A' ' 40' ' ' PRO . 26.2 m-20 63.59 19.96 11.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.857 -171.192 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.405 ' O ' ' N ' ' A' ' 45' ' ' GLU . 98.6 mttt -93.67 0.25 56.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.966 174.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LEU . . . . . 0.4 ' HG ' ' H ' ' A' ' 43' ' ' LEU . 14.1 mt -45.77 -51.77 12.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.951 -166.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -67.67 -26.53 66.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.95 -177.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.405 ' N ' ' O ' ' A' ' 42' ' ' LYS . 98.4 mt-10 -78.68 -33.1 47.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.993 177.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.419 ' HD3' ' HA ' ' A' ' 46' ' ' LYS . 69.0 mmtt -82.72 -30.22 29.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.9 -174.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' PHE . . . . . 0.51 ' HB2' ' HD3' ' A' ' 48' ' ' PRO . 14.1 m-30 -40.72 -56.07 4.08 Favored Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 121.637 0.732 . . . . 0.0 110.826 -177.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . 0.51 ' HD3' ' HB2' ' A' ' 47' ' ' PHE . 51.6 Cg_endo -67.34 -27.44 40.47 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.717 2.278 . . . . 0.0 112.307 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 79.3 mt-30 -79.65 -44.41 20.98 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.843 -174.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 23.2 m -69.75 -27.49 33.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.152 -179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.67 -34.91 78.92 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.101 170.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -70.28 -30.48 67.5 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.08 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 72.3 p -92.58 -12.1 32.64 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.217 177.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . 75.69 15.12 81.48 Favored Glycine 0 N--CA 1.453 -0.175 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.42 175.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 31.3 t0 -163.78 157.31 18.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.91 0.386 . . . . 0.0 110.859 175.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.5 -138.81 2.49 Favored Glycine 0 N--CA 1.45 -0.41 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.468 -178.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PRO . . . . . 0.491 ' HG3' ' CD2' ' A' ' 10' ' ' TRP . 73.6 Cg_endo -67.69 150.41 79.37 Favored 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.655 2.236 . . . . 0.0 112.401 168.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 57.8 t0 -76.32 -38.57 55.83 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.931 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.716 ' HB ' HG23 ' A' ' 9' ' ' ILE . 3.7 mp -126.4 138.66 53.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.207 173.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.514 HG23 ' CZ2' ' A' ' 62' ' ' TRP . 2.2 tp -128.48 129.8 68.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.131 179.718 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.549 ' CE2' HG13 ' A' ' 108' ' ' ILE . 2.0 m-85 -98.53 142.68 29.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.831 175.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TRP . . . . . 0.535 ' HH2' ' HA3' ' A' ' 265' ' ' GLY . 6.1 m-90 -119.68 139.81 51.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.922 176.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.407 ' O ' ' HA ' ' A' ' 262' ' ' LEU . . . -59.65 -85.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.092 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 63.5 m170 -122.52 -61.46 1.46 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 173.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 69.4 m-20 -84.56 -27.92 26.97 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.773 -167.046 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.452 ' HB2' ' HB3' ' A' ' 62' ' ' TRP . 89.4 mtt180 -60.07 -30.5 69.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.891 -158.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . . . . . . . . . 14.3 p90 -67.8 -27.92 67.15 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.91 -170.284 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -64.85 -51.84 47.68 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.515 -173.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . -62.16 -36.27 92.74 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.526 176.515 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' TYR . . . . . 0.574 ' CE2' ' HB3' ' A' ' 76' ' ' LEU . 18.4 t80 -65.98 -38.31 88.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.932 0.396 . . . . 0.0 110.891 -178.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -73.14 -43.94 60.86 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.102 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -62.61 -32.06 73.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.891 -178.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 69.2 m -80.48 -12.57 59.53 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.883 175.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 71.1 31.95 66.17 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.77 -0.728 . . . . 0.0 112.503 175.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.49 -1.26 56.88 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.79 0.329 . . . . 0.0 110.879 -172.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.574 ' HB3' ' CE2' ' A' ' 70' ' ' TYR . 0.5 OUTLIER -130.99 156.94 44.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.975 -179.287 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.62 ' HB2' ' HA ' ' A' ' 268' ' ' ALA . . . -66.9 130.46 43.21 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.132 175.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLU . . . . . . . . . . . . . 22.8 tt0 -69.52 122.97 20.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.929 174.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 42.9 pt -109.3 159.97 8.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.05 -171.82 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 75.6 p -103.23 146.5 32.56 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-O 121.629 0.728 . . . . 0.0 111.065 -171.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.84 146.25 29.56 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.682 2.255 . . . . 0.0 112.326 -178.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 67.7 t0 -107.94 114.68 28.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.854 169.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -52.68 -35.92 56.18 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.828 -179.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -65.08 -40.97 95.38 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.117 179.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 17.7 m-30 -69.97 -38.25 76.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.862 -178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -54.95 -48.61 72.95 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.888 176.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 99.3 m-20 -63.76 -36.39 83.71 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.845 175.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -75.78 -19.99 58.59 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.925 -176.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 304' ' ' LEU . 0.2 OUTLIER -103.34 -103.52 0.29 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.931 -173.304 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 91' ' ' PRO . 43.0 t80 -165.92 134.28 2.41 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.688 0.756 . . . . 0.0 110.933 -172.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 90' ' ' TYR . 70.9 Cg_exo -52.51 -39.94 73.33 Favored 'Trans proline' 0 C--N 1.341 0.168 0 C-N-CA 122.696 2.264 . . . . 0.0 112.375 -170.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -78.44 -30.51 47.58 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.96 -177.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 58.2 m -69.48 -48.7 59.84 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.196 -166.382 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TRP . . . . . 0.454 ' HA ' HG22 ' A' ' 97' ' ' VAL . 51.9 p-90 -66.57 -28.4 68.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.87 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -71.44 -37.59 71.4 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.855 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ALA . . . . . . . . . . . . . . . -67.98 -25.07 65.24 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.141 -179.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.565 ' HB ' ' HB3' ' A' ' 105' ' ' ALA . 21.7 m -101.55 16.54 4.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.189 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ARG . . . . . 0.445 ' HA ' ' HA ' ' A' ' 103' ' ' LEU . 68.1 ttt180 -101.8 133.11 47.07 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.905 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -149.06 130.31 14.61 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.882 178.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 60.3 t30 68.69 36.26 2.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.858 177.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLY . . . . . . . . . . . . . . . 80.12 -5.01 64.16 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.52 174.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -139.73 163.85 31.5 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.881 0.372 . . . . 0.0 110.896 177.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LEU . . . . . 0.553 HD22 HG23 ' A' ' 97' ' ' VAL . 13.1 mt -73.07 146.09 46.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.002 -175.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.431 ' C ' HD12 ' A' ' 104' ' ' ILE . 1.9 pp -122.33 9.91 5.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.179 173.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.876 ' HB1' ' HB3' ' A' ' 263' ' ' SER . . . -168.09 156.68 9.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.045 -177.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' TYR . . . . . 0.436 ' HB3' HD21 ' A' ' 285' ' ' LEU . 21.4 m-85 -124.99 146.34 53.21 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-O 121.766 0.793 . . . . 0.0 110.905 163.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.65 ' HB3' HG11 ' A' ' 261' ' ' VAL . 42.9 Cg_endo -71.4 121.09 7.43 Favored 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 122.616 2.211 . . . . 0.0 112.359 -178.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ILE . . . . . 0.549 HG13 ' CE2' ' A' ' 61' ' ' PHE . 25.1 mm -98.31 -32.28 3.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.137 177.372 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.04 151.34 26.73 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 75.6 t -115.02 132.99 62.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.079 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLU . . . . . . . . . . . . . 56.2 mp0 -112.88 131.72 55.6 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.83 173.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -148.08 154.49 40.29 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.966 176.5 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.425 ' HA ' ' HA2' ' A' ' 228' ' ' GLY . 11.0 mp -94.29 152.05 18.96 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.946 -174.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 91.5 p -148.22 157.59 43.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.875 -178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.813 HD13 ' C ' ' A' ' 115' ' ' LEU . 0.4 OUTLIER -99.23 125.2 44.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.85 174.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ILE . . . . . 0.58 ' N ' HD22 ' A' ' 115' ' ' LEU . 4.7 mp -107.54 132.1 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.131 -176.14 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 53.9 p90 -131.71 145.15 51.48 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.944 -178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 -100.2 113.08 25.47 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.749 177.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 241' ' ' ASN . 99.5 mttt -64.78 -15.01 61.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.812 -176.52 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASP . . . . . 0.456 ' HB2' ' HB2' ' A' ' 241' ' ' ASN . 15.1 t70 -80.47 -29.87 37.46 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.9 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.9 mp -88.83 -46.49 8.91 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.917 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.533 HD22 ' HB1' ' A' ' 223' ' ' ALA . 2.2 mp -111.24 124.94 31.53 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.587 0.708 . . . . 0.0 110.81 175.331 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -71.71 -26.71 19.12 Favored 'Trans proline' 0 C--N 1.341 0.152 0 C-N-CA 122.652 2.234 . . . . 0.0 112.302 173.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . . . . . . . . . 55.4 t-20 -152.47 96.28 3.03 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.628 0.728 . . . . 0.0 110.921 175.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.78 153.99 68.2 Favored 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.687 2.258 . . . . 0.0 112.331 -175.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -70.58 151.53 64.46 Favored 'Trans proline' 0 C--O 1.232 0.202 0 C-N-CA 122.651 2.234 . . . . 0.0 112.38 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -113.62 -5.07 13.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.864 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' THR . . . . . 0.495 HG22 ' H ' ' A' ' 130' ' ' GLU . 11.8 m -127.9 146.08 50.74 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.106 179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TRP . . . . . 0.458 ' HA ' HG12 ' A' ' 132' ' ' ILE . 63.1 m95 -66.39 -25.63 66.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.955 -177.314 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . 0.495 ' H ' HG22 ' A' ' 128' ' ' THR . 98.3 mt-10 -62.11 -30.32 70.94 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.05 177.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -77.15 -19.67 56.54 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.864 -175.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.587 ' N ' ' HD2' ' A' ' 133' ' ' PRO . 49.5 mm -62.0 -53.46 59.38 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.656 0.741 . . . . 0.0 111.133 -166.206 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 132' ' ' ILE . 31.9 Cg_endo -62.75 -40.06 38.81 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.7 2.266 . . . . 0.0 112.339 -177.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -64.0 -59.44 4.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.148 -178.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LEU . . . . . 1.17 ' C ' HD22 ' A' ' 135' ' ' LEU . 0.0 OUTLIER -69.71 -17.67 63.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.948 -175.257 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.637 ' HA ' HD22 ' A' ' 139' ' ' LEU . 39.0 t70 -63.49 -39.08 93.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.851 169.027 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -67.01 -36.72 82.78 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.895 178.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -73.16 -50.3 23.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.839 -174.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 140' ' ' LYS . 0.3 OUTLIER -75.18 -15.2 60.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.892 -176.524 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.675 ' N ' HD23 ' A' ' 139' ' ' LEU . 87.8 tttt -56.28 -35.06 67.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.929 170.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . . . . . . . . . . . -65.18 -23.84 67.21 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.129 179.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -94.9 8.64 42.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.816 178.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 75.22 27.51 63.85 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.425 177.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.434 ' HB2' ' HG ' ' A' ' 139' ' ' LEU . 46.0 mtmt -120.87 165.41 15.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.859 0.361 . . . . 0.0 110.862 173.174 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . 0.52 ' HA ' HD21 ' A' ' 139' ' ' LEU . 37.1 t -128.56 146.69 50.77 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 170.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.409 ' O ' ' HB2' ' A' ' 224' ' ' MET . . . -72.04 -58.31 3.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.084 -164.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 2.3 tm? -138.64 128.87 25.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.922 -161.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 97.1 mmm -105.91 128.64 53.91 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.844 178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 39.8 p90 -153.77 162.38 41.29 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.886 -176.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' ASN . . . . . . . . . . . . . 30.3 t-20 -123.89 142.95 50.67 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.899 171.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.421 ' HG ' HG21 ' A' ' 347' ' ' VAL . 54.4 tp -113.35 -9.73 13.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.975 -175.586 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLN . . . . . . . . . . . . . 87.1 mt-30 -73.71 0.14 13.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.896 -179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -118.0 148.39 43.37 Favored Pre-proline 0 C--N 1.332 -0.191 0 CA-C-O 121.738 0.78 . . . . 0.0 110.828 175.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -64.77 -20.01 64.66 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.595 2.197 . . . . 0.0 112.327 -178.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 65.7 m-85 -62.37 -36.69 83.06 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.933 -174.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' PHE . . . . . . . . . . . . . 53.9 t80 -84.32 -37.69 21.31 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.905 -179.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' THR . . . . . . . . . . . . . 32.4 p -64.09 -37.77 88.63 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.135 -175.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' TRP . . . . . 0.561 ' N ' ' HD2' ' A' ' 159' ' ' PRO . 12.4 t-105 -62.21 -55.13 43.27 Favored Pre-proline 0 C--N 1.328 -0.347 0 CA-C-O 121.621 0.724 . . . . 0.0 110.935 -172.033 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' PRO . . . . . 0.561 ' HD2' ' N ' ' A' ' 158' ' ' TRP . 26.4 Cg_endo -67.37 -32.48 32.4 Favored 'Trans proline' 0 C--O 1.232 0.191 0 C-N-CA 122.68 2.253 . . . . 0.0 112.326 -171.375 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.702 ' O ' HD23 ' A' ' 160' ' ' LEU . 6.5 tt -74.48 -40.31 61.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.981 179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.481 ' HA ' ' HA3' ' A' ' 191' ' ' GLY . 76.0 mt -69.74 -40.44 79.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.128 177.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ALA . . . . . . . . . . . . . . . -69.78 -26.72 64.41 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.142 -179.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ALA . . . . . . . . . . . . . . . -61.59 -30.25 70.55 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.12 -176.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -94.56 0.56 55.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.913 177.996 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . 112.19 5.41 24.96 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.55 176.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.473 ' HA3' HG22 ' A' ' 161' ' ' ILE . . . -79.21 66.68 3.41 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.383 178.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -90.28 152.58 20.98 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.867 0.365 . . . . 0.0 110.883 -174.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -74.68 -17.95 60.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.112 -176.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -147.56 154.04 40.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.087 0.47 . . . . 0.0 110.813 -173.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -97.24 128.93 44.56 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.885 159.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -96.19 122.64 39.26 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.918 179.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' GLU . . . . . . . . . . . . . 88.3 tt0 -149.73 130.71 14.34 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.954 178.015 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ASN . . . . . . . . . . . . . 62.4 t30 56.9 44.28 23.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.873 172.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.14 6.43 74.3 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.46 173.008 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' LYS . . . . . . . . . . . . . 99.7 mttt -132.71 142.39 49.03 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.858 0.361 . . . . 0.0 110.942 -176.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 9.1 m-30 -77.77 134.85 37.97 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.917 165.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ASP . . . . . . . . . . . . . 67.3 t0 -95.12 104.97 16.86 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 177.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.3 tp -65.76 -19.95 26.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.106 -177.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -94.74 -8.43 37.68 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.901 -177.144 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 66.1 t0 -132.63 95.58 3.64 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 174.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' VAL . . . . . 0.501 HG23 HG22 ' A' ' 183' ' ' VAL . 33.1 m -115.82 173.05 3.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.218 -0.447 . . . . 0.0 111.107 -177.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' GLY . . . . . . . . . . . . . . . -99.95 12.13 60.7 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.442 -167.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' VAL . . . . . 0.563 HG21 ' CD1' ' A' ' 368' ' ' ILE . 17.9 m -101.62 -17.92 6.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.768 0.318 . . . . 0.0 111.156 -172.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ASP . . . . . 0.449 ' HB3' ' HG3' ' A' ' 365' ' ' GLN . 57.5 p-10 -95.57 19.85 10.46 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.868 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ASN . . . . . . . . . . . . . 73.5 m-80 -118.11 171.55 8.02 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.868 -176.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -64.08 -24.46 67.71 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.069 -175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.05 -39.78 94.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.524 -172.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.637 ' HB3' HD11 ' A' ' 361' ' ' LEU . . . -65.5 -39.4 91.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.849 0.357 . . . . 0.0 111.068 177.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' LYS . . . . . 0.505 ' HA ' ' HG ' ' A' ' 361' ' ' LEU . 92.2 mttt -59.73 -37.37 78.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.84 173.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -63.58 -38.11 89.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.121 177.8 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . 0.481 ' HA3' ' HA ' ' A' ' 161' ' ' ILE . . . -64.0 -45.41 94.03 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.76 -0.733 . . . . 0.0 112.374 177.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' LEU . . . . . 0.593 HD11 ' HA ' ' A' ' 347' ' ' VAL . 18.7 tp -68.33 -33.31 74.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.928 0.394 . . . . 0.0 110.971 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' THR . . . . . 0.415 ' O ' HG12 ' A' ' 196' ' ' VAL . 89.5 m -63.06 -42.28 99.66 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.159 179.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -67.29 -58.03 5.56 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.87 178.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' LEU . . . . . 0.626 HD12 ' C ' ' A' ' 195' ' ' LEU . 3.4 pp -63.49 -27.78 69.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.969 -165.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' VAL . . . . . 0.563 ' N ' HD12 ' A' ' 195' ' ' LEU . 3.7 p -72.77 -22.55 20.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.11 177.819 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -66.06 -58.79 4.7 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.886 -174.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' LEU . . . . . 1.055 ' H ' ' CD1' ' A' ' 198' ' ' LEU . 0.0 OUTLIER -75.42 -24.54 57.13 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.969 -167.404 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ILE . . . . . 0.804 ' N ' HD22 ' A' ' 198' ' ' LEU . 2.1 pp -77.35 -35.8 22.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.173 172.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -64.89 -30.71 71.72 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.919 169.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 94.5 m-20 -85.55 5.79 29.96 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.843 177.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' LYS . . . . . . . . . . . . . 94.4 mttt 67.26 40.02 2.88 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.904 170.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' HIS . . . . . . . . . . . . . 85.7 m-70 -82.8 -14.36 54.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.862 170.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' MET . . . . . . . . . . . . . 60.5 ttp -133.14 146.31 51.47 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.864 173.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' ASN . . . . . . . . . . . . . 95.8 m-20 -94.94 155.91 16.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.9 178.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' ALA . . . . . . . . . . . . . . . -63.2 -25.03 68.15 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.13 -179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -95.09 -3.5 47.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.877 -177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . . . . . . . . . 95.3 m -63.53 130.88 46.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.17 -175.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ASP . . . . . 0.514 ' H ' HD11 ' A' ' 212' ' ' ILE . 21.5 t0 -146.78 172.24 13.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.878 176.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -75.49 -34.38 60.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.932 -172.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 47.7 t -68.81 -48.3 63.94 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.806 -174.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ILE . . . . . 0.514 HD11 ' H ' ' A' ' 209' ' ' ASP . 29.8 pt -65.94 -24.85 34.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.123 176.201 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ALA . . . . . . . . . . . . . . . -64.97 -35.6 81.71 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.18 -179.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' GLU . . . . . . . . . . . . . 71.5 mm-40 -67.84 -35.96 79.51 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.809 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ALA . . . . . . . . . . . . . . . -62.16 -40.16 95.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.164 173.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.0 -40.49 95.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.136 174.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . . . . . . . . . 71.3 t80 -65.09 -39.4 93.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.868 -177.134 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -63.64 -32.09 73.45 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.842 -179.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -88.17 -10.87 48.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.979 -176.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLY . . . . . . . . . . . . . . . 85.9 25.75 36.9 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.533 -179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -86.54 -26.23 24.64 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.898 0.38 . . . . 0.0 110.805 -175.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 9.0 t -125.45 134.51 52.06 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.131 -179.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' ALA . . . . . 0.533 ' HB1' HD22 ' A' ' 122' ' ' LEU . . . -72.55 -35.74 68.1 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.085 -175.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' MET . . . . . 0.409 ' HB2' ' O ' ' A' ' 146' ' ' ALA . 72.5 mtm -131.99 155.51 47.87 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.938 0.399 . . . . 0.0 110.879 -176.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' THR . . . . . . . . . . . . . 11.6 t -149.01 160.12 43.6 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.099 174.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' ILE . . . . . . . . . . . . . 49.7 mm -115.09 125.02 72.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.114 -175.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 69.8 m-80 -145.02 151.06 37.96 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.907 178.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 113' ' ' LEU . . . -135.07 -97.51 0.55 Allowed Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.457 174.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.93 -17.39 36.83 Favored 'Trans proline' 0 C--N 1.341 0.132 0 C-N-CA 122.741 2.294 . . . . 0.0 112.329 179.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' TRP . . . . . . . . . . . . . 88.5 m95 -67.38 -33.33 74.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.999 -176.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ALA . . . . . . . . . . . . . . . 53.57 32.9 15.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.032 -179.217 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' TRP . . . . . . . . . . . . . 35.2 m0 -72.65 -34.58 67.36 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.035 179.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 19.2 t -55.52 112.77 1.21 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.868 -171.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ASN . . . . . 0.413 ' O ' ' HB ' ' A' ' 235' ' ' ILE . 44.7 p30 -95.47 -162.85 0.99 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.955 -177.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ILE . . . . . 0.527 HG22 ' O ' ' A' ' 235' ' ' ILE . 47.6 mt 69.86 54.54 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.157 -175.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' ASP . . . . . . . . . . . . . 92.1 m-20 -60.03 -29.99 68.88 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.913 -179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' THR . . . . . . . . . . . . . 72.3 p -82.14 169.23 16.88 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.032 -179.47 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' SER . . . . . . . . . . . . . 97.2 p -76.16 -6.11 49.78 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.973 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -61.03 160.56 9.74 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.923 178.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' VAL . . . . . 0.519 ' O ' HG12 ' A' ' 240' ' ' VAL . 11.6 t 55.99 35.0 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.174 -178.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ASN . . . . . 0.46 ' C ' ' O ' ' A' ' 240' ' ' VAL . 77.4 m-20 37.27 70.0 0.2 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.892 169.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.4 ' CD1' ' C ' ' A' ' 242' ' ' TYR . 4.4 t80 -119.48 135.39 54.78 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.908 -171.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' GLY . . . . . . . . . . . . . . . -138.07 158.47 24.77 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.428 175.381 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' VAL . . . . . 0.526 HG22 ' HB2' ' A' ' 319' ' ' ALA . 7.4 p -141.48 139.95 31.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.871 0.367 . . . . 0.0 111.11 -178.37 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . . . . . . . . . 14.3 t -153.02 148.92 27.62 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.162 177.122 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' VAL . . . . . . . . . . . . . 18.9 m -61.76 168.94 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.096 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' LEU . . . . . 0.578 ' HB3' ' OG ' ' A' ' 255' ' ' SER . 3.8 mm? -62.06 146.92 91.31 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.659 0.742 . . . . 0.0 110.895 -162.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' PRO . . . . . . . . . . . . . 71.4 Cg_endo -72.69 -177.42 2.81 Favored 'Trans proline' 0 C--O 1.232 0.212 0 C-N-CA 122.65 2.233 . . . . 0.0 112.35 179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' THR . . . . . . . . . . . . . 72.8 p -108.71 160.02 16.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.15 -175.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -143.59 122.38 12.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 110.89 178.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt 55.02 35.83 25.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.915 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' GLY . . . . . . . . . . . . . . . 87.09 7.35 77.44 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.546 169.93 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' GLN . . . . . . . . . . . . . 33.5 mt-30 -132.83 139.86 35.89 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.613 0.72 . . . . 0.0 110.905 176.285 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -71.87 140.9 36.03 Favored 'Trans proline' 0 C--N 1.341 0.148 0 C-N-CA 122.741 2.294 . . . . 0.0 112.376 -176.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' SER . . . . . 0.578 ' OG ' ' HB3' ' A' ' 247' ' ' LEU . 97.3 p -82.42 -5.87 58.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.865 170.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -49.93 113.33 3.31 Favored Pre-proline 0 C--N 1.33 -0.28 0 CA-C-O 121.545 0.688 . . . . 0.0 110.934 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -78.91 168.89 20.21 Favored 'Trans proline' 0 C--N 1.343 0.246 0 C-N-CA 122.563 2.175 . . . . 0.0 112.426 -175.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' PHE . . . . . . . . . . . . . 76.3 m-85 -72.9 171.75 12.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.883 -177.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.478 HG21 ' HA ' ' A' ' 324' ' ' ALA . 76.4 t -104.33 134.83 44.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.163 -170.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLY . . . . . . . . . . . . . . . -109.77 137.91 14.51 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.502 178.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' VAL . . . . . 0.65 HG11 ' HB3' ' A' ' 107' ' ' PRO . 93.8 t -121.84 124.04 70.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.938 0.399 . . . . 0.0 111.168 -176.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.407 ' HA ' ' O ' ' A' ' 63' ' ' ALA . 5.2 tt -72.09 128.82 36.9 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.875 168.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' SER . . . . . 0.876 ' HB3' ' HB1' ' A' ' 105' ' ' ALA . 58.5 m -121.31 153.89 37.11 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.871 -171.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ALA . . . . . 0.461 ' CB ' HD11 ' A' ' 280' ' ' LEU . . . -134.62 139.79 45.58 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.121 177.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' GLY . . . . . 0.535 ' HA3' ' HH2' ' A' ' 62' ' ' TRP . . . -142.41 172.22 24.37 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.518 -176.392 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 24.4 mm -112.87 134.31 55.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.8 0.333 . . . . 0.0 111.177 -169.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 -64.55 132.07 48.83 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.936 -175.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' ALA . . . . . 0.62 ' HA ' ' HB2' ' A' ' 77' ' ' ALA . . . -64.49 -30.21 71.25 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.116 -179.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' ALA . . . . . . . . . . . . . . . -84.1 -8.76 59.01 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.224 -0.443 . . . . 0.0 111.069 -172.065 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 26.3 t -68.21 121.66 81.11 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.639 0.733 . . . . 0.0 110.937 -174.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' PRO . . . . . . . . . . . . . 88.4 Cg_endo -75.27 -16.95 19.35 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.71 2.273 . . . . 0.0 112.352 175.177 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ASN . . . . . 0.439 ' HB2' HD21 ' A' ' 275' ' ' LEU . 53.1 p-10 -113.24 29.93 7.6 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.814 -178.762 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' LYS . . . . . . . . . . . . . 22.3 pttp -61.87 -25.29 67.45 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.923 -169.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLU . . . . . . . . . . . . . 66.2 mm-40 -65.65 -43.53 89.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.984 0.421 . . . . 0.0 110.805 -168.331 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 272' ' ' ASN . 2.5 pp -74.75 -33.73 62.37 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.919 179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' ALA . . . . . 0.444 ' HB1' HD11 ' A' ' 59' ' ' ILE . . . -65.81 -49.17 69.22 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.117 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' LYS . . . . . . . . . . . . . 49.9 pttt -65.22 -35.13 80.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.933 -177.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' GLU . . . . . 0.422 ' O ' ' HB2' ' A' ' 282' ' ' ASN . 94.0 mt-10 -68.62 -43.39 76.46 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.874 -177.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' PHE . . . . . . . . . . . . . 84.2 t80 -60.12 -46.58 89.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.905 176.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' LEU . . . . . 0.461 HD11 ' CB ' ' A' ' 264' ' ' ALA . 7.6 tt -62.43 -46.56 87.99 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.857 -177.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -70.99 -38.81 72.7 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.832 -177.894 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' ASN . . . . . 0.422 ' HB2' ' O ' ' A' ' 278' ' ' GLU . 94.8 m-20 -102.28 -10.9 19.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 -161.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' TYR . . . . . 0.426 ' O ' ' HA3' ' A' ' 289' ' ' GLY . 53.5 t80 -122.46 -51.57 1.96 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.95 -179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' LEU . . . . . 0.429 ' HA ' HD12 ' A' ' 284' ' ' LEU . 0.5 OUTLIER -70.58 -43.22 69.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.86 -176.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' LEU . . . . . 0.436 HD21 ' HB3' ' A' ' 106' ' ' TYR . 4.5 mm? -81.69 44.95 0.85 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.916 169.183 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' THR . . . . . 0.431 ' O ' ' HG ' ' A' ' 290' ' ' LEU . 89.6 m -145.77 145.37 30.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.168 178.024 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' ASP . . . . . 0.556 ' HA ' HD11 ' A' ' 290' ' ' LEU . 48.5 p-10 -50.11 -25.93 3.98 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.909 -171.203 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -75.78 -45.89 33.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.858 -178.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' GLY . . . . . 0.426 ' HA3' ' O ' ' A' ' 283' ' ' TYR . . . -73.71 -49.71 13.42 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.517 -169.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' LEU . . . . . 0.646 HD21 ' CD2' ' A' ' 304' ' ' LEU . 0.7 OUTLIER -73.06 -23.64 60.59 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.715 0.293 . . . . 0.0 110.877 -177.841 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' GLU . . . . . 0.516 ' N ' HD12 ' A' ' 290' ' ' LEU . 87.7 tt0 -68.71 -40.08 80.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.897 171.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.95 78.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.15 -179.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' VAL . . . . . 0.672 HG13 ' HA3' ' A' ' 19' ' ' GLY . 39.9 t -77.89 -44.57 28.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.103 -179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' ASN . . . . . . . . . . . . . 35.8 t30 -62.92 -29.66 70.95 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.923 177.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -62.01 -27.77 69.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 -178.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' ASP . . . . . . . . . . . . . 65.6 m-20 -89.16 -36.77 15.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.819 -177.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' LYS . . . . . 0.423 ' O ' HD13 ' A' ' 299' ' ' LEU . 85.9 tttt -152.84 138.35 11.57 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-O 121.638 0.732 . . . . 0.0 110.864 175.191 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -51.78 112.72 0.9 Allowed 'Trans proline' 0 C--O 1.233 0.269 0 C-N-CA 122.694 2.263 . . . . 0.0 112.329 175.279 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' LEU . . . . . 0.423 HD13 ' O ' ' A' ' 297' ' ' LYS . 0.1 OUTLIER -88.98 -20.36 24.55 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.871 178.059 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 301' ' ' ALA . . . 102.18 -41.2 2.19 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.785 -0.722 . . . . 0.0 112.573 177.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' ALA . . . . . 0.45 ' HB2' ' O ' ' A' ' 300' ' ' GLY . . . -179.86 175.92 0.79 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.884 0.373 . . . . 0.0 111.069 171.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' VAL . . . . . 0.621 ' CG2' ' HB3' ' A' ' 307' ' ' TYR . 22.3 m -135.85 160.06 39.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.136 162.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' ALA . . . . . . . . . . . . . . . -73.27 -14.2 61.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.07 178.172 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' LEU . . . . . 0.646 ' CD2' HD21 ' A' ' 290' ' ' LEU . 60.4 tp -77.07 128.69 34.91 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.886 -173.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -41.88 -33.22 0.5 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.875 -177.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' SER . . . . . 0.432 ' H ' ' HG ' ' A' ' 304' ' ' LEU . 48.0 t -46.86 -38.66 10.69 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.866 176.256 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' TYR . . . . . 0.621 ' HB3' ' CG2' ' A' ' 302' ' ' VAL . 0.2 OUTLIER -57.36 -44.18 84.14 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.882 175.313 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' GLU . . . . . 0.472 ' N ' ' CG ' ' A' ' 307' ' ' TYR . 88.7 tt0 -56.92 -39.99 75.51 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.786 -179.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -80.01 -64.55 1.16 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.829 -174.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 73.0 mm-40 -85.81 -57.84 2.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.88 -171.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' LEU . . . . . 0.609 ' HB3' HD13 ' A' ' 317' ' ' ILE . 34.3 mt -59.34 -34.77 72.77 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.853 -169.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 318' ' ' ALA . . . -59.66 -18.19 39.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.101 -176.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -65.02 -23.01 67.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.767 -177.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' ASP . . . . . 0.585 ' HB3' HD12 ' A' ' 317' ' ' ILE . 59.9 t0 -86.44 125.7 66.75 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-O 121.442 0.639 . . . . 0.0 110.876 173.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_exo -49.23 -30.85 20.48 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.564 2.176 . . . . 0.0 112.334 -178.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' ARG . . . . . . . . . . . . . 93.3 mtm-85 -65.11 -32.16 73.72 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.851 -179.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' ILE . . . . . 0.609 HD13 ' HB3' ' A' ' 311' ' ' LEU . 6.9 mt -94.88 -36.07 6.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.082 -178.278 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 312' ' ' ALA . . . -53.82 -43.43 69.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.085 -174.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' ALA . . . . . 0.526 ' HB2' HG22 ' A' ' 244' ' ' VAL . . . -66.96 -44.62 80.07 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.091 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' THR . . . . . . . . . . . . . 64.2 p -64.7 -25.58 68.0 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.097 -178.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' MET . . . . . . . . . . . . . 65.8 ttp -62.61 -38.6 90.82 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.911 173.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -66.82 -36.86 83.34 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.789 -177.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' ASN . . . . . 0.444 ' O ' ' N ' ' A' ' 327' ' ' GLY . 63.7 t30 -78.88 -38.66 37.16 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.906 178.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' ALA . . . . . 0.478 ' HA ' HG21 ' A' ' 259' ' ' VAL . . . -64.92 -46.89 79.76 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.057 -175.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -70.36 -33.44 71.44 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.935 -177.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' LYS . . . . . . . . . . . . . 97.9 mttt -98.66 -4.17 34.37 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.906 -177.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' GLY . . . . . 0.444 ' N ' ' O ' ' A' ' 323' ' ' ASN . . . -103.36 -160.2 25.13 Favored Glycine 0 N--CA 1.452 -0.235 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.443 -174.2 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' GLU . . . . . 0.648 ' HB3' ' HG3' ' A' ' 331' ' ' PRO . 94.8 mt-10 -143.41 139.32 29.91 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.841 0.353 . . . . 0.0 110.837 -173.118 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' ILE . . . . . 0.582 ' O ' ' C ' ' A' ' 330' ' ' MET . 43.8 mm -82.35 112.33 20.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.097 -0.502 . . . . 0.0 111.189 -171.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' MET . . . . . 0.582 ' C ' ' O ' ' A' ' 329' ' ' ILE . 74.1 mtm 23.69 56.96 0.31 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.653 0.739 . . . . 0.0 110.892 175.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' PRO . . . . . 0.648 ' HG3' ' HB3' ' A' ' 328' ' ' GLU . 45.0 Cg_endo -93.14 -8.75 2.23 Favored 'Trans proline' 0 C--N 1.343 0.238 0 C-N-CA 122.596 2.197 . . . . 0.0 112.287 -173.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' ASN . . . . . 0.552 ' O ' ' HB ' ' A' ' 333' ' ' ILE . 8.5 t-20 -98.0 11.42 37.6 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.84 -160.019 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' ILE . . . . . 0.616 HG22 ' H ' ' A' ' 335' ' ' GLN . 50.1 mm 86.38 132.34 0.04 OUTLIER Pre-proline 0 C--N 1.329 -0.286 0 CA-C-O 121.69 0.757 . . . . 0.0 111.055 164.785 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -59.41 -24.83 76.31 Favored 'Trans proline' 0 C--O 1.231 0.147 0 C-N-CA 122.662 2.241 . . . . 0.0 112.371 -176.06 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' GLN . . . . . 0.616 ' H ' HG22 ' A' ' 333' ' ' ILE . 99.2 mm-40 -61.93 -17.54 57.18 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.96 174.74 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' MET . . . . . . . . . . . . . 26.3 ptt? -57.57 -27.23 62.5 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.939 -173.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' SER . . . . . . . . . . . . . 74.9 m -61.75 -35.97 79.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.852 179.75 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 338' ' ' ALA . . . . . . . . . . . . . . . -73.34 -37.25 66.18 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.111 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 339' ' ' PHE . . . . . 0.437 ' HA ' HG12 ' A' ' 368' ' ' ILE . 35.4 m-85 -63.9 -49.02 74.34 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.8 174.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 340' ' ' TRP . . . . . . . . . . . . . 43.0 m0 -64.89 -36.8 85.54 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.988 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 341' ' ' TYR . . . . . . . . . . . . . 92.2 t80 -68.72 -47.23 66.88 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.926 178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 342' ' ' ALA . . . . . . . . . . . . . . . -60.78 -39.71 89.85 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.106 -178.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 343' ' ' VAL . . . . . 0.444 ' O ' ' HB3' ' A' ' 346' ' ' ALA . 13.9 m -80.6 -23.48 11.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.217 179.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 344' ' ' ARG . . . . . 0.52 ' O ' HG22 ' A' ' 347' ' ' VAL . 3.0 tmt_? -62.37 -47.39 84.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.861 174.288 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 345' ' ' THR . . . . . . . . . . . . . 81.4 p -60.85 -26.69 67.55 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.148 177.062 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 346' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 364' ' ' ALA . . . -62.06 -41.91 98.64 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.044 178.901 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 347' ' ' VAL . . . . . 0.593 ' HA ' HD11 ' A' ' 192' ' ' LEU . 1.2 m -72.68 -32.83 42.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.072 -175.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 348' ' ' ILE . . . . . . . . . . . . . 1.6 mp -63.94 -45.97 95.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.194 172.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 349' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 -63.8 -35.45 80.65 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.819 -179.436 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 350' ' ' ALA . . . . . . . . . . . . . . . -71.65 -45.76 61.05 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.096 177.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 351' ' ' ALA . . . . . . . . . . . . . . . -66.62 -41.0 89.04 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.185 -175.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 352' ' ' SER . . . . . . . . . . . . . 98.5 p -75.7 -9.99 59.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.947 -177.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 353' ' ' GLY . . . . . . . . . . . . . . . 77.72 16.6 79.91 Favored Glycine 0 C--N 1.332 0.322 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.558 -179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 354' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -79.84 -32.77 40.57 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.719 0.295 . . . . 0.0 110.848 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 355' ' ' GLN . . . . . . . . . . . . . 78.6 mm-40 -138.11 154.76 49.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.003 0.43 . . . . 0.0 110.861 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 356' ' ' THR . . . . . . . . . . . . . 44.8 p -79.66 167.42 20.7 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.217 168.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 357' ' ' VAL . . . . . 0.463 ' HA ' HD23 ' A' ' 192' ' ' LEU . 55.1 t -54.72 -41.94 58.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.061 173.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 358' ' ' ASP . . . . . . . . . . . . . 91.5 m-20 -59.66 -45.76 91.07 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.858 178.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 359' ' ' GLU . . . . . . . . . . . . . 75.8 mm-40 -72.55 -52.84 13.86 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.898 179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 360' ' ' ALA . . . . . . . . . . . . . . . -68.2 -43.64 77.62 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.053 -171.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 361' ' ' LEU . . . . . 0.637 HD11 ' HB3' ' A' ' 188' ' ' ALA . 0.8 OUTLIER -67.52 -40.91 85.12 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.886 -178.471 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 362' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -64.9 -39.83 94.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.936 173.405 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 363' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -63.09 -38.53 91.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.841 178.85 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 364' ' ' ALA . . . . . 0.536 ' HB2' ' HB2' ' A' ' 346' ' ' ALA . . . -63.58 -42.5 98.28 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.083 174.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 365' ' ' GLN . . . . . 0.449 ' HG3' ' HB3' ' A' ' 184' ' ' ASP . 23.1 tm0? -64.27 -36.79 85.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.855 177.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 366' ' ' THR . . . . . 0.414 ' O ' ' N ' ' A' ' 370' ' ' LYS . 92.2 m -66.06 -40.22 90.72 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.165 176.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 367' ' ' ARG . . . . . . . . . . . . . 79.8 mtt-85 -67.59 -35.06 78.28 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.833 178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 368' ' ' ILE . . . . . 0.563 ' CD1' HG21 ' A' ' 183' ' ' VAL . 68.3 mt -62.71 -40.88 90.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.061 175.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 369' ' ' THR . . . . . . . . . . . . . 82.3 p -94.68 -10.53 31.49 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.078 -177.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 370' ' ' LYS . . . . . 0.414 ' N ' ' O ' ' A' ' 366' ' ' THR . 99.5 mttt . . . . . 0 C--N 1.328 -0.347 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.927 179.292 . . . . . . . . 1 1 . 1 stop_ save_